Table of conTenTs Welcome address II about GasTRo 2009, UeGW ...

Welcome address II
about GasTRo 2009,
UeGW/WcoG, london IV
about UeGf, WGo, oMeD, bsG VI
acknowledgements XIV
congress Information XVII
scientific Information XXVI
scientific Programme XXXI
Young clinicians Programme 1
Postgraduate Teaching
Programme 5
Programme per Day
■ Monday, November 23, 2009 16
■ Tuesday, November 24, 2009 36
■ Wednesday, November 25, 2009 62
lunch sessions per Day 85
Poster sessions per Day
■ Monday, November 23, 2009 90
■ Tuesday, November 24, 2009 156
■ Wednesday, November 25, 2009 222
Table of conTenTs
Working Party Reports 291
esGe/oMeD learning area 296
Ultrasound learning area 298
common Interest Group Meetings 301
business Meetings and
Press conferences 311
satellite symposia and
breakfast Meetings 315
GI nurses 2009 esGena/sIGnea 321
fun Run 342
Public Health Day 344
supporting Programme 345
list of Reviewers 357
Index of authors 365
list of exhibitors 485
Plans of excel london 489
I

WelcoMe aDDRess
Juan-R. Malagelada
President, UEGF
Eamonn M.M. Quigley
President, WGO
II
Word of Welcome
The United European Gastroenterology Federation (UEGF) and
the World Gastroenterology Organization (WGO) have joined
forces to launch a truly unique event, GASTRO 2009 UEGW/
WCOG, to be held in London in November 2009. This landmark
congress blends the annual United European Gastroenterology
Week 2009 and the World Congresses of Gastroenterology,
the latter having been due to be held in Europe this year.
Two additional major organizations, the World Organisation of
Digestive Endoscopy (OMED) and the British Society of Gastroenterology
(BSG), are also participating to accomplish a model
partnership that will bring you the very latest and best on every
aspect of gastroenterology from every corner of the globe.
GASTRO 2009 UEGW/WCOG, London provides gastroenterologists
(adult and paediatric), endoscopists and digestive surgeons
from all continents with the most up-to-date information on all
of the clinical issues that confront them on a daily basis and in a
global context.
The GASTRO 2009 Programme Committee, which incorporates
the UEGF Scientific Committee and members from all partner
societies of GASTRO 2009, UEGW/WCOG, London has developed
a stellar educational programme that will ensure high standards
and accredited continuing medical education for attendees.
Juan-R. Malagelada
President, UEGF
Eamonn M.M. Quigley
President, WGO

Anthony T. R. Axon
President, OMED
Chris J. Hawkey
President, BSG
Anthony T. R. Axon
President, OMED
WelcoMe aDDRess
The Programme Committee guarantees the scientific quality
of the original programme through the rigorous peer review of
communications which have been submitted from major clinical
and basic science groups throughout the world.
As at previous World Congresses, Working Party Reports will
provide definitive statements on challenging and controversial
areas in gastroenterology. This unique collaboration will also
provide an opportunity for those who care for patients with digestive
disorders throughout the world to come together in one
of the world’s major cities to exchange ideas and experiences,
renew old acquaintances and make new friends; London, one of
the great capitals of the world, is an ideal location for such a truly
international gathering.
GASTRO 2009 UEGW/WCOG, London will be truly special and an
event that anyone involved in our area of medicine and medical
science cannot afford to miss. We look forward to seeing you and
welcoming you in London.
Chris J. Hawkey
President, BSG
III

aboUT GasTRo 2009 UeGW/WcoG, lonDon
For the first time in the history of gastroenterology, an international conference will take
place which joins together the forces of four pre-eminent organisations:
GASTRO 2009, UEGW/WCOG, London.
The United European Gastroenterology Federation (UEGF) and the World Gastroenterology
Organisation (WGO), together with the World Organisation of Digestive Endoscopy (OMED)
and the British Society of Gastroenterology (BSG), are jointly organising a landmark meeting
in London from November 21 – 25, 2009. This collaboration will ensure the perfect balance
of basic science and clinical practice, will cover all disciplines in gastroenterology (endoscopy,
digestive oncology, nutrition, digestive surgery, hepatology, gastroenterology) and
ensure a truly global context; all presented in the exciting setting of the city of London.
Attendance is expected to reach record heights as participants are provided with a compact
“all-in-one” programme merging the best of several GI meetings. Faculty and participants
from all corners of the earth will merge to provide a truly global environment conducive
to the exchange of ideas and the forming of friendships and collaborations.
sTeeRInG coMMITTee
UEGF representatives
Christoph Beglinger, Switzerland
Dirk Gouma, The Netherlands
Juan-R. Malagelada, Spain
Peter Milla, United Kingdom
WGO representatives
Michael Fried, Switzerland
Douglas LaBrecque, USA
Eamonn Quigley, Ireland
OMED representative
Anthony T. R. Axon, United Kingdom
BSG representative
Christopher J. Hawkey, United Kingdom
Chair Programme Committee
Michael Farthing, United Kingdom
JoInT PUblIc affaIRs coMMITTee
UEGF representatives
Franco Bazzoli, Italy
Miguel Gassull, Spain
Spiros Ladas, Greece
Vincent Lamy, Belgium
Reinhold Stockbrügger, The Netherlands
WGO representatives
Cihan Yurdaydin, Turkey
Greger Lindberg, Sweden
Chair Public Affairs Committee
Colm O’Morain, Ireland
IV
JoInT PRoGRaMMe coMMITTee
UEGF Scientific Committee
Jacques Belghiti, France
Yehuda Chowers, Israel
Guido Costamagna, Italy
Brendan Delaney, United Kingdom
Michel Delvaux, France
Alexander Engel, The Netherlands
Abe Fingerhut, France
Jean Paul Galmiche, France
Mark Hull, United Kingdom
Steffen Husby, Denmark
Simon Jackson, United Kingdom
Markus Lerch, Germany
Francis Megraud, France
Massimo Pinzani, Italy
Tania Roskams, Belgium
Jan van Lanschot, The Netherlands
Severine Vermeire, Belgium
WGO representatives
Hein Gooszen, The Netherlands
John Moore Vierling, USA
Fergus Shanahan, Ireland
OMED representative
Jerome D. Waye, USA
BSG representative
John Atherton, United Kingdom
Chair Programme Committee
Michael Farthing, United Kingdom

InVITaTIon
GASTRO 2009 UEGW/WCOG, London
aboUT GasTRo 2009 UeGW/WcoG, lonDon
oPenInG ceReMonY/WelcoMe RecePTIon – “THe WoRlD of lonDon”
Sunday, November 22, 2009
19:30 – 22:00 at the congress venue
The four host societies of GASTRO 2009
UEGW/WCOG, London (UEGF/WGO/
OMED/BSG) and Visit London are delighted
to welcome all congress officials and
delegates to the “World of London”.
GASTRO 2009 UEGW/WCOG, London is
the largest ever medical congress to come
to London.
To celebrate this unique event, be our
guest at the Opening Ceremony and Welcome
Reception at ExCeL London (the official
congress venue).
We don’t want to reveal too much, as that
might spoil the surprise. Suffice it to say
that the Opening Ceremony will be show-
casing the multicultural city and incorporating
all that this city is famous for – history,
tradition, pomp and ceremony, modern
dance, music and world-class theatre.
Following the official opening, you will
have the opportunity to mingle and network
with your colleagues, friends and
peers and to enjoy some typical London
hospitality.
Entertainment from the “World of
London” will give you a first taste of
the City’s famous icons and culture.
Come and join us, when London
welcomes the World!
V

aboUT UeGf, WGo, oMeD, bsG
VI
United European Gastroenterology Federation (UEGF)
The United European Gastroenterology Federation (UEGF) is a professional
medical non-profit organisation comprising all of the major European societies
with an interest in disease of the digestive system, including the
oesophagus, stomach, liver, gallbladder, pancreas, intestine and bowel.
The European societies that make up the Federation include medicine,
surgery, paediatrics and endoscopy. UEGF is the most comprehensive
organisation of this kind in the world and the affiliated societies represent
over 22,000 European specialists.
www.uegf.org
World Gastroenterology Organisation (WGO)
WGO is a federation of over 100 national and regional gastroenterology
societies, representing over 50,000 gastroenterologists. Its mission is to
promote, to the general public and healthcare professionals, an awareness
of the worldwide prevalence and optimal care of digestive disorders
through the provision of high quality, accessible and independent
education and training.
WGO educational initiatives include international Training Centers,
Train-the-Trainer programmes, World Digestive Health Day and a Global
Guidelines Library.
www.worldgastroenterology.org
World Organisation of Digestive Endoscopy (OMED)
The World Organisation of Digestive Endoscopy (Organisation Mondiale
d’Endoscopie Digestive), OMED, is a non-profit world federation of
national digestive endoscopy societies. Member societies are affiliated
to and represented by three geographical zones: Asian-Pacific (APSDE),
European/ Mediterranean (ESGE) and Inter-American (SIED). Societies
falling outside these zones are independent members.
Through the support of the geographic zones, member societies and
industry partners, OMED’s mission is the worldwide promotion of the
study and advancement of digestive endoscopy.
www.omed.org
British Society of Gastroenterology (BSG)
The British Society of Gastroenterology (BSG) exists to maintain and
promote high standards of patient care in gastroenterology and to enhance
the capacity of its members to discover and apply new knowledge
to benefit patients with digestive disorders.
Founded in 1937, the BSG has over three thousand members drawn
from the ranks of physicians, surgeons, pathologists, radiologists, scientists,
nurses, dietitians, and others.
www.bsg.org.uk
GasTRo 2009 HosT socIeTY booTHs
Information on each of the 4 Host Societies can be obtained at the booths located within
Hall N1/2 of ExCeL London, next to the registration area. The United European Gastroenterology
Federation (UEGF), the World Gastroenterology Organisation (WGO), the World
Organisation of Digestive Endoscopy (OMED) and the British Society of Gastroenterology
(BSG) look forward to welcoming you there!

Professor Guido Tytgat,
The Netherlands
Professor
Jean Frédéric Colombel,
Lille, France
UeGf lIfeTIMe acHIeVeMenT aWaRD & UeGf ReseaRcH PRIZe
UeGf lIfeTIMe acHIeVeMenT aWaRD
UEGF Council is delighted to announce that the UEGF Lifetime
Achievement Award 2009 will be presented to Professor Guido
Tytgat, The Netherlands. UEGF Council felt that his clinical and
scientific leadership, pioneering and innovative contributions
are widely acknowledged throughout the gastroenterological
community and that Prof. Tytgat inspired many to promote the
growth and development of European Gastroenterology. The
Award will be formally presented by the UEGF President, Juan
R. Malagelada during the Plenary Session on Monday November
23, 2009 on the occasion of GASTRO 2009 UEGW/WCOG,
London (08:00 in hall S1/2/3 at the ExCel, London).
The call for nominations for the UEGF Lifetime Achievement
Award 2010 will be circulated in October 2009.
UeGf ReseaRcH PRIZe 2009
It is with great pleasure that we announce that Professor Jean
Frédéric Colombel (Hopital Claude Huriez, Lille) one of the leading
scientists in the international area of Inflammatory Bowel Disease,
has been awarded this year’s UEGF Research Prize. The prize
of 100,000 EUR will be awarded for excellence in basic science,
translational or clinical research within the specialty and will
be presented during the Plenary Session of the GASTRO 2009,
UEGW/WCOG, London on November 23, 2009.
Professor Colombel submitted a project on ‘Observing Relatives,
Immunity, Genetics and the mIcrobiome before the onset of
Crohn’s disease; A multidisciplinary study to evaluate microbial,
environmental and genetic interactions in the origin of Crohn’s
disease. He said that … ‘the project is extremely ambitious, since it
endeavours to identify the causal factors of Crohn’s disease. It aims to
identify the microbial, genetic and environmental interactions that
precede the onset of disease in a very large group of predisposed first
degree relatives. Identifying such factors is necessary for the prevention
of this increasingly common, chronic and debilitating condition. He
hopes that such projects will stimulate the interest of young gastroenterologists
in inflammatory bowel disease …’
The UEGF Scientific Committee selected Professor Colombel as
prize winner out of a large number of extremely strong applicants
and encouraged unsuccessful applicants to consider submitting
a further application in the future.
UEGF
2009
REsEaRch PRizE
★
Call for 2010 Research
prize will be published
in October 2009 at
www.uegf.org.
VII

UNITED UNITED EUROPEAN
EUROPEAN
GASTROENTEROLOGY
FEDERATION
About UEGF – the voice of European Gastroenterology
UEGF is the most comprehensive European Gastroenterological organization and its federated structure
incorporates professional societies with the scope from general gastroenterological medicine, surgery and
endoscopy to focused organ-oriented and special interest associations. To manage and promote the UEGF
mission and goals UEGF has set up an effi cient organizational structure:
Council and Executive Committee – the managing and operating body to run the Federation’s business
Juan-R. Malagelada, Spain UEGF President
Rolf Hultcrantz, Sweden UEGF President Elect
Christoph Beglinger, Switzerland UEGF Secretary General
Peter Milla, United Kingdom UEGF Treasurer
Michael Farthing, United Kingdom UEGF Scientifi c Committee Chair
Lars Lundell, Sweden UEGF Education Programme Committee Chair
Colm O’Morain, Ireland UEGF Public Affairs Committee Chair
Michael Trauner, Austria UEGF Block Representative Liver
Horst Neuhaus, Germany UEGF Block Representative Endoscopy
Franco Bazzoli, Italy UEGF Block Representative General Gastroenterology
Christos Dervenis, Greece UEGF Block Representative Surgery
Dirk Gouma, The Netherlands UEGF Independent Councillor
General Assembly – is the highest authority of the Federation and is composed of the delegates of the
member organizations and 20 European regional members.
Scientifi c Committee – the administrative body to develop the scientifi c core programme of UEGW
Education Committee – the administrative body to initiate and support high-quality educational training
Public Affairs Committee – the administrative body to promote the specialty at a public and political level
UEGF Secretariat – based in Vienna to support all UEGF boards and their activities.
Phone: +43-1-997 16 39 · Fax: +43-1-997 16 39-10
Email: offi ce@uegf.org · Url: www.uegf.org
Founding Members: ASNEMGE * EAGE * EASL * EPC * ESGE * ESPGHAN * ISDS
Associate Members: EAES * ECCO * EDS * EHSG * ESCP * ESGAR * ESNM * ESPCG
VIII

ABOUT UEGF – THE VOICE OF
EUROPEAN GASTROENTEROLOGY
About UEGW
The United European Gastroenterology Week (UEGW) has become the largest und most prestigious GI
meeting in Europe attracting 12.000 physicians, researchers and academics from around the world who
desire to stay up-to-date in their respective fi elds.
Mark your calendars:
18th UEGW, 23 – 27 October, 2010 – Barcelona
19th UEGW, 22 – 26 October, 2011 – Stockholm
UEGF – A partner in Europe and beyond
With the support of a professional Public Affairs agency in Brussels, the UEGF Public Affairs Committee
has taken steps towards active lobbying for gastroenterology on a European level. UEGF wishes to raise
awareness for digestive diseases among the public, the political decision makers and regulatory authorities
at the EU level and other stakeholders. The objective is to strategically position itself toward the
EU decision-making bodies in order to prioritise gastroenterology issues on the EU and national policy
agenda. Visit the new section at the website to learn more on EU News, EU Funding and other activities.
UEGF Awards & Grants
UEGF annually awards the Research Prize (100,000 EUR) for excellence in basic science, translational
or clinical research. The Lifetime Achievement Award recognizes outstanding individuals whose
pioneering and inventiveness throughout their careers have improved Gastroenterology as well as the
Federation and inspired others. Travel grants and Best Poster Awards are offered for best submitted
abstracts to UEGW. International Scholarships support young colleagues of less developed countries
to attend the UEGW.
UEGF supports Education in Europe
Apart from the UEGW the Education Committee initiates further post-graduate courses, basic science
workshops and supports high-quality education to enhance scientifi c knowledge. Members and interested
professionals are invited to apply online.
www.uegf.org
IX

WGo – WoRlD GasTRoenTeRoloGY oRGanIsaTIon
– Promoting Global Digestive Health
World
GastroenteroloGy
orGanisation
The World Gastroenterology Organisation (WGO) is a global federation
of 110 national and regional gastroenterology societies, representing
over 50,000 gastroenterologists.
The WGO mission is:
to promote, to the general
public and healthcare
professionals, an awareness
of the worldwide prevalence
and optimal care of digestive
disorders through the
provision of high quality,
accessible and independent
education and training.
World GastroenteroloGy orGanisation
X
The WGO Executive and Governing Council are responsible
for the general management of the organization and are
accountable to the General Assembly.
WGO Governing Council (2005-2009)
• Eamonn Quigley, Ireland President
• Guido Tytgat, Netherlands Past President/
IDCA Representative
• Bernard Levin, USA Chair
WGO Foundation Board
• Michael Farthing, England Vice-President
• Henry Cohen, Uruguay Secretary General
• David Bjorkman, USA Treasurer
• Richard Kozarek, USA Coordinator
New Projects
• Michael Fried, Switzerland Chair Global Guidelines
and Publications Committee
• James Toouli, Australia Coordinator
Education and Training
• Kwong Ming Fock, Singapore President APAGE
• Franco Bazzoli, Italy President ASNEMGE
• Herbie Schneider, South Africa President AMAGE
• Carlos Ledesma, Ecuador President AIGE

In creating the WGO Training Centers, our
focus has been on the developing world
and, in particular, on areas where access to
high-quality training in gastroenterology
remains problematic.
The WGO Outreach Program connects
equipment manufacturers with both WGO
Training Centers and the home institutions
of WGO Trainees.
The WGO Guidelines Library contains
twenty practice guidelines written from a
viewpoint of global applicability using
a unique cascade approach. To ensure
global accessibility, each WGO guideline
is made available in English, Spanish,
Portuguese, Mandarin, Russian and French.
The WGO Graded Evidence and The Ask
a Librarian services are further features of
the Guidelines library.
In creating the Train the Trainers
workshops WGO has developed a forum
for interaction between world leaders in
education, to hone their educational skills,
share educational experiences and discuss
common teaching challenges.
As an official division of the WGO, the
International Digestive Cancer Alliance
For more information on WGO, its activities
and programmes, please visit:
www.worldgastroenterology.org
WGo – WoRlD GasTRoenTeRoloGY oRGanIsaTIon
ProGrammes and
activities
WGO focuses on promoting global
digestive health and equality in education
through educational initiatives.
(IDCA) has a global mission to promote
awareness, screening, early detection,
primary prevention and treatment of
digestive cancers.
Every 29th May, WGO celebrates World
Digestive Health Day (WDHD) and
initiates a worldwide public health
campaign through its national societies
and members. In 2010 WGO will
concentrate its efforts in educating the
general public and gastroenterologists
alike about Inflammatory Bowel Disease
(IBD). Looking ahead at 2010, WGO
invites all national societies and other
WDHD partners to join us in raising IBD
awareness to a new level.
During GASTRO 2009 UEGW / WCOG,
London we envision promoting further the
global WGO mission and working together
with the other host societies in organizing
a unique landmark congress that will
set the standard for future clinical and
scientific meetings in gastroenterology.
The WGO Foundation, incorporated in
2007, is dedicated to raising funds to
support WGO educational programs
and activities. Find out more at: www.
wgofoundation.org
or contact the WGO Executive Secretariat.
Email: info@worldgastroenterology.org
XI

oMeD – WoRlD oRGanIsaTIon of DIGesTIVe enDoscoPY
oMeD – WoRlD oRGanIsaTIon of
DIGesTIVe enDoscoPY (oRGanIsaTIon
MonDIale D‘enDoscoPIe
DIGesTIVe)
OMED’s mission is to promote highquality
endoscopy throughout the world.
Our aims are to encourage the study
and practice of digestive endoscopy, to
establish high standards of performance
and training, and to organize workshops
in endoscopy-related topics either on our
own or in conjunction with other societies.
OMED Endoscopy Directors´ Workshop,
Cairo, 2007
oMeD enDoscoPY DIRecToRs’
WoRksHoPs
One effective way to improve and standardize
practice is to ensure that those responsible
for the management of endoscopy
have the necessary knowledge and
skills to provide a safe and effective service.
This was the stimulus for OMED to set up
the OMED Endoscopy Directors’ Workshops
which are organized jointly with
a national or regional society. Utilizing a
combined faculty, we cover the essentials
of endoscopy management. The meetings
are small (40 to 80 participants) and informal,
active participation with the audience
is encouraged.
XII
oMeD aDVanceD DIaGnosTIc
enDoscoPY coURses
Rapid advances in technology have provided
endoscopists with sophisticated
equipment that is not always used to its
best advantage. We have therefore taken
a practical initiative by setting up a series
of OMED Advanced Diagnostic Endoscopy
Courses that teach the general endoscopist
how to use modern equipment
and gain the most from it. These courses
cover recent technical advances, focusing
on narrow band imaging, high definition
and fluorescence endoscopy. Courses
have been held in Delhi (India), Dubai
(UAE), Cairo (Egypt), and Taipei (Taiwan).
oMeD cenTeRs of eXcellence
OMED is proud to be closely associated
with an elite group of seventeen
endoscopic centers that have established
outstanding reputations for delivering
international education in the field of
digestive endoscopy. The OMED Centers
of Excellence make an important contribution
to endoscopic education worldwide.
We are grateful to the colleagues in
charge of these units and to those who
work in them for the support that they
have given to OMED not only in teaching
but also by contributing to meetings and
workshops and by assisting with our publications
on clinical practice.
oMeD´s acTIVITIes
aRoUnD THe WoRlD
● OMED Endoscopy Directors´
Workshops
● OMED Centers of Excellence
● OMED Advanced Diagnostic
Endocopy Courses
● ICE2011

oMeD – WoRlD oRGanIsaTIon of DIGesTIVe enDoscoPY
oMeD PUblIcaTIons
It is often difficult to access up-to-date
practical manuals on how to perform
a specific endoscopic procedure. The
OMED “How I do it” series, published on
the OMED website, provides this service.
World leaders in each subject give an indepth,
didactic description of the way they
perform a challenging endoscopic procedure.
Two further international experts
comment on the technique and provide
a summary. This series presents personal
guidelines which will help every endoscopist
engaged in performing these endoscopic
techniques.
OMED has worked closely with other organizations
in holding a number of symposia
and workshops that have led to the development
of publications relating to clinical
practice. This material and other OMED
endeavors may be viewed on the OMED
website at www.omed.org.
THe neW QUaDRennIUM
OMED anticipates many activities for the
coming four years which will be presided
over by our new President, Jerome
D. Waye, supported by a new Council
and Executive. Projects that have been
successful will continue. We look forward
to greater emphasis on practical endoscopy
training by setting up small, intensive
courses to teach the fundamentals of
endoscopic teaching.
The International Congress of Endoscopy
(ICE2011) will be held in Los Angeles
in September 2011 to celebrate the
50th anniversary of the coming together
of an International Organization of Endoscopy
separate from gastroenterology. Its
goal is to bring together the medical and
surgical societies of endoscopy in mutual
cooperation to address the present and
future needs of our sub-specialty. The
educational program will be of the highest
quality, and stimulate new formats for
the future.
There has never before been such a prolonged
and widespread period of growth
in digestive endoscopy. OMED looks forward
to the next quadrennium with confidence.
We hope that the biomedical
industry will continue to innovate, that
endoscopists will remain adventurous and
that our patients will reap the benefit.
XIII

acknoWleDGeMenTs
GASTRO 2009 UEGW/WCOG, London gratefully acknowledges the support of the following
companies:
(as per September 2009)
AstraZeneca
Olympus
Schering-Plough
XIV
PReMIUM PaRTneR
Abbott
MaJoR sPonsoR
Fujinon (Europe) GmbH
Pentax Europe GmbH
Visit London

GeneRal sPonsoRs
a
Actial Pharmaceutica Lda
AIGE – Interamerican Association of
Gastro enterology
Alfa Wassermann SpA
Alton (Shanghai) Medical
Instruments Co., Ltd.
APDW 2010 & Malaysian Society of
Gastroenterology and Hepatology
APSDE – The Asian-Pacific Society for
Digestive Endoscopy
ASGE – American Society for
Gastro intestinal Endoscopy
Avantis Medical Systems, Inc.
Axcan Pharma S.A.
b
Barrx Medical
Bedfont Scientific Ltd.
Belimed AG
Biocodex
Biohit Oyj
BioMed Central
BMJ Group
Boston Scientific
Bracco Diagnostics Inc.
BRACCO International B.V.
BSG – British Society of Gastroenterology
Bühlmann Laboratories AG
c
Calpro AS
Casen Fleet S.L.U.
CBC (Deutschland) GmbH
Chonqqing Jinshan Science & Technology
Inc. Beijing Office
Coeliac UK
Conmed UK
Cook Medical
Custom Ultrasonics
D
DANONE (c/o Allidura)
DDW – Digestive Disease Week
Dr. Falk Pharma GmbH
acknoWleDGeMenTs
e
EASL – European Association for the
Study of the Liver
ECCO – European Crohn‘s and Colitis
Organisation
EDS – European Digestive Surgery
EFCCA – European Federation of
Crohn's & Ulcerative Colitis Association
EGYPT GASTRO HEP
Eisai Europe Ltd. & Janssen-Cilag
ELLA-CS, s.r.o.
Elsevier
EndoChoice
Endo-Flex GmbH
Endoscopy UK Limited
Endosoft BV
EPC – European Pancreatic Club
Epigenomics
ERBE Elektromedizin GmbH
ESGE – European Society of Gastrointestinal
Endoscopy
ESNM – European Society of
Neurogastroenterology and Motility
ESPCG – European Society of Coloproctology
EUMEDICA
Euroimmun AG
Europacolon
f
Ferring Pharmaceuticals
Fresenius Kabi Deutschland GmbH
G
GE Healthcare
GI Health Foundation
Given Imaging
Glaxosmithkline
H
Hitachi Medical Systems Europe Holding AG
I
Imedex – WCGI – World Congress of
GI Cancer
Immersion
Immundiagnostik AG
Infai GmbH
Institut Rosell – L‘Allemand
IntroMedic
Inverness Medical
XV

acknoWleDGeMenTs
k
KARL STORZ GmbH & Co KG
l
Leufen Medical OHG
Life Partners Europe
Lumenis (Germany) GmbH
M
M.I. Tech Co., Ltd.
Mauna Kea Technologies
Mayoly Spindler
Medical Innovations
Medical Measurement Systems b.v.
Medi-Globe GmbH
Meditheque Bookshop
Medwork medical products and services
GmbH
Micro-Tech (Nanjing) Co., Ltd.
Movetis NV
MTW Endoskopie
n
NDS Surgical Imaging
New Zealand Society of Gastroenterology
NHS Evidence – Gastroenterology and
Liver Diseases
Norgine Limited
Nycomed GmbH
Nycomed GmbH
o
OMED – World Organisation of Digestive
Endoscopy
Omnimed Limited
Otsuka Pharmaceutical Europe Ltd.
Ovesco Endoscopy AG
P
Peter Pflugbeil GmbH
Pharmacosmos A/S
Procter and Gamble Pharmaceuticals UK Ltd.
(as per September, 2009)
XVI
Q
Quintron Instrument Co.
R
Reckitt Benckiser
Rome Foundation
s
S. Karger AG
Sandhill Scientific
Satiety Inc.
Shire Pharmaceuticals Group PLC.
Sierra Scientific Instruments
Spirus Medical Inc.
Sterilox Endoscopy – A division of
PuriCore International Ltd.
T
Taewoong Medical
Takeda Pharmaceuticals International, Inc.
Tillotts Pharma AG
U
UEGF – United European
Gastro enterology Federation
Up to Date
US Endoscopy
V
Vifor Pharma
W
Wagner Analysen Technik GmbH
WGO – World Gastroenterology
Organisation
Wiley-Blackwell
Wisepress Ltd.

CONGRESS
INFORMATION

conGRess InfoRMaTIon
oRGanIseR & GasTRo 2009
conGRess secReTaRIaT anD
eXHIbITIon/sPonsoR offIce
GASTRO 2009 Secretariat
Hollandstrasse 14
1020 Vienna/Austria
Tel: +43-(0)1-212 36 91
Fax: +43-(0)1-212 36 91-29
E-Mail: secretariat@gastro2009.org
URL: www.gastro2009.org
GasTRo 2009 oRGanIsInG
secReTaRIaTs
UEGF Secretariat
Wienerbergstrasse 11/12A
A-1100 Vienna, Austria
Tel.: +43-(1)-997 16 39
Fax: +43-(1)-997 16 39-10
E-Mail: office@uegf.org
URL: www.uegf.org
WGO Secretariat
Bruennsteinstrasse 10
D-81541 Munich, Germany
Tel.: +49-(89)-4141 92 42
Fax: +49-(89)-4141 92 45
E-Mail: info@worldgastroenterology.org
URL: www.worldgastroenterology.org
conGRess VenUe
ExCeL London
One Western Gateway, Royal Victoria Dock
London, E16 1XL/UK
Tel: +44-(0)20-7069 5000
Fax: +44-(0)20-7069 4747
E-Mail: info@excel-london.co.uk
URL: www.excel-london.co.uk
conGRess DocUMenTaTIon
Abstract Book
Registered participants receive a voucher
for their GASTRO 2009 UEGW/WCOG,
London Abstract Book. The voucher is included
in the participants’ documents. The
Abstract Book may be picked up with the
congress bag at the distribution point in
the registration area in Hall N1/2.
XVIII
Abstract CD­ROM
The participants’ documents include a
voucher for the GASTRO 2009 UEGW/
WCOG, London Abstract CD-ROM, which
is kindly supported by AstraZeneca. The
Abstract CD-ROM can be picked up at the
exhibition stand of AstraZeneca, booth
number 60, in the Industry Exhibition Hall.
Best of GASTRO 2009 on DVD
A DVD with 30 hours of the best from GAS-
TRO 2009 UEGW/WCOG, London can be preordered
at the congress. Selected keynote
lectures, plenary sessions and symposia will
be recorded on video and made available after
the event. This will provide an insight into
the most important topics, specially chosen
by the GASTRO 2009 Programme Committee
to represent the best of the congress.
The programme will feature video recordings
of the lectures synchronised with the
slides in a user-friendly interface, giving you
a real feel for the live event. Full navigation
will allow you to skip, pause or move between
sessions. You will be able to watch
part of a lecture and come back to it at a
later time. You will also be able to search for
a session by presenter name, title or subject.
This DVD will be an invaluable resource,
enabling you to remain well informed and
to hear from leading experts at your own
convenience.
The DVD can be ordered at the Highlight
DVD counter in the registration area at
the price of EUR 78 incl. VAT and mailing
costs. Make sure you secure your copy –
you will conveniently receive it via mail
after the congress.
Congress Newspaper
Three issues of GASTRO 2009 NEWS will
be distributed free of charge to all registered
participants during GASTRO 2009
UEGW/WCOG, London. The first edition
will be included in the congress bag.

ReGIsTRaTIon Desk
Opening Hours
Friday 14:00 – 18:00
Saturday 07:30 – 18:00
Sunday 07:30 – 20:00
Monday 07:00 – 18:00
Tuesday 07:00 – 18:00
Wednesday 07:30 – 14:00
naMe baDGes
Participants are requested to wear their
name badge at all times during the congress.
The colours of the name badges
have the following significance:
Green GASTRO 2009
Delegates
Dark blue GASTRO 2009 Faculty,
Officers, Organisers
Brown Press
Red GI Nurses 2009
ESGENA/SIGNEA
Delegates, Faculty
Violet Accompanying
Persons
Grey Exhibitors
Clear Post Graduate
Teaching Programme
Yellow Congress Staff
conGRess baGs
Upon registration, participants will receive
their congress bag in exchange for the
voucher which is included in the participants’
documents. The bag distribution point is located
in the registration area in Hall N1/2.
conGRess InfoRMaTIon
ReGIsTRaTIon fees
Registration Fees (EURO/incl. VAT) for
on­site registration
Delegate EUR 750
Fellow in Training
of GASTRO 2009*
EUR 250
Accompanying Person EUR 90
Lunch Sessions EUR 55
Postgraduate
Teaching Programme
EUR 250
PGT Fellow in Training* EUR 100
ESGENA/SIGNEA Conference** EUR 250
* Applicants must be under 35 years of age
and a certificate from the Supervisor or Head of
Department must be forwarded together with
the registration.
** Copy of nurses‘ professional standing or similar
identification is indispensable for proof of status
(confirmation by employer, proof of education or
registration as nurse in ENGLISH or GERMAN).
The registration fee for GASTRO 2009
UEGW/WCOG, London delegates and
fellows in training includes:
■ Admission to all scientific sessions
■ Admission to poster exhibition and
technical exhibition
■ Admission to the ESGE/OMED
Learning Area
■ Admission to the Ultrasound Learning
Area
■ Oyster Card for 5 days’ use of the public
transportation system in London
■ Congress materials (delegate bag,
final programme, abstract book, etc.)
■ Coffee breaks and lunches
(Monday – Wednesday)
■ Admission to the GASTRO 2009
UEGW/WCOG, London
Opening Ceremony & Welcome
Reception on Sunday, November 22,
2009 in Hall S1/2/3
XIX

conGRess InfoRMaTIon
Registration fee for accompanying
persons includes:
■ Oyster Card for 5 days’ use of the public
transportation system in London
■ Admission to the GASTRO 2009
UEGW/WCOG, London
Opening Ceremony & Welcome
Reception on Sunday, November 22,
2009 in Hall S1/2/3
Registration fee for GI Nurses 2009
Conference includes:
■ Admission to all GI Nurses 2009 scientific
sessions and workshops
■ Admission to the GI Nurses 2009
Welcome Reception on Saturday,
November 21, 2009 in the Platinum
Suite
■ Admission to the GASTRO 2009
UEGW/WCOG, London
Opening Ceremony & Welcome
Reception on Sunday, November 22,
2009 in Hall S1/2/3
■ Admission to the GASTRO 2009
UEGW/WCOG, London scientific
sessions
■ Admission to poster and technical
exhibition
■ Admission to the ESGE/OMED
Learning Area
■ Admission to the Ultrasound Learning
Area
■ Oyster Card for 3 days’ use of public
transportation system in London
■ Congress materials (delegate bag,
final programme, GI Nurses 2009
abstract book, etc.)
■ Coffee breaks and lunches
(Saturday – Monday)
Opening Ceremony & Welcome
Reception
You are cordially invited to join the Welcome
Reception on Sunday, November
22, 2009 at 19:30 in Hall S1/2/3 of the
ExCeL Centre. The ceremony will be followed
by an entertainment programme
and will offer delegates the opportunity
to meet with colleagues from all over the
world.
XX
PReVIeW cenTRe
The Preview Centre is located within the
Platinum Suite on level 2 of ExCeL London.
To get there, please take the escalator in the
Platinum Suite one level up. Speakers are
asked to hand in their Power Point Presentation
on a CD-ROM or USB stick preferably
one day before their speech, but at least
3 hours prior to their presentation.
The presentation will be transferred to the
central congress server and will be available
on a special congress notebook in the
hall of the presentation. For time and technical
reasons, we kindly ask speakers not to
use their own notebooks.
In the Preview Centre, several PC workstations
will give speakers the possibility to
work on their presentation in a quiet environment.
Technical staff will be happy to
assist.
Opening Hours
Friday 14:00 – 18:00
Saturday 07:00 – 18:00
Sunday 07:00 – 18:00
Monday 07:00 – 18:00
Tuesday 07:00 – 18:00
Wednesday 07:00 – 16:00
InTeRneT PoInTs & WIReless lan
Several terminals and wireless LAN areas
will allow easy access to the internet on-site:
Platinum Suite/Level 1: Internet Points
Platinum Suite/Level 2: Wireless LAN Area
Industry Exhibition/Hall N4/5/6: Internet
Points and Wireless LAN Area
PRess cenTRe
The Press Office is located in the South
Gallery in room SG20. It will be open from
Sunday, November 22, 12:00 until Wednesday,
November 25, 2009, 16:00. The daily
opening hours are 08:00 to 18:00. The official
GASTRO 2009 UEGW/WCOG, London
press conferences will take place in room
SG21/22 on Monday, November 23, and
on Tuesday, November 24, 2009 at 12:00.

The Press Centre is managed by the press
agency impressum health & science
communication. The agency’s staff will
be pleased to provide more detailed information
related to press activities during
GASTRO 2009 UEGW/WCOG, London.
PosTeR eXHIbITIon
Posters will be displayed from Monday,
November 23 until Wednesday, November
25, 2009 in Hall S10/11/12. All posters will
be changed daily and will be on display
from 09:00 until 17:00.
Authors of posters are asked to mount
their poster on the relevant congress day
between 08:00 and 09:00 and to remove
it between 17:00 and 18:00. Posters that
have not been removed by 18:00 will be
disposed off.
Attention
All poster presenters are asked to sign up
at the poster information desk between
08:00 and 10:00 on the day of their poster
presentation. The poster information
desk is located in Hall S10/11/12 next to
the poster exhibition.
TecHnIcal eXHIbITIon
A technical exhibition will accompany the
congress and will be located in the Exhibition
Hall N4/5/6. You will find the list of
exhibitors and the floor plans on page 489.
Further information is provided in the Exhibition
Guide, which you will receive with
your congress bag!
GASTRO 2009 UEGW/WCOG, London –
Technical Exhibition
Opening hours
Monday, Nov. 23, 2009 09:00 – 17:00
Tuesday, Nov. 24, 2009 09:00 – 17:00
Wednesday, Nov. 25, 2009 09:00 – 16:00
conGRess InfoRMaTIon
coffee bReaks anD lUncHes
Coffee, tea and biscuits will be served during
the morning and the afternoon coffee
breaks from Monday, November 23
until Wednesday, November 25, 2009 free
of charge to all registered GASTRO 2009
UEGW/WCOG, London participants.
Lunches will be served to registered GASTRO
2009 UEGW/WCOG, London delegates from
Monday, November 23, until Wednesday,
November 25, 2009, from 12:30 until 14:00.
The catering areas are located next to the
technical exhibition in Hall N1/2 and next to
the poster exhibition in Hall S10/11/12.
On Saturday, November 21, and Sunday, November
22, 2009, coffee breaks and lunches
for the Postgraduate Teaching Programme
and the ESGENA/GI Nurses 2009 Conference
are embedded in the programme.
Alternatively, it will be possible to purchase
beverages and snacks at several snack bars
within the ExCeL centre.
conGRess lanGUaGe
The official congress language at GASTRO
2009 UEGW/WCOG, London is English. No
simultaneous translation will be provided.
banks anD aTM's
At ExCeL London you will find Barclays and
HSBC ATMs situated in the Boulevard on
level 1 and on level 0, where all bankcards
are accepted; two HSBC machines are at the
west end of the Boulevard, and one at the
east end of the Boulevard.
The nearest banks are located at Canary
Wharf, which is a short train ride away from
ExCeL London.
cURRencY
The United Kingdom’s monetary system
is based on the Pound Sterling (British
Pound). You can exchange your currency
at most banks as well as at exchange bureaus
in the city. Credit cards are widely
accepted.
XXI

conGRess InfoRMaTIon
At the ExCel centre you have the possibility
to change Euro, US Dollar, Australian
Dollar, Canadian Dollar, Swiss Franc, Japanese
Yen, Nez Zealand Dollar and South
African Rand to British Pound Sterling at
the Business Service Desk on level 0.
bUsIness seRVIce Desk
The business service desk is located centrally
in the Boulevard on Level 0, below
the level of the session halls. The operating
times of this facility will correspond to
the events within the venue. The following
services will be available:
Money exchange, transport services, overseas
courier service, photocopying, fax
services, internet access, printing services
from USB/internet, laminating, mobile
phone charger, stationery, hardware items,
batteries, photographic equipment and
mobile phone Sim cards.
cloakRooM
The main cloakroom is located centrally in
the Boulevard on Level 0 (below the level of
the session halls). The cloakroom is free of
charge for GASTRO 2009 participants. There
is a lift adjacent to Hall N7/8 to access Level
0. Normal operating hours are 30 minutes
before the event opens until 30 minutes after
the event closes. When the cloakroom
has closed, all left luggage and coats will be
taken to the Security Control Room, telephone
+44-(0)020-7069 4445.
Other cloakrooms may be in use; please
follow signs within the Boulevard.
eMeRGencY anD fIRsT aID
ExCeL London will deal with any emergencies
within the venue. There are many
emergency phones within and around the
venue (the number is pre-programmed). If
you need to call from another phone, the
contact numbers are:
In the case of an emergency:
+44-(0)20-7069 4444
For general security inquiries:
+44-(0)20-7069 4445
XXII
The First Aid Room is located on Level 0
below the Boulevard. If you require first
aid, please contact the medical treatment
room at +44-(0)20-7069 5556.
HoTel ReseRVaTIon
Hotel accommodation can be reserved
upon availability at the accommodation
desk in the registration area. The staff will
be pleased to help you.
PUblIc TRansPoRTaTIon
All registered GASTRO 2009 UEGW/WCOG,
London delegates, fellows in training, GI-
Nurses and accompanying persons are
entitled to use transport for London’s (TFL)
Central London Transport system during
the 5 days of the congress.
This travel card (called Oyster card) will be
available for collection at the Oyster Card
Counter in the registration area of ExCeL
London from Friday, November 20 to
Wednesday, November 25, 2009. It has a
total value of GPB 30 and can be used on
London’s central transportation system,
which includes the underground (tube),
Docklands Light Railway (DLR) and buses.
To ensure you get charged the lowest
fares you MUST ALWAYS TOUCH IN AND
OUT on the yellow reader located at each
station entry and exit. The reader at ExCeL
is situated at the top of the stairs/ramp
from the platforms, at the beginning of
the main walkway to the congress centre.
Please note, Oyster cards are not valid on
the Heathrow or Gatwick Express trains, or
overland trains and outside of zones 1 – 3
(see tube map). Visit London is organising
special rates for travel from airports to the
city/ExCeL which will be featured on the
GASTRO 2009 website under Housing &
Travel.
In the interests of sustainable event management
we would be grateful if you
could RETURN THE OYSTER CARD ON
YOUR FINAL DAY to one of the collection
boxes at the congress centre.

6
conGRess InfoRMaTIon
Watford 9 8 7 8
5
Amersham
Croxley
Chorleywood
Rickmansworth
Moor Park
Northwood
4
Northwood Hills
6
Hillingdon Ruislip
Harringay
Ruislip Manor
Green Lanes
5
North Harrow
Eastcote
Harrow-
Preston
on-the-Hill
Road
Rayners Lane
3
West Harrow Northwick
4
Neasden
Park
Wembley
Dollis Hill
Park
Willesden Green
Kilburn
West Hampstead
Finchley Road
Kensal Green
Swiss Cottage
Queen’s Park
St. John’s Wood
Maida Vale
Great
Baker Portland
Street Street
2
Euston
Square
ELW
Moorgate
East
Acton
Ealing
Broadway
West
Acton 54
3 2
1 2 3 4
Aldgate
Ealing Common
ELW
Acton
Town
River Thames
381/N381
Stamford
Brook
Bermondsey
1
2
East London line is closed
for major line extension ELC
Southwark
work to become part of
Waterloo East
King
the London Overground
River Thames
George V
network
ELC
3
Woolwich
Arsenal
4
Ravenscourt
Chesham Chalfont &
Watford Junction is outside
Watford Junction
Cockfosters
Latimer
Transport for London zonal
High Barnet
Epping
area. Special fares apply.
Watford High Street
Oakwood
Theydon Bois
Totteridge & Whetstone
Bushey
Loughton
Southgate
Debden
Woodside Park
Carpenders Park
Edgware
West Finchley
Arnos Grove
Buckhurst Hill
Mill Hill East
Hatch End
Roding
West Ruislip
Burnt
Finchley Central
Valley Chigwell
Headstone Lane
Stanmore
Oak
Bounds Green
Harrow &
Colindale
Wood Green
Wealdstone
Canons Park
East Finchley
Pinner
South
Grange Hill
Turnpike Lane
Uxbridge Ickenham
Kenton
Queensbury Hendon Central
Tottenham
Woodford
Highgate Crouch
Hainault
Kingsbury
Hill
Blackhorse
Brent Cross
Seven Sisters Road
Fairlop
Archway
Manor House
South
Ruislip
Golders Green
Gospel
Woodford
Barkingside
Gardens
Hampstead Oak
Tufnell Park
Tottenham Walthamstow
Hampstead Heath
Upper
Hale
Central
Newbury Park
Holloway
Finsbury
South
South Kenton
Park
Walthamstow Snaresbrook Redbridge
Ruislip
Upminster
North Wembley
Arsenal
Queen’s Road
Finchley Road
Kentish
Upminster
Northolt
South Harrow
Kentish
Wembley Central
& Frognal
Town
Holloway
Wanstead Gants
Bridge
Belsize Park Town West
Road
Stonebridge Park
Leytonstone
Hill
Sudbury Hill
Harlesden
Brondesbury
Chalk Farm
Caledonian Road
Highbury &
Sudbury Hill Harrow
Leyton
Willesden Junction
Park
Canonbury
Leytonstone
(no weekend service) 150m
Camden
Islington
Midland Road
Dagenham Hornchurch
Thameslink 200m from
Dalston
High Road
Greenford
Road
Kingsland
East Elm Park
( no Sunday Sudbury Town
Kensal Rise Brondesbury Camden Town
Caledonian
service)
Wanstead
Road &
Hackney
Leyton
Park
Kilburn South
Mornington
Barnsbury
Central
Alperton
Dagenham
High Road Hampstead
Crescent King’s Cross
Homerton
Woodgrange Park
St. Pancras
Heathway
for St. Pancras International
Becontree
Kilburn Park
Hackney Stratford
Perivale
Edgware
Euston
Angel
Upney
Warwick Avenue
Paddington
Wick
Road
Barking
Royal Oak
Westbourne
Old Street
East Ham
Hanger
Park
Bethnal
Warren Street
( no weekend
service)
Lane
Paddington
Green
Mile End
Pudding
Edgware Marylebone
Farringdon
Upton
Regent’s Park
Mill Lane
Road
Euston 200m
Liverpool
Park
Ladbroke Grove
Russell
Street
Shoreditch
Park Royal
Plaistow
Latimer Road
Bayswater
Square Barbican
Limited service
Check publicity for
Bow Bow Bromley- West Ham
information
North Ealing
White
Holland
Lancaster
Goodge
Chancery
Church Road by-Bow
Notting
Bond Oxford
( no weekend
City
Park
Gate
Street
Lane
service)
Stepney
Hill Gate
Street Circus
Holborn
Green
Devons Road
Aldgate
North
Tottenham
St. Paul’s
Queensway Marble
Whitechapel
Shepherd’s
East
Langdon Park
Acton
Bush
Arch
Court Road
Bank
Wood Lane
Covent Garden
Leicester Square 340m
All Saints
Acton
High Street
Hyde Park Green Park
Cannon
Shadwell
East
Central Shepherd’s
Kensington
Corner
Leicester
Street
Westferry Poplar India Canning Town
Bush Market
Mansion
Royal Victoria
Piccadilly
Square
South
House
Circus
Knightsbridge
Monument Tower
Limehouse
Blackwall
Acton
Kensington
Custom House
Goldhawk Road (Olympia)
Charing
Hill
for ExCeL
Cross
Fenchurch Street 150m Tower
Barons
Gloucester
Blackfriars
Gateway Wapping
West
West
Prince Regent
Hammersmith Court
Road
Sloane St. James’s
Underground station
India Quay
South Ealing
Silvertown
closed until late 2011
Square Park
Royal Albert
Northfields
Temple
Rotherhithe Canary Wharf
London
Boston Manor
Beckton Park
Chiswick
West
South Victoria Westminster
Embankment
Bridge
Canary Wharf
Hounslow
Turnham
Earl’s
Pontoon
Charing Cross 100m
Park
Park Kensington
Cyprus
East
Green
North
Court Kensington
Osterley
Canada
Greenwich
Dock
Gallions
Hounslow
West Brompton
Water
Heron Quays
for The O2
Reach
West Hounslow
Central
Fulham
Waterloo
South Quay
Gunnersbury
Surrey Quays
Broadway
London City
Crossharbour
Airport
Beckton
Hatton
Terminals Cross
Parsons Green
Mudchute
1, 2, 3
Kew Gardens
Putney Bridge
Pimlico
Borough
Island Gardens
Terminal 4
Lambeth
East Putney
North
Richmond
New Cross
Heathrow
Cutty Sark
Gate
for Maritime Greenwich
Terminal 5 Airport
Vauxhall
Southfields
Elephant & Castle
New Cross Greenwich
Kennington
100m
Deptford Bridge
Wimbledon Park
Clapham
Elverson Road
Junction
Oval
Lewisham
Interchange stations
Bakerloo Hammersmith Victoria
Wimbledon
Stockwell
& City
Step-free access from the
Clapham North
Central
platform to the street
Clapham High Street 100m
Jubilee Waterloo & City
Improvement works may affect your journey,
Brixton 100m
Connections with National Rail
Circle
particularly at weekends.
Clapham South Clapham Common
Connections with riverboat services
Metropolitan Overground
Check before you travel; look for publicity
District
Connection with Tramlink
Tooting Bec
Balham
at stations, visit tfl.gov.uk/check
Northern
or call 020 7222 1234
Location of Airport
East London
DLR
Colliers Wood
Interchange with National Rail services to airport
Piccadilly
Tooting Broadway
Check before you travel.
line closed, replacement
bus services operate
See poster journey planners.
Morden
South Wimbledon
Reg. user No. 09/1500/P Zonal Map Version J 03.09 Correct at time of going to print
100m
200m
100m
250m
200m
150m
MAYOR OF LONDON Transport for London
XXIII

conGRess InfoRMaTIon
HoW To GeT To THe eXcel cenTRe
The ExCeL centre can easily be reached by
underground – the tube – or by taxi from
the airports as well as from the city centre.
To get to the ExCeL centre from the city
centre by public transportation (e.g. from
Oxford Circus), take the Central Line to
Bank. Change to DLR and exit at Custom
House for ExCeL. The approximate travelling
time is 35 minutes. For any questions
regarding public transportation, please
contact the Oyster Card Counter in the
registration area in hall N1/2.
caR PaRk
There are 2,540 car parking spaces at Ex-
CeL London: The purple and orange car
parks are located in the undercroft and
the multi-storey car park at ExCeL London
West. Please note that parking spaces are
allocated on a "first-come, first-served" basis
and are only for vehicles of transit size
and below. Overnight sleeping within vehicles
is prohibited.
Car Parking Charges
Up to 2 hours: GBP 5.00
Up to 5 hours: GBP 10.00
Up to 15 hours: GBP 15.00
Up to 24 hours: GBP 20.00
Motorcycles park free of charge; coaches
pay a flat fee of GBP 20 per day. Transits up
to 3.5t will be charged a GBP 15 flat fee per
day. Lorry parking is GBP 30 per day.
ExCeL is operating on a Pay and Display
System in all areas except the multi-storey
car park, where tickets are issued via a barrier
system. There are car park payment
machines within the central Boulevard of
ExCeL London and within the car parks
themselves. The payment machines can
be used with credit card and cash.
XXIV
InsURance/lIabIlITY
GASTRO 2009 UEGW/WCOG, London does
not accept any liability for damages and/
or losses of any kind which may be incurred
by the congress participants or by
any persons accompanying them, during
either the official activities or excursions.
Delegates participate in all tours/events at
their own risk. Participants are advised to
take out insurance against loss, accidents
or damage that could be incurred during
the congress.
RecoRDInG
Cameras, video cameras or audio recording
devices are not permitted in session
rooms. Any recording of sessions is strictly
forbidden.
sMokInG
Smoking is prohibited within the ExCeL
London venue!
cHURcH seRVIces
A wide range of church services are available.
Please contact your hotel concierge
for specific locations and timings.
sHoPPInG
Shops and Department Stores are generally
open between 09:00 and 17:30/18:00
from Monday to Saturday. In Knightsbridge
(i.e. the Brompton Road area), some stores
are open until 19:00 on Wednesdays, and
in the West End (i.e. the Oxford Street area),
some shops are open until 19:00 on Thursdays.
General grocery stores often have
late opening up to 22:00 Monday to Saturday,
and 10:00–16:00 on Sunday. Many
petrol/gas stations are open 24 hours a
day and also sell groceries.
TIMe Zone
London is located in the UTC/GMT time
zone. Daylight Saving Time / DST started
on March 29, and ends on October 25,
2009. London is 5 hours ahead of EST /
Eastern Standard Time and 1 hour behind
CET / Central European Time.

– Promoting Global Digestive Health
WORLD
GASTROENTEROLOGY
ORGANISATION
Did you know that you are
a member of the
global GI community?
What WGO offers
the Global GI Community
Quality Training Centers
in true areas of need
Global Guidelines applicable
at every resource level
World Digestive Health Day
raising global awareness
Train the Trainers educational
workshops
Become a part of the
WGO Volunteer Network
Join our Circle of Care and
become a partner in helping others
Adopt a Trainee and
make a difference
Make a single donation and help us
promote global digestive health
Organize a World Digestive Health
Day event in your country
We invite you to meet your WGO leaders and expert team at
our booth in the registration area to learn more
www.worldgastroenterology.org

scIenTIfIc InfoRMaTIon
GASTRO 2009 UEGW/WCOG, London – a
new meeting for the millennium – will provide
an extensive programme including a
range of symposia on clinical updates, the
world’s best gastrointestinal and liver science
and excellent training opportunities for established
and nascent gastroenterologists.
At least 50% of the core programme will
consist of original research communications,
and there will also be Clinical Case Sessions,
Lunch Sessions and a Poster Exhibition.
PRoGRaMMe HIGHlIGHTs
The Programme Committee is committed
to delivering
■ A world beating array of new science
in gastroenterology and hepatology
■ High quality updates on the frontiers
of global clinical practice
■ Interdisciplinary symposia on new approaches
to diagnosis and treatment
■ Live endoscopy from around the
world each day
scIenTIfIc conTenT
foRMaT DescRIPTIons
XXVI
■ A major emphasis on innovative, technical
advances in the non-invasive
management of gastrointestinal and
hepatic disorders
■ An overriding theme will be the importance
of addressing both research
and clinical practice issues at a global
level
■ Eight working team reports which
have been commissioned will be
presented at GASTRO 2009 UEGW/
WCOG, London
■ New research workshops on each day
of the core programme
■ A full two day postgraduate programme
will be offered incorporating
gastroenterology, hepatology, endoscopy,
surgery, imaging and other
diagnostic modalities. Participants will
purchase a “passport” to move around
the various options that will be
running in parallel to allow them to
“pick‘n mix” according to their needs
and interests
saturday sunday Monday Tuesday Wednesday
november 21,
2009
november 22,
2009
Welcome Ceremony
november 23,
2009
Opening Plenary
Session
november 24,
2009
Postgraduate Teaching Programme Symposia
Free Paper Sessions
Video Case Session/Live Endoscopy
Clinical Case Sessions
Working Party Reports
Lunch Sessions
Basic Science Workshops
Poster Exhibition/Poster Rounds
ESGE/OMED Learning Area
Ultrasound Learning Centre
Common Interest Groups
Sponsored Symposia/Satellite & Breakfast Meetings
Exhibition
GI Nurses 2009 ESGENA/SIGNEA Conference
Pre-congress activity: Young Clinicians Core Programme on November 19 – 20, 2009
november 25,
2009

oPenInG PlenaRY sessIon
The Plenary Session will be held on Monday
morning and will include official
speeches and the opening of the core
scientific programme with a mixture of
invited speakers and presentations of the
best submitted abstracts. No parallel sessions
will be scheduled.
PosTGRaDUaTe TeacHInG
PRoGRaMMe
The congress will be offering a full two day
postgraduate programme incorporating
gastroenterology, hepatology, endoscopy,
surgery, imaging and other diagnostic modalities.
Participants will purchase a “passport”
to move around according to their
needs and interests. Full registration for the
congress is not required.
sYMPosIa
Interdisciplinary symposia will cover new
approaches to diagnosis and treatment,
and place major emphasis on innovative
technical advances in the non-invasive
management of gastrointestinal and hepatic
disorders and basic science, including
State-of-the-Art and Named Lectures.
fRee PaPeR sessIons
Submitted abstracts will be reviewed by
a panel of experts and if an abstract is selected
as an oral presentation, it will be allocated
to a Free Paper Session.
VIDeo case sessIon/lIVe
enDoscoPY
The Video Case Session is an excellent platform
for the provision of succinct information
on very current issues of endoscopy.
Live Endoscopy from around the world will
be presented from Monday to Wednesday
from three cities: Hyderabad, London and
Rome.
scIenTIfIc InfoRMaTIon
clInIcal case sessIons
The aim of these sessions will be to promote
discussion on clinical management
problems that fall outside standard clinical
guidelines. Clinical cases will be presented
and illustrated by high-quality endoscopic,
radiological and pathological images. The
audience will be invited to comment and
vote on diagnostic and treatment options.
WoRkInG PaRTY RePoRTs
The “Working Parties” programme has
been a distinctive activity of previous
world congresses and has resulted in the
publication of important documents as
the “Sydney Classification” and “The LA
Grading System”. All member societies of
the hosting organisations were invited
to submit proposals for topics for consideration
and these needed to present
areas in need of a ‘new look’ or where real
guidance is required on classification, diagnostic
criteria or therapeutic strategies.
Working Party topics which focus on key
global issues in gastroenterology were of
particular interest.
Eight excellent proposals were received
and the Programme Committee decided
that all warranted support and exposure.
For an overview of all eight topics and
presenters please go to page 291 and following.
Furthermore, Working Party reports from
“GASTRO 2009 UEGW WCOG, London” will
be submitted for publication in a selection
of peer review journals and will be published
in World Gastroenterology News.
The results will also be posted on the various
participating society websites.
Copies of the Executive Summaries of all
Working Party Reports can be obtained at
the 4 host society booths.
XXVII

scIenTIfIc InfoRMaTIon
lUncH sessIons
Lunch sessions are supposed to be for management
discussion, not didactic teaching
and are offered from Monday to Wednesday
at 12:45 – 14:00. The focus of each session
will be on the daily clinical practice of
gastroenterology. The maximum number
of participants will be strictly limited to 30.
Registrations will be accepted on a “firstcome,
first-served” basis. A lunch will be
provided to all participants. The lunch session
fee is EUR 55. Full registration for the
congress is required.
basIc scIence WoRksHoPs
During the core meeting there will be a
basic science workshop on each day. The
workshops will be aimed at young investigators
and focus on research methodologies,
study design, data analysis etc..
PosTeR eXHIbITIon/PosTeR
RoUnDs
Poster Rounds will be held during the lunch
period. Posters will be displayed from Monday
until Wednesday and will be changed
daily. Selected experts will visit groups of
posters, and the presenter will be expected
to give a 1-2 minute summary of the major
findings described on the poster. The
experts will lead the discussions with other
members attending the poster session. It is
the responsibility of the presenter to ensure
that at least one of the authors is present
during the lunch session to take part in the
poster discussion. The 12 best posters will
be awarded a prize on basis of scientific
merit using the evaluation process of the
GASTRO 2009 UEGW WCOG, London Programme
Committee.
All GASTRO 2009 UEGW WCOG, London
attendees are kindly invited to join the
Award Ceremony, which will be held
each day at 13:45 in the poster exhibition
area. Those authors who receive an
award will be granted free entry to the
Postgraduate Teaching Programme of
next year’s UEGW in Barcelona.
XXVIII
esGe/oMeD leaRnInG aRea
The Learning Area will be divided into
four sections: The Hands-On Training Centre,
which will offer, in cooperation with
ESGENA/SIGNEA, various forms of handson
training throughout the congress; the
Simulator Centre, which will offer practical
training of many aspects of GI endoscopy,
including some on biological models; the
Lecture Theatre, which will offer lectures on
selected topics and provide an opportunity
for small forum discussions with experts;
and the DVD Learning Centre, with DVD stations
offering individual learning for endoscopy.
The Learning Area will be open during
the general opening hours of the congress.
UlTRasoUnD leaRnInG cenTRe
The Ultrasound Learning Centre will promote
the role of a main diagnostic and interventional
tool in gastroenterology: Clinical
ultrasonography in the hands of the
gastroenterologist. The Ultrasound Learning
Centre will offer Individual Hands-On
Mini Practice, Lectures in Abdominal Ultrasonography
and a Postgraduate Course on
Ultrasonography for the Gastroenterologist
which is designed for both the beginner
and the advanced, offering a mix of
lectures and practical training by expert
gastroenterologists.
coMMon InTeResT GRoUPs
Common Interest Groups will have the opportunity
to meet at the congress outside
the core programme and will be open to
all congress participants. Please see page
301 and following for further information.
sPonsoReD sYMPosIa/saTellITe &
bReakfasT MeeTInGs
Satellite Symposia and Breakfast Meetings
are being organised by pharmaceutical
companies and will be open to all congress
participants. Responsibility for the programme
content remains with the sponsor.

GI nURses 2009 – esGena/sIGnea
confeRence
The Conference of the European and
International Society of Gastroenterology
and Endoscopy Nurses and Associates
(ESGENA/SIGNEA) is an associated meeting
at the congress with separate scientific
programme and registration and will be
held from November 21– 23, 2009.
PRe-conGRess acTIVITY: YoUnG
clInIcIans PRoGRaMMe (YcP)
This unique programme has been developed
as a joint organisational venture
between the host societies of GASTRO
2009 UEGW/WCOG, London (UEGF, WGO,
OMED and BSG) as well as the Association
of National European and Mediterranean
Societies of Gastroenterology (ASNEMGE).
A record number of applications to YCP
were received from 65 national societies
and of the 90 available positions, 60 have
been allocated to international nominees
and 30 to local UK nominees.
Further Information and a detailed programme
can be found on page 1 and following.
eaccMe – conTInUInG MeDIcal
eDUcaTIon
The GASTRO 2009 UEGW/WCOG, London
is accredited by the European Accreditation
Council for Continuing Medical Education
(EACCME) to provide the following
CME activity for medical specialists. The
EACCME is an institution of the European
Union of Medical Specialists (UEMS).
www.uems.net
The GASTRO 2009 UEGW/WCOG, London
is designated for a maximum of 29 hours
of European external CME credits. Full
congress days count for 6 credits, half
congress days for 3 credits and Wednesday
counts for 5 credits. Thus, a maximum
of 29 European CME credits can be ob-
tained.
scIenTIfIc InfoRMaTIon
Each medical specialist should claim only
those hours that he/she actually spent in
the educational activity.
EACCME credits are recognised by the
American Medical Association towards
the Physician’s Recognition Award (PRA).
To convert EACCME credit to AMA PRA
category 1 credit, the AMA may be contacted.
In order to obtain CME credits, GASTRO
2009 UEGW/WCOG, London requires feedback
on its educational activities. Therefore,
we kindly ask the delegates to complete
the evaluation form included in the
congress bag and return it to the specific
CME desk on the last day of attendance.
The CME Certificate of EACCME is issued at
the congress at the specific counter in the
registration area.
InfoRMaTIon foR ITalIan
DeleGaTes
Gruppo SC is the official Italian agency
who is authorised to deal with the Italian
Health Authorities.
FISMAD – The Italian Federation of Digestive
Diseases Societies
c/o GRUPPO SC
Studio Congressi
Servizi per la Comunicazione
V.N. Colajanni, 4, 00191 Roma
Tel: +39-06-329 02 50
E-Mail: fismad@grupposc.com
XXIX

Imagestate
UEGW
BARCELONA 2010
18th United European
Gastroenterology Week
www.uegf.org // EACCME applied
October 23 – 27, 2010
Barcelona, Spain
CCIB – Centre Convencions
Internacional Barcelona
Organiser:
UEGF – United European
Gastroenterology Federation
offi ce@uegf.org
Congress and Exhibition Offi ce:
CPO HANSER SERVICE GmbH
uegw2010@cpo-hanser.de
See you in Barcelona!

SCIENTIFIC
PROGRAMME

esT of GasTRo 2009 on DVD
WHY noT eXPeRIence THe sessIons
YoU DID noT aTTenD?
A DVD with 30 hours of the best from
GASTRO 2009 UEGW/WCOG, London can
be pre-ordered at the congress. Selected
keynote lectures, plenary sessions and
symposia will be recorded on video and
made available after the event. This will
provide an insight into the most important
topics, specially chosen by the Programme
Committee of GASTRO 2009 UEGW/
WCOG, London to represent the best of
the congress.
The programme will feature video recordings
of the lectures synchronised with the
slides in a user-friendly interface, giving
you a real feel for the live event. Full navigation
allows you to skip, pause, or move
between sessions. You can watch part of a
lecture and come back to it at a later time.
You’ll also be able to search for a session by
presenter name, title or subject.
This will be an invaluable resource for you
to stay informed and educated, and hear
from the leading experts at your own convenience.
The DVD can be pre-ordered at the congress
counter at a price of EUR 78 incl.
VAT and mailing costs. Make sure to secure
your copy – you will conveniently
receive it via mail after the congress.
The DVD will be published by GASTRO
2009 UEGW/WCOG, London who has contracted
the company Elsevier Ltd. to produce
this DVD and to distribute it.
XXXII
HoW To ReaD THe conGRess
PRoGRaMMe
The GASTRO 2009 UEGW/WCOG, London
congress programme contains Opening
Plenary Session, Symposia, Free Paper Sessions,
Video Case Sessions, Clinical Case
Sessions, Working Party Reports, Lunch Sessions,
Poster Sessions, ESGE/OMED Learning
Area, Ultrasound Learning Centre, Postgraduate
Teaching Programme, Common
Interest Group Meetings, Business Meetings,
Satellite Symposia, Breakfast Meetings
and Basic Science Workshops.
The congress programme is structured by
day and time. Following the programme,
the lunch sessions and posters are listed in
detail. For the Young Clinicians Programme
please see page 1 and following.
The different formats are highlighted
in different colours in order for the participant
to recognise them throughout the
programme:
foRMaTs – coloUR leGenD
OPENING PLENARY SESSION
SYMPOSIA
FREE PAPER SESSIONS
VIDEO CASE SESSION/LIVE ENDOSCOPY
CLINICAL CASE SESSIONS
POSTER ExHIBITION/POSTER ROUNDS
LUNCH SESSIONS
POSTGRADUATE TEACHING
PROGRAMME
ESGE/OMED LEARNING AREA/
ULTRASOUND LEARNING CENTRE
COMMON INTEREST GROUP
MEETINGS/BUSINESS MEETINGS
SPONSORED SYMPOSIA/SATELLITE &
BREAkFAST MEETINGS
BASIC SCIENCE WORkSHOPS
WORkING PARTY REPORTS
YOUNG CLINICANS PROGRAMME

Time Halls
09:00
–
10:30
11:00
–
16:30
Time Halls
08:30
–
13:00
14:00
–
16:00
18:00
–
19:30
oVeRVIeW – sUnDaY, noVeMbeR 22, 2009
S1/2/3 N7/8 N9/10 N11/12
PARALLEL SESSION 5
Quality endoscopy
in 2009
PLENARY SESSION 2
new advances in
the management of
Upper GI bleeding
oVeRVIeW – saTURDaY, noVeMbeR 21, 2009
S1/2/3 N7/8 N9/10 N11/12
PLENARY SESSION 1
Management of
IbD
PARALLEL SESSION 1
Quality endoscopy
in 2009
PARALLEL SESSION 2
fibrogenic diseases
of the liver and
the pancreas: The
science and the
management
PARALLEL SESSION 6
Hepatology world
update
WGO / Procter &
Gamble
Satellite Symposium
PARALLEL SESSION 3
GoRD : challenges
and opportunities
PARALLEL SESSION 7
Ibs: challenges and
opportunities
PARALLEL SESSION 4
surgery
PARALLES SESSION 8
surgery
Please see page 301 and following for information on Common Interest Group Meetings.
XXXIII

oVeRVIeW – MonDaY, noVeMbeR 23, 2009
Halls
Time
07:00
–
08:00
08:15
–
10:30
11:00
–
12:30
12:15
–
14:00
12:45
–
13:45
14:00
–
15:30
15:45
–
17:15
18:00
–
19:30
XXXIV
S1/2/3 S4/5 S6/7 S8/9 N7/8 N9/10
Opening
Plenary Session
Video Case
Session
Place of surgery
in IBD
Rectal cancer
treatment
Obesity: New
understandings
in risks and
treatment
Poster Sessions and Poster Award Ceremony (13:45)
Pentax
Breakfast
Meeting
Quality of life
in chronic liver
disease
Free Paper
Session
“Bugging” the
intestine
Lunch Session Lunch Session Lunch Session Lunch Session Lunch Session Lunch Session
ROOM PR1
Exocrine
pancreatic
insufficiency:
When and how
to prescribe
enzymes
Live Endoscopy:
Hyderabad,
India
Live Endoscopy:
Hyderabad,
India
ROOM PR2
Endoscopic
management
of bariatric
surgery
complications
Free Paper
Session:
New
approaches to
IBD therapy:
Stem cells and
other agents
Free Paper
Session:
Mechanisms
of colorectal
carcinogenesis
AstraZeneca
Satellite
Symposium
ROOM SG3
Management
of persistent
halitosis and
belching
The challenge
of alcoholic
liver disease
NAFLD and
NASH
ROOM SG4
Measuring pH
in GORD: How
should my
centre do it?
Barrett’s
oesophagus:
A global
perspective
Upper GI
bleeding and
NSAIDs: Why do
patients die,
and how can
we save them?
ROOM SG5
What is the
place of
thiopurine
analogues in
the era of anti-
TNF?
Free Paper
Session:
Helicobacter
pylori: A wider
view
Free Paper
Session:
Pancreatic
and biliary
endoscopy
Fujinon
Satellite
Symposium
ROOM SG7
Fecal
incontinence:
An updated
management
Colorectal
cancer
chemoprevention
Changing the
course of IBD:
Is it applicable
to all?
Movetis NV
Satellite
Symposium
Please see page 301 and following for information on Common Interest Group Meetings.

oVeRVIeW – MonDaY, noVeMbeR 23, 2009
N11/12 Platinium 3+4 Platinium 1 Platinium 2 SG 11/12
The liver in the
oncological
patient
Motor and
sensory
disorders of the
GI tract
Lunch Session Lunch Session
ROOM SG8
Treatment
of NASH:
Lifestyle or
pharmacology?
Free Paper
Session:
New imaging
techniques
Global
education for
Gastroenterologists
Management
of GERD and
achalasia
Clinics in
Gastro-
enterology &
Hepatology 1
Intestine:
Diarrhoea and
abdominal
pain: Diagnostic
challenges
Poster Sessions and Poster Award Ceremony (13:45)
ROOM SG9
How to assess
surgical risk in
patients with
liver disease
Free Paper
Session:
Diagnosis and
surveillance
of sporadic
and familiar
colorectal
cancer
Management
of anorectal
disorders: An
update
Free Paper
Session:
Pancreatic and
liver cancer
Free Paper
Session:
Basic
hepatology
Basic Science
Workshop 1
Mechanisms of
liver fibrosis
Free Paper
Session:
GERD:
Epidemiology,
pathogenesis
and diagnostics
Diagnostic EUS
Free Paper
Session:
IBS: Clinical and
phato-
physiological
aspects
Free Paper
Session:
Nutrition and
probiotics
Halls
Time
07:00
–
08:00
08:15
–
10:30
11:00
–
12:30
12:15
–
14:00
12:45
–
13:45
14:00
–
15:30
15:45
–
17:15
18:00
–
19:30
XXXV

oVeRVIeW – TUesDaY, noVeMbeR 24, 2009
Halls
Time
07:00
–
08:00
08:30
–
10:30
11:00
–
12:30
12:15
–
14:00
12:45
–
13:45
14:00
–
15:30
15:45
–
17:15
18:00
–
19:30
XXXVI
S1/2/3 S4/5 S6/7 S8/9 N7/8 N9/10
Live Endoscopy:
London, UK
Live Endoscopy:
London, UK
GORD
treatment:
Current
problems and
new solutions
Free Paper
Session:
Environment
and screening
issues in IBD
Challenges
in the
management
of IBD
Free Paper
Session:
Advanced GI
endoscopy
NOTES: Is there
a future?
Free Paper
Session:
Barrett’s
oesophagus
Poster Sessions and Poster Award Ceremony (13:45)
Boston
Scientific
Breakfast
Meeting
Free Paper
Session: Safety
and outcome
prediction
in IBD
Free Paper
Session: Clinical
hepatology
Schering-
Plough
Breakfast
Meeting
Free Paper
Session:
Screening
for colorectal
cancer
Do we all need
an H. pylori-free
stomach?
Lunch Session Lunch Session Lunch Session Lunch Session Lunch Session Lunch Session
ROOM PR1
ESD
Capsule
endoscopy:
From top to
bottom
Endoscopic
complications:
When to call
the surgeon
ROOM PR2
Branch type
IPMN: When to
observe, when
to operate?
Free Paper
Session:
GI stenting and
NOTES
Free Paper
Session:
Late breaking
news
ROOM SG3
Resistant GORD:
Non-surgical
management
strategies
Best of DDW
Chicago 2009
Enteric
infections
Schering-
Plough
Satellite
Symposium
ROOM SG4
How should
I manage
eosinophilic
oesophagitis?
Treatment of
pancreatic
cancer
Pancreatic
cystic lesions
ROOM SG5
Preventing
and managing
side effects
of biolgical
therapies
Unanswered
questions
on IBD
pathogenesis
Intestinal failure
Norgine
Satellite
Symposium
ROOM SG7
Chronic
abdominal
pain: What’s
intractable, the
pain, the patient
or the doctor?
H. pylori
associated
diseases:
Worldwide
problem
and worldwide
solutions
Upper GI
symptoms in
the community:
Old problems,
new solutions
Nycomed
Satellite
Symposium
Please see page 301 and following for information on Common Interest Group Meetings.

oVeRVIeW – TUesDaY, noVeMbeR 24, 2009
N11/12 Platinium 3+4 Platinium 1 Platinium 2 SG 11/12
Mayoly Spindler
Breakfast
Meeting
Liver fibrosis:
Diagnostic and
therapeutic
challenges
Hepatic
infections and
co-infections
Intrahepatic
gallstones
Obesity and GI
cancer
Lunch Session Lunch Session
ROOM SG8
Nutrition in
patients with
decompen-
sated cirrhosis
Cholestatic liver
diseases
The ageing liver
& The ageing
liver disease
patient
Stem cells in
metaplasia and
cancer
Autoimmune
pancreatitis
Free Paper
Session:
Capsule
endoscopy
Clinics in
Gastroenterology
&
Hepatology 2
The cause of
liver disease is
not always in
the liver
Poster Sessions and Poster Award Ceremony (13:45)
ROOM SG9
Non invasive
discriminators
for liver fibrosis
in everyday
practice
Acute
pancreatitis:
From theory to
practice
Free Paper
Session: Gastroduodenal
malignancies
Free Paper
Session:
Diagnostic and
therapeutic
EUS
Free Paper
Session: Viral
hepatitis
Basic Science
Workshop 2
RNA
interference
and microRNAs
in the GI tract
Free Paper
Session:
Intestinal
inflammation
and therapy:
How does it
work?
Free Paper
Session:
Paediatric
gastroenterology
and
hepatology
Free Paper
Session:
Treatment and
biomarkers
for colorectal
cancer
Free Paper
Session: Benign
colo-rectal
disorders: Potpourri
Free Paper
Session: Novel
agents for
treatment and
prevention
of colorectal
cancer
Halls
Time
07:00
–
08:00
08:30
–
10:30
11:00
–
12:30
12:15
–
14:00
12:45
–
13:45
14:00
–
15:30
15:45
–
17:15
18:00
–
19:30
XXXVII

oVeRVIeW – WeDnesDaY, noVeMbeR 25, 2009
Halls
Time
08:30
–
10:30
11:00
–
12:30
12:15
–
14:00
12:45
–
13:45
14:00
–
15:30
XXXVIII
S1/2/3 S4/5 S6/7 S8/9 N7/8 N9/10
Live Endoscopy:
Rome, Italy
Live Endoscopy:
Rome, Italy
CRC screening
strategies
Free Paper
Session: Coeliac
disease and
enterocyte
function
Free Paper
Session:
Anti TNF therapy
in IBD: Current to
future
Free Paper
Session: GI
infection
Patho-
physiology of
IBS: New insights
Free Paper
Session:
Oesophageal
carcinoma
Poster Sessions and Poster Award Ceremony (13:45)
Coeliac disease
in the 21st
century
Clostridium
difficileassociated
diseases
H. pylori
treatment:
Consensus and
new approaches
Early
oesophageal
cancer and HGD:
Advances in
diagnosis and
treatment
Lunch Session Lunch Session Lunch Session Lunch Session Lunch Session Lunch Session
ROOM PR1
Self-expanding
metallic biliary
stents: Covered
or uncovered?
Free Paper
Session: EMR
and ESD
ROOM PR2
Balloon assisted
endoscopy
Free Paper
Session: Gastro-
intestinal
bleeding
ROOM SG3
“Is it my heart
doctor?” Noncardiac
chest
pain and linked
angina pectoris
Free Paper
Session: Upper
GI neoplasia
ROOM SG4
Individualising
H. pylori
management:
What’s best for
my patient?
Free Paper
Session:
Therapeutic
insights in
functional
digestive
disorders
ROOM SG5
Which vaccines
should my IBD
patient receive?
Palliation of
malignant
gastro-duodenal
obstruction
ROOM SG7
I have a family
history of bowel
cancer, doctor
- do I need a
colonoscopy?’
New insights
in food-gut
interactions
Please see page 301 and following for information on Common Interest Group Meetings.

oVeRVIeW – WeDnesDaY, noVeMbeR 25, 2009
N11/12 Platinium 3+4 Platinium 1 Platinium 2 SG 11/12
Update in the
treatment of
hepatitis B and C
Hepatocellular
carcinoma:
Molecular
markers
and advanced
therapy
New frontiers
in the
management
of colorectal
cancer
CRC surveillance
and treatment
of dysplasia and
early cancer
Lunch Session Lunch Session
ROOM SG8
Liver pathology
for the clinicians:
What is new and
what to ask
Clinical
challenges in
advanced liver
disease
Free Paper
Session:
Treatment of
oesophageal
cancer
Free Paper
Session: Clinical
issues in colonic
diseases
Free Paper
Session:
Cirrhosis and
complications
Clinics in Gastroenterology
&
Hepatology 3
Pancreas:
Surrounding
organs can be
hostile to the
pancreas?
Poster Sessions and Poster Award Ceremony (13:45)
ROOM SG 9
Maintenance
therapy in HCV
non responders:
Is it worth it?
Advances in
nutritional
support: What
the gastro-
enterologist
needs to know
Free Paper
Session:
Management
of colorectal
cancer
Basic Science
Workshop 3
Novel insights
into the
pathogenesis
of acute
pancreatitis
Free Paper
Session:
New
developments in
colonoscopy
Free Paper
Session:
Pancreatitis
Free Paper
Session: New
diagnostic
techniques and
biomarkers
for colorectal
cancer
Halls
Time
08:30
–
10:30
11:00
–
12:30
12:15
–
14:00
12:45
–
13:45
14:00
–
15:30
XXXIX

.artundwork designbüro
HI VISION Preirus
A compact premium ultrasound platform that adapts to your environment
The platform architecture of HI VISION
Preirus has been designed to meet
the needs of the next generation.
Choose HI VISION Preirus for the
latest advanced technology:
• Unique ergonomic design for
maximum comfort in diagnosis
Visit us at booth n° 51!
• Smart Touch graphic user interface
for intuitive operation
• PSS (Patient Scanning Selector) to optimise
patient specific scan parameters
• Enhanced image quality and diagnostic
performance using HI-RTE, Fine Flow Doppler
and Low MI contrast enhanced EUS.
• Maintains compatibility with our diverse
range of transducers
Hitachi Medical Systems Europe Holding AG · Sumpfstrasse 13 · CH-6300 Zug
www.hitachi-medical-systems.com
Discover new
dimensions.

GASTRO 2009
YOUNG
CLINICIANS
PROGRAMME

GasTRo 2009 YoUnG clInIcIans PRoGRaMMe
YoUnG clInIcIans PRoGRaMMe
Course Directors: Professor Chris Hawkey,
Professor Mark Hull
InTRoDUcTIon
The Young Clinicians Programme (YCP) represents
an important educational aspect of
GASTRO 2009 UEGW/WCOG, London and
combines the unique YCP concept as presented
during previous World Congresses of
Gastroenterology with the highly successful
Summer School Course of ASNEMGE, which
represents the European National Societies
of Gastroenterology. The YCP programme
commences two days prior to the main
meeting and will continue throughout the
core meeting bringing together 90 Trainees
from 51 countries (60 international and 30
from the United Kingdom).
Successful Trainee Gastroenterologists
were nominated by their National Societies
and then selected by the YCP Organising
Committee as ‘high-flyers’ and clearly
represent future opinion leaders in their
respective Countries: Albania, Argentina,
Australia, Belgium, Bosnia and Herzegovina,
Brazil, Bulgaria, Canada, China, Costa
Rica, Croatia, Czech Republic, Ecuador,
Egypt, Estonia, Finland, Germany, India,
Indonesia, Iraq, Ireland, Japan, Latvia, Malaysia,
Mexico, Mongolia, Morocco, Netherlands,
Norway, Pakistan, Peru, Philippines,
Poland, Portugal, Romania, Russia, Saudi
Arabia, South Africa, Spain, Sri Lanka, Sudan,
Switzerland, Taiwan, Thailand, United
Arab Emirates, Ukraine, United Kingdom,
Uruguay, United States, Vietnam, Zambia.
We are honoured to have an enthusiastic
Faculty with extensive experience. We
are also delighted that several prominent
UK GI Units have offered to host international
YCP trainees, either prior to or after
GASTRO 2009 UEGW/WCOG, London. We
wish to extend our appreciation to the following
host units:
2
■ Alistair Forbes, University College
London, London
■ Andrew Burroughs, Royal Free
Hospital, London
■ Brian Saunders, St. Marks Hospital,
London
■ C.J. Hawkey, Nottingham University,
Nottingham
■ David Adams, University of Birmingham,
Birmingham
■ Janusz Jankoswki, University Hospitals
of Leicester, Leicester
■ John Mansfield, Newcastle upon Tyne
Hospitals, Newcastle upon Tyne
■ John McLaughlin, University of
Manchester, Manchester
■ Ken McColl, University of Glasgow,
Glasgow
■ Marcus Harbord, Chelsea and Westminster
Hospital, London
■ Mark Hull, Leeds Institute of Molecular
Medicine, Leeds
■ Mark McAlindon, Royal Hallamshire
Hospital, Sheffield
■ Mark Pritchard, University of Liverpool,
Liverpool
■ Mounes Dakkak, Hull Royal Infirmary,
Hull
■ Qazim Aziz, Barts and The London,
London
■ Roger Leicester, St. Georges Hospital,
London
■ Simon Travis, Nuffield Health The
Manor Hospital Oxford, Oxford
■ Tawfique Daneshmend, Nuffield
Health Exeter Hospital, Exeter
A substantial part of the YCP programme is
dedicated to ‘hands-on’ training in various
practical skills. These ‘hands-on’ sessions
are made possible with the generous support
of several companies who have provided
equipment and technical support.
Our appreciation goes to:
Diagmed Healthcare UK, Ltd
ERBE Elektromedizin GmbH
Hitachi Medical Systems
Olympus
Sandhill Scientific
Sierra Scientific Instruments/Synectics
Medical

YcP coRe-WoRksHoP PRoGRaMMe
THe bUll HoTel, GeRRaRDs cRoss, Uk
Wednesday November 18, 2009
19.00 – 20.00
Introduction and Opening Session:
Chris Hawkey and Mark Hull, UK
20.00
Welcome Dinner
Thursday November 19, 2009
08.00 – 09.00
key Note Lecture: Getting your research
work published
Eamonn Quigley, Ireland
09.00 – 10.30
Dyspepsia / Barretts case based session
with key pads
Organiser: Rebecca Fitzgerald, UK
Lecturers: Krish Ragunath, Bjorn Rembacken,
Mark Fox
10.30 – 11.00
Coffee Break
11.00 – 12.30
Liver case based session with key pads:
Organiser: Roger Chapman, UK
Lecturers: Joost Drenth, Lucas Greiner,
Mark Aldersley
12.30 – 13.30
Lunch
13.30 – 16.30
Parallel Skills Training Sessions
■ Endoscopy 1: Krish Ragunath
■ Endoscopy 2: Bjorn Rembacken
■ Capsule Endoscopy: Mark McAlindon,
Carolyn Davison
■ Ultrasound: Lucas Greiner
■ LFT interpretation: Mark Aldersley
■ Motility Testing: Mark Fox
■ Presentation Skills: Joost Drenth
16.45 – 18.00
Poster session
GasTRo 2009 YoUnG clInIcIans PRoGRaMMe
Friday November 20, 2009
07.00 – 08.00
Breakfast
08.00 – 09.00
key Note Lecture: Pepic ulcer bleeding:
The 10 commandments
Joseph Sung, Hong Kong
09.00 – 10.30
IBD case based session with key pads
Organiser: Simon Travis
Lecturers: Mark McAlindon, Chris Hawkey,
Joe West
10.30 – 11.00
Coffee Break
11.00 – 12.30
Colorectal Cancer case based session
with key pads
Organiser: Roger Leicester, UK
Lecturers: Krish Ragunath, Simon Travis,
Mark Hull
12.30 – 13.30
Lunch
13.30 – 16.30
Parallel Skills Training Sessions
as for day 1
16.45 – 17.45
Clinical Quiz: Bjorn Rembacken, UK
17.45 – 18.00
What’s coming up at Gastro 2009:
Mark Hull, UK
Saturday, November 21 – Wednesday, November
25, 2009: YCP participants will join
the core programme of GASTRO 2009 at
ExCel London and participate in the Postgraduate
Course as well as the core scientific
programme. In addition, special commentated
poster rounds and a daily "What
I have learnt" session will be hosted for all
YCP trainees.
3

Therapeutic Advances in
Gastroenterology
Editor-in-Chief:
Timothy Cragin Wang m.d.
Silberberg Professor of Medicine,
Columbia University Medical
Center, New York, NY, USA
Free Access to Volumes 1-3
…now in volume 2 this new journal
published by SAGE encompass the highestquality,
peer-reviewed articles, reviews
and scholarly comment on pioneering
efforts and innovative studies relating
to medicine and pharmacology in the
field of gastroenterology and hepatology.
The journal is aimed at clinicians and
researchers and will be a forum for all
views related to this fast-moving field.
For all commercial sales and sponsorship enquiries, including advertising,
reprints and supplements, please contact: Manuela Brun, Commercial Sales
Executive Tel. +44 020 7324 2220 Email manuela.brun@sagepub.co.uk
The Editor is always looking for good quality clinical research and review
articles in gastroenterology and hepatology.
To submit papers please visit http://mc.manuscriptcentral.com/taig or if
you wish to discuss an idea please email the Editor, Dr Alessandro Baliani
at alex.baliani@sagepub.co.uk
Visit http://tam.sagepub.com to register for
your access today!

POSTGRADUATE
TEACHING
PROGRAMME

PosTGRaDUaTe TeacHInG PRoGRaMMe
saTURDaY
09:00 – 10:30
11:00 – 16:30
sUnDaY
08:30 – 13:00
14:00 – 16:00
saTURDaY, noVeMbeR 21, 2009
09:00 – 10:30 PLENARY 1
Hall S1/2/3
Management of IBD
Director: Severine Vermeire, Belgium
Chairs: Michael Kamm, Australia; Severine Vermeire, Belgium
09:00 – 09:10 The approach to complex perianal Crohn’s disease (Physician)
Michael Kamm, Australia
09:10 – 09:20 The approach to complex perianal Crohn’s disease (Surgeon)
Willem Bemelman, The Netherlands
09:20 – 09:40 Choosing the optimal timing of colectomy in severe ulcerative colitis
Gert Van Assche, Belgium
09:40 – 10:00 Use of anti TNF agents: Which, when and how?
Marc Lemann, France
10:00 – 10:20 Management of extra-intestinal inflammation accompanying IBD
David Rampton, UK
10:20 – 10:30 Discussion
11:00 – 13:00 PARALLEL SESSION 1/ PART 1
Hall S1/2/3
Quality endoscopy in 2009: Diagnostic endoscopy
Directors: Guido Costamagna, Italy; Jerry Waye, USA
Chairs: Anthony Axon, UK; Jean Francois Rey, France
11:00 – 11:20 Oesophagogastroduodenoscopy
Prateek Sharma, USA
6
PLENARY SESSION 1
Management of
IbD
PARALLEL SESSION 1
Quality endoscopy
in 2009
PARALLEL SESSION 5
Quality endoscopy
in 2009
PLENARY SESSION 2
new advances
in the
management of
Upper
GI bleeding
PARALLEL SESSION 2
fibrogenic diseases
of the liver and the
pancreas:
The science and the
management
PARALLEL SESSION 6
Hepatology world
update
PARALLEL SESSION 3
GoRD: challenges
and
opportunities
PARALLEL SESSION 7
Ibs: challenges
and
opportunities
PARALLEL SESSION 4
surgery
PARALLEL SESSION 8
surgery

11:20 – 11:40 Detection of early upper GI Neoplasia
Hisao Tajiri, Japan
11:40 – 12:00 Upper GI EUS
Lars Aabakken, Norway
12:00 – 12:20 Colonoscopy
Christopher Williams, UK
12:20 – 12:40 Detection of early lower GI neoplasia
Shin-ei Kudo, Japan
12:40 – 13:00 Small bowel enteroscopy
Greg Haber, USA
PosTGRaDUaTe TeacHInG PRoGRaMMe
14:00 – 16:00 PARALLEL SESSION 1/ PART 2
Hall S1/2/3
Quality endoscopy in 2009: Therapeutic endoscopy
Directors: Guido Costamagna, Italy; Jerry Waye, USA
Chairs: Hisao Tajiri, Japan; Jerry Waye, USA
14:00 – 14:20 Management of early oesophageal neoplasia
Haru Inoue, Japan
14:20 – 14:40 Management of early gastric neoplasia
Horst Neuhaus, Germany
14:40 – 15:00 Palliation of advanced oesophageal neoplasia
Norman Marcon, Canada
15:00 – 15:20 Polypectomy
Brian Saunders, UK
15:20 – 15:40 Endoscopic submucosal dissection
Naohisa Yahagi, Japan
15:40 – 16:00 Palliation of advanced colorectal neoplasia
Todd Baron, USA
11:00 – 12:00 PARALLEL SESSION 2/ PART 1
Hall N7/8
Fibrogenic diseases of the liver and the pancreas
The science and the management: Fibrogenesis and fibrosis
Directors: Massimo Pinzani, Italy; Tania Roskams, Belgium; Markus Lerch,
Germany
Chair: Massimo Pinzani, Italy
11:00 – 11:20 Liver fibrosis: Cellular and molecular mechanisms
Scott L. Friedman, USA
11:20 – 11:40 Pancreatic fibrosis: Cellular and molecular mechanisms
Jeremy Wilson, Australia
11:40 – 12:00 Alcohol-induced tissue fibrosis
Emanuele Albano, Italy
7

PosTGRaDUaTe TeacHInG PRoGRaMMe
saTURDaY, noVeMbeR 21, 2009 continued
12:00 – 13:00 PARALLEL SESSION 2/ PART 2
Hall N7/8
Fibrogenic diseases of the liver and the pancreas
The science and the management: Staging the disease
Directors: Massimo Pinzani, Italy; Tania Roskams, Belgium; Markus Lerch,
Germany
Chair: Scott L. Friedman, USA
12:00 – 12:20 Fibrotic features of chronic hepatic and pancreatic disorders
Tania Roskams, Belgium
12:20 – 12:40 Non-invasive methods for the assessment of fibrosis in chronic liver
disease
Laurent Castera, France
12:40 – 13:00 Non-invasive methods for the assessment of fibrosis in chronic pancreatic
disease
Julia Mayerle, Germany
14:00 – 15:00 PARALLEL SESSION 2/ PART 3
Hall N7/8
Fibrogenic diseases of the liver and the pancreas
The science and the management: Fibrogenesis, angiogenesis
and cancer
Directors: Massimo Pinzani, Italy; Tania Roskams, Belgium; Markus Lerch,
Germany
Chair: Tania Roskams, Belgium
14:00 – 14:20 Hepatocellular carcinoma and cholangiocarcinoma
Lewis Roberts, USA
14:20 – 14:40 Pancreatic cancer
Matthias Loehr, Sweden
14:40 – 15:00 Is there basis for anti-stroma cancer therapy?
Massimo Pinzani, Italy
15:00 – 16:00 PARALLEL SESSION 2/ PART 4
Hall N7/8
Fibrogenic diseases of the liver and the pancreas
The science and the management: Imaging and Treatment of
fibrotic liver and pancreatic disease
Directors: Massimo Pinzani, Italy; Tania Roskams, Belgium; Markus Lerch,
Germany
Chair: Markus Lerch, Germany
15:00 – 15:20 CT and MRI for detecting malignancies
Ashley Guthrie, UK
15:20 – 15:40 Interventional endoscopy
Marc Giovannini, France
15:40 – 16:00 How to avoid surgery in benign disorders mimicking pancreatic and
biliary malignancies
Henk Van Buuren, The Netherlands
8

11:00 – 14:00 PARALLEL SESSION 3 / PART 1
Hall N9/10
GORD: Challenges and opportunities
PosTGRaDUaTe TeacHInG PRoGRaMMe
Director: Jean Paul Galmiche, France
Chairs: John Dent, Australia; Jean Paul Galmiche, France
11:00 – 11:30 Epidemiology of GORD and Barrett’s cancer
Hashem B. El-Serag, USA
11:30 – 12:00 Pathophysiology of GORD: A new understanding
John Dent, Australia
12:00 – 12:30 Oesophageal sensitivity: A new player
Qasim Aziz, UK
12:30 – 13:00 PH catheter, bravo capsule, and impedance monitoring:
When and how?
Frank Zerbib, France
14:00 – 16:30 PARALLEL SESSION 3 / PART 2
Hall N9/10
GORD: Challenges and opportunities
Director: Jean Paul Galmiche, France
Chairs: J. Tack, Belgium; P. Sharma, USA
14:00 – 14:30 New endoscopic imaging modalities: What do they add?
Prateek Sharma, USA
14:30 – 15:00 Extra-oesophageal manifestations of GORD:
Are they really linked, and can they be treated?
Daniel Sifrim, Belgium
15:00 – 15:30 Medical treatment: Optimising the old and introducing the new
Jan Tack, Belgium
15:30 – 16:00 Endoscopic treatment of GORD: A critical reappraisal
Guido Costamagna, Italy
16:00 – 16:30 The role of surgery in the long-term treatment of GORD
Lars Lundell, Sweden
11:00 – 13:00 PARALLEL SESSION 4/ PART 1
Hall N11/12
Surgery: New techniques in colorectal surgery
Directors: Alexander Engel, The Netherlands; Jan van Lanschot,
The Netherlands
Chairs: Antonio Lacy, Spain; Ronan O’Connell, Ireland
11:00 – 11:30 TEMS versus EMR: Too much or not enough?
Evelien Dekker, The Netherlands
11:30 – 12:00 NOTES: Is anyone taking note?
Thomas Roesch, Germany
12:00 – 12:30 Robotics: Only for whiz kids?
David Jayne, UK
9

PosTGRaDUaTe TeacHInG PRoGRaMMe
saTURDaY, noVeMbeR 21, 2009 continued
12:30 – 13:00 Has laparoscopy delivered?
Mike Parker, UK
14:00 – 15:30 PARALLEL SESSION 4/ PART 2
Hall N11/12
Surgery: New paradigms in diverticular disease
Directors: Alexander Engel, The Netherlands; Jan van Lanschot,
The Netherlands
Chairs: Alexander Engel, The Netherlands; Abe Fingerhut, France
14:00 – 14:20 Natural history of diverticulitis does not support an aggressive surgical
treatment
Gian Andrea Binda, Italy
14:20 – 14:40 Radiological investigation and intervention
Simon Jackson, UK
14:40 – 15:00 Surgery for complicated disease: Open surgery still the gold standard?
M. A. Cuesta, The Netherlands
15:00 – 15:30 Laparoscopic lavage for diverticular perforation
Desmond Winter, Ireland
15:30 – 16:30 PARALLEL SESSION 4/ PART 3
Hall N11/12
Pancreatic disorders
Directors: Alexander Engel, The Netherlands; Jan van Lanschot,
The Netherlands
Chairs: Helmut Friess, Germany; O.J. Garden, UK
15:30 – 15:45 New developments in the treatment of severe acute pancreatitis
Hein Gooszen, The Netherlands
15:45 – 16:00 Classification and treatment of cystic lesions of the pancreas and IPMT
Claudio Bassi, Italy
16:00 – 16:15 Management of endocrine tumours of the pancreas
Casper van Eijck, The Netherlands
16:15 – 16:30 Management of complications following resections
Jacob Izbicki Germany
10

sUnDaY, noVeMbeR 22, 2009
08:30 – 09:30 PARALLEL SESSION 5/ PART 1
Hall S1/2/3
Quality endoscopy in 2009: ERCP Biliary 1
PosTGRaDUaTe TeacHInG PRoGRaMMe
Directors: Guido Costamagna, Italy; Jerry Waye, USA
Chair: Rob Hawes, USA
08:30 – 08:50 Cannulation of the papilla
Jacques Deviere, Belgium
08:50 – 09:10 Endoscopic sphincterotomy and alternative techniques
Chan S Shim, Seoul, Korea
09:10 – 09:30 Cholangioscopy
Claudio Navarrete, Chile
09:30 – 10:30 PARALLEL SESSION 5/ PART 2
Hall S1/2/3
Quality endoscopy in 2009: ERCP Biliary 2
Directors: Guido Costamagna, Italy; Jerry Waye, USA
Chair: Horst Neuhaus, Germany
09:30 – 09:50 Stone extraction
Joseph JY Sung, Hong Kong
09:50 – 10:10 Stenting
Rob Hawes, USA
10:10 – 10:30 Papillectomy
Thierry Ponchon, France
11:00 – 12:00 PARALLEL SESSION 5/ PART 3
Hall S1/2/3
Quality endoscopy in 2009: ERCP Pancreatic
Directors: Guido Costamagna, Italy; Jerry Waye, USA
Chair: Jacques Deviere, Belgium
11:00 – 11:20 Pancreatic sphincterotomy (Major/Minor)
Guido Costamagna, Italy
11:20 – 11:40 ESWL and stone extraction
Jacques Deviere, Belgium
11:40 – 12:00 Pancreatic stenting
David Carr-Locke, USA
12:00 – 13:00 PARALLEL SESSION 5/ PART 4
Hall S1/2/3
Quality endoscopy in 2009: Therapeutic EUS
Directors: Guido Costamagna, Italy; Jerry Waye, USA
Chair: Paul Fockens, The Netherlands
11

PosTGRaDUaTe TeacHInG PRoGRaMMe
sUnDaY, noVeMbeR 22, 2009 continued
12:00 – 12:20 Drainage of pancreatic cysts and necrosectomy
Thomas Roesch, Germany
12:20 – 12:40 Drainage of abdominal abscesses
Marc Giovannini, France
12:40 – 13:00 Delivering therapy through EUS
William Brugge, USA
08:30 – 09:30 PARALLEL SESSION 6/ PART 1
Hall N7/8
Hepatology world update: NAFLD and NASH
Directors: Helena Cortez-Pinto, Portugal; Jean Michel Pawlotsky,
France; Massimo Pinzani; Italy, Michael Trauner, Austria
Chairs: Helena Cortez-Pinto, Portugal, Chris Day, UK
08:30 – 08:50 Diagnosing NAFLD/NASH.
Who to screen and how to confirm the diagnosis
Zobair Younossi, USA
08:50 – 09:10 Is NAFLD a significant co-factor in other liver diseases?
Helena Cortez-Pinto, Portugal
09:10 – 09:30 Who and how to treat?
Is a behavioural approach enough or do we need drugs?
Chris Day, UK
09:30 – 10:30 PARALLEL SESSION 6/ PART 2
Hall N7/8
Hepatology world update: Cholestatic and autoimmune liver
disease
Directors: Helena Cortez-Pinto, Portugal; Jean Michel Pawlotsky,
France; Massimo Pinzani, Italy; Michael Trauner, Austria
Chairs: Jenny Heathcote, Canada; Michael Trauner, Austria
09:30 – 09:50 Update on diagnosis and treatment of autoimmune hepatitis
Christian Strassburg, Germany
09:50 – 10:10 The spectrum of sclerosing cholangitis
Jenny Heathcote, Canada
10:10 – 10:30 Drug therapy of chronic choleastic syndromes and their complications
Michael Trauner, Austria
11:00 – 13:00 PARALLEL SESSION 6/ PART 3
Hall N7/8
Hepatology world update: Viral Hepatitis
Directors: Helena Cortez-Pinto, Portugal; Jean Michel Pawlotsky,
France; Massimo Pinzani, Italy; Michael Trauner, Austria
Chairs: Antonio Craxì, Italy; Jean Michel Pawlotsky, France
11:00 – 11:25 Changing epidemiology of Hepatitis B and C viruses
David Mutimer, UK
12

PosTGRaDUaTe TeacHInG PRoGRaMMe
11:25 – 11:50 EASL Clinical Practice Guidelines on Management of Hepatitis B
Fabien Zoulim, France
11:50 – 12:15 Current treatment of HCV infection
Antonio Craxì, Italy
12:15 – 12:40 Future HCV therapies and resistance
Jean Michel Pawlotsky, France
12:40 – 13:00 Concluding remarks
Massimo Pinzani, Italy
09:00 – 13:00 PARALLEL SESSION 7
Hall N9/10
IBS: Challenges and opportunities
Director: Juan R. Malagelada, Spain
Chairs: Guy Boeckxstaens, The Netherlands; Juan-R. Malagelada, Spain
09:00 – 09:30 Pathophysiology of IBS: An overview
Guy Boeckxstaens, The Netherlands
09:30 – 10:00 Diagnostic criteria: Rome III
Enrico Corazziari, Italy
10:00 – 10:30 Post-infectious IBS
Robin Spiller, UK
11:00 – 11:30 Diet and IBS
Philippe Marteau, France
11:30 – 12:00 Management of the psychosocial aspects
Niek de Wit, The Netherlands
12:00 – 12:30 New targets for medical therapy
Michael Camilleri, USA
12:30 – 13:00 Practical management of the individual patient: How I do it?
Juan R. Malagelada, Spain
08:30 – 10:30 PARALLEL SESSION 8/ PART 1
Hall N11/12
Surgery: Oesophageal and gastric disorders
Directors: Alexander Engel, The Netherlands, Jan van Lanschot, The
Netherlands
Chairs: Simon Paterson-Brown, UK; Jan van Lanschot, The Netherlands
08:30 – 09:00 Open vs minimally invasive radical oesophagectomy: The same operation?
Michael Griffin, UK
09:00 – 09:30 Optimum treatment of primary achalasia: Surgery or dilatation?
Giovanni Zaninotto, Italy
09:30 – 10:00 Presentation, investigation and treatment of giant hiatus hernias:
Surgery for all?
Simon Paterson-Brown, UK
10:00 – 10:30 Individualised surgical therapy for gastric cancer: EMR-ESD-D1-D2-D3
Mitsuru Sasako, Japan
13

PosTGRaDUaTe TeacHInG PRoGRaMMe
sUnDaY, noVeMbeR 22, 2009 continued
11:00 – 13:00 PARALLEL SESSION 8/ PART 2
Hall N11/12
Surgery – Oesophageal and gastric disorders: Liver diseases
Directors: Alexander Engel, The Netherlands; Jan van Lanschot,
The Netherlands
Chairs: Dirk Gouma, The Netherlands; Myrrdin Rees, UK
11:00 – 11:30 Indications and timing of surgery for liver metastases
O.J. Garden, UK
11:30 – 12:00 Impact of chemotherapy and other nonsurgical adjunct tools for the
treatment of colorectal liver metastases
Jacques Belghiti, France
12:00 – 12:30 Partial liver resection for primary malignant liver tumours
Cornelis Verhoef, The Netherlands
12:30 – 13:00 Diagnosis and treatment of benign liver lesions
T.M. van Gulik, The Netherlands
14:00 – 16:00 PLENARY 2
Hall S1/2/3
New advances in the management of Upper GI Bleeding
Director: John Atherton, UK
Chairs: John Atherton, UK; Francis Chan, Hong Kong
14:00 – 14:30 Life threatening haemorrhage from oesophageal and gastric varices
Ibrahim Mostafa, Egypt
14:30 – 15:00 Shifting sands: The management of bleeding peptic ulcers
Dennis Jensen, USA
15:00 – 15:30 When should the radiologist and surgeon intervene….
and what should they do?
Otto van Delden, The Netherlands
15:30 – 16:00 NSAID/aspirin/clopidogrel users: What should I do after the bleed?
Francis Chan, Hong Kong
14

PROGRAMME
PER DAY

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
PlenaRY sessIon
08:00 – 10:30 S1/2/3
opening Plenary session
Chairs:
Juan-R. Malagelada, Barcelona, Spain
Michael Farthing, London, United Kingdom
08:00 – 08:15
Welcome and Introduction
UEGF Lifetime Achievement Award
Juan-R. Malagelada, Barcelona, Spain;
Michael Farthing, London, United Kingdom
08:15 – 08:35
IBD lessons from global variations
C. Bernstein, Canada
08:35 – 08:47 OP001
REFRACTORY COELIAC DISEASE TYPE 2:
DOES AUTOLOGOUS STEM CELL TRANS­
PLANTATION IMPROVE CLINICAL
COURSE?
G.J. Tack, M.J. Wondergem, A. Al-toma,
M.W.J. Schreurs, B.M.E. Von Blomberg,
P.C. Huijgens, C.J. Mulder, O.J. Visser
08:47 – 09:00 OP002
SAFETY AND PHARMACODYNAMICS OF
MEPOLIZUMAB, A HUMANISED MONO­
CLONAL ANTIBODY AGAINST IL­5, IN
PAEDIATRIC SUBJECTS WITH EOSINO­
PHILIC OESOPHAGITIS: A RANDOMISED,
DOUBLE­BLIND, CONTROLLED CLINICAL
TRIAL
M. Thomson, S. Aceves, É. Drouin,
C. Jurgensen, A. Heath, T. Perschy,
D. Templeton, J. Patel, M. Collins, A. Assa’ad
09:00 – 09:20
Hepatocellular carcinoma: A world view
L. Roberts, USA
09:20 – 09:32 OP003
ODN CPG B IN COMBINATION WITH RFA
SEEMS TO CAUSE A CELLULAR BASED
CANCER VACCINATION IN THE Vx2 HEPA­
TOMA IN RABBITS
T.T. Wissniowski, B. Meusel, D. Strobel,
M. Frieser, E.G. Hahn, M. Ocker
16
09:32 – 09:44
UEGF Research Prize
J-F. Colombel, France
09:44 – 09:56 OP004
CHEMOPREVENTIVE EFFECT OF EICOS­
APENTAENOIC ACID (EPA) FREE FATTY
ACID IN FAMILIAL ADENOMATOUS
POLYPOSIS (FAP): RESULTS OF A RAN­
DOMISED, PLACEBO­CONTROLLED
TRIAL
N.J. West, S.K. Clark, A. Belluzzi,
J.M. Hutchinson, M.A. Hull, R.J. Leicester,
R.K.S. Phillips
09:56 – 10:08 OP005
WIRELESS CAPSULE COLONOSCOPY
VERSUS COLONOSCOPY IN PATIENTS
AT AVERAGE OR INCREASED RISk FOR
COLORECTAL CANCER
S. Sacher-Huvelin, M. Le Rhun, L. Planche,
M. Gaudric, R. Benamouzig, J. Boitard,
S. Chaussade, E. Chanteloup, B. Filoche,
M. Frédéric, P. Ducrotte, D. Coumaros,
C. Cellier, D. Heresbach, J. Saurin,
A. Lesidaner, T. Ponchon, F. Cholet,
J.P. Galmiche
10:08 – 10:28
Personalised cancer treatment – a global
challenge
E. van Cutsem, Belgium
VIDeo case sessIon
11:00 – 12:30 S1/2/3
Video case session
Chairs:
T. Baron, USA
M. Giovannini, France
11:00 – 11:07 OP006
CIRCUMFERENTIAL ESD OF AN EARLY
SQUAMOUS ESOPHAGEAL – FIRST Ex­
PERIENCE FROM EUROPE
H. Messmann, H. Arnholdt, A. Probst

11:07 – 11:13 OP007
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION FOR EN­BLOC RESECTION OF
LARGE SUPERFICIAL TUMORS OF THE
ILEOCECAL REGION
N. Ishii, M. Uemura, K. Yamazaki,
M.F. Fauze, M. Matsuda, T. Setoyama,
S. Suzuki, S. Uchida, Y. Iizuka, K. Fukuda,
T. Itoh, N. Horiki, Y. Fujita
11:13 – 11:24 OP008
USEFULNESS OF THE NOVEL IT­kNIFE2
FOR COLORECTAL ESD
F. Emura, J.C. Mejia, O. Ricaurte, C. Osorio,
H. Ikehara, Y. Saito
11:24 – 11:31 OP009
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION OF EARLY COLORECTAL TUMOR
USING A GRASPING TYPE SCISSORS FOR­
CEPS: A PRELIMINARY CLINICAL STUDY
K. Akahoshi, Y. Motomura, R. Okamoto,
M. Kubokawa, N. Higuchi, Y. Kashiwabara,
T. Chaen, T. Osoegawa, N. Nakama,
Y. Tanaka, M. Oya
11:31 – 11:39 OP010
TRANSGASTRIC REMOVAL OF NECROTIC
PANCREAS
E.G.H. Moura, A. Navarro, A.C.S. Borges,
D.T.H. Moura, T.F. Souza, K. Yamazaki,
C.K. Furuya Jr., E.E.L. Artifon, P. Sakai
11:39 – 11:46 OP011
TRANSGASTRIC BILIAIRY DRAINAGE
P. Christiaens, V. Moons, G. D’Haens,
G. Van Olmen
11:46 – 11:53 OP012
ENDOSCOPIC THERAPY OF ZENkER’S DI­
VERTICULUM USING THE HOOk­kNIFE
DEVICE
H. Messmann
11:53 – 12:04 OP013
NEW ACCESSORIES AND TRICkS FOR THE
MANAGEMENT OF A DIFFICULT ESOPHA­
GEAL FISTULA
G. Costamagna, A. Tringali, P. Familiari,
M. Mutignani, V. Perri
scIenTIfIc PRoGRaMMe
12:04 – 12:12 OP014
OVER­THE­SCOPE CLIP (OTSC) SUCCESS­
FUL CLOSURE OF TWO CHRONIC FISTU­
LAS RELATED TO ADJUSTABLE GASTRIC
BAND EROSION
F. Iacopini, A. Scozzarro, F. Altorio, M. Shurr,
N. Di Lorenzo
12:12 – 12:23 OP015
ENDOSCOPIC TREATMENT OF COLONIC
STRICTURES IN CROHN’S DISEASE BY
MEANS OF BIODEGRADABLE STENTS
S. Rejchrt, M. Kopacova, J. Bures
12:23 – 12:31 OP016
INTRODUCING SPIRAL ENTEROSCOPY
IN THE Uk
E.J. Despott, E. Tripoli, K. Konieczko,
A. Polecina, C. Fraser
sYMPosIUM
11:00 – 12:30 S4/5
Place of surgery in IbD
Chairs:
T. Oresland, Norway
W. Reinisch, Austria
11:00 – 11:10
Perineal Crohn‘s Disease needs a surgeon
Y. Chowers, Israel
11:10 – 11:20
Perineal Crohn‘s Disease needs a surgeon
B. Steele, UK
11:20 – 11:30
Limited ileocaecal CD: Medical or surgery?
M. Lemann, France;
11:30 – 11:40
Limited ileocaecal CD: Medical or surgery?
W. Bemelman, The Netherlands
11:40 – 11:50
Dysplasia: Colonoscopy or colectomy?
R. Kiesslich, Germany
17
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
11:50 – 12:00
Dysplasia: Colonoscopy or colectomy?
S. Itzkowitz, USA
12:00 – 12:10
Surgery for UC: Cure or curse?
G. Van Assche, Belgium
12:10 – 12:20
Surgery for UC: Cure or curse?
R. McLeod, Canada
sYMPosIUM
11:00 – 12:30 S6/7
Rectal cancer treatment
Chairs:
E. Van Cutsem, Belgium
J. Waye, USA
11:00 – 11:20
Pretreatment staging
G. Brown, UK
11:20 – 11:40
Endoluminal therapy
N. Yahagi, Japan
11:40 – 12:00
Role of the specialized surgeon
L. Pahlman, Sweden
12:00 – 12:20
Current state of neoadjuvant therapy
R. Sauer, Germany
sYMPosIUM
11:00 – 12:30 S8/9
obesity: new understandings in risks
and treatment
Chairs:
P. Enck, Germany
P. Kopelman, UK
11:00 – 11:20
Obesity: Hormonal problems, hormonal
solutions?
B. Field, UK
18
11:20 – 11:40
Dietary management of obesity:
What works?
C. Summerbell, UK
11:40 – 12:00
Drug treatment of obesity
P. Kopelman, UK
12:00 – 12:20
Life­saving obesity treatment?
The pros and cons of bariatric surgery
J. Toouli, Australia
sYMPosIUM
11:00 – 12:30 N7/8
Quality of life in chronic liver disease
Chairs:
D. Jones, UK
Z. Younossi, USA
11:00 – 11:20
Measuring the quality of life: The theory
D. Jones, UK
11:20 – 11:40
Measuring quality of life: The practice
A. Gerbes, Germany
11:40 – 12:00
Pathogenesis of fatigue in liver disease
J. Newton, UK
12:00 – 12:20
Impact of current therapeutic regimens
on quality of life
M. Angelico, Italy
fRee PaPeR sessIon
11:00 – 12:30 N9/10
‘bugging’ the intestine
Chairs:
J. Dore, France
J-F. Colombel, France

11:00 – 11:10 OP017
INFLUENCE OF PATTERN RECOGNITION
GENE MUTATIONS ON THE GUT MICRO­
BIOTA IN PATIENTS WITH CROHN’S DIS­
EASE
M. Joossens, G. Huys, N. Vermeulen,
I. Cleynen, P. Rutgeerts, P. Vandamme,
S. Vermeire
11:10 – 11:20 OP018
PHYLOGENETIC AND FUNCTIONAL
SPECIFICITIES OF CROHN’S DISEASE MI­
CROBIOTA
S. Mondot, J. Tap, J. Furet, P. Lepage,
J. Doré, P. Marteau, M. Leclerc
11:20 – 11:30 OP019
UNIVERSAL DUODENAL MICROBIOTA
WITH IS­PRO IN INDIVIDUALS UNDER­
GOING ROUTINE GASTROSCOPY
M.E. Grasman, A.E. Budding, C.J. Mulder,
P.H.M. Savelkoul, A.A. van Bodegraven
11:30 – 11:40 OP020
BACTERIAL RECOLONIZATION AFTER
GUT RESECTION FOR CROHN’S DISEASE:
UNIFORMITY AS AN ESSENTIAL FACTOR
TOWARD REMISSION
P. Lepage, S. Mondot, N. Vasquez,
I. Mangin, P. Seksik, S. Cécillon, T. Vogel,
P. Pochart, J. Doré, M. Leclerc, P. Marteau
11:40 – 11:50 OP021
CROHN’S DISEASE­ASSOCIATED ADHER­
ENT­INVASIVE E. COLI ARE SELECTIVELY
FAVOURED BY IMPAIRED AUTOPHAGY
TO REPLICATE INTRACELLULARLY
P. Lapaquette, A. Glasser, A. Huett,
R. Xavier, A. Darfeuille-Michaud
11:50 – 12:00 OP022
CROHN’S DISEASE ADHERENT­INVASIVE
ESCHERICHIA COLI COLONIZE AND IN­
DUCE STRONG GUT INFLAMMATION IN
TRANSGENIC MICE ExPRESSING HUMAN
CEACAM6 RECEPTOR
F.A. Carvalho, N. Barnich, A. Sivignon,
C. Chan, C. Stanners, A. Darfeuille-Michaud
scIenTIfIc PRoGRaMMe
12:00 – 12:10 OP023
ALTERED ExPRESSION OF INNATE IMMU­
NITY GENES IN INTESTINAL MUCOSA OF
PEDIATRIC ULCERATIVE COLITIS
M. Pierdomenico, L. Stronati, A. Negroni,
G. Di Nardo, S. Oliva, F. Conte, S. Cucchiara
12:10 – 12:20 OP024
IN VITRO RESPONSE OF CROHN’S PA­
TIENTS MACROPHAGES TO E.COLI CHAL­
LENGE
B.N. Hudspith, A. Waterman,
N.B. Rayment, N.J. Prescott, G.C. Parkes,
J. Kennedy, T. Elliott, C.G. Mathew,
T.R. Elliott, J.D. Sanderson
12:20 – 12:30 OP025
INNATE IMMUNITY­MEDIATED MUCO­
SAL ANGIOGENESIS: INDUCTION BY DIS­
TINCT NOD­LIkE (NLR) AND TOLL­LIkE
(TLR) RECEPTORS
A. Schirbel, F. Scaldaferri, F. Rieder,
M. Phillips, G. West, C. Fiocchi
sYMPosIUM
11:00 – 12:30 N11/12
The liver in the oncological patient
Chairs:
J. Iredale, UK
G. Ramadori, Germany
11:00 – 11:20
Mechanisms of hepatic metastatization
J. Iredale, UK
11:20 – 11:40
Effects of systemic chemotherapy on
the liver
G. Ramadori, Germany
11:40 – 12:00
Loco­regional approaches
R. Lencioni, Italy
12:00 – 12:20
Liver surgery in the oncological patient
J. Belghiti, France
19
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
sYMPosIUM
11:00 – 12:30 Platinum 3/4
Motor and sensory disorders of the
GI tract
Chairs:
M. Fox, Switzerland
J. Tack, Belgium
11:00 – 11:20
The brain­gut axis
Q. Aziz, UK
11:20 – 11:40
Measuring upper GI motility abnormalities:
Is more precision needed?
M. Fox, Switzerland
11:40 – 12:00
Motor and sensory disorders of the
stomach
J. Tack, Belgium
WoRkInG PaRTY RePoRT
12:00 – 12:30
Guidelines on histological techniques
and reporting: The london classification
of GI
R. De Giorgio, Italy
C. Knowles, UK
fRee PaPeR sessIon
11:00 – 12:30 Platinum 1
Management of GeRD and achalasia
Chairs:
G. Tytgat, The Netherlands
F. Zerbib, France
11:00 – 11:10 OP026
DOES BODY MASS INDEx HAVE AN EF­
FECT ON HEALING RATES ACHIEVED
WITH ESOMEPRAZOLE 40 MG IN PA­
TIENTS WITH REFLUx ESOPHAGITIS?
P. Nagy, G. Långström, T. Lind, Z. Tulassay
20
11:10 – 11:20 OP027
EFFECT OF AZD3355, A NOVEL GABA(B)
AGONIST, ON REFLUx AND LOWER
ESOPHAGEAL SPHINCTER FUNCTION
IN PATIENTS WITH GERD WITH SYMP­
TOMS DESPITE PROTON PUMP INHIBI­
TOR TREATMENT
G.E. Boeckxstaens, H. Denison, M. Ruth,
J. Adler, D. Silberg, D. Sifrim
11:20 – 11:30 OP028
EFFICACY AND TOLERABILITY OF THE
NOVEL REFLUx INHIBITOR, AZD3355,
AS ADD­ON TREATMENT IN PATIENTS
WITH GERD WITH CONTINUED SYMP­
TOMS DESPITE PROTON PUMP INHIBI­
TOR THERAPY
G.E. Boeckstaens, H. Beaumont,
J.G. Hatlebakk, D.G. Silberg, J. Adler,
H. Denison
11:30 – 11:40 OP029
EFFICACY AND TOLERABILITY OF
ADx10059, A NEGATIVE ALLOSTERIC
MODULATOR OF MGLUR5, ON GASTRO­
ESOPHAGEAL REFLUx: PH­IMPEDANCE
STUDY IN HEALTHY SUBJECTS
C. Keywood, F. Zerbib
11:40 – 11:50 OP030
TEN­YEAR OUTCOME OF LAPAROSCOPIC
AND CONVENTIONAL NISSEN FUNDO­
PLICATION: RANDOMISED CLINICAL
TRIAL
J. Broeders, H.G. Rijnhart-de Jong,
W.A. Draaisma, A.J. Bredenoord,
A.J.P.M. Smout, H.G. Gooszen
11:50 – 12:00 OP031
GASTRO­OESOPHAGEAL REFLUx IS NOT
RESPONSIBLE FOR THE MAJORITY OF RE­
CURRENT AND NEW REFLUx RELATED
SYMPTOMS POST FUNDOPLICATION
F.C. Kruger, J.E.C. Botha

12:00 – 12:10 OP032
OBJECTIVE PREDICTORS OF RECURRENT
REFLUx DISEASE AFTER PRIMARY NIS­
SEN FUNDOPLICATION
D.J.G.H. Roks, J.A.J.L. Broeders,
W.A. Draaisma, E.J. Hazebroek,
I.A.M.J. Broeders, A.J.P.M. Smout
12:10 – 12:20 OP033
USE OF ULTRASOUND MINIPROBES
FOR DIAGNOSIS AND THERAPEUTIC AP­
PROACH IN ACHALASIA
C. BOUSTIERE, A. Laquiere, P. Castellani,
O. Lebars, M. Bourliere
12:20 – 12:30 OP034
CLINICAL ExPERIENCES OF PER­ORAL
ENDOSCOPIC MYOTOMY (POEM) FOR
ESOPHAGEAL ACHALASIA
H. Minami, H. Inoue, S. Kudo
clInIcal case sessIon
11:00 – 12:30 Platinum 2
clinics in Gastroenterology and Hepatology
1 – Intestine: Diarrhoea and abdominal
pain: Diagnostic challenges
Chairs:
M. Delvaux, France
J. Atherton, UK
Experts:
S. Jackson, UK; M. Novell, UK; S. Travis, UK;
L. Pironi, Italy; G. Barbara, Italy
11:00 – 11:30 OP035
Diarrhoea starting in childhood and pain
of recent onset: Is it one disease?
M. Machado, Portugal
11:30 – 12:00 OP036
Chronic diarrhoea: An unusual complication
of an uncommon disease!
M. Muthuswamy, USA
12:00 – 12:30 OP037a
Delayed intestinal motility: Where is the
speed limit?
T. Das, UK
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
11:00 – 12:30 SG11/12
Diagnostic eUs
Chairs:
A. Fritscher-Ravens, UK
E. Ng, Hong Kong
11:00 – 11:10 OP038
INDICATIONS FOR AND CLINICAL IM­
PACT OF REPEAT ENDOSCOPIC ULTRA­
SONOGRAPHY
A.P. Ainsworth, T. Hansen, C.W. Fristrup,
M.B. Mortensen
11:10 – 11:20 OP039
IN VIVO IMAGING OF MURINE COLITIS
VIA MRP14­DIRECTED FLUORESCENCE­
MEDIATED TOMOGRAPHY (FMT) AND
HIGH­RESOLUTION ULTRASOUND IM­
AGING
D. Bettenworth, F. Hasenberg,
M. Eisenblaetter, K. Tiemann, J. Heidemann,
W. Domschke, A. Lügering
11:20 – 11:30 OP040
MAGNETIC RESONANCE IMAGING (MRI)
VS ENDOSCOPIC ULTRASONOGRAPHY
(EUS) FOR THE DETECTION OF >=10­
MM PANCREATIC TUMORS IN MULTIPLE
ENDOCRINE NEOPLASIA TYPE 1 (MEN1):
A MULTICENTER STUDY BY THE GTE
C. Barbe, A. Murat, B. Dupas, P. Ruszniewski,
A. Tabarin, M. Vullierme, A. Penfornis,
V. Rohmer, E. Baudin, C. Marcus, G. Cadiot
11:30 – 11:40 OP041
LINEAR ENDOSCOPIC ULTRASONOGRA­
PHY (L­EUS) VS MRI IN DIAGNOSIS AND
STAGING OF “EARLY” AMPULLARY TU­
MORS (ATS)
R. Manta, A. Messerotti, H. Bertani,
E. Dabizzi, E. Vetruccio, L. Guicciardi,
R. Conigliaro
21
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
11:40 – 11:50 OP042
THE CLINICAL IMPACT OF CONTRAST
ENHANCED EUS FOR ASSESSMENT OF
PANCREATICOBILIARY MALIGNANCIES
H. Imazu, Y. Uchiyama, K. Ikeda,
K. Sumiyama, L.T. Ang, H. Tajiri
11:50 – 12:00 OP043
ENDOSCOPIC ULTRASOUND (EUS) IS AN
IMPORTANT TOOL FOR EARLY GASTRIC
CANCER (EGC) STAGING, BUT IT IS NOT
A BEST
S. Eun, D. Lee
12:00 – 12:10 OP044
CONTRAST­ENHANCED HARMONIC EN­
DOSCOPIC ULTRASONOGRAPHY (CEH­
EUS) IN SOLID LESIONS OF THE PANCRE­
AS: RESULTS OF A PILOT STUDY
B. Napoleon, R. Gincul, M. Alvarez, B. Pujol,
C. Lefort, J. Souquet, P. Queneau, T. Ponchon
12:10 – 12:20 OP045
PROSPECTIVE STUDY IN ASSESSING THE
IMPACT OF EUS IN THE MANAGEMENT
OF PANCREATIC CYSTIC LESIONS
P.B. Allen, M. Efthymiou, P.P. De Cruz,
P.V. Desmond, R.Y. Chen
12:20 – 12:30 OP046
ANORECTAL ULTRASONOGRAPHY FIND­
INGS IN INFLAMMATORY BOWEL DIS­
EASE – A SINGLE CENTER ExPERIENCE
T. Moreira, F. Castro-Poças, P. Lago,
R. Pimentel, R. Pinto, M. Salgado,
C. Caetano, J. Areias
lIVe enDoscoPY
14:00 – 17:15 S1/2/3
live endoscopy India – live from the
asian Institute of Gastroenterology,
Hyderabad, India
Chairs:
H. Neuhaus, Germany
N. Marcon, Canada
I. Mostafa, Egypt
22
Experts:
N. Reddy, India
M. Bourke, Australia
J. Lau, Hong Kong
naMeD lecTURe
16:45 – 17:15
oMeD francois Moutier lecture: Therapeutic
endoscopy: from evidencebased
medicine to craftsmanship
G. Costamagna, Italy
Introduced by:
A. Axon, UK
fRee PaPeR sessIon
14:00 – 15:35 S4/5
new approaches to IbD therapy:
stem cells and other agents
Chairs:
S. Schreiber, Germany
Y. Chowers, Israel
14:00 – 14:10 OP047
SAFETY AND FEASIBILITY OF AUTOLO­
GOUS BONE MARROW DERIVED MESEN­
CHYMAL STEM CELL TREATMENT IN RE­
FRACTORY CROHN’S DISEASE PATIENTS
M. Duijvestein, M.H. Verwey, H.H. Fidder,
G.R. van den Brink, H. Roelofs, J. Zwaginga,
W.E. Fibbe, D.W. Hommes
14:10 – 14:20 OP048
IMMUNOLOGICAL CHARACTERIZATION
OF BONE MARROW­DERIVED MESEN­
CHYMAL STROMAL CELLS FROM PA­
TIENTS WITH CROHN’S DISEASE
R. Ciccocioppo, M.E. Bernardo, A. Avanzini,
M.L. Russo, C. Perotti, C. Ubezio, O. Luinetti,
R. Maccario, F. Locatelli, G.R. Corazza

14:20 – 14:30 OP049
EFFECTS OF BONE MARROW­DERIVED
MESENCHYMAL STROMAL CELLS IN­
FUSED IN FISTULAS OF PATIENTS WITH
PERIANAL CROHN’S DISEASE ON SERUM
CYTOkINE PATTERN, SALIVARY IGA PRO­
DUCTION, AND CIRCULATING LYMPHO­
CYTE SUBSETS
R. Ciccocioppo, M.E. Bernardo, A. Avanzini,
M.L. Russo, C. Ubezio, C. Alvisi, O. Luinetti,
R. Maccario, F. Locatelli, G.R. Corazza
14:30 – 14:40 OP050
MESENCHYMAL STEM CELLS IMPROVES
CLINICAL SYMPTOMS AND ARE EFFEC­
TIVE FOR MUCOSAL HEALING IN ULCER­
ATIVE COLITIS AND CROHN’S DISEASE
L.B. Lazebnik, O.V. Knyazev,
A.G. Konoplyannikov, A.I. Parfenov,
I.N. Ruchkina
14:40 – 14:50 OP051
LACk OF TOLERIZATION OF INTESTINAL
MESENCHYMAL AND ENDOTHELIAL
CELLS TO BACTERIAL PRODUCTS AND
TFN­A: A NOVEL MECHANISM TO SUS­
TAIN AND AMPLIFY GUT INFLAMMATION
F. Scaldaferri, M. Phillips, G. West,
M. Scarpa, M. Rhee, F. Rieder, A. Schirbel,
C. McDonald, A. Gasbarrini, C. Fiocchi
14:50 – 15:00 OP052
VERY SMALL EMBRYONIC­LIkE STEM
CELLS (VSELS) ARE MOBILIZED INTO
PERIPHERAL BLOOD IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASE
W.M. Marlicz, E. Paczkowska,
B. Machalinski, T. Starzynska,
M.Z. Ratajczak
15:00 – 15:10 OP053
DIAGNOSIS AND GRADING OF INTESTI­
NAL ACUTE GRAFT­VERSUS­HOST DIS­
EASE FOLLOWING ALLOGENEIC STEM
CELL TRANSPLANTATION BY COLONOS­
COPY
W. Kreisel, M. Dahlberg, J. Harder, H. Bertz,
A. Schmitt-Graeff, J. Finke
scIenTIfIc PRoGRaMMe
15:10 – 15:20 OP054
A RANDOMIZED, DOUBLE­BLIND, PLA­
CEBO­CONTROLLED TRIAL OF ORAL
ALPHA­4 INTEGRIN INHIBITOR (AJM300)
IN PATIENTS WITH ACTIVE CROHN’S DIS­
EASE
M. Takazoe, M. Watanabe, T. Kawaguchi,
T. Matsumoto, N. Oshitani, T. Matsui,
N. Hiwatashi, T. Hibi
15:20 – 15:35
Rising Star: The role of Th17 cytokines and
intestinal chemokine systems in intestinal
inflammation
S. Brandt, Germany
sYMPosIUM
14:00 – 15:30 S6/7
The challenge of alcoholic liver
disease
Chairs:
R. Jalan, UK
P. Mathurin, France
14:00 – 14:20
Public policy on alcohol abuse
I. Gilmore, UK
14:20 – 14:40
Alcohol as co­factor in chronic liver
disease
P. Mathurin, France
14:40 – 15:00
New trends in alcohol abuse:
Binge drinking and recreational drugs
S. Zakhari, USA
15:00 – 15:20
Alcohol consumption after liver transplantation
P. Burra, Italy
sYMPosIUM
14:00 – 15:30 S8/9
barrett’s oesophagus: a global perspective
Chairs:
P. Sharma, USA
G. Tytgat, The Netherlands
23
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
14:00 – 14:20
Is Barrett‘s oesophagus a worldwide
problem?
K. M. Fock, Singapore
WoRkInG PaRTY RePoRT
14:20 – 14:50
early recognition of barrett‘s oesophagus
related neoplasia: The boRn project
P. Sharma, USA
J. Bergmann, The Netherlands
14:50 – 15:10
Can we prevent cancer, and if so, how?
J. Jankowski, UK
15:10 – 15:30
New technologies and techniques: Do
they work, and are they practical for all?
J. Bergman, The Netherlands
fRee PaPeR sessIon
14:00 – 15:30 N7/8
Helicobacter pylori: a wider view
Chairs:
C. O'Morain, Ireland
Y. Yamaoka, Japan
14:00 – 14:10 OP055
EPIDEMIOLOGY OF PEPTIC ULCER DIS­
EASE: THE SYSTEMATIC INVESTIGATION
OF GASTROINTESTINAL DISEASES IN
CHINA (SILC)
Z. Li, D. Zou, X. Ma, J. Chen, X. Shi, Y. Gong,
X. Man, L. Gao, Y. Zhao, R. Wang, X. Yan,
J. Dent, J. Sung, W. Liu, J. He
14:10 – 14:20 OP056
EPIDEMIOLOGICAL TRANSITION FROM
H. PYLORI TO NSAIDS/ASA IN ASSO­
CIATION WITH ULCER IN BELGIUM: A 20
YEARS PROSPECTIVE LONGITUDINAL
STUDY (1989–2008)
A. Burette, Q. Marcelis, C. De Prez,
V.Y. Miendje Deyi, J. Vanderpas
24
14:20 – 14:30 OP057
IN VITRO STUDY OF THE ROLE OF MES­
ENCHYMAL STEM CELLS IN GASTRIC
ADENOCARCINOMA INDUCED BY HELI­
COBACTER PYLORI INFECTION
J. Ferrand, C. Varon, P. Lehours, D. Noël,
A. Ménard, F. Mégraud
14:30 – 14:40 OP058
DIFFERENCES IN GENETIC INSTABILITY
AND CELLULAR PHENOTYPE AMONG
BARRETT’S, CARDIAC, AND GASTRIC IN­
TESTINAL METAPLASIA IN A JAPANESE
POPULATION WITH A HIGH RATE OF H.
PYLORI INFECTION
J. Watari, K. Moriichi, H. Tanabe, M. Fujiya,
J. Sakurai, J. Tanaka, T. Morita, T. Tomita,
Y. Kim, T. Ohshima, K. Hori, K.M. Das,
H. Miwa, Y. Kohgo
14:40 – 14:50 OP059
VACCINATION AGAINST HELICOBACTER
PYLORI WITH GAMMA­GLUTAMYL­
TRANSPEPTIDASE
F. Anderl, K. Goller, R. Semper, C. Bolz,
B. Kalali, R. Schmid, D.H. Busch, M. Gerhard
14:50 – 15:00 OP060
LONG­TERM REMISSION RATE OF EARLY­
STAGE GASTRIC MALT­LYMPHOMA AND
PREDICTIVE FACTORS FOLLOWING HELI­
COBACTER PYLORI ERADICATION
D. Vaira, A. Zullo, C. Hassan, F. Cristofari,
C. Iegri, C. Bassanelli, V. Cardinale, V. De
Francesco, E. Ierardi, S. Morini, C. Ricci
15:00 – 15:10 OP061
LONG­TERM FOLLOW­UP OUTCOME OF
API2­MALT1 POSITIVE GASTRIC MALT
LYMPHOMA
M. Tajika, T. Nakamura, V. Bhatia, H. Kawai,
S. Kondo, A. Sawaki, N. Mizuno, K. Hara,
S. Hijioka, H. Imamura, K. Matsumoto,
Y. Kobayashi, A. Saeki, H. Suzuki,
A. Akabane, K. Yamao, S. Nakamura,
T. Yokoi, Y. Yatabe, M. Seto

15:10 – 15:20 OP062
WEIGHT GAIN AFTER RESOLUTION OF
CORPUS GASTRITIS AS RISk FACTOR OF
DEVELOPMENT OF REFLUx OESOPHA­
GITIS AFTER ERADICATION OF H. PYLORI
J.C.Y. Wu, J.Y.L. Ching, J.J.Y. Sung,
F.K.L. Chan
15:20 – 15:30 OP063
RELATIONSHIP BETWEEN HELICO­
BACTER PYLORI INFECTION, GASTRIC
ATROPHY AND THE RISk OF OESOPHA­
GEAL SQUAMOUS CELL CARCINOMA IN
GERMANY
M. Venerito, S. Kohrs, T. Wex,
K. Mönkemüller, D. Schubert, D. Adolf,
P. Malfertheiner
sYMPosIUM
14:00 – 15:30 N9/10
colorectal cancer chemoprevention
Chairs:
N. Arber, Israel
R. Benamouzig, France
14:00 – 14:20
Molecular targets for chemoprevention
E. Hawk, USA
14:20 – 14:40
Which drug(s)?
R. Logan, UK
14:40 – 15:00
Which dietary intervention(s)?
J. Mathers, UK
15:00 – 15:20
What target population?
R. Bresalier, USA
fRee PaPeR sessIon
14:00 – 15:30 N11/12
new imaging techniques
Chairs:
A. Meining, Germany
S. Jackson, UK
scIenTIfIc PRoGRaMMe
14:00 – 14:10 OP064
COMPARISON BETWEEN AVASCULAR­
AREA OF NBI MAGNIFICATION AND TYPE
V PIT PATTERN FOR INVASION DEPTH DI­
AGNOSIS OF COLORECTAL TUMORS
Y. HIRAGA, M. Sumioka, M. Akagi,
T. Hiramoto, Y. Matsumoto, A. Igawa,
R. Hayashi, C. Watanabe, M. Imagawa,
S. Okamoto
14:10 – 14:20 OP065
PREVALENCE OF PANCREATIC CYSTS IN
INDIVIDUALS UNDERGOING MEDICAL
ExAMINATION BIJ MAGNETIC RESO­
NANCE IMAGING (MRI)
K. de Jong, Y.C. Nio, J.J. Hermans,
M.G. Dijkgraaf, D.J. Gouma, C.H.J. van Eijck,
E. van Heel, G. Klass, P.P. Fockens, M.J. Bruno
14:20 – 14:30 OP066
NEWLY DEVELOPED SURFACE COIL FOR
ENDOLUMINAL MRI, DEPICTION OF PIG
GASTRIC WALL LAYERS AND VASCULAR
ARCHITECTURE IN Ex VIVO STUDY
Y. Morita, H. Kutsumi, H. Yoshinaka,
Y. Matsuoka, M. Sugimoto, M. Yoshida,
T. Azuma
14:30 – 14:40 OP067
IN VIVO MOLECULAR IMAGING OF VEGF
IN GASTROINTESTINAL CANCER USING
CONFOCAL LASER ENDOMICROSCOPY
S. Foersch, R. Kiesslich, M.J. Waldner,
P.R. Galle, M.F. Neurath, M. Goetz
14:40 – 14:50 OP068
IN VIVO DYNAMIC IMAGING OF IN­
CREASED CELLULAR SHEDDING IN­
DUCED BY ENTERAL BACTERIA US­
ING CONFOCAL ENDOMICROSCOPY
IN HUMANS. A NEWLY DISCOVERED
PATHOMECHANISM OF IBD
D. Moussata, M. Goetz, A. Watson,
A. Hoffman, J. Saurin, B. Flourie, C. Trovato,
C. Crosta, P. Galle, M. Neurath, R. Kiesslich
25
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
14:50 – 15:00 OP069
RESULTS OF A PHASE II STUDY ON IN­
TRADUCTAL CONFOCAL MICROSCOPY
(IDCM) IN PATIENTS WITH COMMON BILE
DUCT (CBD) STENOSIS
M. Giovannini, C. Fabrice, G. Monges,
E. Bories, C. Pesenti
15:00 – 15:10 OP070
QUANTITATIVE IN VIVO ASSESSMENT OF
VASCULAR PERMEABILITY IN HUMAN
COLONIC MUCOSA USING CONFOCAL
ENDOMICROSCOPY: CLINICAL IMPLICA­
TIONS FOR COLONIC NEOPLASIA
T. Matysiak-Budnik, E. Coron, J. Mosnier,
M. Le Rhun, J. Galmiche, A. Ahluwalia,
A. Tarnawski
15:10 – 15:20 OP071
IN VIVO EVALUATION OF LIVING CELLS
IN THE ESOPHAGUS WITH ENDOCYTOS­
COPY: ENDOCYTOSCOPIC ATYPIA (ECA)
CLASSIFICATION
N. Ogata, H. Inoue, H. Minami, M. Kaga,
Y. Satou, S. Hamatani, S. Kudo
15:20 – 15:30 OP072
IN VIVO IMAGING OF LIVING CANCER
CELLS IN THE STOMACH; NOVEL STAIN­
ING METHOD AND A NEWLY DESIGNED
SINGLE­CCD ENDOCYTOSCOPE
H. Minami, H. Inoue, A. Yokoyama,
N. Ogata, S. Hamatani, S. Kudo
fRee PaPeR sessIon
14:00 – 15:30 Platinum 3/4
Diagnosis and surveillance of sporadic
and familial colorectal cancer
Chairs:
M. Hull, UK
J. Lynch, USA
14:00 – 14:10 OP073
CAN BOWEL SYMPTOMS BE USED TO IN­
DENTIFY PATIENTS WITH COLORECTAL
CANCER?
B. Adelstein, L. Irwig, P. Macaskill,
R.M. Turner, S. Chan, P.H. Katelaris
26
14:10 – 14:20 OP074
DETERMINANTS OF PATIENT’S AND
DOCTOR’S DELAY IN DIAGNOSIS AND
TREATMENT OF COLORECTAL CANCER
N.J. de Wit, P.H.M. Peeters, F.H. Rutten,
A.M.G.H. van Hout
14:20 – 14:30 OP075
DIAGNOSIS OF CLINICALLY IMPORTANT
COLORECTAL LESIONS IN OLDER SYMP­
TOMATIC PATIENTS: A RANDOMISED
COMPARISON OF COMPUTED TOMO­
GRAPHIC COLONOGRAPHY WITH BAR­
IUM ENEMA
W. Atkin, E. Dadswell, K. Wooldrage,
U. Shah, R. Kanani, S. Halligan
14:30 – 14:40 OP076
RELATIONSHIP BETWEEN THE PRESENCE
OF SYNCHRONOUS ADENOMAS AND
THE INCIDENCE OF METACHRONOUS
NEOPLASTIC LESIONS IN COLORECTAL
CARCINOMA
A. Borda Martín, J. Jiménez-Pérez,
M. Muñoz-Navas, J. Martínez-Peñuela,
J. Carrascosa Gil, F. Borda Celaya
14:40 – 14:50 OP077
THE GENOTYPE­PHENOTYPE RELATION­
SHIP IN YOUNG COLORECTAL CANCER
PATIENTS WITHOUT POLYPS OR CLOSE
AFFECTED RELATIVES
K.J. Monahan, K. Pack, C. Cummings,
H.J.W. Thomas
14:50 – 15:00 OP078
INCREASED COLORECTAL CANCER RISk
DURING FOLLOW­UP IN PATIENTS WITH
HYPERPLASTIC POLYPOSIS SYNDROME:
A MULTICENTRE COHORT STUDY
K.S. Boparai, E.M. Mathus-Vliegen,
J. Koornstra, F.M. Nagengast, M. van
Leerdam, C.J. van Noesel, M. Houben,
A. Cats, L. van Hest, P. Fockens, E. Dekker

15:00 – 15:10 OP079
FIRST­DEGREE RELATIVES OF HYPER­
PLASTIC POLYPOSIS PATIENTS HAVE AN
INCREASED COLORECTAL CANCER RISk
K.S. Boparai, J.B. Reitsma, V. Lemmens,
J. Koornstra, F.M. Nagengast, M.A. Jacobs,
J.J. Keller, E. Dekker
15:10 – 15:20 OP080
A PRACTICAL TWO­STEPPED STRAT­
EGY FOR THE IDENTIFICATION OF
LYNCH SYNDROME IN PATIENTS WITH
COLORECTAL CANCER: A PROSPECTIVE,
MULTICENTRIC STUDY
D. Bonnet, J. Selves, C. Toulas, T. Morin,
T. Chaubard, J. Duffas, E. Lagier, S. Kirzin,
R. Guimbaud
15:20 – 15:30 OP081
LYNCH SYNDROME ASSOCIATED TUMOR
SPECTRUM: A FAMILIAL COLORECTAL
CANCER REGISTRY FROM A SINGLE
CENTER
R.N. Silva, P. Lage, I. Claro, P. Rodrigues,
I. Francisco, B. Filipe, S. Ferreira, S. Mão-de-
Ferro, C. Albuquerque, P. Chaves, C. Nobre-
Leitão
fRee PaPeR sessIon
14:00 – 15:30 Platinum 1
Pancreatic and liver cancer
Chairs:
M. Loehr, Sweden
M. Lerch, Germany
14:00 – 14:10 OP082
THE ROLE OF PPARGAMMA IN THE
GROWTH INHIBITION OF HEPATOCEL­
LULAR CARCINOMA
J. Yu, B. Shen, E. Chu, S. Wang, C. Wu,
K. Cheung, C. Lam, A. Cheng, K. To, N. Teoh,
H. Chan, J. Sung
scIenTIfIc PRoGRaMMe
14:10 – 14:20 OP083
ORGAN­, INFLAMMATION­ AND CANCER
SPECIFIC TRANSCRIPTIONAL FINGER­
PRINTS OF PANCREATIC AND HEPATIC
STELLATE CELLS
M. Erkan, C. Schwager, N. Giese, P.E. Huber,
H. Friess, A. Abdollahi, J. Kleeff
14:20 – 14:30 OP084
SMAD4 SILENCING ON PANIN CELLS AC­
CELERATES kRASG12D­MEDIATED PAN­
CREATIC NEOPLASIA
X. Qi, L. Wang, H. Cao, R. Shen, W. Dong,
L. Zhu, Y. Zhang, D. Tuveson
14:30 – 14:40 OP085
THE MICROENVIRONMENT IN PANCRE­
ATIC CANCER INDUCES NEURONAL
PLASTICITY VIA NERVE GROWTH FAC­
TOR AND ARTEMIN
I.E. Demir, G.O. Ceyhan, U. Rauch,
K. Schäfer, H. Friess
14:40 – 14:50 OP086
THE PI3k­AkT PATHWAY IS A DOWN­
STREAM EFFECTOR OF CD24
I. Naumov, S. Kraus, D. Kazanov, S. Shapira,
E. Sagiv, N. Arber
14:50 – 15:00 OP087
NEUROENDOCRINE TUMOURS OF
GASTRO INTESTINAL TRACT AND PAN­
CREAS (GEP­NETS) ARE MORE FREQUENT
AMONG CARRIERS OF IL­2–330 T/G SNP
M. Cigrovski Berkovic, M. Jokic, V. Zjacic-
Rotkvic, S. Kapitanovic
15:00 – 15:10 OP088
xAF1 AS A PROGNOSTIC BIOMARkER
AND THERAPEUTIC TARGET IN PANCRE­
ATIC CANCER
J. Huang, W. Yao, Q. Zhu, H. Cao, F. Yuan,
H. Wang, Y. Yuan
27
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
15:10 – 15:20 OP089
MOLECULAR IN VIVO IMAGING OF PAN­
CREATIC INTRAEPITHELIAL NEOPLASIA
AND EARLY­STAGE PANCREATIC CANCER
S. Eser, M. Messer, P. Eser, F. Nagl, A. von
Werder, M. Bajbouj, A. Meining, J. von
Burstin, H. Algül, P. Pagel, A. Schnieke,
R.M. Schmid, G. Schneider, D. Saur
15:20 – 15:30 OP090
CHANGING PATIENT CHARACTERISTICS,
INDICATIONS AND OUTCOMES OF PAN­
CREATODUODENECTOMY IN A TERTIARY
REFERRAL HOSPITAL
W.J. Eshuis, O.R.C. Busch, T.M. van Gulik,
D.J. Gouma
basIc scIence
14:00 – 15:30 Platinum 2
basic science Workshop 1:
Mechanisms of liver fibrosis
Chairs:
M. Pinzani, Italy
S. Friedman, USA
F. Russo, Italy
H. Wasmuth, Germany
14:00 – 14:05
Introduction
S. Friedman, USA
14:05 – 14:25
Rising Star: The contribution of the Bone
marrow to liver fibrosis and resolution OR
Extrahepatic origin of liver fibrosis
F. Russo, Italy
14:25 – 14:40 OP091
kNOCkOUT OF THE CANNABINOID RE­
CEPTOR 1 RESULTS IN STRONGER HE­
PATIC INFLAMMATION PAIRED WITH A
DOWNREGULATION OF ECM PRODUC­
TION IN THE TAA/ETHANOL LIVER FIBRO­
SIS MODEL IN MICE
M. Stoll, M. Ocker, E.G. Hahn,
T.T. Wissniowski
28
14:40 – 14:55 OP092
EFFECTS OF OVER­ExPRESSION AND
MUTATION OF PTEN ON THE APOPTOSIS
OF CULTURED HEPATIC STELLATE CELLS
L. Hao, X. Zhang, L. Liu, J. An, H. Jiang,
S. Chen
14:55 – 15:10 OP093
EARLY DEVELOPMENT OF LIVER FIBRO­
SIS IN BILIARY ATRESIA: INVOLVEMENT
OF EPITHELIAL TO MESENCHYMAL
TRANSITION AND HEDGEHOG SIGNAL
TRANSDUCTION
H. Yang, R.C. Lind, T. Lisman, R.J. Porte,
H.J. Verkade, J.B.F. Hulscher
15:10 – 15:30
Rising Star: Chemokines in liver fibrosis:
Genetic and functional analyses
H. Wasmuth, Germany
fRee PaPeR sessIon
14:00 – 15:30 SG11/12
Ibs: clinical and pathophysiological
aspects
Chairs:
P. Enck, Germany
M. Delvaux, France
14:00 – 14:10 OP094
PEDIATRIC ExPOSURE TO ACUTE
GASTRO ENTERITIS (GE) IS ASSOCIAT­
ED WITH POST­INFECTIOUS IRRITABLE
BOWEL SYNDROME (IBS): THE WALkER­
TON HEALTH STUDY (WHS)
M. Thabane, M. Simunovic, N. Akhtar-
Danesh, J.K. Marshall
14:10 – 14:20 OP095
INDICATIONS OF “ATOPIC BOWEL” IN
PATIENTS WITH IRRITABLE BOWEL SYN­
DROME
K. Lillestøl, L. Helgeland, E. Florvaag,
G.A. Lied, R. Lind, J. Valeur, A. Berstad

14:20 – 14:30 OP096
IBS SUBTYPING BASED ON ROME III
CRITERIA IS ASSOCIATED WITH ALTERA­
TIONS IN INTESTINAL MOTILITY AND
SECRETION, BUT NOT WITH SENSITIVITY
OR PSYCHOSOCIAL FACTORS
M. Simren, I. Posserud, H. Abrahamsson,
E.A. Thomas, J.C. Bornstein, H. Sjövall
14:30 – 14:40 OP097
THE SELECTIVE CRF­1 RECEPTOR ANTAG­
ONIST GW876008 ATTENUATES STRESS
INDUCED RECTAL HYPERSENSITIVITY IN
PATIENTS WITH IRRITABLE BOWEL SYN­
DROME (IBS)
N.M. Thoua, A.R. Hobson, G.E. Dukes,
D.L. Kelleher, K.J. Hicks, R.L. Boardley,
A.J. Raeburn, A.V. Emmanuel
14:40 – 14:50 OP098
IBS PATIENTS HAVE NORMAL AND AB­
NORMAL BOWEL HABITS: RELEVANCE
FOR SUBTYPING?
M. Simren, I. Posserud, J. Gunnarsson,
H. Strid, I. Midenfjord, G. Ringström,
P. Jerlstad, A. Lindh, H. Abrahamsson
14:50 – 15:00 OP099
CORRELATIONS BETWEEN SOMATIC EN­
DOGENOUS PAIN MODULATION AND
BRAIN ACTIVITY IN IBS AND HEALTHY
CONTROLS
C.H. Wilder-Smith, Y. Cao, K. Ho,
S. Graham
15:00 – 15:10 OP100
PATIENTS WITH MIGRAINE AND IRRI­
TABLE BOWEL SYNDROME PRESENT
AN ABNORMAL POSTPRANDIAL TONIC
AND PHASIC RECTO­SIGMOID MOTOR
ACTIVITY
M. Di Stefano, E. Pucci, C. Mengoli, P. Tana,
F. Racca, G. Sandrini, G. Nappi, G. Corazza
15:10 – 15:20 OP101
HUMAN PSYCHOPHYSIOLOGICAL RE­
SPONSES TO VISCERAL PAIN
A.D. Farmer, M. Kano, S.J. Coen, Q. Aziz
scIenTIfIc PRoGRaMMe
15:20 – 15:30 OP102
ASSESSING QUALITY OF LIFE IN GASTRO­
ENTEROLOGY: CAN A SHORT GENERIC
QUALITY OF LIFE MEASURE BE AS EF­
FECTIVE AT ELICITING QUALITY OF LIFE
INFORMATION AS LENGTHY DISEASE­
SPECIFIC MEASURES?
C.L. Hunt, R. Jones
fRee PaPeR sessIon
15:45 – 17:15 S4/5
Mechanisms of colorectal carcinogenesis
Chairs:
N. Arber, Israel
N. Barker, The Netherlands
15:45 – 15:55 OP103
ROLE OF CITED1 IN A MODEL OF EARLY
STAGE COLORECTAL CANCER
F. Song, T. Phesse, V. Mureil, J.R. Jenkins,
L. Parry, A. Clarke, A.J.M. Watson
15:55 – 16:05 OP104
THE EZH2 REPRESSIVE CHROMATIN SIG­
NATURE MAY PREDISPOSE THE RUNx3
PROMOTER TO METHYLATION BUT IS
NOT INDEPENDENTLY RESPONSIBLE
FOR ITS TRANSCRIPTIONAL SILENCING
IN COLORECTAL CANCER
L.L. Kodach, R.J. Jacobs, J. Heijmans,
C.J.M. van Noesel, D.W. Hommes, G.R. van
den Brink, J.A. Offerhaus, J.C.H. Hardwick
16:05 – 16:15 OP105
COLON CARCINOGENESIS IS DIVIDED
INTO THE UNDIFFERENTIATION AND
PROLIFERATION REGULATED BY ATOH1
AND BETA­CATENIN ON WNT SIGNAL­
ING, RESPECTIVELY
K. Tsuchiya, R. Okamoto, T. Nakamura,
M. Watanabe
16:15 – 16:25 OP106
CD24 IS ExPRESSED IN SPECIFIC CELLS
IN GASTROINTESTINAL EPITHELIA AND
REGULATES APOPTOSIS IN THIS TISSUE
D. Clyde, D.M. Pritchard
29
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
16:25 – 16:35 OP107
SMAD7 ExPRESSION IN T CELLS PRO­
TECTS FROM COLITIS­ASSOCIATED
COLORECTAL CANCER
M.C. Fantini, A. Rizzo, D. Fina, R. Caruso,
M. Sarra, C. Stolfi, C. Becker, T.T. Macdonald,
F. Pallone, M. Neurath, G. Monteleone
16:35 – 16:45 OP108
SEARCHING FOR REPRESENTATIVE BAC­
TERIA IN THE COLONIC MUCOSA OF
COLORECTAL CANCER PATIENTS
T. Mas-de-Xaxars, X. Aldeguer, C. López-
Oliu, M. Sabat, L. García-Gil
16:45 – 16:55 OP109
EPITHELIAL­BACTERIAL INTERACTION: A
POTENTIAL ROLE IN THE PATHOGENESIS
OF COLON CANCER
P.D. Collins, L. Yu, J.M. Rhodes
16:55 – 17:05 OP110
ANGIOGENESIS REPRESSION REDUCES
RECURRENCE RATE AFTER COLECTOMY
AND METASTATIC POTENTIAL IN AN OR­
THOTOPIC MURINE MODEL OF HUMAN
COLON CANCER
C. Eveno, C. Le Hénaff, J. Nemeth, J. Feron,
E. Dupuy, M. Pocard
17:05 – 17:15 OP111
ROLE OF PRO­INFLAMMATORY CYTOkINES
IN THE RECURRENCE OF HUMAN
PAPILLOMA VIRUS­RELATED ANAL CAR­
CINOMA IN HIV­INFECTED PATIENTS
M. Yaghoobi, S. Le Gouvello, C. Duprez-
Duteuil, F. Walker, J. Zeitoun, I. Sobhani
sYMPosIUM
15:45 – 17:15 S6/7
naflD and nasH
Chairs:
S. Bellentani, Italy
C. Day, UK
15:45 – 16:05
Non­alcoholic fatty liver disease:
Epidemiology and aetiology
S. Bellentani, Italy
30
16:05 – 16:25
Pathogenetic mechanisms of liver damage
and fibrosis
N. Kawada, Japan
16:25 – 16:45
Paediatric NAFLD and NASH
E. Roberts, Canada
16:45 – 17:05
Non­alcoholic fatty liver disease:
Where are we now and where are we
going regarding therapy?
C. Day, UK
sYMPosIUM
15:45 – 17:15 S8/9
Upper GI bleeding and nsaIDs:
Why do patients die, and how can we
save them?
Chairs:
F. Chan, Hong Kong
P. Moayyedi, Canada
15:45 – 16:05
Preventing and treating aspirin/NSAID
ulcers: How and in whom?
F. Chan, Hong Kong
16:05 – 16:25
Best endoscopic treatment for bleeding
ulcers; what does the evidence say?
M. Barthet, France
16:25 – 16:45
Cardiovascular and other adverse effects
of COx­2 selective and non­selective
NSAIDS
G. A. Fitzgerald, USA
16:45 – 17:05
Why do patients die from upper GI
bleeds, and how can we improve outcome?
R. Logan, UK

fRee PaPeR sessIon
15:45 – 17:15 N7/8
Pancreatic and biliary endoscopy
Chairs:
R. Kozarek, USA
R. Carter, UK
15:45 – 15:55 OP112
ONE­STEP EUS­ERCP IN COMMON BILE
DUCT STONES
N. Polimeni, F. Bova, A. Lauria, A. Luverà,
F. Polimeni
15:55 – 16:05 OP113
PERORAL CHOLANGIOSCOPY (POC)
FOR BILARY STICTURES AND BILE DUCT
STONES – AN INTERNATIONAL REGISTRY
USING SPYGLASS
H. Neuhaus, M.A. Parsi, K. Binmoeller,
P.D. Stevens, S. Sherman, D.K. Pleskow,
R. Hawes, A. Slivka, B.T. Petersen, T. Ponchon,
O. Haluszka, G. Costamagna, J. Devière,
S. Meisner, Y.K. Chen
16:05 – 16:15 OP114
WIRE­GUIDED SELECTIVE CANNULATION
OF THE BILE DUCT WITH A SPHINCTER­
OTOME: A PROSPECTIVE RANDOMIZED
COMPARATIVE STUDY WITH THE STAN­
DARD METHOD: AN INTERIM REPORT
T. Nambu, T. Ukita, H. Shigoka, S. Omuta,
T. Endo, I. Maetani
16:15 – 16:25 OP115
MIAMI CLASSIFICATION OF PROBE­
BASED CONFOCAL LASER ENDOMI­
CROSCOPY (PCLE) FINDINGS IN THE
PANCREATICOBILIARY (PB) SYSTEM
FOR EVALUATION OF INDETERMINATE
STRICTURES
Y.K. Chen, R. Shah, D. Pleskow, R. Chuttani,
A. Slivka, P. Stevens, M. Giovannini,
A. Meining
scIenTIfIc PRoGRaMMe
16:25 – 16:35 OP116
URGENT ENDOSCOPIC SPHINCTEROTO­
MY IS BENEFICIAL FOR PATIENTS WITH
ACUTE BILIARY PANCREATITIS (ABP)
WITHOUT COMMON BILE DUCT STONES
(CBDS) – A PROSPECTIVE RANDOMIZED
STUDY
E. Nowakowska-Dulawa, A. Nowak,
T. Marek, R. Kaczor, A. Dziurkowska-Marek
16:35 – 16:45 OP117
PERORAL PANCREATOSCOPY PROVIDES
VALUABLE DIAGNOSTIC INFORMATION
WHEN INTRADUCTAL PAPILLARY MU­
CINOUS NEOPLASMS ARE SUSPECTED
F. Swahn, L. Enochsson, M. Löhr,
R. Segersvärd, U. Arnelo
16:45 – 16:55 OP118
DOUBLE­BALLOON ENDOSCOPY FOR
THE ENDOSCOPIC RETROGRADE CHOL­
ANGIOPANCREATOGRAPHY IN PATIENTS
WITH ROUx­EN­Y ANASTOMOSIS
C. Lin, N. Liu, J. Tang, C. Cheng, Y. Tsou,
H. Cheng, M. Lee, C. Lee, K. Sung
16:55 – 17:05 OP119
SPIRAL ENTEROSCOPY­ASSISTED ERCP
IN PATIENTS WITH LONG LIMB SURGICAL
BILIARY BYPASS
R.J. Shah
17:05 – 17:15 OP120
EFFICACY OF BISPECTRAL MONITORING
AS AN ADJUNCT TO PROPOFOL DEEP
SEDATION FOR ERCP: A RANDOMIZED
CONTROLLED TRIAL
I. Hainaki, G. Tribonias, K. Konstantinidis,
M. Parasiri, R. Rouchota, K. Psaras,
A. Theodoropoulou, E. Vardas, A. Vidaki,
M. Manolaraki, G.A. Paspatis
31
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
sYMPosIUM
15:45 – 17:15 N9/10
changing the course of IbD:
Is it applicable to all?
Chairs:
M. Allez, France
M. Fried, Switzerland
15:45 – 16:05
Identifying candidates for agressive
therapy
E. Louis, Belgium
16:05 – 16:25
Can treatment alter the pattern of
disease?
S. Travis, UK
16:25 – 16:40 OP121
LONG­TERM OUTCOME OF TREAT­
MENT WITH INFLIxIMAB IN PEDIATRIC
CROHN’S DISEASE (CD). A POPULATION­
BASED STUDY
V. Crombé, J. Salleron, G. Savoye, J. Dupas,
G. Vernier-Massouille, E. Lerebours,
A. Cortot, D. Turck, C. Gower-Rousseau,
M. Lemman, J. Colombel, A. Duhamel
16:40 – 16:55 OP122
Reduced Crohn’s resections with increasing
immunosuppressant use in a population­based
Crohn’s disease cohort in
Cardiff (1986–2005)
A.V. Ramadas, S. Gunesh, G. Thomas,
G.T. Williams, A.B. Hawthorne
16:55 – 17:15
Existing IBD guidelines: Ready for global
application?
M. Fried, Switzerland
sYMPosIUM
15:45 – 17:15 N11/12
Global education for Gastroenterologists
Chairs:
E. Quigley, Ireland
R. Kozarek, USA
32
15:45 – 15:50
Introduction
E. Quigley, Ireland
15:50 – 16:00
WGO training centres and Train the
Trainers workshops
J. Toouli, Australia
16:00 – 16:10
Evaluations
G. Metz, Australia
16:10 – 16:20
Train the Trainers Post Workshop
Evaluations
O. T. Terpstra, The Netherlands
16:20 – 16:30
Train the Trainers Evaluation: Six month
follow up Porto
G. Macedo, Portugal
16:30 – 16:40
Train the Trainers Evaluation: Portugal/
USA/Brazil
D. Bjorkman, USA
16:40 – 16:50
Training centre evaluations
R. Saenz, Chile
16:50 – 16:55
Future plans
J. Toouli, Australia
16:55 – 17:15
Discussion

sYMPosIUM
15:45 – 17:15 Platinum 3/4
Management of anorectal disorders:
an update
Chairs:
P. Enck, Germany
S. Rao, USA
15:45 – 16:05
Imaging of the ano­rectum and pelvic
floor: From anatomy to function
V. Laurent, France
16:05 – 16:25
Obstructed defaecation syndrome
S. Rao, USA
16:25 – 16:45
Anorectal sepsis in the immunocompromised
patient
W. R. Schouten, The Netherlands
16:45 – 17:05
Ileo­anal pouch: Surveillance and therapeutic
trends
T. Oresland, Norway
fRee PaPeR sessIon
15:45 – 17:15 Platinum 1
basic hepatology
Chairs:
E. Albano, Italy
Y. Inagaki, Israel
15:45 – 15:55 OP123
HEME OxYGENASE­1 PROTECTS
AGAINST STEATOHEPATITIS BOTH IN VI­
TRO AND IN VIVO
J. Yu, E. Chu, R. Wang, S. Wang, C. Wu,
V. Wong, H. Chan, J. Sung
15:55 – 16:05 OP124
EFFICACY OF PROPRANOLOL AND IMA­
TINIB AMONG RATS WITH INDUCED
ISCHEMIC ANGIOGENESIS BY PARTIAL
PORTAL VEIN LIGATION
A. SOYLU, M. Kalayci, A.S. Kemik, S. Ozkara,
A. Gedikbasi, N. Yasar, K. Demir
scIenTIfIc PRoGRaMMe
16:05 – 16:15 OP125
COMMON SIGNALLING AND REDOx SEN­
SITIVE EVENTS REGULATE MIGRATION
AND CHEMOTAxIS OF BONE MARROW­
DERIVED MESENCHYMAL STEM CELLS
AND HEPATIC STELLATE CELLS
C. Busletta, E. Novo, L. Valfrè di Bonzo,
D. Povero, S. Cannito, C. Paternostro,
A. Compagnone, A. Bandino,
S. Colombatto, F. Marra, M. Pinzani,
M. Parola
16:15 – 16:25 OP126
GALLSTONE DISEASE IN SWEDISH TWINS
IS ASSOCIATED TO ABCG8 D19H RISk
GENOTYPE
D. Katsika, P. Magnusson, M. Krawczyk,
F. Grünhage, P. Lichtenstein, C. Einarsson,
F. Lammert, H. Marschall
16:25 – 16:35 OP127
IDENTIFICATION OF CD8+ T­CELL IM­
MUNODOMINANT EPITOPES DERIVED
FROM MURINE ALPHA­FETOPROTEIN
I. Archambeaud, J. Cany, G. Vassaux,
N. Ferry, S. Conchon
16:35 – 16:45 OP128
TRANSCRIPTIONAL REGULATION OF THE
NA/I SYMPORTER NIS GENE BY P53, P63
AND P73 IN HUMAN CHOLANGIOCAR­
CINOMA (CCA) AND AND HEPATOCEL­
LULAR (HCC) CELLS
F. Guerrieri, V. Schinzari, J. Herve,
D. Samuel, C. Brechot, J. Faivre, M. Levrero
16:45 – 16:55 OP129
MOLECULAR CHARACTERISATION OF
INTRAHEPATIC TUMORS IN ATP7B −/− MICE
W. Schirrmeister, D. Kuester, D. Huster
33
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
scIenTIfIc PRoGRaMMe
16:55 – 17:05 OP130
ENDOTHELIAL NITRIC OxIDE SYNTHASE
CHANGES THE FAT DISTRIBUTION IN
HIGH­FAT DIET­INDUCED NAFLD MICE
Y. Nozaki, K. Fujita, M. Yoneda,
H. Mawatari, Y. Shinohara, K. Imajo,
H. Endo, K. Hosono, H. Takahashi,
H. Kirikoshi, Y. Abe, N. Kobayashi,
M. Inamori, K. Kubota, Y. Nagashima,
S. Saito, A. Nakajima
17:05 – 17:15 OP131
PIOGLITAZONE ATTENUATES ISCHEMIA/
REPERFUSION INDUCED LIVER INJURY
IN RAT
M.H. Somi, B. Hajipour, N. Ahmadi Asl,
R. Estakhri, A. Nourazar, M. Nasirizadeh,
A. Ghorbani Haghjou, A. Vatankhah
fRee PaPeR sessIon
15:45 – 17:15 Platinum 2
GeRD: epidemiology, pathogenesis
and diagnostics
Chairs:
D. Sifrim, Belgium
A. Smout, The Netherlands
15:45 – 15:55
Introduction
A. Smout, The Netherlands
15:55 – 16:05 OP132
NATURAL HISTORY OF NON­EROSIVE RE­
FLUx DISEASE, THE kALIxANDA STUDY,
A POPULATION­BASED STUDY
J. Ronkainen, P. Aro, T. Storskrubb,
N.J. Talley, M. Vieth, E. Bolling-Sternevald,
T. Lind, L. Agréus
16:05 – 16:15 OP133
GASTRO­ESOPHAGEAL REFLUx DISEASE
AND ESOPHAGEAL DYSMOTILITY AFTER
LUNG TRANSPLANTATION
S. Roman, F. Philit, F. Tronc, J. Mornex,
F. Mion
34
16:15 – 16:25 OP134
THE STRUCTURE AND FUNCTION OF THE
GASTRO­OESOPHAGEAL JUNCTION IN
HEALTH AND REFLUx DISEASE
M.R. Fox, J. Curcic, E. Kaufman, A. Pal,
Z. Forras-Kaufman, R. Treier, B. Peter,
M. Fried, W. Schwizer
16:25 – 16:35 OP135
THE MUCOSAL ExPRESSION OF ZONU­
LIN, A REGULATOR OF EPITHELIAL PER­
MEABILITY, IS NOT INCREASED IN THE
CARDIA AND ESOPHAGEAL MUCOSA OF
PATIENTS WITH GASTROESOPHAGEAL
REFLUx DISEASE
K. Mönkemüller, T. Wex, D. Kuester, L. Fry,
P. Malfertheiner
16:35 – 16:45 OP136
OBJECTIVE DEFINITION AND DETECTION
OF TRANSIENT LOWER ESOPHAGEAL
SPHINCTER RELAxATION RE­VISITED: IS
THERE ROOM FOR IMPROVEMENT?
R.H. Holloway, G.E. Boeckxstaens,
R. Penagini, D.A. Sifrim, A.J.P.M. Smout,
C. Kristensson, M. Ruth
16:45 – 16:55 OP137
GERD: HIGH DEFINITION ENDOSCOPY
(HD+) IN CONJUNCTION WITH I­SCAN
AND CHROMOENDOSCOPY RELIABLY
IDENTIFY MINIMAL CHANGE ESOPHA­
GITIS IN NERD AND ASYMPTOMATIC
PATIENTS
A. Hoffman, N. Deris, M. Goetz, J. Mudter,
S. Biesterfeld, P.R. Galle, M.F. Neurath,
R. Kiesslich
16:55 – 17:05 OP138
QUANTIFICATION OF DENTAL EROSIONS
IN GORD USING OPTICAL COHERENCE
TOMOGRAPHY; A PLACEBO­CON­
TROLLED STUDY
C.H. Wilder-Smith, P. Wilder-Smith, A. Lussi

17:05 – 17:15 OP139
EROSIVE AND NONEROSIVE REFLUx
DISEASE AND RISk FOR ESOPHAGEAL
ADENOCARCINOMA
H. Pohl, D.J. Robertson, D.K. Farkas,
L. Pedersen, J.A. Baron, H.T. Sorensen
fRee PaPeR sessIon
15:45 – 17:15 SG11/12
nutrition and probiotics
Chairs:
C. Catassi, Italy
P. Marteau, France
15:45 – 15:55 OP140
DIFFERENTIAL GUT HORMONE SECRE­
TION FROM ENTEROENDOCRINE L­CELLS
IN PATIENTS WITH SHORT BOWEL SYN­
DROME
K. Wallis, C.W. Le Roux, M.A. Ghatei,
J.J. Holst, A. Forbes, S.M. Gabe, J.R.F. Walters
15:55 – 16:05 OP141
THE INFLUENCE OF TEDUGLUTIDE, A
NOVEL GLP­2 ANALOGUE, ON ENERGY
ABSORPTION IN SHORT BOWEL SYN­
DROME (SBS) PATIENTS DEPENDENT ON
PARENTERAL NUTRITION (PN)
P.B. Jeppesen, K.A. Tappenden, R. Gilroy,
S.J. O’Keefe, D.L. Seidner, B. Messing
16:05 – 16:15 OP142
COMBINING ENTERAL & PARENTERAL
NUTRITION IN THE POSTOPERATIVE
PATIENT STIMULATES THE ENTERO­
INSULAR AxIS IMPROVING GLUCOSE
HOMEOSTASIS
P.G. Lidder, D. Flanagan, S. Fleming,
T. Wheatley, J. Rahamin, S. Lewis
16:15 – 16:25 OP143
GASTRIC SENSORY FUNCTIONS AND
HORMONE PROFILES IN NORMAL
WEIGHT AND OBESE PEOPLE
B.K. Wölnerhanssen, M. Napitupulu,
J. Drewe, C. Beglinger
scIenTIfIc PRoGRaMMe
16:25 – 16:35 OP144
EFFECT OF HERBAL MEDICINE RIkkUN­
SHITO ON PLASMA LEVELS OF GASTRO­
INTESTINAL HORMONES THAT REGU­
LATE FOOD INTAkE
K. Yakabi, T. Aoyama, J. Kawashima,
T. Sakurada, S. Ohno, S. Kato, S. Ro
16:35 – 16:45 OP145
IS­PRO: HIGH­THROUGHPUT FINGER­
PRINTING OF THE INTESTINAL MICRO­
BIOTA
A.E. Budding, M. Grasman, D. Soeltan-
Kaersenhout, A. van Bodegraven,
P. Savelkoul
16:45 – 16:55 OP146
BARRIER­PROTECTING EFFECTS OF PRO­
BIOTICS DURING CHRONIC STRESS IN
RATS INVOLVE MAST CELLS AND PPAR­
GAMMA
F. Lutgendorff, A.H. Carlsson,
H. Timmerman, H. Gooszen, L. Akkermans,
J.D. Söderholm
16:55 – 17:05 OP147
THE GENETICALLY MODIFIED LACTO­
COCCUS LACTIS OVA MODULATES T­
CELLS THROUGH AN ANTIGEN­SPECIFIC
EFFECT ON DENDRITIC CELLS
I.L. Huibregtse, H. Braat, T. van Capel,
V. Snoeck, L. Boon, P. Rottiers, S. van
Deventer, M. Kapsenberg, E. de Jong
17:05 – 17:15 OP148
LACTOBACILLUS GG IN THE PREVENTION
OF NOSOCOMIAL GASTROINTESTINAL
AND RESPIRATORY TRACT INFECTIONS:
A RANDOMISED, PLACEBO­CON­
TROLLED, DOUBLE­BLIND STUDY
I. Hojsak, S. Abdovic, H. Szajewska,
Z. Krznaric, Z. Misak, S. Kolacek
35
MonDaY, noVeMbeR 23, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
lIVe enDoscoPY
08:30 – 12:30 S1/2/3
live endoscopy london – live from
st. Mark’s Hospital, london, Uk
Chairs:
E. Swarbrick, UK
J. Waye, USA
C. Williams, UK
Experts at the hospital
B. Saunders, UK; T. Ponchon, France;
C. Fraser, UK; N. Suzuki, UK; T. Toyonaga,
Japan; H. Yamamoto, Japan
naMeD lecTURe
12:00 – 12:30
oMeD sadataka Tasaka lecture:
Recent advances of electronic endoscope:
Image-enhanced endoscopy
H. Tajiri, Japan
Introduced by:
W. S. C. Chao
sYMPosIUM
08:30 – 10:30 S4/5
GoRD treatment: current problems
and new solutions
Chairs:
J. P. Galmiche, France
R. Hunt, Canada
naMeD lecTURe
08:30 – 09:00
WGo Georges brohée Medal lecture:
acid secretion in the developed world:
now too much of a good thing?
K. McColl, UK
Introduced by:
E. Quigley, Ireland
Henry Cohen, Uruguay
09:00 – 09:20
Improving acid suppression: Is the best
to come?
R. Hunt, Canada
36
09:20 – 09:40
Inhibitors of TLOSRs: Where are we
today?
A. Smout, The Netherlands
09:40 – 10:00
Endoscopic treatment: The beginning
of the end or the end of the beginning?
J. Devière, Belgium
10:00 – 10:20
Laparoscopic anti­reflux surgery:
Does LARS last?
D. Watson, Australia
sYMPosIUM
08:30 – 10:30 S6/7
challenges in the management of IbD
Chairs:
S. Vermeire, Belgium
S. Travis, UK
08:30 – 08:50
Tailoring treatment to the individual
patient: How to do it?
R. Panaccione, Canada
08:50 – 09:10
Primary anti­TNF failures: What to do
with them?
M. Allez, France
09:10 – 09:30
keeping the balance between risks and
benefit
J-F. Colombel, France
09:30 – 09:50
Influence of imaging on decision making
M. Delvaux, France
WoRkInG PaRTY RePoRT
09:50 – 10:20
Positioning of biological therapies in
IbD treatment
G. D'Haens, Belgium

sYMPosIUM
08:30 – 10:30 S8/9
noTes: Is there a future?
Chairs:
G. Costamagna, Italy
R. Hawes, USA
08:30 – 08:44
The development and vision of NOTES
N. Reddy, India
08:44 – 08:58
Progress Report Europe (EURONOTES)
P. Fockens, The Netherlands
08:58 – 09:08 OP149
RANDOMIZED COMPARATIVE TRIAL
OF TRANSESOPHAGEAL ENDOSCOPIC
VERSUS THORACOSCOPIC REMOVAL OF
MARkED MEDIASTINAL LYMPHNODES
IN A LONG­TERM ANIMAL SURVIVAL
STUDY
A. Fritscher-Ravens, O. Olagbaiye,
C. Holland, A. Ghanbari, K. Hadeler,
B. Jacobsen, F. Seehusen, K. Mannur
09:08 – 09:22
Progress report North America
R. Hawes, USA
09:22 – 09:32 OP150
RANDOMIZED CONTROLLED TRIAL COM­
PARING ENDOSCOPIC CLIP TECHNIQUES
FOR NOTES GASTROTOMY CLOSURE
D. von Renteln, M.C. Vassiliou,
R.I. Rothstein
09:32 – 09:46
Progress report Asia
E. Ng, Hong Kong
09:46 – 10:00
Progress report Latin America
C. Navarrete, Chile
scIenTIfIc PRoGRaMMe
10:00 – 10:14
A surgeon’s perspective
A. Fingerhut, France
10:14 – 10:28
A gastroenterologist’s perspective
E. Quigley, Ireland
fRee PaPeR sessIon
08:30 – 10:35 N7/8
safety and outcome prediction in IbD
Chairs:
E. Louis, Belgium
W. Reinisch, Austria
08:30 – 08:40 OP151
PREDICTORS OF CLINICAL RESPONSE
AND RELAPSE IN CROHN’S DISEASE
W. Reinisch, D.T. Rubin, A.G. Bensimon,
A.P. Yu, E.Q. Wu, J. Chao, P. Mulani
08:40 – 08:50 OP152
RISk MATRIx MODEL FOR PREDICTION
OF SURGERY IN A POPULATION BASED
STUDY OF PATIENTS WITH CROHN’S DIS­
EASE
I. Solberg, M. Cvancarova, B. Moum
08:50 – 09:00 OP153
PREDICTORS OF POOR OUTCOME IN
PAEDIATRIC CROHN’S DISEASE
J. Salleron, C. Gower-Rousseau, G. Savoye,
J. Dupas, G. Vernier-Massouille, E. Lerebours,
A. Cortot, D. Turck, J. Salomez, M. Lemann,
J. Colombel, A. Duhamel
09:00 – 09:10 OP154
THREE YEAR MORTALITY FOLLOWING
ADMISSION FOR THE TREATMENT OF
ULCERATIVE COLITIS: A 5 YEAR, RETRO­
SPECTIVE CASE REVIEW
J.D. Falvey, I. Ahmed, C.S.J. Probert
37
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
09:10 – 09:20 OP155
CLINICAL AND ECONOMIC OUTCOMES
IN A EUROPEAN COHORT OF ULCER­
ATIVE COLITIS AND CROHN’S DISEASE
BY MARkOV PROBABILITY ANALYSIS
S. Odes, H. Vardi, M. Friger, B. Moum,
T. Bernklev, D. Esser, H. Waters, M. Elkjaer,
R. Stockbrugger, E. Tsianos, P. Munkholm,
E. Langholz
09:20 – 09:30 OP156
OUTCOME OF ACUTE SEVERE ULCER­
ATIVE COLITIS: DATA FROM THE Uk NA­
TIONAL IBD AUDIT
I.D.R. Arnott, K. Leiper, C. Down, J. Rhodes,
J. Potter
09:30 – 09:40 OP157
2 YEAR FOLLOW UP OF A NURSE LED
GUIDED SELF MANAGEMENT PRO­
GRAMME IN IBD
C.J. Stansfield, A. Robinson
09:40 – 09:50 OP158
MORTALITY IN INFLAMMATORY BOW­
EL DISEASE IN THE NETHERLANDS
1991–2002, RESULTS OF A POPULA­
TION BASED STUDY: THE IBD SOUTH­
LIMBURG COHORT
M. Romberg-Camps, E. Kuiper,
L. Schouten, A. Kester, M. Hesselink-van
de Kruijs, C. Limonard, R. Bos, J. Goedhart,
W. Hameeteman, F. Wolters, M. Russel,
R. Stockbrügger, P. Dagnelie
09:50 – 10:00 OP159
LYMPHOMA RISk IN INFLAMMATORY
BOWEL DISEASE PATIENTS TREATED
WITH AZATHIOPRINE IN A DUTCH NA­
TIONWIDE STUDY
A.C.W. Vos, N. Bakkal, R.C. Minnee, D.J. De
Jong, G. Dijkstra, P. Stokkers, A.A. van
Bodegraven, M.J. Pierik, C.J. van der Woude,
B. Oldenburg, D.W. Hommes
38
10:00 – 10:10 OP160
HEPATITIS B (HBV) AND C (HCV) REAC­
TIVATION IN INFLAMMATORY BOWEL
DISEASE (IBD) PATIENTS TREATED WITH
IMMUNOSUPPRESSIVE THERAPY. A NA­
TIONWIDE MULTICENTER STUDY
C. Loras, J. Gisbert, M. Mínguez, O. Merino,
L. Bujanda, C. Saro, E. Domenech, J. Barrio,
M. Andreu, I. Ordás, L. Vida, G. Bastida,
F. González-Huix, M. Piqueras, D. Ginard,
X. Calvet, A. Gutiérrez, A. Abad, M. Torres,
F. Fernández-Bañares, J.M. Viver, M. Esteve
10:10 – 10:20 OP161
RENAL SAFETY OF HIGH AND LOW DOSE
MAINTENANCE TREATMENT WITH ME­
SALAMINE GRANULES IN ULCERATIVE
COLITIS PATIENTS: A RANDOMIZED,
DOUBLE­BLIND, DOUBLE­DUMMY,
DOSE­RANGING, 12­MONTHS STUDY
W. Kruis, R. Greinwald, R. Mueller
10:20 – 10:35
Rising Star: IBD: Genetics, hedgehog and
the regulation of colonic inflammatory
pathways
C. Lees, UK
fRee PaPeR sessIon
08:30 – 10:30 N9/10
screening for colorectal cancer
Chairs:
G. Young, Australia
R. Leceister, UK
08:30 – 08:40 OP162
A SIMPLE BLOOD TEST, EVALUATING THE
LEVEL OF CD24 PROTEIN, CAN DETECT
SUBJECTS WITH ADENOMAS
S. Kraus, I. Naumov, D. Kazanov,
L. Galazan, S. Shapira, V. Lisianski, R. Geva,
E. Shmueli, A. Hallack, I. Shafat, F. Kastrinos,
A.I. Neugut, N. Arber

08:40 – 08:50 OP163
DETECTION OF L­DNA IN STOOL SAM­
PLES USING DENATURING HIGH PER­
FORMANCE LIQUID CHROMATOGRA­
PHY (DHPLC): A NOVEL METHOD FOR
COLORECTAL CANCER SCREENING?
M. Cretella, M. Kalimutho, E. Mannisi,
A. Caruso, M. Cossignani, S. Bernardini,
F. Pallone, G. Del Vecchio Blanco
08:50 – 09:00 OP164
SCREENING FOR COLORECTAL CANCER
BY IMMUNOCHEMICAL TEST: RESULTS
OF FOUR ROUNDS
S. Crotta, C. Senore, N. Segnan, S. Paganin,
B. Dagnes
09:00 – 09:10 OP165
DIAGNOSTIC YIELD AND INTERVAL CAN­
CER RATES OF IMMUNOCHEMICAL FOBT
AND SIGMOIDOSCOPY FOR COLOREC­
TAL CANCER SCREENING
C. Senore, N. Segnan, P. Armaroli,
A. Santarelli, A. Giacomin, O. Giuliani,
F. Falcini, P. Piccini, M. Zappa, L. Bisanti
09:10 – 09:20 OP166
FECAL OCCULT BLOOD TEST SCREENING
INCREASES THE CHANCES FOR RADICAL
SURGERY FOR COLORECTAL CANCER
ONLY SLIGHTLY BUT ENABLES ELIMINA­
TION OF PREMALIGNANT LESIONS
H.M. Paimela, N. Malila, T. Oivanen,
T. Hakulinen, H. Jarvinen, P. Pikkarainen,
M. Rautalahti, R. Sankila, H. Vertio
09:20 – 09:30 OP167
REDUCED STAGE AT DIAGNOSIS OF
COLORECTAL CANCER IN THE NHS BOW­
EL CANCER SCREENING PROGRAMME
T.J.W. Lee, C. Zwart, C. Rees, M.D. Rutter
09:30 – 09:40 OP168
THE IMPACT OF THE NHS BOWEL CAN­
CER SCREENING PROGRAMME ON SUR­
GICAL SERVICE PROVISON IN A DISTRICT
GENERAL HOSPITAL
J.A. Smith, G. Lipscomb, P. Harris
scIenTIfIc PRoGRaMMe
09:40 – 09:50 OP169
A COMPARISON STUDY OF COLORECTAL
CANCER POSITIVE PREDICTIVE VALUE
AND DUkES CLASSIFICATION BETWEEN
THE FIRST DAY POSITIVE AND NEGATIVE
GROUP OF 2 DAYS IMMUNOLOGICAL FE­
CAL OCCULT BLOOD TEST COLORECTAL
CANCER SCREENING
Y. Saito, A. Nakahara, I. Hyodo,
I. Ymaguchi, T. Ishikawa
09:50 – 10:00 OP170
HOW GOOD IS THE GUAIAC­BASED FAE­
CAL OCCULT BLOOD TEST FOR POPULA­
TION SCREENING OF COLORECTAL CAN­
CER?
S.P. Halloran, J. Snowball
10:00 – 10:10 OP171
COST EFFECTIVENESS OF MASS SCREEN­
ING FOR COLORECTAL CANCER: CHOICE
OF FAECAL OCCULT BLOOD TEST AND
STRATEGY OF SCREENING
I. Sobhani, I. Ghout, J. Delchier, I. Durand-
Zaleski
10:10 – 10:20 OP172
ECONOMIC ANALYSIS OF CT COLONOG­
RAPHY SCREENING FOR COLORECTAL
CANCER
D. Lee, D. Muston, A. Sweet, K. Gairy
10:20 – 10:20 OP173
IMPLICATIONS OF THE AMERICAN COL­
LEGE OF RADIOLOGY RECOMMENDA­
TIONS FOR REPORTING CT COLONOG­
RAPHY FINDINGS ON ASYMPTOMATIC
POPULATION IN ASIA
J.J.Y. Sung, K.K.F. Tsoi, M.C.S. Wong, B. Suen,
D.J.Y. Luo
sYMPosIUM
08:30 – 10:30 N11/12
liver fibrosis: Diagnostic and therapeutic
challenges
Chairs:
J. Iredale, UK
M. Pinzani, Italy
39
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
08:30 – 08:50
Biochemical markers
W. Rosenberg, UK
08:50 – 09:10
Transient elastography
L. Castera, France
09:10 – 09:30
Advanced imaging
B. Taouli, USA
09:30 – 09:50
Antifibrotic therapy: Molecular targets
Y. Inagaki, Japan
09:50 – 10:10
Antifibrotic therapy: Clinical end­points
S. L. Friedman, USA
sYMPosIUM
08:30 – 10:30 Platinum 3/4
Intrahepatic gallstones
Chairs:
J. Belghiti, France
J. Sung, Hong Kong
08:30 – 08:50
Classification
J. Belghiti, France
08:50 – 09:10
An Asian perspective
T. Mori, Japan
09:10 – 09:30
Endotherapy
H. Neuhaus, Germany
09:30 – 09:50
The percutaneous approach
C. S. Shim, Korea
09:50 – 10:10
Surgical resection
F. Giuliante, Italy
40
sYMPosIUM
08:30 – 10:30 Platinum 1
stem cells in metaplasia and cancer
Chairs:
J. Slack, USA
N. Wright, UK
08:30 – 09:00
Metaplasia and clonality
N. Wright, UK
09:00-09:30
Tracking intestinal stem cells: From crypt
to cancer
N. Barker, The Netherlands
09:30 – 10:00
Transcriptional regulation of metaplasia
in pancreas, liver and oesophagus
J. Slack, USA
10:00 – 10:30
The role of Cdx proteins
J. Lynch, USA
fRee PaPeR sessIon
08:30 – 10:30 Platinum 2
capsule endoscopy
Chairs:
R. Eliakim, Israel
A. Van Gossum, Belgium
08:30 – 08:40 OP174
PREPARATIONS FOR PILLCAM COLON
CAPSULE ENDOSCOPY ARE AS ACCEPT­
ABLE AND SAFE AS THAT FOR STAN­
DARD COLONOSCOPY
C. Spada, M.E. Riccioni, L. Petruzziello,
P. Cesaro, G. Costamagna
08:40 – 08:50 OP175
EVALUATION OF SMALL BOWEL IMAG­
ES ACCORDING TO THE PREPARATION
METHOD FOR CAPSULE ENDOSCOPY:
NPO VS. PEG 2L VS. PEG 4L
S. Park, K. Lee, J. Kim, J. Hyun, E. Kim,
S. Park, B. Keum, Y. Seo, Y. Kim, Y. Jeen,
H. Chun, S. Um, C. Kim, H. Ryu

08:50 – 09:00 OP176
CAN WE SHORTEN THE SMALL­BOWEL
CAPSULE READING TIME? VALIDATION
OF THE “QUICk­VIEW” IMAGE DETEC­
TION SYSTEM
J. Saurin, M. Lapalus, F. Cholet, P. D’Halluin,
B. Filoche, M. Gaudric, S. Sacher Huvelin,
C. Savale, M. Frédéric, P. Adenis-Lamarre,
E. Ben Soussan
09:00 – 09:10 OP177
IS CAPSULE ENDOSCOPY (CE) UNDE­
RUTILIZED IN EVALUATING PATIENTS
WITH UNExPLAINED IRON DEFICIENCY
ANEMIA (IDA)?
I.M. Gralnek, D. Malvehy
09:10 – 09:20 OP178
SMALL BOWEL ANGIODYSPLASIA AND
LYMPHANGIECTASIA: A POSITIVE ASSO­
CIATION. A NOVEL CLINICAL MARkER OR
A SHARED PATHOPHYSIOLOGY?
J.C. Macdonald, V. Porter, N.W. Scott,
D. McNamara
09:20 – 09:30 OP179
DOES ERYTHROMYCIN ADMINISTRA­
TION PRIOR TO CAPSULE ENDOSCOPY
AFFECT THE RATE OF COMPLETE ExAMI­
NATIONS IN HOSPITALIZED PATIENTS? A
PROSPECTIVE RANDOMIZED TRIAL
I. Fernandez-Urien, E. Borobio, I. Elizalde,
M. Vicuña, B. Gonzalez de la Higuera,
A. Borda, J. Vila, F. Jiménez, F. Borda
09:30 – 09:40 OP180
THE SIZE ESTIMATION OF SMALL BOWEL
LESIONS IN WIRELESS CAPSULE ENDOS­
COPY: COMPARISON OF PILLCAM SB
AND SB2
E. Kim, H. Chun, K. Lee, J. Kim, J. Hyun,
S. Park, S. Park, B. Keum, Y. Seo, Y. Jeen,
S. Um, C. Kim, H. Ryu, Y. Kim
scIenTIfIc PRoGRaMMe
09:40 – 09:50 OP181
TWO CAMERAS DETECT MORE LESIONS
IN THE SMALL­BOWEL THAN ONE. FINAL
RESULTS OF A SMALL­BOWEL CAPSULE
ENDOSCOPY FEASIBILITY TRIAL WITH
PILLCAM COLON ®
K. Triantafyllou, I.S. Papanikolaou,
K. Papaxoinis, I. Binas, P. Karantzas,
G. Karamanolis, S.D. Ladas
09:50 – 10:00 OP182
THE USEFULNESS OF POSITIVE AND
NEGATIVE CAPSULE ENDOSCOPY AND
THEIR IMPACT ON MANAGEMENT OF
SMALL INTESTINAL DISORDERS
A. Fritscher-Ravens, P. Scherbakov,
S. Koletzko, P. de Angelis, T. Ruuska, K. Kolho,
M. Thomson, M. Tabbers, P.J. Milla
10:00 – 10:10 OP183
CLINICAL IMPACT OF GIVEN SB2 VIDEO­
CAPSULE COMPARED TO MIROCAM CAP­
SULE IN OBSCUR DIGESTIVE BLEEDINGS
M. Pioche, J. Saurin, H. Lamouliatte,
J. Gaudin, B. Filoche, P. Jacob, J. Edery,
C. Cellier, M. Gaudric, P. D’halluin
10:10 – 10:20 OP184
EVALUATION OF SMALL BOWEL INJURY
INDUCED BY LOW­DOSE ASPIRIN USING
VIDEO CAPSULE ENDOSCOPY AND CON­
TRAST­ENHANCED ULTRASONOGRAPHY
U. Nishida, M. Kato, G. Kamada, S. Ono,
Y. Shimizu, M. Asaka, M. Nishida
10:20 – 10:30 OP185
EVALUATION OF BOWEL PREPARATION
AND PROCEDURE FOR PILLCAM ® COLON
CAPSULE. AN INTERIM ANALYSIS
C. Spada, M. Riccioni, L. Petruzziello,
P. Cesaro, G. Costamagna
41
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
08:30 – 10:30 SG11/12
Paediatric gastroenterology and
hepatology
Chairs:
L. D’Antiga, Italy
O. Goulet, France
08:30 – 08:40 OP186
INCIDENCE OF ACHALASIA IN CHILD­
HOOD: AN 11­YEAR POPULATION­BASED
EPIDEMIOLOGICAL STUDY
M. Marlais, J.R. Fishman, J.M.E. Fell,
M.J. Haddad, D.J. Rawat
08:40 – 08:50 OP187
EPIDEMIOLOGICAL RISk FACTORS FOR
CHILDHOOD ONSET INFLAMMATORY
BOWEL DISEASE IN SCOTLAND: A CASE­
CONTROL STUDY
J.E. Van Limbergen, H. Spiers, R. Farhadi,
M.L. Wilson, H.E. Drummond, P. Henderson,
R.K. Russell, J. Satsangi, D.C. Wilson
08:50 – 09:00 OP188
PREVALENCE AND MANAGEMENT OF
GASTRO­OESOPHAGEAL REFLUx (GOR)
IN CHILDREN AND TEENAGERS: RESULTS
OF A NATIONAL CROSS­SECTIONAL
STUDY
L. Martigne, P. Delaage, F. Thomas,
P. Barthelemy, F. Gottrand
09:00 – 09:10 OP189
24­HOUR PH MONITORING IN CHILDREN
WITH POLYPS OF CARDIO­ESOPHAGEAL
JUNCTION
S.I. Erdes, E.M. Mukhametova,
T.N. Sergeeva
09:10 – 09:20 OP190
TRANSORAL INCISIONLESS FUNDOPLI­
CATION FOR THE TREATMENT OF PAE­
DIATRIC GASTROESOPHAGEAL REFLUx
DISEASE: A FEASIBILITY STUDY
M. Thomson, A. Lobontiu, P. Rao,
R. Stewart, S. Marven
42
09:20 – 09:30 OP191
TUFTING ENTEROPATHY AND CHRONIC
ARTHRITIS: A NEWLY RECOGNISED AS­
SOCIATION WITH A NOVEL EP CAM GENE
MUTATION
A.I. Al Mehaidib, S.M. Al-Mayouf,
F.S. Alkuraya, N.M. Alsuaied, M.M. Faqih
09:30 – 09:40 OP192
FIRST REPORT OF GLUCOSE REGULATED
PROTEIN­78 AS THE RECEPTOR OF A PO­
TENTIALLY IMPORTANT TOxIN OF GIAR­
DIA LAMBLIA ON HUMAN INTESTINAL
CELL LINE
O. Sachin, M. Konar, R. Kochhar, S. Ghosh
09:40 – 09:50 OP193
ROLE OF ABCB4 MUTATIONS IN ETIOL­
OGY OF PEDIATRIC GALLSTONES
J. Bronsky, M. Jirsa, T. Jirasek, J. Sperl,
L. Dvorakova, V. Valtrova, V. Smajstrla,
J. Horak, J. Nevoral, M. Hrebicek
09:50 – 10:00 OP194
EFFICACY OF PARTIALLY HYDROLYSED
GUAR GUM SUPPLEMENTED MODIFIED
ORAL REHYDRATION SOLUTION IN THE
TREATMENT OF SEVERELY MALNOUR­
ISHED CHILDREN WITH WATERY DIAR­
RHOEA
N.H. Alam, H. Ashraf, M. Olesen,
M.A. Salam, N. Gyr, R. Meier
10:00 – 10:10 OP195
SMALL INTESTINE CONTRAST ULTRA­
SONOGRAPHY: A NEW NON­INVASIVE
TOOL FOR ASSESSING SMALL BOWEL
INVOLVEMENT IN PEDIATRIC CROHN’S
DISEASE
F. Civitelli, N. Pallotta, F. Viola, F. Nuti, G. Di
Nardo, M. Aloi, G. Vincoli, E. Corazziari,
S. Cucchiara

10:10 – 10:20 OP196
A RANDOMIZED CONTROLLED TRIAL:
EFFECT OF A COMBINATION OF LACTO­
BACILLUS ACIDOPHILUS, LACTOBACIL­
LUS DELBRUECkI SUBSP. BULGARICUS
AND BIFIDOBACTERIUM BIFIDUM IN THE
PROPHYLAxIS OF VOMITING AND DIAR­
RHOEA OF HOSPITALISED CHILDREN­1
TO 7 YEARS OF AGE
D. Naydenova, R. Pancheva, K. Stoeva,
M. Georgieva, D. Bliznakova, V. Tsaneva
10:20 – 10:30 OP197
COMPARISON OF THE LOW DOSE POLY­
ETHYLENE GLYCOL, LACTULOSE AND
MAGNESIUM HYDROxIDE IN TREAT­
MENT OF CHILDREN WITH FUNCTIONAL
CONSTIPATION
M. Imanieh, M. Haghighat, S. Gheibi,
S. Dehghani
fRee PaPeR sessIon
11:00 – 12:30 S4/5
environment and screening issues in
IbD
Chairs:
F. Carbonnel, France
S. Itzkowitz, USA
11:00 – 11:10 OP198
ANIMAL PROTEIN INTAkE AND RISk OF
INFLAMMATORY BOWEL DISEASE: THE
E3N PROSPECTIVE STUDY
P. Jantchou, S. Morois, F. Clavel-Chapelon,
M. Boutron-Ruault, F. Carbonnel
11:10 – 11:20 OP199
THE INFLAMMATORY BOWEL DISEASES
AND AIR POLLUTION: A NOVEL ASSOCIA­
TION
G.G. Kaplan, J. Hubbard, J. Korzenik,
B.E. Sands, R. Panaccione, S. Ghosh,
P. Villeneuve
scIenTIfIc PRoGRaMMe
11:20 – 11:30 OP200
lonGsTanDInG UlceRaTIVe colITIs
assocIaTeD DYsPlasIa assesMenT
THRoUGH IMMUnoHIsTocHeMIcal
MaRkeRs: coX2, kI67 anD P53
O.C. Fratila, T. Ilias, D. Puscasiu,
M. Puscasiu, O. Pop, G. Avram
11:30 – 11:40 OP201
A CLINICAL FOLLOW­UP STUDY OF
THREE SUBTYPES OF DYSPLASIA­ASSO­
CIATED LESIONS OR MASSES IN JAPA­
NESE PATIENTS WITH CHRONIC ULCER­
ATIVE COLITIS
N. Hida, K. Hori, K. Fukunaga, Y. Ohda,
M. Iimuro, K. Yoshida, Y. Yokoyama,
K. Kamikozuru, S. Nakamura, T. Matsumoto
11:40 – 11:50 OP202
CONCOMITANT PRIMARY SCLEROSING
CHOLANGITIS DOES NOT INCREASE THE
RISk FOR COLORECTAL DYSPLASIA AND
CANCER IN PATIENTS WITH COLONIC
CROHN’S DISEASE
B. Braden, S. Aryanasingha, Y. Sharifi,
B. Warren, T. Kitiyakara, R.W. Chapman
11:50 – 12:00 OP203
LOW YIELD OF NEOPLASIA AND LACk OF
CLINICAL CONSEQUENCES OF RANDOM
BIOPSIES DO NOT WARRANT THEIR USE
IN COLONOSCOPIC SURVEILLANCE OF
PATIENTS WITH ULCERATIVE COLITIS
F.J.C. van den Broek, R.P.B. Boltjes,
C.Y. Ponsioen, P.C.F. Stokkers, P. Fockens,
E. Dekker
12:00 – 12:10 OP204
COLON CANCER RISk PERCEPTION IN
ULCERATIVE COLITIS: PATIENTS OVERES­
TIMATE THE RISk, BUT DISAGREE WITH
THE THERAPY
D. Awais, F. Velayos, T. Ullman,
A. Swaminath, K. Isaacs, A. Sharabidze,
D. Walkup, P.D.R. Higgins
43
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
12:10 – 12:20 OP205
POWER DOPPLER SONOGRAPHY – AN
ExCELLENT METHOD FOR THE ASSESS­
MENT OF CROHN’S DISEASE ACTIVITY
H. Neye, W. Voderholzer, H. Lochs,
W. Wermke, S. Rickes
12:20 – 12:30 OP206
ANTI­MÜLLERIAN HORMONE MEASURE­
MENT TO ASSESS OVARIAN RESERVE IN
CROHN’S DISEASE WOMEN
T. Freour, D. Masson, C. Miossec,
K. Bach-Ngohou, M. Flamant, P. Barrière,
J. Galmiche, A. Bourreille
fRee PaPeR sessIon
11:00 – 12:30 S6/7
advanced GI endoscopy
Chairs:
H. El-Serag, USA
R. Saenz, Chile
11:00 – 11:10 OP207
DIAGNOSTIC UTILITY, EFFICACY AND
SAFETY OF EMPIRIC OESOPHAGEAL DIL­
ATATION IN UNExPLAINED DYSPHAGIA
A.J. Metz, I.J. Cook
11:10 – 11:20 OP208
SUCCESSFUL ENDOSCOPIC BALLOON
DILATION THERAPY FOR CROHN’S STRIC­
TURES WITH OR WITHOUT FISTULA
K. Sunada, H. Yamamoto, T. Yano,
T. Miyata, N. Nishimura, H. Sato, Y. Miura,
H. Shinhata, Y. Hayashi, K. Sugano
11:20 – 11:30 OP209
DOUBLE­ VERSUS SINGLE­BALLOON
ENTEROSCOPY: COMPARING PERFOR­
MANCE AND PATIENTS TOLERABILITY
IN A RANDOMIZED, BLINDED, INTERNA­
TIONAL MULTICENTER TRIAL
D. Domagk, H. Aktas, P.B.F. Mensink,
L. Aabakken, P. Lenz, H. Ullerich,
M. Bretthauer
44
11:30 – 11:40 OP210
MIDGUT BLEEDING: THE CONCEPT OF
EMERGENCY DOUBLE BALLOON ENTER­
OSCOPY (DBE)
L. Fry, H. Neumann, P. Malfertheiner,
K. Mönkemüller
11:40 – 11:50 OP211
COMPLICATIONS OF SPIRAL ENTEROS­
COPY IN THE FIRST 2950 PATIENTS
P.A. Akerman, D. Cantero
11:50 – 12:00 OP212
RESULTS OF THE IN VITRO UTILIZATION
OF AN AUTOMATED DEVICE OF MOVE­
MENT (ENDOWORM) ADAPTED TO A
CONVENTIONAL ENTEROSCOPY
V. Pons Beltran, C. Sanchez Diaz,
A. Santonja Gimeno, V. Martinez Escapa,
B. Jorda Albiñana, G. Songel Gonzalez,
T. Sala Felis
12:00 – 12:10 OP213
INTERIM ANALYSIS OF SCENT: THE FIRST
Uk PROSPECTIVE, RANDOMISED, HEAD­
TO­HEAD TRIAL OF TRANSNASAL VER­
SUS ORAL UPPER GI ENDOSCOPY
E.J. Despott, M. Baulf, J. Bromley, S. Gupta,
C. Fraser
12:10 – 12:20 OP214
AN ADEQUATE LEVEL OF TRAINING FOR
TECHNICAL COMPETENCE IN DIAGNOS­
TIC UNSEDATED TRANSNASAL ENDOS­
COPY: A PROSPECTIVE ASSESSMENT OF
THE LEARNING CURVE
S. Shin, H. Lim, Y. Lee, K. Lee, K. Lee, J. Kim
12:20 – 12:30 OP215
A CLINICAL TRIAL OF TOPICAL VISCOUS
LIDOCAINE SOLUTION VERSUS LIDO­
CAINE SPRAY FOR PHARYNGEAL ANES­
THESIA IN UNSEDATED ESOPHAGOGAS­
TRODUODENOSCOPY
S. Amornyotin, W. Srikureja,
W. Chalayonnavin, S. Kongphlay,
S. Chatchawankitkul

fRee PaPeR sessIon
11:00 – 12:30 S8/9
barrett’s oesophagus
Chairs:
J. P. Galmiche, France
J. Jankowski, UK
11:00 – 11:10 OP216
INCIDENCE OF GASTRO­OESOPHAGEAL
REFLUx AND BARRETT’S OESOPHAGUS
AND RELATED OESOPHAGEAL CANCER
RATES IN ENGLAND AND WALES, 1996–
2005
K. Alexandropoulou, J. van Vlymen,
A. Poullis, J.Y. Kang
11:10 – 11:20 OP217
SYNERGISTIC COOPERATIVE INTERAC­
TION OF THE BMP­4 PATHWAY AND
CDx­2 ENHANCE TRANSCRIPTION OF IN­
TESTINE SPECIFIC GENES IN BARRETT’S
ESOPHAGUS
F. Milano, A. Pacha, K. Hoebe, N. Buttar,
J. Van Marle, K. Krishnadath
11:20 – 11:30 OP218
CONSTITUTIVE HEDGEHOG SIGNALING
IMPAIRS MATURATION AND MIGRATION
OF ESOPHAGEAL EPITHELIAL PRECUR­
SOR CELLS
W.A. van Dop, A. Uhmann, V. Jaks,
J. Heijmans, G.J.A. Offerhaus, D.W. Hommes,
J.C. Hardwick, R. Toftgård, H. Hahn, G.R. van
den Brink
11:30 – 11:40 OP219
BARRETT’S ESOPHAGUS EVALUATION
USING MAGNIFICATION ENDOSCOPY
AND NARROW BAND IMAGING: ACCU­
RACY AND RELIABILITY OF DIFFERENT
CLASSIFICATION SYSTEMS
F. Baldaque Silva, M. Dinis-Ribeiro,
M. Vieth, T. Rabenstein, K. Goda, R. Kiesslich,
J. Haringsma, A. Edebo, E. Toth, J. Soares,
M. Areia, R. Pereira, L. Lundell, H. Marschall
scIenTIfIc PRoGRaMMe
11:40 – 11:50 OP220
A MULTI­CENTRE RANDOMIZED TRIAL
COMPARING STEPWISE RADICAL EN­
DOSCOPIC RESECTION VERSUS RADIO­
FREQUENCY ABLATION FOR BARRETT
ESOPHAGUS CONTAINING HIGH­GRADE
DYSPLASIA AND/OR EARLY CANCER
F.G.I. van Vilsteren, R.E. Pouw, S. Seewald,
L. Alvarez Herrero, C.M.T. Sondermeijer,
F.J. ten Kate, P. Fockens, K. Kim Yu Teng,
T. Roesch, N. Soehendra, B.L. Weusten,
J.J. Bergman
11:50 – 12:00 OP221
A RANDOMIZED PROSPECTIVE TRIAL IN
74 PATIENTS COMPARING THE ER­CAP
TECHNIQUE AND MULTI­BAND MUCO­
SECTOMY TECHNIQUE FOR PIECEMEAL
ENDOSCOPIC RESECTION IN BARRETT
ESOPHAGUS
R.E. Pouw, L. Alvarez Herrero, F.G.I. van
Vilsteren, F.J.W. ten Kate, B.E. Schenk,
E.J. Schoon, F.T.M. Peters, R. Bisschops,
B.L.A.M. Weusten, J.J. Bergman
12:00 – 12:10 OP222
RADIOFREQUENCY ABLATION FOR
ERADICATION OF BARRETT ESOPHAGUS
CONTAINING HIGH­GRADE DYSPLASIA
OR EARLY CANCER: A PROSPECTIVE SE­
RIES OF 73 PATIENTS
R.E. Pouw, F.G.I. van Vilsteren, L. Alvarez
Herrero, J.J. Gondrie, C.M. Sondermeijer,
F.J.W. ten Kate, P. Fockens, B.L.A.M. Weusten,
J.J. Bergman
12:10 – 12:20 OP223
RADIOFREQUENCY ABLATION FOR VERY
LONG SEGMENTS OF BARRETT OESOPH­
AGUS CONTAINING NEOPLASIA
L. Alvarez Herrero, R.E. Pouw, F.G.I. van
Vilsteren, C.M. Sondemeijer, F.J.W. ten Kate,
P. Fockens, B.L.A.M. Weusten, J.J. Bergman
45
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
12:20 – 12:30 OP224
RADIOFREQUENCY ABLATION OF HIGH
GRADE DYSPLASIA IN BARRETT’S OE­
SOPHAGUS AFTER FAILED PHOTODY­
NAMIC THERAPY – RESULTS OF THE Uk
HALO RFA REGISTRY AFTER ONE YEAR
J.M. Dunn, G. Fullarton, S.M. Thorpe,
M.R. Novelli, S.G. Bown, L. Lovat
fRee PaPeR sessIon
11:00 – 12:30 N7/8
clinical hepatology
Chairs:
J. Vierling, USA
F. Russo, Italy
11:00 – 11:10 OP225
SIGNIFICANT SAMPLING VARIABILITY
IN PATHOLOGIC FINDINGS OF NON­
ALCOHOLIC FATTY LIVER DISEASE: AN
EVALUATION OF POST­MORTEM LIVER
SAMPLES IN 146 SUBJECTS
S. Merat, R. Sotoudehmanesh, M. Peykan-
Heirati, R. Malekzadeh, M. Sotoudeh
11:10 – 11:20 OP226
PREDICTION OF IRON OVERLOAD WITH
A NEW MASS SPECTROMETRY METHOD
FOR DETECTION OF HEPCIDIN IN PLASMA
E. Rosa RIZZOTTO, F. Navaglia, D. Basso,
M. Chiaramonte, I. Petridis, R. Testa,
M. Marra, M. Plebani, A. Floreani
11:20 – 11:30 OP227
COMBINED TREATMENT WITH RIFAMPI­
CIN AND URSODEOxYCHOLIC ACID IN
HUMANS STIMULATES BILE ACID SYN­
THESIS, DETOxIFICATION AND BILIRU­
BIN ELIMINATION
H. Marschall, M. Wagner, G. Zollner,
P. Fickert, U. Gustafsson, S. Sahlin,
M. Trauner
46
11:30 – 11:40 OP228
MODEL FOR END­STAGE LIVER DISEASE
(MELD) SCORE AS A PROGNOSTIC FAC­
TOR FOR SHORT AND LONG TERM OUT­
COME AFTER HEPATETOMY FOR HEPA­
TOCELLULAR CARCINOMA IN PATIENTS
WITH CIRRHOSIS
A. Bakoyiannis, S. Delis, C. Dervenis
11:40 – 11:50 OP229
COMPARISON OF VARIOUS SCORING
SYSTEMS FOR PREDICTING SHORT­TERM
MORTALITY IN PATIENTS WITH ALCO­
HOLIC HEPATITIS
J. Sohn, T. Kim, H. Park
11:50 – 12:00 OP230
PROSPECTIVE COMPARISON OF TRAN­
SIENT ELASTOGRAPHY, LIVER BIOCHEM­
ISTRIES, AND APRI FOR THE ASSESS­
MENT OF METHOTRExATE­INDUCED
LIVER DAMAGE IN PATIENTS WITH DER­
MATOLOGIC OR RHEUMATIC DISEASES
O. Tanapanpanit, T. Tanwandee,
P. Charatcharoenwitthaya,
P. Parichatikanond
12:00 – 12:10 OP231
THE PERFORMANCE OF LIVER STIFFNESS
MEASUREMENTS FOR THE DIAGNOSIS
OF FIBROSIS IN NONALCOHOLIC STE­
ATOHEPATITIS
M. Lupsor, R. Badea, H. Stefanescu,
A. Maniu, Z. Sparchez, H. Branda, A. Serban,
M. Grigorescu
12:10 – 12:20 OP232
DRUG INDUCED LIVER INJURY (DILI) –
CLINICAL AND EPIDEMIOLOGICAL
CHARACTERIZATION OF 11 YEARS OF
HOSPITAL ADMISSIONS
J.M. Nunes, R. Marinho, J. Velosa
12:20 – 12:30 OP233
CLINICAL OUTCOME OF TUBERCULOSIS
IN PATIENTS WITH CIRRHOSIS
N.D. Patel, D.N. Amarapurkar

sYMPosIUM
11:00 – 12:30 N9/10
Do we all need an H. pylori-free stomach?
Chairs:
P. Moayyedi, Canada
L. Pacifico, Italy
11:00 – 11:20
An H. pylori­free stomach is a healthy
stomach; an H. pylori­free world is a
better world
P. Malfertheiner, Germany
11:20 – 11:40
Are there disadvantages to an H. pylorifree
life?
M. Blaser, USA
11:40 – 12:00
Hidden problems of H. pylori­induced
hypochlorhydria
B. Annibale, Italy
12:00 – 12:20
Vaccination: Progress towards life without
H. Pylori
P. Michetti, Switzerland
sYMPosIUM
11:00 – 12:30 N11/12
Hepatic infections and co-infections
Chairs:
G. Shiha, Egypt
B. Runyon, USA
11:00 – 11:20
HBV, HCV and schistosomiasis
G. Shiha, Egypt
11:20 – 11:40
Tuberculosis in chronic liver disease
S. K. Sarin, India
11:40 – 12:00
Tropical infections of the liver
M. Garassini, Venezuela
scIenTIfIc PRoGRaMMe
12:00 – 12:20
Bacterial infections in chronic liver disease
B. Runyon, USA
sYMPosIUM
11:00 – 12:30 Platinum 3/4
obesity and GI cancer
Chairs:
D. Michaud, UK
M. Hull, UK
11:00 – 11:20
Epidemiology of cancer risk
A. Renehan, UK
11:20 – 11:40
Molecular mechanisms linking obesity
and GI carcinogenesis
M. Hull, UK
11:40 – 12:00
Does weight loss reduce cancer risk?
D. Michaud, UK
WoRkInG PaRTY RePoRT
12:00 – 12:30
Recent advances in the pathogenesis
of gall bladder cancer
J. C. Roa, Chile
sYMPosIUM
11:00 – 12:30 Platinum 1
autoimmune pancreatitis
Chairs:
H. Gooszen, The Netherlands
B. Hawes, USA
11:00 – 11:20
Clinical and immunological characterisitcs
of AIP in Asia
M-H. Kim, South Korea
11:20 – 11:40
How to diagnose autoimmune pancreatitis?
L. Frulloni, Italy
47
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
11:40 – 12:00
Imaging characteristics
W. Brugge, USA
12:00 – 12:20
Therapeutic options
C. Suresh, USA
clInIcal case sessIon
11:00 – 12:30 Platinum 2
clinics in Gastroenterology and Hepatology
2 – The cause of liver disease is
not always in the liver
Chairs:
M. Pinzani, Italy
P. Mathurin, France
Experts:
M. Trauner, Austria; T. Roskams, Belgium
A. Laghi, Italy
11:00 – 11:30 OP234
Alcoholic cirrhosis and anaemia:
The liver pleads not guilty!
J. Topping, UK
11:30 – 12:00 OP235
Epigastric pain and macronodular liver:
Is the primary disease in the liver?
P. Montalto, Italy
12:00 – 12:30 OP236a
Case to be published
fRee PaPeR sessIon
11:00 – 12:30 SG11/12
Treatment and biomarkers for
colorectal cancer
Chairs:
R. Benamouzig, France
B. Steele, UK
11:00 – 11:10 OP237
OVERCOMING RESISTANCE TO CHEMO­
THERAPY IN COLORECTAL CANCER
M.D. Cannon, C.G. Concannon, F.E. Murray,
J.H. Prehn
48
11:10 – 11:20 OP238
COExPRESSION OF CCk­B/GASTRIN RE­
CEPTOR AND VEGF REDUCES OVERALL
SURVIVAL IN PATIENTS WITH METASTAT­
IC COLORECTAL CANCER
M. Ellrichmann, P.R. Ritter, J. Munding,
A. Tannapfel, B.A. Menge, H. Schrader,
W.E. Schmidt, J.J. Meier
11.20 – 11:30 OP239
THE RELATIONSHIP BETWEEN SUPEROx­
ID DISMUTASE AND CARBONIC ANHY­
DRASE IN DIAGNOSING AND ESTABLISH­
ING THE STAGE OF DIGESTIVE CANCERS
M. Coltau, G. Domuta, I. Puscas, L. Oroian,
A. Chis
11:30 – 11:40 OP240
THE REPRODUCIBILITY OF DIAGNOSING
IMMUNOHISTOCHEMICALLY DETECTED
OCCULT TUMOUR CELLS IN COLORECTAL
CARCINOMAS
C.J. Buskens, E.S. van der Zaag,
L. Welling, H.M. Peters, M. van de Vijver,
W.A. Bemelman
11:40 – 11:50 OP241
SURVIVAL BENEFIT FROM 5 FLUORO­
URACIL­BASED ADJUVANT CHEMO­
THERAPY IN PATIENTS WITH ASTLER­
COLLER STAGE B2, P21/WAF1 POSITIVE
COLORECTAL CANCER
V. Sulzyc-Bielicka, P. Domagala,
E. Urasinska, D. Bielicki, K. Safranow,
W. Domagala
11:50 – 12:00 OP242
TOLERANCE OF POLYCHEMOTHERAPY
BASED ON 5­FLUOROURACIL AND DI­
HYDROPYRIMIDINE DEHYDROGENASE
DEFICIENCY
C. Le Marchand-Soubiron, C. Le Guellec,
A. Aubourg, K. Haguenoer, M. Boisdron-
Celle, E. Gamelin, E. Dorval, T. Lecomte

12:00 – 12:10 OP243
PREDICTION OF SEVERE FLUOROPYRIMI­
DINE TOxICITY IN GASTRO­INTESTINAL
CANCER CHEMOTHERAPY: ROLE OF DPD
DEFICIENCY
A. Loganayagam, L. Fairbanks,
M. Arenas-Hernandez, P. Ross, A. Marinaki,
J. Sanderson
12:10 – 12:20 OP244
AIMING FOR ZERO LOCAL RECURRENCE
IN RECTAL CANCER PATIENTS: IS THIS RE­
ALLY THE HOLY GRAIL?
W. Truin, J.G. Bloemen, R.G.H. Beets-Tan,
G.L. Beets
12:20 – 12:30 OP245
TUMOUR RESPONSE TO NEOADJUVANT
CHEMORADIATION IN PRIMARY RECTAL
CANCER: CAN POSTCHEMORADIATION
MRI SELECT PATIENTS FOR LOCAL ExCI­
SION?
M. Maas, S.M.E. Engelen, M.J. Lahaye,
G. Lammering, R. Jansen, R.M. van Dam,
D.M.J. Lambregts, J.W.A. Leijtens, J. Konsten,
C.J.H. van de Velde, R.G.H. Beets-Tan,
G.L. Beets
sYMPosIUM
14:00 – 15:30 S1/2/3
capsule endoscopy: from top to bottom
Chairs:
D. Cave, USA
C. Fraser, UK
14:00 – 14:20
Oesophagus
D. Cave, USA
14:20 – 14:40
Small bowel
M. Keuchel, Germany
14:40 – 15:00
Colon
A. Van Gossum, Belgium
15:00 – 15:20
New perspectives
R. Eliakim, Israel
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
14:00 – 15:30 S4/5
GI stenting and noTes
Chairs:
C. S. Shim, Korea
J. Disario, USA
14:00 – 14:10 OP246
INSERTION OF ESOPHAGEAL ExPAND­
ABLE METALLIC STENTS – A COMPARA­
TIVE STUDY BETWEEN FLUOROSCOPIC
AND ENDOSCOPIC GUIDANCE
P. Bastos, F. Ferreira, A. Ribeiro
14:10 – 14:20 OP247
OUTCOME OF SELF­ExPANDABLE METAL
STENTS IN MALIGNANT GASTRO­DUO­
DENAL OBSTRUCTION: SINGLE CENTRE
ExPERIENCE WITH 104 PATIENTS
M. Udd, I. Keränen, A. Lepistö, L. Kylänpää,
J. Halttunen
14:20 – 14:30 OP248
TREATMENT OF MALIGNANT GASTRO­
DUODENAL OBSTRUCTION USING
A NITINOL SELF ExPANDING METAL
STENT – AN INTERNATIONAL PROSPEC­
TIVE MULTICENTER ExPERIENCE
G. Costamagna, A. Tringali, J. Spicak,
P. Familiari, J. Shaw, A. Roy, E. Johnsson,
E. De Moura, S. Cheng, T. Ponchon,
M. Bittinger, H. Messmann, H. Neuhaus,
R. Laugier, J. Saarnio, F. Igea
49
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
14:30 – 14:40 OP249
COVERED VERSUS UNCOVERED SELF­
ExPANDABLE NITINOL METAL STENT IN
THE PALLIATIVE TREATMENT OF MALIG­
NANT DISTAL BILIARY OBSTRUCTION: A
RANDOMISED MULTICENTER TRIAL
E. Kullman, C. Söderlund, S. Linder,
F. Frozanpor, P. Sandström, E. Toth,
G. Lindell, E. Jonas, J. Freedman,
M. Ljungman, P. Tracz, B. Ohlin,
R. Zacharias, C. Leijonmarck, K. Teder,
A. Ringman, E. Svartholm, G. Persson,
M. Gözen
14:40 – 14:50 OP250
PREOPERATIVE BILIARY DRAINAGE VER­
SUS DIRECT OPERATION FOR PANCRE­
ATIC TUMORS CAUSING OBSTRUCTIVE
JAUNDICE
N. van der Gaag, E. Rauws, C. v Eijck,
M. Bruno, E. vd Harst, F. Kubben, J. Gerritsen,
J. Greve, M. Gerhards, I. d Hingh,
J. Klinkenbijl, C. Nio, S. d Castro, O. Busch,
T. v Gulik, P. Bossuyt, D. Gouma
14:50 – 15:00 OP251
COLONIC SEMS INSERTION: FACTORS
THAT INFLUENCE TECHNICAL AND
SHORT­TERM CLINICAL SUCCESS
C.P. Selinger, J. Ramesh, D.F. Martin
15:00 – 15:10 OP252
Ex VIVO COMPARISON OF CURRENT
COLOTOMY CLOSURE MODALITIES FOR
NATURAL ORIFICE TRANSLUMINAL EN­
DOSCOPIC SURGERY (NOTES)
R.P. Voermans, F. Vergouwe, P. Fockens,
M.I. van Berge Henegouwen
15:10 – 15:20 OP253
CLOSURE OF ESOPHAGEAL ACCESS FOR
NOTES USING A SELF­ExPANDING RE­
TRACTABLE COVERED STENT
D. von Renteln, M.C. Vassiliou,
R.I. Rothstein
50
15:20 – 15:30 OP254
GASTRIC WALL HEALING AFTER NOTES
PROCEDURES: ENDOSCOPIC CLIPS
CLOSURE PROVIDE SUPERIOR HISTO­
LOGICAL OUTCOME COMPARING TO
THREADED­TAGS CLOSURE
X. Dray, D. Mukkai Krishnamurty,
G. Donatelli, S.K. Reddings, R.J. Wroblewski,
S.A. Giday, J.M. Buscaglia, A.N. Kalloo,
L. Assumpcao, K.L. Gabrielson,
S.V. Kantsevoy
sYMPosIUM
14:00 – 15:30 S6/7
best of DDW chicago 2009
Chairs:
M. Farthing, UK
J. Atherton, UK
14:00 – 14:18
Intestinal and functional disorders
H. Binder, USA
14:18 – 14:36
Gastric disorders
M. Go, USA
14:36 – 14:54
GI Oncology
P. Holt, USA
14:54 – 15:12
Oesophageal disorders
N. Shaheen, USA
15:12 – 15:30
IBD
W. Tremaine, USA
sYMPosIUM
14:00 – 15:30 S8/9
Treatment of pancreatic cancer
Chairs:
M. Lerch, Germany
J. Neoptolemos, UK

14:00 – 14:20
Molecular tools for early detection of
pancreatic cancer
M. Loehr, Sweden
14:20 – 14:40
Molecular tools for treatment stratification
in pancreatic cancer
M. Lutz, Germany
14:40 – 15:00
Resection of pancreatic cancer:
Is it all paliation?
B. Gudjonsson, Iceland
15:00 – 15:20
Endoscopic palliation in pancreatic cancer
G. Haber, USA
sYMPosIUM
14:00 – 15:30 N7/8
Unanswered questions on IbD pathogenesis
Chairs:
Y. Chowers, Israel
A. Sturm, Germany
14:00 – 14:20
Bugs: The good, the bad and the tolerable
J. Dore, France
14:20 – 14:40
Innate immunity and barrier dysfunction:
Therapeutic opportunity?
S. Keshav, UK
14:40 – 15:00
Mucosal immunology: Veni, vidi, vici,
mori?
M. Abreu, USA
15:00 – 15:20
Pathogenesis of clinical heterogeneity
in IBD
S. Schreiber, Germany
scIenTIfIc PRoGRaMMe
sYMPosIUM
14:00 – 15:30 N9/10
H. pylori associated diseases:
Worldwide problem
Chairs:
M. Blaser, USA
F. Megraud, France
naMeD lecTURe
14:00 – 14:30
WGo Henry l. bockus Medal and lecture:
science, society and the gastroenterologist:
The influence of politics,
pharma and professors
R. Hunt, Canada
Introduced by:
E. Quigley, Ireland
Henry Cohen, Uruguay
14:30 – 14:50
Are there really any enigmas, and if so,
how can we explain them?
D. Forman, UK
14:50 – 15:10
Consequences of H. pylori infection in
childhood
L. Pacifico, Italy
15:10 – 15:30
Population management of H. pylori associated
disease in Japan
Y. Yamaoka, Japan
sYMPosIUM
14:00 – 15:30 N11/12
cholestatic liver diseases
Chairs:
U. Beuers, The Netherlands
J. Heathcote, Canada
14:00 – 14:20
Primary biliary cirrhosis
D. Jones, UK
14:20 – 14:40
Primary sclerosing cholangitis
J. Heathcote, Canada
51
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
14:40 – 15:00
Cholestasis of pregnancy
U. Beuers, The Netherlands
15:00 – 15:20
Neonatal and childhood cholestasis
G. Mieli Vergani, UK
sYMPosIUM
14:00 – 15:30 Platinum 3/4
acute pancreatitis: from theory to
practice
Chairs:
D. Gouma, The Netherlands
J. Mössner, Germany
14:00 – 14:20
Antibiotics: Friend or foe?
J. Spicak, Czech Republic
14:20 – 14:30 OP255
FUNGAL INFECTION IN SEVERE ACUTE
PANCREATITIS – A PROSPECTIVE RAN­
DOMIZED STUDY OF PROPHYLACTIC
ANTIFUNGAL THERAPY
K.G.S. Bharathy, T.D. Yadav, R. Kochhar,
A. Chakrabarti, R. Gupta, R. Singh, J.D. Wig
14:30 – 14:40 OP256
FORMAL ASSESSMENT OF QUAL­
ITY OF LIFE USING VALIDATED EORTC
QUESTIONNAIRES IN PATIENTS TAkING
ANTOx FOR PAINFUL CHRONIC PAN­
CREATITIS: COMPARISON TO A DISEASE­
DURATION MATCHED COHORT
N.S. Shah, A.J. Makin, A.J. Sheen,
A.K. Siriwardena
14:40 – 15:00
Probiotics in pancreatitis: The do‘s and
dont‘s
M. Besselink, The Netherlands
15:00 – 15:20
Peridural analgesia: More than pain
relief?
J. Mayerle, Germany
52
fRee PaPeR sessIon
14:00 – 15:30 Platinum 1
Diagnostic and therapeutic eUs
Chairs:
M. Barthet, France
B. Rembacken, UK
14:00 – 14:10 OP257
ACCURACY OF ENDOSCOPIC ULTRA­
SOUND ELASTOGRAPHY USED FOR
DIFFERENTIAL DIAGNOSIS OF CHRONIC
PANCREATITIS AND PANCREATIC CAN­
CER: A MULTICENTRIC STUDY
A. Saftoiu, P. Vilmann, F. Gorunescu, U. Will,
M. Giovannini, J. Janssen, J. Iglesias-
Garcia, P. Arcidiacono, M. Hocke, C. McKay,
D.I. Gheonea
14:10 – 14:20 OP258
EUS­ELASTOGRAPHY FOR VASCULAR
STAGING OF PANCREATIC CANCER: OVER
BLUE CLOUDS AND GREEN CLOUDS?
S. Carrara, P. Arcidiacono, M. Petrone,
L. Albarello, A. Zerbi, C. Doglioni, P. Testoni
14:20 – 14:30 OP259
ENDOSCOPIC ULTRASONOGRAPHY­
GUIDED FINE NEEDLE ASPIRATION
(EUS­FNA) IN MEDIASTINAL RESTAG­
ING AFTER NEOADJUVANT THERAPY
IN PATIENTS WITH NON­SMALL CELL
LUNG CANCER (NSCLC). PRELIMINARY
RESULTS
A. Gines, O. Sendino, J. Belda, M. Sole,
G. Fernandez-esparrach, L. Colomo,
M. Pellise, E. Martinez, J. Bordas, J. Llach
14:30 – 14:40 OP260
ENDOSCOPIC ULTRASONOGRAPHY­
GUIDED FINE NEEDLE ASPIRATION (EUS­
FNA) VS ENDOSCOPIC ULTRASONOGRA­
PHY­GUIDED TRUCUT BIOPSY (EUS­TNB)
IN THE DIAGNOSIS OF GASTRIC SUBEPI­
THELIAL TUMORS. DEFINITIVE RESULTS
OF A PROSPECTIVE AND COMPARATIVE
STUDY
G. Fernandez-Esparrach, O. Sendino,
M. Pellise, M. Sole, L. Argüello, L. Colomo,
A. Cardenas, J. Bordas, J. Llach, A. Gines

14:40 – 14:50 OP261
DEVELOPMENT OF A PORCINE LYMPH­
ADENOPATHY MODEL FOR IN VIVO
HANDS­ON TEACHING AND TRAINING
OF EUS­FNA
S. Parupudi, C. Holland, P. Milla, K. Hadeler,
A. Fritscher-Ravens
14:50 – 15:00 OP262
BENEFIT OF REPEAT ENDOSCOPIC UL­
TRASOUND­GUIDED FINE NEEDLE ASPI­
RATION IN PATIENTS WITH A SUSPECTED
SOLID PANCREATIC NEOPLASM
S.M. Philcox, R. Burbridge, M. Heacock,
J. Obando, P. Jowell
15:00 – 15:10 OP263
EUS­GUIDED FIDUCIAL PLACEMENT
FOR CYBERkNIFE RADIOTHERAPY OF
ABDOMINAL MALIGNANCY
H. Kim, D. Son, J. Lee, S. Jeong, J. Lee,
K. Kwon, D. Lee, Y. Shin, Y. Kim, H. Kang,
H. Kim, W. Kim
15:10 – 15:20 OP264
EUS­GUIDED BROAD PLExUS­NEUROL­
YSIS OVER THE SUPERIOR MESENTERIC
ARTERY USING 25 GAUGE NEEDLE
H. Sakamoto, M. Kitano, T. Komaki,
H. Imai, K. Kamata, M. Kudo
15:20 – 15:30 OP265
EUS­GUIDED SPLENIC VEIN EMBOLIZA­
TION: A NEW THERAPEUTIC OPTION FOR
VARICEAL BLEEDING
S.V. Kantsevoy, X. Dray, G. Donatelli,
V. Surti, R. Ducharme, D. Mukkai
Krishnamurty, R.J. Wroblewski, S.A. Giday,
A. Zhigalin, E. Dubcenco, J.M. Buscaglia,
E.J. Shin, P.J. Thuluvath
scIenTIfIc PRoGRaMMe
basIc scIence
14:00 – 15:30 Platinum 2
basic science Workshop 2: Rna interference
and microRnas in the GI tract
Chairs:
W. Grady, USA
P. Michl, Germany
M. Hull, UK
14:00 – 14:20
What are microRNAs and RNA interference?
W. Grady, USA
14:20 – 14:35 OP266
REGULATION OF ENTEROCYTE PROLIF­
ERATION BY DIURNALLY RHYTHMIC MI­
CRORNA MIR­16
A. Balakrishnan, A.T. Stearns, D.B. Rhoads,
S.W. Ashley, A. Tavakkolizadeh
14:35 – 14:50 OP267
A MICRORNA CONTRIBUTION TO AB­
ERRANT RAS ACTIVATION IN GASTRIC
CANCER
H. Jin, E. Lam, X. Wang, K. To, J. Yu, J.J.Y.
Sung
14:50 – 15:05 OP268
MICRORNA MIR­21 IS AN EARLY MARkER
OF PANCREATIC NEOPLASIA
M. Chalret du Rieu, J. Torrisani, J. Selves,
A. Souque, M. Dufresne, G. Tsongalis,
A. Suriawinita, N. Carrere, L. Buscail,
P. Cordelier
15:05 – 15:25
Rising Star: Identification of novel targets
in pancreatic cancer by loss-of-function
screens
P. Michl, Germany
15:25 – 15:30
Closing remarks and further discussion
M. Hull, UK
53
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
14:00 – 15:30 SG11/12
benign colo-rectal disorders:
Pot-pourri
Chairs:
F. Shanahan, Ireland
M. Pescatori, Italy
14:00 – 14:10 OP269
PROBIOTICS RESTORES INCREASED PER­
MEATION TO E. COLI IN PATIENTS WITH
CHRONIC POUCHITIS
M.O. Persborn, J.D. Söderholm, C. Wallon,
A. Carlsson, H. Timmerman
14:10 – 14:20 OP270
BILE ACIDS INCREASE BACTERIAL UP­
TAkE IN COLLAGENOUS COLITIS
A. Münch, J. Söderholm, A.H. Carlsson,
K. Magnusson, Å. Öst, M. Ström
14:20 – 14:30 OP271
CLINICAL UTILITY OF FAECAL CALPRO­
TECTIN DURING FIRST PRESENTATION
TO THE GASTROENTEROLOGY CLINIC:
A NOVEL INVESTIGATIVE ALGORITHM
A. Clark, A. Walkden, O. Leach, R. Dart,
G. Brydon, J. Satsangi, I.D.R. Arnott,
C.W. Lees
14:30 – 14:40 OP272
STABLE INCIDENCES OF COLLAGENOUS
COLITIS AND LYMPHOCYTIC COLITIS IN
ÖREBRO, SWEDEN 1999–2008
A. Wickbom, N. Nyhlin, S. Eriksson, J. Bohr,
C. Tysk
14:40 – 14:50 OP273
INDUCIBLE NITRIC OxIDE SYNTHASE
INHIBITION IMPROVES NITRERGIC DYS­
FUNCTION IN DIABETES­PRONE BIO­
BREEDING RATS
T. Masaoka, S. Kindt, W. Boesmans, V. Van
den Abbeel, G. De Hertogh, P. Vanden
Berghe, J. Tack
54
14:50 – 15:00 OP274
A RAT MODEL OF NARCOTIC BOWEL
SYNDROME
S. AGOSTINI, H. Eutamene, M. Broccardo,
G. Improta, C. Petrella, V. Theodorou,
L. Bueno
15:00 – 15:10 OP275
INTRA­INDIVIDUAL REPRODUCIBILITY
OF THE GLUCOSE HYDROGEN BREATH
TEST
A. Rocco, D. Compare, E. Liguori, G. De
Martino, G. Nardone
15:10 – 15:20 OP276
IMMUNOREGULATORY ACTION OF LIP­
ID­RICH NUTRITION IS TRIGGERED VIA A
CHOLECYSTOkININ­MEDIATED PERIPH­
ERAL ACTIVATION OF VAGAL AFFERENTS
T. Lubbers, J. de Haan, M.D.P. Luyer,
M. Hadfoune, I. Verbaeys, C.H.C. Dejong,
W.A. Buurman, J.M. Greve
15:20 – 15:30 OP277
“FOUR QUADRANT CLASSIFICATION OF
FISTULA IN ANO”: DOES THE VARIABLE
DISTRIBUTION OF ANAL GLANDS PLAY A
ROLE IN THE OCCURRENCE OF FISTULA
IN ANO IN THE PERINEUM?
V. Abeysuriya, D. Subasinghe,
N.D. Samarasekera, S.L. Salgado
sYMPosIUM
15:45 – 17:25 S1/2/3
endoscopic complications:
When to call the surgeon
Chairs:
A. Fingerhut, France
T. Kalloo, USA
15:45 – 16:05
Retroperitoneal perforations after
endos copic sphincterotomy
C. Navarrete, Chile
16:05 – 16:25
Necrotizing pancreatitis
R. Carter, UK

16:25 – 16:45
Upper GI perforations
T. Roesch, Germany
16:45 – 17:05
Colonic perforations
A. Engel, The Netherlands
17:05 – 17:25
The role of NOTES
T. Kalloo, USA
fRee PaPeR sessIon
15:45 – 17:15 S4/5
late breaking news
Chairs:
J-R. Malagelada, Spain
C. Hawkey, UK
15:45 – 15:55 OP278
NECATOR AMERICANUS INHIBITS GLU­
TEN SENSITIVITY. A PHASE 2A RANDOM­
IZED DOUBLE BLINDED PLACEBO CON­
TROLLED TRIAL
A.J.M. Daveson, S. Gaze, H. McSorley,
D. Jones, J. McCarthy, A. Clouston,
A. Pascoe, G. Macdonald, R. Speare,
R. Anderson, A. Loukas, J.T. Croese
15:55 – 16:05 OP279
OTILONIUM BROMIDE IMPROVES FRE­
QUENCY OF ABDOMINAL PAIN, SE­
VERITY OF DISTENTION AND TIME TO
RELAPSE IN PATIENTS WITH IRRITABLE
BOWEL SYNDROME. OBIS STUDY WORk­
ING GROUP
J. Tack
16:05 – 16:15 OP280
REMOTE CONTROL OF WIRELESS CAP­
SULE ENDOSCOPE IN THE HUMAN
ESOPHAGUS: FIRST RANDOMIZED CLINI­
CAL STUDY IN HEALTHY VOLUNTEERS
J. Keller, C. Fibbe, P. Swain, F. Volke,
J. Gerber, M. Reimann-Zawadzki,
C.A. Mosse, E. Rabinovitz, A. Schneider,
P. Layer
scIenTIfIc PRoGRaMMe
16:15 – 16:25 OP281
THE VARIABLE PHENOTYPE OF THE
P.A16V MUTATION OF THE CATIONIC
TRYPSINOGEN GENE IN PANCREATITIS
FAMILIES
C.J. Grocock, V. Rebours, M.N. Delhaye,
Å. Andrén-Sandberg, F. Weiss,
R. Mountford, M. Harcus, L.J. Vitone,
S. Dodd, M. Jørgensen, R.W. Ammann,
O. Schaffalitzky de Muckadell, J.V. Butler,
E. Niemczyk, P. Burgess, B. Kerr, R. Charnley,
R. Sutton, M.G. Raraty, J. Devière,
D.C. Whitcomb, J.P. Neoptolemos, P. Lévy,
M.M. Lerch, W. Greenhalf
16:25 – 16:35 OP282
NARROW BAND IMAGING VS. WHITE
LIGHT GASTROSCOPY IN DETECTING
GASTRIC PREMALIGNANT AND EARLY
MALIGNANT LESIONS: A RANDOMIZED
PROSPECTIVE CROSSOVER STUDY
A.K. Dutta, S.K. Gangadharan, A. Chacko
16:35 – 16:45 OP283
METABOLIC SYNDROME PROMOTES
THE OCCURRENCE OF PRE­NEOPASTIC
LESIONS OF THE COLONIC MUCOSA
E. De Masi, F. Franceschi, M. Mancino,
G. Cammarota, A. Cazzato, D. Roccarina,
G. Gigante, B. Giupponi, G. De Marco,
A. Gasbarrini, N. Gentiloni Silveri,
G. GasbarriniLega Italiana per la lotta
contro i tumori
16:45 – 16:55 OP284
DISCERNING ADVANCED NEOPLASIA BY
CT COLONOGRAPHY
L. Correale, C. Senore, N. Segnan,
S. Delsanto, A. Bert, L. Morra,
D. Campanella, D. Molinar, D. Regge
16:55 – 17:05 OP285
PRELIMINARY RESULTS FROM THE Ex­
ETER CANCCER STUDY
I.R. Daniels, L. Mahadavan, W.T. Hamilton
55
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
17:05 – 17:15 OP286
SAFETY AND EFFACY OF NITAZOxANIDE
PLUS RIBAVIRIN IN ADVANCED HEPATI­
TIS C RELATED CIRRHOSIS OF LIVER
R.M. Mehta, K.P. Mehta
sYMPosIUM
15:45 – 17:15 S6/7
enteric infections
Chairs:
M. Farthing, UK
F. Shanahan, Ireland
15:45 – 16:05
Impact of diarrhoeal diseases on growth
and development
W. Checkley, USA
16:05 – 16:25
Acute infectious diarrhoea: Still a killer?
B. Ramakrishna, India
16:25 – 16:45
Vaccination against enteric infections:
Do they work?
P. Michetti, Switzerland
16:45 – 17:05
Prevention of opportunistic infections
in the immunocompromised IBD patient
J-F. Rahier, Belgium
sYMPosIUM
15:45 – 17:15 S8/9
Pancreatic cystic lesions
Chairs:
M. Barthet, France
A. Axon, UK
15:45 – 16:05
Differentiating cystic lesions of the pancreas
M. Barthet, France
16:05 – 16:25
The role of EUS in differentiating pancreatic
lesions
M. Giovannini, France
56
16:25 – 16:45
Intraductal pancreatic mucinous neoplams
(IPMN)
C. Bassi, Italy
16:45 – 17:05
Surgical strategies for metastasized pancreatic
tumours
H. Friess, Germany
sYMPosIUM
15:45 – 17:15 N7/8
Intestinal failure
Chairs:
A. Buchmann, USA
J. Shaffer, UK
15:45 – 16:05
Clinical definition and assessment of
consequences
A. Buchmann, USA
16:05 – 16:25
Nutritional support and medical management
L. Pironi, Italy
16:25 – 16:45
Pathophysiology­driven novel therapies
R. De Giorgio, Italy
16:45 – 17:05
Intestinal transplantation: Is it the ultimate
rescue?
O. Goulet, France
sYMPosIUM
15:45 – 17:15 N9/10
Upper GI symptoms in the community:
old problems, new solutions
Chairs:
X. Calvet, Spain
B. Delaney, UK
15:45 – 16:05
Symptom­based diagnosis of GORD:
How accurate and how necessary?
J. Dent, Australia

16:05 – 16:25
Community dyspepsia management:
Should it differ between countries?
P. Moayyedi, Canada
16:25 – 16:45
Management of difficult functional
dyspepsia and NERD
P. Bytzer, Denmark
16:45 – 17:05
Effectiveness, cost­effectiveness and
safety of PPI
B. Delaney, UK
sYMPosIUM
15:45 – 17:15 N11/12
The ageing liver & The ageing liver
disease patient
Chairs:
A. Floreani, Italy
O. James, UK
15:45 – 16:05
The problem: Liver disease in an ageing
population
O. James, UK
16:05 – 16:25
Regeneration in the aged liver
D. Schmucker, USA
16:25 – 16:45
Age­related liver dysfunction
A. Floreani, Italy
16:45 – 17:05
Chronic HBV and HCV­related chronic
liver disease: Which therapeutic strategies
in the elderly?
A. Craxì, Italy
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
15:45 – 17:15 Platinum 3/4
Gastro-duodenal malignancies
Chairs:
N. Arber, Israel
R. Benamouzig, France
15:45 – 15:55 OP287
RISk AND EPIDEMIOLOGICAL TIME
TRENDS OF GASTRIC CANCER IN LYNCH
SYNDROME CARRIERS IN THE NETHER­
LANDS
L.G. Capelle, N.C. van Grieken,
H.F. Lingsma, E.W. Steyerberg, W.J. Klokman,
M.J. Bruno, H.F. Vasen, E.J. Kuipers
15:55 – 16:05 OP288
RS10889677 VARIATION OF IL23R IS AS­
SOCIATED WITH DECREASED RISk OF
CERTAIN SUBTYPES OF GASTRIC CANCER
IN CHINESE: A CASE­CONTROL STUDY
B. Chen, Z.R. Zeng, X.Q. Wu, F.G. Chen,
L. Xue, Y.T. Hao, J.J.Y. Sung, M.H. Chen, P.J. Hu
16:05 – 16:15 OP289
ELIMINATING CARCINOGENIC ACETAL­
DEHYDE FROM ACHLORHYDRIC STOM­
ACH WITH CYSTEINE
K. Linderborg, T. Marvola, M. Marvola,
M. Salaspuro, M. Färkkilä, S. Väkeväinen
16:15 – 16:25 OP290
GASTRIC STROMAL TUMOR: TWO DIF­
FERENT PATTERN OF VASCULAR ARCHI­
TECTURE
A. Marion-Audibert, R. Barnoud,
J. Boulez, C. Partensky, A. Poulet, V. Hervieu,
P. Bringuier, C. Lombard-Bohas, J. Souquet,
J. Blay, J. Scoazec
16:25 – 16:35 OP291
THE DIFFERENT FEATURES OF LYMPH
NODE METASTASIS BETWEEN POORLY
DIFFERENTIATED ADENOCARCINOMA
AND SIGNET RING CELL CARCINOMA,
COMPOSING AN UNDIFFERENTIATED
TYPE OF EARLY GASTRIC CANCER, FOR
ENDOSCOPIC TREATMENT
H. Kim, J. Cho, H. Cho, K. Pak, W. Hyung,
S. Noh, C. Kim, S. Lee
57
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
16:35 – 16:45 OP292
ENDOSCOPIC RESECTION FOR GASTRIC
LOW GRADE DYSPLASIA: IS IT NECES­
SARY AND FEASIBLE?
S. Cho, I. Choi, C. Kim, J. Lee, M. Kook,
W. Park, K. Ryu, J. Lee, Y. Kim
16:45 – 16:55 OP293
WHAT REASONS LIE BEHIND SURVIVAL
DIFFERENCES FOR GASTRIC CANCER
WITHIN EUROPE?
J. Faivre, A. Verdecchia, D. Forman,
R. Damhuis, A. Bouvier, M. Sant
16:55 – 17:05 OP294
COULD THERAPEUTIC ENDOSCOPY BE
AN ALTERNATIVE TO SURGERY FOR THE
TREATMENT OF ADVANCED DUODENAL
POLYPOSIS IN PATIENTS WITH FAMILIAL
ADENOMATOUS POLYPOSIS ?
D. Moussata, B. Napoleon, V. Lepilliez,
M. Lapalus, S. Nancey, J. Cenni, C. Partensky,
T. Ponchon, J. Chayvialle, J. Saurin
17:05 – 17:15 OP295
CHEMOTHERAPY OF ADVANCED SMALL
BOWEL ADENOCARCINOMA: FINAL
ANALYSIS OF THE MULTICENTRIC RET­
ROSPECTIVE AGEO STUDY
T. Aparicio, A. Zaanan, L. Costes,
M. Liegard, C. Locher, E. Mitry, D. Tougeron,
J. Taieb, T. Lecomte, J. Gornet, I. Sobhani,
V. Moulin, P. Afchain, D. Malka,
T. Mansourbakht, A. Bidault, F. Maire,
F. Bonnetain
58
fRee PaPeR sessIon
15:45 – 17:30 Platinum 1
Viral hepatitis
Chairs:
M. Angelico, Italy
T. Asselah, France
15:45 – 15:55 OP296
PCR AMPLIFICATION AND IN SILICO
ANALYSIS OF REGULATORY SEQUENCE
OF TNF LIGAND AND RECEPTOR SU­
PERFAMILY, MEMBER 6 IN HCV RELATED
LIVER DISEASES
S.S. Swargiary, S. Medhi, M. Deka, P. Kar
15:55 – 16:05 OP297
IFN­ALPHA MODULATES THE EPIGEN­
ETIC CONTROL OF CCCDNA FUNCTION
TO INHIBIT OF HBV REPLICATION
L. Belloni, B. Testoni, C. Scisciani,
T. Pollicino, G. Raimondo, M. Levrero
16:05 – 16:15 OP298
DYNAMICS OF HEV VIREMIA, FECAL
SHEDDING AND ITS RELATIONSHIP WITH
TRANSAMINASES AND ANTIBODY RE­
SPONSE IN SEQUENTIAL SAMPLES FROM
PATIENTS WITH SPORADIC ACUTE HEPA­
TITIS E VIRUS INFECTION
N.S. Behl, N. Singh, R.R. Rai, A. Jha,
A. Sharma, R. Pokharna, S. Nepalia,
S. Nijhawan
16:15 – 16:25 OP299
EVALUATION OF HEPATITIS B IMMUNIZA­
TION STRATEGIES IN NEWBORNS FROM
HBSAG POSITIVE MOTHERS
I. Grigoriu, S. Poiraud, A. Garioud, D. Ancel,
X. Amiot, N. Berkane, J. Grangé
16:25 – 16:35 OP300
A NOVEL SPLICE VARIANT OF HUMAN
CYCLIN A2 WITH INHIBITION OF G1/S
TRANSITION
A. Honda, Y. Valogne, C. Bréchot, J. Faivre

16:35 – 16:45 OP301
COMPARISON BETWEEN QUANTITATIVE
HBSAG, HBEAG AND HBV DNA LEVELS
FOR PREDICTING VIROLOGICAL RE­
SPONSE TO PEG­INTERFERON ALPHA­2B
THERAPY IN HBEAG­POSITIVE CHRONIC
HEPATITIS B
P. Tangkijvanich, P. Komolmit,
V. Mahachai, P. Sa-nguanmoo,
A. Theamboonlers, Y. Poovorawan
16:45 – 16:55 OP302
EFFICACY OF ADDING METFORMIN TO
PEGINTERFERON AND RIBAVIRIN IN
THE TREATMENT OF NAÏVE CHRONIC
HEPATITIS C PATIENTS: A RANDOMIZED,
DOUBLE­BLINDED, CONTROLLED TRIAL
S. Merat, H. Zamini, E. Fakharzadeh,
H. Sharifi, H. Jabbari, R. Ansari,
M. Khatibian, R. Sotoudehmanesh,
R. Malekzadeh
16:55 – 17:05 OP303
OSTEOPENIA AND INCREASED BONE
RESORPTION IN CHRONIC HEPATITIS C.
RELATIONSHIP WITH SERUM LEVELS OF
AMINOTRASFERASES AND SOLUBLE TU­
MOR NECROSIS FACTOR P­55
E. Redondo-Cerezo, F.J. Casado-Caballero,
J. Mundi, E. Ruiz-Escolano, F. Reina, A. Garre,
J.L. Gonzalez-Calvin
17:05 – 17:15 OP304
INVESTIGATION OF MEMORY B CELL
RESPONSES TO HEPATITIS B SURFACE
ANTIGEN IN HEALTHCARE WORkERS
CONSIDERED AS NON RESPONDERS TO
VACCINATION
J. Valats, E. Tuaillon, N. Funakoshi, D. Hoa,
M. Brabet, J. Ducos, J. Vendrell, P. Blanc
17:15 – 17:30
Rising Star: Long-term clinical outcome of
peginterferon and ribavirin treatment for
patients with chronic hepatitis C infection
B. J. Veldt, The Netherlands
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
15:45 – 17:15 Platinum 2
Intestinal inflammation and therapy:
How does it work?
Chairs:
M. Abreu, USA
S. Ben-Horin, Israel
15:45 – 15:55 OP305
CIRCULATING PRO­INFLAMMATORY
MONOCYTES PRODUCE HIGH LEVELS
OF TFN­ALPHA AND ARE TARGETS FOR
THERAPY IN PATIENTS WITH INFLAMMA­
TORY BOWEL DISEASE
L. Linton, M. Karlsson, A. Lindberg,
P. Karlén, O. Winqvist, M. Eberhardson
15:55 – 16:05 OP306
NOD2 REGULATES THE PARACELLULAR
PERMEABILITY BY MODULATING T­CELL
FUNCTION AND MYOSIN LIGHT CHAIN
kINASE IN MOUSE PEYER’S PATCHES
F. Barreau, C. Jung, C. Madre,
M. Dussaillant, J.P. Hugot
16:05 – 16:15 OP307
GALECTIN­2 AND GALECTIN­4 MODU­
LATE INTESTINAL WOUND HEALING,
INDUCE T CELL APOPTOSIS AND THUS
AMELIORATE INTESTINAL INFLAMMA­
TION IN AN ExPERIMENTAL MODEL OF
MURINE COLITIS
D. Paclik, B. Wiedenmann, A. Dignass,
A. Sturm
16:15 – 16:25 OP308
DEPLETION OF REGULATORY T CELLS
INDUCED A FATAL COURSE OF AN Ex­
PERIMENTAL INFECTIOUS COLITIS
M. Ross, T. Meister, F. Hasenberg, K. Loser,
T. Spieker, T. Sparwasser, W. Domschke,
A. Lügering
59
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
scIenTIfIc PRoGRaMMe
16:25 – 16:35 OP309
INCREASED ExPRESSION LEVELS OF
PROTEIN TYROSIN PHOSPHATASE NON
RECEPTOR 2 (PTPN2) IN MUCOSAL T
CELLS FROM INFLAMMATORY BOWEL
DISEASE PATIENTS
A. Schirbel, J. Achkar, M. Phillips, G. West,
C. Fiocchi
16:35 – 16:45 OP310
SELECTIVE EFFECT OF GLUCOCORTI­
COIDS ON T CELL CLONES UNDERPINS
STEROID RESISTANT DISEASE
A.M. Williams, J. Falvey, T. Creed,
C.S.J. Probert
16:45 – 16:55 OP311
UNExPECTED ROLE OF ANTICOAUGU­
LATION PROTEIN C IN CONTROLLING
EPITHELIAL BARRIER INTEGRITY AND
INTESTINAL INFLAMMATION
S. Vetrano, V. Ploplis, M. Sandoval-Cooper,
S. Chapman, D. Donahue, V. Arena,
F. Castellino, S. Danese
16:55 – 17:05 OP312
AZATHIOPRINE INCREASES HUMAN IN­
NATE IMMUNITY VIA THE RAC1/PAk­2
SIGNALING PATHWAY
L. Zhou, G. Dijkstra, L. Visser, A. Regeling,
G. Fuhler, M.P. Peppelenbosch, K. Faber
17:05 – 17:15 OP313
IL­13 MEDIATED FIBROSIS IN CROHN’S
DISEASE INTESTINE
J.R. Bailey, J.F. Tarlton, P.A. Sylvester,
C.S.J. Probert, P.W. Bland, C.V. Whiting
60
fRee PaPeR sessIon
15:45 – 17:15 SG11/12
novel agents for treatment and
prevention of colorectal cancer
Chairs:
E. Hawk, USA
J. Mathers, UK
15:45 – 15:55 OP314
SAFETY AND EFFICACY PROFILE OF A
NOVEL RNAI­BASED THERAPY FOR POL­
YPOSIS
A.D. Silva, N. Bodyak, S. Laroux, C. Grillot-
Courvalin, J.H. Fruehauf
15:55 – 16:05 OP315
STATIN TREATMENT OF COLON CANCER
CELLS LEADS TO AN OVERALL DOWN­
REGULATION OF RECEPTOR TYROSINE
kINASE ACTIVITY
R.J. Jacobs, L.L. Kodach, S.H. Diks,
D.W. Hommes, G.R. Van den Brink,
M.P. Peppelenbosch, J.C.H. Hardwick
16.05 – 16:15 OP316
ANNURCA APPLE POLYPHENOL Ex­
TRACTS (APES) REDUCE POLYPS FOR­
MATION AND GROWTH, AND INCREASE
TUMOR SUPPRESSOR GENES TRAN­
SCRIPTION IN APCMIN/+ MICE EITHER
FED WESTERN OR BALANCED DIETS
L. Fini, M. Selgrad, G. Piazzi, Y. Daoud,
M. Garcia, V. Fogliano, M. Romano,
R. Genta, A. Gasbarrini, C. Boland,
L. Ricciardiello
16:15 – 16:25 OP317
NEW CONCEPTS REGARDING THE ANTI­
TUMOR EFFECT OF VITAMIN C
A. Todea, M. Marza, S. Stanca, C. Baldea
16:25 – 16:35 OP318
−1195A>G COx­2 POLYMORPHISM MAY
BE ASSOCIATED WITH ANTICIPATION
AND HIGHER RISk FOR COLO­RECTAL
CANCER: A STRATEGY FOR CHEMOPRE­
VENTION?
C. Pereira, P. Pimentel-Nunes, C. Brandão,
L. Moreira-Dias, R. Medeiros, M. Dinis-
Ribeiro

16:35 – 16:45 OP319
THE OMEGA­3 POLYUNSATURATED
FATTY ACID EICOSAPENTAENOIC ACID
DRIVES SYNTHESIS OF PROSTAGLANDIN
E3, WHICH ACTS AS A PARTIAL AGONIST
AT THE PGE2­EP4 RECEPTOR, IN HUMAN
COLORECTAL CANCER CELLS
G. Hawcroft, L. Bretsztajn, A.D. Race,
C. Twelves, P.M. Loadman, M.A. Hull
16:45 – 16:55 OP320
REPRESSION OF POLYP FORMATION
AND GROWTH BY EICOSAPENTAENOIC
FREE FATTY ACID IN APCMIN/+ MICE IS
MEDIATED BY STRONG ANTI­COx2 AC­
TIVITY
L. Fini, G. Piazzi, C. Ceccarelli, Y. Daoud,
A. Belluzzi, M. Selgrad, M. Garcia, R. Genta,
C. Boland, L. Ricciardiello
16:55 – 17:05 OP321
EICOSAPENTAENOIC ACID (EPA), AS
THE FREE FATTY ACID, REDUCES CO­
LONIC CRYPT CELL PROLIFERATION IN
PATIENTS WITH SPORADIC COLORECTAL
POLYPS
N.J. West, A. Belluzzi, E. Lund, M. Rodriguez-
Justo, L. Fuccio, L. Laterza, P. Munson,
M. Serrani, T.K. Smith, A. Poullis, F. Bazzoli,
R.J. Leicester
17:05 – 17:15 OP322
A NOVEL ANTI­CD24­TOxIN IMMUNO­
CONJUGATE FOR TARGETED CANCER
THERAPY
S. Shapira, S. Kraus, D. Kazanov, A. Shapira,
P. Altevogt, I. Benhar, N. Arber
scIenTIfIc PRoGRaMMe
61
TUesDaY, noVeMbeR 24, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
lIVe enDoscoPY
08:30 – 13:00 S1/2/3
live endoscopy Rome – live from the
Gemelli Hospital, Rome, Italy
Chairs:
G. Haber, USA
B. Rembacken, UK
C. Navarrete, Chile
Experts at the hospital
J. Deviere, Belgium; H. Neuhaus, Germany;
R. Hawes, USA; G. Costamagna, Italy
naMeD lecTURe
12:00 – 12:30
oMeD Rudolf schindler lecture:
endoscopy and The Ugly Duckling
J. Waye, USA
Introduced by:
A. Axon, UK
WoRkInG PaRTY RePoRT
12:30 – 13:00
endoscopy guidelines for credentialing
D. Faigel, USA
sYMPosIUM
08:30 – 10:30 S4/5
cRc screening strategies
Chairs:
J. Regula, Poland
G. Young, Australia
08:30 – 08:50
Cascade guidelines for CRC screening in
different healthcare systems
N. Amrani, Morocco
08:50 – 09:10
Quality control in colonoscopy and
implications for screening programmes
J. Regula, Poland
09:10 – 09:30
The role CT colonography
A. Laghi, Italy
62
09:30 – 09:50
Molecular screening for colorectal cancer
W. Grady, USA
WoRkInG PaRTY RePoRT
09:50 – 10:20
Guidelines for evaluation of new
screening tests for colorectal and gastric
cancers
G. Young, Australia
fRee PaPeR sessIon
08:30 – 10:30 S6/7
anti Tnf therapy in IbD: current to
future
Chairs:
tba
08:30 – 08:40 OP323
ONE YEAR DATA FROM THE SONIC
STUDY: A RANDOMIZED, DOUBLE­BLIND
TRIAL COMPARING INFLIxIMAB AND IN­
FLIxIMAB PLUS AZATHIOPRINE TO AZA­
THIOPRINE IN PATIENTS WITH CROHN’S
DISEASE NAIVE TO IMMUNOMODULA­
TORS AND BIOLOGIC THERAPY
J. Colombel, P. Rutgeerts, W. Reinisch,
G.J. Mantzaris, A. Kornbluth,
D. Rachmilewitz, S. Lichtiger, G. D’Haens,
R.H. Diamond, D. Broussard, K.L. Tang,
C.J. van der Woude, W.J. Sandborn
08:40 – 08:50 OP324
INITIAL RESPONSE AND LONG­TERM
OUTCOME OF ADALIMUMAB FOR
ULCERATIVE COLITIS PREVIOUSLY
TREATED WITH INFLIxIMAB
J. Estellés, I. Fernandez-Blanco,
J.L. Mendoza, O. Merino, I. Marín-Jimenez,
M. Barreiro, C. Saro, V. García, I. Vera,
M.P. Martinez, S. García-Morán, E. Gento,
C. Taxonera

08:50 – 09:00 OP325
DISEASE ACTIVITY, ANCA AND IL23R
GENOTYPE STATUS DETERMINE EARLY
RESPONSE TO INFLIxIMAB IN PATIENTS
WITH ULCERATIVE COLITIS
M. Jürgens, R.P. Laubender, F. Hartl,
M. Weidinger, J. Seiderer, J. Wagner,
M. Wetzke, F. Beigel, S. Pfennig, J. Stallhofer,
C. Tillack, B. Göke, J. Glas, T. Ochsenkühn,
S. Brand
09:00 – 09:10 OP326
INCIDENCE AND PREDICTORS FOR COL­
ECTOMY IN PATIENTS TREATED WITH
INFLIxIMAB FOR ULCERATIVE COLITIS
G. Bouguen, L. Siproudhis,
V. Desfourneaux, P.N. D’Halluin,
M. Pagenault, S. Manfredi, D. Heresbach,
J.F. Bretagne
09:10 – 09:20 OP327
MUCOSAL HEALING IN CROHN’S DIS­
EASE IS ASSOCIATED WITH HIGH INF­
LIxIMAB TROUGH LEVELS
W. Van Moerkercke, G. Compernolle,
I. Cleynen, S. Organe, T. Coopmans, G. Van
Assche, P. Rutgeerts, A. Gils, S. Vermeire
09:20 – 09:30 OP328
TROUGH LEVELS OF INFLIxIMAB IN A CO­
HORT OF PRIMARY NON­RESPONDERS
W. Van Moerkercke, I. Cleynen,
G. Compernolle, S. Organe, G. Van Assche,
P. Rutgeerts, A. Gils, S. Vermeire
09:30 – 09:40 OP329
TFN­ALPHA BLOCkADE INHIBITS MUCO­
SAL T CELL ACTIVATION AND INDUCE T
CELL CYCLE ARREST
U. Berndt, O. Guckelberger,
B. Wiedenmann, C. Fiocchi, A. Sturm
scIenTIfIc PRoGRaMMe
09:40 – 09:50 OP330
THE IMMUNOGENIC PART OF INFLIx­
IMAB LIES WITHIN THE FAB2 FRAGMENT,
BUT MEASUREMENT OF ANTIBODIES
AGAINST INTACT INFLIxIMAB IS MORE
CLINICALLY USEFUL
S. Ben-Horin, M. Yavzori, L. Katz, O. Picard,
E. Fudim, S. Bar-Meir, Y. Chowers
09:50 – 10:00 OP331
THERAPEUTIC IMMUNIZATION AGAINST
TNF WITH A TFN­kINOID IN CROHN’S
DISEASE PATIENTS IS SAFE AND INDUC­
ES ANTI­TNF ANTIBODIES
P. Benji, F. Burger, D. Kruger, G. Rogler,
P. Michetti, C. Kruger, G. Grouard-Vogel,
O. Dhellin, B. Fanget, P. Vandepapelière
10:00 – 10:10 OP332
ATTENUATION OF COLITIS BY ORAL DE­
LIVERY OF BACTERIAL­MEDIATED RNAI
TARGETING TNF ALPHA
S. Laroux, N. Bodyak, A. Silva, J. Fruehauf
10:10 – 10:20 OP333
TRANSIENT INCREASE IN CIRCULATING
REGULATORY T CELLS DURING INFLIx­
IMAB TREATMENT OF CROHN’S DISEASE
A. Dige, C. Lodberg Hvas, J. Kelsen,
J. Agnholt, L. Ambrosius Christensen,
J. Frederik Dahlerup
10:20 – 10:30 OP334
CANCER RISk IN CROHN’S DISEASE PA­
TIENTS TREATED OR UNTREATED WITH
INFLIxIMAB: A MULTICENTER MATCHED­
PAIR STUDY FROM 1999 TO 2008
L. Biancone, C. Petruzziello, A. Orlando,
A. Kohn, S. Ardizzone, M. Daperno,
E. Angelucci, F. Castiglione, R. D’inca,
C. Papi, G. Meucci, F. Zorzi, G. Riegler,
G. Sica, F. Mocciaro, S. Onali, E. Calabrese,
M. Cottone, F. Pallone
63
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
sYMPosIUM
08:30 – 10:30 S8/9
Pathophysiology of Ibs: new insights
Chairs:
Q. Aziz, UK
G. Boeckxstaens, The Netherlands
08:30 – 08:50
Starting from the brain: The role of antinociceptive
pathways
C. H. Wilder-Smith, Switzerland
08:50 – 09:10
Gas dynamics and motility changes:
What comes first?
J. Serra, Spain
09:10 – 09:30
Mast cells: A central role?
G. Barbara, Italy
09:30 – 09:50
From bugs to brain: Evidence for a
microbe­gut­brain axis
S. Collins, Canada
WoRkInG PaRTY RePoRT
09:50 – 10:20
Post infectious Ibs: a global perspective
R. Spiller, UK
P. Enck, Germany
sYMPosIUM
08:30 – 10:30 N7/8
coeliac disease in the 21st century
Chairs:
J. Bai, Argentina
D. Sanders, UK
08:30 – 08:50
Coeliac disease: A worldwide problem?
C. Catassi, Italy
64
08:50 – 09:00 OP335
CAUSES OF DEATH IN PEOPLE WITH CO­
ELIAC DISEASE: OBSERVATIONS MADE
IN DERBY, Uk OVER A QUARTER OF A
CENTURY
M.J. Grainge, J. West, T.R. Card,
G.K.T. Holmes
09:00 – 09:20
Differences in adaptive and innate immunity:
The key to phenotypic variation?
L. Sollid, Norway
09:20 – 09:40
What diagnostic criteria should we be
using in 2009?
D. Sanders, UK
09:40 – 09:50 OP336
USEFULNESS OF SMALL­BOWEL MU­
COSAL TRANSGLUTAMINASE­2 SPE­
CIFIC IGA AUTONANTIBODY DEPOSITS
IN COELIAC DISEASE DIAGNOSIS AND
FOLLOW­UP
O. Koskinen, P. Collin, K. Lindfors, K. Laurila,
M. Mäki, K. Kaukinen
09:50 – 10:10
New preventive and therapeutic approaches
J. Bai, Argentina
10:10 – 10:20 OP337
EFFECTIVENESS OF CLADRIBINE THER­
APY IN REFRACTORY COELIAC DISEASE
TYPE II
G.J. Tack, W.H.M. Verbeek, A. Al-toma,
M.W.J. Schreurs, D. Kuik, O.J. Visser,
C.J. Mulder
sYMPosIUM
08:30 – 10:30 N9/10
H. pylori treatment: consensus and
new approaches
Chairs:
P. Malfertheiner, Germany
C. O‘Morain, Ireland

08:30 – 08:50
How to treat: Best evidence­based strategies
first, second and third­line
X. Calvet, Spain
08:50 – 09:00 OP338
REGRESSION OF ATROPHY IN PATIENTS
WITH ATROPHIC BODY GASTRITIS FOL­
LOWING HELICOBACTER PYLORI TREAT­
MENT: OCCURRENCE AND PREDICTOR
FACTORS
L. Vannella, E. Lahner, C. Bordi, E. Di Giulio,
V.D. Corleto, A. Sbrozzi-Vanni, G. Delle Fave,
B. Annibale
OP339
Withdrawn by author
09:10 – 09:20 OP340
EARLY HELICOBACTER PYLORI ERADICA­
TION ASSOCIATED WITH DECREASED
RISk OF GASTRIC CANCER IN PEPTIC
ULCER DISEASE
J. Lin, C. Wu, K.N. Kuo, M. Wu, Y. Chen,
C. Wang
09:20 – 09:40
Treatment of H. pylori infection in developing
countries
L. Coelho, Brasil
09:40 – 10:00
New drugs and new approaches
F. Megraud, France
10:00 – 10:20
H. pylori treatment in children: Agreement
at last?
S. Koletzko, Germany
sYMPosIUM
08:30 – 10:30 N11/12
Update in the treatment of hepatitis b
and c
Chairs:
D. Mutimer, UK
J. M. Pawlotsky, France
scIenTIfIc PRoGRaMMe
08:30 – 08:50
Management of the naïve patient
A. Craxì, Italy
08:50 – 09:10
Rising Star: Mechanism of non response
in the treatment of chronic hepatitis C
T. Asselah, France
09:10 – 09:30
Management of the patient with posttransplant
recurrence
D. Mutimer, UK
WoRkInG PaRTY RePoRT
09:30 – 10:00
HcV genotypes 4, 5, 6: The neglected
genotypes
N. Antaki, Syria
10:00 – 10:20
The future for therapeutics: The impact
on decision making today
J. M. Pawlotsky, France
sYMPosIUM
08:30 – 10:30 Platinum 3/4
new frontiers in the management of
colorectal cancer
Chairs:
B. Saunders, UK
W. Schmiegel, Germany
08:30 – 08:50
Imaging algorithms for detecting CRC
recurrence
M. Bellomi, Italy
08:50 – 09:10
The role of laparoscopy and fast track
surgery
W. Bemelman, The Netherlands
09:10 – 09:30
Evolution of surgery for liver metastases
R. Adam, France
65
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
09:30 – 09:50
Endoscopic stenting for palliation
T. Baron, USA
09:50 – 10:10
Targeted treatment and chemotherapy
W. Schmiegel, Germany
fRee PaPeR sessIon
08:30 – 10:30 Platinum 1
Treatment of oesophageal cancer
Chairs:
H. Inoue, Japan
L. Bonavina, Italy
08:30 – 08:40 OP341
ENDOSCOPIC THERAPY IN 1059 PA­
TIENTS WITH HIGH GRADE DYSPLASIA
AND EARLY ADENOCARCINOMA IN BAR­
RETT’S ESOPHAGUS
O. Pech, H. Manner, A. May, J. Pohl, C. Ell
08:40 – 08:50 OP342
ENDOSCOPIC RESECTION FOR MUCOSAL
ESOPHAGEAL CANCER – IS THERE A DIF­
FERENCE IN OUTCOME BETWEEN MUCO­
SAL BARRETT’S CANCER AND MUCOSAL
SQUAMOUS CELL CANCER?
O. Pech, H. Manner, A. May, J. Pohl, C. Ell
08:50 – 09:00 OP343
TREATMENT FOR SUPERFICIAL ESOPHA­
GEAL CANCER
H. Kawakubo, T. Omori
09:00 – 09:10 OP344
ADVANTAGE OF ENDOSCOPIC SUBMU­
COSAL DISSECTION COMPARED WITH
ENDOSCOPIC OBLIQUE ASPIRATION MU­
COSECTOMY FOR SUPERFICIAL ESOPHA­
GEAL TUMOR
Y. Urabe, T. Hiyama, S. Oka, S. Tanaka,
M. Yoshihara, K. Arihiro, K. Chayama
66
09:10 – 09:20 OP345
SURGICAL MANAGEMENT OF SUBMU­
COSAL OESOPHAGEAL CANCER: LIMIT­
ED OR ExTENDED LYMPHADENECTOMY?
B.A. Grotenhuis, M. van Heijl, J. Zehetner,
J. Moons, B.P.L. Wijnhoven, M.I. van Berge
Henegouwen, H.W. Tilanus, T.R. DeMeester,
T. Lerut, J.J.B. van Lanschot
09:20 – 09:30 OP346
SUPERFICIAL ESOPHAGEAL CARCINOMA
WITH ESOPHAGEAL VARICES TREATED
BY ENDOSCOPIC SUBMUCOSAL DISSEC­
TION
M. Takeuchi, M. Kobayashi, S. Hashimoto,
J. Yokoyama, Y. Sato, R. Narisawa, Y. Aoyagi
09:30 – 09:40 OP347
ENDOSCOPIC MUCOSAL RESECTION
AND SUBMUCOSAL DISSECTION FOR
SUPERFICIAL PHARYNGEAL SQUAMOUS
CELL CARCINOMA
T. Oyama, A. Tomori, A. Takahashi
09:40 – 09:50 OP348
A BIODEGRADABLE POLY­L­LACTIC
ACID (PLLA) STENT CAN PREVENT BE­
NIGN STRICTURE AFTER ENDOSCOPIC
SUBMUCOSAL DISSECTION (ESD) FOR
ExTENSIVE SPREADING OESOPHAGEAL
CANCER
O. Inatomi, Y. Saito, T. Tanaka,
Y. Mochizuki, A. Nishida, M. Shioya,
T. Nishimura, Y. Koizumi, S. Bamba,
A. Andoh, T. Tsujikawa, Y. Fujiyama
09:50 – 10:00 OP349
PROGNOSTIC VALUE OF BODY MASS
INDEx ON PERIOPERATIVE OUTCOME
AFTER RESECTION OF OESOPHAGEAL
CANCER
B.A. Grotenhuis, G.J. Hotte, E.P. van
der Stok, B.P.L. Wijnhoven, H.W. Tilanus,
J.J.B. van Lanschot

10:00 – 10:10 OP350
HISTOPATHOLOGICAL REGRESSION
OF THE PRIMARY TUMOR INDICATED
BY PERCENTAGE OF RESIDUAL VIABLE
CELLS IS AN IMPORTANT PROGNOSTIC
FACTOR AFTER NEOADJUVANT CHEMO­
RADIATION THERAPY FOR ESOPHAGEAL
CANCER
D.K.H. Tong, S.Y.K. Law, D.L.W. Kwong,
K.W. Chan, A.K.Y. Lam, K.H. Wong
10:10 – 10.20 OP351
PREDICTIVE FACTOR OF LOCAL RECUR­
RENCE AFTER ENDOSCOPIC RESECTION
OF LARGE ESOPHAGEAL SQUAMOUS
CELL CARCINOMA
R. Ishihara, Y. Takeuchi, N. Uedo,
K. Higashino, H. Iishi
10:20 – 10:30 OP352
LONG TERM PROGNOSIS OF ESD FOR
THE SUPERFICIAL ESOPHAGEAL ADE­
NOCARCINOMA AND SQUAMOUS CELL
CARCINOMA
T. Oyama, A. Takahashi, A. Tomori
fRee PaPeR sessIon
08:30 – 10:30 Platinum 2
cirrhosis and complications
Chairs:
A. Gerbes, Germany
R. Jalan, UK
08:30 – 08:40 OP353
ADDITION OF PROBIOTICS TO ANTIBIOT­
ICS DOES NOT IMPROVE ITS EFFICACY
IN PREVENTION OF SPONTANEOUS BAC­
TERIAL PERITONITIS: A DOUBLE BLIND
PLACEBO­CONTROLLED RANDOMIZED
CONTROLLED TRIAL
C. Pande, A. Kumar, S.K. Sarin
08:40 – 08:50 OP354
ACOUSTIC RADIATION FORCE IMAGING
(ARFI) AS A NEW METHOD OF ULTRASO­
NOGRAPHIC ELASTOGRAPHY ALLOWS
ACCURATE AND FLExIBLE ASSESSMENT
OF LIVER STIFFNESS IN 136 PATIENTS
K. Rifai, I. Mederacke, H. Bantel,
M.P. Manns, M.J. Gebel
scIenTIfIc PRoGRaMMe
08:50 – 09:00 OP355
VON WILLEBRAND FACTOR PREDICTS
RESPONSE TO MEDICAL THERAPY OF
PORTAL HYPERTENSION
A. Ferlitsch, M. Homoncik, T. Reiberger,
G. Ulbrich, A. Gangl, M. Peck-Radosavljevic1
09:00 – 09:10 OP356
ENDOSCOPIC CYANOACRYLATE INJEC­
TION IS SUPERIOR TO BETA­BLOCkER
THERAPY TO PREVENT GASTRIC VARI­
CEAL REBLEEDING: A LARGE RANDOM­
IZED CONTROLLED TRIAL
S.R. Mishra, B.C. Sharma, A. Kumar,
S.K. Sarin
09:10 – 09:20 OP357
THE ADDED VALUE OF SPLEEN STIFF­
NESS MEASUREMENT USING TRANSIENT
ELASTOGRAPHY FOR THE NONINVASIVE
ASSESSEMENT OF ESOPHAGEAL VARI­
CES IN PATIENTS WITH LIVER CIRRHOSIS
H. Stefanescu, R.I. Badea, M. Lupsor,
B. Procopet, M. Grigorescu, A. Maniu
09:20 – 09:30 OP358
HCV CLEARANCE AFTER PEG IFN PLUS
RBV IMPROVES THE COURSE OF HCV
CIRRHOSIS REGARDLESS OF PORTAL
HYPERTENSION
V. Calvaruso, V. Di Marco, S. De Lisi,
D. Ferraro, P. Pizzillo, G. Alaimo, S. Peralta,
A. Craxì
09:30 – 09:40 OP359
BETA­BLOCkERS VERSUS ENDOSCOPIC
VARICEAL BANDING LIGATION FOR
PRIMARY PROPHYLAxIS OF VARICEAL
BLEEDING: AN UPDATED META­ANAL­
YSIS
N. Funakoshi, Y. Duny, J. Valats, F. Ségalas,
I. Chaze, N. Flori, M. Bismuth, J. Daurès,
P. Blanc
09:40 – 09:50 OP360
THE HEPATOADRENAL SYNDROME –
DOES IT ExIST?
S. Datta, F. Ross, J. Winter,
K. Dimacopoulos, M. Priest, M. Wallace,
P.R. Mills
67
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
09:50 – 10:00 OP361
A RANDOMIZED, CONTROLLED TRIAL OF
LIGATION PLUS NADOLOL VS. NADOLOL
ALONE IN THE PROPHYLAxIS OF FIRST
VARICEAL BLEEDING IN CIRRHOSIS
G.H. Lo, W.C. Chen, H.M. Wang
10:00 – 10:10 OP362
RANDOMIZED DOUBLE BLIND DUMMY
CONTROLLED TRIAL OF 24 VERSUS 72
HOURS OF TERLIPRESSIN AS AN ADJU­
VANT THERAPY IN ESOPHAGEAL VARI­
CEAL BLEED
Z. Azam, S. Hamid, W. Jafri
10:10 – 10:20 OP363
CORRELATION OF MODIFIED CHILD
PUGH CLASSIFICATION WITH N­TERMI­
NAL PRO B­TYPE NATRIURETIC PEPTIDE
LEVELS IN PATIENTS WITH NONALCO­
HOLIC CIRRHOSIS
A. Kumbasar, M. Navdar, E. Ataoglu,
I. Uzunhasan, K. Ergen, S. Poturoglu,
F. Basinoglu, F. Yilmaz, M. Yenigun, F. Sar
10:20 – 10:30 OP364
RELATIONSHIP OF GENETIC POLYMOR­
PHISM OF ENOy AND INOS TO SEVERITY
OF CIRRHOTIC PORTAL HYPERTENSION
AND TO THE INFLAMMATORY PARAM­
ETERS
R. Bruha, M. Jachymova, J. Petrtyl, L. Vitek,
M. Lenicek, P. Urbanek, T. Svestka, M. Kalab,
A. Linhart, P. Jansa, Z. Marecek
fRee PaPeR sessIon
08:30 – 10:30 SG11/12
new developments in colonoscopy
Chairs:
J. F. Rey, France
tba
08:30 – 08:40 OP365
EVALUATION OF QUALITY CERTIFICA­
TION FOR ENDOSCOPY UNITS FOR
SCREENING COLONOSCOPY IN AUSTRIA.
DATA FROM THE FIRST 15000 PATIENTS
M. Ferlitsch, C. Wiener, S. Pramhas,
K. Reinhart, W. Weiss
68
08:40 – 08:50 OP366
PATIENT­BASED ASSESSMENT OF COLO­
NOSCOPY SIMULATOR TRAINING
A.D. Koch, J. Haringsma, E.J. Schoon,
R.A. de Man, E.J. Kuipers
08:50 – 09:00 OP367
COMPUTED VIRTUAL CHROMOENDOS­
COPY FOR THE CHARACTERIZATION OF
SMALL POLYPS DURING SCREENING
COLONOSCOPY IN ASYMPTOMATIC
ADULTS
Y. Kim, D. Kim, S. Chung, S. Yang, J. Song
09:00 – 09:10 OP368
COMPUTER AIDED POLYP CHARACTERI­
SATION
A. Ignjatovic, A. Varnavas, J.E. East,
A. Bharath, J. Ng, B.P. Saunders, D. Burling
09:10 – 09:20 OP369
IMPACT OF ExPERIENCE WITH THE THIRD
EYE RETROSCOPE ON DETECTION RATES
AND WITHDRAWAL TIMES DURING
COLONOSCOPY
D.C. DeMarco, E. Odstrcil, D. Bass,
C. Herdman, T. Kinney, K. Gupta, L.F. Lara,
L. Wolf, T. Dewar, M.K. Mehta, M. Anwer,
R. Pellish, J.K. Hamilton, D. Polter,
K.G. Reddy, I. Hanan
09:20 – 09:30 OP370
COST EFFECTIVENESS OF VIRTUAL VS.
OPTICAL COLONOSCOPY IN SYMP­
TOMATIC GASTROENTEROLOGY OUT­
PATIENTS
R.W. Aldridge, L. Jackson, P. Wylie, J. Bell,
C. Toumpanakis, O. Epstein
09:30 – 09:40 OP371
HIGH DEFINITION PLUS COLONOSCOPY
COMBINED WITH I­SCAN IS SUPERIOR
IN THE DETECTION AND CHARACTER­
IZATION OF COLORECTAL NEOPLASIAS
COMPARED TO STANDARD VIDEO COLO­
NOSCOPY – A PROSPECTIVE RANDOM­
IZED TRIAL
A. Hoffman, F. Sar, M. Goetz, J. Mudter,
S. Biesterfeld, P.R. Galle, M.F. Neurath,
R. Kiesslich

09:40 – 09:50 OP372
A POSSIBLE TROPONIN I LEAk ARISING
FROM BOWEL PREPARATION FOR ELEC­
TIVE COLONOSCOPY – ARE THERE MORE
IMPLICATIONS THAN OBSERVED?
A.T. George, A. Rangaraj, C. Davis,
M. Allison, P. Campbell, H. Khan, M. Javed,
C. Edwards, V. Chamary, A. Brain,
K. Swarnkar
09:50 – 10:00 OP373
EVALUATION OF GAS VOLUME, ABDOMI­
NAL PAIN AND ExAMINATION TIME FOR
COLONOSCOPY USING CARBON DIOx­
IDE VS AIR INSUFFLATION WITHOUT
SEDATION
H. Yamano, K. Yoshikawa, T. Kimura,
E. Yamamoto, H. Harada, T. Kudo, R. Katou,
Y. Hayashi, K. Sato
10:00 – 10:10 OP374
EFFECTIVE BOWEL CLEANSING FOR
COLONOSCOPY: A RANDOMISED STUDY
OF HIGH VS. LOW DOSE OF PEG AND
SPLIT VS. NON­SPLIT REGIMEN
R. Marmo, L. Cipolletta, G. Riccio,
M.A. Bianco, A. Marone, C. Marmo,
E. Gregorio, G. D’Alvano, F. Spanò,
N. Procaccio, G. Rotondano
10:10 – 10:20 OP375
NARROW BAND IMAGING (NBI) VS.
PAN­CHROMOCOLONOSCOPY (PCC) IN
COLORECTAL POLYPS SCREENING:
A PROSPECTIVE RANDOMIZED STUDY
D. Zavyalov, S. Kashin, V. Goncharov,
A. Gvozdev, E. Rassadina, A. Nadezhin,
L. Shubin, N. Akhapkin, A. Agamov
10:20 – 10:30 OP376
PATIENTS’ PREFERENCES FOR FEMALE
COLONOSCOPISTS IN SOUTH kOREA
E. Kim, H. Chun, K. Lee, J. Kim, J. Hyun,
S. Park, S. Park, B. Keum, Y. Seo, Y. Jeen,
S. Um, C. Kim, H. Ryu
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
11:00 – 12:30 S4/5
coeliac disease and enterocyte function
Chairs:
S. Husby, Denmark
L. Sollid, Norway
11:00 – 11:10
Introduction
S. Husby, Denmark
11:10 – 11:20 OP377
COELIAC DISEASE AND FOOD ALLERGY
F. Kiparissi, L. Michaelis, N. Shah,
M. Elawad, K. Lindley
11:20 – 11:30 OP378
THE TYPE OF ENTEROPATHY IS A PROG­
NOSTIC FACTOR IN ENTEROPATHY AS­
SOCIATED T CELL LYMPHOMA
G. Malamut, O. Chandesris, V. Verkarre,
B. Meresse, G. Rahmi, E. Macintyre,
N. Brousse, N. Cerf-Bensussan, O. Hermine,
C. Cellier
11:30 – 11:40 OP379
TRANSAMIDATION OF WHEAT FLOUR:
A NEW ENZYME STRATEGY TO BLOCk
GLUTEN TOxICITY IN A SUBSET OF CE­
LIAC DISEASE PATIENTS
G. Mazzarella, V.M. Salvati, G. Iaquinto,
F. Capobianco, R. Stefanile, N. Giardullo,
B. Malamisura, M. Rossi
11:40 – 11:50 OP380
EFFECT OF PROBIOTIC BACTERIA AND
INDOMETHACIN ON ABSORPTION kI­
NETICS OF 13C­D­xYLOSE IN ExPERI­
MENTAL PIGS – A PILOT STUDY
S. Rejchrt, J. Kvetina, V. Vorisek, J. Bukac,
M. Kopacova, J. Spirkova, M. Kunes,
M. Förstl, P. Zivny, V. Palicka, J. Bures
11:50 – 12:00 OP381
PLASMA CITRULLINE IS A MARkER OF
ZP1848­INDUCED SMALL INTESTINAL
GROWTH IN WISTAR RATS
Y.M. Petersen, B. Bjorkenberg, J. Hyttel,
C.B. Knudsen, C. Thorkildsen
69
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
12:00 – 12:10 OP382
COLORECTAL CANCER­DERIVED INTES­
TINAL EPITHELIAL CELLS ExPRESS THE
FUNCTIONAL RECEPTOR COMPLEx FOR
IL­17F MEDIATING MAP kINASE ACTIVA­
TION AND EPITHELIAL RESTITUTION
T. Olszak, J. Diegelmann, E. de Toni,
B. Göke, S. Brand
12:10 – 12:20 OP383
E­CADHERIN HAS A kEY ROLE IN INTES­
TINAL BARRIER FUNCTION AND PANETH
CELL MATURATION
F.T. Kolligs, M. Dahlhoff, D. Horst, B. Hirschi,
K. Trülzsch, J. Müller-Höcker, E. Wolf,
M.R. Schneider
12:20 – 12:30 OP384
LENGTH OF ISCHEMIA DETERMINES THE
ABILITY OF THE HUMAN GUT TO PRE­
VENT INTESTINAL ISCHEMIA­REPERFU­
SION INDUCED INFLAMMATION
J. Grootjans, J.P.M. Derikx, R. Matthijsen,
A. van Bijnen, R. van Dam, C.H.C. Dejong,
W.A. Buurman
fRee PaPeR sessIon
11:00 – 12:30 S6/7
GI infection
Chairs:
M. Farthing, UK
F. Carbonnel, France
11:00 – 11:10 OP385
ENTEROPATHOGENIC ESCHERICHIA COLI
MODULATION OF ALPHA AND BETA
DEFENSIN ANTIMICROBIAL PEPTIDE
ExPRESSION IN HUMAN INTESTINAL
ORGAN CULTURE
M. Lucas, J.B. Kaper, A.D. Phillips
11:10 – 11:20 OP386
DECREASED ExPRESSION OF ANTIMI­
CROBIAL PEPTIDES AND INCREASED
BACTERIAL TRANSLOCATION IN MURINE
SMALL INTESTINE AFTER FOOD DEPRI­
VATION
C.M. Hodin, K. Lenaerts, M. Hadfoune,
J.J. de Haan, W.A. Buurman
70
11:20 – 11:30 OP387
EVALUATION OF SOLUBLE PLANTAIN FI­
BRES AS A POTENTIAL PROPHYLACTIC
THERAPY FOR INFECTIVE DIARRHEA: IN­
HIBITING BACTERIAL TRANSLOCATION
THROUGH M­CELLS
C.L. Roberts, J.M. Rhodes, B.J. Campbell
11:30 – 11:40 OP388
A NEW PROBIOTIC STRATEGY TO FIGHT
SALMONELLA INFECTIONS IN CHILDREN
AND AVOID ANTIBIOTHERAPY
A. Zihler, G. Le Blay, C. Chassard,
M. Gagnon, C.P. Braegger, C. Lacroix
11:40 – 11:50 OP389
INTRACELLULAR INFECTION DURING
INVASIVE NON­TYPHOID SALMONELLA
INFECTION IN HIV
M.A. Gordon, A.L. Walsh, A.M. Kankwatira,
C.M. Parry, M.E. Molyneux, R.S. Heyderman
11:50 – 12:00 OP390
HOST RESPONSE DURING ACUTE NON­
TYPHOID SALMONELLA BACTERAEMIA
IN HIV­INFECTED ADULTS – WHOLE
BLOOD RNA MICROARRAY STUDIES
OF NATURAL INFECTION AND Ex­VIVO
STIMULATION
M.A. Gordon, F. Schreiber, D.J. Lynn,
A. Houston, J. Peters, G. Mwafulirwa,
B. Hancock, R.S. Heyderman, G. Dougan
12:00 – 12:10 OP391
GASTRIC ACID SUPPRESSORS AS A RISk
FACTOR FOR PEDIATRIC CLOSTRIDIUM
DIFFICILE INFECTION
M. Martinelli, R. Turco, A. Tramontano,
E. Miele, E. Roscetto, L. Greco, A. Staiano
12:10 – 12:20 OP392
RAPID DIAGNOSIS OF CLOSTRIDIUM
DIFFICILE USING A DEVICE RESPONSIVE
TO FAECAL VOLATILE ORGANIC COM­
POUNDS
C.S.J. Probert, K. Garner, S. Smth,
B. Delacy Costello, R. Ewen, R. Greenwood,
N.M. Ratcliffe

12:20 – 12:30 OP393
MAJOR REDUCTION IN INCIDENCE OF
CLOSTRIDIUM DIFFICILE ASSOCIATED
DISEASE WITH SIMPLE INFECTION CON­
TROL INTERVENTIONS
M.L. Cowan, R.C.G. Pollok, G. Walters,
R. Law, T. Planche, P. Riley
fRee PaPeR sessIon
11:00 – 12:30 S8/9
oesophageal carcinoma
Chairs:
R. Fitzgerald, UK
D. Watson, Australia
11:00 – 11:10 OP394
SOIL SELENIUM LEVEL AND ESOPHA­
GEAL CANCER: AN ECOLOGICAL STUDY
IN A HIGH RISk AREA FOR ESOPHAGEAL
CANCER
G. Roshandel, S. Semnani, A. Zendehbad,
A. Keshtkar, H. Rahimzadeh, S. Besharat,
N. Abdolahi, A. Moradi, A. Sarikhani,
H. Mirkarimi, S. Hasheminasab
11:10 – 11:20 OP395
ACTIVATION OF WNT AND MAPk PATH­
WAYS IN OESOPHAGEAL ADENOCARCI­
NOMA AND DURING PROGRESSION OF
BARRETT’S OESOPHAGUS
N.B. Shannon, C.J. Peters, J.R. Rees,
J.S. Hardwick, C. Zhang, R.H. Hardwick,
R.C. Fitzgeraldon behalf of the OCCAMS
Study Group
11:20 – 11:30 OP396
HOW ARE MICRORNAS WORkING IN
ESOPHAGEAL SQUAMOUS CELL CARCI­
NOMA?
K. Matsushima, H. Isomoto, N. Inoue,
D. Norimura, Y. Nakashima, N. Yamaguchi,
K. Ohnita, T. Ichikawa, F. Takeshima,
K. Nakao
scIenTIfIc PRoGRaMMe
11:30 – 11:40 OP397
ANALYSIS OF CANCER STEM CELL MARk­
ERS IN OESOPHAGEAL ADENOCARCI­
NOMA
B.A. Grotenhuis, W.N.M. Dinjens,
P. Sonneveld, A. Sacchetti, H. van Dekken,
B.P.L. Wijnhoven, J.J.B. van Lanschot,
R. Fodde
11:40 – 11:50 OP398
PEA3 REGULATES THE INVASIVE AND
PROLIFERATIVE CAPABILITIES OF OE33
OESOPHAGEAL ADENOCARCINOMA
CELLS AND IS A MARkER OF LYMPH
NODE METASTASES IN OESOPHAGEAL
ADENOCARCINOMAS
R. Keld, B. Guo, P. Downey, C. Gulmann,
Y. Ang, A. Sharrocks
11:50 – 12:00 OP399
A SEVEN GENE SIGNATURE OUTPER­
FORMS CLINICAL FEATURES AT PRE­
DICTING SURVIVAL IN OESOPHAGEAL
ADENOCARCINOMA
C.J. Peters, J.R.E. Rees, R.H. Hardwick,
J.S. Hardwick, C. Zhang, S.L. Vowler, V. Save,
M. O’Donovan, C. Caldas, D. Alderson,
R.C. Fitzgeraldon behalf of the OCCAMS
Study Group
12:00 – 12:10 OP400
COMPARISON OF STAGING ACCURACY
BY CONVENTIONAL AND 3D ENDO­
SCOPIC ULTRASOUND IN SURGICALLY
TREATED PATIENTS WITH OESOPHAGEAL
CANCER
S. Inglis, D. Patel, S. Paterson-Brown,
J.N. Plevris
71
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
12:10 – 12:20 OP401
MULTIPLE LUGOL­VOIDING LESIONS AS
A RISk FACTOR FOR A SECOND PRIMARY
ESOPHAGEAL SQUAMOUS CELL CARCI­
NOMA IN PATIENTS WITH ESOPHAGEAL
CANCER AND HEAD AND NECk CANCER
K. Hori, H. Okada, Y. Kawahara,
R. Takenaka, S. Kobayashi, D. Kawai, M. Kita,
D. Tanioka, T. Takao, M. Inoue, S. Kawano,
C. Takekawa, M. Uemura, Y. Shirakawa,
T. Yamatuji, Y. Naomoto, S. Nomiya,
T. Onoda, S. Tominaga, K. Yamamoto
12:20 – 12:30 OP402
CLINICAL FACTORS INFLUENCING DI­
AGNOSIS WHEN USING MAGNIFYING
ENDOSCOPY WITH NBI SYSTEM FOR
SUPERFICIAL ESOPHAGEAL CARCINOMA
D. Kikuchi, T. Iizuka, S. Hoteya, N. Yahagi
sYMPosIUM
11:00 – 12:30 N7/8
Clostridium difficile-associated diseases
Chairs:
J. Atherton, UK
J. Mac Laughlin, UK
11:00 – 11:20
Clostridium difficile in IBD patients:
Double trouble
E. R. Dubberke, USA
11:20 – 11:40
Microbiology
D. Crook, UK
11:40 – 12:00
Clostridium difficile in IBD patients:
Double trouble
D. Rampton, UK
12:00 – 12:20
Diagnosis, prevention and treatment
S. Ben-Horin, Israel
72
sYMPosIUM
11:00 – 12:30 N9/10
early oesophageal cancer and HGD:
advances in diagnosis and treatment
Chairs:
K. Ragunath
C. Ell, Germany
11:00 – 11:20
Advances in endoscopic diagnosis:
The end of blind quadrantic biopsies in
Barrett‘s oesophagus ?
K. Ragunath, UK
11:20 – 11:40
Confocal microscopy: Should it replace
biopsy?
A. Meining, Germany
11:40 – 12:00
Emerging endoscopic therapies for HGD
and early cancer
H. Inoue, Japan
12:00 – 12:20
Minimally invasive surgery
L. Bonavina, Italy
sYMPosIUM
11:00 – 12:30 N11/12
Hepatocellular carcinoma: Molecular
markers and advanced therapy
Chairs:
J. Llovet, Spain
T. Roskams, Belgium
11:00 – 11:20
Molecular pathways of hepatic carcinogenesis
M. Levrero, Belgium
11:20 – 11:40
Molecular/histopathological diagnosis
and classification
T. Roskams, Belgium

11:40 – 12:00
Advances in treatment with biologicals
etc.
J. Llovet, Spain
12:00 – 12:20
Nanotechnologies for the treatment of
HCC
M. Kester, USA
sYMPosIUM
11:00 – 12:30 Platinum 3/4
cRc surveillance and treatment of
dysplasia and early cancer
Chairs:
P. Fockens, The Netherlands
R. Kiesslich, Germany
11:00 – 11:20
Surveillance for sporadic colorectal neoplasia
J. Regula, Poland
11:20 – 11:35 OP403
THE COOPERATIVE FLAT LESIONS ITAL­
IAN NETWORk (FLIN): PREVALENCE OF
NON­POLYPOID COLORECTAL NEOPLA­
SIA. A MULTICENTER OBSERVATIONAL
STUDY
M.A. Bianco, L. Cipolletta, G. Rotondano,
F. Buffoli, G. Gizzi, F. Tessari, FLIN
Investigators
11:35 – 11:50 OP404
RISk OF COLORECTAL CANCER AFTER
RESECTION OF ADENOMAS: A POPULA­
TION­BASED STUDY
V. Cottet, A. Bouvier, V. Jooste, C. Aboa-
Eboulé, J. Faivre, C. Bonithon-Kopp
11:50 – 12:10
Best practice for neoplasia surveillance
in IBD
J. Rhodes, UK
12:10 – 12:30
Endoscopic techniques for surveillance
and treatment of dysplasia
B. Saunders, UK
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
11:00 – 12:30 Platinum 1
clinical issues in colonic diseases
Chairs:
N. Amrani, Marokko
tba
11:00 – 11:10 OP405
EFFECT OF LONG­TERM TREATMENT
WITH MESALAMINE IN PATIENTS WITH
SYMPTOMATIC UNCOMPLICATED DI­
VERTICULAR DISEASE (SUDD): ASSESS­
MENT OF SYMPTOMS IN A FIVE YEARS
FOLLOW­UP STUDY
F. Di Mario, L. Gatta, M. Curlo, A. Franzé,
A. Pilotto, C. Scarpignato
11:10 – 11:20 OP406
WHICH PATIENTS WITH SUSPECTED
ACUTE DIVERTICULITIS NEED DIAGNOS­
TIC IMAGING?
W. Laméris, A. van Randen, T.M. van Gulik,
O.R. Busch, J. Winkelhagen, P.M. Bossuyt,
J. Stoker, M.A. Boermeester
11:20 – 11:30 OP407
ARGON PLASMA COAGULATION VER­
SUS ARGON PLASMA COAGULATION
PLUS ORAL SUCRALFATE FOR CHRONIC
RADIATION PROCTITIS – DOUBLE­BLIND
PLACEBO­CONTROLLED RANDOMIZED
STUDY, QUALITY OF LIFE ANALYSIS
M.R. Chruscielewska-Kiliszek,
M. Rupinski, E. Kraszewska, J. Pachlewski,
E. Czaczkowska-Kurek, E. Butruk, J. Regula
11:30 – 11:40 OP408
MAST CELL INDUCED BACTERIAL TRANS­
LOCATION IN THE PATHOGENESIS OF
POSTOPERATIVE ILEUS
S.A. Snoek, E.P. van der Zanden,
O.I. Stanisor, O. Welting, R.M. van den
Wijngaard, G.E. Boeckxstaens, W.J. de Jonge
73
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
11:40 – 11:50 OP409
EFFECTIVENESS OF PHARMACOTHERA­
PY FOR DIVERTICULAR DISEASE: A SYS­
TEMATIC REVIEW
M.J.P. van Pelt, B.D.L. Broekhuizen,
T.J.M. Verheij, N.J. de Wit
11:50 – 12:00 OP410
LONG­TERM TREATMENT WITH MESALA­
MINE IN PATIENTS WITH SYMPTOMATIC
UNCOMPLICATED DIVERTICULAR DIS­
EASE (SUDD): RECURRENCE OF DIVER­
TICULITIS
F. Di Mario, L. Gatta, M. Curlo, A. Franzé,
A. Pilotto, M. Franceschi, C. Scarpignato
12:00 – 12:10 OP411
A POPULATION­BASED CASE CONTROL
STUDY OF RISk FACTORS FOR PERFO­
RATED DIVERTICULAR DISEASE
D.J. Humes, K. Fleming, R.C. Spiller, J. West
12:10 – 12:20 OP412
DEVELOPMENT OF A THERAPEUTIC AL­
GORITHM FOR MANAGEMENT OF IN­
TESTINAL TUBERCULOSIS AND CROHN’S
DISEASE IN TUBERCULOSIS ENDEMIC
COUNTRIES
S. Srivastava, G.K. Makharia, P. Das,
P. Goswami, S. Datta Gupta
12:20 – 12:30 OP413
FAECAL INCONTINENCE IN SYSTEMIC
SCLEROSIS IS RELATED TO NEUROPATHY
N.M. Thoua, A. Forbes, C. Denton,
A.V. Emmanuel
clInIcal case sessIon
11:00 – 12:30 Platinum 2
clinics in Gastroenterology and Hepatology
3 – Pancreas: surrounding
organs can be hostile to the pancreas?
Chairs:
M. Lerch, Germany; Thierry Ponchon, France
Experts:
M-H. Kim, South Korea; J. Mössner,
Germany; W. Brugge, USA; S. Jackson, UK
74
11:00 – 11:30 OP414
Steatorrhoea followed by jaundice:
Is the pancreas responsible for both?
S. M. Greenfield, UK
11:30 – 12:00 OP415
Do all pancreatic cystic tumours originate
from the pancreas?
M. Marino, Italy
12:00 – 12:30 OP416
Obstructive jaundice: A well concealed
culprit
S. Koilakou, Greece
fRee PaPeR sessIon
11:00 – 12:30 SG11/12
Pancreatitis
Chairs:
J. Mayerle, Germany
P. Berberat, Germany
11:00 – 11:10 OP417
BILE ACID LIPIDOMICS: CHANGES IN
BILE ACID COMPOSITION, DUODENAL
CONCENTRATIONS AND SECRETORY
OUTPUTS IN PATIENTS WITH SEVERE
CHRONIC PANCREATITIS
N.A. TUVIGNON, L. Humbert, C. Wolf,
G. Trugnan, D. Rainteau, R. Laugier,
F. Carriere
11:10 – 11:20 OP418
CHARACTERIZATION OF THE EFFECT OF
CHENODEOxYCHOLATE ON ION TRANS­
PORT IN GUINEA PIG PANCREATIC DUCT
CELLS
V. Venglovecz, Z. Rakonczay Jr., P. Hegyi,
L. Tiszlavicz, B.E. Argent, M.A. Gray
11:20 – 11:30 OP419
10­YEAR ExPERIENCE WITH DUODENUM
AND ORGAN­PRESERVING PANCREATIC
HEAD RESECTION (BERNE­FARkAS MOD­
IFICATION) IN THE SURGICAL TREAT­
MENT OF CHRONIC PANCREATITIS
G. Farkas, L. Leindler, G. Farkas Jr.

11:30 – 11:40 OP420
THERAPEUTIC EFFECT OF GHRELIN IN
THE COURSE OF CERULEIN­INDUCED
ACUTE PANCREATITIS
Z. Warzecha, A. Dembinski, P. Ceranowicz,
J. Cieszkowski, R. Tomaszewska
11:40 – 11:50 OP421
TIMING OF ENDOSCOPIC TRANSPARI­
ETAL PANCREATIC NECROSECTOMY: THE
SOONER THE BETTER?
H. Shehab, L. Buscail, B. Bournet,
G. Fourtanier, J. Escourrou
11:50 – 12:00 OP422
TGFb and TLR4 POLYMORPHISM IN PA­
TIENTS WITH ACUTE PANCREATITIS (AP)
D. Baczewska-Mazurkiewicz, B. Stepien,
J. Rutkowska, W. Olszewski, M. Zagozda,
G. Rydzewska, A. Rydzewski
12:00 – 12:10 OP423
COMPARISON OF GENETIC AND PHENO­
TYPIC CHARACTERIZATION OF PATIENTS
WITH SPORADIC GENETICALLY DETER­
MINED PANCREATITIS WITH AN AGED
MATCHED CONTROL GROUP OF PA­
TIENTS WITH IDIOPATHIC PANCREATITIS
C. Hamoir, X. Pepermans, K. Dahan,
H. Piessevaux, A. Geubel, J. Gigot,
P.H. Deprez
12:10 – 12:20 OP424
LONG TERM OUTCOME OF AUTOIM­
MUNE PANCREATITIS: A FRENCH MONO­
CENTRIC SERIES
F. Maire, Y. Le Baleur, V. Rebours,
M. Vullierme, A. Couvelard, A. Sauvanet,
O. Hentic, P. Levy, P. Ruszniewski, P. Hammel
12:20 – 12:30 OP425
NEAR INFRARED CONFOCAL IMAGING
OF THE HUMAN LIVER DURING ONGO­
ING MINI­LAPAROSCOPY: A NEWLY
DEVELOPED RIGID ENDOMICROSCOPE
WITH INCREASED IMAGING PLANE
DEPTH
M. Goetz, I. Deris, M. Vieth, P. Delaney,
P.R. Galle, M.F. Neurath, R. Kiesslich
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
14:00 – 15:30 S1/2/3
eMR and esD
Chairs:
T. Ponchon, France
tba
14:00 – 14:10 OP426
THE FIRST CLINICAL ExPERIENCE OF
CHEMICALLY ASSISTED MECHANICAL
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION (CAM­ESD) BY USING MESNA
K. Sumiyama, M. Kawamura, H. Imazu,
H. Tajiri
14:10 – 14:20 OP427
EVALUATION OF A NEW MULTI­TASkING
PLATFORM “ENDOSAMURAI” FOR ENDO­
SCOPIC FULL­THICkNESS RESECTION
(EFTR)
K. Ikeda, K. Sumiyama, H. Tajiri
14:20 – 14:30 OP428
CARBON DIOxIDE SUBMUCOSAL INJEC­
TION CUSHION IN ENDOSCOPIC SUBMU­
COSAL DISSECTION
T. Uraoka, Y. Kawahara, N. Ohara, J. Kato,
H. Okada, K. Yamamoto
14:30 – 14:40 OP429
LONG­TERM OUTCOME OF UNDIFFER­
ENTIATED TYPE OF INTRAMUCOSAL (IM)
GASTRIC CANCER AFTER ENDOSCOPIC
SUBMUCOSAL DISSECTION (ESD)
C. Ryu, M. Lee, K. Ryu, Y. Hong, H. Kim,
B. Ko, K. Kwon, S. Hong, J. Kim, J. Cho, J. Lee,
C. Shim, B. Kim, N. Fukami, Y.K. Chen
14:40 – 14:50 OP430
VALIDITY OF ENDOSCOPIC SUBMUCO­
SAL DISSECTION FOR EARLY COLOREC­
TAL NEOPLASM
K. Sasajima, T. Oshima, N. Uemura,
Y. Saitou
75
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
14:50 – 15:00 OP431
EFFICACY OF A ELECTROSURGICAL EN­
DO­kNIFE WITH A WATER­JET FUNCTION
(FLUSHkNIFE) FOR COLORECTAL ENDO­
SCOPIC SUBMUCOSAL DISSECTION OF
SUPERFICIAL COLORECTAL NEOPLASMS:
A RANDOMISED PHASE II TRIAL
Y. Takeuchi, N. Uedo, R. Ishihara, H. Iishi,
T. Kizu, T. Inoue, R. Chatani, N. Hanaoka,
T. Taniguchi, N. Kawada, K. Higashino,
M. Tatsuta
15:00 – 15:10 OP432
USEFUL OF DUAL kNIFE IN ENDOSCOP­
IC SUBMUCOSAL DISSECTION FOR
COLORECTAL NEOPLASMS
N. Hirano, N. Yahagi, S. Yamashita,
N. Nishida, A. Matsui, D. Kikuchi,
M. Nakamura, Y. Kuroki, T. Mitani, Y. Miyata,
T. Iizuka, S. Hoteya, T. Otsuka, S. Sato,
Y. Igarashi
15:10 – 15:20 OP433
DO ELDERLY PATIENTS BENEFIT FROM
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION OF COLORECTAL TUMORS?
T. Mitani, Y. Kuroki, N. Yahagi
15:20 – 15:30 OP434
THE AUSTRALIAN MULTICENTRE COLON­
IC ENDOSCOPIC MUCOSAL RESECTION
DATABASE (AMCEMRD) – PREDICTORS
OF SUBMUCOSAL INVASIVE ADENO­
CARCINOMA AND OUTCOMES FOR EMR
OF LARGE LATERALLY SPREADING TU­
MOURS (LSTS)
A. Moss, M.J. Bourke, S.J. Williams,
L.F. Hourigan, G. Brown, R. Singh, W. Tam,
R. Chen
fRee PaPeR sessIon
14:00 – 15:30 S4/5
Gastrointestinal bleeding
Chairs:
K. McColl, UK
M. Barthet, France
76
14:00 – 14:10 OP435
CHARACTERISTICS OF UPPER AND LOW­
ER GASTROINTESTINAL BLEEDING ASSO­
CIATED WITH ANTIPLATELET THERAPY
(APT). ARE THERE ANY DIFFERENCES
BETWEEN ASPIRIN AND CLOPIDOGREL
TREATMENT?
J. Bretagne, B. Nalet, G. Lesur, B. Bour,
P. Barthélemy, C. Soufflet
14:10 – 14:20 OP436
IS LOW DOSE ASPIRIN USE ASSOCIATED
WITH IRON DEFICIENCY ANAEMIA? AN
ANALYSIS OF DATA FROM THE HEALTH
SURVEY FOR ENGLAND 2006
E.R. Sprigg, K.M. Fleming, R.F.A. Logan
14:20 – 14:30 OP437
CALCIUM CHANNEL BLOCkERS REDUCE
GASTRIC ACID SECRETION. MECHANISM
OF ACTION
M. Coltau, A. Iacobescu, G. Tudor,
G. Domuta, C. Baldea
14:30 – 14:40 OP438
LACk OF GASTRIC MUCOSAL DAMAGE
WITH CHRONIC CYCLOOxYGENASE INHI­
BITION MAY STILL BE ASSOCIATED WITH
PRO­ATHEROGENIC EFFECT
I.T. Padol, R.H. Hunt
14:40 – 14:50 OP439
RE­ASSESSMENT OF RISk OF RE­BLEED­
ING OF FORREST IB (OOZING) PEPTIC
ULCER BLEEDING (PUB)
D.M. Jensen, R. Stuart, H. Ahlbom,
S. Eklund, A. Barkun, E.J. Kuipers, J. Mossner,
J.Y.W. Lau, J.J.Y. Sung
14:50 – 15:00 OP440
GLASGOW BLATCHFORD SCORE AS A
TRIAGE TOOL FOR EMERGENCY ENDOS­
COPY IN PATIENTS WITH UPPER GASTRO­
INTESTINAL BLEED
L.G. Lim, K.Y. Ho, L.L. Lim, Y.H. Chan,
P.L. Teoh, K.G. Yeoh

15:00 – 15:10 OP441
COMPARISON OF A NEW RE­OPENING
ENDOCLIP WITH A STANDARD CLIPPING
SYSTEM: PRELIMINARY RESULTS OF A
PROSPECTIVE, BICENTRIC, RANDOM­
IZED STUDY
I.S. Papanikolaou, K. Triantafyllou,
E. Giannakoulopoulou, P. Karatzas,
E.M. Delicha, B. Wiedenmann, W. Veltzke-
Schlieker, T. Roesch, A. Adler
15:10 – 15:20 OP442
RISk FACTORS FOR RE­BLEEDING IN A
MULTICENTRE CLINICAL TRIAL WITH
HIGH­DOSE INTRAVENOUS ESOMEPRA­
ZOLE IN PATIENTS WITH PEPTIC ULCER
BLEEDING (PUB)
J.J.Y. Sung, A. Barkun, E.J. Kuipers,
J. Mossner, D.M. Jensen, R. Stuart, J.Y.W. Lau,
T. Lind, H. Ahlbom, J. Kilhamn
15:20 – 15:30 OP443
TRENDS IN MORTALITY OF NON­VARI­
CAEL UPPER GASTROINTESTINAL HAEM­
ORRHAGE IN ENGLAND: ANALYSIS OF
HOSPITAL ADMISSIONS 1999 TO 2005
C.J. Crooks, T.R. Card, J. West
fRee PaPeR sessIon
14:00 – 15:30 S6/7
Upper GI neoplasia
Chairs:
L. Lundell, Sweden
tba
14:00 – 14:10 OP444
THE UTILITY OF DEPTH OF TUMOR IN­
VASION BY USING OPTICAL COHERENCE
TOMOGRAPHY IN SUPERFICIAL ESOPHA­
GEAL SQUAMOUS CELL CARCINOMA
W. Hatta, K. Uno, T. Koike, S. Yokosawa,
N. Ara, Y. Abe, K. Iijima, T. Shimosegawa
scIenTIfIc PRoGRaMMe
14:10 – 14:20 OP445
ORIGIN OF SYMPTOMS OCCURRING AF­
TER ANTIREFLUx SURGERY: LESSONS
FROM ESOPHAGEAL MULTICHANNEL
INTRALUMINAL IMPEDANCE (MII)­PH
MONITORING
K. Belhocine, E. Coron, M. Le Rhun,
J.P. Galmiche, S. Bruley des Varannes
14:20 – 14:30 OP446
AUTOFLUORESCENCE ENDOSCOPY IM­
PROVES THE TARGETED DETECTION OF
EARLY BARRETT’S NEOPLASIA BUT SUB­
SEQUENT DETAILED INSPECTION WITH
NARROW BAND IMAGING IS OF LIMITED
VALUE. A MULTI­CENTER RANDOMIZED
CROSS­OVER STUDY COMPARING ENDO­
SCOPIC TRI­MODAL IMAGING WITH
W.L. Curvers, L. Alvarez Herrero,
M.B. Wallace, K. Ragunath, L. Wong Kee
Song, H.C. Wolfsen, V. Subramanian,
K.K. Wang, B.L.A.M. Weusten,
J.J.G.H. Bergman
14:30 – 14:40 OP447
IMPORTANCE OF VERIFYING COMPLETE
ERADICATION OF ENDOSCOPICALLY
EVIDENT BARRETT MUCOSA IN THE
NEOSQUAMOUS EPITHELIUM AFTER
RADIOFREQUENCY ABLATION PRIOR TO
SURVEILLANCE ENDOSCOPY AND BIOP­
SY, IN ORDER TO AVOID FALSE POSITIVE
INTERPRETATION OF BURIED BARRETT
R.E. Pouw, C.M. Sondermeijer, F.J.W. ten
Kate, J.J. Bergman
14:40 – 14:50 OP448
ENDOSCOPIC RESECTION FOR BAR­
RETT’S HIGH GRADE DYSPLASIA AND
EARLY OESOPHAGEAL ADENOCARCI­
NOMA: AN ESSENTIAL STAGING PROCE­
DURE WITH LONG TERM THERAPEUTIC
BENEFIT
A. Moss, M.J. Bourke, L.F. Hourigan,
S. Gupta, M.P. Swan, A.D. Hopper,
S.J. Williams, V. Kwan, A.A. Bailey
77
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
14:50 – 15:00 OP449
DO WE STILL NEED ENDOSCOPIC UL­
TRASOUND (EUS) IN THE WORk­UP OF
PATIENTS WITH EARLY ESOPHAGEAL
NEOPLASIA FOR ENDOSCOPIC TREAT­
MENT? A RETROSPECTIVE ANALYSIS OF
131 CASES
R.E. Pouw, N. Heldoorn, L. Alvarez Herrero,
F.J.W. Ten Kate, K.K. Krishnadath, P. Fockens,
J.J. Bergman
15:00 – 15:10 OP450
PREOPERATIVE AND EARLY POSTOPERA­
TIVE QUALITY OF LIFE PREDICT SURVIV­
AL IN POTENTIALLY CURABLE PATIENTS
WITH OESOPHAGEAL CANCER
M. van Heijl, M.A.G. Sprangers, A.G.E.M. de
Boer, S.M. Lagarde, J.B. Reitsma,
O.R.C. Busch, H.W. Tilanus, J.J.B. van
Lanschot, M.I. van Berge Henegouwen
15:10 – 15:20 OP451
ENDOSONOGRAPHIC FEATURES OF GAS­
TRIC GASTROINTESTINAL STROMAL TU­
MORS: IS IT POSSIBLE TO DIFFERENTIATE
GASTROINTESTINAL STROMAL TUMORS
FROM LEIOMYOMAS BY ENDOSCOPIC
ULTRASONOGRAPHY?
G. Kim, D. Ryu, J. Heo, G. Song, D. Park,
S. Kim, D. Kim, D. Kim, J. Moon, J. Lee, S. Park
15:20 – 15:30 OP452
ENDOSCOPIC FEATURES OF LOW­GRADE
GASTRIC DYSPLASIA ON FORCEPS BIOP­
SY SHOWING UPGRADED HISTOLOGY
AFTER ENDOSCOPIC RESECTION
C. Won, H. Kim, C. Yea, J. Byun, H. Choi,
J. KIm, K. Suk, M. Cho
fRee PaPeR sessIon
14:00 – 15:30 S8/9
Therapeutic insights in functional
digestive disorders
Chairs:
G. Barbara, Italy
P. Bytzer, Denmark
78
14:00 – 14:10 OP453
BULkING AGENTS, ANTISPASMODIC
AND ANTIDEPRESSANT MEDICATION
FOR THE TREATMENT OF IRRITABLE
BOWEL SYNDROME – A COCHRANE RE­
VIEW
L. Ruepert, O.A.O. Quartero, N.N.J. de Wit,
G.G.J. van der Heijden
14:10 – 14:20 OP454
EFFECT OF QUINOTOLAST, A MAST CELL
STABILIZER, ON RESTRAINT STRESS­
INDUCED ABNORMAL DEFECATION,
COLORECTAL DISTENSION­INDUCED AB­
DOMINAL PAIN, AND NORMAL DEFECA­
TION IN RATS WITH COLONIC HYPERSEN­
SITIVITY INDUCED BY INTRACOLONIC
INSTILLATION OF ACETIC ACID A
Y. Keto, R. Takezawa, H. Doihara,
T. Yokoyama, H. Ito, M. Okada, T. Hirata,
S. Akuzawa, M. Sasamata
14:20 – 14:30 OP455
MULTICENTER, 4­WEEk, DOUBLE­BLIND,
RANDOMIZED, PLACEBO­CONTROLLED
TRIAL OF SODIUM PICOSULFATE IN PA­
TIENTS WITH CHRONIC CONSTIPATION
S. Mueller-Lissner, M.A. Kamm, A. Wald,
U. Hinkel, U. Koehler, E. Richter, J. Bubeck
14:30 – 14:40 OP456
INHIBITION OF TRYPTOPHAN HYDROxY­
LASE AS A POTENTIAL TREATMENT FOR
IRRITABLE BOWEL SYNDROME
P. Brown, J.I. Jackson, K. Frazier, Q. Yang,
Q. Liu, J. Freiman
14:40 – 14:50 OP457
SUCCESSFUL GUT DIRECTED GROUP­
HYPNOSIS FOR PATIENTS WITH IRRI­
TABLE BOWEL SYNDROME – PRELIMI­
NARY RESULTS OF A RANDOMIZED
CONTROLLED TRIAL
G. Moser, A. Mikulits, S. Trägner,
M. Michalski, M. Führer, C. Dejaco,
W. Miehsler

14:50 – 15:00 OP458
EFFECT OF BASELINE IBS­C SEVERITY
ON ADEQUATE RELIEF: RESULTS FROM
A PHASE 2 TRIAL OF LINACLOTIDE
J.M. Johnston, J.E. MacDougall, B.J. Lavins,
C.B. Kurtz, A.J. Lembo
15:00 – 15:10 OP459
ALTERNATIVE THERAPIES IN IRRITABLE
BOWEL SYNDROME: RESULTS OF A PRO­
SPECTIVE STUDY
H. Hagege, R. Benamouzig, B. Savarieau,
G. Cargill, J.L. Dupas, L. Bueno, S. Bruley Des
Varannes
15:10 – 15:20 OP460
EFFICACY OF ALVERINE CITRATE/SIMETI­
CONE (ACS) COMBINATION ON ABDOMI­
NAL PAIN/DISCOMFORT: EUROPEAN,
RANDOMISED, DOUBLE­BLIND, PLACE­
BO­CONTROLLED STUDY ON PARALLEL
GROUPS OF PATIENTS WITH IRRITABLE
BOWEL SYNDROME (IBS)
T. Wittmann, L. Paradowski, P. Ducrotte,
L. Bueno, M. Andro-Delestrain, J. Grouin
15:20 – 15:30 OP461
A NOVEL IN VITRO MODEL OF VISCERAL
PAIN USING THE HUMAN APPENDIx
M. Peiris, M.D. Baker, D.C. Bulmer,
G. Boundouki, Q. Aziz, A. Hobson, S. Sinha,
K. Lee, C.H. Knowles
sYMPosIUM
14:00 – 15:30 N7/8
Palliation of malignant gastroduodenal
obstruction
Chairs:
D. Carr-Locke, USA
P. Fockens, The Netherlands
14:00 – 14:20
Metal stents for paliation
D. Carr-Locke, USA
14:20 – 14:40
Magnetic or pressure device anastomoses
N. Chopita, Argentina
14:40 – 15:00
NOTES techniques
A. Fritscher-Ravens, UK
15:00 – 15:20
Or maybe surgery?
H. Bruch, Germany
scIenTIfIc PRoGRaMMe
sYMPosIUM
14:00 – 15:30 N9/10
new insights in food-gut interactions
Chairs:
M. Delvaux, France
S. Collins, Canada
14:00 – 14:20
Pre­ and probiotics
E. Quigley, Ireland
14:20 – 14:40
Nutritional imprinting: Effects of early
life nutrition on adult disease
D. Darmaun, France
14:40 – 14:55 OP462
EFFECTIVENESS AND TOLERABIL­
ITY OF LACTOBACILLUS ACIDOPHILUS
(STRAINS Nk1, Nk2, Nk5, Nk12) IN THE
PREVENTION OF ANTIBIOTIC­ASSOCIAT­
ED DIARRHOEA
N. Ivashkina, A. Samsonov, A. Kazyulin,
E. Vyuchnova, I. Maev
14:55 – 15:10 OP463
GLUTEN AS A CAUSE OF GASTROINTES­
TINAL SYMPTOMS IN PATIENTS WHO DO
NOT HAVE COELIAC DISEASE
P. Irving, J. Biesiekierski, E. Newnham,
J. Barrett, M. Haines, J. Doecke, S. Shepherd,
J. Muir, P. Gibson
15:10 – 15:30
Trial designs to test dietary interventions
P. Enck, Germany
79
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
sYMPosIUM
14:00 – 15:30 N11/12
clinical challenges in advanced liver
disease
Chairs:
J. O‘Grady, UK
S. K. Sarin, India
14:00 – 14:20
Treatment of portal hypertension
S. K. Sarin, India
14:20 – 14:40
Treatment of ascites and refractory
ascites
A. K. Burroughs, UK
14:40 – 15:00
Hepatic encefalopathy
D. Haeussinger, Germany
15:00 – 15:20
Management of acute, chronic and
acute­on­chronic liver failure
R. Jalan, UK
sYMPosIUM
14:00 – 15:30 Platinum 3/4
advances in nutritional support: What
the gastroenterologist needs to know
Chairs:
M. Gassull, Spain
P. Singer, Israel
14:00 – 14:20
Nutritional support in the critically ill:
Parenteral, enteral or both?
P. Singer, Israel
14:20 – 14:40
Post­pyloric enteral feeding: Why, when,
how and in whom?
S. McClave, USA
14:40 – 15:00
Nutritional support in peri­operative
patients: When is it needed?
M. Gassull, Spain
80
15:00 – 15:20
How to manage the high output stoma
J. Shaffer, UK
fRee PaPeR sessIon
14:00 – 15:30 Platinum 1
Management of colorectal cancer
Chairs:
E. Dekker, The Netherlands
tba
14:00 – 14:10 OP464
TOxICITY OF NEOADJUVANT CHEMORA­
DIOTHERAPY IN PATIENTS WITH RECTAL
CANCER AFTER EMERGENCY STENTING
J. Jiménez-Pérez, J. Vila, I. Fernández-
Urién, J. Urman, F. Borda
14:10 – 14:20 OP465
IMPACT OF METABOLIC SYNDROME ON
THE OUTCOMES OF COLORECTAL CAN­
CER SURGERY: A PROSPECTIVE STUDY
V. Lohsiriwat, W. Pongsanguansuk,
N. Lertakyamanee, D. Lohsiriwat
14:20 – 14:30 OP466
THE DEPRESSED TYPE AND LATERALLY
SPREADING TUMOR (NON­GRANULAR
TYPE) COLORECTAL CANCER IS THE DIS­
TINCTIVE PHENOTYPE IN HEREDITARY
NON­POLYPOID COLORECTAL CANCER
PATIENTS
T. Nakajima
14:30 – 14:40 OP467
CLINICAL FEATURES OF EARLY DE­
PRESSED­TYPE NEOPLASMS AND DIAG­
NOSTIC SIGNIFICANCE OF “ENDOCYTO­
SCOPIC CLASSIFICATION” AS WELL AS
PIT PATTERNS IN THE COLORECTUM
H. Miyachi, S. Kudo, K. Wakamura,
N. Ikehara, S. Hamatani, M. Kutsukawa,
Y. Wada, T. Hosoya, T. Hayashi,
F. Yamamura, K. Ohtsuka, H. Kashida

14:40 – 14:50 OP468
SENTINEL NODE PROCEDURE OF THE
SIGMOID USING INDOCYANINE GREEN:
FEASIBILITY STUDT IN A GOAT MODEL
M.H.G.M. van der Pas, G.A.M.S. van
Dongen, F. Cailler, A. Pèlegrin,
W.J.H.J. Meijerink
14:50 – 15:00 OP469
SNARE BASED EN BLOC ENDOSCOPIC
MUCOSAL RESECTION AFTER CIRCUM­
FERENTIAL SUBMUCOSAL INCISION
(CSI­EMR) OF 40MM COLONIC LESIONS
COMPARED WITH CONVENTIONAL EMR
IN A PORCINE MODEL
A. Moss, M.J. Bourke, K. Tran, C. Godfrey,
G. McKay, A.P. Chandra
15:00 – 15:10 OP470
A COMPARISON OF TRANSANAL ExCI­
SION AND ENDOSCOPIC RESECTION FOR
EARLY RECTAL CANCER
S. Lee, S. Jeon, M. Jung, S. Kim, Y. Choi
15:10 – 15:20 OP471
IS ILEOANAL POUCH SURVEILLANCE
INDICATED AFTER RESTORATIVE PROC­
TOCOLECTOMY FOR NEOPLASIA IN UL­
CERATIVE COLITIS?
T. Kuiper, M.S. Vlug, F.J. van den Broek,
K.M. Tytgat, S. van Eeden, P.C. Stokkers,
P. Fockens, W.A. Bemelman, E. Dekker
15:20 – 15:30 OP472
PREBIOTICS AND BUTYRATE TO IMPROVE
INTESTINAL ANASTOMOTIC STRENGTH;
FRIEND OR FOE?
J.G. Bloemen, M.H.F. Schreinemacher,
K. Venema, M. Gijbels, W.A. Buurman,
N.D. Bouvy, C.H.C. Dejong
basIc scIence
14:00 – 15:30 Platinum 2
basic science Workshop 3: novel insights
into the pathogenesis of acute
pancreatitis
Chairs:
M. Lerch, Germany
P. Hegyi, Hungary
H. Algül, Germany
scIenTIfIc PRoGRaMMe
14:00 – 14:10
Introduction: The cells that make pancreatitis
– acinar, ductal and mesenchymal
culprits
P. Hegyi, Hungary
14:10 – 14:25
Rising Star: Transcription factors in acute
experimental pancreatitis- potential therapeutic
targets
H. Algül, Germany
14:25 – 14:30
General discussion on therapeutic
targets
14:30 – 14:40
Introduction: Why risk factors matter for
understanding pancreatitis and designing
therapy
M. Lerch, Germany
14:40 – 14:55 OP473
ALTERED ExPRESSION OF FIBROBLAST
GROWTH FACTOR 15 IN ACUTE PAN­
CREATITIS: POTENTIAL CONSEQUENCES
FOR BACTERIAL TRANSLOCATION AND
INFECTION RISk
R.M. Nijmeijer, L.M. Akkermans,
F.G. Schaap, P.L. Jansen, J. Terlinde,
A. Verheem, A.B. Kroese, M.G. Besselink,
M. Schipper, H.G. Gooszen, K. Van Erpecum
14:55 – 15:10 OP474
GENETIC VARIANTS IN THE MYOSIN
IxB AND PARD3 GENE PREDISPOSE TO
ACUTE PANCREATITIS
R.M. Nijmeijer, H.C. Van Santvoort,
A. Zhernakova, M.G. Besselink,
M.C. Wapenaar, M.A. Boermeester,
G.T. Rijkers, H.G. Gooszen, L.M. Akkermans,
C. Wijmenga
15:10 – 15:25 OP475
TRANSGENIC ExPRESSION OF INTRACEL­
LULAR ACTIVE TRYPSIN CAUSES ACUTE
PANCREATITIS
S. Gaiser, J. Daniluk, Y. Liu, L.L. Tsou, B. Ji,
C.D. Logsdon
15:25 – 15:30
Summary
81
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
scIenTIfIc PRoGRaMMe
fRee PaPeR sessIon
14:00 – 15:30 SG11/12
new diagnostic techniques and biomarkers
for colorectal cancer
Chairs:
W. Grady, USA
R. Bresalier, USA
14:00 – 14:10 OP476
CONFOCAL ENDOMICROSCOPY FOR
DETECTION AND MONITORING OF CO­
LONIC CARCINOGENESIS AND ANGIO­
GENESIS IN A NOVEL MOUSE MODEL
V. Becker, F. Greten, I. Kerle, R. Schmid,
A. Meining
14:10 – 14:20 OP477
NEAR­INFRARED FLUORESCENCE IMAG­
ING USING POLYMERIC NANOPARTICLE­
BASED MMP­ACTIVATABLE PROBE IN
COLON CANCER
S. Yoon, S. Myung, I. Kim, E. Do, Y. Ryu,
S. Park, Y. Kim, J. Ryu, K. Kim, I. Kwon,
M. Kim, D. Moon, D. Yang, K. Kim, B. Ye,
J. Byeon, S. Yang, J. Kim
14:20 – 14:30 OP478
AN ASSOCIATION STUDY OF A COPY
NUMBER POLYMORPHISM WITHIN
MTUS1 AND COLORECTAL CANCER
K.J. Monahan, S. Spain, H.J.W. Thomas,
I.P. Tomlinson
14:30 – 14:40 OP479
A DINUCLEOTIDE DELETION IN CD24
CONFERS PROTECTION AGAINST CRC
I. Naumov, V. Lisianski, D. Kazanov,
S. Kraus, E. Liberman, L. Galazan, A. Hallack,
N. Arber
14:40 – 14:50 OP480
CLINICAL SIGNIFICANCE OF DIPEPTI­
DASE­1 GENE ExPRESSION
Y. Toiyama, H. Yasuda, Y. Inoue, S. Saigusa,
T. Yokoe, Y. Okugawa, C. Miki, M. Kusunoki
82
14:50 – 15:00 OP481
EARLY DETECTION OF COLORECTAL
CANCER PROGRESSION BY MONITORING
OF CIRCULATING TUMOUR CELLS AND
FREE TUMOUR DNA IN PATIENT BLOOD
AND PLASMA SAMPLES
P. Minarikova, L. Benesova, B. Belsanova,
A. Meszarosova, M. Zavoral, L. Lipska,
M. Minarik
15:00 – 15:10 OP482
HIGH MOBILITY GROUP BOx­1: A POTEN­
TIAL BIOMARkER FOR EARLY DETECTION
OF COLON CANCER
A.T. Hammoudi, R. Jenkins, J. Hamlett,
K. Reed, A. Clarke, A. Watson, J. Jenkins
15:10 – 15:20 OP483
PROMOTER HYPERMETHYLATION OF
PHACTR3, A POTENTIAL NEW BIOMARkER
FOR COLORECTAL CANCER DETECTION
L.J.W. Bosch, M. Neerincx, F.A. Oort,
S. Mongera, A. Masclee, D.M. Jonkers,
C.A. Khalid-de Bakker, K. Bierau, J. Louwagie,
W. van Criekinge, A.P. de Bruïne, M. van
Engeland, C.J.J. Mulder, B. Carvalho, G.A. Meijer
15:20 – 15:30 OP484
COLORECTAL CANCER AND ADENOMA
RELATED MRNA ExPRESSION PATTERNS
IN PERIPHERAL BLOOD­RELATION TO
THE MRNA PROFILE OF BIOPSIES AND
MONONUCLEAR CELLS THAT RECIRCU­
LATE COLON AND BLOOD
B. Molnar, O. Galamb, K. Toth, S. Spisak,
Z. Tulassay

Neurogastroenterology
& Motility
Alimentary Pharmacology
& Therapeutics
Edited by Jan Tack, Keith Sharkey
Edited by R.E. Pounder and
and Joseph Joseph Szurszewski W.L. W.L. Peterson Peterson
Considering where to
submit your next paper?
Publishing in Neurogastroenterology &
Motility offers the following benefi ts:
• Rising impact factor 3.48*
• Rapid publication – mean time to fi rst
decision is just 26 days
• Hot topics fast tracked
To view a free sample issue and fi nd out
more go to
www.blackwellpublishing.com/nmo
*2008 Journal Citation reports, Thomson Reuters
Have you discovered
leading articles in
infl ammatory bowel
disease and hepatology
from AP&T?
To view virtual issues, which collate
previously published articles in
infl ammatory bowel disease and
hepatology, visit
www.APandT.org
and click on “Virtual Issues” on the
left hand side
Wiley-Blackwell Gastroenterology Pages – Stay up-to-date with
the latest research at www.wiley.com/go/gastro

BSG 2010
LIVERPOOL ACC:
22nd – 25th March 2010
Provisional programme highlights
The meeting will be held at a new venue in the heart of Liverpool
docklands. The programme is deliberately complementary to
Gastro 2009 and features a new format, including:
• Key pads
• Case based symposia
• Debates
• Future Gazing
• Year’s research highlights
The meeting will feature top speakers, including three Nobel laureates (Sir James Black,
Sir Peter Mansfi eld, Barry Marshall) as well as a number of international faculty.
FRONTLINE GASTROENTEROLOGY
The BSG is creating a new clinical journal called Frontline
Gastroenterology, which will be free to UK based
members, with online access to International members.
The fi rst edition will be available in March 2010 at our
annual meeting and quarterly thereafter. The journal
will focus on quality improvement and the spread of
best practice. We are looking for articles directly related
to clinical practice, education and training in a variety
of formats, from opinion pieces, analysis articles, case
reports, review articles, quality improvement reports
and cost benefi t analysis. If you would like to submit
an article for publication or for more information please
contact info.fg@bmjgroup.com.
• Nobel Laureate symposium
• International research workshop
on infl ammation and cancer
• Postgraduate course
• Launch of e-endoscopy e-learning
BECOME AN
INTERNATIONAL
MEMBER OF THE BSG
For Gastro 2009 we are offering
a special introductory rate on
BSG international membership.
Come to the stand for more
details. Become an international
member of the BSG and regular
updates on research, education
and clinical news as well as
electronic access to Gut and
to our new clinical journal,
Frontline Gastroenterology.
For more information please visit www.bsg2010.org.uk

LUNCH
SESSIONS
PER DAY

lUncH sessIons
Lunch sessions are supposed to be for
management discussion, not didactic
teaching and are offered from Monday to
Wednesday at 12:45 – 14:00. The focus of
each session will be on the daily clinical
practice of gastroenterology. The maximum
number of participants will be strictly
limited to 30. Registrations will be accepted
on a “first-come, first-served” basis.
A lunch will be provided to all participants.
The lunch session fee is EUR 55.
MonDaY, noVeMbeR 23, 2009
12:45 – 13:45
Room PR1
exocrine pancreatic insufficiency:
When and how to prescribe enzymes
Experts:
M. Lerch, Germany
J. Mössner, Germany
Room PR2
endoscopic management of bariatric
surgery complications
Experts:
J. Deviere, Belgium
T. Baron, USA
Room sG3
Management of persistent halitosis
and belching
Experts:
A. Smout, The Netherlands
J. Tack, Belgium
Room sG4
Measuring pH in GoRD:
How should my centre do it?
Experts:
V. Savarino, Italy
D. Sifrim, Belgium
Room sG5
What is the place of thiopurine analogues
in the era of anti-Tnf?
Experts:
S. Ghosh, UK
J. Lindsay, UK
86
Room sG7
fecal incontinence:
an updated management
Experts:
A. Bharucha, USA
M. Pescatori, Italy
Room sG8
Treatment of nasH: lifestyle or
pharma cology?
Experts:
S. Bellentani, Italy
C. Day, UK
Room sG9
How to assess surgical risk in patients
with liver disease
Experts:
J. Belghiti, France
P. Burra, Italy
TUesDaY, noVeMbeR 24, 2009
12:45 – 13:45
Room PR1
esD
Experts:
N. Yahagi, Japan
H. Neuhaus, Germany
Room PR2
branch type IPMn: When to observe,
when to operate?
Experts:
W. Brugge, USA
C. Bassi, Italy
Room sG3
Resistant GoRD: non-surgical management
strategies
Experts:
S. Riley, UK
J. P. Galmiche, France
Room sG4
How should I manage eosinophilic
oesophagitis?
Experts:
P. de Angelis, Italy
S. Husby, Denmark

Room sG5
Preventing and managing side effects
of biolgical therapies
Experts:
F. Carbonnel, France
G. Van Assche, Belgium
Room sG7
chronic abdominal pain: What’s intractable,
the pain, the patient or the
doctor?
Experts:
F. Mearin, Spain
P. Whorwell, UK
Room sG8
nutrition in patients with decompensated
cirrhosis
Experts:
A. Burroughs, UK
J. O‘Grady, UK
Room sG9
non invasive discriminators for liver
fibrosis in everyday practice
Experts:
L. Castera, France
W. Rosenberg, UK
WeDnesDaY, noVeMbeR 25, 2009
12:45 – 13:45
Room PR1
self-expanding metallic biliary stents:
covered or uncovered?
Experts:
D. Carr-Locke, USA
J. Spicak, Czech Republic
Room PR2
balloon assisted endoscopy
Experts:
M. Delvaux, France
M. Keuchel, Germany
lUncH sessIons
Room sG3
‘Is it my heart doctor?’ non-cardiac
chest pain and linked angina pectoris
Experts:
A. Smout, The Netherlands
Q. Aziz, UK
Room sG4
Individualising H. pylori management:
What’s best for my patient?
Experts:
C. O‘Morain, Ireland
X. Calvet, Spain
Room sG5
Which vaccines should my IbD patient
receive?
Experts:
J-F. Rahier, Belgium
M. Gassull, Spain
Room sG7
‘I have a family history of bowel cancer,
doctor – do I need a colonoscopy?’
Experts:
G. Young, Australia
B. Saunders, UK
Room sG8
liver pathology for the clinicians:
What is new and what to ask
Experts:
T. Roskams, Belgium
S. K. Sarin, India
Room sG9
Maintenance therapy in HcV non
responders: Is it worth it?
Experts:
D. Mutimer, UK
A. Craxì, Italy
87

UEGW
STOCKHOLM 2011
19th United European
Gastroenterology Week
EACCME applied
www.uegf.org
October 22 – 26, 2011
Stockholm, Sweden
Stockholm Exhibition &
Congress Center
Future UEGW
Congresses
www.uegf.org
UEGW
BARCELONA 2010
18th United European
Gastroenterology Week
EACCME applied
www.uegf.org
October 23 – 27, 2010
Barcelona, Spain
CCIB
Centre Convencions
Internacional Barcelona

POSTER
SESSIONS
PER DAY

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
PosTeR sessIon
Gastrointestinal bleeding I
P0001
THE APPLICATION OF A CONTINUOUS
QUALITY IMPROVEMENT PROGRAM IM­
PROVES THE ENDOSCOPIC OUTCOMES
OF UPPER GASTROINTESTINAL BLEEDING
A. Amato, G. Imperiali, S. Paggi, F. Radaelli,
G. Spinzi, N. Lenoci, N. Terreni, G. Mandelli,
A. Toldi, V. Terruzzi
P0002
DIOMED LASER ABLATION VERSUS AR­
GON PLASMA COAGULATION FOR ENDO­
SCOPIC TREATMENT OF HEMORRHAGIC
RADIATION PROCTOSIGMOIDITIS
D. Xinopoulos, S.P. Bassioukas, D. Kypreos,
D. Dimitroulopoulos, D. Korkolis,
I. Fragandrea, E. Paraskevas
P0003
PREVENTION BY PROTON PUMP INHIBI­
TORS (PPI) OF UPPER GASTROINTES­
TINAL BLEEDING ASSOCIATED WITH
ANTIPLATELET THERAPY RESULTS OF A
NESTED CASE­CONTROL STUDY
J. Bretagne, B. Nalet, G. Lesur, B. Bour,
P. Barthélemy, C. Soufflet
P0004
LONG TERM EFFICACY AND SAFETY OF N­
BUTYL CYANOACRYLATE IN ENDOSCOPIC
TREATMENT OF GASTRIC VARICES
G. Choudhuri, K. Chetri, G. Bhat,
G. Alexander, K. Das, U. Ghoshal,
P. Paramasivan, K. Das, P. Chandra
P0005
THE EFFICACY OF HEMOSTATIC TREAT­
MENT OF GASTRIC ULCER WITH ARGON
PLASMA COAGULATION
T. Ebato, T. Ishii, A. Isono, Y. Mishina,
S. Nakayama, K. Nagasawa, K. Abe,
K. Hattori, T. Yamamoto, Y. Kuyama
90
P0006
A META­ANALYSIS OF RANDOMIZED
CONTROLLED TRIALS COMPARING
PROTON PUMP INHIBITORS AND H2 RE­
CEPTOR BLOCkERS IN PREVENTING DE­
LAYED BLEEDING AFTER ENDOSCOPIC
RESECTION OF GASTRIC TUMORS
N.I. Estanislao, E. Ang, H.B. Flores,
A.D. Salvana, M. Velasquez, E.S. Tripon,
M. Daez
P0007
LONG­TERM PROGNOSIS IN PATIENTS
WITH OBSCURE GASTROINTESTINAL
BLEEDING AFTER DOUBLE­BALLOON
ENDOSCOPY
M. Fujita, N. Manabe, K. Tarumi, K. Honda,
H. Matsumoto, T. Kamada, A. Shiotani,
J. Hata, K. Haruma
P0008
ACUTE UPPER GASTROINTESTINAL
BLEEDING IN NILE DELTA: A 5 YEAR RET­
ROSPECTIVE STUDY
M. Gabr, N. El-Shall, M. Ghazy
P0009
EVALUATION OF BLEEDING POST RADIA­
TION CHRONIC PROCTITIS’S MANAGE­
MENT BY ARGON PLAMSA COAGULA­
TION IN GASTROENTEROLOGY UNIT
LIMOGES UNIVERSITY HOSPITAL CENTER
A. GIRAUD, A. Le Sidaner, S. Seillan,
F. Cessot, V. Valgueblasse, M. Picard,
D. Sautereau
P0010
USE OF PROkINETICS PRIOR TO ENDOS­
COPY IN ACUTE UPPER GASTROINTESTI­
NAL BLEEDING? A META­ANALYSIS
I.M. Gralnek, A. Barkun, M. Bardou
P0011
CAPSULE ENDOSCOPY (CE) APPEARS
TO BE UNDERUTILIZED IN EVALUATING
OBSCURE GASTROINTESTINAL BLEED­
ING (OGIB)
I.M. Gralnek, D. Malvehy

P0012
EFFICACY OF THROMBIN­FIBRIN GLUE
AND SCLEROSANT IN THE MANAGE­
MENT OF BLEEDING GASTRIC VARICES
S. Gupta
PosTeR sessIon
Helicobacter pylori I
P0013
CORRELATION OF SEROLOGICAL MARk­
ERS WITH ATROPHIC GASTRITIS AND
INTESTINAL METAPLASIA HISTOPATHO­
LOGICAL FINDING BEFORE AND AFTER
HELICOBACTER PYLORI ERADICATION
THERAPY
T. Filipec Kanizaj, M. Katicic, V. Colic
Cvrlje, B. Skurla, M. Prskalo, A. Mrzljak,
S. Naumovski Mihalic
P0014
THE NEW APPROACH TO NONINVASIVE
RECOGNITION OF HELICOBACTER PY­
LORI INFECTION AND ASSOCIATED MU­
COSAL LESIONS IN THE STOMACH AND
DUODENUM
I. Kushch, N.M. Korenev, L.V. Kamarchuk,
A.P. Pospelov, Y.L. Alexandrov,
G.V. Kamarchuk
P0015
DEVELOPMENT OF MONOCLONAL
ANTIBODIES TO HELICOBACTER BILIS­
SPECIFIC ANTIGENS
T. Shimoyama, R. Takahashi, T. Ohmura,
Y. Sano, N. Sakaedani, S. Fukuda, Y. Fukuda
P0016
PRECISION AND SENSITIVITY OF ISO­
TOPE­ SELECTIVE NON DISPERSIVE IN­
FRARED SPECTROMETERS ARE SATIS­
FACTORY WHEN USING HP PLUS 100MG
WITH 30 MINUTES INCUBATION TIME
AND CUT OFF 3.5, BUT UNSATISFACTORY
IN THE CASE OF DIABACT UBT 50MG 13C
UREA BREATH TEST WITH C
V. Skar, G. Mandic, H. Hope, C. Borge
PosTeR sessIon
P0017
IMMUNOHISTOCHEMICAL EVALUATION
OF THE INFLUENCE OF PROTON PUMP
INHIBITORS ON DIAGNOSTIC HELICO­
BACTER PYLORI TESTS
A. SOYLU, S. Ozkara, M. Kalayci, N. Yasar,
I. Sevindir, N. Sever
P0018
SERUM FERRITIN VS ERYTHROCYTE
MEAN CORPUSCULAR VOLUME IN ADO­
LESCENT GIRLS INFECTED WITH HELICO­
BACTER PYLORI
S. Tereshchenko, N. Gorbacheva
P0019
A 20 HOURS ELISA METHOD CHEMO­
SUSCEPTIBILITY RAPID TEST FOR HELI­
COBACTER PYLORI
D. Vaira, F. Perna
P0020
A NEW RAPID UREA TEST FOR DIAGNO­
SIS OF HELICOBACTER PYLORI INFEC­
TION IN 1000 CONSECUTIVE PATIENTS
D. Vaira, N. Vakil, L. Gatta, C. Ricci, F. Perna,
I. Saracino, J. Holton
P0021
ACCURACY OF UREA BREATH TESTS TAB­
LETS AFTER 10 MINUTES COMPARED TO
STANDARD 30 MINUTES TO DIAGNOSE
AND MONITORING HELICOBACTER PY­
LORI INFECTION: A RANDOMISED CON­
TROLLED TRIAL
D. Vaira, L. Gatta, C. Ricci, F. Di Mario,
A. Lanzini
P0022
AGE AND GENDER DIFFERENCES IN
UREA BREATH TEST RESULTS
N. Zevit, Z. Levi, Y. Niv, R. Shamir
91
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0023
GASTRIC CANCER, ESOPHAGEAL CAN­
CER, BARRETT’S ESOPHAGUS AND HE­
LICOBACTER PYLORI
S.M. Bataga, I. Torok, D. Georgescu,
A. Negovan, M. Macarie, S. Mocan,
M. Tilinca
P0024
ADENOCARCINOMAS AT THE GASTRIC
CARDIA (AEG2) SHOW AN INTERMEDI­
ATE ASSOCIATION TO H. PYLORI INFEC­
TION COMPARED TO MORE PROxIMAL
(AEG1) OR MORE DISTAL (AEG3) TUMORS
J. Bornschein, M. Venerito, M. Selgrad,
D. Kuester, P. Malfertheiner
P0025
H. PYLORI POSITIVE PATIENTS WITH
DISTAL GASTRIC CANCER HAVE MORE
TUMOR­ADJACENT INTESTINAL META­
PLASIA
J. Bornschein, C. Albrecht, M. Selgrad,
D. Kuester, T. Wex, P. Malfertheiner
P0026
THE STAGING OF GASTRITIS WITH THE
OLGA SYSTEM USING INTESTINAL META­
PLASIA AS ACCURATE ALTERNATIVE FOR
ATROPHIC GASTRITIS
L.G. Capelle, A.C. de Vries, J. Haringsma,
F. ter Borg, R.A. de Vries, M. Bruno, H. van
Dekken, J. Meijer, N.C. van Grieken,
E.J. Kuipers
P0027
LONG TERM COMPLETE REMISSION OF
GASTRIC DIFFUSE LARGE B CELL LYM­
PHOMA AFTER ERADICATION OF HELI­
COBACTER PYLORI: A RETROSPECTIVE
STUDY OF 10 CASES
L. Sinayoko, S. Franceschetti, E. Roggero,
C. Traullé, M. Lévy, K. Leroy, V. Molinier-
Frankel, R. Barbaza, M. de Boni, E. Pedrinis,
E. Zucca, C. Copie-Bergman, J. Delchier
92
P0028
HELICOBACTER PYLORI DUPA POLY­
MORPHISM CONTRIBUTE TO GASTRIC
ACID SECRETION AND GASTRIC CANCER
DEVELOPMENT: A LONG­TERM RETRO­
SPECTIVE COHORT STUDY OF JAPANESE
PATIENTS WITH PEPTIC ULCER
S. IMAGAWA, M. Ito, M. Yoshihara,
S. Takata, M. Tatsugami, Y. Wada,
Y. Matsumoto, S. Kitamura, A. Takamura,
T. Matsuo, S. Tanaka, K. Chayama
P0029
HELICOBACTER PYLORI SEROPOSITIVITY
AND HOST INFLAMMATORY POLYMOR­
PHISMS IN PATIENTS WITH CHRONIC
ATROPHIC GASTRITIS
P. Karimi, J. Hashemi, M. Akbari
P0030
ANTIBODIES TO HELICOBACTER PYLORI
AND CAGA PROTEIN ARE ASSOCIATED
WITH THE RESPONSE TO ANTIBACTERIAL
THERAPY IN PATIENTS WITH HELICO­
BACTER PYLORI­POSITIVE API2­MALT1­
NEGATIVE GASTRIC MALT LYMPHOMA
Y. Kitadai, T. Sumida, T. Hiyama,
K. Shinagawa, M. Tanaka, M. Kodama,
M. Ito, S. Tanaka, K. Chayama
P0031
THERAPEUTIC ROLE OF RADIATION
THERAPY IN LOW GRADE MUCOSA­
ASSOCIATED LYMPHOID TISSUE LYM­
PHOMA OF THE STOMACH
J. Koo, H. Jung, J. Lee, D. Kim, K. Jung,
J. Chung, K. Choi, K. Choi, H. Song, G. Lee,
J. Kim
P0032
ENDOSCOPIC FEATURES IN THE DIAGNO­
SIS OF PRIMARY GASTRIC LYMPHOMA
P. LLorens Sabate, L. Contreras Melendez

P0033
USEFULLNESS OF NON­INVASIVE DE­
TECTION OF H.PYLORI­ASSOCIATED
GASTRIC PRECANCEROUS CONDITIONS
AND EARLY GASTRIC CANCER (EGC)
E. Melnikova, I. Maev, S. Kashin,
A. Nadezhin, T. Kryukova, L. Shubin
P0034
GLOBAL DNA METHYLATION IS AN
EARLY EVENT IN HP­RELATED GASTRIC
CARCINOGENESIS
A. Rocco, D. Compare, G. De Martino,
E. Liguori, G. Nardone
P0035
SEROLOGICAL ANALYSIS OF HELICO­
BACTER BILIS INFECTION IN PATIENTS
WITH BILIARY DISORDERS
T. Shimoyama, R. Takahashi, I. Mizuki,
D. Abe, T. Ohmura, Y. Sano, S. Fukuda
P0036
INTRAFAMILIAL AGGREGATION OF
GASTRIC CANCER: A COMPREHENSIVE
APPROACH WITH ENVIRONMENTAL
FACTORS, HELICOBACTER PYLORI VIRU­
LENCE FACTORS, AND GENETIC SUSCEP­
TIBILITY
C. Shin, N. Kim, B. Lee, D. Lee, H. Jung,
I. Song
P0037
ASSOCIATION BETWEEN POLYMOR­
PHISMS IN THE 3' UNTRANSLATED RE­
GION (3'­UTR) OF VASCULAR ENDOTHE­
LIAL GROWTH FACTOR (VEGF) GENE
AND GASTRIC CANCER INCIDENCE IN
JAPANESE POPULATION
T. Tahara, T. Shibata, M. Nakamura,
I. Hirata, T. Arisawa
PosTeR sessIon
P0038
CLINICOPATHOLOGICAL ANALYSIS OF
EARLY GASTRIC CANCERS AFTER HELI­
COBACTER PYLORI ERADICATION TREAT­
MENT
K. Yamamoto, M. Kato, S. Ono,
M. Nakagawa, Y. Shimizu, M. Asaka,
K. Kubota, Y. Matsuno, H. Watanabe
PosTeR sessIon
Immunology/Microbiology I
P0039
DIFFERENCES IN PERCEPTION AND AT­
TITUDE AMONG MEDICAL STAFF TO­
WARDS IBS AND IBD – A COMPARATIVE
STUDY
R. Dickman, S. Levy, M. Segev, R. Reicher
Atir, N. Horev, Y. Niv
P0040
COLONIC MICROFLORA ARE UNDER THE
CONTROL OF GASTRIC ACID SECRETION
T. Kanno, T. Matsuki, M. Oka, K. Moribata,
H. Maeda, N. Shingaki, H. Deguchi, K. Ueda,
T. Maekita, I. Inoue, M. Iguchi, H. Tamai,
K. Yanaoka, K. Nomoto, R. Tanaka,
M. Ichinose
P0041
PREBIOTIC EFFECT OF A FRUIT AND VEG­
ETABLE SHOT CONTAINING JERUSALEM
ARTICHOkE INULIN: A HUMAN INTER­
VENTION STUDY
P. Ramnani, E. Gaudier, M. Bingham,
P. Bruggen, K.M. Tuohy, G.R. Gibson
P0042
SACCHAROMYCES BOULARDII INHIBITS
LIPOPOLYSACCHARIDE­INDUCED ACTI­
VATION OF HUMAN DENDRITIC CELLS
AND T CELL PROLIFERATION
S. Thomas, I. Przesdzing, D. Metzke,
J. Schmitz, A. Radbruch, D.C. Baumgart
93
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0043
HYDROGEN AND METHANE BREATH
TESTS IN PATIENTS WITH SYSTEMIC
SCLEROSIS
J. Cyrany, T. Soukup, P. Bradna, Z. Hrncir,
I. Tacheci, M. Kopacova, S. Rejchrt, J. Bures
P0044
ExPRESSION OF TOLL­LIkE RECEPTORS
IN BIOPSY SPECIMENS OF LIVER FROM
CHILDREN INFECTED WITH HEPATITIS C
AND B VIRUSES
I. Mozer-Lisewska, R. Jenek, H. Samara,
M. Figlerowicz, A. Kowala-Piaskowska,
A. Mania, A. Adamek, W. Sluzewski,
J. Zeromski
P0045
DEFECTIVE PANETH CELL MEDIATED
HOST DEFENSE IN PEDIATRIC ILEAL
CROHN’S DISEASE
G. Perminow, J. Beisner, M. Koslowski,
L.G. Lyckander, E. Stange, M.H. Vatn,
J. Wehkamp
P0046
IS GASTROINTESTINAL ENDOSCOPY A
RISk FACTOR FOR CLOSTRIDIUM DIFFI­
CILE ASSOCIATED DIARRHOEA?
C.P. Selinger, S. Greer
P0047
ExTREME METABOLIC DISTURBANCES
CONTRIBUTE TO HIGH MORTALITY IN
ZAMBIAN AIDS PATIENTS WITH INTER­
STINAL INFECTIOUS DISEASE
E. Sinkala, P. Kelly
P0048
HELMINTHS – A SIGNIFICANT BURDEN
OF UNDIAGNOSED DISEASE AMONG
MIGRANTS IN A GASTROENTEROLOGY
CLINIC?
P.J. Smith, B. Theis, S. McCartney, M. Brown
94
P0049
RELIABILITY AND VALIDITY OF kOREAN
BOWEL DISEASE QUESTIONNAIRE AND
PREVALENCE OF FUNCTIONAL GASTRO­
INTESTINAL DISORDERS IN kOREA
H. Song, H. Jung, H. Yeom, M. Kang, J. Jung,
S. Kim, T. Kim, K. Shim, S. Jung, S. Yi, K. Yoo,
I. Moon, N. Talley
P0050
PREVALENCE OF WATERBORNE PARA­
SITES: GIARDIA LAMBLIA AND CRYPTO­
SPORIDIUM PARVUM INFECTION AND
DIARRHEA IN NEPAL
R. Tiwari
P0051
THE PREVALENCE OF GASTROINTESTI­
NAL PARASITES IN HIV POSITIVE SUB­
JECTS AND HIGH RISk GROUP FOR HIV
INFECTION IN NEPAL
R. Tiwari
P0052
ASSESSMENT OF A SCORING SYSTEM
THAT PREDICTS METRONIDAZOLE FAIL­
URE IN CLOSTRIDIUM DIFFICILE DISEASE
N.K. Sandhu, J. Tyrrell-Price, S. D’Arc,
D. Bansi, K.B. Bamford, J.R.F. Walters
P0053
NOVEL INTRA­COLONIC INFUSION OF
THREE ANTI­PARASITE AGENTS FOR
RESISTANT BLASTOCYSTIS HOMINIS IN­
FECTIONS
A.R. Wettstein, T.J. Borody, T. Wee,
M. Torres, S. Ketheeswaran
P0054
IRRITABLE BOWEL SYNDROME: IS IT AS­
SOCIATED WITH GENOTYPES OF BLAS­
TOCYSTIS HOMINIS
J. Yakoob, W. Jafri, M. Beg, Z. Abbas,
R. Khan, S. Naz, M. Islam

P0055
SIGNIFICANCE OF FUNGAL TRANS­
MISSION WITHIN GASTROINTESTINAL
TRACT IN INFLAMMATORY BOWEL DIS­
EASES
M. Zwolinska-Wcislo, D. Trojanowska,
M. Tokarczyk, A. Budak, T. Mach
PosTeR sessIon
Intestinal disorders I
P0056
PRE­ AND POST­MARkETING SAFETY
PROFILE OF RACECADOTRIL CAPSULES,
A “NEW” ANTIDIARRHOEAL DRUG
P. Baumer, Y. Joulin
P0057
ALTERATION OF GUT BARRIER IN A RAT
MODEL OF CHEMOTHERAPY­INDUCED
MUCOSITIS: ROLE OF TIGHT JUNCTION
PROTEINS CLAUDIN­1, OCCLUDIN AND
ZONULA OCCLUDENS­1
S. Beutheu YOUMBA, N. Boukhettala,
L. Galas, P. Déchelotte, M. Coëffier
P0058
URSODEOxYCHOLIC ACID ExERTS AN­
TISECRETORY ACTIONS ON COLONIC
EPITHELIAL CELLS, A NOVEL FINDING
O.B. Kelly, N. Keating, F.E. Murray, S.J. Keely
P0059
THE PROTECTIVE EFFECT OF ANGIOPOI­
ETIN­1 ON x­RAY IRRADIATION INDUCED
CELL DEATH IN CULTURED INTESTINAL
EPITHELIAL CELL
T. Nakayama, H. Hirakawa, K. Shibata,
I. Sekine
P0060
LOW MOLECULAR WEIGHT HEPARIN AL­
TERS GENE ExPRESSION DURING BOWEL
ANASTOMOSIS HEALING IN RATS
N. Krzesniak, A. Paziewska, T. Rubel,
M. Skrzypczak, M. Mikula, A. Dzwonek,
K. Goryca, L. Wyrwicz, M. Woszczynski,
K. Bielecki, J. Ostrowski
PosTeR sessIon
P0061
NATURAL HISTORY OF EOSINOPHILIC
GASTROENTERITIS
G. Pineton de Chambrun, F. Gonzalez,
J. Canva, S. Gonzalez, L. Houssin, A. Cortot,
J. Colombel
P0062
SMALL INTESTINAL BRUSH BORDER
ENZYMES IN CIRRHOSIS AND NON­CIR­
RHOTIC PORTAL HYPERTENSION
S. Srijaya, S.K. Sinha, C.K. Nain, A. Lal,
S. Rana, S.S. Rana, B. Nagi, D.K. Bhasin,
K. Singh
P0063
CEREAL BASED ORAL REHYDRATION
THERAPY FOR TREATMENT OF ADULTS
WITH WATERY DIARRHEA: A META ANAL­
YSIS OF RANDOMIZED CONTROLLED
TRIALS
V. Subramanian, B.S. Ramakrishna
P0064
TREATMENT OF MYOFIBROBLAST WITH
CARBON MONOxIDE (CO) ENHANCE
COLONIC EPITHELIAL CELL RESTITU­
TION VIA INHIBITION OF MICRORNA­710
ExPRESSION AND INCREASE OF FGF15
ExPRESSION
K. Uchiyama, Y. Naito, T. Takagi, O. Handa,
N. Yagi, S. Kokura, T. Yoshikawa
P0065
THE INCIDENCE OF OBESITY AMONG PA­
TIENTS WITH COELIAC DISEASE
E. Tucker, K. Rostami, S. Tang, R. Mansfield,
D.M. Aldulaimi
P0066
POTENTIAL ROLE OF B­CELL ACTIVATING
FACTOR IN NON­IGE­MEDIATED HYPER­
SENSITIVTY REACTIONS TO FOOD
G. Arslan Lied, K. Lillestøl, J. Valeur,
A. Berstad
95
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0067
CHARACTERIZATION OF ANANDAMIDE
METABOLISM IN COELIAC DISEASE
A. Di Sabatino, N. Battista, M. Pucci,
P. Biancheri, L. Rovedatti, P. Cazzola,
M. Guerci, M. Maccarrone, G.R. Corazza
P0068
MUCOSAL INTERFERON­GAMMA RE­
SPONSE TO GLUTEN IN COELIAC DISEASE
M. Brottveit, S. Tollefsen, M. Ráki, J. Bratlie,
L.M. Sollid, K.E.A. Lundin
P0069
kIR/HLA GENOTYPE ASSOCIATED WITH
COMPLICATED CELIAC DISEASE
V. De Re, L. Caggiari, M. De Zorzi,
V. Canzonieri, S. Maiero, R. Cannizzaro
P0070
BLOOD DONATION AND IRON DEFICIEN­
CY: ANOTHER POSSIBLE FACE OF CELIAC
DISEASE
A. Da Ponte, S. Maiero, R. Talamini, V. De Re,
R. Cannizzaro
P0071
PPAR SIGNALLING PATHWAY IS IN­
VOLVED IN CD­ASSOCIATED INFLAM­
MATION
V. De Re, M. Simula, V. Canzonieri,
M. Marin, M. De Zorzi, L. Caggiari, S. Maiero,
R. Cannizzaro
P0072
FATIGUE AS A DETERMINANT OF HEALTH
IN PATIENTS WITH CELIAC DISEASE
F. Casellas, J. López Vivancos
P0073
THE IMPACT OF SMALL INTESTINAL BAC­
TERIAL OVERGROWTH ON LACTOSE IN­
TOLERANCE
J. Zhao, Y. Cong, M. Fox, H. Chu, Y. Shang,
M. Fried, N. Dai
96
P0074
CLINICO­PATHOLOGICAL CO­RELATION
OF CLASSICAL AND ATYPICAL PRESEN­
TATIONS OF COELIAC DISEASE
J.H. Topping, C. Bloxham, M.R. Novelli,
A. Dhar
P0075
PATIENT INTERPRETATION OF THE RELA­
TIONSHIP BETWEEN LACTOSE INTAkE
AND SYMPTOMS
M. Di Stefano, C. Mengoli, F. Racca, P. Tana,
A. Zanaboni, G. Corazza
P0076
REFRACTORY COELIAC DISEASE OUT­
COMES IN A SINGLE TERTIARY REFER­
RAL CENTRE
S.C. Donnelly, C. Ho-Fan, T. Mitchell,
F. Chang, H.J. Ellis, P.J. Ciclitira
P0077
MILD ENTEROPATHY AS A CAUSE OF
IRON­DEFICIENCY ANEMIA (IDA) OF
PREVIOUS UNkNOWN ORIGIN. ROLE OF
GLUTEN­SENSITIVITY ENTEROPATHY
(GSE) AND HELICOBACTER PYLORI (HP)
INFECTION
H. Monzón, M. Forné, M. Esteve,
C. González, J. Martí, M. Rosinach,
M. Mariné, C. Loras, J. Espinós, A. Salas,
J. Viver, F. Fernández-Bañares
P0078
ANTI­TISSUE TRANSGLUTAMINASE AN­
TIBODIES FROM CELIAC PATIENTS ARE
RESPONSIBLE OF TROPHOBLAST DAM­
AGE VIA APOPTOSIS IN VITRO: A POS­
SIBLE ROLE FOR INFERTILITY, EARLY
PREGNANCY LOSS AND INTRAUTERINE
GROWTH RETARDATION?
F. Franceschi, N. Di Simone, D. Roccarina,
G. Gigante, B. Giupponi, G. De Marco,
F. Barbaro, M. Silano, R. Castellani, F. Di
Nicuolo, M. D’Alessio, A. Tritarelli, A. Leone,
G. Gasbarrini, N. Gentiloni Silveri, A. Caruso,
A. Gasbarrini

P0079
CHANGES IN THE ExPRESSION OF ZO­1,
CLAUDIN­2, CLAUDIN­4 AND OCCLU­
DIN IN THE DUODENAL MUCOSA OF PA­
TIENTS WITH CELIAC DISEASE BEFORE
AND AFTER TREATMENT WITH GLUTEN
FREE DIET
P. Goswami, P. Das, S.P. Khanel,
V. Sreenivas, S. Datta Gupta, G.K. Makharia
P0080
FIVE YEAR FOLLOW UP STUDY OF PA­
TIENTS DIAGNOSED WITH MINIMAL
CHANGE COELIAC DISEASE
P.A. Hamilton, A. Awasthi, T. Rashid,
R. Prescott, G. Banait, B. Williams
P0081
SIMULTANEOUS DETECTION OF IGA
AND IGG ANTIBODIES AGAINST TIS­
SUE TRANSGLUTAMINASE AND DEAMI­
DATED GLIADIN PEPTIDES IN CHILDREN
WITH COELIAC DISEASE
I. Dahlbom, E. Heed, B. Nyberg,
A. Dannaeus, T. Hansson
P0082
COELIAC DISEASE PRECEDES THE DEVEL­
OPMENT OF TYPE 1 DIABETES IN CHIL­
DREN WITH BOTH DISEASES
T. Hansson, I. Dahlbom, O. Skog, B. Nyberg,
A. Dannaeus, T. Tuvemo, G. Frisk
PosTeR sessIon
nutrition I
P0083
SONOGRAPHIC ASSESSMENT OF VIS­
CERAL FAT: PROPOSAL OF A NEW CUT­
OFF FOR VISCERAL OBESITY
M. Afonso, S. Leite, J. Pinto, R. Veloso,
R. Pinho, T. Freitas, J. Carvalho, J. Fraga
P0084
GASTRO­OESOPHAGEAL REFLUx SYMP­
TOMS PREVALENCE IN OBESE PATIENTS
REFERRED FOR BARIATRIC SURGERY
K. Belhocine, E. Letessier, S. Avallone,
J.P. Galmiche, S. Bruley des Varannes
PosTeR sessIon
P0085
SAFETY, EFFICACY AND TOLERANCE
OT TWO TYPES OF INTRAGASTRIC BAL­
LOONS PLACED IN OBESE SUBJECTS. A
DOUBLE­BLINDED COMPARATIVE STUDY
L. De Castro, M. Morales, V. Del Campo,
J.R. Pineda, J.M. Sierra, M. Arbones, E. Pena,
J.R. Prada
P0086
SAFETY AND EFFICACY OF THE TRANS­
ORAL ENDOSCOPIC RESTRICTIVE SY­
TEM (TERIS) FOR THE TREATMENT OF
OBESITY
K. de Jong, E.E.M.H. Mathus-Vliegen,
J.J.H. Eshuis, P.P. Fockens
P0087
ONGOING CLINICAL STUDY OF AN EN­
DOSCOPIC, DUODENAL­JEJUNAL BY­
PASS LINER IN OBESE TYPE 2 DIABETICS
E.G.H. de Moura, M.G. Passos Neto,
B.C. Martins, G.S. Lopes, S.L. de Oliveira,
P. Sakai, M.C. Mancini, A. Haupern,
M. Santo, A.B. Garrido
P0088
METABOLIC SYNDROME IS ASSOCI­
ATED WITH AGGRESSIVE COLORECTAL
TUMOUR PHENOTYPE IN MALES ONLY
L.A. Healy, J. Howard, A. Ryan, D. Flannery,
B. Mehigan, R.B. Stephens, J.V. Reynolds
P0089
PROLONGED UP­REGULATION OF REC­
TAL MUCOSAL MACROPHAGE MIGRA­
TION INHIBITORY FACTOR ExPRESSION
AFTER ROUx­EN­Y GASTRIC BYPASS
P. Kant, A. Sainsbury, G. Robins, N. Scott,
S. Pollard, M. Hull
P0090
BARIATRIC THERAPY WITH INTRAGAS­
TRIC BALLOON IMPROVES NAFLD FI­
BROSIS SCORE. PRELIMINARY DATA ON
27 OBESE PATIENTS
F. Pigò, G. Ricci, V. Pasini, A. Rossi,
G. Bersani, A. Schettino, C. Pari, G. De
Fabritiis, V. Alvisi
97
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0091
METABOLIC AND BIOCHEMICAL COR­
RELATIONS IN NONALCOHOLIC FATTY
LIVER DISEASE
C.T. Streba, L. Mogoanta, L.M. Streba,
C.C. Vere, D. Carstea
P0092
RAPID NORMALISATION OF FASTING
SERUM FIBROBLAST GROWTH FACTOR
(FGF) 19 FOLLOWING BARIATRIC SUR­
GERY
S. Kuganolipava, T. Dew, S.S. Pattni,
D. Pournaras, R. Welbourn, C.W. LeRoux,
J.R.F. Walters
PosTeR sessIon
oesophageal, gastric and duodenal
disorders I
P0093
SHOULD WE ALWAYS RESECT GASTRIC
ADENOMA WHICH WAS CONFIRMED BY
ENDOSCOPY?
S.R. Choi, J.S. Jang, Y.H. Baek, S.H. Cho,
J. Han, C.J. Lee, S.W. Choi, H.A. Yoon, S.J. Kim
P0094
NATURAL HISTORY AND MANAGEMENT
OF GASTRIC SUBPITHELIAL TUMORS
M. Kim, H. Jung, K. Choi, H. Song, G. Lee,
J. Kim, S. Park, J. Han, J. Lee, J. Park
P0095
HLA TYPING IN AUTOIMMUNE VS HELI­
COBACTER PYLORI­RELATED ATROPHIC
GASTRITIS
P.I. Bianchi, M. Martinetti, E. Miceli,
A. Marchese, C. Badulli, D. Padula,
M. Perego, E. Trespi, G.R. Corazza
98
P0096
THE MDM2 PROMOTER SNP285C/SN­
P309G HAPLOTYPE IS ASSOCIATED WITH
SUSCEPTIBILITY FOR OESOPHAGEAL
SQUAMOUS CELL CARCINOMA AND
RELATED TO POOR OVERALL SURVIVAL
AFTER SURGICAL RESECTION
J.J. Boonstra, R. van Marion,
L.B. Koppert, E.W. Steyerberg, H.W. Tilanus,
W.N.M. Dinjens
P0097
INHIBITION OF MTOR IN OESOPHAGEAL
ADENOCARCINOMA CELL LINES SEEMS
TO BE MORE EFFECTIVE IN CELL LINES
WITH GENOMIC ABERRATIONS IN THE
PI3k/PTEN/MTOR PATHWAY
J.J. Boonstra, R. van Marion, H.W. Tilanus,
W.N.M. Dinjens
P0098
PROSPECTIVE SINGLE CENTRE STUDY
FOR THE PREVALENCE AND CLINICAL
RELEVANCE OF HETEROTOPIC GASTRIC
MUCOSA IN THE CERVICAL ESOPHAGUS
(INLET PATCH)
F. Iacopini, C. Grossi, P. Rigato, A. Scozzarro
P0099
ARE ALDEHYDE DEHYDROGENASE 2
(ALDH 2) GENE POLYMORPHISMS RELAT­
ED TO RISk FACTORS FOR LOW­GRADE
DYSPLASIA, A PRECURSOR OF ESOPHA­
GEAL SQUAMOUS CELL CARCINOMA?
K. Kaneko, T. Muramoto, K. Konishi,
A. Katagiri, Y. Kubota, K. Minashi, T. Yano,
H. Ikematsu, T. Kojima, Y. Ohno, A. Ohtsu,
M. Imawari
P0100
THE EFFECT OF ACID PUMP ANTAGONIST
ON DIFFERENTIATION AND PROLIFERA­
TION OF OSTEOCLASTS/OSTEOBLASTS
E. Kim, H. Chun, J. Hyun, H. Kim, W. Jung

P0101
ExPRESSION OF THROMBOSPONDIN­1
AND ANGIOGENESIS IN THE PROGRES­
SION OF GASTRIC ADENOCARCINOMA
W. LEE, S. Cho, S. Park, K. Yun, Y. Joo, H. Kim,
S. Choi, J. Rew
P0102
IDENTIFICATION OF ITIH4, MIF, AND
HNP1–3 AS POTENTIAL BIOMARkERS
FOR GASTRIC CANCER
Y. Mohri, T. Mohri, D.G. Ward, W. Wei, Y. Qi,
A. Martin, C. Miki, M. Kusunoki, P.J. Johnson
P0103
INFLUENCE OF OMEPRAZOL­INDUCED
HYPERGASTRINEMIA ON PERIODON­
TIUM TISSUES
K. Neporada, A. Manko, T. Beregova,
O. Tsyryuk
P0104
INCREASED VASCULAR ENDOTHELIAL
GROWTH FACTOR (VEGF) ACTIVITY
AND MODIFICATION IN GLYCOCONJU­
GATES ExPRESSION PROFILE PRECEDE
ESOPHAGEAL EPITHELIAL BARRIER (EEB)
DYSFUNCTION IN THE REPAIR OF ExPER­
IMENTAL NON­EROSIVE ESOPHAGITIS:
THE IMPACT OF ANGIOGENESIS I
M. Savytska, A. Filipskyy, M. Bihun,
O. Zayachkivska, M. Gzhegotsky
P0105
THE INTERACTION BETWEEN HNE AND
GSTA4 MAY PLAY AN IMPORTANT ROLE
IN THE PHOSPHORYLATION OF EGFR
OF THE ESOPHAGEAL SQUAMOUS CELL
CARCINOMA
K. Uno, G. Kusaka, K. Iijima, T. Koike,
T. Shimosegawa
PosTeR sessIon
P0106
ZINC SUPPLEMENTATION ATTENUATES
ETHANOL­ AND ACETALDEHYDE­IN­
DUCED LIVER STELLATE CELL ACTIVA­
TION BY INHIBITING REACTIVE OxYGEN
SPECIES (ROS) PRODUCTION AND BY IN­
FLUENCING INTRACELLULAR SIGNALING
J. Daniluk, A. Ciesielska-Szuster, K. Plewka,
I. Jastrzêbska, A. Zwolak, M. Kandefer-
Szerszeñ
P0107
GASTRIC ADENOCARCINOMA IN YOUNG
ADULTS: DEMOGRAPHIC, CLINICOPATH­
OLOGICAL AND PROGNOSTIC FACTORS
L. Adán Merino, S.S. Gómez Senent,
E. Martín Arranz, C. Froilán Torres, J. Suárez
de Parga, J. Segura Cabral
P0108
CONSERVATIVE MANAGEMENT OF PRI­
MARY GASTRIC LYMPHOMA
N. Ali Arous, Z. Amir, Y. Chikhi, F. Lounes,
S. Cheraitia, R. Ould Gougam, S. Berkane,
S. Ayoub, F. Asselah, H. Asselah
P0109
PROBIOTIC IS PREVENTIVE AGENT
AGAINST STRUCTURAL AND FUNCTION­
AL CHANGES IN STOMACH EVOkED BY
LONG­TERM REDUCTION OF GASTRIC
ACID SECRETION
T.V. Beregova, L.I. Ostapchenko,
O.I. Tsyryuk, O.K. Voronina, O.G. Korotkiy
P0110
HOW ACCURATE IS AN ENDOSCOPIST’S
HUNCH FOR CANCER? CORRELATION
WITH HISTOLOGY
S.K. Butt, K. Jaggs, S. Warren, D. Francis,
M. Ward, M. Klein, N. Van Someren,
K. Besherdas
99
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0111
ANALYSIS OF MTHFR 677T SEGREGA­
TION IN GASTRIC CANCER AND IN SUB­
JECTS WITH A FAMILY HISTORY OF GAS­
TRIC CANCER
V. De Re, R. Cannizzaro, V. Canzonieri,
S. Maiero, E. Cecchin, L. Caggiari, E. De
Mattia, C. Pratesi, P. De Paoli, G. Toffoli
P0112
ASSOCIATION BETWEEN TGFB1 −509C/
T, TGFBR2 −875A/G AND IL6 −634C/G
POLYMORPHISMS AND GASTRIC CAN­
CER OF DIFFERENT CLINICOPATHOLOGI­
CAL PROFILES
B. Chen, Z.R. Zeng, X.Q. Wu, F.G. Chen,
L. Xue, Y.T. Hao, J.J.Y. Sung, M.H. Chen, P.J. Hu
P0113
“REAL WORLD” NEO­ADJUVANT CHE­
MOTHERAPY FOR RESECTABLE GAS­
TRIC CANCER­ EFFECTS ON METASTATIC
LYMPH NODE RATIO
C. Conor Magee, F. Atherton, M. Hartley,
R. Macadam, M. Shrotri, W. Taylor, N. Howes
P0114
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION (ESD) IN THE UPPER GI TRACT: CAN
WE MATCH THE JAPANESE RESULTS ?
P.H. Deprez, A. Jouret, C. Sempoux,
R. Yeung, T. Aouattah, H. Piessevaux
P0115
MANAGEMENT OF PREMALIGNANT LE­
SIONS OF GASTRIC CANCER BY EUROPE­
AN GASTROENTEROLOGISTS: PRELIMI­
NARY RESULTS OF AN ON­LINE SURVEY
J. Matos, T. Salazar, F. Silva, D. Oliveira,
A. Carvalho, M. Santiago, R. Ramos,
R. Loureiro, H. Sousa, J. Cardoso, P. Morais,
A. Silva, C. Leite, C. Laranja, L. Vale,
J. Jacome, R. Santos, M. Dinis-Ribeiro
100
P0116
MODIFIED LEFT SIDE MOBILIZATION OF
STOMACH DURING ExTENDED ­ COM­
BINED GASTRECTOMY WITH PANCRE­
ATICOSPLENECTOMY IN LOCALLY AD­
VANCED GASTRIC CARCINOMA
D. Egamberdiev, M. Djuraev,
A. Yusupbekov, S. Mirzaraimova,
M. Khudayberdieva
P0117
IMPROVEMENT WAYS OF REHABILITA­
TION AND QUALITY OF PATIENTS’ LIFE
AFTER GASTERECTOMY
M. Djuraev, A. Eshonov, D. Egamberdiev,
E. Loktionova
P0118
COMPARATIVE EVALUATION OF LONG­
TERM PROGNOSIS BETWEEN ENDO­
SCOPIC TREATMENT AND SURGERY FOR
EARLY GASTRIC CANCER
K. Fukase, T. Hara, T. Ishizawa, Y. Otaki,
Y. Kakizaki, K. Yoshizawa, Y. Suzuki, T. Abe,
K. Suzuki
P0119
FAECAL CALPROTECTIN CONCENTRA­
TIONS IN CHRONIC GASTRITIS
A. Gallo, M. Montalto, G. Ianiro, R. Ricci,
L. Santoro, F. D’onofrio, G. Cammarota,
M. Vastola, A. Gasbarrini, G. Gasbarrini
P0120
DOUBLE­SCOPE ENDOSCOPIC SUB­
MUCOSAL DISSECTION (ESD) FOR THE
TREATMENT OF EARLY GASTRIC CANCER
DIFFICULT TO MANAGE BY CONVEN­
TIONAL ESD
K. Higuchi, S. Tanabe, T. Sasaki, M. Azuma,
K. Ishido, C. Katada, K. Nakatani,
W. Koizumi

P0121
VALIDITY OF ENDOSCOPIC SUBMUCO­
SAL DISSECTION FOR SUBMUCOSAL
INVASIVE OR ULCERATIVE GASTRIC
CANCER
S. Hoteya, T. Iizuka, S. Yamashita,
D. Kikuchi, M. Nakamura, N. Hirano,
Y. Kuroki, T. Mitani, Y. Miyata, N. Yahagi
P0122
ANGIOGENESIS IN GASTRIC CANCER –
THE PROGNOSTIC ROLE AND THE COR­
RELATION WITH THE RISk OF UPPER GI
BLEEDING
S. Iordache, C. Georgescu, M. Filip,
L. Sandulescu, M. Schenker, D. Gheonea,
A. Saftoiu, T. Ciurea
P0123
IS ANNUAL ENDOSCOPIC SURVEILLANCE
NECESSARY FOR THE EARLY DETECTION
OF GASTRIC REMNANT CANCER IN kO­
REA?: A RETROSPECTIVE MULTI­CENTER
STUDY
H. Jang, J. Kim, Y. Lim, M. Choi, S. Kae,
K. Kim, C. Park, I. Baek, J. Kim, W. Shin,
K. Kim, H. Kim, K. Baik, S. Kim
P0124
WARBURG EFFECT REVISITED: AN EPI­
GENETIC LINk BETWEEN AEROBIC GLY­
COLYSIS AND GASTRIC CARCINOGEN­
ESIS
H. Jin, X. Liu, X. Wang, J. Zhang, E. Lam,
V.Y. Shin, J. Yu, F.K.L. Chan, J.J.Y. Sung
P0125
DIFFERENT PREVALENCE OF COLOREC­
TAL POLYP BETWEEN THE PATIENTS
WHO UNDERWENT ENDOSCOPIC RE­
SECTION FOR GASTRIC DYSPLASIA OR
EARLY GASTRIC CANCER AND NORMAL
HEALTHY SUBJECTS
J. Hwang, M. Joo, J. Park, S. Hong, J. Kim,
J. Yeon, J. Kim, K. Byun, Y. Bak
PosTeR sessIon
P0126
PEA3 IS A MARkER OF METASTASES IN
GASTRIC ADENOCARCINOMA
R. Keld, B. Guo, P. Downey, C. Gulmann,
Y. Ang, A. Sharrocks
P0127
THE CLINICAL AND PATHOLOGICAL IM­
PLICATIONS OF FINE NETWORk PATTERN
I. Kinoshita, E. Kojima, K. Tashiro, T. Tajima,
M. Matsumura
P0128
QUALITY OF LIFE IMPAIRMENT IN COM­
MUNITY SUBJECTS WITH FUNCTIONAL
DYSPEPSIA DEFINED ACCORDING TO
THE ROME III CRITERIA
P. Aro, J. Ronkainen, N.J. Talley,
T. Storskrubb, M. Vieth, E. Bolling-
Sternevald, S. Johansson, L. Agréus
P0129
IMPLEMENTING Uk NATIONAL DYSPEP­
SIA GUIDELINES FOR RETURNING PA­
TIENTS TO SELF­CARE: FINDINGS FROM
AN EDUCATIONAL INTERVENTION AND
12­MONTH FOLLOW­UP CLINICAL RE­
AUDIT
M.P. Connolly, A. Bhatt, R. Simmonds
P0130
NEW ExPLANATIONS REGARDING THE
INCREASE OF GASTRIC ACID SECRETION
INDUCED BY DIFFERENT ANTIBIOTICS
M. Coltau, C. Baldea, L. Oroian, C. Kun,
O. Micle
P0131
NEW APPROACHES OF THE MECHANISM
BY WHICH DESMOPRESSIN PRODUCES
LESIONS OF GASTRIC MUCOSA IN PA­
TIENTS WITH DIABETES INSIPIDUS
D. Cordea, C. Kun, L. Indries, M. Mihaescu,
C. Teusdea
101
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0132
EVALUATION OF DUODENAL HYPER­
SENSITIVITY IN PATIENTS WITH FD IN­
DUCED BY DUODENAL ACIDIFICATION
BY TRANSNASAL ENDOSCOPY
M. Ishii, H. Kusunoki, N. Manabe,
T. Kamada, K. Tarumi, M. Fujita,
H. Matsumoto, H. Imamura, A. Shiotani,
J. Hata, K. Haruma
P0133
IMPAIRED ACCOMMODATION IS A FEA­
TURE OF FUNCTIONAL DYSPEPSIA PA­
TIENTS WITH POSTPRANDIAL DISTRESS
SYNDROME, NOT WITH EPIGASTRIC PAIN
SYNDROME
S. Kindt, R. Bisschops, R. Vos, L. Holvoet,
P. Caenepeel, J. Arts, D. Dewulf, J. Tack
P0134
PERFORMANCE OF SELF­ADMINIS­
TRATED QUESTIONNAIRE TO SCREEN
FOR PSYCHIATRIC COMORBIDITIES IN
FUNCTIONAL DYSPEPSIA
L.H. Lai, A.W.Y. Tse, Y. Chan, F.K.L. Chan,
J.J.Y. Sung, J.C.Y. Wu
P0135
MANAGING UNCOMPLICATED DYSPEP­
SIA WITHOUT ENDOSCOPY: A 10 YEAR
COHORT FOLLOW­UP STUDY
S. Din, A.J. Norman, S. Swain, R.P.H. Logan
P0136
FAECAL CALPROTECTIN PREDICTS UP­
PER GASTROINTESTINAL PATHOLOGY
M. Manz, E. Burri, C. Niederberger,
C. Rothen, C. Beglinger
P0137
TRADITIONAL JAPANESE MEDICINE RIkkUNSHITO
IMPROVES UPPER GASTROIN­
TESTINAL SYMPTOMS IN THE PATIENTS
WITH FUNCTIONAL DYSPEPSIA ACCOM­
PANIED BY THE INCREASE OF PLASMA
GHRELIN LEVEL
T. Matsumura, M. Arai, T. Suzuki,
M. Yoshikawa, F. Imazeki, O. Yokosuka
102
P0138
MANAGEMENT OF GASTROINTESTINAL
DISEASES IN PRIMARY CARE: A SURVEY
IN NINE COUNTRIES OF CENTRAL AND
EASTERN EUROPE
B. Seifert, M. Palka, N. Kral, J. Vojtiskova,
A. Windak, G. Rubin
P0139
DYSPEPTIC SYMPTOMS AMONG LOW­
DOSE ACETYLSALICYLIC ACID USERS
AND THEIR IMPACT ON TREATMENT
ADHERENCE
E. Sörstadius, D. Neuman, V.J. Thompson,
S. Pratt, J. Delgado, E. Elkin, O. Junghard,
E. Nauclér, J. Næsdal
P0140
HOMOZYGOUS TRPV1 315C INFLUENC­
ES THE SUSCEPTIBILITY TO FUNCTIONAL
DYSPEPSIA (FD)
T. Tahara, T. Shibata, M. Nakamura,
M. Okubo, D. Yoshioka, I. Hirata, T. Arisawa
P0141
HEALTH­RELATED QUALITY OF LIFE
CHANGE IN PATIENTS WITH NEW ONSET
DYSPEPSIA TREATED WITH STEPWISE
ACID SUPPRESSION STRATEGIES
C.J. van Marrewijk, M.G.H. van Oijen,
G.A.J. Fransen, S. Mujakovic, J.W. Muris,
N.J. de Wit, M.E. Numans, A.J. Knottnerus,
D.E. Grobbee, R.J.F. Laheij, J.B.M.J. Jansen
P0142
PREVALENCE OF GASTROINTESTINAL
SYMPTOMS IN THE COMMUNITY: RE­
SULTS OF A SURVEY AMONG 50,000
PERSONS
M.G.H. van Oijen, M.M. Tielemans,
L.G.M. van Rossum, T. Eikendal, J. Jaspers
Focks, R.J.F. Laheij, J.B.M.J. Jansen
P0143
RAPID DETECTION OF HYPOLACTA­
SIA AT ENDOSCOPY IN PATIENTS WITH
FUNCTIONAL DYSPEPSIA
S. Sanderson, P.J. Swallow, J.R.F. Walters

P0144
USEFULNESS OF ELECTROGASTROGRA­
PHY IN THE DIFFERENCIAL DIAGNOSIS
OF CLINICAL FORMS OF FUNCTIONAL
DYSPEPSIA
C. Rudnicki, S. Forys, K. Stec-Michalska,
J. Chojnacki, M.A. Wisniewska-Jarosinska
P0145
RISk OF LYMPH NODE METASTASES IN
LATE EARLY ADENOCARCINOMA OF THE
OESOPHAGUS AND CARDIA DIAGNOSED
BY ENDOSCOPIC RESECTION
L. Alvarez Herrero, R.E. Pouw, F.G.I. van
Vilsteren, F.J.W. ten Kate, B.L.A.M. Weusten,
J.J. Bergman
P0146
LECTIN TARGETING OF GLYCAN ALTERA­
TIONS TO DETECT DYSPLASIA IN BAR­
RETT’S OESOPHAGUS
E.L. Bird-Lieberman, P. Lao-Sirieix,
A.A. Neves, M. O’Donovan, K.M. Brindle,
R.C. Fitzgerald
P0147
EFFICACY OF PRE­TREATMENT BIOPSIES
IN PREDICTING FINAL HISTOPATHOLOGY
OF ENDOSCOPICALLY RESECTED EARLY
MALIGNANCIES IN THE UPPER GASTRO­
INTESTINAL TRACT
R. Bisschops, G. De Hertogh, H. Willekens,
J. Beck, P.J. Rutgeerts, K. Geboes
P0148
RADIOFREQUENCY ABLATION IS A
COST EFFECTIVE TREATMENT FOR HIGH
GRADE DYSPLASIA IN BARRETT’S OE­
SOPHAGUS – A Uk BASED ECONOMIC
EVALUATION
P.C. BOGER, D. Turner, P.J. Roderick, P. Patel
P0149
RETINOIC ACID CAUSES INDUCTION OF
CDx2 IN A LONG TERM MODEL OF SQUA­
MOUS OESOPHAGUS
B.J. Colleypriest, M. Farrant, J.M.W. Slack,
D. Tosh
PosTeR sessIon
P0150
ENDOSCOPIC EMR OR ESD FOR HIGH
GRADE DYSPLASIA AND ADENOCAR­
CINOMA IN LONG (L), ExTRA­LONG (xL)
AND ExTRA­ExTRA­LONG (xxL) BAR­
RETT’S ESOPHAGUS: HIGH RATES OF
COMPLETE REMISSION
P.H. Deprez, A. Jouret, C. Sempoux,
T. Aouattah, R. Yeung, H. Piessevaux
P0151
QUALITY OF LIFE FOLLOWING ALA V
PHOTOFRIN PDT FOR DYSPLASTIC BAR­
RETT’S OESOPHAGUS ­ PRELIMINARY
RESULTS OF A RANDOMISED CON­
TROLLED TRIAL
S. Thorpe, J.M. Dunn, G.D. Mackenzie,
C.A. Mosse, M. Austwick, S.G. Bown,
L.B. Lovat
P0152
PATTERNS OF RECURRENCE OF DYSPLA­
SIA POST PHOTODYNAMIC THERAPY
FOR HIGH GRADE DYSPLASIA IN BAR­
RETT’S OESOPHAGUS
J. Gray, G.M. Fullarton
P0153
A COMPARISON OF THE PREVALENCE OF
CENTRAL ADIPOSITY AND METABOLIC
SYNDROME IN BARRETT’S ESOPHAGUS
AND NON BARRETT’S­ GASTRO­ESOPH­
AGEAL REFLUx DISEASE
L.A. Healy, A.M. Ryan, N. Ravi, J.V. Reynolds
P0154
ExPERIMENTAL HYPOALGESIA IN PA­
TIENTS WITH BARRETTS OESOPHAGUS:
A BIOMARkER OF PERIPHERAL NEU­
ROPATHY?
A.L. Krarup, A.M. Drewes, P. Funch-Jensen
P0155
DEMOGRAPHICS AND TEMPORAL
TRENDS IN THE INCIDENCE OF BAR­
RETT’S OESOPHAGUS IN A Uk POPULA­
TION
J. Landy, M. Fullard, A. Leahy
103
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0156
The prominent presence of CD4+ memory
T­cells in ex vivo cultures of Barrett
Esophagus biopsies points at a shift in
homeostatic T­cell homing
A. Lind, L. Koenderman, P.D. Siersema
P0157
DIFFERENCES IN PHENOTYPE OF TISSUE
EOSINOPHILS IN BARRETT ESOPHAGUS
AND REFLUx ESOPHAGITIS
A. Lind, L. Koenderman, P.D. Siersema
P0158
META­ANALYSIS: UTILITY OF NARROW
BAND IMAGING IN CHARACTERISATION
OF EARLY NEOPLASIA IN PATIENTS WITH
BARRETT’S OESOPHAGUS
J. Mannath, V. Subramanian, K. Ragunath
P0159
LOW PREVALENCE OF BARRETT’S
ESOPHAGUS­RELATED NEOPLASIA IN
A FOUR­YEAR PROSPECTIVE COHORT
STUDY FROM CENTRAL EUROPEAN
COUNTRY
T.A. Marek, A. Dziurkowska-Marek,
K. Wdowiak, M. Balicka, A.J. Szczepanska,
A. Mularczyk, P. Palen, M. Kajor, M. Hartleb
P0160
A PROSPECTIVE, RANDOMISED, DOU­
BLE­BLIND TRIAL OF TOPICAL ADREN­
ALINE VS PLACEBO IN BARRETT’S OE­
SOPHAGUS SURVEILLANCE
J.M. McCarthy, M. Buckley
P0161
AMPLIFICATION OF HER2/NEU ONCO­
GENE IN REFLUx­ BARRETT’S METAPLA­
SIA­ DYSPLASIA­ ADENOCARCINOMA
SEQUENCE IN CORRELATION TO HELI­
COBACTER PYLORI INFECTION
A. Mokrowiecka, A. Wierzchniewska-
Lawska, E. Malecka-Panas
104
P0162
INTESTINAL AND GASTRIC TYPE BAR­
RETT’S METAPLASIA DIFFER IN THEIR
SOx­GENE ExPRESSION PATTERN
H. Neumann, K. Mönkemüller, T. Wex,
M. Vieth, O. Müller, P. Malfertheiner
P0163
DESIGN OF A POTENTIALLY PROGNOS­
TIC/DIAGNOSTIC FISH MARkER SET FOR
SURVEILLANCE OF BARRETT’S ESOPHA­
GUS PATIENTS
A.F. Pacha, A. Rygiel, F. Milano, W. Westra,
W. Rosmolen, J. Bergman, K. Krishnadath
P0164
ACCEPTANCE OF ENDOSCOPIC TREAT­
MENT OF EARLY BARRETT’S CANCER IN
GERMANY
O. Pech, C. Ell
P0165
FINAL REQUIEM FOR 4­QUADRANT BI­
OPSIES IN BARRETT’S ESOPHAGUS ?
J. Pohl, O. Pech, A. May, H. Manner,
A. Fissler-Eckhoff, C. Ell
P0166
DEFINING CARCINOMA RISk IN BARRETT
PATIENTS – kNOWN RISk FACTORS MAY
BE LESS IMPORTANT
K. Wrobel, C. Bojarski, W. Voderholzer,
B. Wiedenmann, T. Roesch, H. Pohl
P0167
THE RISk OF SMOkING ON DEVELOP­
MENT OF DYSPLASTIC DISEASE IN
PATIENTS WITH COLUMNARISED OE­
SOPHAGUS
J. Ramus, P. Gatenby, C. Caygill, A. Watson,
M. Winslet

P0168
COMPARISON BETWEEN ESD AND CON­
VENTIONAL EMR FOR SHORT SEGMENT
BARRETT’S ESOPHAGUS CARCINOMA
C. Sato, D. Hirasawa, Y. Maeda, Y. Koike,
K. Suzuki, T. Yamagata, T. Ogawa, Y. Kanno,
T. Ohira, Y. Harada, T. Sugawara, T. Obana,
T. Suzuki, Y. Noda, N. Fujita
P0169
REFLUx PATTERNS IN PATIENTS WITH
SHORT AND LONG SEGMENT BAR­
RETT’S ESOPHAGUS, EROSIVE ESOPHA­
GITIS AND CONTROLS: A STUDY USING
IMPEDANCE­PH MONITORING
E. Savarino, P. Zentilin, D. Pohl,
E. Marabotto, G. Sammito, A. Parodi,
R. Tutuian, V. Savarino
P0170
PROxIMAL MIGRATION OF REFLUx EPI­
SODES IS A RELEVANT FACTOR IN DIS­
TINGUISHING INTESTINAL METAPLASIA
ExTENSION AND REFLUx PERCEPTION
BETWEEN PATIENTS WITH SHORT AND
LONG­SEGMENT BARRETT’S ESOPHA­
GUS
E. Savarino, P. Zentilin, D. Pohl,
E. Marabotto, G. Sammito, A. Parodi,
R. Tutuian, V. Savarino
P0171
DETECTION OF NEOPLASTIC TISSUE IN
PATIENTS WITH BARRETT’S ESOPHA­
GUS USING PROBE CONFOCAL ENDO­
MICROSCOPY: INTERIM RESULTS FROM
THE‘DONT BIOPCE’ TRIAL
P. Sharma, A. Meining, H. Wolfsen,
A. Bansal, M. Bajbouj, G. Lauwers,
M. Wallace
P0172
PREDICTORS FOR NEOPLASTIC PRO­
GRESSION IN PATIENTS WITH BARRETT
ESOPHAGUS: A PROSPECTIVE COHORT
STUDY
M. Sikkema, M. Kerkhof, C.W. Looman,
E.J. Kuipers, P.D. Siersema
PosTeR sessIon
P0173
SURVEILLANCE IN A PROSPECTIVELY
FOLLOWED COHORT OF PATIENTS WITH
BARRETT ESOPHAGUS IN THE NETHER­
LANDS: A COST­EFFECTIVENESS ANALY­
SIS
M. Sikkema, E.W. de Bekker, C.W. Looman,
J.B. Wong, D.T. Provenzale, E.J. Kuipers,
P.D. Siersema, E.W. Steyerberg
P0174
MAGNIFICATION ENDOSCOPY AND
NARROW BAND IMAGING IN THE EVAL­
UATION OF PATIENTS WITH BARRETT’S
ESOPHAGUS
A.J. Tchekmedyian, N. Nabon, J. Bernachin,
M. Mendez, D. Chiodi, A. Mariño, H. Cohen
P0175
INTESTINAL METAPLASIA OF THE GAS­
TRIC CARDIA IS MORE FREQUENT IN
GERD PATIENTS WITH FAMILY HISTORY
OF GERD
P. Tsibouris, K. Goula, C. Kalantzis, C. Liatsos,
C. Tsironis, E. Kalafatis, A. Karameris,
N. Kalantzis
P0176
DETECTION OF HIGH­GRADE DYSPLASIA
AND ESOPHAGEAL ADENOCARCINOMA
USING ENDOSCOPIC MUCOSAL RESEC­
TION IN COMBINATION WITH FLUORES­
CENCE IN SITU HYBRIDIZATION
W.M. Westra, K.C. Halling,
K.K. Krishnadath, K.K. Wang
P0177
BIOMARkER STATUS AT INITIAL FLUO­
RESCENCE IN SITU HYBRIDIZATION
(FISH) ON BRUSH CYTOLOGY SPECIMENS
CAN PREDICT LONG­TERM OUTCOME IN
BARRETT’S ESOPHAGUS PATIENTS WITH
HIGH­GRADE DYSPLASIA
W.M. Westra, K.C. Halling,
K.K. Krishnadath, K.K. Wang
105
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0178
REGRESSION OF BARRETT’S ESOPHA­
GUS WITH PROTON PUMP INHIBITOR
THERAPY
T. Yada, J. Akiyama, N. Uemura
P0179
INTRAGASTRIC SIMULTANEOUS WIRE­
LESS AND TRADITIONAL PH MONITOR­
ING: COMPARISON OVER 24 HOURS AND
DURING REFLUx EPISODES
C. Caparello, P. Cantù, A. Grigolon, I. Bravi,
A. Tenca, R. Penagini
P0180
A MICROSCOPIC ESOPHAGITIS IS THE
BASIC UNDERLYING CONDITION IN NON­
EROSIVE REFLUx DISEASE (NERD)
K. Mönkemüller, T. Wex, H. Neumann,
D. Kuester, L.C. Fry, A. Roessner,
P. Malfertheiner
P0181
IS BILE REFLUx GASTROPATHY ASSO­
CIATED WITH DISEASE SEVERITY AND
CARCINOGENESIS IN PATIENTS WITH
GASTRO­ESOPHAGEAL REFLUx DIS­
EASE?
G. Kouklakis, A. Nakos, P. Zezos,
N. Liratzopoulos, E. Efraimidou, K. Manolas,
E. Maltezos, E. Sivridis
P0182
HIGH NITRATE INTAkE MAY BE RELATED
TO GERD: AN ECOLOGIC STUDY
S. Nasseri-Moghaddam, A. Mofid,
H. Razjouyan, M. Nouraie, R. Malekzadeh
P0183
INCREASED INCIDENCE OF GASTRO­
ESOPHAGEAL REFLUx DISEASE AND
BARRETT ESOPHAGUS IN PATIENTS WITH
CERVICAL INLET PATCH
A.I. Rosztóczy, I. Németh, K. Vadászi,
S. Dulic, F. Izbéki, R. Róka, K. Gecse,
L. Tiszlavicz, T. Gyökeres, I. Kiss, T. Wittmann
106
P0184
MICROSCOPIC ESOPHAGITIS IS MORE
FREQUENT IN PATIENTS WITH PH­POS­
ITIVE NON­EROSIVE REFLUx DISEASE
AND HYPERSENSITIVE ESOPHAGUS
THAN IN THOSE WITH FUNCTIONAL
HEARTBURN: A STUDY USING IMPED­
ANCE­PH AND OPTICAL MICROSCOPY
E. Savarino, P. Zentilin, L. Mastracci,
L. Gemignani, L. Sconfienza, A. Parodi,
E. Marabotto, G. Sammito, P. Dulbecco,
P. Ceppa, R. Fiocca, V. Savarino
P0185
THE EFFECT OF SALIVARY NITRITE ON
GASTRO­OESOPHAGEAL REFLUx
J.P. Seenan, A.A. Wirz, A.T. Clarke,
J.J. Manning, V. Fyfe, A.W. Kelman,
K.E.L. McColl
P0186
ROLE OF THE DUODENUM IN SYMPTOM
GENERATION IN GERD
O.S. van Boxel, J.J.M. ter Linde, J. Oors,
D.R. de Vries, A.J.P.M. Smout, P.D. Siersema
P0187
THE IMPACT OF THE SPEED OF FOOD
INTAkE ON INTRAESOPHAGEAL REFLUx
EVENTS IN OBESE FEMALE PATIENTS
R. Vardar, E. Valytova, E. Belen, B. Bayrakci,
S. Bor
PosTeR sessIon
Paediatric gastroenterology and
hepatology I
P0188
LOW­DOSE ERYTHROMYCIN IN THE
TREATMENT OF GASTROESOPHAGEAL
REFLUx DISEASE IN INFANTS. A PILOT
RANDOMIZED, DOUBLE­BLIND, PLACE­
BO­CONTROLLED TRIAL
A. Banaszkiewicz, A. Gawronska,
P. Albrecht, A. Radzikowski

P0189
HIGH RESOLUTION COMPUTED TOMOG­
RAPHY AND PULMONARY FUNCTION
TESTS IN CHILDREN WITH INFLAMMA­
TORY BOWEL DISEASES. A PILOT STUDY
A. Banaszkiewicz, I. Łazowska-Przeorek,
P. Albrecht, A. Radzikowski, K. Krenke,
J. Peradzynska, J. Lange, M. Kulus
P0190
INCIDENCE OF CLOSTRIDIUM DIFFICILE
INFECTION IN POLISH CHILDREN WITH
INFLAMMATORY BOWEL DISEASE
A. Banaszkiewicz, D. Wultanska,
A. Radzikowski, P. Obuch-Woszczatynski,
H. Pituch, M. Luczak
P0191
TREATMENT OF RECTAL FAECAL IMPAC­
TION A RANDOMIZED CONTROLLED
TRIAL: ENEMAS VERSUS HIGH DOSES
OF PEG 3350
N.L.H. Bekkali, M.M. Van den Berg,
M.G.W. Dijkgraaf, M.P. Van Wijk,
M.E.J. Bongers, O. Liem, M.A. Benninga
P0192
CONSTIPATION AND NON­SPECIFIC AB­
DOMINAL PAIN ARE THE MAIN CULPRIT
IN TEENAGE GIRLS
K.T. Buddingh, E. Wieselmann,
P.M.A. Broens
P0193
CARDIAC EVALUATION IN PEDIATRIC
PATIENTS WAITING FOR LIVER TRANS­
PLANTATION
S. Dehghani, N. Honar, M. Borzoei,
M. Haghighat, S. Malekhosseini
P0194
TACROLIMUS RELATED CARDIOTOxICITY
IN LIVER TRANSPLANT RECIPIENTS
S. Dehghani, M. Haghighat, M. Imanieh,
M. Zahmatkeshan, M. Borzoei,
H. Amoozegar, S. Malekhosseini
PosTeR sessIon
P0195
WIRELESS CAPSULE ENDOSCOPY IS
HELPFUL IN THE DIAGNOSTIC AP­
PROACH TO CHILDREN WITH INFLAM­
MATORY BOWEL DISEASE
G. Di Nardo, V. Mancini, A. Staiano,
S. Oliva, F. Civitelli, G. Lombardi, E. Miele,
E. Romeo, S. Cucchiara
P0196
INCREASED CELL PROLIFERATION AND
APOPTOSIS INDUCED BY H.PYLORI IN­
FECTION PLAYS A VITAL ROLE IN GAS­
TRIC CARCINOGENESIS
A. Durko, I. Planeta-Malecka,
E. Czkwianianc
P0197
H. PYLORI INFECTION AND SMALL IN­
TESTINE BACTERIAL OVERGROWTH IN
PATIENTS WITH FABRY’ DISEASE: DO
THEY ENHANCE THE ExPRESSION OF
FABRY’­RELATED GASTROINTESTINAL
SYMPTOMS?
F. Franceschi, G. Gigante, D. Roccarina,
A. Zampetti, D. Antuzzi, G. Vitale, M. Ainora,
V. Cesario, C. Lauritano, G. De Marco,
B. Giupponi, C. Feliciani, G. Gasbarrini,
A. Gasbarrini, N. Gentiloni Silveri
P0198
THE EFFICACY OF TRIPLE THERAPY
TREATMENT WITH LACTOBACILUS­ CON­
TAINING PROBIOTIC IN ERADICATING
HELICOBACTER PYLORY INFECTION IN
CHILDREN WITH GASTRODUODENITIS
M.M. Gurova, L.V. Nikitina, S.P. Guseva,
E.D. Dutlova
P0199
EFFICACY OF ONDANSETRON IN ACUTE
GASTROENTERITIS ASSOCIATED EMESIS
IN CHILDREN
M. Haghighat, S. Dehghani, M. Imanieh,
S. Osia
107
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0200
THE ROLE OF GROWTH HORMONE ON
GROWTH OF CHILDREN WITH CYSTIC
FIBROSIS
M. Haghighat, S. Dehghani,
Z. Karamizadeh, S. Kashef, F. Ghahramani
P0201
IS THERE A ROLE OF CORTICOSTEROIDS
IN PREVENTING GRAFT HEPATITIS AND
FIBROSIS IN LIVER ALLOGRAFTS FOL­
LOWING PAEDIATRIC LIVER TRANSPLAN­
TATION?
W. Haller, C. Lloyd, S.G. Hubscher,
R.M. Brown, P.J. McKiernan, D. Kelly
PosTeR sessIon
colonic and anorectal disorders I
P0202
PROxIMALISATION OF COLORECTAL
CARCINOMA AND POLYPS IN NORTH­
EAST PART OF POLAND; 10­YEARS OB­
SERVATIONS
A. Gil, J. Romatowski, G. Killar, M. Kralisz,
L. Skwarski, A. Chętnik, Z. Namiot,
J. Stasiewicz, W. Łaszewicz
P0203
INVOLVEMENT OF PHYSICIANS IN THE
NATIONAL FRENCH COLORECTAL CAN­
CER SCREENING PROGRAMME
H. GOULARD, M. Boussac-Zarebska,
N. Duport, E. Salines, J. Bloch
P0204
DIVERTICULAR DISEASE DOES NOT IN­
CREASE THE RISk OF COLON CANCER,
BUT SHOULD BE ExCLUDED AFTER A
PRIMARY EPISODE OF SYMTOMATIC
DISEASE
J.M.W. Granlund, F. Granath, T. Svensson,
F. Hjern, A. Ekbom, P. Blomqvist, P.T. Schmidt
108
P0205
FAMILY HISTORY AND OBESITY ARE RISk
FACTORS FOR DEVELOPING COLOREC­
TAL ADENOMA AND ADENOCARCINO­
MA IN THE JAPANESE YOUNG POPULA­
TION UNDER THE AGE OF 50
K. Hata, M. Shinozaki, O. Toyoshima,
A. Toyoshima, S. Matsumoto, T. Saisho,
G. Tsurita
P0206
DIRECT COUNSELLING PROGRAM FOR
FIRST­DEGREE RELATIVES OF COLOREC­
TAL CANCER AND ADVANCED ADENO­
MA PATIENTS IS EFFECTIVE
I. Kajzrlikova, P. Vitek, J. Chalupa, A. Hajek,
J. Platos, J. Kuchar, P. Reha
P0207
THE DIFFERENT DISTRIBUTION IN AGE
AND GENDER BETWEEN PATIENTS WITH
COLORECTAL ADENOMA AND THOSE
WITH CANCER ACCORDING TO TUMOR
LOCATION
S. Kimura, M. Tanaka
P0208
DO DIABETES PATIENTS WITH kLEB­
SIELLA PNEUMONIAE LIVER ABSCESS
NEED FURTHER EVALUATION OF THE
COLON FOR PRESENCE OF NEOPLASM
IN TAIWAN?
H. Lai, J. Chou, C. Peng, C. Chan, W. Huang,
W. Su
P0209
COLORECTAL CANCER IN LATVIA
J. Misins, A. Stengrevics, V. Krumins, V. Boka,
M. Leja
P0210
THE RISk OF DEVELOPING COLORECTAL
CANCER FOLLOWING PREVIOUS NOR­
MAL COLONIC INVESTIGATIONS AND
THE STAGE OF DISEASE AT DIAGNOSIS
N. Prasad, A. Al Rifai, A. Cairns, E. Kyle,
C. Babbs

P0211
SCREENING COLONOSCOPY IN FIRST­DE­
GREE RELATIVES OF COLORECTAL CAN­
CER PATIENTS; A PRELIMINARY REPORT
F. Dehghgani, R. Ansari, S. Sohrabi,
S. Merat, H. Asl-Soleimani, R. Malekzadeh
P0212
THE COLORECTAL DEPRESSED CANCER
INVADES MORE RAPIDLY THAN THE
OTHER TYPE
M. Tabuchi, Y. Katoh
P0213
DETERMINANTS OF COLONOSCOPIC
SCREENING PARTICIPATION AMONG
HIGH RISk SIBLINGS OF COLORECTAL
CANCER PATIENTS IN FRANCE
M. Taouqi, I. Ingrand, M. Beauchant,
V. Migeot, P. Ingrand
P0214
COLONOSCOPY IN THE ELDERLY. DO
THEY REALLY NEED IT?
F. TOBAL, D. Tobal
P0215
STUDY OF ADVANCED COLONIC NEO­
PLASIA IN GENERAL POPULATION AND
IN PATIENTS WITH FAMILY HISTORY OF
COLORECTAL CANCER
E. Tomas Moros, F. García Durán,
J. Carneros, C. Ciriza, C. Villa, J.R. Agulló
P0216
A LOW LEVEL OF SELF­PERCEIVED SUS­
CEPTIBILITY AND COST CONCERNS ARE
IMPORTANT BARRIERS TO THE UPTAkE
OF COLORECTAL CANCER SCREENING
R.K.M. Wong, M.L. Wong, Y.H. Chan,
Z. Feng, C.T. Wai, K.G. Yeoh
P0217
COLONIC POLYP MAY BE ASSOCIATED
WITH UREASE PRODUCING BACTERIA
K. Yoon, T. Seo, H. Jung, K. Lee, H. Kim,
S. Park, S. Cho, W. Lee, Y. Joo, H. Kim, S. Choi,
J. Rew
PosTeR sessIon
P0218
HUMAN PAPILLOMAVIRUS GENOTYPE
DISTRIBUTION IN ANAL CANCER IN
FRANCE: THE EDITH V STUDY
L. Abramowitz, A. Jacquard, F. Jaroud,
L. Siproudhis, P. Pradat, O. Aynaud,
Y. Leocmach, B. Soubeyrand, D. Riethmuller,
C. Mougin, J. Pretet, F. Denis
P0219
FOLATE MEASUREMENT IN INFLAM­
MATORY BOWEL DISEASE. AN OPPOR­
TUNITY MISSED TO REDUCE RISk OF
COLORECTAL CANCER?
M. Aljabiri, S. Freilich, A. Yogendra,
W. Allen, H. Defoe, C. Ozen, N. Joshi, N. van
Someren, K. Besherdas
P0220
COLORECTAL ADENOCARCINOMA IN
ELDERLY OVER 75 PRESENTS HIGH FRE­
QUENCY OF MICROSATELLITE INSTABIL­
ITY
T. Aparicio, O. Schischmanoff, L. Choudat,
N. Soufir, C. Lagorce, P. Wind, G. DesGuetz,
R. Benamouzig
P0221
ARE HYPERPLASTIC POLYPS PRE­
CURSORS OF COLORECTAL CANCER?
A LONG­TERM RETROSPECTIVE STUDY
M.W.E. Bouwens, E. Rondagh, B. Winkens,
A. Driessen, A. de Bruine, A. Masclee,
S. Sanduleanu
P0222
ExPRESSION OF PROTEASE ACTIVATED
RECEPTOR­2 IN HUMAN COLORECTAL
CANCER AND CORRELATION WITH TU­
MOR PROGRESSION
J. Chang, J. Park, S. Kim, C. Jung, E. Jung,
W. Kang, S. Oh, M. Choi, I. Chung
109
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0223
MICROSATELLITE STATUS OF COLOREC­
TAL CANCER IN PATIENTS WITH PRI­
MARY SCLEROSING CHOLANGITIS AND
CONCURRENT INFLAMMATORY BOWEL
DISEASE
M.M.H. Claessen, F.P. Vleggaar,
M.E.I. Schipper, F.H.M. Morsink,
J.W.J. Hinrichs, P.D. Siersema, G.A. Offerhaus
P0224
ADIPONECTIN INCREASES PROAPOP­
TOTIC POTENTIAL OF COLORECTAL
CANCER CELLS
P. Daniel, O. Stasikowska, M. Danilewicz,
M. Wagrowska-Danilewicz, E. Malecka-
Panas
P0225
IN VITRO, ESTROGEN RECEPTOR LI­
GANDS HAVE A PROTECTIVE ROLE
AGAINST COLON CANCER CARCINO­
GENESIS
B. Dupont, E. Longavenne, A.C. Lefebvre,
B. Sola, J.M. Reimund
P0226
IDENTIFICATION OF AFA/DR DIFFUSELY
ADHERENT COLON CANCER MUCOSA­
ASSOCIATED ESCHERICHIA COLI
M.K. Friswell, C. Winstanley, J. Marchesi,
P. Collins, J.M. Rhodes, B.J. Campbell
P0227
COMPARED THE PROTEINS ExPRESSION
OF APC, β­CATENIN, P53 AND WNT­1 IN
ULCERATIVE COLITIS, COLON CANCER
AND ADENOMA
J. Li, W. Zheng, X. Lu, L. Zhao, Q. Cui, J. Qian
P0228
MOLECULAR CHANGES IN SYNCHRO­
NOUS COLORECTAL POLYPS AND CAN­
CERS
M.B. Mirchev, I.A. Kotzev, P. Kahl,
I. Krasnaliev, R. Buettner
110
P0229
PATIENTS WITH SPORADIC COLORECTAL
CANCER OR ADVANCED ADENOMATOUS
POLYP HAVE ELEVATED ANTI JC VIRUS
ANTIBODY TITER IN COMPARISON WITH
HEALTHY CONTROLS – A PROSPECTIVE,
CONTROLLED STUDY
Y. Niv, A. Vilkin, Z. Levi
P0230
HMLH1 PROMOTER METHYLATION AND
JC VIRUS T ANTIGEN PRESENCE IN THE
TUMOR TISSUE OF COLORECTAL CAN­
CER ISRAELI PATIENTS OF DIFFERENT
ETHNIC GROUPS
Y. Niv, Z. Levi, B. Brenner, J. Kendel,
S. Morgenstern, A. Vilkin
P0231
COLONIC ADENOMAS MODULATE LO­
CAL MICROFLORA VIA THE PRODUCTION
OF ALPHA­DEFENSINS: A POSSIBLE PRO­
CARCINOGENIC FACTOR
C. Pagnini, V. Corleto, E. Pilozzi, S. Torre,
E. Di Giulio, G. Delle Fave
P0232
THE ROLE OF LFA­1 ExPRESSION IN A
SERIES OF COLORECTAL ADENOCARCI­
NOMAS
M.G. Papas, P. Karatzas, I.S. Papanikolaou,
A.C. Lazaris, E. Karamitopoulou, A. Gaglia,
O. Agelopoulou, Z. Tsiamoulos, A. Adler,
K. Triantafyllou, E.S. Patsouris
P0233
OVERExPRESSION OF HER­2/NEU IN PA­
TIENTS WITH COLORECTAL CANCER (CC)
AND COLORECTAL ADENOMAS (CA)
M. Pazurek, B. Smolarz, H. Romanowicz-
Makowska, A. Kulig, E. Małecka-Panas

P0234
EMMPRIN, MATRIx METALLOPROTEIN­
ASE­9 AND TYPE IV COLLAGEN ExPRES­
SION IN COLORECTAL CANCER WITH
DISTANT METASTASIS
T. Seya, N. Tanaka, S. Shinji, M. Yoshioka,
T. Shirakawa, T. Yamada, Y. Kanazawa,
K. Horiba, K. Yokoi, K. Furukawa, Y. Oaki,
E. Uchida
P0235
CDH1 GENE­160 C/A PROMOTER POLY­
MORPHISM AND RISk OF SPORADIC
COLORECTAL CANCER IN POLISH POPU­
LATION
R. Trzcinski, A. Sygut, K. Przybylowska,
E. Langner, M. Mik, L. Dziki, M. Spychalski,
T. Ferenc, A. Dziki
P0236
PRELIMINARY DATA TO SUPPORT A RE­
LATIONSHIP BETWEEN TASTE GENET­
ICS, FOLATE STATUS, FOLATE GENES
AND THE DEVELOPMENT OF COLONIC
ADENOMAS: A NOVEL NUTRIGENOMIC
CIRCUIT
M. Veysey, L. Boyd, R. Wai, X. Ng, V. Skinner,
S. Tang, P. Roach, Z. Yates, M. Lucock
P0237
15­HYDROxYPROSTAGLANDIN DEHY­
DROGENASE IS A POSSIBLE EARLY DE­
TECTION MARkER IN COLON CANCER:
ANALYSIS OF PROSTAGLANDIN PATH­
WAY IN HUMAN TISSUE
D. Yang, S. Myung, I. Kim, H. Song, Y. Ryu,
S. Lee, H. Na, J. Han, J. Lee, S. Yoon, K. Kim,
B. Ye, J. Byeon, S. Yang, J. Kim
P0238
NUMERICAL ANALYSIS OF AUTOFLUO­
RESCENCE INTENSITY OF NEOPLASTIC
AND NON­NEOPLASTIC COLORECTAL
LESIONS USING A NOVEL VIDEOENDOS­
COPY SYSTEM
H. Aihara, S. Saito, H. Tajiri
PosTeR sessIon
P0239
CLINICAL CHARACTERISTICS OF THE
COLONIC DIVERTICULOSIS IN kOREA:
A PROSPECTIVE STUDY
J.H. Park 1 , Y.S. Kim 1 , J.H. Song 2 , H.H. Kim 1 ,
S.H. Ryu 1 , J.H. Lee 1 , J.S. Moon 1
P0240
THE UTILITY OF SCREENING ENDOSCO­
PY IN GYNECOLOGIC CANCER PATIENTS
P. Park 1 , W. Kim 1 , C. Kwon 1 , S. Hong 1
P0241
THE EFFECT OF HYPERBARIC OxYGEN
THERAPY ON THE HEALING OF ISCH­
EMIC COLONIC ANASTOMOSIS. AN Ex­
PERIMENTAL STUDY IN RATS
L. Azevedo, R.S. Parra, A. Ribeiro de Almeida,
L. Ramalho, J. Ribeiro da Rocha, O. Feres
P0242
SYMPTOM BASED DIAGNOSTIC CRITERIA
IS NOT ENOUGH TO RULE OUT MICRO­
SCOPIC COLITIS IN DIARRHEA PREDOMI­
NANT IRRITABLE BOWEL SYNDROME
A. Raihan, M. Rahman, D. Ahmed,
M. Bhuiyan, M. Miah, H. Masud, M. Kamal,
M. Islam, A. Salimullah
P0243
LIGASURE VERSUS MILLIGAN­MORGAN
HEMORRHOIDECTOMY: A PROSPECTIVE
RANDOMIZED CLINICAL TRIAL
M.F. Sakr
P0244
THE RELATIONSHIP OF THE COMPLICAT­
ED DIVERTICULITIS TO OBESITY
S. Shim, H. Lee, K. Lee, O. Lee, B. Yoon,
H. Choi, M. Lee, J. Hahm
P0245
CLINICAL CHARACTERISTICS IN ASSO­
CIATION WITH COLORECTAL NEOPLASM
IN PATIENTS OF GASTRIC CANCER
J. Shin, H. Lee, S. Yun, B. Lee, H. Shin, S. Yun,
S. Kim, H. Kim, I. Song, Y. Lee
111
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0246
FULL THICkNESS RESECTION OF MESEN­
TERIC BOWEL WALL WITH AN ENDOLU­
MINAL COMPRESSION CLIP ­ A PORCINE
MODEL
Y. Kopelman, P.D. Siersema, Y. Nir, A. Szold,
A. Bapaye, D. Kopelman
P0247
NON­CUTTING SETONS FOR PROGRES­
SIVE MIGRATION OF COMPLEx FISTULA
TRACTS: A NEW SPIN ON AN OLD TECH­
NIQUE
G. Subhas, A. Gupta, S. Balaraman,
V.K. Mittal, R. Pearlman
P0248
COMPARISSON BETWEEN TOPICAL DIL­
TIAZEM AND TOPICAL DILTIAZEM PLUS
TEN PERCENT METRONIDAZOL IN TREAT­
MENT OF CHRONIC ANAL FISSURE
A. Taheri, Q. Shafeyee, E. Farhangi,
A. Tahayee
P0249
LEVATOR ANI: WHAT IS LEFT OF IDIO­
PATHIC ANAL INCONTINENCE
C. Thomas, I. Etienney
P0250
CAN ENDOSCOPY DIFFERENTIATE BE­
TWEEN ULCERATIVE COLITIS WITH DI­
VERTICULOSIS, SEGMENTAL COLITIS
ASSOCIATED WITH DIVERTICULOSIS
(“SCAD” SYNDROME) AND ACUTE UN­
COMPLICATED COLONIC DIVERTICULI­
TIS? A PROSPECTIVE STUDY
A. Tursi, G. Brandimarte, W. Elisei, A. Papa,
L. Di Cesare, G. Giorgetti
P0251
PREDICTIVE VALUE OF SEROLOGICAL
MARkERS OF DEGREE OF HISTOLOGICAL
DAMAGE IN ACUTE UNCOMPLICATED
COLONIC DIVERTICULITIS
A. Tursi, W. Elisei, G. Brandimarte,
G. Giorgetti, A. Papa, P.G. Lecca
112
P0252
EFFECT OF CIGARETTE SMOkING AND
APPENDECTOMY ON DIVERTICULOSIS
P. Usai, I. Ibba, A. Lai, F. Boi, G. Dalia,
G. Diaz, R. Cuomo, F. Savarese, S. Gemini,
P. Contu
P0253
Withdrawn by author
P0254
DIVERTICULAR DISEASE IN PRIMARY
CARE: ANALYSIS OF CURRENT PRESCRIP­
TION PRACTICE
M.J.P. van Pelt, B.D.L. Broekhuizen,
T.J.M. Verheij, N.J. de Wit
PosTeR sessIon
Inflammatory bowel disease I
P0255
MOLECULAR MIMICRY AND IMMUNO­
LOGICAL CROSSREACTIVITY BETWEEN
MEASLES VIRUS AND HUMAN INTESTI­
NAL PROTEINS IS NOT A FEATURE OF
CROHN’S DISEASE
Z. Tsiamoulos, D. Polymeros,
A. Koutsoumpas, G. Karamanolis,
K. Triantafyllou, A. Gaglia, D.P. Bogdanos,
S.D. Ladas
P0256
THE TH17 CELL POPULATION IN THE
PERIPHERAL BLOOD IN PATIENTS WITH
CROHN’S DISEASE
K. Radwan-Kwiatek, P. Radwan, J. Roliński,
S. Radej
P0257
AIRWAY INFLAMMATION IN PATIENTS
WITH INFLAMMATORY BOWEL DISEASE
AND AIRWAYS DISEASE
A.A. Raj, W.R. Monteiro, I.D. Pavord

P0258
SUCCESSFUL AMPLIFICATION OF CYTOkINE
RNA FROM CROHN’S DISEASE­DE­
RIVED, E.COLI­LADEN LAMINA PROPRIA
MACROPHAGES ISOLATED BY LASER
CAPTURE MICRODISSECTION (LCM)
N.B. Rayment, B. Hudspith, G. Parkes,
J. Kennedy, J. Brostoff, J. Sanderson
P0259
CIRCULATING MICROPARTICLES ARE IN­
CREASED INFLAMMATORY BOWEL DIS­
EASE PATIENTS AND INDUCE VASCULAR
ALTERATIONS
D. Leonetti, A.L. Bretagne-Bignon, A. Tesse,
M.C. Martinez, R. Andriantsitohaina,
J.M. Reimund
P0260
VIABLE LACTOBACILLUS SALIVARIUS
SSP. SALIVARIUS IS REQUIRED TO ExERT
INTESTINAL ANTI­INFLAMMATORY AC­
TIVITY IN THE TRINITROBENCENESUL­
PHONIC ACID MODEL OF RAT COLITIS
M. Rodriguez-Cabezas, D. Camuesco,
B. Arribas, L. Peran, M. Comalada,
E. Bailon, M. Olivares, J. Xaus, L. Kruidenier,
I.R. Sanderson, A. Zarzuelo, J. Galvez
P0261
INTESTINAL ANTI­INFLAMMATORY EF­
FECTS OF AN ExTRACT FROM THE OLIVE
TREE, AQUOLIVE ® , IN THE TNBS MODEL
OF RAT COLITIS
M. Rodriguez-Cabezas, B. Arribas,
E. Bailon, N. Garrido-Mesa, M. Cueto,
P. Utrilla, M. Comalada, J.C. Quintela,
M. Olivares, E. de la Fuente, J. Galvez
P0262
AN Ex VIVO ORGAN COLTURE AS A MOD­
EL TO STUDY LPS­INDUCED MUCOSAL
CHANGES IN CROHN’S DISEASE: IMPLI­
CATIONS FOR THERAPY
I.I. Russo, A.A. Luciani, C.C. Bucci,
A.A. Rispo, P.P. Andreozzi, P.P. Capone,
C.C. Ciacci
PosTeR sessIon
P0263
INDUCTION AND MODULATION OF T
CELL REGULATORY FUNCTION BY IN­
TESTINAL FIBROBLASTS: INHIBITORY
EFFECT OF INTESTINAL INFLAMMATION
F. Scaldaferri, M. Rhee, F. Rieder,
A. Schirbel, G. West, S. Rutella, S. Danese,
A. Gasbarrini, C. Fiocchi
P0264
LIPOPOLYSACCHARIDE INDUCES DIS­
RUPTION OF THE TIGHT JUNCTION VIA
TOLL­LIkE RECEPTOR 4 AND TUMOR
NECROSIS FACTOR­ALPHA
H. Shiga, K. Aoyagi, I. Morita, Y. Hayashi,
T. Watanabe, S. Sakisaka
P0265
LOWER GASTROINTESTINAL CANCER
ASSOCIATED WITH CROHN’S DISEASE
IN JAPAN
M. Shinozaki, K. Hata, G. Tsurita
P0266
IS QUANTITATIVE DIFFUSION­WEIGHTED
MR IMAGING A RELIABLE METHOD IN
THE ASSESSMENT OF THE INFLAMMA­
TORY ACTIVITY IN ULCERATIVE COLITIS?
A. SOYLU, O. Kilickesmez, I. Sevindir,
T. Demirtas, S. Poturoglu, C. Dolapcioglu,
N. Yasar, T. Cimilli, B. Kumbasar
P0267
EPITHELIAL BARRIER DYSFUNCTION IN
IBD IS MEDIATED BY INCREASED MLCk1
ExPRESSION
R. Spagnuolo, D. Posca, C. Cosco,
P. Cosimo, V. Cosco, I. Luppino, G. Ruggiero,
R. Marasco, P. Doldo
P0268
INCREASED PROPORTION OF CD56++
CD16­ NATURAL kILLER CELLS IN THE
LAMINA PROPRIA OF ULCERATIVE COLI­
TIS AND CROHN’S DISEASE PATIENTS
A. Steel, M. Goodier, B. Gazzard
113
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0269
IS THE INCREASING INCIDENCE OF
CROHN’S DISEASE IN A LOW PREVA­
LENCE AREA ASSOCIATED WITH RE­
DUCED ExPOSURE TO INFECTION WITH
HELMINTHS?
K. Jayakanthan, S. Pugazhendhi,
V. Subramanian, A. Srivastava, H. Binder,
B.S. Ramakrishna
P0270
AN ORALLY ACTIVE ALPHA 4 INTEG­
RIN ANTAGONIST AJM300 PREVENTS
THE DEVELOPMENT OF ExPERIMENTAL
COLITIS INDUCED BY ADOPTIVE TRANS­
FER OF IL­10 DEFICIENT CD4+ T CELLS
IN MICE
T. Sugiura, K. Kuribayashi, S. Kageyama
P0271
THE IMMUNBIOLOGICAL RESPONSES OF
LEUCOCYTES TO ADSORPTIVE CARRIER
BEADS IN THE RESPONDERS AND THE
NON­RESPONDERS TO GRANULOCYTE
AND MONOCYTE ADSORPTION THER­
APY OF PATIENTS WITH ULCERATIVE
COLITIS
Y. Suzuki, O. Osamura, A. Yamada, H. Aoki
P0272
SELECTIVE DEPLETION OF ELEVATED
PERIPHERAL MYELOID LEUCOCYTES IS
FOLLOWED BY A SUSTAINED INCREASE
IN CIRCULATING CD4+CD25+FOxP3+
REGULATORY T CELLS AND TGF­BETA
SECRETION IN CORTICOSTEROID NAIVE
PATIENTS WITH ACTIVE ULCERATIVE
COLITIS
T. Tanaka, H. Okanobu, A. Saniabadi,
T. Oya
P0273
ALTERATION OF MICRORNA ExPRESSION
IN INFLAMED AND INACTIVE COLONIC
MUCOSA OF PATIENTS WITH INFLAMMA­
TORY BOWEL DISEASE
X. Treton, M. Fasseu, E. Pedruzzi, Y. Bouhnik,
T. Aparicio, D. Cazals-Hatem, F. Daniel,
M. Laburthe, A. Groyer, E. Ogier-Denis
114
P0274
WESTERNIZED HIGH­FAT DIET ACCEL­
ERATES DEVELOPMENT OF DExTRAN
SULFATE SODIUM­INDUCED COLITIS IN
MICE AND SUPPLEMENTATION OF HEME
AGGRAVATED ITS DISEASE COURSE
E.M.J. van der Logt, T. Blokzijl, R. van
der Meer, M.P. Peppelenbosch, K.N. Faber,
G. Dijkstra
P0275
LITHIUM, A GLYCOGEN SYNTHASE kI­
NASE 3BETA INHIBITOR, DOES NOT
HAVE BENEFICIAL EFFECTS ON DISEASE
COURSE OF DExTRAN SULFATE SODIUM­
INDUCED COLITIS, BUT SHOWED INTES­
TINOTHROPHIC POTENTIAL
E.M.J. van der Logt, T. Blokzijl, K.N. Faber,
M.P. Peppelenbosch, G. Huls, G. Dijkstra
P0276
A REGENERATIVE RESPONSE PRECEDES
THE DEVELOPMENT OF CHRONIC EN­
TERITIS AFTER CONDITIONAL LOSS OF
INTESTINAL INDIAN HEDGEHOG Ex­
PRESSION
W.A. van Dop, L. Wassenberg, B. Lanske,
A.R. Clarke, G.J.A. Offerhaus, D.W. Hommes,
J.C. Hardwick, I. Biemond, G.R. van den
Brink
P0277
THE CYTOPATHOGENIC EFFECTS IN­
DUCED BY THE HELICOBACTER PULLO­
RUM CYTOLETHAL DISTENDING TOxIN
SUBUNIT B ON HUMAN INTESTINAL EPI­
THELIAL CELLS INVOLVE THE RHOA AN
RAC1 GTPASES
C. Varon, F. Doignon, V. Chuat, F. Mégraud,
A. Ménard
P0278
THE ANTICOAGULANT PROTEIN C SYS­
TEM IS FUNCTIONALLY ExPRESSED BY
MUCOSAL DENDRITIC AND IS DOWN­
REGULATED IN IBD PATIENTS
S. Vetrano, M. Vulcano, C. Martinoli,
C. Correale, A. Spinelli, M. Roncalli, V. Ploplis,
A. Malesci, F. Castellino, S. Danese

P0279
COLONIC MUCOSAL CYTOkINE ExPRES­
SION DIFFERS IN NEWLY DIAGNOSED
AND CHRONIC INFLAMMATORY BOWEL
DISEASES
O.R. Woghiren, A. Howard, J. Arnold,
S. Ghosh, J.R.F. Walters
P0280
IN VITRO PREDICTION OF CLINICAL RE­
SPONSE TO GLUCOCORTICOID THERAPY
IN CROHN’S DISEASE
A.M. Williams, H. Kriel, J. Falvey,
A. DiMamabro, T. Creed, J. Smithson,
C.S.J. Probert
P0281
ANTI­SACCHAROMYCES CEREVISIAE AN­
TIBODIES (ASCA) IN CROHN’S DISEASE
ARE ASSOCIATED WITH A SPECIFIC URI­
NARY METABOLIC PROFILE
H.R.T. Williams, I.J. Cox, D.G. Walker,
H. Sato, S.D. Taylor-Robinson, S.E. Marshall,
T.R. Orchard
P0282
DIFFERENCES IN GUT MICROBIAL ME­
TABOLISM ARE RESPONSIBLE FOR
REDUCED HIPPURATE SYNTHESIS IN
CROHN’S DISEASE
H.R.T. Williams, I.J. Cox, D.G. Walker,
J.F.L. Cobbold, S.E. Marshall, S.D. Taylor-
Robinson, T.R. Orchard
P0283
INTESTINAL BARRIER INTEGRITY IS MOD­
ULATED BY CANNABINOID RECEPTORS
K.L. Wright, R. Seymour, P. Marden,
L. Biddlestone, D.A.F. Robertson, S.G. Ward
P0284
ExPRESSION OF CD25HIGHCD4+ T
CELLS (TREG) AND CD28­CD4+ T CELLS
IN ULCERATIVE COLITIS AFTER SURGERY
Y. Yokoyama, K. Fukunaga, K. Kamikozuru,
H. Miwa, T. Matumoto
PosTeR sessIon
P0285
SERUM LEPTIN AND GHRELIN LEVELS IN
RELATION TO BONE MINERAL DENSITY
IN INFLAMMATORY BOWEL DISEASE
PATIENTS
C. Zavos, I.E. Koutroubakis, G. Papadakis,
I. Nerantzoulakis, T. Voudouri, J. Damilakis,
N. Karkavitsas, E.A. Kouroumalis
P0286
MANNAN­BINDING LECTIN (MBL) IN IN­
FLAMMATORY BOWEL DISEASE – PRE­
LIMINARY REPORT
L. Bak-Romaniszyn, A. Swierzko, A. Szala,
E. Malecka-Panas, K. Zeman, M. Cedzynski
P0287
BLEPHARITIS RISk IN INFLAMMATORY
BOWEL DISEASE PATIENTS TREATED
WITH AZATHIOPRINE
R. Baltar, D. Carpio, E. Fernández-Salgado,
S. Soto, V. Álvarez-Sánchez, S. Vázquez-
Rodríguez, W. Díaz-Saa
P0288
PREDICTION OF SEVERE CROHN DIS­
EASE: A MULTICENTER STUDY IN SPAIN
G. Bastida, O. Merino, M. Aguas,
M. Barreiro, Y. Zabana, D. Ginard,
D. Ceballos, F. Muñoz, V. García, I. Catalán,
A. Lucendo, J. Huguet, C. De la Coba,
X. Aldeguer, A. Palau, D. Monfort, C. Loras,
G. Bastida
P0289
FATIGUE IN NORWEGIAN PATIENTS
WITH INFLAMMATORY BOWEL DISEASE
COMPARED TO FATIGUE IN THE BACk­
GROUND POPULATION
T. Bernklev, L. Jelsness-Jørgensen,
M. Henriksen, R. Torp, B. Moum
115
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0290
THE IMPORTANCE OF CHRONIC FATIGUE
ON HEALTH RELATED QUALITY OF LIFE
IN PATIENTS WITH INFLAMMATORY
BOWEL DISEASE
T. Bernklev, L. Jelsness-Jørgensen,
M. Henriksen, R. Torp, B. Moum
P0291
PREGNANCY OUTCOME IN PATIENTS
WITH INFLAMMATORY BOWEL DISEASE:
A PROSPECTIVE EUROPEAN CASE–CON­
TROL STUDY
A. Bortoli, D. Duricova, N. Pedersen,
P. Munkholm
P0292
CHANGING TIME TRENDS IN THE PHE­
NOTYPE AND OUTCOME OF CROHN’S
DISEASE IN ALGIERS (1981–2007)
N. Bounab, L. Kecili, N. Kaddache,
N. Debzi, A. Balamane, N. Afredj,
K. Layaida, L. Gamar, N. Guessab, N. Baiod,
T. Boucekkine
P0293
ANTI­MULLERIAN HORMONE MEASURE­
MENT TO ASSESS OVARIAN RESERVE IN
CROHN’S DISEASE WOMEN
T. Freour, D. Masson, C. Miossec,
K. Bach-Ngohou, M. Flamant, P. Barriere,
J. Galmiche, A. Bourreille
P0294
FISTULAS AND NOD2 HOMOZYGOSITY
BUT NOT IL23R GENE VARIANTS ARE
STRONGLY ASSOCIATED WITH CON­
COMITANT INTESTINAL STENOSIS IN
PATIENTS WITH CROHN’S DISEASE
M. Jürgens, R.P. Laubender, J. Glas,
J. Seiderer, M. Wetzke, J. Wagner,
S. Pfennig, C. Tillack, F. Beigel, M. Weidinger,
F. Schnitzler, B. Göke, P. Lohse, K. Herrmann,
T. Ochsenkühn, S. Brand
116
P0295
IS ExOGENOUS ADMINISTRATION OF
PGE2 ABLE TO REVERSE THE INTENSITY
OF COLONIC LESIONS IN TNBS INDUCED
COLITIS IN RATS ADMINISTERED ASA OR
SELECTIVE COx­ 2 INHIBITOR CELECOxIB
T. Brzozowski, M. Zwolinska-Wcislo,
R. Pajdo, S. Kwiecien, D. Drozdowicz,
T. Mach, W. Pawlik, K. Urbañczyk
P0296
THE ASSESMENT OF SERUM VASCULAR
ENDOTHELIAL GROWTH FACTOR AND
ENDOSTATIN LEVELS AND THE ExPRES­
SIONS OF VEGF AND ENDOSTATIN AT
COLONIC MUCOSAL SAMPLES OF UL­
CERATIVE COLITIS PATIENTS
E. Kahramanoğlu Aksoy, H. Çetinkaya,
B. Savaş, A. Ensari
P0297
ENDOTHELIAL FUNCTION OF CONDUIT
ARTERIES IS NOT AFFECTED IN PATIENTS
WITH ULCERATIVE COLITIS
A. D’Arienzo, M. Sanges, G. Valente, G. De
Franchis, V. Apuzzi, C. Pirozzi, A. De Sena,
R. Napoli
P0298
A DESCRIPTIVE STUDY OF TUBERCU­
LOSIS IN AN INFLAMMATORY BOWEL
DISEASE COHORT FROM CAPE TOWN,
SOUTH AFRICA
E. Deetlefs, G. Watermeyer, R. Seggie,
D. Epstein
P0299
INFLUENCE OF ENVIRONMENTAL FAC­
TORS IN THE SEVERITY OF INFLAMMA­
TORY BOWEL DISEASE
A. Echarri, J. Castro, S. Pereira, M. Barreiro,
D. Carpio, A. Lorenzo
P0300
EPIDEMIOLOGY OF INFLAMMATORY
BOWEL DESEASES (IBD) IN MOROCCO:
WHICH PARTICULARITIES IN FEZ CITY?
M. El Yousfi, M. El Abkari, I. Mellouki,
N. Aqodad, D. Benajah, A. Ibrahimi

P0301
FAMILIAL AND SPORADIC INFLAMMA­
TORY BOWEL DISEASE OUTCOME AND
SEVERITY ­ A LONG TERM COMPARATIVE
FOLLOW­UP STUDY
L. Gamar, N. Kaddache, A. Balamane,
N. Debzi, N. Bounab, K. Layaida,
L. Kecili, N. Afredj, N. Guessab, N. Baiod,
T. Boucekkine
P0302
FREQUENCY OF LACTOSE MALABSORP­
TION AMONG HEALTHY SOUTHERN AND
NORTHERN INDIAN POPULATION BY GE­
NETIC ANALYSIS, LACTOSE HYDROGEN
BREATH AND TOLERANCE TESTS
U.C. Ghoshal, J. Babu, S. Kumar, P. Babu,
J.H. Prasad
P0303
INTRODUCING A NEW MULTIPLE JOINT
IBD TRANSITION SERVICE
K.J. Greveson, N. Morgan, C. Salvestrini,
F. Torrente, M. Furman, C. Murray
P0304
FECAL CALPROTECTIN IN PATIENTS AF­
FECTED BY INFLAMMATORY BOWEL DIS­
EASE TREATED WITH ANTI­TNF AGENTS
L. Guidi, M. Marzo, C. Felice, F. Forni,
A. Papa, I. De Vitis, A. Armuzzi
P0305
PERSONALITY IN PATIENTS WITH IRRI­
TABLE BOWEL SYNDROME AND INFLAM­
MATORY BOWEL DISEASES
M. Tkalèić, G. Hauser, S. Pletikosić,
D. Štimac
P0306
ADDITIONAL DIAGNOSTIC YIELD OF
NARROW BAND IMAGING FOR THE
SCREENING–SURVEILLANCE PROGRAM
OF LONG­STANDING ULCERATIVE COLI­
TIS: A PILOT PROSPECTIVE BACk­TO­
BACk COLONOSCOPY STUDY
F. Iacopini, L. Petruzziello, L. Biancone,
E. Calabrese, C. Spada, C. Petruzziello,
P. Familiari, F. Pallone, G. Costamagna
PosTeR sessIon
P0307
REDUCTION IN FAECAL ALkALINE
SPHINGOMYELINASE IS RELATED TO AC­
TIVE INFLAMMATION WITHIN THE ILEAL
POUCHES OF PATIENTS POST­RESTOR­
ATIVE PROCTO­COLECTOMY
M.W. Johnson, R. Nicholls, A. Forbes,
P.J. Ciclitira, C. DeSimone
P0308
APPROPRIATENESS OF USE OF INFLIx­
IMAB IN THE SWISS IBD COHORT STUDY
P. Juillerat, V. Pittet, J. Vader, B. Burnand,
J. Gonvers, P. de Saussure, F. Seibold,
G. Rogler, C. Beglinger, M. Sagmeister,
P. Michetti, F. Froehlich
P0309
IS CRP PREDICTIVE FOR MUCOSAL HEAL­
ING IN CD PATIENTS UNDER INFLIxIMAB
THERAPY ?
M. Jürgens, F. Schnitzler, I. Cleynen,
H. Fidder, K. Van Steen, J. Mahachie,
V. Ballet, M. Noman, I. Hoffman, G.A. Van
Assche, P.J. Rutgeerts, S. Vermeire
P0310
PATTERN AND IMMEDIATE OUTCOME
OF ACUTE SEVERE ULCERATIVE COLI­
TIS – A MULTICENTRIC RETROSPECTIVE
STUDY
N. Kaddache, A. Balamane, N. Debzi,
L. Gamar, L. Kecili, N. Bounab, K. Layaida,
N. Afredj, N. Guessab, N. Baiod,
T. Boucekkine
P0311
SMALL­BOWEL VIDEOCAPSULE ENDOS­
COPY HAS LOW THERAPEUTIC IMPACT
IN NON­SELECTED PATIENTS WITH CON­
FIRMED CROHN’S DISEASE
S. Karoui, S. Ouerdiane, L. Kallel,
M. Serghini, N. Ben Mustapha, S. Matri,
M. Fekih, J. Boubaker, A. Filali
117
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0312
ACUTE SEVERE ULCERATIVE COLITIS:
WHAT IS THE CONTRIBUTION OF THE
LABORATORY COMPONENTS TO THE
PROGNOSTIC VALUE OF THE TRUELOVE
AND WITTS’ CRITERIA?
A.J. Kent, L.C. Dinesen, A.J. Walsh,
F. Cummings, B.F. Warren, B. George,
N.J.M. Mortensen, S.P.L. Travis, S. Keshav
P0313
PROSPECTIVE EVALUATION OF CLINI­
CAL UTILITY OF QUANTIFERON­TB
GOLD TEST IN DIFFERENTIAL DIAGNO­
SIS OF INTESTINAL TUBERCULOSIS AND
CROHN’S DISEASE
Y.Y.H. Kim, B. Kim, J.J.H. Lee, J.J.S. Kim,
C.C.H. Choi, W.W.H. Kim, Y.Y.T. Jeen,
Y.Y.S. Park, Y.Y.S. Kim, D.D.S. Han, S.S.A. Jung,
S.S.K. Yang
P0314
SERUM LEVEL OF TFN­α RECEPTOR
TYPE II BETTER CORRELATES WITH AC­
TUAL SEVERITY OF ILEO­CECAL CROHN’S
DISEASE THAN OTHER CYTOkINES OR
CONVENTIONAL CLINICAL ACTIVITY IN­
DICATORS
M. Kohut, T. Kacperek-Hartleb, D. Sojka,
M. Hartleb
P0315
INTEROBSERVER AGREEMENT OF THE
MONTREAL CLASSIFICATION PARAM­
ETERS IN CROHN’S DISEASE AND UL­
CERATIVE COLITIS, AS CAPTURED IN
THE INFLAMMATORY BOWEL DISEASE
INFORMATION SYSTEM (IBDIS) – A EURO­
PEAN CROHN’S AND COLITIS ORGANISA­
TION (ECCO) SUPPORTED PROJECT
S. Koilakou, O. Eckmuellner, A. Aljebreen,
D. Carasel, M. Cesarini, F. Magro, H. Peeters,
T. Sipponen, F. Steinwurz, N. Pedarnig,
W. Reinisch
118
P0316
SURVEILLANCE COLONOSCOPY OF NEO­
PLASM ASSOCIATED WITH ULCERATIVE
COLITIS BY CHROMOENDOSCOPY AND
MAGNIFYING ENDOSCOPY
S. Kudo, H. Ikeda, K. Ohtsuka,
M. Kutsukawa, H. Kashida
P0317
EARLY AZATHIOPRINE/BIOLOGICAL
THERAPY, SMOkING AND DISEASE BE­
HAVIOR ARE PREDIVTIVE FOR FIRST
SURGERY, WHILE PERIANAL DISEASE
AND FREQUENT RELAPSES FOR REOP­
ERATION IN PATIENTS WITH CROHN’S
DISEASE
T. Szamosi, J. Banai, L. Lakatos, Z. Czegledi,
G. David, E. Schafer, T. Pandur, Z. Erdelyi,
O. Gemela, J. Papp, P.L. Lakatos
P0318
ADHERENCE TO THERAPY AND USE OF
COMPLEMENTARY AND ALTERNATIVE
MEDICINE IN PATIENTS WITH INFLAM­
MATORY BOWEL DISEASES
L. Lakatos, G. David, O. Gemela, P. Karoly,
T. Kristof, F. Nagy, A. Salamon, P. Demeter,
T. Szamosi, J. Banai, L. Bene, A. Kovacs,
I. Racz, P. Miheller, P.L. Lakatos
P0319
SERUM LIPOPOLYSACCHARIDE­BINDING
PROTEIN (LBP), AND SOLUBLE CD14
RECEPTOR (SCD14) ARE MARkERS OF
DISEASE ACTIVITY IN PATIENTS WITH
CROHN’S DISEASE
P.L. Lakatos, K. Palatka, I. Altorjay, P. Antal-
Szalmas, G. Farkas, M. Udvardy, T. Molnar,
K. Farkas, O. Gemela, J. Papp, T. Dinya,
M. Papp

P0320
PERIANAL DISEASE, SMALL BOWEL
DISEASE, SMOkING, PRIOR STEROID
OR EARLY AZATHIOPRINE/BIOLOGICAL
THERAPY ARE PREDICTORS OF DISEASE
BEHAVIOR CHANGE IN PATIENTS WITH
CROHN’S DISEASE
P.L. Lakatos, Z. Czegledi, T. Szamosi,
J. Banai, G. David, F. Zsigmond, T. Pandur,
Z. Erdelyi, O. Gemela, J. Papp, L. Lakatos
P0321
A NEW SIMPLE NON INVASIVE INDEx TO
ASSESS BIOLOGICAL ACTIVITY IN IBD
J. Langhorst, J. Boone, A. Rueffer,
G.J. Dobos
P0322
FAECAL CALPROTECTIN IN PATIENTS
WITH ULCERATIVE COLITIS – AN OBSER­
VATIONAL STUDY
A. Lasson, A. Lindgren, B. Rydström,
L. Öhman, H. Strid
P0323
DO PATIENTS WITH ULCERATIVE COLITIS
DIAGNOSED AT YOUNGER AGE HAVE
MORE SEVERE DISEASE ACTIVITY THAN
ELDERLY PATIENTS?
J. Lee, J. Cheon, H. Bok, J. Shin, S. Jeon,
C. Moon, J. Park, S. Hong, T. Kim, W. Kim
P0324
CLINICAL IMPORTANCE OF BILE ACID
MALABSORPTION ASSESMENT IN PA­
TIENTS WITH CROHN’S DISEASE
M. Lenicek, V. Komarek, D. Duricova,
B. Gabrysova, M. Lukas, L. Vitek
P0325
NATIONAL AUDITS OF DIETETIC RE­
SOURCING IN GASTROENTEROLOGY IN
THE Uk: ARE WE IMPROVING SERVICE
PROVISION?
M.C.E. Lomer, K. Whelan, R. Gourgey,
C. Down, I. Arnott, K. Leiper
PosTeR sessIon
P0326
HYBRID PET­CT ENTEROCLYSIS FOR
MONITORING THE RESPONSE TO TREAT­
MENT IN INFLAMMATORY DISEASES OF
INTESTINE
C.J. Das, G.K. Makharia, R. Kumar,
R.P. Tiwari, P. Goswami, R. Sharma,
A.K. Malhotra, R. Kumar
P0327
INCIDENCE AND PREVALENCE OF PSEU­
DOPOLYPOSIS IN OUR INFLAMMATORY
BOWEL DISEASE PATIENTS
P. Markos, S. Cukovic Cavka, Z. Krznaric,
R. Pulanic, J. Jakic Razumovic, B. Vucelic
P0328
kNOWLEDGE OF DISEASE IN PATIENTS
WITH RECENT DIAGNOSIS OF INFLAM­
MATORY BOWEL DISEASE
M. Martinato, M. Ferrante, G.C. Sturniolo,
R. D’Incà
P0329
E­MAIL SERVICE FOR COMMUNICATION
BETWEEN IBD PATIENTS AND HEALTH­
CARE PERSONNEL: A STUDY ON FEASI­
BILITY AND ExPECTATIONS
M. Martinato, R. Caccaro, A. Caruso,
P. Bertomoro, T. Slongo, F. Lamboglia,
L. Oliva, G.C. Sturniolo, R. D’Incà
P0330
FECAL MYELOPEROxIDASE IS AN EFFEC­
TIVE NON INVASIVE MARkER TO ASSES
SEVIRTY AND RESPONSE TO TREATMENT
IN ULCERATIVE COLITIS
I. Masoodi, R. Kochhar, U. Dutta,
C. Vaishnavi, K. Prasad, K. Singh
P0331
REAL­TIME TISSUE ELASTOGRAPHY DE­
TERMINES APPROPRIATE THERAPY AND
PREDICTS THE PROGNOSIS OF ULCER­
ATIVE COLITIS
N. Miyake, T. Ando, O. Watanabe,
K. Ishiguro, T. Kato, S. Hibi, S. Mimura,
M. Nakamura, R. Miyahara, N. Ohmiya,
Y. Hirooka, Y. Niwa, H. Goto
119
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0332
ADHERENCE TO ADALIMUMAB MAINTE­
NANCE THERAPY IS ASSOCIATED WITH
LESSER RATES OF HOSPITALIZATION
AND SHORT­TERM HEALTH CARE COSTS
S. Kane, E. Wu, A. Yu, C. Connolly, J. Tang,
P. Mulani, J. Chao
P0333
ADALIMUMAB IMPROVES WORk PRO­
DUCTIVITY IN PATIENTS WITH MODER­
ATE TO SEVERE CROHN’S DISEASE: THE
ExTEND TRIAL
P. Rutgeerts, D. Binion, G. Van Assche,
N. Chen, P. Mulani, J. Chao
P0334
USE OF INFLIxIMAB AND ADALIMUMAB
IN REFRACTORY POUCHITIS
S. Nobile, P. Gionchetti, G. Straforini,
R. Tambasco, R. Brugnera, G. Liguori,
S. Laureti, G. Poggioli, M. Campieri,
F. Rizzello
P0335
CERTOLIZUMAB PEGOL IS EFFECTIVE
AT INDUCING AND MAINTAINING RE­
SPONSE AND REMISSION IN JAPANESE
PATIENTS WITH CROHN’S DISEASE: RE­
SULTS FROM INDUCTION AND MAINTE­
NANCE STUDIES
H. Ogata, H. Ito, S. Motoya, M. Takazoe,
Y. Suzuki, T. Matsumoto, I. Hirata, T. Matsui,
T. Hibi
P0336
ORAL TACROLIMUS IN THE TREATMENT
OF REFRACTORY SEVERE ULCERATIVE
COLITIS
R. Olmedo Martín, V.M. Amo Trillo,
M. Jimenez Perez, R. Manteca Gonzalez
P0337
TUMOR NECROSIS FACTOR ANTAGO­
NISTS AND INFLAMMATORY BOWEL DIS­
EASES: A NATIONAL PRACTICE SURVEY
A. Oussalah, X. Roblin, D. Laharie,
J. Filippi, M. Flamant, P. Faure, J.M. Phelip,
M.A. Bigard, L. Peyrin-Biroulet
120
P0338
SAFETY AND EFFICACY OF TOTAL DOSE
INFUSION OF LOW MOLECULAR WEIGHT
IRON DExTRAN FOR IRON DEFICIENCY
ANEMIA IN PATIENTS WITH INFLAMMA­
TORY BOWEL DISEASE
P. Oustamanolakis, I.E. Koutroubakis,
C. Karakoidas, G. Mantzaris,
E.A. Kouroumalis
P0339
NON­ADHERENCE TO THE THERAPY IN
CROHN’S DISEASE PATIENTS: PREVA­
LENCE AND RISk FACTORS
F.F. Pimentel, R.A.C. Cornelio, L.A. Chebli,
L.D.M. Chaves, A.L.L. Diniz, A. Zanini,
J.M.F. Chebli
P0340
ADALIMUMAB IS EFFECTIVE IN THE
TREATMENT OF ACTIVE LUMINAL
CROHN’S DISEASE AND MUCOSAL HEAL­
ING: A SINGLE CENTER ExPERIENCE IN
170 PATIENTS
F. Rizzello, P. Gionchetti, R. Brugnera,
S. Nobile, R. Tambasco, C. Calabrese,
G. Straforini, G. Liguori, M. Campieri
P0341
PATIENTS’ PROSPECTIVE ON INFLAMMA­
TORY BOWEL DISEASE (IBD) NURSE LED
SERVICE
E.M. Said, L. Lee, K. Kapur, A.S.G. Soliman
P0342
ONCE DAILY DOSING OF DELAYED­RE­
LEASE ORAL MESALAMINE (400 MG TAB­
LET) IS AS EFFECTIVE AS TWICE DAILY
DOSING FOR MAINTENANCE OF REMIS­
SION OF ULCERATIVE COLITIS: RESULTS
OF THE QDIEM STUDY
W.J. Sandborn, S.V. Kane, J. Korzenik,
B. Lashner, J.A. Leighton, U. Mahadevan,
J.F. Marion, M. Safdi, C.A. Sninsky,
D. Ramsey

P0343
ELAEAGNUS ANGUSTIFOLIA FRUIT Ex­
TRACT ATTENUATES TNBS­INDUCED
COLITIS IN RATS
M. Shiri, M. Motevalian
P0344
THIOGUANINE NUCLEOTIDE MONITOR­
ING AIDS CLINICAL DECISION­MAkING
IN THE INFLAMMATORY BOWEL DISEASE
CLINIC
M.A. Smith, A.M. Marinaki, M. Arenas,
E. Escuredo, J.D. Sanderson
P0345
INFLIxIMAB FOR ACUTE SEVERE UL­
CERATIVE COLITIS; INITIAL ExPERIENCE
FROM BRADFORD
L. Smith, D. Patterson, J. Healey,
C.G. Beckett
P0346
USE OF A SYNBIOTIC IN CROHN’S COLITIS
H. Steed, K.L. Blackett, S. Macfarlane,
S. Walsh, N. Reynolds, J.H. Cummings,
G.T. Macfarlane
P0347
PSYCHOLOGICAL STATUS AFFECTS
HEALTH­RELATED QUALITY OF LIFE IN
CROHN’S DISEASE
N.C. Suares, S. Everett, P. Hamlin,
D. Protheroe, D. Burke
P0348
INTRAVENOUS ANTIHISTAMINE PRE­
MEDICATION CAN ELIMINATE SUB­
SEQUENT INFUSION REACTIONS IN
INFLAMMATORY BOWEL DISEASE PA­
TIENTS WITH PREVIOUS INFLIxIMAB­
RELATED ALLERGY
Z. Szepes, T. Molnar, K. Farkas, F. Nagy,
T. Wittmann
PosTeR sessIon
P0349
ADALIMUMAB IN THE TREATMENT OF
PERIANAL CROHN’S DISEASE: A SINGLE
CENTER ExPERIENCE IN 64 PATIENTS
R. Tambasco, F. Rizzello, R. Brugnera,
S. Nobile, G. Straforini, C. Calabrese,
G. Poggioli, F. Pierangeli, M. Campieri,
P. Gionchetti
P0350
SUPPLEMENTATION WITH THE PROBI­
OTIC VSL#3 TO A STANDARD MEDICAL
TREATMENT IN PATIENTS WITH MILD­TO­
MODERATE ACTIVE ULCERATIVE COLI­
TIS: A DOUBLE­BLIND, RANDOMIZED,
PLACEBO­CONTROLLED STUDY
A. Tursi, G. Brandimarte, A. Papa, A. Giglio,
W. Elisei, G. Giorgetti, G. Forti, S. Danese,
A. Gasbarrini
P0351
OCTREOTIDE TO TREAT DIARRHEA IN
PATIENTS WITH ILEAL POUCH ANAL
ANASTOMOSIS. A RANDOMIZED DOU­
BLE BLIND CROSS­OVER TRIAL
G. Van Assche, A. D’Hoore, G. De Hertogh,
M. Ferrante, S. Vermeire, K. Rans, M. Noman,
K. Geboes, F. Penninckx, P. Rutgeerts
P0352
6­THIOGUANINE IS WELL TOLERATED
AND SAFE IN IBD PATIENTS INTOLERANT
OF OR RESISTANT TO AZATHIOPRINE OR
6­MERCAPTOPURINE
D.P. van Asseldonk, B. Jharap,
N.K.H. de Boer, D.J. Kuik, B.D. Westerveld,
M.G.V.M. Russel, F.J.G.M. Kubben, A.A. van
Bodegraven, C.J. Mulder
P0353
6­THIOGUANINE IS AN EFFECTIVE AND
TOLERABLE RESCUE DRUG IN THE TREAT­
MENT OF ULCERATIVE COLITIS
D.P. van Asseldonk, B. Jharap,
N.K.H. de Boer, D.J. Kuik, B.D. Westerveld,
F.J.G.M. Kubben, M.G.V.M. Russel,
C.J. Mulder, A.A. van Bodegraven
121
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0354
LONG­TERM OUTCOME OF PERIANAL
CROHN’S DISEASDE UNDER NORMAL
CLINICAL PRACTICE CONDITIONS
M. Van Domselaar, F. Bermejo, A. López
San Román, A. Algaba García, E. Garrido
Gómez, S. García Garzón, J. Die
P0355
EFFICACY OF CERTOLIZUMAB PEGOL IS
NOT AFFECTED BY BASELINE ANTI­INF­
LIxIMAB ANTIBODY STATUS IN PATIENTS
WITH CROHN’S DISEASE WITH SECOND­
ARY INFLIxIMAB FAILURE
S. Vermeire, G. D’Haens, J. Colombel,
R.N. Fedorak, M.E. Spehlmann, D.C. Wolf,
K. Mitchev, C. Jamoul, M.T. Abreu,
W.J. Sandborn, P. Rutgeerts
P0356
EFFICACY OF ONCE­DAILY VERSUS
TWICE­DAILY MESALAZINE (PENTASA ® )
FOR LEFT­SIDED COLITIS: RESULTS FROM
THE MULTINATIONAL RANDOMISED PO­
DIUM TRIAL
S. Vermeire, R. Befrits, B. Bokemeyer, I. Gill,
D. Hommes, A. Dignass
P0357
DIMS0150 AS RECTAL THERAPY IN STE­
ROID REFRACTORY ULCERATIVE COLI­
TIS – RESULTS FROM A PLACEBO CON­
TROLLED RANDOMISED TRIAL
R. Befrits, R. Lofberg, A. Ost, P. von Stein,
O.D. von Stein
P0358
THE EFFICACY OF ENTERAL NUTRITION
IN THE MANAGEMENT OF PATIENTS
WITH CROHN’S DISEASE IN REMISSION:
CLINICAL OUTCOMES OF TWO PROSPEC­
TIVE STUDIES
T. Yamamoto, M. Nakahigashi, S. Umegae,
K. Matsumoto, A.R. Saniabadi
122
P0359
THE RELATIONSHIP BETWEEN ENDO­
SCOPIC FINDINGS AT THE PROxIMAL
SITE OF ANASTOMOSIS AND SUBSE­
QUENT RELAPSE FOLLOWING ILEAL/IL­
EOCOLONIC RESECTION FOR CROHN’S
DISEASE: A PROSPECTIVE ENDOSCOPIC
COHORT STUDY
T. Yamamoto, S. Umegae, K. Matsumoto,
A.R. Saniabadi
P0360
CONCOMITANT ENTERAL NUTRITION
THERAPY DURING MAINTENANCE IN­
FLIxIMAB IN PATIENTS WITH CROHN’S
DISEASE: A PROSPECTIVE TRIAL
T. Yamamoto, M. Nakahigashi, S. Umegae,
K. Matsumoto, A.R. Saniabadi
P0361
CLINICAL OUTCOMES AFTER THE FIRST
COURSE OF CORTICOSTEROIDS AND THE
FACTORS PREDICTIVE OF FAVORABLE
RESPONSE IN kOREAN PATIENTS WITH
MODERATE TO SEVERE ULCERATIVE
COLITIS
J. Yoon, J. Park, C. Moon, J. Lee, S. Hong,
J. Cheon, T. Kim, W. Kim
P0362
WHAT ARE THE PREDICTIVE FACTORS
FOR FUNCTIONAL OUTCOMES AFTER
ILEAL POUCH ANAL ANASTOMOSIS FOR
INFLAMMATORY BOWEL DISEASE ?
D. Carmona, A. Sénéjoux, F. Bretagnol,
X. Tréton, C. Stefanescu, Y. Panis, Y. Bouhnik
P0363
LAPAROSCOPIC­ASSISTED VERSUS OPEN
ILEOCOLIC RESECTION FOR CROHN’S
DISEASE: LONG­TERM RESULTS OF A
PROSPECTIVE RANDOMIZED MULTI­
CENTER TRIAL
E.J. Eshuis, F.J.M. Slors, P.C.F. Stokkers,
M.A.G. Sprangers, D.T. Ubbink, M.A. Cuesta,
R.E.G. Pierik, W.A. Bemelman

P0364
EFFECTS OF ANTI­INFLAMMATORY
THERAPY ON HEALING OF COLONIC
ANASTOMOSIS IN DExTRAN SULFATE
SODIUM INDUCED COLITIS IN MICE
P. Myrelid, S. Salim, S. Melgar, M. Pruteanu,
P. Andersson, J.D. Söderholm
P0365
ExTRAINTESTINAL MANIFESTATIONS IN
CROHN’S DISEASE: RISk FACTORS AND
INFLUENCE OF INTESTINAL SURGERY
R. Nascimbeni, F. Di Fabio, A. Lanzini,
F. Lanzarotto, C. Ricci, B. Salerni
P0366
PREDICTORS OF TYPE OF COLECTOMY IN
ULCERATIVE COLITIS PATIENTS
C. Taxonera, X. Calvet, J.P. Gisbert,
L. Rodrigo, L. Bujanda, F. Muñoz, M. Ponce,
F. Gómez-Camacho, J. Estelles, I. Oyagüez,
F.J. Sabater
P0367
COST OF COLECTOMY IN ULCERATIVE
COLITIS PATIENTS
C. Taxonera, J.P. Gisbert, X. Calvet,
J. Panes, L. Rodrigo, L. Bujanda, F. Muñoz,
M. Ponce, F. Gómez-Camacho, J. Mendoza,
I. Oyagüez, F.J. Sabater
P0368
PREOPERATIVE INFLIxIMAB AND RISk
OF POSTOPERATIVE COMPLICATIONS IN
PATIENTS WITH INFLAMMATORY BOWEL
DISEASE: META­ANALYSIS OF OBSERVA­
TIONAL STUDIES
V. Subramanian, C.J. Hawkey
P0369
SELECTIVE DEPLETION OF ELEVATED
LEUCOCYTES OF THE MYELOID LINEAGE
IMPACTS THE COLONIC MUCOSAL LEV­
ELS OF INFILTRATING LEUCOCYTES: IM­
MUNOHISTOCHEMICAL AND CLINICAL
OUTCOMES IN 106 PATIENTS WITH AC­
TIVE ULCERATIVE COLITIS
T. Tanaka, H. Okanobu, A. Saniabadi,
T. Oya
PosTeR sessIon
P0370
THE ASSOCIATION OF PROCESSED
BLOOD VOLUME WITH THE CLINICAL EF­
FICACY OF SELECTIVELY DEPLETING EL­
EVATED GRANULOCYTES/MONOCYTES
IN PATIENTS WITH ULCERATIVE COLITIS
N. Yoshimura, T. Kawaguchi, M. Sako,
T. Yamaka, A. Saniabadi, H. Yoshimoto,
M. Takazoe
PosTeR sessIon
nerve, gut and motility I
P0371
MAGNETIC RESONANCE IMAGING OF
RECTAL VOLUME IN THE ABSENCE OF
APPLIED DISTENSION
L. Di Palma, C. Tomba, M. Coletta,
L. Forzenigo, P. Biondetti, G. Basilisco
P0372
MUSCULARIS MUCOSAE OF THE RECTUM
COMPARISON BETWEEN FUNCTIONAL
CONSTIPATION, HIRSCHSPRUNG’S DIS­
EASE & CONTROLS
N.L.H. Bekkali, M.M. Tabbers, J.C.H. Wilde,
M.W.N. Oomen, M.A. Benninga, F.J.W. Ten
Kate
P0373
INSULIN PROTECTS THE LOSS OF CO­
LONIC INTERSTITIAL CELLS OF CAJAL
AND ENTERIC NERVES IN PATIENTS WITH
TYPE 2 DIABETES MELLITUS
X. Tang, X.S. Yang, Y.Y. Wei, L.P. Duan
P0374
SYMPTOM SEVERITY AND QUALITY OF
LIFE IN PATIENTS WITH CHRONIC CON­
STIPATION: POOLED RESULTS FROM
THREE IDENTICAL RANDOMISED PLA­
CEBO­CONTROLLED TRIALS WITH PRU­
CALOPRIDE
D. Dubois, R. Kerstens, L. Vandeplassche,
J. Tack
123
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0375
GUT PERMEABILITY IN PATIENTS WITH
IRRITABLE BOWEL SYNDROME AND IN­
ACTIVE ULCERATIVE COLITIS
K. Gecse, R. Róka, E. Séra, A. Rosztóczy,
F. Izbéki, F. Nagy, T. Molnár, Z. Szepes,
L. Pávics, L. Bueno, T. Wittmann
P0376
ASSESSMENT OF OBSTRUCTIVE DEF­
ECATION BY HIGH RESOLUTION MA­
NOMETRY COMPARED TO MAGNETIC
RESONANCE DEFECOGRAPHY
H. Frühauf, H. Heinrich, E. Kaufmann,
O. Goetze, D. Weisshaupt, M. Fried, M. Fox
P0377
ANORECTAL MOTOR AND SENSORY
FUNCTION IN PATIENTS WITH FECAL IN­
CONTINENCE ASSESSED BY HIGH RESO­
LUTION MANOMETRY AND BAROSTAT
STUDIES
H. Heinrich, H. Frühauf, E. Kaufman,
A. Gietl, M. Fried, M. Fox
P0378
COPING CAPACITY IN PATIENTS WITH
CHRONIC INTESTINAL PSEUDO­OB­
STRUCTION AND ENTERIC DYSMOTILITY
M. Iwarzon, G. Lindberg
P0379
kIF26A­DEFICIENT MICE DEVELOP
MEGACOLON ASSOCIATED WITH DYS­
FUNCTION OF ENTERIC NEURONAL
CELLS IN THE COLON
T. Makita, S. Hiraoka, T. Sato, T. Katsuno,
T. Nakagawa, Y. Noguchi, Y. Saito,
K. Matsumoto, S. Horie, H. Koseki
P0380
MAGNETIC RESONANCE IMAGING AS­
SESSMENT OF THE WATER DISTRIBUTION
IN THE ASCENDING COLON IN A MODEL
OF DIARRHOEAL DISEASE
E. Placidi, L. Marciani, C.L. Hoad, E.F. Cox,
S. Pritchard, C. Costigan, P.A. Gowland,
R.C. Spiller
124
P0381
POOLED EFFICACY DATA IN ELDERLY PA­
TIENTS TREATED WITH PRUCALOPRIDE
FOR CHRONIC CONSTIPATION
S. Mueller-Lissner, A. Rykx, R. Kerstens,
L. Vandeplassche
P0382
SUCCESSFUL BIOFEEDBACk IN PATIENTS
WITH MULTIPLE SCLEROSIS IS RELATED
TO DISABILITY AND MOOD FACTORS
MORE THAN ANORECTAL PHYSIOLOGY
VARIABLES
G. Preziosi, K. Thiruppathy, P. Boulos,
A.V. Emmanuel
P0383
EVIDENCE OF REDUCED RECTAL COM­
PLIANCE IN CONSTIPATED PATIENTS
WITH MULTIPLE SCLEROSIS
G. Preziosi, N. Thoua, C. Fowler, P. Boulos,
A.V. Emmanuel
P0384
ANORECTAL MANOMETRY: A COMPARI­
SON OF HIGH RESOLUTION AND WATER­
PERFUSED SYSTEMS
M. Puglia, E. Fachnie, P. Bercik
P0385
THE PREDICTING FACTORS OF ANOREC­
TAL PHYSIOLOGIC TESTS FOR THE UNFA­
VORABLE OUTCOME OF BIOFEEDBACk
THERAPY IN PELVIC OUTLET DYSFUNC­
TION
J. Shin, J. Cheon, J. Lee, S. Cheon, H. Bock,
J. Park, C. Moon, S. Hong, T. Kim, W. Kim
P0386
COLONIC TRANSIT TIME INFLUENCES
THE ABNORMAL BOWEL HABIT, BUT NOT
OTHER GASTROINTESTINAL SYMPTOMS,
IN IRRITABLE BOWEL SYNDROME
R. Sadik, I. Posserud, H. Strid, G. Ringström,
H. Abrahamsson, M. Simren

P0387
SUSTAINED EFFICACY OF ORAL PRUCA­
LOPRIDE IN PATIENTS WITH CHRONIC
CONSTIPATION
V. Stanghellini, R. Kerstens,
L. Vandeplassche
P0388
ONLY 27% OF EUROPEAN PATIENTS
WITH CHRONIC CONSTIPATION ARE
SATISFIED WITH CURRENT TREATMENT
OPTIONS
J. Tack, D. Dubois, F. Schenck
P0389
INTRA­JEJUNAL ADMINISTRATION OF
GASTROGRAFIN FOR TREATMENT OF
DISTAL INTESTINAL OBSTRUCTION SYN­
DROME IN CYSTIC FIBROSIS
P.J. Woodland, T. Fotheringham,
L.M.E. Kuitert
P0390
THE EFFECT OF GHRELIN ON MOTILITY
IN ISOLATED, VASCULARLY PERFUSED
RAT COLON
S.J. Youn, B.S. Ko, W.J. Jeon, H.B. Chae,
S.M. Park
P0391
CHANGE IN COLONIC TRANSIT IN PA­
TIENTS WITH MORBID OBESITY AFTER
PLACEMENT OF AN INTRAGASTRIC BAL­
LOON
M. Bouchoucha, M. Potier, G. Airinei,
J. Catheline, J. Fournier, R. Cohen,
J. Raynaud, B. Bejou, C. Bon,
R. Benamouzig
P0392
HIGH RESOLUTION COLONIC MANOM­
ETRY PROVIDES NEW INSIGHTS INTO
THE COMPLExITIES OF PERISTALSIS IN
THE COLON ­ CLINICAL TRIAL RESULTS
FROM A 72 ELEMENT OPTICAL FIBRE
MANOMETRY CATHETER
P.G. Dinning, J.W. Arkwright,
M.M. Szczesniak, S. Fuentealba,
N.G. Blenman, I.D. Underhill, S.A. Maunder,
I.J. Cook
PosTeR sessIon
P0393
BOWEL HABIT SUBTYPES IN IRRITABLE
BOWEL SYNDROME: THE ROLE OF DIARY
CARDS
M. Coletta, L. Di Palma, C. Tomba,
G. Basilisco
P0394
HISTOPATHOLOGICAL ALTERATION IN
POST­INFECTOUS IRRITABLE BOWEL
SYNDROME(PI­IBS) IN A GROUP OF BAN­
GLADESHI POPULATION: A PROSPEC­
TIVE OBSERVATIONAL STUDY
M. Bhuiyan, T. Majumder, A. Raihan,
N. Farha, A. Safiullah
P0395
HOW IS SYMPTOM SEVERITY ASSOCIAT­
ED WITH WORk ABSENTEEISM AND PRO­
DUCTIVITY IN IBS­ROME III PATIENTS? A
REPORT FROM THE MExICAN IBS WORk­
ING GROUP
M. Schmulson, G. Mateos, J.A. Vargas,
J.C. Lopez-Alvarenga, J.M. Remes-Troche,
J.C. Soto-Perez, A. Orozco, Y. Crespo,
A. Jimenez, J.L. Tamayo
P0396
LOW CONCORDANCE BETWEEN PHYSI­
CIANS CLINICAL CLASSIFICATION OF
IBS SUBTYPES USING ROME III CRITERIA,
ROME III DERIVED FROM PATIENTS DIA­
RIES AND ROME II BASED ON A STRUC­
TURED QUESTIONNAIRE IN SUBJECTS
WITH ACTIVE IBS
M. Schmulson, J.M. Remes-Troche,
J.A. Vargas, J.C. Lopez-Alvarenga, J.C. Soto-
Perez, Y. Crespo, A. Jimenez, A. Orozco,
J.L. Tamayo
P0397
SHOULD MORE ATTENTION BE PAID TO
LACTOSE INTOLERANCE IN PATIENTS
WITH IRRITABLE BOWEL SYNDROME IN
CHINA?
Y. Cong, M. Fox, Y. Shang, H. Chu, D. Pohl,
M. Fried, N. Dai
125
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0398
OBSERVATIONAL STUDY ON FUNCTION­
AL BOWEL DISORDERS MEETING OR NOT
ROME III CRITERIA IN FRANCE
M. Dapoigny, M. Vray, A. Albert-Marty
P0399
FAECAL CALPROTECTIN IS A COST­EF­
FECTIVE TEST TO REDUCE THE NUMBER
OF INVESTIGATIONS PERFORMED IN THE
ASSESSMENT OF PATIENTS WITH FUNC­
TIONAL GASTROINTESTINAL DISEASE
A.D. Dhanda, N. Eastley, P. MacMillan,
J. Wassell, M. Lockett
P0400
ORAL SODIUM BUTYRATE FOR TREAT­
MENT OF IBS PREDOMINANT DIAR­
RHOEA – N­of­1 RCT TRIAL
M. Di Stefano, S. Mazzocchi, C. Mengoli,
F. Racca, P. Tana, G. Corazza
P0401
EFFICACY OF A COMBINATION OF ACTI­
VATED CHARCOAL AND SACCHAROMY­
CES CEREVISIAE YEAST (CARBOLEVURE ® )
TO REDUCE THE COLONIC FERMENTA­
TION INDUCED BY ORAL LACTULOSE: A
CROSS­OVER, DOUBLE­BLIND, PLACEBO
CONTROLLED STUDY IN HEALTHY VOL­
UNTEERS
P. Ducrotté, A. Cailleux, A. Leroi, F. Mion,
R. Roche
P0402
IBS SUBTYPE STABILITY EVALUATED
PROSPECTIVELY. RESULTS FROM A RAN­
DOMISED TRIAL
A. Engsbro, B. Søndergaard, R. Ekesbo,
P. Bytzer
P0403
ACUTE PUDENDAL NERVE STIMULATION
VIA A POSTERIOR APPROACH – A FEASI­
BILITY STUDY
A.T. George, T. Dudding, J. Nicholls,
C. Vaizey
126
P0404
HIGH DEPRESSION AND ANxIETY
SCORES IN A SYSTEMATIC REVIEW OF
PSYCHOLOGICAL QUESTIONNAIRES IN
IRRITABLE BOWEL SYNDROME
C. Elliott, M.A. Kamm, D. Bullas,
S.R. Gurmany, N. Arebi
P0405
PERCEPTION DYNAMICS AFTER INGES­
TION OF CAPSAICIN IN HEALTHY VOL­
UNTEERS VERSUS PATIENTS WITH FUNC­
TIONAL DYSPEPSIA
J. Hammer, M. Führer
P0406
SOCIETAL COSTS FOR IRRITABLE BOWEL
SYNDROME – A POPULATION BASED
STUDY
M.T. Hillilä, N. Färkkilä, M.A. Färkkilä
PosTeR sessIon
oncology I
P0407
DEGUELIN, AN AkT INHIBITOR, DOWN­
REGULATES NF­kB SIGNALING, INDUCES
APOPTOSIS IN COLON CANCER CELLS,
AND INHIBITS TUMOR GROWTH IN MICE
H. Kang, J. Kim, M. Cha, H. Jung, I. Song
P0408
INHIBITION OF PLATELET­DERIVED
GROWTH FACTOR RECEPTOR TYROSINE
kINASE REDUCES LYMPHANGIOGEN­
ESIS AND LYMPH NODE METASTASIS IN
A MOUSE MODEL OF HUMAN COLON
CARCINOMA
M. Kodama, Y. Kitadai, M. Tanaka,
T. Sumida, K. Shinagawa, E. Oohara,
M. Oonishi, S. Tanaka, K. Chayama
P0409
THE ROLE OF CDx2 IN THE PROGRES­
SION OF INCOMPLETE INTESTINAL
METAPLASIA
B. Lee, N. Kim, C. Shin, Y. Jeong, Y. Park,
S. Lee, D. Lee

P0410
DEVELOPMENT OF CELL­ASSOCIATED
IMMUNE BIOMARkERS DISCRIMINATING
PATIENTS WITH COLON CANCER FROM
NORMAL HEALTHY SUBJECTS
S. Lee, J. Kim, J. Choi, S. Jee, Y. Lee, E. Jung,
S. Seol, I. Choi, S. Ha, K. Park, C. Ryu, Y. Choi,
H. Seo
P0411
DOWNREGULATION OF ABI1 ExPRES­
SION IS INVOLVED IN PROGRESSION
AND PROGNOSIS OF HUMAN GASTRIC
CARCINOMA
M. Cui, W. Yu, J. Dong, J. Chen, Y. Liu
P0412
THE EFFECTS OF GkN1 ON BIOLOGICAL
BEHAVIOUS OF GASTRIC CANCER CELLS
AND THE RELATIONSHIP BETWEEN GkN1
AND TFF1
W. Mao, J. Chen, T. Peng, X. Yin, M. Chen
P0413
THE ASSOCIATION BETWEEN DNA
METHYLTRANSFERASE 3B C­149T GENO­
TYPE, AND PROMOTER METHYLATION
OF PTEN, AND APC TUMOR SUPPRESSOR
GENES AMONG IRANIAN COLORECTAL
CANCER PATIENTS
F. Naghibalhossaini, I. Khalili, P. Mokarram,
M. Vasei
P0414
STRUCTURAL AND FUNCTIONAL ANALY­
SIS OF SMAD4 GENE 5' REGULATORY RE­
GION IN PANCREATIC CARCINOMA
A. Nikolic, S. Kojic, S. Knezevic, M. Micev,
M. Ristanovic, D. Radojkovic
P0415
Withdrawn by author
PosTeR sessIon
P0416
HOMOZYGOUS 299GLY TOLL­LIkE RE­
CEPTOR 4 GENOTYPE INCREASES THE
RISk OF COLORRECTAL CARCINOMA
DEVELOPMENT IN A CAUCASIAN POPU­
LATION
P. Pimentel-Nunes, A.L. Teixeira, C. Pereira,
C. Brandão, L. Moreira-Dias, R. Medeiros,
M. Dinis-Ribeiro
P0417
SYSTEMATIC ANALYSIS OF TUMOR INI­
TIATING CELLS IN HUMAN COLONIC AD­
ENOCARCINOMA CELL LINES
M. Puglisi, M. Barba, A. Sgambato,
N. Saulnier, A. Boninsegna, E. Giorda,
R. Carsetti, F. Purchiaroni, A. Cittadini,
A. Piscaglia, A. Gasbarrini
P0418
INTENSIVE FOLLOW­UP AFTER CURA­
TIVE SURGERY FOR COLORECTAL CAR­
CINOMA
T. Satani, I. Nakada, H. Nagata, S. Konishi,
H. Ubukata, Y. Watanabe, Y. Goto,
T. Tabuchi
P0419
COLORECTAL CANCER SCREENING WITH
FIBROSIGMOIDOSCOPY EVERY FIVE
YEARS: CAN WE IMPROVE IT?
A. Pinto, P. Chaves, M. Serrano, C. Fidalgo,
P. Lage, I. Claro, S. Mão-Ferro, S. Faias,
S. Ferreira, J. Pereira-Silva, C. Nobre-Leitão
P0420
POLYP CHARACTERISTICS IN BOWEL
CANCER SCREENING PROGRAMME PA­
TIENTS VERSUS THOSE REFERRED ON A
2 WEEk­WAIT PATHWAY
R. Sood, A. Sharma, G. Lipscomb
P0421
PREVALENCE OF CONSTIPATION IN GEN­
ERAL PRACTICE IN ITALY
C. Cottone, G. Disclafani, E. Ubaldi,
R. Cogliandro, V. Stanghellini
127
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0422
AN INTEGRATED RISk PROFILING PRO­
GRAM FOR STEPPED COLORECTAL CAN­
CER SCREENING
I. Stegeman, B.S. Ferket, S.T. van Turenhout,
F.A. Oort, P.M. Bossuyt, G.A. Meijer,
C.J. Mulder, R.A. Kraaijenhagen
P0423
A FAST TRACk IRON DEFICIENCY ANAE­
MIA SERVICE REDUCES TIME TO DIAG­
NOSIS AND TREATMENT FOR GASTRO­
INTESTINAL CANCERS
A. Thapar, B. Karunakaran, J. Musendo,
B. Alves, A. Pantling, E. Moore, S. Cairns
P0424
COMPARISON OF GUAIAC­BASED AND
IMMUNOCHEMICAL FAECAL OCCULT
BLOOD TESTS FOR THE DETECTION OF
ADVANCED COLONIC NEOPLASM IN AN
ASYMPTOMATIC POPULATION IN HONG
kONG
K.K.F. Tsoi, M.C.S. Wong, K.W.K. Ling,
D.J.Y. Luo, J.J.Y. Sung
P0425
COST­EFFECTIVENESS OF FOLLOW­UP
STRATEGIES IN COLON CANCER
E. Una
P0426
THE ASSOCIATION BETWEEN EDUCA­
TIONAL LEVEL AND PANCREATIC CAN­
CER INCIDENCE IN EUROPE
P.G.A. van Boeckel, B.H. Bueno-de-
Mesquita, H.C. Boshuizen, A.E. Kunst,
P.D. Siersema
P0427
ADVANCE NOTIFICATION LETTERS IN ­
CREASE ATTENDANCE RATE IN CO­
LORECTAL CANCER SCREENING: A RAN­
DOMISED POPULATION­BASED TRIAL
A.H.C. van Roon, L. Hol, M. van
Ballegooijen, H.J. van Vuuren, J.C.I. Reijerink,
D.J.D. Habbema, M.E. van Leerdam,
E.J. Kuipers
128
P0428
SAMPLE ERROR AND INTERMITTENT
BLEEDING IN COLORECTAL CANCER
SCREENING: A PILOT STUDY WITH IMMU­
NOCHEMICAL FAECAL OCCULT BLOOD
TESTS
L.G.M. van Rossum, M.G.H. van Oijen,
J. Schuurmans, A.L.M. Verbeek, R.J.F. Laheij,
J.B.M.J. Jansen
P0429
TWO SAMPLES FOR IMMUNOCHEMICAL
FECAL OCCULT BLOOD TESTS IN SCREEN­
ING FOR COLORECTAL CANCER: IMPLE­
MENTATION AND PARTICIPATION
L.G.M. van Rossum, M.G.H. van Oijen,
J. Schuurmans, A.L.M. Verbeek, R.J.F. Laheij,
J.B.M.J. Jansen
P0430
ATROPHIC PANGASTRITIS, SEVERE IN­
TESTINAL METAPLASIA AND PATIENT’S
AGE, ARE RISk FASCTORS FOR PROGRES­
SION TO GASTRIC NEOPLATIC LESIONS
IN PATIENTS WITH ATROPHIC GASTRITIS
L. Vannella, E. Lahner, E. Di Giulio,
V.D. Corleto, J. Osborn, G. Delle Fave,
B. Annibale
P0431
WHICH FAECAL OCCULT BLOOD TEST IS
MOST EFFECTIVE?
M. Veysey, K. King
P0432
FACTORS ASSOCIATED WITH CHOICE
OF COLONOSCOPY IN A TERRITORY
WIDE COLORECTAL CANCER SCREENING
PROGRAMME AMONG ASYMPTOMATIC
CHINESE PARTICIPANTS
M.C.S. Wong, K.K.F. Tsoi, K.W.K. Ling,
S.M. Griffiths, J.J.Y. Sung
P0433
DIETARY RISk FACTORS AND COLOREC­
TAL ADENOMA IN kOREA
S. Yang, Y. Kim, S. Chung, J. Song, I. Lee,
S. Lim, M. Park, J. Yim, D. Kim, C. Kim

P0434
SECONDARY APPENDICEAL TUMOURS –
A SINGLE­CENTRE ExPERIENCE IN kOREA
W. Yoon, Y. Yoon, Y. Kim, J. Ryu, Y. Kim
P0435
DIAGNOSIS OF MALIGNANCY IN JAUN­
DICED PATIENTS WITH BILE DUCT STRIC­
TURES BY FLUORESCENCE IN SITU HY­
BRIDIZATION (FISH)
M. Ballare, M. Sartori, M. Orsello,
F. Montino, M. Balzarini, R. Boldorini,
A. Paganotti, S. Andorno, M. Del Piano
P0436
INTERVALS BETWEEN ROUTINE SURVEIL­
LANCE COLONOSCOPIES ­ ARE GUIDE­
LINES BEING FOLLOWED?
S.K. Butt, N. Van Someren, K. Besherdas
P0437
TRANSRECTAL ULTRASOUND VS. DIGI­
TAL RECTAL ExAMINATION IN SURGI­
CAL TREATMENT DECISION FOR RECTAL
CANCERS: A PROSPECTIVE RANDOM­
IZED CONTROLLED TRIAL
W. Dong, L. Deng, D. Lv, F. He, Q. Gao, Y. Shi,
L. Li
P0438
PROMOTER HYPERMETHYLATION OF
GENE P16 A BIOMARkER FOR EARLY
DETECTION OF GASTRIC CANCER
R. Dumache, M. Puiu, N. Cucu,
B. Bumbacila, G. Anton
P0439
EVALUATION OF FLOW CYTOMETRIC IM­
MUNOPHENOTYPING AND DNA ANAL­
YSIS FOR DETECTION OF MALIGNANT
CELLS IN SEROSAL CAVITY FLUIDS
M.A.A. Ibrahim, D. Sayed, M. Elattar,
A. Mohamed-Hussein
P0440
CAN VITAMIN D BE UTILIZED AS A TU­
MOR MARkER?
S. Majid, Z. Azam
PosTeR sessIon
P0441
OUTCOME OF ANAEMIA REFERRED AS
SUSPECTED UPPER GASTROINTESTINAL
CANCER
D. Mandair, R. Child, M.P. Skander,
M.M. Ahmed, C.H. Lim
P0442
SOLUBLE UROkINASE­TYPE PLASMINO­
GEN ACTIVATOR RECEPTOR (SUPAR) IN
PATIENTS WITH ADVANCED ALIMENTA­
RY TRACT CARCINOMA. RELATIONSHIP
TO LOCALIZATION, SURGICAL TREAT­
MENT AND PRESENCE OF ANAEMIA
L. Usnarska-Zubkiewicz, M. Strutynska-
Karpinska, A. Zubkiewicz-Kucharska
P0443
DOUBLE BALLOON ENTEROSCOPY (DBE)
WITH COMBINATION OF MULTI­SLICE
SPIRAL CT ENTEROCLYSIS (MSCTE)
SHOW HIGHEST DIAGNOSTIC YIELD AND
BRING BETTER PROGNOSIS TO SMALL
INTESTINAL GISTS
L.F. Yu, R. Fan, Z.T. Wang, S.D. Cheng,
J. Zhong
P0444
NUMBERS NEEDED TO DETECT OCCULT
INTRAABDOMINAL MALIGNANCY USING
COMPUTED TOMOGRAPHY IN PATIENTS
PRESENTING WITH ISOLATED WEIGHT
LOSS
S.S. Zeki, S. Kodati, A. Jordan,
J. MacNaughtan, T. Shepherd, M. Jacyna
PosTeR sessIon
liver I
P0445
Withdrawn by author
P0446
Withdrawn by author
129
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0447
TIME COURSE OF THE NEUROPSYCHO­
LOGICAL AND EEG PROFILE AFTER LIVER
TRANSPLANTATION
F. Campagna, A. Biancardi, D. Mapelli,
S. Montagnese, P. Angeli, C. Poci, S. Schiff,
A. Gatta, P. Amodio
P0448
COMPARISON OF FIVE SCORES TO PRE­
DICT MORTALITY IN BRAZILIAN CIR­
RHOTIC PATIENTS IN WAITING LIST FOR
LIVER TRANSPLANTATION
R.S. Castro, D. DeiSanti, T. Sevá-Pereira,
J.R. Almeida, A. Yamanaka, I.F. Boin,
E.C. Soares
P0449
MAJOR IMPACT OF DONOR LIVER LECTIN
COMPLEMENT ACTIVATION PATHWAY
GENE POLYMORPHISMS TO INFECTION
AND MORTALITY AFTER ORTHOTOPIC
LIVER TRANSPLANTATION
B.F. de Rooij, B. van Hoek, W.R. ten Hove,
A. Roos, L.H. Bouwman, A.F. Schaapherder,
M.R. Daha, R.J. Porte, J.J. van der Reijden,
M.J. Coenraad, J. Ringers, A.G. Baranski,
B.G. Hepkema, D.W. Hommes,
H.W. Verspaget
P0450
HYPERAMMONEMIA IN PATIENTS WIT
HYPOxIC HEPATITIS
V. Fuhrmann, A. Drolz, N. Kneidinger,
P. Schenk
P0451
TENOFOVIR REDUCES MORBIDITY AND
MORTALITY IN PATIENTS WITH SPONTA­
NEOUS REACTIVATION OF HEPATITIS B
PRESENTING AS ACUTE­ON­CHRONIC
LIVER FAILURE (ACLF): A RANDOMIZED
PLACEBO CONTROLLED TRIAL
H.K. Garg, A. Kumar, M. Kumar,
B.C. Sharma, S.K. Sarin
130
P0452
COMPARISON OF DEPTH OF ANESTHE­
SIA BY BISPECTERAL INDEx IN DIFFER­
ENT PHASES OF ORTHOTOPIC LIVER
TRANSPLANTATION
S. Ghaffaripour, M. Khosravi, S. Lahsaee,
M. Sahmeddini, H. Sattari, H. Mahmoudi
P0453
INCIDENCE OF VITAMIN D INSUFFICIEN­
CY IN CHILDREN FOLLOWING LIVER
TRANSPLANTATION
M. Legarda, G. Gordon, C. Lloyd,
P.P.J. McKiernan, D.D.A. Kelly, U. Baumann,
N. Shaw
P0454
EARLY DIAGNOSIS AND TREATMENT
OF kLEBSIELLA PNEUMONIA LIVER AB­
SCESS
J. Li, Y. Fu, W. Jiang, C. Tu, L. Li, J. Wang
P0455
EFFECTS OF ISCHEMIA­REPERFUSION
INJURY ON FATTY LIVER MICROCIRCU­
LATION
E. Liguori, V. Di Mauro, D. Lamberti,
D. Sapio, C. Devastato, A. Colantuoni,
G. Nardone
P0456
OUTCOME OF LIVER TRANSPLANTATION
IN CHILDREN WITH CYSTIC FIBROSIS
S. Loganathan, I.D.M. van Mourik,
J. Clarke, C. Lloyd, D.A. Kelly
P0457
IMPACT OF HEPATITIS B CORE ANTIBODY
POSITIVE GRAFTS ON HEPATITIS C RE­
CURRENCE AFTER LIVER TRANSPLAN­
TATION
R. Begum, S. Pungpapong, A.P. Keaveny,
J.H. Nguyen, R.C. Dickson

P0458
EM2+ ELISA: A SEROLOGICAL TEST ABLE
TO PREDICT LONG TERM OUTCOME IN
INOPERABLE ALVEOLAR ECHINOCOCCO­
SIS PATIENTS UNDER BENZIMIDAZOLE
THERAPY
C. Richou, F. Grenouillet, E. Delabrousse,
O. Blagosklonov, S. Ma, Y. Li, L. Millon,
G. Mantion, V. Di Martino, S. Bresson-
Hadni
P0459
SERUM NEOPTERIN AND AUTOIMMUNE
MARkERS IN CHILDREN AND ADOLES­
CENTS WITH LIVER DISEASES OF DIFFER­
ENT ETIOLOGIES
L. Shostakovich-Koretskaya
P0460
FASTING PROTECTS AGAINST HEPATIC
ISCHEMIA/REPERFUSION INJURY VIA
UPREGULATION OF HEMOxYGENASE­1
AND ANTIOxIDANT DEFENCE GENES
M. Verwey, T.M. van Ginhoven,
J.R. Mitchel, S. van den Engel,
F. Bonthuis, E. Torabi, J.N.M. IJzermans,
J.H.J. Hoeijmakers, R.W.F. de Bruin
P0461
ACCURATE FAT FRACTION QUANTIFICA­
TION IN THE LIVER BY MAGNETIC RESO­
NANCE
J. Alústiza, J. Sanchez, L. Bujanda,
E. Hijona, M. Beraza, E. García
P0462
ANALYSIS OF SPLENIC ARTERY PULSA­
TILITY AND RESISTIVE INDICES IN DIF­
FERENTIAL DIAGNOSTICS OF THE ETHI­
OLOGY OF SPLENOMEGALY
I. Grgurevic, M. Kujundzic, O. Jaksic,
Z. Babic, M. Banic, B. Bilic, Z. Bogdanovic,
T. Bokun, Z. Cabrijan, D. Kardum,
L. Perticusic, M. Crncevic-Urek, M. Tadic,
K. Podrug, R. Ajdukovic, V. Haris, R. Kusec,
M. Martinovic, V. Pejsa, M. Pirsic, Z. Prka
PosTeR sessIon
P0463
IMAGING OF LIVER FIBROSIS PROGRES­
SION WITH CONTRAST ULTRASOUND
AND MICROBUBBLES TARGETED TO AL­
PHA V BETA 3
X. Huang, J. Wang
P0464
COMPUTER­AIDED DIAGNOSIS FOR
CLASSIFICATION OF LIVER FIBROSIS BY
USE OF MICRO FLOW IMAGING WITH
CONTRAST­ENHANCED SONOGRAPHY
S. ICHIMURA, K. Sugimoto, J. Shiraishi,
R. Metoki, T. Sano, Y. Miyata, Y. Furuichi,
M. Yamada, Y. Imai, F. Moriyasu, K. Doi
P0465
(18)F­FLUORODEOxYGLUCOSE POSI­
TRON EMISSION TOMOGRAPHY FOR
PREOPERATIVE TREATMENT DECISION­
MAkING IN PANCREATIC CANCER
K. Izuishi, T. Ryusuke, Y. Yamamoto,
R. Kameyama, Y. Nishiyama, T. Masaki,
T. Sano, K. Okano, H. Usuki, Y. Suzuki
P0466
ACOUSTIC RADIATION FORCE IMAGING
(ARFI), A NEW NON­INVASIVE METHOD
OF ULTRASONOGRAPHIC ELASTOGRA­
PHY TO EVALUATE HEPATIC STIFFNESS
H. Kuroda, K. Kakisaka, Y. Miyamoto,
K. Sawara, K. Oikawa, Y. Takikawa,
K. Suazuki
P0467
ACOUSTIC RADIATION FORCE ELASTOG­
RAPHY VERSUS TRANSIENT ELASTOGRA­
PHY FOR NON­INVASIVE ASSESSMENT
OF LIVER FIBROSIS IN CHRONIC HEPATI­
TIS C: A NEW ALTERNATIVE?
M. Lupsor, R. Badea, H. Stefanescu,
A. Maniu, H. Branda, Z. Sparchez, A. Serban
131
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0468
THE PERFORMANCE OF ATTENUATION
COEFFICIENT COMPUTED ON THE UL­
TRASOUND IMAGE IN QUANTIFYING
LIVER STEATOSIS IN NONALCOHOLIC
STEATOHEPATITIS PATIENTS
M. Lupsor, R. Badea, C. Vicas, S. Nedevschi,
M. Grigorescu, H. Stefanescu, C. Radu,
D. Crisan, M. Socaciu, Z. Sparchez, A. Serban
P0469
QUANTITATIVE EVALUATION OF HAE­
MODYNAMIC CHANGES IN CHRONIC
LIVER DISEASES USING A CONTRAST­
ENHANCED ULTRASOUND DEDICATED
SOFTWARE
F. Ridolfi, T. Abbattista, F. Marini,
C. Todeschini, E. Ciabattoni, A. Iasci,
P. Busilacchi, E. Brunelli
P0470
DIAGNOSTIC VALUE OF DIFFUSION­
WEIGHTED MAGNETIC RESONANCE
IMAGING TO PREDICT HEPATIC CON­
GESTION SECONDARY TO PULMONARY
HYPERTENSION
A. SOYLU, Y. Dogan, O. Kilickesmez,
T. Demirbas, K.O. Kilickesmez, N. Yasar,
S. Poturoglu, T. Cimilli, B.A. Kumbasar
P0471
VISUALIZATION AND QUANTIFICATION
OF 3D FLOW CHARACTERISTICS IN THE
PORTAL VENOUS SYSTEM USING FLOW
SENSITIVE 4D MRI
Z. Stankovic, A. Frydrychowicz, Z. Csatari,
P. Deibert, E. Panther, W. Euringer, W. Kreisel,
M. Russe, J. Hennig, M. Langer, M. Markl
P0472
ROLE OF AFLATOxIN B1 IN PRIMARY
LIVER CANCER PATIENTS FROM INDIA
N. Begum, A. Mohammad, L.A. Khan,
M.P. Sarma, S.A. Husain, L. Thayumanavan,
P. Kar
132
P0473
AUTOIMMUNE HEPATITIS INDUCED BY
DRUGS
A. Castiella, M.I. Lucena, E. Zapata,
M. Berenguer, M. Garcia-Bengoechea,
P. Martinez-Odriozola, F. Esandi, H. Hallal,
J. Ibarmia, M. Casado, G. Pelaez, J. Primo,
P. Otazua, R.J. Andrade
P0474
IS PROCOLLAGEN III AMINOPEPTIDE
(PIIINP) A GOOD PREDICTOR OF LIVER
FIBROSIS IN PATIENTS WITH PSORIASIS
ON METHOTRExATE THERAPY?
K. Walsh, S. Riley, Y.C. Lim, A. Dhar
P0475
ETHANOL ALLEVIATES LIVER INJURY
INDUCED BY RESTRICTED BILE DUCT
LIGATION
Y. He, B. Chen, Y. Cui, R. Yang, S. Liu
P0476
HIGH LEVELS OF HEPATOTOxIC MYCO­
TOxINS IN PATIENTS WITH LIVER CIR­
RHOSIS AND HEPATOCELLULAR CARCI­
NOMA
I. Hutanasu, C. Sfarti, A. Trifan,
C. Cojocariu, A. Spac, M. Apostu, L. Miron,
V. Dorneanu, C. Stanciu
P0477
TROVAFLOxACIN/MOxIFLOxACIN IN­
DUCED LIVER INJURY: CAUSALITY AS­
SESSMENT AND CLINICAL FEATURES
FROM SPONTANEOUS REPORTS
C. Janson, M. Stricker, U. Reulbach, Y. Zopf,
E.G. Hahn, M.F. Neurath, H. Dormann
P0478
EFFECT OF ALCOHOL ON THE DEVELOP­
MENT OF HEPATOCELLULAR CARCINO­
MA IN PATIENTS WITH LIVER CIRRHOSIS
CAUSED BY HEPATITIS B VIRUS: A CASE­
CONTROL STUDY
O. Kwon, Y. Kim, J. Kim, S. Kim, Y. Kim, J. Lee,
J. Lee, B. Chun

P0479
SERUM HEPCIDIN LEVELS IN ALCOHOLIC
LIVER DISEASE
A. Sangwaiya, J. Arnold, V. Manglam,
M. Busbridge, M. Thursz
P0480
CLINICAL FEATURES OF ALCOHOLIC
LIVER CIRRHOSIS – FROM A STUDY OF
RECURRENT ESOPHAGEAL VARICES
COMPARING ALCOHOLIC AND VIRAL
LIVER CIRRHOSIS
T. Sano, Y. Furuichi, Y. Miyata, S. Ichimura,
E. Murashima, J. Taira, R. Metoki,
K. Sugimoto, K. Yamada, M. Yamada,
Y. Imai, I. Nakamura, F. Moriyasu
P0481
SERUM ADIPONECTIN INCREASES WITH
THE PROGRESSION OF ALCOHOLIC LIVER
DISEASE
J. Sohn, T. Kim, H. Park, C. Eun, Y. Jeon,
D. Han
P0482
HPLC MEASUREMENT OF THE ALCOHOL
ABUSE BIOMARkER CARBOHYDRATE­
DEFICIENT TRANSFERRIN: EFFECT OF
AGE AND SEx AND REFERENCE RANGE
DEFINITION
M. Vidali, V. Bianchi, A. Ivaldi, M. Bagnati,
G. Bellomo, C. Arfini
P0483
CORRELATION OF MELD WITH kING’S
COLLEGE HOSPITAL CRITERIA IN NON
ALCOHOL AND NON ACETAMINOPHEN
INDUCED ACUTE LIVER FAILURE
O. Parkash, O. Parkash, K. Mumtaz,
S. Wasim Jafri, S. Hamid, S. Abid, S. Hasnain
Alishah
P0484
POTENTIAL ROLE OF SERUM LEPTIN AND
ANGIOGENESIS MARkERS IN PATIENTS
WITH HEPATOCELLULAR CARCINOMA
T.A. Pop, R. Badea, D. Todea, N. Decea,
D. Daicoviciu, O. Mosteanu, M. Socaciu,
M. Acalovschi
PosTeR sessIon
P0485
ULTRASOUND ExAMINATION OF THE RE­
NAL HEMODYNAMICS IN PATIENTS WITH
LIVER CIRRHOSIS
D. Popov, L. Mateva
P0486
ULTRASONOGRAPHIC ELASTOGRAPHY
OF THE SPLEEN USING ACOUSTIC RADIA­
TION FORCE IMAGING (ARFI) IS INFERIOR
TO LIVER ELASTOGRAPHY IN DETECTION
OF PORTAL HYPERTENSION
K. Rifai, M. Bahr, I. Mederacke, M.P. Manns,
M.J. Gebel
P0487
NON­INVASIVE ASSESSMENT OF SYS­
TEMIC HAEMODYNAMICS TO DETER­
MINE OESOPHAGEAL VARICEAL SIZE IN
CIRRHOTIC PATIENTS
K.A. Rye, G. Mortimore, A. Austin,
J. Freeman
P0488
NON­INVASIVE ASSESSMENT OF SYS­
TEMIC HAEMODYNAMICS TO DETER­
MINE VARICEAL BLEEDING RISk IN CIR­
RHOTIC PATIENTS
K.A. Rye, G. Mortimore, A. Austin,
J. Freeman
P0489
THE FEATURES OF LIVER CIRRHOSIS
IN ELDERLY PATIENTS – ESOPHAGEAL
VARICES RECUR LESS FREQUENTLY IN
ELDERLY THAN IN YOUNGER PATIENTS ­
T. Sano, Y. Furuichi, Y. Miyata, S. Ichimura,
E. Murashima, R. Metoki, J. Taira,
K. Sugimoto, K. Yamada, M. Yamada,
Y. Imai, I. Nakamura, F. Moriyasu
P0490
EFFICACY OF ENDOSCOPIC INJECTION
SCLEROTHERAPY FOR RECTAL VARICES
COMPARED WITH BAND LIGATION
T. Sato, K. Yamazaki, J. Akaike, J. Toyota,
Y. Karino, T. Ohmura
133
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0491
ASSESSMENT OF ESOPHAGEAL VARICES
USING FIBROSCAN
C. Sfarti, A. Trifan, C. Cojocariu, A. Singeap,
C. Hutanasu, C. Stanciu
P0492
ZINC DEFICIENCY COMPLICATED BY
HEPATIC ENCEPHALOPATHY IN HEPATIC
CIRRHOSIS PATIENTS
N.A. Shaposhnikova
P0493
ROLE OF DISTURBANCES OF THE INTES­
TINAL MICROBIOCENOSIS IN PATHO­
GENESIS OF THE HEPATOBILIARIS ZONE
DISEASES
I. Skrypnyk
P0494
DOES LEPTOSPIROSIS BEHAVE AD­
VERSELY IN CIRRHOSIS OF THE LIVER?
A. Somasundaram, N. Loganathan,
S. Varghese, S. Shivakumar, V. Jayanthi
P0495
CAN TRANSIENT ELASTOGRAPHY (FI­
BROSCAN) PREDICT THE SEVERITY OF
PORTAL HYPERTENSION?
I. Sporea, I. Ratiu, R. Sirli, A. Deleanu,
A. Tudora
P0496
THE DIAGNOSTIC ROLE OF SERUM
GLYPICAN­3 IN DIFFERENTIATING HEPA­
TOCELLULAR CARCINOMA FROM NON­
MALIGNANT CHRONIC LIVER DISEASE
AND OTHER LIVER CANCERS
P. Tangkijvanich, T. Chanmee,
S. Komtong, V. Mahachai, N. Wisedopas,
P. Pothacharoen, P. Kongtawelert
P0497
TERLIPRESSIN IN HEPATORENAL SYN­
DROME: A META­ANALYSIS
M.T. Te, M.C. Uy, W.Z. Espinosa, J.P. Ong,
E.R. Nolasco, L.S. Daez
134
P0498
HEPATIC VEIN PRESSURE GRADIENT
MEASUREMENT USING ULTRASOUND
VASCULAR DOPPLER AS A PARAMETER
OF SEVERITY OF LIVER CIRRHOSIS AND
ESOPHAGEAL VARICEAL GRADING
T.R. Tedjasaputra, M.M.R. Simadibrata,
U. Budihusodo, N. Akbar, L. Lesmana
P0499
BONE MINERAL DENSITY IN DECOMPEN­
SATED LIVER CIRRHOSIS OF ALCOHOLIC
AND VIRAL ETIOLOGY
R.S. Tomasevic, B. Obradovic,
G. Golubovic, P. Dugalic, L. Burg
P0500
VALIDATION OF A NON INVASIVE METH­
OD FOR PREDICTING OESOPHAGEAL
VARICES IN PATIENTS WITH CHRONIC
VIRAL HEPATITIS
R. Veloso, S. Leite, M. Afonso, J. Pinto,
A. Silva, J. Carvalho, J. Fraga
P0501
SERUM SODIUM AS PREDICTOR OF SUR­
VIVAL FOR “INTERMEDIATE HCC” TREAT­
ED WITH TRANSARTERIAL CHEMIOEM­
BOLIZATION (TACE)
V. Vero, S. Racco, M.L. Gabrieli, M. Pompili,
G. Marrone, A. Forgione, M. Biolato,
C. Cefalo, C. Di Stasi, G. Rapaccini, L. Miele,
A. Grieco
P0502
DOES ASYMMETRIC DIMETHYLARGI­
NINE PLASMA CONCENTRATION PRE­
DICT ESOPHAGEAL VARICES IN PATIENTS
WITH CIRRHOSIS?
M. Vidali, R. Rolla, M. Sartori, S. Andorno,
M. Pagliarulo, E. Garello, S. Carmagnola,
M. Ballarè, M. Orsello, F. Montino, A. Suno,
E. Albano, G. Bellomo, M. Del Piano

P0503
ENDOTOxIN BUT NOT BACTERIAL DNA
IS ASSOCIATED WITH LIVER HAEMO­
DYNAMIC DERANGEMENT IN PATIENTS
WITH DECOMPENSATED CIRRHOSIS:
THE ROLE OF INTESTINAL DECONTAMI­
NATION
J. Vlachogiannakos, G. Daikos, N. Viazis,
A. Saveriadis, I. Zoumbouli-Vafiadi,
D.G. Karamanolis, S.D. Ladas
P0504
THE INULIN CLEARANCE GLOMERULAR
FILTRATION RATE AS A GOLD STANDARD
METHOD TO ASSESS RENAL FUNCTION
IN CIRRHOTIC PATIENTS WITH ASCITES
E. Xirouchakis, G. Germani, I. Giamalis,
N. Johri, A. McDowell, P. Manousou,
V. Calvaruso, M. Pleguezuelo, V. Arvaniti,
M. Hajjaui, S. Maimone, D. Nair, M. Thomas,
A. Hilson, J. O’Beirne, D. Patch, A. Burroughs
P0505
SELECTIVE INTESTINAL DECONTAMINA­
TION IMPROVES IRRITABLE BOWEL SYN­
DROME­LIkE SYMPTOMS IN PATIENTS
WITH LIVER CIRRHOSIS
A.V. Yakovenko, A.V. Kagramanova,
E.P. Yakovenko, N.A. Agafonova, A.N. Ivanov,
I.Z. Gioeva, A.S. Pryanishnikova
P0506
HEPATIC ENCEPHALOPATHY IN AUTOPSY
CASES IN A PERIOD OF 35 YEARS
M.R. Zavala-Solares, V. Lopez, N. Gil,
G. Martinez, L. Chavez, J. Olvera, J. Perez
P0507
PRETREATMENT HBV DNA LEVEL IS A
GOOD PREDICTIVE FACTOR FOR VIRO­
LOGICAL RESPONSE AFTER 48 WEEkS OF
ENTECAVIR TREATMENT IN LAMIVUDINE­
REFRACTORY CHRONIC HEPATITIS B
C. Lee, B. Kim, J. Han, J. Jung, J. Kwon,
E. Kim, H. Kim
PosTeR sessIon
P0508
IS PEGYLATED INTERFERON THERAPY EF­
FECTIVE IN CHRONIC DELTA HEPATITIS ?
F. Gunsar, A. Ozturk, S. Kırdök, M. Akyildiz,
N. Oruc, G. Ersoz, Z. Karasu, U. Akarca
P0509
HEPATIC STEATOSIS AND CHRONIC HEP­
ATITIS B IN PORTUGUESE PATIENTS
R.M. Cerqueira, M.R. Correia,
C.D. Fernandes, H. Schigliano, M.C. Manso
P0510
THE EFFECT OF GENOTYPES ON PA­
TIENTS WITH DUAL INFECTION WITH
CHRONIC HEPATITIS B AND C
J. Chen, S. Tsai
P0511
SIGNIFICANT LIVER INJURY IN HBEAG­
NEGATIVE CHRONIC HEPATITIS B PA­
TIENTS WITH LOW SERUM HBV DNA
S.C. Ferreira, S.G.F. Chacha,
F.F. Souza, A.C. Teixeira, M.G. Villanova,
J.F.C. Figueiredo, S. Zucoloto,
A.L.C. Martinelli
P0512
PREVALENCE OF STEATOSIS IN THE LIVER
OF PATIENTS WITH CHRONIC HEPATITIS
B. ASSOCIATED FACTORS AND RELA­
TIONSHIP WITH SEVERITY OF FIBROSIS
S.C. Ferreira, S.G.F. Chacha,
F.F. Souza, A.C. Teixeira, M.G. Villanova,
L.N.Z. Ramalho, S. Zucoloto,
A.L.C. Martinelli
P0513
TENOFOVIR IS HIGHLY EFFECTIVE FOR
BOTH TREATMENT NAIVE AND TREAT­
MENT ExPERIENCED CHRONIC HEPATI­
TIS B VIRUS INFECTED PATIENTS
S. Hissar, M. Kumar, S.K. Mishra,
N. Trehanpati, S.B. Dar, A. Khanum,
A. Singh, R. Chauhan, P. Sakhuja, S.K. Sarin
135
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0514
EVALUATION OF HBV DNA IN SALIVA
AND SERUM DURING THE FIRST 3
MONTHS OF PEGINTERFERON­ALFA 2A
THERAPY
D.T. Jelev, A.V. Ivanova, A.Z. Krasteva,
V.E. Panov, K.A. Antonov, Z.A. Krastev
P0515
HEPATITIS B VIRUS BCP, PRECORE/CORE,
x GENE MUTATIONS/GENOTYPES AND
THE RISk OF HEPATOCELLULAR CARCI­
NOMA IN INDIA
P. Kar, M. Asim, M.P. Sarma, R. Singla,
L.A. Khan, S.A. Husain, L. Thayumanavan
P0516
RHEUMATOLOGISTS AWARENESS AND
GENERAL PRACTICE IN SCREENING FOR
HEPATITIS B VIRUS (HBV) INFECTION
PRIOR TO INITIATING IMMUNOMODU­
LATING THERAPIES
J. Stine, O.S. Khokhar,
J. Charalambopoulos, V. Shanmugam,
J.H. Lewis
P0517
TENOFOVIR DF (TDF) FOR CHRONIC
HEPATITIS B PATIENTS WITH SUBOPTI­
MAL RESPONSE TO ADEFOVIR (ADV) OR
ADV/LAM TREATMENT: INTERIM ANALY­
SIS OF THE MULTICENTER PROSPECTIVE
OPEN LABEL STUDY OPTIB
M. Levrero, L. Cimino, P. Lampertico,
G. Raimondo, G. Gaeta, E. Sagnelli,
A. Marzano, S. Fagiuoli, G. Niro,
T. Santantonio, V. Di Marco, G. Mazzella,
G. Di Costanzo, M. Angelico, S. Pierconti,
C. Sava’
P0518
CORRELATION OF EARLY VIRAL kINET­
ICS AND TREATMENT RESPONSE DURING
TENOFOVIR TREATMENT IN CHRONIC
HEPATITIS B (CHB) PATIENTS
S.K. Mishra, E. Herrmann, S. Hissar,
M. Kumar, S.B. Dar, S.K. Sarin
136
P0519
PEGYLATED INTERFERON FOR CHRONIC
HEPATITIS B IN ADULTS: A COCHRANE
REVIEW
K. Mumtaz, S. Jafri, S. Hamid
P0520
HEPATITIS B VACCINATION WITH OR
WITHOUT HEPATITIS B IMMUNOGLOBU­
LIN (HBIG) AT BIRTH TO BABIES BORN OF
HBSAG POSITIVE MOTHERS PREVENTS
OVERT HBV TRANSMISSION BUT MAY
NOT PREVENT OCCULT HBV INFECTION
IN BABIES
C. Pande, S.K. Sarin, A. Kumar, S.K. Mishra,
S. Patra, S. Srivastava, K. Bhutia, P. Hazarika,
S.S. Trivedi
P0521
PREVALENCE, RISk FACTORS AND PRO­
FILE OF CHRONIC HEPATITIS B VIRUS
INFECTION IN PREGNANT WOMEN IN
INDIA: STUDY ON TWENTY THOUSAND
PREGNANT WOMEN
C. Pande, S.K. Sarin, S. Patra, K. Bhutia,
S. Mishra, S. Pahuja, M. Jain, S. Srivastava,
S. Bashir, S.S. Trivedi, A. Kumar
P0522
THE RELATION AMONG HEPATITIS B
VIRUS DNA, HISTOLOGICAL HEPATITIS
ACTIVITY AND PROGNOSIS IN PATIENTS
WITH HEPATITIS B VIRUS RELATED HEPA­
TOCELLULAR CARCINOMA
S. Park, H. Lee, K. Yang, Y. Kim, J. Kim,
C. Han, Y. Kim, S. Park, E. Cho, S. Kim,
Y. Jung, S. Lee
P0523
REAL­LIFE SCENARIO OF TREATMENT
ELIGIBILITY IN CHRONIC HEPATITIS B
VIRUS INFECTION
N.D. Patel, D.N. Amarapurkar

P0524
DISCRIMINATIVE ROLE OF THE NEW AND
OLD CUT­OFF ALT VALUES AS PREDIC­
TORS OF LIVER FIBROSIS IN PATIENTS
WITH HEPATITIS B GENOTYPE­D
F.M. Sanai, K.I. Bzeizi, M.A. Babatin,
A.S. Helmy, A.S. AlMdani, H. Al-Ashgar,
M.Q. Khan, A.S. AlGhamdi, H. Albiladi, A. Al-
Qahtani, A. Al-Akwaa, A.A. Abdo
P0525
NONINVASIVE EVALUATION OF LIVER
STIFFNESS THROUGH TRANSIENT ELAS­
TOGRAPHY (FIBROSCAN) IN INACTIVE
HBV CARRIERS
I. Sporea, D. Nicolita, R. Sirli, A. Deleanu,
A. Tudora, S. Bota, M. Cornianu
P0526
EFFECTIVENESS OF LONG TERM COMBI­
NATION THERAPY WITH ADEFOVIR DIP­
IVOxIL AND LAMIVUDINE IN PATIENTS
WITH HBEAG­NEGATIVE CHRONIC HEPA­
TITIS B AND LAMIVUDINE RESISTANCE
S. Manolakopoulos, A. Striki,
G.V. Papatheodoridis, M. Deutsch,
M. Mela, D. TZourmakliotis, E.K. Manesis,
A.J. Archimandritis
P0527
REACTIVATION OF “CLEARED” HEPATITIS
B VIRUS INFECTION AFTER ALLOGENEIC
HEMATOPOIETIC STEM CELL TRANS­
PLANTATION AND ITS ASOCIATION WITH
LIVER GRAFT VERSUS HOST DISEASE
M. Van Domselaar, M. Bastos Oreiro,
M. Canales, A. López de La Guía, R. Arrieta
P0528
NON­INVASIVE ASSESSMENT OF LIVER
FIBROSIS IN CHRONIC HEPATITIS B AND
C PATIENTS: A COMPARISON OF THE GA­
LACTOSE – AND METHACETIN BREATH
TESTS, THE SERUM MARkERS HYAL­
URONIC ACID, APRI AND FIBROTEST
AND TRANSIENT ELASTOGRAPHY TO
LIVER BIOPSY
K.J. Stibbe, C. Verveer, J. Francke,
B.E. Hansen, P.E. Zondervan, E.J. Kuipers,
R.J. de Knegt, A.J. van Vuuren
PosTeR sessIon
biliary I
PosTeR sessIon
P0529
GENE ExPRESSION PROFILE IN INTRA­
HEPATIC CHOLESTASIS OF PREGNANCY
D. Caroli, M. Gervasi, A. Memmo, E. Vidali,
D. Colavito, A. D’Arrigo, A. Leon, R. Lazzari,
N. Cazzagon, A. Floreani
P0530
99MTC­PMT CHOLESCINTIGRAPHY
EVALUATION OF HEPATOBILIARY TRACT
DRAINAGE AND THERAPEUTIC EFFECT
OF URSODEOxYCHOLIC ACID (UDCA) IN
PATIENTS WITH CHOLEDOCHOLITHIASIS
Y. Hashimoto, Y. Takano, N. Maruoka,
J. Takegoshi, Y. Endo, K. Inoue
P0531
DECREASED 1,25­DIHYDROxY VITAMIN
D LEVELS IN WOMEN PRESENTING WITH
INTRAHEPATIC CHOLESTASIS OF PREG­
NANCY
E. Wikström Shemer, H. Marschall
P0532
THE ROLE OF TROPONIN IC SERUM VAL­
UES IN PATIENTS WITH ACUTE CHOLE­
CYSTITIS
Z. Babic, Z. Dorosulic, Z. Bogdanovic,
M. Basha, Z. Krznaric, M. Kujundzic
P0533
CA 19–9 LEVELS IN PATIENTS WITH CHO­
LEDOCHOLITHIASIS
Ü.B. Dogan, Y. Gümürdülü, N. Gölge, B. Kara
P0534
MANAGEMENT OF ACUTE CHOLECYS­
TITIS BY CONVERSION OF ENDOSCOPIC
NASO­GALLBLADDER DRAINAGE TO
INTERNAL DRAINAGE: TUBE CUTTING
WITH A CHANNEL­ATTACHED TIP HOOD
AND SCISSOR FORCEPS
T. Honda, H. Takikawa, K. Tsuji, T. Yasaka
137
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0535
CRITICAL REAPPRAISAL OF CHOLECYS­
TECTOMY IN PATIENTS WITH ASYMP­
TOMATIC GALLSTONES FOR EARLY DI­
AGNOSIS AND REMOVAL OF DYSPLASIA
OR CANCER
S. Hong, J. Kim, J. Hwang, S. Jung, M. Joo,
B. Lee, J. Kim, J. Yeon, J. Park, K. Byun, Y. Bak
P0536
SRB1 ExPRESSION IN GALLBLADDER
MUCOSA FROM CHINESE PATIENTS WITH
CHOLESTEROLOSIS
Z.Y. Jiang, C. Einarsson, P. Parini, T.Q. Han,
H. Hu, S.D. Zhang, G. Eggersten
P0537
A COMPARATIVE STUDY OF OUTCOMES
BETWEEN ENDOSCOPE SPHINCTER­
OTOMY PLUS ENDOSCOPE PAPILLARY
LARGE BALLOON DILATATION AND EN­
DOSCOPIC SPHINCTEROTOMY ALONE IN
PATIENTS WITH LARGE ExTRAHEPATIC
BILE DUCT STONES
T. Kim, Y.W. Sohn, H.J. Oh, S.C. Choi,
E.Y. Cho, H.C. Kim, C.J. Lim, B.J. Yang,
Y.H. Ahn, E.T. Hwang
P0538
EFFECTS OF PRAVASTATIN (HMG­COA
REDUCTASE INHIBITOR) ON THE ExPRES­
SION OF PEROxISOME PROLIFERATOR­
ACTIVATED RECEPTOR (PPAR), LIVER x
RECEPTOR A (LxR A), FARNESOID x RE­
CEPTOR (FxR) AND 7­A­HYDROxYLASE
(CYP7A1) IN THE HUMAN HEP3B CELLS
H. Byun, D. Koh, Y. Choi, C. So, M. Choi,
H. Jang, S. Kae, J. Lee
P0539
THE SIMULTANEOUS LAPARO­ENDO­
SCOPIC “RENDEZ VOUS” FOR PATIENTS
WITH CHOLECYSTO­CHOLEDOCHOLI­
THIASIS IN 120 CASES: EFFECTIVE AND
SAFE
G. La Greca, F. Barbagallo, M. Sofia,
A. Ricotta, S. Gagliardo, S. Latteri, M. Di
Blasi, D. Russello
138
P0540
ENDOSCOPIC ULTRASONOGRAPHY
VERSUS ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY FOR
SUSPECTED CHOLEDOCHOLITHIASIS: A
SYSTEMATIC REVIEW
M.S. Petrov, T.J. Savides
PosTeR sessIon
endoscopy and imaging I
P0541
SAFETY TECHNIQUE OF PERCUTANEOUS
TRANS­ESOPHAGEAL GASTROTUBING
(PTEG) BY ENDOSCOPIC ASSISTANCE
FOR THE PATIENTS THAT PERCUTANE­
OUS ENDOSCOPIC GASTROSTOMY(PEG)
INSERTION IS IMPOSSIBLE
M. Murakami, K. NIshino, Y. Takaoka,
S. Murakami, B. Murakami, S. Tanabe,
M. Kida
P0542
ENDOSCOPIC DIAGNOSIS OF GASTRIC
INTESTINAL METAPLASIA AFTER HELI­
COBACTER PYLORI ERADICATION
N. Nagata, J. Akiyama, N. Uemura
P0543
ENDOSCOPIC FEATURES STRUCTURE
OF SUBMUCOSAL CAPILLARIES AFTER
HELICOBACTER PYLORI ERADICATION
THERAPY
V. Nikishayev, V. Boyko
P0544
UPPER GASTROINTESTINAL ENDOS­
COPY FINDINGS AND CD4 CELL COUNT
IN HUMAN IMMUNODEFICIENCY VIRUS
INFECTED PATIENTS: A PROSPECTIVE
STUDY
M. Nkuize, S. De Wit, V. Muls, R.S. Ntounda,
M. Moumouni, J. Mulkay, R. Saïdi, T. Serste,
M. Buset

P0545
THE USEFULNESS OF NARROW BAND
IMAGING(NBI) MAGNIFYING ENDOS­
COPY
T. Omoritai, H. Kawakubo, T. Ando,
A. Yokoyama
P0546
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION FOR EARLY GASTRIC CANCER
GROWING IN RECONSTRUCTED GASTRIC
TUBE AND GASRIC STUMP
H. Ono, K. Takizawa, M. Tanaka,
N. Kakushima, H. Ikehara, Y. Yamaguchi,
H. Matsubayashi
P0547
THE SAFETY AND EFFICACY OF CARBON
DIOxIDE INSUFFLATION IN ENDOSCOPIC
SUBMUCOSAL DISSECTION FOR GAS­
TRIC NEOPLASMS IN PATIENTS UNDER
CONSCIOUS SEDATION
F. Onogi, H. Araki, Y. Horibe, M. Hayashi,
K. Fukuta, S. Ninomiya, T. Ibuka, M. Nagaki,
H. Moriwaki
P0548
APPROPRIATENESS OF UPPER GI ENDOS­
COPY IN PATIENTS WITH GERD: RESULTS
OF A 2­WEEk MULTICENTRE SURVEY
M. Lombardini, G. Spinzi, W. Piubello,
F. Cosentino, M. Dinelli, E. Masci, A. Frosi,
G. Manes, F. Pace
P0549
A STRATEGY FOR ENDOSCOPIC SUBMU­
COSAL DISSECTION TRAINING WITH PIG
MODELS: ARE THEY USEFUL FOR OVER­
COMING THE LEARNING CURVE?
A. Parra-Blanco, M. Arnau, D. Nicolás-
Pérez, A.Z. Gimeno-García, N. González,
J.A. Díaz-Acosta, A. Jiménez, E. Quintero
PosTeR sessIon
P0550
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION FOR GASTRIC SUPERFICIAL LE­
SIONS IS ALSO FEASIBLE IN EUROPE
P. Pimentel-Nunes, M. Dinis-Ribeiro,
L. Santos, E. Cardoso, M. Afonso, N. Costa,
C. Lopes, L. Moreira-Dias
P0551
EUS­GUIDED DRAINAGE OF PANCREATIC
COLLECTIONS USING A NOVEL AxIAL
ECHOENDOSCOPE (PROTOTYPE OLYM­
PUS xGIF­UCT160J­AL5): RESULTS IN 12
CASES
M. Pioche, T. Ponchon, F. Fumex,
B. Napoléon, C. Lefort
P0552
A MULTI­CENTRE SURVEY ASSESSING
INTERNET USE AMONGST ENDOSCOPY
PATIENTS ­ IS ONLINE CONSENT A FEA­
SIBLE ALTERNATIVE?
C. Calvert, N. Prasad, N. Prasad, W. Jafar,
J. Geraghty, N. Haslam, A. M. Davidson,
Y. Ang
P0553
A NEW CLASSIFICATION OF NARROW
BAND IMAGING MAGNIFICATION EN­
DOSCOPY (NBI­ME) FOR EARLY GASTRIC
NEOPLASMS (EGN) BEFORE ENDOSCOP­
IC SUBMUCOSAL RESECTION (ESD)
C. Ryu, M. Lee, J. Lee, K. Ryu, B. Ko, H. Kim,
K. Kwon, S. Hong, J. Kim, E. Ko, J. Cho, J. Lee,
C. Shim, B. Kim, N. Fukami, Y.K. Chen
P0554
ACCURACY OF ASSESSMENT OF PATIENT
DISCOMFORT DURING ENDOSCOPIC
PROCEDURES
A. Sachdeva, R. Barton, K. Seymour
P0555
OPEN ACCESS GASTROSCOPY: A SUS­
TAINABLE RESOURCE OR FISCAL ALBA­
TROSS?
E.M. Said, M.H. Shiwani, K. Kapur,
A.S.G. Soliman
139
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0556
ExAMINATIONS ABOUT THE RISk FAC­
TORS OF THE CHANGES OF HEMATO­
LOGIC INFLAMMATORY MARkERS AND
HEMOGLOBIN VALUES AFTER ENDO­
SCOPIC MUCOSAL DISSECTION (ESD)
FOR GASTRIC CANCER
T. Shibata, H. Nagasaki, M. Okubo,
T. Tahara, M. Nakamura, I. Hirata
P0557
CAN USING TRANSNASAL ENDOSCOPIC
BIOPSY FORCEPS ALTER THE RESULTS OF
RAPID UREASE TEST AND HISTOLOGIC
DIAGNOSIS?
S. Shin, S. Jeon, Y. Lee, J. Lee, K. Lee, K. Lee,
J. Kim
P0558
ANALYSIS FOR FACTORS AFFECTING ON
PROCEDURE TIME DURING ENDOSCOPIC
SUBMUCOSAL DISSECTION IN GASTRIC
NEOPLASMS
S. Shin, Y. Lee, K. Lee, J. Lee, K. Lee, J. Kim
P0559
STRICTURE AFTER ENDOSCOPIC SUBMU­
COSAL DISSECTION FOR EARLY GASTRIC
CANCERS
N. Sohara, Y. Onozato, H. Iizuka,
H. Ishihara, S. Kakizaki
P0560
UNUSEFULNESS OF BISPECTRAL INDEx
MONITORING OF MIDAZOLAM SEDATION
DURING ROUTINE UPPER ENDOSCOPY IN
PATIENTS WITH LIVER CIRRHOSIS
J. Sohn, T. Kim
P0561
GASRIC MUCOSAL PATTERN USING
MAGNIFYING NBI ENDOSCOPY CLEARLY
H. PYLORI INDUCED CHRONIC GASTRI­
TIS AND PREDICTS GASTRIC CANCER
OCCURRENCE
T. Tahara, T. Shibata, M. Nakamura,
M. Okubo, J. Yonemura, Y. Maeda,
D. Yoshioka, N. Maruyama, T. Kamano,
Y. Kamiya, H. Fujita, Y. Nakagawa,
M. Nagasaka, M. Iwata, T. Arisawa, I. Hirata
140
P0562
NARROW BAND IMAGING WITH MAG­
NIFICATION ENDOSCOPY FOR SUPER­
FICIAL MICRO NEOPLASM AT THE ORO­
HYPOPHARYNx
S. Tanaka, Y. Morita, T. Okuno,
M. Sugimoto, T. Fujita, T. Toyonaga,
H. Kutsumi, T. Azuma
P0563
ONE STEP DIRECT PERCUTANEOUS EN­
DOSCOPIC JEJUNAL TUBE INCERTION
USING AN ULTRATHIN ENDOSCOPE
THROUGH THE GASTROSTOMA. ­A COM­
PARISON WITH THE CONVENTIONAL
TWO­STEP METHOD­
M. Tanaka, N. Hasuike, H. Ono,
K. Takizawa, N. Kakushima, T. Inui,
H. Ikehara, H. Matsubayashi, Y. Yamaguchi
P0564
USEFULNESS OF FLUORESCENCE MAG­
NIFYING ENDOSCOPY BY FLUORESCEIN
FOR IDENTIFICATION OF THE DEMARCA­
TION IN EARLY GASTRIC CANCERS
K. Tanaka, S. Tano, T. Iguchi, K. Nishikawa,
T. Harada, M. Katsurahara, H. Inoue,
N. Horiki, Y. Takei
P0565
MAGNIFYING ENDOSCOPY FOR IDEN­
TIFICATION OF RESIDUAL GASTRIC TU­
MORS AFTER PREVIOUS INSUFFICIENT
ENDOSCOPIC TREATMENT
K. Tanaka, T. Iguchi, S. Tano, K. Nishikawa,
T. Harada, H. Inoue, M. Katsurahara,
N. Horiki, Y. Takei
P0566
FACTORS ASSOCIATED WITH RESPIRATO­
RY DEPRESSION DURING ENDOSCOPIC
SUBMUCOSAL DISSECTION UNDER
PROPOFOL SEDATION USING TARGET
CONTROLLED INFUSION PUMP AND
BISPECTRAL INDEx MONITOR
D. Tanioka, Y. Kawahara, H. Okada,
M. Inoue, S. Kawano, T. Tsuzuki, M. Kita,
K. Hori, D. Kawai, S. Kobayashi, M. Uemura,
K. Yamamoto

P0567
UNSEDATED TRANSNASAL OESOPHA­
GOGASTRODUODENOSCOPY IS FEA­
SIBLE IN PRIMARY CARE ENDOSCOPY
UNIT­ UNITED kINGDOM ExPERIENCE
I. Tiwari, L. Das, S. Fox, M. Roberts
P0568
ROLE OF CONFOCAL ENDOMICROSCOPY
IN THE DIAGNOSIS OF CELIAC DISEASE
K. Venkatesh, A. Abou-Taleb, M. Cohen,
C. Evans, P. Oliver, C.J. Taylor, M. Thomson
P0569
SYSTEMATIC EVALUATION OF THE OVER­
THE­SCOPE­CLIP (OTSC) FOR NOTES
GASTRIC CLOSURE
R.P. Voermans, M.I. van Berge
Henegouwen, W.A. Bemelman, P. Fockens
P0570
NATURAL ORIFICE TRANSLUMINAL EN­
DOSCOPIC SURGERY (NOTES): CARDIO­
PULMONARY SAFETY OF TRANSESOPH­
AGEAL MEDIASTINOSCOPY
S. von Delius, J. Sager, H. Feussner,
D. Wilhelm, S. Hiemer, T. Schuster,
A. Schneider, R.M. Schmid, A. Meining
P0571
QUALITY CONTROL IN UPPER GASTRO­
INTESTINAL ENDOSCOPY: DETECTION
RATES OF GASTRIC CANCER
S.D. Vradelis, N. Maynard, B.F. Warren,
S. Keshav, S.P.L. Travis
P0572
CORRELATION BETWEEN HISTOPATHO­
LOGIC FINDINGS USING THE UPDATED
SYDNEY PROTOCOL FOR GASTRIC BIOP­
SIES AND NARROW BAND IMMAGING
STUDIES WITH TARGETED BIOPSIES
E. Xirouchakis, S. Georgopoulos, F. Laoudi,
P. Christoforidis
PosTeR sessIon
P0573
FACTORS BOTH SIZE AND LOCATION
INFLUENCE ACCURATE ENDOSONO­
GRAPHIC ASSESSMENT WITH MINI­
PROBE FOR INVASION DEPTH OF EARLY
GASTRIC CANCER
S. Yamamoto, T. Nishida, S. Tsutsui, T. Kizu,
M. Kato, Y. Hayashi, T. Akasaka, T. Yamada,
H. Ogiyama, K. Watabe, H. Iijima, M. Tsujii,
N. Hayashi
P0574
EFFECTIVENESS AND LIMITATIONS OF
USING TRANSNASAL ENDOSCOPY DUR­
ING PLACEMENT OF LONG INTESTINAL
TUBE
T. Yamasaki, M. Miyano, S. Hiramatsu,
E. Sasaki, K. Adachi, O. Kurai
P0575
NOVEL MAGNIFYING ENDOSCOPIC
CLASSIFICATION FOR EARLY GASTRIC
CANCER WITH NARROW BAND IMAGING
SYSTEM; PARTICULARLY FOCUSING ON
MICRO­VASCULAR PATTERN AND SUR­
FACE GLANDULAR STRUCTURE
A. Yokoyama, H. Inoue, H. Minami,
Y. Wada, S. Kudo, S. Hamatani
P0576
IS 5 DAYS HOSPITALIZATION REALLY
NECESSARY FOR COLORECTAL ENDO­
SCOPIC SUBMUCOSAL DISSECTION
(ESD)?
T. Aoki, Y. Saito, T. Matsuda, T. Nakajima,
T. Sakamoto
P0577
PREDICTORS OF COLONOSCOPY PROCE­
DURE TIMES: THE CANADIAN ASSOCIA­
TION OF GASTROENTEROLOGY ENDOS­
COPY QUALITY INITIATIVE
D. Armstrong, D. MacIntosh, C. Dubé,
R. Hollingworth, S. Daniels, P. Sinclair,
S. Gittens, J. Cabrera, Y. Chen, R. Bridges
141
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0578
USEFULNESS OF GASTROINTESTINAL
ENDOSCOPY IN ExTREMELY ELDERLY
PATIENTS
A. Barbado, G. Cacho, I. Gomez,
G. Rodriguez, J. Lui Lledó, C. Fernández
Rodriguez
P0579
DOSE FINDING FOR INTRAVENOUS AP­
PLICATION OF FLUORESCEIN FOR MINI­
PROBE BASED CONFOCAL LASER SCAN­
NING MICROSCOPY IN PIGS
V. Becker, F. van den Broek, M. Wallace,
S. Delius, R. Schmid, A. Meining
P0580
ENDOSCOPIC MUCOSAL RESECTION
IN A REGIONAL CANCER CENTRE –
THE SOUTHAMPTON ExPERIENCE
P.C. Boger, J. Neale, P. Patel
P0581
NARROW­BAND IMAGING IMPROVES
THE DETECTION OF POLYPS IN PATIENTS
WITH HYPERPLASTIC POLYPOSIS SYN­
DROME: A PROSPECTIVE RANDOMIZED
STUDY COMPARING NARROW­BAND
IMAGING VS HIGH­RESOLUTION WHITE
LIGHT IMAGING
K.S. Boparai, F.J. van den Broek, S. van
Eeden, P. Fockens, E. Dekker
P0582
SHOULD PATIENTS PRESENTING WITH
MELAENA AND A NORMAL GASTROS­
COPY HAVE COLONIC INVESTIGATIONS?
A.J. Brooks, J.A. Campbell, E.J. Lunn,
M. Kurien, M.T. Donnelly, J.M. Hebden
P0583
CAN HIDROCOLONIC ULTRASONOGRA­
PHY BE USEFUL IN DETECTION OF CO­
LONIC LESIONS? A PROSPECTIVE STUDY
A.I.L.P. Caldeira, B. Pereira, E. Pereira,
R. Sousa, R. Gonçalves, J. Tristan,
A. Banhudo
142
P0584
ACCURACY OF COLORECTAL CANCER
LOCATION BY COLONOSCOPISTS: A Uk
REGION­WIDE AUDIT
N. Chandra, S. Sharma, M. Foster, C. Hilton,
J. Collier, J. Simmons, A. McIntyre
P0585
EFFICACY OF MORNING PREPARATION
FOR THE PREPARATION QUALITY IN THE
AFTERNOON COLONOSCOPY
B. Chang, H. Lee
P0586
AUTOLYTIC CHANGES OF THE RESECT­
ED SPECIMENS IN COLON ENDOSCOPIC
SUBMUCOSAL DISSECTION(ESD) MAY
LEAD TO THE INCOMPLETE PATHOLOGIC
EVALUATION
J. Cho, Y. Cho, J. Kim, G. Jung, Y. Lee, S. Park
P0587
THE FACTORS AFFECTING THE QUAL­
ITY OF BOWEL PREPARATION PRIOR TO
COLONOSCOPY
C. Choi, S. Hwang, S. Lee, B. Cha, E. Baek,
K. Kim, H. Lee, H. Kim, J. Do, S. Chang
P0588
MECHANICAL BOWEL PREPARATION
FOR COLONOSCOPY
M. CIRILLO, F. Piantadosi, M. Sannino,
C. Mattera, C. Fedele, F. Frattolillo,
G. Gargiulo, N. Gennarelli, A. Calogero,
R. Lobello
P0589
DOES PRE PROCEDURAL PATIENT ANxI­
ETY INFLUENCE COMPLETION RATES?
B.J. Colleypriest, P.F. Marden

P0590
QUALITY CONTROL OF COLONOSCOPY
PROCEDURES: A PROSPECTIVE MULTI­
CENTER VALIDATED AND REPRODUC­
IBLE METHOD TO EVALUATE ALL ENDO­
SCOPIC UNITS
R. Coriat, A. Lecler, C. Cassaz, H. Roche,
P. Podevin, B. Mesnard, O. Berretta, C. Nizou,
D. Sautereau, M. Bouygues, C. Brezault,
U. Chaput, D. Lamarque, J. Monnin,
M. Gaudric, F. Prat, S. Chaussade
P0591
LOW­VOLUME PEG­SOLUTION PLUS
ASCORBIC ACID VERSUS HIGH­VOLUME
PEG­SOLUTION AS BOWEL PREPARA­
TION FOR COLONOSCOPY
S. Corporaal, J.H. Kleibeuker, J.J. Koornstra
P0592
COLONOSCOPY IN THE ELDERLY
L.A. Corry, T. Quinn, A. Cahill
P0593
IS BOWEL PREPARATION MORE EFFEC­
TIVE IN PATIENTS WITH A PREVIOUS
HEMICOLECTOMY? A CASE­CONTROL
STUDY
F. Cristofari, V. Cardinale, A. Zullo, C. Hassan,
R. Lorenzetti, M. de Matthaeis, S.M. Campo,
S. Morini
P0594
THE BURDEN OF COLONOSCOPY: GAS­
TROENTEROLOGISTS OVERESTIMATE
THE IMPORTANCE OF PAIN
M.J. Denters, M. Deutekom, B.H.F. Derkx,
P. Fockens, E. Dekker
P0595
RIGID SIGMOIDOSCOPY: WIDELY USED
BUT POORLY TAUGHT. A SURVEY OF Uk
SURGICAL AND MEDICAL GASTROEN­
TEROLOGY TRAINEES
A.D. Dhanda, P. Marden
PosTeR sessIon
P0596
ENDOSCOPIC RESECTION OF LARGE
SESSILE AND FLAT COLORECTAL POLPS:
SAFETY AND RISk OF INVASIVE CANCER
M.D. Duku, R.J. Mead, D. Poller, P. Bhandari
P0597
NARROW BAND IMAGING (NBI) FOR
ADENOMA DETECTION IN HIGH RISk PA­
TIENTS: A RANDOMISED, CONTROLLED
TRIAL
J.E. East, N. Suzuki, T. Guenther, N. Palmer,
M. Stavrinidis, A. Ignjatovic, B.P. Saunders
P0598
THE UTILITY OF COLONOSCOPY IN THE
ELDERLY WITH NON IRON DEFICIENT
ANAEMIA – ARE WE MISSING SERIOUS
PATHOLOGY?
A. Fikree, A. Graham, S. Valiji-Bharmal,
S. Preston
P0599
MAGNIFYING CHROMOENDOSCOPY FOR
DIAGNOSIS OF SERRATED ADENOMA
T. Fujii, K. Fu, M. Katano, T. Fujimori
P0600
CARBON DIOxIDE INSUFFLATION IN
COLONOSCOPY IS SAFE: ExPERIENCE
OF 348 PATIENTS
M. Geyer, U. Guller, C. Beglinger
P0601
NECCESITY FOR IMPROVEMENT IN EN­
DOSCOPY TRAINING DURING SURGICAL
RESIDENCY IN THE USA
A. Gupta, G. Subhas, V. Mittal
P0602
ENDOSCOPIC TREATMENT FOR LAT­
ERALLY SPREADING TUMORS IN COL­
ORECTUM OVER 20 MM IN DIAMETER;
EMR(EPMR) OR ESD?
T. Hayashi, H. Kashida, F. Yamamura,
N. Ikehara, H. Miyachi, Y. Wada,
K. Wakamura, T. Hosoya, S. Hamatani,
S. Kudo
143
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0603
CLINICOPATHOLOGICAL CHARACTER­
ISTICS OF SMALL EARLY COLORECTAL
CANCER
S. Hayashi, T. Hayashi, H. Kashida,
H. Miyachi, H. Yamamura, S. Hamatani,
S. Kudo
P0604
POLYP LOCATION IS A RISk FACTOR FOR
DELAYED TYPE POST­POLYPECTOMY
HAEMORRHAGE: A MULTI­CENTER CASE­
CONTROL STUDY
T. Herngreen, T.K. Buddingh, J. Haringsma,
F.P. Vleggaar, R. Breumelhof, F. ter Borg
P0605
ENDOSCOPIC TREATMENT FOR RECTAL
CARCINOID TUMOR. WHICH METHOD
IS BETTER?
D. Hirasawa, K. Suzuki, N. Fujita, C. Sato,
Y. Maeda
P0606
SAFETY OF PROPOFOL SEDATION BY
TRAINED NURSES DURING ENDOSCOP­
IC PROCEDURES IN ASA III­IV PATIENTS:
RESULTS OF A PROSPECTIVE REGISTRY
C. Huertas Nadal, M. Figa Francesch,
M. Pérez Contreras, J. Miquel Casachs,
M. Hombrados Verde, F. González-Huix
Lladó
P0607
ARE WE READY FOR OPTICAL DIAGNO­
SIS? DISCARD STUDY: EARLY RESULTS
A. Ignjatovic, J.E. East, N. Suzuki, M. Vance,
N. Palmer, T. Guenther, B. Saunders
P0608
MANAGEMENT OF BILIARY COMPLI­
CATIONS AFTER LIVER TRANSPLANTA­
TION – LESSONS LEARNED FROM MORE
THAN 1000 PATIENTS
R. Schwarzer, G. Gyoeri, F. Langer,
A. Puespoek, M. Peck-Radosavljevic,
R. Steininger, A. Ferlitsch
144
P0609
THERAPEUTIC ERCP­RELATED PERFORA­
TIONS DIAGNOSED BY CT: INCIDENCE,
RISk FACTORS AND OUTCOME
M. Shapiro, L. Copel, D. Abramovith,
M. Yair, E. Broide, E. Scapa
P0610
SAFETY AND EFFICACY OF ENDOSCOPIC
AMPULLECTOMY IN TUMORS WITH AND
WITHOUT INTRADUCTAL ExTENSION
AND PREDICTIVE FACTORS OF SUCCESS:
A PROSPECTIVE STUDY
H. Shehab, L. Buscail, B. Bournet,
P. Gourraud, J. Escourrou
P0611
Withdrawn by author
P0612
ENDOSCOPIC MANAGEMENT OF POST­
CHOLECYSTECTOMY BILIARY LEAkS
V. Singh, R. Gupta, G. Singh, G.R. Verma
P0613
EFFECTIVENESS OF PROPHYLAxIS OF
POST­ERCP PANCREATITIS FOR RISk
GROUP BY ENDOSCOPIC PANCREATIC
SPONTANEOUS DISLODGEMENT STENT
­RANDOMIZED CONTROLLED MULTI­
CENTER TRIAL­
A. Sofuni, H. Maguchi, T. Itoi, C. Authors
P0614
ONE CENTER ExPERIENCE FROM CONFO­
CAL LASER ENDOMICROSCOPY OF THE
PANCREATOBILIARY DUCTS
F. Swahn, U. Arnelo, L. Enochsson, M. Löhr
P0615
A SEQUENTIAL CANNULATION PROTO­
COL INCLUDING EARLY PANCREATIC
STENT PLACEMENT AND NEEDLE kNIFE
SPHINCTEROTOMY: INTERIM ANALYSIS
OF A RANDOMISED TRIAL
M.P. Swan, M.J. Bourke, S. Alexander,
A. Moss, A.A. Bailey, S.J. Williams

P0616
FAILED CANNULATION AFTER INITIAL
ERCP: BENEFIT OF A TERTIARY REFER­
RAL ERCP SERVICE
M.P. Swan, M.J. Bourke, S. Alexander,
S.J. Williams, R. Hope, D.C. Ruppin
P0617
PREDICTING THE LIkEHOOD OF THERA­
PEUTIC ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY
M. Tadic, M. Kujundzic, Z. Babic, M. Banic,
B. Bilic, Z. Cabrijan, I. Grgurevic, D. Kardum,
M. Urek, J. Bozikov
P0618
HIGHER RATE OF BLEEDING AFTER
SPHINCTEROTOMY IN LIVER TRANS­
PLANTED PATIENTS
A. Tenca, D. Pugliese, D. Consonni, P. Cantu’,
G. Rossi, F. Donato, D. Conte, R. Penagini
P0619
MONITORING OF RADIATON ExPOSURE
IN THERAPEUTIC ERCP AND EVAULA­
TION TO REDUCE RADIATON ExPOSURE
F. Garcia Fernandez, J. Infantes,
F. Mendoza, Y. Torres Dominguez, F. Alcazar,
A. Piñar
P0620
COVERED AND UNCOVERED SELF Ex­
PANDABLE METALLIC STENTS ARE
EQUALLY EFFICACIOUS IN BILE DUCT
STRICTURES
K. Ung, P. Stotzer, L. Rydberg, A. Kylebäck,
Å. Nilsson, M. Gustavsson, E. Johnsson
P0621
FEASIBILITY AND OUTCOMES OF COM­
BINED ENDOSCOPIC ULTRASONOGRA­
PHY AND ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY PER­
FORMED IN A SINGLE SESSION
J.J. Vila, J. Jimenez-Perez, I. Fernandez-
Urien, F. Bolado, J. Urman, B. Gonzalez de la
Higuera, D. Ruiz-Clavijo, F. Borda
PosTeR sessIon
P0622
PREDICTORS OF DIFFICULTY AT ERCP:
RESULTS OF A LARGE SCALE PROSPEC­
TIVE MULTI­CENTRE STUDY
E.J. Williams, R. Ogollah, P. Thomas,
A. Hamlyn, R.F. Logan, D. Martin,
M.L. Wilkinson, M. Lombard
P0623
LARGE BALLOON ENDOSCOPIC PAPIL­
LARY DILATATION (OVER 15 MM) NEVER
CAUSE SEVERE PANCREATITIS IN PA­
TIENTS WITH APPROPRIATELY DILATED
COMMON BILE DUCT FOR CLEARING
BILE DUCT STONE
Y. Youn, H. Lim, S. Jang, J. You, S. Lee, D. Lee
P0624
SINGLE BALLOON ENTEROSCOPY (SBE)
VERSUS DOUBLE BALLOON (DBE) ERCP
IN PATIENTS WITH ROUx­EN­Y ANASTO­
MOSIS
H. Neumann, L.C. Fry, S. Rickes,
P. Malfertheiner, K. Mönkemüller
P0625
STAGING ACCURACY OF ESOPHAGEAL
CANCER BY ENDOSCOPIC ULTRASONOG­
RAPHY – A SINGLE CENTER ExPERIENCE
T. Moreira, F. Castro-Poças, P. Lago,
J. Areias
P0626
THE PATTERN OF ENDOSCOPIC ULTRA­
SOUND (EUS) UTILIZATION IN A LARGE
REFERRAL ENDOSCOPY CENTER IN A
DEVELOPING COUNTRY
T. Sriprayoon, N. Pausawasdi,
S. Pomgprasobchai, T. Akaraviputh,
A. Methasate, V. Prachayakul,
S. Leelakusolvong, W. Srikureja
145
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0627
ESTIMATION OF THE MALIGNANT PO­
TENTIAL OF GASTROINTESTINAL STRO­
MAL TUMORS: THE VALUE OF CONTRAST
ENHANCED HARMONIC EUS
H. Sakamoto, M. Kitano, T. Komaki,
H. Imai, K. Kamata, M. Kudo
P0628
CONTRIBUTION OF ENDOSCOPIC ULTRA­
SOUND FINE NEEDLE ASPIRATION TO
THE WORkUP OF MEDIASTINAL LYMPH
NODES
F. Salom, L. Mangialavori, G. Roseau,
S. Chaussade, F. Prat
P0629
REAL­TIME HARMONICS CONTRAST­EN­
HANCED ENDOSCOPIC ULTRASONOG­
RAPHY (SONOVUE) FOR PANCREATIC
FOCAL LESIONS WITH UNDETERMINED
ORIGIN
A. Seicean, R. Stan-Iuga, R. Badea, T. Pop
P0630
PREDICTIVE FACTORS OF EUS­GUIDED
DRAINAGE FAILURE IN PANCREATIC
FLUID COLLECTIONS WITHOUT FLUO­
ROSCOPIC ASSISTANCE
A. Seicean, R. Stan-Iuga, M. Tantau,
T. Mocan, R. Badea, O. Pascu
P0631
ENDOSCOPIC ULTRASONOGRAPHY­
GUIDED FINE NEEDLE ASPIRATION (EUS­
FNA) VS EUS­GUIDED CYTOBRUSHING
TO ASSESS CELLULAR DIAGNOSIS IN
CYSTIC PANCREATIC LESIONS. DEFINI­
TIVE RESULTS OF A PROSPECTIVE AND
COMPARATIVE STUDY
O. SENDINO, G. Fernandez-esparrach,
M. Sole, L. Colomo, A. Pardo, C. Guarner,
M. Pellise, J. Llach, A. Cardenas, J. Bordas,
A. Gines
146
P0632
MOLECULAR ANALYISIS OF EGFR AND
kRAS IN SAMPLES OBTAINED BY ENDO­
SCOPIC ULTRASONOGRAPHY­GUIDED
FINE NEEDLE ASPIRATION (EUS­FNA) IN
PATIENTS WITH NON­SMALL CELL LUNG
CANCER (NSCLC)
O. Sendino, V. Alonso-Espinaco, M. Pellise,
M. Sole, G. Fernandez-Esparrach, J. Muñoz,
L. Colomo, J. Llach, S. Castellvi-Bel,
A. Castells, A. Gines
P0633
FREQUENCY OF INCIDENTAL FINDINGS
IN PATIENTS ON ENDOSCOPIC ULTRASO­
NOGRAPHY
R. Sotoudehmanesh, P. Arab,
M. Khatibinan, J. Mikaeli, R. Ansari, S. Merat
P0634
ENDOSONOGRAFIC EVALUATION OF AD­
RENAL GLAND MASSES
M. Tadic, T. Stoos Veić, M. Kujundzic,
Z. Babic, M. Banic, B. Bilic, Z. Cabrijan,
I. Grgurevic, D. Kardum, M. Urek, T. Bokun,
M. Vukelic Markovic
P0635
DOES ESOPHAGEAL MUSCLE THICkNESS
IN PATIENT WITH ACHALASIA PREDICT
PNEUMATIC DILATATION RESULTS?
A. Tebaibia, M. Balamane, N. Chiali,
M. Boudjella, N. Oumnia, N. Matougui,
M. Lahcene, D. Boutarene, B. Touchene
P0636
Withdrawn by author
P0637
OUR RESULTS OF EUS­FNA FOR GASTRO­
ENTEROLOGICAL DISEASES
M. Watanabe, M. Kida, H. Ikeda, M. Araki,
S. Miyazawa, M. Takezawa, H. Kikuchi,
H. Imaizumi, K. Kobayashi, K. Saigenji

P0638
SPIRAL ENTEROSCOPY ERCP IN SURGI­
CALLY ALTERED GASTROINTESTINAL
ANATOMY
P.A. Akerman, D. Cantero
P0639
COMPLICATIONS OF DOUBLE­BALLOON
ENTEROSCOPY: 4 YEARS OF ExPERIENCE
R. Carvalho, N. Almeida, P. Figueiredo,
S. Lopes, H. Gouveia, M.C. Leitão
P0640
ExPANDING THE INTERNATIONAL
DOUBLE BALLOON ENTEROSCOPY Ex­
PERIENCE: FIRST RESULTS FROM THE Uk
MULTI­CENTRE DBE REGISTRY
E.J. Despott, S. Hughes, A. Deo,
D.S. Sanders, R. Sidhu, R. Willert, J. Plevris,
K. Trimble, C. Fraser
P0641
DOUBLE BALLOON ENTEROSCOPY AS­
SISTED POLYPECTOMY IN PEUTZ­JEGH­
ERS SYNDROME: RESULTS FROM THE
LARGEST PATIENT COHORT IN THE Uk
E.J. Despott, R.K. Phillips, S. Clark,
A. O’Rourke, E. Tripoli, K. Konieczko, C. Fraser
P0642
FIRST ExPERIENCE OF SPIRAL ENTEROS­
COPY IN THE Uk: LET’S “TORQUE” ABOUT
IT!
E.J. Despott, S. Hughes, P. Marden, C. Fraser
P0643
THE ExTENT, LIMITS AND COMPLICA­
TIONS OF DIAGNOSTIC AND THERAPEU­
TIC SINGLE­BALLOON ENTEROSCOPY IN
PATIENTS WITH SMALL BOWEL ABNOR­
MALITIES
E.D. Fedorov, E.V. Ivanova, M.E. Timofeev,
O.I. Yudin
PosTeR sessIon
P0644
CLINICOPATHOLOGICAL ANALYSIS ON
MICROSCOPIC SMALL INTESTINAL LE­
SIONS OF MALIGNANT LYMPHOMA
T. Ibuka, H. Araki, F. Onogi, M. Shiraki,
M. Shimizu, H. Tsurumi, M. Nagaki, T. Kato,
H. Moriwaki
P0645
NON­SMALL­BOWEL LESIONS ENCOUN­
TERED DURING DOUBLE­BALLOON EN­
TEROSCOPY­ WHAT LESSONS CAN WE
LEARN?
H. Tee, A.J. Kaffes
P0646
ANTEGRADE DOUBLE BALLOON ENTER­
OSCOPY FOR CONTINUED OBSCURE GI
BLEEDING FOLLOWING PUSH ENTEROS­
COPY. IS THERE A ROLE?
R. Chettiar, W.S. Selby, A.J. Kaffes
P0647
WHAT IS THE LEARNING CURVE FOR
DOUBLE­BALLOON ENTEROSCOPY? A
RETROSPECTIVE ANALYSIS WITH RE­
GARDS TO THE TECHNICAL AND CLINI­
CAL SUCCESS RATES
H. Tee, A.J. Kaffes
P0648
ASSOCIATION OF HYPERAMYLASEMIA
AND ACUTE PANCREATITIS WITH ORAL
DOUBLE BALLOON ENTEROSCOPY: 100
CONSECUTIVE ORAL PROCEDURES
M. Kopacova, S. Rejchrt, I. Tacheci, J. Bures
P0649
DOUBLE­BALLOON ENTEROSCOPY FOR
THE DIAGNOSIS AND TREATMENT OF
OBSCURE BLEEDING, INFLAMMATORY
BOWEL DISEASES AND POLYPOSIS SYN­
DROMES: AN EASTERN EUROPEAN ExPE­
RIENCE IN 137 ExAMINATIONS
P.L. Lakatos, H.C. Horvath, L. Zubek,
P. Fuszek, A. Nagypal, O. Gemela, J. Papp
147
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0650
INITIAL ExPERIENCE WITH RETROGRADE
OVERTUBE ASSISTED ENTEROSCOPY
USING A SPIRAL TIP OVERTUBE (ROAE­
SPIRAL)
L.F. Lara, S. Singh, J. Sreenarasimhaiah
P0651
AN ENDOSCOPIC ANALYSIS OF ULCERS
OF SMALL INTESTINE DETECTED BY
DOUBLE BALLOON ENTEROSCOPY
T. Lee, J. Kim, H. Kim, W. Kim, Y. Cho, J. Cho,
J. Lee, B. Ko, M. Lee
P0652
MALIGNANT SMALL BOWEL TUMORS
IN PATIENTS IN PATIENTS UNDERGO­
ING DOUBLE­BALLOON ENTEROSCOPY
(DBE) FOR OBSCURE GASTROINTESTI­
NAL BLEEDING (OGIB)
H. Neumann, L.C. Fry, S. Rickes,
P. Malfertheiner, K. Mönkemüller
P0653
CAPSULE ENDOSCOPY (CE) INCREASES
THE DIAGNOSTIC YIELD OF DOUBLE
BALLOON ENTEROSCOPY DBE IN PA­
TIENTS BEING INVESTIGATED FOR OB­
SCURE GASTROINTESTINAL BLEEDING
(OGIB)
L.C. Fry, H. Neumann, P. Malfertheiner,
K. Mönkemüller
P0654
COMPARISON BETWEEN VIDEO CAPSULE
ENDOSCOPY AND DOUBLE­BALLOON
ENTEROSCOPY IN PATIENTS WITH OB­
SCURE GASTROINTESTINAL BLEEDING
A. Mussetto, M.L. Brancaccio, A. Buzzi,
F. Cantoni, S. Gasperoni, T. Casetti
P0655
TOTAL ENTEROSCOPY USING SINGLE
BALLOON ENDOSCOPE WITH CARBON
DIOxIDE INSUFFLATION
K. Ohtsuka, H. Ikeda, H. Kashida,
K. Kodama, N. Ogata, A. Yokoyama,
H. Miyachi, N. Ikehara, F. Yamamura,
S. Kudo
148
P0656
DIAGNOSTIC USEFULNESS OF COM­
PUTER TOMOGRAPHIC ENTEROGRA­
PHY FOR THE PATIENTS PRESENTING
WITH UNSPECIFIED GASTROINTESTINAL
SYMPTOMS
H. Park, J. Cheon, J. Park, C. Moon, J. Lee,
T. Kim, W. Kim
P0657
IS SINGLE BALLOON ENTEROSCOPY
DANGEROUS?
J.F. Rey
P0658
SPIRAL ENTEROSCOPY USING THE DIS­
COVERY SMALL BOWEL DEVICE AND
VISTA SYSTEM: TECHNIQUE, FEASIBILITY
AND PRELIMINARY RESULTS
M. Riccioni, C. Spada, A. Cazzato,
A. Bizzotto, G. Costamagna
P0659
LONG TERM OUTCOME OF PATIENTS
WITH VASCULAR SMALL BOWEL LE­
SIONS TREATED WITH DOUBLE BAL­
LOON ENTEROSCOPY
E.G. Samaha, G. Rahmi, J. Canard,
B. Landi, T. Maniere, L. Trinquart, F. Bloch,
R. Jian, C. Cellier
P0660
IS CONSCIOUS SEDATION ADEQUATE
FOR DOUBLE BALLOON ENTEROSCOPY
?­ A STUDY ON PATIENT TOLERABILITY
WITH CONTROLS
R. Sidhu, M.E. McAlindon, S. Hardcastle,
D. Sanders
P0661
SMALL BOWEL GASTROINTESTINAL
STROMAL TUMORS: THE ROLE OF COM­
BINATION OF DOUBLE BALLOON ENTER­
OSCOPY AND LAPAROSCOPIC­ASSISTED
BOWEL SURGERY
M. Su, C. Chen, W. Lin, C. Hsu, C. Sung,
C. Chiu, P. Chen

P0662
ENDOSCOPIC FEATURES OF SMALL
INTESTINAL LYMPHOMA DIAGNOSED
BY DOUBLE­BALLOON ENTEROSCOPY:
A SINGLE CENTER ExPERIENCE
T. Suzuki, M. Matsushima, I. Okita,
K. Shirakura, Y. Tsukune, K. Watanabe,
J. Koike, T. Shirai, T. Mine
P0663
THE EFFICACY OF RETROGRADE DEEP
INSERTION OF SINGLE BALLOON EN­
DOSCOPY FOR PATIENTS WITH CROHN’S
DISEASE AT TIMES OF CONVENTIONAL
COLONOSCOPY ON OUTPATIENTS: PRO­
SPECTIVE, OPEN­LABEL, FEASIBILITY
STUDY
K. Watanabe, M. Sogawa, S. Hosomi, Y. Ito,
K. Morimoto, M. Takatsuka, N. Kamata,
H. Yamagami, T. Watanabe, K. Tominaga,
Y. Fujiwara, T. Arakawa
PosTeR sessIon
Pancreas I
P0664
MINIMAL ACCESS NECROSECTOMY FOR
INFECTED PANCREATIC NECROSIS – INI­
TIAL ExPERIENCE IN A HIGH VOLUME
CENTRE
D. Mizgirev, B. Duberman, V. Pozdeev,
A. Epstain
P0665
PREDICTIVE FACTORS OF POSITIVE DI­
AGNOSIS OF BILIOPANCREATIC ULTRA­
SOUND ENDOSCOPY IN ACUTE PRE­
SUMED IDIOPATHIC PANCREATITIS
H. Montialoux, S. Lecleire, S. Grigioni,
M. Antonietti, I. Iwanicki Caron, P. Ducrotté,
E. Lerebours
P0666
MANNAN­BINDING LECTIN AND MAN­
NAN­BINDING LECTIN ASSOCIATED
SERINE PROTEASE­2 IN ACUTE PANCRE­
ATITIS
S. Novovic, A.M. Andersen, L.N. Jorgensen,
H.J. Nielsen, J.C. Jensenius, M.B. Hansen
PosTeR sessIon
P0667
ENDOSCOPIC THERAPY OF BILIARY
STRICTURES CAUSED BY ACUTE PAN­
CREATITIS
Y. Ozin, E. Parlak, S. Disibeyaz, Z. Kilic,
N. Sasmaz, B. Sahin
P0668
POST ERC PANCREATITIS – PROSPECTIVE
CONTROLLED STUDY
K. Palaniappan, M. Narashiman,
R. Ardhanari
P0669
NAFAMOSTAT MESILATE IN THE PREVEN­
TION OF POST­ERCP PANCREATITIS AND
RISk FACTORS FOR POST­ERCP PANCRE­
ATTIS
J. Park, S. Lee, J. Lee, J. Eum, E. Jeong, Y. Bae,
C. Choi, H. kim, D. Kang
P0670
CLASSIFYING THE SEVERITY OF ACUTE
PANCREATITIS: AN ARGUMENT FOR
A‘CRITICAL’ CATEGORY
M.S. Petrov, J.A. Windsor
P0671
SERUM CREATININE, UREA NITROGEN
AND HEMATOCRIT IN EARLY DETECTION
OF PANCREATIC NECROSIS
G. Poropat, G.G.H. Hauser, V.V.L. Licul,
D.D.S. Stimac
P0672
PATIENTS WITH GALLSTONE PANCREATI­
TIS AND CLINICAL PREDICTORS OF RE­
TAINED COMMON BILE DUCT STONES:
WHO REALLY HAVE CHOLEDOCHOLI­
THIASIS?
S. Rodríguez-Gómez, A. Fuentes-Coronel,
P. Fradejas-Salazar, C. Ochoa-Sangrador,
C. Bailador-Andrés, E. Martín-Garrido,
P. Conde-Gacho, M. Martín-Arribas
149
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0673
MANAGEMENT OF ACUTE PANCREATI­
TIS IN THE ELDERLY ­ CAN WE PERFORM
BETTER ?
K. Somasekar, G. Morris-Stiff, H. Al-Madfai,
A. Hassn
P0674
THE EFFICACY OF FDG­PET/CT FOR AU­
TOIMMUNE PANCREATITIS
Y. Takemoto, T. Omura, G. Saito,
K. Kawamoto, Y. Koba, I. Kishimoto,
J. Shibuya, T. Takahashi, M. Ozawa,
K. Satoh, T. Takahashi
P0675
ENDOSCOPIC MANAGEMENT OF PAN­
CREATIC INJURY AFTER BLUNT TRAUMA
ABDOMEN­ ExPERIENCE FORM INDIAN
SUBCONTINENT
P. Tyagi, B. Sharma, A. Puri, S. Sachdeva,
P. Sharma, Y. Sarin, A. Shingal
P0676
ACUTE PANCREATITIS ASSOCIATED WITH
PEGYLATED INTERFERON ALPHA 2B
PLUS RIBAVIRIN THERAPY IN PATIENTS
WITH CHRONIC HEPATITIS C
M. Yamada, C. Kojima, H. Tomida,
D. Suzuki, T. Kihara, H. Sugimoto,
T. Mabuchi, M. Takeuchi, T. Hosoi
P0677
SYNCHRONOUS AUTOIMMUNE PANCRE­
ATITIS AND PANCREATIC INTRAEPITHE­
LIAL NEOPLASIA (PANIN) IN PATIENTS
UNDERGONE SURGERY FOR AN IPMN:
A CASE SERIES
M. Petrone, P. Arcidiacono, S. Carrara,
C. Boemo, A. Giussani, L. Albarello,
C. Doglioni
P0678
TGF­BETA AND ITS TYPE II RECEPTOR
GENE ExPRESSION IN PERIPHERAL
BLOOD MONONUCLEAR CELLS MAY
HELP DISTINGUISH EARLY­STAGE PAN­
CREATIC CANCER FROM CHRONIC PAN­
CREATITIS
A. Plata, A. Nowak, J. Orchel, U. Mazurek
150
P0679
GENETIC ALTERATIONS OF P16 AND k­
RAS GENE IN PANCREATIC CANCER PA­
TIENTS IN NORTH INDIAN POPULATION
S.K. Polipalli, S.A. Husain, A. Agarwal,
R. Gondal, S. Medhi, N. Begum,
A. Mohammad, P. Kar
P0680
RISk OF PANCREATIC CANCER IN CALCI­
FIED CHRONIC PANCREATITIS
N. Sasahira, M. Tada, S. Mizuno,
K. Yamamoto, H. Yagioka, H. Kogure,
T. Sasaki, K. Kawakubo, Y. Nakai, K. Hirano,
H. Isayama, M. Omata, K. Koike
P0681
PROGNOSTIC RELEVANCE OF ExTRA­
CAPSULAR LYMPH NODE INVOLVEMENT
IN PANCREATIC DUCTAL ADENOCARCI­
NOMA
G. Sergeant, N. Ectors, S. Fieuws, R. Aerts,
B. Topal
P0682
CYST FLUID PROTEOMIC ANALYSIS SIG­
NIFICANTLY IMPROVES THE SENSITIV­
ITY FOR THE DETECTION OF PANCRE­
ATIC CYSTIC TUMOURS: A PROSPECTIVE
STUDY
K.E. Sjoberg, M.E.V. Johansson,
A.G. Hyltander, M. Shafazand, E. Kalaitzakis,
J. Hansen, H. Sjovall, G.C. Hansson, R. Sadik
P0683
CHANGES IN QUALITY OF LIFE MEA­
SURES IN PATIENTS WITH PANCREATIC
CANCER WITH AND WITHOUT SURGERY
J.M. Solheim, T. Heiberg, T. Buanes

P0684
THE VALUE OF REAL­TIME CONTRAST­
ENHANCED ULTRASONOGRAPHY (SO­
NOVUE) WHEN CHARACTERIZING THE
MICROCIRCULATION IN PANCREATIC
DISEASE
R. Badea, A. Seicean, B. Diaconu, R. Stan-
Iuga, M. Socaciu, Z. Sparchez, M. Tantau,
A. Serban
P0685
PREOPERATIVE CA19–9 IS A SIGNIFI­
CANT PREDICTOR OF EARLY RECUR­
RENCE AND POOR PROGNOSIS AFTER
RESECTION FOR PANCREATIC ADENO­
CARCINOMA
T. Sugiura, T. Mizuno, H. Kanemoto,
K. Uesaka
P0686
CLINICAL SIGNIFICANCE OF SERUM NE­
OPTERIN, TPS AND CA19–9 MEASURE­
MENT IN PATIENTS WITH PANCREATIC
ADENOCARCINOMA AND CHRONIC
PANCREATITIS
R. Talar-Wojnarowska, A. Gasiorowska,
M. Olakowski, A. Lekstan, P. Lampe,
B. Smolarz, H. Romanowicz-Makowska,
A. Kulig, E. Malecka-Panas
P0687
MUCIN PRODUCTION DETERMINES SEN­
SITIVITY TO BORTEZOMIB AND GEM­
CITABINE IN PANCREATIC CANCER CELLS
T.T. Wissniowski, E.G. Hahn, S. Meister,
J.R. Kalden, R. Voll, M. Ocker
P0688
CLINICAL COURSE AND CHARACTERIS­
TICS OF INTRADUCTAL PAPILLARY MU­
CINOUS NEOPLASMS WITH CONCOMI­
TANT PANCREATIC CARCINOMA
S. Yamamoto, J. Yoshino, K. Inui, M. Hattori
PosTeR sessIon
P0689
DUAL THERAPY WITH GEMCITABINE AND
CONCURRENT LOCAL HEATING HYPER­
THERMIA FOR INOPERABLE ADVANCED
PANCREATIC CANCER CAN IMPROVE
SURVIVAL RATE, PROLONG SURVIVAL
PERIOD AND REDUCE ADVERSE EFFECTS
COMPARED WITH GEMCITABINE MONO­
THERAPY
M. Yasuda, S. Kokura, Y. Naito, M. Kondo,
T. Yoshikawa
P0690
EFFICACY AND TOLERANCE OF DACAR­
BAZINE OR TEMOZOLOMIDE CHEMO­
THERAPY COMBINED OR NOT WITH
5­FU FOR ENDOCRINE CARCINOMAS: A
RETROSPECTIVE MULTICENTER STUDY
FROM THE GROUPE D’ETUDE DES TU­
MEURS ENDOCRINES (GTE)
S. Pecout, E. Baudin, A. Paoli, F. Maire,
E. Terrebonne, C. Barbe, O. Hentic, M. Pavel,
H. Brixi-Benmansour, G. Cadiot
P0691
NEW ASPECTS IN DIAGNOSING THE
ZOLLINGER­ELLISON SYNDROME
O. Pop, M. Nasta, A. Bodea, A. Vlad
P0692
EUS­GUIDED FINE NEEDLE TATTOOING
(EUS­FNT) FOR PREOPERATIVE LOCAL­
IZATION OF SMALL PANCREATIC NEURO­
ENDOCRINE TUMORS: A SINGLE CENTER
ExPERIENCE
T. Seerden, S. Alfieri, D. Galasso, M. Rafaelli,
F. Rosa, A. Fusco, R. Bellantone, G. Doglietto,
L. De Marinis, G. Costamagna, A. Larghi
PosTeR sessIon
surgery I
P0693
PERFORATED PEPTIC ULCER IN SOUTH­
EASTERN TAIWAN
M. Bair
151
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0694
OUTCOMES OF OESOPHAGECTOMY IN
PATIENTS WITH MORBID OBESITY
C. Conor Magee, A. Khan, M. Hartley,
N. Howes, M. Shackcloth, R. Page
P0695
ENDOLUMINAL SURGERY IN GASTRIC
BYPASS PATIENTS WHO REGAINED
WEIGHT: A FEASIBILITY STUDY
E.R. GOODMAN, C. Virk
P0696
PAEDIATRIC TYPE I INSULIN DEPENDENT
DIABETES MELLITUS AND CELIAC DIS­
EASE
F. Kiparissi, S. Macdonald, M. Elawad,
K. Lindley
P0697
TREATMENT WITH SILDENAFIL (VIAGRA),
IN TWO PATIENTS WITH INTRACTABLE
EMESIS AND FOREGUT DYSMOTILITY
F. Kiparissi, M. Elawad, K. Lindley
P0698
RESULTS OF GASTRIC CANCER SURGERY
IN THE OVER 70 AGE GROUP
C. Magee, M. Shrotri, R. Macadam,
W. Taylor
P0699
METASTATIC LYMPH NODE RATIO (MLR)
IS PREDICTIVE OF SURVIVAL FOLLOW­
ING RESECTED OESOPHAGEAL CANCER
C. Magee, F. Atherton, M. Hartley,
N. Howes, G. Khera, M. Shackcloth, R. Page
P0700
S­1 TREATMENT IMPROVED THE SUR­
VIVAL OF GASTRIC CANCER PATIENTS
WITH PERITONEAL DISSEMINATION AF­
TER PALLIATIVE GASTRECTOMY
R. Takebayashi, K. Izuishi, R. Haba,
Y. Kushida, K. Kadota, T. Sano, M. Hagiike,
K. Okano, H. Usuki, Y. Suzuki
152
P0701
RISk FACTORS FOR DEVELOPMENT AND
PERSISTENCY OF BENIGN CERVICAL
ANASTOMOTIC STRICTURES AFTER OE­
SOPHAGECTOMY
M. van Heijl, J.A.H. Gooszen, P. Fockens,
O.R.C. Busch, J.J.B. van Lanschot, M.I. van
Berge Henegouwen
P0702
PERFORATED PEPTIC ULCER IN THE EL­
DERLY AND ITS LAPAROSCOPIC MAN­
AGEMENT
D.C.T. WONG, S.K.H. Wong, M.K.W. Li
P0703
SURGICAL TREATMENT OF GIANT CAV­
ERNOUS HEMANGIOMA OF THE LIVER
K.A. Abou El-Ella, H.H. Negmy, M. Al
Waraky
P0704
OVERWEIGHT AND FATTY PANCREAS
INCREASE THE RISk OF PANCREATIC
FISTULA FOLLOWING PANCREATICO­
DUODENECTOMY
S. Gaujoux, A. Couvelard, A. Cortes,
L. Clavel, S. Noullet, P. Levy, P. Ruszniewski,
A. Sauvanet, J. Belghiti
P0705
L­ORNITHINE APPLICATION IN THE COM­
PLEx TREATMENT OF BENIGN OBSTRUC­
TIVE JAUNDICE
N.E. Givirovskaya, V.V. Laptev,
S.A. Rumyanceva, A.Yu. Tskaev,
A.V. Chernyakov, G.V. Postrelova
P0706
SURGERY FOR PANCRETIC METASTASES
OF RENAL CELL CARCINOMA
M. Levy, V. Visokai, L. Lipska

P0707
A NOVEL SURGICAL TECHNIQUE USING
VIO SOFT­COAGULATION SYSTEM FOR
THE PREVENTION OF PANCREATIC LEAk­
AGE FOLLOWING PANCREATECTOMY
Y. Nagakawa, A. Tsuchida, H. Saito,
Y. Tohyama, T. Matsudo, B. Kyo, T. Ikeda,
Y. Suzuki, T. Ozawa, T. Aoki
P0708
MANAGEMENT OF MAJOR BLEEDING
AFTER PANCREATIC SURGERY
M. Schäfer, S. Heinrich, T. Pfammatter,
P.A. Clavien
P0709
CAN DIFFICULTY OF LAPAROSCOPIC
CHOLECYSTECTOMY BE PREDICTED?
M. Soltes
P0710
PROLONGED LAPAROSCOPIC CHOLE­
CYSTECTOMY (OPERATIVE TIME GREAT­
ER THAN 3 HOURS)­ REASONS AND RE­
SULTS
G. Subhas, A. Gupta, L. Ferguson,
M. Jacobs, W. Kestenberg, R. Kolachalam,
S. Silapaswan, V. Mittal
P0711
SHUNT SURGERY FOR HYPER­SPLEN­
ISM IN ExTRA­HEPATIC PORTAL VEIN
OBSTRUCTION ALSO RELIEVES PORTAL
BILIOPATHY
A.K. Tank, A. Prakash, R.K. Singh, A. Behari,
A. Kumar, R. Saxena, V.K. Kapoor
P0712
LIVER MOBILIZATION DURING LIVER
RESECTION INDUCES IMMEDIATE AND
PROFOUND HEPATOCELLULAR DAMAGE
IN HUMANS
M.A.J. van den Broek, J.G. Bloemen,
M.C. van de Poll, M.H. Bemelmans, R.M. van
Dam, W.A. Buurman, C.H. Dejong, S.W. Olde
Damink
PosTeR sessIon
PosTeR sessIon
Therapeutic endoscopy/Interventional
radiology I
P0713
SYNDROME OF PLUMMER­VINSON
AND ENDOSCOPIC DILATION: ABOUT
15 CASES
D. Benajah, R. Zamharir, I. Mellouki,
M. Elyousfi, N. Aqodad, M. El Abkari,
A. Ibrahimi
P0714
COVERED SEMS, AN ALTERNATIVE TO
SURGERY IN COMPLICATED DUODENAL
ULCER PERFORATION
P. Park, L. Nelvin, M. Bergstrom
P0715
COLONIC OBSTRUCTION – SELF­Ex­
PANDABLE METALLIC STENT IS A GOOD
ALTERNATIVE TO SURGERY
D. Asplund, E. Angenete, H. Lindegren,
M. Bergstrom, P. Park
P0716
AN 11 YEAR ExPERIENCE OF ENDOSCOP­
IC OESOPHAGEAL STENT INSERTION FOR
MALIGNANT STRICTURE IN A DISTRICT
GENERAL HOSPITAL
J. Berrill, G. Watts, P. Duane, U. Dave
P0717
LONG TERM RESULTS OF ENDOSCOPIC
BALLOON DILATION FOR GASTRIC OUT­
LET OBSTRUCTION RELATED TO PEPTIC
ULCER DISEASE
R. Bouali, S. Bizid, H. Ben Abdallah,
N. Aissa, N. Abdelli
P0718
SELF­ExPANDING METAL STENTS FOR
ACUTE TREATMENT OF BLEEDING OE­
SOPHAGEAL VARICES
L. Bremholm, F. Bendtsen, E.F. Hansen
153
MonDaY, noVeMbeR 23, 2009

MonDaY, noVeMbeR 23, 2009
PosTeR sessIon
P0719
POLYDIOxANONE BIODEGRADABLE
STENTS IN REFRACTORY BENIGN OE­
SOPHAGEAL STRICTURES – FIRST RE­
PORT OF 4 PATIENTS
A. Dhar, J.H. Topping, E.C. Johns, A. Allan,
D. O’Neill
P0720
A TWO MICRON CONTINUOUS WAVE
LASER SYSTEM IS SAFE AND EFFECTIVE
FOR PERITONEAL ACCESS & HIGH PRECI­
SION DISSECTION DURING NOTES PRO­
CEDURES
X. Dray, G. Donatelli, D. Mukkai
Krishnamurty, R.J. Wroblewski,
L. Assumpcao, S.A. Giday, J.M. Buscaglia,
E.J. Shin, E. Dubcenco, P. Magno,
L.J. Pipitone, M.R. Marohn, S.V. Kantsevoy,
A.N. Kalloo
P0721
PREVENTIVE ENDOSCOPIC BALLOON
DILATATION FOR SYMPTOMATIC POST­
ESD STRICTURE IN LARGE SEMICIRCU­
LAR ESOPHAGEAL NEOPLASM
S. Fujiwara, Y. Morita, T. Toyonaga,
M. Sugimoto, H. Kutsumi, T. Azuma
P0722
SELF ExPANDABLE METAL STENTS
(SEMS) FOR COLONIC OBSTRUCTION­A
12 YEAR SINGLE CENTER ExPERIENCE
A.T. George, A. Strazzanti, E. Farinella,
N. Suzuki, A. Gupta, M. Marshall,
B. Saunders
P0723
ENDOSCOPICALLY INSERTED REMOV­
ABLE COVERED METAL SELF­ExPAND­
ABLE STENTS FOR TREATMENT OF FISTU­
LAE IN THE UPPER GASTRO­INTESTINAL
TRACT
B.J.M. Leenders, F. Smulders,
G.A. Nieuwenhuijzen, L.P.L. Gilissen
154
P0724
LAPAROSCOPIC ASSISTED RETROGRADE
OESOPHAGEAL STENTING IN MALIG­
NANT OESOPHAGO PLUERAL FISTULA
K. Govindaraj, K. Govindaraj,
T. Karunaharan, S. Kumar, R. Chandrahasan
P0725
PERCUTANEOUS RADIOFREQUENCY
ABLATION WITH ARTIFICIAL ASCITES
FOR HEPATOCELLULAR CARCINOMA IN
PROBLEMATIC LOCATIONS
L. Adán Merino, A. Olveira Martín,
J. Pérez Robledo, I. Prieto, F. Gea Rodriguez,
E. Martín Arranz, P. Castillo Grau, S. Gómez
Senent, J. Segura Cabral
P0726
OUTCOMES FOLLOWING GASTROS­
TOMY: RADIOLOGICALLY INSERTED VS.
PERCUTANEOUS ENDOSCOPIC GAS­
TROSTOMY
J.S. Leeds, M.E. McAlindon, J. Grant,
H.E. Robson, F.K.T. Lee, D.S. Sanders
P0727
INTERVENTIONAL OUTCOME OF EN­
DOSCOPIC RETROGRADE CHOLAN­
GIOPANCREATOGRAPHY VERSUS
PERCUTANEOUS TRANSHEPATIC CHOL­
ANGIOGRAPHY IN MALIGNANT BILIARY
STRICTURES
S. Majid, A. Ahmed, A. Nasir
P0728
RADIATION ExPOSURE TO PERSONNEL
PERFORMING ERCP; A GASTROENTEROL­
OGY CLINICAL STUDY
E. Oztas, E. Parlak, F. Kucukay, M. Arhan,
U. Dagli, D. Etik, F. Onder, T. Olcer,
N. Sasmaz
P0729
SURVEY ON RADIATION PROTECTION
PRACTICE FOR ENDOSCOPISTS DURING
ENDOSCOPIC RETROGRADE CHOLANGI­
OPANCREATOGRAPHY (ERCP) IN kOREA
B. Son, S. Lee, K. Lee, J. Kim

P0730
OVERALL SUCCESS RATES IN THE OUT­
COME OF PURE ENDOSCOPIC DRAIN­
AGE OF PSEUDOCYSTS: ExPERIENCE IN
ROMANIA
M. Tantau, T. Pop, O. Mosteanu, B. Pintea,
A. Tantau, G. Mester
GasTRo 2009 UeGW/WcoG, london
would like to thank the following
experts for their contribution to the
GasTRo 2009 UeGW/WcoG, london
Poster Rounds on Monday, november
23, 2009
■ J. Bergman, The Netherlands
■ G. Costamagna, Italy
■ S. Danese, Italy
■ R. Eliakim, Israel
■ C. Ell, Germany
■ M. Fox, Switzerland
■ J-P. Galmiche, France
■ M. Gassull, Spain
■ F. Giuliante, Italy
■ S. Husby, Denmark
■ N. Kawada, Japan
■ R. Lencioni, Italy
■ F. Megraud, France
■ I. Mostafa, Egypt
■ T. Ponchon, France
■ G. van den Brink, The Netherlands
■ S. Vermeire, Belgium
■ J. Vierling, USA
■ S. Zakhari, USA
PosTeR sessIon
155
MonDaY, noVeMbeR 23, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
PosTeR sessIon
Gastrointestinal bleeding II
P0731
THE UTILITY OF TRANSCATHETER ANGI­
OGRAPHY AND EMBOLISATION IN THE
MANAGEMENT OF REFRACTORY PEPTIC
ULCER HAEMORRHAGE
J. Iqbal, U.I. Aujla, A. Craig, Y. Reddy,
A.J. Makin, N. Chalmers, G. Murphy,
F. Farquharson, S. Butterfield, R. Ashleigh,
J. Ramesh
P0732
CLINICAL OUTCOMES ASSOCIATED WITH
CURRENT MANAGEMENT STRATEGIES
FOR NON­VARICEAL UPPER GASTROIN­
TESTINAL BLEEDING (UGIB): AN OBSER­
VATIONAL EUROPEAN STUDY
A. Lanas, M. Tafalla, J. Nuevo
P0733
SYNCHRONOUS BIDIRECTIONAL EN­
DOSCOPY FOR ANAEMIA. IS IT APPRO­
PRIATE FOR PATIENTS UNDER 50?
J. Landy, R. Chaudhary, B. MacFarlane
P0734
BOLUS VS CONTINUOUS INFUSION OF
OMEPRAZOLE IN ACTIVELY BLEEDING
DUODENAL ULCER IN PREVENTION OF
REBLEED
S. Majid, A. Sattar
P0735
PREDICTION OF MORTALITY FROM NON
VARICEAL UPPER GASTRO INTESTINAL
BLEEDING: COMPARISON OF ROCkALL
VS PNED SCORE
R. Marmo, L. Cipolletta, M. Koch, L. Capurso,
G. Trallori, R. Cestari, G. Frosini, G. Imperiali,
T. Casetti, S. Boschetto, R. Di Mitri,
I. Stroppa, M. Del Piano, M. Salvagnini,
G. Gatto, I. Sorrentini, S. De Stefano, M. Di
Cicco, P. Michetti, I. Lorenzini, F. Fornari,
W. Piubello, E. Grossi, G. Rotondano
156
P0736
THE FREQUENCY OF GASTROINTES­
TINAL HAEMORRHAGE IN PATIENTS
TREATED FOR ACUTE CORONARY SYN­
DROMES: AN OBSERVATIONAL STUDY
K.J. Monahan, J.R. Arnold, N.I. McNeil,
T.R. Orchard
P0737
INFLUENCE OF WEEkEND VERSUS WEEk­
DAY ADMISSION ON THE PROGNOSIS
OF UPPER GI BLEEDING (UGIB) CAUSED
BY PORTAL HYPERTENSION: POST HOC
ANALYSIS OF A FRENCH PROSPECTIVE
STUDY
S. Nahon, V. Jouannaud, A. Pariente,
A. Pauwels, A. Boruchowicz, R. Vitte,
B. Coulibaly, G. Tielman, B. Bour, H. Hagège
P0738
GASTROINTESTINAL BLEEDING (GIB)
AND ANTIPLATELET THERAPY (APT). A
FRENCH NATIONAL OBSERVATIONAL
SURVEY INCLUDING 1010 PATIENTS IN
THE HOSPITAL SETTING. COMPARISON
OF THE RESULTS BASED ON THE ORIGIN
OF THE PATIENTS (ACADEMIC HOSPITAL
(AH) OR COMMUNITY HOSP
B. Nalet, J. Bretagne, G. Lesur, B. Bour,
P. Barthélemy, C. Soufflet
P0739
CAPSULE ENDOSCOPY GUIDED PUSH­
AND­PULL ENTEROSCOPY IN PATIENTS
WITH OBSCURE GASTROINTESTINAL
BLEEDING
P. Ordubadi, E. Lakovic, B. Blaha,
A. Holzäpfel, S. Stavjanik, K. Glaser,
R. Fortelny, M. Gschwantler
P0740
USING THE BLATCHFORD SCORE TO
PREDICT THE NEED FOR THERAPEUTIC
ENDOSCOPY IN PATIENTS WITH UPPER
GASTROINTESTINAL HAEMORRHAGE
S.H. Pang, J. Ching, J.Y. Lau, J.J. Sung,
F.K.L. Chan

P0741
PREDICTION OF THE NEED FOR ENDO­
SCOPIC HAEMOSTASIS IN UPPER GAS­
TROINTESTINAL HEMORRHAGE (UGIH):
A STUDY ON RISk SCORE DERIVATION,
VALIDATION AND COMPARISON WITH
THE BLATCHFORD SCORE
S.H. Pang, K.K. Tsoi, J.Y. Lau, F.K.L. Chan,
J.J. Sung
P0742
THERAPEUTIC EFFICACY OF SUPERSE­
LECTIVE ARTERIAL EMBOLIZATION IN
PATIENTS WITH GASTROINTESTINAL
HEMORRHAGE
K. Park, J. Kwon, S. Lee, K. Cho, E. Kim
PosTeR sessIon
Helicobacter pylori II
P0743
EFFECTS OF AN EPIDERMAL GROWTH
FACTOR RECEPTOR (EGFR) INHIBITOR
UPON THE DEVELOPMENT OF HELICO­
BACTER­INDUCED GASTRIC CANCER IN
HYPERGASTRINAEMIC INS­GAS MICE
A.A. Abuderman, C. Duval, A. Varro,
P.A. Robinson, J.E. Crabtree, D.M. Pritchard
P0744
NF­kAPPAB2 REGULATES THE DEVEL­
OPMENT OF HELICOBACTER­INDUCED
GASTRIC APOPTOSIS, INFLAMMATION
AND ATROPHY
M.D. Burkitt, J. Caamano, A. Varro,
D.M. Pritchard
P0745
PREVALENCE OF HELICOBACTER PY­
LORI – ASSOCIATED CORPUS­PREDOM­
INANT GASTRITIS IN CHILDREN
W. Höpler, K. Hammer, A. Vecsei,
A. Innerhofer, J. Hammer
PosTeR sessIon
P0746
GASTRIC LYMPHO­EPITHELIAL LESIONS;
CLINICAL SIGNIFICANCE OR CONCOMI­
TANT HISTOLOGIC FINDINGS
M. Katicic, T. Filipec-Kanizaj, A. Mrzljak,
M. Prskalo, B. Skurla, B. Sabaric,
S. Naumovski-Mihalic, V. Colic-Cvrlje,
S. Gasparov, S. Dzebro, M. Dominis
P0747
HOST SINGLE NUCLEOTIDES POLYMO­
ROPHYISMS OF MMP­9 −1562/TIMP­1
372 HAVE GENDER DIFFERENCES IN
THE RISk OF GASTRIC INTESTINAL META­
PLASIA AFTER H. PYLORI INFECTION IN
TAIWAN
B.S. Sheu, K. Hung, C. Lu, H. Yang, J.J. Wu
P0748
INTEROBSERVER DIFFERENCES IN EVAL­
UATING HISTOPATHOLOGICAL FINDINGS
OF CHRONIC GASTRITIS WITH SYDNEY
SYSTEM
A. Soylu, N. Yasar, N. Sever, S. Ozkara,
I. Sevindir, B. Kumbasar
P0749
COMPARISON OF IL­17 PRODUCING
CD3+ LYMPHOCYTES (PREDOMINANTLY
TH17­CELLS) IN EPITHELIAL AND LAMI­
NA­PROPRIA LAYERS IN HELICOBACTER
PYLORI­INFECTED GASTRIC MUCOSAE
S.A. Zulquernain, Y. O’Donnaghue,
R.A.R. Ali, L. Egan, J. O’Keeffe, J. Lee,
A.P. Moran
P0750
SEQUENTIAL THERAPY VERSUS STAN­
DARD TRIPLE THERAPY FOR HELICO­
BACTER PYLORI ERADICATION IN PEP­
TIC ULCER PATIENTS IN BANGLADESH:
A RANDOMIZED CONTROLLED TRIAL
M.M. Ahmad, M.G. Kibria, M.M. Rahman,
M.A. Masud, A.R. Sarker, K. Ahasan,
F. Ahmed, M. Hasan, A. Khan
157
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0751
THE DEVELOPMENT OF SELECTIVE IN­
HIBITORS OF H. PYLORI GAMMA­GLU­
TAMYLTRANSPEPTIDASE
C. Bolz, B. Kalali, J. Probst, F. Anderl,
D.H. Busch, M. Gerhard
P0752
SUPPRESSIVE EFFECT OF BERRY Ex­
TRACTS ON HELICOBACTER PYLORI IN­
FECTION
C. Chang, H. Shang, A. Chang
P0753
BOVINE ANTIBODY­BASED ORAL IM­
MUNOTHERAPY FOR REDUCTION OF
INTRAGASTRIC HELICOBACTER PYLORI
COLONIZATION
C.M. den Hoed, A.C. de Vries, C.M. Diericx,
P.B.F. Mensink, L.S. Capelle, H. van Dekken,
N. de Groot, E.J. Kuipers
P0754
ERADICATION RATE OF HELICOBACTER
PYLORI IN IMMIGRANT PATIENTS COM­
PARED TO ITALIAN PATIENTS: RESULTS
OF A CLINICAL TRIAL
F. Di Mario, L. Gatta, A. Franzé,
C. Scarpignato, N. Dal Bò, L. Guida
P0755
ANTIBACTERIAL ACTIVITY OF BROCCOLI
(BRASSICA OLERACEA) AGAINST HELI­
COBACTER PYLORI, IN BIOPSIES OF PA­
TIENTS WITH CHRONIC GASTRITIS
G. Farfan, H. Espinoza, H. Paucar, V. Sucner
P0756
IS LEVOFLOxACIN A FEASIBLE OPTION
FOR HELICOBACTER PYLORI RESCUE
THERAPY IN SINGAPORE?
B. Goh, Y. Wang, S. Lui, K. Ling
P0757
FEASIBILITY OF REDUCING ASPIRIN­AS­
SOCIATED ULCER BLEEDING BY HELICO­
BACTER PYLORI ERADICATION
C. J. Hawkey, J.C. Atherton, R.F.A. Logan,
A. Avery, A. Shonde, M. Leighton, D. Kendrick
158
P0758
EFFICACY OF SEQUENTIAL THERAPY
VERSUS 14­DAY STANDARD TRIPLE
THERAPY IN ERADICATION OF HELICO­
BACTER PYLORI: A RANDOMIZED, PRO­
SPECTIVE STUDY
S. Kim, S. Lee, C. Lee, G. Baik, J. Kim, Y. Kim,
J. Kim, D. Kim
P0759
A NEW SECOND­LINE SEQUENTIAL REGI­
MEN FOR HELICOBACTER PYLORI ERADI­
CATION BASED ON LEVOFLOxACIN
C.S. Krystallis, D.K. Kamberoglou,
D.I. Pistiolas, C.I. Anifanti, A.L. Koutsoumpas,
V.G. Doulgeroglou, V.D. Tzias
P0760
PANTOPRAZOLE AND REBAMIPIDE PRO­
VIDE EFFECTIVE HEALING OF EROSIVE
AND ULCERATIVE LESIONS OF GASTRO­
DUODENAL ZONE, ASSOCIATED WITH
HELICOBACTER PYLORI, IN PATIENTS
WITH LEUkEMIA
A. Maslova, I. Skrypnyk
P0761
ORAL AND INTRAVENOUS OMEPRAZOLE
IN PEPTIC ULCER BLEEDING – DO THEY
HAVE COMPARABLE EFFECTS TO OR
OBVIATE THE EFFECTS OF ENDOSCOPIC
HAEMOSTASIS FOLLOWED BY INTRAVE­
NOUS OMEPRAZOLE?
M.A. Masud, M.M. Ahmad, M.M. Rahman,
M.G. Kibria, A.R. Sarker, M. Hasan
P0762
THE 10­DAY SEQUENTIAL THERAPY
FOR HELICOBACTER PYLORI ERADICA­
TION IN kOREA: LESS EFFECTIVE THAN
ExPECTED
S. Park, H. Chun, H. Choi, K. Lee, J. Kim,
J. Hyun, E. Kim, S. Park, B. Keum, Y. Seo,
Y. Jeen, S. Um, C. Kim, H. Ryu

P0763
THE HISTOLOGICAL DYNAMICS AND SE­
RUM LEVELS OF PEPSINOGEN I, II AND
GASTRIN 17 IN ATROPHIC GASTRITIS
AFTER HELICOBACTER PYLORI’S ERADI­
CATION
K.V. Purveeva, M. Konkov, O. Sclanckaya,
T. Lapina, V. Ivashkin
P0764
LEVOFLOxACIN­BASED SEQUENTIAL
THERAPY FOR ERADICATION OF H. PY­
LORI INFECTION
M. Romano, A.G. Gravina, A. Federico,
A. Miranda, A. Tiso, L. Gaeta, R. Salerno,
M.A. Bianco, V. Gallo, A. Cuomo
P0765
SEQUENTIAL THERAPY OR TRIPLE
THERAPY FOR HELICOBACTER PYLORI
INFECTION: SYSTEMATIC REVIEW AND
META­ANALYSIS OF RANDOMIZED CON­
TROLLED TRIALS IN ADULTS AND CHIL­
DREN
D. Vaira, L. Gatta, G. Leandro, N. Vakil, F. Di
Mario
P0766
ERADICATION THERAPY FOR HELICO­
BACTER PYLORI IN PATIENTS WITH GAS­
TRIC MALT­LYMPHOMA: A POOLED­DA­
TA ANALYSIS
D. Vaira, A. Zullo, C. Hassan, F. Cristofari,
C. Iegri, C. Bassanelli, V. Cardinale, V. De
Francesco, E. Ierardi, S. Morini, C. Ricci
PosTeR sessIon
Immunology/Microbiology II
P0767
NON­STEROIDAL ANTI­INFLAMMATORY
DRUGS AND PROBIOTICS INFLUENCE ON
PORCINE COLONIC BACTERIA EVALUAT­
ED BY HYDROGEN PRODUCTION IN VI­
TRO – A PILOT STUDY
J. Cyrany, J. Kvetina, M. Kunes, M. Förstl,
M. Moravkova, J. Lesna, V. Bartos,
M. Kopacova, S. Rejchrt, J. Bures
PosTeR sessIon
P0768
THE INTER­RELATIONSHIP BETWEEN CIR­
CULATING AND TUMOURAL ExPRESION
OF C­REACTIVE PROTEIN AND SURVIVAL
IN PATIENTS WHO HAVE UNDERGONE
SYNCHRONOUS RESECTION FOR DUkES
D COLORECTAL CANCER
J.H. Darrien, P. Horgan, D.C. McMillan
P0769
THE RELATIONSHIP BETWEEN THE SYS­
TEMIC INFLAMMATORY RESPONSE,
TISSUE HYPOxIA INDUCIBLE FACTOR
AND CANCER SPECIFIC SURVIVAL IN
PATIENTS WHO HAVE UNDERGONE SYN­
CHRONOUS RESECTION FOR DUkES D
COLORECTAL CANCER
J.H. Darrien, H. Singh, P. Horgan,
D.C. McMillan
P0770
PREVALENCE AND ENDURANCE OF GAS­
TROINTESTINAL SYMPTOMS. THE HUNT
STUDY
C.G.P. Platou, E. Ness-Jensen, K. Hveem
P0771
CIRCULATING DENDRITIC CELLS AS A
NOVEL DISEASE ACTIVITY MARkER IN
INFLAMMATORY BOWEL DISEASE?
K. Radwan-Kwiatek, P. Radwan,
J. Tabarkiewicz, J. Roliński
P0772
VIDEOCAPSULE ExAMINATION FOR
INTESTINAL INFLAMMATORY INVOLVE­
MENT IN PATIENTS WITH SERONEGATIVE
SPONDYLOARTHROPATHY. REPORT OF
24 CASES
M. Rimbas, M. Marinescu, R. Prodan,
S. Caraiola, M.I. Parvu, C.R. Baicus,
C. Tanasescu, S. Bucurica, M.R. Voiosu
159
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0773
ExPRESSION OF GROWTH FACTORS AND
EPITHELIAL MARkERS IN SUBEPITHELI­
AL FOLLICLES IN ULCERATIVE COLITIS:
THEIR EFFECTS ON EPITHELIAL REGEN­
ERATION
F. Sipos, O. Galamb, S. Spisák, G. Valcz,
K. Tóth, K. Leiszter, G. Mûzes, B. Molnár,
Z. Tulassay
P0774
APPEARANCE OF MESENCHYMAL STEM
CELLS OF BONE MARROW ORIGIN IN
HEALTHY AND REGENERATIVE COLONIC
EPITHELIUM
G. Valcz, T. Krenacs, F. Sipos, Z. Balogh,
A. Csizmadia, K. Leiszter, K. Toth,
K. Hagymasi, T. Masszi, B. Molnar,
Z. Tulassay
P0775
DIFFERENCES IN OUTCOME AND COSTS
BETWEEN A SHORT AND LONG PREOP­
ERATIVE PERIOD OF CONVALESCENCE
OF PATIENTS WITH ENTEROCUTANEOUS
FISTULAS, A COHORT STUDY
R.G.J. Visschers, S.W.M. Olde Damink,
B. Winkens, A. Ament, P.B. Soeters, W.G. van
Gemert
P0776
STOOL CULTURE PROFILE AND LONG
TERM FOLLOW UP OF ANTIBIOTIC AS­
SOCIATED HEMORHAGIC COLITIS
M. Yilmaz, Y. Aybar Bilir, Y. Erzin, A. Celik,
R. Ozturk
P0777
THE EFFECT OF TREATMENT WITH PRA­
ZIQUANTEL ON LIVER PATHOLOGY AS­
SOCIATED WITH SCHISTOSOMA MAN­
SONI INFECTION ON UkEREWE ISLAND,
TANZANIA
K.W.M. Abeysekera, A. Fenwick, L. Blair
160
P0778
EFFICACY, TOLERABILITY, AND SAFETY
OF RACECADOTRIL VERSUS LOPER­
AMIDE IN ACUTE DIARRHEA AMONG
ADULTS – A META­ANALYSIS
E.R. Ang, H.H. Flores, N.N. Estanislao,
M.M. Uy
P0779
EVALUATION OF FAECAL CALPROTECTIN
AND LACTOFERRIN TESTS IN SCREEN­
ING HOSPITALIZED PATIENTS FOR DI­
AGNOSING INFLAMMATORY AND NON­
INFLAMMATORY ACUTE INFECTIOUS
DIARRHOEA IN DHAkA, BANGLADESH
P.K. Bardhan, H. Ashraf, J. Akter, R. Haque,
N. Gyr
P0780
CHROMOENDOSCOPY IN A PATIENT
WITH DILATION OF THE INTRA Y ExTRA­
HEPATIC BILE DUCT AS A CONSEQUENCE
OF INTESTINAL INFECTION FROM GIAR­
DIA LAMBLIA
R. Barreto, J. Marin, C. Yela
P0781
GIARDIASIS IN PATIENTS WITH CHRONIC
DYSPEPTIC SYNDROME
M. Demeter, P. Banovcin, J. Bozikova,
R. Hyrdel
P0782
THE EFFECT OF PHYSIOLOGICAL CON­
CENTRATIONS OF BILE ACIDS ON IN
VITRO GROWTH OF MYCOBACTERIUM
TUBERCULOSIS
D. Epstein, K. Mistry, A. Whitelaw,
G. Watermeyer, K. Pettengell
P0783
NOSOCOMIAL INFECTION IN CIRRHOTIC
PATIENTS ADMITTED IN A GASTROEN­
TEROLOGY INTENSIVE CARE UNIT
P. Freire, J.M. Romãozinho, G. Duque,
P. Amaro, M. Ferreira, E. Camacho,
M.C. Leitão

PosTeR sessIon
Intestinal disorders II
P0784
PLASMA CITRULLINE AS QUANTITATIVE
BIOMARkER OF HIV ASSOCIATED VIL­
LOUS ATROPHY IN A TROPICAL ENTER­
OPATHY POPULATION
C. Papadia, P. Kelly, S. Bertolini, A. Franzè,
G. Corazza, A. Forbes, S. Caini, T. Shawa,
A. Di Sabatino
P0785
A COMPARISON BETWEEN LACTOSE
BREATH TEST AND A QUICk TEST ON
DUODENAL BIOPSIES FOR LACTASE
DEFICIENCY, IN PATIENTS WITH A SELF
REPORTED LACTOSE INTOLERANCE
J. Franzè, A. Parodi, E. Savarino, E. Morana,
A. Bertelè, V. Savarino, F. Di Mario
P0786
THE ASSOCIATION BETWEEN RIFAxIMIN
AND PARTIALLY HYDROLYZED GUAR
GUM IS MORE EFFECTIVE IN ERADICAT­
ING SIBO THAN RIFAxIMIN ALONE
A. Parodi, M. Furnari, E. Savarino,
E. Marabotto, A. Greco, L. Isola, V. Savarino
P0787
INVERSE RELATIONSHIP OF FIBROBLAST
GROWTH FACTOR 19 AND 7α­HYDROxY­
4­CHOLESTEN­3­ONE IN THE EVALU­
ATION OF BILE ACID DIARRHEA IN PA­
TIENTS WITH CHRONIC DIARRHEA
S.S. Pattni, G.W. Brydon, T. Dew,
J.R.F. Walters
P0788
PREVALENCE OF CELIAC DISEASE
AMONG PATIENTS OF TYPE 1 DIABETES
MELLITUS IN NORTH INDIA
K.S. Poornachandra, S. Badada,
R. Kochhar, U. Dutta, P. Ravikiran, K. Singh,
C.K. Nain, A. Bhansali, P. Malhotra, S. Varma
PosTeR sessIon
P0789
FATTY ACID SYNTHASE (FAS) ExPRES­
SION IN DUODENAL MUCOSA OF CELIAC
PATIENTS
M. Rivera, P. Crispino, P.L. Alò, D. Barillà,
S. Basso, H. Unim, E. Angelucci, A. Picarelli,
D. Vitolo, R. Pica, P. Paoluzi
P0790
WOMEN WITH COELIAC DISEASE LIVING
ON A GLUTEN­FREE DIET FOR YEARS
CONTINUE TO SEEk MORE HEALTH
CARE – A CONTROLLED STUDY
S. Roos, A. Kärner, S. Wilhelmsson,
C. Hallert
P0791
NEITHER MICROSCOPIC NOR MACRO­
SCOPIC ENTERITIS REFLECT THE SEVER­
ITY OF GLUTEN SENSITIVITY
T. Sharaki, K. Rostami, M. Shahraki, J. Bold,
D. Al Dulaimi, V. Villanacci, G. Bassoti
P0792
ADHERENCE TO THE GLUTEN­FREE DIET
IN ADULT­ONSET COELIAC DISEASE
N. Hall, G. Rubin, A. Charnock
P0793
PREVALENCE OF CELIAC DISEASE
AMONG ADULT PATIENTS WITH GASTRO­
INTESTINAL SYMPTOMS IN MOSCOW
E. Sabelnikova, A. Parfenov, L. Krums,
N. Vorobyova, R. Gudkova
P0794
LONG TERM FOLLOW UP OF PATIENTS
WITH REFRACTORY COELIAC DISEASE:
A SINGLE CENTRE ExPERIENCE
S.S. Salunke, M. Priest, R. Jackson,
A.J. Morris
P0795
DIAGNOSIS AND TREATMENT OF BLIND
LOOP SYNDROME USING DOUBLE BAL­
LOON ENDOSCOPY
T. Sato, T. Katsuno, T. Nakagawa,
Y. Takahashi, M. Saito, T. Makita, Y. Mandai,
S. Saduka, O. Yokosuka
161
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0796
HLA­DQ GENOTYPE PREDICTS SEVERITY
OF THE INTESTINAL LESION, CHANCE OF
HEALING ON A GLUTEN­FREE DIET AF­
TER 12 MONTHS AND LIkELIHOOD OF
SYSTEMIC COMPLICATIONS IN NEWLY
DIAGNOSED COELIAC DISEASE
S.J. Shepherd, P.R. Gibson, R. Burgell,
P. Hosking
P0797
COELIAC DISEASE (CD) – SCREENING THE
SYMPTOMATIC: “HIT” YET NOT “MISS”
M. Srinivas, P. Basumani, B.S. Hoeroldt,
P.J. Willemse, K.D. Bardhan
P0798
FAMILY PRACTITIONER REPORTED
PNEUMOCOCCAL VACCINATION IN
ADULT COELIAC DISEASE
S. Bellringer, A. Steel, J.R.F. Walters
P0799
CAN PROLYL ENDOPROTEASE ENZYME
TREATMENT MITIGATE THE TOxIC EF­
FECT OF GLUTEN IN COELIAC PATIENTS?
G.J. Tack, J.M.W. van de Water, E.M.C. Kooy-
Winkelaar, J. van Bergen, G.A. Meijer,
B.M.E. Von Blomberg, M.W.J. Schreurs,
M.J. Bruins, L. Edens, C.J. Mulder, F. Koning
P0800
EVALUATION OF SEROLOGICAL DIAG­
NOSTIC MEASURES IN COELIAC DISEASE
P. Toftedal, C. Nielsen, J.T. Madsen,
K. Titlestad, S. Husby, S.T. Lillevang
P0801
THE SIGNIFICANCE OF INTRAEPITHELIAL
LYMPHOCYTOSIS WITHOUT VILLOUS AT­
ROPHY FOR THE DIAGNOSIS OF CELIAC
DISEASE
L. van den Heuvel, E.J. van der Wouden,
J. Vecht, F. Moll, H. Engel, M.A.C. Meijssen
162
P0802
SERUM I­FABP LEVELS ARE ELEVATED IN
CHILDREN WITH CELIAC DISEASE AND
RAPIDLY RECOVER AFTER INITIATION OF
A GLUTEN FREE DIET
A. Vreugdenhil, V. Wolters, A. Van den
Neucker, R. Houwen, W. Buurman
P0803
COMPARISON OF CLINICAL FEATURES
AND HISTOLOGICAL ATROPHY IN ADULT
COELIAC DISEASE PATIENTS PRESENT­
ING WITH “CLASSICAL” SYMPTOMS OR
IRON DEFICIENCY ANAEMIA
C.F. Smith, L. Igali, M.P. Williams
P0804
CELIAC DISEASE AT THE TIME OF DIAG­
NOSIS IN A COHORT OF 605 PATIENTS:
AGE­RELATED DIFFERENCES IN CLINI­
CAL, SEROLOGICAL AND HISTOPATHO­
LOGICAL FEATURES
B. Zanini, A. Mora, S. Bertolazzi,
F. Lanzarotto, D. Turini, B. Petroboni,
F. Caselani, C. Ricci, A. Lanzini
P0805
CORRELATION OF TISSUE TRANSGLUTA­
MINASE LEVELS AND DUODENAL HISTO­
PATHOLOGY: RETROSPECTIVE ANALYSIS
OF A COHORT OF 187 CELIAC PATIENTS
B. Zanini, S. Bertolazzi, A. Mora, D. Turini,
F. Lanzarotto, C. Ricci, A. Pozzi, B. Petroboni,
V. Villanacci, A. Lanzini
P0806
FIVE YEARS TIME­COURSE OF T­TRANS­
GLUTAMINASES (T­TG) ANTIBODIES
AND ADHERENCE TO GLUTEN FREE DIET
(GFD) AMONG CELIAC PATIENTS IN THE
GENERAL POPULATION: RESULTS OF A
“CELIAC DISEASE­WATCH” POPULATION
BASED PROGRAM
A. Lanzini, B. Zanini, A. Mora, S. Bertolazzi,
D. Turini, F. Lanzarotto, C. Ricci, B. Petroboni,
F. Donato

P0807
HLA GENE DOSE EFFECT AND HELI­
COBACTER PYLORI INFECTION DO
NOT CONTRIBUTE TO PERSISTENCE
OF INTRAEPITHELIAL LYMPHOCYTO­
SIS FREQUENTLY OBSERVED IN CELIAC
PATIENTS ADHERENT TO GLUTEN FREE
DIET
A. Lanzini, D. Turini, A. Mora, S. Bertolazzi,
G. Carella, A. Malagoli, B. Petroboni,
F. Caselani, B. Zanini, F. Lanzarotto, C. Ricci
P0808
IS SEVERITY OF DUODENAL HISTOPA­
THOLOGY MIRRORED BY DIFFERENCES
IN CLINICAL AND LABORATORY PRESEN­
TATION IN CELIAC DISEASE? A SINGLE
UNIT STUDY IN A COHORT OF 1140 PA­
TIENTS
B. Zanini, F. Caselani, F. Lanzarotto,
S. Bertolazzi, A. Mora, D. Turini, V. Villanacci,
C. Ricci, A. Lanzini
P0809
CAN QUINOA PROLAMINS STIMULATE
INTESTINAL T­CELLS?
V.F. Zevallos, L.I. Herencia, H.J. Ellis,
P.J. Ciclitira
P0810
EOSINOPHILIC GASTROENTERITIS: CLIN­
ICAL, ENDOSCOPIC, RADIOLOGICAL FEA­
TURES AND TREATMENTS
L. Zhang, J. Lu, Z. Jin, R. Cui, A. Wang,
L. Duan
PosTeR sessIon
nutrition II
P0811
PREVALENCE OF OSTEOPOROSIS IN PA­
TIENTS STARTING HOME PARENTERAL
NUTRITION
M. Boufassa, M. Bouin, A. Dupont,
M. Lemoyne
PosTeR sessIon
P0812
A RANDOMISED DOUBLE BLIND CON­
TROLLED CROSSOVER TRIAL OF TAURINE
SUPPLEMENTATION IN HOME PAREN­
TERAL NUTRITION
A. Culkin, A. Madden, A. Forbes, S. Gabe
P0813
CITRULLINE PRESENTS A USEFUL BIO­
MARkER TO PREDICT PARENTERAL NU­
TRITION REDUCTIONS IN PATIENTS WITH
SHORT BOWEL SYNDROME TREATED
WITH TEDUGLUTIDE
R. Gilroy, F. Joly, S.J. O’Keefe, P. Jeppesen,
K.N. Jeejeebhoy, B. Messing
P0814
TEDUGLUTIDE, A NOVEL GLP­2 ANA­
LOGUE, DECREASES FECAL WET WEIGHT,
SODIUM AND POTASSIUM ExCRETION
IN SHORT BOWEL SYNDROME PATIENTS
DEPENDENT ON PARENTERAL NUTRI­
TION
P.B. Jeppesen, K.A. Tappenden, R. Gilroy,
S.J. O’Keefe, D.L. Seidner, B. Messing
P0815
RADIATION ENTERITIS LEADING TO IN­
TESTINAL FAILURE: A DECADE OF Ex­
PERIENCE IN A NATIONAL REFERRAL
CENTRE
R. Kalaiselvan, V. Theis, A. Teubner,
I.D. Anderson, J.L. Shaffer, G.L. Carlson, S. Lal
P0816
COMPARISON OF EARLY ENTERAL NU­
TRITION IN SEVERE ACUTE PANCREATI­
TIS WITH PREBIOTIC FIBER SUPPLEMEN­
TATION VERSUS STANDARD ENTERAL
SOLUTION: A PROSPECTIVE RANDOM­
IZED DOUBLE­BLIND STUDY
T. Karakan, M. Ergun, I. Dogan,
M. Cindoruk, S. Unal
163
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0817
TRICkLE FEEDING WITH ENTERAL NUTRI­
TION IN PARENTERALLY FED SURGICAL
PATIENTS PRESERVES INTESTINAL MU­
COSAL PERMEABILITY
P.G. Lidder, D. Flanagan, S. Fleming,
T. Wheatley, J. Rahamin, S. Lewis
P0818
REFERRAL AND SURVIVAL RATES OF
ADULT PATIENTS IDENTIFIED AS INTES­
TINAL TRANSPLANTATION CANDIDATES.
A 4 YEAR SINGLE CENTRE PROSPECTIVE
FOLLOW UP STUDY
A.U. Murugananthan, P. Paskaran,
D.A.J. LLoyd, J.M.D. Nightingale,
S.J. Middleton, S.M. Gabe
P0819
(SEMI)­ELEMENTAL VERSUS POLYMER­
IC NUTRITIONAL FORMULAE IN ACUTE
PANCREATITIS: AN INDIRECT ADJUSTED
META­ANALYSIS
M.S. Petrov, B.P. Loveday, A.R. Phillips,
J.A. Windsor
P0820
NICE OR NASTY. DO THE NICE CRITERIA
PREDICT RE­FEEDING SYNDROME FOR
INPATIENTS RECEIVING INTRAVENOUS
NUTRITION?
Z.N. Raos, S. Hill, S. Larsen, A. Verhage,
R. Walmsley
P0821
RESTRICTIVE DIETS INCREASE THE RISk
OF UNDERNUTRITION IN FREE­LIVING
ELDERLY
O. Molato, F. Le Duff, O. Guérin,
G. Zeanandin, X. Hébuterne,
S.M. Schneider
P0822
PREDICTIVE FACTORS FOR MORTALITY
AND HPN DEPENDENCE IN A REFERRAL
HOME PARENTERAL NUTRITION CENTRE
G. Zeanandin, F. Berthier, K. Arab,
X. Hébuterne, S.M. Schneider
164
PosTeR sessIon
oesophageal, gastric and duodenal
disorders II
P0823
EFFECT OF DUAL COx/LOx INHIBITION
BY THIAZOLIDIN DERIVATIVES ON LIPO­
PEROxIDATION PROCESSES IN HEART
TISSUE AND GASTRIC MUCOSA OF RATS
I.S. Fomenko, A.Ya. Sklyarov,
T.I. Bondarchuk
P0824
GI CYTOPROTECTION AFTER CORONARY
STENTING
A. Joshi, F. Bursey, S. Connors
P0825
LONG­TERM USE OF PROTON PUMP IN­
HIBITORS IN PRIMARY CARE PATIENTS
C. Reimer, P. Bytzer
P0826
THE INVESTIGATION OF UPPER GASTRO­
INTESTINAL BLEEDING AFTER IMPLAN­
TATION OF DRUG­ELUTING STENTS;
PROSPECTIVE COHORT STUDY
T. Toyokawa, T. Inaba, S. Ishikawa,
M. Nakatsu, M. Ando, J. Tomoda
P0827
A DOUBLE­BLIND, ACTIVE­COMPARA­
TOR 7­DAY ENDOSCOPIC TRIAL OF LT­
NS001, A NAPROxEN PRO­DRUG, DEM­
ONSTRATING A SIGNIFICANT DECREASE
IN TOTAL MODIFIED GASTRODUODENAL
LANZA SCORE AND GASTRIC ULCER
RATE COMPARED WITH NAPROSYN®
J.L. Goldstein, A. Jungwirthová, J. David,
E. Spindel, L. Bouchner, F. Pesek, S. Searle,
J. Skopek, J. Grim, I. Ulc, F. Bieberdorf

P0828
LT­NS001, A NAPROxEN PRO­DRUG
WITH MINIMAL COx INHIBITION WHILE
INTACT, RESULTS IN EQUAL PLASMA
ExPOSURE TO NAPROxEN IN VOLUN­
TEERS AGED 45–70 COMPARED WITH
NAPROSYN®
J.L. Goldstein, W.G. Kramer, S. Searle,
J. Skopek, J. Grim, I. Ulc, F. Bieberdorf,
K.L. Sewell
P0829
INHIBITION OF SECRETORY PHOSPHO­
LIPASE A2 ATTENUATES NSAID ASSO­
CIATED LIPOxYGENASE “SHUNT” AND
REDUCES GASTRIC DAMAGE IN MICE
I.T. Padol, C. Wang, R.H. Hunt
P0830
PREVALENCE OF CONCURRANT CLOPI­
DOGREL AND PROTON PUMP INHIBITOR
THERAPY IN A GROUP OF Uk PRIMARY
CARE PRACTICES
D.M. Aldulaimi, M. Bamford,
S.A. Vathenen, R. Mansfield, P. Clamp
P0831
PROTECTIVE EFFECT OF NIGELLA SA­
TIVA, GARLIC AND ONION ON GASTRIC
ULCER INDUCED BY ACIDIFIED ETHANOL
A.M.H. Al Dhaheri, N.F.J. Al Jaberi,
F.S.S. Marzouqi, N. Amir, S.M.A. Bastaki
P0832
APPROPRIATENESS OF PROTON PUMP
INHIBITOR USE IN A DISTRICT GENERAL
HOSPITAL
V. Konala, J. Berrill, A. Pisarczyk, J. Rees
P0833
H. PYLORI ERADICATION ALONE ON THE
LONG­TERM INCIDENCE OF PEPTIC UL­
CER BLEEDING IN LOW­DOSE ASPIRIN
USERS WITH HIGH GASTROINTESTINAL
RISk
F.K.L. Chan, J.Y.L. Ching, B.Y. Suen, J.C.Y. Wu,
J.J.Y. Sung
PosTeR sessIon
P0834
OBESTATIN ACCELERATES THE HEALING
OF CHRONIC GASTRIC ULCERS IN RATS
A. Dembinski, Z. Warzecha, P. Ceranowicz,
J. Cieszkowski, A. Ptak-Belowska
P0835
ROLE OF INOS AND L­ARGININE IN CY­
TOPROTECTIVE MECHANISMS OF THE
ACTION OF OPIOID PEPTIDE – DALARGIN
I.S. Fomenko, V. Yemelyanenko, A. Sklyarov
P0836
[13C]­PANTOPRAZOLE BREATH TEST TO
PREDICT EFFICACY OF PROTON PUMP
INHIBITOR
T. Furuta, C. Kodaira, M. Nishino,
M. Yamade, M. Sugimoto, M. Ikuma,
A. Hishida, H. Watanabe, K. Umemura
P0837
PPI, IS IT A FRIEND OR A FOE TO THE OS­
TEOCLASTS?
J.J. Hyun, E.S. Kim, H.S. Kim, W.W. Jung,
H.J. Chun
P0838
REBAMIPIDE PROMOTES GASTRIC ULCER
HEALING AFTER ENDOSCOPIC SUBMU­
COSAL DISSECTION
T. Kato, H. Araki, F. Onogi, T. Ibuka,
A. Sugiyama, E. Tomita, M. Nagaki,
H. Moriwaki
P0839
EFFECTIVE ADMINISTRATION METHOD
OF INTRAVENOUS PROTON PUMP IN­
HIBITOR: A NOVEL TESTING USING A
BRAVO CATHETERLESS PH MONITOR­
ING SYSTEM
K. Kim, M. Park, S. Park, W. Moon, J. Eum
P0840
“A SURVIVING MYTH” – CORTICOSTE­
ROIDS ARE STILL CONSIDERED ULCERO­
GENIC IN A MAJORITY OF PHYSICIANS
J. Martinek, K. Hlavova, F. Zavada,
B. Seifert, S. Rejchrt, O. Urban, M. Zavoral
165
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0841
ARE PROTON PUMP INHIBITORS BEING
USED APPROPRIATELY IN PATIENTS AD­
MITTED WITH ACUTE GASTROINTESTI­
NAL BLEEDING?
D. McKean, S. El-Shunnar, A. McColl,
A. Briggs, Y. Peng, R. Manhas, M. Weldon
P0842
EFFECT OF CLINICAL USE OF PROTON
PUMP INHIBITORS ON SERUM LEVEL OF
GASTRIN­17, PEPSINOGEN I, AND PEP­
SINOGEN II
D. Nasrollahzadeh, K. Aghcheli,
M. Sotoudeh, C. Persson, R. Shakeri,
C.C. Abnet, F. Kamangar, F. Islami,
S.M. Dawsey, P. Boffetta, L. Engstrand,
R. Malekzadeh, W. Ye
P0843
PREVENTION OF LOW­DOSE ACETYL­
SALICYLIC ACID­ASSOCIATED GASTRIC/
DUODENAL ULCERS WITH ESOMEPRA­
ZOLE 20 MG AND 40 MG ONCE DAILY IN
PATIENTS AT INCREASED RISk OF ULCER
DEVELOPMENT: A RANDOMISED CON­
TROLLED TRIAL (OBERON)
J. Scheiman, C.J. van Rensburg, P. Uebel,
L. Douda, K. Niezgoda, E. Nauclér,
L. Svedberg
P0844
GHRELIN ACCELERATES THE HEALING
OF CYSTEAMINE­INDUCED DUODENAL
ULCERS
Z. Warzecha, A. Dembinski, P. Ceranowicz,
J. Cieszkowski, R. Sendur, J. Bilski
P0845
CONCOMITANT USE OF CLOPIDOGREL
AND PROTON PUMP INHIBITORS, OR
CIMETIDINE, FOLLOWING ACUTE MYO­
CARDIAL INFARCTION WOULD INCREASE
THE RISk OF RE­INFARCTION
S.S.W. Wang, P. Hsu, S. Tsai, C. Yang, D. Wu
166
P0846
SUCCESSFUL IMPLEMENTATION OF EN­
DOSCOPIC SUBMUCOSAL DISSECTION
FOR EARLY GASTRIC CANCER IN A SMALL
DISTRICT HOSPITAL IN JAPAN
E. Kojima, K. Tashiro, T. Tajima,
M. Matsumura, I. Kinoshita
P0847
NO RELATIONSHIP BETWEEN BRCA1,
BRCA2 GERM­LINE MUTATION AND GAS­
TRIC CANCER
M. Lawniczak, W. Rogoza-Mateja,
K. Ciepiela, J. Lubiñski, T. Starzynska
P0848
PROGNOSTIC VALUE OF THE MUCINS’
IMMUNOHISTOCHEMICAL ExPRESSION
IN GASTRIC CARCINOMAS
D.E. Lazar, S. Taban, I. Sporea, M. Cornianu,
A. Goldis, I. Ratiu, C. Vernic
P0849
CORRELATIONS BETWEEN P53 IMMU­
NOHISTOCHEMICAL ExPRESSION AND
CLINICOPATHOLOGICAL FACTORS IN
GASTRIC CANCER
D.E. Lazar, S. Taban, M. Cornianu,
A. Goldis, E. Lazar, I. Sporea, C. Vernic
P0850
IMMUNOHISTOCHEMICAL ExPRESSION
OF CELLULAR PROLIFERATION INDEx
(kI­67) IN GASTRIC CARCINOMAS
D.E. Lazar, S. Taban, M. Cornianu,
A. Goldis, E. Lazar, R. Goldis, I. Sporea
P0851
IDENTIFICATION OF GAS1 AS AN EPIRU­
BICIN RESISTANCE­RELATED GENE IN
HUMAN GASTRIC CANCER WITH A PAR­
TIALLY RANDOMIZED SIRNA LIBRARY
Z. Liu, L. Zhao, Y. Pan, Y. Gang, H. Wang,
D. Fan

P0852
COMPREHENSIVE EVALUATION OF IL­
1B GENE POLYMORPHISMS IN GASTRIC
PRECANCEROUS LESIONS IN CHINA
Z. Huang, C. Guo, Z. Liu, X. Wang
P0853
WHAT SURGERY IS NEEDED FOR GAS­
TRIC CARDIA TREATMENT?
N.O. Lukavetskyy, T. Fetsych
P0854
PRE­OPERATIVE PLATELET: LYMPHO­
CYTE RATIO (PLR) IS NOT A PROGNOSTIC
FACTOR IN RESECTED GASTRIC CANCER
C. Magee, F. Atherton, E. Platt, T. Owen,
S. Ball, G. Khera, N. Howes, M. Hartley
P0855
RELATION BETWEEN REFLUx BILE ACID
INTO THE STOMACH AND GASTRIC MU­
COSAL ATROPHY, INTESTINAL META­
PLASIA – A MULTI­CENTER STUDY OF
2,283 CASES
T. Matsuhisa, K. Haruma, T. Arakwa,
T. Watanabe, S. Okamura, M. Ito,
T. Tokutomi, A. Sugiyama, S. Chono,
H. Sasaki
P0856
GASTRIC CANCER IN LATVIA
J. Misins, A. Stengrevics, V. Krumins, V. Boka,
M. Leja
P0857
INVESTIGATION OF FACTORS WHICH
AFFECT THE DEVELOPMENT OF TYPE 1
GASTRIC CARCINOID TUMOURS
S.V. Murugesan, A. Varro, D.M. Pritchard
P0858
OCTREOTIDE SUPPRESSION TEST PRE­
DICTS SUITABILITY FOR ANTRECTOMY IN
TYPE 1 GASTRIC CARCINOID TUMOURS
S.V. Murugesan, I. Steele, R. Dimaline,
A. Varro, D.M. Pritchard
PosTeR sessIon
P0859
CANCER CELLS ON INTRAOPERATIVE
PERITONEAL CYTOLOGY FOR GASTRIC
CANCER
T. Nakamura, N. Haga, Y. Fukai, T. Akao,
T. Takada, H. Ojima
P0860
TREATMENT MODALITIES IN GASTRO­
ESOPHAGEAL CANCER – A MULTIDISCI­
PLINARY APPROACH?
S.F. Neong, I.R. Sargeant, D.L. Morris,
J. Deacon
P0861
FUNCTIONAL FEATURES OF GENE Ex­
PRESSION PROFILES DIFFERENTIATING
GASTROINTESTINAL STROMAL TU­
MOURS ACCORDING TO kIT MUTATIONS
AND ExPRESSION
J. Ostrowski, M. Polkowski, A. Paziewska,
M. Skrzypczak, K. Goryca, T. Rubel,
K. Kokoszynska, P. Rutkowski, Z.I. Nowecki,
A. Jerzak vel Dobosz, D. Jarosz, W. Ruka,
L. Wyrwicz
P0862
FACTORS AFFECTING MEDICAL RE­
SOURCES UTILIZATION FOR GASTREC­
TOMY IN PATIENTS WITH GASTRIC CAN­
CER
C. Perng, C. Chien, C. Wu, H. Lin, S. Lo,
Y. Huang, H. Lin, S. Lee
P0863
ENTERO­CT VS SMALL INTESTINE CON­
TRAST ULTRASONOGRAPHY (SICUS) IN
ASSESSING ILEAL LESIONS IN CROHN’S
DISEASE: A PROSPECTIVE LONGITUDI­
NAL STUDY AFTER ILEO­COLONIC RE­
SECTION
S. Onali, E. Calabrese, R. Fiori,
C. Petruzziello, G. Condino, G. Palmieri,
G. Sica, E. Lolli, F. Pallone, L. Biancone
P0864
Withdrawn by author
167
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0865
SERUM BIOMARkERS OF ATROPHIC GAS­
TRITIS IN MULTIETHNIC POPULATION
O.V. Reshetnikov, S.A. Kurilovich,
S.A. Krotov, V.A. Krotova
P0866
ORIGINAL AND GENERIC PANTOPRA­
ZOLE FOR THE SHORT­TERM TREATMENT
OF GASTRO­OESOPHAGEAL REFLUx DIS­
EASE
G.M. Buzás
P0867
PREDICTION OF WORk PRODUCTIVITY
IMPROVEMENT AFTER PPI THERAPY BY
THE RESPONSE ALGORITHM IN DANISH
PRIMARY CARE PATIENTS CONSULTING
WITH UPPER GASTROINTESTINAL SYMP­
TOMS
P. Bytzer, V. Meineche-Schmidt,
E. Christensen, I. Malmberg
P0868
VECAM: SUPERIOR CONTROL OF
NIGHTTIME ACID SECRETION, TOWARDS
A NOVEL TREATMENT FOR NIGHTTIME
HEARTBURN
Y. Chowers, T. Atarot, M. Naveh,
A. Kostadinov, M. Nudelman, C. Foote,
V.S. Pratha, R. Fass, N. Edwards
P0869
IS BMI ASSOCIATED WITH PHARMACO­
DYNAMIC EFFECTS OF SINGLE DOSES OF
RABEPRAZOLE 20 MG AND PANTOPRA­
ZOLE 40 MG IN GERD PATIENTS?
S. Bruley des Varannes, P. Ducrotté,
J. Xiang, Y. Sun, J. LoCoco, B. Coudsy, H. Li,
B. DeLemos
P0870
EFFECT OF PPI TREATMENT IN SLEEP
APNEA SYNDROME: AN ESOPHAGEAL
IMPEDANCE­PH STUDY
F. Ermis, F. Akyuz, S. Arici, A. Uyanikoglu,
F. Yakar, B. Pinarbasi, K. Demir, S. Ozdil,
F. Besisik, S. Kaymakoglu, G. Boztas,
C. Cuhadaroglu, Z. Mungan
168
P0871
PROTON PUMP INHIBITORS: ARE WE
WASTING MONEY AND IGNORING THE
RISk?
B. Graf, A.J. Kent, M. Harbord
P0872
PERSISTENT SYMPTOMS AND IMPACT
ON QUALITY OF LIFE IN PATIENTS WITH
GASTRO­OESOPHAGEAL REFLUx DIS­
EASE MANAGED IN PRIMARY CARE
R. Jones, C.L. Hunt, M. Cohen
P0873
RECURRENCE RATE AND TREATMENT RE­
SPONSE IN GASTRO­ESOPHAGEAL RE­
FLUx DISEASE PATIENTS TREATED WITH
PROTON PUMP INHIBITOR IN kOREA
Y. Jeong, T. Choi, T. Hwang, B. Lee, D. Lee,
Y. Park, N. Kim
P0874
RABEPRAZOLE OR ESOMEPRAZOLE FOR
SYMPTOM RESOLUTION IN PATIENTS
WITH GASTRO­OESOPHAGEAL REFLUx:
UNIVARIATE ANALYSIS OF BASELINE
CHARACTERISTICS
A. Eggleston, P. Katelaris, S. Nandurkar,
G. Holtmann
P0875
A COMPARISON OF PANTOPRAZOLE
40 MG AND ESOMEPRAZOLE 40 MG FOR
REDUCTION OF ‘ACID COMPLAINTS’ AF­
TER 28 DAYS OF TREATMENT
P.H. Katelaris, V. Stanghellini, H. Doerfler,
A. Tholen
P0876
EFFECTS OF E3710, A NEW PROTON
PUMP INHIBITOR WITH A LONG­LASITNG
INHIBITORY EFFECT, ON 24­H INTRAGAS­
TRIC PH IN GASTRIC FISTULA DOGS
K. Kodama, H. Fujisaki, A. Kubota,
H. Kato, K. Hirota, H. Kuramochi,
M. Murota, Y. Tabata, M. Ueda, H. Harada,
T. Kawahara, M. Shinoda, N. Watanabe,
D. Iida, H. Terauchi, S. Yashui, S. Miyazawa,
J. Nagakawa

P0877
E3710, A NEW PROTON PUMP INHIBITOR
WITH A LONG­LASTING INHIBITORY EF­
FECT
K. Kodama, H. Fujisaki, A. Kubota,
H. Kato, K. Hirota, H. Kuramochi,
M. Murota, Y. Tabata, M. Ueda, H. Harada,
T. Kawahara, M. Shinoda, N. Watanabe,
D. Iida, H. Terauchi, S. Yashui, S. Miyazawa,
J. Nagakawa
P0878
A NEW DEVICE TO MONITOR THE IN­
TRAOPERATIVE LOWER OESOPHAGEAL
SPHINCTER PRESSURE DURING THE
LAPAROSCOPIC ANTIREFLUx SURGERY –
THE FEASIBILITY STUDY
P. Kysela, Z. Kala, V. Procházka, F. Marek,
J. Dolina, R. Kroupa
P0879
LONG TERM EVALUATION OF PPI’S
IN GASTROESOPHAGEAL REFLUx IN
SCLERODERMA
M. Lahcene, N. Oumnia, N. Matougui,
A. Tebaibia, M. Boudjella, B. Touchene
P0880
EFFECT OF RABEPRAZOLE 10 MG TWICE
DAILY, 20 MG ONCE DAILY ON GASTRIC
ACID SUPPRESSION, ESOPHAGEAL ACID
ExPOSURE AND SYMPTOM RELIEF OF
PATIENTS WITH GASTROESOPHAGEAL
REFLUx DISEASE
J. Lin, Y. Xiao, M. Ren, L. Yang, M. Chen
P0881
CARDIANOTES – AN ANTI REFLUx PROS­
THESIS FOR TRANSLUMENAL SURGERY
D. Wilhelm, A. Meining, A. Schneider,
J. Sager, S. von Delius, H. Feussner
P0882
PROTON PUMP INHIBITOR TREATMENT
FOR GASTRO­ESOPHAGEAL REFLUx IN
SLEEP APNEA SYNDROME PATIENTS
I. Modolell, E. Esteller, F. Segarra
PosTeR sessIon
P0883
“TRUE” NON EROSIVE REFLUx DISEASE
(NERD) IS CHARACTERIZED BY A LOWER
RESPONSE TO PROTON­PUMP INHIBI­
TORS (PPIS) COMPARED TO EROSIVE
REFLUx DISEASE (ERD)
F. Pace, G. Riegler, A. de Leone, P. Dominici,
E. Grossi
P0884
RELATIONSHIP BETWEEN SYMPTOM
RESPONSE AND THE OESOPHAGEAL PH
LEVEL ON STANDARD DOSE OF ESOME­
PRAZOLE TREATMENT FOR GASTRO­
OESOPHAGEAL REFLUx DISEASE
S. Peng, M.H. Chen, L.S. Xiong, Y.L. Xiao
P0885
DOUBLE­DOSED PANTOPRAZOLE AC­
CELERATES SUSTAINED SYMPTOMATIC
RESPONSE IN OVERWEIGHT & OBESITY
PATIETNS WITH REFLUx ESOPHAGITIS IN
LOS ANGELES GRADE A&B
B.S. Sheu, W. Chen, C. Lu, H. Cheng,
W. Chang, Y. Tsai
P0886
PANTOPRAZOLE 40 MG IS MORE EFFEC­
TIVE THAN OMEPRAZOLE 20 MG FOR
FIRST AND SUSTAINED SYMPTOM RELIEF
IN PATIENTS WITH GASTROESOPHAGEAL
REFLUx DISEASE (GERD)
V. Stanghellini, P.H. Katelaris, P. Sommerer,
A. Tholen
P0887
PREDICTIVE FACTORS FOR THERAPEU­
TIC FAILURE IN THE MANAGEMENT OF
GASTROESOPHGEAL REFLUx DISEASE
IN A PRIMARY CARE PRACTICE SETTING
IN SPAIN
M. Tafalla, J. Nuevo, J.P. Gisbert
169
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0888
USE OF ANTISECRETORY MEDICATION
AFTER ANTIREFLUx SURGERY: EVIDENCE
OF AN UNMET NEED?
Y. Yuan, N.D. Dattani, C. Scarpignato,
R.H. Hunt
P0889
ADVERSE EVENTS WITH OMEPRAZOLE
FOR 2–4 WEEkS IN ASIAN SUBJECTS
IN RANDOMIZED CONTROLLED TRI­
ALS (RCT): A SYSTEMATIC REVIEW
Y. Yuan, R.H. Hunt
P0890
BRONCHOALVEOLAR LAVAGE FLUID
ANALYSIS IN INDIVIDUALS WITH GAS­
TROESOPHAGEAL REFLUx
O. Aksu, Y. Songür, N. Songür, Ö. Öztürk,
A. Adiloglu, N. Kapucuoglu, G. Acartürk,
M. Akin
P0891
IMPAIRMENT OF SLEEP AND NEURO­
COGNITIVE FUNCTIONS IN GASTRO­OE­
SOPHAGEAL REFLUx DISEASE AND RE­
SPONSE TO PROTON PUMP INHIBITORS
R. Dewan, R. Nehru, N. Nischal,
D. Manocha, A. Subramanian, A. Joshi,
M. Negi
P0892
PATIENTS WITH GASTRO ESOPHAGEAL
REFLUx DISEASE AND RESPIRATORY
MANIFESTATIONS DON’T PRESENT LUNG
FUNCTION DISORDERS DURING ExER­
CISE TEST
C.J. Giannikoulis, K.P. Karkoulias,
K.X. Thomopoulos, M. Marangos,
K. Spiropoulos, V.N. Nikolopoulou
P0893
EPIDEMIOLOGY OF GASTROESOPHA­
GEAL REFLUx DISEASE AND REFLUx
ESOPHAGITIS: THE SYSTEMATIC INVES­
TIGATION OF GASTROINTESTINAL DIS­
EASES IN CHINA (SILC)
D. Zou, J. He, J. Chen, Y. Gong, X. Man,
L. Gao, R. Wang, Y. Zhao, X. Ma, X. Yan,
W. Liu, J. Dent, J. Sung, L. Mastracci, Z. Li
170
P0894
A STUDY ON THE CORRELATION BE­
TWEEN GASTROESOPHAGEAL REFLUx
DISEASE AND OBSTRUCTIVE SLEEP AP­
NEA HYPOPNEA SYNDROME IN CHINA
F. Liu, Y. Xiao, J. Li, J. Lv, W. Gong, W. Wen,
M. Chen
P0895
EOSINOPHILIC INFLAMMATION OF THE
OESOPHAGUS IN PATIENTS WITH ASTH­
MA, WITH AND WITHOUT SYMPTOMS
OF GASTRO­OEOSPHAGEAL REFLUx
DISEASE
A.A. Raj, W.R. Monteiro, R.E. Edwards, J. de
Caestecker, I.D. Pavord
P0896
CARDITIS CAN PARTIALLY REGRESS AF­
TER H. PYLORI ERADICATION BUT NOT
PROTON PUMP INHIBITOR TREATMENT
P. Tsibouris, K. Goula, C. Kalantzis,
P. Apostolopoulos, C. Tsironis,
G. Alexandrakis, A. Karameris, N. Kalantzis
P0897
STAGING EARLY OESOPHAGEAL NEO­
PLASIA; THE INITIAL BIOPSY AND EUS
STAGING COMPARED WITH HISTOPATH­
OLOGICAL STAGE FROM A SUBSEQUENT
EMR SPECIMEN
J. Ainley, C. Gordon, N. Davies
P0898
METAL STENTS FOR THE MANAGEMENT
OF OESOPHAGEAL MALIGNANT TU­
MOUR THEY ARE SAFE AND A BRIDGE
TO A BETTER OUTCOME, A FOLLOW UP
EVALUATION
M. Aljabiri, N. Shah, D. Menzies,
D. O’Riordan
P0899
EVALUATION OF EFFICACY AND COMPLI­
CATIONS OF SELF­ExPANDABLE METAL
STENTS (SEMS) IN THE TREATMENT OF
ADVANCED OESOPHAGEAL CANCER
B.A. Amendolara, N. Chopita, N. Condado,
F. Tufare, A. Villaverde, F. Baldoni,
A. Bernedo, N. Landoni

P0900
OESOPHAGEAL CANCER PROFILE IN THE
POPULATION OF SOUTHERN PART OF
IRELAND NOW AND FIFTEEN YEARS AGO
J. Bukowczan, G. O’Sullivan,
M.J.M. Buckley
P0901
CLINICOPATHOLOGICAL STUDIES OF
ESOPHAGEAL CARCINOSARCOMA:
ANALYSES OF ITS MORPHOLOGICAL
CHARACTERISTICS AND OUTCOME OF
SURGICAL TREATMENT
O. Chino, H. Shimada, Y. Kise, T. Nishi,
T. Hanashi, T. Hara, S. Yamaoto, M. Nakui,
A. Kazuno, H. Makuuchi
P0902
QUALITY OF LIFE IN LONG­TERM SUR­
VIVORS AFTER POTENTIALLY CURATIVE
TREATMENT FOR OESOPHAGEAL CANCER
E.F.W. Courrech Staal, N.K. Aaronson,
B.M.P. Aleman, H. Boot, F. van Coevorden,
J.W. van Sandick
P0903
PATHOLOGICAL ASSESSMENT OF TU­
MOUR RESPONSE AFTER NEOADJUVANT
CHEMORADIOTHERAPY FOR OESOPHA­
GEAL CANCER
E.F.W. Courrech Staal, M.F. van
Velthuysen, B.M.P. Aleman, F. van
Coevorden, A. Cats, J.W. van Sandick
P0904
CHEMORADIATION FOR OESOPHAGEAL
CANCER: PATIENT­TAILORED TREATMENT
TO MINIMIZE TOxICITY AND MAxIMIZE
EFFICACY
E.F.W. Courrech Staal, B.M.P. Aleman,
H. Boot, A. Cats, M.F. van Velthuysen,
E.P.M. Jansen, F. van Coevorden, J.W. van
Sandick
PosTeR sessIon
P0905
FATTY ACID SYNTHASE ExPRESSION IN
ESOPHAGEAL MUCOSA OF PATIENTS
WITH ESOPHAGITIS, BARRETT’S ESOPH­
AGUS AND ADENOCARCINOMA
P. Crispino, P.L. Alò, M. Rivera, D. Barillà,
F. Nardi, M. Mariotti, G. Zotti, C. Botti,
R. Pica, H. Unim, E.S. Corazziari, P. Paoluzi
P0906
VARIATION IN FATTY ACID SYNTHASE,
kI67 AND P53 ESOPHAGEAL MUCOSA
ExPRESSIONS IN BARRETT’S OESOPHA­
GUS PATIENTS TREATED FOR ONE YEAR
WITH TWO ESOMEPRAZOLE DIFFERENT
REGIMENS
P. Crispino, P.L. Alò, M. Rivera, D. Barillà,
F. Nardi, M. Mariotti, G. Zotti, D. Colarusso,
R. Pica, H. Unim, C. Cassieri, E.S. Corazziari,
P. Paoluzi
P0907
LEPTIN AND PROINFLAMMATORY CYTOkINES
IN GASTROESOPHAGEAL CANCER
CACHExIA
D. Diakowska, K. Markocka-Maczka,
K. Grabowski, M. Strutynska-Karpinska,
M. Matusiewicz, M. Krzystek-Korpacka
P0908
INITIAL RESULTS OF RADIOFREQUENCY
ABLATION FOR THE TREATMENT OF
SQUAMOUS HIGH GRADE DYSPLASIA
OF THE OESOPHAGUS
J.M. Dunn, S. Thrope, M.R. Novelli,
S.G. Bown, L.B. Lovat
P0909
CLINICAL USEFULNESS OF FDG­PET/CT
IN EVALUATING THE CLINICAL STAGE
AND RESPONSE TO NEOADJUVANT
CHEMORADIOTHERAPY IN OESOPHA­
GEAL SQUAMOUS CELL CARCINOMA
Y. Fujiwara, N. Kaibe, H. Yamashita,
T. Matsumoto, K. Koishi, R. Yoshikawa,
M. Sasako
171
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0910
IMPACT OF DELAY IN DIAGNOSTIC
WORk­UP AND TREATMENT OF PATIENTS
WITH OESOPHAGEAL CANCER
B.A. Grotenhuis, P. van Hagen,
B.P.L. Wijnhoven, H.W. Tilanus, J.J.B. van
Lanschot
P0911
AN IMMUNOHISTOCHEMICAL STUDY OF
EMMPRIN AND MATRIx METALLOPRO­
TEINASES IN ESOPHAGEAL SQUAMOUS
CELL CARCINOMA
K. Horiba, N. Tanaka, K. Furukawa, K. Yokoi,
T. Seya, H. Makino, M. Miyashita, E. Uchida,
Y. Ohaki
P0912
MORE CAREFUL MANAGEMENT USING
PROPOFOL SEDATION IS NECESSARY
FOR OESOPHAGEAL ESD COMPARED
WITH GASTRIC ESD
A. Imagawa, Y. Kohno, M. Takahara,
T. Imada, S. Yagi, H. Miyatake, M. Nakatsu,
M. Ando
P0913
ANNExIN 1 ExPRESSSION IN OESOPHA­
GEAL ADENOCARCINOMA: ASSOCIA­
TION WITH CLINICO­PATHOLOGICAL
FACTORS
A.J. Jolly, O. Rotimi, E. Di Martino, C.P. Wild,
L.J. Hardie
P0914
UNDIAGNOSED COELIAC DISEASE AND
RISk OF OESOPHAGEAL SQUAMOUS
CELL CARCINOMA
B.J. Kendall, G.A. Macdonald,
N.K. Hayward, A.C. Green, P.M. Webb,
D.C. Whiteman
P0915
CLINICOPATHOLOGICAL CHARACTERIS­
TICS OF BARRETT’S ESOPHAGEAL CAN­
CER IN JAPANESE PATIENTS AND LONG­
TERM RESULTS OF THERAPY
T. Koike, T. Horii, Y. Abe, N. Ara,
K. Uno, N. Asano, K. Iijima, A. Imatani,
T. Shimosegawa
172
P0916
IMMUNOHISTOCHEMICAL STUDY OF
ExPRESSION OF APOPTOTIC AND PRO­
LIFERATIVE MOLECULAR MARkERS IN
OESOPHAGEAL ADENOCARCINOMA
A.I. Kotzev, A. Kotzev, K.G. Chernev,
M. Kamenova
P0917
RS BALLOON CYTOLOGY ACCURACY
FOR IDENTIFICATION OF PRECURSOR
LESIONS IN INDIVIDUALS AT RISk FOR
SQUAMOUS CELL CANCER OF THE
ESOPHAGUS: PRELIMINARY RESULTS
A.B. Lopes, R. Reichert, L.B. Müller,
C.C. Moraes, A.M. Capra, J.C. Prolla,
A.R. Diehl, L. Meurer, S.G.S. Barros,
R.B. Fagundes
P0918
INTERFERON­GAMMA RESTORES
TRASTUZUMAB MEDIATED CTL RE­
SPONSE IN ESOPHAGEAL ADENOCAR­
CINOMA THROUGH RESTORATION OF
TAP­2 FUNCTION
F. Milano, K. Krishnadath
PosTeR sessIon
Paediatric gastroenterology and
hepatology II
P0919
THE PREVALENCE OF NON­PYLORI HELI­
COBACTER ORGANISMS IN PAEDIATRIC
INFLAMMATORY BOWEL DISEASE
R. Hansen, G.L. Hold, S.H. Berry,
J.M. Thomson, N.E. El-Sakka, W. Bisset,
G. Mahdi, G.I. Murray, P.J. Helms, E.M. El-
Omar
P0920
GASTRO­OESOPHAGEAL REFLUx AND
GASTRIC EMPTYING IN CHILDREN WITH
CYSTIC FIBROSIS
B. Hauser, K. Blondeau, A. Malfroot, I. De
Schutter, E. De Wachter, D. Sifrim, J. De
Schepper, T. Devreker, Y. Vandenplas

P0921
GASTRIC EMPTYING MEASUREMENTS
OF LIQUIDS IN CHILDREN WITH THE 13C­
ACETATE BREATH TEST: COMPARISON
WITH THE 99M TECHNETIUM RADIOS­
CINTIGRAPHY
B. Hauser, J. De Schepper, V. Caveliers,
T. Devreker, Y. Vandenplas
P0922
GASTRIC EMPTYING MEASUREMENTS
OF LIQUIDS IN CHILDREN WITH THE
13C­ACETATE BREATH TEST: INFLUENCE
OF AGE AND GENDER ON GASTRIC EMP­
TYING
B. Hauser, J. De Schepper, V. Caveliers,
T. Devreker, Y. Vandenplas
P0923
GASTRIC EMPTYING MEASUREMENTS
OF SOLIDS IN CHILDREN WITH THE 13C­
OCTANOIC ACID BREATH TEST: COM­
PARISON WITH THE 99M TECHNETIUM
RADIOSCINTIGRAPHY
B. Hauser, J. De Schepper, V. Caveliers,
T. Devreker, Y. Vandenplas
P0924
GASTRIC EMPTYING MEASUREMENTS
OF SOLIDS IN CHILDREN WITH THE 13C­
OCTANOIC ACID BREATH TEST: INFLU­
ENCE OF AGE AND GENDER ON GASTRIC
EMPTYING
B. Hauser, J. De Schepper, V. Caveliers,
T. Devreker, Y. Vandenplas
P0925
ROUTINE ABDOMINAL ULTRASOUND
ExAMINATION FOR ABDOMINAL PAIN
DECREASES THE INCIDENCE OF HOSPI­
TAL ADMISSIONS AND APPENDECTOMY
RATES IN CHILDREN AND ADOLESCENTS
E.Q. Haxhija, A.S. Komoni, K. Geiger,
D. Bäumel, M.E. Höllwarth
PosTeR sessIon
P0926
MAINTENANCE TREATMENT WITH PRO­
TON PUMP INHIBITORS AFTER HEALING
OF REFLUx ESOPHAGITIS IN PAEDIATRIC
PATIENTS: A SYSTEMATIC REVIEW
M. Illueca, B. Wernersson, C. Henderson,
P. Lundborg
P0927
AN EIGHT YEARS SURVEY OF HELICO­
BACTER PYLORI PREVALENCE IN SYMP­
TOMATIC CHILDREN: AN ExPERIENCE OF
A SINGLE CENTER
V. Hurduc, D. Plesca, G. Lesanu,
A. Zamfirescu, M. Stefanescu, A. Davitoiu,
L. Preda
P0928
ESOMEPRAZOLE FOR THE TREATMENT
OF GASTRO­OESOPHAGEAL REFLUx DIS­
EASE IN INFANTS
M. Illueca, P.N. Barker, T. Gunasekaran,
V. Tolia, F. Gottrand, H. Winter
P0929
SEVERITY OF PRESENTING SYMPTOMS
OF GASTRO­OESOPHAGEAL REFLUx
DISEASE IN INFANTS AND THE EFFECTS
OF TREATMENT WITH ESOMEPRAZOLE
M. Illueca, P.N. Barker, H.S. Winter
P0930
FREQUENCY OF STEROID DEPENDENCY
AND IMPACT ON DISEASE COURSE IN
PAEDIATRIC INFLAMMATORY BOWEL
DISEASE
C. Jakobsen, P. Munkholm, A. Paerregaard,
V. Wewer
P0931
THE DIFFERENCE OF ENTERIC NEURO­
HORMONE CHANGES ASSESSMENT IN
CHILDREN WITH FUNCTIONAL GASTRO­
INTESTINAL DISORDERS AND HELICO­
BACTER PYLORI INFECTION
M. Ludzik, L. Bak-Romaniszyn,
J. Lukamowicz, E. Czkwianianc, E. Malecka-
Panas
173
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0932
Withdrawn by author
PosTeR sessIon
colonic and anorectal disorders II
P0933
COLORECTAL POYLP CARCINOMAS DE­
TECTED BY BOWEL CANCER SCREENING
WITHIN THE UNITED kINGDOM
E.L. Blower, L. Tobin, D. Parr, J. Adams,
G. Lipscombe, R. Sturgess
P0934
ANALYSIS OF ADVANCED COLONIC NEO­
PLASIA IN GENERAL POPULATION AND
IN PATIENTS WITH FAMILY HISTORY OF
COLORECTAL CANCER IN RELATION TO
AGE
J. Carneros Martín, E. Tomás, F. Garcia
Durán, C. Villa, C. Ciriza, J.R. Agulló
P0935
NEURAL INVASION IS AN INDEPENDENT
PROGNOSTIC FACTOR AMONG PATIENTS
UNDERGOING NEOADJUVANT TREAT­
MENT FOR RECTAL CANCER
G.O. Ceyhan, F. Liebl, K. Becker, M. Maak,
H. Friess, R. Rosenberg
P0936
FREQUENCY OF ADVANCED ADENOMAS
AND HIGH GRADE NEOPLASIA AMONG
SMALL AND DIMINUTIVE POLYPS
U. Chaput, S. Folgado Alberto, V. Viallon,
B. Terris, F. Beuvon, R. Coriat, H. Roche,
M. Gaudric, F. Prat, S. Chaussade
P0937
THE NHS BOWEL CANCER SCREENING
PROGRAMME IN ENGLAND
L. Coleman, J. Patnick, C. Nickerson, T. Day
174
P0938
DESMOPLASIA INFLUENCED MORTAL­
ITY IN STAGE III COLORECTAL CANCER
WITHIN FIVE YEARS FROM SURGERY
AND ADJUVANT THERAPY
P. Crispino, G. De Toma, A. Ciardi, E. Di
Nardo, G. Gulotta, G. Cocorullo, R. De
Lorenzo, M. Rivera, H. Unim, R. Pica,
D. Colarusso, G. Cavallaro, A. Polistena,
E. Corazziari, P. Paoluzi
P0939
ROLE OF DESMOPLASIA IN RECURRENCE
OF STAGE II COLORECTAL CANCER WITH­
IN FIVE YEARS AFTER SURGERY AND
THERAPEUTIC IMPLICATION
P. Crispino, G. De Toma, A. Ciardi, A. Bella,
M. Rivera, G. Cavallaro, A. Polistena,
H. Unim, R. Pica, P.L. Mingazzini,
E.S. Corazziari, P. Paoluzi
P0940
CONFOCAL ENDOMICROSCOPY (CEM)
WITH PORTABLE MINI PROBES FOR
CHARACTERIZATION OF POLYPOID AND
NON­POLYPOID COLORECTAL LESIONS:
A NEW TOOL FOR THE NExT GENERA­
TION
R. Manta, E. Dabizzi, H. Bertani, M. Manno,
A. Mussetto, P. Trande, G. Olivetti,
R. Conigliaro
P0941
HIGH­RESOLUTION PROBE­BASED CON­
FOCAL LASER ENDOMICROSCOPY IN
COMBINATION WITH VIDEO MOSAIC­
ING FOR THE CHARACTERIZATION OF
COLORECTAL NEOPLASIA. RESULTS OF
A PRELIMINARY STUDY
G.D. De Palma, S. Stefania, S. Siciliano,
D. Esposito, F. Maione, M. Siano,
M. Mascolo, G. Persico

P0942
UNDETECTED COLORECTAL CANCER
AFTER PREVIOUS LOWER ENDOSCOPY:
FREQUENCY AND CAUSES IN A GENERAL
HOSPITAL IN THE NETHERLANDS
N.D.H. Esveldt, H. Geldof, W.A. Bode,
D.R. de Vries, P.D. Siersema
P0943
SEPTIN 9 MRNA, PROTEIN ExPRES­
SION AND METHYLATED DNA LEVEL IN
COLORECTAL ADENOMA­DYSPLASIA­
CARCINOMA SEQUENCE
K. Toth, S. Spisak, O. Galamb, F. Sipos,
B. Wichmann, K. Leiszter, O. Jasz, G. Valcz,
Z. Tulassay, B. Molnar
P0944
PERIPHERAL BLOOD BIOMARkERS OF
COLORECTAL ADENOMAS, CIRCULAT­
ING MONONUCLEAR CELLS ENRICHED
IN FOLLICLES ARE THE INFORMATION
TRANSPORTERS
K. Toth, S. Spisak, O. Galamb, F. Sipos,
B. Wichmann, K. Leiszter, A. Kalmar,
G. Valcz, Z. Tulassay, B. Molnar
P0945
COMPARISON OF IMMUNOCHEMICAL
AND GUAIAC FAECAL OCCULT BLOOD
TESTS FOR COLORECTAL CANCER
SCREENING ACCORDING TO CUTOFF
AND NUMBER OF SAMPLES
L. Guittet, V. Bouvier, O. Lantieri, G. Launoy
P0946
COLORECTAL SERRATED LESIONS;
CLINICOPATHOLOGICAL FEATURES AND
MAGNIFYING ENDOSCOPIC FINDINGS
INCLUDING ENDOCYTOSCPY
N. Ikehara, H. Kashida, S. Hamatani,
K. Wakamura, M. Kutsukawa, H. MIyachi,
Y. Wada, S. Kudo
PosTeR sessIon
P0947
ACCURACY OF CAPILLARY PATTERN
CLASSIFICATION USING NBI MAGNIFICA­
TION FOR DIAGNOSIS OF COLORECTAL
LESIONS
H. Ikematsu, Y. Sano, Y. Yoda, Y. Ohno,
T. Kojima, K. Minashi, T. Yano, K. Kaneko,
A. Ohtsu
P0948
A NOVEL PROBE OF TWO­PHOTON MI­
CROSCOPY FOR GI TRACT MALIGNANCY
E. Kim, H. Chun, K. Lee, J. Kim, J. Hyun,
S. Park, S. Park, B. Keum, Y. Seo, Y. Jeen,
S. Um, C. Kim, H. Ryu, Y. Kim
P0949
CHARACTERISTICS OF PATIENTS WITH
PEDUNCULATED ADENOMAS AND CAR­
CINOMAS REMOVED BY COLONOSCOPY
S. Kimura, M. Tanaka
P0950
COMPARISON BETWEEN QUANTITATIVE
IMMUNOCHEMICAL FECAL OCCULT
BLOOD TEST (QI­FOBT) AND COLONOS­
COPY IN CZECH POPULATION
P. Kohout, J. Granatova, J. Kovarova,
P. Kocna, Z. Vanickova, Z. Benes
P0951
CLINICAL USEFULNESS OF ENDOCYTOS­
COPY FOR ESTIMATING THE INVASION
DEPTH OF SUBMUCOSAL CANCERS
M. Kutsukawa, H. Kashida, K. Wakamura,
Y. Wada, S. Hamatani, N. Ikehara,
H. Miyachi, S. Kudo
P0952
ACCURACY OF GADOFOSVESET­EN­
HANCED MRI FOR PREDICTING NODAL
STATUS IN PRIMARY RECTAL CANCER:
INITIAL ExPERIENCE
M. Maas, D.M.J. Lambregts, R.G.H. Beets-
Tan, A.G.H. Kessels, F.C.H. Bakers, R.M. van
Dam, M.J. Lahaye, S.M.E. Engelen, A.P. de
Bruïne, J.E. Wildberger, G.L. Beets
175
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0953
MISSED COLORECTAL CANCERS – CHAR­
ACTERISTICS OF FALSE­NEGATIVE COLO­
NOSCOPIES
D.C. Macdonald, M. Banks
P0954
TRENDS IN COLORECTAL NEUROENDO­
CRINE TUMORS: A 10 YEAR REVIEW
B. Bogacka, W.M. Marlicz, A. Bialek,
A. Lewosiuk, D. Bielicki, T. Starzynska
P0955
COLONIC BIOPSY SPECIMENS OBTAINED
DURING CONFOCAL ENDOMICROSCOPY
ARE IN VIVO PRESTAINED WITH FLUO­
RESCEIN AND ExCEPTIONALLY SUITED
FOR CELLULAR AND MOLECULAR IMAG­
ING
E. Coron, J. Mosnier, A. Ahluwalia, M. Le
Rhun, A. Tarnawski, T. Matysiak-Budnik,
J. Galmiche
P0956
CYCLOOxYGENASE­2 IN DUkE’S B CO­
LON CANCER
Z.J. Sundov, V. Capkun, N.N.D. Kunac,
M. Kalebic, N. Druzijanic, L. Puljak, S. Tomic
P0957
NEURAL NETWORkS IN THE PREDICTION
OF COLON CANCER
J. Tharakan, D. Koutsomanis,
A. Koulaouzidis
P0958
DIAGNOSTIC YIELD OF COLONOSCOPY
IN COLORECTAL CANCER SCREENING
AMONG UNDER 50­YEAR­OLD HIGH­
RISk POPULATION
F. Tobal, D. Tobal
P0959
CT COLONOGRAPHY IS NOT SENSITIVE
TO DETECT LATERALLY SPREADING TU­
MORS IN THE COLORECTUM
K. Togashi, K. Utano, Y. Sato, S. Kijima,
T. Miyata, H. Horie, A.T. Lefor, Y. Yasuda,
H. Sugimoto
176
P0960
CONFOCAL LASER ENDOMICROSCOPY
FOR ANAL INTRAEPITHELIAL NEOPLASIA
IN­VIVO DIAGNOSIS: PRELIMINARY DATA
C. Trovato, A. Sonzogni, D. Ravizza,
D. Tamayo, G. De Roberto, G. Fiori, C. Crosta
P0961
IS THE PERFORMANCE OF A FAECAL OC­
CULT BLOOD TEST REALLY DIFFERENT IN
A REFERRED POPULATION COMPARED
WITH A SCREENING POPULATION?
S.T. van Turenhout, L.G. van Rossum,
F.A. Oort, R.J. Laheij, A.F. van Rijn,
G.A. Meijer, J.B. Jansen, E. Dekker,
C.J.J. Mulder
P0962
PERFORMANCE OF AN INTEGRATED RISk
PROFILE FOR SELECTION OF HIGH RISk
INDIVIDUALS FOR COLORECTAL CANCER
S.T. van Turenhout, I. Stegeman, F.A. Oort,
B.S. Ferket, C.K. van Kalken, G.A. Meijer,
R.A. Kraaijenhagen, C.J.J. Mulder
P0963
MORPHOLOGICAL CRITERION TO AS­
SESS LYMPH NODE METASTASIS PREOP­
ERATIVELY UNDER MULTI­SLICE SPIRAL
CT IN COLORECTAL CANCER
X. Wang, D. Lv, S. Ouyang, L. Deng, W. Ye,
J. Wu, L. Li
P0964
CLINICAL PERFORMANCE OF A BLOOD­
BASED TEST FOR DETECTION OF THE
SEPTIN 9 BIOMARkER FOR COLORECTAL
CANCER SCREENING
G. Weiss, P. Schatz, A. Fassbender,
I. Fuhrmann, E. Heiden, J. Distler,
R. Grützmann, A. Hartmann, B. Molnar

P0965
ASCITES ON CT SCAN IS A FACTOR PRE­
DICTING SEVERE PSEUDOMEMBRA­
NOUS COLITIS
S. Lee, S. Kim, B. Jeon, S. Lee, K. Ko, S. Nam,
Y. Lee, S. Lee, H. Jeong, I. Kim, S. Kim, S. Lee,
D. Kim
P0966
ENDOSCOPIC RESECTION OF RECTAL
CARCINOID TUMORS: CONVENTIONAL
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION VS ENDOSCOPIC SUBMUCOSAL
RESECTION WITH LIGATION DEVICE
T. Kim, S. Lee, G. Song
P0967
ABDOMINAL OBESITY AND INSULIN
RESISTANCE AS THE RISk FACTORS OF
COLORECTAL ADENOMA IN NON­DI­
ABETICS: A PROSPECTIVE CASE­CON­
TROLLED STUDY
H.Y. KIM, W.G. Shin, H.W. Park, J.W. Park,
H.S. Kim, J.H. Lee, K.H. Kim
P0968
THE VALUE OF QUANTIFERON­TB GOLD
TEST IN THE DIFFERENTIAL DIAGNOSIS
OF INTESTINAL TUBERCULOSIS
H. Kim, W. Lee, Y. Joo, H. Kim, S. Choi, J. Rew
P0969
NO INCREASED INCIDENCE AND PREV­
ALENCE OF COLORECTAL CARCINOMA
AND ADENOMAS IN PATIENTS WITH DI­
VERTICULITIS: A RETROSPECTIVE LON­
GITUDINAL STUDY
T.J. Lam, M.M. Meurs-Szojda, L. Gundlach,
J.A.M. Belien, G.A. Meijer, C.J.J. Mulder,
R.J.F. Felt-Bersma
P0970
CRITICAL REAPPRAISAL OF ANOREC­
TAL FUNCTION TESTS IN FECAL INCON­
TINENCE: ONLY ANAL ULTRASOUND IS
DISCRIMINATORY
T.J. Lam, C.J. Mulder, R.J.F. Felt-Bersm
PosTeR sessIon
P0971
TRANSLATION AND VALIDATION OF
ROME III QUESTIONNAIRE INTO BAHASA
MALAYSIA LANGUAGE AND THE PREVA­
LENCE OF IRRITABLE BOWEL SYNDROME
AMONG HEALTHY VOLUNTEERS IN THE
CAMPUS OF A UNIVERSITY HOSPITAL
Y. Lee, A. Waid
P0972
FILIFORM POLYPOSIS CONFINED TO THE
LEFT SIDED COLON WITHOUT INFLAM­
MATORY BOWEL DISEASE OR INTESTI­
NAL TUBERCULOSIS
Y. Lim, J. Choi, H. Jang
P0973
ANAL FISTULA PLUG: EFFICACY IN CLO­
SURE OF COMPLEx ANAL FISTULAS
M.F. Lutke Holzik, R. Koop, J.M. Klaase
P0974
FECAL IMPACTION: IN HOSPITAL COM­
PLICATIONS AND THEIR PREDICTORS IN
A RETROSPECTIVE STUDY ON 130 PA­
TIENTS IN A TERTIARY CARE CENTER
K.A. Maasri, F.H. Mourad, K.A. Barada
P0975
AETIOLOGY OF MICROSCOPIC COLITIS:
RESULTS OF A RETROSPECTIVE MULTI­
CENTRIC STUDY IN 64 PATIENTS
G. Macaigne1, C. Locher 2 , J. Boivin 3 ,
J. Cucherousset 4 , N. Cucherousset 5 ,
M. Auriault 6 , S. Nahon 7
P0976
BECLOMETHASONE DIPROPIONATE IN
MICROSCOPIC COLITIS. A RESTROSPEC­
TIVE STUDY
J. Martin Ibañez, P. Romero Cara,
J.J.A. Martinez Oton, J.J.M. Candel Erenas,
P. Montoro Martinez, I. Garcia Tercero,
S. Moran Sanchez, J.J.P. Rincon Fuentes,
J. Garcia Solano, F. Carrion
177
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0977
IS THE ANAL PAP TEST AN EFFECTIVE
SCREENING TOOL IN PREVENTION OF
HPV RELATED ANAL CANCER? COM­
PARISON BETWEEN CYTOLOGY AND
HISTOLOGY RESULTS IN PATIENTS WITH
ANORECTAL WARTS
G. Alexandrakis, P. Mavrogianni,
A. Katsampas, A. Karameris, A. Mela,
C. Stefanaki, G. Rouvas, P. Apostolopoulos,
T. Lira, E. Tsiampas, E. Kalafatis, N. Kalantzis
P0978
HUMAN PAPILOMAVIRUS GENOTYPING
ANALYSIS IN GREEk POPULATION WITH
ANORECTAL CONDYLOMATA ACUMI­
NATA
P. Mavrogianni, G. Alexandrakis,
G. Bethimoutis, G. Rouvas,
P. Apostolopoulos, C. Liatsos,
M. Hadzyvassiliou, E. Nikolaidou,
P. Tsibouris, C. Kalantzis, N. Kalantzis
P0979
DETECTION OF ADENOMAS AND/OR
CANCER IN SYMPTOMATIC AND ASYMP­
TOMATIC INDIVIDUALS OF DIFFERENT
AGE GROUPS
F. Dimopoulos, C. Gianopoulos,
P. Anapliotis, H. Chrysanthopoulou,
M. Mavros, E. Zambeli, S. Michopoulos
P0980
RECTAL EVACUATORY DYSFUNCTION:
DO THE ADDED SYMPTOMS OF IRRI­
TABLE BOWEL SYNDROME HAVE ANY
SIGNIFICANCE?
S.D. Mohammed, N. Zarate, P.J. Lunniss,
Q. Aziz, S.M. Scott
P0981
USEFULNESS OF ENDOSCOPIC ASPIRA­
TON MUCOSECTOMY FOR TREATMENT
OF SMALL RECTAL CARCINOID TUMORS,
AND ASSESSMENT OF MALIGNANT PO­
TENTIAL OF THE SPECIMENS
Y. Nakagawa, T. Nagai, H. Okawara,
H. Nakashima, T. Tasaki, W. Soma,
A. Hisamatu, K. Murakami, T. Fujioka
178
P0982
DETECTION OF SPIROCHAETA IN THE
COLON; IMPLICATION OF ITS SUSCEP­
TIBILITY OF INJURED COLON MUCOSA
AND GENDER DOMINANCE
H. Nakajima, S. Urita, M. Sugimoto,
M. Sanaka, N. Egawa, T. Kamisawa, M. Ono,
A. Nishizawa, T. Fujiwara
P0983
EFFECT OF ECABET SODIUM ENEMA ON
ACUTE HEMORRHAGIC RECTAL ULCER
M. Nomura, S. Mitsui, H. Aoki, H. Shida,
S. Kato, H. Maguchi
P0984
CLINICAL CHARACTERISTICS OF PRIMA­
RY EPIPLOIC APPENDAGITIS
J. Park, S. Jung, Y. Noh, M. Kang, J. Jung,
S. Kim, H. Jung, K. Shim, T. Kim, K. Yoo,
I. Moon, S. Yi
PosTeR sessIon
Inflammatory bowel disease II
P0985
INFLAMMATORY BOWEL DISEASE IN
PATIENTS WITH PRIMARY SCLEROSING
CHOLANGITIS: A DISTINCT CLINICAL, EN­
DOSCOPIC AND PATHOLOGIC ENTITY?
K.K. Jørgensen, K. Grzyb, K.E. Lundin,
O. Clausen, M.H. Vatn, K.M. Boberg
P0986
PREVALENCE AND DETERMINANTS OF
HYPERHOMOCYSTEINEMIA IN CROHN’S
DISEASE: RESULTS OF A CONTROLLED
STUDY
L. Kallel, S. Ben Romdhane, M. Fekih,
S. Karoui, L. Sghaier, M. Feki, J. Boubaker,
A. Filali, N. Kaabachi

P0987
THE SIGNIFICANCE OF MONITORING
PERIPHERAL CD4+ T­CELLS ExPRESSING
REGULATORY CD25HIGH+ AND THE IM­
MUNE­DEFICIENCY CD4+ T­CELLS LACk­
ING CD28 IN PATIENTS WITH CROHN’S
DISEASE UNDER INFLIxIMAB THERAPY
K. Kamikozuru, K. Fukunaga, Y. Yokoyama,
H. Miwa, T. Matsumoto
P0988
P110DELTA PHOSPHOINOSITIDE 3­kI­
NASE UNCOUPLES COLITIS FROM COLI­
TIS­ASSOCIATED CANCER
K. Kok, M. Bijlsma, F. ten Kate, J. Offerhaus,
D.W. Hommes, B. Vanhaesebroeck,
M.P. Peppelenbosch
P0989
BONE TURNOVER MARkERS IN PATIENTS
WITH INFLAMMATORY BOWEL DISEASES
E. Kresanova, T. Hlavaty, T. Koller, J. Toth,
K. Holociova, L. Baqi, Z. Killinger, M. Huorka,
J. Payer
P0990
BUDESONIDE TREATMENT OF PATIENTS
WITH COLLAGENOUS COLITIS RESTORES
NORMAL EOSINOPHIL ACTIVITY IN THE
COLON
M. Lampinen, M. Wagner, P. Sangfelt,
M. Carlson
P0991
THE INFLUENCE OF MESENCHYMAL
STEM CELLS OVER IMMUNE STATUS IN
ULCERATIVE COLITIS
L.B. Lazebnik, T. Tsaregorodseva,
O. Knyazev, T. Serova
P0992
DETECTION OF EPITHELIAL APOPTOSIS
IN PELVIC ILEAL POUCHES FOR ULCER­
ATIVE COLITIS
R.F. Leal, M.S. Ayrizono, J.J. Fagundes,
M. Milanski, J.C. Moraes, A. Coope,
L.A. Velloso, C.S.R. Coy
PosTeR sessIon
P0993
GENERIC LESSONS FOR CHRONIC COLI­
TIS: WHOLE­TRANSCRIPT ExPRESSION
ANALYSIS IN TRICHURIS MURIS COLITIS
S.E. Levison, J.T. McLaughlin, L.A.H. Zeef,
J.L. Pennock
P0994
IL­23 INDUCES Nk CELL ACTIVATION
AND CYTOTOxICITY IN INFLAMMATORY
BOWEL DISEASE
Z. Liu, X. Yang, Z. Huang, X. Wang
P0995
REAL­TIME PCR QUANTIFICATION OF
MUCOSA­ASSOCIATED ESCHERICHIA
COLI AND FAECALIBACTERIUM PRAUS­
NITZII TO SUPPORT CROHN’S DISEASE
DIAGNOSTICS
M. Lopez-Siles, M. Martinez-Medina,
X. Aldeguer, C. Lopez-Oliu, J. Garcia-Gil
P0996
PSEUDOMONAS FLUORESCENS MODU­
LATES PERMEABILITY AND TRANSLO­
CATES ACROSS CACO­2/TC7 POLARIZED
EPITHELIAL MONOLAYERS
A. Madi, N. Connil, P. Svinareff, N. Orange,
M.G.J. Feuilloley
P0997
A PROSPECTIVE STUDY OF Bk VIRUS
INFECTION IN INFLAMMATORY BOWEL
DISEASE
I. Marín-Jiménez, V. Flores, L. Menchén,
P. Muñoz, E. Bouza, J. Ledesma, C. Beceiro
P0998
CONFOCAL ENDOMICROSCOPY UNCOV­
ERS ABNORMAL ANGIOGENESIS AND
INCREASED MICROVASCULAR PERME­
ABILITY IN ENDOSCOPICALLY ‘NORMAL’
APPEARING MUCOSA OF PATIENTS WITH
IBD IN REMISSION: THE UNDERLYING
MECHANISMS AND IMPLICATION FOR
ULCERATION RECURRENCE
A. Tarnawski, E. Coron, J. Mosnier,
A. Ahluwalia, M. Le Rhun, J. Galmiche,
A. Bourreille, T. Matysiak-Budnik
179
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P0999
EFFECT OF THE PEG COMPONENT OF
CERTOLIZUMAB PEGOL ON STIMULATED
MAST CELL DEGRANULATION
S. Lamour, M. Bracher, A. Nesbitt
P1000
COMPARISON OF THE DISTRIBUTION OF
AN IGG AND A PEGYLATED FAB’ FORM
OF AN ANTI­TFN­α ANTIBODY IN THE
INFLAMED GUT OF COLITIC MICE
A. Eddleston, M. Marenzana, D. Marshall,
A. Nesbitt
P1001
THE PEG MOIETY OF CERTOLIZUMAB
PEGOL IS RAPIDLY CLEARED FROM THE
BLOOD OF HUMANS BY THE kIDNEYS
ONCE IT IS CLEAVED FROM THE FAB’
T. Parton, L. King, G. Parker, A. Nesbitt
P1002
DIFFERENTIAL EFFECTS OF THE ANTI­
TNFα AGENTS IN MEDIATING INHIBITION
OF LPS­ AND PHA­STIMULATED CYTOkINE
PRODUCTION IN WHOLE BLOOD
CULTURES
A. Nesbitt, G. Fossati
P1003
ExPRESSION OF TOLL­LIkE RECEPTOR 4
AND PRODUCTION OF INTERLEUkIN­6
BY INTESTINAL DENDRITIC CELLS COR­
RELATE WITH DISEASE ACTIVITY AND C­
REACTIVE PROTEIN IN ACTIVE CROHN’S
DISEASE
S.C. Ng, N.E. McCarthy, S. Plamondon,
J.L. Benjamin, C.R.H. Hedin,
A. Koutsoumpas, A.L. Hart, M.A. Kamm,
A. Forbes, K. Whelan, S.C. Knight,
J.O. Lindsay, A.J. Stagg
180
P1004
ALTERED INTESTINAL DENDRITIC CELL
FUNCTION IN PATIENTS WITH ACTIVE
CROHN’S DISEASE IS ASSOCIATED WITH
AN IMBALANCE IN PRO­ AND ANTI­IN­
FLAMMATORY FAECAL MICROBIOTA
S.C. Ng, J.L. Benjamin, A. Koutsoumpas,
N.E. McCarthy, C.R.H. Hedin, S. Plamondon,
C.L. Price, A.L. Hart, M.A. Kamm, A. Forbes,
S.C. Knight, J.O. Lindsay, K. Whelan,
A.J. Stagg
P1005
ENTEROVIRUSES ARE A COMMON FIND­
ING IN GASTRIC, SMALL INTESTINAL
AND COLONIC MUCOSA IN PAEDIATRIC
CROHN’S DISEASE AT ONSET
N. Nyström, A. Wanders, G. Frisk, J. Fuxe,
U. Gyllensten, I. Hansson, Y. Finkel
P1006
INVESTIGATION OF THE NATURAL HIS­
TORY AND SEROLOGICAL PROFILE OF
PATIENTS WITH ISOLATED ACTIVE ILEITIS
S. O’Donnell, N. Breslin, P. Crotty, A. Qasim,
M. O’Sullivan, H.J. O’Connor, C.A. O’Morain,
B.M. Ryan
P1007
CREEPING FAT: INFLAMMATORY, FI­
BROUS, BUT NO AN ADIPOSE TISSUE
I. Olivier, V. Théodorou, V. Philippe,
I. Castan-Laurell, G. Hervé, J. Bertrand-
Michel, G. Portier, L. Ferrier, H. Eutamène
P1008
PROTEOMIC DISCOVERY OF THE DOWN­
REGULATION OF PEROxIREDOxIN­6 IN
MURINE DExTRAN SODIUM SULFATE­
INDUCED COLITIS
T. Omatsu, Y. Naito, T. Takagi,
K. Mizushima, H. Okada, K. Inoue,
K. Fukumoto, S. Yamada, A. Harusato,
I. Hirata, T.O. Ito, K. Uchiyama, O. Handa,
N. Yagi, S. Kokura, H. Ichikawa, T. Yoshikawa

P1009
kINOME PROFILING OF INFLAMED AND
NON­IFLAMED MUCOSA REVEALS AC­
TIVE SUPPRESSION OF P21RAC SIGNAL­
ING IN THE NON­INFLAMED MUCOSA OF
PATIENTS WITH CROHN’S DISEASE
K.B. Parikh, G. Dijkstra, M.P. Peppelenbosch
P1010
THE ROLE OF TH17/IL­23 PATHWAY ON
INTESTINAL INFLAMMATION IN SkG
MICE
H. Park, D. Han, J. Choi, S. Ahn, C. Eun,
J. Youn
P1011
ExTRAINTESTINAL MANIFESTATIONS IN
INFLAMMATORY BOWEL DISEASE. ARE
THEY ASSOCIATED WITH MORE SEVERE
DISEASE?
S. Pereira, J. Castro, A. Lorenzo, A. Echarri,
M. Barreiro, D. Carpio
P1012
EFFECTIVE ATTENUATION OF SMALL
INTESTINAL INFLAMMATION USING A
NOVEL SMALL INTESTINAL MUCOSAL
ENHANCER: ZP1848
Y.M. Petersen, J. Skarbaliene,
K. Christjansen, H.D. Pedersen,
B. Björkenberg, K. Larsen, K. Ebbenhoej,
C. Thorkildsen
P1013
PECULIAR ANTIBODY REACTIVITY TO
HUMAN CONNExIN 37 AND ITS MICRO­
BIAL MIMICS IN PATIENTS WITH CROHN’S
DISEASE
A. Koutsoumpas, D. Polymeros,
Z. Tsiamoulos, G. Karamanolis, T. Kali,
K. Triantafyllou, D.P. Bogdanos, S.D. Ladas
PosTeR sessIon
P1014
CONCORDANCE FOR DISEASE PHENO­
TYPE, SURGERY AND MEDICAL THERAPY
IN BRITISH TWINS WITH INFLAMMATORY
BOWEL DISEASE
S. Woodrow, N. Patel, S.C. Ng, B. Udani,
A. Samji, J. Subhani, M. Harbord
P1015
DISCORDANT TWINS WITH INFLAMMA­
TORY BOWEL DISEASE: DISEASE PHENO­
TYPE AND THE ROLE OF ENVIRONMEN­
TAL FACTORS
S.C. Ng, N. Patel, S. Woodrow, B. Udani,
A. Samji, J. Subhani, M. Harbord
P1016
PREVALENCE OF INFLAMMATORY BOW­
EL DISEASE IN THE COLOMBO AND GAM­
PAHA DISTRICTS OF SRI LANkA
M.A. Niriella, A.P. de Silva,
H.G.A.K. Dayaratne, M. Ariyasinghe,
N.M.M. Navarathne, S.K.R. Peiris,
D.N. Samarasekara, R.L. Satharasinghe,
S. Rajindrajith, A.S. Dassanayake,
A.R. Wickramasinghe, H.J. de Silva
P1017
SYMPTOM BURDEN IN COLLAGENOUS
AND LYMPHOCYTIC COLITIS COMPARED
TO A MATCHED CONTROL GROUP
N. Nyhlin, A. Wickbom, S.M. Montgomery,
C. Tysk, J. Bohr
P1018
USE OF COMPLEMENTARY AND ALTER­
NATIVE MEDICINE IN INFLAMMATORY
BOWEL DISEASE. RESULTS FROM A POP­
ULATION­BASED INCEPTION COHORT,
THE IBSEN STUDY
R. Opheim, M. Hoivik, C. Solberg, B. Moum,
The IBSEN Study Group
181
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1019
PREVALENCE OF HEPATITIS B AND C AND
RISk FACTORS FOR NON­VACCINATION
IN INFLAMMATORY BOWEL DISEASE PA­
TIENTS IN THE NORTH­EAST OF FRANCE
J.B. Chevaux, A. Nani, A. Oussalah,
V. Venard, M. Bensenane, A. Belle,
M.A. Bigard, J.P. Bronowicki, L. Peyrin-
Biroulet
P1020
STOOL PATTERNS AND SYMPTOMS OF
DISORDERED ANORECTAL FUNCTION IN
PATIENTS WITH INFLAMMATORY BOWEL
DISEASES
P.W. Petryszyn, L. Paradowski
P1021
PSICHOSOCIAL SUPPORT GROUP IN IN­
FLAMMATORY BOWEL DISEASE – REA­
SONS FOR ATTENDANCE AND ABAN­
DONMENT
G. Pignaton, H. Fogaça, A. Carneiro, C. Elia
P1022
INCREASED HEALTH BURDEN ASSOCI­
ATED WITH CO­ExISTENT CLOSTRIDIUM
DIFFICILE INFECTION IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASE IN
ENGLAND
M. Jen, S.K. Saxena, A. Bottle, P. Aylin,
R.C.G. Pollok
P1023
FROM THE OLD VIENNA TO THE NEW
MONTREAL: PHENOTYPE CHARACTER­
IZATION AND OVER TIME EVOLUTION OF
A POPULATION WITH CROHN’S DISEASE
A.I. Rebelo, B.J. Rosa, S.M. Leite,
M.J. Moreira, J.M. Ribeiro, J.B. Cotter
182
P1024
THE INFLUENCE OF FATIGUE ON THE
HEALTH RELATED QUALITY OF LIFE IN
INFLAMMATORY BOWEL DISEASE, RE­
SULTS OF A POPULATION BASED STUDY
IN THE NETHERLANDS: THE IBD­SOUTH
LIMBURG COHORT
M. Romberg-Camps, Y. Bol, P. Dagnelie,
M. Hesselink-van de Kruijs, A. Kester,
L. Engels, C. van Deursen, W. Hameeteman,
M. Pierik, F. Wolters, M. Russel,
R. Stockbrügger
P1025
FATIGUE IN INFLAMMATORY BOWEL
DISEASE, RESULTS OF A POPULATION
BASED STUDY IN THE NETHERLANDS;
THE IBD­SOUTH LIMBURG COHORT
M. Romberg-Camps, Y. Bol, P. Dagnelie,
M. Hesselink-van de Kruijs, A. Kester,
L. Engels, C. van Deursen, W. Hameeteman,
M. Pierik, F. Wolters, M. Russel,
R. Stockbrügger
P1026
ULCERATIVE COLITIS IN THE COUNTY OF
UPPSALA 1945–2007
A. Rönnblom, S. Samuelsson, A. Ekbom
P1027
HIDDEN IBD IN THE Uk BOWEL CANCER
SCREENING PROGRAMME
G.J. Sadler, H. Al-Sader, M. Bouwer,
A.P. Poullis, C.J. Groves, D.M. Forton,
R.J. Leicester, R.C.G. Pollok
P1028
A BRIEF REPORT OF THE EPIDEMIOLO­
GY OF OBESITY IN THE INFLAMMATORY
BOWEL DISEASE POPULATION OF TAY­
SIDE, SCOTLAND
H. Steed, S. Walsh, N. Reynolds
P1029
FACTORS DETERMINING THE SEVERITY
OF FATIGUE IN CROHN’S DISEASE PA­
TIENTS
L. Vogelaar, A. van’t Spijker, Z. Zelinkova,
E.J. Kuipers, C.J. van der Woude

P1030
URINARY METABOLIC PROFILING SUG­
GESTS DIFFERENCES IN THE INTESTINAL
MICROBIOTA BETWEEN ETHNIC GROUPS
WITH ULCERATIVE COLITIS
D.G. Walker, H.R.T. Williams, I.J. Cox,
T.R. Orchard
P1031
THE IMPACT OF INFLIxIMAB THERAPY
ON INTESTINAL MUCOSAL ExPRESSION
OF MATRIx METALLOPROTEINASE AND
ADAM GENES IN PATIENTS WITH IN­
FLAMMATORY BOWEL DISEASE
I. Arijs, K. Lemaire, R. Quintens, L. Van
Lommel, C. Perrier, K. Van Steen, G. De
Hertogh, G. Van Assche, S. Vermeire,
K. Geboes, F. Schuit, P. Rutgeerts
P1032
EVIDENCE FOR DIFFERENT AUTOPHAGY
GENES IN CROHN’S DISEASE SUSCEPTI­
BILITY
I. Cleynen, L. Henckaerts, W. Van
Moerkercke, P. Rutgeerts, S. Vermeire
P1033
HAPLOTYPE TAGGING APPROACH RE­
VEALS CONTRIBUTION OF DIFFERENT
INTERLEUkIN 23 RECEPTOR VARIANTS
TO CROHN’S DISEASE IN THE BELGIAN
POPULATION
I. Cleynen, W. Van Moerkercke, V. Ballet,
P. Rutgeerts, S. Vermeire
P1034
CLUSTER ANALYSIS OF GENETIC VARI­
ANTS ENABLES RECLASSIFICATION OF
CROHN’S DISEASE AT THE MOLECULAR
LEVEL
I. Cleynen, W. Van Moerkercke,
J.M. Mahachie John, P. Rutgeerts, K. Van
Steen, S. Vermeire
PosTeR sessIon
P1035
CARD15 GENE MUTATIONS AND PERI­
ANAL FISTULATING CROHN’S DISEASE:
CORRELATION AND PREDICTIVE VALUE
OF ANTIBIOTIC RESPONSE
P. Freire, F. Portela, J. Ferrão, M.M. Donato,
G. Duque, H.T. Sousa, M. Ferreira, P. Andrade,
M.C. Leitão
P1036
DIFFERENCES IN COSTIMULATORY MOL­
ECULE GENE ExPRESSION ON ENDO­
SCOPIC BIOPSIES FROM PATIENTS WITH
ULCERATIVE COLITIS
P. Henderson, C.L. Noble, A.R. Abbas,
J. Schwarze, D.C. Wilson, J. Satsangi
P1037
GENETIC POLYMORPHISMS OF INTER­
LEUkIN 17A AND ITS ASSOCIATION WITH
INFLAMMATORY BOWEL DISEASE
S. Kim, E. Kim, C. Moon, J. Park, T. Kim,
W. Kim, J. Cheon
P1038
GENE POLYMORPHISMS OF TOLL­LIkE
RECEPTOR­2 AND ­4 IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASE
A.C. Manolakis, A.N. Kapsoritakis,
A. Gerovassili, M. Satra, E.K. Tiaka,
K. Oikonomou, A. Kyritsaka, A. Tsiberidis,
N. Vamvakopoulos, S.P. Potamianos
P1039
MYO9B VARIANTS ARE ASSOCIATED
WITH ULCERATIVE COLITIS IN AN EAST
ANGLIAN Uk PANEL
D.C.O. Massey, C. Berzuini, M. Tremelling,
H. Zhang, F. Bredin, S.F. Bingham, M. Parkes
P1040
VARIANTS IN NLRP3 ARE NOT ASSOCI­
ATED WITH CROHN’S DISEASE IN AN
EAST ANGLIAN PANEL
D.C.O. Massey, G.J. Lewis, H. Zhang, J. Lee,
F. Bredin, M. Tremelling, M. Parkes
183
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1041
THE MOST SENSITIVITY MSI MARkER IN
PATIENTS WITH HEREDITARY NONPOL­
YPOSIS COLORECTAL CANCER (HNPCC)
M. Montazer Haghighi, S. Mohebbi,
S. Fatemi, R. Najjar Sadeghi, B. Damavand,
M. Zali
P1042
SIGNAL TRANSDUCER AND ACTIVATOR
OF TRANSCRIPTION 4 (STAT4) GENETIC
POLYMORPHISMS ARE ASSOCIATED
WITH SPECIFIC SUBGROUPS OF ULCER­
ATIVE COLITIS AND CROHN’S DISEASE
C. Moon, J. Cheon, S. Kim, E. Kim, J. Park,
J. Lee, S. Jeon, H. Bok, J. Shin, T. Kim, W. Kim
P1043
CONTRIBUTION OF Nkx2–3, PTPN2 AND
TNFSF15 GENES VARIANTS TO IBD PRE­
DISPOSITION IN ITALIAN POPULATION
O. Palmieri, A. Latiano, F. Bossa,
M.R. Valvano, R. D’Inca, G. Guariso,
G. Corritore, T. Latiano, G. Riegler, M. Castro,
S. Cucchiara, V. Annese
P1044
META­ANALYSIS PROVIDES NO EVI­
DENCE FOR GLIOMA­ASSOCIATED ON­
COGENE HOMOLOG 1 AS A RISk FACTOR
FOR INFLAMMATORY BOWEL DISEASE IN
CAUCASIANS
R.W. Bentley, I. Cleynen, R.B. Gearry,
M.L. Barclay, P. Rutgeerts, T.R. Merriman,
M. Ferrante, R.L. Roberts, S. Vermeire
P1045
ASSOCIATION OF INCREASED BETA­DE­
FENSIN 2 GENOMIC COPY NUMBER WITH
CROHN’S DISEASE
R.W. Bentley, J. Pearson, R.B. Gearry,
M.L. Barclay, C. McKinney, T.R. Merriman,
R.L. Roberts
184
P1046
ExTRACELLULAR MATRIx PROTEIN 1 IS
ASSOCIATED WITH ULCERATIVE COLITIS
BUT IS NOT IMPLICATED IN CROHN’S DIS­
EASE
D.M. Glubb, J.E. Hollis-Moffatt,
R.K.G. Topless, R.B. Gearry, L.A. Simms,
J.D. Doecke, Z. Zhao, N.K. Hayward,
P.M. Webb, D.C. Whitman, T.H.J. Florin,
M.L. Barclay, G.W. Montgomery,
T.R. Merriman, G.L. Radford-Smith,
R.L. Roberts
P1047
DIAGNOSTIC POTENTIAL OF VOLATILE
ORGANIC COMPOUNDS IN INFLAMMA­
TORY BOWEL DISEASE
I. Ahmed, S. Smith, E. Johnson, C. Broderick,
R. Greenwood, N. Ratcliffe, C.S. Probert
P1048
IS THERE ANY CORRELATION BETWEEN
ENDOSCOPIC AND HISTOLOGICAL FIND­
INGS IN IBD?
M. Aljabiri, H. Defoe, S. Freilich,
A. Yogendra, W. Allen, C. Ozen, N. Joshi,
N. van Someren, K. Besherdas
P1049
IS ANAEMIA A CONSISTENT CLINICAL
FEATURE IN IBD?
M. Aljabiri, S. Freilich, A. Yogendra,
H. Defoe, W. Allen, N. Joshi, C. C, N. van
Someren, K. Besherdas
P1050
PATIENT­CENTRED TEST FOR THE EVALU­
ATION OF ENTEROCOLONIC SYMPTOMS
(PC­TEES) IN INFLAMMATORY BOWEL
DISEASE (IBD): RECOGNIZING THE
SPECTRUM OF GASTROINTESTINAL (GI)
SYMPTOMS
S. Dhaliwal, D. Armstrong, R.H. Hunt

P1051
THE PROFILE OF INFLAMMATORY BOW­
EL DISEASE (IBD) IN THE Uk. LESSONS
LEARNED FROM THE IBD DATABASE
K.D. Bardhan, N. Simmonds, C. Royston,
A. Dhar, C. Edwards
P1052
ALMOST ONE HALF OF INFLAMMATORY
BOWEL DISEASE (IBD) PATIENTS AT HIGH
RISk OF COLORECTAL NEOPLASIA DO
NOT UNDERGO ENDOSCOPIC SURVEIL­
LANCE: A CLINICAL PRACTICE STUDY
NESTED IN THE CESAME COHORT
A. Vienne, T. Simon, J. Cosnes, M. Lemann,
Y. Bouhnik, J. Soule, S. Chaussade,
P. Marteau, R. Jian, J. Delchier, B. Coffin,
E. Drouet, F. Carrat, F. Admane, L. Beaugerie
P1053
WHAT FACTORS INFLUENCE ADHESION
TO THERAPY IN INFLAMMATORY BOWEL
DISEASE?
F. Bermejo, A. López-Sanromán, A. Algaba,
J.A. Carneros, P. Valer, B. Piqueras, I. Guerra,
S. García-Garzón, J.C. Villa, A. Bermejo,
F. García-Durán, E. Tomás, J.L. Rodriguez-
Agulló
P1054
FOLATE AND B12 VITAMIN DEFICIENCY
IN CROHN’S DISEASE: PROSPECTIVE
CONTROLLED ANALYSIS OF THEIR PREV­
ALENCE AND RISk FACTORS
F. Bermejo, A. Algaba, S. García-Garzón,
I. Guerra, B. Piqueras, P. Valer, F. García-
Durán, E. Tomás, J.A. Carneros, J.C. Villa,
A. Bermejo, J.L. Rodriguez-Agulló
P1055
METHYLATED METABOLITES/6­TGN RA­
TIO AND TPMT GENOTYPE IN THE PHAR­
MACOLOGICAL MONITORING OF IBD PA­
TIENTS UNDER THIOPURINES
X. Fonrose, A. Chartier, N. Mathieu,
N. Jourdil, G. Bessard, B. Bonaz
PosTeR sessIon
P1056
FORMATION OF ANTINUCLEAR AND
DOUBLE STRAND DNA ANTIBODIES
AND OCCURRENCE OF LUPUS­LIkE SYN­
DROME DURING ANTI­TNF THERAPY IN
A LARGE IBD COHORT
F. Beigel, F. Schnitzler, R. Laubender,
S. Pfennig, B. Göke, J. Seiderer,
T. Ochsenkühn, S. Brand
P1057
INFLAMMATORY BOWEL DISEASE IN PRI­
MARY CARE
M.A. Butt, Y. Adjei-Gyamfi, M. Afzal, S. Zar,
A. Mahmood
P1058
VALIDATION OF THREE QUESTION­
NAIRES FOR FATIGUE MEASUREMENT
IN INFLAMMATORY BOWEL DISEASE
A. Peláez, F. Casellas, N. Borruel, I. Castells,
A. Torrejón, F. Guarner, J. Malagelada,
F. Azpiroz
P1059
PET­CT COLONOGRAPHY: A NOVEL NON­
INVASIVE TECHNIQUE FOR ASSESSMENT
OF ExTENT AND ACTIVITY OF THE DIS­
EASE IN PATIENTS WITH ULCERATIVE
COLITIS
C.J. Das, G.K. Makharia, R. Kumar,
P. Goswami, R.P. Tiwari, R. Sharma,
A.K. Malhotra, R. Kumar
P1060
COMPARATIVE STUDY OF TWO HISTO­
LOGICAL TECHNIQUES FOR THE IDEN­
TIFICATION OF CYTOMEGALOVIRUS
INFECTION IN COLORECTAL BIOPSIES
OF PATIENTS WITH CHRONIC INFLAM­
MATORY BOWEL DISEASE
L. De Castro, A. Tardio, V. Del Campo,
A. Estévez, V. Hernández, R. Prada
185
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1061
ABDOMINAL COMPUTED TOMOGRAPHY
IN CROHN’S DISEASE: SERUM C­REAC­
TIVE PROTEIN DOES NOT PREDICT THE
ExTENT OF NON­PENETRATING DISEASE
ACTIVITY
A.N. Desmond, K. O’Regan, N. Malik,
S. McWilliams, M.M. Maher, E.M. Quigley,
F. Shanahan
P1062
IMPACT OF NEW BRITISH SOCIETY OF
GASTROENTEROLOGY COLITIS SUR­
VEILLANCE GUIDELINES: COSTS AND
SURVEILLANCE INTERVALS
N.N. Elsadani, J.E. East, D. Westaby,
P. Vlavianos, S. Ghosh, J.P. Martin,
A.V. Thillainayagam, D. Bansi, G. Smith,
P. Cohen, G.W. Stamp, J.R.F. Walters
P1063
MAGNETIC RESONANCE ENTEROGRA­
PHY FOR ASSESSMENT OF STENOSIS IN
ILEAL CROHN’S DISEASE: CORRELATION
WITH CLINICAL/ENDOSCOPIC SEVERITY
AND C REACTIVE PROTEIN
A. Echarri, C. Gallego, A. Porta, V. Ollero,
J. Castro
P1064
POOR COMPLIANCE WITH BRITISH SO­
CIETY OF GASTROENTEROLOGY (BSG)
GUIDELINES FOR ULCERATIVE COLITIS
SURVEILLANCE: AUDIT OF UNIVERSITY
HOSPITALS OF LEICESTER
M.A. Ejaz, J.F. Mayberry, F. Khan
P1065
MONITORING OF INFLAMMATION BUR­
DEN IN ULCERATIVE COLITIS BY FAECAL
CALPROTECTIN HOME TEST – FACT OR
FICTION?
M. Elkjaer, J. Burisch, V. Voxen Hansen,
B. Deibjerg Kristensen, J. Slott Jensen,
P. Munkholm
186
P1066
IMPACT OF INTESTINAL RESECTION ON
AND PROGNOSTIC VALUE OF ANTI­SAC­
CHAROMYCES CEREVISIAE SEROLOGY IN
PATIENTS WITH CROHN’S DISEASE DUR­
ING LONG­TERM FOLLOW­UP
A. Eser, P. Papay, W. Miehsler, C. Dejaco,
A. Gangl, C. Lichtenberger, H. Vogelsang,
W. Reinisch
P1067
HOMECARE SYSTEMS FOR MONITORING
INFLAMMATORY BOWEL DISEASES ARE
FEASIBLE AND APPRECIATED BY BOTH
PATIENTS AND HEALTHCARE PROFES­
SIONALS
R.R.B. van Helden, M. Luker, H.H. Fidder,
S.S.M. Zunder, B. Ballieux, N. Kent,
S. van Dijk, A. Sundset, R.R.R. de Bats,
D.W. Hommes
P1068
A PROSPECTIVE COMPARISON BETWEEN
COMPUTERIZED TOMOGRAPHY (CT)
AND MAGNETIC RESONANCE (MR) IN
ILEO­COLONIC CROHN’S DISEASE: A
SINGLE­CENTER ExPERIENCE
G. Fiorino, C. Bonifacio, F. Minuti, A. Repici,
A. Spinelli, P.D. Omodei, A. Malesci,
L. Balzarini, S. Danese
P1069
HOW DELAYED DIAGNOSIS HAS AN IN­
FLUENCE ON THE BEHAVIOUR AT DIAG­
NOSIS OF CROHN’S DISEASE
A. Frattino, D. Musto, A. Cirillo,
L. Martorelli, M. Russo, S. Giaquinto, A. de
Leone, P. Esposito, M.I. Russo, G. Riegler
P1070
TRUE IBS IS UNCOMMON IN CROHN’S
DISEASE: IBS SYMPTOMS IMPLY ACTIVE
DISEASE
J.R. Goodhand, M. Wahed, J.O. Lindsay,
D.S. Rampton

P1071
EVIDENCE QUALITY ASSESSMENT FOR
USE OF CAPSULE ENDOSCOPY (CE) IN
SUSPECTED SMALL BOWEL CROHN’S
DISEASE (CD)
I.M. Gralnek, J. Leighton, F. Papatheofanis
P1072
THE APPROPRIATENESS OF CONCOMI­
TANT IMMUNOMODULATORS WITH
ANTI­TNF IN CROHN’S DISEASE: AN EVI­
DENCE BASED APPROACH
G. Melmed, B. Spiegel, B. Bressler, A. Cheifetz,
S. Devlin, L. Harrell, P. Irving, J. Jones,
G. Kaplan, P. Kozuch, M. Sparrow, F. Velayos,
L. Baidoo, C. Siegel
P1073
SYSTEMATIC REVIEW: NEW INSIGHTS
INTO VARIABLES ASSOCIATED WITH
NON­ADHERENCE TO MEDICATION IN
IBD
C.A. Jackson, J. Clatworthy, A. Robinson,
R. Horne
P1074
ASSESSMENT OF ANTI­PROLIFERATIVE
RESPONSE SEEN WHEN ADDING SONI­
CATES FROM THE ISOLATED VSL#3 OR­
GANISMS TO PRE­STIMULATED MONO­
CYTES
M.W. Johnson, F. Pryen, P. Brigidi, A. Forbes,
P.J. Ciclitira, R. Nicholls
P1075
ADSORPTIVE DEPLETION OF CIRCULAT­
ING ALPHA4 INTEGRIN HI AND Cx3CR1
HI ExPRESSING PROINFLAMMATORY
MONOCYTES IN PATIENTS WITH ACTIVE
ULCERATIVE COLITIS
S. Takeda, T. Sato, T. Katsuno, T. Nakagawa,
Y. Noguchi, O. Yokosuka, Y. Saito
P1076
BONE METABOLISM FOLLOWING GRAN­
ULOCYTAPHERESIS THERAPY OF PA­
TIENTS WITH ULCERATIVE COLITIS
R. Kunisaki, K. Tanaka, Y. Suzuki
PosTeR sessIon
P1077
MUCOSAL HEALING WITH METHOTREx­
ATE IN CROHN’S DISEASE: A PROSPEC­
TIVE COMPARATIVE STUDY WITH AZA­
THIOPRINE AND INFLIxIMAB
D. Laharie, A. Reffet, E. Chabrun, C. Subtil,
E. Chanteloup, S. Razaire, V. de Lédinghen
P1078
MEDIUM TERM EFFICACY AND SAFETY
OF ADALIMUMAB THERAPY IN PATIENTS
WITH CROHN’S DISEASE. NATIONAL
DATA FROM HUNGARY
Z. Czegledi, P. Miheller, L. Lakatos,
A. Salamon, T. Molnar, A. Vincze, K. Palatka,
J. Czimmer, T. Szamosi, J. Banai, Z. Tulassay,
I. Altorjay, M. Papp, G. Horvath, O. Gemela,
K. Farkas, F. Nagy, J. Papp, P.L. Lakatos
P1079
MODULATING ExPRESSION OF FOxP3
CORRELATES WITH CLINICAL RESPONSE
TO INFLIxIMAB: NEW MECHANISM OF
ACTION FOR ANTI­TNF THERAPY IN IN­
FLAMMATORY BOWEL DISEASE
Z. Li, D. Bullens, S. Vermeire, I. Arijs,
M. Noman, C. Perrier, L. Coorevits, F. Schuit,
P. Rutgeerts, J. Ceuppens, G. Van Assche
P1080
A RANDOMISED, DOUBLE­BLIND, PLACE­
BO­CONTROLLED TRIAL INVESTIGATING
THE CLINICAL, MICROBIOLOGICAL AND
IMMUNOLOGICAL IMPACT OF FRUCTO­
OLIGOSACCHARIDES IN PATIENTS WITH
ACTIVE CROHN’S DISEASE
J.L. Benjamin, C.R.H. Hedin,
A. Koutsoumpas, S.C. Ng, A.L. Hart,
M.A. Kamm, J.D. Sanderson, S.C. Knight,
A. Forbes, A.J. Stagg, K. Whelan,
J.O. Lindsay
P1081
INFLIxIMAB MONOTHERAPY OR INFLIx­
IMAB IN COMBINATION WITH METHO­
TRExATE AND MUCOSAL HEALING IN
PATIENT WITH ULCERATIVE COLITIS
P.A. Makarchuk
187
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1082
LONG­TERM OUTCOME OF ULCERATIVE
COLITIS IN PATIENTS RESPONDING TO A
FIRST COURSE OF STEROIDS
E. Garcia-Planella, M. Mañosa, M. Van
Domselaar, J. Gordillo, Y. Zabana, E. Cabré,
A. Lopez-San Roman, E. Domènech
P1083
INFLUENCE OF SMOkING ON AZATHIO­
PRINE EFFICACY IN STEROID­DEPEN­
DENT INFLAMMATORY BOWEL DISEASE
M. Mañosa, E. Garcia-Planella, S. Carrion,
J. Gordillo, E. Cabré, M. Poca, C. Guarner,
E. Domènech
P1084
FACTORS ASSOCIATED WITH NONAD­
HERENCE TO MEDICAL THERAPY IN
INFLAMMATORY BOWEL DISEASE: THE
TOTEM SURVEY ON 1145 PATIENTS IN
FRANCE
M.C. Boutron-Ruault, P. Seksik, G. Tucat,
M.C. Dolléans, I. Idier, A. Marteau-Baudin,
C. Ramogida, G. Nisand, P. Marteau
P1085
ENROLLMENT IN IBD CLINICAL RE­
SEARCH: THE PATIENT’S POINT OF VIEW
M. Martinato, R. Caccaro, A. Caruso,
P. Bertomoro, L. Oliva, G.C. Sturniolo,
R. D’Incà
P1086
LOCAL GENE TRANSFER BY VESICULAR
STOMATITIS VIRUS G PROTEIN PSEUDO­
TYPED LENTIVIRUS (VSV­G LV) MEDI­
ATED MOUSE INTERLEUkIN 10 (MIL10)
SUPPRESSES THE DEVELOPMENT AND
RELAPSE OF ExPERIMENTAL MURINE
COLITIS
H. Matsumoto, K. Haga, I. Ohno, J. Elliott,
E. Faure-Kumar, N. Kasahara, P. Anton,
I. McGowan
188
P1087
APPROPRIATENESS OF THERAPY FOR
ACTIVE CROHN’S DISEASE: RESULTS OF
A MULTIDISCIPLINARY INTERNATIONAL
ExPERT PANEL (EPACT II)
P. Michetti, P. Juillerat, C. Mottet, V. Pittet,
M. Gassull, F. Heil, E. Stange, J. Gonvers,
J. Vader, F. Froehlich, C. Felley
P1088
INFLIxIMAB­INDUCED SERIAL CHANGES
IN CYTOkINE LEVELS IN CROHN’S DIS­
EASE
T. Mizutani, T. Chiba, R. Akasaka, K. Tomita,
K. Suzuki
P1089
INFLIxIMAB OR CYCLOSPORINE IN SE­
VERE STEROID­REFRACTORY ULCER­
ATIVE COLITIS: SHORT AND LONG­TERM
RESULTS IN TWO GROUPS OF TREATED
PATIENTS (A HISTORICAL COMPARISON)
F. Mocciaro, L. Oliva, A. Orlando,
D. Scimeca, S. Renna, M. Cottone
P1090
INFLIxIMAB FOR SEVERE ULCERATIVE
COLITIS: SHORT­TERM AND ONE YEAR
OUTCOME OF THREE DOSE REGIMEN.
AN ITALIAN MULTICENTRE OPEN­LABEL
STUDY
R. Monterubbianesi, A. Armuzzi, C. Papi,
M. Daperno, M. Marrollo, L. Biancone,
M. Cappello, A. Lavagna, V. Annese,
A. Orlando, A. Viscido, G. Riegler, G. Meucci,
R. Sostegni, L. Guidi, C. Petruzziello,
S. Peralta, C. Prantera, A. Kohn
P1091
WHICH DRUGS ARE SAFE IN MALE
AND FEMALE PATIENTS CONSIDER­
ING CONCEPTION, AND IN PREGNANT
WOMEN AND NURSING MOTHERS, WITH
CROHN’S DISEASE? RESULTS OF A MUL­
TIDISCIPLINARY INTERNATIONAL Ex­
PERT PANEL (EPACT II)
C. Mottet, J. Vader, C. Felley, F. Froehlich,
J. Gonvers, P. Juillerat, R. Stockbrügger,
E. Angelucci, F. Seibold, P. Michetti, V. Pittet

P1092
A COMBINED DELAYED AND ExTENDED
RELEASE FORMULATION OF MESALA­
MINE DEMONSTRATES BETTER CLINICAL
OUTCOME IN DISTAL, ACTIVE ULCER­
ATIVE COLITIS THAN A SOLELY DELAYED
RELEASE FORMULATION
P. Gibson, W. Kruis, R. Greinwald, R. Mueller
P1093
EFFICACY AND SAFETY OF ORAL MESA­
LAMINE IN ELDERLY ULCERATIVE COLITIS
PATIENTS: A POOLED ANALYSIS FROM
FOUR RANDOMIZED, DOUBLE­BLIND,
CONTROLLED CLINICAL TRIALS
W. Kruis, R. Greinwald, R. Mueller
P1094
EFFECT OF ADALIMUMAB ON CLINICAL
COMPLICATIONS/ABNORMALITIES INDI­
CATED BY CLINICAL LAB PARAMETERS
FOR PATIENTS WITH MODERATE TO SE­
VERE CROHN’S DISEASE
D.T. Rubin, S. Ghosh, A.G. Bensimon,
A.P. Yu, E.Q. Wu, P.F. Pollack, P. Mulani,
J. Chao
P1095
Withdrawn by author
P1096
HEALTH CARE RESOURCE USE BY PA­
TIENTS WITH CROHN’S DISEASE IN EU­
ROPE
E. Louis, E.V. Loftus Jr., J. Cristino, J. Pike,
P. Mulani, J. Chao
P1097
EFFECT OF ADALIMUMAB ON WORk
PRODUCTIVITY AND INDIRECT COSTS
IN MODERATE TO SEVERE CROHN’S DIS­
EASE: A META­ANALYSIS
D. Binion, E. Louis, A.P. Yu, A.G. Bensimon,
E.Q. Wu, P. Mulani, J. Chao
PosTeR sessIon
P1098
SEVERITY AT TIME OF DIAGNOSIS IS AS­
SOCIATED WITH THE FURTHER DEVEL­
OPMENT OF STRICTURING CROHN’S
DISEASE
E. Louis, J. Cristino, J. Pike, J. Chao,
P. Mulani
P1099
MUCOSAL HEALING IS ASSOCATED
WITH SUBSEQUENT QUALITY­OF­LIFE
IMPROVEMENTS IN PATIENTS WITH
CROHNS’S DISEASE: SUBGROUP ANALY­
SIS OF THE ExTEND TRIAL
K. Geboes, P. Rutgeerts, A. Camez, N. Chen,
P. Mulani, J. Chao
PosTeR sessIon
nerve, gut and motility II
P1100
RECTAL TONE AND SENSATION IN PA­
TIENTS WITH CONGENITAL AND TRAU­
MATIC SPINAL CORD INJURY IN FASTING
AND FED STATES
R.A. Awad, S. Camacho, C. Santillan
P1101
ANTI­INFLAMMATORY EFFECT OF VA­
GUS NERVE STIMULATION IN A RAT
MODEL OF COLITIS
J. Meregnani, D. Clarençon, C. Picq,
V. Sinniger, B. Bonaz
P1102
INFLUENCE OF GASTROINTESTINAL
FOOD ALLERGY ON COLONIC IMMUNE
ACTIVATION AND BARRIER INTEGRITY IN
THE IRRITABLE BOWEL SYNDROME
R. Dainese, P. Stéphanie, M. Vivinus,
M. Saint-Paul, J. Nano, A. Bernard,
A. Iannelli, X. Hébuterne, M. Neunlist,
T. Piche
189
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1103
PROTEASE ACTIVATED RECEPTOR 2
EVOkED VISCERAL HYPERSENSITIVITY IN
RAT IS PARTIALLY MUCOSA MAST CELL
DEPENDENT
Y.Y. Wei, Y.X. Leng, L.P. Duan
P1104
CHANGES IN EVOkED BRAIN POTEN­
TIALS TO GUT STIMULATION IN DIABE­
TES PATIENTS WITH GASTROINTESTINAL
SYMPTOMS
J.B. Frøkjær, E. Søfteland, C. Graversen,
G. Dimcevski, L.L. Egsgaard, A.M. Drewes
P1105
CENTRAL NEUROPLASTIC REORGANI­
SATION OF GASTROINTESTINAL PAIN
PROCESSING IN DIABETIC AUTONOMIC
NEUROPATHY
J.B. Frøkjær, L.L. Egsgaard, C. Graversen,
E. Søfteland, G. Dimcevski, A.M. Drewes
P1106
SACRAL NERVE STIMULATION (SNS) FOR
FUNCTIONAL ANAL PAIN IS NOT AN EF­
FECTIVE TREATMENT OPTION
J. Hollingshead, A.T. George, T. Dudding,
J. Nicholls, C. Vaizey
P1107
ROLE OF CENTRAL CRF2 PATHWAY
IN THE MODULATION OF IN STRESS­
INDUCED COLONIC SENSITIVE­MOTOR
FUNCTIONS
G. Gourcerol, M. Million, M. Larauche,
Y. Taché
P1108
INTRAGASTRIC LOCALIZATION OF CON­
TENTS DETERMINES HUNGER AND SATI­
ETY SENSATIONS: EFFECTS OF GHRELIN
AND GLUCAGON­LIkE PEPTIDE­1
P.M. Hellström, M. Degerblad, T. Edholm,
F. Levin, P.T. Schmidt, P. Grybäck,
H. Jacobsson, J.J. Holst, E. Näslund
190
P1109
EFFECTS OF SMOkING CESSATION ON
LEPTIN AND GHRELIN LEVEL IN SMOk­
ERS
K. Kadota, F. Takeshima, A. Yoda,
Y. Tatsuta, Y. Nagaura, K. Inoue, S. Yoshioka,
S. Nakamichi, Y. Ozono
P1110
LONG TERM FOLLOW­UP OF SYMPTOM­
ATIC AND NEUROPATHIC CHANGES IN
PATIENTS WITH POSTCHOLECYSTEC­
TOMY SYNDROME AND SPHINCTER OF
ODDI DYSFUNCTION AFTER ENDOSCOP­
IC SPHINCTEROTOMY – RISk FACTORS
OF THERAPEUTIC FAILURE
G. Kurucsai, V. Juhasz, I. Joo, R. Fejes,
A. Szekely, I. Szekely, P. Funch-Jensen,
L. Madacsy
P1111
UROCORTIN, CORTICOTROPIN­RELEAS­
ING FACTOR FAMILY, DECREASES FEED­
ING VIA INHIBITION OF SECRETION AND
PRODUCTION OF GHRELIN
S. Ohno, S. Ro, T. Onouchi, M. Ochiai,
S. Kato, M. Noguchi, M. Yuzurihara,
T. Hattori, K. Yakabi
P1112
THE RELATIONSHIP BETWEEN BOWEL
AND URO­GENITAL DYSFUNCTION IN
MULTIPLE SCLEROSIS
G. Preziosi, N. Thoua, P. Boulos,
A. Emmanuel
P1113
RAT MODELS OF COLONIC HYPERSEN­
SITIVITY INDUCED BY INTRACOLONIC
INSTILLATION OF ACETIC ACID AND
PROTEASE­ACTIVATED RECEPTOR­2
AGONIST: EFFECTS OF A MAST CELL
STABILIZER AND 5­HT3 RECEPTOR AN­
TAGONIST
R. Takezawa, H. Doihara, Y. Keto,
H. Tanaka, T. Yokoyama, M. Okada, H. Ito

P1114
REDUCED MUCOSAL EOSINOPHIL AC­
TIVITY IN THE JEJUNUM OF DIARRHEA­
PRONE IRRITABLE BOWEL SYNDROME
PATIENTS
M. Vicario, C. Martinez, B. Lobo, L. Ramos,
M. Guilarte, C. Alonso, I. de Torres, J. Santos
P1115
ABNORMAL VISCERAL AND SOMATIC
PAIN MODULATION IN IBS PATIENTS OF
DIFFERENT ETHNICITY
C.H. Wilder-Smith
P1116
MEASUREMENTS OF BISACODYL AND
SODIUM PICOSULFATE IN BREAST MILk
OF HEALTHY POSTPARTUM WOMEN
C. Friedrich, U. Hinkel, E. Richter,
D. Trommeshauser, S. de Kruif, J. Bubeck
P1117
SENSATION ELICITED DURING DISTEN­
SION IN THE ESOPHAGUS IN PATIENTS
WITH FUNCTIONAL CHEST PAIN IS
CAUSED BY MECHANICAL FACTORS
RATHER THAN BY MUCOSAL ISCHEMIA
D.A.L. Hoff, H. Gregersen, S. Oedegaard,
J.G. Hatlebakk
P1118
SYMPTOM SEVERITY, QUALITY OF LIFE
AND ASSOCIATED FACTORS IN PATIENTS
WITH IRRITABLE BOWEL SYNDROME
MANAGED IN PRIMARY CARE
R. Jones, C.L. Hunt, A.P.S. Hungin
P1119
EFFECT OF LINACLOTIDE DURING THE
FIRST WEEk OF TREATMENT ON IBS­C
SYMPTOMS: RESULTS FROM A PHASE
2B STUDY
J.M. Johnston, B.J. Lavins, J.E. MacDougall,
H.A. Schneier, S.J. Shiff, M.G. Currie,
C.B. Kurtz, A.J. Lembo
PosTeR sessIon
P1120
CORRELATIONAL STRUCTURE OF IBS­C
PRO SYMPTOM MEASURES DETERMINED
BY ExPLORATORY FACTOR ANALYSIS
AND RELATIONSHIP TO GLOBAL PRO AS­
SESSMENTS: RESULTS FROM A PHASE 2
TRIAL OF LINACLOTIDE IN IBS C
J.M. Johnston, R.T. Carson, L.M. Nelson,
M.A. Price, V.S.L. Williams, J.E. MacDougall
P1121
THE EFFICACY OF BIOBRAN, ARABINOx­
YLAN COMPOUND DERIVED FROM RICE
BRAN, IN PATIENTS WITH IRRITABLE
BOWEL SYNDROME
T. Kamiya, M. Shikano, M. Tanaka,
T. Nizushima, Y. Hirata, M. Ebi, I. Kobayashi,
T. Shimura, K. Murakami, T. Mizoshita,
E. Kubota, S. Tanida, H. Kataoka, T. Joh
P1122
THE EFFICACY OF FLUOxETINE IN COM­
PARE WITH DOxEPIN IN TREATMENT OF
IRRITABLE BOWEL SYNDROME; RESULTS
OF RANDOMIZED CLINICAL TRIAL
A.A. Keshavarz, H. Bashiri, S. Bazargan-
Hejazi, I. Rezaei
P1123
RANDOMIZED PLACEBO­CONTROLLED
TRIAL ASSESSING THE EFFECT OF LAC­
TOBACILLUS ACIDOPHILUS IN IRRITABLE
BOWEL SYNDROME MODULATING IN­
TESTINAL PAR2 AND MAST CELL
D. Kim, S. Myung, S. Lee, I. Kim, Y. Cho,
Y. Park, D. Yang, S. Yoon, K. Kim, B. Ye,
J. Byeon, H. Jung, S. Yang, J. Kim
P1124
THE INCIDENCE AND RISk FACTORS OF
IRRITABLE BOWEL SYNDROME AFTER
BACTERIAL DYSENTERY IN kOREA: PRE­
LIMINARY RESULTS FROM ONGOING
STUDY
S.J. Koh, D.H. Lee, N.Y. Kim, Y.S. Park,
H.C. Jung
191
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1125
EFFICACY OF VENLAFAxINE FOR SYMP­
TOMATIC RELIEF IN YOUNG ADULT
PATIENTS WITH FUNCTIONAL CHEST
PAIN – A RANDOMISED, DOUBLE­BLIND,
PLACEBO­CONTROLLED, CROSSOVER
TRIAL
H. Lee, J. Kim, P. Rhee, H. Son, J. Kim, J. Rhee
P1126
EVOkED PRESSURE CURVES FROM ANAL
SPHINCTER BY MAGNETIC STIMULATION
IN HEALTHY VOLUNTEERS IN PATIENTS
WITH ANAL INCONTINENCE
A. Leroi, G. Gourcerol, E. Verin, N. Chastan,
J. Weber
P1127
THE EFFECTS OF GROUND AND WHOLE
LINSEEDS ON THE SYMPTOMS OF IRRITA­
BLE BOWEL SYNDROME: A PILOT STUDY
K. Cockerell, S. Watkins, L. Goddard,
L. Reeves, M.C.E. Lomer
P1128
CYCLIC VOMITING SYNDROME (CVS):
TEN­YEAR ExPERIENCE IN A REFERRAL
CENTER
S. Martinazzi, F. Gottardi, C. Monfredini,
A. Ravelli
P1129
LACTOBACILLUS REUTERI IN INFANTS
WITH FUNCTIONAL CHRONIC CONSTI­
PATION: A DOUBLE­BLINDED, RANDOM­
IZED, PLACEBO­CONTROLLED STUDY
M. Martinelli, P. Coccorullo, E. Miele,
D. Russo, L. Greco, A. Staiano
P1130
IRRITABLE BOWEL SYNDROME AND
CHRONIC CONSTIPATION IN PATIENTS
WITH ENDOMETRIOSIS
M.M. Meurs-Szojda, V. Mijatovic,
R.J.F. Felt-Bersma, P.G.A. Hompes
192
P1131
THE ROLE OF BOTULINUM TOxIN IN THE
MANAGEMENT OF ACALCULUS BILIARY
PAIN
W.R. Murray, S.C. Kong
PosTeR sessIon
oncology II
P1132
POSTOPERATIVE SURVEILLANCE AFTER
COLORECTAL CANCER OPERATION, ES­
PECIALLY WITH INCOMPLETE PREOPERA­
TIVE COLONOSCOPY
D. Hwang, E. Jung, C. Ryu, S. Moon
P1133
CRYPTOSPORIDIUM PARVUM CAN IN­
DUCE GASTRO­INTESTINAL CANCER IN
IMMUNOSUPPRESSED HOSTS
G. Certad, C. Creusy, T. Ngouanesavanh,
K. Guyot, N. Gantois, A. Mouray, T. Chassat,
L. Fleurisse, A. Pinon, E. Dei-Cas
P1134
ELEVATED OSTEOPONTIN ExPRESSION
AND PROLIFERATIO/APOPTOSIS RA­
TIO IN THE COURSE OF COLORECTAL
ADENOMA­DYSPLASIA­CARCINOMA
SEQUENCE
G. Valcz, F. Sipos, O. Galamb, T. Krenacs,
S. Spisak, K. Toth, N. Solymosi, B. Molnar,
Z. Tulassay
P1135
EVALUATION OF PROLIFERATIVE/APOP­
TOTIC RATIO AND MITOTIC INDEx IN HIS­
TOLOGICALLY INTACT CHILDREN COLON
SAMPLES AND IN ADULT ADENOMA­
DYSPLASIA­CARCINOMA SEQUENCE
K. Leiszter, F. Sipos, O. Galamb, T. Krenacs,
S. Spisak, G. Veres, A. Kiss, B. Wichmann,
K. Toth, G. Valcz, O. Jasz, A. Kalmar,
B. Molnar, Z. Tulassay

P1136
ANTICANCER EFFECTS OF ASTAxANTHIN
IN STOMACH CANCER CELL LINES
J. Park, B. Lee, S. Hong, M. Joo, J. Hwang,
Y. Chung, J. Kim, J. Yeon, J. Kim, K. Byun,
Y. Bak
P1137
EFFECTS OF NEW MALEIMIDE DERIVATE
ON THE 1,2­DIMETHYLHYDRAZINE­IN­
DUCED COLON CARCINOGENESIS IN
RATS
O. Lynchak, G. Ostrovska, V. Rybalchenko
P1138
Withdrawn by author
P1139
SIMULATION OF A COLORECTAL POLYP­
OID LESION – A PILOT PORCINE MODEL
D. Kopelman, A. Szold, Y. Kopelman,
A. Geller, S. Lelcuk, A. Bapaye,
P.D. Siersema
P1140
HYPOxIA UP­REGULATES SERPIN B3 IN
HEPG2 CELLS: A HIF­2ALFA ASSOCIATED
AND REDOx SENSITIVE EVENT RELATED
TO INVASIVENESS AND EPITHELIAL TO
MESENCHYMAL TRANSITION
S. Cannito, C. Turato, S. Quarta,
C. Paternostro, T. Musso, E. David,
S. Colombatto, A. Biasiolo, P. Pontisso,
M. Parola
P1141
MSI­H STATUS PREDICTS THE ABSENCE
OF RESPONSE TO ADJUVANT
G. Des Guetz, B. Uzzan, O. Schischmanoff,
P. Nicolas, R. Benamouzig, G. Perret,
J. Morere
PosTeR sessIon
P1142
HIGH RESOLUTION ARRAY COMPARA­
TIVE GENOMIC HYBRIDIZATION IN SPO­
RADIC AND COELIAC DISEASE­RELATED
SMALL BOWEL ADENOCARCINOMAS
B. Diosdado, T.E. Buffart, R. Watkins,
B. Carvalho, B. Ylstra, M. Tijssen,
A.S. Bolijn, F. Lewis, K. Maude, C. Verbeke,
I.D. Nagtegaal, H.I. Grabsch, C.J.J. Mulder,
P. Quirke, P.D. Howdle, G.A. Meijer
P1143
IDENTIFICATION OF CANDIDATE PRO­
TEIN BIOMARkERS FOR COLORECTAL
CANCER SCREENING
R.J.A. Fijneman, M. de Wit,
M. Pourghiasian, P.M. van Diemen,
S. Piersma, E.C. Robanus-Maandag,
R. Smits, R. Fodde, V.W.M. van Hinsbergh,
G.A. Meijer, C.R. Jimenez
P1144
REVERSAL OF GENE ExPRESSION PAT­
TERN CHANGES IN THE COLORECTAL
NORMAL­ADENOMA BUT LESS IN THE
NORMAL­CARCINOMA PATHWAY BY NS­
398 SELECTIVE COx­2 INHIBITOR
O. Galamb, F. Sipos, S. Spisak, K. Toth,
N. Solymosi, B. Wichmann, T. Krenacs,
G. Valcz, O. Jasz, B. Molnar, Z. Tulassay
P1145
ENDOGLIN (ENG)/CD105: A NOVEL
MARkER FOR kIT+ CELLS IN MOUSE AND
HUMAN GASTROINTESTINAL STROMAL
TUMOURS
P. Gromova, C. Erneux, B.P. Rubin,
J. Vanderwinden
P1146
COPY NUMBER PROFILES FROM SMALL
BOWEL ADENOCARCINOMAS ARE MORE
SIMILAR TO PROFILES FROM COLOREC­
TAL CANCER THAN GASTRIC CANCER
J.C. Haan, T.E. Buffart, M.A. van de Wiel,
B. Carvalho, C. Postma, N.C.T. van Grieken,
I.D. Nagtegaal, C.J. Mulder, K. Maude,
P. Howdle, P. Quirke, H. Grabsch, B. Ylstra,
G.A. Meijer
193
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1147
CLINICAL VALUE OF RECURRENT FOCAL
DELETIONS IN STAGE II COLON CANCER
R.P.M. Brosens, J.C. Haan, B. Carvalho,
F. Rustenburg, H. Grabsch, A.F. Engel,
M.A. Cuesta, M. Flens, G.A. Meijer, B. Ylstra
P1148
CLINICOPATHOLOGICAL CHARACTER­
ISTICS OF INVASIVE MICROPAPILLARY
VARIANT (IMPV) AS A PROGNOSIS FAC­
TOR OF THE GALLBLADDER CANCER
S. Hara, H. Kijima, Y. Kudo, H. Akasaka,
H. Jin, S. Tsutsumi, K. Okada, Y. Igarashi
P1149
CLINICAL SIGNIFICANCE OF HUMAN
kALLIkREIN7 GENE ExPRESSION IN
COLORECTAL CANCER
Y. Inoue, T. Yokobori, T. Yokoe, Y. Toiyama,
C. MIki, K. Mimori, M. Mori, M. Kusunoki
P1150
ESTROGEN RECEPTOR ALPHA (ER AL­
PHA) SIGNALING PATHWAY IS A NEW
THERAPEUTIC TARGET IN ER ALPHA­
POSITIVE GASTRIC CANCER: A POSSIBLE
CROSSTALk BETWEEN ER ALPHA AND
HEDGEHOG SIGNALING PATHWAYS
C. Kameda, M. Nakamura, H. Ohnishi,
M. Kubo, M. Tanaka, M. Katano
P1151
NON NEOPLASTIC DIAGNOSES IN THE
NHS BOWEL CANCER SCREENING PRO­
GRAMME
T.J.W. Lee, L. Wells, M. Ritchie, G. Clifford,
C. Rees, M.D. Rutter
P1152
SHOULD THE COLONOSCOPY BE RECOM­
MENDED IN HEALTHY SUBJECTS WITH
THE ELEVATED LEVEL OF CARCINOEM­
BRYONIC ANTIGEN AND NEGATIVE FIND­
INGS OF EGD?: CASE­CONTROL STUDY
J. Lee, S. Hong, H. Bok, J. Shin, S. Jeon,
C. Moon, J. Park, J. Cheon, T. Kim, W. Kim
194
P1153
COMPARISON OF DIFFERENT IMMU­
NOLOGICAL FOBTS WITH M2­Pk FOR
COLORECTAL CANCER SCREENING:
DOES THE CHOICE OF TEST MATTER?
A. Leodolter, D. Zielinski, M. Vieth,
J. Labenz
P1154
B­PREDICT TRIAL: 3­YEARS RESULTS OF A
STATE­WIDE SCREENING PROGRAM FOR
PREVENTION OF COLORECTAL NEOPLA­
SIA WITH AN IMMUNOLOGICAL FOBT (IF­
OBT) IN THE PROVINCE BURGENLAND/
AUSTRIA
G. Leeb, A. Leodolter, G. Haidinger, C. Vutuc,
F. Stockenhuber, K. Mach
P1155
COLONOSCOPY FOR BOWEL CANCER
SCREENING IN A DISTRICT GENERAL
HOSPITAL – THE PATIENTS VIEW
G.R. Lipscomb, E. O’Brien, R. Sringeri
P1156
THE NATIONAL BOWEL CANCER SCREEN­
ING PROJECT; THE FIRST TWO YEARS
ExPERIENCE IN A DISTRICT GENERAL
HOSPITAL
G.R. Lipscomb, E. O’Brien, R. Sringeri,
J. Adams
P1157
MALNUTRITION IN GASTROENTEROPAN­
CREATIC NEUROENDOCRINE TUMOURS:
PREVALENCE, SEVERITY AND INFLUENCE
ON CLINICAL OUTCOME
S. Maasberg, B. Drzikova, H. Jann,
K.H. Weylandt, T. Denecke, M.E. Pavel,
B. Wiedenmann, A. Sturm, U. Pape
P1158
INCIDENCE AND OUTCOME OF UP­
PER GASTROINTESTINAL CANCERS
AMONGST URGENT CANCER REFERRALS
IN A Uk DISTRICT GENERAL HOSPITAL
S. Mahmood, T. Ali, J. White, S. Sajjad,
A. Palejwala

P1159
DETECTION OF ADVANCED NEOPLASIA
IN A SCREENING PROGRAM FOR A FIRST
DEGREE RELATIVES OF PATIENTS DIAG­
NOSED OF COLORECTAL CANCER
M.A. Marin, J.J. Puente, P. Bueno,
J.L. Dominguez, E. Bernal, J. Torralbo,
E. Pelado, R. Copado
P1160
RESULTS OF A POPULATION BASED
COLORECTAL CANCER SCREENING PI­
LOT PROGRAM IN MURCIA, SPAIN WITH
MODIFIED FIT THRESHOLDS: ARE MANY
SIGNIFICANT LESIONS MISSED WHEN
LESS COLONOSCOPIES ARE INDICATED?
A. Ono, F. Carballo, F. Riquelme, J. Cruzado,
E. Torrella, P. Esteban, M. Cavas, E. Perez
Cuadrado
P1161
FLAT COLONIC NEOPLASIA ARE LEFT UN­
DETECTED BY FECAL IMMUNOCHEMI­
CAL TESTS (FIT) AND WILL BE MISSED
IN COLORECTAL CANCER SCREENING
F.A. Oort, J.S. Terhaar sive Droste,
R.W.M. Van der Hulst, S.T. Van Turenhout,
H.A. Van Heukelem, R.J.L.F. Loffeld,
E.I.C. Wesdorp, Q.J.M. Voorham, G.A. Meijer,
C.J.J. Mulder
P1162
HIGHER CUT OFF VALUES FOR FIT IN
CRC­SCREENING: LESS COLONOSCOPIES,
SAME DETECTION RATES FOR CURABLE
CANCERS
F.A. Oort, J.S. Terhaar sive Droste,
R.W.M. Van der Hulst, S.T. Van Turenhout,
H.A. Van Heukelem, R.J.L.F. Loffeld,
E.I.C. Wesdorp, I. Ben Larbi, S.L. Kanis,
M. Neerincx, M. Räkers, V.H.M. Coupé,
G.A. Meijer, C.J.J. Mulder
PosTeR sessIon
P1163
ADVANCED NEOPLASIA OF THE LEFT
HEMICOLON ARE BETTER DETECTED BY
FIT THAN RIGHT SIDED LESIONS
F.A. Oort, R.W.M. Van der Hulst,
J.S. Terhaar sive Droste, S.T. Van Turenhout,
H.A. Van Heukelem, R.J.L.F. Loffeld,
E.I.C. Wesdorp, R. Duijkers, R.A.M. Ooteman,
Z.D. Valdehueza, M.Q. Wentink,
V.M.H. Coupé, G.A. Meijer, C.J.J. Mulder
P1164
GASTROINTESTINAL NEUROENDOCRINE
TUMOURS: TUMOUR CHARACTERISTICS
AND TREATMENT MODALITIES DETER­
MINE LONG­TERM CLINICAL OUTCOME
U. Pape, S. Maasberg, H. Jann, R. Lohmann,
U. Plöckinger, D. Hörsch, A. Rinke,
P. Goretzki, C. Auernhammer, H. Lehnert,
G. Klöppel, B. Wiedenmann
P1165
SOCIOECONOMIC FACTORS OF
COLORECTAL CANCER SCREENING COM­
PLIANCE
C. Pornet, O. Dejardin, F. Morlais, V. Bouvier,
G. Launoy
P1166
PARTICIPANT’S AGE AND NUMBER OF
FAECAL SAMPLES HAVE SIGNIFICANT IM­
PACT IN POPULATION­BASED COLOREC­
TAL CANCER SCREENING PROGRAMME
A. Qasim, N. Ullah, N. Appleby, N. Lee,
N. Swan, G. Boran, P. Neary, E. Eguare,
D. Hughes, P. O’Gorman, J. O’Loughlin,
P. Walsh, C. Condon, W. Torreggiani,
C. O’Morain
P1167
NITRATE AND NITRITE CONTAMINATION
AND THE RISk OF UPPER GASTROINTES­
TINAL CANCERS IN GOLESTAN PROV­
INCE, NORTHEAST OF IRAN
A. Arabali, S. Semnani, S. Besharat,
G. Roshandel, A. Keshtkar, N. Behnampour,
T. Amiriani
195
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1168
RANDOMIZED CONTROLLED TRIAL
EVALUATING THE EFFECTIVENESS OF
ONE­SHOT SCREENING COLONOSCOPY:
STUDY DESIGN
H. Saito, S. Yamamoto, S. Kudo, K. Kodama,
F. Ishida, H. Yamano
P1169
LIFESTYLE AND GASTRIC METAPLASIA­
CANCER. A HOSPITAL BASED CASE CON­
TROL STUDY IN ECUADOR
I. Salvador, M. Fornasini, L. Carrillo,
R. Guerrero, M. Mencias, F. Palomeque,
P. Villacis, M. Fierro, C. Garces, J. Atiaja
PosTeR sessIon
liver II
P1170
INSULIN RESISTANCE, STEATOSIS AND
FIBROSIS IN EGYPTIAN PATIENTS WITH
CHRONIC HEPATITIS C VIRAL INFECTION
A.M. Ahmed, M.S.H. Hassan, H.G. Rashed,
H.E. Esmaeel, A.F. Hassanen
P1171
CLINICAL AND RADIOLOGICAL FEA­
TURES OF PATHOLOGICALLY­PROVEN
FOCAL NODULAR HYPERPLASIA AND
MULTIACINAR REGENERATIVE NODULE
OF THE LIVER
J. Choi, H. Lee, K. Kim, Y. Lim, Y. Chung,
Y. Lee, D. Suh
P1172
ENDOSCOPIC VARICEAL LIGATION AND
PROPRANOLOL ARE EQUALLY EFFECTIVE
IN PREVENTION OF VARICEAL REBLEED­
ING IN PATIENTS WITH NON CIRRHOTIC
PORTAL HYPERTENSION: A RANDOM­
IZED CONTROLLED TRIAL
N. Gupta, A. Kumar, S.R. Mishra,
A. Agrawal, S.K. Sarin
196
P1173
LIVER DAMAGE RELATED WITH “HERBAL
MEDICINE” AND OTHER MEDICATIONS.
ExPERIENCE IN A NATIONAL MEDICAL
CENTER IN MExICO
M.L. Hernandez Reyes, M. Dehesa V,
L. Cabrera, O.V. Hdez Mondragon
P1174
LIVER DISEASE IN COMMON VARIABLE
IMMUNODEFICIENCY
A. Aravinthan, S. Davies, G. Alexander,
W. Griffiths, P. Richardson
P1175
Withdrawn by author
P1176
DOES HLA­DR7 DIFFERENTIATE THE
OVERLAP SYNDROME OF AUTO­IM­
MUNE HEPATITIS­PRIMARY BILIARY
CIRRHOSIS FROM THOSE WITH AUTO­
IMMUNE HEPATITIS TYPE 1?
E. Coss-Adame, U. Misael, G. Julio, T. Aldo
P1177
SMALL DUCT PSC IS NOT A DISEASE EN­
TITY OF ITS OWN – ITS ONLY A QUESTION
OF DIAGNOSTIC TECHNIQUES
M.A. Färkkilä, K. Numminen, L. Krogerus
P1178
IMPACT OF AGE ON NATURAL HISTORY
AND RESPONSE TO TREATMENT OF
TYPE 1 AUTO­IMMUNE HEPATITIS
A. Heurgué-Berlot, P. Toupance, F. Vitry,
B. Bernard-Chabert, M. Diebold, H. Louvet,
P. Geoffroy, G. Thiéfin
P1179
HERPES SIMPLEx VIRUS TYPE 1 AS A
TRIGGER OF DISEASE­SPECIFIC ANTI­
NUCLEAR RESPONSES IN PATIENTS WITH
PRIMARY BILIARY CIRRHOSIS
A.L. Koutsoumpas, P. Pavlides,
M.G. Mytilinaiou, E.I. Rigopoulou,
D. Vergani, D.P. Bogdanos

P1180
HISTOLOGICAL STEATOSIS PRESENTA­
TION IN PRIMARY BILIARY CIRRHOSIS
PATIENTS CORRELATES WITH BODY
MASS INDEx, DIABETES MELLITUS CO­
MORBIDITY AND INDICES OF BILE DUCT­
ULES INJURY
V. Liakina, A. Barakauskiene, D. Speiciene,
J. Valantinas
P1181
AUTOIMMUNE HEPATITIS: RETROSPEC­
TIVE EVALUATION OF THE LAST 10 YEARS
AND COMPARISON OF TWO DIAGNOS­
TIC SCORES
M.V. Machado, J. Nunes, A. Costa,
A. Fernandes, H. Cortez-Pinto, J. Velosa
P1182
GENETIC POLYMORPHISMS OF MAVS
ARE ASSOCIATED WITH HEPATITIS C VI­
RUS RELATED SEVERE LIVER DISEASES
S. Medhi, M. Deka, P. Kar
P1183
CHARACTERIZATION OF CHOLANGITIS
ASSOCIATED WITH ExPERIMENTAL AU­
TOIMMUNE PANCREATITIS IN MICE
A. Nishio, M. Yamashina, S. Nakayama,
T. Fukui, K. Uchida, K. Okazaki
P1184
SEVERITY OF ACUTE HEPATITIS AND
OUTCOME IN PATIENTS WITH DENGUE
FEVER AT A TERTIARY CARE CENTER
O. Parkash, O. Parkash, A. Almas,
S. Hasnain Alishah, S. Wasim Jafri,
S. Hamid, J. Akhtar
P1185
SPECTRUM OF SCLEROSING CHOLANGI­
TIS IN TROPICAL COUNTRY LIkE INDIA
N.D. Patel, D.N. Amarapurkar
PosTeR sessIon
P1186
IMPAIRED CHEMOkINE RECEPTOR BUT
NOT T REGULATORY CELL ExPRESSION
IS PARTIALLY RESTORED AFTER VACCI­
NATION IN NEWBORNS BORN TO HBV
POSITIVE MOTHERS
S. Shrivastava, N. Trehanpati, C. Pande,
K. Bhutia, S. Patra, S. Trivedi, S. Sarin
P1187
MOLECULAR MIMICRY MECHANISMS
IN THE DEVELOPMENT OF ANTI­CYTO­
CHROME P4502E1 AUTO­ANTIBODIES
ASSOCIATED WITH CHRONIC HEPATI­
TIS C
S. Sutti, M. Vidali, C. Mombello, M. Sartori,
E. Albano
P1188
AN INVESTIGATION INTO THE ASSOCIA­
TION BETWEEN E. COLI URINARY TRACT
INFECTION AND DEVELOPMENT OF PRI­
MARY BILIARY CIRRHOSIS, A CASE CON­
TROL STUDY
F. Varyani, J. West, T. Card
P1189
ABSENCE OF TUMOR OUTCOME AFTER
AUTOLOGUS BONE MARROW (BM) STEM
CELL TRANSPLANTATION FOR LIVER CIR­
RHOSIS
R. Malekzadeh, M. Bagheri,
K. Alimoghaddam, M. Mohamadnejad,
H. Baharvand, A. Ghavamzadeh
P1190
EVALUATION OF DIETARY CHANGE FOR
TYPE 2 DIABETES PATIENTS WITH HEPA­
TITIS C
E.D. Rusu, F.I. Rusu, A. Dragomir,
G. Radulian, M. Jinga, I. Ancuta, S. Stanciu,
V. Stoica, D. Cheta
197
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1191
DEVELOPMENT OF SYSTEMS FOR CUL­
TURING MURINE BONE MARROW­DE­
RIVED CELLS USING THE HIGH­DENSITY
METHOD AND ISOLATING SENESCENT
BONE MARROW CELLS
T. Takami, S. Terai, I. Sakaida
P1192
THE ELECTRON MICROSCOPICAL ANALY­
SIS FOR CELL LINEAGE OF BONE MAR­
ROW CELL DIFFERENTIATION IN CIRRHO­
SIS MICE
N. Yamamoto, S. Terai, T. Iwamoto,
T. Ishikawa, T. Takami, K. Omori, K. Uchida,
T. Yamasaki, H. Nishina, I. Sakaida
P1193
NON­ALCOHOLIC FATTY LIVER DISEASE
IN PATIENTS WITH METABOLIC SYN­
DROME – ASSESSEMENT OF CLINICAL
PREDICTORS OF SEVERITY
A.S.P. Adabala, M. Kilari, M. Palakurthi,
P. Edara
P1194
ASSESSMENT OF METABOLIC SYN­
DROME IN PATIENTS WITH PRIMARY
BILIARY CIRRHOSIS
T. Alempijevic, R. Jesic, D. Macut, B. Milicic,
S. Damjanovic, A. Sokic Milutinovic,
I. Jovanovic, M. Petrovic, N. Kovacevic,
M. Krstic
P1195
IMPACT OF A NURSE­LED LIFESTYLE
CLINIC ON THE OUTCOME OF NAFLD
S. Al-shamma, H. Smart, M. Lombard,
H. Caldwell, J. Barr, D. Mallon, M. Fox
P1196
PREVALENCE OF NON ALCOHOLIC FATTY
LIVER DISEASE AND ASSOCIATED RISk
FACTORS IN PATIENTS UNDERGOING
CHOLECYSTECTOMY
S. Nijhawan, N.S. Behl, S. Kumpawat,
K.D. Mehenderitta, P. Ashdhir, G. Gupta,
A. Mathur, S. Nepalia, R.R. Rai
198
P1197
VALIDATION OF THE FATTY LIVER INDEx
(FLI) FOR THE DIAGNOSIS OF NAFLD IN
PRIMARY CARE IN ITALY
S. Bellentani, C. Nebia Colombo, C. Tosetti,
E. Benedetto
P1198
PREVALENCE AND CLINICAL SIGNIFI­
CANCE OF SLIGHTLY INCREASED LIVER
TRANSAMINASES LEVELS IN CONSECU­
TIVE SUBJECTS TESTED IN A HOSPITAL
LABORATORY
F. Benini, C. Guion, O. Angelini, E. Mori, O. Di
Stefano, A. Lanzini
P1199
GENOTYPE­PHENOTYPE CORRELATION
STUDY AT PATIENT WITH WILSON’S DIS­
EASE – A SINGLE CENTRE ExPERIENCE
R. Bruha, Z. Marecek, P. Martasek,
L. Pospisilova, J. Petrtyl, P. Urbanek,
T. Svestka, S. Nevsimalova, H. Kalistova,
L. Vitek, M. Lenicek, P. Ferenci
P1200
THE SIGNIFICANCE OF H63D MUTATION
IN HOMOZYGOSIS IN BASQUE POPULA­
TION WITH HEMOCHROMATOSIS
A. Castiella, E. Zapata, P. Otazua, M.D. De
Juan, J. Fernandez, L. Zubiaurre, J.A. Arriola,
E. Elosegui, L.F. Alzate, F. Mugica, E. Utrilla
P1201
ALCOHOL­METABOLIZING ENZYME
GENE POLYMORPHISMS IN ALCOHOL
LIVER CIRRHOSIS AMONG POLISH INDI­
VIDUALS
H. Cichoz-Lach, E. Lis, K. Celiñski,
M. Slomka
P1202
IS THE PRO12ALA PEROxISOME PROLIF­
ERATOR­ACTIVATED RECEPTOR­GAMMA
GENE POLYMORPHISM ASSOCIATED
WITH NASH?
F.A. Domenici, A.L.C. Martinelli,
M.M. Rocha, A.C. Teixeira, A.F. Guirado,
V.F. Muglia, C. Yang, J. Elias Junior,
S. Zucoloto, H. Vannucchi

P1203
TRANSFORMING GROWTH FACTOR BETA
ONE AND NON ALCOHOLIC FATTY LIVER
DISEASE
K.M. Hadhoud, H.M. El-Sadek, A.M. Abdel-
Rahman, F.A. El-messallamy, M.M. Fawzy
P1204
MEASUREMENT OF SERUM FREE CHO­
LINE SCORE MAY BE USED IN GENERAL
PRACTICE AS INITIAL SCREENING TOOLS
OF NAFLD BEFORE LIVER BIOPSY
K. Fujita, Y. Nozaki, M. Yoneda, K. Imajyo,
Y. Shinohara, H. Mawatari, H. Kirikoshi,
S. Saito, A. Nakajima
P1205
TELMISARTAN, BUT NOT VALSARTAN
MAY BE A CANDIDATE FOR THERAPY IN
MILD­TO­MODERATE HYPERTENSION­
ASSOCIATED NASH
E.F. Georgescu, R.I. Ionescu, M. Niculescu
P1206
THE FREQUENCY OF COPPER­ASSOCIAT­
ED LIVER DISEASE IN PATIENTS
A. Iranikhah, M. Ghadir, M. Najafi
P1207
THE PREVALENCE OF NON­ALCOHOLIC
FATTY LIVER DISEASE IN RUSSIAN FED­
ERATION
V.T. Ivashkin, O.M. Drapkina
P1208
CHANGES OF HEPATOCYTE NUCLEUS
IN PATIENTS WITH INSULIN RESISTANCE
L.B. Lazebnik, S.G. Khomeriki,
L.A. Zvenigorodskaya, E.G. Egorova
P1209
INFLUENCE OF ALPHA­1 ANTITRYPSIN
HETEROZYGOSITY ON TREATMENT EF­
FICACY OF HCV COMBINATION THERAPY
K.F. Kok, H. van Soest, A.E. van
Herwaarden, M.G.H. van Oijen, G.J. Boland,
J. Halangk, T. Berg, R.A. de Vries,
J.P.H. Drenth
PosTeR sessIon
P1210
URSODEOxYCHOLIC ACID AND SIMVAS­
TATIN IN THE TREATMENT OF NON­ALCO­
HOLIC FATTY LIVER DISEASE IN PATIENTS
WITH METABOLIC SYNDROME
O.N. Korneeva, O.M. Drapkina,
V.T. Ivashkin
P1211
VALUE OF LIFESTYLE OPTIMIZATION
METHODS IN TREATING METABOLIC
LIVER DISEASE IN PATIENTS WITH TYPE 2
DIABETES MELLITUS
C.M. Lacatusu, B. Mihai, M. Graur, C. Mihai,
C. Cijevschi Prelipcean
P1212
LIVER INVOLVEMENT IN TYPE 2 DIABETIC
PATIENTS IS ASSOCIATED TO SPECIFIC
FEATURES OF METABOLIC SYNDROME
C.M. Lacatusu, B. Mihai, M. Graur, C. Mihai,
C. Cijevschi Prelipcean
P1213
SYSTEM OF MATRIx METALLOPROTEIN­
ASE­1 IN PATIENTS WITH TYPE 2 DIABE­
TES MELLITUS AND NONALCOHOLIC
STEATOHEPATITIS
O.V. Lavrynenko, V.M. Khvorostinka
P1214
LIPID LOWERING EFFECT OF FENOFI­
BRATE AND ZINC ON HIGH FAT DIET IN­
DUCED FATTY LIVER IN SPLAGUE DAW­
LEY RATS
Y. Lee, S. Heo, K. Han, K. Lee, J. Kim, Y. Lee,
Y. Jeong, S. Yoon
P1215
THE ROLE OF THE HFE H63D MUTATION
IN NON­ALCOHOLIC FATTY LIVER DIS­
EASE
S. Lee, S. Jeong, Y. Park, J. Hwang, J. Kim,
N. Kim, D. Lee, W. Kang, S. Park, Y. Jung
199
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1216
NEITHER IRON OVERLOAD NOR IN­
CREASED FERRITIN IS PRESENT IN MOR­
BID OBESITY PATIENTS WITH NONALCO­
HOLIC FATTY LIVER DISEASE
M.V. Machado, A. Costa, J. Coutinho,
F. Carepa, A. Natália, H. Cortez-Pinto
P1217
NON­ORGAN SPECIFIC AUTOANTIBOD­
IES IN MORBID OBESITY: CORRELATION
WITH NON ALCOHOLIC FATTY LIVER
DISEASE SEVERITY AND RISk FACTORS
M.V. Machado, A. Costa, J. Coutinho,
F. Carepa, N. Alves, H. Cortez-Pinto
P1218
DO LEPTIN AND GRHELIN LEVELS COR­
RELATE WITH THE SEVERITY OF NON­
ALCOHOLIC FATTY LIVER IN MORBID
OBESITY?
M.V. Machado, F. Carepa, J. Coutinho,
A. Costa, V. Caçador, H. Cortez-Pinto
P1219
HEPATOCELLULAR CARCINOMA OCCUR­
ING IN NONCIRRHOTIC LIVER: IMPACT OF
NAFLD?
A. Marion-Audibert, E. Morineaux,
B. Bancel, S. Radenne, J. Baulieux,
J. Souquet, C. Ducerf, C. Gouillat, F. Zoulim,
C. Trepo, P. Merle
P1220
THE 15 AND 30 MINUTES SAMPLING
OF 13C­BREATH TESTING ARE ABLE TO
PREDICT SEVERE HEPATIC FIBROSIS AND
SEVERITY OF LIVER DISEASE
L. Miele, M. Candelli, G. Marrone,
M.A. Zocco, M. Biolato, G. Gigante, S. Racco,
C. Cefalo, M. Pompili, G. Rapaccini,
A. Grieco, A. Gasbarrini
200
P1221
THE INTERACTION OF HEMOCHROMA­
TOSIS GENE MUTATIONS AND TRANS­
FERRIN GENE POLYMORPHISM TO PHE­
NOTYPIC ExPRESSION IN PATIENTS WITH
IRON OVERLOAD
S. Milic, S. Ristic, N. Starcevic Cizmarevic,
D. Stimac
P1222
ADIPONECTIN, LEPTIN AND INSULIN
LEVELS IN PATIENTS WITH NON ALCO­
HOLIC STEATOHEPATITIS (NASH) AND
IMPAIRED GALBLADDER MOTILITY
O. Mosteanu, T. Pop, C. Buzas,
M. Grigorescu, M. Acalovschi
P1223
ADIPOkINES AND THEIR ROLE IN DIAG­
NOSIS OF NON­ALCOHOLIC FATTY LIVER
DISEASE
D. Neagoe, G. Ianosi, A. Amzolini,
M. Popescu, V. Comanescu, A. Turculeanu
P1224
VALUE OF ALANINE TRANSAMINASE
LEVELS AS A SCREENING TEST FOR
NON­ALCOHOLIC FATTY LIVER DISEASE
IN AN URBAN ADULT SRI LANkAN POPU­
LATION
M.A. Niriella, A.S. Dassanayake,
K.V.U. Kalubowila, S. Rajindrajith, A.P. de
Silva, S. Chakrawarthi, M. Makaya, N. Kato,
A.R. Wickramasinghe, H.J. de Silva
P1225
ADVANCE OF ARTERIOSCLEROSIS PRO­
MOTED BY NON­ALCOHOLIC FATTY
LIVER DISEASE
Y. Nishizaki, H. Shiozawa, S. Motegi,
S. Gocho, J. Aoki, T. Mine, N. Watanabe
P1226
JUVENILE HAEMOCHROMATOSIS IN
ASIAN FAMILIES
E. Nixon, G.S. Banait, K.J. Robson, C.Y. Lok

P1227
VALIDATION OF NAFLD FIBROSIS SCORE
IN A POPULATION OF PATIENTS WITH
NON ALCOHOLIC STEATOHEPATITIS
J.I. Pinto, S. Leite, M. Afonso, R. Veloso,
S. Fernandes, R. Pinho, L. Proença,
J. Carvalho, J. Fraga
P1228
SERUM TFN­α AS A PREDICTIVE BIO­
MARkER OF NON­ALCOHOLIC FATTY LIV­
ER DISEASE; 5­YEAR FOLLOW­UP STUDY
S. Shin, Y. Cho, J. Park, H. Kim, D. Park,
C. Sohn, W. Jeon, B. Kim
P1229
PREVALENCE OF HETEROZYGOUS AL­
PHA 1 ANTITRYPSIN DEFICIENCY IN A
LIVER TRANSPLANT POPULATION AND
ITS INFLUENCE ON OUTCOME POST OR­
THOTOPIC LIVER TRANSPLANT
C.M. Waterhouse, W.J. Cash,
P.A. McCormick
P1230
PROTEOMIC ANALYSIS OF SERUM IN PA­
TIENTS WITH NONALCOHOLIC STEATO­
HEPATITIS USING MALDI­TOF/MS
Y. Yilmaz, E. Dolar, S. Moshkovskii,
M. Vlasova, M. Pyatnitskiy, O. Atug,
E. Ulukaya
P1231
SERUM CONCENTRATIONS OF HUMAN
ANGIOPOIETIN­LIkE PROTEIN 3 IN PA­
TIENTS WITH NONALCOHOLIC FATTY
LIVER DISEASE: ASSOCIATION WITH IN­
SULIN RESISTANCE
Y. Yilmaz, E. Ulukaya, O. Atug, E. Dolar
P1232
CLINICOPATHOLOGIC FEATURES OF HE­
PATOCELLULAR CARCINOMA PATIENTS
ALIVE 10 YEARS AFTER INITIAL TREAT­
MENT: A RETROSPECTIVE STUDY
T. Ichiya, K. Tsuji, J. Kang, T. Matsui,
F. Komaba, Y. Sakurai, Y. Kodama,
H. Maguchi
PosTeR sessIon
P1233
INTRA­ABDOMINAL PRESSURE IN CIR­
RHOTICS WITH ASCITES CORRELATES
WITH HEPATIC VENOUS PRESSURE GRA­
DIENT (HVPG)
P. Jain, A. Kumar, R.C. Soni, P. Sharma,
B.C. Sharma, S.K. Sarin
P1234
Withdrawn by author
P1235
UPDATED MELD AND UPDATED MELD­
NA, ARE THEY SUPERIOR TO MELD OR
CHILD­PUGH SCORE FOR PREDICTING
SURVIVAL OF CIRRHOTIC PATIENTS?
J. Kim, H. Yim, Y. Jung, S. Jung, J. Kim, Y. Seo,
J. Yeon, H. Lee, S. Um, K. Byun, S. Lee, J. Choi,
H. Ryu
P1236
NATURAL HISTORY OF ASYMPTOMATIC
AND SYMPTOMATIC PORTAL BILIOPA­
THY IN PATIENTS WITH ExTRA­HEPATIC
PORTAL VEIN OBSTRUCTION (EHPVO)
A. Kumar, N. Gupta, S.K. Sarin
P1237
CIRRHOTIC PATIENTS WITH LARGE
ESOPHAGEAL VARICES AND HIGHER AGE
HAVE POOR HEMODYNAMIC RESPONSE
TO TERLIPRESSIN
A. Kumar, P. Sharma, V.V. Mittal, N. Gupta,
S.R. Mishra, S.K. Sarin
P1238
EVALUATION OF ACUTE AND 14­DAYS
HEPATIC VENOUS PRESSURE GRADI­
ENT RESPONSE TO CARVEDILOL AND
NEBIVOLOL IN PATIENTS WITH LIVER
CIRRHOSIS
L. Kupcinskas, V. Silkauskaite, A. Pranculis,
J. Kupcinskas, V. Petrenkiene
201
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1239
INCREASED SERUM ACTIVITY OF MATRIx
METALLOPROTEINASE­9 IN PATIENTS
WITH ACUTE VARICEAL BLEEDING
O. Kwon, M. Cho, K. Bae, Y. Kim, I. Jung,
Y. Ku, Y. Kim, J. Kim
P1240
PERCUTANEOUS RADIOFREQUENCY
ABLATION OF HEPATOCELLULAR CAR­
CINOMA IN PATIENTS WITH CIRRHOSIS
OLDER THAN 75 YEARS
M. Lahbabi, G. N’Kontchou, O. Seror,
M. Beaugrand
P1241
MANAGEMENT AND PROGNOSIS OF PRI­
MARY LIVER CANCER: MANY CHANGES
OVER 30 YEARS (A FRENCH POPULA­
TION­BASED STUDY)
B. Guiu, C. Lepage, A. Minello, P. Hillon,
J. Faivre, A. Bouvier
P1242
IDENTIFICATION OF SEPTIC CIRRHOTIC
PATIENTS WITH HIGH MORTALITY RISk
L.G. Lim, X.X. Tan, S.G. Lim
P1243
ONE YEAR FOLLOW UP AFTER THE FIRST
EPISODE OF SPONTANEOUS BACTERIAL
PERITONITIS
M.V. Machado, J. Nunes, R.T. Marinho,
H. Cortez-Pinto, F. Ramalho, J. Velosa
P1244
EARLY EFFECT OF EDUCATIONAL PRO­
GRAMS ON NATURAL COURSE OF CIR­
RHOTIC PATIENTS’ DISEASE
M. Alizadeh-Naini, H. Mahmoudi,
F. Banaee, H. Rabiee, Z. Salehi, M. Asadi-Lari,
S. Ghaffari
P1245
HEPCIDIN IN ASCITIC FLUID: AN ANTIMI­
CROBIAL PEPTIDE
V.K. Manglam, A. Sangwaiya, A. Pal,
M. Busbridge, J. Arnold
202
P1246
SHORT­TERM TREATMENT WITH HIGH
DOSE OF VSL#3 MODULATES INTES­
TINAL MICROBIOTA BUT HAS NO EF­
FECT ON CYTOkINES INVOLVED IN THE
PATHOGENESIS OF HEPATO­RENAL SYN­
DROME
W.M. Marlicz, E. Wunsch, M. Mydlowska,
J. Czyszek, M. Milkiewicz, P. Milkiewicz
P1247
ASSESSMENT OF EARLY PHASE PORTAL
HYPERTENSION WITH ULTRASONOGRA­
PHY IN COMPENSATED CHRONIC LIVER
DISEASE PATIENTS
S. Matustani, T. Fukuzawa, H. Mizumoto,
Y. Suzuki
P1248
ARE BAREFOOT CIRRHOTICS AT IN­
CREASED RISk OF SkIN INFECTION AND
MORTALITY IN THE DEVELOPING WORLD
P. Mohan, B. Ramu, E. Bhaskar,
J. Venkataraman
P1249
SPONTANEOUS BACTERIAL PERITONI­
TIS PROPHYLAxIS WITH NORFLOxACIN
VS RIFAxIMIN IN CIRRHOTIC PATIENTS
WITH LOW ASCITIC ALBUMIN LEVELS.
A DOUBLE­BLIND, PROSPECTIVE STUDY
A.M. Mpoumponaris, D. Gkisakis,
T. Vassiliadis, K. Soufleris, N. Grammatikos,
N. Evgenidis
P1250
MEASSUREMENT OF C­REACTIVE PRO­
TEIN IN BACTEREMIC PATIENTS WITH
AND WITHOUT HEPATIC CIRRHOSIS
J.M. Munita, A. Alvarez, J. Contreras,
G. Mezzano, M. Canals, M. Rodriguez,
J.P. Miranda, J. Perez

P1251
PREDICTORS RELATED TO SURVIVAL OF
“GENERAL RULES FOR THE CLINICAL
AND PATHOLOGICAL STUDY OF PRI­
MARY LIVER CANCER” STAGE 1–2 AND
STAGE 3–4 HEPATOCELLULAR CARCI­
NOMA (HCC) IN JAPAN
M. Nakano, E. Ando, Y. Yano, K. Fukumori,
S. Sumie, K. Kuwaki, M. Satani, A. Takata,
R. Kuromatsu, T. Torimura, M. Tanaka,
T. Ueno, M. Sata
P1252
HAPTOGLOBIN POLYMORPHISM:
A NOVEL GENETIC RISk FACTOR FOR THE
DEVELOPMENT OF INFECTION IN LIVER
CIRRHOSIS
Z. Vitalis, I. Tornai, I. Altorjay, K. Palatka,
K. Sandor, E. Palyu, M. Udvardy, J. Harsfalvi,
T. Dinya, P.L. Lakatos, M. Papp
P1253
MANNOSE­BINDING LECTIN DEFICIEN­
CY CONFERS RISk FOR INFECTIONS IN
A LARGE HUNGARIAN COHORT OF PA­
TIENTS WITH LIVER CIRRHOSIS
M. Papp, Z. Vitalis, I. Tornai, K. Palatka,
S. Kacska, G. Farkas, M. Udvardy, J. Harsfalvi,
T. Dinya, P. Orosz, B. Lombay, G. Par, A. Par,
F. Szalay, A. Csepregi, P.L. Lakatos, I. Altorjay
P1254
PRESENCE OF ANTI­MICROBIAL AN­
TIBODIES IS ASSOCIATED WITH IN­
CREASED RISk FOR SYSTEMIC INFEC­
TIONS IN A LARGE HUNGARIAN COHORT
OF PATIENTS WITH LIVER CIRRHOSIS
M. Papp, Z. Vitalis, I. Tornai, I. Altorjay,
E. Palyu, M. Udvardy, G.L. Norman, T. Dinya,
P. Orosz, B. Lombay, G. Par, A. Par, F. Szalay,
P.L. Lakatos
PosTeR sessIon
biliary II
P1255
BILIARY ASCARIASIS
M. Zurita, B.C. Andrade, S.B. Andrade
PosTeR sessIon
P1256
LOOkING FOR A SPECIFIC MARkER FOR
CHOLANGIOCARCINOMA: MUC5AC Ex­
PRESSION AND ITS PROGNOSTIC VALUE
F. Pedica, L. Bortesi, S. Pachera,
A. Ruzzenente, A. Guglielmi, M. Chilosi,
F. Menestrina, P. Capelli
P1257
GENETIC SIGNATURE UNDERLYING TU­
MOR PROGRESSION AND SORAFENIB EF­
FECTS ON HGF/CMET PATHWAY IN LIVER
CANCER CELL LINES
A.C. Piscaglia, N. Saulnier, M. Barba,
L. Castellini, V. Tesori, M. Campanale,
F. Purchiaroni, T. Galeotti, G. Pani,
A. Gasbarrini
P1258
Withdrawn by author
P1259
EARLY DETECTION OF GALLBLADDER
CARCINOMA USING CONTRAST­EN­
HANCED ULTRASONOGRAPHY
K. Rifai, B. Boozari, M.P. Manns, M.J. Gebel
P1260
EFFECTS OF THE MTOR INHIBITOR RAPA­
MYCIN IN PATIENTS WITH HEPATOCEL­
LULAR CARCINOMA: A PHASE I/II TRIAL
M. Schöniger-Hekele, C. Müller
P1261
PROGNOSTIC VALUE OF TUMOR HYPOx­
IA IN GALLBLADDER CANCER
G. Sergeant, E. Lerut, N. Ectors,
T. Hendrickx, R. Aerts, B. Topal
P1262
PLASMA CYTOkINE LEVELS AND THE
CYTOkINE PRODUCING CAPACITY
OF CD4CD57&;alpha;βTCR­POSITIVE
T CELLS IN HCV­RELATED HEPATOCEL­
LULAR CARCINOMA PATIENTS DURING
TUMOR PROGRESSION
T. Shiraki, E. Takayama, H. Magari,
T. Nakata, Y. Mori, K. Moribata, N. Shingaki,
M. Iguchi, H. Tamai, K. Yanaoka, M. Oka,
N. Kondoh, M. Ichinose
203
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1263
FIVE­YEAR SURVIVAL ANALYSIS OF A
COHORT OF HEPATOCELLULAR CARCI­
NOMA PATIENTS TREATED AT SINGLE
CENTER IN kOREA
S.S. Lee, H.D. Shin, S.Y. Yun, S.B. Kim, J.E. Shin,
H.J. Kim, S.H. Yang, I.H. Song
P1264
YTTRIUM­90 MICROSPHERES FOR THE
TREATMENT OF UNRESECTABLE HEPA­
TOCELLULAR CARCINOMA: OUTCOMES
OF AN ASIAN COHORT
E.W.L. Wee, S. Wang, M. Aung, B. Shuter,
S.G. Lim
P1265
SURVIVAL OF BRAZILIAN PATIENTS WITH
HEPATOCELLULAR CARCINOMA: EVALU­
ATION OF EIGHT STAGING SYSTEMS
F.E.B. Xavier, G.C. Perdoná, A.V.C. Franca
P1266
MASS SCREEING BY ANNUAL AND INTER­
MITTENT ULTRASONOGRAPHYIES FOR
DETECTING HEPATOCELLULAR CARCI­
NOMA AND THE OTHER MALIGNANCIES
Y. Yoda, I.I. Takayama
PosTeR sessIon
endoscopy and imaging II
P1267
AUDIT OF SAFETY AND SEDATION DUR­
ING GASTROINTESTINAL ENDOSCOPIC
PROCEDURES: HOW GOOD ARE WE?
S.D. Jafri, S. Tarique
P1268
RISk FACTORS FOR RECURRENCE OF
GASTRIC ARTIFICIAL ULCERS AFTER EN­
DOSCOPIC SUBMUCOSAL DISSECTION
N. Kakushima, Y. Huang, K. Takizawa,
M. Tanaka, H. Ikehara, Y. Yamaguchi,
H. Matsubayashi, H. Ono
204
P1269
IMPROVING REFERRAL QUALITY AND
REDUCING DELAYS FOR INPATIENT EN­
DOSCOPIC PROCEDURES
H. Rafferty, P. Kant, M. Dakkak
P1270
EFFECTIVENESS OF NARROW BAND
IMAGING (NBI) WITH HIGH­MAGNIFICA­
TION (HME) IN DETECTION OF MUCOSAL
AND VESSEL PATTERNS IN BARRETT’S
ESOPHAGUS: CORRELATION BETWEEN
ENDOSCOPY AND HISTOLOGY
S. Kashin, I. Ivanikov, E. Zakrevskaya,
A. Nadezhin, A. Borbat, D. Zavyalov,
V. Goncharov, A. Pavlov
P1271
PHOTODYNAMIC DIAGNOSIS OF EARLY
GASTRIC CANCER USING 5­AMINOLEV­
ULINIC ACID – FIRST CLINICAL ExPERI­
ENCES
Y. Kawahara, T. Tsuzuki, K. Hori, D. Kawai,
S. Kawano, M. Inoue, D. Tanioka, H. Okada,
K. Yamamoto
P1272
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION (ESD) USING NEW DEVICE MUCO­
SECTOM2 FOR ESOPHAGEAL CANCER
Y. Kawahara, H. Okada, K. Yamamoto
P1273
ULTRA­THIN HIGH RESOLUTION ENDOS­
COPY IN THE DIAGNOSIS OF EARLY GAS­
TRIC CANCERS
Y. Kawahara, H. Okada, K. Yamamoto
P1274
NARROW­BAND IMAGING ON DETEC­
TION OF ESOPHAGEAL DISORDER USING
TRANSNASAL­EGD
T. Kawai, K. Yamamoto, M. Fukuwzwa,
T. Yamagishi, K. Yagi, M. Fukuwzwa,
M. Kataoka, K. Kawakami, Y. Sakai,
F. Moriyasu, Y. Takagi, T. Aoki

P1275
MAGNIFYING ENDOSCOPIC FINDINGS
OF THE SURFACE STRUCTURE OF NON­
CANCEROUS MUCOSA SURROUNDING
DIFFERENTIATED­ AND UNDIFFERENTI­
ATED­TYPE GASTRIC CARCINOMA
M. Kawamura, S. Abe, K. Oikawa, S. Terai,
M. Saito
P1276
THE COMPARISON OF NOVEL ACID
PUMP ANTAGONIST AND PROTON
PUMP INHIBITOR FOR THE TREATMENT
OF IATROGENIC ULCER CAUSED BY EN­
DOSCOPIC SUBMUCOSAL DISSECTION
B. Jang, Y. Kim, T. Kim
P1277
EFFECT OF PRETREATMENT WITH LIDO­
CAINE ON PROPOFOL INJECTION PAIN
DURING SEDATIVE UPPER GASTROIN­
TESTINAL ENDOSCOPY
E.S. Kim, B.K. Jang, K.S. Park, K.B. Cho,
J.S. Hwang
P1278
THE MINIMAL INVASIVE TREATMENT OF
ESOPHAGEAL PERFORATION; ENDO­
SCOPIC CLIP APPLICATION
K. Kim, S. Choi, G. Seo, Y. Sohn, C. Choi,
Y. Kim
P1279
H2 RECEPTOR ANTAGONIST IS EQUIVA­
LENT TO PPI FOR THE PREVENTION OF
BLEEDING AND THE HEALING OF ULCER
AFTER ENDOSCOPIC SUBMUCOSAL DIS­
SECTION: A PROSPECTIVE RANDOMIZED
CONTROLLED TRIAL
K. Kim 1 , S. Choi 1 , Y. Sohn 1 , G. Seo 1 , Y. Kim 1 ,
C. Choi 1 , C. Im 1 , J. Kweon 1
P1280
THE USEFULLNESS OF MAGNIFYING
ENDOSCOPY WITH NARROW BAND IM­
AGING FOR DETERMINING THE TUMOR
MARGIN: COMPARISON WITH INDIGO
CARMINE CHROMOENDOSCOPY
S. Kiyotoki, J. Nishikawa, M. Saito,
K. Hamabe, T. Okamoto, I. Sakaida
PosTeR sessIon
P1281
MAGNIFYING ENDOSCOPY WITH NAR­
ROW­BAND IMAGING FOR DIAGNOSIS
OF DIFFERENTIATED­TYPE EARLY GAS­
TRIC CARCINOMA MIxED WITH UNDIF­
FERENTIATED COMPONENT
M. Kobayashi, M. Takeuchi, S. Hashimoto,
R. Narisawa, Y. Aoyagi, Y. Ajioka
P1282
MONITORING OF OROPHARYNGEAL
COLONIZATION AND PERCUTANEOUS
ENDOSCOPIC GASTROSTOMY SITE IN­
FECTION: RATIONALE FOR TARGETED
ANTIMICROBIAL PROPHYLAxIS IN DIF­
FERENT INDICATIONS SUBGROUPS
R. Kroupa, J. Jurankova, M. Dastych,
M. Senkyrik, I. Novotny
P1283
ASSOCIATION BETWEEN MICROSUR­
FACE STRUCTURE AND MICROVASCU­
LAR PATTERN OBSERVED THROUGH
MAGNIFYING ENDOSCOPY IN EARLY
GASTRIC CANCER
K. Kudo, Y. Tamegai, T. Koike, D. Yoshizawa
P1284
ENDO­CYTOSCOPIC OBSERVATION FOR
ESOPHAGEAL SQUAMOUS CELL CARCI­
NOMA
Y. Kumagai, K. Kawada, S. Yamazaki,
T. Kawano, K. Takubo
P1285
BLEEDING FROM OESOPHAGEAL UL­
CERATION INDUCED BY ENDOSCOPIC
VARICEAL LIGATION FOR PRIMARY PRO­
PHYLAxIS
R.S. Kumarasena, M.A. Niriella,
U. Kalubovila, A.P. de Silva,
A.S. Dassanayake, J.H. de Silva
P1286
DUODENAL ENDOSCOPIC MUCOSAL
RESECTION: A SINGLE, PROSPECTIVE,
ExPERIMENTED CENTER ExPERIENCE
S. Leblanc, M. Gaudric, U. Chaput,
W. Cacheux, S. Chaussade, F. Prat
205
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1287
LUGOL CHROMO­ENDOSCOPY VS NAR­
ROW BAND IMAGING FOR ENDOSCOPIC
SCREENING OF ESOPHAGEAL SQUA­
MOUS­CELL CARCINOMA IN VERY HIGH­
RISk PATIENTS: A PILOT STUDY
S. Lecleire, M. Antonietti, I. Iwanicki-Caron,
A. Duclos, P. Michel, P. Ducrotté, F. Di Fiore
P1288
RISk FACTOR OF HYPOxEMIA DURING
CONSCIOUS SEDATION UPPER GASTRO­
INTESTINAL ENDOSCOPY
S. Lee, B. Jang, K. Kim, J. Eun, T. Kim, K. Lee
P1289
OPTIMAL SURVEILLANCE STRATEGY
AFTER ENDOSCOPIC SUBMUCOSAL
DISSECTION FOR ADENOMA AND EARLY
GASTRIC CANCER
S. Lee, T. Kim, B. Jang, K. Kim, J. Eun, K. Lee
P1290
PATIENT SELECTION FOR PERCUTANE­
OUS ENDOSCOPIC GASTROSTOMY:
WHAT HAPPENS TO PATIENTS WHO ARE
DEFFERED?
J.S. Leeds, J. Grant, H.E. Robson,
M.E. McAlindon, D.S. Sanders
P1291
COMPARISON OF THE SHEFFIELD GAS­
TROSTOMY SCORE WITH AN ARTIFICIAL
NEURAL NETWORk ANALYSIS
J.S. Leeds, S. Morley, H.E. Robson, J. Grant,
J. Henman, K. Worden, M.E. McAlindon,
D.S. Sanders
P1292
THE DETECTION OF DYSPLASIA WITHIN
BARRETT’S OESOPHAGUS USING ACETIC
ACID ENHANCED CHROMOENDOSCOPY:
RESULTS FROM A LARGE PROSPECTIVE
SERIES
G.R. Longcroft-Wheaton, M. Duku,
R. Mead, D. Poller, P. Bhandari
206
P1293
PANCREATIC FLUID COLLECTIONS: CLIN­
ICAL OUTCOME OF ENDOSCOPIC DRAIN­
AGE AS AN ALTERNATIVE TO PERCUTA­
NEOUS AND SURGICAL DRAINAGES
S. Lopes, A. Rosa, F. Portela, E. Camacho,
D. Gomes, P. Amaro, M. Ferreira,
J.M. Romãozinho, H. Gouveia, M.C. Leitão
P1294
EVALUATION OF MEDIASTINAL EMPHY­
SEMA AFTER ESD (ENDOSCOPIC SUBMU­
COSAL DISSECTION) FOR SUPERFICIAL
ESOPHAGEAL CANCER WITH COMPUTER
TOMOGRAPHY: A PROSPECTIVE, CON­
SECUTIVE CASE STUDY
Y. Maeda, D. Hirasawa, C. Sato, Y. Kanno,
T. Suzuki, T. Obana, T. Sugawara, Y. Harada,
T. Ohira, K. Suzuki, T. Yamagata, Y. Koike,
T. Ogawa, Y. Noda, N. Fujita
P1295
IMPACT OF EMR ON MANAGEMENT OF
BARRETT’S NEOPLASIA IN A Uk SETTING
R. Mead, M. Duku, P. Bhandari
P1296
5 YEARS ExPERIENCE OF ENDOSCOPIC
RESECTION THROUGHOUT THE UPPER
GASTROINTESTINAL TRACT
R. Mead, M. Duku, P. Bhandari
P1297
RESULTS OF THE INITIAL PILOT OF THE
NEW JAG APPROVED WEB­BASED E­
PORTFOLIO FOR TRAINEES IN ENDOS­
COPY
T.A. Mehta, J. Wood, E.A. Pettitt, B.R. Disney,
H. Youssef, L. Merricks, S. Harnden,
K. Dowler, B. McKaig, R. Valori, P. Dunckley
P1298
NARROW BAND IMAGING DOES NOT
ACCELERATE DETECTION OF GASTRO­
INTESTINAL LESIONS – A STUDY USING
“EYE­TRACkING” IN NON­ENDOSCOPIC
ExPERTS
A. Meining, S. Atasoy, M. Bajbouj,
N. Navab, A. Chung, G. Yang

P1299
USEFULNESS OF MEASURING WIDTH OF
SUBMUCOSAL LAYER BY EUS TO DETER­
MINE THE INDICATION OF ENDOSCOPIC
TREATMENT OF EARLY GASTRIC CANCER
A. Mitsunaga, T. Hamano, H. Teramoto,
E. Nakao, M. Shirato, I. Shirato, T. Nishino
P1300
FACTORS PREDICTING POST ENDOSCOP­
IC VARICEAL LIGATION ULCER BLEED IN
PATIENTS WITH CIRRHOSIS
V.V. Mittal, A. Kumar, N. Gupta,
B.C. Sharma, S.K. Sarin
P1301
HIGH COMPLICATION RATES OF FREkA
PExACT GASTROSTOMY IN ONCOLOGY
PATIENTS
E. Van Dyck, T.G. Moreels, E.J. Macken,
B. Roth, P.A. Pelckmans
P1302
CHARACTERISATION OF COLONIC
POLYPS: WHITE LIGHT, AUTOFLUORES­
CENCE, AND NARROW BAND IMAGING
WITH OR WITHOUT MAGNIFICATION
A. Ignjatovic, J.E. East, T. Guenther,
J. Hoare, J. Morris, K. Ragunath, A. Shonde,
J. Simmons, N. Suzuki, S. Thomas-Gibson,
B. Saunders
P1303
CLINICOPATHOLOGICAL FACTORS AS­
SOCIATED WITH CLINICAL OUTCOMES
OF ENDOSCOPIC SUBMUCOSAL DIS­
SECTION FOR COLORECTAL EPITHELIAL
NEOPLASMS
H. Isomoto
P1304
PREPARATION PRIOR TO COLONOSCOPY:
A RANDOMIZED CONTROLLED TRIAL
COMPARING DIFFERENT REGIMES
S.V. Jansen, C.T. van Deursen,
J.G. Goedhard, B. Winkens
PosTeR sessIon
P1305
COMPARISON OF 3­DIMENSIONAL MAG­
NETIC ENDOSCOPIC IMAGING (MEI) AND
C­ARM FLUOROSCOPY ON OVERALL
COLONOSCOPY OUTCOME
L. Jelsness-Jørgensen, M. Henriksen,
P.K.R. Sandvei, P. Ravneng, E.H. Gunther,
H. Næs, M. Pettersen, L. Ødegård, T. Owen,
T. Søberg, F. Lerang
P1306
Withdrawn by author
P1307
A FEASIBILITY STUDY OF PROBIOTICS
PRETREATMENT AS A BOWEL PREPARA­
TION FOR COLONOSCOPY IN CONSTI­
PATED PATIENTS
Y. Jo, H. Lee, Y. Kim, J. Kim, D. Chang,
P. Rhee, J. Kim, J. Rhee, S. Bae
P1308
USE OF THE BRISTOL STOOL CHART AS
A SCREENING TOOL IN PREDICTING THE
PRESENCE AND TYPE OF COLONIC PA­
THOLOGY
N.M. Joshi, M. Aljabiri, D. Ramdass,
N. vanSomeren, K. Besherdas
P1309
A PROSPECTIVE RANDOMIZED CON­
TROLLED TRIAL EVALUATING CAP­AS­
SISTED COLONOSCOPY VERSUS STAN­
DARD COLONOSCOPY – A WESTERN
ExPERIENCE
H. Tee, C. Corte, H. Al-Ghamdi, E. Prokoso,
R. Chettiar, J. Darke, W. Rahman, S. Davison,
J. Lawler, G. Paven, W.S. Selby, S.P. Griffin,
A.J. Kaffes
P1310
CONTINUOUS QUALITY IMPROVEMENT
OF SCREENING COLONOSCOPY: DATA
FROM A LARGE COLORECTAL CANCER
SCREENING PROGRAM
M.F. Kaminski, E. Kraszewska,
M. Polkowski, J. Regula
207
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1311
USEFULNESS OF NARROW BAND IMAG­
ING WITH MAGNIFICATION IN THE DI­
AGNOSIS OF LOCALIZED COLORECTAL
LESIONS
H. Kashida, Y. Wada, M. Misawa,
K. Wakamura, T. Hosoya, T. Hayashi,
N. Ikehara, F. Yamamura, K. Ohtsuka,
S. Kudo, S. Hamatani
P1312
IS FULL COLONOSCOPIC ExAMINATION
NECESSARY IN YOUNG SOUTH ASIAN
PATIENTS WITH FRESH BLEEDING PER
RECTUM?
A. Khalid, S. Majid, M. Salih, W. Jafri
P1313
FACTORS ASSOCIATED WITH ABDOMI­
NAL PAIN DURING AND AFTER COLO­
NOSCOPY
S. Kondo, Y. Yamaji, N. Toda, R. Matsuda,
Y. Watanabe, S. Mikami, T. Minami,
A. Takata, T. Motoyama, S. Yotsuya,
T. Ochiai, A. Yamada, T. Tanaka, G. Togo
P1314
ENDOCYTOSCOPIC FINDINGS AND OUR
CLASSIFICATION IN THE COLORECTUM
S. Kudo, K. Wakamura, H. Kashida,
N. Ikehara, Y. Wada, T. Hayashi, T. Hosoya,
M. Kutsukawa, H. Miyachi, H. Inoue,
S. Hamatani
P1315
EFFICACY OF ENDOSCOPIC SUBMU­
COSAL DISSECTION (ESD) FOR NON­
GRANULAR TYPE (NG TYPE) OF LATER­
ALLY SPREADING TUMOR (LST) IN THE
COLORECTUM
Y. Kuroki, T. Mitani, D. Kikuchi, N. Hirano,
M. Nakamura, T. Iizuka, S. Hoteya, Y. Miyata,
N. Yahagi
P1316
IS BOWEL PREPARATION FOR COLONOS­
COPY PATIENT ORIENTATED? PRACTICE
WITHIN GREATER LONDON
J. Landy, A. Mian
208
P1317
MULTICENTRE PROSPECTIVE EVALU­
ATION OF THE QUALITY OF BOWEL
PREPARATION FOR COLONOSCOPY IN
1,019 PATIENTS
J. Lapuelle, E. Abdini, J. Canard,
P. Coulom, B. Croguennec, J. Letard,
C. Boustiere, J. Cassigneul, J. Cazals,
P. Dalbies, N. Gimbert, T. Helbert, P. Houcke,
P. Pienkowski, R. Systchenko, C. Chaussier,
F. Kohler, F. Vicari
P1318
LOW­VOLUME POLYETHYLENE GLYCOL
+ BISACODYL, A GOOD ALTERNATIVE
TO BOWEL PREPARATION WITH SODIUM
PHOSPHATE SOLUTION BEFORE COLO­
NOSCOPY
A. Lasson, A. Lindgren, A. Olsson, H. Strid
P1319
DIMINUTIVE COLONIC OR RECTAL ADE­
NOMAS: ARE THEY NEGLIGIBLE POLYPS?
C. Elie, M. Antonietti, I. Iwanicki-Caron,
F. Lemoine, F. Le Pessot, F. Di Fiore, P. Michel,
P. Ducrotté, S. Lecleire
P1320
A SURVEY OF ENDOSCOPIC WORkLOAD
IN NORTHERN ENGLAND: LOWER GAS­
TROINTESTINAL ENDOSCOPY WORk­
LOAD ExCEEDS BRITISH SOCIETY OF
GASTROENTEROLOGY PROJECTIONS
T.J.W. Lee, C. Zwart, M.D. Rutter, C. Rees
P1321
FEASIBILITY OF ENDOSCOPIC SUBMU­
COSAL DISSECTION FOR TREATMENT OF
RECTAL CARCINOID TUMORS
D. Lee, S. Jeon, S. Park, M. Jung, C. Cho,
W. Tak, Y. Kweon, S. Kim, Y. Choi
P1322
COMPUTER­AIDED COLONOSCOPY: A
NOVEL ENDOSCOPY NAVIGATION SYS­
TEM TO AID INSERTION OF COLONOS­
COPY BY HIERARCHICAL IMAGE SEG­
MENTATION ALGORITHMS
T. Lee, S. Peng, H. Chang, H. Wang

P1323
INCIDENCE OF BACTEREMIA AFTER
ARGON PLASMA COAGULATION IN PA­
TIENTS WITH CHRONIC RADIATION CO­
LOPROCTOPATHY
L. Lenz, F. Prata Martins, J. Tafarel,
L. Correia, D. Queiroz, G.F. Gomes, F. Nakao,
E. Della Libera, R. Rohr, A.P. Ferrari
P1324
A RANDOMIZED PROSPECTIVE STUDY
OF ENDOSCOPIC BIPOLAR AND ARGON
PLASMA CAUTERIZATION ON CHRONIC
RECTAL BLEEDING SECONDARY TO RA­
DIATION TELANGIECTASIAS
L. Lenz, F. Prata Martins, J. Tafarel,
M. Santos, R. Rodrigues, G. de Paulo,
F. Nakao, E. Della Libera, R. Rohr, A.P. Ferrari
P1325
FACTORS PREDICTING POOR BOWEL
PREPARATION FOR AMBULATORY COLO­
NOSCOPY
S.Y.W. Liu, M.C.M. Poon, S.S.M. Ng, J.C.M. Li,
J.F.Y. Lee, H.T. Leong, J.Y.W. Lau
P1326
INVESTIGATION INTO BOWEL PREPARA­
TION FOR COLONOSCOPY: TIME FOR A
PARADIGM SHIFT?
G.R. Longcroft-Wheaton, W. Edwards,
R. Duane-Moore, P. Bhandari
P1327
THE QUEENSLAND BOWEL CANCER
SCREENING PROGRAM AUTHORISED
PROVIDER MODEL – AN AUSTRALIAN
SUCCESS STORY. EVALUATION RESULTS
AND FUTURE DIRECTIONS
N. Main, E.A. Wardle, E. Ford, A. Thompson,
M. Appleyard
PosTeR sessIon
P1328
“JUST IN TIME” COLONOSCOPY IN PA­
TIENTS WITH COLONIC SYMPTOMS –
THE POTENTIAL IMPACT OF CT COLO­
NOGRAPHY FOLLOWED BY IMMEDIATE
OPTICAL ENDOSCOPY ON ENDOSCOPY
WORkLOAD
L. Marelli, R. Katz, L. Jackson, P. Wylie,
J. Bell, O. Epstein
P1329
A TWO­YEAR RETROSPECTIVE STUDY
OF ENDOSCOPIC MUCOSAL RESECTION:
INCIDENCE AND COMPLICATIONS IN A
TERTIARY REFFERAL CENTER
P. Markos, T. Brkic, H. Ivekovic, M. Kalauz,
M. Opacic, N. Rustemovic, J. Jakic
Razumovic, R. Pulanic, B. Vucelic
P1330
TRAINEES, ACCEPTABILITY, COMFORT,
AND SEDATION IN MODERN Uk COLO­
NOSCOPY
R. Mead, M. Duku, D. Pearl
P1331
PREDICTORS OF POST PROCEDURAL
BLEEDING FOLLOWING ENDOSCOPIC
MUCOSAL RESECTION (EMR) OF LARGE
COLONIC LATERALLY SPREADING TU­
MOURS (LSTS)
A.J. Metz, M.J. Bourke, S. Williams,
M. Swan, A. Moss
P1332
SIMPLE COLONOSCOPIC TECHNIQUE
COMBINING WATER INFUSION AND
COMPLETE AIR REMOVAL FROM THE
RECTOSIGOMOID COLON: COLLAPSE­
SUBMERGENCE METHOD
T. Mizukami, H. Komatsu, T. Hibi
P1333
SUCCINYLATED GELATIN SUBSTAN­
TIALLY INCREASES EN BLOC RESECTION
SIZE IN COLONIC ENDOSCOPIC MUCO­
SAL RESECTION (EMR): A RANDOMISED
BLINDED TRIAL IN A PORCINE MODEL
A. Moss, M.J. Bourke, V. Kwan, K. Tran,
C. Godfrey, G. McKay
209
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1334
NEEDLE kNIFE FISTULOTOMY IN DIF­
FICULT AMPULLARY CANNULATION
INCREASES THE RATE OF BILIARY CAN­
NULATION, 10 YEAR ExPERIENCE IN A
DISTRICT GENERAL HOSPITAL
M. Aljabiri, N. Joshi, N. van Someren,
K. Besherdas
P1335
DOES BISPECTRAL INDEx (BIS) MONI­
TORING OF CONSCIOUS SEDATION
DURING ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY (ERCP)
REDUCE ADVERSE EVENTS?
U.I. Aujla, J. Iqbal, J. Ramesh, D.F. Martin
P1336
COMBINING ANALYSIS OF PER ERCP BILE
ASPIRATION AND ENDOBILIARY BRUSH­
ING IMPROVE THE DIAGNOSTIC YIELD OF
CYTOLOGY IN MALIGNANT STRICTURES
OF THE BILIARY TRACT. MONO­CENTRIC
PROSPECTIVE STUDY
P. Bichard, J. Auroux, M. Fior Gozlan,
F. Chelbabi, E. Germain, A. Tatu, V. Leroy,
J. Zarski
P1337
THE ROLES OF INTRADUCTAL ULTRASO­
NOGRAPHY IN IDIOPATHIC RECURRENT
PANCREATITIS WITHOUT A DEFINITE
CAUSE ON ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY
H. Choi, J. Moon, B. Ko, S. Hong, H. Kim,
J. Park, Y. Cheon, Y. Cho, J. Lee, M. Lee
P1338
FACTORS PROMOTING BILE DUCT CAN­
NULATION IN ERCP. DATA FROM 11069
ERCP ExAMINATIONS IN THE SWEDISH
REGISTER FOR GALLSTONE SURGERY
AND ERCP (GALLRIkS) 2007–2008
L. Enochsson, F. Swahn, U. Arnelo, M. Löhr,
G. Persson
210
P1339
ENDOSCOPIC SNARE PAPILLECTOMY:
OUTCOMES OF A LARGE CONSECUTIVE
SERIES OF PATIENTS
P. Familiari, M. Martino, M. Mutignani,
M. Pandolfi, A. Tringali, V. Perri, F. Di Matteo,
G. Costamagna
P1340
ANALYSIS OF RISk FACTORS FOR DE­
VELOPING ACUTE PANCREATITIS AFTER
ENDOSCOPIC RETROGRADE CHOLANGI­
OPANCREATOGRAPHY (ERCP) – MONO­
CENTRIC RETROSPECTIVE STUDY OF
1275 PATIENTS
H.S. Heinzow, T. Meister, C. Berssenbrügge,
R. Hoehr, H. Ullerich, W. Domschke,
D. Domagk
P1341
PANCREATIC GUIDEWIRE PLACEMENT
WITH WIRE­GUIDED CANNULATION:
DOES IT MAkE A SUCCESS OF BILIARY
CANNULATION AND REDUCE A RISk OF
POST­ERCP PANCREATITIS?
T. Hisa
P1342
ENDOSCOPIC DIAGNOISIS FOR THE
MALIGNANT BILLIARY DISEASE USING
PERORAL CHOLANGIOVIDEOSCOPY
(CHF­B260) WITH NARROW­BAND IM­
AGING (NBI)
Y. Igarashi, K. Ito, T. Mimura, Y. Kishimoto,
I. Kamata, N. Okano, S. Hara, S. Nakano,
Y. Sumino
P1343
USE OF PANCREATIC DUCT STENT: IN­
FLUENCE ON POST ERCP PANCREATITIS
AND SELECTIVE DEEP CANNULATION
RATES IN PATIENTS WITHOUT PREVIOUS
SPHINCTEROTOMY. RESULTS OF A PRO­
SPECTIVE REGISTRY IN A COMMUNITY
HOSPITAL
F. Igea, R. Madrigal, J. Barcenilla,
E. Saracibar, S. Maestro, H. Nuñez, A. Del
Moral, A. Perez Millan, I. Garcia

P1344
ERCP IN PATIENTS WITH BILLROTH II
GASTRECTOMY – A TERTIARY REFERRAL
CENTRE ExPERIENCE
J. Iqbal, U.I. Aujla, T. Cooksley, J. Ramesh,
D.F. Martin
P1345
THE RESULTS OF THE TOkYO TRIAL OF
PREVENTION OF POST­ERCP PANCRE­
ATITIS WITH RISPERIDONE (TOkYO P3R)
H. Isayama, T. Tsujino, Y. Nakai, Y. Ito,
O. Togawa, N. Toda, T. Arizumi, H. Kogure,
K. Yamamoto, S. Mizuno, Y. Yashima,
H. Yagioka, T. Sasaki, S. Matsubara,
K. Hirano, N. Sasahira, M. Tada, M. Omata,
K. Koike
P1346
BRUSH CYTOLOGY IN DETECTION OF
MALIGNANT BILE AND PANCREATIC
DUCT STRICTURES
A. Jablonska, M. Smoczynski, M. Dubowik,
I. Marek, K. Jaskiewicz
P1347
EARLY USE OF NEEDLE­kNIFE FISTU­
LOTOMY IN PATIENTS WITH ExPECTED
DIFFICULT BILIARY CANNULATION
K. Joo, S. Jung, H. Shin, J. Cha, J. Lee, S. Joo
P1348
LONG­TERM EFFECTIVENESS OF ENDO­
SCOPIC PAPILLARY LARGE BALLOON
DILATATION COMBINED WITH SPHINC­
TEROTOMY FOR THE REMOVAL OF COM­
MON DUCT STONES
T. Kim, B. Jang, K. Kim, S. Lee, J. Eun
P1349
SERUM AMYLASE LEVEL IS A RELIABLE
PREDICTOR OF POST­ERCP PANCREATI­
TIS AFTER ENDOBILIARY STENTING
M. Kujundzic, B. Bilic, T. Bokun, Z. Babic,
M. Banic, Z. Cabrijan, M. Crncevic Urek,
I. Grgurevic, D. Kardum, L. Petricusic,
M. Tadic
PosTeR sessIon
P1350
OPTIMAL TIMING OF RESCUE ERCP AND
SMALL CALIBER PANCREATIC STENT IN­
SERTION TO PREVENT THE EVOLUTION
OF SEVERE POST­ERCP PANCREATITIS
L. Madacsy, G. Kurucsai, I. Joo, R. Fejes,
A. Szekely, I. Szekely
P1351
ENDOSCOPIC ULTRASOUND­GUIDED
TRUCUT BIOPSY (EUS­TCB) IS SAFE AND
ACCURATE FOR THE DIAGNOSIS FOR
MEDIASTINAL MASSES OR LYMPHADE­
NOPATHY
M.W. James, T. Thomas, M. Sovani, P. Kaye,
K. Ragunath, G.P. Aithal
P1352
PROSPECTIVE COMPARISON OF EN­
DOSCOPIC ULTRASONOGRAPHY AND
TRANSABDOMINAL ULTRASONOGRA­
PHY WITH ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY IN THE
EVALUATION OF BILIARY OBSTRUCTION
M. Joshi, Y.S. Divakara, T. Mukuntharajan,
S. Palaniappan, N. Mohan, R. Ardhanari
P1353
DEDICATED SUPERVISED TRAINING IN
PANCREATOBILIARY EUS FNA – DOES IT
MAkE A DIFFERENCE?
D. Joy, M. Nayar, V. Wadehra, T. Mansy,
K. Oppong
P1354
EUS­GUIDED DRAINAGE OF PANCRE­
ATIC FLUID COLLECTIONS USING CYS­
TOTOME: LONG­TERM FOLLOW­UP OF
41 PATIENTS
M. Cindoruk, T. Karakan, A. Dursun
P1355
ENDOSONOGRAPHY GUIDED BIOPSIES:
THE LONG­TERM ExPERIENCE OF A SIN­
GLE CENTRE
A. Razack, S. Khulusi
211
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1356
IMPROVING ENDOSONOGRAPHY SER­
VICES: WHAT CAN WE LEARN FROM OUR
PATIENTS?
S. Brown, S. Nicholson, A. Razack,
S. Khulusi
P1357
PRELIMINARY REPORT OF NEWLY DE­
VELOPED FORWARD VIEW CONVEx EUS
FOR FNA
M. Kida, S. Miyazawa, H. Ikeda,
M. Takezawa, M. Araki, M. Watanabe,
H. Imaizumi, K. Kobayashi, K. Saigenji
P1358
EUS­FNA OF PANCREATIC MASSES: THE
UTILITY AND IMPACT ON THE MANAGE­
MENT OF PATIENTS – A PROSPECTIVE
STUDY
M. Kliment, O. Urban, P. Fojtík, P. Falt,
M. Cegan, R. Havlik, M. Lovecek, M. Straka,
F. Jaluvka
P1359
ENDOSCOPIC ULTRASOUND GUIDED
FINE NEEDLE ASPIRATION OF PANCRE­
ATIC LESIONS: PERFORMANCE AND
OUTCOMES
A. Laquiere, P. Castellani, X. Adhoute,
O. Lebars, H. Perrier, M. Julien, A. Chollatnamy,
M. Bourliere, C. Boustiere
P1360
SUCCESSFUL TRANSDUODENAL ENDO­
SCOPIC ULTRASOUND­GUIDED FINE­
NEEDLE ASPIRATION OF RIGHT ADRE­
NAL MASSES
A. Laquiere, P. Castellani, X. Adhoute,
O. Lebars, H. Perrier, M. Julien, M. Bouliere,
C. Boustiere
212
P1361
PERFORMANCE OF THE FORWARD VIEW­
ING LINEAR ECHOENDOSCOPE FOR FINE
NEEDLE ASPIRATION OF SOLID AND
CYSTIC LESIONS THROUGHOUT THE GI
TRACT: A LARGE SINGLE CENTER ExPE­
RIENCE
A. Larghi, E.D. Rossi, D. Galasso,
M. Stobinski, K. Zachariah, G. Fadda,
G. Costamagna
P1362
EUS­GUIDED FINE NEEDLE TISSUE
ACQUISITION (EUS­FNTA) USING THE
FORWARD VIEWING LINEAR ECHOEN­
DOSCOPE FOR THE DIAGNOSIS OF SUB­
EPITHELIAL LESIONS: ExPANDING THE
ROLE OF A NEWLY BORN EUS SCOPE
A. Larghi, D. Galasso, E.D. Rossi, R. Persiani,
S. Alfieri, F. Pacelli, N. Uchida, R. Ricci,
D. D’Ugo, G.B. Doglietto, G. Costamagna
P1363
THE ENDOSCOPIC ULTRASOUND
GUIDED FINE NEEDLE ASPIRATION OF
SUBMUCOSAL TUMOR IN THE UPPER
GASTROINTESTINAL TRACT: LEARNING
CURVE IN THE SINGLE CENTER
J. Lee, K. Choi, H. Song, G. Lee, H. Jung,
D. Seo, J. Kim
P1364
ENDOSCOPIC ULTRASONOGRAPHY­
GUIDED FINE NEEDLE ASPIRATION OF
PELVIC AND PERIRRECTAL MASSES
C. Marra-López, J. Subtil, I. Fernandez-
Urien, M. Lozano, M. Betes, M. Muñoz-
Navas
P1365
OUR FIRST ExPERIENCE WITH ENDO­
SCOPIC ULTRASOUND IN SUDAN
S.B.M. Modawi

P1366
THE PILLCAM© COLON CAPSULE FOR
THE STUDY OF COLONIC PATHOLOGY IN
CLINICAL PRACTICE. STUDY OF AGREE­
MENT WITH COLONOSCOPY
J. Herrerías Gutiérrez, F. Argüelles Arias,
A. Caunedo Alvarez, M. San Juan Acosta,
J. Romero Vazquez, F. Pellicer Bautista
P1367
AGE BUT NOT SEx OR BODY HABITUS
INFLUENCES SMALL BOWEL TRANSIT
DURING VIDEO CAPSULE ENDOSCOPY
M.S. Bassan, H. Ephrath, A.D. Keegan
P1368
SMALL BOWEL CAPSULE ENDOSCOPY IN
OCTOGENARIANS
C.M. Girelli, S. Maiero, P. Porta,
R. Cannizzaro
P1369
CLINICAL IMPACT OF VIDEOCAPSULE
ENDOSCOPY IN ESTABLISHED PEDIATRIC
CROHN’S DISEASE
F. Costea, E.G. Seidman
P1370
THE COMPARISON OF THREE CAPSULE
ENDOSCOPY SYSTEMS’ SOFTWARE US­
ING FIRST 100 PATIENTS ExPERIENCE
A. Derovs, J. Derova, J. Pokrotnieks
P1371
PREDICTING FACTORS FOR INCOMPLETE
CAPSULE ENDOSCOPY OF THE SMALL
BOWEL: A MULTIVARIATE ANALYSIS
I. Fernandez-Urien, I. Elizalde, E. Borobio,
R. Irisarri, B. Gonzalez de la Higuera,
A. Borda, J. Vila, F. Jimenez, F. Borda
P1372
CAPSULE ENDOSCOPY FOR OBSCURE
GASTROINTESTINAL BLEEDING IN THE
TROPICS: A REPORT FROM INDIA
U.C. Ghoshal, C.P. Lakshmi, S. Kumar,
K. Das, A. Misra, P. Rai, S. Mohindra,
V.A. Saraswat, A. Kumar, G. Choudhuri
PosTeR sessIon
P1373
EFFECT OF MOSAPRIDE CITRATE ON
INTESTINAL­TRANSIT TIME AND DIAG­
NOSTIC YIELD OF CAPSULE ENDOSCOPY
IN HEALTHY SUBJECTS: A PROSPECTIVE
DOUBLE­BLIND CROSS­OVER STUDY
M. Hayashida, A. Ohno, A. Sakuraba,
Y. Yamada, Y. Ikei, K. Imase, G. Koyama,
S. Takahashi
P1374
CLINICAL IMPACT OF CAPSULE ENDOS­
COPY AS A LESS INVASIVE PROCEDURE
IN THE EVALUATION OF INTESTINAL
COMPLICATIONS FOLLOWING ALLO­
GENEIC HEMATOPOIETIC STEM CELL
TRANSPLANTATION
Y. Kakugawa, T. Gotoda, Y. Saito
P1375
A FAECAL CALPROTECTIN LEVEL OF
>100 mg/g IS ASSOCIATED WITH HIGH
DETECTION RATE OF SMALL BOWEL
CROHN’S BY CASULE ENDOSCOPY IN
THOSE WITH PREVIOUSLY NEGATIVE
INVESTIGATIONS
A. Koulaouzidis, S. Douglas, I. Arnott,
J.N. Plevris
P1376
STRING, CLING FILM COVERED VIDEO
CAPSULE ESOPHAGOSCOPY WITH
METHYLENE BLUE STAINING FOR BAR­
RETT’S ESOPHAGUS. A FEASIBILITY
STUDY
K. Papaxoinis, I. Binas, S.D. Ladas
P1377
SCREENING FOR ESOPHAGITIS AND BAR­
RETT’S ESOPHAGUS WITH ESOPHAGEAL
CAPSULE ENDOSCOPY IN FIRST DEGREE
RELATIVES OF PATIENTS AFFECTED BY
BARRETT’S ESOPHAGUS: PRELIMINARY
RESULTS
A. Mussetto, M. Manno, M. Frazzoni,
R.L. Conigliaro
213
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1378
RACE TO URANUS: A COMPARISON BE­
TWEEN THE PILLCAM AND MIROCAM
CAPSULE ENDOSCOPY SYSTEMS
A. Patrick, K. Ekanayake, M. Alansari,
P. Casey, C. Tibbats, M. Gowans
P1379
DIAGNOSTIC ROLE OF CAPSULE ENDOS­
COPY IN PATIENTS WITH SYMPTOMS
HIGHLY COMPATIBLE WITH CROHN’S
DISEASE
C. Petruzziello, P. Naccarato, S. Onali,
E. Calabrese, E. Lolli, F. Zorzi, G. Condino,
F. Pallone, L. Biancone
P1380
VIDEO CAPSULE ENDOSCOPY – WHAT
NExT?
P.T. Rajasekhar, C. Davison, S.J. Panter
P1381
VALIDATING A STRUCTURED CT COLO­
NOGRAPHY TRAINING PROGRAMME
A. Haycock, D. Burling, P. Wylie, J. Muckian,
A. Gupta, R. Ilangovan, S. Thomas-Gibson
P1382
COMPARISON OF VIRTUAL ENDOSCOPIC
ANALYSIS BY MULTISLICE CT AND DIFFU­
SION­WEIGHTED MRI FOR THE DETEC­
TION OF GASTRIC CANCER AND LYMPH
NODE METASTASIS
M. Hirayama, G. Kuroiwa, S. Takahashi,
K. Kinoshita, E. Tamoto, M. Kusano,
T. Okushiba, T. Kawamura, H. Tobioka,
T. Sagawa, T. Hayashi, Y. Sato, K. Miyanishi,
J. Kato
P1383
ENDOCYTOSCOPY SYSTEM FOR GASTRIC
NEOPLASTIC LESIONS AND ADJACENT
MUCOSA
A. Imai, M. Kato, T. Yoshida, S. Ono,
M. Nakagawa, Y. Shimizu, M. Asaka
214
P1384
COLONIC STRICTURES IN CT COLO­
NOGRAPHY: DIFFERENTIATING BENIGN
FROM MALIGNANT
M.J. Sangwaiya, R. Perez Johnston,
J. Simeone, M.E. Zalis, E.F. Halpern, T. Stern,
M. Cushing
P1385
IN VIVO DIAGNOSIS OF COLONIC AD­
ENOMAS WITH CONFOCAL ENDOMI­
CROSCOPY BY AN INExPERIENCED EN­
DOSCOPIST AND PATHOLOGIST
M. Lopez-Ceron, M. Jimeno, M. Zabalza,
C. Rodriguez de Miguel, O. Sendino,
G. Fernandez-Esparrach, A. Gines,
A. Cardenas, J. Bordas, A. Castells, J. Llach,
M. Pellise
P1386
DIAGNOSTIC YIELD OF WATER ENEMA
COMPUTED TOMOGRAPHY (WECT) IN
FIRST LINE INVESTIGATION FOR LOWER
GI BLEEDING IN ELDERLY PATIENTS
S. Nahon, V. Jouannaud, M. Lequoy,
H. Caugnat, C. Poupardin, M. Cymbalista,
B. Lesgourgues
P1387
CT­COLOGRAPHY AFTER INCOMPLETE
COLONOSCOPY: WHAT IS THE DIAGNOS­
TIC YIELD?
H.J.M. Pullens, M.S. van Leeuwen,
F.P. Vleggaar, P.D. Siersema
P1388
THREE­DIMENSIONAL NAVIGATION FOR
NOTES TRANSGASTRIC SURGERY USING
HIGH­SPATIAL­RESOLUTION MAGNETIC
RESONANCE ENDOSCOPY AND MAG­
NETIC SCOPE DETECTION SYSTEM
M. Sugimoto, Y. Morita, Y. Matsuoka,
H. Yoshinaka, T. Sanuki, M. Yoshida,
T. Toyonaga, H. Kutsumi, K. Kuroda,
T. Azuma

P1389
IMAGING OF AN Ex VIVO PANCREATIC
ADENOCARCINOMA WITH A CATHETER­
MOUNTED MAGNETIC RESONANCE DE­
TECTOR MICROCOIL
C.A. Wadsworth, S.D. Taylor-Robinson,
S.A. Khan, L. Sundblom, M.M. Ahmad,
I.R. Young, R.R.A. Syms
PosTeR sessIon
Pancreas II
P1390
THE JANUS kINASE­SIGNAL TRANS­
DUCER AND ACTIVATOR OF TRANSCRIP­
TION SIGNALING MEDIATES CERULEIN­
INDUCED INFLAMMATORY RESPONSE IN
PANCREATIC ACINAR CELL LINE AR42J
P. Chen, W.Y. Yao, Y.P. Zhang, Y.Z. Yuan
P1391
IS PINEAL GLAND INVOLVED IN THE
PANCREATIC DEFENCE AGAINST ACUTE
INFLAMMATION?
J. Jaworek, K. Nawrot-Porabka,
J. Szklarczyk, M. Kot, K. Zwirska-Korczala,
S.J. Konturek, W.W. Pawlik
P1392
PANCREATIC TUBERCULOSIS DIAG­
NOSED WITH EUS­FNA; IMPORTANT
AWARENESS FOR CYSTIC PANCREATIC
LESIONS IN ENDEMIC AREAS
R. Sotoudehmanesh, M. Khatibian,
A. Zandi, J. Shokri, M. Sotoudeh,
A. Yaghoobi, N. Ebrahimi-Daryani,
R. Ansari, J. Mikaeli, S. Merat
P1393
CYCLOOxYGENASE­2 AND ENDOTHE­
LIN­1 IN ACUTE PANCREATITIS
I. Bihalskyy, S. Chooklin, M. Lyba
PosTeR sessIon
P1394
INFECTED PANCREATIC NECROSIS: SIN­
GLE PROCEDURE TRANSGASTRIC ENDO­
SCOPIC TREATMENT
A. Charachon, M. Levy, D. Karsenti,
A. Laurent, C. Tayar, F. Brunetti, M. Karoui,
I. Sobhani, D. Cherqui, J. Delchier
P1395
LAPAROENDOSCOPIC MANAGEMENT
FOR MILD BILIARY PANCREATITIS
S. Chen, W.W.Z. Wu, J.J.C. Wang
P1396
ROLE OF URGENT DUODENOSCOPY IN
DIAGNOSIS AND TREATMENT OF ACUTE
BILIARY PANCREATITIS
A.M. Epshteyn, S.M. Dynkov
P1397
ACUTE PANCREATITIS IN PREGNANCY
ASSOCIATED WITH PREECLAMPSIA
A.A. Goldyreva, A.A. Popov,
V.P. Cheremiskin, Y.P. Sandakov, A.I. Ershova
P1398
CHANGES OF SERUM CYTOkINES AND
MATRIx METALLOPROTEINASE 9 LEVELS
IN BILIARY, ALCOHOLIC AND IDIOPATHIC
PANCREATITIS
I.N. Grigorieva, M.F. Osipenko, Y.I. Ragino,
T.I. Romanova, T.M. Nikitenko
P1399
EUS­GUIDED ENDOSCOPIC PANCREATIC
NECROSECTOMY: HOW MUCH ENDOS­
COPY IS NEEDED?
C. Juergensen, F. Neser, J. Boese-Landgraf,
D. Schuppan, U. Stoelzel, A. Fritscher-
Ravens
P1400
THE RELEVANCE OF SERUM GHRELIN
LEVEL TO SEVERITY OF ACUTE PANCRE­
ATITIS
Y. Kim, W. Jeong, S. Lee, H. Lee, M. Cho,
H. Joung, S. Lee, K. Han, G. Cheon
215
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1401
SEVERE ACUTE PANCREATITIS: IMPOR­
TANCE OF AGE AND CTSI AS PROGNOS­
TIC FACTORS
I. Krznaric Zrnic, L. Bilic Zulle, G. Poropat,
S. Milic, D. Stimac
P1402
PANCREAS DIVISUM IS NOT A CAUSE OF
PANCREATITIS BY ITSELF
C. Bertin, A. Pelletier, M. Vullierme,
F. Maire, O. Hentic, V. Rebours, P. Hammel,
P. Ruszniewski, P. Levy
P1403
AN AUDIT OF THE MANAGEMENT OF
ACUTE PANCREATITIS IN A DISTRICT
GENERAL HOSPITAL
A. Mathew, M. Thomas, J. Dmitrewski
P1404
EARLY DETECTION OF INFECTED PAN­
CREONECROSIS
S.V. Mihaylusov, E.V. Moiseenkova,
A.V. Chernyakov, M.S. Eshtrekov
P1405
IMPACT ON CELL PROLIFERATION OF
PROTEINS OF THE AkT/MTOR AND MAPk
PATHWAYS IN HUMAN PANCREATIC AD­
ENOCARCINOMA
A. Handra-Luca, P. Hammel, V. Rebours,
A. Sauvanet, A. Martin, R. Fagard, J. Flejou,
J. Belghiti, P. Bedossa, P. Ruszniewski,
A. Couvelard
P1406
EUS SURVEILLANCE OF INDIVIDUALS
AT HIGH­RISk OF PANCREATIC CANCER:
FOCAL AREAS OF HYPOECHOGENICITY
SUSPICIOUS FOR A MASS LESION WITH
SPONTANEOUS RESOLVEMENT
F. Harinck, P. Fockens, J.W. Poley,
D.J. Gouma, C.H.J. van Eijck, Y. Nio,
J.J. Hermans, I. Kluijt, M.J. Bruno
216
P1407
COMPARATIVE YIELD OF ENDOSONOG­
RAPHY AND MAGNETIC RESONANCE
IMAGING IN INDIVIDUALS AT HIGH­RISk
FOR PANCREATIC CANCER
F. Harinck, I. Kluiijt, J.W. Poley, A. Cats,
C.M. Aalfs, D.J. Gouma, Y. Nio, P. Fockens,
M.J. Bruno
P1408
PREVALENCE OF FEATURES OF CHRONIC
PANCREATITIS IN A DUTCH COHORT OF
INDIVIDUALS AT HIGH­RISk OF DEVEL­
OPING PANCREATIC CANCER
F. Harinck, J.W. Poley, I. Kluiijt,
M.G.W. Dijkgraaf, R. Timmer, H.J. van
Dullemen, M.J. Bruno, P. Fockens
P1409
IDENTIFICATION OF PATIENT REPORTED
IMPORTANT IMPACT OF PANCREATIC
CANCER ON AREAS OF HEALTH
T. Heiberg, T. Buanes
P1410
HELICAL TOMOTHERAPY WITH CONCUR­
RENT CAPECITABINE FOR THE TREAT­
MENT OF ADVANCED PANCREATIC
CANCER
J. Ji, C. Han, J. Jang, B. Lee, B. Kim, H. Choi,
C. Kay
P1411
PROTEOMIC PROFILING OF BILE IN PA­
TIENTS WITH MALIGNANT AND BENIGN
PANCREATOBILIARY DISEASE
F. Laird, R.J. Edwards, S.D. Taylor-Robinson,
C.A. Wadsworth, D. Westaby, I. Cox,
S.A. Khan
P1412
OPPOSITE EFFECTS OF TWO BH3­ONLY
PRO­APOPTOTIC BCL­2 MEMBERS IN
PANCREATIC CANCER
M. Erkan, S. Streit, T. Samkharadze,
C. Reiser-Erkan, T. DeOliveira, N. Giese,
I. Esposito, H. Friess, J. Kleeff

P1413
LEPTIN AND ADIPONECTIN PLASMA
CONCENTRATIONS IN PANCREATIC CAN­
CER PATIENTS
T. Krechler, M. Jachymova, M. Pavlikova,
A. Zak, M. Zeman, J. Macasek
P1414
INVOLVEMENT OF MEL A/B RECEPTORS
IN PREAPOPTOTIC SIGNALLING PATH­
WAYS IN HUMAN PANCREATIC CARCI­
NOMA CELLS (PANC­1)
A. Leja-Szpak, J. Jaworek, P. Pierzchalski,
W.W. Pawlik
P1415
INCIDENCE OF GLUCOSE­IMPAIRMENT
IN PATIENTS REFERRED FOR ENDOSCOP­
IC ULTRASOUND PREDATING DIAGNOSIS
OF PANCREATIC CANCER
A. Madan, S. Urayama
P1416
INVESTIGATING THE ANTITUMORAL
AND IMMUNOSTIMULATORY EFFECTS
OF A MIxED BACTERIAL VACCINE –
COLEYS TOxIN
C. Maletzki, W. Obst, P. Bodammer, U. Klier,
B. Kreikemeyer, J. Emmrich
P1417
ZINC ALPHA2­GLYCOPROTEIN IS A
NOVEL TUMOR SUPPRESSOR WHICH
DECREASES EPITHELIAL­TO­MESEN­
CHYMAL TRANSDIFFERENTIATION IN
PANCREATIC CANCER
C.W. Michalski, B. Kong, X. Hong, S. Streit,
I. Esposito, H. Friess, J. Kleeff
P1418
LAPAROSCOPIC MANAGEMENT OF CYS­
TIC NEOPLASM OF PANCREAS
K. Palaniappan, M. Narashiman,
R. Ardhanari
PosTeR sessIon
surgery II
PosTeR sessIon
P1419
ENDOSCOPIC MUCOSAL RESECTION
APPEARS EQUALLY EFFECTIVE, BUT AS­
SOCIATED WITH LESS MORBIDITY THAN
TRANSANAL ENDOSCOPIC MICROSUR­
GERY FOR THE TREATMENT OF LARGE
RECTAL ADENOMAS
R.M. Barendse, F.J.C. van den Broek, J. van
Schooten, W.A. Bemelman, E. de Graaf,
P. Fockens, E. Dekker
P1420
CYTOREDUCTIVE SURGERY WITH HEAT­
ED INTRAPERITONEAL CHEMOTHERAPY
FOR PERITONEAL CARCINOMATOSIS
FROM COLON CANCER
J. Bereder, M. Desantis, E. Benizri, J. Habre,
D. Benchimol
P1421
TRANSANAL RESECTION OF THE RECTO­
SIGMOID COLON: A NATURAL ORIFICES
TRANSLUMINAL ENDOSCOPIC SURGERY
TECHNIQUE BASED ON THE PRINCIPLES
OF TRANSANAL ENDOSCOPIC MICRO­
SURGERY
H.K. Bhattacharjee, F.C. Becera Garcia,
G.F. Buess
P1422
ERTAPENEM IN SURGICAL SITE INFEC­
TIONS PROPHYLAxIS IN GASTROINTES­
TINAL SURGERY
M. Cirillo, G. Gargiulo, N. Gennarelli,
F. Frattolillo, C. Fedele, A. Calogero,
F. Piantadosi, M. Sannino, C. Mattera,
R. Lobello
P1423
NUTRITIONAL CONDITION OF PATIENTS
UNDERGOING ELECTIVE COLORECTAL
RESECTION FOR CANCER
L. Moerman, E. De Waele, B. De Waele,
G. Delvaux
217
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1424
THE MALONE ANTEGRADE CONTINENCE
ENEMA IN CHILDREN WITH DEFECATION
DISORDERS, THE AMSTERDAM ExPERI­
ENCE
L.T. Hoekstra, C.F. Kuijper, D.C. Aronson,
R. Bakx, M.A. Benninga
P1425
GUT INFLAMMATION IN CHILDREN WITH
JUVENILE IDIOPATHIC ARTHRITIS
F. Kiparissi, C. Ong, K. Lindley, M. Elawad
P1426
PAEDIATRIC INDETERMINATE COLITIS –
A SINGLE CENTER ExPERIENCE
F. Kiparissi, A. Kader, K. Lindley, M. Elawad
P1427
THE USE OF INFLIxIMAB IN THE TREAT­
MENT OF REFRACTORY INFLAMMATORY
BOWEL DISEASE IN CHILDREN
F. Kiparissi, M. Elawad, K. Lindley
P1428
SACRAL NERVE STIMULATION IN PA­
TIENTS WITH FAECAL INCONTINENCE:
RESULTS FROM A COHORT STUDY
A. Leroi, S. Gallas, F. Michot, G. Meurette,
P. Lehur, X. Barth, H. Damon, F. Mion,
J. Faucheron, P. Orsoni, E. Rullier, F. Zerbib,
I. Sielezneff, V. Desfourneaux, L. Siproudhis,
L. Bresler, M. Mathonnet, J. Menard
P1429
THE PLAIN ABDOMINAL RADIOGRAPH –
OFTEN USED, SELDOM USEFUL
A. Mathew, A. Dubb, A. Rehman,
A. Wolinski
P1430
RECTUM­SPARING SURGERY MAY BE AP­
PROPRIATE FOR BIALLELIC MYH­ASSOCI­
ATED POLYPOSIS
R. Nascimbeni, D. Di Lorenzo, M. Gervasi,
C. Casella, F. Di Fabio
218
P1431
THE PERCEPTIONS AND ExPERIENCES
OF BIOFEEDBACk THERAPISTS
C. Taylor
P1432
ELEVATED FAECAL CALPROTECTIN IN
CHILDREN WITH COLONIC JUVENILE
POLYPS
E. Toth, A. Nemeth, J. Nielsen, C. Benoni,
P. Almqvist, D. Agardh
P1433
COLORECTAL SUBSPECIALISATION AND
IMPROVED OUTCOME FOLLOWING AB­
DOMINOPERINEAL RESECTION FOR REC­
TAL ADENOCARCINOMA
J.R.L. Wild, L. Toquero, M. Khan, S. Amin
P1434
BUDD­CHIARI SYNDROME. MULTICEN­
TRIC STUDY OF 43 CASES
M. Lahcene, N. Oumnia, R. Ouldgougam,
D. Hakem, S. Taharboucht, Z. Lerari,
F. Bouali, B. Touchene
P1435
MODULATION OF VASCULAR AND SE­
CRETORY PROCESSES IN THE ORGAN­
ISM. THE PH THEORY
I. Puscas, M. Coltau, G. Domuta, C.I. Puscas
P1436
ABDOMINAL ULTRASONOGRAPHY IN
DETECTION OF POSSIBLE ASYMPTOM­
ATIC THROMBOSIS IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASE
I. Tozzi di Angelo, V. Procházka,
M. Holinka, A. Hluší, J. Zapletalová
P1437
INHIBITORY EFFECT OF BETA 1 AND
BETA 2 ADRENERGIC ANTAGONISTS ON
GASTRIC ACID SECRETION
L. Unita, A. Iacobescu, M. Nasta, C. Mraz,
P. Gavril

P1438
ENDOSCOPIC VISIBLE LIGHT SPECTROS­
COPY: A NEW, MINIMALLY INVASIVE
TECHNIQUE FOR THE DIAGNOSIS OF
CHRONIC GASTROINTESTINAL ISCH­
EMIA
D. van Noord, A. Sana, D.A. Benaron,
P.M. Pattynama, H.J. Verhagen, B.E. Hansen,
E.J. Kuipers, P.B. Mensink
PosTeR sessIon
Therapeutic endoscopy/
Interventional radiology II
P1439
ENDOSCOPIC RETROGRADE PANCREA­
TOGRAPHY IN THE DIAGNOSIS AND
TREATMENT OF LOCAL COMPLICATIONS
OF PANCREATIC TRAUMA
L. Cairncross, J.E. Krige, J.M. Shaw,
P.C. Bornman, U.K. Kotze, M.F. Hameed
P1440
ENDOSCOPIC VERSUS SURGICAL DRAIN­
AGE FOR THE TREATMENT OF WALLED­
OFF PANCREATIC NECROSIS
D.E. Coelho, M. Mader, J. Ardengh,
J.R. Eulálio, J.F. Manso, E. Rios, J.E. Coelho
P1441
SUMP SYNDROME FOLLOWING CHO­
LEDOCHODUODENOSTOMY: EVALUA­
TION OF THE RESULTS OF ENDOSCOPIC
THERAPY
D.E. Coelho, L.P. Gomes, J. Ardengh, E. Rios,
J.R. Eulálio, J.F. Manso, J.E. Coelho
P1442
ENDOSCOPIC TREATMENT OF PORTAL
BILIOPATHY; LONG TERM RESULTS
S. Disibeyaz, E. Parlak, O.F. Onder,
O. Tayfur, B. Cicek, N. Sasmaz, B. Sahin
PosTeR sessIon
P1443
LONG TERM RESULTS OF BILIARY RE­
CONSTRUCTION AND STENTING FOR
COMPLETE TRANSECTION OF THE MAIN
COMMON BILE DUCT
F. Fiocca, F.M. Salvatori, F. Fanelli, A. Bruni,
V. Ceci, G. Donatelli, M. Corona, C. Modini
P1444
INITIAL ExPERIENCE WITH THE NEW FUL­
LY COVERED WALLFLEx® BILIARY STENT
USED AS A REMOVABLE ENDOPROSTHE­
SIS IN BENIGN CONDITIONS
J. García-Cano, V. Delgado-Torres,
C. Jimeno-Ayllón, R. Martínez-Fernández,
L. Serrano-Sánchez, M. Viñuelas-Chicano,
C. Gómez-Ruiz, J. Morillas-Ariño, G. Pérez-
Vigara, J. Pérez-García, Á. Pérez-Sola
P1445
A NOVEL ANTI­REFLUx METAL STENT
FOR THE PALLIATION OF DISTAL BILI­
ARY MALIGNANCIES: A PRELIMINARY
REPORT
B. Hu, T. Wang, Z. Shi, S. Wang, F. Xu, Y. Li
P1446
SINGLE­SESSION ENDOSCOPIC Y­CON­
FIGURED PLACEMENT OF NEWLY DE­
SIGNED METAL STENTS FOR HILAR MA­
LIGNANT BILIARY OBSTRUCTION
Y. Kanno, K. Ito, N. Fujita, Y. Noda,
G. Kobayashi, T. Obana, J. Horaguchi,
Y. Kato, S. Koshita, Y. Yamashita, T. Ogawa
P1447
RESULTS OF ENDOSCOPIC ULTRA­
SOUND­GUIDED CHOLEDOCODUODE­
NOSTOMY
A. Katanuma, H. Maguchi, M. Otubo,
S. Hashigo, T. Kin, A. Kurita, K. Yane,
M. Osanai, K. Takahashi
219
TUesDaY, noVeMbeR 24, 2009

TUesDaY, noVeMbeR 24, 2009
PosTeR sessIon
P1448
NEW ERA OF ExPAMDABLE METALLIC
STENT FOR BILIOPANCREAS MALIGNAN­
CY PATIENTS ExPECTED TO BE LONGER
SURVIVAL BY ADVANCEMENT OF CHE­
MOTHERAPY
M. Kida, S. Miyazawa, T. Iwai, H. Ikeda,
H. Kikuchi, M. Watanabe, H. Imaizumi,
K. Saigenji
P1449
PLACEMENT OF FULLY COVERED SELF­
ExPANDABLE METALLIC STENTS FOR
REFRACTORY BENIGN PANCREATIC DUC­
TAL STRICTURES
M. Kim, S. Moon, D. Park, T. Song, J. Eum,
S. Lee, D. Seo, S. Lee
P1450
PANCREATIC STENTING AFTER EARLY
ENDOSCOPIC REMOVAL OF BILE DUCT
STONES IN PATIENTS WITH SEVERE
ACUTE BILIARY PANCREATITIS MIGHT
PREVENT LOCAL COMPLICATIONS
J. Lee, S. Lee, J. Hwang, J. Lee
P1451
LEARNING CURVE OF BALLOON­AS­
SISTED ENTEROSCOPE ENDOSCOPIC
RETROGRADE CHOLANGIOPANCREA­
TOGRAPHY (ERCP)
H. Neumann, L.C. Fry, P. Malfertheiner,
K. Mönkemüller
P1452
ENDOSCOPIC TREATMENTS OF POSTOP­
ERATIVE BILE LEAkAGE AFTER CHOLE­
CYSTECTOMY, HEPATECTOMY OR LIVER
TRANSPLANTATION
S. Park, H. Kim, J. Park, J. Chung, S. Bang,
S. Song, S. Park
220
P1453
USEFULNESS OF SLIMMER AND OPEN­
CELL DESIGN STENT FOR ENDOSCOPIC
BILATERAL STENTING AND ENDOSCOP­
IC REVISION IN PATIENTS WITH HILAR
CHOLANGIOCARCINOMA
J. Park, S. Lee, J. Lee, J. Eum, E. Jeong, Y. Bae,
C. Choi, H. Kim, D. Kang
P1454
ENDOSCOPIC AMPULLECTOMY: RE­
SULTS OF A MONOCENTRIC STUDY
S. Salmi, S. Ezzedine, C. Menard, A. Desjeux,
J. Grimaud, M. Barthet
P1455
PERCUTANEOUS ENDOSCOPIC GAS­
TROSTOMY/JEJUNOSTOMY COMBINED
WITH PERCUTANEOUS TRANSHEPATIC
BILIARY DRAINAGE IN TREATING MALIG­
NANT BILIARY OBSTRUCTION
J. Shu, Q. Yang, X. Lv, W. Zhang, M. Li,
X. Zhang, H. Song, G. Ye, L. Wang
P1456
ENDOSCOPIC PANCREATIC DUCT STENT­
ING FOR CHRONIC PANCREATITIS WITH
LONG TERM FOLLOW­UP: A ROMANIAN
ExPERIENCE
M. Tantau, O. Mosteanu, T. Pop, B. Pintea,
G. Mester, A. Tantau
P1457
COMPARATIVE STUDY OF AIR CHOLAN­
GIOGRAM VERSUS DYE CHOLANGIO­
GRAM FOR METAL STENTING IN MALIG­
NANT HILAR BLOCkS
R. Sud, R. Puri, A. Thawrani, S. Hussain,
M. Kumar

P1458
EFFICIENCY OF COMBINED ENDOSCOPIC
ULTRSOUND GUIDDED FINE NEEDLE AS­
PIRATION AND BILIARY OR DUODENAL
STENTING IN PATIENTS WITH NON OPER­
ABLE PANCREATIC CANCER
I. Trouilloud, F. Salom, J. Huppertz, B. Terris,
L. Mangialavori, J. Duchmann, M. Gaudric,
G. Roseau, E. Mitry, P. Rougier, S. Chaussade,
F. Prat
P1459
48 CASES OF PANCREATIC DISEASE
TREATED BY ENDOSCOPY VIA MINOR
PAPILLA
T. Tsuji, M. Katoh, H. Kaneda, H. Katsura,
T. Kakimoto, H. Shinozaki, K. Yokoyama,
I. Asami, A. Itoh, K. Yamafuji, K. Takeshima,
N. Okamoto, K. Saruki
GasTRo 2009 UeGW/WcoG, london
would like to thank the following
experts for their contribution to the
GasTRo 2009 UeGW/WcoG, london
Poster Rounds on Tuesday, november
24, 2009
■ B. Annibale, Italy
■ J. Atherton, UK
■ G. Barbara, Italy
■ R. Benamouzig, France
■ M. Delvaux, France
■ M. Garassini, Venezuela
■ H. Gooszen, The Netherlands
■ Y. Inagaki, Japan
■ E. Louis, Belgium
■ M. Lutz, Germany
■ J. Mayerle, Germany
■ G. Mieli-Vergani, UK
■ J. Neoptolemos, UK
■ T. Roskams, Belgium
■ D. Sanders, UK
■ D. Schmucker, USA
■ J. Van Lanschot, The Netherlands
■ Y. Yamaoka, Japan
■ F. Zerbib, France
PosTeR sessIon
221
TUesDaY, noVeMbeR 24, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
PosTeR sessIon
Gastrointestinal bleeding III
P1460
THE OUTCOMES OF DOUBLE BALLOON
ENTEROSCOPY IN THE PATIENTS SUS­
PECTED OF SMALL BOWEL BLEEDING:
LAYING EMPHASIS ON REBLEEDING
J. Park, J. Byeon, S. Boo, B. Ye, S. Myung,
S. Yang, J. Kim
P1461
THE USE OF N­2­BUTYL CYANOACRY­
LATE AS A RESCUE THERAPY FOR RE­
BLEEDING AND UNCONTROLLABLE
BLEEDING FROM ESOPHAGEAL VARICES
W. Safwat
P1462
IMPROVED CHARACTERIZATION OF
VISIBLE VESSELS IN BLEEDING ULCERS
USING MAGNIFICATION ENDOSCOPY:
RESULTS OF A PILOT STUDY
L. Cipolletta, M.A. Bianco, R. Salerno,
R. Marmo, F. Cipolletta, S. Sansone,
G. Rotondano
P1463
LONG­TERM OUTCOME OF PATIENTS
WITH OBSCURE GASTROINTESTINAL
BLEEDING INVESTIGATED BY DOUBLE
BALLOON ENDOSCOPY
S. Shinozaki, H. Yamamoto, T. Yano,
K. Sunada, T. Miyata, Y. Hayashi, K. Sugano
P1464
HIGH INCIDENCE OF MALIGNANCY
FOUND IN THE FOLLOW­UP PERIOD IN
PATIENTS WITH OBSCURE GASTROIN­
TESTINAL BLEEDING AND MINOR FIND­
INGS AT CAPSULE ENDOSCOPY. INVES­
TIGATIONAL ALGORITHMS NEED TO BE
REVISED
E. Skogestad
222
P1465
THE GLASGOW BLATCHFORD SCORE
ENABLES ACCURATE RISk STRATIFICA­
TION OF PATIENTS WITH UPPER GASTRO­
INTESTINAL HAEMORRHAGE
R. Srirajaskanthan, R. Conn, C. Bulwer,
S. Mashru, P. Irving
P1466
COLONIC DIVERTICULAR BLEEDING AND
LOW­DOSE ASPIRIN
Y. Tomomatsu, J. Yoshino, K. Inui
P1467
EFFICACY OF ENDOSCOPIC THERAPY
PLUS INTRAVENOUS PROTON PUMP IN­
HIBITOR FOR PEPTIC ULCER BLEEDING
IN UREMIC PATIENTS – A CASE CONTROL
STUDY
G. Tseng, H. Lin
P1468
EROSIVE GASTRITIS AND PROxIMAL
BOWEL EROSIONS ARE MORE FREQUENT
IN PATIENTS WITH IRON DEFICIENCY
ANAEMIA REFERRED FOR CAPSULE EN­
DOSCOPY AND RECEIVE NSAIDS
P. Tsibouris, C. Kalantzis, A. Zalonis,
V. Kakavetsi, C. Liatsos, C. Tsironis,
G. Alexandrakis, N. Kalantzis
P1469
PER OS RABEPRAZOLE TREATMENT IS
SAFER THAN PARENTERAL CONTINUOUS
INFUSION OF PANTOPRAZOLE IN PA­
TIENTS WITH SEVERE ISCHAEMIC HEART
DISEASE AND NON VARICEAL BLEEDING
P. Tsibouris, C. Kalantzis, C. Liatsos,
P. Apostolopoulos, G. Alexandrakis,
C. Tsironis, P. Mavrogianni, N. Kalantzis

P1470
ASSOCIATION BETWEEN NONSTEROI­
DAL ANTI­INFLAMMATORY DRUGS AND
HEMORRHAGE CAUSED BY ISCHEMIC
COLITIS OR COLONIC DIVERTICULUM: A
CASE CONTROL STUDY
N. Tsuruoka, Y. Sakata, N. Tominaga,
M. Nakayama, R. Shimoda, S. Tsunada,
T. Noda, H. Sakata, R. Iwakiri, K. Fujimoto
P1471
OUTCOME OF PATIENTS WITH OBSCURE
GASTROINTESTINAL BLEEDING FOL­
LOWING CAPSULE ENDOSCOPY IN THE
NON­TERTIARY CARE SETTING
T. Valliani, J. Williams, T. Norbury, G. Shire,
P. Thomas
P1472
THE IMPORTANCE OF BLOOD UREA NI­
TROGEN ON THE STRATIFICATION OF
NON­VARICEAL GASTROINTESTINAL
HEMORRHAGE
R. Veloso, S. Leite, M. Afonso, J. Pinto,
A. Silva, J. Carvalho, J. Fraga
PosTeR sessIon
Helicobacter pylori III
P1473
A PROSPECTIVE RANDOMIZED TRIAL OF
REVERSE SEQUENTIAL THERAPY VERSUS
SEQUENTIAL THERAPY FOR HELICO­
BACTER PYLORI INFECTION
P. Hsu, F. Tsay, D. Wu, K. Lai
P1474
HELICOBACTER PYLORI INFECTION AND
BONE MINERAL DENSITY IN POSTMENO­
PAUSAL WOMEN
K. Papamichael, G. Papaioannou,
A. Polymeris, H. Karga, G.J. Mantzaris
PosTeR sessIon
P1475
THE LEVEL OF ExPRESSION OF SOMA­
TOSTATIN IN GASTRIC MUCOSA OF
FUNCTIONAL DYSPEPTIC PATIENTS WITH
FAMILY HISTORY OF GASTRIC CANCER
AND INFECTION OF HELICOBACTER PY­
LORI. CORRELATION WITH THE LEVEL OF
SOMATOSTATIN RECEPTOR SUBTYPE 3
K. Stec-Michalska, S. Malicki, L. Peczek,
B. Michalski, M. Wisniewska-Jarosinska,
B. Nawrot
P1476
A SIGNIFICANT INCREASE OF FASTING
SERUM PEPSINOGEN I/II RATIO IS A RELI­
ABLE BIOMARkER FOR THE SUCCESSFUL
HELICOBACTER PYLORI ERADICATION IN
PATIENTS WITHOUT PEPTIC ULCER OR
GASTRIC CANCER
T. Suganuma, Y. Yamamoto, N. Uragami,
J. Fujisaki, E. Hoshino, H. Takahashi, K. Miki
P1477
PARENTAL REARING IS ASSOCIATED
WITH FUNCTIONAL GASTROINTESTINAL
DISORDER
T. Ålander, M.R. Eisemann, K. Svärdsudd,
L. Agréus
P1478
PREVALENCE AND RISk FACTORS FOR
HELICOBACTER PYLORI INFECTION IN
THE FRENCH NAVY
J. Bronstein, P. Baert, A. Merens,
O. Bouilland, M. Richecoeur, C. Delluc
P1479
HELICOBACTER PYLORI INFECTION IS
LESS LIkELY IN PATIENTS WITH INFLAM­
MATORY BOWEL DISEASE: A SYSTEM­
ATIC REVIEW AND META­ANALYSIS OF
RELATIVE RISk
M. Dave, J. Luther, P.D.R. Higgins, J.Y. Kao
P1480
CLUSERING OF HELICOBACTER PYLORI
INFECTION AMONG COUPLES IN kOREA
D. Kim, B. Kim
223
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1481
HELICOBACTER PYLORI INFECTION
AMONG CHILDREN WITH GASTROINTES­
TINAL SYMPTOMS: A LOW PREVALENCE
OF INFECTION AMONG PATIENTS WITH
REFLUx OESOPHAGITIS
L. Kupcinskas, R. Kucinskiene,
G. Pranculiene, N. Urbonaviciene,
L. Rasmussen, L.P. Andersen
P1482
THE ROLE OF SOCIOECULTURAL AND
DIETARY FACTORS IN ExPLAINING LOW
PREVALENCE OF HELICOBACTER PYLORI
INFECTION AMONG MALAY SUBJECTS
AT NORTHEASTERN REGION OF PENIN­
SULAR MALAYSIA
Y. Lee, A. Ramli, S. Maran, N. Mustaffa,
N. Abdul Majid, K. Choo, H.M. Malaty,
D.Y. Graham
P1483
INFECTION WITH HELICOBACTER PYLORI
IS ASSOCIATED WITH AN ATHEROGENIC
PROFILE: DYSLIPIDAEMIA AND MODIFI­
CATION OF INFLAMMATORY INDICES
A.C. Manolakis, A.N. Kapsoritakis,
E.K. Tiaka, F. Tsiopoulos, A. Kapsoritaki,
A. Psychos, I. Tsiobanidis, S.P. Potamianos
P1484
RECURRENCE OF HELICOBACTER PYLORI
INFECTION ONE YEAR AFTER SUCCESS­
FUL ERADICATION; A PROSPECTIVE
STUDY IN GUILAN NORTH PROVINCE
OF IRAN
F. Mansour-Ghanaei, N. Taefeh, F. Joukar,
S. Besharati, M. Naghipour
P1485
PREVALENCE AND FACTORS ASSOCIAT­
ED WITH HELICOBACTER PYLORI INFEC­
TION AMONG CHILDREN ADMITTED TO
MULAGO HOSPITAL IN UGANDA
P.M. Mugaba, G. Ndeezi, J.K. Tumwine
224
P1486
PROSPECTIVE RANDOMIZED CON­
TROLLED TRIAL OF PROTON­PUMP IN­
HIBITOR VERSUS REBAMIPIDE­BASED
PROTON­PUMP INHIBITOR THERAPY
FOR TREATMENT OF ENDOSCOPIC SUB­
MUCOSAL DISSECTION­RELATED COM­
PLICATION
M. Nakamura, T. Arisawa, T. Shibata,
T. Tahara, M. Okubo, I. Hirata
P1487
FALLING PREVALENCE OF HELICO­
BACTER PYLORI INFECTION AND THE
BURDEN OF ULCER DISEASE: THE END
OF TEST AND TREAT?
A.J. Norman, S. Swain, R.H.P. Logan
P1488
NATURAL HISTORY AND PROGNOSTIC
FACTORS OF ADVANCED CHOLAN­
GIOCARCINOMA WITHOUT SURGERY,
CHEMOTHERAPY OR RADIOTHERAPY:
A LARGE­OBSERVATIONAL STUDY
J. Park, S. Din, M. Kim, K. Kim, D. Park,
S. Moon, T. Song, J. Eum, S. Lee, D. Seo, S. Lee
P1489
BREASTFEEDING AND HELICOBACTER
PYLORI INFECTION IN PRE­SCHOOL
CHILDREN
T. Sabbi
P1490
THE ROLE OF HELICOBACTER PYLORI
INFECTION AND USE OF NON­STEROI­
DAL ANTI­INFLAMMATORY DRUGS IN
THE PATHOGENESIS OF PEPTIC ULCER
BLEEDING
Z.S. Savic, D. Damjanov, L. Hadnadjev,
Z. Mrdja, Z. Petrovic, A. Knezevic, T. Pesic,
T. Jocic

P1491
CORRELATION OF PEPSINOGEN I, II,
GASTRIN AND CAG A LEVELS WITH DE­
MOGRAPHIC, LIFE STYLE CHARACTER­
ISTICS AND DYSPEPSIA SYMPTOM IN
A RANDOM HEALTHY POPULATION IN
SHIRAZ, SOUTHERN IRAN
M. Saberi-Firouzi, S. Shamsdin,
D. Mehrabani, S. Heydari
P1492
CORRELATION BETWEEN GENETIC MU­
TATIONS IN 23S RRNA AND GYRASE A OF
H.PYLORI STRAINS IN JAPAN
M. Yamade, C. Kodaira, M. Nishino,
M. Sugimoto, M. Ikuma, T. Furuta
P1493
PREVALENCE OF HELICOBACTER PYLORI
GENOTYPES IN PATIENTS WITH HEPATO­
BILIARY DISEASES
G. Isaeva, E.R. Abuzarova, N. Frans
P1494
DIFFERENT CAGA AND VACA POLY­
MORPHISMS ARE FOUND IN THE CHI­
NESE VERSUS THE MALAY AND INDIAN
POPULATIONS: AN ANALYSIS OF HELI­
COBACTER PYLORI VIRULENCE GENES IN
SINGAPORE
S. Chuah, S. Lui, H. Goh, K. Lee, V. Lee, B. Ho,
K. Ling
P1495
CAGA­POSITIVE STRAINS OF H. PYLORI
MAY PLAY A ROLE IN PRE­ECLAMPSIA
AND POLIABORTIVITY THROUGH A
CROSS REACTIVITY WITH TROPHOBLAST
CELLS
F. Franceschi, N. Di Simone, G. Gigante,
D. Roccarina, B. Giupponi, G. De Marco,
G. Merra, R. Castellani, M. D’Alessio,
F. Di Nicuolo, S. D’Ippolito, C. Tersigni,
G. Gasbarrini, A. Gasbarrini, A. Caruso,
N. Gentiloni Silveri
PosTeR sessIon
PosTeR sessIon
Immunology/Microbiology III
P1496
PROGNOSTIC VALUE OF APACHE II AND
SAPS II SCORES IN A GASTROENTEROL­
OGY INTENSIVE CARE UNIT (GEICU)
P. Freire, J.M. Romãozinho, P. Amaro,
M. Ferreira, G. Duque, E. Camacho,
M.C. Leitão
P1497
ADVANCED STRATEGIES COMBINING IN
VITRO MODELS TO PREDICT AND INVES­
TIGATE INTERACTIONS BETWEEN SAL­
MONELLA ISOLATES AND PROBIOTICS: A
NEW TOOL FOR PRECLINICAL DEVELOP­
MENT OF ANTIMICROBIALS
M. Gagnon, A. Zihler, C. Chassard,
C. Braegger, C. Lacroix
P1498
THERAPEUTIC STRATEGY FOR HYPER­
INFECTION SYNDROME CAUSED BY
STRONGYLOIDES STERCORALIS: 9 CASES
STUDY
M. GELU-SIMEON, M. Tabue Tuego,
G. Saint-Georges, L. Do Amaral, M. Laurent,
M. Borel, E. Saillard
P1499
PHARMACOVIGILIANCE REDUCES THE
INCIDENCE OF CLOSTRIDIUM DIFFICILE
ASSOCIATED DIARRHOEA BUT HAS NO
EFFECT ON MORTALITY
V. Tse, J.R. Goodhand, M. Myers,
C. Goodbourn, J. O’Brien
P1500
RISk FACTORS OF TREATMENT FAILURE
AND RELAPSE AFTER METRONIDAZOLE
OR VANCOMYCIN TREATMENT FOR
CLOSTRIDIUM DIFFICILE­ASSOCIATED
DIARRHEA: A 10­YEAR STUDY IN A SIN­
GLE TERTIARY CENTER IN kOREA
K.S. Jung, J.H. Cheon, J.J. Park, J.H. Lee,
S.M. Cheon, H.J. Bock, C.M. Moon, T.I. Kim,
W.H. Kim
225
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1501
BACTEREMIA AND ENDOTOxEMIA AF­
TER ENDOSCOPIC SUBMUCOSAL DIS­
SECTION FOR GASTRIC NEOPLASIA
M. Kato, M. Kaise, T. Obata, J. Yonezawa,
H. Toyoizumi, N. Yoshimura, Y. Yoshida,
H. Horiuchi, M. Kawamura, H. Tajiri
P1502
A REVIEW OF CURRENT ANTIBIOTIC RE­
COMENDATIONS IN WHIPPLES DISEASE
M.G. Keane, V. Potter, M. Shariff, G. Smith
P1503
THE ANTIBACTERIAL ACTIVITY OF HON­
EY AGAINST A HYPERVIRULENT CLOS­
TRIDIUM DIFFICILE STRAIN
R. Laheij, C. Ingham, M. van Oijen,
P. Sbeeberger
P1504
CYTOMEGALOVIRUS COLITIS: A 10­YEAR
REVIEW IN A REGIONAL HOSPITAL IN
HONG kONG
T.F.H. Lo, V.K.S. Leung, T.N. Chau, C.Y. Leung
P1505
FECAL TRANSPLANTATION FOR RECUR­
RENT CLOSTRIDIUM DIFFICILE COLITIS,
AN UNDERUSED TREATMENT MODALITY
S. Naegels, I. Ruytjens, L. Terriere, G. Blinder,
J. Holvoet, R. Hellemans
P1506
INTESTINAL CHALLENGE BETWEEN EN­
TEROPATHOGENS AND PROBIOTICS ON
MACROPHAGES: REAL­TIME BACTERIAL
QUANTIFICATIONS AND MELT CURVE
PROFILES
L. Nissen, C. Santini, W. Chingwaru,
B. Biavati, A. Cencic, B. Sgorbati
P1507
ABDOMINAL TUBERCULOSIS IN THE NEW
MILLENNIUM: EIGHT­YEARS ExPERIENCE
AT kING GEORGE HOSPITAL
E. Panteliou, S.L. Grainger
226
P1508
TWO NEGATIVE TESTS BY TOxIN DETEC­
TION ExCLUDES CLOSTRIDIUM DIFFICILE
INFECTION
R. Parker, I. Ahmed, C.S. Probert
P1509
NEW APPROACHES TO PATHOGENETIC
THERAPY OF SALMONELLOSIS COM­
PLICATED WITH THE DEVELOPMENT OF
HYPOVOLEMIC SHOCk
D.V. Piskun
P1510
DETERMINATION OF BLOOD D­LACTATE
CONCENTRATION FOR DIFFERENTIAL DI­
AGNOSTICS OF BACTERIAL INTESTINAL
INFECTIONS COMPLICATED WITH HYPO­
VOLEMIC SHOCk
D.V. Piskun
P1511
HOSPITAL EPISODE STATISTICS (HES) IS
A VALUABLE TOOL FOR EVALUATING THE
BURDEN OF HOSPITAL ADMISSIONS FOR
CLOSTRIDIUM DIFFICILE INFECTION IN
ENGLAND
M. Jen, R.C.G. Pollok, A. Bottle, P. Aylin,
S.K. Saxena
P1512
CAMPYLOBACTER JEJUNI ILEOCOLITIS:
AN EARLY DIAGNOSIS MAY HELP ITS DIF­
FERENTIATION FROM ACUTE ABDOMEN
AND INFLAMMATORY BOWEL DISEASE
A. Qasim, N. Appleby, N. Ullah,
S. O’Donnell, P. Murphy, C. O’Morain
P1513
LIVER ABSCESS IN ADULTS: A RETRO­
SPECTIVE STUDY
S. Safavi, S. Ahmad, G. Chakrabarty,
A. Mahmood, S. Zar

PosTeR sessIon
Intestinal disorders III
P1514
COELIAC DISEASE SCREENING IN PAE­
DIATRIC TYPE I DIABETES: HELP OR HIN­
DRANCE?
P. Henderson, L.E. Bath, K.J. Noyes,
P.M. Gillett
P1515
COELIAC DISEASE AND DIET: NO ALTRU­
ISM BUT COST BURDEN
I.T. Hettiarachchi, C.S. Probert, G.L. Swift,
R. Crimmins, D.S. Rowbotham, M. Gallagher
P1516
TO DETERMINE THE INCIDENCE AND
PREVALENCE OF ADULT COELIAC DIS­
EASE IN DERBY CITY 1972–2006
G.K.T. Holmes
P1517
FREQUENCY OF DIAGNOSIS AND AGE
AND SEx DISTRIBUTION OF PATIENTS
WITH ADULT COELIAC DISEASE IN A
SINGLE CENTRE 1973–2007
G.K.T. Holmes
P1518
SYMPTOM CONTROL, QUALITY OF LIFE
AND PSYCHOLOGICAL STATE IN PA­
TIENTS WITH COELIAC DISEASE
R. Jones, C.L. Hunt, J. Dalrymple, S. Sleet,
R. Stevens
P1519
THE CELIAC DISEASE SEROLOGY MAY
PREDICT COMPLIANCE WITH THE GLU­
TEN­FREE DIET IN THE LONG­TERM FOL­
LOW­UP. PROSPECTIVE STUDY USING A
COMPLETE SET OF ASSAYS
F. Nachman, E. Sugai, H. Vazquez,
A. Gonzalez, P. Andrenacci, S. Niveloni,
R. Mazure, E. Smecuol, H.J. Hwang, I. Pinto
Sanchez, E. Mauriño, J. Bai
PosTeR sessIon
P1520
LONG­TERM PROSPECTIVE ASSESSMENT
OF QUALITY OF LIFE IN CELIAC DISEASE
PATIENTS. DETERIORATION AT FOUR­
YEARS IS ASSOCIATED TO THE DEGREE
OF COMPLIANCE WITH THE DIET
F. Nachman, E. Sugai, H. Vazquez,
A. Gonzalez, P. Andrenacci, S. Niveloni,
R. Mazure, E. Smecuol, H.J. Hwang, I. Pinto
Sanchez, E. Mauriño, J. Bai
P1521
CLINICAL, SEROLOGICAL AND HISTO­
LOGICAL CO­RELATION OF NON COM­
PLIANT CELIAC DISEASE PATIENTS:
A 2­YEAR PROSPECTIVE STUDY
P. Jain, S. Sachdeva, P. Tyagi, A.S. Puri
P1522
MONITORING IGA DEFICIENT COELIAC
DISEASE BY MEASURING SERUM ANTI­
BODIES AGAINST DEAMIDATED GLIADIN
PEPTIDES
I.R. Korponay-Szabo, J. Tumpek, E. Nemes,
B. Toth, Z. Vecsei, R. Kiraly, M. Papp, S. Sipka
P1523
PASSIVE TRANSFER MODEL OF COELIAC
AUTOIMMUNITY IN NEWBORNS FROM
MOTHERS WITH COELIAC DISEASE AND
TRANSGLUTAMINASE ANTIBODIES
I.R. Korponay-Szabo, R. Kiraly, E. Nemes,
B. Toth, Z. Vecsei, K. Juuti-Uusitalo,
J. Gyimesi, M. Papp, L. Fesus, M. Maki
P1524
ARE THYROID PEROxIDASE ANTIBODIES
HELPFUL IN PREDICTING THYROID DIS­
EASE IN PATIENTS WITH ADULT COELIAC
DISEASE? THE LARGEST PROSPECTIVE
LONGITUDINAL STUDY
A.J. Ball, J.S. Leeds, R.C. Bunn, D.S. Sanders
227
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1525
PANCREATIC INSUFFICIENCY IN ADULT
COELIAC DISEASE. DO PATIENTS NEED
PROLONGED ENZYME SUPPLEMENTA­
TION?
J.S. Leeds, S. Morley, D.S. Sanders
P1526
WHAT ARE THE IMPLICATIONS OF NEWLY
IDENTIFIED COELIAC DISEASE IN ADULT
PATIENTS WITH TYPE 1 DIABETES MEL­
LITUS? EFFECT UPON GLYCAEMIC CON­
TROL, QUALITY OF LIFE, CARDIAC RISk
FACTORS, ALBUMINURIA AND PERIPH­
ERAL NERVE FUNCTION
J.S. Leeds, A.D. Hopper, M. Hadjivassiliou,
S. Tesfaye, D.S. Sanders
P1527
WHO IS AT RISk OF COELIAC DISEASE?
A PROSPECTIVE CASE FINDING STUDY
J.S. Leeds, R. Sidhu, E.J. Hall, V.S. Jandu,
N. Libzo, A.D. Hopper, A.J. Lobo,
M.E. McAlindon, D.S. Sanders
P1528
THE ROLE OF DUODENAL BULB BIOPSY
IN THE DIAGNOSIS OF CELIAC DISEASE
IN CHILDREN
R. Levinson Castiel, S. Morgenstern,
Y. Avitzur, C. Hartman, A. Hirsch,
Y. Rozenbach, R. Shapiro, N. Zevit,
H. Fleischaker, Y. Niv, R. Shamir
P1529
IS THE DIAGNOSIS OF COELIAC DISEASE
ASSOCIATED WITH SOCIO­ECONOMIC
STATUS? A POPULATION­BASED STUDY
N.R. Lewis, R.F.A. Logan, D.S. Sanders,
J. West
P1530
FERTILITY AND PREGNANCY­RELATED
OUTCOMES IN WOMEN WITH COELIAC
DISEASE: A POPULATION BASED QUES­
TIONNAIRE STUDY
N.R. Lewis, R.F.A. Logan, D.S. Sanders,
G.K.T. Holmes, J. West
228
P1531
IS DEAMIDATED GLIADIN PEPTIDE ANTI­
BODY A BETTER TEST FOR COELIAC DIS­
EASE THAN TISSUE TRANSGLUTAMINASE
ANTIBODY? A SYSTEMATIC REVIEW AND
META­ANALYSIS
N.R. Lewis, B.B. Scott
P1532
MILD ENTEROPATHY (MARSH 1 AND 2)
COELIAC DISEASE: A COMPARISON WITH
MORE SEVERE DISEASE USING A POPU­
LATION BASED COHORT
N.R. Lewis, R.F.A. Logan, D.S. Sanders,
J. West
P1533
REPRODUCTIVE AND HORMONAL RISk
FACTORS FOR BREAST CANCER AMONG
WOMEN WITH COELIAC DISEASE: A
POPULATION BASED QUESTIONNAIRE
STUDY
N.R. Lewis, R.F.A. Logan, D.S. Sanders,
G.K.T. Holmes, J. West
P1534
IS SMALL BOWEL BIOPSY ALWAYS MAN­
DATORY FOR DIAGNOSING COELIAC DIS­
EASE?
S. Mahmood, M. Yazbek-Hanna,
K. Hassan, V. Agaraval, A. Palejwala
P1535
AN EPIDEMIOLOGICAL STUDY OF CE­
LIAC DISEASE (CD) ADJUSTED FOR AGE
AND SEx TO THE CATALONIA POPULA­
TION (NORTH SPAIN) SUGGESTS A HIGH
FREQUENCY OF EVOLUTION TOWARDS
LATENCY
M. Mariné, C. Farre, M. Alsina, P. Vilar,
M. Cortijo, A. Salas, F. Fernández-Bañares,
M. Rosinach, R. Santaolalla, C. Loras,
T. Marquès, V. Cusí, M. Hernández,
A. Carrasco, J. Viver, M. Esteve

P1536
ARE HOSPITAL DOCTORS FORGETTING
TO CHECk IGA LEVELS IN COELIAC
SCREENING?
S.J. Mehta, M. Wong, S.D. Mann
P1537
BENEFICIAL EFFECTS OF CHRONIC CON­
SUMPTION OF PROBIOTICS ON SYMP­
TOMS AND BREATH­HYDROGEN Ex­
CRETION AFTER LACTOSE CHALLENGE
IN LACTOSE­INTOLERANT SUBJECTS
MAY PERSIST AFTER SUSPENSION OF
THERAPY
C.C. Almeida, S.L.S. Lorena, M.A. Mesquita
P1538
COELIAC DISEASE IGA MODULATES
VASCULAR PERMEABILITY IN VITRO
THROUGH THE ACTIVITY OF TRANSGLU­
TAMINASE 2 AND RHOA
E. Myrsky, S. Caja, Z. Simon-Vecsei,
I.R. Korponay-Szabo, C. Nadalutti,
R. Collighan, A. Mongeot, G. Martin,
M. Mäki, K. Kaukinen, K. Lindfors
P1539
COELIAC DISEASE FOLLOW­UP IN PRI­
MARY SCHOOL­CHILDREN DETECTED BY
SALIVARY TEST. PRELIMINARY RESULTS
OF THE STUDY PERFORMED IN 5000 SIx/
EIGHT­YEAR SCHOLARS
R. Nenna, M. Montuori, R. Luparia,
A. Turchetti, M. Mennini, L. Petrarca,
F. Lucantoni, C. Tiberti, M. Bonamico
P1540
BONE MINERAL DENSITY IN CHILDREN
AND ADOLESCENTS WITH CELIAC DIS­
EASE STRICTLY AND NON­STRICTLY AD­
HERENT TO GLUTEN FREE DIET
R. Orel, Š. Blazina, N. Bratanič, A. Širca-
Čampa
PosTeR sessIon
nutrition III
PosTeR sessIon
P1541
PREVALENCE OF VITAMIN D DEFICIENCY
IN ADULT PATIENTS WITH IRON DEFI­
CIENCY ANAEMIA
A.A. Al-Joudeh, S. Srinivas, P.J. Willemse,
P. Basumani, K.D. Bardhan, R. Ellis,
B. Horoldt
P1542
PREVALENCE OF VITAMIN D DEFICIENCY
IN ALCOHOLIC LIVER DISEASE PATIENTS
I. Aziz, B. Horoldt, A. Al-Joudeh, P. Willemse,
P. Basumani, M. Srinivas, K. Bardhan, R. Ellis
P1543
ACUTE EFFECTS OF ExERCISE INTEN­
SITY ON FOOD INTAkE AND RELEASE
OF GASTROINTESTINAL PEPTIDES IN
YOUNG MEN
J. Bilski, T. Brzozowski, J. Pokorski, J. Nitecki,
J. Pokorska, A. Dembinski, Z. Warzecha,
W.W. Pawlik
P1544
HYDROGEN AND METHANE BREATH
TESTS IN ExPERIMENTAL PIGS TREATED
WITH SHORT­TERM HIGH­DOSE INDO­
METHACIN WITH OR WITHOUT PROBI­
OTIC BACTERIA – A PILOT STUDY
J. Bures, J. Kvetina, J. Cyrany, V. Vorisek,
M. Kunes, M. Förstl, D. Kohoutova, I. Tacheci,
V. Palicka, S. Rejchrt, M. Kopacova
P1545
CORRELATION BETWEEN LACTASE GENE
POLYMORPHISMS AND LACTASE PERSIS­
TENCE IN SOUTHERN CHINA
Y. Deng, L. Guo, M. Fox, H. Chu, Y. Shang,
Y. Cong, D. Pohl, M. Fried, N. Dai
229
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1546
EARLY LOSS OF INTESTINAL INTEGRITY
FOLLOWING HEMORRHAGIC SHOCk IS
REVERSED BY LIPID­RICH ENTERAL NU­
TRITION
J.J. de Haan, G. Thuijls, T. Lubbers,
M. Hadfoune, K. Reisinger, W.A. Buurman,
J.M. Greve
P1547
MAxIMUM INTAkE CAPACITY AS MEA­
SURED BY A STANDARD NUTRIENT
DRINk TEST HELPS TO PREDICT WEIGHT
LOSS AFTER BARIATRIC SURGERY
L. Ilzarbe, S. Torra, J. Ramon, A. Goday,
J. Muñoz Galitó, I. Ibañez Zafón, M. Alonso,
F. Bory, M. Andreu Garcia, S. Delgado-Aros
P1548
LACTOBACILLUS CASEI DN­114 OO1
STRAIN IN THE PREVENTION OF POSTOP­
ERATIVE RECURRENCE OF CROHN’S DIS­
EASE: A RANDOMISED, DOUBLE­BLIND
PLACEBO­CONTROLLED TRIAL
P. Desreumaux, O. Dewit, J. Belaiche,
G. Savoye, J. Dupas, M. Lemann, Y. Bouhnik,
J. Grimaud, F. Casellas, J. Panes, A. Bigard,
M. De Vos, F. Carbonnel, P. Marteau,
S. Vermeire, A. Bourreille, J. Gisbert,
A. Darfeuille-michaud, F. Tondu, F. Dif,
J. Colombel
P1549
SALT INTAkE AFTER BARIATRIC SURGERY
P. Hallersund, T. Olbers, L. Sjöström,
H. Lönhroth, L.M. Carlsson, L. Fändriks
P1550
GERMINATED BARLEY FOODSTUFF
AMELIORATES INFLAMMATION IN MICE
WITH COLITIS THROUGH MODULATION
OF MUCOSAL IMMUNE SYSTEM
O. Kanauchi, A. Andoh, K. Mitsuyama
230
P1551
NUTRITIONAL IMPACT ANALYSIS OF THE
FOOD AIDS DISTRIDUTED IN THE SAHA­
RAWI REFUGEE CAMPS: POSSIBLE IMPLI­
CATIONS WITH CELIAC DISEASE
S. Martinazzi, C. Monfredini, A. Ravelli,
L. Menchini
P1552
CLINICAL BENEFIT OF DIETARY ADVICE
IN ULCERATIVE COLITIS (UC): RESULTS OF
A PILOT STUDY
T. Moshkovska, J.F. Mayberry
P1553
SOLUBLE PLANT FIBRES, PARTICULAR­
LY PLANTAIN AND BROCCOLI, INHIBIT
TRANSLOCATION OF CROHN’S DISEASE
MUCOSA­ASSOCIATED ADHERENT­
INVASIVE ESCHERICHIA COLI ACROSS
INTESTINAL M­CELLS
C.L. Roberts, B.J. Campbell, J.M. Rhodes
P1554
ESOPHAGOPROTECTIVE AND HEALING
POTENTIAL OF PROBIOTICS (PB) ON THE
RAT MODEL OF NON­EROSIVE ESOPHA­
GITIS (NEE)
M. Savytska, O. Zayachkivska,
M. Gzhegotsky, A. Yaschenko, A. Lutsyk
P1555
A STUDY OF THE FACTORS RELATED
TO HOSPITAL MALNUTRITION WITH A
GRADING SYSTEM
A. Sayyari, F. Imanzadeh, M. Moradi,
H. Javaherizadeh, F. Azarshin
PosTeR sessIon
oesophageal, gastric and duodenal
disorders III
P1556
MEDIUM TERM EFFICACY AND SAFETY
OF THE LOCAL APPLICATION OF MITO­
MYCINE C TO REFRACTORY ESOPHA­
GEAL STRICTURES IN CHILDREN
S. Coopman, L. Michaud, P. Fayoux,
A. Delattre, R. Sfeir, D. Turck, F. Gottrand

P1557
ESOPHAGEAL BIOPSIES IN PATIENTS
WITH DYSPHAGIA OR ESOPHAGEAL BO­
LUS IMPACTION. A SIMPLE DIAGNOSTIC
TOOL FOR AN UNDERDIAGNOSED DIS­
EASE: EOSINOPHILIC ESOPHAGITIS
M. Da Costa, A. Mata, V. Vila, J. Roca,
J. Turró, J. Espinós
P1558
EOSINOPHILIC OESOPHAGITIS: ARE WE
MISSING IT?
S. Dantuluri, P. Ramani, D. Basude,
B. Sandhu, C. Spray
P1559
COMPARISON OF THE EFFICACY OF RIG­
ID DILATORS AND BALLOON DILATORS
FOR BENIGN ESOPHAGEAL STRICTURES:
A META­ANALYSIS
N.I. Estanislao, H.B. Flores, E. Ang,
A. Salvana, E.S. Tripon, M. Velasquez,
M. Daez
P1560
PROSPECTIVE SINGLE­CENTER COHORT
STUDY FOR THE EVALUATION OF THE
LONG­TERM CLINICAL EFFICACY OF
FLExIBLE ENDOSCOPIC DIVERTICULO­
SCOPE­ASSISTED ZENkER’S DIVERTICU­
LOTOMY
F. Iacopini, A. Bizzotto, M. Marchese,
A. Tringali, V. Perri, M. Mutignani,
G. Costamagna
P1561
HIGH LEVELS OF PANCREATIC POLYPEP­
TIDE LOWERS ESOPHAGEAL MOTILITY IN
TYPE 2 DIABETICS
J.X. Jorge, C.C. Borges, F.J. Delgado,
M.H. Oliveira, M.H. Oliveira, M.A. Simoes,
E.A. Panão, A.L. Silva, A.C. Coelho,
C.C. Almeida
PosTeR sessIon
P1562
ESOPHAGEAL MOTILITY IS NOT IM­
PAIRED IN PATIENTS WITH SIGNIFICANT­
LY ELEVATED SERUM GASTRIN LEVELS
G. Kabaçam, M. Bektas, M. Alkan,
H. Cetinkaya, I. Soykan
P1563
EOSINOPHILIC OESOPHAGITIS: DOES
REFLUx PLAY A ROLE?
A.L. Krarup, G. Villadsen, P. Funch-Jensen,
A.M. Drewes, S.S. Olesen
P1564
MORE COMFORT, SAME PRECISION: PRE­
LIMINARY COMPARISON OF THE NEW
SMALL DIAMETER SOLID­STATE HIGH­
RESOLUTION MANOMETRIC ASSEMBLY
FOR ASSESSMENT OF OESOPHAGEAL
FUNCTION IN ADULTS
D. Luger, J.E. Pandolfino, T.R. Parks,
P.J. Kahrilas, M.A. Kwiatek
P1565
EOSINOPHILIC OESOPHAGITIS IN ENDO­
SCOPICALLY NORMAL PATIENTS WITH
DYSPHAGIA – UNDER­RECOGNISED AND
UNDER­BIOPSIED
S. Leedham, N. Jawad, J. Chin Aleong,
S. Preston
P1566
SUBEPITHELIAL FIBROSIS IN ADULT EO­
SINOPHILIC OESOPHAGITIS: EFFECT OF
TOPIC STEROID TREATMENT OVER COL­
LAGEN DEPOSITION AND PROFIBRO­
GENIC CITOkINES GENE ExPRESSION
A.J. Lucendo, A. Arias, J. Yagüe Compadre,
L.C. De Rezende, T. Mota Huertas,
S. González Castillo, T. Bellón
P1567
ENDODSCOPIC DIVERTICULOTOMY
IN THE ELDERLY: NO MORE NEED FOR
SURGEONS?
S. Meinzer, J. Kunz, D. Brenke, B. Koehrer,
A. Lutterer, L. Gossner
231
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1568
COMPARISON BETWEEN COMBINED
TREATMENT (BOTULINUM TOxIN IN­
JECTION AND PNEUMATIC DILATION)
WITH PNEUMATIC DILATION IN LOW
RESPONDER ACHALASIA PATIENTS
J. Mikaeli, A. Bakhshipour, R. Rabbani,
R. Sotoudehmanesh, R. Ansari, S. Merat,
M. Khatibian
P1569
THE CORRELATION BETWEEN EOSINO­
PHILIC OESOPHAGITIS AND AEROAL­
LERGENS
F.J. Moawad, G.R. Veerappan, T.J. Duncan,
C. Maydonovitch, B.R. Haymore, S.E. Kosisky,
R.K. Wong
P1570
EOSINOPHILIC OESOPHAGITIS­ ATOPIC
OF THE 21ST CENTURY
S. O’Donnell, O.B. Kelly, N. Breslin, P. Crotty,
H.J. O’Connor, B.M. Ryan, N. Swan,
C.A. O’Morain
P1571
ASSOCIATION BETWEEN IDIOPATHIC
ACHALASIA AND THE IL23R GENE
A. Ruiz de León, A. González Vigo, J. Pérez
de la Serna, J. Santiago, C. Sevilla-
Mantilla, M. Fernández Arquero
P1572
DIFFERENT SHORTENING OF THE ESOPH­
AGUS IN THE SUBTYPES OF ACHALASIA
A. Ruiz de León, J. Pérez de la Serna,
C. Sevilla-Mantilla, P. Vázquez de Parga,
I. Romero Sánchez-Miguel, A. Molina Parra,
M. Díaz-Rubio
P1573
FACTORS ASSOCIATED WITH ESOPHA­
GEAL INVOLVEMENT IN SYSTEMIC SCLE­
ROSIS: A HIGH RESOLUTION MANOM­
ETRY STUDY
S. Roman, A. Hot, J. Ninet, F. Mion
232
P1574
PREVALENCE OFF OESOPHAGITIS IN PA­
TIENTS WITH ACHALASIA AFTER PNEU­
MATIC DILATATION
A. Tebaibia, M. Boudjella, N. Matougui,
N. Oumnia, M. Lahcene, D. Boutarene,
B. Touchene
P1575
CLINICAL OUTCOMES OF ENDOSCOPIC
SUBMUCOSAL DISSECTION FOR EARLY
GASTRIC CANCER WITH ExPANDED CRI­
TERIA: SINGLE CENTER STUDY
C. Ryu, S. Seol, Y. Lee, S. Jee, J. Choi, J. Kim,
S. Lee, E. Jung, K. Park, S. Ha, Y. Choi, H. Seo
P1576
Dkk­2, A MODULATOR OF WNT­SIGNAL­
ING PATHWAY, IS SPECIFICALLY INDUCED
IN GASTRIC CANCER
M. Selgrad, J. Molnár, S. Schreiber,
D. Kuester, J. Hoffmann, J. Bornschein,
L. Ricciardiello, T. Wex, P. Malfertheiner
P1577
LUMICAN ExPRESSION CORRELATES
WITH LYMPHOVASCULAR INVASION
AND RECURRENCE RATE IN GASTRIC
CANCER
T. Seya, N. Tanaka, Y. Takahashi,
S. Shinji, T. Shirakawa, K. Horiba, K. Yokoi,
K. Furukawa, Y. Oaki, T. Ishiwata, Z. Naito,
E. Uchida
P1578
N RATIO IN GASTRIC CANCER PATIENTS
TREATED BY D1 LYMPHADENECTOMY.
RESULTS FROM LATVIAN ONCOLOGY
CENTER ­ ExPERIENCE ON 526 PATIENTS
A. Sivins, C. Pedrazzani, A. Sivins,
G. Ancans, D. Marrelli, G. Corso, V. Krumins,
F. Roviello, M. Leja
P1579
FRACTAL ANALYSIS OF NUCLEAR AND
VASCULAR PATTERNS IN GASTRIC AD­
ENOCARCINOMAS
D. Pirici, L. Mogoanta, B. Oprea, C.T. Streba

P1580
HISTOLOGICAL STUDY OF THE GASTRIC
MUCOSA WITH INTESTINAL METAPLASIA
L. Mogoanta, C.T. Streba, D. Pirici,
C.F. Popescu, L.M. Streba, R. Dirnu
P1581
CHRONIC NONSTEROIDAL ANTI­IN­
FLAMMATORY DRUG (NSAID) USE SUP­
PRESSES MULTIPLE CPG ISLANDS HY­
PER METHYLATION (CIHM) OF TUMOR
SUPPRESSOR GENES IN THE HUMAN
GASTRIC
T. Tahara, T. Shibata, M. Nakamura,
M. Okubo, J. Yonemura, Y. Maeda,
D. Yoshioka, H. Yamashita, I. Hirata,
T. Arisawa
P1582
THE RELATIONSHIP BETWEEN NBI MAG­
NIFIED ENDOSCOPIC FINDINGS AND
PATHOLOGICAL TYPE OF GASTRIC CAN­
CER
A. Takahashi, T. Oyama, A. Tomori
P1583
THE STRATEGY OF ESD FOR ESOPHAGO
GASTRIC JUNCTIONAL CANCERS
A. Takahashi, T. Oyama, A. Tomori
P1584
CLINICOPATHOLOGICAL FEATURES OF
INTRAMUCOSAL GASTRIC CANCER OF
DIFFERENTIATED AND UNDIFFERENTI­
ATED MIxED TYPE
K. Takizawa, H. Ono, N. Kakushima,
M. Tanaka, H. Ikehara, H. Matsubayashi,
Y. Yamaguchi, E. Bando, M. Terashima,
K. Kusafuka
P1585
PHASE III RANDOMIZED CONTROLLED
TRIAL OF HYPOTONIC INTRAPERITO­
NEAL CISPLATIN DURING SURGERY FOR
THE ADJUVANT TREATMENT OF GASTRIC
CANCER WITH SEROSAL INVASION
S. Tsujitani, H. Saito, S. Tatebe, K. Katano,
A. Kondo, M. Ikeguchi
PosTeR sessIon
P1586
COMPUTED TOMOGRAPHY IN PREOP­
ERATIVE GASTRIC CANCER: IS IT USEFUL?
E. Una
P1587
CHEMOPREVENTION EFFECT OF NON­
STEROIDAL ANTI­INFLAMMATORY
DRUGS IN PEPTIC ULCER DISEASE: A
POPULATION­BASED COHORT STUDY
C. Wu, M. Wu, K.N. Kuo, Y. Chen, C. Wang,
J. Lin
P1588
RED FLAT ELEVATION MIGHT BE AN
EARLY FORM OF GASTRIC CANCER WITH
MICROSATELLITE INSTABILITY
K. Yamashita, Y. Arimura, H. Suzuki,
H. Okuda, T. Tanuma, H. Yamamoto,
S. Watanabe, Y. Shinomura
P1589
GASTRIC HEPATOID ADENOCARCINOMA
IN TAIWAN: ONE SINGLE­CENTER STUDY
H. Yeh, C. Chiu, R. Wu, D. Yeh
P1590
THE METABONOMICS: THE STUDYING IN
PRECANCER AND CANCEROUS GASTRIC
LESIONS
L. Yu, R. Shi, J. A, L. Cheng, M. Sun
P1591
IDENTIFICATING RAF kINASE INHIBI­
TOR PROTEIN (RkIP) AS A BIOMARkER
IN GASTRIC ADENOCARCINOMA BY LA­
SER CAPTURE MICRODISSECTION AND
QUANTITATIVE PROTEOMIC ANALYSIS
Z. Zhang, G. Zhang, M. Li
P1592
CLINICAOPATHOLOGICAL FEATURES
AND SURVIVAL ANALYSIS OF PRIMARY
MALIGNANT DUODENAL TUMORS IN
SOUTH CHINA: A 10­YEAR ExPERIENCE
S.H. Zhang, B.H. Zhong, Z.J. Weng,
X.R. Gong, Y. Cui, M.H. Chen
233
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1593
INHIBITORY EFFECT OF kNOCkDOWN OF
MACROPHAGE MIGRATION INHIBITORY
FACTOR ExPRESSION ON PROLIFERA­
TION OF GASTRIC CANCER AGS CELLS
BY RNA INTERFERENCE
S. Zhu, L. He, D. Xie, P. Hu, H. Kung
P1594
GENETIC RISk FACTORS FOR INTESTI­
NAL METAPLASIA IN A HIGH RISk SIN­
GAPORE­CHINESE POPULATION
F. Zhu, M. Loh, J. Hill, S. Lee, K.X. Koh,
K.W. Lai, M. Salto-Tellez, W.C. Lim, C.K. Chia,
H.C. Low, K.G. Yeoh, R. Soong
P1595
GASTRO­INTESTINAL SYMPTOMS IN
CANDIDATES FOR BARIATRIC SURGERY
K. Alexandropoulou, H.F. Medina Lucena,
M. Reddy, A. Wan, A. Poullis, J.Y. Kang
P1596
THE FREQUENCY AND SEVERITY OF GAS­
TRO­OESOPHAGEAL REFLUx SYMPTOMS
IN A POPULATION OF ADULT ASTHMAT­
ICS IN SRI LANkA
L. Amarasiri, A. Pathmeswaran,
C.D. Ranasinha, J. De Silva
P1597
THE HIGH RATE OF FEAR OF CANCER IN
PATIENTS WITH GASTROESOPHAGEAL
REFLUx DISEASE IN A COUNTRY WITH
LOW PREVALENCE OF BARRETT ESOPH­
AGUS
B. Bayrakci, R. Vardar, S. Bor
P1598
GASTROESOPHAGEAL REFLUx DISEASE
IN RUSSIA: NATIONAL SURVEY OF 7812
ADULTS
L.B. Lazebnik, D.S. Bordin, A.A. Masharova,
Y.V. Vasyliev
234
P1599
CHARACTERISTICS OF GASTROESOPHA­
GEAL REFLUx DISEASE IN ELDERLY; THE
IMPORTANCE OF NOCTURNAL REFLUx
EPISODES
M. Crncevic Urek, M. Banic, Z. Babic,
I. Grgurevic, D. Kardum, Z. Cabrijan,
B. Bilic, M. Tadic, L. Petricusic, T. Bokun,
M. Kujundzic
P1600
IMPACT OF ABDOMINAL OBESITY (AO)
ON GASTRO­OESOPHAGAL REFLUx
(GOR) SYMPTOMS: RESULTS OF AN OB­
SERVATIONAL STUDY IN FRANCE
B. Coffin, P. Delaage, M. Licour,
P. Barthelemy
P1601
AGEING AND GASTROESOPHAGEAL RE­
FLUx DISEASE – A SYSTEMATIC REVIEW
J. Dent
P1602
THE IMPACT OF GASTROESOPHAGEAL
REFLUx DISEASE ON DAILY LIFE: THE
SYSTEMATIC INVESTIGATION OF GAS­
TROINTESTINAL DISEASES IN CHINA
(SILC)
R. Wang, D. Zou, Y. Zhao, X. Ma, X. Yan,
J. Dent, J. Sung, W. Liu, J. He
P1603
GASTROESOPHAGEAL REFLUx DISEASE
PREVALENCE AND ASSOCIATED FAC­
TORS: THE SYSTEMATIC INVESTIGATION
OF GASTROINTESTINAL DISEASES IN
CHINA (SILC)
J. He, X. Ma, Y. Zhao, R. Wang, X. Yan,
D. Zou, J. Dent, J. Sung, W. Liu, Z. Li
P1604
RELATIONSHIP BETWEEN PSYCHOLOGI­
CAL FACTORS AND QUALITY OF LIFE IN
SUBTYPES OF GASTROESOPHAGEAL
REFLUx DISEASE
H. Lee, J. Oh, T. KiM, M. Choi, E. Jeon,
S. Choi, C. Lee, I. Chung

P1605
INCIDENCE OF GASTROESOPHAGEAL
REFLUx DISEASE SYMPTOMS AMONG
PATIENTS UNDER ACUTE NON­STEROI­
DAL ANTI­INFLAMMATORY DRUGS/
ACETYLIC SALICYLIC ACID TREATMENT
C. Martin de Argila, M. Caballero Correa,
P. Martinez Jimenez
P1606
GERD IN ELDERLY: FINAL RESULTS OF
THE PROSPECTIVE SENIOR STUDY
A. Myftiu, J. Raynaud, P. Loriquet,
H. Moutaffian, C. Bon, B. Bejou, G. Airinei,
R. Benamouzig
P1607
HEARTBURN PATIENTS: THE ROLE OF
STRESS AS A TRIGGER FOR BOWEL
SYMPTOMS
K.L. Oliver, G.J. Davies, P.W. Dettmar
P1608
DATA MINING OF GERD SYMPTOMS
THROUGH A NOVEL ADAPTING AUTO­
CM MAPPING METHOD
A. de Leone, F. Pace, P. Dominici, E. Grossi
P1609
PREVALENCE OF EROSIVE ESOPHAGITIS
AND BARRETT’S ESOPHAGUS IN ASYMP­
TOMATIC CHINESE ADULT POPULATION
S. Peng, M.H. Chen, Y. Cui, Y.L. Xiao,
L.S. Xiong, C.J. Li, P.J. Hu
P1610
STRUCTURED GP SUPPORT IN A HEALTH
INSURANCE COMPANY INITIATED
MULTI­FACETTED INTERVENTION FOR
OPTIMISING ACID­SUPPRESSING DRUG
PRESCRIPTIONS IN PRIMARY CARE; A SE­
QUENTIAL RANDOMISED CONTROLLED
TRIAL
H.M. Smeets, N.J. de Wit, N.P.A. Zuithoff,
P.C.M. van Dijk, A.P.M. van der Lee, A.W. Hoes
PosTeR sessIon
P1611
THE BURDEN OF GASTROESOPHAGEAL
REFLUx DISEASE AMONG PARTIAL/NON­
RESPONDERS TO PROTON PUMP INHIBI­
TOR THERAPY: A DATABASE STUDY IN US
AND EUROPEAN COHORTS
S. Toghanian, D. Johnson, S. Bolge,
F. Zerbib
P1612
EVALUATION OF THE IMPACT OF GERD
ON DAILY ACTIVITIES USING THE SELF­
ADMINISTERED GERD IMPACT SCALE
(GIS) QUESTIONNAIRE: RESULTS OF A
PROSPECTIVE OBSERVATIONAL STUDY
IN THE GENERAL PRACTICE SETTING
F. Zerbib, P. Barthélemy, C. Soufflet
P1613
THE IMPEDANCE­PH MONITORING FOR
GASTRO­OESOPHAGEAL REFLUx IN
CHILDREN WITH CYSTIC FIBROSIS
J. Brecelj, R. Orel
P1614
RELATIONSHIP OF UPPER ABDOMINAL
SYMPTOMS AND GASTROESOPHAGEAL
REFLUx DISEASE (GERD) WITH PROGRES­
SION OF CHRONIC ATROPHIC GASTRITIS
ASSOCIATED WITH HELICOBACTER PY­
LORI INFECTION
S. Enomoto, M. Oka, H. Ohata,
C. Mukoubayashi, M. Watanabe,
H. Deguchi, K. Ueda, I. Inoue, T. Maekita,
M. Iguchi, K. Yanaoka, H. Tamai, O. Mohara,
M. Ichinose
P1615
LEVEL OF HEARTBURN SYMPTOMS
AND HEATH­RELATED QUALITY OF LIFE
AMONG PATIENTS WITH REFLUx DIS­
EASE
R. Filip, R. Gorczyca, J. Schabowski, J. Huk
235
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1616
96 H WIRELESS VS 24 H TRADITIONAL
PH MONITORING: AN OUTCOME STUDY
A. Grigolon, D. Consonni, I. Bravi, A. Tenca,
R. Penagini
P1617
A MULTI­CENTER, RANDOMIZED, COM­
PARATIVE STUDY TO DETERMINE THE
APPROPRIATE DOSE OF LANSOPRAZOLE
FOR THE DIAGNOSTIC TEST IN kOREAN
PATIENTS WITH GASTROESOPHAGEAL
REFLUx DISEASE
B. Jang, C. Yang, J. Kwon, S. Jeon, K. Cho,
K. Park, C. Park, H. Kim, E. Kim, T. Kim
P1618
SEVERITY OF SLEEP DISORDERS IS
STRONGLY CORRELATED WITH ESOPH­
AGEAL PH PARAMETERS IN PATIENTS
WITH GASTRO­ESOPHAGEAL REFLUx
DISEASE
S. Karoui, O. Chtara, N. Bibani, L. Zouiten,
L. Kallel, S. Matri, M. Serghini, N. Ben
Mustapha, M. Fekih, J. Boubaker, A. Filali
P1619
RATIO OF PROxIMAL REFLUx EPISODES:
THE MOST IMPORTANT PARAMETER IN
EVALUATION OF PATHOLOGICAL PROxI­
MAL GASTRO­ESOPHAGEAL REFLUx IN
PATIENTS WITH E.N.T MANIFESTATIONS
S. Karoui, N. Bibani, L. Zouiten, L. Kallel,
S. Matri, M. Serghini, N. Ben Mustapha,
M. Fekih, J. Boubaker, S. Sahtout, A. Filali
P1620
NIGHTTIME PROxIMAL GASTRO­ESOPH­
AGEAL ACID REFLUx IN PATIENTS WITH
CHRONIC PHARYNGITIS AND LARYNGI­
TIS
S. Karoui, N. Bibani, L. Kallel, L. Zouiten,
S. Matri, M. Serghini, N. Ben Mustapha,
M. Fekih, J. Boubaker, S. Sahtout, A. Filali
236
P1621
SIMULTANEOUS INTRALUMINAL IMPED­
ANCE AND PH MONITORING IN CHIL­
DREN WITH CEREBRAL PALSY
R. Orel, I. Orel, K. Groleger-Sršen
P1622
BILE ACID & PEPSIN ­RELIABLE AND
QUANTIFIABLE MARkERS OF REFLUx?
S. Parikh, B. Verdon, A.G.N. Robertson,
C. Ward, P.W. Dettmar, J.P. Pearson
P1623
ABDOMINAL ExAMINATION ON TRIAL:
AN ANALYSIS OF PATIENTS IN AMBULA­
TORY GASTROENTEROLOGY
P. Saxena, P.H. Katelaris
P1624
96 HOUR WIRELESS OESOPHAGEAL PH
MONITORING INCREASES YIELD IN PA­
TIENTS WITH NEGATIVE 24 HOUR CATH­
ETER­BASED STUDIES
R.R. Sweis, A. Anggiansah, R. Anggiansah,
M. Fox, T. Wong
P1625
GLOBUS SYMPTOMS AND REFLUx: AS­
SESSEMENT BY ESOPHAGEAL IMPED­
ANCE PH­MONITORING
S. Vanden Branden, B. Roosens,
J. Hulstaert, F. Mana, U. Daniel
P1626
SExUAL INTERCOURSE DOES NOT IN­
CREASE THE REFLUx
S. Bor, R. Vardar, E. Valytova, E. Belen
Moscow Gastroenterology Research
Institute, moskow, Russian Federation
P1627
UPPER GASTROINTESTINAL ENDOSCO­
PY HAS NO ROLE ON THE DIAGNOSIS OF
LARYNGOPHARYNGEAL REFLUx
R. Vardar, A. Varis, B. Bayrakci, S. Akyildiz,
T. Kirazli, S. Bor

P1628
PATTERNS OF LARYNGOPHARYNGEAL
AND GASTROESOPHAGEAL REFLUx OF
LARYNGITIS PATIENTS AND PREDICTORS
OF ACID SUPPRESSION SUCCESS
A. Wang, M. Liang, J. Chen, J. Lin, S. Peng,
A. Jiang, W. Wen, P. Hu, M. Chen
P1629
DIFFERENCE IN DETECTION OF ACID
REFLUx BETWEEN IMPEDANCE AND
PH­METRY MAY BE CAUSED BY SMALL
VOLUME REFLUx RELATED TO HIATAL
HERNIA
J. Weigt, P. Malfertheiner
P1630
LIFE STYLE FACTORS INFLUENCING SUR­
VIVAL OF OESOPHAGEAL SQUAMOUS
CELL CARCINOMA
D. Nasrollahzadeh, H.A. Marjani,
R. Shakeri, F. Islami, K. Aghcheli,
R. Malekzadeh
P1631
SURVIVING GASTROESOPHAGEAL CAN­
CER ­ MYTH OR FACT
S.F. Neong, I.R. Sargeant, D.L. Morris,
J. Deacon
P1632
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION FOR CANCERS OF OROPHARYNx
USING TRANSNASAL ULTRA­THIN EN­
DOSCOPE
T. Ogo, K. Kawada, T. Okada, Y. Miyawaki,
A. Hoshino, T. Suzuki, Y. Nakajima,
T. Nishikage, K. Nagai, H. Kawachi,
T. Kawano
P1633
SUBEPITHELIAL ABLATION WITH ARGON
PLASMA COAGULATION OF ESOPHA­
GEAL SQUSMOUS CELL NEOPLASMS
T. Okada, K. Kawada, Y. Miyawaki,
A. Hoshino, T. Suzuki, Y. Nakajima,
T. Nishikage, K. Nagai, H. Kawachi,
T. Kawano
PosTeR sessIon
P1634
ENDOSCOPIC RESECTION FOR EARLY
ESOPHAGEAL SQUAMOUS CELL CAN­
CER – LONG­TERM FOLLOW UP IN A
LARGE WESTERN COHORT
O. Pech, H. Manner, A. May, J. Pohl, C. Ell
P1635
ESOPHAGEAL CANCER: STAGING, THER­
APEUTIC AND SURVIVAL EVALUATION IN
A PORTUGUESE REFERAL CENTER
M. Serrano, S. Ribeiro, S. Mão-de-Ferro,
L. Mirones, J. Freire, R. Casaca, J. Cunha,
A. Bettencourt, P. Chaves, A. Dias Pereira,
C. Nobre Leitão
P1636
ExPRESSION ANALYSIS OF COLLAGEN
TRIPLE HELIx REPEAT CONTAINING 1 IN
THE DEVELOPMENT OF ESOPHAGEAL
CARCINOMA
R. Shi, W. Liu, H. Zhu
P1637
THE ExPRESSION OF ANGIOPOIETIN­
LIkE 4 (ANGPTL4) PREDICTS THE RECUR­
RENCE PATTERN IN HUMAN OESOPHA­
GEAL CANCER
K. Shibata, T. Nakayama, H. Hirakawa,
T. Nagayasu
P1638
THE ANALYSIS OF HEAD AND NECk
CANCERS COINCIDING WITH THORACIC
ESOPHAGEAL CANCER
Y. Shirakawa, S. Tanabe, Y. Fujiwara,
K. Noma, K. Sakurama, M. Takaoka,
T. Yamatsuji, J. Matsuoka, Y. Naomoto
P1639
FDG­PET SCANS: VALUE FOR MONEY?
H. Steed, I. Tanswell, J. Jones
P1640
ANAEMIA AT DIGNOSIS IS OF PROGNOS­
TIC SIGNFICANCE IN PATIENTS WITH OE­
SOPHAGEAL ADENOCARCINOMA
I. Tanswell, H. Steed, S. Ahmad,
J. Butterworth, G. Townson
237
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1641
COMBINATION TREATMENT HAS SUR­
VIVAL ADVANTAGE IN OESOPHAGEAL
CANCER PALLIATION
C. Subbiah Somasundaram, N. Jawad,
S. Raouf, P. Premchand
P1642
MAGNIFIED ENDOSCOPIC FINDINGS OF
ESOPHAGEAL CANCER
A. Takahashi, T. Oyama, A. Tomori
P1643
EFFICACY AND SAFETY OF ENDOSCOPIC
SUBMUCOSAL DISSECTION FOR ESOPH­
AGEAL SQUAMOUS CELL CARCINOMA
R. Takenaka, Y. Kawahara, A. Imagawa,
K. Takemoto, A. Taira, H. Tsugeno, S. Fujiki,
H. Okada, K. Yamamoto
P1644
SALVAGE ENDOSCOPIC SUBMUCOSAL
DISSECTION OF RECURRENT OR RESID­
UAL SUPERFICIAL ESOPHAGEAL CARCI­
NOMA AFTER CHEMORADIOTHERAPY
M. Takeuchi, M. Kobayashi, S. Hashimoto,
J. Yokoyama, Y. Sato, R. Narisawa, Y. Aoyagi
P1645
THERAPEUTIC USEFULNESS OF ARGON
PLASMA COAGULATION IN PATIENTS
WITH SUPERFICIAL ESOPHAGEAL CAN­
CER
S. Tanabe, K. Higuchi, K. Tahara, T. Sasaki,
C. Katada, M. Azuma, K. Ishido, W. Koizumi
P1646
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION IS A SAFE AND EFFECTIVE TREAT­
MENT FOR SUPERFICIAL ESOPHAGEAL
NEOPLASMS IN ELDERLY PATIENTS
S. Uchida, N. Ishii, K. Yamazaki, F.M. Filho,
S. Suzuki, M. Uemura, Y. Iizuka, K. Fukuda,
Y. Fujita
238
P1647
EARLY RESPONSE ASSESSMENT OF NEO­
ADJUVANT THERAPY WITH POSITRON
EMISSION TOMOGRAPHY IN PATIENTS
WITH OESOPHAGEAL CANCER
M. van Heijl, J.M.T. Omloo, G.W. Sloof,
M.I. van Berge Henegouwen, J.J.B. van
Lanschot
P1648
IMPACT OF DIFFERENT PH CUT­OFF VAL­
UES ON PATIENTS WITH LARYNGOPHA­
RYNGEAL REFLUx DISEASE
S. Akyildiz, A. Varis, R. Vardar, B. Bayrakci,
T. Kirazli, S. Bor
P1649
PATTERN FOR EARLY RECURRENCE FOL­
LOWING MINIMALLY INVASIVE OESOPH­
AGECTOMY
R. Velineni, D. Veeramootoo, M.G. Bani-
Hani, R. Krishnadas, T.K. Daneshmend,
R.G. Berrisford, S.A. Wajed
P1650
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION FOR ESOPHAGEAL NEOPLASMS
IN CONSECUTIVE 67 CASES
H. Yajima, H. Isomoto, N. Yamaguchi,
D. Norimura, K. Ohnita, H. Oda,
H. Nishiyama, K. Ikeda, S. Shikuwa,
Y. Mizuta, K. Nakao
P1651
EFFECT OF SELECTED CYCLOOxYGEN­
ASE­2 INHIBITOR OR DUAL CYCLOOxY­
GENASE­2/5­LIPOxYGENASE INHIBITOR
ON THE PROLIFERATION INHIBITING OF
ESOPHAGEAL SQUAMOUS CELLS
Z. Zhuang, J. Wei, F. Wang, L. Yang

PosTeR sessIon
Paediatric gastroenterology and
hepatology III
P1652
QUALITY OF LIFE IN CHILDREN WITH
GASTRO­OESOPHAGEAL REFLUx DIS­
EASE: A CASE­CONTROLLED STUDY
M. Marlais, J.R. Fishman, J. Köglmeier,
J.M.E. Fell, D.J. Rawat
P1653
EROSIVE ESOPHAGITIS IN CHILDREN:
PATTERNS OF 24­HOUR PH MONITORING
E.M. Mukhametova, S.I. Erdes,
T.N. Sergeeva, M.M. Lokhmatov
P1654
USEFULNESS OF NONINVASIVE STOOL
MARkERS IN ASSESSING INTESTINAL
INFLAMMATION IN CHILDREN WITH IN­
FLAMMATORY BOWEL DISEASE
M. Neaga, F. Nuti, E. Del Giudice, F. Civitelli,
F. Viola, I. Antonozzi, S. Cucchiara,
P. Mariani
P1655
Withdrawn by author
P1656
GROWTH RETARDATION IN ExTRAHE­
PATIC PORTAL VEIN OBSTRUCTION: DI­
GESTIVE OR ENDOCRINE ABNORMAL­
ITY?
G.S. Sidhu, K.K. Prasad, B.R. Thapa,
C.K. Nain, B. Nagi, K. Singh
P1657
HISTOLOGIC PARAMETERS OF H. PYLORI­
ASSOCIATED GASTRITIS IN ExTRAHEPAT­
IC PORTAL VEIN OBSTRUCTION
K.K. Prasad, B.R. Thapa, A.K. Sharma,
C.K. Nain, B. Nagi, K. Singh
PosTeR sessIon
P1658
CLINICAL, PATHOLOGICAL & EPIDEMI­
OLOGICAL FEATURES OF PAEDIATRIC
EOSINOPHILIC OESOPHAGITIS IN THE
NORTH OF ENGLAND
P. Rao, M. Thomson, H. Brownlow, M. Al-
Adnani, M. Cohen
P1659
ZINC SUPPLEMENTATION TO PATIENTS
WITH CELIAC DISEASE­ IS IT REQUIRED?
P. Rawal, B. Thapa, R. Prasad, K. Prasad,
C. Nain, K. Singh
P1660
PHENOTYPIC CHARACTERISTICS OF IN­
FLAMMATORY BOWEL DISEASE: ADULTS
VS PEDIATRIC POPULATION
D.E. Serban, A. Krupoves, A. Bitton,
V. Bucionis, V. Marcil, F. Costea, E. Seidman
P1661
JUVENILE COLONIC POLYPS DETECTED
IN CHILDREN WITH ELEVATED FAECAL
CALPROTECTIN INVESTIGATED FOR
SUSPECTED INFLAMMATORY BOWEL
DISEASE
D. Agardh, A. Nemeth, J. Nielsen, E. Toth
P1662
CLINICAL OUTCOME IN CYSTIC FIBROSIS
PATIENTS WITH OR WITHOUT MECONI­
UM ILEUS: A COMPARATIVE STUDY
K. Venkatesh, C.J. Taylor
P1663
DEVELOPMENT OF A MEASURE OF
GASTROINTESTINAL SYMPTOMS IN
CHILDREN WITH AUTISTIC SPECTRUM
DISORDER
M.L. Wilson, C. Livingstone, A. O’Hare,
D.C. Wilson
239
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1664
DIFFERENCES IN RESPONSE TO COM­
MON TREATMENTS IN PAEDIATRIC AND
ADULT CROHN’S DISEASE – REAL OR
PROTOCOL DRIVEN?
J.E. Van Limbergen, J. Satsangi,
D.C. Wilson
PosTeR sessIon
colonic and anorectal disorders III
P1665
EVALUATION STUDY ON THE COLONI­
CAL POLYPS WITH I­SCAN TECHNIQUE:
PRELIMINARY DATA
B. Mangiavillano, P. Viaggi, E. Morandi,
E. Masci
P1666
COLONIC STENT USAGE IN MODERN DAY
MANAGEMENT FOR COLONIC OBSTRUC­
TION
M. Aljabiri, C. Thorne, K. Jaggs, S. Uppal,
H. Defoe, C. Kelly, N. Joshi, N. van Someren,
K. Besherdas
P1667
CHEMOPREVENTIVE EFFECTS OF COL­
TECT, A NOVEL DIETARY SUPPLEMENT
AND 5­AMINOSALICYLIC ACID, IN 1,
2­DIMETHYLHYDRAZINE­INDUCED CO­
LON CARCINOGENESIS IN RATS
I. Aroch, E. Ron, A. Hallack, S. Kraus,
D. Kazanov, S. Ben-Ari, B. Shpitz, I. Dotan,
N. Arber
P1668
PREDICTION VALUE OF “kUDO” CLASSI­
FICATION OF POLYPS IN COLON – SINGLE
CENTER PROSPECTIVE STUDY
M. Benes, P. Stirand, P. Drastich, P. Wohl,
T. Hucl, J. Spicak
240
P1669
INFLUENCE OF ALCOHOL INTAkE ON
THE FREQUENCY OF METACHRONOUS
NEOPLASIAS IN COLORECTAL CANCER
A. Borda Martín, M. Muñoz-Navas,
J. Jiménez Pérez, J. Martínez-Peñuela
Virseda, C. Carretero Ribón, F. Borda Celaya
P1670
HNPCC FAMILY MEMBERS SHOW SIMI­
LAR QUALITY OF LIFE AND PSYCHOLOGI­
CAL DISTRESS SCORES REGARDLESS OF
ABSENCE OF IDENTIFIED MUTATIONS IN
DNA MISMATCH REPAIR (MMR) GENES
C. Carvalho, C. Dias, P. Rodrigues, P. Lage,
M. Dinis-Ribeiro
P1671
A PHASE II STUDY OF OxALIPLATIN WITH
5­FU/ FOLINIC ACID AND CONCOMITANT
RADIOTHERAPY AS A PREOPERATIVE
TREATMENT IN PATIENTS WITH LOCALLY
ADVANCED RECTAL CANCER
I. Chitapanarux, T. Chitapanarux,
P. Kamnerdsupaphon, P. Siriwittayakorn,
S. Yamada, V. Lorvidhaya, V. Sukthomya
P1672
SELF ExPANDABLE METALLIC STENTS AS
A TREATMENT OPTION FOR ACUTE MA­
LIGNANT LARGE BOWEL OBSTRUCTION
G. Christodoulidis, V. Pappi, P. Vamvakas,
M. Spyridakis, D. Dimas, K. Tepetes
P1673
ENDOLUMINAL SELF­ExPANDING MET­
AL STENT AND LAPAROSCOPIC COLEC­
TOMY AS A MINIMALLY INVASIVE TREAT­
MENT FOR OBSTRUCTION OF THE LEFT
COLON
L.J. Delgado-Plasencia, D. Rodríguez-
González, A. Bravo, A. Alarcó Hernández
P1674
CETUxIMAB SPECIFIC IMMUNOGLOBU­
LIN E CAN PREDICT CETUxIMAB­RELAT­
ED ANAPHYLAxIS
B. Dupont, D. Mariotte, M.P. Galais,
K. Bouhier-Leporrier, D. Laroche, B. Le Mauff,
J.M. Reimund, R. Gervais

P1675
NEOANGIOGENESIS GOING WITH HEPAT­
IC METASTATIC PROCESS IS REFLECTED
IN MODIFICATION OF BLOOD FLOW VE­
LOCITIES IN HEPATIC ARTERY IN AN OR­
THOTOPIC MURINE MODEL OF HUMAN
COLON CANCER
C. Eveno, P. Bonnin, C. Le Hénaff, J. Nemeth,
E. Dupuy, M. Pocard
P1676
IMPACT OF OBESITY ON SURGICAL AND
ONCOLOGICAL OUTCOMES IN THE MAN­
AGEMENT OF COLORECTAL CANCER
L.A. Healy, A.M. Ryan, E. Sutton,
B. Mehigan, R. Stephens, J.V. Reynolds
P1677
STAGE IV OBSTRUCTIVE COLORECTAL
CANCER: IS THERE STILL A PLACE FOR
EMERGENCY SURGERY?
J. Jiménez-Pérez, J. Suárez, J. Vila, E. Balen,
F. Borda
P1678
RISk FACTORS FOR LYMPH NODE METAS­
TASIS AFTER ENDOSCOPIC RESECTION
FOR EARLY COLORECTAL CANCER
S. Jung, I. Jeong, D. Kim
P1679
THE FACTORS ASSOCIATED WITH THE
LONG­TERM OUTCOME OF A SELF Ex­
PANDABLE COLON STENT IN PALLIA­
TION FOR MALIGNANT COLORECTAL
OBSTRUCTION
M. Jung, D. Kim, S. Jeon, S. Kim, Y. Choi
P1680
ENDOSCOPIC TREATMENT WITH LARGE
DIAMETER COLONIC STENT FOR MALIG­
NANT OBSTRUCTION:A SINGLE CENTER
PROSPECTIVE ExPERIENCE
C. Luigiano, F. Ferrara, S. Ghersi, M. Bassi,
C. Fabbri, A. Polifemo, P. Billi, P. Landi,
V. Cennamo, N. D’Imperio
PosTeR sessIon
P1681
LOCAL ExCISION FOR EARLY RECTAL
CANCER AS SELECTED WITH MRI WITH
LYMPH NODE SPECIFIC CONTRAST
M. Maas, I.D. Ayodeji, S.M.E. Engelen,
R.M. van Dam, D.M.J. Lambregts,
J.W.A. Leijtens, R.G.H. Beets-Tan, G.L. Beets
P1682
WAIT­AND­SEE POLICY IN CLINICAL
COMPLETE RESPONDERS TO CHEMORA­
DIATION IN RECTAL CANCER: A PROMIS­
ING ALTERNATIVE
M. Maas, R.M. van Dam, P.J. Nelemans,
D.M.J. Lambregts, G. Lammering, R. Jansen,
R.G.H. Beets-Tan, G.L. Beets
P1683
IS ENDOSCOPIC RESSECTION A VALU­
ABLE THERAPEUTIC OPTION FOR MA­
LIGNANT COLORECTAL POLYPS?
P. Monsanto, N. Almeida, P. Duarte,
C. Lérias, P. Amaro, J.P. Cabral, C. Sofia,
H. Gouveia, M.C. Leitão
P1684
PILOT STUDY OF FAST­TRACk SURGERY
PROTOCOL FOR COLON CANCER
J. Moreira-da-Silva, L. Miranda, R. Valente,
S. Cabral, M. Dinis-Ribeiro, D. Gomes,
J. Abreu-de-Sousa, L. Lara-Santos
P1685
NON­HODGkIN’S LYMPHOMAS OF THE
LARGE BOWEL – SINGLE CENTER ExPE­
RIENCE
M.D. Nestorovic, G.Z. Stanojevic,
B.B. Brankovic, V.M. Pecic
P1686
IS IT NECESSARY FOR ELDERLY POPULA­
TION TO UNDERGO ADDITIONAL COLO­
NOSCOPY AFTER NEGATIVE COLONOS­
COPY?
K. Niimi, O. Goto, K. Hirano, S. Ono,
S. Kodashima, N. Yamamichi, M. Fujishiro,
K. Koike
241
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1687
LONG­TERM QUALITY OF LIFE AFTER IN­
TERSPHINCTERIC RESECTION FOR REC­
TAL CANCER
S. Sivapathasundaram, R.C. Siriwardana,
K.I. Deen, A.N. Meepe
P1688
SHOULD WE REMOVE PRIMARY COLON
TUMOUR IN STAGE VI DISEASE COLON
CANCER PATIENTS WITH SYNCHRONOUS
METASTASES ?
I. Sobhani, F. Roudo-Thoraval, F. Mesli,
C. Louvet, E. Mitry, T. Aparicio, B. Landy,
G. DeGuetz, A. Charachon
P1689
ExPECTED AND SURPRISING OUTCOMES
OF COLORECTAL CANCER SCREENING
PROGRAMME BASED ON FOBT AND
COLONOSCOPY IN AREA WITH HIGH IN­
CIDENCY OF THIS MALIGNANCY
J. Spicak, M. Benes, T. Hucl, P. Stirand,
P. Drastich, P. Wohl
P1690
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION FOR THE TREATMENT OF GASTRO­
INTESTINAL CARCINOID TUMORS
S. Suzuki, N. Ishii, K. Yamazaki, M. Fauze,
S. Uchida, M. Uemura, Y. Iizuka, K. Fukuda,
Y. Fujita
P1691
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION WITH THE COMBINATION OF
FLEx­kNIFE AND SMALL­CALIBER­TIP
TRANSPARENT HOOD FOR “EN­BLOC”
RESECTION OF LARGE SUPERFICIAL
ESOPHAGEAL AND COLORECTAL NEO­
PLASMS
S. Suzuki, N. Ishii, K. Yamazaki, F. Filho,
S. Uchida, M. Uemura, M. Matsuda,
T. Setoyama, Y. Iizuka, K. Fukuda, Y. Fujita
242
P1692
PREOPERATIVE CHEMOTHERAPY AND/
OR RADIATION IN RECTAL CANCER PA­
TIENTS REDUCES HEPATIC INSULIN SEN­
SITIVITY
M.F.M. van Stijn, J.J. Atema, M.R. Soeters,
M.J.M. Serlie, M.T. Ackermans, P.A.M. van
Leeuwen, A.P.J. Houdijk
P1693
CHARACTERISTICS OF COLONIC DIVER­
TICULAR HEMORRHAGE IN THE LATE­
STAGE ELDERLY POPULATION IN JAPAN
K. Abe, A. Isono, Y. Mishina, T. Ebato,
S. Nakayama, K. Nagasawa, K. Hattori,
T. Yamamoto, T. Ishii, Y. Kuyama
P1694
A STUDY OF ANORECTAL LESIONS REC­
OGNIZED BY RETROFLEx COLONOSCO­
PY IN HEALTHY CASES
W. Adachi, O. Komatsu, K. Kishimoto,
H. Shiozawa
P1695
DIGITAL RECTAL EVACUATION IS COM­
MON IN SOLITARY RECTAL ULCER SYN­
DROME
M. Babaei, J. Moghimi, H. Nobakht
P1696
ASSOCIATION WITH PROxIMAL HYPER­
PLASTIC POLYPS AND ADENOMAS
S.Y. Bae, E.R. Kim, J.Y. Kim, J.H. Lee,
D.K. Chang, H.J. Son, P.L. Rhee, J.J. Kim,
J.C. Rhee, Y.H. Kim
P1697
FACTORS PREDICTING LIkELIHOOD OF
FAECAL URGENCY AFTER RADIOTHER­
APY FOR PROSTATE CANCER
A.A. Bajwa, P. Boulos, A.V. Emmanuel
P1698
ANORECTAL TOxICITY AFTER HIGH DOSE
3D CONFORMAL RADIOTHERAPY FOR
PROSTATE CANCER
A.A. Bajwa, K. Thiruppathy, P. Boulos,
A.V. Emmanuel

P1699
THE UTILITY OF CONDITIONING SE­
QUENCES IN BAROSTAT PROTOCOLS
FOR THE MEASUREMENT OF RECTAL
COMPLIANCE
A.A. Bajwa, K. Thiruppathy, A.V. Emmanuel
P1700
SIGNIFICANCE OF ILEOCOLONOSCO­
PY WITH BIOPSY IN THE DIAGNOSTIC
EVALUATION OF RENAL TRANSPLANT
PATIENTS WITH PERSISTENT CHRONIC
DIARRHEA
G. Bamias, T. Argyropoulos, S. Siakavellas,
C. Skalioti, I. Delladetsima, I. Boletis,
S.D. Ladas
P1701
COLON – IS A POSSIBLE CAUSE OF PRO­
GRESSION OF CHRONIC HEART FAILURE
N.A. Blova, G.P. Arutyunov, L.I. Kafarskaya,
N.A. Savelov, Y.A. Pokrovskii, N.V. Kokosadze,
A.B. Risnenko, Z.A. Chernaya
P1702
HOW ALERT ARE WE IN DETECTING MI­
CROSCOPIC COLITIS?
S.K. Butt, H. Defoe, A. Joshi, N. Van
Someren, K. Besherdas
P1703
PREOPERATIVE “VIRTUAL COLONOSCO­
PY” (VC) IS USEFUL IN PATIENTS WITH
STENOSING COLORECTAL CANCER
S. Venturini, M. Fornasarig, L. Balestreri,
R. Sigon, R. Cannizzaro
P1704
RISk FACTORS ASSOCIATED TO THE DE­
VELOPMENT OF ISCHEMIC COLITIS
J. Cubiella Fernández, M. García García,
L. Núñez Calvo, E. González Vázquez,
P. Quintas Lorenzo, J. Fernández Seara
PosTeR sessIon
P1705
ASSESSMENT OF SYMPTOMS IN PA­
TIENTS WITH SYMPTOMATIC UNCOMPLI­
CATED DIVERTICULAR DISEASE (SUDD)
L. Gatta, F. Di Mario, C. Margherita,
A. Franzé, A. Pilotto, C. Scarpignato
P1706
SEQUENTIAL VERSUS COMBINATION
“CHEMICAL SPHINCTEROTOMY” FOR
CHRONIC ANAL FISSURE: LONG­TERM
RESULTS OF A PROSPECTIVE OPEN LA­
BEL CLINICAL STUDY
R. Díez, L. Arias, G. Rascarachi, M. Sierra,
A. Domínguez, B. Matilla, P. Gonzalez,
J. Ruiz de Morales, S. Vivas
P1707
LONG­TERM RESULTS OF TOPICAL DIL­
TIAZEM PLUS BOTULINUM TOxIN A FOR
CHRONIC ANAL FISSURE: A PROSPEC­
TIVE OPEN LABEL STUDY
L. Arias, R. Díez, M. Sierra, G. Rascarachi,
A. Domínguez, P. Gónzalez, B. Matilla,
J. Ruiz de Morales, S. Vivas
P1708
MICROSCOPIC COLITIS IN ROUTINE
COLONOSCOPIES IN THE REGION OF
NORTHEASTERN GREECE
A. Gatopoulou, G. Kouklakis
P1709
EFFICACY OF 5­ASA IN THE TREATMENT
OF COLONIC DIVERTICULAR DISEASE:
A SYSTEMATIC REVIEW
L. Gatta, F. Di Mario, N. Vakil, D. Vaira,
A. Pilotto, M. Curlo, G. Comparato, U. Ferro,
M. Lera, S. Milletti, G. Leandro
P1710
LANSOPRAZOLE ASSOCIATED COLLAG­
ENOUS COLITIS ARE NEW EMERGING
DRUG­ASSOCIATED ENTEROPATHY WITH
UNIQUE COLONOSCOPIC FINDINGS AND
CLINICAL MANIFESTATIONS
Y. Hashimoto, Y. Endo, N. Maruoka,
K. Inoue
243
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1711
IMPACT OF ANORECTAL SYMPTOMS ON
QUALITY OF LIFE IN PATIENTS WITH FAE­
CAL INCONTINENCE
W.P.M. Hopman, R. Smeenk, R. de Vries,
D.J. de Jong, E.N.J. van Lin
P1712
MINIMAL RECTAL SENSIBILITY, MAxI­
MUM RECTAL CAPACITY AND RECTO
ANAL INHIBITORY REFLEx BEHAVIOR IN
TYPE 2 DIABETICS WITH AND WITHOUT
INCOMPLETE DEFECATION SENSATION
J.X. Jorge, C.C. Borges, F.J. Delgado,
M.A. Simoes, E.A. Panão, C.C. Almeida
P1713
CLINICAL OUTCOMES OF STERCORAL
COLITIS: SINGLE CENTER ExPERIENCE
IN SOUTH kOREA
H. Joung, K. Han, M. Cho, H. Lee, W. Jeong,
Y. Kim, S. Lee, J. Ahn, G. Kang, G. Cheon
P1714
THE EFFECT OF ANTIDEPRESSANT THER­
APY IN PATIENTS WITH SOLITARY RECTAL
ULCER
A.A. Keshavarz, H. Bashiri
PosTeR sessIon
Inflammatory bowel disease III
P1715
2008 Uk NATIONAL INFLAMMATORY
BOWEL DISEASE (IBD) AUDIT: IMPROVE­
MENT DEMONSTRATED BUT FURTHER
SERVICE DEVELOPMENT NEEDED
I.D.R. Arnott, K. Leiper, C. Down, J. Rhodes,
J. Potter
P1716
ROLE OF TISSUE FACTOR IN THE PATHO­
PHYSIOLOGY OF INFLAMMATORY BOW­
EL DISEASE
K.C.S. Queiroz, H.L. Aberson, A.P. Groot,
M.I. Verstege, J.J.T.H. Roelofs, A.A. te Velde,
C. van ‘t Veer, C.A. Spek
244
P1717
PRIMARY SCLEROSING CHOLANGITIS
AND INFLAMMATORY BOWEL DISEASE
A. Alakkari, D. Keegan, D. O’Donoghue
P1718
ExPRESSION OF INTERLEUkIN­24, AN
ACTIVATOR OF THE JAk1/STAT3/SOCS3
CASCADE, IS ENHANCED IN INFLAMMA­
TORY BOWEL DISEASE
S. Bamba, M. Shioya, A. Nishida,
T. Tsujikawa, S. Kim-Mitsuyama,
Y. Fujiyama, A. Andoh
P1719
MEASUREMENT OF SOLUBLE TISSUE
INHIBITORS OF METALLOPROTEINASES
(TIMPS) IN PATIENTS WITH ULCERATIVE
COLITIS (UC) AND CROHN’S DISEASE
(CD) USING A MULTIPLEx FLUOROMET­
RIC ASSAY
G. Bamias, S. Siakavellas, G. Kaltsa,
P. Tzafestas, D. Perrea, I. Zoumbouli-Vafiadi,
S.D. Ladas
P1720
DENDRITIC CELLS FROM CROHN’S PA­
TIENTS CAN MODULATE OWN FUNC­
TION THROUGH HYDROxYLATION OF
25­HYDROxY VITAMIN D3
L.E. Bartels, S.P. Jørgensen, M. Bendix-
Struve, C.L. Hvas, J. Agnholt, R. Agger,
J.F. Dahlerup
P1721
INFLAMMATORY RESPONSE OF PRIMA­
RY HUMAN MYELOID DENDRITIC CELLS
DUE TO INCREASED TLR4 ExPRESSION
AND UPTAkE OF LIPOPOLYSACCHARIDE
IN PATIENTS WITH INFLAMMATORY
BOWEL DISEASE
D.C. Baumgart, S. Thomas, I. Przesdzing,
D. Metzke, C. Bielecki, S.M. Lehmann,
S. Lehnardt, Y. Dörffel, A. Sturm, A. Scheffold,
J. Schmitz, A. Radbruch

P1722
PERIPHERAL T­LYMPHOCYTES FROM
NAÏVE CROHN’S DISEASE PATIENTS ARE
RESISTANT TO AGONIST FAS ANTIBODY
MEDIATED APOPTOSIS
B. Beltran, I. Moret, M. Iborra, G. Bastida,
F. Rausell, J. Ponce, P. Nos
P1723
THE LUMINAL MICROBIOTA IN PATIENTS
WITH ACTIVE CROHN’S DISEASE CON­
SISTS OF HIGHER PRO­INFLAMMATORY
BACTEROIDES AND LOWER IMMUNO­
REGULATORY FAECALIBACTERIUM
PRAUSNITZII IN BOTH SMOkERS AND
THOSE WITH ILEAL INVOLVEMENT
J.L. Benjamin, A. Koutsoumpas,
C.R.H. Hedin, S.C. Ng, M.A. Kamm, A.L. Hart,
J.D. Sanderson, S.C. Knight, A. Forbes,
A.J. Stagg, J.O. Lindsay, K. Whelan
P1724
k(D)PT, A MELANOCORTIN­DERIVED TRI­
PEPTIDE, AMELIORATES THE COURSE OF
MURINE COLITIS
D. Bettenworth, T. Brzoska, M. Böhm,
J. Heidemann, C. Maaser, T. Nowacki,
W. Domschke, A. Lügering
P1725
ATTENUATION OF DSS­INDUCED COLITIS
IN MICE BY SCHISTOSOMA MANSONI
P. Bodammer, G. Waitz, E. Reisinger,
J. Emmrich
P1726
BOVINE COLOSTRUM ATTENUATES
CLINICAL SYMPTOMS OF DSS­INDUCED
COLITIS IN MICE
P. Bodammer, C. Maletzki, G. Waitz,
J. Emmrich
PosTeR sessIon
P1727
ANTI­TNF ALPHA ANTIBODY THERAPY
RAPIDLY ENHANCES NUMBER AND
FUNCTION OF PERIPHERAL FOxP3+
REGULATORY T CELLS IN INFLAMMA­
TORY BOWEL DISEASES
G. Boschetti, F. Sardi, X. Roblin, B. Flourié,
D. Kaiserlian, S. Nancey
P1728
IL­27 INCREASES INTESTINAL EPITHE­
LIAL CELL PROLIFERATION AND MI­
GRATION AND ITS MRNA ExPRESSION
IS UP­REGULATED IN ACTIVE CROHN’S
DISEASE
J. Diegelmann, T. Olszak, E. de Toni,
B. Göke, S. Brand
P1729
THE COMMENSAL FLORA INDUCES TAR­
GETING OF LUMENAL ANTIGENS INTO
MHC CLASS II­ENRICHED COMPART­
MENTS IN INTESTINAL EPITHELIAL CELLS
N. Möller, A. Rehman, S. Schreiber,
K. Tafazzoli, W. Nicklas, K. Fellermann,
J. Büning
P1730
CROHNS DISEASE AND ULCERATIVE
COLITIS AFFECT THE ANTIGEN PRESEN­
TATION PATHWAY IN INTESTINAL EPI­
THELIAL CELLS
J. Büning, K. Zimmer, G. Hundorfean,
K. Fellermann
P1731
EOSINOPHIL ACTIVATION IN TWINS,
REVEALING A POSSIBLE PATHOPHYSI­
OLOGICAL MECHANISM IN INFLAMMA­
TORY BOWEL DISEASE?
J. Halfvarson, C. Peterson, A. Gustavsson,
I. Stolt, J. Bohr, C. Tysk, L. Bodin, M. Carlson
245
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1732
AGONIST (ROSIGLITAZONE) AND AN­
TAGONIST (BIPHENOL A DIGLICYDYL
ETHER) OF PPAR­GAMMA RECEPTORS –
INFLUENCE ON ExPERIMANTAL MODEL
OF COLITIS IN RATS
K. Celinski, T. Dworzañski, A. Korolczuk,
M. Slomka, H. Cichoz-Lach, S. Radej,
G. Czechowska
P1733
INFLUENCE OF SMOkING HABITS ON
HOMOCYSTEINE LEVEL IN PATIENTS
WITH INFLAMMATORY BOWEL DISEASES
D. Owczarek, D. Cibor, K. Salapa, T. Mach
P1734
THROMBOMODULIN IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASES
D. Owczarek, D. Cibor, K. Salapa, T. Mach
P1735
INTESTINAL ANTI­INFLAMMATORY EF­
FECTS OF A NEW PREBIOTIC, DIFRUC­
TOSE DIANHYDRIDE­ENRICHED CAR­
AMEL, IN THE TNBS MODEL OF RAT
COLITIS
M. Comalada, B. Arribas, N. Garrido-Mesa,
M. Cueto, E. Bailon, M. Rodriguez-Cabezas,
E. Suárez-Pereira, D. Camuesco, C. Ortiz-
Mellet, J. Garcia-Fernandez, A. Zarzuelo,
J. Galvez
P1736
THE INTESTINAL ANTI­INFLAMMATORY
EFFECT OF DERSALAZINE SODIUM IN
THE DSS MODEL OF COLITIS IN MICE IS
ASSOCIATED WITH A DOWNREGULA­
TION IN TH1 AND TH17 CYTOkINE PRO­
DUCTION
M. Cueto, M. Rodriguez-Cabezas,
B. Arribas, E. Bailon, M. Comalada,
N. Garrido-Mesa, A. Nieto, J. Roman,
D. Balsa, M. Merlos, A. Zarzuelo, J. Galvez
246
P1737
MUCOSAL IL­6 PRODUCTION IN VARI­
OUS PARTS OF INTESTINE IN IBD PA­
TIENTS
P. Drastich, L. Frolova-Brizova, P. Zanvit,
J. Spicak, H. Tlaskalova-Hogenova
P1738
CROSSTALk BETWEEN COLONIC EPITHE­
LIAL CELLS AND SUBEPITHELIAL MYOFI­
BROBASTS REGULATES BOWEL FIBROSIS
IN CROHN’S DISEASE
I. Drygiannakis, V. Valatas, G. Notas,
L. Bourikas, P. Manousou, G. Kolios,
E. Kouroumalis
P1739
THE ExPRESSION OF EGFR AND NF­kB IN
COLONIC MUCOSA IN INFLAMMATORY
BOWEL DISEASES
L.M. Durko, O. Stasikowska, M. Danilewicz,
M. Wagrowska-Danilewicz, E. Malecka-
Panas
P1740
NEW THERAPEUTICAL APPROACH IN UL­
CERATIVE COLITIS – THE IMPORTANCE
OF ION TRANSPORT ACTIVITIES IN HU­
MAN COLONIC EPITHELIAL CELLS
K. Farkas, S. Yeruva, J. Hubricht,
Z. Rakonczay Jr., F. Nagy, T. Molnar,
Z. Szepes, L. Varga, V. Venglovecz,
T. Wittmann, B. Riederer, U. Seidler, P. Hegyi
P1741
BRA101, A NOVEL SMALL MOLECULE
WITH PROFOUND EFFICACY IN MURINE
DSS­COLITIS
H. Sheridan, N.H. Frankish
P1742
GLIAL­DERIVED NEUROTROPHIC FAC­
TOR REGULATES INTESTINAL EPITHELIAL
BARRIER FUNCTION AND INFLAMMA­
TION AND IS THERAPEUTIC FOR MURINE
COLITIS
H. Gan, D. Zhang, D. Cui, F. He, Q. Xie

P1743
THE IMMUNODULATORY PROPERTIES
OF MINOCYCLINE CONTRIBUTE TO ITS
INTESTINAL ANTI­INFLAMMATORY EF­
FECTS IN THE TRINITROBENCENESUL­
PHONIC ACID MODEL OF RAT COLITIS
N. Garrido-Mesa, D. Camuesco, B. Arribas,
M. Comalada, E. Bailon, M. Cueto,
A. Zarzuelo, A. Nieto, M. Rodriguez-Cabezas,
J. Galvez
P1744
SIMILARITY IN THE METABOLIC PROFILE
IN MACROSCOPICALLY INVOLVED AND
UNINVOLVED COLONIC MUCOSA IN PA­
TIENTS WITH INFLAMMATORY BOWEL
DISEASE: AN IN­VITRO PROTON MR
SPECTROSCOPY STUDY
U. Sharma, R.R. Singh, P. Goswami,
V. Ahuja, G.K. Makharia, N.R. Jagannathan
P1745
PROTECTIVE EFFECT OF PROLYL HY­
DROxYLASE INHIBITION ON TUMOR NE­
CROSIS FACTOR ­ INDUCED INTESTINAL
PATHOLOGY
P. Hindryckx, D. Laukens, P. Jacques,
A. Waeytens, L. Ferdinande, H. Peeters,
D. Elewaut, G. Kollias, M. De Vos Laboratory
of Molecular Genetics, Hellenic Pasteur
Institute, Athens, Greece
P1746
CD26+ LYMPHOCYTES AND SERUM SOL­
UBLE CD26/ DIPEPTIDYL PEPTIDASE IV
ARE INVOLVED IN THE PATHOGENESIS
OF CROHN’S DISEASE
N. Inoue, T. Hisamatsu, T. Takayama,
N. Kamada, S. Okamoto, T. Yamada,
O. Hosono, C. Morimoto, T. Hibi
PosTeR sessIon
P1747
INTESTINAL PERMEABILITY IN PATIENTS
WITH IRRITABLE BOWEL SYNDROME
(IBS), CROHN DISEASE (CD) AND CON­
TROLS: A STUDY USING LACTULOSE/
MANNITOLE TEST IN A TERTIARY ITAL­
IAN CENTER
L. Isola, A. Greco, E. Savarino, F. Mattioli,
C. Fucile, V. Marini, C. Mansi, V. Savarino
P1748
ABUNDANCE OF FAECALIBACTERIUM
PRAUSNITZII AND SULFATE­REDUCING
BACTERIA IN PATIENTS WITH INFLAMMA­
TORY BOWEL DISEASE
R. Whitehead, W. Jia, L. Griffiths,
C. Dawson, S. Basser, D. Ramsden,
R. Waring, C. Turner, C. Bessant, C. Walton,
D. Fowler, J. Cole, J. Hunter
P1749
CHRONIC ISCHEMIC ETIOLOGY IN
CROHN’S DISEASE AND MESENTERIC
FIBROMUSCULAR DYSPLASIA INVOLV­
ING BOTH ARTERIES AND VEINS
S. Goksel, A.F. Celik, Y. Erzin, S. Cetin,
I. Hatemi, G. Dogusoy, I. Hamzaoglu
P1750
ARE MOOD DISORDERS MORE COMMON
IN PATIENTS WITH ACTIVE THAN INAC­
TIVE INFLAMMATORY BOWEL DISEASE?
J.R. Goodhand, M. Wahed, A.D. Farmer,
J.E. Mawdsley, Q. Aziz, D.S. Rampton
P1751
INCIDENCE OF PRE­MALIGNANT LE­
SIONS IN PATIENTS WITH LONG STAND­
ING ULCERATIVE COLITIS
J. Gordillo, Y. Zabana, E. Garcia-Planella,
M. Mañosa, M. Concepción, J. Boix, S. Sáinz,
E. Cabré, C. Guarner, E. Domènech
247
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1752
CANCER IN ULCERATIVE COLITIS: IN­
CIDENCE AND CLINICAL FEATURES IN
JAPANESE SINGLE CENTER COHORT
A. Harusato, Y. Naito, T. Takagi, I. Hirata,
T. Omatsu, K. Uchiyama, O. Handa,
H. Konishi, N. Yagi, N. Wakabayashi,
T. Yoshikawa
P1753
THE ROLE OF ExTRA­INTESTINAL VIRAL
INFECTIONS IN ExACERBATIONS OF IN­
FLAMMATORY BOWEL DISEASE: A SYS­
TEMATIC REVIEW
P. Henderson, J. Schwarze, D.C. Wilson
P1754
EPIDEMIOLOGIC RISk FACTORS RELATED
TO IMMUNE SYSTEM STIMULATION ARE
ASSOCIATED WITH CROHN’S DISEASE
AND ULCERATIVE COLITIS
T. Hlavaty, J. Toth, T. Koller, E. Kresanova,
J. Hlinstakova, S. Oravcova, M. Huorka
P1755
DIETARY HABITS OF INFLAMMATO­
RY BOWEL DISEASES PATIENTS AND
HEALTHY CONTROLS SHOW SIGNIFI­
CANT DIFFERENCES
T. Hlavaty, T. Koller, J. Toth, S. Oravcova,
E. Kresanova, S. Cervenova, M. Huorka
P1756
SACROILIITIS IS COMMON IN kOREAN
CROHN’S DISEASE PATIENTS WITH PERI­
ANAL OR UPPER GASTROINTESTINAL IN­
VOLVEMENT
Y. Hwangbo, H. Kim, J. Park, K. Ryu, N. Kim,
J. Shim, Y. Chang, J. Jang, S. Dong, B. Kim,
R. Chang
248
P1757
PRIMARY SCLEROSING CHOLANGITIS IN
THE FIRST 10 YEARS AFTER DIAGNOSIS
OF INFLAMMATORY BOWEL DISEASE:
RESULTS FROM A POPULATION­BASED
COHORT
R.A. Isene, S. Odes, P. Munkholm,
R. Stockbrügger, E. Tsianos, J. Freitas,
T. Bernklev, B. Moum
P1758
PREDICTORS OF COMPLICATIONS FOL­
LOWING A COLECTOMY FOR ULCER­
ATIVE COLITIS PATIENTS: A POPULA­
TION­BASED STUDY
S. de Silva, M. Crespin, C. Ma,
M. Prusinkiewicz, R. Panaccione, S. Ghosh,
A. MacLean, D. Buie, S. Devlin, C. Seow,
Y. Leung, J. Hubbard, G.G. Kaplan
P1759
INFLAMMATORY BOWEL DISEASES AND
PREGNANCY: A RETROSPECTIVE STUDY
L. Kecili, N. Kaddache, A. Balamane,
N. Debzi, N. Bounab, L. Gamar, K. Belhocine,
N. Afredj, N. Guessab, A. Nani, K. Layaida,
N. Baiod, T. Boucekkine
P1760
ULCERATIVE COLITIS IN SINGAPORE: EPI­
DEMIOLOGY AND CLINICAL FEATURES
A. Kwek, K. Fock, E. Teo, J. Ong, T. Ang,
J. Tan, J. Ang
P1761
PHENOTYPE OF FAMILIAL INFLAMMA­
TORY BOWEL DISEASE IN ALGERIA: COM­
PARISON OF INDEx AND FIRST DEGREE
RELATIVE CASES TO SPORADIC CASES. A
RETROSPECTIVE STUDY
K. Layaida, N. Kaddache, A. Bousseloub,
N. Bounab, L. Gamar, M. Nakmouche,
N. Baiod, L. Kecili, N. Afredj, N. Guessab,
T. Boucekkine

P1762
THE INCIDENCE OF COLORECTAL CAN­
CER IN PATIENTS WITH INFLAMMATORY
BOWEL DISEASE IN THE PIRkANMAA
DISTRICT, FINLAND, 1986–2007
P.M. Manninen, A.L. Karvonen, H. Huhtala,
H. Hemminki, P. Collin
P1763
VITAMIN D STATUS IN CROHN’S DISEASE:
AN IMMUNOLOGICAL ROLE?
A.N. Milestone, M. Jacyna, J.R.F. Walters,
A.L. Hart
P1764
HOSPITALIZATION, SURGERY AND HOS­
PITAL CHARGES IN AN ITALIAN ULCER­
ATIVE COLITIS COHORT: 6 YEARS FOL­
LOW UP
R. Monterubbianesi, V. Fano, M. Davoli,
E. Stasi, M. Marrollo, C. Perucci, C. Prantera,
A. Kohn
P1765
IBS­SYMPTOMS IN PATIENTS WITH GERD
H. Neumann, K. Mönkemüller, U. von
Arnim, P. Malfertheiner
P1766
PREGNANCY OUTCOME IN WOMEN
WITH INFLAMMATORY BOWEL DISEASE
ACCORDING TO THE ACTIVITY OF THE
DISEASE AND THE DRUG TREATMENT
T. Molnar, K. Farkas, F. Nagy, P. Lakatos,
P. Miheller, T. Nyari, Z. Szepes, T. Wittmann
P1767
EFFECT OF HUMAN IMMUNODEFICIEN­
CY VIRUS INFECTION IN INFLAMMATORY
BOWEL DISEASE
D. Monfort, F. Fernandez, M. Mañosa,
M. Barreiro, J. Gordillo, O. Merino,
L. Menchen, J. Echevers, S. Tabernero,
M. Piqueras, D. Ginard
PosTeR sessIon
P1768
PREDICTIVE FACTORS FOR THE DEVEL­
OPMENT OF INTESTINAL COMPLICA­
TIONS IN INTESTINAL BEHÇET’S DISEASE
C. Moon, J. Cheon, E. Kim, J. Lee, S. Jeon,
H. Bok, J. Shin, J. Park, T. Kim, W. Kim
P1769
HIGH RESOLUTION ULTRASOUND­ AN
ExCELLENT NON­INVASIVE METHOD
FOR THE DIAGNOSIS OF CROHN’S DIS­
EASE COMPLICATIONS
H. Neye, D. Ensberg, P. Rauh, U. Peitz,
G. Treiber, S. Klauck, P. Malfertheiner,
S. Rickes
P1770
CAPSULE ENDOSCOPY CROHN’S DIS­
EASE ACTIVITY INDEx (CECDAI), VALI­
DATION OF A SIMPLE NEW SCORE – A
PRELIMINARY REPORT OF THE FIRST
24 PATIENTS
Y. Niv, C.A. O’Morain, E. Scapa, Z. Fireman,
E. Gal, Y. Honen, S. Ilani
P1771
UNDERREPORTING OF STRICTURES IN
THE MONTREAL CLASSIFICATION
C. Gratzer, W. Reinisch, P. Papay, W. Miehsler,
C. Dejaco, H. Vogelsang, G. Novacek
P1772
DIRECT COST OF ILLNESS OF PATIENTS
WITH LONG­STANDING CROHN’S DIS­
EASE IN A TERTIARY CENTRE
G. Novacek, A. Vavrovsky, S. Bauinger,
W. Miehsler, C. Primas, W. Reinisch
P1773
SIGNIFICANCE OF HIGH PLASMA CORTI­
SOL LEVELS IN INFLAMMATORY BOWEL
DISEASE (IBD)
A.C.R. Nunes, S.G. Rodrigues,
H.M.C. Cardoso, A.P. Ribeiro
249
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1774
MUCOSAL HEALING AND RISk OF COL­
ECTOMY IN PATIENTS WITH ExTENSIVE
ULCERATIVE COLITIS: A PROSPECTIVE
SINGLE CENTER FOLLOW­UP STUDY
A. Papa, I. De Vitis, A. Armuzzi, G. Mocci,
F. Scaldaferri, M. Bonizzi, G. Andrisani,
C. Felice, M. Marzo, L. Sparano, G. Vitale,
M. Covino, L. Guidi, A. Gasbarrini
P1775
FAECAL CALPROTECTIN REFLECTS THE
UNDERLYING ENDOSCOPIC DISEASE
ACTIVITY IN PATIENTS WITH CROHN’S
DISEASE ON BIOLOGIC THERAPIES
K. Papamichael, C. Karakoidas,
A. Smyrnidis, E. Archaulis, S. Koilakou,
G. Agalos, I. Theodoropoulos, D. Tzivras,
A. Christidou, G.J. Mantzaris
P1776
CORRELATION OF ERYTHROCYTE SEDI­
MENTATION RATE AND C­REACTIVE
PROTEIN
J. Park, J. Cheon, C. Moon, J. Lee, S. Hong,
T. Kim, W. Kim
P1777
EVOLUTION OF THE LESIONS RELATED
TO CROHN’S DISEASE RECURRENCE AS
ASSESSED BY ULTRASONOGRAPHY:
A PROSPECTIVE LONGITUDINAL STUDY
F. Zorzi, E. Calabrese, C. Petruzziello,
S. Onali, G. Condino, P. Naccarato,
M. Ascolani, F. Pallone, L. Biancone
P1778
ANORECTAL FUNCTION IN PATIENTS
WITH INFLAMMATORY BOWEL DIS­
EASES – WHAT INFLUENCE IT AND HOW
DOES IT CORRELATE WITH SYMPTOMS?
P.W. Petryszyn, L. Paradowski
P1779
INCREASED ANAL RESTING PRESSURE
AND RECTAL SENSITIVITY IN INFLAM­
MATORY BOWEL DISEASES
P.W. Petryszyn, L. Paradowski
250
P1780
MAGNETIC RISONANCE IMAGING IN
PERIANAL CROHN’S DISEASE: STIR VER­
SUS T1W POST­CONTRAST FAT­SAT IM­
AGING
C. Randazzo, G. Lo Re, M. Cappello,
M. Cottone, M. Galia, G. Solina
P1781
BOWEL SONOGRAPHY IN PREDICTING
POST­OPERATIVE COURSE OF CROHN’S
DISEASE
A. Rispo, A. Testa, F. Sabbatini, L. Bucci,
G. Pesce, G.D. De Palma, N. Caporaso,
F. Castiglione
P1782
WIRELESS CAPSULE ENDOSCOPY AND
FAECAL CALPROTECTIN: ARE THEY COM­
PLIMNTARY IN SYMPTOMATIC PATIENTS
WITH NORMAL ENDO­COLONOSCOPY?
S.S. Salunke, N. Rae, A. Morris
P1783
P­GLYCOPROTEIN 170 (P­GP) FUNC­
TIONAL ACTIVITY IN PERIPHERAL BLOOD
LYMPHOCYTES (PBL) ACCORDING THER­
APEUTIC RESPONSE IN ULCERATIVE
COLITIS (UC)
A.M. Sambuelli, C. Cortada, A.H. Gil,
S. Negreira, S. Huernos, S. Goncalves,
P. Tirado, M. Bellicoso, M.A. Carballo
P1784
INVESTIGATING DIARRHOEA IN PA­
TIENTS UNDER 50 – WORTH GOING THE
DISTANCE?
M.J.H. Shale, D. Westaby
P1785
FAECAL LACTOFERRIN­ A NON INVA­
SIVE MARkER FOR THE DETECTION OF
GASTROINTESTINAL INFLAMMATION­
A COMPARATIVE STUDY OF PATIENTS
WITH IBD, IBS AND HEALTHY CONTROLS
R. Sidhu, L. Foye, P. Wilson, S. Morley,
A. Wright, M.E. McAlindon, A.J. Lobo,
D.S. Sanders

P1786
ENDOLUMINAL IMAGING OF COLITIS IN
MURINE MODEL BY ULTRASOUND BIO­
MICROSCOPY
M. Soldan, K.Z. Alves, A.L.P. Viana,
A. Schanaider, J.C. Machado
P1787
EVALUATION OF QT AND P WAVE DIS­
PERSION AND MPV AMONG INFLAMMA­
TORY BOWEL DISEASE PATIENTS
A. SOYLU, Y. Dogan, S. Poturoglu,
C. Dolapcioglu, H. Duman, N. Yasar,
B. Kumbasar
P1788
COMPARISON OF CT AND MR ENTEROG­
RAPHY IN DIAGNOSIS OF POSTOPERA­
TIVE INTESTINAL ADHESIONS IN PA­
TIENTS WITH CROHN’ S DISEASE
N.P. Spasic, M. Protic, D. Bojic,
V. Gligorijevic, N. Jojic
P1789
BONE MINERAL DENSITY IN STEROID­
NAÏVE ULCERATIVE COLITIS PATIENTS
R.S. Tomasevic, G. Golubovic,
B. Obradovic, P. Dugalic, L. Burg
P1790
IDENTIFICATION OF ITEMS TO BE IN­
CLUDED IN AN ULCERATIVE COLITIS EN­
DOSCOPIC INDEx OF SEVERITY (UCEIS)
S.P.L. Travis, W.J. Sandborn, S.B. Hanauer,
M. Lemann, B.E. Sands, P. Marteau,
J. Colombel, M.T. Abreu, G.R. Lichtenstein,
B.G. Feagan, D.G. Altman, J. Mary,
D. Schnell, B. Yacyshyn, P. Krzeski,
C. A. Bernhard
P1791
ULCERATIVE COLITIS IN INFANCY
E. Tsimbalova, A. Potapov
PosTeR sessIon
P1792
CLINICIANS OVERESTIMATE THEIR COM­
PLIANCE WITH BRITISH SOCIETY OF GAS­
TROENTEROLOGY (BSG) GUIDELINES
FOR CANCER SCREENING IN ULCERATIVE
COLITIS (UC)
M. Ejaz, Z. Vali, F. Khan, J. Mayberry
P1793
INCIDENCE AND CLINICAL OUTCOME
OF INTERSPHINCTERIC ABSCESSES IN
PATIENTS WITH PERIANAL CROHN’S
DISEASE
C. Vigano’, F. Caprioli, A. Losco, D. Conte,
G. Basilisco
P1794
COLORECTAL CANCER IN THE ExETER
INFLAMMATORY BOWEL DISEASE (IBD)
POPULATION
E. Wesley, T.K. Daneshmend, T. Ahmad
P1795
IMPACT OF THE INTRODUCTION OF MR
ENTEROCLYSIS ON THE CLINICAL MAN­
AGEMENT OF PATIENTS WITH CROHN’S
DISEASE AT A TERTIARY REFERRAL CEN­
TRE
A. Yamamoto, C. Forde,
S. Pathmakanthan, T. Anderson, J. Goh
P1796
EVALUATION OF POST­THERAPY MU­
COSAL HEALING IN SMALL BOWEL
CROHN’S DISEASE BY DOUBLE BALLOON
ENTEROSCOPY
J. Zhong, L.F. Yu, S.Q. Xu, Z.T. Wang, R. Fan,
S.D. Cheng
P1797
ROLE OF DYNAMIC CONTRAST EN­
HANCED ULTRASOUND IN THE FOLLOW
UP OF CROHN’S DISEASE PATIENTS UN­
DER CORTICOSTEROID TREATMENT
M. Zocco, M.E. Ainora, A. Lupascu, F. De
Vincentis, I.A. Cazzato, A.C. Piscaglia,
M.T. Doddato, F. Ponziani, A. Santoliquido,
R. Flore, P. Tondi, A. Gasbarrini
251
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1798
THE ROLE OF PSYCHOLOGICAL FACTORS
IN THE PATHOGENESIS OF INFLAMMA­
TORY BOWEL DISEASE
M. Zwolinska-Wcislo, B. Froch, T. Mach,
K. Jablonski
P1799
TPMT GENE POLYMORPHISMS AND AC­
TIVITY IN CHINESE IBD PATIENTS WITH
AZATHIOPRINE TREATMENT
Q. Cao, Q. Zhu, J.M. Si
P1800
TFN­ALPHA ANTAGONISTS IN CROHN’S
DISEASE: RESULTS OF ENDOSCOPY
GUIDED THERAPY
C. af Björkesten, U. Nieminen, U. Turunen,
P.E.T. Arkkila, T. Sipponen, M.A. Färkkilä
P1801
Withdrawn by author
P1802
LOCAL INJECTION OF INFLIxIMAB IN SE­
VERE FISTULISING PERIANAL CROHN’S
DISEASE: HEALING RATE AND LONG
TERM RESULTS
L. Alessandroni, A. Kohn, R. Cosintino,
R. Mencacci, M. Marrollo, R. Tersigni
P1803
THE COURSE OF INFLIxIMAB DISCON­
TINUATION AFTER LONG­TERM MAIN­
TENANCE THERAPY IN CROHN’S DISEASE
A. Armuzzi, M. Rizzi, R. Monterubbianesi,
M. Marzo, M. Cicala, L. Guidi, C. Prantera,
A. Kohn
P1804
LONG­TERM SCHEDULED THERAPY WITH
INFLIxIMAB IN INFLAMMATORY BOWEL
DISEASE
A. Armuzzi, M. Marzo, C. Felice, F. De
Vincentis, G. Mocci, B. De Pascalis, P. Fedeli,
I. De Vitis, A. Papa, A. Gasbarrini, L. Guidi
252
P1805
INFLIxIMAB PHARMACOkINETIC­PHAR­
MACODYNAMIC MODELING IN INFLAM­
MATORY BOWEL DISEASES
A. Aubourg, D. Ternant, C. Magdelaine-
Beuzelin, E. Dorval, L. Picon, G. Paintaud
P1806
FACTORS AFFECTING THE EFFICACY OF
CYCLOSPORIN A THERAPY FOR REFRAC­
TORY ULCERATIVE COLITIS
S. Bamba, T. Tsujikawa, O. Inatomi,
T. Nakahara, Y. Koizumi, Y. Saitoh, M. Sasaki,
Y. Fujiyama, A. Andoh
P1807
TOLERABILITY AND EFFICACY OF MER­
CAPTOPURINE IN AZATHIOPRINE INTOL­
ERANT PATIENTS WITH INFLAMMATORY
BOWEL DISEASE
D.N. Barthel, K. Fellermann, J. Wehkamp,
E.F. Stange, K.R. Herrlinger
P1808
INFLIxIMAB AS RESCUE MEDICATION
FOR PATIENTS WITH SEVERE ULCER­
ATIVE/INDETERMINATE COLITIS REFRAC­
TORY TO TACROLIMUS (AND VICE VERSA)
D.N. Barthel, C.S. Barthel, K. Fellermann,
J. Wehkamp, E.F. Stange, K.R. Herrlinger
P1809
THE ROLE OF MERCAPTOPURINE IN
GASTROINTESTINAL INTOLERANCE
TO AZATHIOPRINE IN INFLAMMATORY
BOWEL DISEASE PATIENTS: A PROSPEC­
TIVE STUDY
G. Bastida, M. Aguas, B. Beltran, M. Iborra,
A. Nevarez, I. Moret, F. Rausell, M. García-
Eliz, J. Ponce, P. Nos

P1810
PROTECT­1 STUDY OF INTESTINE­
SPECIFIC CHEMOkINE RECEPTOR AN­
TAGONIST CCx282­B (TRAFICET­EN) IN
CROHN’S DISEASE
S. Keshav, T. Vanásek, Y. Niv, R. Petryka,
S. Howaldt, M. Bafutto, I. Rácz, D. Hetzel,
O.H. Nielsen, S. Vermeire, W. Reinisch,
P. Karlén, S. Schreiber, D. Johnson, T.J. Schall,
P. Bekker
P1811
EFFECT OF ORAL GLUTAMINE ON INTES­
TINAL PERMEABILITY AND MORPHOLO­
GY IN PATIENTS WITH CROHN’S DISEASE:
A RANDOMIZED CONTROLLED TRIAL
J. Benjamin, G.K. Makharia, V. Ahuja,
A. Rajan Kd, K. Mani, Y.K. Joshi
P1812
MERCAPTOPURINE RESCUE AFTER AZA­
THIOPRINE­INDUCED LIVER INJURY IN
INFLAMMATORY BOWEL DISEASE
F. Bermejo, M. Van Domselaar, A. Algaba,
E. Garrido, J.P. Gisbert, I. Guerra, G. Poza,
P. Valer, A. López-Sanromán, B. Piqueras,
G. Arranz, S. García-Garzón
P1813
STUDY ON A NOVEL ORALLY ACTIVE
INHIBITOR OF CYTOPLASMATIC PHOS­
PHOLIPASE A2 ALPHA THAT INHIBITS
ExPERIMENTAL COLITIS IN MICE
D. Bettenworth, M. Brückner, M. Lehr,
M. Brüwer, A. Lügering, J. Heidemann
P1814
T­REGULATORY CELLS IN CROHN’S DIS­
EASE PATIENTS TREATED WITH INFLIx­
IMAB
P. Biancheri, A. Di Sabatino, S. Piconese,
M. Rosado, C. Ubezio, L. Rovedatti,
S. Ardizzone, G. Bianchi Porro,
M.P. Colombo, R. Carsetti, T.T. MacDonald,
G.R. Corazza
PosTeR sessIon
P1815
EFFICACY AND SAFETY OF LONG­TERM
CONTINUOUS ExPOSURE TO CERTOLI­
ZUMAB PEGOL OVER 3.5 YEARS IN
PATIENTS WITH CROHN’S DISEASE: RE­
SULTS FROM THE PRECISE 3 MAINTE­
NANCE STUDY
S. Schreiber, G.R. Lichtenstein,
O.O. Thomsen, I.C. Lawrance, S.B. Hanauer,
R. Bloomfield, W.J. Sandborn
P1816
ARE ANTI­TNFS ABLE TO CLOSE ENTERO­
CUTANEOUS FISTULA IN CROHN’S DIS­
EASE?
V. Setakhr, P. Seksik, X. Treton, M. Allez,
M. De Vos, D. Laharie, J. Colombel,
J. Delchier, V. Abitbol, J. Reimund, J. Moreau,
J. Cosnes, M. Lemann, Y. Bouhnik
P1817
IMPROVEMENT IN WORk PRODUCTIV­
ITY AND DAILY ACTIVITIES BY CERTOLI­
ZUMAB PEGOL IN CROHN’S DISEASE PA­
TIENTS WITH PRIOR LOSS OF RESPONSE
OR INTOLERANCE TO INFLIxIMAB
B. Feagan, D.C. Wolf, S. Tan, Y. Brabant,
M. Brown
P1818
CERTOLIZUMAB PEGOL TREATMENT
IMPACTS HOSPITALIZATIONS AND SUR­
GERIES IN CROHN’S DISEASE PATIENTS
WITH PRIOR FAILURE TO INFLIxIMAB:
RESULTS FROM WELCOME TRIAL
B. Feagan, D.C. Wolf, S. Tan, Y. Brabant,
M. Brown
P1819
EFFICACY AND SAFETY OF COLE­
SEVELAM (CHOLESTAGEL ® ) FOR THE
TREATMENT OF BILE ACID MALABSORP­
TION IN PATIENTS WITH CROHN’S DIS­
EASE AFTER ILEOCOECAL RESECTION
F. Beigel, F. Schnitzler, J. Seiderer, B. Göke,
T. Ochsenkühn, S. Brand, S. Howaldt
253
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1820
CROHN’S DISEASE, SMOkING AND THIO­
PURINES: A COMPLEx RELATIONSHIP?
A.J. Brooks, D.S. Sanders, K.D. Bardhan,
L. Lennard
P1821
AZATHIOPRINE MAINTAINS LONG­TERM
STEROID­FREE REMISSION THROUGH 3
YEARS IN PATIENTS WITH STEROID­DE­
PENDENT ULCERATIVE COLITIS
L.A. Chebli, L.D. Miranda Chaves,
F.F. Pimentel, D.M. Guerra, P.D. Gaburri,
A. Zanini, J.M.F. Chebli
P1822
IBD AND TRAVELLING: WHAT’S HAPPEN­
ING TO OUR PATIENTS?
A. Claridge, J. Watson, F. Cummings
P1823
A HEAD­TO­HEAD IMMUNOLOGICAL
COMPARISON OF TREATMENTS WITH
CORTICOSTEROIDS AND LEUkOCY­
TAPHERESIS IN IBD­PATIENTS
M. Karlsson, L. Linton, A. Lindberg,
E. Hjalmarsson, P. Karlén, O. Winqvist,
M. Eberhardson
P1824
INJECTION SITE PAIN, BURNING, AND
STINGING ARE IMPORTANT, UNDER­RE­
PORTED SIDE EFFECTS OF SUBCUTANE­
OUS ANTI­TFN­ALPHA THERAPIES FOR
PATIENTS WITH RHEUMATOID ARTHRITIS
N. Furfaro, K. Dewing, J. Carlone,
E. Eberhardt Customer Insights
Immunology, UCB, Brussels, Belgium
P1825
APPROPRIATE THERAPY FOR FISTULIZ­
ING AND FIBROSTENOTIC CROHN’S
DISEASE: RESULTS OF A MULTIDISCI­
PLINARY INTERNATIONAL ExPERT PAN­
EL (EPACT II)
C. Felley, J. Vader, P. Juillerat, V. Pittet,
Y. Panis, C. O’Morain, B. Vucelic, J. Gonvers,
C. Mottet, F. Froehlich, P. Michetti
254
P1826
ORAL INTAkE OF AN ExTRACT BASED ON
THE MEDICINAL MUSHROOM AGARICUS
BLAZEI MURILL REDUCES LEVELS OF FE­
CAL CALPROTECTIN IN PATIENTS WITH
ULCERATIVE COLITIS BUT NOT CROHN’S
DISEASE
D.T. Forland, G. Hetland, T. Lyberg,
L. Saetre, I. Lygren, E. Johnson
P1827
METHOTRExATE FOR MAINTENANCE
IN CHRONIC ACTIVE CROHN’S DISEASE:
LONG­TERM RESULTS OF A SINGLE CEN­
TER
J. Hausmann, K. Zabel, E. Hermann,
O. Schröder
P1828
AUTOLOGOUS STEM CELL TRANSPLAN­
TATION FOR CROHN’S DISEASE (ASTIC)
TRIAL: SAFETY PROFILE
C. J. Hawkey, E. Ricart, S.P. Travis,
J. Colombel, M. Allez, S. Danese
P1829
PROBIOTIC AND PREBIOTIC USE BY PA­
TIENTS WITH INFLAMMATORY BOWEL
DISEASE COMPARED WITH HEALTHY
CONTROLS: A QUESTIONNAIRE INTER­
VIEW STUDY
C.R.H. Hedin, E. Sharratt, C. Jansen,
M. Graczer, J.D. Sanderson, A.J. Stagg,
J.O. Lindsay, K. Whelan
P1830
FACTORS ASSOCIATED WITH IMPAIRED
QUALITY OF LIFE IN PATIENTS WITH IN­
FLAMMATORY BOWEL DISEASE
R. Jones, C.L. Hunt, S. Fox, R. Driscoll,
G. Rubin

PosTeR sessIon
nerve, gut and motility III
P1831
THE EFFECT OF GLUCAGON­LIkE PEP­
TIDE­2 ON MESENTERIC BLOOD FLOW
AND CARDIAC PARAMETERS IN PA­
TIENTS WITH INTESTINAL FAILURE
L. Bremholm, U.B. Andersen, M. Hornum,
J.J. Holst, P.B. Jeppesen
P1832
GASTRIC NEURONAL PLASTICITY DUR­
ING WESTERN DIET­INDUCED OBESITY
IN MICE
C. Baudry, R. Moriez, P. Aubert, M. Neunlist,
S. Bruley des Varannes
P1833
CHARACTERIZATION OF NERVE­MEDI­
ATED INTESTINAL RESPONSES IN INTER­
LEUkIN­10 kNOCkOUT MICE
J. Kwon, J. Jung, E. Kim, H. Kim, J. Sin,
B. Jang, J. Choi, D. Kim, D. You, T. Kim,
G. Park
P1834
PREGNANCY AND GASTRIC ELECTRICAL
STIMULATION (GES, “GASTRIC PACING”)
J.E.A. Brun, H. Lönroth, G. Ringstrom,
M. Simrén, H. Abrahamsson
P1835
IS THE POSITION OF THE PATIENT WHEN
PERFORMING HIGH RESOLUTION OE­
SOPHAGEAL MANOMETRY IMPORTANT
IN THE DIAGNOSIS?
C. Ciriza de los Ríos, F. Canga, J. Aranda,
Y. Sánchez, G. Castellano
P1836
NEW HIGH­RESOLUTION FUNCTIONAL
LUMINAL IMAGING SYSTEM FOR THE
OESOPHAGO­GASTRIC JUNCTION
H. Gregersen, F. Gravesen, S.S. Olesen,
A.M. Drewes, B.P. McMahon
PosTeR sessIon
P1837
VARIATION OF UPPER AND LOWER OE­
SOPHAGEAL SPHINCTER PRESSURE
DURING STATIONARY HIGH RESOLUTION
MANOMETRY
H. Heinrich, E. Kaufman, A. Gietl, M. Fox,
M. Fried, H. Frühauf
P1838
INFLUENCE OF THE CB1 RECEPTOR AN­
TAGONIST RIMONABANT ON INTERDI­
GESTIVE MOTILITY AND HUNGER RAT­
INGS IN HEALTHY VOLUNTEERS
S. Kindt, R. Vos, E. Scarpellini, H. Nicolai,
I. Depoortere, P. Vanden Berghe, J. Tack
P1839
THE EFFICACY OF RIkkUNSHITO, A
TRADITIONAL JAPANESE MEDICINE
(kAMPO), FOR TREATING FUNCTIONAL
DYSPEPSIA
H. Kusunoki, J. Hata, H. Hasuo,
N. Yamashita, K. Honda, M. Ishii,
Y. Yamanaka, M. Fujita, K. Tarumi,
Y. Imamura, N. Manabe, T. Kamada,
A. Shiotani, K. Haruma
P1840
THE CONSEQUENCES OF LARGE GAS­
TRIC RESIDUAL VOLUMES AFTER THE
START OF ENTERAL FEEDING IN CRITI­
CAL ILL PATIENTS
R. Laheij, C. de Jager, M. Markese, M. van
Oijen
P1841
AUDIT OF UPPER GASTRO­INTESTINAL
PHYSIOLOGICAL STUDIES ­ A Uk SINGLE
CENTRE ExPERIENCE
N.V. Radhakrishnan, E. Mohamed,
J. Barlow, R. George, R.K. Sharma, L. Quest,
K. Akhtar, S. Senapati
255
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1842
OCCURENCE OF GASTROINTESTINAL
SYMPTOMS IN PATIENTS WITH NUT­
CRACkER ESOPHAGUS AND THE PRE­
DOMINANT SYMPTOMS’ ASSOCIATION
WITH ABNORMALITIES IN ExAMINA­
TIONS
L. Rosa-e-Silva, P. Honda, J. Pini,
L. Rossetto, O. Nogueira, R. Pontes
P1843
OESOPHAGEAL MOTOR ABNORMALI­
TIES IN EOSINOPHILIC ESOPHAGITIS
IDENTIFIED BY HIGH­RESOLUTION MA­
NOMETRY. RESULTS OF COMBINED MUL­
TICHANNEL INTRALUMINAL IMPEDANCE
AND PH MONITORING
C. Santander, J. Espinoza-Ríos,
C. Chavarría-Herbozo, L. Martín Martín,
J.P. Gisbert, R. Moreno-Otero
P1844
RELATIONSHIP BETWEEN HUNGER AND
GASTROINTESTINAL MOTILITY IN FAST­
ING AND POSTPRANDIAL STATE IN MAN
E. Scarpellini, R. Vos, I. Depoortere, D. Ang,
P. Vanden Berghe, J. Tack
P1845
EFFECTS OF BOLUS CONSISTENCY AND
BODY POSITION ON OESOPHAGEAL
FUNCTION ASSESSED BY HIGH RESOLU­
TION MANOMETRY
R.R. Sweis, T. Wong, A. Anggiansah, M. Fox
P1846
CHARACTERIZATION AND TREATMENT
OF NUTCRACkER ESOPHAGUS WITH
GASTROESOPHAGEAL REFLUx DISEASE
(GERD). A CLINICAL AND PATHOPHYSI­
OLOGICAL APPROACH
O. Teramoto, S. Sobrino, A. Gollas,
M. Hernandez, J. Soto, J. Vargas, J. Lopez
256
P1847
5HT4 RECEPTOR AGONIST, A MO­
SAPRIDE CITRATE, FACILITATE BOTH
GASTRIC ACCOMMODATION AND EMP­
TYING IN HEALTHY VOLUNTEERS
T. Tomita, T. Okugawa, F. Toyoshima,
T. Yamasaki, J. Sakurai, J. Tanaka, T. Morita,
Y. Kim, T. Oshima, K. Hori, J. Watari,
T. Matsumoto, T. Kashiwagi, H. Miwa
P1848
ENDOGENOUS GLUCAGON­LIkE PEP­
TIDE­1 IS INVOLVED IN REGULATION OF
GASTRIC MOTILITY AND PANCREATIC
ENDOCRINE SECRETION
A. Witte, P. Grybäck, H. Jacobsson,
E. Näslund, P.M. Hellström, J.J. Holst,
L. Hilsted, P.T. Schmidt
P1849
CONCORDANCE OF THE ROME II CRITE­
RIA AND THE ROME III CRITERIA IN THE
DIAGNOSIS AND SUBTYPING OF THE IR­
RITABLE BOWEL SYNDROME – A POPU­
LATION­BASED STUDY
M. Nakmouche, A. Bousseloub,
N. Kaddache, N. Bounab, L. Gamar, L. Kecili,
A. Balamane, W. Menni, N. Afredj, N. Baiod,
T. Boucekkine
P1850
USE OF LUBIPROSTONE (24 MCG BID) IN
PATIENTS WITH IRRITABLE BOWEL SYM­
DROME WITH CONSTIPATION
R.M. Panas, C.B. Scott, R. Ueno
P1851
LONG­TERM EFFICACY OF LUBIPRO­
STONE DEMONSTRATED IN PATIENTS
WITH CONSTIPATION REGARDLESS OF
AGE, GENDER, OR RACE
R.M. Panas, C.B. Scott, R. Ueno

P1852
LUBIPROSTONE INITIATES IMPROVE­
MENT IN CONSTIPATION SYMPTOMS IN
REFRACTORY PATIENTS
R.M. Panas, D. Dodds, C.B. Scott, R. Ueno
P1853
LUBIPROSTONE DEMONSTRATES EFFI­
CACY IN ADULT PATIENTS WITH CONSTI­
PATION REGARDLESS OF AGE, GENDER,
OR RACE
R.M. Panas, C.B. Scott, R. Ueno
P1854
GASTROINTESTINAL SYMPTOMS AND
QUALITY OF LIFE IN PATIENTS WITH END­
STAGE RENAL DISEASE UNDERGOING
TREATMENT BY HEMODIALYSIS
S. Park, C. Choi, S. Lee, B. Cha, E. Baek,
K. Kim, H. Lee, H. Kim, J. Do, S. Chang
P1855
USEFULNESS OF LACTULOSE BREATH
TEST FOR SMALL INTESTINAL BACTE­
RIAL OVERGROWTH
H. Lim, J. Kim, Y. Youn, H. Park, S. Lee
P1856
LACTOBACILLUS GG IMPROVES SYMP­
TOMS AND BOWEL FUNCTION IN PA­
TIENTS WITH FUNCTIONAL CONSTIPA­
TION
V.I. Pilipenko, E.A. Burlyaeva, V.A. Isakov
P1857
SERUM LEPTIN LEVELS AND IRRITABLE
BOWEL SYNDROME: A NEW HYPOTHESIS
G. Roshandel, S. Semnani, A. Keshtkar,
L. Najafi, T. Amiriani, M. Farajollahi,
A. Moradi, H. Joshaghani, A. Noohi,
N. Abdolahi, S. Besharat, M. Okhly,
H. Mirkarimi, D. Mirzamohammadi
PosTeR sessIon
257
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1858
VALIDITY OF THE ROME III CRITERIA FOR
FUNCTIONAL DYSPEPSIA: A POPULA­
TION­BASED PREVALENCE STUDY
D.K.F. Siu, J. Wu, Y. Chan, A. Mak, J. Ching,
J. Sung, F. Chan, S. Lee
P1859
PROSPECTIVE VALIDATION OF THE ROME
III CRITERIA FOR IRRITABLE BOWEL SYN­
DROME WITH PREDOMINANT DIARRHEA
BY COLONOSCOPY AND MULTIPLE SEG­
MENTAL COLONIC BIOPSIES
V.K. Thorat, A.L. Kakrani, M.M. Khandekar
P1860
EVALUATION OF THE EFFICACY OF
DRIED POWDERED ExTRACT OF AEGLE
MARMELOS FRUIT FOR THE MANAGE­
MENT OF SYMPTOMS IN PATIENTS WITH
IRRITABLE BOWEL SYNDROME WITH
PREDOMINANT DIARRHEA BY A PRO­
SPECTIVE RANDOMISED CONTROLLED
DOUBLE BLIND TRIAL
V.K. Thorat, A.L. Kakrani, M.M. Khandekar,
N. Gupte
P1861
FUNCTIONAL DYSPEPSIA AND MELA­
TONIN
A. Uyanikoglu, O. Yonal, F. Ermis, F. Akyuz,
B. Pinarbasi, S. Ciftci, F. Keskin, Z. Mungan
P1862
PREVALENCE OF IRRITABLE BOWEL SYN­
DROME IN THE GREEk GENERAL POPU­
LATION
N. Viazis, G. Papatheodoridis,
J. Vlachogiannakos, D. Georgiadis,
I. Karaitianos, D.G. Karamanolis
P1863
EFFECT OF GLUCOMANNAN IN SUB­
JECTS WITH MILD ALTERATIONS OF THE
INTESTINAL HABIT
S. Passaretti, M. Corsetti, S. di Pietro,
P. Giollo, G. Castellaneta, M. Volonté,
P.A. Testoni
258
P1864
FEATURES OF SOMATIC PAIN AND CON­
STIPATION CLEARLY DISTINGUISH BE­
TWEEN NERD AND EROSIVE OESOPHA­
GITIS PATIENTS
J. Zimmerman
PosTeR sessIon
oncology III
P1865
THE DYNAMIC ROLE OF MARCkS DUR­
ING CELL MOTILITY IN HUMAN COLON
CANCER CELLS
K. Rombouts, A. Caligiuri, F. Marra,
M. Pinzani
P1866
SATB1 PROTEIN IS ASSOCIATED WITH
A MORE AGGRESSIVE PHENOTYPE OF
COLORECTAL CANCER CELL LINES
A.M. Rygiel, A.L. Davelaar, F. Milano,
E. Dekker, C.J. van Noesel, P. Fockens,
K.K. Krishnadath
P1867
ACTIVATION OF SIGNALLING PATHWAYS
IN THE MOUSE GUT AND IN A MURINE
MODEL OF GASTROINTESTINAL STRO­
MAL TUMOURS: AN IMMUNOFLUORES­
CENCE STUDY
F.Z. Saddouk, P. Gromova, S. Ralea,
L. Deneubourg, C. Erneux, B.P. Rubin,
J. Vanderwinden
P1868
CELECOxIB SELECTIVELY TARGETS
GENES AND PATHWAYS INVOLVED IN
INFLAMMATION AND MALIGNANT
TRANSFORMATION IN TUMOR BUT NOT
NORMAL CELLS
E. Sagiv, M. Sheffer, D. Kazanov, S. Shapira,
I. Naumov, S. Kraus, E. Domany, N. Arber

P1869
NEk2 AS A NOVEL MOLECULAR TAR­
GET FOR INHIBITION OF TUMORIGENIC
GROWTH AND LIVER METASTASIS OF
PANCREATIC CANCER
K. Suzuki, S. Hibino, T. Kokuryo, T. Senga,
Y. Yokoyama, M. Nagino, M. Hamaguchi
P1870
THE P53­PARALOG DNP73 ONCOGENE
IS REPRESSED BY α­IFN/STAT2 THROUGH
THE RECRUITMENT OF YY1 AND HDAC1
TRANSCRIPTIONAL REPRESSORS
B. Testoni, C. Scisciani, V. Schinzari,
N. Pediconi, M. Levrero
P1871
CHROMOSOMAL LOSSES OF 5Q OR 14Q
IN GASTRIC ADENOCARCINOMAS PRE­
DICT GOOD CLINICAL OUTCOME
T.E. Buffart, B. Carvalho, N.C.T. van
Grieken, W.N. van Wieringen, M. Tijssen,
E.M. Klein Kranenbarg, H. Grabsch, B. Ylstra,
C.J.H. van de Velde, G.A. Meijer
P1872
THROMBOEMBOLIC COMPLICATIONS OF
NEOADJUVANT CHEMOTHERAPY FOR
OESOPHAGO­GASTRIC CANCER
M.G. Bani-Hani, D. Veeramootoo,
R. Velineni, M. Napier, E. Toy,
T.K. Daneshmend, R.G. Berrisford, S.A. Wajed
P1873
METHYLATION PATTERN OF HIGH RISk
FLAT LESIONS IN CRC
Q.J.M. Voorham, B. Carvalho, A.J. Spiertz,
N.C.T. van Grieken, S. Derks, H.I. Grabsch,
B. Rembacken, M. Kliment, A.P. de Bruïne,
C.J.J. Mulder, M. van Engeland, G.A. Meijer
PosTeR sessIon
P1874
RELATIONSHIP BETWEEN POLYMOR­
PHISMS OF INTERLEUkIN­17A AND IN­
TERLEUkIN­17F GENES AND CLINICAL
PATHOLOGICAL CHARACTERISTICS IN
CHINESE GASTRIC CANCER PATIENTS
X.Q. Wu, Z.R. Zeng, B. Chen, L. Xue, Y.T. Hao,
J. Yu, M.H. Chen, J.J.Y. Sung, P.J. Hu
P1875
PREOPERATIVE CHEMORADIOTHERAPY
IS CRUCIAL FOR ERADICATING AGGRES­
SIVE CANCER PROGENITOR CELLS CAUS­
ING RECURRENCE IN OESOPHAGEAL
CANCER PATIENTS: STEM CELL­RELATED
MARkERS IN OESOPHAGEAL CANCER
R. Yoshikawa, L. Tao, T. Tsujimura,
M. Sasako, Y. Fujiwara
P1876
METHYLATION SPECIFIC­HIGH RESOLU­
TION MELTING ANALYSIS OF A NOVEL
METHYLATION PANEL IN STOOL DNA
D. Azuara, F. Rodriguez, J. de Oca,
J. Boadas, A. Soriano, J. Guardiola, I. Blanco,
M. Esteller, V. Moreno, G. Capellá
P1877
GASTRIC GLANDULAR ATROPHY HAS AN
INDEPENDENT INFLUENCE ON SERUM
PEPSINOGEN LEVELS IN PATIENTS WITH
GASTRIC CANCER
J. Bornschein, M. Warnecke, M. Selgrad,
T. Wex, D. Kuester, P. Malfertheiner
P1878
PREVALENCE OF ADVANCED HISTOL­
OGY IN DIMINUTIVE COLONIC POLYPS
IN AN AVERAGE RISk POPULATION: IM­
PLICATIONS FOR COLORECTAL CANCER
SCREENING
A. Buda, M. De Bona, E. Zabeo, P. Piselli,
R. Barbazza, A. Bellumat, F. Valiante,
G.C. Sturniolo, M. Pignatelli, M. De Boni
259
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1879
TRENDS IN SCREENING FOR COLOREC­
TAL CANCER IN FRANCE
A. Calazel Benque, F. Eisinger, J. Blay,
Y. Coscas, J. Morère, X. Pivot, C. Roussel,
J. Viguier
P1880
NON­STEROIDAL ANTI­INFLAMMATORY
DRUGS, ANTIPLATELETS AND ANTICO­
AGULANTS – THE EFFECT ON THE FAE­
CAL OCCULT BLOOD TEST
L.B. Chalmers, G. Smith, J. Martin
P1881
SERUM HIGH MOBILITY GROUP BOx­1
(HMGB1) IS CLOSELY ASSOCIATED WITH
THE CLINICAL AND PATHOLOGIC FEA­
TURES OF GASTRIC CANCER
H. Chung, S. Lee, H. Kim, D. Hong, J. Chung,
J. Lim
P1882
EPIDEMIOLOGY AND PROGNOSIS OF
COLORECTAL CANCER’S SYNCHRONOUS
AND METACHRONOUS LUNG METASTA­
SES IN A WELL DEFINED FRENCH POPU­
LATION
S. Cosconea Cioaca, E. Mitry, C. Lepage,
B. Guiu, J. Faivre, A. Bouvier
P1883
COLORECTAL CANCER SCREENING BY
COLONOSCOPY: ExPERIENCE IN HIGH
AND AVERAGE RISk POPULATION
G. Del Vecchio Blanco, A. Caruso,
M. Cretella, E. Mannisi, F. Sevadei,
O. Paoluzi, E. Grasso, M. Giannelli,
L. Biancone, F. Pallone
P1884
POPULATION UPTAkE AND SCREENING
TOOL PREFERENCE FOR COLORECTAL
CANCER SCREENING IN THE MALTESE
POPULATION
P. Ellul, C. Ellul, M. Vassallo
260
P1885
HOW DO DOCTORS DEAL WITH THEIR
OWN COLORECTAL CANCER SCREEN­
ING AND WHAT DO THEY RECOMMEND
THEIR PATIENTS? A NATION­WIDE AND
REGIONAL SURVEY UNDER GERMAN
DOCTORS
W. Fischbach, C. Klassert, O. Al-Taie
P1886
AWARENESS OF THE NATIONAL
COLORECTAL CANCER SCREENING PRO­
GRAM UNDER GERMAN DOCTORS. RE­
SULTS OF A REGIONAL AND A NATION­
WIDE SURVEY
W. Fischbach, C. Klassert, O. Al-Taie
P1887
ANALYSIS AND GEOGRAPHICAL MAP­
PING OF UPTAkE, SCREENING RESULTS
AND COLONOSCOPY OUTCOMES FOR
THE NHS BOWEL CANCER SCREENING
SOUTHERN PROGRAMME HUB
S.P. Halloran, J. Snowball
P1888
TRENDS IN INCIDENCE, MANAGEMENT,
AND SURVIVAL OF GASTRIC AND CAR­
DIA CARCINOMAS IN THE AREA OF FIN­
ISTERE (FRANCE) BETWEEN 1984 AND
2003
J. Jezequel, C. Bessaguet, J. Faycal,
A. Volant, J. Cauvin, Z. Richert,
J. Nousbaum, H. Gouérou,
M. Robaszkiewicz
P1889
ADVANCED COLONIC NEOPLASIA AT 12
MONTH SURVEILLANCE COLONOSCOPY
IN THE NHS BOWEL CANCER SCREENING
PROGRAMME: ANALYSIS OF THE NA­
TIONAL DATABASE
T.J.W. Lee, C. Nickerson, J. Patnick,
M.D. Rutter

P1890
HIGH BMI, NON USE OF ASPIRIN AND
MALE SEx ARE ASSOCIATED WITH
HIGHER RISk ADENOMA AND CANCER
IN THE NHS BOWEL CANCER SCREENING
PROGRAMME
T.J.W. Lee, G. Clifford, M.A. Hull,
D. Nylander, J. Painter, J. Singh, M.D. Rutter,
C. Rees
P1891
INCIDENCE OF COMPLICATIONS IN BOW­
EL CANCER SCREENING COLONOSCOPY
IS LOW DESPITE THE INCREASED NEED
FOR ENDOSCOPIC THERAPY
D. Nylander, T.J.W. Lee, M. Ritchie,
J. Painter, L. Hurst, J. Singh, C. Rees,
M.D. Rutter
P1892
LAPAROSCOPIC ASSISTED SURGERY FOR
COLORECTAL CANCER: SHORT TERM
RESULTS AND FOLLOW­UP OF 218 PA­
TIENTS
S.M. Alexander, G.G.D. Slooter
P1893
kNOW­HOW TRANSFER FROM JAPAN:
AN ITALIAN SINGLE CENTER PRELIMI­
NARY ExPERIENCE WITH ENDOSCOPIC
SUBMUCOSAL DISSECTION FOR EARLY
GASTROINTESTINAL CANCERS
S. Coda, P. Trentino, F. Antonellis, F. Gossetti,
F. Pugliese, F. Ruberto, G. d’Amati, P. Negro,
T. Gotoda
P1894
USEFULNESS OF STAGING SYSTEMS FOR
HEPATOCELLULAR CARCINOMA IN PRE­
DICTING RECURRENCE AFTER SURGICAL
THERAPY
S. Iacob, S. Dima, E. Matei, R. Iacob,
L. Gheorghe, C. Gheorghe, I. Popescu
PosTeR sessIon
P1895
SAFETY AND EFFICACY OF DEEP SEDA­
TION FOR ENDOSCOPIC SUBMUCOSAL
DISSECTION: PROPOFOL VERSUS PRO­
POFOL PLUS MIDAZOLAM, RANDOM­
IZED PROSPECTIVE STUDY
K. Kim, K. Kim, K. Lee, C. Park, T. Hahn,
K. Yoo, S. Park, J. Kim, C. Park
P1896
CLINICAL OUTCOMES OF ENDOSCOPIC
SUBMUCOSAL DISSECTION FOR DUODE­
NAL EPITHELIAL TUMORS
Y. Miyata, N. Yahagi
P1897
A STUDY FOR INDIVIDUALIZED CHEMO­
THERAPY FOR COLORECTAL CANCER
(CRC) BASED ON THE COLLAGEN GEL
DROPLET EMBEDDED CULTURE­DRUG
SENSITIVITY TEST (CD­DST): WHICH IS
THE FIRST LINE, FOLFOx OR FOLFIRI ?
T. Ochiai, K. Nishimura, T. Watanabe,
M. Kitajima, A. Nakatani, T. Hashiguchi,
T. Marusasa, A. Muraki, N. Sakuyama,
S. Futagawa, I. Nagaoka
P1898
EVALUATION OF CHEMOTHERAPY
PRACTICES IN PATIENTS TREATED FOR
COLORECTAL CANCER IN THE BOR­
DEAUx TEACHING HOSPITAL: METHOD­
OLOGY AND PRELIMINARY RESULTS OF
THE COLCHIC COHORT STUDY
D. Smith, E. Terrebonne, J.F. Blanc, D. Breilh,
S. Pedeboscq, M. Rouyer, A. Le Monies,
D. Jayles, N. Moore, A. Fourrier-Réglat
P1899
A 15­YEARS SINGLE CENTER ExPERI­
ENCE: 25 CONSECUTIVE CASES WITH
PROGREDIENT METASTATIC GASTROIN­
TESTINAL CARCINOID TUMOUR TREAT­
ED WITH DACARBAZINE
T. Savvoukidis, T. Armbrust, G. Ramadori
261
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1900
A TRADITIONAL JAPANESE MEDICINE
(kAMPO) RIkkUNSHITO IS A NEW CAN­
DIDATE SUPPORTING DRUG WHICH IM­
PROVES QOL DURING CHEMOTHERAPY
WITH DOCETAxEL/ 5­FU/ CDDP FOR
ADVANCED ESOPHAGEAL CANCER PA­
TIENTS
J. Seike, T. Sawada, N. Kawakita,
Y. Yamamoto, Y. Yuasa, H. Yamai,
H. Takechi, T. Yoshida, A. Tangoku
P1901
ENDOSCOPIC TREATMENT FOR SUPER­
FICIAL ORO­HYPOPHARYNGEAL CARCI­
NOMA
T. Suzuki, K. Kawada, K. Nagai,
T. Nishikage, Y. Nakajima, A. Hoshino,
Y. Miyawaki, T. Okada, H. Kawachi,
T. Kawano
P1902
IMPACT OF ADJUVANT THERAPY IN AM­
PULLARY CARCINOMA
A.K. Tank, R.K. Singh, A. Prakash, A. Behari,
A. Kumar, R. Saxena, V.K. Kapoor
PosTeR sessIon
liver III
P1903
THE EFFECTS OF FOCAL ADHESION kI­
NASE GENE SILENCING ON PROLIFERA­
TION AND APOPTOSIS OF HEPATIC STEL­
LATE CELLS
J. An, S. Xie, X. Zhang, D. Yao, S. Fang, J. Yao
P1904
THE ANTIVIRAL AND ANTI­INFLAMMA­
TORY EFFECT OF STATIN TREATMENT IN
CHRONIC HEPATITIS C: PRELIMINARY
STUDY
O.C. Fratila, G. Avram, R. Mihaila, A. Gal,
T. Ilias
262
P1905
PROTECTIVE EFFECT OF METHYLPRED­
NISOLONE ON WARM ISCHEMIA­REPER­
FUSION INJURY IN A CHOLESTATIC RAT
LIVER
A. Gupta, G. Subhas, D. Bakston,
B. Silberberg, C. Lobocki, L. Andrus,
M. Decker, V. Mittal, M. Jacobs
P1906
BILIARY EPITHELIAL CELLS PROLIFER­
ATE ACCOMPANIED BY UP­REGULATED
ExPRESSION OF TGF­B GENES IN CHO­
LESTATIC LIVERS
Y. He, B. Chen, R. Yang, S. Liu, Z. Zeng, Y. Cui
P1907
DIFFERENT PROFILES IN PIG SERUM AND
BILE DUCT LIGATION INDUCED RAT LIV­
ER FIBROSIS
Y. He, B. Chen, Y. Xiao, L. Yang, Y. Cui,
Z. Zeng
P1908
ASSOCIATION OF HUMAN MAJOR HIS­
TOCOMPATIBILITY COMPLEx (HLA) AL­
LELES IN THE DEVELOPMENT OF LIVER
FIBROSIS IN PATIENTS WITH CHRONIC
HEPATITIS C
S. Leite, H. Alves, A. Silva, J. Pinto,
M. Afonso, R. Veloso, B. Lima, M. Dias,
S. Fernandes, J. Carvalho, J. Fraga
P1909
IMMUNOHISTOCHEMICAL STAINING OF
HUMAN LIVER AND DUODENAL TISSUE
FOR DETECTION OF HEPCIDIN
A. Sangwaiya, J. Arnold, M. Busbridge,
V. Manglam, M. Thursz
P1910
EPIGENETIC SYLENCING AND TRAN­
SCRIPTIONAL REGULATION OF miRNAs
MODULATED IN HUMAN HCCs
V. Schinzari, N. Pediconi, S. Vossio,
C. Scisciani, R. De Iaco, M. Levrero

P1911
CURCUMIN PREVENTS LIVER FIBROSIS
BY INDUCING APOPTOSIS AND SUP­
PRESSING ACTIVATION OF HEPATIC
STELLATE CELLS
J. Shu, Y. He, X. Lv, G. Ye, H. Zhu, L. Wang
P1912
THE INTESTINAL BARRIER FUNCTION OF
RATS WITH NONALCOHOLIC FATTY LIVER
DISEASE
L. Su, Y.L. Liu
P1913
NEUROTROPHIN FAMILY RECEPTOR Ex­
PRESSIONS IN RESECTABLE HUMAN HE­
PATOCELLULAR CARCINOMA AND THEIR
RELATIONSHIPS BETWEEN TWIST­1 AND
TWIST­2
J. Yoon, Y. Cho, B. Kim, W. Jeon, H. Kim,
B. Son, S. Chae, J. Kim, W. Jin, H. Lee
P1914
INTERLEUkIN­29 (INTERFERON­LAMBDA
1) INHIBITS GROWTH OF HEPATOCEL­
LULAR CARCINOMA IN AN ORTHOTOPE
MURINE TUMOR MODEL IN VIVO
F. Beigel, B. Schwarz, I. Ischenko,
J. Diegelmann, E. de Toni, K. Jauch, B. Göke,
C. Bruns, S. Brand
P1915
MELATONIN DOWNREGULATES NUCLE­
AR ERYTHROID 2­RELATED FACTOR 2
AND NUCLEAR FACTOR­kAPPAB DUR­
ING PREVENTION OF OxIDATIVE LIVER
INJURY IN A DIMETHYLNITROSAMINE
MODEL
K. Jung, S. Hong, H. Zheng, D. Lee, H. Kim,
K. Kwon, Y. Shin, S. HONG
P1916
QUANTITATIVE EVALUATION OF CAPIL­
LARY NETWORk IN GASTRIC MUCOSA IN
PATIENTS WITH LIVER CIRRHOSIS, COM­
PLICATED BY PORTAL HYPERTENSION
L.B. Lazebnik, S.G. Khomeriki,
I.O. Koviazina, A.G. Zhukov
PosTeR sessIon
P1917
DYSREGULATION OF TOLL­LIkE RECEP­
TOR 2 AND 4 MEDIATED IMMUNE RE­
SPONSE IN PATIENTS WITH ALCOHOLIC
CIRRHOSIS
P. Pimentel-Nunes, R. Roncon-
Albuquerque Jr., N. Gonçalves,
C. Fernandes-Cerqueira, H. Cardoso,
R.P. Bastos, M. Marques, J.A. Sarmento,
C. Costa-Santos, M. Pestana, M. Dinis-
Ribeiro, A.F. Leite-Moreira
P1918
PREDICTORS OF NONRESPONSE TO
LACTULOSE FOR MINIMAL HEPATIC
ENCEPHALOPATHY IN PATIENTS WITH
CIRRHOSIS
P. Sharma, B.C. Sharma, S.K. Sarin
P1919
PHARMACOkINETICS OF CIPROFLOxA­
CIN IN PATIENTS WITH LIVER CIRRHOSIS
AND ASCITES SYNDROME
S.Y. Silvestrova, E.V. Vinnitskaya,
V.N. Drozdov, A.V. Petrakov, V. Kondrashova,
N.A. Shaposhnikova, L.V. Fedulenkova
P1920
DEVELOPMENT OF THE HEPATOPULMO­
NARY SYNDROME IN MICE IS ACCOMPA­
NIED WITH PULMONARY ANGIOGENESIS
C.C.L. Van Steenkiste, M. Waterloos,
A. Geerts, F. De Vos, M. De Vos, H. Van
Vlierberghe, I. Colle
P1921
ANALYSIS OF WALL SHEAR STRESS IN
DIFFERENT MODELS OF PORTAL HYPER­
TENSION AND CIRRHOSIS
C.C.L. Van Steenkiste, B. Trachet,
C. Casteleyn, D. Van Loo, P. Segers, M. De
Vos, H. Van Vlierberghe, I. Colle
263
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1922
LONGITUDINAL DYNAMIC STUDIES OF
PORTO­SYSTEMIC SHUNTING IN PORTAL
HYPERTENSIVE AND CIRRHOTIC MICE BY
QUANTITATIVE MICRO­SPECT IMAGING
C.C.L. Van Steenkiste, S. Staelens, S. De
Leye, F. De Vos, S. Vandenberghe, C. Van De
Wiele, M. De Vos, H. Van Vlierberghe, I. Colle
P1923
ATRIAL NATRIURETIC PEPTIDE (ANP)
AND C­TYPE NATRIURETIC PEPTIDE
(CNP) PREVENTED LIVER FIBROSIS AND
HAD THE PROTECTIVE ACTION OF LIVER
N. Yamamoto, N. Ishigaki, H. Jin, K. Uchida,
S. Terai, T. Yamasaki, I. Sakaida
P1924
CAN ANTIBIOTIC PROPHYLAxIS REDUCE
SERUM NITRIC OxIDE AND EARLY RE­
BLEEDING AFTER ENDOSCOPIC THER­
APY IN ACUTE ESOPHAGEAL VARICEAL
HEMORRHAGE?
B. Kim, C. Lee, K. Kim, J. Park, Y. Shin, S. Han,
J. Cheon
P1925
STUDY OF THE SERUM LEVEL OF VASCU­
LAR ENDOTHELIAL GROWTH FACTOR IN
PATIENTS WITH HEPATOCELLULAR CAR­
CINOMA BEFORE AND AFTER LOCAL RA­
DIO­FREQUENCY THERMAL ABLATION
THERAPY
Y.M. Taher, A.A.L.Y. Abd El Moety,
E.H. Ibrahim, B. El Sayed, P.E. Salem
P1926
MANIFESTATIONS OF SEVERE PORTAL
HYPERTENSION: PROPOSAL OF NON­
INVASIVE SCORE IN CIRRHOTIC PATIENTS
M. Afonso, S. Leite, J. Pinto, R. Veloso,
T. Freitas, J. Carvalho, J. Fraga
264
P1927
FREQUENCY OF PORTAL HYPERTENSIVE
GASTROPATHY AND ITS INTERRELATED
FACTORS IN PATIENTS WITH VIRAL CIR­
RHOSIS
S. Ahmed, S. Ahmed, K. Mumtaz,
H. Alishah, S. Abid, W. Jafri, S. Hamid
P1928
NON­INVASIVE ASSESSMENT OF DIS­
EASE STAGE IN PATIENTS WITH PRIMARY
BILIARY CIRRHOSIS
T. Alempijevic, M. Krstic, R. Jesic, A. Sokic
Milutinovic, I. Jovanovic, T. Cvejic,
N. Kovacevic
P1929
SERUM ANGIOPOIETIN­2 IN EGYPTIAN
PATIENTS WITH HCV INDUCED LIVER CIR­
RHOSIS AND HEPATOCELLULAR CARCI­
NOMA
H.M. Badran, H. Elshenawy, N. Allam,
H. Elsaiid, M. Hasouna, E. Rewisha,
W. Ahmed
P1930
ASSESSMENT OF PREVALENCE OF HEPA­
TOPULMONARY SYNDROME IN CHRON­
IC LIVER DISEASE AND ExTRA HEPATIC
PORTAL VENOUS OBSTRUCTION AND ITS
IMPACT ON QUALITY OF LIFE
N.S. BEHL, P. Ashdhir, R. Pokharna,
S. Nijhawan, S. Kumpawat, S. Nepalia,
S.S. Sharma, R.R. Rai
P1931
MINIMAL HEPATIC ENCEPHALOPATHY
(MHE) IN ExTRA HEPATIC PORTAL VE­
NOUS OBSTRUCTION (EHPVO): DOES IT
IMPACT QUALITY OF LIFE?
N.S. BEHL, S. Kumpawat, R.R. Rai,
P. Ashdhir, G. Gupta, B. Sapra, S.S. Sharma,
S. Nepalia, S. Nijhawan

P1932
DEGREE OF THROMBOCYTOPENIA AS
AN INDICATOR OF SEVERITY OF LIVER
DISEASE IN PATIENTS EVALUATED FOR
OR AWAITING LIVER TRANSPLANTATION
R.S. Brown, R. Odeh-Ramadan,
N.H. Afdhal, M.P. Curry, R. Reddy,
F. Poordad, T. Schiano, M. Charlton, S. Han,
D. Theodore, K. Grotzinger, J.K. Ishak,
K.A. Payne, N. Lordan
P1933
MEASUREMENT OF SPLEEN STIFF­
NESS BY TRANSIENT ELASTOGRAPHY
INCREASES THE ACCURACY OF DETEC­
TION OF PORTAL HYPERTENSION IN HCV
CIRRHOSIS
V. Calvaruso, V. Di Marco, F. Bronte,
G. Licata, D. Cabibbi, N. Alessi, F. Simone,
C. Cammà, A. Craxì
P1934
MEDICAL PROCEDURES IN PATIENTS
WITH CHRONIC LIVER DISEASE: THROM­
BOCYTOPENIA AND TRANSFUSION USE
M.P. Curry, N.H. Afdhal, R.S. Brown Jr.,
R. Odeh-Ramadan Jr., R. Reddy, F. Poordad,
T.D. Schiano, M.R. Charlton, S. Han,
D. Theodore, K.M. Grotzinger, J. Ishak,
K. Payne
P1935
CLINICAL VALIDITY OF THE SERUM LEV­
EL OF LEPTIN AND SOLUBLE TUMOR NE­
CROSIS FACTOR RECEPTOR 1 (S TNFR­1)
IN CHRONIC HEPATITIS C (HCV) PATIENTS
F.A.A. El-Garbawy, L.A.L. Assar,
A.H. Hassab, A.F. El-Shayeb,
R.A.M. AbouYoussef
P1936
PROBIOTICS IN MINIMAL HEPATIC EN­
CEPHALOPATHY
M.H. Emara, A.A. Mourad, S.A. Elhawary
City, Country
PosTeR sessIon
P1937
CARDIOPULMONARY EVALUATION IN
PEDIATRIC LIVER TRANSPLANT CANDI­
DATES
A. Eshraghian, S. Dehghani,
M. Haghighat, M. Imanieh, N. Honar,
S. Malekhosseini
P1938
OCTREOTIDE IN THE TREATMENT OF
NON RESECTABLE HEPATOCELLULAR
CARCINOMA: A META­ANALYSIS
N.I. Estanislao, J. Ong
P1939
NEW PREDICTIVE MODEL (MELD SCORE
PLUS NATRIUM LEVEL) FOR PATIENTS
WITH RESISTANT ASCITIS
V.T. Ivashkin, E.A. Fedosina,
M.V. Maevskaya
P1940
BRANCHED CHAIN AMINO ACIDS IN
IMPROVING SURVIVAL AND DECREAS­
ING THE RISk OF LIVER FAILURE AMONG
CIRRHOTIC PATIENTS: A META­ANALYSIS
H.B. Flores, E.R. Ang, N. Estanislao,
W. Espinosa, M. Talingdan-Te, M. Uy, J. Ong,
V. Banez
P1941
PROGNOSTIC VALUE OF CHILD­PUGH
AND MELD IN A GASTROENTEROLOGY
INTENSIVE CARE UNIT
P. Freire, J.M. Romãozinho, P. Amaro,
M. Ferreira, G. Duque, E. Camacho,
M.C. Leitão
P1942
INPATIENTS AT A GASTROENTEROLOGY
INTENSIVE CARE UNIT: THE LIVER DIS­
EASE FACTOR
P. Freire, J.M. Romãozinho, G. Duque,
P. Amaro, M. Ferreira, E. Camacho,
M.C. Leitão
265
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1943
ECHOGRAFIC DETECTION OF HEPATO­
CELLULAR CARCINOMA (HCC) DURING
FOLLOW UP IN CIRRHOTIC PATIENTS
WITH PREVOIUS HCC. COMPARISON
AMONG UNENHANCED­US, SPIRAL CT
AND A NEW PANORAMIC 3­DIMEN­
SIONAL CONTRAST­ENHANCED US WITH
NAVIGATOR SYSTEM (3­D NAV CEUS).
ExPERIE
F. Giangregorio, L. Fanigliulo,
M. Marinone, G. Comparato, G. Aragona,
M. Di Stasi, G. Sbolli, P. Tansini, F. Fornari
P1944
TRANSPLANTATION OF AUTOLOGOUS
BONE MARROW STEM CELLS VIA HE­
PATIC ARTERY FOR 45 PATIENTS OF DE­
COMPENSATED CIRRHOSIS
X.Z. GUO, D. Wang, F. Liu, H. Li, J. Zhao,
X. Shao
P1945
PERCUTANEOUS LIVER BIOPSY UTILITY
FOLLOWING A NON­DIAGNOSTIC LIVER
AETIOLOGY SCREEN
V.S. Hegade, D.G.N. Craig, M.H. Giaffer
P1946
INCREASED INTESTINAL PERMEABILITY
(IP) IN CIRRHOTIC PATIENTS COULD BE
RELATED TO THE SEVERITY OF THE LIVER
DISEASE
H.J. Hwang, H. Vazquez, E.G. Smecuol,
E. Sugai, A. Czech, R. Abecasis, E. Mauriño,
K. Park, J. Meddings, R. Terg, J.C. Bai
P1947
HISTOPATHOLOGICAL CHANGES IN
CHRONIC HEPATITIS B WITH PERSIS­
TENTLY NORMAL OR MINIMALLY EL­
EVATED ALT
S. Alam, N. Ahmad, G. Mustafa, K. Alam,
M. Khan
266
P1948
PREVALENCE AND RISk FACTORS OF
HEPATITIS B AND C VIRUS INFECTIONS
IN AN URBAN COMMUNITY IN DHAkA,
BANGLADESH
H. Ashraf, N.H. Alam, M.A. Salam, N. Gyr
P1949
PHYLOGENETIC ANALYSIS OF HEPATITIS
E VIRUS ISOLATES IN WESTERN INDIA:
CHANGING EPIDEMIOLOGY
N.S. Behl, N. Singh, S. Nijhawan,
R. Pokharna, S. Nepalia, R.R. Rai
P1950
NOVEL MUTATIONS OCCUR IN THE PRE­
CORE, CORE AND CORE­PROMOTER
REGIONS IN PATIENTS WITH HEPATITIS
B RELATED ACUTE­ON­CHRONIC LIVER
FAILURE
K. Das, S. Kazim, B.C. Sharma, S.K. Sarin
P1951
EVALUATION OF THE ANGIOGENESIS
DURING CHRONIC HEPATOPATHIES: IS
CHRONIC HEPATITIS C MORE ANGIO­
GENIC ?
N. Fathallah, L. Charfi, B. Zouari, S. Chatti,
M. Azouz
P1952
MUTAGENIC PROFILE IN HBEAG NEGA­
TIVE TREATED PATIENTS: LESSONS FROM
BASAL CORE PROMOTER REGION
S.I. Lopes, P. Pereira, C. Rolanda, F. Branca,
J. Soares, G. Macedo
P1953
REDUCED HEPATIC MTP ExPRESSION
IS ASSOCIATED WITH VIRAL STEATO­
SIS, BUT NOT METABOLIC STEATOSIS IN
SUBJECTS WITH CHRONIC HEPATITIS C
S. McPherson, J. Jonsson, H. Barrie,
A. Clouston, E. Powell

P1954
MUTATIONS IN PkR­ EIF2 ALPHA PHOS­
PHORYLATION HOMOLOGY DOMAIN
(PEPHD) OF E2 PROTEIN AND PkR BIND­
ING DOMAIN OF NS5A PROTEIN OF
HEPATITIS C VIRUS AND ITS RELATION
TO RESPONSE TO TREATMENT
N. Yahoo, K. Shahzamani, F. Sabahi,
E. Fakharzadeh, H. Zamini, H. Jabbari,
H. Sharifi, R. Malekzadeh, S. Merat
P1955
WHAT IS THE CAUSE OF IRON OVERLOAD
IN HBV RELATED CHRONIC LIVER DIS­
EASE: DECREASED HEPCIDIN LEVELS?
O. Yonal, F. Akyuz, K. Demir, B. Pinarbasi,
A. Uyanikoglu, S. Ozdil, G. Boztas, F. Besisik,
S. Kaymakoglu, Y. Cakaloglu, Z. Mungan,
A. Okten
P1956
EFFECTIVENESS OF INTERFERON­AL­
PHA IN THE PREVENTION OF HEPATITIS
C VIRUS­RELATED HEPATOCELLULAR
CANCER RECURRENCE AFTER SURGICAL
RESECTION: A META­ANALYSIS
E.R. Ang, J.J. Ong, H.H. Flores,
N.N. Estanislao
P1957
LIVER STIFFNESS: A FEATURE IN CHRON­
IC HEPATITIS C
C. Baldaia, F. Serejo, C.N. Ferreira,
R. Marinho, J. Velosa
P1958
LIVER STIFFNESS VARIATION: A PREDIC­
TOR OF RESPONSE TO ANTIVIRAL THER­
APY IN CHRONIC HEPATITIS C
C. Baldaia, F. Serejo, C. Ferreira, R. Marinho,
J. Velosa
PosTeR sessIon
P1959
LONG­TERM EVALUATION OF FIBROSIS
BY TRANSIENT ELASTOGRAPHY IN PA­
TIENTS CLEARING HCV ON ANTIVIRAL
THERAPY
V. Calvaruso, P. Almasio, P. Pizzillo, R. Di
Stefano, V. Di Marco, C. Cottone, S. Petta,
A. Calì, A. Craxì
P1960
PEG­INTERFERON PLUS RIBAVIRIN IN
COMPENSATED HCV CIRRHOSIS WITH
PORTAL HYPERTENSION: THE ROLE OF
RAPID AND EARLY VIROLOGICAL RE­
SPONSE IN PREDICTING THE SUSTAINED
VIROLOGICAL RESPONSE
V. Calvaruso, V. Di Marco, P. Almasio, S. De
Lisi, D. Ferraro, P. Pizzillo, S. Peralta, A. Craxì
P1961
DISCOVERY OF SERUM BIOMARkERS
FOR HCV INFECTED LIVER FIBROSIS
BY TWO­DIMENSION DIFFERENCE GEL
ELECTROPHORESIS
C. Cheng, S. Lee, M. Liu, J. Lee, C. Wang,
A. Ho
P1962
LIPID POLYUNSATURATION IN PRE­
TREATMENT LIVER BIOPSY TISSUE IS
GREATER IN PATIENTS ATTAINING A SUS­
TAINED VIROLOGICAL RESPONSE THAN
IN TREATMENT FAILURES IN CHRONIC
HEPATITIS C
J.F.L. Cobbold, A.S. Brown, R.D. Goldin,
M.M.E. Crossey, H.C. Thomas, I.J. Cox,
S.D. Taylor-Robinson
P1963
PERIPHERAL BLOOD AND INTRAHEPAT­
IC NATURAL kILLER CELLS IN CHRONIC
HEPATITIS C: RELATION TO DISEASE AC­
TIVITY AND HEPATIC FIBROSIS
H.A. El Aggaan, F.S. Mohamed, N.M.F. El
Deeb, M.M. El Sawy, M.S. Shater
267
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1964
PSYCHIATRIC SYMPTOMS AMONG PA­
TIENTS WITH CHRONIC HEPATITIS C IN­
FECTION
M.S.H. Hassan, A.M. Nasr, S.Z. Mahmoud,
R.M. Shams, A.D. Mohamed, S.A. Labib
P1965
A PRACTICE SUPPORT PROGRAMME FOR
PRIMARY CARE LEADS TO SUBSTANTIAL
IMPROVEMENTS IN THE EFFECTIVENESS
OF A HEPATITIS C PUBLIC CAMPAIGN
C.W. Helsper, G.A. van Essen,
M.J.M. Bonten, N.J. de Wit
P1966
QUANTIFICATION OF SERUM ALPHA­2
MACROGLOBULIN AT DIFFERENT STAG­
ES OF LIVER FIBROSIS IN HEPATITIS C
PATIENTS USING BEAD­BASED FLExIBLE
MULTI­ANALYTE PROFILING
A. Ho, M. Liu, J. Lee, S. Lee, C. Cheng,
C. Wang
P1967
LONG TERM FOLLOW­UP OF CHRONIC
HEPATITIS C PATIENTS AFTER INTERFER­
ON BASED ANTI­VIRAL THERAPY
H. Hofer, T.M. Scherzer, S. Beinhardt,
K. Rutter, A.F. Stättermayer, P. Munda,
P. Ferenci
P1968
IMPACT OF DIET AND ExERCISE INTER­
VENTION ON INSULIN RESISTANCE AND
EARLY VIROLOGICAL RESPONSE TO PE­
GYLATED INTERFERON PLUS RIBAVIRIN
IN PATIENTS WITH CHRONIC HEPATITIS C
Y. Kawaguchi, T. Mizuta, T. Kuwashiro,
S. Oeda, N. Oza, H. Takahashi,
M. Fukuyama, N. Matsuda, M. Ushirokawa,
H. Horie, E. Ishibashi, Y. Kitajima, Y. Eguchi,
I. Ozaki, K. Fujimoto
268
P1969
PRESENCE AND FREQUENT DISTRIBU­
TION OF DIFFERENT HCV GENOTYPES IN
PLASMA, PBMC AND LIVER OF CHRONI­
CALLY INFECTED PATIENTS WITH HCV
F. Bokharaei Salim, H. Keyvani, F. Zamani,
F. Jahanbakhsh, A. Amiri
P1970
HCV INFECTION IS MAINLY A COExIST­
ING AND NOT SINGLE PROMOTING FAC­
TOR IN PORPHYRIA CUTANEA TARDA
Z.A. Krastev, A.V. Ivanova, K. Antonov,
D. Adjarov
P1971
ANGIOGENESIS AND SERUM ADIPOkINES
IN CHRONIC HEPATITIS C
M. Kukla, A. Gabriel, A. Berdowska,
K. Zwirska-Korczala, M. Waluga, W. Mazur,
E. Wozniak-Grygiel, R. Buldak, M. Jarosz
P1972
VALIDATION OF TRANSIENT ELASTOG­
RAPHY FOR PREDICTING THE FIBROSIS
STAGE IN A LARGE COHORT OF CHRONIC
HEPATITIS C PATIENTS
M. Lupsor, R. Badea, H. Stefanescu,
Z. Sparchez, H. Branda, A. Serban, A. Maniu
P1973
COMBINATION ANTIVIRAL THERAPY FOR
THE TREATMENT OF CHRONIC HEPATITIS
C IN PATIENTS WITH END­STAGE RENAL
DISEASE IS EFFICACIOUS AND SAFE
S. Masson, O. Greyson, N. Ashman,
G. Foster, R. Marley
P1974
SOLUBLE TUMOR NECROSIS FACTOR
RECEPTORS 1 AND 2 IN NON­CIRRHOTIC
CHRONIC HEPATITIS C PATIENTS WITH
AND WITHOUT TYPE 2 DIABETES MEL­
LITUS
K.A. Mohammed, M. Foda, A. Foad clinical
pathology, Ain Shams University, Cairo,
Egypt

P1975
ExTENDED TREATMENT DURATION OF
PEGINTERFERON­ALPHA2B PLUS RIBAVI­
RIN FOR 96 WEEkS IN HEPATITIS C GENO­
TYPE 1­INFECTED SLOW RESPONDERS
M. Nagaki, M. Shimizu, J. Sugihara,
E. Tomita, K. Amano, C. Sano, Y. Tsukada,
A. Suetsugu, Y. Osawa, T. Naiki, K. Kimura,
H. Moriwaki
P1976
COMBINATION THERAPY WITH STAN­
DARD OR PEGYLATED INTERFERON IN
CHRONIC HEPATITIS C: SIMILAR EFFI­
CACY AT SIGNIFICANTLY LOWER COSTS
U. Nieminen, P.E.T. Arkkila, M.A. Färkkilä
P1977
CHRONIC HCV INFECTION IS ASSOCIAT­
ED WITH INCREASED IL­10, TFN­ALPHA
AND IFN­GAMMA PRODUCTION OF AC­
TIVATED Nk CELLS
G. Par, L. Szereday, A. Miseta, G. Hegedus,
Z. Szereday, A. Vincze, A. Par
P1978
PEG­INTERFERON ALFA­2A AND RIBAVI­
RIN IN PATIENTS WITH CHRONIC HEPATI­
TIS C WHO HAVE FAILED PRIOR TREAT­
MENT
T. Pham Thi, D. T. Ho
P1979
WEEk 8 IS THE OPTIMAL TIME POINT TO
SELECT PATIENTS WITH CHRONIC HEPA­
TITIS C, GENOTYPE 1/4 FOR TREATMENT
ExTENSION TO 72 WEEkS
T. Scherzer, H. Kerschner, S. Beinhardt,
K. Rutter, H. Hofer, P. Steindl-Munda,
T. Popow-Kraupp, P. Ferenci
PosTeR sessIon
P1980
VARIATIONS IN GENERAL PSYCHOLOGI­
CAL WELL­BEING AS SIDE­EFFECT OF AN­
TIVIRAL TREATMENT IN ADDICTED PA­
TIENTS ON METHADONE MAINTENANCE
THERAPY WITH CHRONIC HEPATITIS C
M.Y. Simonova, K. Katzarov, N. Tomov,
D. Aleksieva, G. Vasilev, M. Malenov
P1981
COMPARATIVE STUDY REGARDING NON­
INVASIVE TESTS FOR THE ASSESSMENT
OF FIBROSIS IN CHRONIC HCV HEPATITIS
(FIBROSCAN, APRI, FORNS INDEx, LOk
INDEx, FIB­4)
R. Sirli, S. Bota, A. Martie, A. Tudora,
A. Deleanu, I. Sporea
P1982
USEFULNESS OF REAL TIME­ELASTOG­
RAPHY (SIEMENS) FOR THE EVALUATION
OF LIVER STIFFNESS
I. Sporea, R. Badea, R. Sirli, M. Lupsor,
A. Popescu, M. Danila, A. Deleanu
P1983
DIFFERENCES IN NEUROCOGNITIVE
FUNCTION AND MEMORY TESTING BE­
TWEEN SUBJECTS WITH CHRONIC HIV­
HCV CO­INFECTION AND CHRONIC HIV
MONO­INFECTION
A. Thiyagarajan, L.J. Garvey, P. Maruff,
G. Scullard, J. Main, S. Taylor-Robinson,
A. Winston
P1984
PLASMA PROHEPCIDIN LEVELS IN PA­
TIENTS WITH CHRONIC VIRAL HEPATITIS:
RELATIONSHIP WITH LIVER FIBROSIS
O.F. Olmez, Y. Yilmaz, S. Gurel
269
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P1985
COMBINATION THERAPY WITH PEGYLAT­
ED INTERFERON PLUS RIBAVIRIN VERSUS
PEGYLATED MONOTHERAPY IN MAJOR
THALASSEMIC PATIENTS WITH CHRONIC
HEPATITIS C
F. Zamani, R. Shakeri, A. Amiri, M. Eslami,
S. Khaleghi, M. Moradi
P1986
ILLICIT DRUG USERS AND COMBINATION
TREATMENT FOR CHRONIC HEPATITIS C:
META­ANALYSIS OF PROSPECTIVE OB­
SERVATIONAL STUDIES
B. Zanini, L. Covolo, F. Donato, A. Lanzini
PosTeR sessIon
biliary III
P1987
HEPATOCELLULAR CARCINOMA: ROLE
OF INSULIN RESISTANCE AND HYPERIN­
SULINEMIA IN PATIENTS WITH ALCOHOL
ABUSE AND TYPE 2 DIABETES MELLITUS
V. Donadon, M. Balbi, G. Zanette,
C. Miranda, P. Casarin, S. Grazioli,
M. Ghersetti, G. Della Valentina,
R. Gardenal, M. Dal Mas
P1988
SCREENING FOR HEPATOCELLULAR
CARCINOMA IN CIRRHOTICS: 17 YEARS
ExPERIENCE
R. Bouali, S. Bizid, H. Ben Abdallah,
H. Elloumi, N. Abdelli
P1989
PREDICTIVE VALUES OF NEOPLASTIC
GALLBLADDER POLYPOID LESION:
MORE THAN 10MM SIZED 210 CASES
WHICH PERFORMED CHOLECYSTEC­
TOMY, SINGLE CENTER STUDY
B. Cha, S. Lee, J. Kim, J. Hwang, J. Cho,
Y. Yoon, H. Han, H. Kim, S. Kim
270
P1990
PREOPERATIVE SERUM CA 19–9 LEVEL
AS A PREDICTIVE FACTOR OF RECUR­
RENCE AFTER CURATIVE RESECTION OF
BILIARY TRACT CANCER
M. Chung, S. Park, J. Park, S. Bang, S. Park,
W. Lee, S. Song, J. Chung
P1991
ADJUVANT IMMUNOTHERAPY IN PA­
TIENTS WITH HEPATOCELLULAR CAR­
CINOMA WHO UNDERWENT CURATIVE
RESECTION: A META­ANALYSIS
H.B. Flores, E.R. Ang, N.I. Estanislao, J. Ong,
E.R. Nolasco, L. Daez, V. Banez
P1992
SINGLE SESSION ENDOSCOPIC MUCO­
SAL RESECTION (EMR) AND PAPILLECTO­
MY FOR GIANT AMPULLARY ADENOMAS
WITH SIGNIFICANT ExTRA­PAPILLARY
ExTENSION (GAPE): TECHNIQUE AND
OUTCOME
A.D. Hopper, M.J. Bourke, S.J. Williams,
M.P. Swan
P1993
OPTICAL COHERENCE TOMOGRAPHY, AS
AN OBJECTIVE METHOD TO DETERMINE
TUMOUR BORDERS IN ExTRAHEPATIC
BILE DUCTS
V. Kukosh, V. Zagainov, E. Zagainova,
L. Shcalova, G. Geliconov
P1994
CURVED MULTIPLANAR REFORMATTED
IMAGES OF MULTI­DETECTOR CT FOR
DIFFERENTIATION OF BILIARY STENT OC­
CLUSION IN PATIENTS WITH MALIGNANT
BILIARY OBSTRUCTION
K. Kwon, D. Lee, J. Lee, H. Kim, Y. Shin,
Y. Kim, D. Jang, H. Kang, S. Park

P1995
EPIDEMIOLOGY AND RISk FACTORS OF
THE HEPATOCELLULAR CARCINOMA IN
THE SOUTH OF MADRID COMMUNITY
(CENTRAL SPAIN). A CASE­CONTROL
STUDY
J.L. Lledó, T. Pérez, M. Fernández, G. Cacho,
C. Fernández
P1996
PROGNOSTIC FACTORS OF HEPATOCEL­
LULAR CARCINOMA PATIENTS WITH
BONE METASTASIS
K. Moribata, H. Tamai, Y. Mori, N. Shingaki,
T. Shiraki, Y. Maeda, H. Maeda, K. Ueda,
H. Deguchi, T. Maekita, I. Inoue, M. Iguchi,
K. Yanaoka, M. Oka, M. Ichinose
P1997
SMALL INTESTINAL BACTERIAL OVER­
GROWTH AS A PREDICTIVE FACTOR FOR
DEVELOPMENT OF DIARRHEA IN HCC PA­
TIENTS TREATED WITH SORAFENIB
M.M. Novi, E. Lauritano, E. Rinninella,
M. Santoro, A. Tortora, A. Lupascu,
F. Barbaro, M. Ferraro, F. Fiore, A. Piscaglia,
M. Zoco, A. Gasbarrini
PosTeR sessIon
endoscopy and imaging III
P1998
IS PROPOFOL SEDATION SAFE DURING
ENDOSCOPIC PROCEDURES WITHOUT
ANESTESIOLOGIST?
U. Akyuz, Y. Erzin, C. Pata
P1999
RISk MANAGEMENT IN DIGESTIVE EN­
DOSCOPY: EFFICACY AND SAFETY OF A
PROTOCOL FOR INTERRUPTION AND RE­
SUMPTION OF ORAL ANTICOAGULANT
THERAPY
V. Boarino, A. Merighi, M. Marietta,
R. Molinari, A. Callegaro, A. Scarcelli,
A. Bertani, A. Primerano, A. Antonioli, E. Villa
PosTeR sessIon
P2000
EFFECTIVENESS OF CONTRAST­EN­
HANCED US IN THE DIAGNOSIS OF
ACUTE APPENDICITIS TO EVALUATE THE
SEVERITY OF DISEASE
M. Ishii, J. Hata, H. Kusunoki, T. Kamada,
H. Imamura, N. Yamashita, M. Sato,
A. Shiotani, K. Haruma
P2001
A LINk BETWEEN ETHNIC ORIGIN, RE­
LIGIOUS BELIEF AND SOCIOECONOMIC
STATUS AND ENDOSCOPISTS’ GENDER
PREFERENCE
A. Lahat, H. Fidder, L. Katz, I. Schushan-
Eisen, S. Bar-Meir Gastroenterology,
Leiden University Medical Center, Leiden,
Netherlands, Pediatric, Sheba Medical
Center, Ramat Gan, Israel
P2002
BALLOON ASSISTED DIRECT CHOLAN­
GIOSCOPY BY USING AN ULTRATHIN
ENDOSCOPE
A. Mori, N. Ohashi, K. Sakai, H. Tatebe
P2003
EUS­FNA VERSUS BILIARY BRUSHINGS
AND ASSESSMENT OF SIMULTANEOUS
PERFORMANCE IN JAUNDICED PA­
TIENTS WITH SUSPECTED MALIGNANT
OBSTRUCTION
K. Oppong, D. Raine, M. Nayar, V. Wadehra,
S. Ramakrishnan, R.M. Charnley
P2004
E­WORM AND PILLCAM COLON CAP­
SULE: FEASIBILITY AND PATIENT AC­
CEPTANCE
M. Principi, R. Guido, N. De Tullio, A. Pisani,
A. Francavilla, A. Di Leo
P2005
RESULTS FROM AN ENDOSCOPY VALIDA­
TION PROJECT
R.H. Shah, D.H. Chan, D.H. Dewar,
M. Johnson
271
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2006
AUDIT OF CLINICAL INDICATION FOR
RECALL ENDOSCOPY IN 974 PATIENTS
R.H. Shah, D.H. Chan, D.H. Dewar
P2007
RELOCALISATION METHOD FOR AN AC­
CURATE MATCHING OF OPTICAL AND
HISTOLOGICAL BIOPSY SITES IN BAR­
RETT’S OESOPHAGUS
B. Allain, M. Hu, L. Lovat, R. Cook,
S. Ourselin, D. Hawkes
P2008
PREVALENCE OF HELICOBACTER PYLORI
INFECTION, ENDOSCOPIC AND PATHO­
LOGICAL FINDINGS IN PATIENTS WITH
END STAGE RENAL DISEASE IN RAZI
EDUCATIONAL HOSPITAL IN RASHT, A
NORTHERN CITY OF IRAN,SINCE 1998
TILL 2007
K. Aminian, M. Khosravi, R. Jafarshad
P2009
CARDIOVASCULAR CONSIDERATIONS
OF UNSEDATED TRANSORAL AND
TRANSNASAL GASTROINTESTINAL EN­
DOSCOPY IN YOUNG, MIDDLE­AGED
AND ELDERLY PATIENTS
T. Ando, K. Uchiyama, S. Takemura,
T. Ishikawa, N. Sakamoto, N. Yoshida,
T. Takagi, O. Handa, H. Konishi,
N. Wakabayashi, N. Yagi, S. Kokura, Y. Naito,
T. Yoshikawa
P2010
IN VIVO DIAGNOSIS OF HETEROTOPIC
GASTRIC MUCOSA IN THE ESOPHAGUS
BY CONFOCAL LASER ENDOMICROS­
COPY
F. Baldaque Silva, M. Vieth, H. Marschall
272
P2011
PROSPECTIVE RANDOMIZED EVALUA­
TION OF MINIPROBE CONFOCAL LASER
MICROSCOPY FOR THE DIAGNOSIS OF
ACTIVE CELIAC SPRUE
H. Pohl, T. Rösch, B.T. Tanczos, A. Meining,
A. Khalifa, B. Rudolph, D.C. Baumgart
P2012
NEEDLE­BASED CONFOCAL ENDOMI­
CROSCOPY FOR IN­VIVO HISTOLOGY
OF INTRAABDOMINAL ORGANS: FIRST
RESULTS IN A PORCINE MODEL
V. Becker, M. Wallace, P. Fockens, S. Delius,
R. Voermans, T. Woodward, M. Raimondo,
A. Meining
P2013
ROLE OF RIGOROUS SCHEDULE OF TRI­
AMCINOLONE INJECTION IN CORROSIVE
ESOPHAGEAL STRICTURE: MORE THE
MERRIER
N.S. BEHL, S. Nijhawan, H. Udawat,
P. Ashdhir, A. Mathur, R. Pokharna,
S. Nepalia, R.R. Rai
P2014
COMPLICATIONS OESOPHAGEAL FOR­
EIGN BODIES AMONG CHILDREN
F. Benhassine, M.M.L. Benhassine,
M.M. Baghriche
P2015
REVEALING CHANGES OF SUBMUCOSAL
CAPILLARIES WITH HELICOBACTER PY­
LORI BY MEANS OF VIDEOENDOSCOPY
WITH MAGNIFICATION
V. Boyko, V. Nikishayev
P2016
FOLLOW­UP OUTCOMES OF INCOM­
PLETE ENDOSCOPIC RESECTION FOR
GASTRIC NEOPLASTIC LESIONS
H.J. Chun, J.J. Hyun, J. Kim, K.G. Lee,
E.S. Kim, S.C. Park, S. Park, B. Keum, Y.S. Seo,
Y.S. Kim, Y.T. Jeen, S.H. Um, C.D. Kim, H.S. Ryu

P2017
SEDATION DURING UPPER ENDOSCOPY
IN CIRRHOTIC PATIENTS: A RANDOM­
IZED CONTROLLED TRIAL COMPARING
PROPOFOL AND FENTANYL VERSUS
MIDAZOLAM AND FENTANYL
L.M. Correia, D.Q. Bonilha, G.F. Gomes,
J.R. Brito, L. Lenz, G.A. Paulo, F.P. Martins,
M. Rohr, F.S. Nakao, A.P. Ferrari, E. Della
Libera
P2018
UPPER GASTROINTESTINAL kAPOSI’S
SARCOMA IN BRAZILIAN PATIENTS WITH
ACQUIRED IMMUNODEFICIENCY SYN­
DROME: A REVIEW OF 23 CASES IN TEN
YEARS OF ENDOSCOPY OBSERVATION
T.V. Costa, E.B. Hyppólito, J.P. Modena,
A.A. Machado, R.E.F. Rezende
P2019
TEN YEAR ExPERIENCE OF SPORADIC
DUODENAL POLYPS IN A Uk DISTRICT
HOSPITAL
E.L. Culver, L. Green, S. Cullen, D. Gorard,
A.S. McIntyre
P2020
THE AGREEMENT BETWEEN GENERAL
PRACTITIONERS REPORTED DYSPEPSIA
AND PATIENTS FILLED DYSPEPSIA QUES­
TIONNAIRE IS NO BETTER THAN CHANCE
A.N. Datta, R. Child, M.P. Skander,
M.M. Ahmed, C.H. Lim
P2021
PRACTICE OF ENDOSCOPIC SUBMUCO­
SAL DISSECTION BY EUROPEAN GAS­
TROENTEROLOGISTS: PRELIMINARY
RESULTS OF AN ON­LINE SURVEY
F. Mourao, C. Ferreira, M. Formigo, A. Morais,
J. Santos, R. Santos, A. Carvalho, J. Costa,
J. Jacome, R. Santos, P. Pimentel-Nunes,
M. Dinis-Ribeiro
PosTeR sessIon
P2022
COMPUTER­ASSISTED ANALYSIS OF
GASTRIC MAGNIFICATION CHROMO­
ENDOSCOPY IMAGES: FEASIBILITY AND
POTENTIAL APLICATIONS
M. Dinis-Ribeiro, F. Riaz, A. Sousa,
P. Pimentel-Nunes, M. Areia, M. Coimbra
P2023
A META­ANALYSIS ON ENDOSCOPIC
TREATMENT OF GASTRIC VARICES: N­
BUTYL­2­BROMIDE­CYANOACRYLATE
INJECTION VERSUS BAND LIGATION
W.Z. Espinosa, M.C. Uy, M.T. Te, J.P. Ong
P2024
FLORA CHARACTERIZATION DURING
FLExIBLE TRANSGASTRIC PERITONEOS­
COPY USING A HYBRID PROCEDURE IN
A SURVIVAL PORCINE ANIMAL MODEL
S. Fernandez-Díez, S. Ochagavia,
F.J. Candel, P. Gonzalez, A.J. Torres, M. Diaz-
Rubio
P2025
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION OF SUBMUCOSAL TUMORS IN THE
GI TRACT: A SERIES OF 18 CASES
L. Ficano, D. Miceli, A. Granata, A. Palma,
D. Ligresti
P2026
UPPER GASTROINTESTINAL INVESTIGA­
TION IN THE ELDERLY: ARE WE SCREEN­
ING OUT TREATABLE PATHOLOGY BY
ONLY SCREENING IN IRON DEFICIENCY
ANAEMIA?
A. Fikree, S. Valiji-Bharmal, A. Graham,
S. Preston
273
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2027
CESSATION OF PROTON PUMP INHIBI­
TORS FOLLOWING TRANSORAL INCI­
SIONLESS FUNDOPLICATION IS AS­
SOCIATED WITH REDUCED PROxIMAL
ExTENT OF REFLUxATE
P. Youd, A. Emmanuel, S. Sivanesan,
A. Raeburn, A. Gawlicka, E. Tripoli,
K. Konieczko, C. Fraser
P2028
USEFULNESS OF TRANSNASAL ENDOS­
COPY WITH FICE FOR DIAGNOSIS OF
RECURRENT ESOPHAGEAL VARICES IN
PROSPECTIVE AND RANDOMIZED CON­
TROLLED STUDY
Y. Furuichi, T. Kawai, S. Ichimura,
Y. Miyata, R. Metoki, T. Sano, E. Murashima,
J. Taira, M. Yamada, Y. Imai, I. Nakamura,
F. Moriyasu
P2029
SEDATIVE­FREE TREATMENT OF ESOPH­
AGEAL VARICES – THE POSSIBILITY
OF APC USING NASAL ENDOSCOPE IN
PROSPECTIVE AND RANDOMIZED CON­
TROLLED STUDY
Y. Furuichi, T. Kawai, S. Ichimura, Y. Miyata,
R. Metoki, T. Sano, E. Murashima, J. Taira,
K. Sugimoto, K. Yamada, M. Yamada,
Y. Imai, I. Nakamura, F. Moriyasu
P2030
DETECTION OF SIGNIFICANT DISEASE
OUTSIDE THE UPPER GASTROINTES­
TINAL TRACT IN PATIENTS FULFILLING
THE CRITERIA FOR STRAIGHT TO TEST
INVESTIGATION OF SUSPECTED UPPER
GI MALIGNANCY
T. Ghosh, J. Bowen, S. Everett
274
P2031
STUDY OF MULTIPLE GASTRIC CANCERS
IN PATIENTS UNDERGOING ENDOSCOPIC
SUBMUCOSAL DISSECTION FOR EARLY
GASTRIC CANCER
M. HARADA, S. Nyuzuki, K. Kawauchi,
S. Oyama, R. Yamakawa, Y. Ajioka
P2032
TEAM LEARNING AND IT­SUPPORT FOR
SELF­DIRECTED PROCESS OPMTIMIZA­
TION IN ENDOSCOPY UNITS
M. Holderried, C. Falge, P. Mauz, U. Rosin,
M. Mueller
P2033
ESOPHAGOGASTRODUODENOSCOPY
TOLERANCE PREDICTION BY THE MAL­
LAMPATI CLASSIFICATION
H. Huang, Y. Shih, T. Huang, H. Chu,
W. Chang, T. Hsieh
P2034
GASTRIC WALL NOTES ACCESS SITE
CLOUSURE BY DOUBLE ENDOLOOP
TECHNIQUE
T. Hucl, M. Benes, M. Kocik, M. Krak,
J. Maluskova, E. Kieslichova, M. Oliverius,
J. Spicak
P2035
STRATEGY FOR THE PREVENTION OF
ESD­RELATED BLEEDING
M. Iguchi, M. Oka, K. Yanaoka, H. Tamai,
I. Inoue, T. Maekita, H. Deguchi, K. Ueda,
N. Shingaki, Y. Muraki, H. Maeda,
K. Morihata, Y. Maeda, Y. Mori, S. Shirai,
M. Sanda, J. Nuta, S. Yoshida, M. Ichinose
P2036
SAFETY AND FEASIBILITY OF ENDO­
SCOPIC SUBMUCOSAL DISSECTION FOR
MESO AND HYPOPHARYNGEAL CANCER
­PROSPECTIVE STUDY­
T. Iizuka, D. Kikuchi, S. Hoteya, N. Yahagi

P2037
BASAL PROTRUSION OF ULCERS IN­
DUCED BY ENDOSCOPIC SUBMUCOSAL
DISSECTION DURING TREATMENT WITH
PROTON PUMP INHIBITORS, AND THE
SUPPRESSIVE EFFECTS OF POLAPREZINC
T. Inaba, S. Ishikawa, T. Toyokawa,
H. Ishikawa, K. Miyahara, M. Wato,
K. Kawai, H. Okada, K. Yamamoto
P2038
FEASIBILITY STUDY OF DETECTION OF
DNA MISMATCH REPAIR GENES ExPRES­
SION
A. Ioncica, A. Saftoiu, M. Ioana, C. Soare,
C. Popescu, T. Ciurea, A. Malos, S. Iordache,
M. Filip, D. Gheonea
P2039
PROSPECTIVE EVALUATION OF NAR­
ROW­BAND IMAGING ENDOSCOPY FOR
SCREENING OF SQUAMOUS MUCOSAL
HIGH­GRADE NEOPLASIA IN THE ESOPH­
AGUS
R. Ishihara, Y. Takeuchi, R. Chatani, T. Kidu,
T. Inoue, N. Uedo, K. Higashino, H. Iishi
P2040
DIAGNOSIS FOR THE DEPTH OF INVA­
SION IN SUPERFICIAL ESOPHAGEAL
CANCER BY CONVENTIONAL ENDOS­
COPY IN COMBINATION WITH NBI MAG­
NIFIED ENDOSCOPY AND EUS
K. Ishikawa, H. Kita, S. Arai, K. Nonaka,
K. Yoshino, M. Nakao, O. Togawa,
K. Koyanagi, I. Koyama
P2041
DETECTION OF COLORECTAL LESIONS
AT SCREENING COLONOSCOPY: A STUDY
BETWEEN CONVENTIONAL IMAGING
AND PANCOLONIC INDIGO CARMINE
DYE
S. Mouzyka, A. Vinnytska
PosTeR sessIon
P2042
BLEEDING PROPHYLAxIS AFTER CON­
VENTIONAL POLYPECTOMY: COMPARI­
SON BETWEEN POLIDOCANOL AND
EPINEPHRINE­SALINE SUBMUCOSAL
INJECTION FOR LARGE COLON POLYPS
N. Muscatiello, M. Di Maso, C. Panella,
E. Ierardi, S. Prencipe, M.C. Nacchiero
P2043
DIAGNOSTIC AND THERAPEUTIC COLO­
NOSCOPY USING A MAGNIFYING GAS­
TROSCOPE WITH A SHORT BLACk HOOD
H. Nakamura, K. Fu, A. Yamamura
P2044
DIFFERENCES BETWEEN NORTH AMERI­
CA AND EUROPE IN RENAL IMPAIRMENT
FROM ORAL SODIUM PHOSPHATE
N. Qizilbash, A. Navarro Medical Affairs,
Laboratorios Casen Fleet S.L.U., Pozuelo de
Alarcón, Spain
P2045
COLONIC WALL THICkENING ON COM­
PUTED TOMOGRAPHY AS AN INDICA­
TION FOR COLONOSCOPY
B.D. Nicholson, R. Hyland, D. Tolan,
L. Cuthbertson, B. Rembacken, M.A. Hull,
M. Denyer
P2046
LATERALLY SPREADING TUMOURS OF
THE COLORECTUM: DIFFERENCES BE­
TWEEN THE TWO SUBTYPES
H. Oikawa, N. Ogata, H. Kashida,
N. Toyoshima, H. Shiwaku, K. Wakamura,
Y. Wada, H. Miyachi, N. Ikehara,
F. Yamamura, K. Ohtuka, S. Kudo
275
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2047
BALANCED PROPOFOL SEDATION AD­
MINISTERED BY NON ANESTHESIOLO­
GISTS IN DIAGNOSTIC COLONOSCOPY.
A SINGLE CENTER PROSPECTIVE ExPE­
RIENCE
A. Repici, N. Pagano, M. Arosio, G. Rando,
F. Romeo, G. Strangio, A. Carlino, E. Vietta,
A. Malesci
P2048
WARM WATER IRRIGATION VERSUS AIR
INSUFFLATION FOR UNSEDATED COLO­
NOSCOPY: PRELIMINARY RESULTS OF A
RANDOMISED CONTROLLED TRIAL
S. Paggi, F. Radaelli, A. Amato, G. Spinzi,
G. Imperiali, N. Lenoci, N. Terreni,
G. Mandelli, A. Toldi, V. Terruzzi
P2049
IS OIL­ASSISTED COLONOSCOPY USE­
FUL?
S. Park, K. Lee, J. Kim, J. Hyun, E. Kim,
S. Park, B. Keum, Y. Seo, Y. Kim, Y. Jeen,
H. Chun, S. Um, C. Kim, H. Ryu
P2050
ROLE OF INTRAVENOUSLY ADMINIS­
TERED HYOSCINE N­BUTYL BROMIDE
AT THE TIME OF COLONOSCOPIC WITH­
DRAWAL FOR POLYP DETECTION RATE:
A RANDOMIZED, DOUBLE­BLINDED,
PLACEBO­CONTROLLED TRIAL
H. Park, D. Han, Y. Hyun, J. Bae, S. Ahn,
T. Kim, C. Eun, Y. Jeon, J. Sohn
P2051
COMPARISON OF STANDARD VS HIGH
DEFINITION COLONOSCOPY FOR POL­
YP DETECTION: A RANDOMIZED CON­
TROLLED TRIAL
G. Tribonias, A. Theodoropoulou,
K. Konstantinidis, E. Vardas, K. Karmiris,
A. Vidaki, N. Chroniaris, G. Chlouverakis,
G.A. Paspatis
276
P2052
A MULTI­CENTRE STUDY LOOkING AT
THE EFFICACY OF DIFFERENT BOWEL
PREPARATION REGIMENS FOR COLO­
NOSCOPY IN THE ELDERLY
K.P. Patel, N. Patel, D.S. Bansi,
S.M. Greenfield, P. McIntyre, D. Morris,
K.S. Samsheer, A.V. Thillainayagam
P2053
A STUDY OF PATIENTS’ PREFERNECES
FOR METHOD OF BOWEL PREPARATION
USED FOR FLExIBLE SIGMOIDOSCPY
A.C. Pick, N. Mistry, L. Juby
P2054
CANCERS AFTER COLONOSCOPY ARE
LIkELY RELATED TO MISSED LESIONS
H. Pohl, D.J. Robertson
P2055
ADVANTAGES OF FULL DIAGNOSTIC
COLONOSCOPY OVER FLExIBLE SIG­
MOIDOSCOPY IN PATIENTS OVER 50
YEARS OF AGE PRESENTING WITH REC­
TAL BLEEDING
K. Soufidi, H.J.M. Pullens, M.A. Brink
P2056
A COMPARATIVE AUDIT ON SENSITIV­
ITY, SPECIFICITY AND STABILITY OF THE
GUAIAC­ AND IMMUNOCHEMICAL FAE­
CAL OCCULT BLOOD TESTS
A. Qasim, M. Shuhaibar, P. O’Gorman,
G. Boran, C. O’Morain
P2057
A NOVEL GRIPPING DEVICE TO ASSIST
COLONOSCOPISTS
G.J. Sadler, A. McCulloch, G. Amarasinghe,
R.C.G. Pollok
P2058
TYPE V PIT PATTERN: THE IMPACT OF
CLINICAL ExPERIENCE AND MAGNIFY­
ING CHROMOENDOSCOPY
T. Sakamoto, Y. Saito, T. Matsuda,
T. Nakajima, T. Fujii

P2059
RETROSPECTIVE AUDIT OF HEALTH
SCREENING QUESTIONNAIRE AS AN EF­
FECTIVE TRIAGE TOOL FOR DIRECTING
PARTICIPANTS ALONG AN AUSTRALIAN
BOWEL CANCER SCREENING PATHWAY
G.L. Schofield, N. Main, E.A. Wardle
P2060
ISOLATED ABDOMINAL PAIN: IS THIS AN
APPROPRIATE INDICATION FOR COLO­
NOSCOPY?
C.P. Selinger, S.S. Campbell
P2061
PREDICTIVE FACTORS OF BOWEL­PREPA­
RATION QUALITY USING POLYETHYLENE
GLYCOL: A PROSPECTIVE STUDY
J. Shin, H. Lee, S. Yun, B. Lee, H. Shin, S. Yun,
S. Kim, H. Kim, I. Song, Y. Lee
P2062
THIRD EYE RETROSCOPE RANDOMIZED
CLINICAL EVALUATION – (“TERRACE”
STUDY): INITIAL RESULTS
A.M. Leufkens, A. Repici, P. Deprez,
B. Saunders, F.P. Vleggaar, G. Rando,
K. Azzouzi, O. Dewit, J. East, A. Ignjatovic,
P.D. Siersema
P2063
CLOSURE OF TRANS­COLONIC ACCESS
AND FULL­THICkNESS COLONIC RESEC­
TION USING A NOVEL FLExIBLE STA­
PLING DEVICE
M.H. Sodergren, J. Clark, J. Beardsley,
T. Bryant, K. Horton, A. Darzi, J. Teare
P2064
OUTCOME AND COMPLICATIONS OF
COLONOSCOPY: A PROSPECTIVE MULTI­
CENTER STUDY IN NORTHERN ISRAEL
A. Suissa, O.S. Bentur, K. Yassin, J. Lachter,
I. Chermesh, I. Gralnek, A. Karban,
I. Khamaysi, Y. Nave, A. Tamir, A. Shahbari,
R. Eliakim
PosTeR sessIon
P2065
ESD FOR LARGE COLORECTAL TUMOR
HAS BECOME A SAFE AND RADICAL
THERAPEUTIC METHOD
Y. Tamegai, K. Kudo, T. Koike, D. Yoshizawa
P2066
COLONOSCOPY IN THE OCTOGENAR­
IANS: WELL TOLERATED AND A HIGHER
YIELD
R. Thimmappa, S. Khan, S. Clarke, C. Oza,
C. Mitchell, S. Babu, J. McFie, K. Mainprize,
C. McNaught, J. Ratcliffe, A. Hopper,
A. McKie
P2067
EFFICACY AND SAFETY OF HIGH RISk
ENDOSCOPIC POLYPECTOMY IN THE
ELDERLY
R.P. Toner, B. Rembacken
P2068
AUDIT OF “SEDATION­FREE” COLONOS­
COPY PERFORMANCE IN AN OFFICE
BASED PRIVATE ENDOSCOPY PRACTICE.
SATISFACTORY RESULTS WITH NO COM­
PLICATIONS
K.D. Triantafyllou, C.S. Angeletopoulou
P2069
WARM­WATER ASSISTED COLONOSCOPY
IS NOT BETTER THAN CONVENTIONAL
AIR ASSISTED COLONOSCOPY
M.C. Uy, V.P. Banez, A.C. Comia,
M.U. Javelosa, M.O. Daez, J.P. Ong,
M.C. Talingdan-Te, W.Z. Espinosa,
N.I. Estanislao, E.R. Ang, H.B. Flores, P.P. Sy,
E.T. Rasco-Nolasco
277
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2070
ACCURACY OF VASCULAR PATTERN AND
PIT PATTERN DIAGNOSIS IN COLOREC­
TAL LESIONS
Y. Wada, H. Kashida, M. Misawa,
T. Hayashi, H. Miyachi, N. Ikehara,
K. Ohtsuka, S. Kudo, S. Hamatani
P2071
ROLE OF SCREENING COLONOSCOPY
IN PATIENTS WITH END­STAGE LIVER
DISEASE AS PART OF THE PRE­LIVER­
TRANSPLANT EVALUATION – RESULTS
OF A PROSPECTIVE STUDY
T.J. Weismüller, F. Bleich, A. Negm,
A. Schneider, T.O. Lankisch, C.P. Strassburg,
M.P. Manns, J. Wedemeyer
P2072
A PROSPECTIVE RANDOMISED ASSESS­
MENT OF TOLERABILITY, MUCOSAL
CLEANSING EFFICACY AND PREPARA­
TION INDUCED MUCOSAL ABNORMALI­
TIES ASSOCIATED WITH THREE BOWEL
PREPARATIONS USED IN COLONOSCOPY
R.P. Willert, A.K. Chong, C. Pearce,
I.C. Lawrance Centre for Inflammatory
Bowel Disease, Fremantle Hospital, Perth,
Australia
P2073
POST­ERCP PANCREATITIS IS PREDICTED
BY A DURATION FOR BILE DUCT CANNU­
LATION OF MORE THAN 15 MIN AND A
SERUM LIPASE LEVEL HIGHER THAN 10N
FOUR HOURS AFTER THE PROCEDURE
A. Duclos, M. Antonietti, E. Ben Soussan,
D. Ouvry, I. Iwanicki-Caron, F. Di Fiore,
P. Ducrotté, S. Lecleire
P2074
THE INFLUENCE OF JUxTAPAPILLARY
DUODENAL DIVERTICULA (JPDD) ON
BILIARY STONE DISEASE
S. Lee, K. Ko, S. Kim, I. Kim, S. Kim, D. Kim,
S. Lee
278
P2075
LARGE BALLOON DILATATION ASSOCI­
ATED TO SPHINCTEROTOMY IN DIFFI­
CULT BILE DUCT STONES REMOVAL.
A THIRD CARE HOSPITAL ExPERIENCE
E. Martin Arranz, R. Rey Sanz, M. Martin
Arranz, F. Gea Rodriguez, P. Mora, L. Adan,
S. Gomez, J. Segura Cabral
P2076
INCIDENCE, RISk FACTORS AND ERCP
TREATMENT FOR BILIARY COMPLICA­
TIONS AFTER CADAVERIC ORTHOTOPIC
LIVER TRANSPLANTATION
F.P. Martins, G.A. De Paulo, R.D. Conceição,
M.P. Zurstrassen, T. Thomé, B. Ferraz-Neto,
A.P. Ferrari
P2077
SES+EPLBD METHOD FOR THE TREAT­
MENT OF BILE DUCT STONE HAD MADE
NO BILE DUCT STENOSE
A. Minami, S. Hirata
P2078
IMPACT OF WIRE­GUIDED CANNULA­
TION ON PROCEDURE­RELATED RISk
FACTORS FOR POST­ERCP PANCREATITIS
E.J. Morena-Madrigal, E. Pérez-Arellano,
Y. González-Lama, A. Albillos
P2079
VALUE OF ROUTINE MICROBIOLOGICAL
ANALYSIS OF BILE DURING CHOLANGI­
OGRAPHY: RESULTS OF PROSPECTIVE
STUDY AND IMPACT ON MANAGEMENT
OF CHOLANGITIS
A. Negm, A. Schott, R. Vonberg,
A. Schneider, M. Manns, J. Wedemeyer,
T. Lankisch
P2080
PATIENT IRRADIATION DURING ENDO­
SCOPIC RETROGRADE CHOLANGIOPAN­
CREATOGRAPHY
C.M. Nichita, A. Aroua, F. Verdun,
P. Maerten, D. Velin, M. Ortner, P.F. Michetti,
G.O.H. Dorta

P2081
ENDOSCOPIC RETROGRADE CHOLAN­
GIOPANCREATOGRAPHY (ERCP) AND
LAPAROSCOPIC CHOLECYSTECTOMY
AS A SINGLE­STEP PROCEDURE PER­
FORMED UNDER GENERAL ANESTHESIA
E. Nussinson, A. Shahbari, M. Rudin, I. Lavi,
A. Beker, D. Kopelman
P2082
MICROBIOLOGICAL ExAMINATIONS
AND IN­VITRO TESTING OF DIFFERENT
ANTIBIOTICS IN THERAPEUTIC ENDOS­
COPY OF THE BILIARY SYSTEM
D. Gargouri, A. Ouakaa-Kchaou,
A. Kochlef, H. Elloumi, N. Aissa, A. Kilani,
M. Romani, J. Kharrat, A. Ghorbel
P2083
EVALUATION OF A PROTOCOL FOR THE
PREOPERATIVE DIAGNOSIS OF COM­
MON BILE DUCT STONES ­ PROSPECTIVE
STUDY
K. Palaniappan, N. Chandran,
M. Narashiman, R. Ardhanari
P2084
WHICH BILIARY STONE IS DIFFICULT
STONE?
E. Parlak, S. Dişibeyaz, B. Çiçek, M.Z.Y. Kılıç,
B. Ödemiş, N. Sasmaz, B. Şahin
P2085
EARLY REPEAT ERCP
E. Parlak, C. Cengiz, S. Dişibeyaz, B. Çiçek,
Y. Özin, S. Kacar, N. Şaşmaz, B. Şahin
P2086
SUCCESS OF PRECUT BILIARY SPHINC­
TEROTOMY
R.M.M. Ramos, M. Areia, R. Gradiz,
S. Nobre, D. Gomes, E. Camacho, A. Rosa,
H. Gouveia, M. Leitao
PosTeR sessIon
P2087
ENDOSCOPIC MANAGEMENT OF BILIARY
COMPLICATIONS AFTER ORTHOTOPIC
LIVER TRANSPLANTATION
R.M.M. Ramos, M. Areia, R. Gradiz,
D. Gomes, E. Camacho, A. Rosa, H. Gouveia,
M. Leitao
P2088
OUTCOME OF ENDOSCOPIC RETRO­
GRADE CHOLANGIOPANCREATOGRA­
PHY DURING LIVE ENDOSCOPY DEM­
ONSTRATIONS
W. Ridtitid, R. Rerknimitr, P. Kongkam,
S. Treeprasertsuk, V. Mahachai,
P. Kullavanijaya
P2089
ERCP RELATED RETROPERITONEAL PER­
FORATION: DOES IT ALWAYS MEAN A
SURGICAL INTERVENTION?
A. Puri, S. Sachdeva, P. Tyagi, R. Reddy,
N. Gupta, R. Soni
P2090
COMPARISON OF EUS­FNA CITOLOGY
AND HISTOLOGY IN INTRADUCTAL PAP­
ILLARY MUCINOUS NEOPLASIA
C. Boemo, S. Carrara, M.C. Petrone,
C. Doglioni, P.G. Arcidiacono, P.A. Testoni
P2091
MUCINS ExPRESSION ON MATERIAL
OBTAINED UNDER EUS­GUIDED FNA IN
PATIENTS WITH PANCREATIC LESIONS
S. Carrara, G. Cangi, G. Mezzi, M. Petrone,
C. Boemo, G. Grassini, C. Doglioni, F. Perri,
P. Arcidiacono, P. Testoni
P2092
ROLE OF ENDOSCOPIC ULTRASOUND
AND COMPUTED TOMOGRAPHY IN THE
DETECTION AND CHARACTERIZATION
OF ESOPHAGEAL DUPLICATION CYSTS
IN ADULTS
U. Cioffi, A. Lemos, M. De Simone, L. Rosso,
M. Galliera, E. Contessini-Avesani,
L. Santambrogio
279
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2093
IS THERE A ROLE FOR CONTRAST­EN­
HANCED EUS IN THE CHALLENGING
DIFFERENTIAL DIAGNOSIS OF SOLID
PANCREATIC MASSES?
C.G. De Angelis, A. Balbo Mussetto,
M. Goss, P. Carucci, M. Bruno, L. Mezzabotta,
R. Pellicano, P. Allegranza, M. Rizzetto
P2094
EUS­GUIDED CYTOLOGIC DIAGNOSIS OF
PANCREATIC ENDOCRINE TUMORS: IM­
MUNOCYTOCHEMICAL FEATURES AND
THE IMPACT OF ON­SITE CYTOPATHO­
LOGICAL ASSESSMENT
C.G. De Angelis, D. Pacchioni, P. Carucci,
M. Bruno, P. Allegranza, A. Barreca,
A. Balbo Mussetto, L. Mezzabotta, M. Goss,
G. Bussolati, M. Rizzetto
P2095
ENDOSCOPIC ULTRASOUND FINE NEE­
DLE ASPIRATION WITH RAPID ON SITE
EVALUATION IN THE DIAGNOSIS OF IN­
TRAPANCREATIC ACCESSORY SPLEEN:
REPORT OF TWO CASES
C.G. De Angelis, E. Maldi, P. Carucci,
D. Pacchioni, M. Bruno, A. Balbo Mussetto,
P. Allegranza, G. Bussolati, M. Rizzetto
P2096
REASONS FOR FINE­NEEDLE ASPIRA­
TION WITHOLDING IN A COHORT OF
PATIENTS REFERRED FOR ENDOSCOPIC
ULTRASOUND­FNA OF THE PANCREAS
C.G. De Angelis, M. Bruno, P. Carucci,
R. Pellicano, M. Goss, P. Allegranza, A. Balbo
Mussetto, G.M. Saracco, M. Rizzetto
280
P2097
HOW EFFECTIVE AND SAFE IS EUS­GUID­
ED FINE NEEDLE ASPIRATION (EUS­FNA)
IN THE EVALUATION OF CYSTIC LESIONS
OF THE PANCREAS?
K. de Jong, M.J. Bruno, M. Visser, Y.C. Nio,
D.J. Gouma, J.J. Hermans, C.H.J. van Eijck,
J.W. Poley, P. Fockens
P2098
ENDOSCOPIC ULTRASOUND ­ GUIDED
FINE­NEEDLE ASPIRATION OF SUB­
MUCOSAL LESIONS OF THE DIGESTIVE
TRACT: 19G OR 22G NEEDLE?
C. Fidalgo, S. Faias, R. Fonseca,
E. Mendonça, C. Nobre Leitão
P2099
ENDOSCOPIC ULTRASOUND ­ GUIDED
FINE­NEEDLE ASPIRATION WITH CYST
FLUID ANALYSIS IN THE DIFFERENTIAL
DIAGNOSIS OF PANCREATIC CYSTIC LE­
SIONS
C. Fidalgo, S. Faias, R. Fonseca,
E. Mendonça, C. Nobre Leitão
P2100
EUS­GUIDED FINE NEEDLE TISSUE AC­
QUISITION USING A 19­GAUGE NEEDLE
IN A HIGHLY SELECTED PATIENTS POPO­
LATION: A PROSPECTIVE STUDY
D. Galasso, E.D. Rossi, N. Uchida,
K. Zachariah, R. Ricci, G. Costamagna,
A. Larghi
P2101
ENDOSCOPIC ULTRASONOGRAPHY
(EUS) STRAIN RATIO (SR­EUS) VS. CON­
TRAST­ENHANCED EUS (CE­EUS) FOR
THE DIAGNOSIS OF FOCAL PANCREATIC
SOLID LESIONS
M. Giovannini, F. Figuereida, G. Monges,
E. Bories, C. Pesenti, F. Caillol

P2102
EUS­FNA PREDICTS 5­YEAR SURVIVAL IN
PANCREATIC ENDOCRINE TUMORS
M. Giovannini, F. Figuereida, G. Monges,
E. Bories, F. Caillol, C. Pesenti
P2103
PERFORMANCE OF EUS­FNA FOR MEDI­
ASTINAL LYMPHADENOPATHY: IMPACT
ON PATIENT MANAGEMENT AND COST
IN LOW­VOLUME EUS CENTERS
M.M.C. Hirdes, T.M. Schwartz, K.M. Tytgat,
N.J. Schloesser, D.M. Sie-Go, M.A. Brink,
B. Oldenbrug, P.D. Siersema, F.P. Vleggaar
P2104
VIDEO CAPSULE RETENTION – A GOOD
THING ?
P.T. Rajasekhar, C. Davison, S.J. Panter
P2105
THE ROLE OF WIRELESS CAPSULE EN­
DOSCOPY IN PATIENTS WITH SUSPECTED
CROHN’S DISEASE
B.J. Rosa, A.I. Rebelo, M.J. Moreira,
J.B. Cotter
P2106
THE LARGEST UNITED kINGDOM (Uk)
ExPERIENCE ON CAPSULE ENDOSCOPY
R. Sidhu, D.S. Sanders, K. Drew,
M.E. McAlindon
P2107
EARLY ExPERIENCE OF COLON CAPSULE
ENDOSCOPY IN ROUTINE CLINICAL
PRACTICE
R. Sidhu, D.S. Sanders, K. Drew,
M.E. McAlindon
P2108
SIMETICONE IMPROVES MUCOSAL VISU­
ALISATION IN SMALL BOWEL CAPSULE
ENDOSCOPY
R. Srirajaskanthan, D. Borrow,
S.H.C. Anderson
PosTeR sessIon
P2109
BOWEL PREPARATION IMPROVES MU­
COSAL VISUALISATION IN PATIENTS
UNDERGOING SMALL BOWEL CAPSULE
ENTEROSCOPY
R. Srirajaskanthan, D. Borrow,
S.H.C. Anderson
P2110
SMALL BOWEL CAPSULE ENDOSCOPY
RARELY ALTERS MANAGEMENT IN PA­
TIENTS WITH NON­SPECIFIC ABDOMI­
NAL PAIN?
R. Srirajaskanthan, D. Borrow,
S.H.C. Anderson
P2111
PATENCY CAPSULE REDUCES RETEN­
TION RATE OF SMALL BOWEL VIDEO
CAPSULES IN HIGH RISk PATIENTS
I. Steinbrueck, M. Keuchel, A. Zorn,
M. Knieper, E. Gaida, F. Hagenmueller
P2112
DIAGNOSTIC YIELD OF WIRELESS CAP­
SULE ENDOSCOPY IN NON­STEROIDAL
ANTI­INFLAMMATORY DRUGS INDUCED
ENTEROPATHY IN ExPERIMENTAL PIGS
I. Tachecí, J. Květina, J. Bureš,
J. Österreicher, M. Kuneš, J. Pejchal,
S. Rejchrt, S. Špelda, M. Kopáčová
P2113
EFFECT OF METOCLOPRAMIDE ON
GASTROINTESTINAL TRANSIT TIME OF
CAPSULE ENDOSCOPY IN PATIENTS
WITH GASTROINTESTINAL SYMPTOMS
AFTER ALLOGENEIC HEMATOPOIETIC
STEM CELL TRANSPLANTATION ­ A PILOT
STUDY ­
H. Takisawa, Y. Kakugawa, T. Fukuda,
T. Matsuda, T. Nakajima, S. Kim, S. Mori,
R. Tanosaki, Y. Takaue, Y. Saito
281
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2114
COPMPARISON OF MAGNETIC RESO­
NANCE ENTEROGRAPHY AND CAPSULE
ENDOSCOPY IN EVALUATING SMALL
BOWEL DISEASE
I. Tetlay, A. Srivastava, A. Kaul, V. Gummer,
S. Jain, M. McStay
P2115
CAPSULE RETENTION IN A SINGLE­
CENTER CLINICAL ExPERIENCE OF 1791
VIDEO CAPSULE PROCEDURES
E. Toth, A. Nemeth, J. Nielsen, H. Thorlacius
P2116
CAPSULE ENDOSCOPY FINDINGS IN
PATIENTS WITH OBSCURE OR OVERT
BLEEDING AGED MORE THAN 80 YEARS
P. Tsibouris, C. Kalantzis, A. Zalonis,
V. Kakavetsi, C. Liatsos, C. Tsironis,
E. Kalafatis, N. Kalantzis
P2117
WIRELESS CAPSULE ENDOSCOPY FIND­
INGS IN PATIENTS WITH SMALL BOWEL
BACTERIAL OVERGROWTH
M.J. Perez-Grueso, J. Valle, J. Navajas,
M. Alcantara, A. Garcia-Vela, J.M. Carrobles
P2118
BLEEDING LESIONS WITHIN REACH OF
CONVENTIONAL ENDOSCOPY IN PA­
TIENTS SUBJECTED TO CAPSULE EN­
DOSCOPY FOR OBSCURE GASTROIN­
TESTINAL BLEEDING. DOES REFERRAL
MATTER?
J. Vlachogiannakos, K. Papaxoinis,
N. Viazis, A. Kegioglou, I. Binas,
D.G. Karamanolis, S.D. Ladas
282
P2119
CAPSULE ENDOSCOPY FINDINGS IN THE
SMALL BOWEL OF PATIENTS WITH HEPA­
TOCELLULAR CARCINOMA: A PROSPEC­
TIVE STUDY
A. Yamada, H. Watabe, T. Sugimoto,
S. Kondo, M. Ohta, S. Obi, G. Togo, K. Ogura,
Y. Yamaji, M. Okamoto, H. Yoshida,
T. Kawabe, M. Omata
PosTeR sessIon
Pancreas III
P2120
ANGIOTENSIN II RECEPTOR BLOCkERS
AND RISk OF POST ENDOSCOPIC RETRO­
GRADE CHOLANGIO­PANCREATOGRA­
PHY HYPERENZYMEMIA – A RANDOM­
IZED CONTROLLED TRIAL
T. Sjoberg Bexelius, J. Blomberg, Y. Lu,
H. Håkansson, P. Möller, C. Nordgren,
U. Arnelo, J. Lagergren, M. Lindblad
P2121
CHANGE OF METALLOTHIONEIN, ZINC
AND INSULIN CONCENTRATIONS IN PA­
TIENTS WITH CHRONIC PANCREATITIS
A. Bizon, M. Sliwinska-Mosson,
H. Milnerowicz
P2122
DOES LEPTIN MODULATE APOPTOSIS
PATHWAYS IN THE PANCREATIC AR42J
CELLS?
J. Bonior, J. Jaworek, S.J. Konturek,
W.W. Pawlik
P2123
NON­CONJUGATED BILE ACIDS INDUCE
MITOCHONDRIAL DAMAGE AND INHIBIT
BICARBONATE TRANSPORT MECHA­
NISMS IN PANCREATIC DUCT CELLS
P. Hegyi, J. Maleth, V. Venglovecz, Z. Razga,
L. Tiszlavicz, Z. Rakonczay Jr.

P2124
ANTISECRETORY FACTOR (AF) AFFECTS
AMYLASE RELEASE FROM PANCREATIC
ACINI AND ExPRESSION OF PANCREATIC
CCk RECEPTOR
K. Nawrot-Porabka, J. Jaworek, A. Leja-
Szpak, M. Kot, W.W. Pawlik, B. Sternby,
S. Lange
P2125
THE INVOLVEMENT OF PH CHANGES IN
THE SECRETION OF PANCREATIC HOR­
MONES
I. Puscas, G. Domuta, M. Coltau, O. Pop
P2126
GENES RESPONSIBLE FOR RECEPTOR­
AND MITOCHONDRIAL­MEDIATED
APOPTOSIS ARE UNDERExPRESSED IN
PATIENTS WITH ACUTE BILIARY PANCRE­
ATITIS
M. Szaflarska, A. Nowak, U. Mazurek,
M. Stachowicz, A. Wieclawek, B. Strzalka-
Mrozik
P2127
IDIOPATHIC PANCREATITIS: IS IT A CON­
SEQUENCE OF AN ALTERING SPECTRUM
OF BILE NUCLEATION TIME?
V. Abeysuriya, K.I. Deen, N.M. Navaratne,
S.K. Kumarage Gastroenterology, The
National Hospital of Sri Lanka, Colombo,
Sri Lanka
P2128
TREFOIL FACTOR FAMILY (TFF) PEPTIDES
AND THE TFF­INTERACTING PROTEIN
GASTROkINE­2 IN NORMAL AND DIS­
EASED HUMAN PANCREAS
N.J. Guppy, W.R. Otto, R. Jeffery, T. Hunt,
M.E. El-Bahrawy, M.R. Alison, N.A.W. Wright
P2129
LONG­TERM FOLLOW­UP OF CHRONIC
PANCREATITIS IN A PEDIATRIC POPULA­
TION UNDERGOING ENDOTHERAPY
F. Iacopini, M. Mutignani, V. Perri,
P. Familiari, A. Tringali, G. Costamagna
PosTeR sessIon
P2130
TOTAL SURGICAL PARENCHYMAL AND
DUCTAL DECOMPRESSION LEADS TO
THE SIGNIFICANT PANCREAS SIZE DE­
CREASE AND MAJORITY OF COMPLICA­
TIONS DISAPPEARANCE
A.V. Klymenko, V.N. Klymenko
P2131
ULTRASONOGRAPHIC IMAGING OF BILE
DUCT LESIONS IN AUTOIMMUNE PAN­
CREATOBILIARY DISEASE
R. Koyama, T. Imamura, T. Tamura,
Y. Koizumi, C. Okuda, K. Takeuchi
P2132
EFFICACY AND SAFETY OF PANCRE­
LIPASE DELAYED­RELEASE CAPSULES
(CREON ® ) IN PATIENTS WITH PANCRE­
ATIC INSUFFICIENCY DUE TO CHRONIC
PANCREATITIS OR PANCREATIC SURGERY
D.C. Whitcomb, E. Malecka-Panas,
G.A. Lehman, G. Vasileva, N. Gubergrits,
S. Caras, Y. Shen, S. Sander-Struckmeier
P2133
COMPARATIVE CROSS­OVER STUDY
OF PANCREATIN TABLETS AND MICRO­
SPHERES IN TREATMENT OF PAIN IN
CHRONIC PANCREATITIS
A.V. Okhlobystin, V.T. Ivashkin, B. Nyamaa
P2134
PAIN MECHANISMS IN CHRONIC PAN­
CREATITIS: EVIDENCE OF ALTERED CE­
REBRAL PAIN PROCESSING
S.S. Olesen, J.B. Frøkjær, A.L. Krarup,
A.M. Drewes
P2135
SYMPTOMS ARE EARLIER FROM GEN­
ERATION TO GENERATION IN PATIENTS
WITH HEREDITARY PANCREATITIS (HP)
V. REBOURS, O. Hentic, F. Maire, C. Férec,
P. Hammel, P. Levy, P. Ruszniewski
283
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2136
CELL­ADHESION MOLECULE E­CAD­
HERIN IS REGULATED BY A MULTIPRO­
TEIN COMPLEx OF HISTONE­DEACET­
YLASES AND THE TRANSCRIPTIONAL
REPRESSOR ZEB1 IN PANCREATIC CAN­
CER
A. Aghdassi, F.U. Weiss, C.O. Behn,
J. Mayerle, M.W. Büchler, H. Friess,
C. Heidecke, M.M. Lerch
P2137
SECOND­LINE THERAPY IN GEMCITABI­
NE­PRETREATED PATIENTS WITH AD­
VANCED PANCREATIC CANCER
R. ALTWEGG, M. Ychou, S. Thezenas,
T. Mazard, N. Flori, E. Assenat
P2138
PRECURSORS LESIONS OF PANCREATIC
CANCER: THE ROLE OF ENDOSONOGRA­
PHY IN THE IDENTIFICATION, STAGING
AND HYSTOLOGICAL DIAGNOSIS
J.C. Ardengh, D.E. Coelho, J.F.E. Coelho,
M.D. Begnami, E.T. Orsini, J.S. Santos,
J.L.P. Módena
P2139
MUCINOUS CYSTIC TUMOR: COM­
PARATIVE STUDY BETWEEN TRANSAB­
DOMINAL ULTRASOUND (US), HELICAL
COMPUTERIZED TOMOGRAPHY (CT),
MAGNETIC RESONANCE IMAGING (MRI)
AND ENDOSCOPIC ULTRASOUND (EUS)
IN THE DIFFERENTIAL DIAGNOSIS AND
STAGING
J.C. Ardengh, G. D’Ipolitto, J.F.E. Coelho,
D.E. Coelho, J.L.P. Módena, J.S. Santos,
J. Ardengh
P2140
RESECTABLE ADENOCARCINOMA OF
THE PANCREATIC HEAD: SURGERY FIRST
VERSUS PREOPERATIVE CHEMORADIA­
TION
L.A. Barbier, O. Turrini, E. Grégoire, C. de
Chaisemartin, Y. Le Treut, J. Delpero
284
P2141
PROGNOSIS IMPACT OF kRAS AND BRAF
MUTATIONS ON LOCALLY ADVANCED
AND/OR METASTATIC PANCREATIC CAN­
CER PATIENTS: A PROSPECTIVE MULTI­
CENTER STUDY
B. Bournet, A. Souque, D. Le Corre,
F. Muscari, P. Senesse, E. Assenat, M. Barthet,
N. Lesavre, A. Aubert, D. O’Toole, P. Hammel,
P. Levy, P. Ruszniewski, R. Guimbaud,
P. Laurent-Puig, P. Cordelier, L. Buscail
P2142
CHEMOPREVENTION OF N­NITROSOBIS
(2­OxOPROPYL)AMINE­INDUCED PAN­
CREATIC CANCERS IN HAMSTERS BY THE
FARNESYLTRANSFERASE INHIBITOR
H. Chung, S. Park, J. Chung, S. Song
P2143
FOLFOx4 AS A RESCUE CHEMOTHERAPY
IN GEMCITABINE BASED CHEMOTHERA­
PY REFRACTORY PANCREATIC CANCER
J. Chung, M. Chung, S. Park, J. Park, S. Park,
S. Song, J. Chung, S. Bang
P2144
COMPARISON OF ENDOSCOPIC ULTRA­
SOUND GUIDED DIRECTIONAL E­FLOW
USING MICROBUBBLE CONTRAST AGENT
WITH POWER DOPPLER AND COLOR
DOPPLER IN SOLID PANCREATIC LE­
SIONS
K. Das, M. Kitano, H. Sakamoto, T. Komaki,
T. Takagi, K. Yamao, M. Kudo
P2145
COMPARATIVE STUDY OF EUS­GUIDED
25­GAUGE NEEDLE VERSUS EUS­GUIDED
22­GAUGE NEEDLE FOR FNA IN PATIENTS
WITH SOLID PANCREATIC MASSES: PRE­
LIMINARY RESULTS
C. Fabbri, A.M. Polifemo, C. Luigiano,
P. Baccarini, G. Collina, V. Cennamo,
L. Fuccio, S. Macchia, F. Ferrara,
A. Maimone, N. Zanini, E. Jovine,
N. D’Imperio

P2146
GLUCOSE TOLERANCE, INSULIN SENSI­
TIVITY, SUBCLINICAL INFLAMMATION
AND ENDOTHELIAL DYSFUNCTION IN
SUBJECTS WITH NEWLY DIAGNOSED
PANCREATIC CANCER
A. Gasiorowska, R. Talar-Wojnarowska,
L. Czupryniak, A. Borkowska, J. Loba,
E. Malecka-Panas
P2147
QUANTITATIVE RT­PCR OF MISMATCH
REPAIR GENES IN FOCAL PANCREATIC
LESIONS ASSESSED BY ENDOSCOPIC
ULTRASOUND­GUIDED FINE NEEDLE
ASPIRATION
D.I. Gheonea, C. Soare, M. Ioana,
S. Iordache, M. Filip, T. Ciurea, A. Saftoiu
P2148
FAMILIAL PANCREATIC CANCER: PREV­
ALENCE OF GERMLINE MUTATIONS IN
CDkN2A, CDk4 AND BRCA2 GENES AND
PRELIMINARY RESULTS OF SCREENING
IN RELATIVES
P. Hammel, N. Soufir, P. Lévy, C. Collas,
F. Coulet, A. Gueho, A. Riffaut, F. Maire,
V. Rebours, O. Hentic, A. Aubert, F. Soubrier,
D. Vidaud, B. Grandchamp, P. Ruszniewski
PosTeR sessIon
surgery III
P2149
NEW ENDOSCOPIC STRATEGY FOR
TREATMENT OF ANASTOMOTIC LEAkS
AFTER BARIATRIC SURGERY
T. Bege, P. Ah Soune, O. Emungania,
S. Ezzedine, D. Nocca, P. Noel, J. Grimaud,
M. Barthet
P2150
RADIONUCLIDE HEPATOBILIARY IMAG­
ING IN EFFICIENCY RATING OF SURGI­
CAL TREATMENT OF AFFERENT LOOP
SYNDROM
M.N. Belyaev, A.V. Popov, Y.P. Sandakov,
A.I. Ershova
PosTeR sessIon
P2151
A SECOND­LOOk ENDOSCOPY AFTER
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION (ESD) FOR GASTRIC EPITHELIAL
NEOPLASM MAY BE UNNECESSARY: A
RETROSPECTIVE ANALYSIS OF POST­ESD
BLEEDING
O. Goto, M. Fujishiro, S. Kodashima, S. Ono,
K. Niimi, K. Hirano, N. Yamamichi, K. Koike
P2152
FEMALE FERTILITY AFTER COLORECTAL
SURGERY FOR FAMILIAL ADENOMATOUS
POLYPOSIS (FAP)
M.H. Nieuwenhuis, K.F. Douma,
E.M. Bleiker, N.K. Aaronson, W.A. Bemelman,
H.F. Vasen
P2153
THE ENDOSCOPIC TREATMENT OF FIS­
TULAE AND POST­SURGICAL ANASTO­
MOTIC DEHISCENCES WITH FIBRIN GLUE
A. Paterlini, C. Petruzzellis, F. Buffoli, F. Milesi,
M. Lovera, F. Rolfi, P. Cesari
P2154
THE ROLE OF HISTOLOGICAL INFLAM­
MATION IN THE DURATION OF POST
OPERATIVE ILEUS IN PATIENTS UNDER­
GOING COLECTOMY FOR ULCERATIVE
COLITIS
S.S. Zeki, D. Balmforth, J. MacNaughtan,
M. Jacyna, S. Gabe, J. Nightingale
P2155
TRANSGASTRIC VERSUS LAPAROSCOPIC
VENTRAL HERNIA REPAIR: A RANDOM­
IZED CONTROLLED TRIAL IN A LIVE POR­
CINE MODEL
S.V. Kantsevoy, X. Dray, E. Shin,
G. Donatelli, D. Mukkai Krishnamurty,
J. Lyn-Sue, A. Gupta, S.A. Giday,
J.M. Buscaglia, A. Zhigalin, R.J. Wroblewski,
M.R. Marohn, M.A. Schweitzer
285
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2156
TRANSCOLONIC SPECIMEN REMOVAL IN
LAPAROSCOPIC ILEOCOLIC RESECTION
FOR CROHN’S DISEASE: INITIAL ExPERI­
ENCE
E.J. Eshuis, R.P. Voermans, D.P. Hirsch,
P.C.F. Stokkers, M.I. van Berge Henegouwen,
P. Fockens, W.A. Bemelman
P2157
NO INCISION (NOTES) VS SINGLE INCI­
SION (SILS) SURGERY FOR ACCESS TO
ELECTIVE SITES OF PERITONEAL CARCI­
NOMATOSIS: BACk­TO­BACk COMPARI­
SON IN A LIVE PORCINE MODEL
Y. Ladjici, X. Dray, M. Camus, P. Marteau,
P. Valleur, M. Pocard
P2158
LAPAROSCOPIC MANAGEMENT OF GAS­
TRIC GASTROINTESTINAL STROMAL TU­
MORS
K. Palaniappan, M. Narashiman,
R. Ardhanari
P2159
ADHESION FORMATION AND FIBRINO­
LYTIC RESPONSE IN OPEN, LAPARO­
SCOPIC AND NOTES TRANSGASTRIC
SURGERY
M. Bergstrom, A. Azadani, H. Jonsson,
P. Park
P2160
TRANSGASTRIC APPROACH DOES NOT
INCREASE POSTOPERATIVE INFECTIONS
OR COMPLICATIONS IN SWINE UTERINE
HORN RESECTION
A. Azadani, M. Bergstrom, H. Jonsson,
P. Park
P2161
SINGLE INCISION LAPAROSCOPIC SUR­
GERY (SILS) IN GENERAL SURGERY –
A SYSTEMATIC REVIEW
F. Froghi, M.H. Sodergren, A. Darzi,
P. Paraskeva
286
P2162
SINGLE­CENTRE ExPERIENCE IN SYSTEM­
IC STRESS AND SHORT­TERM MORBID­
ITY OF SINGLE­INCISION LAPAROSCOPIC
CHOLECYSTECTOMY
M.H. Sodergren, F. Froghi, A. Darzi,
P. Paraskeva
P2163
GASLESS AND LESS
J.R. Speranza
P2164
LAPAROSCOPIC ISCHAEMIC CONDITION­
ING REDUCES GASTRIC CONDUIT FAIL­
URE FOLLOWING MINIMALLY INVASIVE
OESOPHAGECTOMY
D. Veeramootoo, A.C. Shore,
T. Daneshmend, M.J. Cooper, R.G. Berrisford,
S.A. Wajed
P2165
RANDOMISED, BLINDED COMPARISON
OF TRANSGASTRIC, TRANSCOLONIC
AND LAPAROSCOPIC PERITONEOSCOPY
FOR THE DETECTION OF PERITONEAL
METASTASES IN A HUMAN CADAVER
MODEL
R.P. Voermans, M.I. van Berge
Henegouwen, E.M.V. de Cuba, F.J.C. van
den Broek, G.J.D. van Acker, R. Timmer,
P. Fockens
P2166
TRANSGASTRIC LAPAROSCOPIC ASSIST­
ED ENDOSCOPIC CHOLECYSTECTOMY: A
SAFE AND INEVITABLE BRIDGE TO NOTES
R.P. Voermans, W.A. Bemelman,
P. Fockens, M.I. van Berge Henegouwen

P2167
RANDOMIZED CONTROLLED TRIAL
COMPARING LAPAROSCOPIC AND
NOTES GASTROJEJUNOSTOMY FOR
DUODENAL OBSTRUCTION
M.C. Vassiliou, D. von Renteln,
D. McKenna, P. Swain, R.I. Rothstein
Imperial College, London University,
London, United Kingdom
P2168
A RANDOMIZED CONTROLLED TRIAL
COMPARING LAPAROSCOPIC AND
NOTES EPIGASTRIC VESSEL LIGATION
M.C. Vassiliou, D. von Renteln,
D. McKenna, T. Trus, P. Swain, R.I. Rothstein
Imperial College, London University,
London, United Kingdom
PosTeR sessIon
Therapeutic endoscopy/
Interventional radiology III
P2169
SIMULTANEOUS MALIGNANT BILIARY
AND DUODENAL OBSTRUCTION: TECH­
NICAL FEASIBILITY AND CLINICAL EF­
FICACY OF COMBINED ENDOSCOPIC
STENT PLACEMENT
D. Xinopoulos, D. Kypreos, S.P. Bassioukas,
P. Pappas, D. Dimitroulopoulos, D. Korkolis,
K. Tsamakides, E. Paraskevas
P2170
ENDOSCOPIC BAND LIGATION IN PRO­
PHYLACTIC TREATMENT OF OESOPHA­
GEAL VARICES: LONG TERM RESULTS
H. Ben Abdallah, S. Bizid, O. Chtara,
I. Kilani, R. Bouali, N. Abdelli
P2171
5­YEAR CLINICAL OUTCOMES OF ENDO­
SCOPIC SUBMUCOSAL DISSECTION(ESD)
FOR EARLY GASTRIC CANCER ­ SINGLE
CENTER RESULTS
J. Cho, W. Cho, Y. Cho, Y. Jung, T. Lee, H. Kim,
J. Kim, J. Lee, S. Jin, S. Whan KIm
PosTeR sessIon
P2172
ExPERIENCE WITH ENDOSCOPIC ENU­
CLEATION OF GASTRIC SUBEPITHELIAL
TUMORS ORIGINATING FROM THE MUS­
CULARIS PROPRIA LAYER
I. Jeong, S. Jung, D. Kim
P2173
THERAPEUTIC STRATEGY FOR ENDO­
SCOPIC TREATMENT OF RECTAL CARCI­
NOID TUMORS
S. Kakizaki, Y. Onozato, H. Iizuka,
N. Sohara, H. Ishihara, M. Mori, H. Itoh
P2174
ENDOSCOPIC SUBMUCOSAL DIS­
SECTION (ESD) OF LARGE MUCOSAL
AND SUBMUCOSAL LESIONS IN THE
GI TRACT – ExPERIENCE IN THE WEST­
ERN WORLD
A. Probst, D. Golger, B. Pommer,
H. Arnholdt, H. Messmann
P2175
ENDOSCOPIC SUBMUCOSAL DISSEC­
TION FOR RECTAL CARCINOIDS
S. Shimaoka, A. Matsuda, T. Nioh,
K. Tsukasa, H. Torimaru, K. Tashiro,
T. Niihara, Y. Nishimata, M. Hori,
H. Nishimata, S. Tanaka
P2176
IMPACT OF ENDOSCOPIC SUBMUCOSAL
DISSECTION FOR LOCAL RECURRENCE
OR RESIDUAL TUMOURS IN THE COL­
ORECTUM
T. Uraoka, J. Kato, Y. Kawahara, R. Higashi,
E. Kaji, S. Ishikawa, H. Suzuki, K. Yamamoto
P2177
THE EFFECT OF STEROID INJECTION
THERAPY TO PREVENT ESOPHAGEAL
STRICTURE AFTER ENDOSCOPIC SUB­
MUCOSAL DISSECTION
S. Hashimoto, M. Kobayashi, M. Takeuchi,
Y. Sato, R. Narisawa, Y. Aoyagi
287
WeDnesDaY, noVeMbeR 25, 2009

WeDnesDaY, noVeMbeR 25, 2009
PosTeR sessIon
P2178
COMVI STENT FOR MALIGNANT GASTRIC
OUTLET OBSTRUCTION (GOO)
H. Isayama, Y. Nakai, O. Togawa,
K. Yamamoto, S. Mizuno, Y. Yashima,
H. Yagioka, H. Kogure, T. Sasaki, T. Arizumi,
Y. Ito, S. Matsubara, K. Hirano, N. Sasahira,
T. Tsujino, M. Tada, M. Omata, K. Koike
P2179
86 CASES OF STENT PLACEMENT IN
PATIENTS WITH MALIGNANT OBSTRUC­
TION OF GASTROINTESTINAL TRACT: AS
A BRIDGE TO CHEMOTHERAPY, IN ADDI­
TION TO A PALLIATIVE ROLE
T. Kayahara, M. Kikuyama
P2180
STENTING OF MALIGNANT GASTRIC
OUTLET OBSTRUCTION: THE EFFECT ON
RATE OF GASTRIC EMPTYING
L. Larssen, T. Hauge, A.W. Medhus
P2181
THE FINDINGS INFLUENCING RESTE­
NOSIS IN ESOPHAGEAL ANASTOMOTIC
STRICTURE AFTER ENDOSCOPIC BAL­
LOON DILATION
C. Paik, W. Chung, K. Lee, S. Jung
P2182
ANCHORING WITH ENDOSCOPIC CLIPS
FOR PREVENTION OF ENTERAL STENT
MIGRATION IN PATIENTS WITH MALIG­
NANT GASTRIC OUTLET OBSTRUCTION
J. Park, S. Lee, J. Lee, J. Eum, E. Jeong, Y. Bae,
C. Choi, H. kim, D. Kang
P2183
“DYNAMIC STENT” FOR ESOPHAGEAL
STENOSIS IN CHILDREN
F. Foschia, E. Romeo, F. Torroni, P. De
Angelis, T. Caldaro, G. Federici di Abriola,
A. Pane, L. Dall’Oglio
288
P2184
ARE SELF­ExPANDABLE METAL STENTS
(SEMS) A LONG­TERM SOLUTION FOR
COLONIC OBSTRUCTION?
C.P. Selinger, J. Ramesh, D.F. Martin
P2185
PALLIATIVE OESOPHAGEAL STENTING
FOR DYSPHAGIA: ITS EFFECTIVENESS
AND COMPLICATIONS
R. Tiwari, R.R. Karki
P2186
STENT PLACEMENT FOR COLONIC STE­
NOSIS IN 41 PATIENTS
N.A. Tuvignon, J. Grimaud, M. Barthet,
M. Gasmi, A. Laquiere, R. Laugier
P2187
A NEW METAL STENT WITH CONTROLLED
RELEASE SYSTEM (EVOLUTION) FOR PAL­
LIATION OF MALIGNANT DYSPHAGIA: A
PROSPECTIVE FOLLOW­UP STUDY
P.G.A. van Boeckel, A. Repici, B. Solito,
F.P. Vleggaar, G. Rando, C. Cortelezzi,
M. Rossi, P.D. Siersema
P2188
ESOPHAGEAL STENTS FOR THE RELIEF
OF MALIGNANT DYSPHAGIA DUE TO
ExTRINSIC COMPRESSION
N.C.M. van Heel, J. Haringsma,
M.C.W. Spaander, M.J. Bruno, E.J. Kuipers

GasTRo 2009 UeGW WcoG, london
would like to thank the following
experts for their contribution to the
GasTRo 2009 UeGW WcoG, london
Poster Rounds on Wednesday,
november 25, 2009
■ M. Allez, France
■ T. Asselah, France
■ W. Bemelman, The Netherlands
■ L. Bonavina, Italy
■ Y. Chowers, Israel
■ P. de Angelis, Italy
■ B. Delaney, UK
■ M. Garassini, Venezuela
■ R. Leceister, UK
■ M. Levrero, Italy
■ L. Lundell, Sweden
■ G. Mantzaris, Greece
■ M. Pinzani, Italy
■ G. Ramadori, Germany
■ W. Reinisch, Austria
■ B. Seifert, Czech Republic
■ A. Sturm, Germany
■ D. Watson, Australia
■ J. West, UK
PosTeR sessIon
289
WeDnesDaY, noVeMbeR 25, 2009

Visit us at the
Visit Visit GASTRO us us at at the 2009 the in London,
GASTRO november 2009 2009 21– in 25, in London, 2009
november Exhibition 21– Hall, 21– 25, 25, booth 2009 200939
Exhibition Hall, Hall, booth 39 39
www.fujinon.de
www.fujinon.de
Welcome to the Fujinon Symposium at GASTRO
Welcome
2009! Gastrointestinal
to to the the Fujinon
endoscopy
Symposium
has
at
made
at GASTRO
tremen­
2009! 2009!
dous
Gastrointestinal
progress
Gastrointestinal
in the last
endoscopy
decade due
has has
to
made
the
made
develop
tremen­
ment
dousdous of new
progress
techniques
in the in the last
for
last decade
diagnosis
decade due due
and
to the to
therapy.
the develop
DBE
ment ment
has
of of
become
new new techniques
a valuable
for for
tool
diagnosis
for the
and
small
and therapy.
bowel,
therapy. DBE
ERCP
DBE has
and
has
become
difficult
a
colonoscopies.
valuable a valuable tool tool for
Advances
for the the small small
in
bowel,
EMR
bowel,
and
ERCP ERCP
ESD
and
have
and
difficult
allowed
colonoscopies.
the resection
Advances
of
Advances
larger mucosal
in EMR in EMR and
tumours
and ESD ESD have
endo­
have
allowed
scopically.
the the resection
We
resection
invite
of
you
of larger larger
to join
mucosal
us and
tumours
look
tumours
forward
endoendo­ to
scopically.
your participation.
We We invite invite
Fujinon.
you you to to join
To
join
see
us us and
more
and look
is
look
to
forward
know
forward
more.
to to
your your participation. Fujinon. To To see see more more is to is know to know more. more.
>> ViSiOnARy EndOScOpy
>> >> ViSiOnARy EndOScOpy
Medical TV ccTV Machine Vision Binoculars
Medical TV TVccTV ccTV Machine Vision Vision Binoculars
Fujinon Satellite Symposium.
Fujinon Satellite Symposium.
Frontiers of endoscopy:
Frontiers exploring of of the endoscopy:
boundaries
exploring the the boundaries
date: Monday, november 23, 2009
date: date: Monday, november 23, 23, 2009 2009
Time: 6.00 – 7.30 p.m.
Time: Time: 6.00 6.00 – 7.30 – 7.30 p.m. p.m.
catering: 5.00 – 6.00 p.m.
catering: 5.00 5.00 – 6.00 – 6.00 p.m. p.m.
Venue: Excel London, room: n7/n8
Venue: Excel London, room: n7/n8
FUJinOn (EUROpE) GMBH, HALSKESTRASSE 4, 47877 WILLICH, GERMANY, TEL.: +49 (0)21 54 924­0, FAX: +49 (0)21 54 924­290, www.fujinon.de
FUJinOn FUJinOn (EUROpE) cORpORATiOn, (EUROpE) GMBH, GMBH, HALSKESTRASSE 1­324 HALSKESTRASSE UETAKE, KITAKU, 4, 47877 4, SAITAMA 47877 WILLICH, WILLICH, CITY, GERMANY, 331­9624 GERMANY, SAITAMA, TEL.: TEL.: +49 +49 JAPAN, (0)21 (0)21 54 TEL.: 924­0, 54 924­0, +81 FAX: (0)48 FAX: +49 668 +49 (0)21 21(0)21 53, 54 FAX: 924­290, 54 924­290, +81 (0)48 www.fujinon.de
668 15 70, www.fujinon.co.jp
FUJinOn cORpORATiOn, 1­324 1­324 UETAKE, UETAKE, KITAKU, KITAKU, SAITAMA SAITAMA CITY, CITY, 331­9624 331­9624 SAITAMA, JAPAN, JAPAN, TEL.: TEL.: +81 +81 (0)48 (0)48 668 668 21 53, 21FAX: 53, FAX: +81 +81 (0)48 (0)48 668 668 15 70, 15www.fujinon.co.jp 70, www.fujinon.co.jp

WORKING
PARTY REPORTS

WoRkInG PaRTY RePoRTs
An overview of all 8 GASTRO 2009 Working
Party Reports is provided here. Copies
of the Executive Summaries of all Working
Party Reports can be obtained at the 4
host society booths
Monday, November 23, 2009
11:00 – 12:30
Room Platinum Suite3/4
Session Title: Motor and sensory
disorders of the GI tract
12:00 – 12:30
Working Party Report: Guidelines on
histological techniques and reporting:
The London Classification of GI
neuromuscular pathology
Working Party Presenter:
R. De Giorgio, Italy
C. Knowles, UK
14:00 – 15:30
Room S8/9
Session Title: Barrett’s oesophagus:
A global perspective
14:20 – 14:50
Working Party Report: Early recognition
of Barrett’s oesophagus related
neoplasia: The BORN project
Working Party Presenter:
P. Sharma, USA
J. Bergman, Netherlands
292
Tuesday, November 24, 2009
08:30 – 10:30
Room S6/7
Session Title: Challenges in the
management of IBD
09:50 – 10:20
Working Party Report: Positioning of
biological therapies in IBD treatment
Working Party Presenter:
G. D'Haens, Belgium
11:00 – 12:30
Room Platinum Suite 3/4
Session Title: Obesity and GI cancer
12:00 – 12:30
Working Party Report: Recent advances
in the pathogenesis of gall
bladder cancer
Working Party Presenter:
R. C. Roa, Chile

Wednesday, November 25, 2009
08:30 – 10:30
Room S4/5
Session Title: CRC screening strategies
09:50 – 10:20
Working Party Report: Guidelines for
evaluation of new screening tests for
colorectal and gastric cancers
Presenter:
G. Young, Australia
08:30 – 10:30
Room 8/9
Session Title: Pathophysiology of IBS:
New insights
09:50 – 10:20
Working Party Report: Post infectious
IBS: A global perspective
Working Party Presenters:
R. Spiller, UK
P. Enck, Germany
WoRkInG PaRTY RePoRTs
08:30 – 10:30
Room N11/12
Session Title: Update in the treatment
of hepatitis B and C
09:30 – 10:00
Working Party Report: HCV genotypes
4, 5, 6: The neglected genotypes
Working Party Presenter:
N. Antaki, Syria
08:30 – 13:00
Room S1/2/3
Session Title: Live Endoscopy Rome
Live from the Gemelli Hospital, Rome,
Italy
12:30 – 13:00
Working Party Report: Endoscopy
Guidelines for Credentialing
Working Party Presenter:
D. Faigel, USA
293

World Organisation of Digestive Endoscopy
“…the voice of world endoscopy”
We look forward to providing an interesting, practical and educational experience
VISIT OMED
Booth in the registration area
to learn about our activities
Endoscopy Directors´ Workshops
OMED Guidelines
“How I Do It” series of articles
Meeting research reports
Colorectal Cancer Screening
Committee
Ethics and Endoscopy
Gastric Cancer Screening
Committee
Terminology Documentation and
Standardisation
Equipment Compendium
Endoscopy Training Curriculum
Design of Endoscopy Units
NOTES
Sedation in Endoscopy
E-Newsletter
takes great pleasure
in welcoming you to
OMED is responsible for the endoscopic
input to GASTRO 2009, together with ESGE.
On Saturday and Sunday there is a first rate
Postgraduate Course that will appeal to all
endoscopists. Additionally, the OMED/ESGE
Learning Area provides the opportunity for
hands on learning with biologic models, DVD
teaching and interactive seminars with experts.
From Monday to Wednesday, Live endoscopy
will be transmitted from three of the OMED
Centers of Excellence. Video presentations,
named lectures, research sessions, symposia
and the presentation of working party reports
will enhance the variety of our program.
See the ESGE/OMED brochure in your
congress bag for further details on endoscopic
activities at GASTRO 2009.
Prof. A.T.R. Axon,
OMED President
2005-2009
Dr J.D. Waye,
OMED President
2009-2013
www.omed.org

ESGE/OMED
LEARNING
AREA
and
ULTRASOUND
LEARNING
CENTRE

esGe/oMeD leaRnInG aRea
esGe/oMeD leaRnInG aRea
The European Society of Gastrointestinal
Endoscopy (ESGE) and the World Organisation
of Digestive Endoscopy (OMED)
are jointly hosting the ESGE/OMED Learning
Area at GASTRO 2009 UEGW/WCOG,
London. The Learning Area will serve endoscopic
educational purposes and its
doors are open to all GASTRO 2009 UEGW/
WCOG, London delegates. The activities
are outlined below. In past years the ESGE
Learning Area has attracted increasing
numbers of attendees and participants,
especially for the scheduled activities. Several
events are open on a walk-in basis,
while others require registration.
HanDs-on-TRaInInG on bIoloGIc
MoDels
(in cooperation with esGena)
With access to state of the art endoscopic
equipment and accessories and with personal
doctor and nurse tutoring, the aim
of this activity is to increase the awareness
of diagnostic and therapeutic techniques
and to offer delegates the possibility of
practicing their skills.
Saturday, November 21, 2009
Hands­on­Training Centre
Hands-on-Training on biologic models:
Techniques offered:
■ EMR
■ Hemostasis
■ Polypectomy / Mucosectomy
■ ERCP beginners
AFTERNOON
Session 1 13:30 – 15:00
Session 2 15:30 – 17:00
Sunday, November 22, 2009
Hands­on­Training Centre
Hands-on-Training on biologic models:
Techniques offered:
■ EMR
■ Hemostasis
■ Polypectomy / Mucosectomy
■ ERCP beginners
■ Short wire systems
296
MORNING
Session 3 09:00 – 10:30
Session 4 11:00 – 12:30
AFTERNOON
Session 5 13:30 – 15:00
Session 6 15:30 – 17:00
esGe/oMeD DVD leaRnInG cenTRe
The DVD Learning Centre offers all delegates
the opportunity to visit 18 stations
where the latest teaching material may be
viewed on video screens with headphone
sound transmission.
Case studies from the ESGE DVD Encyclopaedia
are complemented by select video
submissions from OMED, ASGE and contributors
from Japan. This offering is ideal
for individual study and special interest.
DVD stations
1. ESGE PGC, Vienna 2008: Live demonstrations
2. New trends in therapeutic ERCP
3. Best of Gastroenterology and Endotherapy
Week (G.E.E.W)
4. Upper GI bleeding endoscopic management
5. Lower GI bleeding endoscopic management
6. Upper GI therapeutic endoscopy
7. Video capsule endoscopy and balloon
enteroscopy for small bowel exploration
8. Superficial colorectal neoplastic lesions
9. Endoscopic aspects of the digestive
mucosa with narrow band imaging
10. Trimodal endoscopic diagnosis and
ESD for colorectal tumor
11. Double balloon endoscopy
12. Image enhanced endoscopy-i-scan
13. EMRC for early gastric adenocarcinoma
14. EMR for early stage esophageal cancer
15. Unusual GI and biliary stenting
16. Therapeutic EUS
17. Endoscopic therapy in pancreatic disorders
18. Endoscopic management of variceal
hemorrhage in cirrhosis

esGe/oMeD lecTURe THeaTRe
Experts in their fields focus on topics of special
interest before a small audience. All are
invited to join in discussion following the
presentation. In favour of a classroom atmosphere,
the number of participants is limited
to 70. The talks will be recorded and included
on the ESGE/OMED compilation DVD that
will be produced after the congress ends.
Further information can be found in the
special brochure “Endoscopy at GASTRO
2009” in your congress bag.
Sunday, November 22, 2009
11:30 – 12:00
SEMS: Utility in the upper GIT
T. Baron, USA
13:00 – 13:30
Colonoscopy: Expert tips and tricks
B. Saunders, UK
13:45 – 14:15
Endoscopic papillectomy
T. Ponchon, France
Monday, November 23, 2009
10:45 – 11:15
Diagnostic EUS, EUS-FNA: Expert tips and
tricks
W.R. Brugge, USA
11:30 – 12:00
Variceal bleeding, treatment and prevention
I. Mostafa, Egypt
12:15 – 12:45
Balloon Enteroscopy
H. Yamamoto, Japan
13:00 – 13:30
SEMS: Biliopancreatic system
G. Costamagna, Italy
13:45 – 14:15
ERCOP and EST: Expert tips and tricks
H. Neuhaus, Germany
14:30 – 15:00
Capsule endoscopy: Current role in small
bowel
M. Pennazio, Italy
esGe/oMeD leaRnInG aRea
Tuesday, November 24, 2009
10:30 – 11:00
Enhancing white light endoscopy in the
upper GIT
R. Bisschops, Belgium
11:30 – 12:00
Management of non-variceal upper GI
bleeding
J.J.Y. Sung, China
12:15 – 12:45
Endotherapy of chronic pancreatitis
J. Deviere, Belgium
13:30 – 14:00
EMR or ablation in the esophagus
B. Rembacken, UK
14:15 – 14:45
Therapeutic EUS: Expert tips and tricks
M. Giovannini, France
Wednesday, November 25, 2009
10:45 – 11:15
EMR or ESD? The European approach
J. Haringsma, The Netherlands
11:30 – 12:00
Polypectomy and EMR in the colon
J. Waye, USA
297

UlTRasoUnD leaRnInG cenTRe
UlTRasonoGRaPHY – WHY!
Abdominal ultrasonography performed by
the gastroenterologist him/herself is the
first and in many respects the best way to
look into the abdomen.
It is – in the hands of the clinician – an ideal
tool to
■ directly see all the abdominal organs
in question,
in a real-time fashion, and
directly and unfiltered
■ directly distinguish between normality
and pathology,
■ directly integrate all other findings
and data from the patient`s
history,
physical examination,
endoscopic examination, and
lab examinations
■ quickly make decisions on the further
diagnostic and therapeutic steps to
be taken
Moreover, and interestingly, ultrasonography
performed by the clinician is a perfect
starting point for establishing good
relations with the patient; such “sonopsychology”
is aided by the fact that the
ultrasound machine is increasingly recognised
to be a powerful instrument by the
public.
THe GasTRo 2009 UlTRasoUnD
leaRnInG cenTRe
Ultrasonography is easy to learn and easy
to apply. This is what we mainly want to
demonstrate with our Ultrasound Learning
Centre, as an integral part of the Learning
Area and not incidentally side-by-side
with the Endoscopy Learning Area: ultrasonography
and endoscopy, as the two
eyes of the gastroenterologist, are ideal
partners, even if they have not yet really
fallen in love, let alone married!
298
GasTRo 2009
London
We are offering three forms of training and
teaching in ultrasonography for gastroenterologists:
■ hands-on practice – guided by experienced
medical colleagues,
■ lectures in theory – systematically
organ by organ, and oriented towards
clinical problems, and
■ combined hands-on practice and
lectures
The latter – the combination of hands-on
practice and lectures – will be the form of
our Postgraduate Course in Clinical Ultrasonography
for Gastroenterologists, to be
held on two days: Saturday, November 21
and Sunday, November 22, 2009. The programme
outline is given below; it is possible
to visit either both days or just one.
There will be no pre-registration (and no
fees, by the way); a GASTRO 2009 UEGW/
WCOG London certificate is to be prepared
for those who have attended all the lectures
(which are more systematically oriented)
and hands-on training periods.
The subsequent days – Monday, November
23, to Wednesday, November 25,
2009 – are dedicated to those who want to
experience some ‘mini’ hands-on practice
as an introduction to ultrasonography; this
will be offered throughout each day from
09:00 to 16:00. In addition, noon lectures
from 12:30 to 14:00 will cover more specific
clinical topics – the programme outline for
these noon lectures is given below as well.

GasTRo 2009 PosTGRaDUaTe
coURse:
clInIcal UlTRasonoGRaPHY foR
GasTRoenTeRoloGIsTs
Saturday, November 21, 2009
09:00 – 09:15
Planning the aims of today’s course
L. Greiner
09:15 – 09:45
Read the Abdomen with Ultrasonography
L. Greiner
09:45 – 10:15
Sono-anatomy: Abdominal Vessels
D. Nürnberg
10:15 – 11:00
Training I: Live Demo and Hands On
Faculty members
11:00 – 11:20
Sono-anatomy: Liver
D. Nürnberg
11:20 – 11:40
Sono-anatomy: Gallbladder and Bile Ducts
A. Popescu
11:40 – 12:30
Training II: Live Demo and Hands On
Faculty members
12:30 ­ 13:00
Lunch Break
13:00 – 13.20
Sono-anatomy: Kidneys
D. Nürnberg
13:20 – 14:00
Training III: Live Demo and Hands On
Faculty members
14:00 – 14:20
Sono-anatomy: Pancreas
I. Sporea
14:20 – 15:00
Khartoum case reports
S. Elhakim
UlTRasoUnD leaRnInG cenTRe
15:00 – 15.30
Training IV: Testing the course participants
Faculty members
15:30 – 16:00
Frequent pathology in the abdomen
L. Greiner
Sunday, November 22, 2009
09:00 – 09:15
Planning the aims of today’s course
L. Greiner
09:15 – 09:45
Movie case reports
I. Sporea
09:45 – 10:15
Abdominal landmarks: the big vessels
D. Nürnberg
10:15 – 10:30
Stones in the gallbladder
A. Popescu
10:30 – 11:00
Training V: Live Demo and Hands On
Faculty members
11:00 – 11:15
Stones in the bile ducts
D. Nürnberg
11:15 – 11:30
Liver pathology – diffuse changes
I. Sporea
11:30 – 11:40
Liver pathology – focal lesions
L. Greiner
11:40 – 12:15
Training VI: Live Demo and Hands On
Faculty members
12:15 – 12:30
To puncture or not to puncture in liver
disease?
D. Nürnberg
12:30 – 13:00
Lunch Break
299

UlTRasoUnD leaRnInG cenTRe
13:00 – 13:15
From mouth to rectum – the intestinal
channel
O. H. Gilja
13:15 – 13:30
High-frequency precision imaging in
bowel disease
G. Hanenberg
13:30 – 14:00
Training VII: Live Demo and Hands On
Faculty members
14:00 – 14:15
Pancreas pathology – focal lesions
I. Sporea
14:15 – 14:30
Pancreas pathology – diffuse changes
L.Greiner
14:00 – 14:30
Case reports – your diagnosis!
Faculty members
14:30 – 15:00
Contrast-enhanced ultrasonography in
liver disease
A.-M. Barreiros
15:00 – 15:20
What can go wrong – pitfalls and errors
A. Popescu
15:20 – 15:50
Contrast-enhanced ultrasonography in
non-hepatic indications
H. Kinkel
15:50 – 16:00
Certification
Faculty members
300
GasTRo 2009 UlTRasoUnD
leaRnInG cenTRe:
noon lecTURes
Monday, November 23, 2009
12:30 – 14:00
Extrahepatic signs of portal hypertension
J. Valantinas/Lithuania
Gallstones in ultrasonography
A. Popescu/Romania
EUS – endoscopic ultrasonography –
revisited
L. Aabakken/Norway
Elastography in liver disease
H. Kinkel/Germany
Tuesday, November 24, 2009
12:30 – 14:00
Abdominal disease: ultrasonography first –
no CT
I. Sporea/Romania
Hydatic liver cysts – diagnosis and treatment
M. Benazzouz/Marocco
How and when to puncture, and how and
when not to puncture
G. Hanenberg
Case reports from Khartoum
Suzan Elhakim/Sudan
Wednesday, November 25, 2009
12.30 – 14.00
What can go wrong in ultrasonography –
pitfalls
L. Greiner, C. Nolte/Germany
CEUS – contrast-enhanced ultrasonography
H. Kinkel/Germany
Biliopancreatic disease – ultrasonography
first, no MRCP
A. Popescu/Romania
My best movies
L. Greiner, C. Nolte/Germany

COMMON
INTEREST
GROUP
MEETINGS

coMMon InTeResT GRoUP MeeTInGs
UEGF/IDCA/ESDO/IARC: European
Guidelines for Quality Assurance
in Colorectal Cancer Screening –
Network meeting and UEGF workshop
Saturday, November 21, 2009
08:00 – 18:00 Room SG 25/26
Organising Committee:
C. O’Morain, M. Classen, S. Madai, J. Patnick,
N. Segnan, L. Faulds Wood, L. von Karsa
09:00 – 09:50
Session 1:
Welcome
Chair:
C. O’Morain, S. Madai, L. Faulds Wood
09:00 – 09:10
Welcome
C. O’Morain, S. Madai, J. Patnick
09:10 – 09:20
Information and introduction of the
participants
S. Madai, M. Classen
09:20 – 09:30
EU policy on colorectal cancer screening
K. Freese
09:30 – 09:40
Transatlantic Symposium Colorectal
Cancer Screening and Prevention
C. Maar, M. Classen, S. Winawer
09:40 – 09:50
How patients can help to make screening
programmes successful
L. Faulds Wood
09:50 – 10:40
Session 2:
Introduction
Chair:
R. Ancelle-Park, J. Regula, M. Zappa
09:50 – 10:00
Meeting objectives
L. von Karsa
10:00 – 10:10
Guideline outline and methodology
J. Patnick
302
10:10 – 10:20
Evaluation of evidence
N. Segnan
10:20 – 10:40
Chapter 1: Introduction
I. Vogelaar
11:00 – 12:30
Session 3:
EU Guidelines presentation and
discussion – 1
Chair:
J. Patnick, N. Segnan, G. Hoff
11:00 – 11:20
Chapter 2: Organisation
N. Malila
11:20 – 11:40
Chapter 3: Evaluation
S. Moss
11:40 – 12:00
Chapter 4: FOBT
S. Halloran
12:00 – 12:30
Chapter 5: Endoscopy
R. Valori
14:00 – 15:20
Session 4:
EU Guidelines presentation and
discussion – 2
Chair:
L. von Karsa, R. Lambert, R. Leicester,
W. Schmiegel
14:00 – 14:20
Chapter 6: Training
B. Steele
14:20 – 14:40
Chapter 7: Pathology
P. Quirke
14:40 – 15:00
Chapter 8: Management of lesions
detected in screening
B. Steele
15:00 – 15:20
Chapter 9: Surveillance
W. Atkin

15:40 – 16:30
Session 5:
EU Guidelines presentation and
discussion – 3
Chair:
J. Patnick, N. Segnan, L. von Karsa
15:40 – 16:00
Chapter 10: Communication
J. Austoker
16:00 – 16:30
Final discussion and future guideline
topics
16:30 – 18:00
Poster viewing in Room SG 24
Chair:
J. Faivre, G. Hoff, S. Tornberg
Reviewer:
M. Classen, R. Hultcrantz, N. Malila, C. Pox,
D. Ransohof, J. Regula, C. Senore, G. Tytgat,
S. Winawer
17:30 – 18:00
Parallel Session: Poster viewing
meeting
Chair:
J. Faivre, G. Hoff, S. Tornberg
OMED/JGES: Narrow Band Imaging
(NBI): From Classification to Clinical
Practice
Sunday, November 22, 2009
09:00 – 12:45 Room SG 11/12
Organising Committee:
J-F. Rey
Chair:
A.T.R. Axon, M. Kaminishi
09:00 – 09:05
Opening remarks
A.T.R. Axon
09:05 – 11:00
Session 1
Moderator:
H. Tajiri, J-F. Rey
09:05 – 09:30
Technical Update on NBI
J-F. Rey, L. Aabakken
coMMon InTeResT GRoUP MeeTInGs
09:30 – 10:00
NBI and Barrett oesophagus
P. Sharma
10:00 – 10:30
Overview of other endoscopic situations
(such as stomach and duodenum)
M. Kato
10:30 – 11:00
Correlation between endoscopic aspects
and pathology
R. Lambert
11:00­11:10
Break
11:10 – 12:30
Session 2
Moderator:
B. Saunders, S. Tanaka
11:10 – 11:30
NBI for detection of colonic neoplasia
T. Kaltenbach
11:30 – 11:50
NBI for lesion characterisation in the colon
J. East
11:50 – 12:10
NBI classification systems for colonic
neoplasia and early cancer
S. Tanaka
12:10 – 12:30
NBI to assess UC related dysplasia and
inflammation
E. Dekker
12:30 – 12:45
Closing remarks
M. Kaminishi
Task Force Thiopurines
(AZA, 6­MP and 6­TG)
Sunday, November 22, 2009
09:00 – 12:30 Platinum 1
Organising Committee:
C.J.J. Mulder, A.A. van Bodegraven
Chair:
G.J. Mantzaris, J. Sanderson
303

coMMon InTeResT GRoUP MeeTInGs
09:00 – 10:30
Session 1:
Conventional thiopurine therapy in
IBD
09:00­09:10
Therapeutic drug monitoring and the role
of co-medication
M.P. Sparrow
09:30 – 09:40
Indications and follow-up of thiopurine
therapy in the postoperative setting
W. Reinisch
10:00 – 10:10
How long to prolong thiopurine therapy
M. Lemann
11:00 – 12:30
Session 2:
Toxicological considerations and
alternative thiopurines
11:00 – 11:10
Toxicity of conventional thiopurines;
epidemiology and pathophysiological
hypotheses
A. Ansari
11:30 – 11:40
Therapeutic drug monitoring and
hepatotoxicity of 6-TG in comparison with
conventional thiopurines
N.K.H. de Boer
12:00 – 12:10
Update on efficacy and toxicity of 6-TG
S.H. Almer
2009 Update to International
Guidelines on the Management of
Patients with Non Variceal Upper
Gastrointestinal Bleeding – The
Vienna Consensus Conference
Sunday, November 22, 2009
13:00 – 14:45 Platinum 3/4
Organising Committee:
A. Barkun, M. Bardou, E. Kuipers, L. Lundell,
J. Sung
Chair:
L. Lundell
304
13:00 – 13:05
Introduction
L. Lundell
13:05 – 13:25
Background, methods, supportive measures
and pre-endoscopic management
A. Barkun
13:25 – 13:40
Endoscopic management
J. Sung
13:40 – 13:55
Pharmacotherapy and in-hospital care
M. Bardou
13:55 – 14:10
Secondary prophylaxis of ulcer bleeding
E. Kuipers
14:10 – 14:40
Question and Answer period
14:40 – 14:45
Concluding remarks
L. Lundell
Stomach Health Initiative
Sunday, November 22, 2009
13:00 – 16:00 Room SG 9
Organising Committee:
P. Malfertheiner
Meeting of the European Society for
the Study of Coeliac Disease (ESSCD)
Sunday, November 22, 2009
13:30 – 17:30 Platinum 1
Organising Committee:
C.J.J. Mulder, K.E.A. Lundin, C. Cellier, P. Collin
Chair:
P. Ciclitira, C.J.J. Mulder
13:30 – 14:10
Session 1:
Coeliac Disease in developing
countries
13:30 – 13:50
Speeding up Coeliac Disease diagnosis
in Brazil
S. Crovella

13:50 – 14:10
Indian North-South shift in Coeliac
Disease; lack of wheat in South India?
A.S. Puri
14:10 – 17:30
Session 2:
When is a coeliac a coeliac?
Update of Amsterdam UEGF 2001
14:10 – 14:30
Is EMA+ve with Marsh 0 already Coeliac
Disease?
P. Collin
14:30 – 14:50
How to manage Marsh I
W. Dickey
14:50 – 15:10
Antibodies: minimal approach: tTGA takes
over EMA in clinical practice?
C. Catassi
15:10 – 15:30
Coffee break
15:30 – 15:50
Follow-up serology (tTGA) and biopsies
(1 year?)
D.S. Sanders
15:50 – 16:10
Immunogenetics: DQ2 DQ8; which
heterodimers to calculate risks?
R. Troncone
16:10 – 16:30
Screening once a lifetime or only in high
risk groups?
C.J.J. Mulder
16:30 – 16:50
Wheat starch and oats: which limitations
K.E.A. Lundin
16:50 – 17:05
Refractory coeliacs: work-up;
Monoclonality and immunogenetics
C. Cellier
17:05 – 17:20
T-flow of duodenal biopsies to distinguish
RCD I / RCD II
W.H.M. Verbeek
coMMon InTeResT GRoUP MeeTInGs
17:20 – 17:30
Logistic approach “UEGF Guidelines 2010”
Deadline Final Concept: Where to publish
General Discussion: All participants
ESDO/IDCA Postgraduate Course on
Digestive Oncology:“HGE and modern
oncology”
Sunday, November 22, 2009
14:00 – 18:00 Hall N 11/12
Organising Committee:
P. Rougier, W. Schmiegel, E. van Cutsem,
S. Winawer
14:00 – 14:30
Session 1:
Introduction: multidisciplinarity in
Digestive Oncology
Chair:
G. Tytgat, S. Winawer, P. Rougier
Importance of oncology for UEGW and
ESDO
R. Hultcrantz
What is ESDO? Plans for the future
E. van Cutsem
Who treat the digestive cancers in
Europe?
P. Rougier
14:30 – 15:30
Session 2:
Management of colorectal cancer
Progress in management of colorectal
cancer in 2009
Chair:
E. van Cutsem, M. Classen
Adjuvant treatment for colorectal cancer
in 2009?
W. Schmiegel
Metastatic CRC which chemotherapy as
first treatment?
M. Seymour
Metastatic colorectal cancers place of
targeted therapy
E. van Cutsem
305

coMMon InTeResT GRoUP MeeTInGs
15:30 – 16:30
Session 3:
Strategy in liver metastases from CRC;
round table
Chair:
W. Schmiegel, G. Poston
A case of resectable LM
J. Figueras
A case of potentially resectable LM
G. Poston
A case of synchronous non resectable LM
P. Rougier
16:30 – 16:45
Break
16:45 – 17:45
Session 4:
What's new in (the best in 10 minutes
messages)
Chair:
J. Sung, R. Glynes Jones
Liver (HCC)
T. Seufferlein
Pancreatic cancers
M. Lutz
Gastric cancer
P. Michel
Rectal cancer
R. Glynes Jones
European guidelines of screening for CRC
N. Segnan
Targeted tt in digestive endocrine tumors
P. Ruszniewski
17:45­18:00
Conclusion: Importance of integrating
digestive oncology in the official formation
of hepatogastro enterologist in
Europe
W. Schmiegel
306
ESNM: High Resolution Manometry
Consensus Group
Sunday, November 22, 2009
15:00 – 18:00 Room NG 18
Organising Committee:
M. Fox, J. Pandolfino, A. Bredenoord
Chair:
A. Smout, P. Kahrilas
15:00 – 15:40
Presentation of on-line study:
Inter-observer reproducibility of swallow
classification
M. Fox
15:40 – 16:20
Study Planning: Inter-observer reproducibility
of diagnostic classification
J. Pandolfino
16:20 – 17:00
The Next Steps: Z-HRM, test meals and
other advances
D. Sifrim, R. Sweis
17:00 – 18:00
XHRM open access format
D. Menne
Rome Foundation Breakfast Meeting
Monday, November 23, 2009
07:00 – 08:00 Room SG 24
Organising Committee:
R. Spiller, E. Coriziari, F. Azpiroz
How I manage a patient with difficult…
Chair:
E. Coriziari, F. Azpiroz
07:00 – 07:20
J. Tack
07:20 – 07:40
M. Fox
07:40 – 08:00
S. Rao

IBD infusion unit performance.
The prospective FAST cohort study of
IBD patients with accelerated anti TNF
infusions. A European collaborative
effort.
Monday, November 23, 2009
17:00 – 18:30 Room SG 13
Organising Committee:
G. van Assche, C. O’Morain,
J.C. Vanderwoude, R. Befrits,
S. Veerapan, P.J. Hamlin
Cohort progress: inclusion status, CRF,
interim results and planning further
study conduct
Chair:
R. Befrits, G. van Assche
OMED: Safe sedation in
Gastrointestinal Endoscopy
Monday, November 23, 2009
17:15 – 19:15 Room SG 24
Organising Committee:
S. Ladas, A.T.R. Axon, G. Costamagna,
T. Ponchon, D. Bjorkman
17:15 – 17:45
Session 1:
Introductory lectures
Chair:
G. Costamagna
17:15 – 17:25
Meeting Philosophy
A.T.R. Axon, G. Costamagna
17:25 – 17:35
Sedation for GI Endoscopy: Views around
the world
S. Ladas
17:35 – 17:45
Throat Spray, sedation or anesthetic?
A.T.R. Axon
17:45 – 18:05
Session 2:
Safety in endoscopic sedation
Chair:
S. Ladas
coMMon InTeResT GRoUP MeeTInGs
17:45 –17:55
Preprocedural Assessment
J-M. Dumonceau
17:55 – 18:05
Sedation and Reversal Agents
A. Fassoulaki
18:05 – 18:25
Session 3:
Monitoring the patient
Chair:
J-M. Dumonceau
18:05 – 18:15
Basic requirements (Blood pressure, Pulse
Oximetry, EKG)
D. Bjorkman
18:15 – 18:25
Visual assessment of sedation levels
(Ramsey, MOAA/S, Capnography)
T. Wehrmann
18:25 – 18:55
Session 4:
Sedation Issues
Chair:
A.T.R. Axon
18:25 – 18:35
Level of intended sedation
G. Paspatis
18:35 – 18:45
Sedation by non-Anesthesiologists
T. Wehrmann
18:45 – 18:55
When to consider anaesthesiology
assistance
T. Ponchon
18:55 – 19:15
Session 5:
Sedation Training
Chair:
T. Ponchon
18:55 – 19:05
Elements of airway training
A. Fassoulaki
19:05 – 19:15
Documentation of Competency
D. Bjorkman
307

coMMon InTeResT GRoUP MeeTInGs
Biomarkers as diagnostic in
Gastrointestinal Tumors and
prognostic tool
Monday, November 23, 2009
17:15 – 19:45 Room PR 1
Organising Committee:
G. Ramadori
Chair:
F. Farinati, P. Malfertheiner
17:05 – 17:20
Chip array in liver cancer
T. Roskams
17:25 – 17:40
Single gene mutation assays in CRC
D. Hughes
17:45 – 18:00
Biomarkers for identification of gastric
cancer precursor lesions
M. Leja
18:05 – 18:20
Biomarkers in pancreatic cancer
M. Löhr
18:25 – 18:40
MicroRNAs biomarkers and healthcare:
the near future of high-throughput
screening
I. Amarantos
18:45 – 19:00
Techniques and possibilities of every day
practice of endoscopic sampling and the
future directions
A. Pap
19:05 – 19:20
MicroRNA biomarkers in Barrett’s oesophagus
and oesophageal adenocarcinoma
J.W.P.M. van Baal
19:20 – 19:35
Tumor microenvironment: which cell to
target
S. Cameron
19:40 – 19:45
Closing Remarks and Snack
G. Ramadori
308
Role of Small Bowel Endoscopy in the
management of patients with IBD: An
International OMED­ECCO Consensus
Monday, November 23, 2009
17:30 – 18:30 Room SG 25/26
Organising Committee:
S. Travis, A. van Gossum, J-F. Colombel
17:30 – 17:50
Definitions, procedures and process
A. Borreille
17:50 – 18:10
Indications, outcomes and complications
A. Ignjatovic
18:10 – 18:30
Discussion
S. Travis
The South Asian Health Foundation
(U.k.)
Monday, November 23, 2009
17:30 – 19:30 Platinum 1
Organising Committee:
N. Bhala, S. Pathmakkantham, S. Singhal,
T. Iqbal
Ethnic differences in gastrointestinal
diseases: where are we now and where
are we going?
Chair:
K. Bardhan, J. Mayberry
Setting the scene – ethnicity & health
N. Bhala
Ethnic differences in liver disease
R. Jalan
Ethnic differences in luminal
gastroenterology
T. Iqbal
Gastrointestinal disease in India
B. Ramakrishna
Gastrointestinal disease in China
F. Chan
Parallels with other diseases – what can
we expect in gastroenterology?
C. Bardhan

EDMC: 5th workshop on severe GI
Motility Disorders
Tuesday, November 24, 2009
07:00 – 08:00 Platinum 1
Organising Committee:
A. Accarino, F. Azpiroz, J.R. Malagelada,
S. Delgado-Aros, S. Mueller-Lissner,
V. Stanghellini, R. De Giorgio, J-M.
Vanderwinden, B. Coffin, W. Kruis, S. Böhm,
J. Tack, G. Boeckxstaens, J.P. Galmiche,
S. Bruley des Varannes, R. Spiller, J. Wright,
E. Husebye, G. Lindberg, H. Tornblom,
A. Smout, M. Fried, H. Frühauf, W. Schwizer
Chair:
S. Delgado-Aros
07:05 – 07:30
Session 1:
07:05 – 07:20
A new type of small bowel motor
dysfunction with hyperactivity
A. Accarino
Expert:
V. Stanghellini, R. De Giorgio,
J.-M. Vanderwinden
07:20 – 07:30
Discussion with the audience
A. Accarino
07:30 – 07:55
Session 2:
07:30 – 07:45
A 39-year old man with tachyduodenia
A. Smout
Expert:
G. Lindberg, R. De Giorgio
07:45 – 07:55
Discussion with the audience
A. Smout
07:55 – 08:00
Chair closes session
coMMon InTeResT GRoUP MeeTInGs
ECSSID Meeting
Tuesday, November 24, 2009
17:30 – 19:30 Room SG 25/26
Organising Committee:
G. Gay, M. Pennazio, J.M. Herrerías,
A. Caunedo, J-C. Saurin
Small Bowel Tumors
Chair:
G. Gay, J.M. Herrerías
17:30 – 17:40
Introduction
G. Gay
17:40 – 18:00
Small Bowel tumors: overview
M-D. Diebold
18:00 – 18:20
Radiology and small bowel tumors
V. Laurent
18:20 – 18:40
Capsule endoscopy and small bowel
tumors
M. Pennazio
18:40 – 19:00
Enteroscopy and small bowel tumors
M. Keuchel
19:00 – 19:20
Technical approach of small bowel tumors
and influence on outcomes
M. Delvaux
19:20 – 19:30
General Discussion
309

high five
the power of
in ulcerative colitis
Come and see us
at booth 84
Adverse events should be reported.
Information about adverse event reporting
can be found at www.yellowcard.gov.uk
Prescribers are recommended to consult
the Summary of Product Characteristics before
prescribing, particularly in relation to side-effects,
precautions and contra-indications.
Further information is available on request from:
Ferring International Center SA, Chemin de la
Vergognausaz 50,1162 Saint-Prex, Switzerland,
+41 58 301 00 00
Date of preparation: July 2009
mesalazine
Celebrate PODIUM -
a study demonstrating
excellent clinical efficacy
POM

BUSINESS
MEETINGS
and
PRESS
CONFERENCES

UsIness MeeTInGs
GASTRO 2009
Saturday, November 21, 2009
08:00 – 09:00, Room NG 4
GASTRO 2009 Steering Committee Meeting
Wednesday, November 25, 2009
11:00 – 12:30, Room SG 24
Industry Debriefing GASTRO 2009
Briefing UEGW 2010 and 2011
UEGF
Friday, November 20, 2009
15:00 – 20:00, Room NG 4
UEGF Council Meeting
Sunday, November 22, 2009
09:00 – 13:00, Room NG 9
UEGF/EBG CME Evaluation Committee
16:00 – 19:00, Room SG 24
UEGF General Assembly Meeting
Monday, November 23, 2009
16:00 – 18:30, Room NG 4
UEGF Scientific Committee Meeting
Tuesday, November 24, 2009
07:30 – 09:30, Room NG 4
UEGF Public Affairs Committee Meeting
12:00 – 14:00, Room NG 4
UEGF Education Programme Committee
Meeting
WGO
Thursday, November 19, 2009
09:00 – 17:00, Room NG 6
WGO Executive Committee Meeting
Friday, November 20, 2009
09:00 – 17:00, Room NG 6
WGO Executive Committee Meeting
Saturday, November 21, 2009
10:00 – 12:00, Room NG 6
Finance Committee Meeting
14:00 – 17:00, Room NG 6
WGO Governing Council Meeting
Sunday, November 22, 2009
08:00 – 10:00, Room SG 17
Education and Training Committee Meeting
312
14:00 – 15:30, Room NG 13
WGO Guidelines and Promotion Committee
Meeting
Monday, November 23, 2009
08:00 – 10:00, Room NG 6
WGO Outreach Taskforce (E&T)
12:00 – 15:00, Room NG 6
WGO Foundation Board Meeting
Tuesday, November 24, 2009
14:00 – 17:00, Room SG 25/26
WGO-OMGE General Assembly
BSG
Monday, November 23, 2009
12:30 – 13:30, Room NG 13
Oesophageal section at the BSG
GI Nurses 2009 – ESGENA/SIGNEA
Saturday, November 21, 2009
17:15 – 18:15, Room SG 23
SIGNEA General Assembly
Sunday, November 22, 2009
18:00 – 19:00, Room SG 23
ESGENA General Assembly
ASGE
Saturday, November 21, 2009
08:00 – 11:00, Room NG 12
International Committee Meeting
Sunday, November
09:00 – 10:00, Boulevard Office NO5 up
APDW 2010
ASNEMGE
Saturday, November 21, 2009
13:00 – 16:00, Room NG 12
Governing Council Executive Meeting
Sunday, November 22, 2009
08:00 – 10:45, Room NG 18
ASNEMGE/AGA Exchange Meeting
18:30 – 20:00, Room SG 10
Presidential Reception
Monday, November 23, 2009
16:30 – 18:00, Room SG 17
General Assembly

EAGE
Saturday, November 21, 2009
14:00 – 18:30, Room PR 2
Board Meeting & General Assembly
ECCO
Saturday, November 21, 2009
09:00 – 13:00, Room SG 17
Pathogenesis Workshop/Group
12:45 – 13:45, Room NG 18
Organising Committee ECCO’11 Dublin
14:00 – 16:00, Room PR 1
Consensus Meeting – Pregnancy
14:00 – 16:00, Room NG 18
SciCom
16:15 – 18:15, Room NG 18
EduCom
Sunday, November 22, 2009
08:00 – 12:00, Room PR 2
EpiCom
08:00 – 13:30, Room NG 13
Governing Board
13:00 – 15:00, Room NG 12
NECCO Steering Committee Meeting
14:00 – 15:00, Room PR 2
ORIGIN (IBD Family Project)
15:00 – 17:00, Room NG 12
NECCO National Reps Meeting
16:00 – 19:00, Room SG 11/12
National Reps
EDS
Tuesday, November 24, 2009
12.30 – 14.30, Room NG 12
Council Meeting
EPC
Monday, November 23, 2009
12:30 – 14:30, Room NG 12
Council Meeting
bUsIness MeeTInGs
ESNM
Sunday, November 22, 2009
08:00 – 10:00, Room PR 1
ESNM Steering Committee Meeting
10:00 – 11:00, Room PR 1
ESNM Members’ Assembly
ESPGHAN
Sunday, November 22, 2009
11:00 – 13:00, Boulevard Office NO5 up
ESPGHAN Publication Committee Meeting
14:00 – 17:00, Boulevard Office NO5 up
ESPGHAN/UEGF Sub-Committee Meeting
Monday, November 23, 2009
14:30 – 15:30, Room NG 13
ESPGHAN Trainee Meeting
Tuesday, November 24, 2009
08:00 – 16:00, Room NG 13
Working group on Celiac Disease Diagnosis
in Children
09:00 – 12:00, Room NG 12
EMEA Meeting
fEMGA
Sunday, November 22, 2009
12:00 – 14:00, Room NG 18
fEMGA Business Meeting
313

PRess confeRences
Press Room
South Gallery room SG 20
Press Conference I
Monday, November 23, 2009
12:00 – 13:00, room SG 21/22
■ Abdominal disorders:
Diet: Facts and fiction
Chris Hawkey (UK)
■ The robotic surgeon
Lord Darzi (UK)
■ New guidelines for colorectal cancer
screening
Colm O'Morain (Ireland)
Lynn Faulds Wood (UK)
314
Press Conference II
Tuesday, November 24, 2009
12:00 – 13:00, room SG 21/22
■ Dietary prevention of colorectal
cancer?
John Mathers (UK)
■ A non-recognised burden in the west:
Hepatitis B
Cihan Yurdaydin (Turkey)
■ Quality assurance in endoscopy:
Who cares?
tba

SATELLITE
SYMPOSIA
and
BREAKFAST
MEETINGS

saTellITe sYMPosIa anD bReakfasT MeeTInGs
Sunday, November 22, 2009
18:00 – 19:30, Hall N 7/8
New Horizons in Irritable Bowel
Syndrome: developments in
pathogenesis and a report from the
WGO Task Force.
Organiser: WGO supported by an
educational grant from Procter and
Gamble Healthcare
Chair: E. Quigley, Ireland; C. Olano,
Uruguay; R. Hunt, Canada
18:00 – 18:20
The Enteric Microbiota: Implications for
IBS
F. Guarner, Spain
18:20 – 18:40
IBS: An Inflammatory Disorder?
G. Barbara, Italy
18:40 – 19:00
A Global Perspective on IBS:
A Report from the WGO IBS Task Force
E. Quigley, Ireland
19:00 – 19:20
Panel Discussion
Monday, November 23, 2009
07:00 – 08:00, Hall N 7/8
The benefit of advanced imaging
modalities for colon cancer screening
and therapy
Organiser: Pentax Europe GmbH
Chair: P. A. Testoni, Italy
07:00 – 07:10
Welcome & Introduction
P. A. Testoni, Italy
07:10 – 07:25
The value of detection during colon
cancer screening using HD+ and i-scan
R. Bisschops, Belgium
316
07:25 – 07:40
Detailed analysis is important:
Characterization of colorectal lesions
using i-scan and endomicroscopy
R. Kiesslich, Germany
07:40 – 07:55
Polyp/lesion resection in the colorectum
by ESD technique in combination with
i-scan
F. Kawahara
07:55 – 08:00
Conclusions
P. A. Testoni, Italy
Monday, November 23, 2009
18:00 – 19:30, Hall N 7/8
Frontiers of endoscopy: exploring the
boundaries
Organiser: Fujinon (Europe) GmbH
Chair: D. Carr-Locke, USA; C. Ell, Germany;
H. Yamamoto, Japan
18:00 – 18:05
Introduction
D. Carr-Locke, USA
18:05 – 18:20
Endoscopic Submucosal Dissection (ESD)
from the Japanese point of view
T. Toyonaga, Japan
18:20 – 18:35
Endoscopic Submucosal Dissection(ESD)
from the European point of view
T. Ponchon, France
18:35 – 18:50
Keynote lecture: Double Ballon
Endoscopy (DBE)
H. Yamamoto, Japan
18:50 – 19:05
Double Ballon Endoscopy (DBE) vs. Single
Ballon Endoscopy (SBE): The result of a
comparison
A. May, Germany

19:05 – 19:20
Double Ballon Endoscopy (DBE) in altered
anatomy
G. Haber, USA
19:20 – 19:30
Comment, conclusion and adjourn
Monday, November 23, 2009
18:00 – 19:30, Hall N 9/10
The clinical dilemma of chronic constipation:
Prucalopride – The new way
forward?
Organiser: Movetis NV
Chair: M. Kamm, Australia
18:00 – 18:05
Introduction and opening remarks
M. Kamm, Australia
18:05 – 18:15
How do we currently manage chronic
constipation?
M. Kamm, Australia
18:15 – 18:35
Disordered motility and therapeutic
targets in chronic constipation
J. Tack, Belgium
18:35 – 18:55
Prucalopride and its place in chronic
constipation management
M. Camilleri, USA
18:55 – 19:10
Patient selection for prucalopride use
S. Müller-Lissner, Germany
19:10 – 19:25
Case-based discussion session
M. Kamm, Australia
19:25 – 19:30
Closing remarks
M. Kamm, Australia
saTellITe sYMPosIa anD bReakfasT MeeTInGs
Monday, November 23, 2009
18:00 – 19:30, Hall S 4/5
“Extending the opportunities for better
clinical outcomes in acid­related
disorders"
Organiser: AstraZeneca
Chair: E. Kuipers, The Netherlands
18:00 – 18:20
The challenge of improving management
of patients at high risk of peptic ulcer
secondary to NSAIDs and low-dose ASA
A. Lanas, Spain
18:20 – 18:50
Required clinical steps to improve
outcomes in peptic ulcer bleed
E. Kuipers, The Netherlands
18:50 – 19:20
How can GERD management be further
improved?
P. Bytzer, Denmark
19:20 – 19:30
Panel discussion and Q&A
Tuesday, November 24, 2009
07:00 – 08:00, Hall N 7/8
Esophageal Stenting: Changing
Algorithms, Changing Outcomes
Organiser: Boston Scientific
Chair: H. Neuhaus, Germany
Malignant Strictures: Advancing treatment
algorithms
M. Giovannini, France
Benign Conditions: Expanding the role of
stents
J. Devière, Belgium
Stenting: Minimizing reintervention rates
P. Siersema, The Netherlands
317

saTellITe sYMPosIa anD bReakfasT MeeTInGs
Tuesday, November 24, 2009
07:00 – 08:00, Hall N 9/10
Moving Forward in the Management
of Ulcerative Colitis
Organiser: Schering-Plough
Chair: G. Van Assche, Belgium
07:00 – 07:10
Opening Remarks
G. Van Assche, Belgium
07:10 – 07:25
Patient Selection:Which UC Patient Do We
TreatWith a Biologic?
J. Panés, Spain
07:25 – 07:40
Timing of Treatment: How Do We
Move Faster Through the UC Treatment
Algorithm?
W. Reinisch, Austria
07:40 – 07:45
Closing Remarks
G. Van Assche, Belgium
07:45 – 08:00
Question-and-Answer Session
Tuesday, November 24, 2009
07:00 – 08:00, Hall N 11/12
What’s new regarding actuality,
epidemiology and treatment of IBS?
Organiser: Mayoly Spindler
Chair: P. Ducrotte, France
07:00 – 07:20
From barrier disorders to hypersensitivity
in IBS patients
L. Bueno, France
07:20 – 07:40
Epidemiology of IBS with previous and
current Rome criteria
M. Dapoigny, France
318
18:20 – 18:40
Improving patient outcomes: Existing
treatment options and emerging targeted
therapies
J. Tack, Belgium
07:40 – 08:00
Alverine citrate and simeticone
combination significantly relieves
abdominal pain/discomfort in IBS patients
T. Wittmann, Hungary
Tuesday, November 24, 2009
18:00 – 19:30, Hall N 7/8
The dark side of IBS
Organiser: Norgine
Chair: F. Azpiroz
IBS – a multidimensional disorder
V. Stanghellini
IBS: Bacteria and Inflammation
R. Spiller
Evidence based treatment of IBS
W. Chey
Q&A / Panel discussion
F. Azpiroz
Tuesday, November 24, 2009
18:00 – 19:30, Hall N 9/10
PPIs and GLP­2: more than just a gut
feeling?
Organiser: Nycomed
Chair: E. Quigley, Ireland
Unraveling the mechanisms and
consequences of drug interactions
L. Welage, USA
The appropriate use of PPIs: Closing the
treatment gap
P. Katelaris, Australia
Short bowel syndrome: is GLP-2 the short
answer?
P. Jeppesen, Denmark

Tuesday, November 24, 2009
18:00 – 19:30, Hall S 6/7
Mucosal Healing: Following the Right
Track in Crohn’s Disease
Organiser: Schering-Plough
Chair: D. Hommes, The Netherlands
18:00 – 18:10
Opening Remarks
D. Hommes, The Netherlands
18:10 – 18:35
SONIC: Practical Lessons in the
Management of CD With Remicade®
J-F. Colombel, France
18:35 – 18:55
Why Should We Aim to Achieve Mucosal
Healing?
F. Schnitzler, Germany
18:55 – 19:10
What Do Patients Want in the
Management of Their CD?
G. Van Assche, Belgium
19:10 – 19:15
Closing Remarks
D. Hommes, The Netherlands
19:15 – 19:30
Question-and-Answer Session
saTellITe sYMPosIa anD bReakfasT MeeTInGs
319

GI Nurses 2009
ESGENA/SIGNEA
London
hosted by the
“Endoscopy Associates Group of the
British Society of Gastroenterology
(BSG­EAG)”
in conjunction with
At the ExCeL Centre in London, UK,
November 21 – 23, 2009

GI nURses 2009 esGena/sIGnea lonDon
WelcoMe aDDRess
Dear Colleagues,
Ulrike beilenhoff
President of esGena
norah connelly
President of sIGnea
Pauline Hutson
chair of bsG-eaG
322
In conjunction with “GASTRO 2009 UEGW/WCOG, London”, the
“European Society of Gastroenterology and Endoscopy Nurses
and Associates (ESGENA)” and the “Society of International
Gastroenterological Nurses and Endoscopy Associates (SIGNEA)”
organise a joint meeting on 21–23 November 2009, hosted
by the “Endoscopy Associates Group of the British Society of
Gastroenterology (BSG-EAG)”. The meeting is called “GI Nurses 2009”.
It is with great pleasure that we invite you to this comprehensive
three-day conference with interesting topics in Gastroenterology
and Endoscopy. This format will encourage networking and
communication between colleagues from all over the world.
On Saturday, there will be an opportunity to attend a choice of 12
workshops organized in four parallel rooms. The workshops will have
a practical focus and will be held in smaller groups – up to 50 – to
encourage discussion, questions and exchange of ideas. Following
success at previous conferences, we will be offering hands-on
training using biosimulators for nurses on Saturday and Sunday. These
workshops will be organised in close cooperation with ESGE and
OMED. Nurses will also have access to the post-graduate course of
GASTRO 2009 UEGW/WCOG, London on Saturday and Sunday and the
live demonstrations, which are planned from Monday to Wednesday.
The conference will officially open with the GI Nurses 2009
Welcome Reception on the Saturday evening. In the past, this has
been a most enjoyable, informal evening with the opportunity to
meet colleagues and friends from all over Europe and overseas.
This evening will be organised by the BSG-EAG as hosts of the
conference.
On Sunday, the scientific programme, which includes two free
paper sessions and a nurses’ poster session, will offer mainly nursingoriented
lectures in two parallel halls. In addition, 3 parallel lunch
sessions will have a more practical focus. On Monday morning, the
Plenary Session will bring together all the delegates and prizes will
be awarded for the best free paper and the best poster.
The trade exhibition will open on Monday at lunchtime, and there should be enough time
to browse the stands if the medical scientific programme does not tempt you back into
the lecture halls.
We look forward to welcoming you to GI Nurses 2009 in November 2009 in London, UK.
Ulrike Beilenhoff
President of ESGENA
Norah Connelly
President of SIGNEA
Pauline Hutson
Chair of BSG-EAG

scIenTIfIc secReTaRIaT
Ulrike Beilenhoff (President)
c/o Medconnect GmbH
Brunnsteinstr. 10
81541 Munich, Germany
Telephone: +49 731 950 3945
Email: UK-Beilenhoff@t-online.de
You may also contact www.esgena.org
and www.signea.org and
www.gastro2009.org
sIGnea annUal GeneRal MeeTInG
SIGNEA Annual General Meeting will be
held on Saturday November 21, 2009.
Access for SIGNEA members only.
esGena annUal GeneRal
MeeTInG
ESGENA Annual General Meeting will
be held on Sunday, November 22, 2009.
Access for ESGENA members only.
oRGanIseR & conGRess offIce
GASTRO 2009 Secretariat
Hollandstrasse 14/Mezzanine
1020 Vienna/Austria
Tel: +43-(0)1-212 36 91
Fax: +43-(0)1-212 36 91-29
E-mail: secretariat@gastro2009.org
conGRess VenUe
ExCeL London
One Western Gateway, Royal Victoria Dock
E16 1XL London
Tel: +44-(0)20-7069 5000
Fax: +44-(0)20-7069 4747
E-mail: info@ExCeL-london.co.uk
www.ExCeL-london.co.uk
conGRess lanGUaGe
The congress language is English. No
simultaneous translation will be provided.
GI nURses 2009 GeneRal InfoRMaTIon
socIal eVenTs
Saturday, November 21, 2009
■ Evening: Welcome Reception &
Opening of GI Nurses 2009, from
17.30 – 19.30 at ExCeL, Platinum Suite
■ Attendance at the Welcome Reception
is included in the registration
■ Ticket: Access only with badges of GI
NURSES 2009
■ The Endoscopy Associates Group of
the British Society of Gastroenterology
(BSG-EAG) will act as local organisers
for the event.
Sunday, November 22, 2009
■ Evening: Welcome Reception &
Opening of GASTRO 2009, UEGW/
WCOG, London
■ included in registration fee of GI
Nurses 2009
Opening Ceremony & Welcome
Reception of GASTRO 2009
UGW/WCOG, London
You are cordially invited to join the
Welcome Reception on Sunday,
November 22, 2009, at 19:30 at the ExCeL
Centre. The ceremony will be followed
by an entertainment programme and
will offer the opportunity to meet with
colleagues from all over the world.
323

GI nURses 2009 PRoGRaMMe
saTURDaY, noVeMbeR 21, 2009
■ All day: 12 workshops in four parallel
sessions
■ Afternoon: hands-on training on
biosimulators
■ All day: Postgraduate Teaching
Programme of GASTRO 2009, UEGW/
WCOG, London
sUnDaY, noVeMbeR 22, 2009
■ All day: GI Nurses 2009 scientific
programme with free paper and
poster sessions and 3 parallel lunch
sessions
■ All day: hands-on training on biosimulators
■ All day: Postgraduate Teaching
Programme of GASTRO 2009 UEGW/
WCOG, London
MonDaY, noVeMbeR 23, 2009
■ Morning: GI Nurses 2009 Plenary
Session and scientific programme
■ All day: technical exhibition and the
ESGE/OMED Learning Area (exhibition
will open at 09.00 a.m.)
HanDs-on TRaInInG on saTURDaY
anD sUnDaY
■ Hands-on training on biosimulators
will be offered in co-operation with
ESGE and OMED.
■ Registration for nurses will be handled
by ESGENA.
■ Registration will be treated on a firstcome,
first-served basis.
■ Please note that there are only a
limited number of tickets available in
order to ensure small training groups
at each station.
■ Tickets for nurses will be available at
the ESGENA information desk
PosTeR sessIon of GI nURses 2009
■ Scientific posters will be displayed on
Saturday, November 21 and Sunday,
November 22, 2009
■ Two poster sessions will be held on
Sunday
324
lUncH sessIons of GI nURses 2009
■ Lunch sessions will combine stateof-the-art
lectures with hands-on
training on different stations
■ On Sunday, November 22, 2009, 3 parallel
lunch sessions will be offered.
■ Tickets for nurses will be available at
the ESGENA information desk
■ Please note that there are only a
limited number of tickets available in
order to ensure small training groups
at each station.
caTeRInG
■ Conference catering in Hall S 10/11/12
■ Cafés and snack bars in the Boulevard
of ExCel centre.
PosTGRaDUaTe TeacHInG
PRoGRaMMe of GasTRo 2009
■ On Saturday and Sunday, GASTRO
2009 will be offering a full two-day
post-graduate programme incorporating
gastroenterology, hepatology,
endoscopy, surgery, imaging and
other diagnostic modalities.
■ On Monday to Wednesday, live demonstrations
will be transmitted from
London (UK), Hyderabad (India) and
Rome (Italy)

GI nURses 2009 – PRoGRaMMe oVeRVIeW
SATURDAY, NOVEMBER 21, 2009
Lecture Halls Platinum 3/4 S 4/5 S 6/7 S 8/9
08:30 – 18:00
GASTRO 2009 –
PG Training
Programme
GASTRO 2009 –
PG Training
Programme
GASTRO 2009–
PG Training
Programme
11:00 – 12:30
Workshop 1
Sierra Scientific
Instruments:
See it All in One
Colourful Shot:
The Beauty of
practical High-
Resolution
Manometry
13:30 – 15:00
Workshop 5
ESGENA/
BSG-EAG:
Current Issues
around Bowel
Preparation
15:30 – 17:00
Workshop 10
Abbott:
The pivotal Role
of the Gastroenterology
Nurse in
Managing
Crohn’s Disease:
from biological
Therapy to
enabling
cross-speciality
Care
11:00 – 12:30
Workshop 2
BSG-EAG:
Managing
Endoscopy in
the UK
Lunch break
11:00 – 12:30
Workshop 3
CBC Germany /
Kaigen:
Easy-to-use
Endoscope
Channel
Cleaning
with High
Performance
12:30 – 13:30
SIGNEA Annual General Assembly
(members only)
13:30 – 15:00
Workshop 6
Boston Europe:
Endoscopic Clipping:
Changing
Algorithms,
Changing
Outcomes
15:30 – 17:00
Workshop 11
Custom
Ultrasonic:
The Risk of
Biofims and
Transmission of
Clostridium difficile
and other
epidemiologically
important
infectious
Agents during GI
endoscopy
Coffee Break
13:30 – 15:00
Workshop 7
Olympus Europe:
Endoscope
Drying and
Storage:
Current State
of the Art
and future
Challenges
15:30 – 17:00
Workshop 12
Olympus
America:
Benchmarking
and best
Practices,
utilizing
a global
Perspective
17:30 – 19:30
Welcome Reception
GI NURSES 2009
Platinum Suite, ExCeL Centre
11:00 – 12:30
Workshop 4
Pentax:
Automating
Operational
Efficiencies to
Drive quality
Patient Care
13:30 – 15:00
Workshop 8
Given Imaging:
New
Developments
in Capsule
Endoscopy
15:30 – 17:00
Workshop 13
Given Imaging:
Bravo pH
Monitoring
N 13
ESGE / OMED
Learning Area
13:30 – 15:00
Workshop 9
Hands-on
Training on
Biosimulators:
Upper GI
Bleeding
ERCP
Colonoscopy
15:30 – 17:00
Workshop 14
Hands-on
Training on
Biosimulators
Upper GI
Bleeding
ERCP
Colonoscopy
325

GI nURses 2009 – PRoGRaMMe oVeRVIeW
326
SUNDAY, NOVEMBER 21, 2009
Hall S 6/7 Hall S 8/9 Hall S 4/5 Hall S 10 N 13
ESGE / OMED
Learning Area
08:30 – 10:00
Session 1
Free Paper Session
10:00 – 11:00
Coffee
11:00 – 12:30
Session 3
Free Paper Session
12:30 – 14:30
Lunch
13:00 – 14:30
Lunch Session 1
New techniques &
developments
14:30 – 16:00
Session 5
Ethics
08:30 – 10:00
Session 2
Nutrition
10:00 – 11:00
Coffee
11:00 – 12:30
Session 4
Lower GI
12:30 – 14:30
Lunch
13:00 – 14:30
Lunch Session 2:
Key Points of
Endoscope
Reprocessing
14:30 – 16:00
Session 6
GI Diseases
10:00 – 11:00
Coffee
13:00 – 14:30
Lunch Session 3:
Upper GI Endoscopy
and Small Bowel
Endoscopy
16:00 – 16:30 Coffee 16:00 – 16:30 Coffee 16:00 – 16:30 Coffee
16:30 – 18:00
Session 7
IBD
18:00 – 19:00
ESGENA General
Assembly
(members only)
16:30 – 18:00
Session 8
Staff Welfare &
Management
10:00 – 11:00
Poster Round I &
Coffee
13:00 – 14:00
Poster Round II &
Lunch
11:00 – 12:30
Workshop 15
Hands-on-Training
on Biosimulators
ERCP Short wire
System Cook
13:30 – 15:00
Workshop 16
Hands-on-Training
on Biosimulators
ERCP Short Wire
System Olympus
15:30 – 17:00
Workshop 17
Hands-on-Training
on Biosimulators
ERCP Short Wire
System Boston
Upper GI bleeding

GI nURses 2009 – PRoGRaMMe oVeRVIeW
MONDAY, NOVEMBER 22, 2009
Hall S 8/9
08:30 – 10:30
New Techniques and Developments in Endoscopy
Presentation by Major Sponsors
New Technologies in the Detection and Characterisation of Colorectal Neoplasias
Double Balloon Endoscopy –
how many Balloons and Prevention of Complications
Marsha Dreyer Memorial Lecture
Advancements in Endoscopic Treatment of Pancreatic Disease – Yesterday and Today
Best Free Paper and Best Poster Award
Invitation to next conferences
10:30 – 11:00 Coffee
Visit of Exhibition
ESGE/OMED Learning Area
GASTRO 2009 UEGW/WCOG, London Sessions
12:30 – 14:00 Lunch
Visit of Exhibition
ESGE/OMED Learning Area
GASTRO 2009 UEGW/WCOG, London Sessions
GASTRO 2009 UEGW/WCOG, London live demonstrations
15:30 – 16:00 Coffee
Visit of Exhibition
ESGE/OMED Learning Area
GASTRO 2009 UEGW/WCOG, London Sessions
GASTRO 2009 UEGW/WCOG, London live demonstrations
327

GI nURses 2009 – DeTaIleD PRoGRaMMe
saTURDaY, noVeMbeR 21, 2009
WoRksHoP 1:
See It All in One Colourful Shot:
The Beauty of Practical High –
Resolution Manometry
This workshop is organised by Sierra
Scientific Instruments
11:00 – 12:30 Hall Platinum 3/4
Chair:
Debbie den Boer, Rebecca Chandler, USA
Aim:
This learning activity is designed for
nurses, technicians and other healthcare
professionals who perform oesophageal
motility and want to build a foundation
which will enable the user to perform
accurate high-resolution manometry
(HRM) with the ManoScan 360 system
and establish an effective, organized
motility lab.
Objectives upon completion of the
workshop: The participant should be able to:
■ Describe the basic anatomy of the
upper gastrointestinal tract
■ Recognize the swallowing process,
which will be assessed during the
ManoScan study.
■ Be aware of the role of respiration on
the abdominal and thoracic cavity
pressure in aiding the ManoScan
catheter positioning.
■ Comprehend the basic study analysis
with the ManoView Analysis program.
■ Briefly review sample ManoScan
images for normal and abnormal
function
■ Describe the nursing process related
to motility procedures.
WoRksHoP 2:
Managing Endoscopy in the Uk
This workshop is organised by the BSG-
EAG
11:00 – 12:30 Hall S 4/5
Chair:
Alison Ball, Bethan Davies, Susan Dreyer,
Wendy Edwards, Linda Hodgson,
Andrea Nicholls, Libby Thomson, UK
328
Since the advent of the National Bowel
Cancer Screening Programme in the UK,
all endoscopy units have been subjected
to a rigorous quality assurance visit from
the Joint Advisory Group (JAG). This
has stimulated a number of initiatives
to improve training and education for
endoscopy staff. The Endoscopy Team
Leadership Programme is a recent project
which has been generated in order
to address the learning needs of the
Endoscopy Lead.
Aims
■ To define the difference between a
manager and a leader
■ To consider how the leadership role
impacts on goal achievement
■ To discuss common challenges within
the endoscopy environment and how
these can be addressed
Objectives
■ To be able to deliver plans for an effective
and high-quality service
■ To be able to challenge inappropriate
behaviour through competence and
confidence
■ To be able to provide evidence of a
motivated, high-quality team
WoRksHoP 3:
Easy­to­use Endoscope Channel
Cleaning with High Performance
This workshop is organized by CBC Group,
Tokyo, Japan
11:00 – 12:30 Hall S 6/7
Chair:
Monica Cimbro, Italy
Aims & Objectives
This workshop will present a new method
to mechanically clean endoscope
channels by using the channel cleaner
ball brush system. Efficient channel
brushing and cleaning is a prerequisite to
ensure sufficient disinfection. The quality
of cleaning and brushing an endoscope
is dependent on the skill of the worker.
This new method of channel brushing/
cleaning minimizes this variability. It is
easy to handle and provides reproducible

efficient results. Tests performed and
presented during this session show the
good efficacy in lowering the residual
protein and bacteria.
Content
11:00 – 11:30
Evaluation of the cleaning efficacy of
a brushing procedure for endoscope
channels using the ball brush; in vitro trials
Marlene Richard, France
11:30 – 12:00
Clinical experience using the channel
cleaner ball brush method
Maria Vittoria, Italy
12:00 – 12:30
Presentation of cleaning efficacy of the
combination of ball brush and washer
disinfector
WoRksHoP 4:
Automating Operational Efficiencies to
Drive Quality Patient Care
11:00 – 12:30 Hall S 8/9
This workshop is organised by PENTAX
Medical Company America
Chair:
Dariele Burchfield, USA
Aims & Objectives
At the conclusion of this presentation, the
participants will be able to:
■ Describe a structured performance
improvement methodology
■ Understand the definition of benchmarking
and how it can impact and
drive performance improvement
■ Verbalize key data collection points
to measure operational efficiencies
as they relate to patient throughput,
resource utilization, patient satisfaction
and quality indicators
■ Understand tools available to automate
the data collection process
■ Discuss importance of buy-in from
administration, physician and nursing
staff
■ Verbalize take-away strategies for
performance improvement
GI nURses 2009 – DeTaIleD PRoGRaMMe
WoRksHoP 5
Current Issues Around Bowel
Preparation
This workshop is organised by BSG-EAG
13:30 – 15:00 Hall Platinum 3/4
Chair:
Pauline Hutson, UK
Within the UK a recent report highlighted
the dangers of administering bowel
preparation in certain patients.
Recommendations to improve current
practice were subsequently given within
the report, which has had a direct impact
on the administration and supply of
bowel preparation. Gastroenterology and
Endoscopy services have therefore had to
review their services and new guidelines
have been written by the British Society of
Gastroenterology in order to help units to
comply with these changes.
Aims
■ To consider how recent guidelines
relating to bowel preparation have
impacted on the Gastroenterology
and Endoscopy services in the UK and
what lessons can be learnt by other
countries
■ To review areas of good practice,
which relate to the supply and administration
of bowel preparation
■ To discuss the differences in bowel
preparation
Objectives
■ To be able to understand the reason
for the recent National Patient Safety
Agency report in the UK.
■ To be able to challenge current practice
where necessary and implement
change if required.
■ To have an understanding of the
recent British Society of Gastroenterology
guidelines and to be able to
justify new practice.
329

GI nURses 2009 – DeTaIleD PRoGRaMMe
WoRksHoP 6:
Endoscopic Clipping: Changing
Algorithms, Changing Outcomes
This workshop is organised by Boston
Europe
13:30 – 15:00 Hall 4/5
Chair:
Francisco Ou, France
Content:
13:30 – 13:50
The Physician’s view
13:50 – 14:10
The Nurse’s view
14:10 – 14:20
Q&A
14:20 – 15:00
Resolution Clip Hands-on
WoRksHoP 7:
Endoscope Drying and Storage –
Current State of the Art and Future
Challenges
This workshop is organised by Olympus
Medical Systems Europe GmbH, Hamburg,
Germany
13:30 – 15:00 Hall S 6/7
Chair:
Reinhard Blum, Germany
Aims & Objectives
Reliable and effective reprocessing of
endoscopes has been a major focus for
many years. Many recommendations and
new European norms have been published
on this subject. However, the importance of
proper endoscope drying and especially the
storage of ready-to-use endoscopes were of
minor interest in the past. This situation has
started to change. Within the framework of
quality assurance, the documentation and
traceability of endoscopes even during
drying and storage are playing a more
and more important role. This workshop is
intended to
■ show current practice
■ give examples of microbiological risks
in the event of inadequate storage
■ present current guidelines and regulations
330
■ summarise typical and important
product features
■ provide information about documentation
and traceability measures
Speaker:
Lionel Pineau, France; Ulrike Beilenhoff,
Germany; Jayne Tillot, UK
WoRksHoP 8:
New Developments in Capsule
Endoscopy – Reading by Nurse/
Endoscopy Assistant
This workshop is organised by Given
Imaging GmbH, Germany
13:30 – 15:00 Hall S 8/9
Chair:
Owen Epstein, UK
Content
■ How nurses and endoscopy assistants
can do the reading of capsule endoscopy
videos (educational background,
indications, facilities and procedure of
reading, follow-up, legal issues)
■ How medical doctors can benefit
from pre-reading done by nurses
■ How the final report will be compiled
Presentations:
■ Indications, Contraindications, Clinical
Application of Capsuleendoscopy
Owen Epstein, UK
■ Workflow for CE, Scheduling of CE
Reading –Difficulties –Solution
Owen Epstein, UK
■ Pre-Reading by Nurse –When, How,
Tips & Tricks for Reading
Linda Jackson, UK
■ Final Diagnosis Report
Owen Epstein, UK
WoRksHoP 9:
Hands­on Training on Biosimulators
13:30 – 15:00 Hall N13: ESGE/OMED
Learning Area
Chair:
Michael Ortmann, Eric Pflimlin, Switzerland
Hands-on training on biosimulators (pig
models) under the supervision of highly
experienced tutors:
Participants will have the opportunity to
perform endoscopic techniques on the
following topics:

■ OGD with injection techniques, ligation,
clipping, APC
■ Colonoscopy with polypectomy, EMR
and APC
■ ERCP with stone extraction and stenting
As participation will be limited, registration
will be treated on a first-come, first-served
basis.
Tickets will be available onsite only – at the
ESGENA membership desk
WoRksHoP 10:
The Pivotal Role of the
Gastroenterology Nurse in Managing
Crohn’s Disease: From biological
Therapy to Enabling Cross­Speciality
Care
This workshop is organised by Abbott
Laboratories, Abbott Park, Chicago,
Illinois
15:30 – 17:00 Hall S 8/9
Chair:
A multidisciplinary approach is fundamental
to best practice in the management of
Crohn’s disease. From diagnosis onwards, the
gastroenterology nurse plays a critical role as
the patient’s advocate, and is uniquely placed
to coordinate a responsive service that meets
the patient’s changing needs. In this interactive
workshop, IBD nurses and other members
of the healthcare team will illustrate various
aspects of one patient’s journey, up to
and including the use of anti-TNF therapy.
Aims:
In this workshop, gastroenterology
nurses will gain a practical insight into
achieving best practice in individualized
clinical management, including care
for patients receiving anti-TNF therapy.
It will also provide an opportunity to
discuss and reflect on their pivotal role
in the collaborative approach to the
management of Crohn’s disease.
Content:
■ Rationale for treatment history, including
decision to prescribe an anti-TNF
■ Provision of information and support,
ongoing since diagnosis
■ Coordination of cross-speciality care
throughout the treatment journey
GI nURses 2009 – DeTaIleD PRoGRaMMe
■ Anti-TNF therapy: screening, administration
and monitoring
■ The patient’s interpretation of their
disease, and its impact on their life
■ Their counselling need at different
stages of their disease
■ Tailoring of dietary recommendations
with and for this patient
WoRksHoP 11:
The Risk of Biofilms and Transmission
of Clostridium difficile and Other
Epidemiologically Important Infectious
Agents During GI Endoscopy
This workshop is organised by Custom
Ultrasonic
15:30 – 17:00 Hall S 4/5
Chair:
Lawrence F Muscarella, USA
Aims:
A focus on biofilms, multidrug-resistant
organisms (MDROs), and reprocessing
breaches in GI endoscopy.
Objectives
■ Discuss the properties of biofilms,
how they form, and some of the
different surfaces on which they may
form.
■ Investigate whether GI endoscopy
is a risk factor for the transmission of
biofilms.
■ Review the epidemiology of C. difficile,
MDROs, including MRSA and
VRE, and other “epidemiologically
important” microorganisms.
■ Investigate whether GI endoscopy is
a risk factor for the transmission of C.
difficile and MDROs.
■ Discuss standard precautions, the
three primary modes of disease
transmission and transmission-based
precautions, including contact precautions,
which may be necessary to
prevent transmission of C. difficile and
MDROs.
■ Outline strategies to prevent the
transmission of biofilms, C. difficile
and MDROs during GI endoscopy.
■ Answer the audience’s questions
331

GI nURses 2009 – DeTaIleD PRoGRaMMe
WoRksHoP 12:
Benchmarking and Best Practices,
Utilizing a Global Perspective
This workshop is organised by Olympus
America
15:30 – 17:00 Hall S 6/7
Chair:
Nancy Vacante, USA
Description:
It has been said that healthcare facilities
are often data-rich and informationpoor.
Today’s GI facility is no exception.
A quality benchmarking programme can
help convert data into useful information
and improve the business and quality of
care of any GI unit. This presentation will
summarize the features of an effective
benchmarking service applicable to any
country as well as highlight the key 2009
U.S. findings compared to other initiatives
in Canada and Japan. Session attendees
will identify which key findings can be
applied to their practice setting in an effort
to determine their own best practice goals.
Objectives
■ Identify quality benchmarking service
features
■ Identify key U.S. benchmarking findings
and relate to various GI practice
settings
Content:
■ Quality Benchmarking service features
■ What’s available in U.S. versus other
countries
■ Benchmarkings versus Best Practices
■ Highlight 2009 benchmarking results
■ Factors to consider for application to
the individual practice setting
332
WoRksHoP 13:
Bravo pH Monitoring
This workshop is organised by Given
Imaging GmbH
15:30 – 17:00 Hall S 8/9
Chair:
Rami Sweis, Israel
Ambulatory reflux studies provide a
definitive diagnosis in patients with
symptoms that may be related to
gastro-oesophageal reflux. Standard pH
monitoring is performed by placement
of a naso-oesophageal catheter with
a pH electrode 5 cm above the lower
oesophageal sphincter. However, this
can be limited by local discomfort and
social embarrassment, both of which
can result in a modified diet and lifestyle
which may not be representative of
normal daily life and thus reduce refluxprovoking
activities. Furthermore results
of 24-hr catheter-based pH monitoring
are compromised by the high day-to-day
variability in acid exposure in patients with
reflux symptoms. This reduces diagnostic
accuracy and the ability of pH studies to
guide effective clinical management.
Bravo is a new technique which involves
placement of a capsule directly onto the
mucosa of the lower oesophagus. This
transmits information regarding acid
reflux events to a wireless receiver and
can associate symptoms with reflux events
over a prolonged period (48-96 hours).
Prior to its placement, the capsule requires
careful preparation and calibration.
On its return the information recorded
needs to be downloaded and accurately
analysed by an experienced physiologist.
Furthermore, in most centres capsules
are placed endoscopically and require the
assistance of a trained healthcare specialist.
Therefore Bravo wireless pH monitoring
is a coordinated endeavour between
experienced doctors, physiologists and
healthcare professionals.

Aims & Objectives
The seminar will begin with an
introduction to the principles and
practice of modern reflux studies and
the benefits of prolonged ambulatory pH
monitoring. It will then be followed by
brief presentations about the preparation,
insertion and downloading of the data.
The seminar will then develop into an
interactive discussion about reading and
interpreting Bravo pH studies using case
presentations.
Participants
The seminar will be of interest for nurses,
physiologists and physicians caring
for patients with reflux disease and,
in particular, for physicians and staff
performing, reading and interpreting
reflux studies.
Presentations
■ 15:30 – 15:45
Historical background to development of
Bravo TM
Terry Wong, UK
■ 15:45 – 16:00
Improvement in patient tolerability and
diagnostic yield using 48 and 96 hour
Bravo TM studies
Rami Sweis, UK
■ 16:00 – 16:10
Bravo TM preparation/calibration and introduction
to the patient
Jayne Fong, UK
■ 16:10 – 16:20
Endoscopic deployment of Bravo TM capsule,
challenges and possible complications
Dean Borrows and Rami Sweis, UK
■ 16:20 – 16:30
Downloading the data from receiver and
diary card
Jayne Fong, UK
■ 16:30 – 16:50
Reading and interpreting Bravo-pH studies
with interactive case discussions
Rami Sweis and team, UK
■ 16:50 – 17:00
Summary and final questions to the panel
Terry Wong, UK
GI nURses 2009 – DeTaIleD PRoGRaMMe
WoRksHoP 14:
Hands­on Training on Biosimulators
15:30 – 17:00 N 13: ESGE/OMED
Learning Area
Chair:
Michael Ortmann, Eric Pflimlin, Switzerland
Hands-on training on Biosimulators (pig
models) under the supervision of highly
experienced tutors.
Participants will have the opportunity to
perform endoscopic techniques on the
following topics:
■ OGD with injection techniques,
ligation, clipping, APC
■ Colonoscopy with polypectomy,
EMR and APC
■ ERCP with stone extraction and stenting
As participation will be limited, registration
will be treated on a first-come, first-served
basis.
Tickets will be available onsite only – at the
ESGENA membership desk
17:30 – 19:30
Welcome Reception
GI NURSES 2009
Platinum Suite, ExCeL Centre
333

GI nURses 2009 – DeTaIleD PRoGRaMMe
sUnDaY noVeMbeR 22, 2009
sessIon 1:
Free Paper Session
08:30 – 10:00 Hall S 6/7
Chair:
Diane Campbell, UK; Di Jones, Australia;
Linda Hodgson, UK
08:30 – 08:35 Welcome
Ulrike Beilenhoff, Germany
08:35 – 08:50
Nursing and technical Perceptions
of the usefulness Applicability,
Enjoyment and Realism of simulationbased
Training in the Pediatric GI
Endoscopy Unit
Meghan Fredette, Lisa Heard, Jenifer
Lightdale, USA
08:50 – 09:05
First Norwegian computer­based
Nursing Care plan for Patients
undergoing Gastrointestinal
Endoscopy
Bjørg Kjos, Kristin Woldstad, Norway
09:05 – 09:20
The Development of a Nurse Led
Hepatitis C Treatment Service
Joanne Spicer, UK
09:20 – 09:35
Nursing Patients with Hepatitis
Encephalopathy – Evidence­based
clinical Guidelines
Lea Ladegaard, Denmark
09:35 – 09:50
Is the Use of intravenous Opioids
essential to control Pain during
Colonoscopy? The Patient’s Perception:
a critical Review
Pauline Hutson, UK
09:50 – 10:00
Drying and Storage of Endoscopes –
Survey in European Countries
Ulrike Beilenhoff, Germany
sessIon 2:
Nutrition
08:30 – 10:00 Hall S 8/9
Chair:
Stanka Popovic, Slovenia; Debbie den Boer,
USA; Bethan Davies, UK
334
08:30 – 08:40 Welcome
Norah Connelly, USA
08:40 – 09:05
Treatment of Patients with Eating
Disorders
Rebecca Cashmore, UK
09:05 – 09:30
Establishing Hookworms in Coeliac
Disease – a novel Approach for an
increasingly common Disease
James Daveson, Australia
09:30 – 09:55
Buried Bumper – Treatment without
Surgery
Ben Witteman, The Netherlands
GI nURses 2009 PosTeR RoUnD I
(ManaGeMenT, PaTIenT caRe &
HYGIene)
10:00 – 11:00 Hall S 10
Chair:
Jayne Tillett, UK; Herdis Astradsdottir, Iceland;
Mandy Collins, UK
1. Endoscopy Pre­Assessment: Service
provision & patient satisfaction
Julie Bowen, Geri Beech, Jo Corrigan, UK
2. Cross­city Emergency out­of­hours
on­call Service: the Endoscopy
Nurse’s Experience
Rachel Rawnsley, Jo Corrigan , UK
3. P.I.N.S. – Patient Safety and Involvement
Networks – who is involved?
Pat Bottrill, UK
4. Computerization of the digestive
service, the medical Pharmacologist
Prescription and the Nurse’s
Registry Chart
Natalia Bartolomé, Victoria Balauder,
Noemí Aguirre, Margarita Bastida,;
Mª Jesús VIlar, Spain
5. Development of a Quality
Assurance System and improved
Quality in the Gastroenterology
Institute
Sigal Shafran-Tikvah, Nurit Porat,
Goldin Eran, Israel
6. Do psychological Factors explain
Symptoms in Patients with selfreported
Food Hypersensitivity?
Lind R, Berstad A, Kristine Lillestøl,
Arslan Lied G, Norway

7. The Awareness and Level of Preparedness
of Patients for Endoscopic gastrointestinal
Tract Procedures in Latvia
Valentina Lapina, Ina Mezina-Mamajeva,
Polina Domburga, Latvia
8. The Patient’s Perception of Gastroscopy
compared to the Professional’s
Perception.
Díaz Rodríguez, DR. Granados Martín,
M., Spain
9. Description of Factors that influence
toleration of Upper Gastrointestinal
Endoscopy Toleration.
Granados Martín, M.; Díaz Rodríguez,
DR., Spain
10. Needless Fasting: Can Fasting be
avoided?
E. Mathus-Vliegen, M. Kloppenburg-
Flieringa, S. Simson, G. Veenboer ,
P. Fockens, The Netherlands
11. Teaching Cleaning and Disinfection
Procedures to medical Students –
new Role to Nurses
Linden, Ane Isabel, Muller,Suzana, Brazil
12. Multidrug­resistant Organisms and
the Implications for Endoscopy Units
Linden, Ane Isabel, Brazil
13. Efficacy of Manual Cleaning of Gastrointestinal
Endoscopes with the
Ball Brush Method
Mattiola R, Chiarioni L, Coppolino M,
Lamanna L , Locoro S, Puddu D, Ferrari
A, Garripoli A. Italy
sessIon 3:
Free Paper Session
11:00 – 12:30 Hall S 6/7
Chair:
Diane Campbell, UK; Di Jones, Australia;
Linda Hodgson, UK
11:00 – 11:15
What is the Experience of Patients with
Barrett’s Columnar­lined Oesophagus
undergoing Endoscopic Disease
Surveillance?
Helen Griffiths, UK
11:15 – 11:30
Gastric, small intestinal and colonic
Findings in a specialist Nurse­Led
Capsule Endoscopy Service
Linda Jackson, Owen Epstein, UK
GI nURses 2009 – DeTaIleD PRoGRaMMe
11:30 – 11:45
Lean Patients are at increased risk for
Failure to complete small intestinal
Transit of Capsule Endoscopy
Rachel Shley, Dorit Skinezes; Israel
11:45 – 12:00
Diabetic Colon Preparation Study
Ann Hayes, Martha Buffum, Joyce Hughes,
USA
12:00 – 12:15
High Prevalence of Fatigue in Patients
with Inflammatory Bowel Disease:
Results of a Case­Control Study.
Maria van Vugt- van Pinxteren, Tessa
Römkens, Fokko Nagengast, Martijn van
Oijen, Dirk de Jong, The Netherlands
12:15 – 12:30
A hermeutic Study of Patient's
Experiences and sacrifices Living with
irretable Bowel Syndrome
Margit Rønnevig, Per Olav Vandvik,
Ingegerd Bergbom, Norway
sessIon 4:
Lower Gastrointestinal Tract
11:00 – 12:30 Hall S 8/9
Chair:
Mette Olesen, Denmark; Raewyn Paviour,
New Zealand; Karen Linton, UK
11:00 – 11:30
Bowel Preparation – a Review
Owen Epstein, UK
11:30 – 12:00
Colorectal Cancer Screening
worldwide
Jerome Waye, USA
12:00 – 12:30
Norovirus – the highest Incidence of all
Gastroenteritis
Friedrich von Rheinbaben, Germany
WoRksHoP 15:
Hands­on Training on Biosimulators
11:00 – 12:30 N 13 / ESGE/OMED
Learning Centre on level 1
Chair:
Björn Fehrke, Eric Pflimlin, Switzerland
Hands-on training on Biosimulators
(pig models) under the supervision of
highly experienced tutors.
335

GI nURses 2009 – DeTaIleD PRoGRaMMe
Participants will have the opportunity to
perform endoscopic techniques on the
following topics:
■ ERCP short wire system of COOK
As participation will be limited, registration will
be treated on a first-come, first-served basis.
Tickets will be available onsite only – at the
ESGENA membership desk
GI nURses PosTeR RoUnD II
(TReaTMenT anD PaTIenT caRe)
13:00 – 14:00 Hall S 10
Chair:
Jayne Tillett, UK; Herdis Astradsdottir, Iceland;
Mandy Collins, UK
14. Percutaneus Endoscopy Gastrostomy
(PEG) in a new hospital
Dania Rocío Díaz-Rodríguez, M José
Gómez-Guerra, Marta Valbuena-
González, Aurora de Pedro-Esteban,
Alberto Ibáñez-Pinto, Juan Jesús Pérez-
Poveda, Esteban Hernández-Surman,
Purificación Pardo del Río, Milagros
Ochoa Carmena, Spain.
15. Capsule Agile Patency© in suspected
intestinal Stricture Patients: Role
of Nursing Staff in Selection and
follow­up of Patients.
Ibáñez Zafón IA, Alonso MC, Muñoz
Galitó J, Dedeu Cuscó JM, Cañas-Ventura
A, Delgado-Aros S, Andreu García M,
Bory Ros F and Gonzalez Suárez B., Spain
16. Clinical Impact of Utilization of correct
Accessories in the EUS­guided
Drainage of pancreatic Pseudocysts
Daniela Burtea, Monica Molete,
Mihaela Caliţă, Romania
17. Patient Satisfaction with Endosonography
Services
Sally-Hannah Brown, Sharon Nicholson,
Abdul Razack and Sam Khulusi.UK
18. The Difference a Nurse makes: Hepatitis
B Research in Aotearoa, New
Zealand
Kathryn Adams, Jennifer Masters, New
Zealand
19. Treatment of Patients with acute
Liver Failure without Gastric Tube
reduces Mortality.
Iben Asmussen, Yvonne Boegh, Steen
Vadstrup, Denmark.
336
20. Establishment of the Nursing Consultation
for specific Control and Monitoring
of Patients with portal Hypertension
on Drug Treatment for Prophylaxis
of Gastrointestinal Bleeding.
Pablo Leis, AI, Gonzalo Domínguez,
E, Chorro, V,Gallardo, C., González,
MC.,Pinilla, MC.,Plaza, AI, Spain
21. Impact of different oral Agents for
Bowel Preparation
Palle Bager, Lotte Hansen and Helle
Nielsen, Denmark
22. A prospective single­blinded randomized
Trial of Polyethelene Glycol­electrolyte
Solution vs. Sodium
phosphate as a bowel Preparation
for Colonoscopy in Lynch Syndrome
Gene Carriers.
Maria van Vugt-van Pinxteren, Mariëtte
van Kouwen, Martijn van Oijen, Fokko
Nagengast, The Netherlands
23. 4­litre kleanprep© versus 2­litre
Moviprep©: Assessment by Physician,
Patient and Laboratory Values
Elisabeth Mathus-Vliegen, Karin van
der Vliet, Marjon de Pater, Paul Fockens,
The Netherlands
24. What is preferable for Cleansing:
Soffodex or PEG? A Comparison of
two Methods of colonic cleansing
prior to Colonoscopy
Sigal Shafran-Tikva, Dov Wengrove 1 ,
Natalia Belenko, Eran Golden, Israel
25. Adverse – Side Effects during the
Administration of Inflixuas: A Study
of 1271 Infusions in 88 Patients.
Paulo P. Nogueira; Rafael Oliveira; Sara
Travassos, Miguel Silva, Patricia Gonzalez,
Daniela Roque, Crista Canvalho, Portugal
26. The Relationship between Health
Locus of Control and health­related
Quality of Life in Patients with inflammatory
Bowel Disease
Sheila Mair, Hairmyres Hospital, East
Kilbride, UK
27. Application of biological Treatment to
Patients with IBD in the Czech Republic
Eliska Konecna, Czech Republic
28. Enrolment in IBD clinical Research:
the Patient’s Point of View
Matteo Martinato, Roberta Caccaro,

Antonino Caruso, Perla Bertomoro, Lydia
Oliva, Giacomo Carlo Sturniolo, Renata
D‘Incà, Italy
29. knowledge of Disease in Patients
with Recent Diagnosis of Inflammatory
Bowel Disease
Matteo Martinato, Michele Ferrante, Giacomo
Carlo Sturniolo, Renata D‘Incà, Italy
30. E­mail Service for Communication
between IBD Patients and Healthcare
Personnel: A Study on Feasibility
and Expectations
Matteo Martinato, Roberta Caccaro, Antonino
Caruso, Perla Bertomoro, Tiziana Slongo,
Francesca Lamboglia, Lydia Oliva, Giacomo
Carlo Sturniolo, Renata D‘Incà, Italy
31. Quality Improvement of Education
for Patients Post Colonoscopy at
Outpatient Services, NkC Institute of
Gastroenterology and Hepatology
Siriporn Ratanalert, Wanpen Pinyopatsakul,
Sopa Boonviriya, Varaporn Senapitakkul,
Sulee Saengnil, Ruankwan Pongprayoon,
Thailand.
lUncH sessIon 1:
New Techniques and Developments
12:30 – 14:30 Hall S 6/7
Chairs:
Marjon de Pater, The Netherlands; Cindy
Hamilton, Canada; Pauline Hutson, UK;
Michael Ortmann, Switzerland; Theresa Vos,
USA; Susan Dreyer, UK
Content
This lunch session will focus on various
endoscopic developments. Hands-on
training will be offered for the following
endoscopic techniques:
■ Devices and techniques for haemostasis
and ESD (Olympus Europe)
■ Clipmaster³ (Medwork Medical
Products and Services GmbH)
■ New single-use lithotriptor system
(Medwork Medical Products and
Services GmbH)
■ Feel the difference – Olympus short
guidewire system (Olympus Europe)
■ Gastro Pack TM – the smallest endoscopy
unit (Karl Storz GmbH & Co.KG)
■ Advanced dilatation and EUS solution
(Cook Medical)
GI nURses 2009 – DeTaIleD PRoGRaMMe
lUncH sessIon 2:
key Points of Endoscope Reprocessing
12:30 – 14:30 Hall S 8/9
Chairs:
Ulrike Beilenhoff, Germany; Siriporn
Ratanalert, Thailand; Libby Thompson, UK
Content
Cleaning, drying and storage of
endoscopes are key points of the
reprocessing cycle. New developments in
endoscope cleaning and storage will be
presented:
■ Initial cleaning and safe transportation
of your endoscopes (Medical Innovations)
■ Endoscopy Bed Side Care Kit (Peskett
Solutions)
■ Cleaning balls (CBC-Group, Tokio,
Japan)
■ Endoscope storage (Sterilox UK)
■ Drying cabinets (Lancer UK)
■ Training and education on decontamination
(Lancer UK)
lUncH sessIon 3:
Upper GI Endoscopy and Small Bowel
Endoscopy
12:30 – 14:30 Hall S 4/5
Chairs:
Gail DeCosta, USA; Alison Ball, UK; Wendy
Edwards, UK; Sylvia Lahey, The Netherlands
Content
This session will cover two main aspects of
upper GI endoscopy. There will be formal
presentations followed by:
■ Managing challenges in providing
effective symptom relief in patients
awaiting endoscopy, and in subsequent
management of scoped
patients (Reckitt Benckiser Group)
■ Fujinon‘s Double Balloon Endoscopy
System
■ „NaviAid BGE – The next generation
of small bowel endoscopy from
Pentax
■ Double balloon endoscopy of Olympus
with the use of single-balloons
■ Including hands-on-training
337

GI nURses 2009 – DeTaIleD PRoGRaMMe
WoRksHoP 16:
Hands­on Training on Biosimulators
13:30 – 15:30 ESGE/OMED Learning
Centre on level 1
Chair:
Björn Fehrke, Eric Pflimlin, Switzerland
Hands-on training on Biosimulators
(pig models) under the supervision of
highly experienced tutors.
Participants will have the opportunity to
perform endoscopic techniques on the
following topics:
■ OGD with therapeutic procedures
■ ERCP short wire system of Olympus
Europe
As participation will be limited, registration
will be treated on a first-come, first-served
basis.
Tickets will be available onsite only – at the
ESGENA membership desk
sessIon 5:
Ethics
14:30 – 16:00 Hall S 6/7
Chair:
Christiane Neumann, UK; Theresa Vos, USA;
Alison Ball, UK
14:30 – 15:00
National Variations of what is
perceived to be ethical in Patient Care
Timothy James, UK
15:00 – 15:30
How to ensure our Patients are well
informed
Raewyn Paviour, New Zealand
15:30 – 16:00
Patient Choice – should we do what
Patients want?
Christiane Neumann, UK
sessIon 6:
GI Diseases
14:30 – 16:00 Hall S 7/8
Chair:
Christine Petersen, The Netherlands; Suzana
Muller, Brazil; Suzan Dreyer, UK
14:30 – 15:00
World View of Hepatitis B & C
Ken O‘ Riordan, USA
338
15:00 – 15:30
Complementary Medicine – Is there a
Place in Gastroenterology?
Irene Dunkley, UK
15:30 – 16:00
Emergency within Gastroenterology
Mark Feeney, UK
WoRksHoP 17:
Hands­on Training on Biosimulators
15:30 – 17:00 Hall N 13: ESGE/OMED
Learning Area
Chair:
Björn Fehrke, Eric Pflimlin, Switzerland
Hands-on training on biosimulators (pig
models) under the supervision of highly
experienced tutors.
Participants will have the opportunity to
perform endoscopic techniques on the
following topics:
■ ERCP short wire system from Boston
Scientific
As participation will be limited, registration
will be treated on a first-come, first-served
basis.
Tickets will be available onsite only – at the
ESGENA membership desk
sessIon 7:
Inflammatory Bowel Disease (IBD)
16:30 – 18:00 Hall S 6/7
Chair:
Pilar Perez-Rojo, Spain; Gail De Costa, USA;
Wendy Edwards, UK
16:30 – 17:00
IBD – an international Overview
Matthew Lewis, UK
17:00 – 17:30
Alternative Treatments of Crohn’s
Disease
A.B. Hawthrone, UK
17:30 – 18:00
Nursing Management of IBD Patients
Marika Huovinen, Finland

sessIon 8:
Staff Welfare & Management
16:30 – 18:00 Hall S 7/8
Chair:
Michael Ortmann, Switzerland;
Rebecca Chandler, USA; Stephen Collins , UK
16:30 – 16:50
Global Rating Scores (GRS) as an
Instrument for Quality Assurance
Roland Valori, UK
16:50 – 17:10
Accreditation of Endoscopy Units
Debbie Johnson, UK
17:10 – 17:30
A national Training Programme
for Management of Sedation in GI
Endoscopy
Ulrike Beilenhoff, Germany
17:30 – 17:50
Creating a Healthy Work Environment
by Using Intelligent Light
Jesper Durup, Denmark
17:50 – 18:00
Discussions
MonDaY, noVeMbeR 23, 2009
sessIon 9:
New Techniques and Developments in
Endoscopy
08:30 – 10:30 Hall S 8/9
Chair:
Ulrike Beilenhoff, Germany; Norah Connelly,
USA; Pauline Hutson, UK
08:30 – 09:30
Presentations from the Major Sponsors
Industry
08:30 – 08:40
Advanced Imaging, revealing the
hidden Colors of Disease (Pentax)
Greg Calder, USA
08:40 – 08:50
News from Olympus
Rüdiger Tamm, Germany
08:50 – 09:00
New Technologies in Endoscopy (Cook
Medical)
Fritz Haller, Ireland
GI nURses 2009 – DeTaIleD PRoGRaMMe
09:00 – 09:10
Boston Scientific: The Innovation
Journey
Francisco Ou, France
09:10 – 09:20
Endoscope Channel Validation
(Custom Ultrasonics, Inc)
Frank Weber, USA
09:20 – 09:30
New Technologies in the detection
and characterization of colorectal
neoplasias
Arthur Hoffmann, Germany
09:30 – 09:50
Double Balloon Endoscopy – How
many Balloons and Prevention of
Complications
Andrea May, Germany
09:50 – 10:20
Marsha Dreyer Memorial Lecture:
Advancements in endoscopic
Treatment of pancreatic Disease ­
Yesterday and Today (sponsored by
Cook Medical)
Theresa Vos, USA
10:20 – 10:25
Best Free Paper and Best Poster Award
(sponsored by PENTAx)
Ulrike Beilenhoff, Germany; Norah Connelly,
USA
10:25 – 10:30
Invitation to the next ESGENA
Conference 2010 in Barcelona
Pilar Perez-Rojo, Spain
Invitation to the next SIGNEA
Conference
Norah Connelly, USA
339

FUN RUN,
PUBLIC
HEALTH DAY
and
SUPPORTING
PROGRAMME

fUn RUn
GasTRo 2009 fUn RUn
Sunday, November 22, 2009
10:00 at the congress venue
The Public Affairs Committee of GASTRO
2009 UEGW/WCOG, London has the pleasure
of announcing this charitable event
on the occasion of GASTRO 2009 UEGW/
WCOG, London.
Improve your health and support a medical
charity!
In its 3rd year, the Fun Run 2009 will start
from ExCeL London (the official congress
venue). The unique 5-km running track
will lead along the waterfronts of London’s
modern East End.
As the location for the annual London Triathlon
and one of the future official sites
for the 2012 Olympic Games, this will provide
the perfect setting for an exciting
event.
342
Registration fee includes
■ Runners wind breaker
■ Start number and rental of
timing chip
■ Free runners breakfast
■ Finisher medals
■ Personalised certificate
■ Changing rooms outside
Register until Sunday morning on­site!
Registration is possible until Saturday, November
21, at the Fun Run counter in the
registration area at the ExCel. Please note
that participation is not limited to participants
of GASTRO 2009, UEGW/WCOG, London
but only to maximum of 500 runners.
Detailed information:
Start at 10:00 at the congress venue
Course: ExCeL London – Waterfront –
ExCeL London (2 laps, each of 2.5 km)
Distance: 5 km
Registration fee: Euro 10.00
COELIAC Uk will benefit from the
proceeds of the Fun Run 2009.
The Fun Run is kindly supported by
Kindly supported by

RUnnInG TRack
343

PUblIc HealTH DaY
cHRonIc GUT conDITIons:
PaTIenT eXPeRIence & MeDIcal
ResPonse
GASTRO 2009 Public Affairs Committee in
collaboration with the National Association
for Colitis and Crohn’s Disease (NACC),
Coeliac UK and the GUT Trust are organising
a public information event. Members of the
public are invited to attend a public information
event at GASTRO 2009 UEGW/WCOG,
London – the first joint international Gastroenterology
conference to be held in London.
Chaired by medical broadcaster and journalist,
Dr. Mark Porter, this informative
event will offer the opportunity to hear
from world renowned experts on the latest
medical opinion and research, diagnosis
and management and how to live with,
and take control of, chronic gut conditions.
Experts, together with patients, will discuss
the following topics:
Inflammatory Bowel Disease (IBD),
Irritable Bowel Syndrome (IBS) and
Coeliac Disease
The latest medical opinion and research
Primary care diagnosis and management
Living with and taking control of
chronic gut conditions
344
PRoGRaMMe
sUnDaY, noVeMbeR 22, 2009
13:30 Registration
14:00 Welcome Address by Professor
Colm O’Morain (Chairman of the
United European Gastroenterology
Federation Public Affairs Committee)
14:05 Introduction by Dr. Mark Porter
14:10 How to cope with Coeliac
Disease? Recommendations
from an expert. by Professor Chris
Mulder (European Society for the
Study of Coeliac Disease and Honorary
member of the South African
Gastroenterology Society) followed
by audience and panel discussion
14:40 Who gets Irritable Bowel
Syndrome and why, and what
can be done about it by Prof.
Eamonn Quigley (President of
World Gastroenterology Organisation
and Vice President of the
American College of Gastroenterology)
followed by audience and
panel discussion
15:10 Presentation on Inflammatory
Bowel Disease by Prof. Chris
Hawkey (President of the British Society
of Gastroenterology) followed
by audience and panel discussion
15:40 Panel summary
15:50 Refreshments and information
display
16:20 – 17:20 Choice of seminars on
IBS, IBD and Coeliac Disease:
Coeliac UK – the management of
Coeliac Disease
The Gut Trust – topic to be confirmed
National Association for Colitis and
Crohn‘s Disease – topic to be confirmed
For registration of your complimentary
place, please contact the Public Health
Day Registration Counter in the registration
area in Hall N1/2/3 of the ExCeL centre.
For further information call +44-(0)1-
444 484 888 or email justin@spinkpr.com

Half- anD fUll-DaY ToURs
Take advantage of being in one of the
most historical cities in Europe, and discover
the many “faces” of London. Make
your choice and experience its immense
richness and diversity.
The following programme was created specifically
for GASTRO 2009 UEGW/WCOG,
London and is exclusively offered to its participants.
Great attention has been paid to
its design, with careful selection of the right
content for the given time. The programme
showcases the different “faces” and “flavours”
of the City of London and its surroundings.
With the following unique selections we
have tried to cater for all personal interests.
Choose your favoured programme(s) and
prepare to be captivated.
All tours will be conducted in English.
All half- and full-day tours will start
and end in the City of London – at
the Hilton Metropole (further address
details will be provided after confirmation
of bookings).
Meeting point for departure:
GASTRO 2009 UEGW/WCOG, London
Tours desk in the lobby of the Hilton
Metropole.
A minimum participation of 20 guests
is required to operate each tour!
For all questions regarding tours and
booking please contact the tours desk
in the registration area.
Saturday, November 21, 2009
09:00 – 12:30
Sunday, November 22, 2009
09:00 – 12:30
Monday, November 23, 2009
09:00 – 12:30
H-1 – lonDon oRIenTaTIon ToUR
anD flIGHT on THe „lonDon eYe“
(Half-DaY)
This tour covers the
major landmarks
and sights of both
the City and the
West End of London
sUPPoRTInG PRoGRaMMe
and includes a flight on the London Eye.
The tour incorporates photo-stops only;
there are no interior visits. The many sights
to be viewed will include the famous shopping
avenues of Oxford Street, Bond Street
and Regent Street, where you find many
of the famous department stores. You
will also see the famous historical sights
of London, including Westminster Abbey,
St. Paul‘s Cathedral, the Tower of London
and the Inns of Court. You will be shown
the important seats of Government, such
as the Houses of Parliament (including Big
Ben) and Downing Street, and will see the
Horseguards along Whitehall. The tour also
includes areas such as Piccadilly Circus, Trafalgar
Square (with Nelson‘s Column), Fleet
Street, many of the famous museums, the
City (the „financial and business“ area) and
London’s newest landmark - the London
Eye. Of course, no tour of London is complete
without seeing Buckingham Palace.
The “British Airways
London Eye” is the
world’s largest observatory
wheel. It is
managed and operated
by UK visitors’ attraction owner, The
Tussauds Group, and was built by a European
consortium with over 1400 tonnes
of steel provided by British Steel. The
London Eye is situated on the South Bank
of the River Thames, just down from and
opposite the Houses of Parliament, and is
accessed via the new Millennium Pier. It
has been christened “The Eye” because of
the unique views that it offers over London,
and it is set to become one of the
world’s most popular
visitor attractions.
At 135 metres
(450 feet) high, the
London Eye is the
city’s fourth tallest structure. Its gradual
30-minute 360 degree rotation gives passengers
totally new perspectives on some
of the capital’s most famous landmarks
and provides a bird’s-eye view usually
accessible only by helicopter or aircraft,
345

sUPPoRTInG PRoGRaMMe
with unrivalled and unencumbered vistas
across an approximate radius of 30 miles.
Services included: Deluxe coach, Licensed
guide, a flight on the London Eye
Saturday, November 21, 2009
13:30 – 17:00
Tuesday, November 24, 2009
09:00 – 12:30
H-2 – cITY of lonDon ToUR
(Half-DaY)
From the
West End, you
journey into
the oldest
and most historic
part of London, past the Law Courts
and down Fleet Street - formally the heart
of the country’s newspaper industry. You
will see and drive past St. Paul’s Cathedral,
Sir Christopher Wren’s great masterpiece,
before continuing through the City’s financial
district to the Tower of London,
the highlight of the tour. The Tower is
probably London’s most famous landmark
and rightly so ... it has stood for over 900
years, fulfilling various functions as a Royal
Palace, Prison, Garrison, Mint, and even as
the home of the Royal Zoo! Time will be allowed
for a visit not only to the Tower but
also to see the fabulous Crown Jewels and
the many more historic treasures which
are now housed there.
Services included: Deluxe coach, Licensed
guide, Entrance fee to Tower of London
Sunday, November 22, 2009
14:00 – 17:30
Wednesday, November 25, 2009
09:30 – 13:00
H-3 – MeDIcal lonDon: floRence
nIGHTInGale MUseUM & olD
oPeRaTInG THeaTRe (Half-DaY)
Florence Nightingale is famous around the
world for her influence on modern nursing,
but she herself was more than a nurse.
As one of the most famous women in British
history, it is not surprising that Florence
346
Nightingale should have a
museum dedicated to her
memory. The Florence Nightingale
Museum celebrates
the woman who almost
single-handedly created the
modern nursing profession
in Britain following her experiences during
the Crimean War. She is famous for answering
a call from God and helping hundreds
of soldiers during the Crimean War – even
now she is referred to as the Lady of the
Lamp because of her night-time walks
tending to sick and wounded soldiers.
On her return from this bloody conflict
she established the Nightingale Training
School for nurses at St
Thomas’ Hospital. As a
result of her groundbreaking
work, her
name is synonymous
with caring and nursing to this day. This
museum features an incredible collection
of artefacts from her lifetime, including,
in their original form, 53 of the 200 books
that she wrote.
Hidden in the roof of a church, a 300-yearold
herb garret houses Britain‘s only surviving
19th century operating theatre. This
museum, one of London‘s most intriguing
historical interiors, contains the Operating
Theatre in use between 1821 and 1862, in
the days before anaesthetic and antiseptic
surgery.
Services included: Deluxe coach, Licensed
guide, Entrance fee to Florence Nightingale
Museum & Old Operating Theatre
Sunday, November 22, 2009
09:00 – 18:30
f-1 – WInDsoR, eTon anD
RUnnYMeDe (fUll-DaY)
Only a short
drive from
London is
the historic
town of Windsor with its imposing Castle,
overlooking the River Thames, which is the

favourite Royal Residence of Queen Elizabeth
II. The original building was started in
1080 by William the Conqueror, but nothing
now remains of this wooden structure,
which was soon replaced by a stone-built
tower that still stands at the heart of the
Castle. This was added to by the following
Kings and Queens over subsequent
centuries, to create the magnificent complex
that is Windsor Castle today. You will
visit the State Apartments (Court Arrangements
permitting; if not, then St.
George’s Chapel). Then there will be time
to wander through the lanes of the quaint
old part of Windsor
town or to cross the
Thames footbridge to
the adjacent hamlet
of Eton, where Eton
College, England’s most pre-eminent boys’
“public school” (private!) is situated. Then
you will be driven along the banks of the
River Thames to nearby Runnymede. It was
here in 1215 that King John was forced to
sign the Magna Carta - the basis of British
democracy ever since, and an integral part
of the United States constitution. In the
Park stands the John F. Kennedy Memorial,
donated by the American Bar Association,
and the Royal Air Force Memorial.
Services included: Deluxe coach, Licensed
guide, Entrance fee to precincts of Windsor
Castle
Lunch is independent and at your own
expense
Sunday, November 22, 2009
19:00 – 23:15
e-1 – THaMes RIVeR DInneR-Dance
cRUIse on THe M/V “sYMPHonY”
(eVenInG)
Step aboard
the Symphony,
London’s floating
glass palace,
for an evening’s
dining, dancing and maybe dreaming
against the backdrop of London from the
sUPPoRTInG PRoGRaMMe
River Thames. See London
from a different
view. With panoramic
windows and exterior
floodlights, the Symphony
will show you the riverside sights
of London: The Houses of Parliament, Big
Ben, The London Eye, Tower Bridge, The
Tower of London, The Millennium Dome
and much, much more.
Services included: Escorted round-trip
transfers, Welcome drink, 4-course à la carte
dinner with coffee & chocolates, Live entertainment
with after-dinner dancing
NB: The dress code for the Dinner Cruise
is smart to formal. Gentlemen are encouraged
to wear a jacket and tie. Jeans,
denim and trainers/training shoes are not
allowed. Please note that Bateaux London
refuse entry based on inappropriate attire
and refunds will not be offered should a
guest be turned away for not observing
our dress code.
Monday, November 23, 2009
13:30 – 17:00
H-4 – WesT enD of lonDon ToUR
(Half-DaY)
Today‘s tour covers in depth
one half of London, the
West End. Westminster was
once a country village lying
to the west of the City
of London, where King Edward
the Confessor built a chapel during
the 11th century. The original building
was replaced and much enlarged over
the following centuries, and the Abbey
was chosen as the burial place for most
of the medieval Kings of England. The importance
of Westminster in the history of
British Royalty has never been in question -
indeed only two monarchs have not been
crowned there since the reign of Edward
II. After visiting the Abbey, you will be able
to view the other aspect of British Government
- the two Houses of Parliament,
located beside Westminster Abbey in the
347

sUPPoRTInG PRoGRaMMe
complex known as the Palace of Westminster,
standing on the site of an earlier Royal
Palace. From the earliest times, the Hall at
Westminster was the central and highest
Court of Justice, and it is a natural progression
for the „Mother of Parliaments“ to be
located there today.
Services included: Deluxe coach, Licensed
guide, Entrance fee to Westminster Abbey
Monday, November 23, 2009
08:30 – 18:30
f-2 – sToneHenGe anD baTH
(fUll-DaY)
This tour passes
through the counties
of Surrey,
Hampshire, and
Wiltshire, into the
West Country. The first stop is Stonehenge,
the mysterious prehistoric Stone
Age monument which has fascinated and
perplexed historians through the ages. Finally
you will reach Bath, the county town
of Avon and one of the most beautiful
cities in Europe. It was first named Aquae
Sulis by the Romans, who used its natural
warm springs for bathing, and the baths
that they built rival some of those in Italy
itself. After the decline of the Roman Empire,
the city fell into decay, but the same
warm springs resulted in its renaissance
during the 18 th century under the benevolent
hand of the local squire, Ralph Allen,
who was the model for “Squire Allworthy”
in Henry Fielding’s novel,
“Tom Jones”. Making use
of two talented local architects,
John Wood the Elder
and his son, the town was
laid out in classical Georgian
style. Happily, much
of their work remains, including the magnificent
Royal Crescent and the intriguing
Pulteney Bridge with shops standing
on it, designed by Robert Adam. Lunch is
independent but your guide/escort will
recommend a choice of establishments
348
and there will be time for souvenir shopping
in the Bath pedestrianised shopping
area before returning to London via the
motorway.
Services included: Deluxe coach, Licensed
guide, Entrance fees to Stonehenge and the
Roman Baths in Bath
Lunch is independent and at your own
expense
Tuesday, November 24, 2009
13:30 – 17:30
H-5 – HaMPTon coURT Palace
(Half-DaY)
Hampton Court Palace
lies to the South West
of London, on the banks
of the River Thames, surrounded
by parkland
and beautiful gardens. It was built by Cardinal
Wolsey in 1514 and later presented
by him to Henry VIII in an attempt to gain
the King‘s favour. It has been occupied by
many members of the Royal Family since,
and a substantial enlargement to the original
building was added by Christopher
Wren. The Palace is no longer used as a
Royal residence, but remains as a superb
example of Tudor and Wren architecture,
with extensive grounds that include a famous
maze and ancient vine. Henry VIII‘s
Tennis court, still in use to this day, may be
visited, and within the Palace you will have
a chance to tour the State Apartments.
These have recently re-opened after restoration
following a dreadful fire, and have
been reinstated as they were in the Georgian
period, with fine collections of tapestries,
clocks and paintings. The original
kitchens and Chapel may also be visited.
Services included: Deluxe coach, Licensed
guide, Entrance fee to Hampton Court
Palace

Tuesday, November 24, 2009
08:30 – 18:30
f-3 – sTRaTfoRD-UPon-aVon anD
WaRWIck (fUll-DaY)
On this full day excursion,
you will drive north along
the motorway directly
to Warwick, the country
town on the banks of the
River Avon with its pleasant
blend of Tudor and Georgian architecture.
The 14th-century Warwick Castle
is one of the few
English original medieval
fortresses to
have been continuously
inhabited. Built
on a crag, it is a treasure house of paintings
and furnishings. As well as visiting the
castle itself, you will see the two exhibits
designed by Madame Tussaud’s waxworks,
which recreate life in olden times – “Kingmaker”,
which depicts life in the castle at
the time of the Wars of the Roses, and
“House Party”, which faithfully recreates a
weekend house party held at the castle by
Lord Brook at the turn of the last century.
After the visit, you
will drive to nearby
S t r a t f o r d - U p o n -
Avon, a very pretty
town, made famous
by the quill of the “Bard of Avon”. The son
of a prosperous leather merchant, William
Shakespeare left his native town whilst in
his early twenties but in the next 25 years
he was to make it one of the most famous
places in World Literature - and it was to
Stratford that he returned when he retired.
You will be able to see his birthplace and
also his wife’s house, Anne Hathaway’s
Cottage, an architectural masterpiece of a
thatched country farmstead of its period,
still containing the settle on which he and
Anne did their courting!
Services included: Deluxe coach, Licensed
guide, Entrance fees to Shakespeare’s
sUPPoRTInG PRoGRaMMe
Birthplace & Anne Hathaway’s Cottage and
Warwick Castle
Lunch is independent and at your own
expense
Tuesday, November 24, 2009
19:30 – 23:30
e-2 – THe DoVeR sTReeT
ResTaURanT & baR (eVenInG)
The Dover Street Restaurant
& Bar is one of
the premier jazz venues
in London. Set in
the heart of London’s
fashionable Mayfair, Dover Street offers a
combination of fine French/European cuisine
and nightly live music ranging from
Jazz & Blues to Latin & Soul with dancing
to a resident DJ until 03:00. With a unique
atmosphere that is equally suited for both
individual diners and larger groups, the
Mayfair restaurant is
intimate enough for romantic
dinners and stylish
enough for corporate
events and for companies
to entertain their clients. As well as
playing host to numerous personalities
from the worlds of stage, film, television
and sport, Dover Street is a favourite spot
for theatre-goers; its enviable West End location
makes it an ideal pre-theatre restaurant.
With last orders for food at 02:00 and
dancing until 03:00, Dover Street is a late
night venue that offers some of the best
live jazz in London.
Services included: Escorted round-trip transfers,
3-course à la carte dinner with coffee
Drinks are independent and at your own
expense
349

sUPPoRTInG PRoGRaMMe
Wednesday, November 25, 2009
14:30 – 18:00
H-6 – Wallace collecTIon &
foUnDlInG MUseUM (Half-DaY)
The Wallace Collection
is a national museum
in an historic London
town house. In 25 galleries
are unsurpassed
displays of French 18th century painting,
furniture and porcelain with superb Old
Master paintings and a world class armoury.
This world-class collection
of art was
largely put together
by the Fourth Marquess
of Hertford, a
recluse who lived in Paris. He was helped
by his illegitimate son, Richard Wallace, who
eventually inherited the collection. They
were able to buy many of the paintings,
porcelain and furniture that make up the
collection cheaply in post-Revolutionary
France, because of its politically dangerous
associations. Richard Wallace finally
moved the collection to England due to the
unstable situation there, and added many
examples of Renaissance ceramics, bronzes,
armour, and jewellery over the years. His
wife finally left the collection to the nation
in 1897. The Foundling Hospital was
founded by philanthropist Thomas Coram
and artist William Hogarth in 1739 „for the
maintenance and education of exposed
and deserted children“. The museum tells
the story of the first hospital of its kind to
be opened in London and looks at its supporters,
Thomas Coram, the artist William
Hogarth and the composer George Frideric
Handel. The museum houses the hospital’s
extensive art collection, with works by Hogarth,
Reynolds, Gainsborough, Wilson, Hayman,
Highmore, Roubiliac and Rysbrack.
The museum also tells the story of the
27,000 children who stayed at the hospital
until it closed in 1954.
Services included: Deluxe coach, Licensed
guide, Entrance fees to Wallace Collection
and the Foundling Museum
350
Wednesday, November 25, 2009
08:30 – 18:30
f-4 – oXfoRD anD THe THaMes
ValleY (fUll-DaY)
This full-day excursion visits
England‘s oldest university
town. Oxford, a thriving city,
an Episcopal see, and the seat
of an ancient university, is
one of the most famous and
interesting towns in Europe. The beautiful
grouping of its „dreaming“ spires and towers
as seen from a distance is renowned,
as are the noble architecture of its colleges,
such as Christ Church, Brasenose
and Balliol, and the „streamlike windings“
of its famous High Street. Learn all about
the history of the „Town“ and „Gown“. After
leaving Oxford, we shall head for Henley,
which is best known for its Royal Regatta
held every July since 1839. For about a mile
at Henley the river is straight, providing an
ideal course for what has become a major
international event. It became ‚Royal‘ in
1851 when Prince Albert became Patron
of the Regatta. As well as a sporting event
it is a major social event, retaining much of
the ‚garden party‘ feel of Edwardian times.
The town became established in the 12th
century as a river crossing and port for the
supply of timber and grain along the river
to London. The present five-arched bridge
over the river was
built in 1786 with the
church of St. Mary
close by. The church
has a 16th century
tower built with decorative flint and stone
chequerwork. Although restored in the
19th century, the 13th century and nave
arcades can still be seen. Many buildings
in Henley are designated ‚of special architectural
interest‘, including a 14th century
chantry house, connected to the church,
and the Speaker’s house, the home of
William Lenthall, Speaker of the House of
Commons (1629-1640), who was a signatory
to the warrant for the execution of
Charles I. The main street has many Georgian
frontages built onto older buildings.

There are many coaching inns, including
the Red Lion, which, so legend has it, has
accommodated Charles I, Boswell and
George III. Our last stop is in Marlow. Marlow
is a pleasant Georgian town, situated
on a beautiful stretch of the River Thames,
midway between Reading and Windsor.
Tour
no.
Tour name
sUPPoRTInG PRoGRaMMe
Services included: Deluxe coach, Licensed
guide, Entrance fees to one of the Oxford
colleges
Lunch is independent and at your own
expense
£ (GbP)
per person
H-1 London Orientation Tour and Flight on the “London Eye” 55
H-2 City of London Tour 55
H-3
Medical London:
Florence Nightingale Museum & Old Operating Theatre
55
H-4 West End of London Tour 48
H-5 Hampton Court Palace 55
H-6 Wallace Collection & Foundling Museum 60
F-1 Windsor, Eton and Runnymede 80
F-2 Stonehenge and Bath 90
F-3 Stratford-upon-Avon and Warwick 100
F-4 Oxford and The Thames Valley 78
E-1 Thames River Dinner-Dance Cruise on the M/V “Symphony 120
E-2 The Dover Street Restaurant & Bar 68
For bookings and further questions please contact the tours desk in the registration area.
351

sUPPoRTInG PRoGRaMMe
PosT-conGRess ToURs
Take advantage of the post-Congress tours
and discover the historical richness and
cultural diversity of Great Britain. Visit one
of the famous cities/regions and experience
its beauty at first hand.
The following programme was created specifically
for GASTRO 2009 UEGW/WCOG,
London and is exclusively offered to its participants.
Great attention has been paid to
its design, with careful selection of the right
content for the given time. Each tour will
provide an informative introduction to its
destination, enabling participants to learn
about its unique history and character in a
relaxed and comfortable fashion.
All tours will be conducted in English.
All tours will start in the City of London –
at the Hilton Metropole (further address
details will be provided after confirmation
of bookings).
All tours will end either at the London
Heathrow Airport or at the Hilton
Metropole.
Meeting point for departure: GASTRO
2009 UEGW/WCOG, London Tours desk in
the lobby of the Hilton Metropole.
A minimum participation of 20 guests is
required to operate each tour!
For all questions regarding tours and
booking please contact the tours desk in
the registration area.
Wednesday, November 25 –
Saturday, November 28, 2009
PT-1 – “eDInbURGH – THe caPITal
of scoTlanD”
Day 1 – Depart from
the Hilton Metropole
hotel in the late afternoon.
A short transfer
by coach will bring you
to Kings Cross railway
station, where you will
352
board the train to take your reserved firstclass
seats on the Intercity Express service
to Edinburgh. During the journey you will
be served an afternoon tea snack.
On arrival at Edinburgh Waverley Station
you will be met by your local Scottish
guide, who will escort you throughout
your visit to Scotland’s capital city! A
short transfer will bring you to the 4-star
Macdonald Holyrood Hotel, located in the
heart of Edinburgh’s city centre near the
end of the historic Royal Mile. From here it
is easy to reach all the main areas of Scotland’s
capital city!
Day 2 – This
morning you
will enjoy a
guided tour
of Edinburgh,
including a visit to the famous and historic
Castle.
Edinburgh is justifiably famous as one of
the most beautiful capital cities in Europe.
This ancient town lies along the “Royal
Mile” which stretches from the massive
fortress of Edinburgh Castle, perched
on its rocky crag, to the Royal Palace of
Holyroodhouse, the official residence of
the Queen in Scotland. During your visit
to the Castle you will have time to see
the Scottish Crown Jewels (known as the
“Honours of Scotland”), which are reputed
to be of greater antiquity than the Crown
Jewels in the Tower of London. Whilst at
the Castle you can enjoy the panoramic
view of the graceful squares and streets
of this elegant example of Georgian architecture.
Touring the town, you will
see the differences between the Old and
New Towns, you will see St. Giles’ Cathedral,
and you will hear the stories of John
Knox, Burke & Hare, “Greyfriars Bobby” and
much, much more.
Afternoon at leisure.
In the evening, you will enjoy dinner at
one of the characterful old taverns in the
city, featuring a menu that will present

Day 3 – Full day at leisure.
you with some Scottish
traditional dishes! A bagpiper
will be on hand to
welcome you in the timehonoured
fashion of Scottish
hospitality!
Day 4 – This morning, after a leisurely
breakfast, transportation will be provided
to Edinburgh Airport for your departure
flights.
Services included: Transportation by coach
from Hilton London Metropole Hotel to
Kings Cross Railway Station, First class rail
ticket between London and Edinburgh,
Afternoon tea snack on the train between
London & Edinburgh, Transportation by
coach from Edinburgh Waverley Railway
Station to MacDonald Holyrood Hotel,
Three nights’ accommodation at the Macdonald
Holyrood Hotel, Edinburgh (shared
double room, with private bath/shower),
Full breakfast daily, Half-day guided tour
of Edinburgh including visit to Edinburgh
Castle, Scottish style 3-course dinner with
coffee in a local pub, with welcome by a
traditional bagpiper, Departure transfer to
Edinburgh Airport, Services of a qualified
English-speaking guide escort/tour manager
during all organised activities, Porterage
of one suitcase per person throughout (NB:
portering service not available at railway
stations)
Thursday, November 26 –
Saturday, November 28, 2009
PT-2 – “baTH”
Day 1 – Depart
from London (Hilton
London Metropole
Hotel) early in
the morning and
travel through the rolling English countryside
of Surrey, Hampshire and Wiltshire,
out to the West Country. The first stop is
Stonehenge, the mysterious prehistoric
Stone Age monument, which has fasci-
sUPPoRTInG PRoGRaMMe
nated and perplexed historians through
the ages. After time to view this astonishing
monument, you will continue to the
nearby town of Salisbury. Salisbury was
founded in 1220, when the old hill-top
settlement of Old Sarum was abandoned
(being too arid and windswept) in favour
of a new site among the lush water meadows
where the Rivers Avon, Nadder and
Bourne meet. Creamy white limestone
was floated down the Nadder from Chilmark,
12 miles west of Salisbury, for the
construction of a new cathedral which was
built mostly in the early 13th century, over
the remarkably short space of 38 years.
Its magnificent landmark spire, the tallest
in England, was an inspired afterthought
added in 1280-1310.
Today, Salisbury has
much to recommend it,
with attractions including
the Cathedral Close,
Mompesson House and
the Salisbury & South
Wiltshire Museum, along with some of the
best shopping in this part of the country.
There will be free time in Salisbury for private
shopping and lunch before continuing
across the open spaces of Salisbury
Plain to eventually reach Bath, the county
town of Avon and one of the most beautiful
cities in Europe. It was first named
Aquae Sulis by the Romans, who used its
natural warm springs for bathing, and the
baths that they built rival some of those in
Italy itself. After the decline of the Roman
Empire, the city fell into decay, but the
same warm springs resulted in its renaissance
during the 18 th century under the
benevolent hand of the local squire, Ralph
Allen, who was the model for “Squire Allworthy”
in Henry Fielding’s novel, “Tom
Jones”. Making use of two talented local architects,
John Wood the Elder and his son,
the town was laid out in classical Georgian
style. Happily much of their work remains,
including the magnificent Royal Crescent
and the intriguing Pulteney Bridge with
shops standing on it, designed by Robert
Adam.
353

sUPPoRTInG PRoGRaMMe
Check in to the luxurious
5-star Bath Spa
Hotel for two night‘s
accommodation.
Guests are welcome
to make use of the Spa facilities of this elegant
hotel during their stay.
354
Day 2 – This morning
you will enjoy a
walking tour of the
city of Bath, including
a guided visit to
the Roman Baths.
The first stop for any visitor to Bath is the
Roman Baths surrounding the hot springs
where the city began. Here you will see
one of the country‘s finest ancient monuments
– the great Roman temple and
bathing complex built almost 2000 years
ago. Discover the everyday life of the Roman
spa. See the ancient treasures from
the temple of Sulis Minerva and many
other objects recovered from the sacred
spring where they were thrown as offerings
to the goddess.
Lunch, afternoon and dinner at leisure.
Day 3 – After a leisurely breakfast, transportation
will be provided to London’s
Heathrow Airport.
Services included: Transportation from Central
London (Hilton London Metropole Hotel)
to Bath Hotel with en route sightseeing visits
to Salisbury and Stonehenge, Two nights’ accommodation
at the Bath Spa Hotel (shared
double room, with private bath/shower), Full
breakfast daily, Half-day guided walking tour
of Bath including visit to Roman Baths complex,
Departure transfer to Heathrow Airport,
Services of a qualified English speaking guide
escort/tour manager during all organised
activities, Porterage of one suitcase per person
throughout.
Thursday, November 26 –
Saturday, November 28, 2009
PT-3 – “enGlIsH VIllaGe lIfe”
Day 1 – Depart
from London
(Hilton Metropole
Hotel)
early this morning and travel westwards,
to reach historic Windsor town after a
short drive. This small but important town,
with its imposing Castle overlooking the
River Thames, is the favourite Royal Residence
of Queen Elizabeth II. The original
building was started in 1080 by William
the Conqueror, but nothing now remains
of this wooden structure, which was soon
replaced by a stone-built tower that still
stands at the heart of the Castle. This
was added to by the following Kings and
Queens over subsequent centuries, to create
the magnificent complex that is Windsor
Castle today. You will visit the State
Apartments (Court Arrangements permitting)
and tour the extensive precincts of
this ancient building; you will then have
time to enjoy walking through the cobbled
streets of the old town in front of the
Castle. After free time for lunch, you will
continue through the attractive Thames
Valley countryside to the picturesque
town of Henley-on-Thames, overlooked
by the beautiful Chiltern landscape of
wooded hills and green fields. Just a few
strides from the riverbank is the very heart
of Henley with its historic church, town hall
and market square, the
latter bustling with busy
stall-holders and shoppers
on market days.
They also enjoy browsing
the town’s many
boutiques. Founded in the 12th century,
and best known for the annual Royal Regatta,
Henley attracts some of the world´s
finest rowers. Statues of those great Olympians
Sir Steve Redgrave and Sir Matthew
Pinsent greet visitors to the town´s award
winning River and Rowing Museum. Henley
also attracts golfers to local courses,

and is home to the nationally known Henley
Hawks rugby club as well as successful
cricket and football clubs. There is also a
privately owned polo ground.
From Henley it is only
a short drive to the
charming old market
town of Amersham,
nestling in a small valley
at the foot of the Chiltern Hills. Here
you will check in to the old Crown Inn,
an original coaching inn and staging post
that has been sympathetically modernised
to offer comfortable accommodation
whilst retaining the traditions of hospitality,
warmth and comfort associated with
old town taverns of yesteryear!
Tonight, you will enjoy a traditional English
supper at the Crown Inn, featuring traditional
dishes of fresh local produce, specially
prepared by the Inn’s renowned chef,
Rosie Sykes, who is an acclaimed culinary
expert and journalist
Day 2 – This morning you
will enjoy a visit to Oxford.
Oxford is famous for its ancient
university, which is the
oldest in Britain, dating to
the 13th century. The grouping
of its towers and spires
makes a beautiful sight in the distance. On
Tour
no.
Tour name
sUPPoRTInG PRoGRaMMe
closer inspection, the college buildings
prove rich in excellent examples of every
period from the medieval to the present,
and of most major English architects since
the Renaissance. Their combined effect,
seen at its best in High Street, Broad Street
and the square where the Radcliffe Camera
stands, is sometimes skilfully planned
and sometimes happily accidental. You
will take a walking tour of many of the colleges
and enjoy seeing this architecturally
astonishing city at close hand!
Lunch, afternoon and dinner at leisure.
Day 3 – After a leisurely breakfast, transportation
will be provided to London’s
Heathrow Airport.
Services included: Transportation from Central
London (Hilton London Metropole Hotel)
to The Crown Hotel, Amersham with en
route sightseeing visits to Windsor and Henley,
Two nights’ accommodation at the The
Crown Hotel (shared double room, with private
bath/shower), Traditional English country
feast 3-course dinner with coffee at The
Crown Hotel, Amersham, Full breakfast daily,
Half-day guided tour of Oxford including a
visit to one of the Oxford Colleges, Departure
transfer to Heathrow Airport, Services of a
qualified English speaking guide escort/tour
manager during all organised activities, Porterage
of one suitcase per person throughout.
£ (GbP)
per person
in a double
room
PT-1 Edinburgh – The Capital Of Scotland 500
PT-2 Bath 490
PT-3 English Village Life 380
£ (GbP)
per person
in a single
room
Available upon
request
Available upon
request
Available upon
request
For bookings and further questions please contact the tours desk in the registration area.
355

Delivering proven stent solutions for you.
Expanding treatment options for your patients.
For more than two decades.
Each year, physicians worldwide place approximately 100,000 Boston Scientific self-expanding GI stents, including the
WALLSTENT ®
Endoprosthesis, Ultraflex
Stent and our newest technology, the WallFlex ®
Stent. These are stents you
know and trust, cited in hundreds of journal articles worldwide and chosen by you for their clinical efficacy and
consistent performance. Every day, our field representatives work with your clinical teams, sharing their knowledge
and experience and providing training and support. Yesterday, today and tomorrow – we continue to advance stent
technologies that make more treatment options possible and improve patient care.
Visit Boston Scientific at Booth 47
Copyright © 2009 by Boston Scientific Corporation or its affiliates. All rights reserved.
Data on file – Boston Scientific PSST5325

LIST OF
REVIEWERS

lIsT of ReVIeWeRs
Professor
Michael Farthing
Chair Programme
Committee
358
leTTeR of THanks To GasTRo 2009 UeGW/WcoG,
lonDon ReVIeWeRs
On behalf of the GASTRO 2009 Programme Committee I would
like to take this opportunity to thank you most sincerely for your
contribution as an abstract reviewer for the original part of the
programme. I know just how much time and effort this takes but
without your expertise we would not have the quality that I believe
we have achieved in the free paper and poster sessions. I am
delighted to announce that we have received a record number
of 4.071 abstracts for GASTRO 2009 UEGW/WCOG, London.
This represents an increase of 30% over UEGW Vienna 2008.
2.664 abstracts were accepted, giving an acceptance rate of
65%. 474 abstracts will be delivered as oral presentations and
2.190 as posters. This is really excellent news and confirms that
GASTRO 2009 UEGW/WCOG is an important place to present
your best science.
In addition, we have received 100 clinical cases and 32 video
cases which were formally evaluated by the Programme Committee
for presentation in London. As last year the late breaking
abstracts will be scored by the Programme Committee only
because of the limited time that is available for decision making.
The quality of reviewing this year was better than we have seen
in previous years with excellent consistency of scores between
reviewers. We refreshed our reviewer database this year which
we believe made an important difference in achieving out target
of ensuring that abstracts were scored by at least six reviewers.
Thanks to all of you within Europe and the many investigators
from outside Europe who are clearly contributing to make
GASTRO 2009 UEGW/WCOG, London a great success.
Professor Michael Farthing
Chair Programme Committee

a
Aabakken, Lars
Abraldes, Juan G
Abreu, Maria
Albano, Emanuele
Albert, Jörg
Algül, Hana
Allez, Matthieu
Almasio, Piero Luigi
Annibale, Bruno
Ardizzone, Sandro
Asselah, Tarik
Assenat, Eric
Atherton, John
Attili, Adolfo
Attwood, Stephen
Azpiroz, Fernando
b
Bajaj-Elliott, Mona
Bardhan, Pradip
Barthet, Marc
Basoli, Antonio
Bataller, Ramon
Bazzoli, Franco
Beaugerie, Laurent
Beglinger, Christoph
Belghiti, Jacques
Bemelman, Willem
Benamouzig, Robert
Bendtsen, Flemming
Bergmann, Jacques J.G.H.M.
Bhandari, Pradeep
Binder, Henry
Binek, Janek
Bisschops, Raf
Böcker, Ulrich
Bohnacker, Sabine
Bouhnik, Yoram
Boureille, Arnaud
Bozkaya, Hakan
Brand, Stephan
Brand, Randy
Branski, David
Bredenoord, Albert
Broelsch, Christoph
Bruno, Marco
Brynskov, Jørn
Bueno, Lionel
Bures, Jan
Butzer, Peter
c
Campbell, Simon
Carrilho-Ribeiro, Luis
Carter, Ross
Castells, Antoni
Castera, Laurent
Castiella, Agustin
Cats, Annemieke
Cellier, Christophe
Ceyhan, Güralp
Chmiela, Magdalena
Clavien, Pierre-Alain
Calvet Clavo, Xavier
Colle, Isabelle
Colombel, Jean-Frédéric
Corazziari, Enrico
Cortez-Pinto, Helena
Cortot, Antoine
Cosnes, Jaques
Costamagna, Guido
Cottone, Mario
Crabtree, Jean
Wang, Timothy Cragin
Craxi, Antonio
Crocetti, Laura
Crowe, Sheila
Csepregi, Antal
Cuesta, Miguel
D
D´Elios, Mario Milco
Olde Damink, Steven
Danese, Silvio
De Boer, K
De Franchis, Roberto
De Giorgio, Roberto
De Moura, Miguel Cameiro
De Palma, Giovanni
De Ridder, Mark
Delchier, Jean-Charles
Delhaye, Myriam
Delvaux, Michael
Devenis, Christos
Devière, Jacques
di Lorenzo, Carlo
Dicato, Mario
Dotan, Iris
Drenth, Joost
Ducrotte, Philippe
Dufour, Jean Francois
Dupont, Christophe
Duris, Ivan
lIsT of ReVIeWeRs
359

lIsT of ReVIeWeRs
e
El Omar, Emad
Eliakim, Rami
Enck, Paul
Engel, Alexander
Eutamene, Helene
f
Faisal, Wasek
Farthing, Michael
Fass, Ronnie
Ferenci, Peter
Ferrante, Marc
Festen, Henk
Fickert, Peter
Figer, Arie
Figueiredo, Ceu
Fine, David
Fioramonti, Jean
Fiorucci, Stefano
Fischbach, Wolfgang
Fitzgerald, Rebecca
Floreani, Annarosa
Ford, Alexander Charles
Forgacs, Ian
Fox, Mark
Fried, Ronald
Friess, Helmut
Fritscher-Ravens, Annette
Froehlich, Florian
Frossard, Jean-Louis
Fujishiro, Mitsuhiro
G
Gaiser, Sebastian
Galli, Andrea
Galmiche, Jean Paul
Galmiche, Jean Paul
Gamal, Esmat
Gasbarrini, Antonio
Gassull, Miquel
Gerhard, Markus
Ghaneh, Paula
Iacopini, Giampaolo
Giangregorio, Francesco
Gilja, Odd Helge
Giovannini, Marc
Gisbert, Javier
Gonvers, Jean-Jacques
360
Gorelick, Fred
Gottrand, Frederic
Gouma, Dirk
Greiner, Lucas
Gress, Thomas
Greten, Florian R.
Grønbæk, Henning
Grundy, David
Guslandi, Mario
H
Haagen Haagen Nielsen, Ole
Häfner, Michael
Halangk, Walter
Hamdy, Shaheen
Hammad, Essam
Hammer, Johann
Hammer, Heinz
Handra-Luca, Adriana
Hatakeyama, Masanori
Hawkey, Chris
Heading, Robert
Heim, Markus
Hellström, Per
Ho, Gwo-Tzer
Hoentjen, Frank
Hofer, Harald
Hoffman, Arthur
Holtmann, Gerald
Hommes, Daan W
Huibregtse, Inge
Hull, Mark
Hultcrantz, Rolf
Husby, Steffen
I
Ilan, Yaron
Ilyas, Mohammad
Iovanna, Juan
Itzkowitz, Steven
Izbicki, Jacob
J
Jackson, Simon
Jankowski, Janusz
Janssen, Harry
Jeppsson, Bengt
Jesnowsky, Ralf

k
Karagiannis, John A
Kaser, Arthur
Kelly, Paul
Keshav, Satish
Kida, Mitsuhiro
Kim, Won Ho
Koletzko, Berthold
Koning, Frits
Krejs, Guenter
Kuipers, Ernst
l
LaBrecque, Douglas
Ladas, Spiros
Laheij, Robert
Lamarque, Dominique
Lambert, René
Lameris, J.S.
Lampertico, Pietro
László, Herszényi
Laurent-Puig, Pierre
Le Moine, Olivier
Lebrec, Didier
Leclerq, Isabelle
Lees, Charlie
Lehr, Hans-Anton
Leicester, Roger
Leja, Marcis
Lemann, Marc
Lencioni, Ricardo
Lenz, Kurt
Lepage, Côme Henri
Lerch, Markus
Leroi, Anne-Marie
Lèvy, Phillippe
Lindberg, Greger
Lindley, Keith J
Lindsay, James
Logan, Richard F.A.
Loudianos, Georgios
Louis, Edouard
Lügering, Andreas
Lundell, Lars
Lundin, Knut
Luzza, Francesco
M
Maaroos, Heidi-Ingrid
Maaser, Christian
Makristatathis, Athanasios
Malfertheiner, Peter
Manns, Michael Peter
Mantzaris, Gerassimos
Maraca, Maurizio
Marchesini, Giulio
Marek, Tomasz Andrzej
Marra, Fabio
Marteau, Philippe
Masamune, Atsushi
Mathurin, Philippe
Matysiak-Budnik, Tamara
Mayerle, Julia
Mc Coll, Kenneth
McKay, Colin
McKiernan, Pat
McLaughlin, John
Mearin, Fermin
Megraud, Francis
Meier, Peter
Merkel, Carlo
Michl, Patrick
Michopoulos, Spyros
Moeller, Soeren
Monkemuller, Klaus
Mönnikes, Hubert
Moreels, Tom
Morgan, Marsha
Mösser, Joachim
Moum, Bjørn
Mouzas, Ioannis
Muñoz Navas, Miguel
Murray, Charles
Musso, Alessandro
Mutignani, Massimiliano
n
Nakayama, Toshiyuki
Nardone, Gerardo
Naylor, Gregory
Neuberger, James
Neunlist, Michel
Nevens, Frederick
Nobili, Valerio
Nowak, Andrzej
Nowakowska-Dulawa, Ewa
Numans, Mattijs
lIsT of ReVIeWeRs
361

lIsT of ReVIeWeRs
o
O´Morain, Colm
Odes, Selwyn
Okolicsanyi, Lajos
P
Paerregaard, Anders
Paganini, Alessandro
Pallone, Francesco
Panes, Julian
Pap, Akos
Parola, Maurizio
Peck-Radosavljevic, Markus
Pedersen, Natalia
Peeters, Harald
Pereira, Steven
Petrosillo, Nicola
Peyrin-Biroulet, Laurent
Peyrin-Biroulet, Laurent
Pfeiffer, Johann
Phillips, Alan
Pinzani, Massimo
Piqué, Joseph
Piscaglia, Anna
Plentz, Ruben
Pollok, Richard
Prager, Gerhard
Pritchard, David Mark
Puespoek, Andreas
Q
Quigley, Eamonn
Quintero, Enrique
R
Rácz, István
Ragunath, Kris
Raimondo, Giovanni
Ramadori, Giuliano
Ramakrishna, B S
Rautelin, Hilpi
Regula, Jaroslaw
Reinisch, Walter
Rey, Jean Francois
Riis, Lene
Robaszkiewicz, Michel
Rodenas, Clara Garcia
Rodríguez, Luis García
Rokkas, Theodore
362
Ronkainen, Jukka
Rossini, Francesco Paolo
Rubin, Greg
Rugge, Massimo
Russo, Francesco Paolo
Ruszniewski, Philippe
s
Salupere, Riina
Santos, Javier
Saunders, Brian
Saur, Dieter
Schaffalitzky de Muckadell, Ove B.
Schmiegel, Wolfgang
Schmoll, Hans-Joachim
Schoefl, Rainer
Schölmerich, Jurgen
Scoazec, Jean-Yves
Seewald, Stefan
Shamir, Raanan
Sheridan, James
Shiffmann, Mitch
Siegmund, Britta
Sifrim, Daniel
Simren, Magnus
Simrén, Magnus
Siriwardena, Ajith
Siveke, Jens
slors, j.f.m.
Smout, Andre J.P.
Sobhani, Iradj
Söderholm, Johan
Sollid, Ludvig
Sousa, Rita
Sperber, Ami
Spiller, Robin
Staiano, Annamaria
Stieger, Bruno
Stoker, Jaap
Sunk, Joseph

T
Tack, Jan
Tamori, Akihiro
Tannapfel, Andrea
Testoni, Pier Alberto
Thibault, Ronan
Thomson, Mike
Thorlacius, Henrik
Tilg, Herbert
Timm, Joerg
Tiniakos, Dina
Toth, Ervin
Trauner, Michael
Trifan, Anca
Troncone, Riccardo
Tsavaris, Nikolas
Tutuian, Radu
Tysk, Curt
U
Uraoka, Toshio
Urbonas, Vaidotas
V
Vaira, Dino
Van Assche, Gert
Van Cutsem, Eric
Van den Brink, Gijs R.
van Hooft, Jeanin E.
van Lanschot, Jan
Van Oijen, Martijn
Veldt, Bart J.
Veres, Gábor
Vermeire, Severine
Villa, Erica
Vilmann, Peter
Vito, Annese
W
Walker, Marjorie
Watson, Alistair
Wehkamp, Jan
Wente, Moritz
Wijmenga, Cisca
Wilder-Smith, Clive
Wittenburg, Henning
Y
Yamaoka, Yoshio
Yao, Kenshi
Z
Zaninotto, Giovanni
Zerbib, Frank
Zoller, Heinz
lIsT of ReVIeWeRs
363

©2009 Inverness Medical.
All rights reserved.
Extend your reach
Inverness Medical brings you rapid and reliable tests
for the management of Enteric Disease:
Infectious Diarrhoea
Intestinal Inflammation
Parasitology
When you need to diagnose and manage enteric disease
reach out to us
WE GIVE YOU ANSWERS FAST...
check out our range of enteric tests now at www.invmed.com/uegw
or email us at professionaldiagnostic@invmed.com
See us at GASTRO on stand 72

INDEX OF
AUTHORS
(CORE PROGRAMME)

InDeX of aUTHoRs
aUTHoR InDeX
How to use the index
Presenters are listed alphabetically by last
name. Names are published exactly as
they were submitted, i.e., no corrections or
changes have been made.
At least one number follows each name;
sometimes several numbers appear. Most
numbers are preceded by letters indicating
oral (OP) or poster (P) presentations.
Numbers without a prefix indicate the
page numbers of presentations by invited
speakers. To sum up:
■ Numbers without a prefix indicate the
page number of a presentation by an
invited speaker.
■ Numbers with the prefix “OP” are oral
presentations. Title and session details
are listed under the given oral presentation
number (starting at page 16).
■ Numbers with the prefix “P” are poster
presentations. Title and session details
are listed under the given poster presentation
number (starting at page 90).
366
Examples
Albano, E. 3
This is a presentation by an invited speaker.
More information is available on page 3 of
this book.
Kessler, W.R. OP111
This is an oral presentation. For quick reference,
the number ranges for oral presentations
on each day are shown in the table
below. It can be seen that OP111 will be
given on Monday as one of the later presentations.
Muraca, M. P1387, 58
This is a poster presentation plus an invited
presentation. For quick reference, the
number ranges for poster presentations
on each day are shown in the table below.
It can be seen that P1387 will be presented
on Wednesday. More information about
the invited presentation can be found on
page 58 of this book.
Number ranges for each day for all oral and poster presentations:
Date Oral Presentations Poster Presentations
Monday, November 23, 2009
Tuesday, November 24, 2009
Wednesday, November 25, 2009
OP001 – OP148
Pages: 16 – 35
OP149 – OP322
Pages: 37 – 61
OP323 – OP484
Pages: 62 – 82
P0001 – P0730
Pages: 90 – 155
P0731 – P1459
Pages: 156 – 221
P1460 – P2188
Pages: 222 - 291
P = poster presentation, OP = oral presentation, number only = page number

a
A, J.: P1590
Aabakken, L.: OP209
Aalfs, C.M.: P1407
Aaronson, N.K.: P0902, P2152
Abad, A.: OP160*
Abbas, A.R.: P1036
Abbas, Z.: P0054
Abbattista, T.: P0469
Abd El Moety, A.A.L.Y.: P1925
Abdel-Rahman, A.M.: P1203
Abdelli, N.: P0717, P1988, P2170
Abdini, E.: P1317
Abdo, A.A.: P0524
Abdolahi, N.: OP394*, P1857
Abdollahi, A.: OP083
Abdovic, S.: OP148*
Abdul Majid, N.: P1482
Abe, D.: P0035
Abe, K.: P0005, P1693
Abe, S.: P1275
Abe, T.: P0118
Abe, Y.: OP130*, OP444*, P0915
Abecasis, R.: P1946
Aberson, H.L.: P1716
Abeysekera, K.W.M.: P0777
Abeysuriya, V.: OP277*, P2127
Abid, S.: P0483, P1927
Abitbol, V.: P1816
Abnet, C.C.: P0842
Aboa-Eboulé, C.: OP404*
Abou El-Ella, K.A.: P0703
Abou-Taleb, A.: P0568
AbouYoussef, R.A.M.: P1935
Abrahamsson, H.: OP096, OP098,
P0386, P1834
Abramovith, D.: P0609
Abramowitz, L.: P0218
Abreu, M.: 51
Abreu, M.T.: P0355, P1790
Abreu-de-Sousa, J.: P1684
Abuderman, A.A.: P0743*
Abuzarova, E.R.: P1493
Acalovschi, M.: P0484, P1222
Acartürk, G.: P0890
Aceves, S.: OP002
Achkar, J.: OP309*
Ackermans, M.T.: P1692
Adabala, A.S.P.: P1193
Adachi, K.: P0574
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Adachi, W.: P1694
Adamek, A.: P0044
Adam, R.: 65
Adams, J.: P0933, P1156
Adan, L.: P2075
Adán Merino, L.: P0107, P0725
Adelstein, B.: OP073
Adenis-Lamarre, P.: OP176
Adhoute, X.: P1359, P1360
Adiloglu, A.: P0890
Adjarov, D.: P1970
Adjei-Gyamfi, Y.: P1057
Adler, A.: OP441, P0232
Adler, J.: OP027, OP028
Admane, F.: P1052
Adolf, D.: OP063*
Aerts, R.: P0681, P1261
af Björkesten, C.: P1800
Afchain, P.: OP295
Afdhal, N.H.: P1932, P1934
Afonso, M.: P0083, P0500, P0550, P1227,
P1472, P1908, P1926
Afredj, N.: P0292, P0301, P0310, P1759,
P1761, P1849
Afzal, M.: P1057
Agafonova, N.A.: P0505
Agalos, G.: P1775
Agamov, A.: OP375*
Agaraval, V.: P1534
Agardh, D.: P1432, P1661
Agarwal, A.: P0679
Agelopoulou, O.: P0232
Agger, R.: P1720
Aghcheli, K.: P0842, P1630
Aghdassi, A.: P2136
Agnholt, J.: OP333*, P1720
Agostini, S.: OP274*
Agrawal, A.: P1172
Agréus, L.: OP132, P0128, P1477
Aguas, M.: P0288, P1809
Agulló, J.R.: P0215, P0934
Ah Soune, P.: P2149
Ahasan, K.: P0750
Ahlbom, H.: OP439, OP442
Ahluwalia, A.: OP070, P0955, P0998
Ahmad, M.M.: P0750, P0761, P1389
Ahmad, N.: P1947
Ahmad, S.: P1513, P1640
Ahmad, T.: P1794
Ahmadi Asl, N.: OP131
367

InDeX of aUTHoRs
Ahmed, A.: P0727
Ahmed, A.M.: P1170
Ahmed, D.: P0242
Ahmed, F.: P0750
Ahmed, I.: OP154*, P1047, P1508
Ahmed, M.M.: P0441, P2020
Ahmed, S.: P1927
Ahmed, W.: P1929
Ahn, J.: P1713
Ahn, S.: P1010, P2050
Ahn, Y.H.: P0537
Ahuja, V.: P1744, P1811
Aihara, H.: P0238
Ainley, J.: P0897
Ainora, M.: P0197
Ainora, M.E.: P1797
Ainsworth, A.P.: OP038
Airinei, G.: P0391, P1606
Aissa, N.: P0717, P2082
Aithal, G.P.: P1351
Ajdukovic, R.: P0462
Ajioka, Y.: P1281, P2031
Akabane, A.: OP061
Akagi, M.: OP064
Akahoshi, K.: OP009
Akaike, J.: P0490
Akao, T.: P0859
Akaraviputh, T.: P0626
Akarca, U.: P0508
Akasaka, H.: P1148
Akasaka, R.: P1088
Akasaka, T.: P0573
Akbar, N.: P0498
Akbari, M.: P0029
Akerman, P.A.: OP211, P0638
Akhapkin, N.: OP375*
Akhtar, J.: P1184
Akhtar, K.: P1841
Akhtar-Danesh, N.: OP094*
Akin, M.: P0890
Akiyama, J.: P0178, P0542
Akkermans, L.: OP146
Akkermans, L.M.: OP473*, OP474
Aksu, O.: P0890
Aktas, H.: OP209
Akter, J.: P0779
Akuzawa, S.: OP454
Akyildiz, M.: P0508
Akyildiz, S.: P1627, P1648
Akyuz, F.: P0870, P1861, P1955
368
Akyuz, U.: P1998
Al-Adnani, M.: P1658
Al-Akwaa, A.: P0524
Al-Ashgar, H.: P0524
Al Dhaheri, A.M.H.: P0831
Al Dulaimi, D.: P0791
Al-Ghamdi, H.: P1309
Al Jaberi, N.F.J.: P0831
Al-Joudeh, A.: P1542
Al-Joudeh, A.A.: P1541
Al-Madfai, H.: P0673
Al-Mayouf, S.M.: OP191
Al Mehaidib, A.I.: OP191
Al-Qahtani, A.: P0524
Al Rifai, A.: P0210
Al-Sader, H.: P1027
Al-Shamma, S.: P1195
Al-Taie, O.: P1885, P1886
Al-toma, A.: OP001*, OP337
Al Waraky, M.: P0703
Alaimo, G.: OP358*
Alakkari, A.: P1717
Alam, K.: P1947
Alam, N.H.: OP194, P1948
Alam, S.: P1947
Ålander, T.: P1477
Alansari, M.: P1378
Alarcó Hernández, A.: P1673
Albano, E.: P0502, P1187*
Albarello, L.: OP258*, P0677
Albert-Marty, A.: P0398
Albiladi, H.: P0524
Albillos, A.: P2078
Albrecht, C.: P0025
Albrecht, P.: P0188, P0189
Albuquerque, C.: OP081*
Alcantara, M.: P2117
Alcazar, F.: P0619
Aldeguer, X.: OP108*, P0288, P0995
Alderson, D.: OP399*
Aldo, T.: P1176
Aldridge, R.W.: OP370*
Aldulaimi, D.M.: P0065, P0830
Aleksieva, D.: P1980
Aleman, B.M.P.: P0902, P0903, P0904
Alempijevic, T.: P1194, P1928
Alessandroni, L.: P1802
Alessi, N.: P1933
Alexander, G.: P0004, P1174
Alexander, S.: P0615, P0616
P = poster presentation, OP = oral presentation, number only = page number

Alexander, S.M.: P1892
Alexandrakis, G.: P0896, P0977*, P0978*,
P1468, P1469
Alexandropoulou, K.: OP216*, P1595
Alexandrov, Y.L.: P0014
Alfieri, S.: P0692, P1362
Algaba, A.: P1053, P1054, P1812
Algaba García, A.: P0354
AlGhamdi, A.S.: P0524
Algül, H.: OP089*, 81
Ali, R.A.R.: P0749
Ali, T.: P1158
Ali Arous, N.: P0108
Alimoghaddam, K.: P1189
Alishah, H.: P1927
Alison, M.R.: P2128
Alizadeh-Naini, M.: P1244
Aljabiri, M.: P0219, P0898, P1048,
P1049, P1308, P1334, P1666
Aljebreen, A.: P0315
Alkan, M.: P1562
Alkuraya, F.S.: OP191
Allain, B.: P2007
Allam, N.: P1929
Allan, A.: P0719
Allegranza, P.: P2093, P2094, P2095, P2096
Allen, P.B.: OP045*
Allen, W.: P0219, P1048, P1049
Allez, M.: P1816, P1828, 36
Allison, M.: OP372*
Almas, A.: P1184
Almasio, P.: P1959, P1960
AlMdani, A.S.: P0524
Almeida, C.C.: P1537, P1561, P1712
Almeida, J.R.: P0448
Almeida, N.: P0639, P1683
Almqvist, P.: P1432
Alò, P.L.: P0789, P0905, P0906
Aloi, M.: OP195*
Alonso, C.: P1114
Alonso, M.: P1547
Alonso-Espinaco, V.: P0632
Alsina, M.: P1535
Alsuaied, N.M.: OP191
Altevogt, P.: OP322*
Altman, D.G.: P1790
Altorio, F.: OP014
Altorjay, I.: P0319, P1078, P1252,
P1253, P1254
Altwegg, R.: P2137
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Alústiza, J.: P0461
Alvarez, A.: P1250
Alvarez, M.: OP044
Alvarez Herrero, L.: OP220*, OP221, OP222,
OP223, OP446*, OP449*, P0145
Álvarez-Sánchez, V.: P0287
Alves, B.: P0423
Alves, H.: P1908
Alves, K.Z.: P1786
Alves, N.: P1217
Alvisi, C.: OP049
Alvisi, V.: P0090
Alzate, L.F.: P1200
Amano, K.: P1975
Amarapurkar, D.N.: OP233*, P0523, P1185
Amarasinghe, G.: P2057
Amarasiri, L.: P1596
Amaro, P.: P0783, P1293, P1496, P1683,
P1941, P1942
Amato, A.: P0001, P2048
Ambrosius Christensen, L.: OP333*
Amendolara, B.A.: P0899
Ament, A.: P0775
Amin, S.: P1433
Aminian, K.: P2008
Amiot, X.: OP299*
Amir, N.: P0831
Amir, Z.: P0108
Amiri, A.: P1969, P1985
Amiriani, T.: P1167, P1857
Ammann, R.W.: OP281
Amo Trillo, V.M.: P0336
Amodio, P.: P0447
Amoozegar, H.: P0194
Amornyotin, S.: OP215
Amrani, N.: 62
Amzolini, A.: P1223
An, J.: OP092, P1903
Anapliotis, P.: P0979
Ancans, G.: P1578*
Ancel, D.: OP299*
Ancuta, I.: P1190
Anderl, F.: OP059*, P0751*
Andersen, A.M.: P0666
Andersen, L.P.: P1481
Andersen, U.B.: P1831
Anderson, I.D.: P0815
Anderson, R.: OP278
Anderson, S.H.C.: P2108, P2109, P2110
Anderson, T.: P1795
369

InDeX of aUTHoRs
Andersson, P.: P0364*
Ando, E.: P1251
Ando, M.: P0826, P0912
Ando, T.: P0331, P0545, P2009
Andoh, A.: OP348*, P1550, P1718, P1806
Andorno, S.: P0435, P0502
Andrade, B.C.: P1255
Andrade, P.: P1035
Andrade, R.J.: P0473
Andrade, S.B.: P1255
Andrén-Sandberg, Å.: OP281
Andrenacci, P.: P1519, P1520
Andreozzi, P.P.: P0262
Andreu, M.: OP160*
Andreu Garcia, M.: P1547
Andriantsitohaina, R.: P0259
Andrisani, G.: P1774
Andro-Delestrain, M.: OP460
Andrus, L.: P1905*
Ang, D.: P1844
Ang, E.: P0006, P1559
Ang, E.R.: P0778, P1940, P1956,
P1991, P2069
Ang, J.: P1760
Ang, L.T.: OP042
Ang, T.: P1760
Ang, Y.: OP398*, P0126, P0552*
Angeletopoulou, C.S.: P2068
Angeli, P.: P0447
Angelico, M.: P0517, 18
Angelini, O.: P1198
Angelucci, E.: OP334, P0789, P1091
Angenete, E.: P0715
Anggiansah, A.: P1624, P1845
Anggiansah, R.: P1624
Anifanti, C.I.: P0759
Annese, V.: P1043, P1090
Annibale, B.: OP338*, P0430, 47
Ansari, R.: OP302, P0211, P0633,
P1392, P1568
Antaki, N.: 65
Antal-Szalmas, P.: P0319
Anton, G.: P0438*
Anton, P.: P1086
Antonellis, F.: P1893
Antonietti, M.: P0665, P1287, P1319, P2073
Antonioli, A.: P1999
Antonov, K.: P1970
Antonov, K.A.: P0514
Antonozzi, I.: P1654
370
Antuzzi, D.: P0197
Anwer, M.: OP369
Aoki, H.: P0271, P0983
Aoki, J.: P1225
Aoki, T.: P0576, P0707, P1274
Aouattah, T.: P0114, P0150
Aoyagi, K.: P0264
Aoyagi, Y.: OP346, P1281, P1644, P2177
Aoyama, T.: OP144
Aparicio, T.: OP295, P0220, P0273*, P1688
Apostolopoulos, P.: P0896, P0977*,
P0978*, P1469
Apostu, M.: P0476
Appleby, N.: P1166, P1512
Appleyard, M.: P1327
Apuzzi, V.: P0297
Aqodad, N.: P0300, P0713
Ara, N.: OP444*, P0915
Arab, K.: P0822
Arab, P.: P0633
Arabali, A.: P1167
Aragona, G.: P1943
Arai, M.: P0137
Arai, S.: P2040
Arakawa, T.: P0663
Araki, H.: P0547, P0644, P0838
Araki, M.: P0637, P1357
Arakwa, T.: P0855
Aranda, J.: P1835
Aravinthan, A.: P1174
Arber, N.: OP086*, OP162, OP322*,
OP479, P1667*, P1868
Arbones, M.: P0085
Archambeaud, I.: OP127*
Archaulis, E.: P1775
Archimandritis, A.J.: P0526
Arcidiacono, P.: OP257*, OP258*, P0677,
P2091
Arcidiacono, P.G.: P2090
Ardengh, J.: P1440, P1441, P2139
Ardengh, J.C.: P2138, P2139
Ardhanari, R.: P0668, P1352, P1418,
P2083, P2158
Ardizzone, S.: OP334, P1814*
Arebi, N.: P0404
Areia, M.: OP219*, P2022, P2086, P2087
Areias, J.: OP046*, P0625
Arena, V.: OP311*
Arenas, M.: P0344
Arenas-Hernandez, M.: OP243*
P = poster presentation, OP = oral presentation, number only = page number

Arfini, C.: P0482
Argent, B.E.: OP418*
Argüelles Arias, F.: P1366
Argüello, L.: OP260*
Argyropoulos, T.: P1700
Arhan, M.: P0728
Arias, A.: P1566
Arias, L.: P1706, P1707
Arici, S.: P0870
Arihiro, K.: OP344*
Arijs, I.: P1031*, P1079
Arimura, Y.: P1588
Arisawa, T.: P0037, P0140*, P0561,
P1486, P1581
Ariyasinghe, M.: P1016
Arizumi, T.: P1345, P2178
Arkkila, P.E.T.: P1800, P1976
Arkwright, J.W.: P0392
Armaroli, P.: OP165
Armbrust, T.: P1899
Armstrong, D.: P0577, P1050
Armuzzi, A.: P0304, P1090, P1774,
P1803, P1804
Arnau, M.: P0549
Arnelo, U.: OP117, P0614, P1338, P2120
Arnholdt, H.: OP006, P2174
Arnold, J.: P0279, P0479, P1245, P1909
Arnold, J.R.: P0736
Arnott, I.: P0325, P1375
Arnott, I.D.R.: OP156, OP271, P1715
Aro, P.: OP132, P0128
Aroch, I.: P1667*
Aronson, D.C.: P1424
Arosio, M.: P2047
Aroua, A.: P2080
Arranz, G.: P1812
Arribas, B.: P0260*, P0261, P1735,
P1736, P1743
Arrieta, R.: P0527
Arriola, J.A.: P1200
Arslan Lied, G.: P0066
Artifon, E.E.L.: OP010
Arts, J.: P0133
Arutyunov, G.P.: P1701
Arvaniti, V.: P0504
Aryanasingha, S.: OP202
Asadi-Lari, M.: P1244
Asaka, M.: OP184*, P0038, P1383
Asami, I.: P1459
Asano, N.: P0915
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Ascolani, M.: P1777
Ashdhir, P.: P1196, P1930, P1931, P2013
Ashleigh, R.: P0731
Ashley, S.W.: OP266*
Ashman, N.: P1973
Ashraf, H.: OP194, P0779, P1948
Asim, M.: P0515
Asl-Soleimani, H.: P0211
Asplund, D.: P0715
Assa'ad, A.: OP002
Assar, L.A.L.: P1935
Asselah, F.: P0108
Asselah, H.: P0108
Asselah, T.: 65
Assenat, E.: P2137, P2141
Assumpcao, L.: OP254, P0720
Ataoglu, E.: OP363
Atarot, T.: P0868
Atasoy, S.: P1298
Atema, J.J.: P1692
Atherton, F.: P0113, P0699, P0854
Atherton, J.C.: P0757
Atiaja, J.: P1169
Atkin, W.: OP075
Atug, O.: P1230*, P1231
Aubert, A.: P2141, P2148
Aubert, P.: P1832
Aubourg, A.: OP242*, P1805
Auernhammer, C.: P1164
Aujla, U.I.: P0731, P1335, P1344
Aung, M.: P1264
Auriault, M.: P0975
Auroux, J.: P1336
Austin, A.: P0487, P0488
Austwick, M.: P0151
Avallone, S.: P0084
Avanzini, A.: OP048, OP049
Avery, A.: P0757
Avitzur, Y.: P1528
Avram, G.: OP200, P1904
Awad, R.A.: P1100
Awais, D.: OP204
Awasthi, A.: P0080
Aybar Bilir, Y.: P0776
Aylin, P.: P1022, P1511
Aynaud, O.: P0218
Ayodeji, I.D.: P1681
Ayoub, S.: P0108
Ayrizono, M.S.: P0992
Azadani, A.: P2159, P2160
371

InDeX of aUTHoRs
Azam, Z.: OP362, P0440
Azarshin, F.: P1555
Azevedo, L.: P0241
Aziz, I.: P1542
Aziz, Q.: OP101, OP461*, P0980, P1750, 20
Azouz, M.: P1951*
Azpiroz, F.: P1058
Azuara, D.: P1876*
Azuma, M.: P0120, P1645
Azuma, T.: OP066, P0562, P0721, P1388*
Azzouzi, K.: P2062
b
Babaei, M.: P1695
Babatin, M.A.: P0524
Babbs, C.: P0210
Babic, Z.: P0462, P0532, P0617, P0634,
P1349, P1599
Babu, J.: P0302
Babu, P.: P0302
Babu, S.: P2066
Baccarini, P.: P2145
Bach-Ngohou, K.: OP206, P0293
Baczewska-Mazurkiewicz, D.: OP422
Badada, S.: P0788
Badea, R.: OP231*, P0467, P0468, P0484,
P0629, P0630, P0684, P1972, P1982
Badea, R.I.: OP357*
Badran, H.M.: P1929
Badulli, C.: P0095
Bae, J.: P2050
Bae, K.S.: P1239
Bae, S.Y.: P1307, P1696
Bae, Y.: P0669, P1453, P2182
Baek, E.: P0587, P1854
Baek, I.H.: P0123
Baek, Y.H.: P0093
Baert, P.: P1478
Bafutto, M.: P1810
Bagheri, M.: P1189
Baghriche, M.M.: P2014
Bagnati, M.: P0482
Baharvand, H.: P1189
Bahr, M.: P0486
Bai, J.: P1519, P1520, 64
Bai, J.C.: P1946
Baicus, C.R.: P0772
Baidoo, L.: P1072
Baik, G.H.: P0758
Baik, K.H.: P0123
372
Bailador-Andrés, C.: P0672
Bailey, A.A.: OP448, P0615
Bailey, J.R.: OP313
Bailon, E.: P0260*, P0261, P1735,
P1736, P1743
Baiod, N.: P0292, P0301, P0310, P1759,
P1761, P1849
Bair, M.: P0693
Bajbouj, M.: OP089*, P0171, P1298
Bajwa, A.A.: P1697, P1698, P1699
Bak, Y.T.: P0125, P0535, P1136
Bak-Romaniszyn, L.: P0286, P0931
Baker, M.D.: OP461*
Bakers, F.C.H.: P0952
Bakhshipour, A.: P1568
Bakkal, N.: OP159*
Bakoyiannis, A.: OP228*
Bakston, D.: P1905*
Bakx, R.: P1424
Balakrishnan, A.: OP266*
Balamane, A.: P0292, P0301, P0310,
P1759, P1849
Balamane, M.: P0635
Balaraman, S.: P0247
Balbi, M.: P1987
Balbo Mussetto, A.: P2093, P2094, P2095,
P2096
Baldaia, C.: P1957, P1958
Baldaque Silva, F.: OP219*, P2010
Baldea, C.: OP317, OP437, P0130
Baldoni, F.: P0899
Balen, E.: P1677
Balestreri, L.: P1703
Balicka, M.: P0159
Ball, A.J.: P1524
Ball, S.: P0854
Ballare, M.: P0435
Ballarè, M.: P0502
Ballet, V.: P0309, P1033
Ballieux, B.: P1067
Balmforth, D.: P2154
Balogh, Z.: P0774
Balsa, D.: P1736
Baltar, R.: P0287
Balzarini, L.: P1068
Balzarini, M.: P0435
Bamba, S.: OP348*, P1718, P1806
Bamford, K.B.: P0052
Bamford, M.: P0830
Bamias, G.: P1700, P1719
P = poster presentation, OP = oral presentation, number only = page number

Banaee, F.: P1244
Banai, J.: P0317, P0318, P0320, P1078
Banait, G.: P0080
Banait, G.S.: P1226
Banaszkiewicz, A.: P0188, P0189, P0190
Bancel, B.: P1219
Bandino, A.: OP125*
Bando, E.: P1584
Banez, V.: P1940, P1991
Banez, V.P.: P2069
Bang, S.M.: P1452, P1990, P2143
Banhudo, A.: P0583
Bani-Hani, M.G.: P1649*, P1872
Banic, M.: P0462, P0617, P0634,
P1349, P1599
Banks, M.: P0953
Banovcin, P.: P0781
Bansal, A.: P0171
Bansi, D.: P0052, P1062
Bansi, D.S.: P2052
Bantel, H.: OP354
Bapaye, A.: P0246, P1139
Baqi, L.: P0989
Bar-Meir, S.: OP330, P2001
Barada, K.A.: P0974
Barakauskiene, A.: P1180
Baranski, A.G.: P0449
Barba, M.: P0417, P1257
Barbado, A.: P0578
Barbagallo, F.: P0539
Barbara, G.: 64
Barbaro, F.: P0078, P1997*
Barbaza, R.: P0027
Barbazza, R.: P1878
Barbe, C.: OP040, P0690
Barbier, L.A.: P2140
Barcenilla, J.: P1343
Barclay, M.L.: P1044, P1045, P1046
Bardhan, K.: P1542
Bardhan, K.D.: P0797, P1051, P1541, P1820
Bardhan, P.K.: P0779
Bardou, M.: P0010
Barendse, R.M.: P1419
Barillà, D.: P0789, P0905, P0906
Barker, N.: 40
Barker, P.N.: P0928, P0929
Barkun, A.: OP439, OP442, P0010
Barlow, J.: P1841
Barnich, N.: OP022*
Barnoud, R.: OP290
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Baron, J.A.: OP139
Baron, T.: 66
Barr, J.: P1195
Barreau, F.: OP306*
Barreca, A.: P2094
Barreiro, M.: OP324, P0288, P0299, P1011,
P1767
Barreto, R.: P0780
Barrett, J.: OP463
Barrie, H.: P1953
Barriere, P.: P0293
Barrière, P.: OP206
Barrio, J.: OP160*
Barros, S.G.S.: P0917*
Bartels, L.E.: P1720
Barth, X.: P1428
Barthel, C.S.: P1808
Barthel, D.N.: P1807, P1808
Barthelemy, P.: OP188*, P1600
Barthélemy, P.: OP435, P0003, P0738, P1612
Barthet, M.: P1454, P2141, P2149,
P2186, 30, 56
Barton, R.: P0554
Bartos, V.: P0767
Basha, M.: P0532
Bashir, S.: P0521
Bashiri, H.: P1122, P1714
Basilisco, G.: P0371, P0393, P1793
Basinoglu, F.: OP363
Bass, D.: OP369
Bassan, M.S.: P1367
Bassanelli, C.: OP060, P0766
Basser, S.: P1748
Bassi, C.: 56
Bassi, M.: P1680
Bassioukas, S.P.: P0002, P2169
Basso, D.: OP226*
Basso, S.: P0789
Bassoti, G.: P0791
Bastaki, S.M.A.: P0831
Bastida, G.: OP160*, P0288, P1722*, P1809
Bastos, P.: OP246*
Bastos, R.P.: P1917
Bastos Oreiro, M.: P0527
Basude, D.: P1558
Basumani, P.: P0797, P1541, P1542
Bataga, S.M.: P0023
Bath, L.E.: P1514
Battista, N.: P0067
Baudin, E.: OP040, P0690
373

InDeX of aUTHoRs
Baudry, C.: P1832
Bauinger, S.: P1772
Baulf, M.: OP213
Baulieux, J.: P1219
Baumann, U.: P0453
Bäumel, D.: P0925
Baumer, P.: P0056
Baumgart, D.C.: P0042*, P1721, P2011
Bayrakci, B.: P0187, P1597, P1627, P1648
Bazargan-Hejazi, S.: P1122
Bazzoli, F.: OP321
Beardsley, J.: P2063
Beauchant, M.: P0213
Beaugerie, L.: P1052
Beaugrand, M.: P1240
Beaumont, H.: OP028
Beceiro, C.: P0997
Becera Garcia, F.C.: P1421
Beck, J.: P0147
Becker, C.: OP107*
Becker, K.: P0935
Becker, V.: OP476*, P0579, P2012
Beckett, C.G.: P0345
Bedossa, P.: P1405
Beets, G.L.: OP244*, OP245*, P0952,
P1681, P1682
Beets-Tan, R.G.H.: OP244*, OP245*, P0952,
P1681, P1682
Befrits, R.: P0356, P0357
Beg, M.: P0054
Bege, T.: P2149
Beglinger, C.: OP143*, P0136, P0308, P0600
Begnami, M.D.: P2138
Begum, N.: P0472*, P0679
Begum, R.: P0457
Behari, A.: P0711*, P1902
Behl, N.S.: OP298*, P1196, P1930,
P1931, P1949, P2013
Behn, C.O.: P2136
Behnampour, N.: P1167
Beigel, F.: OP325*, P0294, P1056,
P1819, P1914
Beinhardt, S.: P1967, P1979
Beisner, J.: P0045
Bejou, B.: P0391, P1606
Beker, A.: P2081
Bekkali, N.L.H.: P0191, P0372
Bekker, P.: P1810
Bektas, M.: P1562
Belaiche, J.: P1548
374
Belda, J.: OP259*
Belen, E.: P0187, P1626
Belghiti, J.: P0704, P1405, 19, 40
Belhocine, K.: OP445, P0084, P1759
Belien, J.A.M.: P0969
Bell, J.: OP370*, P1328
Bella, A.: P0939
Bellantone, R.: P0692
Belle, A.: P1019
Bellentani, S.: P1197, 30
Bellicoso, M.: P1783
Bellomi, M.: 65
Bellomo, G.: P0482, P0502
Bellón, T.: P1566
Belloni, L.: OP297*
Bellringer, S.: P0798
Bellumat, A.: P1878
Belluzzi, A.: OP004, OP320, OP321
Belsanova, B.: OP481*
Beltran, B.: P1722*, P1809
Belyaev, M.N.: P2150
Bemelman, W.: 17, 65
Bemelman, W.A.: OP240*, OP471*,
P0363, P0569, P1419,
P2152, P2156, P2166
Bemelmans, M.H.: P0712*
Ben Abdallah, H.: P0717, P1988, P2170
Ben-Ari, S.: P1667*
Ben-Horin, S.: OP330, 72
Ben Larbi, I.: P1162
Ben Mustapha, N.: P0311, P1618, P1619,
P1620
Ben Romdhane, S.: P0986
Ben Soussan, E.: OP176, P2073
Benajah, D.: P0300, P0713
Benamouzig, R.: OP005, OP459, P0220,
P0391, P1141, P1606
Benaron, D.A.: P1438*
Benchimol, D.: P1420
Bendix-Struve, M.: P1720
Bendtsen, F.: P0718
Bene, L.: P0318
Benedetto, E.: P1197
Benes, M.: P1668, P1689, P2034
Benes, Z.: P0950
Benesova, L.: OP481*
Benhar, I.: OP322*
Benhassine, F.: P2014
Benhassine, M.M.L.: P2014
Benini, F.: P1198
P = poster presentation, OP = oral presentation, number only = page number

Benizri, E.: P1420
Benjamin, J.: P1811
Benjamin, J.L.: P1003, P1004, P1080, P1723
Benji, P.: OP331
Benninga, M.A.: P0191, P0372, P1424
Benoni, C.: P1432
Bensenane, M.: P1019
Bensimon, A.G.: OP151, P1094, P1097
Bentley, R.W.: P1044, P1045
Bentur, O.S.: P2064
Beraza, M.: P0461
Bercik, P.: P0384
Berdowska, A.: P1971
Bereder, J.: P1420
Beregova, T.: P0103
Beregova, T.V.: P0109
Berenguer, M.: P0473
Berg, T.: P1209
Bergman, J.: P0163*, 24
Bergman, J.J.: OP220*, OP221, OP222,
OP223, OP447, OP449*, P0145
Bergman, J.J.G.H.: OP446*
Bergstrom, M.: P0714, P0715, P2159,
P2160
Berkane, N.: OP299*
Berkane, S.: P0108
Bermejo, A.: P1053, P1054
Bermejo, F.: P0354, P1053, P1054, P1812
Bernachin, J.: P0174
Bernal, E.: P1159
Bernard, A.: P1102
Bernard-Chabert, B.: P1178
Bernardini, S.: OP163*
Bernardo, M.E.: OP048, OP049
Berndt, U.: OP329*
Bernedo, A.: P0899
Bernhardt, C.A.: P1790
Bernklev, T.: OP155, P0289, P0290, P1757
Bernstein, C.: 16
Berretta, O.: P0590
Berrill, J.: P0716, P0832
Berrisford, R.G.: P1649*, P1872, P2164
Berry, S.H.: P0919
Bersani, G.: P0090
Berssenbrügge, C.: P1340
Berstad, A.: OP095*, P0066
Bert, A.: OP284
Bertani, A.: P1999
Bertani, H.: OP041*, P0940
Bertelè, A.: P0785
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Berthier, F.: P0822
Bertin, C.: P1402
Bertolazzi, S.: P0804, P0805, P0806,
P0807, P0808
Bertolini, S.: P0784
Bertomoro, P.: P0329, P1085
Bertrand-Michel, J.: P1007*
Bertz, H.: OP053
Berzuini, C.: P1039
Besharat, S.: OP394*, P1167, P1857
Besharati, S.: P1484
Besherdas, K.: P0110, P0219, P0436,
P1048, P1049, P1308,
P1334, P1666, P1702
Besisik, F.: P0870, P1955
Bessaguet, C.: P1888*
Bessant, C.: P1748
Bessard, G.: P1055
Besselink, M.: 52
Besselink, M.G.: OP473*, OP474
Betes, M.: P1364
Bethimoutis, G.: P0978*
Bettencourt, A.: P1635
Bettenworth, D.: OP039*, P1724, P1813
Beuers, U.: 52
Beutheu Youmba, S.: P0057*
Beuvon, F.: P0936
Bhandari, P.: P0596, P1292, P1295,
P1296, P1326
Bhansali, A.: P0788
Bharath, A.: OP368
Bharathy, K.G.S.: OP255*
Bhasin, D.K.: P0062
Bhaskar, E.: P1248
Bhat, G.: P0004
Bhatia, V.: OP061
Bhatt, A.: P0129
Bhattacharjee, H.K.: P1421
Bhuiyan, M.: P0242, P0394
Bhutia, K.: P0520, P0521, P1186*
Bialek, A.: P0954
Biancardi, A.: P0447
Biancheri, P.: P0067, P1814*
Bianchi, P.I.: P0095
Bianchi, V.: P0482
Bianchi Porro, G.: P1814*
Bianco, M.A.: OP374, OP403, P0764, P1462
Biancone, L.: OP334, P0306, P0863,
P1090, P1379, P1777, P1883
Biasiolo, A.: P1140
375

InDeX of aUTHoRs
Biavati, B.: P1506
Bibani, N.: P1618, P1619, P1620
Bichard, P.: P1336
Bidault, A.: OP295
Biddlestone, L.: P0283
Bieberdorf, F.: P0827, P0828
Bielecki, C.: P1721
Bielecki, K.: P0060
Bielicki, D.: OP241, P0954
Biemond, I.: P0276
Bierau, K.: OP483*
Biesiekierski, J.: OP463
Biesterfeld, S.: OP137*, OP371
Bigard, A.: P1548
Bigard, M.A.: P0337, P1019
Bihalskyy, I.: P1393
Bihun, M.: P0104*
Bijlsma, M.: P0988
Bilic, B.: P0462, P0617, P0634, P1349, P1599
Bilic Zulle, L.: P1401
Billi, P.: P1680
Bilski, J.: P0844, P1543
Binas, I.: OP181, P1376, P2118
Binder, H.: P0269
Bingham, M.: P0041*
Bingham, S.F.: P1039
Binion, D.: P0333, P1097
Binmoeller, K.: OP113
Biolato, M.: P0501, P1220
Biondetti, P.: P0371
Bird-Lieberman, E.L.: P0146
Bisanti, L.: OP165
Bismuth, M.: OP359*
Bisschops, R.: OP221, P0133, P0147
Bisset, W.: P0919
Bittinger, M.: OP248
Bitton, A.: P1660
Bizid, S.: P0717, P1988, P2170
Bizon, A.: P2121
Bizzotto, A.: P0658, P1560
Bjorkenberg, B.: OP381*
Björkenberg, B.: P1012
Bjorkman, D.: 32
Blackett, K.L.: P0346
Blagosklonov, O.: P0458
Blaha, B.: P0739
Blair, L.: P0777
Blanc, J.F.: P1898
Blanc, P.: OP304*, OP359*
Blanco, I.: P1876*
376
Bland, P.W.: OP313
Blaser, M.: 47
Blay, J.: OP290, P1879
Blazina, Š.: P1540
Bleich, F.: P2071
Bleiker, E.M.: P2152
Blenman, N.G.: P0392
Blinder, G.: P1505
Bliznakova, D.: OP196*
Bloch, F.: P0659
Bloch, J.: P0203
Bloemen, J.G.: OP244*, OP472*, P0712*
Blokzijl, T.: P0274, P0275
Blomberg, J.: P2120
Blomqvist, P.: P0204
Blondeau, K.: P0920
Bloomfield, R.: P1815
Blova, N.A.: P1701
Blower, E.L.: P0933
Bloxham, C.: P0074
Boadas, J.: P1876*
Boardley, R.L.: OP097*
Boarino, V.: P1999
Boberg, K.M.: P0985
Bock, H.: P0385
Bock, H.J.: P1500
Bodammer, P.: P1416, P1725, P1726
Bode, W.A.: P0942
Bodea, A.: P0691
Bodin, L.: P1731
Bodyak, N.: OP314*, OP332*
Boeckstaens, G.E.: OP028
Boeckxstaens, G.E.: OP027, OP136, OP408*
Boemo, C.: P0677, P2090, P2091
Boermeester, M.A.: OP406, OP474
Boese-Landgraf, J.: P1399
Boesmans, W.: OP273*
Boffetta, P.: P0842
Bogacka, B.: P0954
Bogdanos, D.P.: P0255, P1013, P1179
Bogdanovic, Z.: P0462, P0532
Boger, P.C.: P0148, P0580
Böhm, M.: P1724
Bohr, J.: OP272, P1017, P1731
Boi, F.: P0252
Boin, I.F.: P0448
Boisdron-Celle, M.: OP242*
Boitard, J.: OP005
Boivin, J.: P0975
Boix, J.: P1751
P = poster presentation, OP = oral presentation, number only = page number

Bojarski, C.: P0166
Bojic, D.: P1788
Bok, H.: P0323, P1042, P1152, P1768
Boka, V.: P0209, P0856
Bokemeyer, B.: P0356
Bokharaei Salim, F.: P1969
Bokun, T.: P0462, P0634, P1349, P1599
Bol, Y.: P1024, P1025
Bolado, F.: P0621
Boland, C.: OP316*, OP320
Boland, G.J.: P1209
Bold, J.: P0791
Boldorini, R.: P0435
Boletis, I.: P1700
Bolge, S.: P1611
Bolijn, A.S.: P1142
Bolling-Sternevald, E.: OP132, P0128
Boltjes, R.P.B.: OP203*
Bolz, C.: OP059*, P0751*
Bon, C.: P0391, P1606
Bonamico, M.: P1539
Bonavina, L.: 72
Bonaz, B.: P1055, P1101
Bondarchuk, T.I.: P0823
Bongers, M.E.J.: P0191
Bonifacio, C.: P1068
Bonilha, D.Q.: P2017
Boninsegna, A.: P0417
Bonior, J.: P2122
Bonithon-Kopp, C.: OP404*
Bonizzi, M.: P1774
Bonnet, D.: OP080*
Bonnetain, F.: OP295
Bonnin, P.: P1675
Bonten, M.J.M.: P1965
Bonthuis, F.: P0460
Boo, S.: P1460
Boon, L.: OP147*
Boone, J.: P0321
Boonstra, J.J.: P0096*, P0097
Boot, H.: P0902, P0904
Boozari, B.: P1259
Boparai, K.S.: OP078, OP079*, P0581
Bor, S.: P0187, P1597, P1626,
P1627, P1648
Boran, G.: P1166, P2056
Borbat, A.: P1270
Borda, A.: OP179*, P1371
Borda, F.: OP179*, OP464, P0621,
P1371, P1677
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Borda Celaya, F.: OP076*, P1669
Borda Martín, A.: OP076*, P1669
Bordas, J.: OP259*, OP260*, P0631*, P1385
Bordi, C.: OP338*
Bordin, D.S.: P1598
Borel, M.: P1498
Borge, C.: P0016
Borges, A.C.S.: OP010
Borges, C.C.: P1561, P1712
Bories, E.: OP069, P2101, P2102
Borkowska, A.: P2146
Bornman, P.C.: P1439
Bornschein, J.: P0024, P0025, P1576*,
P1877
Bornstein, J.C.: OP096
Borobio, E.: OP179*, P1371
Borody, T.J.: P0053
Borrow, D.: P2108, P2109, P2110
Borruel, N.: P1058
Bortesi, L.: P1256
Bortoli, A.: P0291
Boruchowicz, A.: P0737
Bory, F.: P1547
Borzoei, M.: P0193, P0194
Bos, R.: OP158
Bosch, L.J.W.: OP483*
Boschetti, G.: P1727*
Boschetto, S.: P0735
Boshuizen, H.C.: P0426
Bossa, F.: P1043
Bossuyt, P.: OP250*
Bossuyt, P.M.: OP406, P0422
Bota, S.: P0525, P1981
Botha, J.E.C.: OP031
Botti, C.: P0905
Bottle, A.: P1022, P1511
Bouali, F.: P1434
Bouali, R.: P0717, P1988, P2170
Boubaker, J.: P0311, P0986, P1618,
P1619, P1620
Boucekkine, T.: P0292, P0301, P0310,
P1759, P1761, P1849
Bouchner, L.: P0827
Bouchoucha, M.: P0391
Boudjella, M.: P0635, P0879, P1574
Boufassa, M.: P0811
Bouguen, G.: OP326*
Bouhier-Leporrier, K.: P1674
Bouhnik, Y.: P0273*, P0362,
P1052, P1548, P1816
377

InDeX of aUTHoRs
Bouilland, O.: P1478
Bouin, M.: P0811
Boukhettala, N.: P0057*
Boulez, J.: OP290
Bouliere, M.: P1360
Boulos, P.: P0382, P0383, P1112,
P1697, P1698
Bounab, N.: P0292, P0301, P0310,
P1759, P1761, P1849
Boundouki, G.: OP461*
Bour, B.: OP435, P0003, P0737, P0738
Bourikas, L.: P1738
Bourke, M.J.: OP434*, OP448, OP469,
P0615, P0616, P1331, P1333, P1992
Bourliere, M.: OP033, P1359
Bournet, B.: OP421, P0610, P2141
Bourreille, A.: OP206, P0293, P0998, P1548
Boussac-Zarebska, M.: P0203
Bousseloub, A.: P1761, P1849
Boustiere, C.: OP033, P1317, P1359, P1360
Boutarene, D.: P0635, P1574
Boutron-Ruault, M.: OP198*
Boutron-Ruault, M.C.: P1084
Bouvier, A.: OP293, OP404*, P1241, P1882
Bouvier, V.: P0945, P1165
Bouvy, N.D.: OP472*
Bouwens, M.W.E.: P0221*
Bouwer, M.: P1027
Bouwman, L.H.: P0449
Bouygues, M.: P0590
Bouza, E.: P0997
Bova, F.: OP112
Bowen, J.: P2030
Bown, S.G.: OP224, P0151, P0908
Boyd, L.: P0236
Boyko, V.: P0543, P2015
Bozikov, J.: P0617
Bozikova, J.: P0781
Boztas, G.: P0870, P1955
Braat, H.: OP147*
Brabant, Y.: P1817, P1818
Brabet, M.: OP304*
Bracher, M.: P0999
Braden, B.: OP202
Bradna, P.: P0043
Braegger, C.: P1497*
Braegger, C.P.: OP388*
Brain, A.: OP372*
Branca, F.: P1952
Brancaccio, M.L.: P0654
378
Brand, S.: OP325*, OP382*, P0294, P1056,
P1728, P1819, P1914
Brandt, S.: 23
Branda, H.: OP231*, P0467, P1972
Brandão, C.: OP318*, P0416
Brandimarte, G.: P0250, P0251, P0350
Brankovic, B.B.: P1685
Bratanič, N.: P1540
Bratlie, J.: P0068
Bravi, I.: P0179, P1616
Bravo, A.: P1673
Brecelj, J.: P1613
Brechot, C.: OP128*
Bréchot, C.: OP300
Bredenoord, A.J.: OP030*
Bredin, F.: P1039, P1040
Breilh, D.: P1898
Bremholm, L.: P0718, P1831
Brenke, D.: P1567
Brenner, B.: P0230
Bresalier, R.: 25
Bresler, L.: P1428
Breslin, N.: P1006, P1570
Bressler, B.: P1072
Bresson-Hadni, S.: P0458
Bretagne, J.: OP435, P0003, P0738
Bretagne, J.F.: OP326*
Bretagne-Bignon, A.L.: P0259
Bretagnol, F.: P0362
Bretsztajn, L.: OP319
Bretthauer, M.: OP209
Breumelhof, R.: P0604
Brezault, C.: P0590
Bridges, R.: P0577
Briggs, A.: P0841
Brigidi, P.: P1074
Brindle, K.M.: P0146
Bringuier, P.: OP290
Brink, M.A.: P2055, P2103
Brito, J.R.: P2017
Brixi-Benmansour, H.: P0690
Brkic, T.: P1329
Broccardo, M.: OP274*
Broderick, C.: P1047
Broeders, I.A.M.J.: OP032*
Broeders, J.: OP030*
Broeders, J.A.J.L.: OP032*
Broekhuizen, B.D.L.: OP409, P0254
Broens, P.M.A.: P0192
Broide, E.: P0609
P = poster presentation, OP = oral presentation, number only = page number

Bromley, J.: OP213
Bronowicki, J.P.: P1019
Bronsky, J.: OP193*
Bronstein, J.: P1478
Bronte, F.: P1933
Brooks, A.J.: P0582, P1820
Brosens, R.P.M.: P1147
Brostoff, J.: P0258
Brottveit, M.: P0068
Broussard, D.: OP323
Brousse, N.: OP378
Brown, A.S.: P1962
Brown, G.: OP434*, 18
Brown, M.: P0048, P1817, P1818
Brown, P.: OP456
Brown, R.M.: P0201
Brown, R.S.: P1932
Brown, S.: P1356
Brown Jr., R.S.: P1934
Brownlow, H.: P1658
Bruch, H.: 79
Brückner, M.: P1813
Brugge, W.: 48
Bruggen, P.: P0041*
Brugnera, R.: P0334, P0340, P0349
Bruha, R.: OP364, P1199
Bruins, M.J.: P0799
Bruley Des Varannes, S.: OP459
Bruley des Varannes, S.: OP445, P0084,
P0869, P1832
Brun, J.E.A.: P1834
Brunelli, E.: P0469
Brunetti, F.: P1394
Bruni, A.: P1443
Bruno, M.: OP250*, P0026, P2093, P2094,
P2095, P2096
Bruno, M.J.: OP065*, OP287*, P1406,
P1407, P1408, P2097, P2188
Bruns, C.: P1914
Brüwer, M.: P1813
Bryant, T.: P2063
Brydon, G.: OP271
Brydon, G.W.: P0787
Brzoska, T.: P1724
Brzozowski, T.: P0295, P1543
Buanes, T.: P0683, P1409
Bubeck, J.: OP455, P1116
Bucci, C.C.: P0262
Bucci, L.: P1781
Büchler, M.W.: P2136
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Buchman, A.: 56
Bucionis, V.: P1660
Buckley, M.: P0160
Buckley, M.J.M.: P0900
Bucurica, S.: P0772
Buda, A.: P1878
Budak, A.: P0055
Budding, A.E.: OP019*, OP145*
Buddingh, K.T.: P0192
Buddingh, T.K.: P0604
Budihusodo, U.: P0498
Bueno, L.: OP274*, OP459, OP460, P0375
Bueno, P.: P1159
Bueno-de-Mesquita, B.H.: P0426
Buess, G.F.: P1421
Buettner, R.: P0228
Buffart, T.E.: P1142, P1146*, P1871
Buffoli, F.: OP403, P2153
Buie, D.: P1758
Bujanda, L.: OP160*, P0366, P0367, P0461
Bukac, J.: OP380
Bukowczan, J.: P0900
Buldak, R.: P1971
Bullas, D.: P0404
Bullens, D.: P1079
Bulmer, D.C.: OP461*
Bulwer, C.: P1465
Bumbacila, B.: P0438*
Büning, J.: P1729*, P1730
Bunn, R.C.: P1524
Burbridge, R.: OP262
Bures, J.: OP015, OP380, P0043, P0648,
P0767, P1544
Bureš, J.: P2112
Burette, A.: OP056
Burg, L.: P0499, P1789
Burgell, R.: P0796
Burger, F.: OP331
Burgess, P.: OP281
Burisch, J.: P1065
Burke, D.: P0347
Burkitt, M.D.: P0744
Burling, D.: OP368, P1381
Burlyaeva, E.A.: P1856
Burnand, B.: P0308
Burra, P.: 23
Burri, E.: P0136
Burroughs, A.: P0504
Burroughs, A.K.: 80
Bursey, F.: P0824
379

InDeX of aUTHoRs
Busbridge, M.: P0479, P1245, P1909
Buscaglia, J.M.: OP254, OP265, P0720,
P2155
Buscail, L.: OP268*, OP421, P0610, P2141
Busch, D.H.: OP059*, P0751*
Busch, O.: OP250*
Busch, O.R.: OP406
Busch, O.R.C.: OP090*, OP450*, P0701
Buset, M.: P0544
Busilacchi, P.: P0469
Buskens, C.J.: OP240*
Busletta, C.: OP125*
Bussolati, G.: P2094, P2095
Butler, J.V.: OP281
Butruk, E.: OP407
Butt, M.A.: P1057
Butt, S.K.: P0110, P0436, P1702
Buttar, N.: OP217*
Butterfield, S.: P0731
Butterworth, J.: P1640
Buurman, W.: P0802
Buurman, W.A.: OP276*, OP384*, OP386*,
OP472*, P0712*, P1546
Buzas, C.: P1222
Buzás, G.M.: P0866
Buzzi, A.: P0654
Byeon, J.: P0237, P1123
Byeon, J.S.: OP477*, P1460
Bytzer, P.: P0402, P0825, P0867, 57
Byun, H.: P0538
Byun, J.: OP452
Byun, K.S.: P0125, P0535, P1136, P1235
Bzeizi, K.I.: P0524
c
C, C.: P1049
Caamano, J.: P0744
Caballero Correa, M.: P1605
Cabibbi, D.: P1933
Cabral, J.P.: P1683
Cabral, S.: P1684
Cabré, E.: P1082, P1083, P1751
Cabrera, J.: P0577
Cabrera, L.: P1173
Cabrijan, Z.: P0462, P0617, P0634,
P1349, P1599
Caçador, V.: P1218
Caccaro, R.: P0329, P1085
Cacheux, W.: P1286
Cacho, G.: P0578, P1995
380
Cadiot, G.: OP040, P0690
Caenepeel, P.: P0133
Caetano, C.: OP046*
Caggiari, L.: P0069, P0071, P0111
Cahill, A.: P0592
Cailler, F.: OP468*
Cailleux, A.: P0401
Caillol, F.: P2101, P2102
Caini, S.: P0784
Cairncross, L.L.: P1439
Cairns, A.: P0210
Cairns, S.: P0423
Caja, S.: P1538
Cakaloglu, Y.: P1955
Calabrese, C.: P0340, P0349
Calabrese, E.: OP334, P0306, P0863,
P1379, P1777
Calazel Benque, A.: P1879
Caldaro, T.: P2183
Caldas, C.: OP399*
Caldeira, A.I.L.P.: P0583
Caldwell, H.: P1195
Calì, A.: P1959
Caligiuri, A.: P1865
Callegaro, A.: P1999
Calogero, A.: P0588, P1422
Calvaruso, V.: OP358*, P0504, P1933,
P1959, P1960
Calvert, C.: P0552*
Calvet, X.: OP160*, P0366, P0367, 65
Camacho, E.: P0783, P1293, P1496, P1941,
P1942, P2086, P2087
Camacho, S.: P1100
Camez, A.: P1099
Cammà, C.: P1933
Cammarota, G.: OP283, P0119
Campagna, F.: P0447
Campanale, M.: P1257
Campanella, D.: OP284
Campbell, B.J.: OP387*, P0226*, P1553*
Campbell, J.A.: P0582
Campbell, P.: OP372*
Campbell, S.S.: P2060
Campieri, M.: P0334, P0340, P0349
Campo, S.M.: P0593
Camuesco, D.: P0260*, P1735, P1743
Camus, M.: P2157
Canales, M.: P0527
Canals, M.: P1250
Canard, J.: P0659, P1317
P = poster presentation, OP = oral presentation, number only = page number

Candel, F.J.: P2024
Candel Erenas, J.J.M.: P0976
Candelli, M.: P1220
Canga, F.: P1835
Cangi, G.: P2091
Cannito, S.: OP125*, P1140
Cannizzaro, R.: P0069, P0070, P0071,
P0111, P1368, P1703
Cannon, M.D.: OP237*
Cantero, D.: OP211, P0638
Cantoni, F.: P0654
Cantu', P.: P0618
Cantù, P.: P0179
Canva, J.: P0061
Cany, J.: OP127*
Canzonieri, V.: P0069, P0071, P0111
Cao, H.: OP084*, OP088*
Cao, Q.: P1799
Cao, Y.: OP099
Caparello, C.: P0179
Capellá, G.: P1876*
Capelle, L.G.: OP287*, P0026
Capelle, L.S.: P0753
Capelli, P.: P1256
Capkun, V.: P0956
Capobianco, F.: OP379
Capone, P.P.: P0262
Caporaso, N.: P1781
Cappello, M.: P1090, P1780
Capra, A.M.: P0917*
Caprioli, F.: P1793
Capurso, L.: P0735
Caraiola, S.: P0772
Caras, S.: P2132
Carasel, D.: P0315
Carballo, F.: P1160
Carballo, M.A.: P1783
Carbonnel, F.: OP198*, P1548
Card, T.: P1188
Card, T.R.: OP335*, OP443*
Cardenas, A.: OP260*, P0631*, P1385
Cardinale, V.: OP060, P0593, P0766
Cardoso, E.: P0550
Cardoso, H.: P1917
Cardoso, H.M.C.: P1773
Cardoso, J.: P0115
Carella, G.: P0807
Carepa, F.: P1216, P1217, P1218
Cargill, G.: OP459
Carlino, A.: P2047
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Carlone, J.: P1824
Carlson, G.L.: P0815
Carlson, M.: P0990, P1731
Carlsson, A.: OP269*
Carlsson, A.H.: OP146, OP270*
Carlsson, L.M.: P1549
Carmagnola, S.: P0502
Carmona, D.: P0362
Carneiro, A.: P1021
Carneros, J.: P0215
Carneros, J.A.: P1053, P1054
Carneros Martín, J.: P0934
Caroli, D.: P0529*
Carpio, D.: P0287, P0299, P1011
Carr-Locke, D.: 79
Carrara, S.: OP258*, P0677, P2090, P2091
Carrasco, A.: P1535
Carrascosa Gil, J.: OP076*
Carrat, F.: P1052
Carrère, N.: OP268*
Carretero Ribón, C.: P1669
Carriere, F.: OP417*
Carrillo, L.: P1169
Carrion, F.: P0976
Carrion, S.: P1083
Carrobles, J.M.: P2117
Carsetti, R.: P0417, P1814*
Carson, R.T.: P1120
Carstea, D.: P0091
Carter, R.: 54
Carucci, P.: P2093, P2094, P2095, P2096
Caruso, A.: OP163*, P0078, P0329, P1085,
P1495, P1883
Caruso, R.: OP107*
Carvalho, A.: P0115, P2021
Carvalho, B.: OP483*, P1142, P1146*,
P1147, P1871, P1873
Carvalho, C.: P1670
Carvalho, F.A.: OP022*
Carvalho, J.: P0083, P0500, P1227, P1472,
P1908, P1926
Carvalho, R.: P0639
Casaca, R.: P1635
Casado, M.: P0473
Casado-Caballero, F.J.: OP303
Casarin, P.: P1987
Caselani, F.: P0804, P0807, P0808
Casella, C.: P1430
Casellas, F.: P0072, P1058, P1548
Casetti, T.: P0654, P0735
381

InDeX of aUTHoRs
Casey, P.: P1378
Cash, W.J.: P1229
Cassaz, C.: P0590
Cassieri, C.: P0906
Cassigneul, J.: P1317
Castan-Laurell, I.: P1007*
Casteleyn, C.: P1921
Castellaneta, G.: P1863
Castellani, P.: OP033, P1359, P1360
Castellani, R.: P0078, P1495
Castellano, G.: P1835
Castellini, L.: P1257
Castellino, F.: OP311*, P0278
Castells, A.: P0632, P1385
Castells, I.: P1058
Castellvi-Bel, S.: P0632
Castera, L.: 40
Castiella, A.: P0473, P1200
Castiglione, F.: OP334, P1781
Castillo Grau, P.: P0725
Castro, J.: P0299, P1011, P1063
Castro, M.: P1043
Castro, R.S.: P0448
Castro-Poças, F.: OP046*, P0625
Catalán, I.: P0288
Catassi, C.: 64
Catheline, J.: P0391
Cats, A.: OP078, P0903, P0904, P1407
Caugnat, H.: P1386
Caunedo Alvarez, A.: P1366
Cauvin, J.: P1888*
Cavallaro, G.: P0938, P0939
Cavas, M.: P1160
Cave, D.: 49
Caveliers, V.: P0921, P0922, P0923, P0924
Caygill, C.: P0167
Cazals, J.: P1317
Cazals-Hatem, D.: P0273*
Cazzagon, N.: P0529*
Cazzato, A.: OP283, P0658
Cazzato, I.A.: P1797
Cazzola, P.: P0067
Ceballos, D.: P0288
Ceccarelli, C.: OP320
Cecchin, E.: P0111
Ceci, V.: P1443
Cécillon, S.: OP020*
Cedzynski, M.: P0286
Cefalo, C.: P0501, P1220
Cegan, M.: P1358*
382
Celik, A.: P0776
Celik, A.F.: P1749
Celinski, K.: P1732
Celiñski, K.: P1201
Cellier, C.: OP005, OP183, OP378, P0659
Cencic, A.: P1506
Cengiz, C.: P2085
Cennamo, V.: P1680, P2145
Cenni, J.: OP294
Ceppa, P.: P0184
Ceranowicz, P.: OP420, P0834, P0844
Cerf-Bensussan, N.: OP378
Cerqueira, R.M.: P0509
Certad, G.: P1133
Cervenova, S.: P1755
Cesari, P.: P2153
Cesarini, M.: P0315
Cesario, V.: P0197
Cesaro, P.: OP174, OP185
Cessot, F.: P0009
Cestari, R.: P0735
Cetin, S.: P1749
Cetinkaya, H.: P1562
Çetinkaya, H.: P0296
Ceuppens, J.: P1079
Ceyhan, G.O.: OP085*, P0935
Cha, B.: P0587, P1854, P1989
Cha, J.: P1347
Cha, M.: P0407
Chabrun, E.: P1077
Chacha, S.G.F.: P0511, P0512
Chacko, A.: OP282
Chae, H.B.: P0390
Chae, S.: P1913
Chaen, T.: OP009
Chakrabarti, A.: OP255*
Chakrabarty, G.: P1513
Chakrawarthi, S.: P1224
Chalayonnavin, W.: OP215
Chalmers, L.B.: P1880
Chalmers, N.: P0731
Chalret du Rieu, M.: OP268*
Chalupa, J.: P0206
Chamary, V.: OP372*
Chan, C.: OP022*, P0208
Chan, D.H.: P2005, P2006
Chan, F.: P1858, 30
Chan, F.K.L.: OP062, P0124, P0134, P0740,
P0741, P0833
Chan, H.: OP082, OP123
P = poster presentation, OP = oral presentation, number only = page number

Chan, K.W.: OP350
Chan, S.: OP073
Chan, Y.: P0134, P1858
Chan, Y.H.: OP440*, P0216
Chandesris, O.: OP378
Chandra, A.P.: OP469
Chandra, N.: P0584
Chandra, P.: P0004
Chandrahasan, R.: P0724
Chandran, N.: P2083
Chang, A.: P0752
Chang, B.: P0585
Chang, C.: P0752
Chang, D.K.: P1307, P1696
Chang, F.: P0076
Chang, H.: P1322
Chang, J.: P0222
Chang, R.: P1756
Chang, S.: P0587, P1854
Chang, W.: P0885, P2033
Chang, Y.: P1756
Chanmee, T.: P0496
Chanteloup, E.: OP005, P1077
Chao, J.: OP151, P0332, P0333,
P1094, P1096, P1097,
P1098, P1099
Chapman, R.W.: OP202
Chapman, S.: OP311*
Chaput, U.: P0590, P0936, P1286
Charachon, A.: P1394, P1688
Characoidas, C.: P1775
Charalambopoulos, J.: P0516
Charatcharoenwitthaya, P.: OP230*
Charfi, L.: P1951*
Charlton, M.: P1932
Charlton, M.R.: P1934
Charnley, R.: OP281
Charnley, R.M.: P2003
Charnock, A.: P0792
Chartier, A.: P1055
Chassard, C.: OP388*, P1497*
Chassat, T.: P1133
Chastan, N.: P1126
Chatani, R.: OP431, P2039
Chatchawankitkul, S.: OP215
Chatti, S.: P1951*
Chau, T.N.: P1504
Chaubard, T.: OP080*
Chaudhary, R.: P0733
Chauhan, R.: P0513*
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Chaussade, S.: OP005, P0590, P0628,
P0936, P1052, P1286, P1458
Chaussier, C.: P1317
Chavarría-Herbozo, C.: P1843
Chaves, L.D.M.: P0339
Chaves, P.: OP081*, P0419, P1635
Chavez, L.: P0506*
Chayama, K.: OP344*, P0028, P0030, P0408
Chayvialle, J.: OP294
Chaze, I.: OP359*
Chebli, J.M.F.: P0339, P1821
Chebli, L.A.: P0339, P1821
Checkley, W.: 56
Cheifetz, A.: P1072
Chelbabi, F.: P1336
Chen, B.: OP288*, P0112, P0475,
P1874, P1906, P1907
Chen, C.: P0661
Chen, F.G.: OP288*, P0112
Chen, J.: OP055, P0411, P0412,
P0510, P0893, P1628
Chen, M.: P0412, P0880, P0894, P1628
Chen, M.H.: OP288*, P0112, P0884,
P1592, P1609, P1874
Chen, N.: P0333, P1099
Chen, P.: P0661, P1390*
Chen, R.: OP434*
Chen, R.Y.: OP045*
Chen, S.: OP092, P1395
Chen, W.: P0885
Chen, W.C.: OP361
Chen, Y.: OP340, P0577, P1587
Chen, Y.K.: OP113, OP115, OP429, P0553
Cheng, A.: OP082
Cheng, C.: OP118, P1961, P1966
Cheng, H.: OP118, P0885
Cheng, L.: P1590
Cheng, S.: OP248
Cheng, S.D.: P0443, P1796
Cheon, G.: P1713
Cheon, G.J.: P1400
Cheon, J.: P0323, P0361, P0385, P0656,
P1037, P1042, P1152, P1768, P1776, P1924
Cheon, J.H.: P1500
Cheon, S.: P0385
Cheon, S.M.: P1500
Cheon, Y.: P1337
Cheraitia, S.: P0108
Cheremiskin, V.P.: P1397
Chermesh, I.: P2064
383

InDeX of aUTHoRs
Chernaya, Z.A.: P1701
Chernev, K.G.: P0916
Chernyakov, A.V.: P0705, P1404
Cherqui, D.: P1394
Cheta, D.: P1190
Chętnik, A.: P0202
Chetri, K.: P0004
Chettiar, R.: P0646, P1309
Cheung, K.: OP082
Chevaux, J.B.: P1019
Chia, C.K.: P1594
Chiali, N.: P0635
Chiaramonte, M.: OP226*
Chiba, T.: P1088
Chien, C.W.: P0862
Chikhi, Y.: P0108
Child, R.: P0441, P2020
Chilosi, M.: P1256
Chin Aleong, J.: P1565
Ching, J.: P0740, P1858
Ching, J.Y.L.: OP062, P0833
Chingwaru, W.: P1506
Chino, O.: P0901
Chiodi, D.: P0174
Chis, A.: OP239
Chitapanarux, I.: P1671
Chitapanarux, T.: P1671
Chiu, C.: P0661, P1589
Chlouverakis, G.: P2051
Cho, C.: P1321
Cho, E.H.: P0522
Cho, E.Y.: P0537
Cho, H.: OP291
Cho, J.: OP291, OP429, P0586,
P0651, P1989, P2171
Cho, J.Y.: P0553
Cho, K.: P0742, P1617
Cho, K.B.: P1277
Cho, M.: OP452, P1713
Cho, M.H.: P1400
Cho, M.S.: P1239
Cho, S.: P0101
Cho, S.B.: P0217
Cho, S.H.: P0093
Cho, S.J.: OP292*
Cho, W.: P2171
Cho, Y.: P0586, P0651, P1123, P1228,
P1337, P1913, P2171
Choi, C.: P0587, P0669, P1278, P1279,
P1453, P1854, P2182
384
Choi, C.C.H.: P0313
Choi, C.S.: P0537
Choi, H.: OP452, P0244, P1337, P1410
Choi, H.S.: P0762
Choi, I.: P0410
Choi, I.J.: OP292*
Choi, J.: P0410, P0972, P1010,
P1171*, P1575*, P1833
Choi, J.H.: P1235
Choi, K.: P0094, P1363
Choi, K.D.: P0031
Choi, K.S.: P0031
Choi, M.: P0222, P0538, P1604
Choi, M.H.: P0123
Choi, S.: P0101, P1278, P1279, P1604
Choi, S.K.: P0217, P0968
Choi, S.R.: P0093
Choi, S.W.: P0093
Choi, T.: P0873
Choi, Y.: OP470*, P0410, P0538,
P1321, P1575*, P1679
Chojnacki, J.: P0144
Cholet, F.: OP005, OP176
Chollat-namy, A.: P1359
Chong, A.K.: P2072
Chono, S.: P0855
Choo, K.: P1482
Chooklin, S.: P1393
Chopita, N.: P0899, 79
Chou, J.: P0208
Choudat, L.: P0220
Choudhuri, G.: P0004, P1372
Chowers, Y.: OP330, P0868, 17
Christensen, E.: P0867
Christiaens, P.: OP011
Christidou, A.: P1775
Christjansen, K.: P1012
Christodoulidis, G.: P1672
Christoforidis, P.: P0572
Chroniaris, N.: P2051
Chruscielewska-Kiliszek, M.R.: OP407
Chrysanthopoulou, H.: P0979
Chtara, O.: P1618, P2170
Chu, E.: OP082, OP123
Chu, H.: P0073, P0397,
P1545, P2033
Chuah, S.: P1494
Chuat, V.: P0277
Chun, B.C.: P0478
Chun, H.: P0100*
P = poster presentation, OP = oral presentation, number only = page number

Chun, H.J.: OP175, OP180*, OP376*,
P0762, P0837*,
P0948, P2016, P2049
Chung, A.: P1298
Chung, H.: P1881, P2142
Chung, I.: P0222, P1604
Chung, J.: P0031, P1881, P2142
Chung, J.B.: P1452, P1990, P2143
Chung, J.W.: P2143
Chung, M.J.: P1990, P2143
Chung, S.: OP367, P0433
Chung, W.: P2181
Chung, Y.: P1171*
Chung, Y.G.: P1136
Chuttani, R.: OP115
Ciabattoni, E.: P0469
Ciacci, C.C.: P0262
Ciardi, A.: P0938, P0939
Cibor, D.: P1733, P1734
Cicala, M.: P1803
Ciccocioppo, R.: OP048, OP049
Cicek, B.: P1442
Çiçek, B.: P2084, P2085
Cichoz-Lach, H.: P1201
Cichoż-Lach, H.: P1732
Ciclitira, P.J.: P0076, P0307, P0809, P1074
Ciepiela, K.: P0847
Ciesielska-Szuster, A.: P0106
Cieszkowski, J.: OP420, P0834, P0844
Ciftci, S.: P1861
Cigrovski Berkovic, M.: OP087*
Cijevschi Prelipcean, C.: P1211, P1212
Cimilli, T.: P0266, P0470
Cimino, L.: P0517
Cindoruk, M.: P0816, P1354
Cioffi, U.: P2092
Cipolletta, F.: P1462
Cipolletta, L.: OP374, OP403, P0735, P1462
Cirillo, A.: P1069
Cirillo, M.: P0588, P1422
Ciriza, C.: P0215, P0934
Ciriza de los Ríos, C.: P1835
Cittadini, A.: P0417
Ciurea, T.: P0122, P2038*, P2147
Civitelli, F.: OP195*, P0195, P1654
Claessen, M.M.H.: P0223
Clamp, P.: P0830
Clarençon, D.: P1101
Claridge, A.: P1822
Clark, A.: OP271
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Clark, J.: P2063
Clark, S.: P0641
Clark, S.K.: OP004
Clarke, A.: OP103, OP482*
Clarke, A.R.: P0276
Clarke, A.T.: P0185
Clarke, J.: P0456
Clarke, S.: P2066
Claro, I.: OP081*, P0419
Clatworthy, J.: P1073
Clausen, O.: P0985
Clavel, L.: P0704
Clavel-Chapelon, F.: OP198*
Clavien, P.A.: P0708
Cleynen, I.: OP017*, OP327*, OP328,
P0309, P1032, P1033, P1034, P1044
Clifford, G.: P1151, P1890
Clouston, A.: OP278, P1953
Clyde, D.: OP106
Cobbold, J.F.L.: P0282, P1962
Coccorullo, P.: P1129
Cockerell, K.: P1127
Cocorullo, G.: P0938
Coda, S.: P1893
Coëffier, M.: P0057*
Coelho, A.C.: P1561
Coelho, D.E.: P1440, P1441, P2138, P2139
Coelho, J.E.: P1440, P1441
Coelho, J.F.E.: P2138, P2139
Coelho, L.: 65
Coen, S.J.: OP101
Coenraad, M.J.: P0449
Coffin, B.: P1052, P1600
Cogliandro, R.: P0421
Cohen, H.: P0174
Cohen, M.: P0568, P0872, P1658
Cohen, P.: P1062
Cohen, R.: P0391
Coimbra, M.: P2022
Cojocariu, C.: P0476, P0491
Colantuoni, A.: P0455
Colarusso, D.: P0906, P0938
Colavito, D.: P0529*
Cole, J.: P1748
Coleman, L.: P0937
Coletta, M.: P0371, P0393
Colic Cvrlje, V.: P0013
Colic-Cvrlje, V.: P0746
Collas, C.: P2148
Colle, I.: P1920*, P1921, P1922
385

InDeX of aUTHoRs
Colleypriest, B.J.: P0149, P0589
Collier, J.: P0584
Collighan, R.: P1538
Collin, P.: OP336, P1762
Collina, G.: P2145
Collins, M.: OP002
Collins, P.: P0226*
Collins, P.D.: OP109*
Collins, S.: 64
Colombatto, S.: OP125*, P1140
Colombel, J.F.: OP121, OP153, OP323,
P0061, P0355, P1548, P1790,
P1816, P1828, 16, 36
Colombo, M.P.: P1814*
Colomo, L.: OP259*, OP260*, P0631*,
P0632
Coltau, M.: OP239, OP437, P0130,
P1435, P2125
Comalada, M.: P0260*, P0261, P1735,
P1736, P1743
Comanescu, V.: P1223
Comia, A.C.: P2069
Compagnone, A.: OP125*
Comparato, G.: P1709, P1943
Compare, D.: OP275, P0034
Compernolle, G.: OP327*, OP328
Concannon, C.G.: OP237*
Conceição, R.D.: P2076
Concepción, M.: P1751
Conchon, S.: OP127*
Condado, N.: P0899
Conde-Gacho, P.: P0672
Condino, G.: P0863, P1379, P1777
Condon, C.: P1166
Cong, Y.: P0073, P0397, P1545
Conigliaro, R.: OP041*, P0940
Conigliaro, R.L.: P1377
Conn, R.: P1465
Connil, N.: P0996
Connolly, C.: P0332
Connolly, M.P.: P0129
Connors, S.: P0824
Conor Magee, C.: P0113, P0694
Consonni, D.: P0618, P1616
Conte, D.: P0618, P1793
Conte, F.: OP023
Contessini-Avesani, E.: P2092
Contreras, J.: P1250
Contreras Melendez, L.: P0032
Contu, P.: P0252
386
Cook, I.J.: OP207*, P0392
Cook, R.: P2007
Cooksley, T.: P1344
Coope, A.: P0992
Cooper, M.J.: P2164
Coopman, S.: P1556
Coopmans, T.: OP327*
Coorevits, L.: P1079
Copado, R.: P1159
Copel, L.: P0609
Copie-Bergman, C.: P0027
Corazza, G.: OP100, P0075, P0400, P0784
Corazza, G.R.: OP048, OP049, P0067,
P0095, P1814*
Corazziari, E.: OP195*, P0938
Corazziari, E.S.: P0905, P0906, P0939
Cordea, D.: P0131
Cordelier, P.: OP268*, P2141
Coriat, R.: P0590, P0936
Corleto, V.: P0231
Corleto, V.D.: OP338*, P0430
Cornelio, R.A.C.: P0339
Cornianu, M.: P0525, P0848, P0849, P0850
Coron, E.: OP070, OP445, P0955, P0998
Corona, M.: P1443
Corporaal, S.: P0591
Correale, C.: P0278
Correale, L.: OP284
Correia, L.: P1323
Correia, L.M.: P2017
Correia, M.R.: P0509
Corritore, G.: P1043
Corry, L.A.: P0592
Corsetti, M.: P1863
Corso, G.: P1578*
Cortada, C.: P1783
Corte, C.: P1309
Cortelezzi, C.: P2187
Cortes, A.: P0704
Cortez-Pinto, H.: P1181, P1216, P1217,
P1218, P1243
Cortijo, M.: P1535
Cortot, A.: OP121, OP153, P0061
Coscas, Y.: P1879
Cosco, C.: P0267
Cosco, V.: P0267
Cosconea Cioaca, S.: P1882
Cosentino, F.: P0548
Cosimo, P.: P0267
Cosintino, R.: P1802
P = poster presentation, OP = oral presentation, number only = page number

Cosnes, J.: P1052, P1816
Coss-Adame, E.: P1176
Cossignani, M.: OP163*
Costa, A.: P1181, P1216, P1217, P1218
Costa, J.: P2021
Costa, N.: P0550
Costa, T.V.: P2018
Costa-Santos, C.: P1917
Costamagna, G.: OP013, OP113, OP174,
OP185, OP248, P0306, P0658,
P0692, P1339, P1361, P1362,
P1560, P2100, P2129, 22
Costea, F.: P1369, P1660
Costes, L.: OP295
Costigan, C.: P0380
Cotter, J.B.: P1023*, P2105
Cottet, V.: OP404*
Cottone, C.: P0421, P1959
Cottone, M.: OP334, P1089, P1780
Coudsy, B.: P0869
Coulet, F.: P2148
Coulibaly, B.: P0737
Coulom, P.: P1317
Coumaros, D.: OP005
Coupé, V.H.M.: P1162
Coupé, V.M.H.: P1163
Courrech Staal, E.F.W.: P0902, P0903, P0904
Coutinho, J.: P1216, P1217, P1218
Couvelard, A.: OP424, P0704, P1405
Covino, M.: P1774
Covolo, L.: P1986
Cowan, M.L.: OP393
Cox, E.F.: P0380
Cox, I.: P1411
Cox, I.J.: P0281, P0282, P1030, P1962
Coy, C.S.R.: P0992
Crabtree, J.E.: P0743*
Craig, A.: P0731
Craig, D.G.N.: P1945
Craxì, A.: OP358*, P1933, P1959,
P1960, 57, 65
Creed, T.: OP310*, P0280
Crespin, M.: P1758
Crespo, Y.: P0395, P0396
Cretella, M.: OP163*, P1883
Creusy, C.: P1133
Crimmins, R.: P1515
Crisan, D.: P0468
Crispino, P.: P0789, P0905, P0906,
P0938, P0939
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Cristino, J.: P1096, P1098
Cristofari, F.: OP060, P0593, P0766
Crncevic Urek, M.: P1349, P1599
Crncevic-Urek, M.: P0462
Croese, J.T.: OP278
Croguennec, B.: P1317
Crombé, V.: OP121
Crook, D.: 72
Crooks, C.J.: OP443*
Crossey, M.M.E.: P1962
Crosta, C.: OP068, P0960
Crotta, S.: OP164
Crotty, P.: P1006, P1570
Cruzado, J.: P1160
Csatari, Z.: P0471
Csepregi, A.: P1253
Csizmadia, A.: P0774
Cubiella Fernández, J.: P1704
Cucchiara, S.: OP023, OP195*, P0195,
P1043, P1654
Cucherousset, J.: P0975
Cucherousset, N.: P0975
Cucu, N.: P0438*
Cuesta, M.A.: P0363, P1147
Cueto, M.: P0261, P1735, P1736, P1743
Cuhadaroglu, C.: P0870
Cui, D.: P1742
Cui, M.: P0411
Cui, Q.: P0227
Cui, R.: P0810
Cui, Y.: P0475, P1592, P1609, P1906, P1907
Cukovic Cavka, S.: P0327
Culkin, A.: P0812
Cullen, S.: P2019
Culver, E.L.: P2019
Cummings, C.: OP077*
Cummings, F.: P0312, P1822
Cummings, J.H.: P0346
Cunha, J.: P1635
Cuomo, A.: P0764
Cuomo, R.: P0252
Curcic, J.: OP134
Curlo, M.: OP405, OP410, P1709
Currie, M.G.: P1119
Curry, M.P.: P1932, P1934
Curvers, W.L.: OP446*
Cushing, M.: P1384
Cusí, V.: P1535
Cuthbertson, L.: P2045*
Cvancarova, M.: OP152
387

InDeX of aUTHoRs
Cvejic, T.: P1928
Cymbalista, M.: P1386
Cyrany, J.: P0043, P0767, P1544
Czaczkowska-Kurek, E.: OP407
Czech, A.: P1946
Czechowska, G.: P1732
Czegledi, Z.: P0317, P0320, P1078
Czimmer, J.: P1078
Czkwianianc, E.: P0196, P0931
Czupryniak, L.: P2146
Czyszek, J.: P1246
D
d Castro, S.: OP250*
D'Haens, G.: 36
d Hingh, I.: OP250*
Da Costa, M.: P1557
Da Ponte, A.: P0070
Dabizzi, E.: OP041*, P0940
Dadswell, E.: OP075
Daez, L.: P1991
Daez, L.S.: P0497
Daez, M.: P0006, P1559
Daez, M.O.: P2069
Dagli, U.: P0728
Dagnelie, P.: OP158, P1024, P1025
Dagnes, B.: OP164
Daha, M.R.: P0449
Dahan, K.: OP423*
Dahlberg, M.: OP053
Dahlbom, I.: P0081, P0082
Dahlerup, J.F.: P1720
Dahlhoff, M.: OP383
Dai, N.: P0073, P0397, P1545
Daicoviciu, D.: P0484
Daikos, G.: P0503
Dainese, R.: P1102
Dakkak, M.: P1269
Dal Bò, N.: P0754
Dal Mas, M.: P1987
Dalbies, P.: P1317
D'Alessio, M.: P0078, P1495
Dalia, G.: P0252
Dall'Oglio, L.: P2183
Dalrymple, J.: P1518
D'Alvano, G.: OP374
d'Amati, G.: P1893
Damavand, B.: P1041
Damhuis, R.: OP293
Damilakis, J.: P0285*
388
Damjanov, D.: P1490
Damjanovic, S.: P1194
Damon, H.: P1428
Danese, S.: OP311*, P0263, P0278,
P0350, P1068, P1828
Daneshmend, T.: P2164
Daneshmend, T.K.: P1649*, P1794, P1872
Daniel, F.: P0273*
Daniel, P.: P0224
Daniel, U.: P1625
Daniels, I.R.: OP285
Daniels, S.: P0577
Danila, M.: P1982
Danilewicz, M.: P0224, P1739
Daniluk, J.: OP475*, P0106
Dannaeus, A.: P0081, P0082
Dantuluri, S.: P1558
Daoud, Y.: OP316*, OP320
Daperno, M.: OP334, P1090
Dapoigny, M.: P0398
Dar, S.B.: P0513*, P0518
D'Arc, S.: P0052
Darfeuille-Michaud, A.: OP021*, OP022*, P1548
D'Arienzo, A.: P0297
Darke, J.: P1309
Darmaun, D.: 79
Darrien, J.H.: P0768, P0769
D'Arrigo, A.: P0529*
Dart, R.: OP271
Darzi, A.: P2063, P2161, P2162
Das, C.J.: P0326, P1059
Das, K.: P1372, P1950, P2144
Das, K.M.: OP058
Das, Kanak: P0004
Das, Kshaunish: P0004
Das, L.: P0567
Das, P.: OP412*, P0079
Das, T.: OP037a
Dassanayake, A.S.: P1016, P1224, P1285*
Dastych, M.: P1282
Datta, A.N.: P2020
Datta, S.: OP360
Datta Gupta, S.: OP412*, P0079
Dattani, N.D.: P0888
Daurès, J.: OP359*
Dave, M.: P1479
Dave, U.: P0716
Davelaar, A.L.: P1866
Daveson, A.J.M.: OP278
David, E.: P1140
P = poster presentation, OP = oral presentation, number only = page number

David, G.: P0317, P0318, P0320
David, J.: P0827
Davidson, A.M.: P0552*
Davies, G.J.: P1607
Davies, N.: P0897
Davies, S.: P1174
Davis, C.: OP372*
Davison, C.: P1380, P2104
Davison, S.: P1309
Davitoiu, A.: P0927
Davoli, M.: P1764
Dawsey, S.M.: P0842
Dawson, C.: P1748
Day, C.: 30
Day, T.: P0937
Dayaratne, H.G.A.K.: P1016
De Angelis, C.G.: P2093, P2094, P2095,
P2096
De Angelis, P.: P2183
de Angelis, P.: OP182
de Bats, R.R.R.: P1067
de Bekker, E.W.: P0173
de Boer, A.G.E.M.: OP450*
de Boer, N.K.H.: P0352*, P0353
De Bona, M.: P1878
De Boni, M.: P1878
de Boni, M.: P0027
de Bruin, R.W.F.: P0460
de Bruine, A.: P0221*
de Bruïne, A.P.: OP483*, P0952, P1873
de Caestecker, J.: P0895
De Castro, L.: P0085, P1060
de Chaisemartin, C.: P2140
De Cruz, P.P.: OP045*
de Cuba, E.M.V.: P2165
De Giorgio, R.: 20, 56
De Fabritiis, G.: P0090
De Francesco, V.: OP060, P0766
De Franchis, G.: P0297
de Graaf, E.: P1419
de Groot, N.: P0753
de Haan, J.: OP276*
de Haan, J.J.: OP386*, P1546
De Hertogh, G.: OP273*, P0147, P0351, P1031*
De Iaco, R.: P1910
de Jager, C.: P1840
De Jong, D.J.: OP159*
de Jong, D.J.: P1711
de Jong, E.: OP147*
de Jong, K.: OP065*, P0086, P2097
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
de Jonge, W.J.: OP408*
De Juan, M.D.: P1200
de Knegt, R.J.: P0528
de Kruif, S.: P1116
De la Coba, C.: P0288
de la Fuente, E.: P0261
de Lédinghen, V.: P1077
de Leone, A.: P0883, P1069, P1608
De Leye, S.: P1922
De Lisi, S.: OP358*, P1960
De Lorenzo, R.: P0938
de Man, R.A.: OP366
De Marco, G.: OP283, P0078, P0197, P1495
De Marinis, L.: P0692
De Martino, G.: OP275, P0034
De Masi, E.: OP283
de Matthaeis, M.: P0593
De Mattia, E.: P0111
De Moura, E.: OP248
de Moura, E.G.H.: P0087
de Oca, J.: P1876*
de Oliveira, S.L.: P0087
De Palma, G.D.: P0941, P1781
De Paoli, P.: P0111
De Pascalis, B.: P1804
de Paulo, G.: P1324
De Paulo, G.A.: P2076
De Prez, C.: OP056
De Re, V.: P0069, P0070, P0071, P0111
De Rezende, L.C.: P1566
De Roberto, G.: P0960
de Rooij, B.F.: P0449
de Saussure, P.: P0308
De Schepper, J.: P0920, P0921, P0922,
P0923, P0924
De Schutter, I.: P0920
De Sena, A.: P0297
de Silva, A.P.: P1016, P1224, P1285*
de Silva, H.J.: P1016, P1224
De Silva, J.: P1596
de Silva, J.H.: P1285*
de Silva, S.: P1758
De Simone, M.: P2092
De Stefano, S.: P0735
De Toma, G.: P0938, P0939
de Toni, E.: OP382*, P1728, P1914
de Torres, I.: P1114
De Tullio, N.: P2004
De Vincentis, F.: P1797, P1804
De Vitis, I.: P0304, P1774, P1804
389

InDeX of aUTHoRs
De Vos, F.: P1920*, P1922
De Vos, M.: P1548, P1745, P1816, P1920*,
P1921, P1922
de Vries, A.C.: P0026, P0753
de Vries, D.R.: P0186*, P0942
de Vries, R.: P1711
de Vries, R.A.: P0026, P1209
De Wachter, E.: P0920
De Waele, B.: P1423
De Waele, E.: P1423
de Wit, M.: P1143
de Wit, N.J.: OP074, OP409, P0141, P0254,
P1610, P1965
de Wit, N.N.J.: OP453
De Wit, S.: P0544
De Zorzi, M.: P0069, P0071
Deacon, J.: P0860, P1631
Debzi, N.: P0292, P0301, P0310, P1759
Decea, N.: P0484
Déchelotte, P.: P0057*
Decker, M.: P1905*
Deen, K.I.: P1687, P2127
Deetlefs, E.: P0298
Defoe, H.: P0219, P1048, P1049,
P1666, P1702
Degerblad, M.: P1108
Deguchi, H.: P0040, P1614, P1996, P2035
DeGuetz, G.: P1688
Dehesa V, M.: P1173
Dehghani, S.: OP197, P0193, P0194,
P0199, P0200, P1937*
Dehghgani, F.: P0211
Dei-Cas, E.: P1133
Deibert, P.: P0471
Deibjerg Kristensen, B.: P1065
DeiSanti, D.: P0448
Dejaco, C.: OP457, P1066, P1771
Dejardin, O.: P1165
Dejong, C.H.: P0712*
Dejong, C.H.C.: OP276*, OP384*, OP472*
Deka, M.: OP296*, P1182*
Dekker, E.: OP078, OP079*, OP203*,
OP471*, P0581, P0594,
P0961, P1419, P1866
Del Campo, V.: P0085, P1060
Del Giudice, E.: P1654
Del Moral, A.: P1343
Del Piano, M.: P0435, P0502, P0735
Del Vecchio Blanco, G.: OP163*, P1883
Delaage, P.: OP188*, P1600
390
Delabrousse, E.: P0458
Delacy Costello, B.: OP392
Delaney, B.: 57
Delaney, P.: OP425
Delattre, A.: P1556
Delchier, J.: OP171, P0027, P1052,
P1394, P1816
Deleanu, A.: P0495, P0525, P1981, P1982
DeLemos, B.: P0869
Delgado, F.J.: P1561, P1712
Delgado, J.: P0139
Delgado-Aros, S.: P1547
Delgado-Plasencia, L.J.: P1673
Delgado-Torres, V.: P1444
Delhaye, M.N.: OP281
Delicha, E.M.: OP441
Delis, S.: OP228*
Delius, S.: P0579, P2012
Della Libera, E.: P1323, P1324, P2017
Della Valentina, G.: P1987
Delladetsima, I.: P1700
Delle Fave, G.: OP338*, P0231, P0430
Delluc, C.: P1478
Delpero, J.: P2140
Delsanto, S.: OP284
Delvaux, G.: P1423
Delvaux, M.: 36
DeMarco, D.C.: OP369
Dembinski, A.: OP420, P0834, P0844,
P1543
DeMeester, T.R.: OP345*
Demeter, M.: P0781
Demeter, P.: P0318
Demir, I.E.: OP085*
Demir, K.: OP124, P0870, P1955
Demirbas, T.: P0470
Demirtas, T.: P0266
den Hoed, C.M.: P0753
Denecke, T.: P1157
Deneubourg, L.: P1867
Deng, L.: P0437, P0963
Deng, Y.: P1545
Denis, F.: P0218
Denison, H.: OP027, OP028
Dent, J.: OP055, P0893, P1601,
P1602, P1603, 56
Denters, M.J.: P0594
Denton, C.: OP413
Denyer, M.: P2045*
Deo, A.: P0640
P = poster presentation, OP = oral presentation, number only = page number

DeOliveira, T.: P1412*
Depoortere, I.: P1838, P1844
Deprez, P.: P2062
Deprez, P.H.: OP423*, P0114, P0150
Derikx, J.P.M.: OP384*
Deris, I.: OP425
Deris, N.: OP137*
Derks, S.: P1873
Derkx, B.H.F.: P0594
Derova, J.: P1370
Derovs, A.: P1370
Dervenis, C.: OP228*
Des Guetz, G.: P1141
Desantis, M.: P1420
Desfourneaux, V.: OP326*, P1428
DesGuetz, G.: P0220
DeSimone, C.: P0307
Desjeux, A.: P1454
Desmond, A.N.: P1061
Desmond, P.V.: OP045*
Despott, E.J.: OP016, OP213, P0640,
P0641, P0642
Desreumaux, P.: P1548
Dettmar, P.W.: P1607, P1622
Deutekom, M.: P0594
Deutsch, M.: P0526
Devastato, C.: P0455
Devière, J.: OP113, OP281, 36
Devlin, S.: P1072, P1758
Devreker, T.: P0920, P0921, P0922, P0923,
P0924
Dew, T.: P0092, P0787
Dewan, R.: P0891
Dewar, D.H.: P2005, P2006
Dewar, T.: OP369
Dewing, K.: P1824
Dewit, O.: P1548, P2062
Dewulf, D.: P0133
D'Haens, G.: OP011, OP323, P0355
Dhaliwal, S.: P1050
D'Halluin, P.: OP176, OP183
D'Halluin, P.N.: OP326*
Dhanda, A.D.: P0399, P0595
Dhar, A.: P0074, P0474, P0719, P1051
Dhellin, O.: OP331
D'Hoore, A.: P0351
Di Blasi, M.: P0539
Di Cesare, L.: P0250
Di Cicco, M.: P0735
Di Costanzo, G.: P0517
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Di Fabio, F.: P0365, P1430
Di Fiore, F.: P1287, P1319, P2073
Di Giulio, E.: OP338*, P0231, P0430
Di Leo, A.: P2004
Di Lorenzo, D.: P1430
Di Lorenzo, N.: OP014
Di Marco, V.: OP358*, P0517, P1933,
P1959, P1960
Di Mario, F.: OP405, OP410, P0021,
P0754, P0765, P0785, P1705, P1709
Di Martino, E.: P0913
Di Martino, V.: P0458
Di Maso, M.: P2042
Di Matteo, F.: P1339
Di Mauro, V.: P0455
Di Mitri, R.: P0735
Di Nardo, E.: P0938
Di Nardo, G.: OP023, OP195*, P0195
Di Nicuolo, F.: P0078, P1495
Di Palma, L.: P0371, P0393
di Pietro, S.: P1863
Di Sabatino, A.: P0067, P0784, P1814*
Di Simone, N.: P0078, P1495
Di Stasi, C.: P0501
Di Stasi, M.: P1943
Di Stefano, M.: OP100, P0075, P0400
Di Stefano, O.: P1198
Di Stefano, R.: P1959
Diaconu, B.: P0684
Diakowska, D.: P0907
Diamond, R.H.: OP323
Dias, C.: P1670
Dias, M.: P1908
Dias Pereira, A.: P1635
Diaz, G.: P0252
Díaz-Acosta, J.A.: P0549
Diaz-Rubio, M.: P2024
Díaz-Rubio, M.: P1572
Díaz-Saa, W.: P0287
Dickman, R.: P0039
Dickson, R.C.: P0457
Die, J.: P0354
Diebold, M.: P1178
Diegelmann, J.: OP382*, P1728, P1914
Diehl, A.R.: P0917*
Diericx, C.M.: P0753
Díez, R.: P1706, P1707
Dif, F.: P1548
Dige, A.: OP333*
Dignass, A.: OP307*, P0356
391

InDeX of aUTHoRs
Dijkgraaf, M.G.: OP065*
Dijkgraaf, M.G.W.: P0191, P1408
Dijkstra, G.: OP159*, OP312*, P0274,
P0275, P1009
Diks, S.H.: OP315*
Dima, S.: P1894
Dimacopoulos, K.: OP360
Dimaline, R.: P0858
DiMamabro, A.: P0280
Dimas, D.: P1672
Dimcevski, G.: P1104, P1105
Dimitroulopoulos, D.: P0002, P2169
Dimopoulos, F.: P0979
D'Imperio, N.: P1680, P2145
Din, S.: P0135
D'Inca, R.: OP334, P1043
D'Incà, R.: P0328, P0329, P1085
Dinelli, M.: P0548
Dinesen, L.C.: P0312
Dinis-Ribeiro, M.: OP219*, OP318*, P0115,
P0416, P0550, P1670,
P1684, P1917, P2021, P2022
Diniz, A.L.L.: P0339
Dinjens, W.N.M.: OP397*, P0096*, P0097
Dinning, P.G.: P0392
Dinya, T.: P0319, P1252, P1253, P1254
Diosdado, B.: P1142
D'Ipolitto, G.: P2139
D'Ippolito, S.: P1495
Dirnu, R.: P1580
Disclafani, G.: P0421
Disibeyaz, S.: P0667, P1442
Dişibeyaz, S.: P2084, P2085
Disney, B.R.: P1297
Distler, J.: P0964
Divakara, Y.S.: P1352
Djuraev, M.: P0116, P0117
Dmitrewski, J.: P1403
Do, E.J.: OP477*
Do, J.: P0587, P1854
Do Amaral, L.: P1498
Dobos, G.J.: P0321
Dodd, S.: OP281
Doddato, M.T.: P1797
Dodds, D.: P1852
Doecke, J.: OP463
Doecke, J.D.: P1046
Doerfler, H.: P0875
Dogan, I.: P0816
Dogan, Ü.B.: P0533
392
Dogan, Y.: P0470, P1787
Doglietto, G.: P0692
Doglietto, G.B.: P1362
Doglioni, C.: OP258*, P0677, P2090, P2091
Dogusoy, G.: P1749
Doi, K.: P0464
Doignon, F.: P0277
Doihara, H.: OP454, P1113
Dolapcioglu, C.: P0266, P1787
Dolar, E.: P1230*, P1231
Doldo, P.: P0267
Dolina, J.: P0878
Dolléans, M.C.: P1084
Domagala, P.: OP241
Domagala, W.: OP241
Domagk, D.: OP209, P1340
Domany, E.: P1868
Domenech, E.: OP160*
Domènech, E.: P1082, P1083, P1751
Domenici, F.A.: P1202
Domínguez, A.: P1706, P1707
Dominguez, J.L.: P1159
Dominici, P.: P0883, P1608
Dominis, M.: P0746
Domschke, W.: OP039*, OP308*, P1340,
P1724
Domuta, G.: OP239, OP437, P1435, P2125
Donadon, V.: P1987
Donahue, D.: OP311*
Donatelli, G.: OP254, OP265, P0720,
P1443, P2155
Donato, F.: P0618, P0806, P1986
Donato, M.M.: P1035
Dong, J.: P0411
Dong, S.: P1756
Dong, W.: OP084*, P0437
Donnelly, M.T.: P0582
Donnelly, S.C.: P0076
D'Onofrio, F.: P0119
Doré, J.: OP018*, OP020*, 51
Dörffel, Y.: P1721
Dormann, H.: P0477
Dorneanu, V.: P0476
Dorosulic, Z.: P0532
Dorta, G.O.H.: P2080
Dorval, E.: OP242*, P1805
Dotan, I.: P1667*
Douda, L.: P0843
Dougan, G.: OP390
Douglas, S.: P1375
P = poster presentation, OP = oral presentation, number only = page number

Doulgeroglou, V.G.: P0759
Douma, K.F.: P2152
Dowler, K.: P1297
Down, C.: OP156, P0325, P1715
Downey, P.: OP398*, P0126
Draaisma, W.A.: OP030*, OP032*
Dragomir, A.: P1190
Drapkina, O.M.: P1207, P1210
Drastich, P.: P1668, P1689, P1737
Dray, X.: OP254, OP265, P0720,
P2155, P2157
Drenth, J.P.H.: P1209
Drew, K.: P2106*, P2107
Drewe, J.: OP143*
Drewes, A.M.: P0154, P1104, P1105,
P1563, P1836, P2134
Driessen, A.: P0221*
Driscoll, R.: P1830
Drolz, A.: P0450
Drouet, E.: P1052
Drouin, É.: OP002
Drozdov, V.N.: P1919
Drozdowicz, D.: P0295
Drummond, H.E.: OP187*
Druzijanic, N.: P0956
Drygiannakis, I.: P1738
Drzikova, B.: P1157
Duan, L.: P0810
Duan, L.P.: P0373, P1103*
Duane, P.: P0716
Duane-Moore, R.: P1326
Duarte, P.: P1683
Dubb, A.: P1429
Dubberke, E.R.: 72
Dubcenco, E.: OP265, P0720
Dubé, C.: P0577
Duberman, B.: P0664
Dubois, D.: P0374, P0388
Dubowik, M.: P1346
Ducerf, C.: P1219
Ducharme, R.: OP265
Duchmann, J.: P1458
Duclos, A.: P1287, P2073
Ducos, J.: OP304*
Ducrotte, P.: OP005, OP460
Ducrotté, P.: P0401, P0665, P0869, P1287,
P1319, P2073
Dudding, T.: P0403, P1106
Duffas, J.: OP080*
Dufresne, M.: OP268*
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Dugalic, P.: P0499, P1789
D'Ugo, D.: P1362
Duhamel, A.: OP121, OP153
Duijkers, R.: P1163
Duijvestein, M.: OP047*
Dukes, G.E.: OP097*
Duku, M.: P1292, P1295, P1296, P1330
Duku, M.D.: P0596
Dulbecco, P.: P0184
Dulic, S.: P0183
Dumache, R.: P0438*
Duman, H.: P1787
Duncan, T.J.: P1569*
Dunckley, P.: P1297
Dunn, J.M.: OP224, P0151, P0908
Duny, Y.: OP359*
Dupas, B.: OP040
Dupas, J.: OP121, OP153, P1548
Dupas, J.L.: OP459
Dupont, A.: P0811
Dupont, B.: P0225, P1674
Duport, N.: P0203
Duprez-Duteuil, C.: OP111
Dupuy, E.: OP110*, P1675
Duque, G.: P0783, P1035, P1496,
P1941, P1942
Durand-Zaleski, I.: OP171
Duricova, D.: P0291, P0324
Durko, A.: P0196
Durko, L.M.: P1739
Dursun, A.: P1354
Dussaillant, M.: OP306*
Dutlova, E.D.: P0198
Dutta, A.K.: OP282
Dutta, U.: P0330, P0788
Duval, C.: P0743*
Dvorakova, L.: OP193*
Dworzañski, T.: P1732
Dynkov, S.M.: P1396
Dzebro, S.: P0746
Dziki, A.: P0235
Dziki, L.: P0235
Dziurkowska-Marek, A.: OP116, P0159
Dzwonek, A.: P0060
e
East, J.: P2062
East, J.E.: OP368, P0597, P0607, P1062,
P1302
Eastley, N.: P0399
393

InDeX of aUTHoRs
Ebato, T.: P0005, P1693
Ebbenhoej, K.: P1012
Eberhardson, M.: OP305, P1823
Eberhardt, E.: P1824
Ebi, M.: P1121
Ebrahimi-Daryani, N.: P1392
Echarri, A.: P0299, P1011, P1063
Echevers, J.: P1767
Eckmuellner, O.: P0315
Ectors, N.: P0681, P1261
Edara, P.: P1193
Eddleston, A.: P1000
Edebo, A.: OP219*
Edens, L.: P0799
Edery, J.: OP183
Edholm, T.: P1108
Edwards, C.: OP372*, P1051
Edwards, N.: P0868
Edwards, R.E.: P0895
Edwards, R.J.: P1411
Edwards, W.: P1326
Efraimidou, E.: P0181
Efthymiou, M.: OP045*
Egamberdiev, D.: P0116, P0117
Egan, L.: P0749
Egawa, N.: P0982
Eggersten, G.: P0536*
Eggleston, A.: P0874
Egorova, E.G.: P1208
Egsgaard, L.L.: P1104, P1105
Eguare, E.: P1166
Eguchi, Y.: P1968
Eikendal, T.: P0142
Einarsson, C.: OP126, P0536*
Eisemann, M.R.: P1477
Eisenblaetter, M.: OP039*
Eisinger, F.: P1879
Ejaz, M.: P1792
Ejaz, M.A.: P1064
Ekanayake, K.: P1378
Ekbom, A.: P0204, P1026
Ekesbo, R.: P0402
Eklund, S.: OP439
El Abkari, M.: P0300, P0713
El Aggaan, H.A.: P1963
El-Bahrawy, M.E.: P2128
El Deeb, N.M.F.: P1963
El-Garbawy, F.A.A.: P1935
El-Messallamy, F.A.: P1203
El-Omar, E.M.: P0919
394
El-Sadek, H.M.: P1203
El-Sakka, N.E.: P0919
El Sawy, M.M.: P1963
El Sayed, B.: P1925
El-Shall, N.: P0008
El-Shayeb, A.F.: P1935
El-Shunnar, S.: P0841
El Yousfi, M.: P0300
Elattar, M.: P0439
Elawad, M.: OP377, P0696, P0697,
P1425, P1426, P1427
Elewaut, D.: P1745
Elhawary, S.A.: P1936
Elia, C.: P1021
Eliakim, R.: P2064, 49
Elias Junior, J.: P1202
Elie, C.: P1319
Elisei, W.: P0250, P0251, P0350
Elizalde, I.: OP179*, P1371
Elkin, E.: P0139
Elkjaer, M.: OP155, P1065
Ell, C.: OP341, OP342, P0164, P0165, P1634
Elliott, C.: P0404
Elliott, J.: P1086
Elliott, T.: OP024
Elliott, T.R.: OP024
Ellis, H.J.: P0076, P0809
Ellis, R.: P1541, P1542
Elloumi, H.: P1988, P2082
Ellrichmann, M.: OP238*
Ellul, C.: P1884
Ellul, P.: P1884
Elosegui, E.: P1200
Elsadani, N.N.: P1062
Elsaiid, H.: P1929
Elshenawy, H.: P1929
Elyousfi, M.: P0713
Emara, M.H.: P1936
Emmanuel, A.: P1112, P2027
Emmanuel, A.V.: OP097*, OP413, P0382,
P0383, P1697, P1698, P1699
Emmrich, J.: P1416, P1725, P1726
Emungania, O.: P2149
Emura, F.: OP008
Enck, P.: 64, 79
Endo, H.: OP130*
Endo, T.: OP114
Endo, Y.: P0530, P1710
Engel, A.: 55
Engel, A.F.: P1147
P = poster presentation, OP = oral presentation, number only = page number

Engel, H.: P0801
Engelen, S.M.E.: OP245*, P0952, P1681
Engels, L.: P1024, P1025
Engsbro, A.: P0402
Engstrand, L.: P0842
Enochsson, L.: OP117, P0614, P1338
Enomoto, S.: P1614
Ensari, A.: P0296
Ensberg, D.: P1769
Ephrath, H.: P1367
Epshteyn, A.M.: P1396
Epstain, A.: P0664
Epstein, D.: P0298, P0782
Epstein, O.: OP370*, P1328
Erdelyi, Z.: P0317, P0320
Erdes, S.I.: OP189*, P1653
Ergen, K.: OP363
Ergun, M.: P0816
Eriksson, S.: OP272
Erkan, M.: OP083, P1412*
Ermis, F.: P0870, P1861
Erneux, C.: P1145*, P1867
Ershova, A.I.: P1397, P2150
Ersoz, G.: P0508
Erzin, Y.: P0776, P1749, P1998
Esandi, F.: P0473
Escourrou, J.: OP421, P0610
Escuredo, E.: P0344
Eser, A.: P1066
Eser, P.: OP089*
Eser, S.: OP089*
Eshonov, A.: P0117
Eshraghian, A.: P1937*
Eshtrekov, M.S.: P1404
Eshuis, E.J.: P0363, P2156
Eshuis, J.J.H.: P0086
Eshuis, W.J.: OP090*
Eslami, M.: P1985
Esmaeel, H.E.: P1170
Espinós, J.: P0077, P1557
Espinosa, W.: P1940
Espinosa, W.Z.: P0497, P2023, P2069
Espinoza, H.: P0755
Espinoza-Ríos, J.: P1843
Esposito, D.: P0941
Esposito, I.: P1412*, P1417*
Esposito, P.: P1069
Esser, D.: OP155
Estakhri, R.: OP131
Estanislao, N.: P1940
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Estanislao, N.I.: P0006, P1559, P1938,
P1991, P2069
Estanislao, N.N.: P0778, P1956
Esteban, P.: P1160
Esteller, E.: P0882
Esteller, M.: P1876*
Estelles, J.: P0366
Estellés, J.: OP324
Esteve, M.: OP160*, P0077, P1535
Estévez, A.: P1060
Esveldt, N.D.H.: P0942
Etienney, I.: P0249
Etik, D.: P0728
Eulálio, J.R.: P1440, P1441
Eum, J.: P0669, P0839, P1453, P2182
Eum, J.B.: P1449, P1488
Eun, C.: P0481, P1010, P2050
Eun, J.: P1288, P1289, P1348
Eun, S.: OP043
Euringer, W.: P0471
Eutamene, H.: OP274*
Eutamène, H.: P1007*
Evans, C.: P0568
Eveno, C.: OP110*, P1675
Everett, S.: P0347, P2030
Evgenidis, N.: P1249
Ewen, R.: OP392
Ezzedine, S.: P1454, P2149
f
Fabbri, C.: P1680, P2145
Faber, K.: OP312*
Faber, K.N.: P0274, P0275
Fabrice, C.: OP069
Fachnie, E.: P0384
Fadda, G.: P1361
Fagard, R.: P1405
Fagiuoli, S.: P0517
Fagundes, J.J.: P0992
Fagundes, R.B.: P0917*
Faias, S.: P0419, P2098, P2099
Faigel, D.: 62
Fairbanks, L.: OP243*
Faivre, J.: OP128*, OP293, OP300,
OP404*, P1241, P1882
Fakharzadeh, E.: OP302, P1954
Falcini, F.: OP165
Falge, C.: P2032
Falt, P.: P1358*
Falvey, J.: OP310*, P0280
395

InDeX of aUTHoRs
Falvey, J.D.: OP154*
Familiari, P.: OP013, OP248, P0306,
P1339, P2129
Fan, D.: P0851*
Fan, R.: P0443, P1796
Fändriks, L.: P1549
Fanelli, F.: P1443
Fang, S.: P1903
Fanget, B.: OP331
Fanigliulo, L.: P1943
Fano, V.: P1764
Fantini, M.C.: OP107*
Faqih, M.M.: OP191
Farajollahi, M.: P1857
Farfan, G.: P0755
Farha, N.: P0394
Farhadi, R.: OP187*
Farhangi, E.: P0248
Farinella, E.: P0722
Farkas, D.K.: OP139
Farkas, G.: OP419, P0319, P1253
Farkas, K.: P0319, P0348, P1078,
P1740, P1766
Farkas Jr., G.: OP419
Färkkilä, M.: OP289
Färkkilä, M.A.: P0406, P1177, P1800, P1976
Färkkilä, N.: P0406
Farmer, A.D.: OP101, P1750
Farquharson, F.: P0731
Farrant, M.: P0149
Farre, C.: P1535
Fass, R.: P0868
Fassbender, A.: P0964
Fasseu, M.: P0273*
Fatemi, S.: P1041
Fathallah, N.: P1951*
Faucheron, J.: P1428
Faure, P.: P0337
Faure-Kumar, E.: P1086
Fauze, M.: P1690
Fauze, M.F.: OP007
Fawzy, M.M.: P1203
Faycal, J.: P1888*
Fayoux, P.: P1556
Feagan, B.: P1817, P1818
Feagan, B.G.: P1790
Fedele, C.: P0588, P1422
Fedeli, P.: P1804
Federici di Abriola, G.: P2183
Federico, A.: P0764
396
Fedorak, R.N.: P0355
Fedorov, E.D.: P0643
Fedosina, E.A.: P1939
Fedulenkova, L.V.: P1919
Fejes, R.: P1110, P1350
Feki, M.: P0986
Fekih, M.: P0311, P0986, P1618,
P1619, P1620
Felice, C.: P0304, P1774, P1804
Feliciani, C.: P0197
Fell, J.M.E.: OP186*, P1652
Fellermann, K.: P1729*, P1730, P1807,
P1808
Felley, C.: P1087, P1091, P1825
Felt-Bersm, R.J.F.: P0970
Felt-Bersma, R.J.F.: P0969, P1130
Feng, Z.: P0216
Fenwick, A.: P0777
Ferdinande, L.: P1745
Férec, C.: P2135
Ferenc, T.: P0235
Ferenci, P.: P1199, P1967, P1979
Feres, O.: P0241
Ferguson, L.: P0710
Ferket, B.S.: P0422, P0962
Ferlitsch, A.: OP355*, P0608
Ferlitsch, M.: OP365*
Fernandes, A.: P1181
Fernandes, C.D.: P0509
Fernandes, S.: P1227, P1908
Fernandes-Cerqueira, C.: P1917
Fernández, C.: P1995
Fernandez, F.: P1767
Fernandez, J.: P1200
Fernández, M.: P1995
Fernández Arquero, M.: P1571
Fernández-Bañares, F.: OP160*, P0077,
P1535
Fernandez-Blanco, I.: OP324
Fernandez-Díez, S.: P2024
Fernandez-Esparrach, G.: OP259*, OP260*,
P0631*, P0632, P1385
Fernández Rodriguez, C.: P0578
Fernández-Salgado, E.: P0287
Fernández Seara, J.: P1704
Fernandez-Urien, I.: OP179*, P0621,
P1364, P1371
Fernández-Urién, I.: OP464
Feron, J.: OP110*
Ferrand, J.: OP057*
P = poster presentation, OP = oral presentation, number only = page number

Ferrante, M.: P0328, P0351, P1044
Ferrão, J.: P1035
Ferrara, F.: P1680, P2145
Ferrari, A.P.: P1323, P1324, P2017, P2076
Ferraro, D.: OP358*, P1960
Ferraro, M.: P1997*
Ferraz-Neto, B.: P2076
Ferreira, C.: P1958, P2021
Ferreira, C.N.: P1957
Ferreira, F.: OP246*
Ferreira, M.: P0783, P1035, P1293,
P1496, P1941, P1942
Ferreira, S.: OP081*, P0419
Ferreira, S.C.: P0511, P0512
Ferrier, L.: P1007*
Ferro, U.: P1709
Ferry, N.: OP127*
Fesus, L.: P1523
Fetsych, T.: P0853
Feuilloley, M.G.J.: P0996
Feussner, H.: P0570, P0881
Fibbe, C.: OP280
Fibbe, W.E.: OP047*
Ficano, L.: P2025
Fickert, P.: OP227
Fidalgo, C.: P0419, P2098, P2099
Fidder, H.: P0309, P2001
Fidder, H.H.: OP047*, P1067
Field, B.: 18
Fierro, M.: P1169
Fieuws, S.: P0681
Figa Francesch, M.: P0606
Figlerowicz, M.: P0044
Figueiredo, J.F.C.: P0511
Figueiredo, P.: P0639
Figuereida, F.: P2101, P2102
Fijneman, R.J.A.: P1143
Fikree, A.: P0598, P2026
Filali, A.: P0311, P0986, P1618,
P1619, P1620
Filho, F.: P1691
Filho, F.M.: P1646
Filip, M.: P0122, P2038*, P2147
Filip, R.: P1615
Filipe, B.: OP081*
Filipec Kanizaj, T.: P0013
Filipec-Kanizaj, T.: P0746
Filippi, J.: P0337
Filipskyy, A.: P0104*
Filoche, B.: OP005, OP176, OP183
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Fina, D.: OP107*
Fingerhut, A.: 37
Fini, L.: OP316*, OP320
Finke, J.: OP053
Finkel, Y.: P1005
Fiocca, F.: P1443
Fiocca, R.: P0184
Fiocchi, C.: OP025*, OP051*, OP309*,
OP329*, P0263
Fior Gozlan, M.: P1336
Fiore, F.: P1997*
Fiori, G.: P0960
Fiori, R.: P0863
Fiorino, G.: P1068
Fireman, Z.: P1770
Fischbach, W.: P1885, P1886
Fishman, J.R.: OP186*, P1652
Fissler-Eckhoff, A.: P0165
Fitzgerald, G.A.: 30
Fitzgerald, R.C.: OP395*, OP399*, P0146
Flamant, M.: OP206, P0293, P0337
Flanagan, D.: OP142, P0817
Flannery, D.: P0088
Fleischaker, H.: P1528
Flejou, J.: P1405
Fleming, K.: OP411
Fleming, K.M.: OP436*
Fleming, S.: OP142, P0817
Flens, M.: P1147
Fleurisse, L.: P1133
FLIN Investigators: OP403
Flore, R.: P1797
Floreani, A.: OP226*, P0529*, 57
Flores, H.B.: P0006, P1559, P1940,
P1991, P2069
Flores, H.H.: P0778, P1956
Flores, V.: P0997
Flori, N.: OP359*, P2137
Florin, T.H.J.: P1046
Florvaag, E.: OP095*
Flourie, B.: OP068
Flourié, B.: P1727*
Foad, A.: P1974
Fock, K.: P1760
Fock, K.M.: 24
Fockens, P.: OP078, OP203*, OP220*,
OP222, OP223, OP252*, OP449*,
OP471*, P0569, P0581, P0594, P0701,
P1406, P1407, P1408, P1419, P1866,
P2012, P2097, P2156, P2165, P2166, 37
397

InDeX of aUTHoRs
Fockens, P.P.: OP065*, P0086
Foda, M.: P1974
Fodde, R.: OP397*, P1143
Foersch, S.: OP067*
Fogaça, H.: P1021
Fogliano, V.: OP316*
Fojtík, P.: P1358*
Folgado Alberto, S.: P0936
Fomenko, I.S.: P0823, P0835
Fonrose, X.: P1055
Fonseca, R.: P2098, P2099
Foote, C.: P0868
Forbes, A.: OP140, OP413, P0307, P0784,
P0812, P1003, P1004, P1074, P1080, P1723
Ford, E.: P1327
Forde, C.: P1795
Forgione, A.: P0501
Forland, D.T.: P1826
Forman, D.: OP293, 51
Formigo, M.: P2021
Fornari, F.: P0735, P1943
Fornasarig, M.: P1703
Fornasini, M.: P1169
Forné, M.: P0077
Forni, F.: P0304
Forras-Kaufman, Z.: OP134
Förstl, M.: OP380, P0767, P1544
Fortelny, R.: P0739
Forti, G.: P0350
Forton, D.M.: P1027
Forys, S.: P0144
Forzenigo, L.: P0371
Foschia, F.: P2183
Fossati, G.: P1002
Foster, G.: P1973
Foster, M.: P0584
Fotheringham, T.: P0389
Fournier, J.: P0391
Fourrier-Réglat, A.: P1898
Fourtanier, G.: OP421
Fowler, C.: P0383
Fowler, D.: P1748
Fox, M.: P0073, P0376, P0377, P0397,
P1195, P1545, P1624, P1837, P1845, 20
Fox, M.R.: OP134
Fox, S.: P0567, P1830
Foye, L.: P1785
Fradejas-Salazar, P.: P0672
Fraga, J.: P0083, P0500, P1227, P1472,
P1908, P1926
398
Fragandrea, I.: P0002
Franca, A.V.C.: P1265
Francavilla, A.: P2004
Franceschetti, S.: P0027
Franceschi, F.: OP283, P0078, P0197,
P1495
Franceschi, M.: OP410
Francis, D.: P0110
Francisco, I.: OP081*
Francke, J.: P0528
Frankish, N.H.: P1741
Frans, N.: P1493
Fransen, G.A.J.: P0141
Franzè, A.: P0784
Franzé, A.: OP405, OP410, P0754,
P1705, P1709
Franzè, J.: P0785
Fraser, C.: OP016, OP213, P0640, P0641,
P0642, P2027
Fratila, O.C.: OP200, P1904
Frattino, A.: P1069
Frattolillo, F.: P0588, P1422
Frazier, K.: OP456
Frazzoni, M.: P1377
Frédéric, M.: OP005, OP176
Frederik Dahlerup, J.: OP333*
Freedman, J.: OP249
Freeman, J.: P0487, P0488
Freilich, S.: P0219, P1048, P1049
Freiman, J.: OP456
Freire, J.: P1635
Freire, P.: P0783, P1035, P1496,
P1941, P1942
Freitas, J.: P1757
Freitas, T.: P0083, P1926
Freour, T.: OP206, P0293
Fried, M.: OP134, P0073, P0376, P0377,
P0397, P1545, P1837, 32
Friedman, S.L.: 40
Friedrich, C.: P1116
Frieser, M.: OP003*
Friess, H.: OP083, OP085*, P0935, P1412*,
P1417*, P2136, 56
Friger, M.: OP155
Frisk, G.: P0082, P1005
Fristrup, C.W.: OP038
Friswell, M.K.: P0226*
Fritscher-Ravens, A.: OP149, OP182,
OP261, P1399, 79
Froch, B.: P1798
P = poster presentation, OP = oral presentation, number only = page number

Froehlich, F.: P0308, P1087, P1091, P1825
Froghi, F.: P2161, P2162
Froilán Torres, C.: P0107
Frøkjær, J.B.: P1104, P1105, P2134
Frolova-Brizova, L.: P1737
Frosi, A.: P0548
Frosini, G.: P0735
Frozanpor, F.: OP249
Fruehauf, J.: OP332*
Fruehauf, J.H.: OP314*
Frühauf, H.: P0376, P0377, P1837
Frulloni, L.: 47
Fry, L.: OP135, OP210*
Fry, L.C.: P0180, P0624, P0652, P0653,
P1451
Frydrychowicz, A.: P0471
Fu, K.: P0599, P2043
Fu, Y.: P0454
Fuccio, L.: OP321, P2145
Fucile, C.: P1747
Fudim, E.: OP330
Fuentealba, S.: P0392
Fuentes-Coronel, A.: P0672
Fuhler, G.: OP312*
Führer, M.: OP457, P0405
Fuhrmann, I.: P0964
Fuhrmann, V.: P0450
Fujii, T.: P0599, P2058*
Fujiki, S.: P1643
Fujimori, T.: P0599
Fujimoto, K.: P1470, P1968
Fujioka, T.: P0981
Fujisaki, H.: P0876, P0877
Fujisaki, J.: P1476
Fujishiro, M.: P1686, P2151
Fujita, H.: P0561
Fujita, K.: OP130*, P1204
Fujita, M.: P0007, P0132, P1839
Fujita, N.: P0168, P0605, P1294, P1446
Fujita, T.: P0562
Fujita, Y.: OP007, P1646, P1690, P1691
Fujiwara, S.: P0721
Fujiwara, T.: P0982
Fujiwara, Y.: P0663, P0909, P1638, P1875
Fujiya, M.: OP058
Fujiyama, Y.: OP348*, P1718, P1806
Fukai, Y.: P0859
Fukami, N.: OP429, P0553
Fukase, K.: P0118
Fukuda, K.: OP007, P1646, P1690, P1691
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Fukuda, S.: P0015, P0035
Fukuda, T.: P2113
Fukuda, Y.: P0015
Fukui, T.: P1183
Fukumori, K.: P1251
Fukumoto, K.: P1008
Fukunaga, K.: OP201, P0284, P0987
Fukuta, K.: P0547
Fukuwzwa, Mari: P1274
Fukuwzwa, Masakatsu: P1274
Fukuyama, M.: P1968
Fukuzawa, T.: P1247
Fullard, M.: P0155
Fullarton, G.: OP224
Fullarton, G.M.: P0152
Fumex, F.: P0551
Funakoshi, N.: OP304*, OP359*
Funch-Jensen, P.: P0154, P1110, P1563
Furet, J.: OP018*
Furfaro, N.: P1824
Furman, M.: P0303
Furnari, M.: P0786
Furuichi, Y.: P0464, P0480, P0489,
P2028, P2029
Furukawa, K.: P0234, P0911, P1577
Furuta, T.: P0836, P1492
Furuya Jr., C.K.: OP010
Fusco, A.: P0692
Fuszek, P.: P0649
Futagawa, S.: P1897
Fuxe, J.: P1005
Fyfe, V.: P0185
G
Gabe, S.: P0812, P2154
Gabe, S.M.: OP140, P0818
Gabr, M.: P0008
Gabriel, A.: P1971
Gabrieli, M.L.: P0501
Gabrielson, K.L.: OP254
Gabrysova, B.: P0324
Gaburri, P.D.: P1821
Gaeta, G.: P0517
Gaeta, L.: P0764
Gaglia, A.: P0232, P0255
Gagliardo, S.: P0539
Gagnon, M.: OP388*, P1497*
Gaida, E.: P2111
Gairy, K.: OP172
Gaiser, S.: OP475*
399

InDeX of aUTHoRs
Gal, A.: P1904
Gal, E.: P1770
Galais, M.P.: P1674
Galamb, O.: OP484, P0773*, P0943,
P0944, P1134*, P1135, P1144
Galas, L.: P0057*
Galasso, D.: P0692, P1361, P1362, P2100
Galazan, L.: OP162, OP479
Galeotti, T.: P1257
Galia, M.: P1780
Gallagher, M.: P1515
Gallas, S.: P1428
Galle, P.: OP068
Galle, P.R.: OP067*, OP137*, OP371, OP425
Gallego, C.: P1063
Galliera, M.: P2092
Gallo, A.: P0119
Gallo, V.: P0764
Galmiche, J.: OP070, OP206, P0293,
P0955, P0998
Galmiche, J.P.: OP005, OP445, P0084
Galvez, J.: P0260*, P0261, P1735,
P1736, P1743
Gamar, L.: P0292, P0301, P0310,
P1759, P1761, P1849
Gamelin, E.: OP242*
Gan, H.: P1742
Gang, Y.: P0851*
Gangadharan, S.K.: OP282
Gangl, A.: OP355*, P1066
Gantois, N.: P1133
Gao, L.: OP055, P0893
Gao, Q.: P0437, P0963
Garassini, M.: 47
Garces, C.: P1169
García, E.: P0461
Garcia, I.: P1343
Garcia, M.: OP316*, OP320
García, V.: OP324, P0288
Garcia-Bengoechea, M.: P0473
García-Cano, J.: P1444
Garcia Durán, F.: P0934
García Durán, F.: P0215
García-Durán, F.: P1053, P1054
García-Eliz, M.: P1809
Garcia Fernandez, F.: P0619
Garcia-Fernandez, J.: P1735
García García, M.: P1704
García Garzón, S.: P0354
García-Garzón, S.: P1053, P1054, P1812
400
Garcia-Gil, J.: P0995
García-Gil, L.: OP108*
García-Morán, S.: OP324
Garcia-Planella, E.: P1082, P1083, P1751
Garcia Solano, J.: P0976
Garcia Tercero, I.: P0976
Garcia-Vela, A.: P2117
Gardenal, R.: P1987
Garello, E.: P0502
Garg, H.K.: P0451
Gargiulo, G.: P0588, P1422
Gargouri, D.: P2082
Garioud, A.: OP299*
Garner, K.: OP392
Garre, A.: OP303
Garrido, A.B.: P0087
Garrido, E.: P1812
Garrido Gómez, E.: P0354
Garrido-Mesa, N.: P0261, P1735,
P1736, P1743
Garvey, L.J.: P1983
Gasbarrini, A.: OP051*, OP283, OP316*,
P0078, P0119, P0197, P0263,
P0350, P0417, P1220, P1257, P1495,
P1774, P1797, P1804, P1997*
Gasbarrini, G.: OP283, P0078, P0119,
P0197, P1495
Gasiorowska, A.: P0686, P2146
Gasmi, M.: P2186
Gasparov, S.: P0746
Gasperoni, S.: P0654
Gassull, M.: P1087, 80
Gatenby, P.: P0167
Gatopoulou, A.: P1708
Gatta, A.: P0447
Gatta, L.: OP405, OP410, P0020, P0021,
P0754, P0765, P1705, P1709
Gatto, G.: P0735
Gaudier, E.: P0041*
Gaudin, J.: OP183
Gaudric, M.: OP005, OP176, OP183
, P0590, P0936, P1286, P1458
Gaujoux, S.: P0704
Gavril, P.: P1437
Gawlicka, A.: P2027
Gawronska, A.: P0188
Gaze, S.: OP278
Gazzard, B.: P0268
Gea Rodriguez, F.: P0725, P2075
Gearry, R.B.: P1044, P1045, P1046
P = poster presentation, OP = oral presentation, number only = page number

Gebel, M.J.: OP354, P0486, P1259
Geboes, K.: P0147, P0351, P1031*, P1099
Gecse, K.: P0183, P0375
Gedikbasi, A.: OP124
Geerts, A.: P1920*
Geiger, K.: P0925
Geldof, H.: P0942
Geliconov, G.: P1993
Geller, A.: P1139
Gelu-Simeon, M.: P1498
Gemela, O.: P0317, P0318, P0319, P0320,
P0649, P1078
Gemignani, L.: P0184
Gemini, S.: P0252
Gennarelli, N.: P0588, P1422
Genta, R.: OP316*, OP320
Gentiloni Silveri, N.: OP283, P0078, P0197,
P1495
Gento, E.: OP324
Geoffroy, P.: P1178
George, A.T.: OP372*, P0403, P0722,
P1106
George, B.: P0312
George, R.: P1841
Georgescu, C.: P0122
Georgescu, D.: P0023
Georgescu, E.F.: P1205
Georgiadis, D.: P1862
Georgieva, M.: OP196*
Georgopoulos, S.: P0572
Geraghty, J.: P0552*
Gerber, J.: OP280
Gerbes, A.: 18
Gerhard, M.: OP059*, P0751*
Gerhards, M.: OP250*
Germain, E.: P1336
Germani, G.: P0504
Gerovassili, A.: P1038
Gerritsen, J.: OP250*
Gervais, R.: P1674
Gervasi, M.: P0529*, P1430
Geubel, A.: OP423*
Geva, R.: OP162
Geyer, M.: P0600
Ghadir, M.: P1206
Ghaffari, S.: P1244
Ghaffaripour, S.: P0452
Ghahramani, F.: P0200
Ghanbari, A.: OP149
Ghatei, M.A.: OP140
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Ghavamzadeh, A.: P1189
Ghazy, M.: P0008
Gheibi, S.: OP197
Gheonea, D.: P0122, P2038*
Gheonea, D.I.: OP257*, P2147
Gheorghe, C.: P1894
Gheorghe, L.: P1894
Ghersetti, M.: P1987
Ghersi, S.: P1680
Ghorbani Haghjou, A.: OP131
Ghorbel, A.: P2082
Ghosh, S.: OP192*, OP199*, P0279,
P1062, P1094, P1758
Ghosh, T.: P2030
Ghoshal, U.: P0004
Ghoshal, U.C.: P0302, P1372
Ghout, I.: OP171
Giacomin, A.: OP165
Giaffer, M.H.: P1945
Giamalis, I.: P0504
Giangregorio, F.: P1943
Giannakoulopoulou, E.: OP441
Giannelli, M.: P1883
Giannikoulis, C.J.: P0892
Gianopoulos, C.: P0979
Giaquinto, S.: P1069
Giardullo, N.: OP379
Gibson, G.R.: P0041*
Gibson, P.: OP463, P1092
Gibson, P.R.: P0796
Giday, S.A.: OP254, OP265, P0720, P2155
Giese, N.: OP083, P1412*
Gietl, A.: P0377, P1837
Gigante, G.: OP283, P0078, P0197,
P1220, P1495
Giglio, A.: P0350
Gigot, J.: OP423*
Gijbels, M.: OP472*
Gil, A.: P0202
Gil, A.H.: P1783
Gil, N.: P0506*
Gilissen, L.P.L.: P0723
Gill, I.: P0356
Gillett, P.M.: P1514
Gilmore, I.: 23
Gilroy, R.: OP141, P0813, P0814
Gils, A.: OP327*, OP328
Gimbert, N.: P1317
Gimeno-García, A.Z.: P0549
Ginard, D.: OP160*, P0288, P1767
401

InDeX of aUTHoRs
Gincul, R.: OP044
Gines, A.: OP259*, OP260*, P0631*,
P0632, P1385
Gioeva, I.Z.: P0505
Giollo, P.: P1863
Gionchetti, P.: P0334, P0340, P0349
Giorda, E.: P0417
Giorgetti, G.: P0250, P0251, P0350
Giovannini, M.: OP069, OP115, OP257*,
P2101, P2102, 56
Giraud, A.: P0009
Girelli, C.M.: P1368
Gisbert, J.: OP160*, P1548
Gisbert, J.P.: P0366, P0367, P0887,
P1812, P1843
Gittens, S.: P0577
Giuliani, O.: OP165
Giuliante, F.: 40
Giupponi, B.: OP283, P0078, P0197, P1495
Giussani, A.: P0677
Givirovskaya, N.E.: P0705
Gizzi, G.: OP403
Gkisakis, D.: P1249
Glas, J.: OP325*, P0294
Glaser, K.: P0739
Glasser, A.: OP021*
Gligorijevic, V.: P1788
Glubb, D.M.: P1046
Go, M.: 50
Gocho, S.: P1225
Goda, K.: OP219*
Goday, A.: P1547
Goddard, L.: P1127
Godfrey, C.: OP469, P1333
Goedhard, J.G.: P1304
Goedhart, J.: OP158
Goetz, M.: OP067*, OP068, OP137*,
OP371, OP425
Goetze, O.: P0376
Goh, B.: P0756
Goh, H.: P1494
Goh, J.: P1795
Göke, B.: OP325*, OP382*, P0294, P1056,
P1728, P1819, P1914
Goksel, S.: P1749
Goldin, R.D.: P1962
Goldis, A.: P0848, P0849, P0850
Goldis, R.: P0850
Goldstein, J.L.: P0827, P0828
Goldyreva, A.A.: P1397
402
Gölge, N.: P0533
Golger, D.: P2174
Gollas, A.: P1846
Goller, K.: OP059*
Golubovic, G.: P0499, P1789
Gomes, D.: P1293, P1684, P2086, P2087
Gomes, G.F.: P1323, P2017
Gomes, L.P.: P1441
Gomez, I.: P0578
Gomez, S.: P2075
Gómez-Camacho, F.: P0366, P0367
Gómez-Ruiz, C.: P1444
Gómez Senent, S.: P0725
Gómez Senent, S.S.: P0107
Gonçalves, N.: P1917
Gonçalves, R.: P0583
Goncalves, S.: P1783
Goncharov, V.: OP375*, P1270
Gondal, R.: P0679
Gondrie, J.J.: OP222
Gong, W.: P0894
Gong, X.R.: P1592
Gong, Y.: OP055, P0893
Gonvers, J.: P0308, P1087, P1091, P1825
Gonzalez, A.: P1519, P1520
González, C.: P0077
Gonzalez, F.: P0061
González, N.: P0549
Gonzalez, P.: P1706, P2024
Gónzalez, P.: P1707
Gonzalez, S.: P0061
Gonzalez-Calvin, J.L.: OP303
González Castillo, S.: P1566
Gonzalez de la Higuera, B.: OP179*,
P0621, P1371
González-Huix, F.: OP160*
González-Huix Lladó, F.: P0606
González-Lama, Y.: P2078
González Vázquez, E.: P1704
González Vigo, A.: P1571
Goodbourn, C.: P1499
Goodhand, J.R.: P1070, P1499, P1750
Goodier, M.: P0268
Goodman, E.R.: P0695
Gooszen, H.: OP146
Gooszen, H.G.: OP030*, OP473*, OP474
Gooszen, J.A.H.: P0701
Gorard, D.: P2019
Gorbacheva, N.: P0018
Gorczyca, R.: P1615
P = poster presentation, OP = oral presentation, number only = page number

Gordillo, J.: P1082, P1083, P1751, P1767
Gordon, C.: P0897
Gordon, G.: P0453
Gordon, M.A.: OP389, OP390
Goretzki, P.: P1164
Gornet, J.: OP295
Gorunescu, F.: OP257*
Goryca, K.: P0060, P0861
Goss, M.: P2093, P2094, P2096
Gossetti, F.: P1893
Gossner, L.: P1567
Goswami, P.: OP412*, P0079, P0326,
P1059, P1744
Goto, H.: P0331
Goto, O.: P1686, P2151
Goto, Y.: P0418
Gotoda, T.: P1374, P1893
Gottardi, F.: P1128
Gottrand, F.: OP188*, P0928, P1556
Gouérou, H.: P1888*
Gouillat, C.: P1219
Goula, K.: P0175, P0896
Goulard, H.: P0203
Goulet, O.: 56
Gouma, D.: OP250*
Gouma, D.J.: OP065*, OP090*, P1406,
P1407, P2097
Gourcerol, G.: P1107, P1126
Gourgey, R.: P0325
Gourraud, P.: P0610
Gouveia, H.: P0639, P1293, P1683, P2086,
P2087
Govindaraj, K.: P0724
Gowans, M.: P1378
Gower-Rousseau, C.: OP121, OP153
Gowland, P.A.: P0380
Gözen, M.: OP249
Grabowski, K.: P0907
Grabsch, H.: P1146*, P1147, P1871
Grabsch, H.I.: P1142, P1873
Graczer, M.: P1829
Gradiz, R.: P2086, P2087
Grady, W.: 62
Graf, B.: P0871
Graham, A.: P0598, P2026
Graham, D.Y.: P1482
Graham, S.: OP099
Grainge, M.J.: OP335*
Grainger, S.L.: P1507
Gralnek, I.: P2064
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Gralnek, I.M.: OP177, P0010, P0011, P1071
Grammatikos, N.: P1249
Granata, A.: P2025
Granath, F.: P0204
Granatova, J.: P0950
Grandchamp, B.: P2148
Grangé, J.: OP299*
Granlund, J.M.W.: P0204
Grant, J.: P0726, P1290, P1291
Grasman, M.: OP145*
Grasman, M.E.: OP019*
Grassini, G.: P2091
Grasso, E.: P1883
Gratzer, C.: P1771
Graur, M.: P1211, P1212
Graversen, C.: P1104, P1105
Gravesen, F.: P1836
Gravina, A.G.: P0764
Gray, J.: P0152
Gray, M.A.: OP418*
Grazioli, S.: P1987
Greco, A.: P0786, P1747
Greco, L.: OP391*, P1129
Green, A.C.: P0914
Green, L.: P2019
Greenfield, S.M.: P2052
Greenhalf, W.: OP281
Greenwood, R.: OP392, P1047
Greer, S.: P0046
Gregersen, H.: P1117, P1836
Grégoire, E.: P2140
Gregorio, E.: OP374
Greinwald, R.: OP161, P1092, P1093
Grenouillet, F.: P0458
Greten, F.: OP476*
Greve, J.: OP250*
Greve, J.M.: OP276*, P1546
Greveson, K.J.: P0303
Greyson, O.: P1973
Grgurevic, I.: P0462, P0617, P0634,
P1349, P1599
Grieco, A.: P0501, P1220
Griffin, S.P.: P1309
Griffiths, L.: P1748
Griffiths, S.M.: P0432
Griffiths, W.: P1174
Grigioni, S.: P0665
Grigolon, A.: P0179, P1616
Grigorescu, M.: OP231*, OP357*, P0468,
P1222
403

InDeX of aUTHoRs
Grigorieva, I.N.: P1398
Grigoriu, I.: OP299*
Grillot-Courvalin, C.: OP314*
Grim, J.: P0827, P0828
Grimaud, J.: P1454, P1548, P2149, P2186
Grobbee, D.E.: P0141
Grocock, C.J.: OP281
Groleger-Sršen, K.: P1621
Gromova, P.: P1145*, P1867
Groot, A.P.: P1716
Grootjans, J.: OP384*
Grossi, C.: P0098
Grossi, E.: P0735, P0883, P1608
Grotenhuis, B.A.: OP345*, OP349,
OP397*, P0910
Grotzinger, K.: P1932
Grotzinger, K.M.: P1934
Grouard-Vogel, G.: OP331
Grouin, J.: OP460
Groves, C.J.: P1027
Groyer, A.: P0273*
Grünhage, F.: OP126
Grützmann, R.: P0964
Grybäck, P.: P1108, P1848
Grzyb, K.: P0985
Gschwantler, M.: P0739
Guardiola, J.: P1876*
Guariso, G.: P1043
Guarner, C.: P0631*, P1083, P1751
Guarner, F.: P1058
Gubergrits, N.: P2132
Guckelberger, O.: OP329*
Gudjonsson, B.: 51
Gudkova, R.: P0793
Gueho, A.: P2148
Guenther, T.: P0597, P0607, P1302
Guerci, M.: P0067
Guérin, O.: P0821
Guerra, D.M.: P1821
Guerra, I.: P1053, P1054, P1812
Guerrero, R.: P1169
Guerrieri, F.: OP128*
Guessab, N.: P0292, P0301, P0310,
P1759, P1761
Guglielmi, A.: P1256
Guicciardi, L.: OP041*
Guida, L.: P0754
Guidi, L.: P0304, P1090, P1774,
P1803, P1804
Guido, R.: P2004
404
Guilarte, M.: P1114
Guimbaud, R.: OP080*, P2141
Guion, C.: P1198
Guirado, A.F.: P1202
Guittet, L.: P0945
Guiu, B.: P1241, P1882
Guller, U.: P0600
Gulmann, C.: OP398*, P0126
Gulotta, G.: P0938
Gummer, V.: P2114
Gümürdülü, Y.: P0533
Gunasekaran, T.: P0928
Gundlach, L.: P0969
Gunesh, S.: OP122*
Gunnarsson, J.: OP098
Gunsar, F.: P0508
Gunther, E.H.: P1305
Guo, B.: OP398*, P0126
Guo, C.: P0852
Guo, L.: P1545
Guo, X.Z.: P1944
Guppy, N.J.: P2128
Gupta, A.: P0247, P0601, P0710, P0722,
P1381, P1905*, P2155
Gupta, G.: P1196, P1931
Gupta, K.: OP369
Gupta, N.: P1172, P1236, P1237,
P1300, P2089
Gupta, R.: OP255*, P0612
Gupta, S.: OP213, OP448, P0012
Gupte, N.: P1860
Gurel, S.: P1984
Gurmany, S.R.: P0404
Gurova, M.M.: P0198
Guseva, S.P.: P0198
Gustafsson, U.: OP227
Gustavsson, A.: P1731
Gustavsson, M.: P0620
Gutiérrez, A.: OP160*
Guyot, K.: P1133
Gvozdev, A.: OP375*
Gyimesi, J.: P1523
Gyllensten, U.: P1005
Gyr, N.: OP194, P0779, P1948
Gzhegotsky, M.: P0104*, P1554
H
Ha, S.: P0410, P1575*
Haan, J.C.: P1146*, P1147
Haba, R.: P0700
P = poster presentation, OP = oral presentation, number only = page number

Habbema, D.J.D.: P0427
Haber, G.: 51
Habre, J.: P1420
Haddad, M.J.: OP186*
Hadeler, K.: OP149, OP261
Hadfoune, M.: OP276*, OP386*, P1546
Hadhoud, K.M.: P1203
Hadjivassiliou, M.: P1526
Hadnadjev, L.: P1490
Hadzyvassiliou, M.: P0978*
Haeussinger, D.: 80
Haga, K.: P1086
Haga, N.: P0859
Hagege, H.: OP459
Hagège, H.: P0737
Hagenmueller, F.: P2111
Haghighat, M.: OP197, P0193, P0194,
P0199, P0200, P1937*
Hagiike, M.: P0700
Haguenoer, K.: OP242*
Hagymasi, K.: P0774
Hahm, J.: P0244
Hahn, E.G.: OP003*, OP091*, P0477, P0687
Hahn, H.: OP218*
Hahn, T.H.: P1895
Haidinger, G.: P1154
Hainaki, I.: OP120
Haines, M.: OP463
Hajek, A.: P0206
Hajipour, B.: OP131
Hajjaui, M.: P0504
Håkansson, H.: P2120
Hakem, D.: P1434
Hakulinen, T.: OP166
Halangk, J.: P1209
Halfvarson, J.: P1731
Hall, E.J.: P1527
Hall, N.: P0792
Hallack, A.: OP162, OP479, P1667*
Hallal, H.: P0473
Haller, W.: P0201
Hallersund, P.: P1549
Hallert, C.: P0790
Halligan, S.: OP075
Halling, K.C.: P0176*, P0177
Halloran, S.P.: OP170, P1887
Halpern, E.F.: P1384
Halttunen, J.: OP247
Haluszka, O.: OP113
Hamabe, K.: P1280
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Hamaguchi, M.: P1869*
Hamano, T.: P1299
Hamatani, S.: OP071*, OP072*, OP467*,
P0575, P0602, P0603, P0946,
P0951, P1311, P1314, P2070
Hameed, M.F.: P1439
Hameeteman, W.: OP158, P1024, P1025
Hamid, S.: OP362, P0483, P0519,
P1184, P1927
Hamilton, J.K.: OP369
Hamilton, P.A.: P0080
Hamilton, W.T.: OP285
Hamlett, J.: OP482*
Hamlin, P.: P0347
Hamlyn, A.: P0622
Hammel, P.: OP424, P1402, P1405,
P2135, P2141, P2148
Hammer, J.: P0405, P0745
Hammer, K.: P0745
Hammoudi, A.T.: OP482*
Hamoir, C.: OP423*
Hamzaoglu, I.: P1749
Han, C.: P1410
Han, C.J.: P0522
Han, D.: P0481, P1010, P2050
Han, D.D.S.: P0313
Han, H.: P1989
Han, J.: P0093, P0094, P0237, P0507
Han, K.: P1713
Han, K.H.: P1214, P1400
Han, S.: P1924, P1932, P1934
Han, T.Q.: P0536*
Hanan, I.: OP369
Hanaoka, N.: OP431
Hanashi, T.: P0901
Hanauer, S.B.: P1790, P1815
Hancock, B.: OP390
Handa, O.: P0064*, P1008, P1752, P2009
Handra-Luca, A.: P1405
Hansen, B.E.: P0528, P1438*
Hansen, E.F.: P0718
Hansen, J.: P0682*
Hansen, M.B.: P0666
Hansen, R.: P0919
Hansen, T.: OP038
Hansson, G.C.: P0682*
Hansson, I.: P1005
Hansson, T.: P0081, P0082
Hao, L.: OP092
Hao, Y.T.: OP288*, P0112, P1874
405

InDeX of aUTHoRs
Haque, R.: P0779
Hara, K.: OP061
Hara, S.: P1148, P1342
Hara, T.: P0118, P0901
Harada, H.: OP373, P0876, P0877
Harada, M.: P2031
Harada, T.: P0564, P0565
Harada, Y.: P0168, P1294
Harbord, M.: P0871, P1014*, P1015
Harcus, M.: OP281
Hardcastle, S.: P0660
Harder, J.: OP053
Hardie, L.J.: P0913
Hardwick, J.C.: OP218*, P0276
Hardwick, J.C.H.: OP104*, OP315*
Hardwick, J.S.: OP395*, OP399*
Hardwick, R.H.: OP395*, OP399*
Harinck, F.: P1406, P1407, P1408
Haringsma, J.: OP219*, OP366, P0026,
P0604, P2188
Haris, V.: P0462
Harnden, S.: P1297
Harrell, L.: P1072
Harris, P.: OP168*
Harsfalvi, J.: P1252, P1253
Hart, A.L.: P1003, P1004, P1080,
P1723, P1763
Hartl, F.: OP325*
Hartleb, M.: P0159, P0314
Hartley, M.: P0113, P0694, P0699, P0854
Hartman, C.: P1528
Hartmann, A.: P0964
Haruma, K.: P0007, P0132, P0855,
P1839, P2000
Harusato, A.: P1008, P1752
Hasan, M.: P0750, P0761
Hasenberg, F.: OP039*, OP308*
Hashemi, J.: P0029
Hasheminasab, S.: OP394*
Hashigo, S.: P1447
Hashiguchi, T.: P1897
Hashimoto, S.: OP346, P1281, P1644,
P2177
Hashimoto, Y.: P0530, P1710
Haslam, N.: P0552*
Hasnain Alishah, S.: P0483, P1184
Hasouna, M.: P1929
Hassab, A.H.: P1935
Hassan, C.: OP060, P0593, P0766
Hassan, K.: P1534
406
Hassan, M.S.H.: P1170, P1964
Hassanen, A.F.: P1170
Hassn, A.: P0673
Hasuike, N.: P0563
Hasuo, H.: P1839
Hata, J.: P0007, P0132, P1839, P2000
Hata, K.: P0205, P0265
Hatemi, I.: P1749
Hatlebakk, J.G.: OP028, P1117
Hatta, W.: OP444*
Hattori, K.: P0005, P1693
Hattori, M.: P0688
Hattori, T.: P1111
Hauge, T.: P2180
Haupern, A.: P0087
Hauser, B.: P0920, P0921, P0922,
P0923, P0924
Hauser, G.: P0305
Hauser, G.G.H.: P0671
Hausmann, J.: P1827
Havlik, R.: P1358*
Hawcroft, G.: OP319
Hawes, R.: OP113
Hawk, E.: 25
Hawkes, D.: P2007
Hawkey, C.J.: P0757, P1828,
P0368
Hawthorne, A.B.: OP122*
Haxhija, E.Q.: P0925
Hayashi, M.: P0547
Hayashi, N.: P0573
Hayashi, R.: OP064
Hayashi, S.: P0603
Hayashi, T.: OP467*, P0602, P0603,
P1311, P1314, P1382, P2070
Hayashi, Y.: OP208, OP373, P0264,
P0573, P1463
Hayashida, M.: P1373
Haycock, A.: P1381
Haymore, B.R.: P1569*
Hayward, N.K.: P0914, P1046
Hazarika, P.: P0520
Hazebroek, E.J.: OP032*
Hdez Mondragon, O.V.: P1173
He, F.: P0437, P1742
He, J.: OP055, P0893, P1602, P1603
He, L.: P1593
He, Y.: P0475, P1906, P1907, P1911
Heacock, M.: OP262
Healey, J.: P0345
P = poster presentation, OP = oral presentation, number only = page number

Healy, L.A.: P0088, P0153, P1676
Heath, A.: OP002
Heathcote, J.: 51
Hebden, J.M.: P0582
Hébuterne, X.: P0821, P0822, P1102
Hedin, C.R.H.: P1003, P1004, P1080,
P1723, P1829
Heed, E.: P0081
Hegade, V.S.: P1945
Hegedus, G.: P1977
Hegyi, P.: OP418*, P1740, P2123*
Heiberg, T.: P0683, P1409
Heidecke, C.: P2136
Heidemann, J.: OP039*, P1724, P1813
Heiden, E.: P0964
Heijmans, J.: OP104*, OP218*
Heil, F.: P1087
Heinrich, H.: P0376, P0377, P1837
Heinrich, S.: P0708
Heinzow, H.S.: P1340
Helbert, T.: P1317
Heldoorn, N.: OP449*
Helgeland, L.: OP095*
Hellemans, R.: P1505
Hellström, P.M.: P1108, P1848
Helms, P.J.: P0919
Helmy, A.S.: P0524
Helsper, C.W.: P1965
Hemminki, H.: P1762
Henckaerts, L.: P1032
Henderson, C.: P0926
Henderson, P.: OP187*, P1036, P1514,
P1753
Hendrickx, T.: P1261
Henman, J.: P1291
Hennig, J.: P0471
Henriksen, M.: P0289, P0290, P1305
Hentic, O.: OP424, P0690, P1402,
P2135, P2148
Heo, J.: OP451
Heo, S.H.: P1214
Hepkema, B.G.: P0449
Herdman, C.: OP369
Herencia, L.I.: P0809
Heresbach, D.: OP005, OP326*
Hermann, E.: P1827
Hermans, J.J.: OP065*, P1406, P2097
Hermine, O.: OP378
Hernandez, M.: P1846
Hernández, M.: P1535
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Hernández, V.: P1060
Hernandez Reyes, M.L.: P1173
Herngreen, T.: P0604
Herrerías Gutiérrez, J.: P1366
Herrlinger, K.R.: P1807, P1808
Herrmann, E.: P0518
Herrmann, K.: P0294
Hervé, G.: P1007*
Herve, J.: OP128*
Hervieu, V.: OP290
Hesselink-van de Kruijs, M.: OP158, P1024,
P1025
Hetland, G.: P1826
Hettiarachchi, I.T.: P1515
Hetzel, D.: P1810
Heurgué-Berlot, A.: P1178
Heydari, S.: P1491
Heyderman, R.S.: OP389, OP390
Hibi, S.: P0331
Hibi, T.: OP054*, P0335, P1332, P1746
Hibino, S.: P1869*
Hicks, K.J.: OP097*
Hida, N.: OP201
Hiemer, S.: P0570
Higashi, R.: P2176
Higashino, K.: OP351, OP431, P2039
Higgins, P.D.R.: OP204, P1479
Higuchi, K.: P0120, P1645
Higuchi, N.: OP009
Hijioka, S.: OP061
Hijona, E.: P0461
Hill, J.: P1594
Hill, S.: P0820
Hillilä, M.T.: P0406
Hillon, P.: P1241
Hilson, A.: P0504
Hilsted, L.: P1848
Hilton, C.: P0584
Hindryckx, P.: P1745
Hinkel, U.: OP455, P1116
Hinrichs, J.W.J.: P0223
Hiraga, Y.: OP064
Hirakawa, H.: P0059, P1637
Hiramatsu, S.: P0574
Hiramoto, T.: OP064
Hirano, K.: P0680, P1345, P1686,
P2151, P2178
Hirano, N.: OP432*, P0121, P1315
Hiraoka, S.: P0379
Hirasawa, D.: P0168, P0605, P1294
407

InDeX of aUTHoRs
Hirata, I.: P0037, P0140*, P0335, P0556,
P0561, P1008, P1486, P1581, P1752
Hirata, S.: P2077
Hirata, T.: OP454
Hirata, Y.: P1121
Hirayama, M.: P1382
Hirdes, M.M.C.: P2103
Hirooka, Y.: P0331
Hirota, K.: P0876, P0877
Hirsch, A.: P1528
Hirsch, D.P.: P2156
Hirschi, B.: OP383
Hisa, T.: P1341
Hisamatsu, T.: P1746
Hisamatu, A.: P0981
Hishida, A.: P0836
Hissar, S.: P0513*, P0518
Hiwatashi, N.: OP054*
Hiyama, T.: OP344*, P0030
Hjalmarsson, E.: P1823
Hjern, F.: P0204
Hlavaty, T.: P0989, P1754, P1755
Hlavova, K.: P0840
Hlinstakova, J.: P1754
Hluší, A.: P1436
Ho, A.: P1961, P1966
Ho, B.: P1494
Ho, D.T.: P1978
Ho, K.: OP099
Ho, K.Y.: OP440*
Ho-Fan, C.: P0076
Hoa, D.: OP304*
Hoad, C.L.: P0380
Hoare, J.: P1302
Hobson, A.: OP461*
Hobson, A.R.: OP097*
Hocke, M.: OP257*
Hodin, C.M.: OP386*
Hoebe, K.: OP217*
Hoehr, R.: P1340
Hoeijmakers, J.H.J.: P0460
Hoekstra, L.T.: P1424
Hoeroldt, B.S.: P0797
Hoes, A.W.: P1610
Hofer, H.: P1967, P1979
Hoff, D.A.L.: P1117
Hoffman, A.: OP068, OP137*, OP371
Hoffman, I.: P0309
Hoffmann, J.: P1576*
Hoivik, M.: P1018
408
Hojsak, I.: OP148*
Hol, L.: P0427
Hold, G.L.: P0919
Holderried, M.: P2032
Holinka, M.: P1436
Holland, C.: OP149, OP261
Hollingshead, J.: P1106
Hollingworth, R.: P0577
Hollis-Moffatt, J.E.: P1046
Holloway, R.H.: OP136
Höllwarth, M.E.: P0925
Holmes, G.K.T.: OP335*, P1516, P1517,
P1530, P1533
Holociova, K.: P0989
Holst, J.J.: OP140, P1108, P1831, P1848
Holt, P.: 50
Holtmann, G.: P0874
Holton, J.: P0020
Holvoet, J.: P1505
Holvoet, L.: P0133
Holzäpfel, A.: P0739
Hombrados Verde, M.: P0606
Hommes, D.: P0356
Hommes, D.W.: OP047*, OP104*, OP159*,
OP218*, OP315*, P0276,
P0449, P0988, P1067
Homoncik, M.: OP355*
Hompes, P.G.A.: P1130
Honar, N.: P0193, P1937*
Honda, A.: OP300
Honda, K.: P0007, P1839
Honda, P.: P1842
Honda, T.: P0534
Honen, Y.: P1770
Hong, D.: P1881
Hong, S.: OP429, P0240, P0323, P0361,
P0385, P1152, P1337, P1776
Hong, S.G.: P0125, P0535, P1136
Hong, S.J.: P0553
Hong, S.S.: P1915
Hong, S.W.: P1915
Hong, X.: P1417*
Hong, Y.: OP429
Hope, H.: P0016
Hope, R.: P0616
Höpler, W.: P0745
Hopman, W.P.M.: P1711
Hopper, A.: P2066
Hopper, A.D.: OP448, P1526, P1527, P1992
Horaguchi, J.: P1446
P = poster presentation, OP = oral presentation, number only = page number

Horak, J.: OP193*
Horev, N.: P0039
Horgan, P.: P0768, P0769
Hori, K.: OP058, OP201, OP401, P0566,
P1271, P1847
Hori, M.: P2175
Horiba, K.: P0234, P0911, P1577
Horibe, Y.: P0547
Horie, H.: P0959, P1968
Horie, S.: P0379
Horii, T.: P0915
Horiki, N.: OP007, P0564, P0565
Horiuchi, H.: P1501
Horne, R.: P1073
Hornum, M.: P1831
Horoldt, B.: P1541, P1542
Hörsch, D.: P1164
Horst, D.: OP383
Horton, K.: P2063
Horvath, G.: P1078
Horvath, H.C.: P0649
Hoshino, A.: P1632*, P1633, P1901
Hoshino, E.: P1476
Hosking, P.: P0796
Hosoi, T.: P0676
Hosomi, S.: P0663
Hosono, K.: OP130*
Hosono, O.: P1746
Hosoya, T.: OP467*, P0602, P1311, P1314
Hot, A.: P1573
Hoteya, S.: OP402, OP432*, P0121,
P1315, P2036
Hotte, G.J.: OP349
Houben, M.: OP078
Houcke, P.: P1317
Houdijk, A.P.J.: P1692
Hourigan, L.F.: OP434*, OP448
Houssin, L.: P0061
Houston, A.: OP390
Houwen, R.: P0802
Howaldt, S.: P1810, P1819
Howard, A.: P0279
Howard, J.: P0088
Howdle, P.: P1146*
Howdle, P.D.: P1142
Howes, N.: P0113, P0694, P0699, P0854
Hrebicek, M.: OP193*
Hrncir, Z.: P0043
Hsieh, T.: P2033
Hsu, C.: P0661
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Hsu, P.: P0845, P1473
Hu, B.: P1445
Hu, H.: P0536*
Hu, M.: P2007
Hu, P.: P1593, P1628
Hu, P.J.: OP288*, P0112, P1609, P1874
Huang, H.: P2033
Huang, J.: OP088*
Huang, T.: P2033
Huang, W.: P0208
Huang, X.: P0463*
Huang, Y.: P1268
Huang, Y.S.: P0862
Huang, Z.: P0852, P0994
Hubbard, J.: OP199*, P1758
Huber, P.E.: OP083
Hubricht, J.: P1740
Hubscher, S.G.: P0201
Hucl, T.: P1668, P1689, P2034
Hudspith, B.: P0258
Hudspith, B.N.: OP024
Huernos, S.: P1783
Huertas Nadal, C.: P0606
Huett, A.: OP021*
Hughes, D.: P1166
Hughes, S.: P0640, P0642
Hugot, J.P.: OP306*
Huguet, J.: P0288
Huhtala, H.: P1762
Huibregtse, I.L.: OP147*
Huijgens, P.C.: OP001*
Huk, J.: P1615
Hull, M.: P0089, 47
Hull, M.A.: OP004, OP319, P1890, P2045*
Huls, G.: P0275
Hulscher, J.B.F.: OP093
Hulstaert, J.: P1625
Humbert, L.: OP417*
Humes, D.J.: OP411
Hundorfean, G.: P1730
Hung, K.: P0747
Hungin, A.P.S.: P1118
Hunt, C.L.: OP102, P0872, P1118,
P1518, P1830
Hunt, R.: 36, 51
Hunt, R.H.: OP438*, P0829, P0888,
P0889, P1050
Hunt, T.: P2128
Hunter, J.: P1748
Huorka, M.: P0989, P1754, P1755
409

InDeX of aUTHoRs
Huppertz, J.: P1458
Hurduc, V.: P0927
Hurst, L.: P1891
Husain, S.A.: P0472*, P0515, P0679
Husby, S.: P0800
Hussain, S.: P1457
Huster, D.: OP129*
Hutanasu, C.: P0491
Hutanasu, I.: P0476
Hutchinson, J.M.: OP004
Huys, G.: OP017*
Hvas, C.L.: P1720
Hveem, K.: P0770
Hwang, D.: P1132
Hwang, E.T.: P0537
Hwang, H.J.: P1519, P1520, P1946
Hwang, J.: P1215, P1989
Hwang, J.H.: P1450
Hwang, J.K.: P0125, P0535, P1136
Hwang, J.S.: P1277
Hwang, S.: P0587
Hwang, T.: P0873
Hwangbo, Y.: P1756
Hyland, R.: P2045*
Hyltander, A.G.: P0682*
Hyodo, I.: OP169
Hyppólito, E.B.: P2018
Hyrdel, R.: P0781
Hyttel, J.: OP381*
Hyun, J.: P0100*
Hyun, J.J.: OP175, OP180*, OP376*, P0762,
P0837*, P0948, P2016, P2049
Hyun, Y.: P2050
Hyung, W.: OP291
I
Iacob, R.: P1894
Iacob, S.: P1894
Iacobescu, A.: OP437, P1437
Iacopini, F.: OP014, P0098, P0306,
P1560, P2129
Ianiro, G.: P0119
Iannelli, A.: P1102
Ianosi, G.: P1223
Iaquinto, G.: OP379
Iasci, A.: P0469
Ibañez Zafón, I.: P1547
Ibarmia, J.: P0473
Ibba, I.: P0252
Iborra, M.: P1722*, P1809
410
Ibrahim, E.H.: P1925
Ibrahim, M.A.A.: P0439
Ibrahimi, A.: P0300, P0713
Ibuka, T.: P0547, P0644, P0838
Ichikawa, H.: P1008
Ichikawa, T.: OP396*
Ichimura, S.: P0464, P0480, P0489,
P2028, P2029
Ichinose, M.: P0040, P1262, P1614,
P1996, P2035
Ichiya, T.: P1232
Idier, I.: P1084
Iegri, C.: OP060, P0766
Ierardi, E.: OP060, P0766, P2042
Igali, L.: P0803
Igarashi, Y.: OP432*, P1148, P1342
Igawa, A.: OP064
Igea, F.: OP248, P1343
Iglesias-Garcia, J.: OP257*
Ignjatovic, A.: OP368, P0597, P0607,
P1302, P2062
Iguchi, M.: P0040, P1262, P1614,
P1996, P2035
Iguchi, T.: P0564, P0565
Iida, D.: P0876, P0877
Iijima, H.: P0573
Iijima, K.: OP444*, P0105, P0915
Iimuro, M.: OP201
Iishi, H.: OP351, OP431, P2039
Iizuka, H.: P0559, P2173
Iizuka, T.: OP402, OP432*, P0121,
P1315, P2036
Iizuka, Y.: OP007, P1646, P1690, P1691
IJzermans, J.N.M.: P0460
Ikeda, H.: P0316, P0637, P0655,
P1357, P1448
Ikeda, K.: OP042, OP427, P1650
Ikeda, T.: P0707
Ikeguchi, M.: P1585
Ikehara, H.: OP008, P0546, P0563,
P1268, P1584
Ikehara, N.: OP467*, P0602, P0655,
P0946, P0951, P1311,
P1314, P2046, P2070
Ikei, Y.: P1373
Ikematsu, H.: P0099, P0947
Ikuma, M.: P0836, P1492
Ilangovan, R.: P1381
Ilani, S.: P1770
Ilias, T.: OP200, P1904
P = poster presentation, OP = oral presentation, number only = page number

Illueca, M.: P0926, P0928, P0929
Ilzarbe, L.: P1547
Im, C.: P1279
Imada, T.: P0912
Imagawa, A.: P0912, P1643
Imagawa, M.: OP064
Imagawa, S.: P0028
Imai, A.: P1383
Imai, H.: OP264*, P0627
Imai, Y.: P0464, P0480, P0489, P2028, P2029
Imaizumi, H.: P0637, P1357, P1448
Imajo, K.: OP130*
Imajyo, K.: P1204
Imamura, H.: OP061, P0132, P2000
Imamura, T.: P2131
Imamura, Y.: P1839
Imanieh, M.: OP197, P0194, P0199, P1937*
Imanzadeh, F.: P1555
Imase, K.: P1373
Imatani, A.: P0915
Imawari, M.: P0099
Imazeki, F.: P0137
Imazu, H.: OP042, OP426
Imperiali, G.: P0001, P0735, P2048
Improta, G.: OP274*
Inaba, T.: P0826, P2037
Inagaki, Y.: 40
Inamori, M.: OP130*
Inatomi, O.: OP348*, P1806
Indries, L.: P0131
Infantes, J.: P0619
Ingham, C.: P1503
Inglis, S.: OP400
Ingrand, I.: P0213
Ingrand, P.: P0213
Innerhofer, A.: P0745
Inoue, H.: OP034, OP071*, OP072*,
P0564, P0565, P0575, P1314, 72
Inoue, I.: P0040, P1614, P1996, P2035
Inoue, K.: P0530, P1008, P1109, P1710
Inoue, M.: OP401, P0566, P1271
Inoue, N.: OP396*, P1746
Inoue, T.: OP431, P2039
Inoue, Y.: OP480, P1149
Inui, K.: P0688, P1466
Inui, T.: P0563
Ioana, M.: P2038*, P2147
Ioncica, A.: P2038*
Ionescu, R.I.: P1205
Iordache, S.: P0122, P2038*, P2147
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Iqbal, J.: P0731, P1335, P1344
Iranikhah, A.: P1206
Iredale, J.: 19
Irisarri, R.: P1371
Irving, P.: OP463, P1072, P1465
Irwig, L.: OP073
Isaacs, K.: OP204
Isaeva, G.: P1493
Isakov, V.A.: P1856
Isayama, H.: P0680, P1345, P2178
Ischenko, I.: P1914
Isene, R.A.: P1757
Ishak, J.: P1934
Ishak, J.K.: P1932
Ishibashi, E.: P1968
Ishida, F.: P1168
Ishido, K.: P0120, P1645
Ishigaki, N.: P1923*
Ishiguro, K.: P0331
Ishihara, H.: P0559, P2173
Ishihara, R.: OP351, OP431, P2039
Ishii, M.: P0132, P1839, P2000
Ishii, N.: OP007, P1646, P1690, P1691
Ishii, T.: P0005, P1693
Ishikawa, H.: P2037
Ishikawa, K.: P2040
Ishikawa, S.: P0826, P2037, P2176
Ishikawa, T.: OP169, P1192, P2009
Ishiwata, T.: P1577
Ishizawa, T.: P0118
Islam, M.: P0054, P0242
Islami, F.: P0842, P1630
Isola, L.: P0786, P1747
Isomoto, H.: OP396*, P1303, P1650
Isono, A.: P0005, P1693
Ito, H.: OP454, P0335, P1113
Ito, K.: P1342, P1446
Ito, M.: P0028, P0030, P0855
Ito, T.O.: P1008
Ito, Y.: P0663, P1345, P2178
Itoh, A.: P1459
Itoh, H.: P2173
Itoh, T.: OP007
Itoi, T.: P0613
Itzkowitz, S.: 18
Ivaldi, A.: P0482
Ivanikov, I.: P1270
Ivanov, A.N.: P0505
Ivanova, A.V.: P0514, P1970
Ivanova, E.V.: P0643
411

InDeX of aUTHoRs
Ivashkin, V.: P0763
Ivashkin, V.T.: P1207, P1210, P1939, P2133
Ivashkina, N.: OP462*
Ivekovic, H.: P1329
Iwai, T.: P1448
Iwakiri, R.: P1470
Iwamoto, T.: P1192
Iwanicki Caron, I.: P0665
Iwanicki-Caron, I.: P1287, P1319, P2073
Iwarzon, M.: P0378
Iwata, M.: P0561
Izbéki, F.: P0183, P0375
Izuishi, K.: P0465, P0700
J
Jabbari, H.: OP302, P1954
Jablonska, A.: P1346
Jablonski, K.: P1798
Jachymova, M.: OP364, P1413
Jackson, C.A.: P1073
Jackson, J.I.: OP456
Jackson, L.: OP370*, P1328
Jackson, R.: P0794
Jacob, P.: OP183
Jacobs, M.: P0710, P1905*
Jacobs, M.A.: OP079*
Jacobs, R.J.: OP104*, OP315*
Jacobsen, B.: OP149
Jacobsson, H.: P1108, P1848
Jacome, J.: P0115, P2021
Jacquard, A.: P0218
Jacques, P.: P1745
Jacyna, M.: P0444, P1763, P2154
Jafar, W.: P0552*
Jafarshad, R.: P2008
Jafri, S.: P0519
Jafri, S.D.: P1267
Jafri, W.: OP362, P0054, P1312, P1927
Jagannathan, N.R.: P1744
Jaggs, K.: P0110, P1666
Jahanbakhsh, F.: P1969
Jain, M.: P0521
Jain, P.: P1233, P1521
Jain, S.: P2114
Jakic Razumovic, J.: P0327, P1329
Jakobsen, C.: P0930
Jaks, V.: OP218*
Jaksic, O.: P0462
Jalan, R.: 80
Jaluvka, F.: P1358*
412
James, M.W.: P1351
James, O.: 57
Jamoul, C.: P0355
Jandu, V.S.: P1527
Jang, B.: P1276, P1288, P1289,
P1348, P1617, P1833
Jang, B.K.: P1277
Jang, D.: P1994
Jang, H.: P0538, P0972
Jang, H.J.: P0123
Jang, J.: P1410, P1756
Jang, J.S.: P0093
Jang, S.: P0623
Jankowski, J.: 24
Jann, H.: P1157, P1164
Jansa, P.: OP364
Jansen, C.: P1829
Jansen, E.P.M.: P0904
Jansen, J.B.: P0961
Jansen, J.B.M.J.: P0141, P0142, P0428,
P0429
Jansen, P.L.: OP473*
Jansen, R.: OP245*, P1682
Jansen, S.V.: P1304
Janson, C.: P0477
Janssen, J.: OP257*
Jantchou, P.: OP198*
Jarosz, D.: P0861
Jarosz, M.: P1971
Jaroud, F.: P0218
Jarvinen, H.: OP166
Jaskiewicz, K.: P1346
Jaspers Focks, J.: P0142
Jastrzêbska, I.: P0106
Jasz, O.: P0943, P1135, P1144
Jauch, K.: P1914
Javaherizadeh, H.: P1555
Javed, M.: OP372*
Javelosa, M.U.: P2069
Jawad, N.: P1565, P1641
Jaworek, J.: P1391, P1414, P2122, P2124
Jayakanthan, K.: P0269
Jayanthi, V.: P0494
Jayles, D.: P1898
Jee, S.: P0410, P1575*
Jeejeebhoy, K.N.: P0813
Jeen, Y.T.: OP175, OP180*, OP376*,
P0762, P0948, P2016, P2049
Jeen, Y.Y.T.: P0313
Jeffery, R.: P2128
P = poster presentation, OP = oral presentation, number only = page number

Jelev, D.T.: P0514
Jelsness-Jørgensen, L.: P0289, P0290,
P1305
Jen, M.: P1022, P1511
Jenek, R.: P0044
Jenkins, J.: OP482*
Jenkins, J.R.: OP103
Jenkins, R.: OP482*
Jensen, D.M.: OP439, OP442
Jensenius, J.C.: P0666
Jeon, B.J.: P0965
Jeon, E.: P1604
Jeon, S.: OP470*, P0323, P1042, P1152,
P1321, P1617, P1679, P1768
Jeon, S.J.: P0557
Jeon, W.: P1228, P1913
Jeon, W.J.: P0390
Jeon, Y.: P0481, P2050
Jeong, E.: P0669, P1453, P2182
Jeong, H.J.: P0965
Jeong, I.: P1678, P2172
Jeong, S.: OP263, P1215
Jeong, W.: P1713
Jeong, W.J.: P1400
Jeong, Y.: P0409, P0873
Jeong, Y.H.: P1214
Jeppesen, P.: P0813
Jeppesen, P.B.: OP141, P0814, P1831
Jerlstad, P.: OP098
Jerzak vel Dobosz, A.: P0861
Jesic, R.: P1194, P1928
Jezequel, J.: P1888*
Jha, A.: OP298*
Jharap, B.: P0352*, P0353
Ji, B.: OP475*
Ji, J.: P1410
Jia, W.: P1748
Jian, R.: P0659, P1052
Jiang, A.: P1628
Jiang, H.: OP092
Jiang, W.: P0454
Jiang, Z.Y.: P0536*
Jimenez, A.: P0395, P0396
Jiménez, A.: P0549
Jimenez, C.R.: P1143
Jimenez, F.: P1371
Jiménez, F.: OP179*
Jimenez-Perez, J.: P0621
Jiménez Pérez, J.: P1669
Jiménez-Pérez, J.: OP076*, OP464, P1677
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Jimenez Perez, M.: P0336
Jimeno, M.: P1385
Jimeno-Ayllón, C.: P1444
Jin, H.: OP267*, P0124, P1148, P1923*
Jin, S.: P2171
Jin, W.: P1913
Jin, Z.: P0810
Jinga, M.: P1190
Jirasek, T.: OP193*
Jirsa, M.: OP193*
Jo, Y.C.: P1307
Jocic, T.: P1490
Joh, T.: P1121
Johansson, M.E.V.: P0682*
Johansson, S.: P0128
Johns, E.C.: P0719
Johnson, D.: P1611, P1810
Johnson, E.: P1047, P1826
Johnson, M.: P2005
Johnson, M.W.: P0307, P1074
Johnson, P.J.: P0102
Johnsson, E.: OP248, P0620
Johnston, J.M.: OP458, P1119, P1120
Johri, N.: P0504
Jojic, N.: P1788
Jokic, M.: OP087*
Jolly, A.J.: P0913
Joly, F.: P0813
Jonas, E.: OP249
Jones, D.: OP278, 18, 51
Jones, J.: P1072, P1639
Jones, R.: OP102, P0872, P1118,
P1518, P1830
Jonkers, D.M.: OP483*
Jonsson, H.: P2159, P2160
Jonsson, J.: P1953
Joo, I.: P1110, P1350
Joo, K.: P1347
Joo, M.K.: P0125, P0535, P1136
Joo, S.: P1347
Joo, Y.: P0101
Joo, Y.E.: P0217, P0968
Joossens, M.: OP017*
Jooste, V.: OP404*
Jorda Albiñana, B.: OP212
Jordan, A.: P0444
Jorge, J.X.: P1561, P1712
Jørgensen, K.K.: P0985
Jorgensen, L.N.: P0666
Jørgensen, M.: OP281
413

InDeX of aUTHoRs
Jørgensen, S.P.: P1720
Joshaghani, H.: P1857
Joshi, A.: P0824, P0891, P1702
Joshi, M.: P1352
Joshi, N.: P0219, P1048, P1049,
P1334, P1666
Joshi, N.M.: P1308
Joshi, Y.K.: P1811
Jouannaud, V.: P0737, P1386
Joukar, F.: P1484
Joulin, Y.: P0056
Joung, H.: P1713
Joung, H.C.: P1400
Jourdil, N.: P1055
Jouret, A.: P0114, P0150
Jovanovic, I.: P1194, P1928
Jovine, E.: P2145
Jowell, P.: OP262
Joy, D.: P1353
Juby, L.: P2053
Juergensen, C.: P1399
Juhasz, V.: P1110
Juillerat, P.: P0308, P1087, P1091, P1825
Julien, M.: P1359, P1360
Julio, G.: P1176
Jung, C.: OP306*, P0222
Jung, E.: P0222, P0410, P1132, P1575*
Jung, G.: P0586
Jung, H.: P0031, P0036, P0049, P0094,
P0407, P0984, P1123, P1363
Jung, H.C.: P1124
Jung, H.K.: P0217
Jung, I.S.: P1239
Jung, J.: P0049, P0507, P0984, P1833
Jung, K.: P0031
Jung, K.H.: P1915
Jung, K.S.: P1500
Jung, M.: OP470*, P1321, P1679
Jung, S.: P0049, P0984, P1347,
P1678, P2172, P2181
Jung, S.J.: P0535
Jung, S.S.A.: P0313
Jung, S.W.: P1235
Jung, W.: P0100*
Jung, W.W.: P0837*
Jung, Y.: P1215, P2171
Jung, Y.J.: P0522
Jung, Y.K.: P1235
Junghard, O.: P0139
Jungwirthová, A.: P0827
414
Jurankova, J.: P1282
Jürgens, M.: OP325*, P0294, P0309
Jurgensen, C.: OP002
Juuti-Uusitalo, K.: P1523
k
Kaabachi, N.: P0986
Kabaçam, G.: P1562
Kacar, S.: P2085
Kacperek-Hartleb, T.: P0314
Kacska, S.: P1253
Kaczor, R.: OP116
Kaddache, N.: P0292, P0301, P0310,
P1759, P1761, P1849
Kader, A.: P1426
Kadota, K.: P0700, P1109
Kae, S.: P0538
Kae, S.H.: P0123
Kafarskaya, L.I.: P1701
Kaffes, A.J.: P0645, P0646,
P0647, P1309
Kaga, M.: OP071*
Kageyama, S.: P0270*
Kagramanova, A.V.: P0505
Kahl, P.: P0228
Kahramanoğlu Aksoy, E.: P0296
Kahrilas, P.J.: P1564
Kaibe, N.: P0909
Kaise, M.: P1501
Kaiserlian, D.: P1727*
Kaji, E.: P2176
Kajor, M.: P0159
Kajzrlikova, I.: P0206
Kakavetsi, V.: P1468, P2116
Kakimoto, T.: P1459
Kakisaka, K.: P0466
Kakizaki, S.: P0559, P2173
Kakizaki, Y.: P0118
Kakrani, A.L.: P1859, P1860
Kakugawa, Y.: P1374, P2113
Kakushima, N.: P0546, P0563, P1268,
P1584
Kala, Z.: P0878
Kalab, M.: OP364
Kalafatis, E.: P0175, P0977*, P2116
Kalaiselvan, R.: P0815
Kalaitzakis, E.: P0682*
Kalali, B.: OP059*, P0751*
Kalantzis, C.: P0175, P0896, P0978*,
P1468, P1469, P2116
P = poster presentation, OP = oral presentation, number only = page number

Kalantzis, N.: P0175, P0896, P0977*,
P0978*, P1468, P1469, P2116
Kalauz, M.: P1329
Kalayci, M.: OP124, P0017
Kalden, J.R.: P0687
Kalebic, M.: P0956
Kali, T.: P1013
Kalimutho, M.: OP163*
Kalistova, H.: P1199
Kallel, L.: P0311, P0986, P1618,
P1619, P1620
Kalloo, A.N.: OP254, P0720
Kalloo, T.: 55
Kalmar, A.: P0944, P1135
Kaltsa, G.: P1719
Kalubovila, U.: P1285*
Kalubowila, K.V.U.: P1224
Kamada, G.: OP184*
Kamada, N.: P1746
Kamada, T.: P0007, P0132, P1839, P2000
Kamal, M.: P0242
Kamangar, F.: P0842
Kamano, T.: P0561
Kamarchuk, G.V.: P0014
Kamarchuk, L.V.: P0014
Kamata, I.: P1342
Kamata, K.: OP264*, P0627
Kamata, N.: P0663
Kamberoglou, D.K.: P0759
Kameda, C.: P1150
Kamenova, M.: P0916
Kameyama, R.: P0465
Kamikozuru, K.: OP201, P0284, P0987
Kaminski, M.F.: P1310
Kamisawa, T.: P0982
Kamiya, T.: P1121
Kamiya, Y.: P0561
Kamm, M.A.: OP455, P0404, P1003,
P1004, P1080, P1723
Kamnerdsupaphon, P.: P1671
Kanani, R.: OP075
Kanauchi, O.: P1550
Kanazawa, Y.: P0234
Kandefer-Szerszeñ, M.: P0106
Kane, S.: P0332
Kane, S.V.: P0342
Kaneda, H.: P1459
Kaneko, K.: P0099, P0947
Kanemoto, H.: P0685
Kang, D.: P0669, P1453, P2182
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Kang, G.: P1713
Kang, H.: P0407, P1994
Kang, H.S.: OP263
Kang, J.: P1232
Kang, J.Y.: OP216*, P1595
Kang, M.: P0049, P0984
Kang, W.: P0222, P1215
Kanis, S.L.: P1162
Kankwatira, A.M.: OP389
Kanno, T.: P0040
Kanno, Y.: P0168, P1294, P1446
Kano, M.: OP101
Kant, P.: P0089, P1269
Kantsevoy, S.V.: OP254, OP265, P0720,
P2155
Kao, J.Y.: P1479
Kaper, J.B.: OP385*
Kapitanovic, S.: OP087*
Kaplan, G.: P1072
Kaplan, G.G.: OP199*, P1758
Kapoor, V.K.: P0711*, P1902
Kapsenberg, M.: OP147*
Kapsoritaki, A.: P1483
Kapsoritakis, A.N.: P1038, P1483
Kapucuoglu, N.: P0890
Kapur, K.: P0341, P0555
Kar, P.: OP296*, P0472*, P0515, P0679,
P1182*
Kara, B.: P0533
Karaitianos, I.: P1862
Karakan, T.: P0816, P1354
Karakoidas, C.: P0338
Karamanolis, D.G.: P0503, P1862, P2118
Karamanolis, G.: OP181, P0255, P1013
Karameris, A.: P0175, P0896, P0977*
Karamitopoulou, E.: P0232
Karamizadeh, Z.: P0200
Karantzas, P.: OP181
Karasu, Z.: P0508
Karatzas, P.: OP441, P0232
Karban, A.: P2064
Kardum, D.: P0462, P0617, P0634, P1349,
P1599
Karga, H.: P1474
Karimi, P.: P0029
Karino, Y.: P0490
Karkavitsas, N.: P0285*
Karki, R.R.: P2185
Karkoulias, K.P.: P0892
Karlén, P.: OP305, P1810, P1823
415

InDeX of aUTHoRs
Karlsson, M.: OP305, P1823
Karmiris, K.: P2051
Kärner, A.: P0790
Karoly, P.: P0318
Karoui, M.: P1394
Karoui, S.: P0311, P0986, P1618, P1619,
P1620
Karsenti, D.: P1394
Karunaharan, T.: P0724
Karunakaran, B.: P0423
Karvonen, A.L.: P1762
Kasahara, N.: P1086
Kashef, S.: P0200
Kashida, H.: OP467*, P0316, P0602,
P0603, P0655, P0946, P0951,
P1311, P1314, P2046, P2070
Kashin, S.: OP375*, P0033, P1270
Kashiwabara, Y.: OP009
Kashiwagi, T.: P1847
Kastrinos, F.: OP162
Katada, C.: P0120, P1645
Katagiri, A.: P0099
Katano, K.: P1585
Katano, M.: P0599, P1150
Katanuma, A.: P1447
Kataoka, H.: P1121
Kataoka, M.: P1274
Katelaris, P.: P0874
Katelaris, P.H.: OP073, P0875, P0886,
P1623
Katicic, M.: P0013, P0746
Kato, H.: P0876, P0877
Kato, J.: OP428, P1382, P2176
Kato, M.: OP184*, P0038, P0573,
P1383, P1501
Kato, N.: P1224
Kato, S.: OP144, P0983, P1111
Kato, T.: P0331, P0644, P0838
Kato, Y.: P1446
Katoh, M.: P1459
Katoh, Y.: P0212
Katou, R.: OP373
Katsampas, A.: P0977*
Katsika, D.: OP126
Katsuno, T.: P0379, P0795, P1075
Katsura, H.: P1459
Katsurahara, M.: P0564, P0565
Katz, L.: OP330, P2001
Katz, R.: P1328
Katzarov, K.: P1980
416
Kaufman, E.: OP134, P0377, P1837
Kaufmann, E.: P0376
Kaukinen, K.: OP336, P1538
Kaul, A.: P2114
Kawabe, T.: P2119
Kawachi, H.: P1632*, P1633, P1901
Kawada, K.: P1284, P1632*, P1633, P1901
Kawada, N.: OP431, 30
Kawaguchi, T.: OP054*, P0370
Kawaguchi, Y.: P1968
Kawahara, T.: P0876, P0877
Kawahara, Y.: OP401, OP428, P0566,
P1271, P1272, P1273, P1643, P2176
Kawai, D.: OP401, P0566, P1271
Kawai, H.: OP061
Kawai, K.: P2037
Kawai, T.: P1274, P2028, P2029
Kawakami, K.: P1274
Kawakita, N.: P1900
Kawakubo, H.: OP343, P0545
Kawakubo, K.: P0680
Kawamoto, K.: P0674
Kawamura, M.: OP426, P1275, P1501
Kawamura, T.: P1382
Kawano, S.: OP401, P0566, P1271
Kawano, T.: P1284, P1632*, P1633, P1901
Kawashima, J.: OP144
Kawauchi, K.: P2031
Kay, C.: P1410
Kayahara, T.: P2179
Kaye, P.: P1351
Kaymakoglu, S.: P0870, P1955
Kazanov, D.: OP086*, OP162, OP322*,
OP479, P1667*, P1868
Kazim, S.: P1950
Kazuno, A.: P0901
Kazyulin, A.: OP462*
Keane, M.G.: P1502
Keating, N.: P0058*
Keaveny, A.P.: P0457
Kecili, L.: P0292, P0301, P0310,
P1759, P1761, P1849
Keegan, A.D.: P1367
Keegan, D.: P1717
Keely, S.J.: P0058*
Kegioglou, A.: P2118
Keld, R.: OP398*, P0126
Kelleher, D.L.: OP097*
Keller, J.: OP280
Keller, J.J.: OP079*
P = poster presentation, OP = oral presentation, number only = page number

Kelly, C.: P1666
Kelly, D.: P0201
Kelly, D.A.: P0456
Kelly, D.D.A.: P0453
Kelly, O.B.: P0058*, P1570
Kelly, P.: P0047, P0784
Kelman, A.W.: P0185
Kelsen, J.: OP333*
Kemik, A.S.: OP124
Kendall, B.J.: P0914
Kendel, J.: P0230
Kendrick, D.: P0757
Kennedy, J.: OP024, P0258
Kent, A.J.: P0312, P0871
Kent, N.: P1067
Keränen, I.: OP247
Kerkhof, M.: P0172
Kerle, I.: OP476*
Kerr, B.: OP281
Kerschner, H.: P1979
Kerstens, R.: P0374, P0381, P0387
Keshav, S.: P0312, P0571, P1810, 51
Keshavarz, A.A.: P1122, P1714
Keshtkar, A.: OP394*, P1167, P1857
Keskin, F.: P1861
Kessels, A.G.H.: P0952
Kestenberg, W.: P0710
Kester, A.: OP158, P1024, P1025
Kester, M.: 73
Ketheeswaran, S.: P0053
Keto, Y.: OP454, P1113
Keuchel, M.: P2111, 49
Keum, B.: OP175, OP180*, OP376*,
P0762, P0948, P2016, P2049
Keyvani, H.: P1969
Keywood, C.: OP029
Khaleghi, S.: P1985
Khalid, A.: P1312
Khalid-de Bakker, C.A.: OP483*
Khalifa, A.: P2011
Khalili, I.: P0413
Khamaysi, I.: P2064
Khan, A.: P0694, P0750
Khan, F.: P1064, P1792
Khan, H.: OP372*
Khan, L.A.: P0472*, P0515
Khan, M.: P1433, P1947
Khan, M.Q.: P0524
Khan, R.: P0054
Khan, S.: P2066
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Khan, S.A.: P1389, P1411
Khandekar, M.M.: P1859, P1860
Khanel, S.P.: P0079
Khanum, A.: P0513*
Kharrat, J.: P2082
Khatibian, M.: OP302, P1392, P1568
Khatibinan, M.: P0633
Khera, G.: P0699, P0854
Khokhar, O.S.: P0516
Khomeriki, S.G.: P1208, P1916
Khosravi, M.: P0452, P2008
Khudayberdieva, M.: P0116
Khulusi, S.: P1355, P1356
Khvorostinka, V.M.: P1213
Kibria, M.G.: P0750, P0761
Kida, M.: P0541, P0637, P1357, P1448
Kidu, T.: P2039
Kieslichova, E.: P2034
Kiesslich, R.: OP067*, OP068, OP137*,
OP219*, OP371, OP425, 17
Kihara, T.: P0676
Kijima, H.: P1148
Kijima, S.: P0959
Kikuchi, D.: OP402, OP432*, P0121,
P1315, P2036
Kikuchi, H.: P0637, P1448
Kikuyama, M.: P2179
Kilani, A.: P2082
Kilani, I.: P2170
Kilari, M.: P1193
Kilhamn, J.: OP442
Kilic, Z.: P0667
Kilickesmez, K.O.: P0470
Kilickesmez, O.: P0266, P0470
Killar, G.: P0202
Killinger, Z.: P0989
Kim, B.: OP429, P0313, P0507, P1228,
P1410, P1480, P1756, P1913, P1924
Kim, B.S.: P0553
Kim, C.: OP291, P0433
Kim, C.D.: OP175, OP180*, OP376*,
P0762, P0948, P2016, P2049
Kim, C.G.: OP292*
Kim, D.: OP367, P0031, P0433, P1123,
P1480, P1678, P1679,
P1833, P2172
Kim, D.G.: P0965, P2074
Kim, D.J.: P0758
Kim, Dae Hwan: OP451
Kim, Dong Heon: OP451
417

InDeX of aUTHoRs
Kim, E.: P0507, P0742, P1037, P1042,
P1617, P1768, P1833
Kim, E.R.: P1696
Kim, E.S.: OP175, OP180*, OP376*,
P0100*, P0762, P0837*, P0948,
P1277, P2016, P2049
Kim, G.H.: OP451
Kim, H.: OP291, OP429, OP452, P0100*,
P0101, P0507, P0587, P0651, P1228,
P1337, P1453, P1617, P1756,
P1833, P1854, P1881, P1913,
P1989, P1994, P2171
kim, H.: P0669, P2182
Kim, H.C.: P0537
Kim, H.G.: P1915
Kim, H.H.: P0239
Kim, H.I.: P0217, P0968
Kim, H.J.: OP263, P0245, P1263, P2061
Kim, H.K.: OP263, P0553
Kim, H.M.: P1452
Kim, H.S.: P0217, P0837*, P0967, P0968
Kim, H.Y.: P0123, P0967
Kim, I.: P0237, P1123
Kim, I.H.: P0965, P2074
Kim, I.W.: OP477*
Kim, J.: OP429, OP452, P0031, P0094,
P0237, P0407, P0410, P0522, P0586,
P0651, P0729, P1123, P1215, P1363,
P1460, P1575*, P1855, P1913,
P1989, P2016, P2171
Kim, J.B.: P0123, P0758
Kim, J.H.: OP214, OP477*, P0123, P0125,
P0478, P0535, P0557, P0558, P0758,
P0762, P1125*, P1136, P1239, P1895
Kim, J.J.: P1125*, P1307, P1696
Kim, J.J.S.: P0313
Kim, J.O.: P0553
Kim, J.S.: P0125, P0535, P1136
Kim, J.Y.: OP175, OP180*, OP376*, P0948,
P1214, P1307, P1696, P2049
Kim, Jeong Han: P1235
Kim, Ji Hoon: P1235
Kim, K.: P0237, P0587, P0839, P1123,
P1171*, P1278, P1279, P1288,
P1289, P1348, P1854, P1924
Kim, K.H.: P0123, P0967
Kim, K.J.: OP477*
Kim, K.M.: OP477*
Kim, K.O.: P0123, P1895
Kim, K.P.: P1488
418
Kim, M.: P0094
Kim, M.-H.: 47
Kim, M.H.: P1449, P1488
Kim, M.J.: OP477*
Kim, N.: P0036, P0409, P0873, P1215, P1756
Kim, N.Y.: P1124
Kim, S.: OP451, OP470*, P0049, P0222,
P0984, P1037, P1042, P1321,
P1679, P1989, P2113
Kim, S.B.: P0245, P0522, P1263, P2061
Kim, S.G.: P0478
Kim, S.H.: P0965, P2074
Kim, S.J.: P0093, P0123, P0758
Kim, S.W.: P0965, P2074, P2171
Kim, T.: OP229, P0049, P0323, P0361,
P0385, P0481, P0560, P0656,
P0966, P0984, P1037, P1042,
P1152, P1276, P1288, P1289,
P1348, P1604, P1617, P1768,
P1776, P1833, P2050
Kim, T.H.: P0537
Kim, T.I.: P1500
Kim, W.: P0240, P0323, P0361, P0385,
P0651, P0656, P1037,
P1042, P1152, P1768, P1776
Kim, W.H.: P1500
Kim, W.K.: OP263
Kim, W.W.H.: P0313
Kim, Y.: OP058, OP367, P0433, P1276,
P1278, P1279, P1713, P1847, P1994
Kim, Y.C.: P0522
Kim, Y.D.: P1400
Kim, Y.H.: P1307, P1696
Kim, Y.J.: P0434*, P0522, P1239
Kim, Y.M.: P0758
Kim, Y.R.: OP477*
Kim, Y.S.: OP175, OP180*, OP263, P0239,
P0948, P1239, P2016, P2049
Kim, Y.T.: P0434*
Kim, Y.W.: OP292*
Kim, Y.Y.H.: P0313
Kim, Y.Y.S.: P0313
Kim, Young Seok: P0478
Kim, Yun Soo: P0478
Kim-Mitsuyama, S.: P1718
Kim Yu Teng, K.: OP220*
Kimura, K.: P1975
Kimura, S.: P0207, P0949
Kimura, T.: OP373
Kin, T.: P1447
P = poster presentation, OP = oral presentation, number only = page number

Kindt, S.: OP273*, P0133, P1838
King, K.: P0431
King, L.: P1001
Kinney, T.: OP369
Kinoshita, I.: P0127, P0846
Kinoshita, K.: P1382
Kiparissi, F.: OP377, P0696, P0697,
P1425, P1426, P1427
Kiraly, R.: P1522, P1523
Kirazli, T.: P1627, P1648
Kirikoshi, H.: OP130*, P1204
Kirzin, S.: OP080*
Kise, Y.: P0901
Kishimoto, I.: P0674
Kishimoto, K.: P1694
Kishimoto, Y.: P1342
Kiss, A.: P1135
Kiss, I.: P0183
Kita, H.: P2040
Kita, M.: OP401, P0566
Kitadai, Y.: P0030, P0408
Kitajima, M.: P1897
Kitajima, Y.: P1968
Kitamura, S.: P0028
Kitano, M.: OP264*, P0627, P2144
Kitiyakara, T.: OP202
Kiyotoki, S.: P1280
Kizu, T.: OP431, P0573
Klaase, J.M.: P0973
Klass, G.: OP065*
Klassert, C.: P1885, P1886
Klauck, S.: P1769
Kılıç, M.Z.Y.: P2084
Kleeff, J.: OP083, P1412*, P1417*
Kleibeuker, J.H.: P0591
Klein, M.: P0110
Klein Kranenbarg, E.M.: P1871
Klier, U.: P1416
Kliment, M.: P1358*, P1873
Klinkenbijl, J.: OP250*
Klokman, W.J.: OP287*
Klöppel, G.: P1164
Kluiijt, I.: P1407, P1408
Kluijt, I.: P1406
Klymenko, A.V.: P2130
Klymenko, V.N.: P2130
Kneidinger, N.: P0450
Knezevic, A.: P1490
Knezevic, S.: P0414
Knieper, M.: P2111
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Knight, S.C.: P1003, P1004, P1080, P1723
Knottnerus, A.J.: P0141
Knowles, C.: 20
Knowles, C.H.: OP461*
Knudsen, C.B.: OP381*
Knyazev, O.: P0991
Knyazev, O.V.: OP050
Ko, B.: OP429, P0651, P1337
Ko, B.M.: P0553
Ko, B.S.: P0390
Ko, E.S.: P0553
Ko, K.S.: P0965, P2074
Koba, Y.: P0674
Kobayashi, G.: P1446
Kobayashi, I.: P1121
Kobayashi, K.: P0637, P1357
Kobayashi, M.: OP346, P1281, P1644,
P2177
Kobayashi, N.: OP130*
Kobayashi, S.: OP401, P0566
Kobayashi, Y.: OP061
Koch, A.D.: OP366
Koch, M.: P0735
Kochhar, R.: OP192*, OP255*, P0330,
P0788
Kochlef, A.: P2082
Kocik, M.: P2034
Kocna, P.: P0950
Kodach, L.L.: OP104*, OP315*
Kodaira, C.: P0836, P1492
Kodama, K.: P0655, P0876, P0877, P1168
Kodama, M.: P0030, P0408
Kodama, Y.: P1232
Kodashima, S.: P1686, P2151
Kodati, S.: P0444
Koehler, U.: OP455
Koehrer, B.: P1567
Koenderman, L.: P0156, P0157
Köglmeier, J.: P1652
Kogure, H.: P0680, P1345, P2178
Koh, D.: P0538
Koh, K.X.: P1594
Koh, S.J.: P1124
Kohgo, Y.: OP058
Kohler, F.: P1317
Kohn, A.: OP334, P1090, P1764,
P1802, P1803
Kohno, Y.: P0912
Kohout, P.: P0950
Kohoutova, D.: P1544
419

InDeX of aUTHoRs
Kohrs, S.: OP063*
Kohut, M.: P0314
Koike, J.: P0662
Koike, K.: P0680, P1345, P1686,
P2151, P2178
Koike, T.: OP444*, P0105, P0915,
P1283, P2065
Koike, Y.: P0168, P1294
Koilakou, S.: P0315, P1775
Koishi, K.: P0909
Koizumi, W.: P0120, P1645
Koizumi, Y.: OP348*, P1806, P2131
Kojic, S.: P0414
Kojima, C.: P0676
Kojima, E.: P0127, P0846
Kojima, T.: P0099, P0947
Kok, K.: P0988
Kok, K.F.: P1209
Kokosadze, N.V.: P1701
Kokoszynska, K.: P0861
Kokura, S.: P0064*, P0689, P1008, P2009
Kokuryo, T.: P1869*
Kolacek, S.: OP148*
Kolachalam, R.: P0710
Koletzko, S.: OP182, 65
Kolho, K.: OP182
Kolios, G.: P1738
Koller, T.: P0989, P1754, P1755
Kollias, G.: P1745
Kolligs, F.T.: OP383
Komaba, F.: P1232
Komaki, T.: OP264*, P0627, P2144
Komarek, V.: P0324
Komatsu, H.: P1332
Komatsu, O.: P1694
Komolmit, P.: OP301
Komoni, A.S.: P0925
Komtong, S.: P0496
Konala, V.: P0832
Konar, M.: OP192*
Kondo, A.: P1585
Kondo, M.: P0689
Kondo, S.: OP061, P1313, P2119
Kondoh, N.: P1262
Kondrashova, V.: P1919
Kong, B.: P1417*
Kong, S.C.: P1131
Kongkam, P.: P2088
Kongphlay, S.: OP215
Kongtawelert, P.: P0496
420
Konieczko, K.: OP016, P0641, P2027
Koning, F.: P0799
Konishi, H.: P1752, P2009
Konishi, K.: P0099
Konishi, S.: P0418
Konkov, M.: P0763
Konoplyannikov, A.G.: OP050
Konstantinidis, K.: OP120, P2051
Konsten, J.: OP245*
Konturek, S.J.: P1391, P2122
Koo, J.: P0031
Kook, M.C.: OP292*
Koop, R.: P0973
Koornstra, J.: OP078, OP079*
Koornstra, J.J.: P0591
Kooy-Winkelaar, E.M.C.: P0799
Kopacova, M.: OP015, OP380, P0043,
P0648, P0767, P1544
Kopáčová, M.: P2112
Kopelman, D.: P0246, P1139, P2081
Kopelman, P.: 18
Kopelman, Y.: P0246, P1139
Koppert, L.B.: P0096*
Korenev, N.M.: P0014
Korkolis, D.: P0002, P2169
Kornbluth, A.: OP323
Korneeva, O.N.: P1210
Korolczuk, A.: P1732
Korotkiy, O.G.: P0109
Korponay-Szabo, I.R.: P1522, P1523, P1538
Korzenik, J.: OP199*, P0342
Koseki, H.: P0379
Koshita, S.: P1446
Kosisky, S.E.: P1569*
Koskinen, O.: OP336
Koslowski, M.: P0045
Kostadinov, A.: P0868
Kot, M.: P1391, P2124
Kotze, U.: P1439
Kotzev, A.: P0916
Kotzev, A.I.: P0916
Kotzev, I.A.: P0228
Kouklakis, G.: P0181, P1708
Koulaouzidis, A.: P0957, P1375
Kouroumalis, E.: P1738
Kouroumalis, E.A.: P0285*, P0338
Koutroubakis, I.E.: P0285*, P0338
Koutsomanis, D.: P0957
Koutsoumpas, A.: P0255, P1003, P1004,
P1013, P1080, P1723
P = poster presentation, OP = oral presentation, number only = page number

Koutsoumpas, A.L.: P0759, P1179
Kovacevic, N.: P1194, P1928
Kovacs, A.: P0318
Kovarova, J.: P0950
Koviazina, I.O.: P1916
Kowala-Piaskowska, A.: P0044
Koyama, G.: P1373
Koyama, I.: P2040
Koyama, R.: P2131
Koyanagi, K.: P2040
Kozuch, P.: P1072
Kraaijenhagen, R.A.: P0422, P0962
Krak, M.: P2034
Kral, N.: P0138
Kralisz, M.: P0202
Kramer, W.G.: P0828
Krarup, A.L.: P0154, P1563, P2134
Krasnaliev, I.: P0228
Krastev, Z.A.: P0514, P1970
Krasteva, A.Z.: P0514
Kraszewska, E.: OP407, P1310
Kraus, S.: OP086*, OP162, OP322*,
OP479, P1667*, P1868
Krawczyk, M.: OP126
Kırdök, S.: P0508
Krechler, T.: P1413
Kreikemeyer, B.: P1416
Kreisel, W.: OP053, P0471
Krenacs, T.: P0774, P1134*, P1135, P1144
Krenke, K.: P0189
Kresanova, E.: P0989, P1754, P1755
Kriel, H.: P0280
Krige, J.E.: P1439
Krishnadas, R.: P1649*
Krishnadath, K.: OP217*, P0163*, P0918
Krishnadath, K.K.: OP449*, P0176*, P0177,
P1866
Kristensson, C.: OP136
Kristof, T.: P0318
Kroese, A.B.: OP473*
Krogerus, L.: P1177
Krotov, S.A.: P0865
Krotova, V.A.: P0865
Kroupa, R.: P0878, P1282
Krstic, M.: P1194, P1928
Kruger, C.: OP331
Kruger, D.: OP331
Kruger, F.C.: OP031
Kruidenier, L.: P0260*
Kruis, W.: OP161, P1092, P1093
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Krumins, V.: P0209, P0856, P1578*
Krums, L.: P0793
Krupoves, A.: P1660
Krystallis, C.S.: P0759
Kryukova, T.: P0033
Krzeski, P.: P1790
Krzesniak, N.: P0060
Krznaric, Z.: OP148*, P0327, P0532
Krznaric Zrnic, I.: P1401
Krzystek-Korpacka, M.: P0907
Ku, Y.S.: P1239
Kubben, F.: OP250*
Kubben, F.J.G.M.: P0352*, P0353
Kubo, M.: P1150
Kubokawa, M.: OP009
Kubota, A.: P0876, P0877
Kubota, E.: P1121
Kubota, K.: OP130*, P0038
Kubota, Y.: P0099
Kuchar, J.: P0206
Kucinskiene, R.: P1481
Kucukay, F.: P0728
Kudo, K.: P1283, P2065
Kudo, M.: OP264*, P0627, P2144
Kudo, S.: OP034, OP071*, OP072*,
OP467*, P0316, P0575, P0602, P0603,
P0655, P0946, P0951, P1168,
P1311, P1314, P2046, P2070
Kudo, T.: OP373
Kudo, Y.: P1148
Kuester, D.: OP129*, OP135, P0024,
P0025, P0180, P1576*, P1877
Kuganolipava, S.: P0092
Kuijper, C.F.: P1424
Kuik, D.: OP337
Kuik, D.J.: P0352*, P0353
Kuiper, E.: OP158
Kuiper, T.: OP471*
Kuipers, E.J.: OP287*, OP366, OP439
, OP442, P0026, P0172, P0173, P0427,
P0528, P0753, P1029, P1438*, P2188
Kuitert, L.M.E.: P0389
Kujundzic, M.: P0462, P0532, P0617,
P0634, P1349, P1599
Kukla, M.: P1971
Kukosh, V.: P1993
Kulig, A.: P0233, P0686
Kullavanijaya, P.: P2088
Kullman, E.: OP249
Kulus, M.: P0189
421

InDeX of aUTHoRs
Kumagai, Y.: P1284
Kumar, A.: OP353, OP356, P0451, P0520,
P0521, P0711*, P1172, P1233, P1236,
P1237, P1300, P1372, P1902
Kumar, M.: P0451, P0513*, P0518, P1457
Kumar, Rajinder: P0326, P1059
Kumar, Rakesh: P0326, P1059
Kumar, S.: P0302, P0724, P1372
Kumarage, S.K.: P2127
Kumarasena, R.S.: P1285*
Kumbasar, A.: OP363
Kumbasar, B.: P0266, P0748, P1787
Kumbasar, B.A.: P0470
Kumpawat, S.: P1196, P1930, P1931
Kun, C.: P0130, P0131
Kunac, N.: P0956
Kunes, M.: OP380, P0767, P1544
Kuneš, M.: P2112
Kung, H.: P1593
Kunisaki, R.: P1076
Kunst, A.E.: P0426
Kunz, J.: P1567
Kuo, K.N.: OP340, P1587
Kupcinskas, J.: P1238
Kupcinskas, L.: P1238, P1481
Kurai, O.: P0574
Kuramochi, H.: P0876, P0877
Kuribayashi, K.: P0270*
Kurien, M.: P0582
Kurilovich, S.A.: P0865
Kurita, A.: P1447
Kuroda, H.: P0466
Kuroda, K.: P1388*
Kuroiwa, G.: P1382
Kuroki, Y.: OP432*, OP433, P0121, P1315
Kuromatsu, R.: P1251
Kurtz, C.B.: OP458, P1119
Kurucsai, G.: P1110, P1350
Kusafuka, K.: P1584
Kusaka, G.: P0105
Kusano, M.: P1382
Kusec, R.: P0462
Kushch, I.: P0014
Kushida, Y.: P0700
Kusunoki, H.: P0132, P1839, P2000
Kusunoki, M.: OP480, P0102, P1149
Kutsukawa, M.: OP467*, P0316, P0946,
P0951, P1314
Kutsumi, H.: OP066, P0562, P0721, P1388*
Kuwaki, K.: P1251
422
Kuwashiro, T.: P1968
Kuyama, Y.: P0005, P1693
Kvetina, J.: OP380, P0767, P1544
Kvĕtina, J.: P2112
Kwan, V.: OP448, P1333
Kwek, A.: P1760
Kweon, J.: P1279
Kweon, Y.: P1321
Kwiatek, M.A.: P1564
Kwiecien, S.: P0295
Kwon, C.: P0240
Kwon, I.C.: OP477*
Kwon, J.: P0507, P0742, P1617, P1833
Kwon, K.: OP429, P1994
Kwon, K.S.: OP263, P1915
Kwon, K.W.: P0553
Kwon, O.S.: P0478, P1239
Kwong, D.L.W.: OP350
Kylänpää, L.: OP247
Kyle, E.: P0210
Kylebäck, A.: P0620
Kyo, B.: P0707
Kypreos, D.: P0002, P2169
Kyritsaka, A.: P1038
Kysela, P.: P0878
l
La Greca, G.: P0539
Labenz, J.: P1153
Labib, S.A.: P1964
Laburthe, M.: P0273*
Lacatusu, C.M.: P1211, P1212
Lachter, J.: P2064
Lacroix, C.: OP388*, P1497*
Ladas, S.D.: OP181, P0255, P0503, P1013,
P1376, P1700, P1719, P2118
Ladjici, Y.: P2157
Lagarde, S.M.: OP450*
Lage, P.: OP081*, P0419, P1670
Lagergren, J.: P2120
Laghi, A.: 62
Lagier, E.: OP080*
Lago, P.: OP046*, P0625
Lagorce, C.: P0220
Laharie, D.: P0337, P1077, P1816
Lahat, A.: P2001
Lahaye, M.J.: OP245*, P0952
Lahbabi, M.: P1240
Lahcene, M.: P0635, P0879, P1434, P1574
Laheij, R.: P1503, P1840
P = poster presentation, OP = oral presentation, number only = page number

Laheij, R.J.: P0961
Laheij, R.J.F.: P0141, P0142, P0428, P0429
Lahner, E.: OP338*, P0430
Lahsaee, S.: P0452
Lai, A.: P0252
Lai, H.: P0208
Lai, K.: P1473
Lai, K.W.: P1594
Lai, L.H.: P0134
Laird, F.: P1411
Lakatos, L.: P0317, P0318, P0320, P1078
Lakatos, P.: P1766
Lakatos, P.L.: P0317, P0318, P0319,
P0320, P0649, P1078,
P1252, P1253, P1254
Lakovic, E.: P0739
Lakshmi, C.P.: P1372
Lal, A.: P0062
Lal, S.: P0815
Lam, A.K.Y.: OP350
Lam, C.: OP082
Lam, E.: OP267*, P0124
Lam, T.J.: P0969, P0970
Lamarque, D.: P0590
Lamberti, D.: P0455
Lamboglia, F.: P0329
Lambregts, D.M.J.: OP245*, P0952,
P1681, P1682
Laméris, W.: OP406
Lammering, G.: OP245*, P1682
Lammert, F.: OP126
Lamouliatte, H.: OP183
Lamour, S.: P0999
Lampe, P.: P0686
Lampertico, P.: P0517
Lampinen, M.: P0990
Lanas, A.: P0732
Landi, B.: P0659
Landi, P.: P1680
Landoni, N.: P0899
Landy, B.: P1688
Landy, J.: P0155, P0733, P1316
Lange, J.: P0189
Lange, S.: P2124
Langer, F.: P0608
Langer, M.: P0471
Langholz, E.: OP155
Langhorst, J.: P0321
Langner, E.: P0235
Långström, G.: OP026
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Lankisch, T.: P2079
Lankisch, T.O.: P2071
Lanske, B.: P0276
Lantieri, O.: P0945
Lanzarotto, F.: P0365, P0804, P0805,
P0806, P0807, P0808
Lanzini, A.: P0021, P0365, P0804,
P0805, P0806, P0807,
P0808, P1198, P1986
Lao-Sirieix, P.: P0146
Laoudi, F.: P0572
Lapalus, M.: OP176, OP294
Lapaquette, P.: OP021*
Lapina, T.: P0763
Laptev, V.V.: P0705
Lapuelle, J.: P1317
Laquiere, A.: OP033, P1359,
P1360, P2186
Lara, L.F.: OP369, P0650
Lara-Santos, L.: P1684
Laranja, C.: P0115
Larauche, M.: P1107
Larghi, A.: P0692, P1361, P1362, P2100
Laroche, D.: P1674
Laroux, S.: OP314*, OP332*
Larsen, K.: P1012
Larsen, S.: P0820
Larssen, L.: P2180
Lashner, B.: P0342
Lasson, A.: P0322, P1318
Łaszewicz, W.: P0202
Laterza, L.: OP321
Latiano, A.: P1043
Latiano, T.: P1043
Latteri, S.: P0539
Lau, J.Y.: P0740, P0741
Lau, J.Y.W.: OP439, OP442, P1325
Laubender, R.: P1056
Laubender, R.P.: OP325*, P0294
Laugier, R.: OP248, OP417*, P2186
Laukens, D.: P1745
Launoy, G.: P0945, P1165
Laurent, A.: P1394
Laurent, M.: P1498
Laurent-Puig, P.: P2141
Laurent, V.: 33
Laureti, S.: P0334
Lauria, A.: OP112
Laurila, K.: OP336
Lauritano, C.: P0197
423

InDeX of aUTHoRs
Lauritano, E.: P1997*
Lauwers, G.: P0171
Lavagna, A.: P1090
Lavi, I.: P2081
Lavins, B.J.: OP458, P1119
Lavrynenko, O.V.: P1213
Law, R.: OP393
Law, S.Y.K.: OP350
Lawler, J.: P1309
Lawniczak, M.: P0847
Lawrance, I.C.: P1815, P2072
Layaida, K.: P0292, P0301, P0310,
P1759, P1761
Layer, P.: OP280
Lazar, D.E.: P0848, P0849, P0850
Lazar, E.: P0849, P0850
Lazaris, A.C.: P0232
Lazebnik, L.B.: OP050, P0991, P1208,
P1598, P1916
Łazowska-Przeorek, I.: P0189
Lazzari, R.: P0529*
Le Baleur, Y.: OP424
Le Blay, G.: OP388*
Le Corre, D.: P2141
Le Duff, F.: P0821
Le Gouvello, S.: OP111
Le Guellec, C.: OP242*
Le Hénaff, C.: OP110*, P1675
Le Marchand-Soubiron, C.: OP242*
Le Mauff, B.: P1674
Le Monies, A.: P1898
Le Pessot, F.: P1319
Le Rhun, M.: OP005, OP070, OP445,
P0955, P0998
Le Roux, C.W.: OP140
Le Sidaner, A.: P0009
Le Treut, Y.: P2140
Leach, O.: OP271
Leahy, A.: P0155
Leal, R.F.: P0992
Leandro, G.: P0765, P1709
Lebars, O.: OP033, P1359, P1360
Leblanc, S.: P1286
Lecca, P.G.: P0251
Lecleire, S.: P0665, P1287, P1319, P2073
Lecler, A.: P0590
Leclerc, M.: OP018*, OP020*
Lecomte, T.: OP242*, OP295
Ledesma, J.: P0997
Lee, ?.: P0244
424
Lee, B.: P0036, P0409, P0873, P1410
Lee, B.H.: P0245, P2061
Lee, B.J.: P0535, P1136
Lee, C.: OP118, P0507, P1604, P1924
Lee, C.J.: P0093
Lee, C.W.: P0758
Lee, D.: OP043, OP172, OP263,
P0036, P0409, P0623,
P0873, P1215,
P1321, P1994
Lee, D.H.: P1124, P1915
Lee, F.K.T.: P0726
Lee, G.: P0031, P0094, P1363
Lee, H.: P0244, P0585, P0587, P1125*,
P1171*, P1307, P1604,
P1713, P1854, P1913
Lee, H.J.: P0522
Lee, H.S.: P1235, P1400
Lee, H.Y.: P0245, P2061
Lee, I.: P0433
Lee, J.: OP429, P0031, P0094, P0237,
P0323, P0361, P0385, P0538,
P0651, P0656, P0669, P0749, P1040,
P1042, P1152, P1337, P1347, P1363,
P1453, P1768, P1776, P1961, P1966,
P1994, P2171, P2182
Lee, J.C.: P0553
Lee, J.F.Y.: P1325
Lee, J.H.: OP292*, P0239, P0557, P0558,
P0967, P1450, P1500, P1696
Lee, J.I.: OP263, P0478
Lee, J.J.H.: P0313
Lee, J.K.: P1450
Lee, J.S.: OP451, P0553
Lee, J.W.: OP263, P0478
Lee, J.Y.: OP292*
Lee, K.: OP461*, P0729, P1288,
P1289, P1494, P2181
Lee, K.G.: OP175, OP180*, OP376*,
P0762, P0948, P2016, P2049
Lee, K.H.: P1214, P1895
Lee, K.J.: OP214, P0557, P0558
Lee, K.M.: OP214, P0557, P0558
Lee, K.R.: P0217
Lee, L.: P0341
Lee, M.: OP118, OP429, P0244,
P0651, P1337
Lee, M.S.: P0553
Lee, N.: P1166
Lee, O.: P0244
P = poster presentation, OP = oral presentation, number only = page number

Lee, S.: OP291, OP470*, P0237, P0409,
P0410, P0587, P0623, P0669, P0729,
P0742, P0965, P0966, P1123, P1215,
P1288, P1289, P1348, P1453, P1575*,
P1594, P1713, P1854, P1855, P1858,
P1881, P1961, P1966, P1989, P2182
Lee, S.D.: P0862
Lee, S.H.: P0522, P0758, P1400, P1450
Lee, S.J.: P1400
Lee, S.K.: P1449, P1488
Lee, S.O.: P0965, P2074
Lee, S.S.: P1263, P1449, P1488
Lee, S.T.: P0965, P2074
Lee, S.W.: P1235
Lee, S.Y.: P0965
Lee, T.: P0651, P1322, P2171
Lee, T.J.W.: OP167*, P1151, P1320,
P1889, P1890, P1891
Lee, V.: P1494
Lee, W.: P0101
Lee, W.J.: P1990
Lee, W.S.: P0217, P0968
Lee, Y.: P0410, P0586, P0971, P1171*,
P1482, P1575*
Lee, Y.C.: OP214, P0557, P0558
Lee, Y.J.: P0245, P0965, P1214, P2061
Lee, Y.S.: P1214
Leeb, G.: P1154
Leedham, S.: P1565
Leeds, J.S.: P0726, P1290, P1291, P1524,
P1525, P1526, P1527
Leelakusolvong, S.: P0626
Leenders, B.J.M.: P0723
Lees, C.: 38
Lees, C.W.: OP271
Lefebvre, A.C.: P0225
Lefor, A.T.: P0959
Lefort, C.: OP044, P0551
Legarda, M.: P0453
Lehman, G.A.: P2132
Lehmann, S.M.: P1721
Lehnardt, S.: P1721
Lehnert, H.: P1164
Lehours, P.: OP057*
Lehr, M.: P1813
Lehur, P.: P1428
Leicester, R.J.: OP004, OP321, P1027
Leighton, J.: P1071
Leighton, J.A.: P0342
Leighton, M.: P0757
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Leijonmarck, C.: OP249
Leijtens, J.W.A.: OP245*, P1681
Leindler, L.: OP419
Leiper, K.: OP156, P0325, P1715
Leiszter, K.: P0773*, P0774, P0943,
P0944, P1135
Leitao, M.: P2086, P2087
Leitão, M.C.: P0639, P0783, P1035, P1293,
P1496, P1683, P1941, P1942
Leite, C.: P0115
Leite, S.: P0083, P0500, P1227, P1472,
P1908, P1926
Leite, S.M.: P1023*
Leite-Moreira, A.F.: P1917
Leja, M.: P0209, P0856, P1578*
Leja-Szpak, A.: P1414, P2124
Lekstan, A.: P0686
Lelcuk, S.: P1139
Lemaire, K.: P1031*
Lemann, M.: OP153, P1052, P1548,
P1790, P1816, 17
Lembo, A.J.: OP458, P1119
Lemman, M.: OP121
Lemmens, V.: OP079*
Lemoine, F.: P1319
Lemos, A.: P2092
Lemoyne, M.: P0811
Lenaerts, K.: OP386*
Lencioni, R.: 19
Leng, Y.X.: P1103*
Lenicek, M.: OP364, P0324, P1199
Lennard, L.: P1820
Lenoci, N.: P0001, P2048
Lenz, L.: P1323, P1324, P2017
Lenz, P.: OP209
Leocmach, Y.: P0218
Leodolter, A.: P1153, P1154
Leon, A.: P0529*
Leone, A.: P0078
Leonetti, D.: P0259
Leong, H.T.: P1325
Lepage, C.: P1241, P1882
Lepage, P.: OP018*, OP020*
Lepilliez, V.: OP294
Lepistö, A.: OP247
Lequoy, M.: P1386
Lera, M.: P1709
Lerang, F.: P1305
Lerari, Z.: P1434
Lerch, M.M.: OP281, P2136
425

InDeX of aUTHoRs
Lerebours, E.: OP121, OP153, P0665
Lérias, C.: P1683
Leroi, A.: P0401, P1126, P1428
LeRoux, C.W.: P0092
Leroy, K.: P0027
Leroy, V.: P1336
Lertakyamanee, N.: OP465*
Lerut, E.: P1261
Lerut, T.: OP345*
Lesanu, G.: P0927
Lesavre, N.: P2141
Lesgourgues, B.: P1386
Lesidaner, A.: OP005
Lesmana, L.: P0498
Lesna, J.: P0767
Lesur, G.: OP435, P0003, P0738
Letard, J.: P1317
Letessier, E.: P0084
Leufkens, A.M.: P2062
Leung, C.Y.: P1504
Leung, V.K.S.: P1504
Leung, Y.: P1758
Levi, Z.: P0022, P0229, P0230
Levin, F.: P1108
Levinson Castiel, R.: P1528
Levison, S.E.: P0993
Levrero, M.: OP128*, OP297*, P0517,
P1870, P1910
Levy, M.: P0706, P1394
Lévy, M.: P0027
Levy, P.: OP424, P0704, P1402,
P2135, P2141
Lévy, P.: OP281, P2148
Levy, S.: P0039
Lewis, F.: P1142
Lewis, G.J.: P1040
Lewis, J.H.: P0516
Lewis, N.R.: P1529, P1530, P1531,
P1532, P1533
Lewis, S.: OP142, P0817
Lewosiuk, A.: P0954
Li, C.J.: P1609
Li, H.: P0869, P1944
Li, J.: P0227, P0454, P0894
Li, J.C.M.: P1325
Li, L.: P0437, P0454, P0963
Li, M.: P1455, P1591
Li, M.K.W.: P0702
Li, Y.: P0458, P1445
Li, Z.: OP055, P0893, P1079, P1603
426
Liakina, V.: P1180
Liang, M.: P1628
Liatsos, C.: P0175, P0978*, P1468,
P1469, P2116
Liberman, E.: OP479
Libzo, N.: P1527
Licata, G.: P1933
Lichtenberger, C.: P1066
Lichtenstein, G.R.: P1790, P1815
Lichtenstein, P.: OP126
Lichtiger, S.: OP323
Licour, M.: P1600
Licul, V.V.L.: P0671
Lidder, P.G.: OP142, P0817
Liebl, F.: P0935
Lied, G.A.: OP095*
Liegard, M.: OP295
Liem, O.: P0191
Ligresti, D.: P2025
Liguori, E.: OP275, P0034, P0455
Liguori, G.: P0334, P0340
Lillestøl, K.: OP095*, P0066
Lillevang, S.T.: P0800
Lim, C.H.: P0441, P2020
Lim, C.J.: P0537
Lim, H.: P0623, P1855
Lim, H.C.: OP214
Lim, J.: P1881
Lim, L.G.: OP440*, P1242
Lim, L.L.: OP440*
Lim, S.: P0433
Lim, S.G.: P1242, P1264
Lim, W.C.: P1594
Lim, Y.: P0972, P1171*
Lim, Y.C.: P0474
Lim, Y.J.: P0123
Lima, B.: P1908
Limonard, C.: OP158
Lin, C.: OP118
Lin, H.: P1467
Lin, H.C.: P0862
Lin, H.J.: P0862
Lin, J.: OP340, P0880, P1587, P1628
Lin, W.: P0661
Lind, A.: P0156, P0157
Lind, R.: OP095*
Lind, R.C.: OP093
Lind, T.: OP026, OP132, OP442
Lindberg, A.: OP305, P1823
Lindberg, G.: P0378
P = poster presentation, OP = oral presentation, number only = page number

Lindblad, M.: P2120
Lindegren, H.: P0715
Lindell, G.: OP249
Linder, S.: OP249
Linderborg, K.: OP289
Lindfors, K.: OP336, P1538
Lindgren, A.: P0322, P1318
Lindh, A.: OP098
Lindley, K.: OP377, P0696, P0697,
P1425, P1426, P1427
Lindsay, J.O.: P1003, P1004, P1070,
P1080, P1723, P1829
Ling, K.: P0756, P1494
Ling, K.W.K.: P0424, P0432
Lingsma, H.F.: OP287*
Linhart, A.: OP364
Linton, L.: OP305, P1823
Lipscomb, G.: OP168*, P0420
Lipscomb, G.R.: P1155, P1156
Lipscombe, G.: P0933
Lipska, L.: OP481*, P0706
Lira, T.: P0977*
Liratzopoulos, N.: P0181
Lis, E.: P1201
Lisianski, V.: OP162, OP479
Lisman, T.: OP093
Liu, F.: P0894, P1944
Liu, L.: OP092
Liu, M.: P1961, P1966
Liu, N.: OP118
Liu, Q.: OP456
Liu, S.: P0475, P1906
Liu, S.Y.W.: P1325
Liu, W.: OP055, P0893, P1602, P1603, P1636
Liu, X.: P0124
Liu, Y.: OP475*, P0411
Liu, Y.L.: P1912*
Liu, Z.: P0851*, P0852, P0994
Livingstone, C.: P1663
Ljungman, M.: OP249
Llach, J.: OP259*, OP260*, P0631*,
P0632, P1385
Lledó, J.L.: P1995
LLorens Sabate, P.: P0032
Llovet, J.: 73
Lloyd, C.: P0201, P0453, P0456
Lloyd, D.A.J.: P0818
Lo, G.H..: OP361
Lo, S.S.: P0862
Lo, T.F.H.: P1504
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Lo Re, G.: P1780
Loadman, P.M.: OP319
Loba, J.: P2146
Lobello, R.: P0588, P1422
Lobo, A.J.: P1527, P1785
Lobo, B.: P1114
Lobocki, C.: P1905*
Lobontiu, A.: OP190*
Locatelli, F.: OP048, OP049
Locher, C.: OP295, P0975
Lochs, H.: OP205
Lockett, M.: P0399
LoCoco, J.: P0869
Lodberg Hvas, C.: OP333*
Loehr, M.: 51
Lofberg, R.: P0357
Loffeld, R.J.L.F.: P1161, P1162, P1163
Loftus Jr., E.V.: P1096
Logan, R.: 25, 30
Logan, R.F.: P0622
Logan, R.F.A.: OP436*, P0757, P1529,
P1530, P1532, P1533
Logan, R.H.P.: P1487
Logan, R.P.H.: P0135
Loganathan, N.: P0494
Loganathan, S.: P0456
Loganayagam, A.: OP243*
Logsdon, C.D.: OP475*
Loh, M.: P1594
Lohmann, R.: P1164
Löhr, M.: OP117, P0614, P1338
Lohse, P.: P0294
Lohsiriwat, D.: OP465*
Lohsiriwat, V.: OP465*
Lok, C.Y.: P1226
Lokhmatov, M.M.: P1653
Loktionova, E.: P0117
Lolli, E.: P0863, P1379
Lombard, M.: P0622, P1195
Lombard-Bohas, C.: OP290
Lombardi, G.: P0195
Lombardini, M.: P0548
Lombay, B.: P1253, P1254
Lomer, M.C.E.: P0325, P1127
Longavenne, E.: P0225
Longcroft-Wheaton, G.R.: P1292, P1326
Lönhroth, H.: P1549
Lönroth, H.: P1834
Looman, C.W.: P0172, P0173
Lopes, A.B.: P0917*
427

InDeX of aUTHoRs
Lopes, C.: P0550
Lopes, G.S.: P0087
Lopes, S.: P0639, P1293
Lopes, S.I.: P1952
Lopez, J.: P1846
Lopez, V.: P0506*
Lopez-Alvarenga, J.C.: P0395, P0396
Lopez-Ceron, M.: P1385
López de La Guía, A.: P0527
Lopez-Oliu, C.: P0995
López-Oliu, C.: OP108*
Lopez-San Roman, A.: P1082
López San Román, A.: P0354
López-Sanromán, A.: P1053, P1812
Lopez-Siles, M.: P0995
López Vivancos, J.: P0072
Loras, C.: OP160*, P0077, P0288, P1535
Lordan, N.: P1932
Lorena, S.L.S.: P1537
Lorenzetti, R.: P0593
Lorenzini, I.: P0735
Lorenzo, A.: P0299, P1011
Loriquet, P.: P1606
Lorvidhaya, V.: P1671
Losco, A.: P1793
Loser, K.: OP308*
Louis, E.: P1096, P1097, P1098, 32
Loukas, A.: OP278
Lounes, F.: P0108
Loureiro, R.: P0115
Louvet, C.: P1688
Louvet, H.: P1178
Louwagie, J.: OP483*
Lovat, L.: OP224, P2007
Lovat, L.B.: P0151, P0908
Lovecek, M.: P1358*
Loveday, B.P.: P0819
Lovera, M.: P2153
Low, H.C.: P1594
Lozano, M.: P1364
Lu, C.: P0747, P0885
Lu, J.: P0810
Lu, X.: P0227
Lu, Y.: P2120
Lubbers, T.: OP276*, P1546
Lubiñski, J.: P0847
Lucantoni, F.: P1539
Lucas, M.: OP385*
Lucena, M.I.: P0473
Lucendo, A.: P0288
428
Lucendo, A.J.: P1566
Luciani, A.A.: P0262
Lucock, M.: P0236
Luczak, M.: P0190
Ludzik, M.: P0931
Luger, D.: P1564
Lügering, A.: OP039*, OP308*,
P1724, P1813
Lui, S.: P0756, P1494
Lui Lledó, J.: P0578
Luigiano, C.: P1680, P2145
Luinetti, O.: OP048, OP049
Lukamowicz, J.: P0931
Lukas, M.: P0324
Lukavetskyy, N.O.: P0853
Luker, M.: P1067
Lund, E.: OP321
Lundborg, P.: P0926
Lundell, L.: OP219*
Lundin, K.E.: P0985
Lundin, K.E.A.: P0068
Lunn, E.J.: P0582
Lunniss, P.J.: P0980
Luo, D.J.Y.: OP173, P0424
Luparia, R.: P1539
Lupascu, A.: P1797, P1997*
Luppino, I.: P0267
Lupsor, M.: OP231*, OP357*, P0467,
P0468, P1972, P1982
Lussi, A.: OP138
Lutgendorff, F.: OP146
Luther, J.: P1479
Lutke Holzik, M.F.: P0973
Lutsyk, A.: P1554
Lutterer, A.: P1567
Lutz, M.: 51
Luverà, A.: OP112
Luyer, M.D.P.: OP276*
Lv, D.: P0437, P0963
Lv, J.: P0894
Lv, X.: P1455, P1911
Lyba, M.: P1393
Lyberg, T.: P1826
Lyckander, L.G.: P0045
Lygren, I.: P1826
Lyn-Sue, J.: P2155
Lynch, J.: 40
Lynchak, O.: P1137
Lynn, D.J.: OP390
P = poster presentation, OP = oral presentation, number only = page number

M
Ma, C.: P1758
Ma, S.: P0458
Ma, X.: OP055, P0893, P1602, P1603
Maak, M.: P0935
Maas, M.: OP245*, P0952, P1681, P1682
Maasberg, S.: P1157, P1164
Maaser, C.: P1724
Maasri, K.A.: P0974
Mabuchi, T.: P0676
Macadam, R.: P0113, P0698
Macaigne, G.: P0975
Macarie, M.: P0023
Macasek, J.: P1413
Macaskill, P.: OP073
Maccario, R.: OP048, OP049
Maccarrone, M.: P0067
Macchia, S.: P2145
Macdonald, D.C.: P0953
Macdonald, G.: OP278
Macdonald, G.A.: P0914
Macdonald, J.C.: OP178
Macdonald, S.: P0696
MacDonald, T.T.: P1814*
Macdonald, T.T.: OP107*
MacDougall, J.E.: OP458, P1119, P1120
Macedo, G.: P1952, 32
MacFarlane, B.: P0733
Macfarlane, G.T.: P0346
Macfarlane, S.: P0346
Mach, K.: P1154
Mach, T.: P0055, P0295, P1733,
P1734, P1798
Machado, A.A.: P2018
Machado, J.C.: P1786
Machado, M.V.: P1181, P1216, P1217,
P1218, P1243
Machalinski, B.: OP052*
MacIntosh, D.: P0577
Macintyre, E.: OP378
Macken, E.J.: P1301
Mackenzie, G.D.: P0151
MacLean, A.: P1758
MacMillan, P.: P0399
MacNaughtan, J.: P0444, P2154
Macut, D.: P1194
Madacsy, L.: P1110, P1350
Madan, A.: P1415
Madden, A.: P0812
Mader, M.: P1440
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Madi, A.: P0996
Madre, C.: OP306*
Madrigal, R.: P1343
Madsen, J.T.: P0800
Maeda, H.: P0040, P1996, P2035
Maeda, Y.: P0168, P0561, P0605, P1294,
P1581, P1996, P2035
Maekita, T.: P0040, P1614, P1996, P2035
Maerten, P.: P2080
Maestro, S.: P1343
Maetani, I.: OP114
Maev, I.: OP462*, P0033
Maevskaya, M.V.: P1939
Magari, H.: P1262
Magdelaine-Beuzelin, C.: P1805
Magee, C.: P0698, P0699, P0854
Magno, P.: P0720
Magnusson, K.: OP270*
Magnusson, P.: OP126
Magro, F.: P0315
Maguchi, H.: P0613, P0983, P1232, P1447
Mahachai, V.: OP301, P0496, P2088
Mahachie, J.: P0309
Mahachie John, J.M.: P1034
Mahadavan, L.: OP285
Mahadevan, U.: P0342
Mahdi, G.: P0919
Maher, M.M.: P1061
Mahmood, A.: P1057, P1513
Mahmood, S.: P1158, P1534
Mahmoud, S.Z.: P1964
Mahmoudi, H.: P0452, P1244
Maiero, S.: P0069, P0070, P0071,
P0111, P1368
Maimone, A.: P2145
Maimone, S.: P0504
Main, J.: P1983
Main, N.: P1327, P2059
Mainprize, K.: P2066
Maione, F.: P0941
Maire, F.: OP295, OP424, P0690,
P1402, P2135, P2148
Majid, S.: P0440, P0727, P0734, P1312
Majumder, T.: P0394
Mak, A.: P1858
Makarchuk, P.A.: P1081
Makaya, M.: P1224
Makharia, G.K.: OP412*, P0079, P0326,
P1059, P1744, P1811
Maki, M.: P1523
429

InDeX of aUTHoRs
Mäki, M.: OP336, P1538
Makin, A.J.: OP256*, P0731
Makino, H.: P0911
Makita, T.: P0379, P0795
Makuuchi, H.: P0901
Malagelada, J.: P1058
Malagoli, A.: P0807
Malamisura, B.: OP379
Malamut, G.: OP378
Malaty, H.M.: P1482
Maldi, E.: P2095
Malecka-Panas, E.: P0161*, P0224, P0286,
P0686, P0931, P1739, P2132, P2146
Małecka-Panas, E.: P0233
Malekhosseini, S.: P0193, P0194, P1937*
Malekzadeh, R.: OP225, OP302, P0182,
P0211, P0842, P1189, P1630, P1954
Malenov, M.: P1980
Malesci, A.: P0278, P1068, P2047
Maleth, J.: P2123*
Maletzki, C.: P1416, P1726
Malfertheiner, P.: OP063*, OP135, OP210*,
P0024, P0025, P0162, P0180, P0624,
P0652, P0653, P1451, P1576*, P1629,
P1765, P1769, P1877, 47
Malfroot, A.: P0920
Malhotra, A.K.: P0326, P1059
Malhotra, P.: P0788
Malicki, S.: P1475
Malik, N.: P1061
Malila, N.: OP166
Malka, D.: OP295
Mallon, D.: P1195
Malmberg, I.: P0867
Malos, A.: P2038*
Maltezos, E.: P0181
Maluskova, J.: P2034
Malvehy, D.: OP177, P0011
Man, X.: OP055, P0893
Mana, F.: P1625
Manabe, N.: P0007, P0132, P1839
Mancini, M.C.: P0087
Mancini, V.: P0195
Mancino, M.: OP283
Mandai, Y.: P0795
Mandair, D.: P0441
Mandelli, G.: P0001, P2048
Mandic, G.: P0016
Manes, G.: P0548
Manesis, E.K.: P0526
430
Manfredi, S.: OP326*
Mangialavori, L.: P0628, P1458
Mangiavillano, B.: P1665
Mangin, I.: OP020*
Manglam, V.: P0479, P1909
Manglam, V.K.: P1245
Manhas, R.: P0841
Mani, K.: P1811
Mania, A.: P0044
Maniere, T.: P0659
Maniu, A.: OP231*, OP357*, P0467, P1972
Manko, A.: P0103
Mann, S.D.: P1536
Mannath, J.: P0158
Manner, H.: OP341, OP342, P0165, P1634
Manninen, P.M.: P1762
Manning, J.J.: P0185
Mannisi, E.: OP163*, P1883
Manno, M.: P0940, P1377
Manns, M.: P2079
Manns, M.P.: OP354, P0486, P1259, P2071
Mannur, K.: OP149
Manocha, D.: P0891
Manolakis, A.C.: P1038, P1483
Manolakopoulos, S.: P0526
Manolaraki, M.: OP120
Manolas, K.: P0181
Mañosa, M.: P1082, P1083, P1751, P1767
Manousou, P.: P0504, P1738
Mansfield, R.: P0065, P0830
Mansi, C.: P1747
Manso, J.F.: P1440, P1441
Manso, M.C.: P0509
Mansour-Ghanaei, F.: P1484
Mansourbakht, T.: OP295
Mansy, T.: P1353
Manta, R.: OP041*, P0940
Manteca Gonzalez, R.: P0336
Mantion, G.: P0458
Mantzaris, G.: P0338
Mantzaris, G.J.: OP323, P1474, P1775
Manz, M.: P0136
Mao, W.: P0412
Mão-de-Ferro, S.: OP081*, P1635
Mão-Ferro, S.: P0419
Mapelli, D.: P0447
Marabotto, E.: P0169, P0170, P0184, P0786
Maran, S.: P1482
Marangos, M.: P0892
Marasco, R.: P0267
P = poster presentation, OP = oral presentation, number only = page number

Marcelis, Q.: OP056
Marchese, A.: P0095
Marchese, M.: P1560
Marchesi, J.: P0226*
Marciani, L.: P0380
Marcil, V.: P1660
Marcus, C.: OP040
Marden, P.: P0283, P0595, P0642
Marden, P.F.: P0589
Marecek, Z.: OP364, P1199
Marek, F.: P0878
Marek, I.: P1346
Marek, T.: OP116
Marek, T.A.: P0159
Marelli, L.: P1328
Marenzana, M.: P1000
Margherita, C.: P1705
Mariani, P.: P1654
Marietta, M.: P1999
Marin, J.: P0780
Marin, M.: P0071
Marin, M.A.: P1159
Marín-Jimenez, I.: OP324
Marín-Jiménez, I.: P0997
Marinaki, A.: OP243*
Marinaki, A.M.: P0344
Mariné, M.: P0077, P1535
Marinescu, M.: P0772
Marinho, R.: OP232*, P1957, P1958
Marinho, R.T.: P1243
Marini, F.: P0469
Marini, V.: P1747
Mariño, A.: P0174
Marinone, M.: P1943
Marion, J.F.: P0342
Marion-Audibert, A.: OP290, P1219
Mariotte, D.: P1674
Mariotti, M.: P0905, P0906
Marjani, H.A.: P1630
Markese, M.: P1840
Markl, M.: P0471
Markocka-Maczka, K.: P0907
Markos, P.: P0327, P1329
Marlais, M.: OP186*, P1652
Marley, R.: P1973
Marlicz, W.M.: OP052*, P0954, P1246
Marmo, C.: OP374
Marmo, R.: OP374, P0735, P1462
Marohn, M.R.: P0720, P2155
Marone, A.: OP374
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Marques, M.: P1917
Marquès, T.: P1535
Marra, F.: OP125*, P1865
Marra, M.: OP226*
Marra-López, C.: P1364
Marrelli, D.: P1578*
Marrollo, M.: P1090, P1764, P1802
Marrone, G.: P0501, P1220
Marschall, H.: OP126, OP219*, OP227,
P0531, P2010
Marshall, D.: P1000
Marshall, J.K.: OP094*
Marshall, M.: P0722
Marshall, S.E.: P0281, P0282
Martasek, P.: P1199
Marteau, P.: OP018*, OP020*, P1052,
P1084, P1548, P1790, P2157
Marteau-Baudin, A.: P1084
Martí, J.: P0077
Martie, A.: P1981
Martigne, L.: OP188*
Martin, A.: P0102, P1405
Martin, D.: P0622
Martin, D.F.: OP251, P1335, P1344, P2184
Martin, G.: P1538
Martin, J.: P1880
Martin, J.P.: P1062
Martin Arranz, E.: P2075
Martín Arranz, E.: P0107, P0725
Martin Arranz, M.: P2075
Martín-Arribas, M.: P0672
Martin de Argila, C.: P1605
Martín-Garrido, E.: P0672
Martin Ibañez, J.: P0976
Martín Martín, L.: P1843
Martinato, M.: P0328, P0329, P1085
Martinazzi, S.: P1128, P1551
Martinek, J.: P0840
Martinelli, A.L.C.: P0511, P0512, P1202
Martinelli, M.: OP391*, P1129
Martinetti, M.: P0095
Martinez, C.: P1114
Martinez, E.: OP259*
Martinez, G.: P0506*
Martinez, M.C.: P0259
Martinez, M.P.: OP324
Martinez Escapa, V.: OP212
Martínez-Fernández, R.: P1444
Martinez Jimenez, P.: P1605
Martinez-Medina, M.: P0995
431

InDeX of aUTHoRs
Martinez-Odriozola, P.: P0473
Martinez Oton, J.J.A.: P0976
Martínez-Peñuela, J.: OP076*
Martínez-Peñuela Virseda, J.: P1669
Martino, M.: P1339
Martinoli, C.: P0278
Martinovic, M.: P0462
Martins, B.C.: P0087
Martins, F.P.: P2017, P2076
Martorelli, L.: P1069
Maruff, P.: P1983
Maruoka, N.: P0530, P1710
Marusasa, T.: P1897
Maruyama, N.: P0561
Marven, S.: OP190*
Marvola, M.: OP289
Marvola, T.: OP289
Mary, J.: P1790
Marza, M.: OP317
Marzano, A.: P0517
Marzo, M.: P0304, P1774, P1803, P1804
Marzouqi, F.S.S.: P0831
Mas-de-Xaxars, T.: OP108*
Masaki, T.: P0465
Masaoka, T.: OP273*
Masci, E.: P0548, P1665
Masclee, A.: OP483*, P0221*
Mascolo, M.: P0941
Masharova, A.A.: P1598
Mashru, S.: P1465
Maslova, A.: P0760
Masoodi, I.: P0330
Massey, D.C.O.: P1039, P1040
Masson, D.: OP206, P0293
Masson, S.: P1973
Masszi, T.: P0774
Mastracci, L.: P0184, P0893
Masud, H.: P0242
Masud, M.A.: P0750, P0761
Mata, A.: P1557
Matei, E.: P1894
Mateos, G.: P0395
Mateva, L.: P0485
Mathers, J.: 25
Mathew, A.: P1403, P1429
Mathew, C.G.: OP024
Mathieu, N.: P1055
Mathonnet, M.: P1428
Mathur, A.: P1196, P2013
Mathurin, P.: 23
432
Mathus-Vliegen, E.E.M.H.: P0086
Mathus-Vliegen, E.M.: OP078
Matilla, B.: P1706, P1707
Matos, J.: P0115
Matougui, N.: P0635, P0879, P1574
Matri, S.: P0311, P1618, P1619, P1620
Matsubara, S.: P1345, P2178
Matsubayashi, H.: P0546, P0563, P1268,
P1584
Matsuda, A.: P2175
Matsuda, M.: OP007, P1691
Matsuda, N.: P1968
Matsuda, R.: P1313
Matsuda, T.: P0576, P2058*, P2113
Matsudo, T.: P0707
Matsuhisa, T.: P0855
Matsui, A.: OP432*
Matsui, T.: OP054*, P0335, P1232
Matsuki, T.: P0040
Matsumoto, H.: P0007, P0132, P1086
Matsumoto, K.: OP061, P0358, P0359,
P0360, P0379
Matsumoto, S.: P0205
Matsumoto, T.: OP054*, OP201, P0335,
P0909, P0987, P1847
Matsumoto, Y.: OP064, P0028
Matsumura, M.: P0127, P0846
Matsumura, T.: P0137
Matsuno, Y.: P0038
Matsuo, T.: P0028
Matsuoka, J.: P1638
Matsuoka, Y.: OP066, P1388*
Matsushima, K.: OP396*
Matsushima, M.: P0662
Mattera, C.: P0588, P1422
Matthijsen, R.: OP384*
Mattioli, F.: P1747
Matumoto, T.: P0284
Matusiewicz, M.: P0907
Matustani, S.: P1247
Matysiak-Budnik, T.: OP070, P0955, P0998
Maude, K.: P1142, P1146*
Maunder, S.A.: P0392
Mauriño, E.: P1519, P1520, P1946
Mauz, P.: P2032
Mavrogianni, P.: P0977*, P0978*, P1469
Mavros, M.: P0979
Mawatari, H.: OP130*, P1204
Mawdsley, J.E.: P1750
May, A.: OP341, OP342, P0165, P1634
P = poster presentation, OP = oral presentation, number only = page number

Mayberry, J.: P1792
Mayberry, J.F.: P1064, P1552
Maydonovitch, C.: P1569*
Mayerle, J.: P2136, 52
Maynard, N.: P0571
Mazard, T.: P2137
Mazur, W.: P1971
Mazure, R.: P1519, P1520
Mazurek, U.: P0678, P2126
Mazzarella, G.: OP379
Mazzella, G.: P0517
Mazzocchi, S.: P0400
McAlindon, M.E.: P0660, P0726, P1290,
P1291, P1527, P1785, P2106*, P2107
McCarthy, J.: OP278
McCarthy, J.M.: P0160
McCarthy, N.E.: P1003, P1004
McCartney, S.: P0048
McClave, S.: 80
McColl, A.: P0841
McColl, K.: 36
McColl, K.E.L.: P0185
McCormick, P.A.: P1229
McCulloch, A.: P2057
McDonald, C.: OP051*
McDowell, A.: P0504
McFie, J.: P2066
McGowan, I.: P1086
McIntyre, A.: P0584
McIntyre, A.S.: P2019
McIntyre, P.: P2052
McKaig, B.: P1297
McKay, C.: OP257*
McKay, G.: OP469, P1333
McKean, D.: P0841
McKenna, D.: P2167, P2168
McKie, A.: P2066
McKiernan, P.J.: P0201
McKiernan, P.P.J.: P0453
McKinney, C.: P1045
McLaughlin, J.T.: P0993
McLeod, R.: 18
McMahon, B.P.: P1836
McMillan, D.C.: P0768, P0769
McNamara, D.: OP178
McNaught, C.: P2066
McNeil, N.I.: P0736
McPherson, S.: P1953
McSorley, H.: OP278
McStay, M.: P2114
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
McWilliams, S.: P1061
Mead, R.: P1292, P1295, P1296, P1330
Mead, R.J.: P0596
Meddings, J.: P1946
Medeiros, R.: OP318*, P0416
Mederacke, I.: OP354, P0486
Medhi, S.: OP296*, P0679, P1182*
Medhus, A.W.: P2180
Medina Lucena, H.F.: P1595
Meepe, A.N.: P1687
Mégraud, F.: OP057*, P0277, 65
Mehenderitta, K.D.: P1196
Mehigan, B.: P0088, P1676
Mehrabani, D.: P1491
Mehta, K.P.: OP286
Mehta, M.K.: OP369
Mehta, R.M.: OP286
Mehta, S.J.: P1536
Mehta, T.A.: P1297
Meier, J.J.: OP238*
Meier, R.: OP194
Meijer, G.A.: OP483*, P0422, P0799,
P0961, P0962, P0969, P1142, P1143,
P1146*, P1147, P1161, P1162
, P1163, P1871, P1873
Meijer, J.: P0026
Meijerink, W.J.H.J.: OP468*
Meijssen, M.A.C.: P0801
Meineche-Schmidt, V.: P0867
Meining, A.: OP089*, OP115, OP476*,
P0171, P0570, P0579, P0881,
P1298, P2011, P2012, 72
Meinzer, S.: P1567
Meisner, S.: OP113
Meister, S.: P0687
Meister, T.: OP308*, P1340
Mejia, J.C.: OP008
Mela, A.: P0977*
Mela, M.: P0526
Melgar, S.: P0364*
Mellouki, I.: P0300, P0713
Melmed, G.: P1072
Melnikova, E.: P0033
Memmo, A.: P0529*
Ménard, A.: OP057*, P0277
Menard, C.: P1454
Menard, J.: P1428
Mencacci, R.: P1802
Menchen, L.: P1767
Menchén, L.: P0997
433

InDeX of aUTHoRs
Menchini, L.: P1551
Mencias, M.: P1169
Mendez, M.: P0174
Mendonça, E.: P2098, P2099
Mendoza, F.: P0619
Mendoza, J.: P0367
Mendoza, J.L.: OP324
Menestrina, F.: P1256
Menge, B.A.: OP238*
Mengoli, C.: OP100, P0075, P0400
Menni, W.: P1849
Mennini, M.: P1539
Mensink, P.B.: P1438*
Mensink, P.B.F.: OP209, P0753
Menzies, D.: P0898
Merat, S.: OP225, OP302, P0211, P0633,
P1392, P1568, P1954
Meregnani, J.: P1101
Merens, A.: P1478
Meresse, B.: OP378
Merighi, A.: P1999
Merino, O.: OP160*, OP324, P0288, P1767
Merle, P.: P1219
Merlos, M.: P1736
Merra, G.: P1495
Merricks, L.: P1297
Merriman, T.R.: P1044, P1045, P1046
Mesli, F.: P1688
Mesnard, B.: P0590
Mesquita, M.A.: P1537
Messer, M.: OP089*
Messerotti, A.: OP041*
Messing, B.: OP141, P0813, P0814
Messmann, H.: OP006, OP012, OP248,
P2174
Mester, G.: P0730, P1456
Meszarosova, A.: OP481*
Methasate, A.: P0626
Metoki, R.: P0464, P0480, P0489,
P2028, P2029
Metz, A.J.: OP207*, P1331
Metz, G.: 32
Metzke, D.: P0042*, P1721
Meucci, G.: OP334, P1090
Meurer, L.: P0917*
Meurette, G.: P1428
Meurs-Szojda, M.M.: P0969, P1130
Meusel, B.: OP003*
Mezzabotta, L.: P2093, P2094
Mezzano, G.: P1250
434
Mezzi, G.: P2091
Miah, M.: P0242
Mian, A.: P1316
Miceli, D.: P2025
Miceli, E.: P0095
Micev, M.: P0414
Michaelis, L.: OP377
Michalski, B.: P1475
Michalski, C.W.: P1417*
Michalski, M.: OP457
Michaud, D.: 47
Michaud, L.: P1556
Michel, P.: P1287, P1319
Michetti, P.: OP331, P0308, P0735, P1087,
P1091, P1825, 47, 56
Michl, P.: 53
Michetti, P.F.: P2080
Michopoulos, S.: P0979
Michot, F.: P1428
Micle, O.: P0130
Middleton, S.J.: P0818
Midenfjord, I.: OP098
Miehsler, W.: OP457, P1066, P1771, P1772
Miele, E.: OP391*, P0195, P1129
Miele, L.: P0501, P1220
Mieli Vergani, G.: 52
Miendje Deyi, V.Y.: OP056
Migeot, V.: P0213
Mihaescu, M.: P0131
Mihai, B.: P1211, P1212
Mihai, C.: P1211, P1212
Mihaila, R.: P1904
Mihaylusov, S.V.: P1404
Miheller, P.: P0318, P1078, P1766
Mijatovic, V.: P1130
Mik, M.: P0235
Mikaeli, J.: P0633, P1392, P1568
Mikami, S.: P1313
Miki, C.: OP480, P0102, P1149
Miki, K.: P1476
Mikula, M.: P0060
Mikulits, A.: OP457
Milano, F.: OP217*, P0163*, P0918, P1866
Milanski, M.: P0992
Milesi, F.: P2153
Milestone, A.N.: P1763
Milic, S.: P1221, P1401
Milicic, B.: P1194
Milkiewicz, M.: P1246
Milkiewicz, P.: P1246
P = poster presentation, OP = oral presentation, number only = page number

Milla, P.: OP261
Milla, P.J.: OP182
Milletti, S.: P1709
Million, M.: P1107
Millon, L.: P0458
Mills, P.R.: OP360
Milnerowicz, H.: P2121
Mimori, K.: P1149
Mimura, S.: P0331
Mimura, T.: P1342
Minami, A.: P2077
Minami, H.: OP034, OP071*, OP072*,
P0575
Minami, T.: P1313
Minarik, M.: OP481*
Minarikova, P.: OP481*
Minashi, K.: P0099, P0947
Mine, T.: P0662, P1225
Minello, A.: P1241
Mingazzini, P.L.: P0939
Mínguez, M.: OP160*
Minnee, R.C.: OP159*
Minuti, F.: P1068
Mion, F.: OP133, P0401, P1428, P1573
Miossec, C.: OP206, P0293
Miquel Casachs, J.: P0606
Miranda, A.: P0764
Miranda, C.: P1987
Miranda, J.P.: P1250
Miranda, L.: P1684
Miranda Chaves, L.D.: P1821
Mirchev, M.B.: P0228
Mirkarimi, H.: OP394*, P1857
Miron, L.: P0476
Mirones, L.: P1635
Mirzamohammadi, D.: P1857
Mirzaraimova, S.: P0116
Misael, U.: P1176
Misak, Z.: OP148*
Misawa, M.: P1311, P2070
Miseta, A.: P1977
Mishina, Y.: P0005, P1693
Mishra, S.: P0521
Mishra, S.K.: P0513*, P0518, P0520
Mishra, S.R.: OP356, P1172, P1237
Misins, J.: P0209, P0856
Misra, A.: P1372
Mistry, K.: P0782
Mistry, N.: P2053
Mitani, T.: OP432*, OP433, P0121, P1315
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Mitchel, J.R.: P0460
Mitchell, C.: P2066
Mitchell, T.: P0076
Mitchev, K.: P0355
Mitry, E.: OP295, P1458, P1688, P1882
Mitsui, S.: P0983
Mitsunaga, A.: P1299
Mitsuyama, K.: P1550
Mittal, V.: P0601, P0710, P1905*
Mittal, V.K.: P0247
Mittal, V.V.: P1237, P1300
Miura, Y.: OP208
Miwa, H.: OP058, P0284, P0987, P1847
Miyachi, H.: OP467*, P0602, P0603,
P0655, P0946, P0951, P1314,
P2046, P2070
Miyahara, K.: P2037
Miyahara, R.: P0331
Miyake, N.: P0331
Miyamoto, Y.: P0466
Miyanishi, K.: P1382
Miyano, M.: P0574
Miyashita, M.: P0911
Miyata, T.: OP208, P0959, P1463
Miyata, Y.: OP432*, P0121, P0464, P0480,
P0489, P1315, P1896, P2028, P2029
Miyatake, H.: P0912
Miyawaki, Y.: P1632*, P1633, P1901
Miyazawa, S.: P0637, P0876, P0877,
P1357, P1448
Mizgirev, D.: P0664
Mizoshita, T.: P1121
Mizukami, T.: P1332
Mizuki, I.: P0035
Mizumoto, H.: P1247
Mizuno, N.: OP061
Mizuno, S.: P0680, P1345, P2178
Mizuno, T.: P0685
Mizushima, K.: P1008
Mizuta, T.: P1968
Mizuta, Y.: P1650
Mizutani, T.: P1088
Moawad, F.J.: P1569*
Moayyedi, P.: 57
Mocan, S.: P0023
Mocan, T.: P0630
Mocci, G.: P1774, P1804
Mocciaro, F.: OP334, P1089
Mochizuki, Y.: OP348*
Modawi, S.B.M.: P1365
435

InDeX of aUTHoRs
Módena, J.L.P.: P2138, P2139
Modena, J.P.: P2018
Modini, C.: P1443
Modolell, I.: P0882
Moerman, L.: P1423
Mofid, A.: P0182
Moghimi, J.: P1695
Mogoanta, L.: P0091, P1579, P1580
Mohamadnejad, M.: P1189
Mohamed, A.D.: P1964
Mohamed, E.: P1841
Mohamed, F.S.: P1963
Mohamed-Hussein, A.: P0439
Mohammad, A.: P0472*, P0679
Mohammed, K.A.: P1974
Mohammed, S.D.: P0980
Mohan, N.: P1352
Mohan, P.: P1248
Mohara, O.: P1614
Mohebbi, S.: P1041
Mohindra, S.: P1372
Mohri, T.: P0102
Mohri, Y.: P0102
Moiseenkova, E.V.: P1404
Mokarram, P.: P0413
Mokrowiecka, A.: P0161*
Molato, O.: P0821
Molina Parra, A.: P1572
Molinar, D.: OP284
Molinari, R.: P1999
Molinier-Frankel, V.: P0027
Moll, F.: P0801
Möller, N.: P1729*
Möller, P.: P2120
Molnar, B.: OP484, P0774, P0943, P0944,
P0964, P1134*, P1135, P1144
Molnár, B.: P0773*
Molnár, J.: P1576*
Molnar, T.: P0319, P0348, P1078,
P1740, P1766
Molnár, T.: P0375
Molyneux, M.E.: OP389
Mombello, C.: P1187*
Monahan, K.J.: OP077*, OP478, P0736
Mondot, S.: OP018*, OP020*
Monfort, D.: P0288, P1767
Monfredini, C.: P1128, P1551
Mongeot, A.: P1538
Mongera, S.: OP483*
Monges, G.: OP069, P2101, P2102
436
Mönkemüller, K.: OP063*, OP135, OP210*,
P0162, P0180, P0624, P0652,
P0653, P1451, P1765
Monnin, J.: P0590
Monsanto, P.: P1683
Montagnese, S.: P0447
Montalto, M.: P0119
Montazer Haghighi, M.: P1041
Monteiro, W.R.: P0257, P0895
Monteleone, G.: OP107*
Monterubbianesi, R.: P1090, P1764, P1803
Montgomery, G.W.: P1046
Montgomery, S.M.: P1017
Montialoux, H.: P0665
Montino, F.: P0435, P0502
Montoro Martinez, P.: P0976
Montuori, M.: P1539
Monzón, H.: P0077
Moon, C.: P0323, P0361, P0385, P0656,
P1037, P1042, P1152, P1768, P1776
Moon, C.M.: P1500
Moon, D.H.: OP477*
Moon, I.: P0049, P0984
Moon, J.: P1337
Moon, J.H.: OP451
Moon, J.S.: P0239
Moon, S.: P1132
Moon, S.H.: P1449, P1488
Moon, W.: P0839
Moons, J.: OP345*
Moons, V.: OP011
Moore, E.: P0423
Moore, N.: P1898
Mora, A.: P0804, P0805, P0806,
P0807, P0808
Mora, P.: P2075
Moradi, A.: OP394*, P1857
Moradi, M.: P1555, P1985
Moraes, C.C.: P0917*
Moraes, J.C.: P0992
Morais, A.: P2021
Morais, P.: P0115
Morales, M.: P0085
Moran, A.P.: P0749
Moran Sanchez, S.: P0976
Morana, E.: P0785
Morandi, E.: P1665
Moravkova, M.: P0767
Moreau, J.: P1816
Moreels, T.G.: P1301
P = poster presentation, OP = oral presentation, number only = page number

Moreira, M.J.: P1023*, P2105
Moreira, T.: OP046*, P0625
Moreira-da-Silva, J.: P1684
Moreira-Dias, L.: OP318*, P0416, P0550
Morena-Madrigal, E.J.: P2078
Moreno, V.: P1876*
Moreno-Otero, R.: P1843
Morere, J.: P1141
Morère, J.: P1879
Moret, I.: P1722*, P1809
Morgan, N.: P0303
Morgenstern, S.: P0230, P1528
Mori, A.: P2002
Mori, E.: P1198
Mori, M.: P1149, P2173
Mori, S.: P2113
Mori, T.: 40
Mori, Y.: P1262, P1996, P2035
Moribata, K.: P0040, P1262, P1996
Moriez, R.: P1832
Morihata, K.: P2035
Moriichi, K.: OP058
Morillas-Ariño, J.: P1444
Morimoto, C.: P1746
Morimoto, K.: P0663
Morin, T.: OP080*
Morineaux, E.: P1219
Morini, S.: OP060, P0593, P0766
Morita, I.: P0264
Morita, T.: OP058, P1847
Morita, Y.: OP066, P0562, P0721, P1388*
Moriwaki, H.: P0547, P0644, P0838, P1975
Moriyasu, F.: P0464, P0480, P0489,
P1274, P2028, P2029
Morlais, F.: P1165
Morley, S.: P1291, P1525, P1785
Mornex, J.: OP133
Morois, S.: OP198*
Morra, L.: OP284
Morris, A.: P1782
Morris, A.J.: P0794
Morris, D.: P2052
Morris, D.L.: P0860, P1631
Morris, J.: P1302
Morris-Stiff, G.: P0673
Morsink, F.H.M.: P0223
Mortensen, M.B.: OP038
Mortensen, N.J.M.: P0312
Mortimore, G.: P0487, P0488
Moser, G.: OP457
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Moshkovska, T.: P1552
Moshkovskii, S.: P1230*
Mosnier, J.: OP070, P0955, P0998
Moss, A.: OP434*, OP448, OP469,
P0615, P1331, P1333
Mosse, C.A.: OP280, P0151
Mossner, J.: OP439, OP442
Mosteanu, O.: P0484, P0730, P1222, P1456
Mota Huertas, T.: P1566
Motegi, S.: P1225
Motevalian, M.: P0343
Motomura, Y.: OP009
Motoya, S.: P0335
Motoyama, T.: P1313
Mottet, C.: P1087, P1091, P1825
Mougin, C.: P0218
Moulin, V.: OP295
Moum, B.: OP152, OP155, P0289,
P0290, P1018, P1757
Moumouni, M.: P0544
Mountford, R.: OP281
Moura, D.T.H.: OP010
Moura, E.G.H.: OP010
Mourad, A.A.: P1936
Mourad, F.H.: P0974
Mourao, F.: P2021
Mouray, A.: P1133
Moussata, D.: OP068, OP294
Moutaffian, H.: P1606
Mouzyka, S.: P2041
Mozer-Lisewska, I.: P0044
Mpoumponaris, A.M.: P1249
Mraz, C.: P1437
Mrdja, Z.: P1490
Mrzljak, A.: P0013, P0746
Muckian, J.: P1381
Mudter, J.: OP137*, OP371
Mueller, M.: P2032
Mueller, R.: OP161, P1092, P1093
Mueller-Lissner, S.: OP455, P0381
Mugaba, P.M.: P1485
Mugica, F.: P1200
Muglia, V.F.: P1202
Muir, J.: OP463
Mujakovic, S.: P0141
Mukhametova, E.M.: OP189*, P1653
Mukkai Krishnamurty, D.: OP254, OP265,
P0720, P2155
Mukoubayashi, C.: P1614
Mukuntharajan, T.: P1352
437

InDeX of aUTHoRs
Mulani, P.: OP151, P0332, P0333, P1094,
P1096, P1097, P1098, P1099
Mularczyk, A.: P0159
Mulder, C.J.: OP001*, OP019*, OP337,
P0352*, P0353, P0422,
P0799, P0970, P1146*
Mulder, C.J.J.: OP483*, P0961, P0962,
P0969, P1142, P1161, P1162, P1163, P1873
Mulkay, J.: P0544
Müller, C.: P1260
Müller, L.B.: P0917*
Müller, O.: P0162
Müller-Höcker, J.: OP383
Muls, V.: P0544
Mumtaz, K.: P0483, P0519, P1927
Münch, A.: OP270*
Munda, P.: P1967
Mundi, J.: OP303
Munding, J.: OP238*
Mungan, Z.: P0870, P1861, P1955
Munita, J.M.: P1250
Munkholm, P.: OP155, P0291, P0930,
P1065, P1757
Muñoz, F.: P0288, P0366, P0367
Muñoz, J.: P0632
Muñoz, P.: P0997
Muñoz Galitó, J.: P1547
Muñoz-Navas, M.: OP076*, P1364, P1669
Munson, P.: OP321
Murakami, B.: P0541
Murakami, K.: P0981, P1121
Murakami, M.: P0541
Murakami, S.: P0541
Muraki, A.: P1897
Muraki, Y.: P2035
Muramoto, T.: P0099
Murashima, E.: P0480, P0489, P2028, P2029
Murat, A.: OP040
Mureil, V.: OP103
Muris, J.W.: P0141
Murota, M.: P0876, P0877
Murphy, G.: P0731
Murphy, P.: P1512
Murray, C.: P0303
Murray, F.E.: OP237*, P0058*
Murray, G.I.: P0919
Murray, W.R.: P1131
Murugananthan, A.U.: P0818
Murugesan, S.V.: P0857, P0858
Muscari, F.: P2141
438
Muscatiello, N.: P2042
Musendo, J.: P0423
Mussetto, A.: P0654, P0940, P1377
Musso, T.: P1140
Mustafa, G.: P1947
Mustaffa, N.: P1482
Musto, D.: P1069
Muston, D.: OP172
Mutignani, M.: OP013, P1339, P1560, P2129
Mutimer, D.: 65
Mûzes, G.: P0773*
Mwafulirwa, G.: OP390
Mydlowska, M.: P1246
Myers, M.: P1499
Myftiu, A.: P1606
Myrelid, P.: P0364*
Myrsky, E.: P1538
Mytilinaiou, M.G.: P1179
Myung, S.: P0237, P1123, P1460
Myung, S.J.: OP477*
n
Na, H.: P0237
Nabon, N.: P0174
Naccarato, P.: P1379, P1777
Nacchiero, M.C.: P2042
Nachman, F.: P1519, P1520
Nadalutti, C.: P1538
Nadezhin, A.: OP375*, P0033, P1270
Naegels, S.: P1505
Nagai, K.: P1632*, P1633, P1901
Nagai, T.: P0981
Nagakawa, J.: P0876, P0877
Nagakawa, Y.: P0707
Nagaki, M.: P0547, P0644, P0838, P1975
Nagaoka, I.: P1897
Nagasaka, M.: P0561
Nagasaki, H.: P0556
Nagasawa, K.: P0005, P1693
Nagashima, Y.: OP130*
Nagata, H.: P0418
Nagata, N.: P0542
Nagaura, Y.: P1109
Nagayasu, T.: P1637
Nagengast, F.M.: OP078, OP079*
Naghibalhossaini, F.: P0413
Naghipour, M.: P1484
Nagi, B.: P0062, P1656*, P1657
Nagino, M.: P1869*
Nagl, F.: OP089*
P = poster presentation, OP = oral presentation, number only = page number

Nagtegaal, I.D.: P1142, P1146*
Nagy, F.: P0318, P0348, P0375,
P1078, P1740, P1766
Nagy, P.: OP026
Nagypal, A.: P0649
Nahon, S.: P0737, P0975, P1386
Naiki, T.: P1975
Nain, C.: P1659
Nain, C.K.: P0062, P0788, P1656*, P1657
Nair, D.: P0504
Naito, Y.: P0064*, P0689, P1008,
P1752, P2009
Naito, Z.: P1577
Najafi, L.: P1857
Najafi, M.: P1206
Najjar Sadeghi, R.: P1041
Nakada, I.: P0418
Nakagawa, M.: P0038, P1383
Nakagawa, T.: P0379, P0795, P1075
Nakagawa, Y.: P0561, P0981
Nakahara, A.: OP169
Nakahara, T.: P1806
Nakahigashi, M.: P0358, P0360
Nakai, Y.: P0680, P1345, P2178
Nakajima, A.: OP130*, P1204
Nakajima, H.: P0982
Nakajima, T.: OP466, P0576, P2058*, P2113
Nakajima, Y.: P1632*, P1633, P1901
Nakama, N.: OP009
Nakamichi, S.: P1109
Nakamura, H.: P2043
Nakamura, I.: P0480, P0489, P2028, P2029
Nakamura, M.: OP432*, P0037, P0121,
P0140*, P0331, P0556, P0561,
P1150, P1315, P1486, P1581
Nakamura, S.: OP061, OP201
Nakamura, T.: OP061, OP105*, P0859
Nakano, M.: P1251
Nakano, S.: P1342
Nakao, E.: P1299
Nakao, F.: P1323, P1324
Nakao, F.S.: P2017
Nakao, K.: OP396*, P1650
Nakao, M.: P2040
Nakashima, H.: P0981
Nakashima, Y.: OP396*
Nakata, T.: P1262
Nakatani, A.: P1897
Nakatani, K.: P0120
Nakatsu, M.: P0826, P0912
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Nakayama, M.: P1470
Nakayama, S.: P0005, P1183, P1693
Nakayama, T.: P0059, P1637
Nakmouche, M.: P1761, P1849
Nakos, A.: P0181
Nakui, M.: P0901
Nalet, B.: OP435, P0003, P0738
Nam, S.W.: P0965
Nambu, T.: OP114
Namiot, Z.: P0202
Nancey, S.: OP294, P1727*
Nandurkar, S.: P0874
Nani, A.: P1019, P1759
Nano, J.: P1102
Naomoto, Y.: OP401, P1638
Napier, M.: P1872
Napitupulu, M.: OP143*
Napoleon, B.: OP044, OP294
Napoléon, B.: P0551
Napoli, R.: P0297
Nappi, G.: OP100
Narashiman, M.: P0668, P1418, P2083,
P2158
Nardi, F.: P0905, P0906
Nardone, G.: OP275, P0034, P0455
Narisawa, R.: OP346, P1281, P1644, P2177
Nascimbeni, R.: P0365, P1430
Nasir, A.: P0727
Nasirizadeh, M.: OP131
Näslund, E.: P1108, P1848
Nasr, A.M.: P1964
Nasrollahzadeh, D.: P0842, P1630
Nasseri-Moghaddam, S.: P0182
Nasta, M.: P0691, P1437
Natália, A.: P1216
Nauclér, E.: P0139, P0843
Naumov, I.: OP086*, OP162, OP479, P1868
Naumovski Mihalic, S.: P0013
Naumovski-Mihalic, S.: P0746
Navab, N.: P1298
Navaglia, F.: OP226*
Navajas, J.: P2117
Navarathne, N.M.M.: P1016
Navaratne, N.M.: P2127
Navarrete, C.: 37, 54
Navarro, A.: OP010, P2044
Navdar, M.: OP363
Nave, Y.: P2064
Naveh, M.: P0868
Nawrot, B.: P1475
439

InDeX of aUTHoRs
Nawrot-Porabka, K.: P1391, P2124
Nayar, M.: P1353, P2003
Naydenova, D.: OP196*
Naz, S.: P0054
Ndeezi, G.: P1485
Neaga, M.: P1654
Neagoe, D.: P1223
Neale, J.: P0580
Neary, P.: P1166
Nebia Colombo, C.: P1197
Nedevschi, S.: P0468
Neerincx, M.: OP483*, P1162
Negi, M.: P0891
Negm, A.: P2071, P2079
Negmy, H.H.: P0703
Negovan, A.: P0023
Negreira, S.: P1783
Negro, P.: P1893
Negroni, A.: OP023
Nehru, R.: P0891
Nelemans, P.J.: P1682
Nelson, L.M.: P1120
Nelvin, L.: P0714
Nemes, E.: P1522, P1523
Nemeth, A.: P1432, P1661, P2115
Németh, I.: P0183
Nemeth, J.: OP110*, P1675
Nenna, R.: P1539
Neong, S.F.: P0860, P1631
Neoptolemos, J.P.: OP281
Nepalia, S.: OP298*, P1196, P1930,
P1931, P1949, P2013
Neporada, K.: P0103
Nerantzoulakis, I.: P0285*
Nesbitt, A.: P0999, P1000, P1001, P1002
Neser, F.: P1399
Ness-Jensen, E.: P0770
Nestorovic, M.D.: P1685
Neugut, A.I.: OP162
Neuhaus, H.: OP113, OP248, 40
Neuman, D.: P0139
Neumann, H.: OP210*, P0162, P0180,
P0624, P0652, P0653, P1451, P1765
Neunlist, M.: P1102, P1832
Neurath, M.: OP068, OP107*
Neurath, M.F.: OP067*, OP137*, OP371,
OP425, P0477
Nevarez, A.: P1809
Neves, A.A.: P0146
Nevoral, J.: OP193*
440
Nevsimalova, S.: P1199
Newnham, E.: OP463
Newton, J.: 18
Neye, H.: OP205, P1769
Ng, E.: 37
Ng, J.: OP368
Ng, S.C.: P1003, P1004, P1014*,
P1015, P1080, P1723
Ng, S.S.M.: P1325
Ng, X.: P0236
Ngouanesavanh, T.: P1133
Nguyen, J.H.: P0457
Nichita, C.M.: P2080
Nicholls, J.: P0403, P1106
Nicholls, R.: P0307, P1074
Nicholson, B.D.: P2045*
Nicholson, S.: P1356
Nickerson, C.: P0937, P1889
Nicklas, W.: P1729*
Nicolai, H.: P1838
Nicolas, P.: P1141
Nicolás-Pérez, D.: P0549
Nicolita, D.: P0525
Niculescu, M.: P1205
Niederberger, C.: P0136
Nielsen, C.: P0800
Nielsen, H.J.: P0666
Nielsen, J.: P1432, P1661, P2115
Nielsen, O.H.: P1810
Niemczyk, E.: OP281
Nieminen, U.: P1800, P1976
Nieto, A.: P1736, P1743
Nieuwenhuijzen, G.A.: P0723
Nieuwenhuis, M.H.: P2152
Niezgoda, K.: P0843
Nightingale, J.: P2154
Nightingale, J.M.D.: P0818
Niihara, T.: P2175
Niimi, K.: P1686, P2151
Nijhawan, S.: OP298*, P1196, P1930,
P1931, P1949, P2013
Nijmeijer, R.M.: OP473*, OP474
Nikishayev, V.: P0543, P2015
Nikitenko, T.M.: P1398
Nikitina, L.V.: P0198
Nikolaidou, E.: P0978*
Nikolic, A.: P0414
Nikolopoulou, V.N.: P0892
Nilsson, Å.: P0620
Ninet, J.: P1573
P = poster presentation, OP = oral presentation, number only = page number

Ninomiya, S.: P0547
Nio, C.: OP250*
Nio, Y.: P1406, P1407
Nio, Y.C.: OP065*, P2097
Nioh, T.: P2175
Nir, Y.: P0246
Niriella, M.A.: P1016, P1224, P1285*
Niro, G.: P0517
Nisand, G.: P1084
Nischal, N.: P0891
Nishi, T.: P0901
Nishida, A.: OP348*, P1718
Nishida, M.: OP184*
Nishida, N.: OP432*
Nishida, T.: P0573
Nishida, U.: OP184*
Nishikage, T.: P1632*, P1633, P1901
Nishikawa, J.: P1280
Nishikawa, K.: P0564, P0565
Nishimata, H.: P2175
Nishimata, Y.: P2175
Nishimura, K.: P1897
Nishimura, N.: OP208
Nishimura, T.: OP348*
Nishina, H.: P1192
Nishino, K.: P0541
Nishino, M.: P0836, P1492
Nishino, T.: P1299
Nishio, A.: P1183
Nishiyama, H.: P1650
Nishiyama, Y.: P0465
Nishizaki, Y.: P1225
Nishizawa, A.: P0982
Nissen, L.: P1506
Nitecki, J.: P1543
Niv, Y.: P0022, P0039, P0229, P0230,
P1528, P1770, P1810
Niveloni, S.: P1519, P1520
Niwa, Y.: P0331
Nixon, E.: P1226
Nizou, C.: P0590
Nizushima, T.: P1121
N'Kontchou, G.: P1240
Nkuize, M.: P0544
Nobakht, H.: P1695
Nobile, S.: P0334, P0340, P0349
Noble, C.L.: P1036
Nobre, S.: P2086
Nobre Leitão, C.: P1635, P2098, P2099
Nobre-Leitão, C.: OP081*, P0419
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Nocca, D.: P2149
Noda, T.: P1470
Noda, Y.: P0168, P1294, P1446
Noël, D.: OP057*
Noel, P.: P2149
Noguchi, M.: P1111
Noguchi, Y.: P0379, P1075
Nogueira, O.: P1842
Noh, S.: OP291
Noh, Y.: P0984
Nolasco, E.R.: P0497, P1991
Noma, K.: P1638
Noman, M.: P0309, P0351, P1079
Nomiya, S.: OP401
Nomoto, K.: P0040
Nomura, M.: P0983
Nonaka, K.: P2040
Noohi, A.: P1857
Norbury, T.: P1471
Nordgren, C.: P2120
Norimura, D.: OP396*, P1650
Norman, A.J.: P0135, P1487
Norman, G.L.: P1254
Nos, P.: P1722*, P1809
Notas, G.: P1738
Noullet, S.: P0704
Nouraie, M.: P0182
Nourazar, A.: OP131
Nousbaum, J.: P1888*
Novacek, G.: P1771, P1772
Novelli, M.R.: OP224, P0074, P0908
Novi, M.M.: P1997*
Novo, E.: OP125*
Novotny, I.: P1282
Novovic, S.: P0666
Nowacki, T.: P1724
Nowak, A.: OP116, P0678, P2126
Nowakowska-Dulawa, E.: OP116
Nowecki, Z.I.: P0861
Noyes, K.J.: P1514
Nozaki, Y.: OP130*, P1204
Næs, H.: P1305
Næsdal, J.: P0139
Ntounda, R.S.: P0544
Nudelman, M.: P0868
Nuevo, J.: P0732, P0887
Numans, M.E.: P0141
Numminen, K.: P1177
Nunes, A.C.R.: P1773
Nunes, J.: P1181, P1243
441

InDeX of aUTHoRs
Nunes, J.M.: OP232*
Nuñez, H.: P1343
Núñez Calvo, L.: P1704
Nussinson, E.: P2081
Nuta, J.: P2035
Nuti, F.: OP195*, P1654
Nyamaa, B.: P2133
Nyari, T.: P1766
Nyberg, B.: P0081, P0082
Nyhlin, N.: OP272, P1017
Nylander, D.: P1890, P1891
Nyström, N.: P1005
Nyuzuki, S.: P2031
o
Oaki, Y.: P0234, P1577
Obana, T.: P0168, P1294, P1446
Obando, J.: OP262
Obata, T.: P1501
O'Beirne, J.: P0504
Obi, S.: P2119
Obradovic, B.: P0499, P1789
O'Brien, E.: P1155, P1156
O'Brien, J.: P1499
Obst, W.: P1416
Obuch-Woszczatynski, P.: P0190
Ochagavia, S.: P2024
Ochiai, M.: P1111
Ochiai, T.: P1313, P1897
Ochoa-Sangrador, C.: P0672
Ochsenkühn, T.: OP325*, P0294, P1056,
P1819
Ocker, M.: OP003*, OP091*, P0687
O'Connor, H.J.: P1006, P1570
Oda, H.: P1650
Ødegård, L.: P1305
Odeh-Ramadan, R.: P1932
Odeh-Ramadan Jr., R.: P1934
Ödemiş, B.: P2084
Odes, S.: OP155, P1757
O'Donnaghue, Y.: P0749
O'Donnell, S.: P1006, P1512, P1570
O'Donoghue, D.: P1717
O'Donovan, M.: OP399*, P0146
Odstrcil, E.: OP369
Oeda, S.: P1968
Oedegaard, S.: P1117
Offerhaus, G.A.: P0223
Offerhaus, G.J.A.: OP218*, P0276
Offerhaus, J.: P0988
442
Offerhaus, J.A.: OP104*
Ogata, H.: P0335
Ogata, N.: OP071*, OP072*, P0655, P2046
Ogawa, T.: P0168, P1294, P1446
Ogier-Denis, E.: P0273*
Ogiyama, H.: P0573
Ogo, T.: P1632*
Ogollah, R.: P0622
O'Gorman, P.: P1166, P2056
Ogura, K.: P2119
Oh, H.J.: P0537
Oh, J.: P1604
Oh, S.: P0222
Ohaki, Y.: P0911
Ohara, N.: OP428
O'Hare, A.: P1663
Ohashi, N.: P2002
Ohata, H.: P1614
Ohda, Y.: OP201
Ohira, T.: P0168, P1294
Ohlin, B.: OP249
Öhman, L.: P0322
Ohmiya, N.: P0331
Ohmura, T.: P0015, P0035, P0490
Ohnishi, H.: P1150
Ohnita, K.: OP396*, P1650
Ohno, A.: P1373
Ohno, I.: P1086
Ohno, S.: OP144, P1111
Ohno, Y.: P0099, P0947
Ohshima, T.: OP058
Ohta, M.: P2119
Ohtsu, A.: P0099, P0947
Ohtsuka, K.: OP467*, P0316, P0655,
P1311, P2070
Ohtuka, K.: P2046
Oikawa, H.: P2046
Oikawa, K.: P0466, P1275
Oikonomou, K.: P1038
Oivanen, T.: OP166
Ojima, H.: P0859
Oka, M.: P0040, P1262, P1614,
P1996, P2035
Oka, S.: OP344*
Okada, H.: OP401, OP428, P0566, P1008,
P1271, P1272, P1273, P1643, P2037
Okada, K.: P1148
Okada, M.: OP454, P1113
Okada, T.: P1632*, P1633, P1901
Okamoto, M.: P2119
P = poster presentation, OP = oral presentation, number only = page number

Okamoto, N.: P1459
Okamoto, R.: OP009, OP105*
Okamoto, S.: OP064, P1746
Okamoto, T.: P1280
Okamura, S.: P0855
Okano, K.: P0465, P0700
Okano, N.: P1342
Okanobu, H.: P0272, P0369*
Okawara, H.: P0981
Okazaki, K.: P1183
O'Keefe, S.J.: OP141, P0813, P0814
O'Keeffe, J.: P0749
Okhlobystin, A.V.: P2133
Okhly, M.: P1857
Okita, I.: P0662
Okten, A.: P1955
Okubo, M.: P0140*, P0556, P0561,
P1486, P1581
Okuda, C.: P2131
Okuda, H.: P1588
Okugawa, T.: P1847
Okugawa, Y.: OP480
Okuno, T.: P0562
Okushiba, T.: P1382
Olagbaiye, O.: OP149
Olakowski, M.: P0686
Olbers, T.: P1549
Olcer, T.: P0728
Olde Damink, S.W.: P0712*
Olde Damink, S.W.M.: P0775
Oldenbrug, B.: P2103
Oldenburg, B.: OP159*
Olesen, M.: OP194
Olesen, S.S.: P1563, P1836, P2134
Oliva, L.: P0329, P1085, P1089
Oliva, S.: OP023, P0195
Olivares, M.: P0260*, P0261
Oliveira, D.: P0115
Oliveira, Manuel H.: P1561
Oliveira, Maria H.: P1561
Oliver, K.L.: P1607
Oliver, P.: P0568
Oliverius, M.: P2034
Olivetti, G.: P0940
Olivier, I.: P1007*
Ollero, V.: P1063
Olmedo Martín, R.: P0336
Olmez, O.F.: P1984
O'Loughlin, J.: P1166
Olsson, A.: P1318
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Olszak, T.: OP382*, P1728
Olszewski, W.: OP422
Olveira Martín, A.: P0725
Olvera, J.: P0506*
Omata, M.: P0680, P1345, P2119, P2178
Omatsu, T.: P1008, P1752
Omloo, J.M.T.: P1647
Omodei, P.D.: P1068
O'Morain, C.: P1166, P1512, P1825,
P2056
O'Morain, C.A.: P1006, P1570, P1770
Omori, K.: P1192
Omori, T.: OP343
Omoritai, T.: P0545
Omura, T.: P0674
Omuta, S.: OP114
Onali, S.: OP334, P0863, P1379, P1777
Onder, F.: P0728
Onder, O.F.: P1442
O'Neill, D.: P0719
Ong, C.: P1425
Ong, J.: P1760, P1938, P1940, P1991
Ong, J.J.: P1956
Ong, J.P.: P0497, P2023, P2069
Ono, A.: P1160
Ono, H.: P0546, P0563, P1268, P1584
Ono, M.: P0982
Ono, S.: OP184*, P0038, P1383,
P1686, P2151
Onoda, T.: OP401
Onogi, F.: P0547, P0644, P0838
Onouchi, T.: P1111
Onozato, Y.: P0559, P2173
Oohara, E.: P0408
Oomen, M.W.N.: P0372
Oonishi, M.: P0408
Oors, J.: P0186*
Oort, F.A.: OP483*, P0422, P0961, P0962,
P1161, P1162, P1163
Ooteman, R.A.M.: P1163
Opacic, M.: P1329
Opheim, R.: P1018
Oppong, K.: P1353, P2003
Oprea, B.: P1579
Orange, N.: P0996
Oravcova, S.: P1754, P1755
Orchard, T.R.: P0281, P0282, P0736, P1030
Orchel, J.: P0678
Ordás, I.: OP160*
Ordubadi, P.: P0739
443

InDeX of aUTHoRs
O'Regan, K.: P1061
Orel, I.: P1621
Orel, R.: P1540, P1613, P1621
Oresland, T.: 33
Organe, S.: OP327*, OP328
O'Riordan, D.: P0898
Orlando, A.: OP334, P1089, P1090
Oroian, L.: OP239, P0130
Orosz, P.: P1253, P1254
O'Rourke, A.: P0641
Orozco, A.: P0395, P0396
Orsello, M.: P0435, P0502
Orsini, E.T.: P2138
Orsoni, P.: P1428
Ortiz-Mellet, C.: P1735
Ortner, M.: P2080
Oruc, N.: P0508
Osamura, O.: P0271
Osanai, M.: P1447
Osawa, Y.: P1975
Osborn, J.: P0430
Oshima, T.: OP430, P1847
Oshitani, N.: OP054*
Osia, S.: P0199
Osipenko, M.F.: P1398
Osoegawa, T.: OP009
Osorio, C.: OP008
Ost, A.: P0357
Öst, Å.: OP270*
Ostapchenko, L.I.: P0109
Österreicher, J.: P2112
Ostrovska, G.: P1137
Ostrowski, J.: P0060, P0861
O'Sullivan, G.: P0900
O'Sullivan, M.: P1006
Otaki, Y.: P0118
Otazua, P.: P0473, P1200
O'Toole, D.: P2141
Otsuka, T.: OP432*
Otto, W.R.: P2128
Otubo, M.: P1447
Ouakaa-Kchaou, A.: P2082
Ouerdiane, S.: P0311
Ould Gougam, R.: P0108
Ouldgougam, R.: P1434
Oumnia, N.: P0635, P0879, P1434, P1574
Ourselin, S.: P2007
Oussalah, A.: P0337, P1019
Oustamanolakis, P.: P0338
Ouvry, D.: P2073
444
Ouyang, S.: P0963
Owczarek, D.: P1733, P1734
Owen, T.: P0854, P1305
Oya, M.: OP009
Oya, T.: P0272, P0369*
Oyagüez, I.: P0366, P0367
Oyama, S.: P2031
Oyama, T.: OP347, OP352, P1582,
P1583, P1642
Oza, C.: P2066
Oza, N.: P1968
Ozaki, I.: P1968
Ozawa, M.: P0674
Ozawa, T.: P0707
Ozdil, S.: P0870, P1955
Ozen, C.: P0219, P1048
Ozin, Y.: P0667
Özin, Y.: P2085
Ozkara, S.: OP124, P0017, P0748
Ozono, Y.: P1109
Oztas, E.: P0728
Ozturk, A.: P0508
Öztürk, Ö.: P0890
Ozturk, R.: P0776
P
Pacchioni, D.: P2094, P2095
Pace, F.: P0548, P0883, P1608
Pacelli, F.: P1362
Pacha, A.: OP217*
Pacha, A.F.: P0163*
Pachera, S.: P1256
Pachlewski, J.: OP407
Pacifico, L.: 51
Pack, K.: OP077*
Paclik, D.: OP307*
Paczkowska, E.: OP052*
Padol, I.T.: OP438*, P0829
Padula, D.: P0095
Paerregaard, A.: P0930
Paganin, S.: OP164
Pagano, N.: P2047
Paganotti, A.: P0435
Page, R.: P0694, P0699
Pagel, P.: OP089*
Pagenault, M.: OP326*
Paggi, S.: P0001, P2048
Pagliarulo, M.: P0502
Pagnini, C.: P0231
Pahlman, L.: 18
P = poster presentation, OP = oral presentation, number only = page number

Pahuja, S.: P0521
Paik, C.: P2181
Paimela, H.M.: OP166
Paintaud, G.: P1805
Painter, J.: P1890, P1891
Pajdo, R.: P0295
Pak, K.: OP291
Pal, A.: OP134, P1245
Palakurthi, M.: P1193
Palaniappan, K.: P0668, P1418,
P2083, P2158
Palaniappan, S.: P1352
Palatka, K.: P0319, P1078, P1252, P1253
Palau, A.: P0288
Palejwala, A.: P1158, P1534
Palen, P.: P0159
Palicka, V.: OP380, P1544
Palka, M.: P0138
Pallone, F.: OP107*, OP163*, OP334,
P0306, P0863, P1379, P1777, P1883
Pallotta, N.: OP195*
Palma, A.: P2025
Palmer, N.: P0597, P0607
Palmieri, G.: P0863
Palmieri, O.: P1043
Palomeque, F.: P1169
Palyu, E.: P1252, P1254
Pan, Y.: P0851*
Panaccione, R.: OP199*, P1758, 36
Panão, E.A.: P1561, P1712
Panas, R.M.: P1850, P1851,
P1852, P1853
Pancheva, R.: OP196*
Pande, C.: OP353, P0520, P0521, P1186*
Pandolfi, M.: P1339
Pandolfino, J.E.: P1564
Pandur, T.: P0317, P0320
Pane, A.: P2183
Panella, C.: P2042
Panes, J.: P0367, P1548
Pang, S.H.: P0740, P0741
Pani, G.: P1257
Panis, Y.: P0362, P1825
Panov, V.E.: P0514
Panteliou, E.: P1507
Panter, S.J.: P1380, P2104
Panther, E.: P0471
Pantling, A.: P0423
Paoli, A.: P0690
Paoluzi, O.: P1883
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Paoluzi, P.: P0789, P0905, P0906,
P0938, P0939
Papa, A.: P0250, P0251, P0304,
P0350, P1774, P1804
Papadakis, G.: P0285*
Papadia, C.: P0784
Papaioannou, G.: P1474
Papamichael, K.: P1474, P1775
Papanikolaou, I.S.: OP181, OP441, P0232
Papas, M.G.: P0232
Papatheodoridis, G.: P1862
Papatheodoridis, G.V.: P0526
Papatheofanis, F.: P1071
Papaxoinis, K.: OP181, P1376, P2118
Papay, P.: P1066, P1771
Pape, U.: P1157, P1164
Papi, C.: OP334, P1090
Papp, J.: P0317, P0319, P0320,
P0649, P1078
Papp, M.: P0319, P1078, P1252, P1253,
P1254, P1522, P1523
Pappas, P.: P2169
Pappi, V.: P1672
Par, A.: P1253, P1254, P1977
Par, G.: P1253, P1254, P1977
Paradowski, L.: OP460, P1020, P1778,
P1779
Paramasivan, P.: P0004
Parasiri, M.: OP120
Paraskeva, P.: P2161, P2162
Paraskevas, E.: P0002, P2169
Pardo, A.: P0631*
Parfenov, A.: P0793
Parfenov, A.I.: OP050
Pari, C.: P0090
Parichatikanond, P.: OP230*
Pariente, A.: P0737
Parikh, K.B.: P1009
Parikh, S.: P1622
Parini, P.: P0536*
Park, C.: P1617
Park, C.H.: P0123, P1895
Park, C.K.: P1895
Park, D.: P1228
Park, D.H.: P1449, P1488
Park, D.Y.: OP451
Park, G.: P1833
Park, H.: OP229, P0481, P0656,
P1010, P1855, P2050
Park, H.W.: P0967
445

InDeX of aUTHoRs
Park, J.: P0094, P0222, P0323, P0361,
P0385, P0656, P0669, P0984, P1037,
P1042, P1152, P1228, P1337, P1453,
P1460, P1756, P1768,
P1776, P1924, P2182
Park, J.H.: P0239, P1488
Park, J.J.: P0125, P0535, P1136, P1500
Park, J.W.: P0967
Park, J.Y.: P1452, P1990, P2143
Park, K.: P0410, P0742, P1575*,
P1617, P1946
Park, K.S.: P1277
Park, M.: P0433, P0839
Park, P.: P0240, P0714, P0715,
P2159, P2160
Park, S.: P0094, P0101, P0586, P0839,
P1215, P1321, P1854,
P1994, P2016, P2142
Park, S.C.: OP175, OP180*, OP376*,
P0522, P0762, P0948, P2016, P2049
Park, S.G.: OP451
Park, S.H.: OP175, OP180*, OP376*,
P0522, P0762, P0948, P1895, P2049
Park, S.J.: OP477*
Park, S.M.: P0390, P1452, P1990, P2143
Park, S.W.: P1452, P1990, P2143
Park, S.Y.: P0217
Park, W.S.: OP292*
Park, Y.: P0409, P0873, P1123, P1215
Park, Y.S.: P1124
Park, Y.Y.S.: P0313
Parkash, O.: P0483, P1184
Parker, G.: P1001
Parker, R.: P1508
Parkes, G.: P0258
Parkes, G.C.: OP024
Parkes, M.: P1039, P1040
Parks, T.R.: P1564
Parlak, E.: P0667, P0728, P1442,
P2084, P2085
Parodi, A.: P0169, P0170, P0184,
P0785, P0786
Parola, M.: OP125*, P1140
Parr, D.: P0933
Parra, R.S.: P0241
Parra-Blanco, A.: P0549
Parry, C.M.: OP389
Parry, L.: OP103
Parsi, M.A.: OP113
Partensky, C.: OP290, OP294
446
Parton, T.: P1001
Parupudi, S.: OP261
Parvu, M.I.: P0772
Pascoe, A.: OP278
Pascu, O.: P0630
Pasini, V.: P0090
Paskaran, P.: P0818
Paspatis, G.A.: OP120, P2051
Passaretti, S.: P1863
Passos Neto, M.G.: P0087
Pata, C.: P1998
Patch, D.: P0504
Patel, D.: OP400
Patel, J.: OP002
Patel, K.P.: P2052
Patel, N.: P1014*, P1015, P2052
Patel, N.D.: OP233*, P0523, P1185
Patel, P.: P0148, P0580
Paterlini, A.: P2153
Paternostro, C.: OP125*, P1140
Paterson-Brown, S.: OP400
Pathmakanthan, S.: P1795
Pathmeswaran, A.: P1596
Patnick, J.: P0937, P1889
Patra, S.: P0520, P0521, P1186*
Patrick, A.: P1378
Patsouris, E.S.: P0232
Patterson, D.: P0345
Pattni, S.S.: P0092, P0787
Pattynama, P.M.: P1438*
Paucar, H.: P0755
Paulo, G.A.: P2017
Pausawasdi, N.: P0626
Pauwels, A.: P0737
Pavel, M.: P0690
Pavel, M.E.: P1157
Paven, G.: P1309
Pávics, L.: P0375
Pavlides, P.: P1179
Pavlikova, M.: P1413
Pavlov, A.: P1270
Pavord, I.D.: P0257, P0895
Pawlik, W.: P0295
Pawlik, W.W.: P1391, P1414, P1543,
P2122, P2124
Pawlotsky, J.M.: 65
Payer, J.: P0989
Payne, K.: P1934
Payne, K.A.: P1932
Paziewska, A.: P0060, P0861
P = poster presentation, OP = oral presentation, number only = page number

Pazurek, M.: P0233
Pearce, C.: P2072
Pearl, D.: P1330
Pearlman, R.: P0247
Pearson, J.: P1045
Pearson, J.P.: P1622
Pech, O.: OP341, OP342, P0164,
P0165, P1634
Pecic, V.M.: P1685
Peck-Radosavljevic, M.: OP355*, P0608
Pecout, S.: P0690
Peczek, L.: P1475
Pedarnig, N.: P0315
Pedeboscq, S.: P1898
Pedersen, H.D.: P1012
Pedersen, L.: OP139
Pedersen, N.: P0291
Pedica, F.: P1256
Pediconi, N.: P1870, P1910
Pedrazzani, C.: P1578*
Pedrinis, E.: P0027
Pedruzzi, E.: P0273*
Peeters, H.: P0315, P1745
Peeters, P.H.M.: OP074
Peiris, M.: OP461*
Peiris, S.K.R.: P1016
Peitz, U.: P1769
Pejchal, J.: P2112
Pejsa, V.: P0462
Pelado, E.: P1159
Peláez, A.: P1058
Pelaez, G.: P0473
Pelckmans, P.A.: P1301
Pèlegrin, A.: OP468*
Pelletier, A.: P1402
Pellicano, R.: P2093, P2096
Pellicer Bautista, F.: P1366
Pellise, M.: OP259*, OP260*, P0631*,
P0632, P1385
Pellish, R.: OP369
Pena, E.: P0085
Penagini, R.: OP136, P0179, P0618, P1616
Penfornis, A.: OP040
Peng, C.: P0208
Peng, S.: P0884, P1322, P1609, P1628
Peng, T.: P0412
Peng, Y.: P0841
Penninckx, F.: P0351
Pennock, J.L.: P0993
Pepermans, X.: OP423*
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Peppelenbosch, M.P.: OP312*, OP315*,
P0274, P0275, P0988, P1009
Peradzynska, J.: P0189
Peralta, S.: OP358*, P1090, P1960
Peran, L.: P0260*
Perdoná, G.C.: P1265
Perego, M.: P0095
Pereira, B.: P0583
Pereira, C.: OP318*, P0416
Pereira, E.: P0583
Pereira, P.: P1952
Pereira, R.: OP219*
Pereira, S.: P0299, P1011
Pereira-Silva, J.: P0419
Perez, J.: P0506*, P1250
Pérez, T.: P1995
Pérez-Arellano, E.: P2078
Pérez Contreras, M.: P0606
Perez Cuadrado, E.: P1160
Pérez de la Serna, J.: P1571, P1572
Pérez-García, J.: P1444
Perez-Grueso, M.J.: P2117
Perez Johnston, R.: P1384
Perez Millan, A.: P1343
Pérez Robledo, J.: P0725
Pérez-Sola, Á.: P1444
Pérez-Vigara, G.: P1444
Perminow, G.: P0045
Perna, F.: P0019, P0020
Perng, C.L.: P0862
Perotti, C.: OP048
Perrea, D.: P1719
Perret, G.: P1141
Perri, F.: P2091
Perri, V.: OP013, P1339, P1560, P2129
Perrier, C.: P1031*, P1079
Perrier, H.: P1359, P1360
Persborn, M.O.: OP269*
Perschy, T.: OP002
Persiani, R.: P1362
Persico, G.: P0941
Persson, C.: P0842
Persson, G.: OP249, P1338
Perticusic, L.: P0462
Perucci, C.: P1764
Pesce, G.: P1781
Pesek, F.: P0827
Pesenti, C.: OP069, P2101, P2102
Pesic, T.: P1490
Pestana, M.: P1917
447

InDeX of aUTHoRs
Peter, B.: OP134
Peters, C.J.: OP395*, OP399*
Peters, F.T.M.: OP221
Peters, H.M.: OP240*
Peters, J.: OP390
Petersen, B.T.: OP113
Petersen, Y.M.: OP381*, P1012
Peterson, C.: P1731
Petrakov, A.V.: P1919
Petrarca, L.: P1539
Petrella, C.: OP274*
Petrenkiene, V.: P1238
Petricusic, L.: P1349, P1599
Petridis, I.: OP226*
Petroboni, B.: P0804, P0805, P0806, P0807
Petrone, M.: OP258*, P0677, P2091
Petrone, M.C.: P2090
Petrov, M.S.: P0540*, P0670, P0819
Petrovic, M.: P1194
Petrovic, Z.: P1490
Petrtyl, J.: OP364, P1199
Petruzzellis, C.: P2153
Petruzziello, C.: OP334, P0306, P0863,
P1090, P1379, P1777
Petruzziello, L.: OP174, OP185, P0306
Petryka, R.: P1810
Petryszyn, P.W.: P1020, P1778, P1779
Petta, S.: P1959
Pettengell, K.: P0782
Pettersen, M.: P1305
Pettitt, E.A.: P1297
Peykan-Heirati, M.: OP225
Peyrin-Biroulet, L.: P0337, P1019
Pfammatter, T.: P0708
Pfennig, S.: OP325*, P0294, P1056
Pham Thi, T.T.: P1978
Phelip, J.M.: P0337
Phesse, T.: OP103
Philcox, S.M.: OP262
Philippe, V.: P1007*
Philit, F.: OP133
Phillips, A.D.: OP385*
Phillips, A.R.: P0819
Phillips, M.: OP025*, OP051*, OP309*
Phillips, R.K.: P0641
Phillips, R.K.S.: OP004
Piantadosi, F.: P0588, P1422
Piazzi, G.: OP316*, OP320
Pica, R.: P0789, P0905, P0906, P0938, P0939
Picard, M.: P0009
448
Picard, O.: OP330
Picarelli, A.: P0789
Piccini, P.: OP165
Piche, T.: P1102
Pick, A.C.: P2053
Picon, L.: P1805
Piconese, S.: P1814*
Picq, C.: P1101
Pienkowski, P.: P1317
Pierangeli, F.: P0349
Pierconti, S.: P0517
Pierdomenico, M.: OP023
Pierik, M.: P1024, P1025
Pierik, M.J.: OP159*
Pierik, R.E.G.: P0363
Piersma, S.: P1143
Pierzchalski, P.: P1414
Piessevaux, H.: OP423*, P0114, P0150
Pignatelli, M.: P1878
Pignaton, G.: P1021
Pigò, F.: P0090
Pike, J.: P1096, P1098
Pikkarainen, P.: OP166
Pilipenko, V.I.: P1856
Pilotto, A.: OP405, OP410, P1705, P1709
Pilozzi, E.: P0231
Pimentel, F.F.: P0339, P1821
Pimentel, R.: OP046*
Pimentel-Nunes, P.: OP318*, P0416,
P0550, P1917, P2021, P2022
Piñar, A.: P0619
Pinarbasi, B.: P0870, P1861, P1955
Pineda, J.R.: P0085
Pineton de Chambrun, G.: P0061
Pinho, R.: P0083, P1227
Pini, J.: P1842
Pinon, A.: P1133
Pintea, B.: P0730, P1456
Pinto, A.: P0419
Pinto, J.: P0083, P0500, P1472,
P1908, P1926
Pinto, J.I.: P1227
Pinto, R.: OP046*
Pinto Sanchez, I.: P1519, P1520
Pinzani, M.: OP125*, P1865
Pioche, M.: OP183, P0551
Pipitone, L.J.: P0720
Piqueras, B.: P1053, P1054, P1812
Piqueras, M.: OP160*, P1767
Pirici, D.: P1579, P1580
P = poster presentation, OP = oral presentation, number only = page number

Pironi, L.: 56
Pirozzi, C.: P0297
Pirsic, M.: P0462
Pisani, A.: P2004
Pisarczyk, A.: P0832
Piscaglia, A.: P0417, P1997*
Piscaglia, A.C.: P1257, P1797
Piselli, P.: P1878
Piskun, D.V.: P1509, P1510
Pistiolas, D.I.: P0759
Pittet, V.: P0308, P1087, P1091, P1825
Pituch, H.: P0190
Piubello, W.: P0548, P0735
Pivot, X.: P1879
Pizzillo, P.: OP358*, P1959, P1960
Placidi, E.: P0380
Plamondon, S.: P1003, P1004
Planche, L.: OP005
Planche, T.: OP393
Planeta-Malecka, I.: P0196
Plata, A.: P0678
Platos, J.: P0206
Platou, C.G.P.: P0770
Platt, E.: P0854
Plebani, M.: OP226*
Pleguezuelo, M.: P0504
Plesca, D.: P0927
Pleskow, D.: OP115
Pleskow, D.K.: OP113
Pletikosić, S.: P0305
Plevris, J.: P0640
Plevris, J.N.: OP400, P1375
Plewka, K.: P0106
Plöckinger, U.: P1164
Ploplis, V.: OP311*, P0278
Poca, M.: P1083
Pocard, M.: OP110*, P1675, P2157
Pochart, P.: OP020*
Poci, C.: P0447
Podevin, P.: P0590
Podrug, K.: P0462
Poggioli, G.: P0334, P0349
Pohl, D.: P0169, P0170, P0397, P1545
Pohl, H.: OP139, P0166, P2011, P2054
Pohl, J.: OP341, OP342, P0165, P1634
Poiraud, S.: OP299*
Pokharna, R.: OP298*, P1930, P1949, P2013
Pokorska, J.: P1543
Pokorski, J.: P1543
Pokrotnieks, J.: P1370
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Pokrovskii, Y.A.: P1701
Polecina, A.: OP016
Poley, J.W.: P1406, P1407, P1408, P2097
Polifemo, A.: P1680
Polifemo, A.M.: P2145
Polimeni, F.: OP112
Polimeni, N.: OP112
Polipalli, S.K.: P0679
Polistena, A.: P0938, P0939
Polkowski, M.: P0861, P1310
Pollack, P.F.: P1094
Pollard, S.: P0089
Poller, D.: P0596, P1292
Pollicino, T.: OP297*
Pollok, R.C.G.: OP393, P1022, P1027,
P1511, P2057
Polter, D.: OP369
Polymeris, A.: P1474
Polymeros, D.: P0255, P1013
Pomgprasobchai, S.: P0626
Pommer, B.: P2174
Pompili, M.: P0501, P1220
Ponce, J.: P1722*, P1809
Ponce, M.: P0366, P0367
Ponchon, T.: OP005, OP044, OP113,
OP248, OP294, P0551
Pongsanguansuk, W.: OP465*
Pons Beltran, V.: OP212
Ponsioen, C.Y.: OP203*
Pontes, R.: P1842
Pontisso, P.: P1140
Ponziani, F.: P1797
Poon, M.C.M.: P1325
Poordad, F.: P1932, P1934
Poornachandra, K.S.: P0788
Poovorawan, Y.: OP301
Pop, O.: OP200, P0691, P2125
Pop, T.: P0629, P0730, P1222, P1456
Pop, T.A.: P0484
Popescu, A.: P1982
Popescu, C.: P2038*
Popescu, C.F.: P1580
Popescu, I.: P1894
Popescu, M.: P1223
Popov, A.A.: P1397
Popov, A.V.: P2150
Popov, D.: P0485
Popow-Kraupp, T.: P1979
Pornet, C.: P1165
Poropat, G.: P0671, P1401
449

InDeX of aUTHoRs
Porta, A.: P1063
Porta, P.: P1368
Porte, R.J.: OP093, P0449
Portela, F.: P1035, P1293
Porter, V.: OP178
Portier, G.: P1007*
Posca, D.: P0267
Pospelov, A.P.: P0014
Pospisilova, L.: P1199
Posserud, I.: OP096, OP098, P0386
Postma, C.: P1146*
Postrelova, G.V.: P0705
Potamianos, S.P.: P1038, P1483
Potapov, A.: P1791
Pothacharoen, P.: P0496
Potier, M.: P0391
Potter, J.: OP156, P1715
Potter, V.: P1502
Poturoglu, S.: OP363, P0266, P0470, P1787
Poulet, A.: OP290
Poullis, A.: OP216*, OP321, P1595
Poullis, A.P.: P1027
Poupardin, C.: P1386
Pourghiasian, M.: P1143
Pournaras, D.: P0092
Pouw, R.E.: OP220*, OP221, OP222,
OP223, OP447, OP449*, P0145
Povero, D.: OP125*
Powell, E.: P1953
Poza, G.: P1812
Pozdeev, V.: P0664
Pozzi, A.: P0805
Prachayakul, V.: P0626
Prada, J.R.: P0085
Prada, R.: P1060
Pradat, P.: P0218
Prakash, A.: P0711*, P1902
Pramhas, S.: OP365*
Pranculiene, G.: P1481
Pranculis, A.: P1238
Prantera, C.: P1090, P1764, P1803
Prasad, J.H.: P0302
Prasad, K.: P0330, P1659
Prasad, K.K.: P1656*, P1657
Prasad, N.: P0210
Prasad, Neeraj: P0552*
Prasad, Neil: P0552*
Prasad, R.: P1659
Prat, F.: P0590, P0628, P0936, P1286, P1458
Prata Martins, F.: P1323, P1324
450
Pratesi, C.: P0111
Pratha, V.S.: P0868
Pratt, S.: P0139
Preda, L.: P0927
Prehn, J.H.: OP237*
Premchand, P.: P1641
Prencipe, S.: P2042
Prescott, N.J.: OP024
Prescott, R.: P0080
Preston, S.: P0598, P1565, P2026
Pretet, J.: P0218
Preziosi, G.: P0382, P0383, P1112
Price, C.L.: P1004
Price, M.A.: P1120
Priest, M.: OP360, P0794
Prieto, I.: P0725
Primas, C.: P1772
Primerano, A.: P1999
Primo, J.: P0473
Principi, M.: P2004
Pritchard, D.M.: OP106, P0743*, P0744,
P0857, P0858
Pritchard, S.: P0380
Prka, Z.: P0462
Probert, C.S.: P1047, P1508, P1515
Probert, C.S.J.: OP154*, OP310*, OP313,
OP392, P0280
Probst, A.: OP006, P2174
Probst, J.: P0751*
Procaccio, N.: OP374
Procházka, V.: P0878, P1436
Procopet, B.: OP357*
Prodan, R.: P0772
Proença, L.: P1227
Prokoso, E.: P1309
Prolla, J.C.: P0917*
Protheroe, D.: P0347
Protic, M.: P1788
Provenzale, D.T.: P0173
Prskalo, M.: P0013, P0746
Prusinkiewicz, M.: P1758
Pruteanu, M.: P0364*
Pryanishnikova, A.S.: P0505
Pryen, F.: P1074
Przesdzing, I.: P0042*, P1721
Przybylowska, K.: P0235
Psaras, K.: OP120
Psychos, A.: P1483
Ptak-Belowska, A.: P0834
Pucci, E.: OP100
P = poster presentation, OP = oral presentation, number only = page number

Pucci, M.: P0067
Puente, J.J.: P1159
Puespoek, A.: P0608
Pugazhendhi, S.: P0269
Puglia, M.: P0384
Pugliese, D.: P0618
Pugliese, F.: P1893
Puglisi, M.: P0417
Puiu, M.: P0438*
Pujol, B.: OP044
Pulanic, R.: P0327, P1329
Puljak, L.: P0956
Pullens, H.J.M.: P1387, P2055
Pungpapong, S.: P0457
Purchiaroni, F.: P0417, P1257
Puri, A.: P0675, P2089
Puri, A.S.: P1521
Puri, R.: P1457
Purveeva, K.V.: P0763
Puscas, C.I.: P1435
Puscas, I.: OP239, P1435, P2125
Puscasiu, D.: OP200
Puscasiu, M.: OP200
Pyatnitskiy, M.: P1230*
Q
Qasim, A.: P1006, P1166, P1512, P2056
Qi, X.: OP084*
Qi, Y.: P0102
Qian, J.: P0227
Qizilbash, N.: P2044
Quarta, S.: P1140
Quartero, O.A.O.: OP453
Queiroz, D.: P1323
Queiroz, K.C.S.: P1716
Queneau, P.: OP044
Quest, L.: P1841
Quigley, E.: 32, 37, 51, 7965
Quigley, E.M.: P1061
Quinn, T.: P0592
Quintas Lorenzo, P.: P1704
Quintela, J.C.: P0261
Quintens, R.: P1031*
Quintero, E.: P0549
Quirke, P.: P1142, P1146*
R
Rabbani, R.: P1568
Rabenstein, T.: OP219*
Rabiee, H.: P1244
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Rabinovitz, E.: OP280
Racca, F.: OP100, P0075, P0400
Racco, S.: P0501, P1220
Race, A.D.: OP319
Rachmilewitz, D.: OP323
Racz, I.: P0318
Rácz, I.: P1810
Radaelli, F.: P0001, P2048
Radbruch, A.: P0042*, P1721
Radej, S.: P0256, P1732
Radenne, S.: P1219
Radford-Smith, G.L.: P1046
Radhakrishnan, N.V.: P1841
Radojkovic, D.: P0414
Radu, C.: P0468
Radulian, G.: P1190
Radwan, P.: P0256, P0771*
Radwan-Kwiatek, K.: P0256, P0771*
Radzikowski, A.: P0188, P0189, P0190
Rae, N.: P1782
Raeburn, A.: P2027
Raeburn, A.J.: OP097*
Rafaelli, M.: P0692
Rafferty, H.: P1269
Ragino, Y.I.: P1398
Ragunath, K.: OP446*, P0158, P1302,
P1351, 72
Rahamin, J.: OP142, P0817
Rahier, J-F.: 56
Rahimzadeh, H.: OP394*
Rahman, M.: P0242
Rahman, M.M.: P0750, P0761
Rahman, W.: P1309
Rahmi, G.: OP378, P0659
Rai, P.: P1372
Rai, R.R.: OP298*, P1196, P1930,
P1931, P1949, P2013
Raihan, A.: P0242, P0394
Raimondo, G.: OP297*, P0517
Raimondo, M.: P2012
Raine, D.: P2003
Rainteau, D.: OP417*
Raj, A.A.: P0257, P0895
Rajan Kd, A.: P1811
Rajasekhar, P.T.: P1380, P2104
Rajindrajith, S.: P1016, P1224
Räkers, M.: P1162
Ráki, M.: P0068
Rakonczay Jr., Z.: OP418*, P1740, P2123*
Ralea, S.: P1867
451

InDeX of aUTHoRs
Ramadas, A.V.: OP122*
Ramadori, G.: P1899, 19
Ramakrishna, B.: 56
Ramakrishna, B.S.: P0063, P0269
Ramakrishnan, S.: P2003
Ramalho, F.: P1243
Ramalho, L.: P0241
Ramalho, L.N.Z.: P0512
Ramani, P.: P1558
Ramdass, D.: P1308
Ramesh, J.: OP251, P0731, P1335,
P1344, P2184
Ramli, A.: P1482
Ramnani, P.: P0041*
Ramogida, C.: P1084
Ramon, J.: P1547
Ramos, L.: P1114
Ramos, R.: P0115
Ramos, R.M.M.: P2086, P2087
Rampton, D.: 58
Rampton, D.S.: P1070, P1750
Ramsden, D.: P1748
Ramsey, D.: P0342
Ramu, B.: P1248
Ramus, J.: P0167
Rana, S.: P0062
Rana, S.S.: P0062
Ranasinha, C.D.: P1596
Randazzo, C.: P1780
Rando, G.: P2047, P2062, P2187
Rangaraj, A.: OP372*
Rans, K.: P0351
Rao, P.: OP190*, P1658
Rao, S.: 33
Raos, Z.N.: P0820
Raouf, S.: P1641
Rapaccini, G.: P0501, P1220
Raraty, M.G.: OP281
Rascarachi, G.: P1706, P1707
Rasco-Nolasco, E.T.: P2069
Rashed, H.G.: P1170
Rashid, T.: P0080
Rasmussen, L.: P1481
Rassadina, E.: OP375*
Ratajczak, M.Z.: OP052*
Ratcliffe, J.: P2066
Ratcliffe, N.: P1047
Ratcliffe, N.M.: OP392
Ratiu, I.: P0495, P0848
Rauch, U.: OP085*
452
Rauh, P.: P1769
Rausell, F.: P1722*, P1809
Rautalahti, M.: OP166
Rauws, E.: OP250*
Ravelli, A.: P1128, P1551
Ravi, N.: P0153
Ravikiran, P.: P0788
Ravizza, D.: P0960
Ravneng, P.: P1305
Rawal, P.: P1659
Rawat, D.J.: OP186*, P1652
Rayment, N.B.: OP024, P0258
Raynaud, J.: P0391, P1606
Razack, A.: P1355, P1356
Razaire, S.: P1077
Razga, Z.: P2123*
Razjouyan, H.: P0182
Rebelo, A.I.: P1023*, P2105
Rebours, V.: OP281, OP424, P1402,
P1405, P2135, P2148
Reddings, S.K.: OP254
Reddy, K.G.: OP369
Reddy, M.: P1595
Reddy, N.: 37
Reddy, R.: P1932, P1934, P2089
Reddy, Y.: P0731
Redondo-Cerezo, E.: OP303
Reed, K.: OP482*
Rees, C.: OP167*, P1151, P1320,
P1890, P1891
Rees, J.: P0832
Rees, J.R.: OP395*
Rees, J.R.E.: OP399*
Reeves, L.: P1127
Reffet, A.: P1077
Regeling, A.: OP312*
Regge, D.: OP284
Regula, J.: OP407, P1310, 62, 73
Reha, P.: P0206
Rehman, A.: P1429, P1729*
Reiberger, T.: OP355*
Reicher Atir, R.: P0039
Reichert, R.: P0917*
Reijerink, J.C.I.: P0427
Reimann-Zawadzki, M.: OP280
Reimer, C.: P0825
Reimund, J.: P1816
Reimund, J.M.: P0225, P0259, P1674
Reina, F.: OP303
Reinhart, K.: OP365*
P = poster presentation, OP = oral presentation, number only = page number

Reinisch, W.: OP151, OP323, P0315,
P1066, P1771, P1772, P1810
Reiser-Erkan, C.: P1412*
Reisinger, E.: P1725
Reisinger, K.: P1546
Reitsma, J.B.: OP079*, OP450*
Rejchrt, S.: OP015, OP380, P0043,
P0648, P0767, P0840, P1544, P2112
Rembacken, B.: P1873, P2045*, P2067
Remes-Troche, J.M.: P0395, P0396
Ren, M.: P0880
Renehan, A.: 47
Renna, S.: P1089
Repici, A.: P1068, P2047, P2062, P2187
Rerknimitr, R.: P2088
Reshetnikov, O.V.: P0865
Reulbach, U.: P0477
Rew, J.: P0101
Rew, J.S.: P0217, P0968
Rewisha, E.: P1929
Rey, J.F.: P0657
Rey Sanz, R.: P2075
Reynolds, J.V.: P0088, P0153, P1676
Reynolds, N.: P0346, P1028
Rezaei, I.: P1122
Rezende, R.E.F.: P2018
Rhee, J.C.: P1125*, P1307, P1696
Rhee, M.: OP051*, P0263
Rhee, P.L.: P1125*, P1307, P1696
Rhoads, D.B.: OP266*
Rhodes, J.: OP156, P1715, 73
Rhodes, J.M.: OP109*, OP387*, P0226*,
P1553*
Riaz, F.: P2022
Ribeiro, A.: OP246*
Ribeiro, A.P.: P1773
Ribeiro, J.M.: P1023*
Ribeiro, S.: P1635
Ribeiro da Rocha, J.: P0241
Ribeiro de Almeida, A.: P0241
Ricart, E.: P1828
Ricaurte, O.: OP008
Ricci, C.: OP060, P0020, P0021, P0365,
P0766, P0804, P0805, P0806, P0807, P0808
Ricci, G.: P0090
Ricci, R.: P0119, P1362, P2100
Ricciardiello, L.: OP316*, OP320, P1576*
Riccio, G.: OP374
Riccioni, M.: OP185, P0658
Riccioni, M.E.: OP174
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Richardson, P.: P1174
Richecoeur, M.: P1478
Richert, Z.: P1888*
Richou, C.: P0458
Richter, E.: OP455, P1116
Rickes, S.: OP205, P0624, P0652, P1769
Ricotta, A.: P0539
Ridolfi, F.: P0469
Ridtitid, W.: P2088
Rieder, F.: OP025*, OP051*, P0263
Riederer, B.: P1740
Riegler, G.: OP334, P0883, P1043,
P1069, P1090
Riethmuller, D.: P0218
Rifai, K.: OP354, P0486, P1259
Riffaut, A.: P2148
Rigato, P.: P0098
Rigopoulou, E.I.: P1179
Rijkers, G.T.: OP474
Rijnhart-de Jong, H.G.: OP030*
Riley, P.: OP393
Riley, S.: P0474
Rimbas, M.: P0772
Rincon Fuentes, J.J.P.: P0976
Ringers, J.: P0449
Ringman, A.: OP249
Ringstrom, G.: P1834
Ringström, G.: OP098, P0386
Rinke, A.: P1164
Rinninella, E.: P1997*
Rios, E.: P1440, P1441
Riquelme, F.: P1160
Risnenko, A.B.: P1701
Rispo, A.: P1781
Rispo, A.A.: P0262
Ristanovic, M.: P0414
Ristic, S.: P1221
Ritchie, M.: P1151, P1891
Ritter, P.R.: OP238*
Rivera, M.: P0789, P0905, P0906,
P0938, P0939
Rizzello, F.: P0334, P0340, P0349
Rizzetto, M.: P2093, P2094, P2095, P2096
Rizzi, M.: P1803
Rizzo, A.: OP107*
Ro, S.: OP144, P1111
Roa, J.C.: 47
Roach, P.: P0236
Robanus-Maandag, E.C.: P1143
Robaszkiewicz, M.: P1888*
453

InDeX of aUTHoRs
Roberts, C.L.: OP387*, P1553*
Roberts, E.: 30
Roberts, L.: 16
Roberts, M.: P0567
Roberts, R.L.: P1044, P1045, P1046
Robertson, A.G.N.: P1622
Robertson, D.A.F.: P0283
Robertson, D.J.: OP139, P2054
Robins, G.: P0089
Robinson, A.: OP157, P1073
Robinson, P.A.: P0743*
Roblin, X.: P0337, P1727*
Robson, H.E.: P0726, P1290, P1291
Robson, K.J.: P1226
Roca, J.: P1557
Roccarina, D.: OP283, P0078, P0197, P1495
Rocco, A.: OP275, P0034
Rocha, M.M.: P1202
Roche, H.: P0590, P0936
Roche, R.: P0401
Roderick, P.J.: P0148
Rodrigo, L.: P0366, P0367
Rodrigues, P.: OP081*, P1670
Rodrigues, R.: P1324
Rodrigues, S.G.: P1773
Rodriguez, F.: P1876*
Rodriguez, G.: P0578
Rodriguez, M.: P1250
Rodriguez-Agulló, J.L.: P1053, P1054
Rodriguez-Cabezas, M.: P0260*, P0261,
P1735, P1736, P1743
Rodriguez de Miguel, C.: P1385
Rodríguez-Gómez, S.: P0672
Rodríguez-González, D.: P1673
Rodriguez-Justo, M.: OP321
Roelofs, H.: OP047*
Roelofs, J.J.T.H.: P1716
Roesch, T.: OP220*, OP441, P0166, 55
Roessner, A.: P0180
Roggero, E.: P0027
Rogler, G.: OP331, P0308
Rogoza-Mateja, W.: P0847
Rohmer, V.: OP040
Rohr, M.: P2017
Rohr, R.: P1323, P1324
Róka, R.: P0183, P0375
Roks, D.J.G.H.: OP032*
Rolanda, C.: P1952
Rolfi, F.: P2153
Roliński, J.: P0256, P0771*
454
Rolla, R.: P0502
Roman, J.: P1736
Roman, S.: OP133, P1573
Romani, M.: P2082
Romano, M.: OP316*, P0764
Romanova, T.I.: P1398
Romanowicz-Makowska, H.: P0233, P0686
Romãozinho, J.M.: P0783, P1293, P1496,
P1941, P1942
Romatowski, J.: P0202
Romberg-Camps, M.: OP158, P1024,
P1025
Rombouts, K.: P1865
Romeo, E.: P0195, P2183
Romeo, F.: P2047
Romero Cara, P.: P0976
Romero Sánchez-Miguel, I.: P1572
Romero Vazquez, J.: P1366
Ron, E.: P1667*
Roncalli, M.: P0278
Roncon-Albuquerque Jr., R.: P1917
Rondagh, E.: P0221*
Ronkainen, J.: OP132, P0128
Rönnblom, A.: P1026
Roos, A.: P0449
Roos, S.: P0790
Roosens, B.: P1625
Rosa, A.: P1293, P2086, P2087
Rosa, B.J.: P1023*, P2105
Rosa, F.: P0692
Rosa-e-Silva, L.: P1842
Rosa RIZZOTTO, E.: OP226*
Rosado, M.: P1814*
Roscetto, E.: OP391*
Rösch, T.: P2011
Roseau, G.: P0628, P1458
Rosenberg, R.: P0935
Rosenberg, W.: 40
Roshandel, G.: OP394*, P1167, P1857
Rosin, U.: P2032
Rosinach, M.: P0077, P1535
Roskams, T.: 72
Rosmolen, W.: P0163*
Ross, F.: OP360
Ross, M.: OP308*
Ross, P.: OP243*
Rossetto, L.: P1842
Rossi, A.: P0090
Rossi, E.D.: P1361, P1362, P2100
Rossi, G.: P0618
P = poster presentation, OP = oral presentation, number only = page number

Rossi, M.: OP379, P2187
Rosso, L.: P2092
Rostami, K.: P0065, P0791
Rosztóczy, A.: P0375
Rosztóczy, A.I.: P0183
Roth, B.: P1301
Rothen, C.: P0136
Rothstein, R.I.: OP150*, OP253, P2167,
P2168
Rotimi, O.: P0913
Rotondano, G.: OP374, OP403, P0735,
P1462
Rottiers, P.: OP147*
Rouchota, R.: OP120
Roudo-Thoraval, F.: P1688
Rougier, P.: P1458
Roussel, C.: P1879
Rouvas, G.: P0977*, P0978*
Rouyer, M.: P1898
Rovedatti, L.: P0067, P1814*
Roviello, F.: P1578*
Rowbotham, D.S.: P1515
Roy, A.: OP248
Royston, C.: P1051
Rozenbach, Y.: P1528
Rubel, T.: P0060, P0861
Ruberto, F.: P1893
Rubin, B.P.: P1145*, P1867
Rubin, D.T.: OP151, P1094
Rubin, G.: P0138, P0792, P1830
Ruchkina, I.N.: OP050
Rudin, M.: P2081
Rudnicki, C.: P0144
Rudolph, B.: P2011
Rueffer, A.: P0321
Ruepert, L.: OP453
Ruggiero, G.: P0267
Ruiz-Clavijo, D.: P0621
Ruiz de León, A.: P1571, P1572
Ruiz de Morales, J.: P1706, P1707
Ruiz-Escolano, E.: OP303
Ruka, W.: P0861
Rullier, E.: P1428
Rumyanceva, S.A.: P0705
Runyon, B.: 47
Rupinski, M.: OP407
Ruppin, D.C.: P0616
Russe, M.: P0471
Russel, M.: OP158, P1024, P1025
Russel, M.G.V.M.: P0352*, P0353
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Russell, R.K.: OP187*
Russello, D.: P0539
Russo, D.: P1129
Russo, F.: 28
Russo, I.I.: P0262
Russo, M.: P1069
Russo, M.I.: P1069
Russo, M.L.: OP048, OP049
Rustemovic, N.: P1329
Rustenburg, F.: P1147
Rusu, E.D.: P1190
Rusu, F.I.: P1190
Ruszniewski, P.: OP040, OP424, P0704,
P1402, P1405, P2135, P2141, P2148
Rutella, S.: P0263
Rutgeerts, P.: OP017*, OP323, OP327*,
OP328, P0333, P0351, P0355, P1031*,
P1032, P1033, P1034, P1044, P1079, P1099
Rutgeerts, P.J.: P0147, P0309
Ruth, M.: OP027, OP136
Rutkowska, J.: OP422
Rutkowski, P.: P0861
Rutten, F.H.: OP074
Rutter, K.: P1967, P1979
Rutter, M.D.: OP167*, P1151, P1320,
P1889, P1890, P1891
Ruuska, T.: OP182
Ruytjens, I.: P1505
Ruzzenente, A.: P1256
Ryan, A.: P0088
Ryan, A.M.: P0153, P1676
Ryan, B.M.: P1006, P1570
Rybalchenko, V.: P1137
Rydberg, L.: P0620
Rydström, B.: P0322
Rydzewska, G.: OP422
Rydzewski, A.: OP422
Rye, K.A.: P0487, P0488
Rygiel, A.: P0163*
Rygiel, A.M.: P1866
Rykx, A.: P0381
Ryu, C.: OP429, P0410, P1132, P1575*
Ryu, C.B.: P0553
Ryu, D.Y.: OP451
Ryu, H.S.: OP175, OP180*, OP376*,
P0762, P0948, P1235, P2016, P2049
Ryu, J.H.: OP477*
Ryu, J.K.: P0434*
Ryu, K.: OP429, P1756
Ryu, K.H.: P0553
455

InDeX of aUTHoRs
Ryu, K.W.: OP292*
Ryu, S.H.: P0239
Ryu, Y.: P0237
Ryu, Y.M.: OP477*
Ryusuke, T.: P0465
s
Sa-nguanmoo, P.: OP301
Saarnio, J.: OP248
Sabahi, F.: P1954
Sabaric, B.: P0746
Sabat, M.: OP108*
Sabater, F.J.: P0366, P0367
Sabbatini, F.: P1781
Sabbi, T.: P1489
Sabelnikova, E.: P0793
Saberi-Firouzi, M.: P1491
Sacchetti, A.: OP397*
Sachdeva, A.: P0554
Sachdeva, S.: P0675, P1521, P2089
Sacher Huvelin, S.: OP176
Sacher-Huvelin, S.: OP005
Sachin, O.: OP192*
Saddouk, F.Z.: P1867
Sadik, R.: P0386, P0682*
Sadler, G.J.: P1027, P2057
Saduka, S.: P0795
Saeki, A.: OP061
Saenz, R.: 32
Saetre, L.: P1826
Safavi, S.: P1513
Safdi, M.: P0342
Safiullah, A.: P0394
Safranow, K.: OP241
Saftoiu, A.: OP257*, P0122, P2038*, P2147
Safwat, W.: P1461
Sagawa, T.: P1382
Sager, J.: P0570, P0881
Sagiv, E.: OP086*, P1868
Sagmeister, M.: P0308
Sagnelli, E.: P0517
Sahin, B.: P0667, P1442
Şahin, B.: P2084, P2085
Sahlin, S.: OP227
Sahmeddini, M.: P0452
Sahtout, S.: P1619, P1620
Said, E.M.: P0341, P0555
Saïdi, R.: P0544
Saigenji, K.: P0637, P1357, P1448
Saigusa, S.: OP480
456
Saillard, E.: P1498
Sainsbury, A.: P0089
Saint-Georges, G.: P1498
Saint-Paul, M.: P1102
Sáinz, S.: P1751
Saisho, T.: P0205
Saito, G.: P0674
Saito, H.: P0707, P1168, P1585
Saito, M.: P0795, P1275, P1280
Saito, S.: OP130*, P0238, P1204
Saito, Y.: OP008, OP169, OP348*, P0379,
P0576, P1075, P1374, P2058*, P2113
Saitoh, Y.: P1806
Saitou, Y.: OP430
Sajjad, S.: P1158
Sakaedani, N.: P0015
Sakai, K.: P2002
Sakai, P.: OP010, P0087
Sakai, Y.: P1274
Sakaida, I.: P1191, P1192, P1280, P1923*
Sakamoto, H.: OP264*, P0627, P2144
Sakamoto, N.: P2009
Sakamoto, T.: P0576, P2058*
Sakata, H.: P1470
Sakata, Y.: P1470
Sakhuja, P.: P0513*
Sakisaka, S.: P0264
Sako, M.: P0370
Sakr, M.F.: P0243
Sakuraba, A.: P1373
Sakurada, T.: OP144
Sakurai, J.: OP058, P1847
Sakurai, Y.: P1232
Sakurama, K.: P1638
Sakuyama, N.: P1897
Sala Felis, T.: OP212
Salam, M.A.: OP194, P1948
Salamon, A.: P0318, P1078
Salapa, K.: P1733, P1734
Salas, A.: P0077, P1535
Salaspuro, M.: OP289
Salazar, T.: P0115
Salehi, Z.: P1244
Salem, P.E.: P1925
Salerni, B.: P0365
Salerno, R.: P0764, P1462
Salgado, M.: OP046*
Salgado, S.L.: OP277*
Salih, M.: P1312
Salim, S.: P0364*
P = poster presentation, OP = oral presentation, number only = page number

Salimullah, A.: P0242
Salines, E.: P0203
Salleron, J.: OP121, OP153
Salmi, S.: P1454
Salom, F.: P0628, P1458
Salomez, J.: OP153
Salto-Tellez, M.: P1594
Salunke, S.S.: P0794, P1782
Salvador, I.: P1169
Salvagnini, M.: P0735
Salvana, A.: P1559
Salvana, A.D.: P0006
Salvati, V.M.: OP379
Salvatori, F.M.: P1443
Salvestrini, C.: P0303
Samaha, E.G.: P0659
Samara, H.: P0044
Samarasekara, D.N.: P1016
Samarasekera, N.D.: OP277*
Sambuelli, A.M.: P1783
Samji, A.: P1014*, P1015
Samkharadze, T.: P1412*
Sammito, G.: P0169, P0170, P0184
Samsheer, K.S.: P2052
Samsonov, A.: OP462*
Samuel, D.: OP128*
Samuelsson, S.: P1026
San Juan Acosta, M.: P1366
Sana, A.: P1438*
Sanai, F.M.: P0524
Sanaka, M.: P0982
Sanchez, J.: P0461
Sánchez, Y.: P1835
Sanchez Diaz, C.: OP212
Sanda, M.: P2035
Sandakov, Y.P.: P1397, P2150
Sandborn, W.J.: OP323, P0342, P0355,
P1790, P1815
Sander-Struckmeier, S.: P2132
Sanders, D.: P0660, 64
Sanders, D.S.: P0640, P0726, P1290, P1291,
P1524, P1525, P1526, P1527, P1529,
P1530, P1532, P1533, P1785
, P1820, P2106*, P2107
Sanderson, I.R.: P0260*
Sanderson, J.: OP243*, P0258
Sanderson, J.D.: OP024, P0344, P1080,
P1723, P1829
Sanderson, S.: P0143
Sandhu, B.: P1558
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Sandhu, N.K.: P0052
Sandor, K.: P1252
Sandoval-Cooper, M.: OP311*
Sandrini, G.: OP100
Sands, B.E.: OP199*, P1790
Sandström, P.: OP249
Sanduleanu, S.: P0221*
Sandulescu, L.: P0122
Sandvei, P.K.R.: P1305
Sanges, M.: P0297
Sangfelt, P.: P0990
Sangwaiya, A.: P0479, P1245, P1909
Sangwaiya, M.J.: P1384
Saniabadi, A.: P0272, P0369*, P0370
Saniabadi, A.R.: P0358, P0359, P0360
Sankila, R.: OP166
Sannino, M.: P0588, P1422
Sano, C.: P1975
Sano, T.: P0464, P0465, P0480, P0489,
P0700, P2028, P2029
Sano, Y.: P0015, P0035, P0947
Sansone, S.: P1462
Sant, M.: OP293
Santambrogio, L.: P2092
Santander, C.: P1843
Santantonio, T.: P0517
Santaolalla, R.: P1535
Santarelli, A.: OP165
Santiago, J.: P1571
Santiago, M.: P0115
Santillan, C.: P1100
Santini, C.: P1506
Santo, M.: P0087
Santoliquido, A.: P1797
Santonja Gimeno, A.: OP212
Santoro, L.: P0119
Santoro, M.: P1997*
Santos, J.: P1114, P2021
Santos, J.S.: P2138, P2139
Santos, L.: P0550
Santos, M.: P1324
Santos, R.: P0115
Santos, Raquel: P2021
Santos, Ricardo: P2021
Sanuki, T.: P1388*
Sapio, D.: P0455
Sapra, B.: P1931
Sar, F.: OP363, OP371
Saracco, G.M.: P2096
Saracibar, E.: P1343
457

InDeX of aUTHoRs
Saracino, I.: P0020
Saraswat, V.A.: P1372
Sardi, F.: P1727*
Sargeant, I.R.: P0860, P1631
Sarikhani, A.: OP394*
Sarin, S.: P1186*
Sarin, S.K.: OP353, OP356, P0451, P0513*,
P0518, P0520, P0521, P1172,
P1233, P1236, P1237, P1300,
P1918, P1950, 47, 80
Sarin, Y.: P0675
Sarker, A.R.: P0750, P0761
Sarma, M.P.: P0472*, P0515
Sarmento, J.A.: P1917
Saro, C.: OP160*, OP324
Sarra, M.: OP107*
Sartori, M.: P0435, P0502, P1187*
Saruki, K.: P1459
Sasahira, N.: P0680, P1345, P2178
Sasajima, K.: OP430
Sasaki, E.: P0574
Sasaki, H.: P0855
Sasaki, M.: P1806
Sasaki, T.: P0120, P0680, P1345,
P1645, P2178
Sasako, M.: P0909, P1875
Sasamata, M.: OP454
Sasmaz, N.: P0667, P0728, P1442, P2084
Şaşmaz, N.: P2085
Sata, M.: P1251
Satani, M.: P1251
Satani, T.: P0418
Satharasinghe, R.L.: P1016
Sato, C.: P0168, P0605, P1294
Sato, H.: OP208, P0281
Sato, K.: OP373
Sato, M.: P2000
Sato, S.: OP432*
Sato, T.: P0379, P0490, P0795, P1075
Sato, Y.: OP346, P0959, P1382,
P1644, P2177
Satoh, K.: P0674
Satou, Y.: OP071*
Satra, M.: P1038
Satsangi, J.: OP187*, OP271,
P1036, P1664
Sattar, A.: P0734
Sattari, H.: P0452
Sauer, R.: 18
Saulnier, N.: P0417, P1257
458
Saunders, B.: P0607, P0722, P1302,
P2062, 73
Saunders, B.P.: OP368, P0597
Saur, D.: OP089*
Saurin, J.: OP005, OP068, OP176,
OP183, OP294
Sautereau, D.: P0009, P0590
Sauvanet, A.: OP424, P0704, P1405
Sava', C.: P0517
Savale, C.: OP176
Savarese, F.: P0252
Savarieau, B.: OP459
Savarino, E.: P0169, P0170, P0184,
P0785, P0786, P1747
Savarino, V.: P0169, P0170, P0184,
P0785, P0786, P1747
Savaş, B.: P0296
Save, V.: OP399*
Savelkoul, P.: OP145*
Savelkoul, P.H.M.: OP019*
Savelov, N.A.: P1701
Saveriadis, A.: P0503
Savic, Z.S.: P1490
Savides, T.J.: P0540*
Savoye, G.: OP121, OP153, P1548
Savvoukidis, T.: P1899
Savytska, M.: P0104*, P1554
Sawada, T.: P1900
Sawaki, A.: OP061
Sawara, K.: P0466
Saxena, P.: P1623
Saxena, R.: P0711*, P1902
Saxena, S.K.: P1022, P1511
Sayed, D.: P0439
Sayyari, A.: P1555
Sbeeberger, P.: P1503
Sbolli, G.: P1943
Sbrozzi-Vanni, A.: OP338*
Scaldaferri, F.: OP025*, OP051*,
P0263, P1774
Scapa, E.: P0609, P1770
Scarcelli, A.: P1999
Scarpa, M.: OP051*
Scarpellini, E.: P1838, P1844
Scarpignato, C.: OP405, OP410, P0754,
P0888, P1705
Schaap, F.G.: OP473*
Schaapherder, A.F.: P0449
Schabowski, J.: P1615
Schafer, E.: P0317
P = poster presentation, OP = oral presentation, number only = page number

Schäfer, K.: OP085*
Schäfer, M.: P0708
Schaffalitzky de Muckadell, O.: OP281
Schall, T.J.: P1810
Schanaider, A.: P1786
Schatz, P.: P0964
Scheffold, A.: P1721
Scheiman, J.: P0843
Schenck, F.: P0388
Schenk, B.E.: OP221
Schenk, P.: P0450
Schenker, M.: P0122
Scherbakov, P.: OP182
Scherzer, T.: P1979
Scherzer, T.M.: P1967
Schettino, A.: P0090
Schiano, T.: P1932
Schiano, T.D.: P1934
Schiff, S.: P0447
Schigliano, H.: P0509
Schinzari, V.: OP128*, P1870, P1910
Schipper, M.: OP473*
Schipper, M.E.I.: P0223
Schirbel, A.: OP025*, OP051*, OP309*,
P0263
Schirrmeister, W.: OP129*
Schischmanoff, O.: P0220, P1141
Schloesser, N.J.: P2103
Schmid, R.: OP059*, OP476*, P0579
Schmid, R.M.: OP089*, P0570
Schmidt, P.T.: P0204, P1108, P1848
Schmidt, W.E.: OP238*
Schmiegel, W.: 66
Schmitt-Graeff, A.: OP053
Schmitz, J.: P0042*, P1721
Schmucker, D.: 57
Schmulson, M.: P0395, P0396
Schneider, A.: OP280, P0570, P0881,
P2071, P2079
Schneider, G.: OP089*
Schneider, M.R.: OP383
Schneider, S.M.: P0821, P0822
Schneier, H.A.: P1119
Schnell, D.: P1790
Schnieke, A.: OP089*
Schnitzler, F.: P0294, P0309, P1056, P1819
Schofield, G.L.: P2059
Schöniger-Hekele, M.: P1260
Schoon, E.J.: OP221, OP366
Schott, A.: P2079
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Schouten, L.: OP158
Schouten, W.R.: 33
Schrader, H.: OP238*
Schreiber, F.: OP390
Schreiber, S.: P1576*, P1729*, P1810,
P1815, 51
Schreinemacher, M.H.F.: OP472*
Schreurs, M.W.J.: OP001*, OP337, P0799
Schröder, O.: P1827
Schubert, D.: OP063*
Schuit, F.: P1031*, P1079
Schuppan, D.: P1399
Schushan-Eisen, I.: P2001
Schuster, T.: P0570
Schuurmans, J.: P0428, P0429
Schwager, C.: OP083
Schwartz, T.M.: P2103
Schwarz, B.: P1914
Schwarze, J.: P1036, P1753
Schwarzer, R.: P0608
Schweitzer, M.A.: P2155
Schwizer, W.: OP134
Scimeca, D.: P1089
Scisciani, C.: OP297*, P1870, P1910
Sclanckaya, O.: P0763
Scoazec, J.: OP290
Sconfienza, L.: P0184
Scott, B.B.: P1531
Scott, C.B.: P1850, P1851, P1852, P1853
Scott, N.: P0089
Scott, N.W.: OP178
Scott, S.M.: P0980
Scozzarro, A.: OP014, P0098
Scullard, G.: P1983
Searle, S.: P0827, P0828
Seehusen, F.: OP149
Seenan, J.P.: P0185
Seerden, T.: P0692
Seewald, S.: OP220*
Ségalas, F.: OP359*
Segarra, F.: P0882
Segers, P.: P1921
Segersvärd, R.: OP117
Segev, M.: P0039
Seggie, R.: P0298
Segnan, N.: OP164, OP165, OP284
Segura Cabral, J.: P0107, P0725, P2075
Seibold, F.: P0308, P1091
Seicean, A.: P0629, P0630, P0684
Seiderer, J.: OP325*, P0294, P1056, P1819
459

InDeX of aUTHoRs
Seidler, U.: P1740
Seidman, E.: P1660
Seidman, E.G.: P1369
Seidner, D.L.: OP141, P0814
Seifert, B.: P0138, P0840
Seike, J.: P1900
Seillan, S.: P0009
Sekine, I.: P0059
Seksik, P.: OP020*, P1084, P1816
Selby, W.S.: P0646, P1309
Selgrad, M.: OP316*, OP320, P0024,
P0025, P1576*, P1877
Selinger, C.P.: OP251, P0046, P2060,
P2184
Selves, J.: OP080*, OP268*
Semnani, S.: OP394*, P1167, P1857
Semper, R.: OP059*
Sempoux, C.: P0114, P0150
Senapati, S.: P1841
Sendino, O.: OP259*, OP260*, P0631*,
P0632, P1385
Sendur, R.: P0844
Sénéjoux, A.: P0362
Senesse, P.: P2141
Senga, T.: P1869*
Senkyrik, M.: P1282
Senore, C.: OP164, OP165, OP284
Seo, D.: P1363
Seo, D.W.: P1449, P1488
Seo, G.: P1278, P1279
Seo, H.: P0410, P1575*
Seo, T.J.: P0217
Seo, Y.S.: OP175, OP180*, OP376*, P0762,
P0948, P1235, P2016, P2049
Seol, S.: P0410, P1575*
Seow, C.: P1758
Séra, E.: P0375
Serban, A.: OP231*, P0467, P0468,
P0684, P1972
Serban, D.E.: P1660
Serejo, F.: P1957, P1958
Sergeant, G.: P0681, P1261
Sergeeva, T.N.: OP189*, P1653
Serghini, M.: P0311, P1618, P1619, P1620
Serlie, M.J.M.: P1692
Seror, O.: P1240
Serova, T.: P0991
Serra, J.: 64
Serrani, M.: OP321
Serrano, M.: P0419, P1635
460
Serrano-Sánchez, L.: P1444
Serste, T.: P0544
Setakhr, V.: P1816
Seto, M.: OP061
Setoyama, T.: OP007, P1691
Sevá-Pereira, T.: P0448
Sevadei, F.: P1883
Sever, N.: P0017, P0748
Sevilla-Mantilla, C.: P1571, P1572
Sevindir, I.: P0017, P0266, P0748
Sewell, K.L.: P0828
Seya, T.: P0234, P0911, P1577
Seymour, K.: P0554
Seymour, R.: P0283
Sfarti, C.: P0476, P0491
Sfeir, R.: P1556
Sgambato, A.: P0417
Sghaier, L.: P0986
Sgorbati, B.: P1506
Shackcloth, M.: P0694, P0699
Shafat, I.: OP162
Shafazand, M.: P0682*
Shafeyee, Q.: P0248
Shaffer, J.: 80
Shaffer, J.L.: P0815
Shah, N.: OP377, P0898
Shah, N.S.: OP256*
Shah, R.: OP115
Shah, R.H.: P2005, P2006
Shah, R.J.: OP119
Shah, U.: OP075
Shahbari, A.: P2064, P2081
Shaheen, N.: 50
Shahraki, M.: P0791
Shahzamani, K.: P1954
Shakeri, R.: P0842, P1630, P1985
Shale, M.J.H.: P1784
Shamir, R.: P0022, P1528
Shams, R.M.: P1964
Shamsdin, S.: P1491
Shanahan, F.: P1061
Shang, H.: P0752
Shang, Y.: P0073, P0397, P1545
Shanmugam, V.: P0516
Shannon, N.B.: OP395*
Shao, X.: P1944
Shapira, A.: OP322*
Shapira, S.: OP086*, OP162, OP322*, P1868
Shapiro, M.: P0609
Shapiro, R.: P1528
P = poster presentation, OP = oral presentation, number only = page number

Shaposhnikova, N.A.: P0492, P1919
Sharabidze, A.: OP204
Sharaki, T.: P0791
Shariff, M.: P1502
Sharifi, H.: OP302, P1954
Sharifi, Y.: OP202
Sharma, A.: OP298*, P0420
Sharma, A.K.: P1657
Sharma, B.: P0675
Sharma, B.C.: OP356, P0451, P1233,
P1300, P1918, P1950
Sharma, P.: P0171, P0675, P1233,
P1237, P1918, 24
Sharma, R.: P0326, P1059
Sharma, R.K.: P1841
Sharma, S.: P0584
Sharma, S.S.: P1930, P1931
Sharma, U.: P1744
Sharratt, E.: P1829
Sharrocks, A.: OP398*, P0126
Shater, M.S.: P1963
Shaw, J.: OP248
Shaw, J.M.: P1439
Shaw, N.: P0453
Shawa, T.: P0784
Shcalova, L.: P1993
Sheen, A.J.: OP256*
Sheffer, M.: P1868
Shehab, H.: OP421, P0610
Shen, B.: OP082
Shen, R.: OP084*
Shen, Y.: P2132
Shepherd, S.: OP463
Shepherd, S.J.: P0796
Shepherd, T.: P0444
Sheridan, H.: P1741
Sherman, S.: OP113
Sheu, B.S.: P0747, P0885
Shi, R.: P1590, P1636
Shi, X.: OP055
Shi, Y.: P0437
Shi, Z.: P1445
Shibata, K.: P0059, P1637
Shibata, T.: P0037, P0140*, P0556,
P0561, P1486, P1581
Shibuya, J.: P0674
Shida, H.: P0983
Shiff, S.J.: P1119
Shiga, H.: P0264
Shigoka, H.: OP114
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Shih, Y.: P2033
Shiha, G.: 47
Shikano, M.: P1121
Shikuwa, S.: P1650
Shim, C.: OP429
Shim, C.S.: P0553, 40
Shim, J.: P1756
Shim, K.: P0049, P0984
Shim, S.: P0244
Shim, T.N.: P0065
Shimada, H.: P0901
Shimaoka, S.: P2175
Shimizu, M.: P0644, P1975
Shimizu, Y.: OP184*, P0038, P1383
Shimoda, R.: P1470
Shimosegawa, T.: OP444*, P0105, P0915
Shimoyama, T.: P0015, P0035
Shimura, T.: P1121
Shin, C.: P0036, P0409
Shin, E.: P2155
Shin, E.J.: OP265, P0720
Shin, H.: P1347
Shin, H.D.: P0245, P1263, P2061
Shin, J.: P0323, P0385, P1042,
P1152, P1768
Shin, J.E.: P0245, P1263, P2061
Shin, S.: P1228
Shin, S.J.: OP214, P0557, P0558
Shin, V.Y.: P0124
Shin, W.G.: P0123, P0967
Shin, Y.: P1924, P1994
Shin, Y.W.: OP263, P1915
Shinagawa, K.: P0030, P0408
Shingaki, N.: P0040, P1262, P1996, P2035
Shingal, A.: P0675
Shinhata, H.: OP208
Shinji, S.: P0234, P1577
Shinoda, M.: P0876, P0877
Shinohara, Y.: OP130*, P1204
Shinomura, Y.: P1588
Shinozaki, H.: P1459
Shinozaki, M.: P0205, P0265
Shinozaki, S.: P1463
Shiotani, A.: P0007, P0132, P1839, P2000
Shioya, M.: OP348*, P1718
Shiozawa, H.: P1225, P1694
Shirai, S.: P2035
Shirai, T.: P0662
Shiraishi, J.: P0464
Shirakawa, T.: P0234, P1577
461

InDeX of aUTHoRs
Shirakawa, Y.: OP401, P1638
Shiraki, M.: P0644
Shiraki, T.: P1262, P1996
Shirakura, K.: P0662
Shirato, I.: P1299
Shirato, M.: P1299
Shire, G.: P1471
Shiri, M.: P0343
Shivakumar, S.: P0494
Shiwaku, H.: P2046
Shiwani, M.H.: P0555
Shmueli, E.: OP162
Shokri, J.: P1392
Shonde, A.: P0757, P1302
Shore, A.C.: P2164
Shostakovich-Koretskaya, L.: P0459
Shpitz, B.: P1667*
Shrivastava, S.: P1186*
Shrotri, M.: P0113, P0698
Shu, J.: P1455, P1911
Shubin, L.: OP375*, P0033
Shuhaibar, M.: P2056
Shurr, M.: OP014
Shuter, B.: P1264
Si, J.M.: P1799
Siakavellas, S.: P1700, P1719
Siano, M.: P0941
Sica, G.: OP334, P0863
Siciliano, S.: P0941
Sidhu, G.S.: P1656*
Sidhu, R.: P0640, P0660, P1527, P1785,
P2106*, P2107
Sie-Go, D.M.: P2103
Siegel, C.: P1072
Sielezneff, I.: P1428
Sierra, J.M.: P0085
Sierra, M.: P1706, P1707
Siersema, P.D.: P0156, P0157, P0172,
P0173, P0186*, P0223, P0246,
P0426, P0942, P1139, P1387,
P2062, P2103, P2187
Sifrim, D.: OP027, P0920
Sifrim, D.A.: OP136
Sigon, R.: P1703
Sikkema, M.: P0172, P0173
Silano, M.: P0078
Silapaswan, S.: P0710
Silberberg, B.: P1905*
Silberg, D.: OP027
Silberg, D.G.: OP028
462
Silkauskaite, V.: P1238
Silva, A.: OP332*, P0115, P0500,
P1472, P1908
Silva, A.D.: OP314*
Silva, A.L.: P1561
Silva, F.: P0115
Silva, R.N.: OP081*
Silvestrova, S.Y.: P1919
Simadibrata, M.: P0498
Simeone, J.: P1384
Simmonds, N.: P1051
Simmonds, R.: P0129
Simmons, J.: P0584, P1302
Simms, L.A.: P1046
Simoes, M.A.: P1561, P1712
Simon, T.: P1052
Simon-Vecsei, Z.: P1538
Simone, F.: P1933
Simonova, M.Y.: P1980
Simren, M.: OP096, OP098, P0386
Simrén, M.: P1834
Simula, M.: P0071
Simunovic, M.: OP094*
Sin, J.: P1833
Sinayoko, L.: P0027
Sinclair, P.: P0577
Singeap, A.: P0491
Singer, P.: 80
Singh, A.: P0513*
Singh, G.: P0612
Singh, H.: P0769
Singh, J.: P1890, P1891
Singh, K.: P0062, P0330, P0788,
P1656*, P1657, P1659
Singh, N.: OP298*, P1949
Singh, R.: OP255*, OP434*
Singh, R.K.: P0711*, P1902
Singh, R.R.: P1744
Singh, S.: P0650
Singh, V.: P0612
Singla, R.: P0515
Sinha, S.: OP461*
Sinha, S.K.: P0062
Sinkala, E.: P0047
Sinniger, V.: P1101
Sipka, S.: P1522
Sipos, F.: P0773*, P0774, P0943, P0944,
P1134*, P1135, P1144
Sipponen, T.: P0315, P1800
Siproudhis, L.: OP326*, P0218, P1428
P = poster presentation, OP = oral presentation, number only = page number

Širca-Čampa, A.: P1540
Siriwardana, R.C.: P1687
Siriwardena, A.K.: OP256*
Siriwittayakorn, P.: P1671
Sirli, R.: P0495, P0525, P1981, P1982
Siu, D.K.F.: P1858
Sivanesan, S.: P2027
Sivapathasundaram, S.: P1687
Sivignon, A.: OP022*
Sivins, A.: P1578*
Sivridis, E.: P0181
Sjoberg, K.E.: P0682*
Sjoberg Bexelius, T.: P2120
Sjöström, L.: P1549
Sjovall, H.: P0682*
Sjövall, H.: OP096
Skalioti, C.: P1700
Skander, M.P.: P0441, P2020
Skar, V.: P0016
Skarbaliene, J.: P1012
Skinner, V.: P0236
Sklyarov, A.: P0835
Sklyarov, A.Ya.: P0823
Skog, O.: P0082
Skogestad, E.: P1464
Skopek, J.: P0827, P0828
Skrypnyk, I.: P0493, P0760
Skrzypczak, M.: P0060, P0861
Skurla, B.: P0013, P0746
Skwarski, L.: P0202
Slack, J.: 40
Slack, J.M.W.: P0149
Sleet, S.: P1518
Slivka, A.: OP113, OP115
Sliwinska-Mosson, M.: P2121
Slomka, M.: P1201, P1732
Slongo, T.: P0329
Sloof, G.W.: P1647
Slooter, G.G.D.: P1892
Slors, F.J.M.: P0363
Slott Jensen, J.: P1065
Sluzewski, W.: P0044
Smajstrla, V.: OP193*
Smart, H.: P1195
Smecuol, E.: P1519, P1520
Smecuol, E.G.: P1946
Smeenk, R.: P1711
Smeets, H.M.: P1610
Smith, C.F.: P0803
Smith, D.: P1898
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Smith, G.: P1062, P1502, P1880
Smith, J.A.: OP168*
Smith, L.: P0345
Smith, M.A.: P0344
Smith, P.J.: P0048
Smith, S.: P1047
Smith, T.K.: OP321
Smithson, J.: P0280
Smits, R.: P1143
Smoczynski, M.: P1346
Smolarz, B.: P0233, P0686
Smout, A.: 36
Smout, A.J.P.M.: OP030*, OP032*,
OP136, P0186*
Smth, S.: OP392
Smulders, F.: P0723
Smyrnidis, A.: P1775
Sninsky, C.A.: P0342
Snoeck, V.: OP147*
Snoek, S.A.: OP408*
Snowball, J.: OP170, P1887
So, C.: P0538
Soare, C.: P2038*, P2147
Soares, E.C.: P0448
Soares, J.: OP219*, P1952
Søberg, T.: P1305
Sobhani, I.: OP111, OP171, OP295,
P1394, P1688
Sobrino, S.: P1846
Socaciu, M.: P0468, P0484, P0684
Sodergren, M.H.: P2063, P2161, P2162
Söderholm, J.: OP270*
Söderholm, J.D.: OP146, OP269*, P0364*
Söderlund, C.: OP249
Soehendra, N.: OP220*
Soeltan-Kaersenhout, D.: OP145*
Soeters, M.R.: P1692
Soeters, P.B.: P0775
Sofia, C.: P1683
Sofia, M.: P0539
Søfteland, E.: P1104, P1105
Sofuni, A.: P0613
Sogawa, M.: P0663
Sohara, N.: P0559, P2173
Sohn, C.: P1228
Sohn, J.: OP229, P0481, P0560, P2050
Sohn, Y.: P1278, P1279
Sohn, Y.W.: P0537
Sohrabi, S.: P0211
Sojka, D.: P0314
463

InDeX of aUTHoRs
Sokic Milutinovic, A.: P1194, P1928
Sola, B.: P0225
Solberg, C.: P1018
Solberg, I.: OP152
Soldan, M.: P1786
Sole, M.: OP259*, OP260*, P0631*, P0632
Solheim, J.M.: P0683
Soliman, A.S.G.: P0341, P0555
Solina, G.: P1780
Solito, B.: P2187
Sollid, L.: 64
Sollid, L.M.: P0068
Soltes, M.: P0709
Solymosi, N.: P1134*, P1144
Soma, W.: P0981
Somasekar, K.: P0673
Somasundaram, A.: P0494
Somi, M.H.: OP131
Sommerer, P.: P0886
Son, B.: P0729, P1913
Son, D.W.: OP263
Son, H.J.: P1125*, P1696
Sondemeijer, C.M.: OP223
Søndergaard, B.: P0402
Sondermeijer, C.M.: OP222, OP447
Sondermeijer, C.M.T.: OP220*
Song, F.: OP103
Song, G.: P0966
Song, G.A.: OP451
Song, H.: P0031, P0049, P0094,
P0237, P1363, P1455
Song, I.: P0036, P0407
Song, I.H.: P0245, P1263, P2061
Song, J.: OP367, P0433
Song, J.H.: P0239
Song, S.: P2142
Song, S.Y.: P1452, P1990, P2143
Song, T.J.: P1449, P1488
Songel Gonzalez, G.: OP212
Songür, N.: P0890
Songür, Y.: P0890
Soni, R.: P2089
Soni, R.C.: P1233
Sonneveld, P.: OP397*
Sonzogni, A.: P0960
Sood, R.: P0420
Soong, R.: P1594
Sorensen, H.T.: OP139
Soriano, A.: P1876*
Sorrentini, I.: P0735
464
Sörstadius, E.: P0139
Sostegni, R.: P1090
Soto, J.: P1846
Soto, S.: P0287
Soto-Perez, J.C.: P0395, P0396
Sotoudeh, M.: OP225, P0842, P1392
Sotoudehmanesh, R.: OP225, OP302,
P0633, P1392, P1568
Soubeyrand, B.: P0218
Soubrier, F.: P2148
Soufflet, C.: OP435, P0003, P0738, P1612
Soufidi, K.: P2055
Soufir, N.: P0220, P2148
Soufleris, K.: P1249
Soukup, T.: P0043
Soule, J.: P1052
Souque, A.: OP268*, P2141
Souquet, J.: OP044, OP290, P1219
Sousa, A.: P2022
Sousa, H.: P0115
Sousa, H.T.: P1035
Sousa, R.: P0583
Souza, F.F.: P0511, P0512
Souza, T.F.: OP010
Sovani, M.: P1351
Soykan, I.: P1562
Soylu, A.: OP124, P0017, P0266,
P0470, P0748, P1787
Spaander, M.C.W.: P2188
Spac, A.: P0476
Spada, C.: OP174, OP185, P0306, P0658
Spagnuolo, R.: P0267
Spain, S.: OP478
Spanò, F.: OP374
Sparano, L.: P1774
Sparchez, Z.: OP231*, P0467, P0468,
P0684, P1972
Sparrow, M.: P1072
Sparwasser, T.: OP308*
Spasic, N.P.: P1788
Speare, R.: OP278
Spehlmann, M.E.: P0355
Speiciene, D.: P1180
Spek, C.A.: P1716
Špelda, S.: P2112
Speranza, J.R.: P2163
Sperl, J.: OP193*
Spicak, J.: OP248, P1668, P1689,
P1737, P2034, 52
Spiegel, B.: P1072
P = poster presentation, OP = oral presentation, number only = page number

Spieker, T.: OP308*
Spiers, H.: OP187*
Spiertz, A.J.: P1873
Spiller, R.: 64
Spiller, R.C.: OP411, P0380
Spindel, E.: P0827
Spinelli, A.: P0278, P1068
Spinzi, G.: P0001, P0548, P2048
Spirkova, J.: OP380
Spiropoulos, K.: P0892
Spisak, S.: OP484, P0943, P0944,
P1134*, P1135, P1144
Spisák, S.: P0773*
Sporea, I.: P0495, P0525, P0848, P0849,
P0850, P1981, P1982
Sprangers, M.A.G.: OP450*, P0363
Spray, C.: P1558
Sprigg, E.R.: OP436*
Spychalski, M.: P0235
Spyridakis, M.: P1672
Sreenarasimhaiah, J.: P0650
Sreenivas, V.: P0079
Srijaya, S.: P0062
Srikureja, W.: OP215, P0626
Sringeri, R.: P1155, P1156
Srinivas, M.: P0797, P1542
Srinivas, S.: P1541
Sriprayoon, T.: P0626
Srirajaskanthan, R.: P1465, P2108, P2109,
P2110
Srivastava, A.: P0269, P2114
Srivastava, S.: OP412*, P0520, P0521
Stachowicz, M.: P2126
Staelens, S.: P1922
Stagg, A.J.: P1003, P1004, P1080,
P1723, P1829
Staiano, A.: OP391*, P0195, P1129
Stallhofer, J.: OP325*
Stamp, G.W.: P1062
Stan-Iuga, R.: P0629, P0630, P0684
Stanca, S.: OP317
Stanciu, C.: P0476, P0491
Stanciu, S.: P1190
Stange, E.: P0045, P1087
Stange, E.F.: P1807, P1808
Stanghellini, V.: P0387, P0421, P0875,
P0886
Stanisor, O.I.: OP408*
Stankovic, Z.: P0471
Stanners, C.: OP022*
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Stanojevic, G.Z.: P1685
Stansfield, C.J.: OP157
Starcevic Cizmarevic, N.: P1221
Starzynska, T.: OP052*, P0847, P0954
Stasi, E.: P1764
Stasiewicz, J.: P0202
Stasikowska, O.: P0224, P1739
Stättermayer, A.F.: P1967
Stavjanik, S.: P0739
Stavrinidis, M.: P0597
Stearns, A.T.: OP266*
Stec-Michalska, K.: P0144, P1475
Steed, H.: P0346, P1028, P1639, P1640
Steel, A.: P0268, P0798
Steele, B.: 17
Steele, I.: P0858
Stefanaki, C.: P0977*
Stefanescu, C.: P0362
Stefanescu, H.: OP231*, OP357*, P0467,
P0468, P1972
Stefanescu, M.: P0927
Stefania, S.: P0941
Stefanile, R.: OP379
Stegeman, I.: P0422, P0962
Steinbrueck, I.: P2111
Steindl-Munda, P.: P1979
Steininger, R.: P0608
Steinwurz, F.: P0315
Stengrevics, A.: P0209, P0856
Stéphanie, P.: P1102
Stephens, R.: P1676
Stephens, R.B.: P0088
Stepien, B.: OP422
Stern, T.: P1384
Sternby, B.: P2124
Stevens, P.: OP115
Stevens, P.D.: OP113
Stevens, R.: P1518
Stewart, R.: OP190*
Steyerberg, E.W.: OP287*, P0096*, P0173
Stibbe, K.J.: P0528
Stimac, D.: P1221, P1401
Štimac, D.: P0305
Stimac, D.D.S.: P0671
Stine, J.: P0516
Stirand, P.: P1668, P1689
Stobinski, M.: P1361
Stockbrugger, R.: OP155
Stockbrügger, R.: OP158, P1024, P1025,
P1091, P1757
465

InDeX of aUTHoRs
Stockenhuber, F.: P1154
Stoelzel, U.: P1399
Stoeva, K.: OP196*
Stoica, V.: P1190
Stoker, J.: OP406
Stokkers, P.: OP159*
Stokkers, P.C.: OP471*
Stokkers, P.C.F.: OP203*, P0363, P2156
Stolfi, C.: OP107*
Stoll, M.: OP091*
Stolt, I.: P1731
Stoos Veić, T.: P0634
Storskrubb, T.: OP132, P0128
Stotzer, P.: P0620
Straforini, G.: P0334, P0340, P0349
Straka, M.: P1358*
Strangio, G.: P2047
Strassburg, C.P.: P2071
Strazzanti, A.: P0722
Streba, C.T.: P0091, P1579, P1580
Streba, L.M.: P0091, P1580
Streit, S.: P1412*, P1417*
Stricker, M.: P0477
Strid, H.: OP098, P0322, P0386, P1318
Striki, A.: P0526
Strobel, D.: OP003*
Ström, M.: OP270*
Stronati, L.: OP023
Stroppa, I.: P0735
Strutynska-Karpinska, M.: P0442, P0907
Strzalka-Mrozik, B.: P2126
Stuart, R.: OP439, OP442
Sturgess, R.: P0933
Sturm, A.: OP307*, OP329*, P1157, P1721
Sturniolo, G.C.: P0328, P0329, P1085, P1878
Su, L.: P1912*
Su, M.: P0661
Su, W.: P0208
Suares, N.C.: P0347
Suárez, J.: P1677
Suárez de Parga, J.: P0107
Suárez-Pereira, E.: P1735
Suazuki, K.: P0466
Subasinghe, D.: OP277*
Subbiah Somasundaram, C.: P1641
Subhani, J.: P1014*, P1015
Subhas, G.: P0247, P0601, P0710, P1905*
Subramanian, A.: P0891
Subramanian, V.: OP446*, P0063, P0158,
P0269, P0368
466
Subtil, C.: P1077
Subtil, J.: P1364
Sucner, V.: P0755
Sud, R.: P1457
Suen, B.: OP173
Suen, B.Y.: P0833
Suetsugu, A.: P1975
Sugai, E.: P1519, P1520, P1946
Sugano, K.: OP208, P1463
Suganuma, T.: P1476
Sugawara, T.: P0168, P1294
Sugihara, J.: P1975
Sugimoto, H.: P0676, P0959
Sugimoto, K.: P0464, P0480, P0489, P2029
Sugimoto, M.: OP066, P0562, P0721,
P0836, P0982, P1388*, P1492
Sugimoto, T.: P2119
Sugiura, T.: P0270*, P0685
Sugiyama, A.: P0838, P0855
Suh, D.: P1171*
Suissa, A.: P2064
Suk, K.: OP452
Sukthomya, V.: P1671
Sulzyc-Bielicka, V.: OP241
Sumida, T.: P0030, P0408
Sumie, S.: P1251
Sumino, Y.: P1342
Sumioka, M.: OP064
Sumiyama, K.: OP042, OP426, OP427
Summerbell, C.: 18
Sun, M.: P1590
Sun, Y.: P0869
Sunada, K.: OP208, P1463
Sundblom, L.: P1389
Sundov, Z.J.: P0956
Sundset, A.: P1067
Sung, C.: P0661
Sung, J.: OP055, OP082, OP123, P0893,
P1602, P1603, P1858
Sung, J.J.: P0740, P0741
Sung, J.J.Y.: OP062, OP173, OP267*,
OP288*, OP439, OP442, P0112, P0124,
P0134, P0424, P0432, P0833, P1874
Sung, K.: OP118
Suno, A.: P0502
Suresh, C.: 48
Suriawinita, A.: OP268*
Surti, V.: OP265
Sutti, S.: P1187*
Sutton, E.: P1676
P = poster presentation, OP = oral presentation, number only = page number

Sutton, R.: OP281
Suzuki, D.: P0676
Suzuki, H.: OP061, P1588, P2176
Suzuki, K.: P0118, P0168, P0605, P1088,
P1294, P1869*
Suzuki, N.: P0597, P0607, P0722, P1302
Suzuki, S.: OP007, P1646, P1690, P1691
Suzuki, T.: P0137, P0168, P0662, P1294,
P1632*, P1633, P1901
Suzuki, Y.: P0118, P0271, P0335, P0465,
P0700, P0707, P1076, P1247
Svärdsudd, K.: P1477
Svartholm, E.: OP249
Svedberg, L.: P0843
Svensson, T.: P0204
Svestka, T.: OP364, P1199
Svinareff, P.: P0996
Swahn, F.: OP117, P0614, P1338
Swain, P.: OP280, P2167, P2168
Swain, S.: P0135, P1487
Swallow, P.J.: P0143
Swaminath, A.: OP204
Swan, M.: P1331
Swan, M.P.: OP448, P0615, P0616, P1992
Swan, N.: P1166, P1570
Swargiary, S.S.: OP296*
Swarnkar, K.: OP372*
Sweet, A.: OP172
Sweis, R.R.: P1624, P1845
Swierzko, A.: P0286
Swift, G.L.: P1515
Sy, P.P.: P2069
Sygut, A.: P0235
Sylvester, P.A.: OP313
Syms, R.R.A.: P1389
Systchenko, R.: P1317
Szaflarska, M.: P2126
Szajewska, H.: OP148*
Szala, A.: P0286
Szalay, F.: P1253, P1254
Szamosi, T.: P0317, P0318, P0320, P1078
Szczepanska, A.J.: P0159
Szczesniak, M.M.: P0392
Szekely, A.: P1110, P1350
Szekely, I.: P1110, P1350
Szepes, Z.: P0348, P0375, P1740, P1766
Szereday, L.: P1977
Szereday, Z.: P1977
Szklarczyk, J.: P1391
Szold, A.: P0246, P1139
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
T
Taban, S.: P0848, P0849, P0850
Tabarin, A.: OP040
Tabarkiewicz, J.: P0771*
Tabata, Y.: P0876, P0877
Tabbers, M.: OP182
Tabbers, M.M.: P0372
Tabernero, S.: P1767
Tabuchi, M.: P0212
Tabuchi, T.: P0418
Tabue Tuego, M.: P1498
Taché, Y.: P1107
Tacheci, I.: P0043, P0648, P1544
Tachecí, I.: P2112
Tack, G.J.: OP001*, OP337, P0799
Tack, J.: OP273*, OP279, P0133, P0374,
P0388, P1838, P1844, 20
Tada, M.: P0680, P1345, P2178
Tadic, M.: P0462, P0617, P0634, P1349,
P1599
Taefeh, N.: P1484
Tafalla, M.: P0732, P0887
Tafarel, J.: P1323, P1324
Tafazzoli, K.: P1729*
Tahara, K.: P1645
Tahara, T.: P0037, P0140*, P0556,
P0561, P1486, P1581
Taharboucht, S.: P1434
Tahayee, A.: P0248
Taher, Y.M.: P1925
Taheri, A.: P0248
Taieb, J.: OP295
Taira, A.: P1643
Taira, J.: P0480, P0489, P2028, P2029
Tajika, M.: OP061
Tajima, T.: P0127, P0846
Tajiri, H.: OP042, OP426, OP427,
P0238, P1501, 36
Tak, W.: P1321
Takada, T.: P0859
Takagi, T.: P0064*, P1008, P1752,
P2009, P2144
Takagi, Y.: P1274
Takahara, M.: P0912
Takahashi, A.: OP347, OP352, P1582,
P1583, P1642
Takahashi, H.: OP130*, P1476, P1968
Takahashi, K.: P1447
Takahashi, R.: P0015, P0035
Takahashi, S.: P1373, P1382
467

InDeX of aUTHoRs
Takahashi, Takenobu: P0674
Takahashi, Tsuyoshi: P0674
Takahashi, Y.: P0795, P1577
Takami, T.: P1191, P1192
Takamura, A.: P0028
Takano, Y.: P0530
Takao, T.: OP401
Takaoka, M.: P1638
Takaoka, Y.: P0541
Takata, A.: P1251, P1313
Takata, S.: P0028
Takatsuka, M.: P0663
Takaue, Y.: P2113
Takayama, E.: P1262
Takayama, I.I.: P1266
Takayama, T.: P1746
Takazoe, M.: OP054*, P0335, P0370
Takebayashi, R.: P0700
Takechi, H.: P1900
Takeda, S.: P1075
Takegoshi, J.: P0530
Takei, Y.: P0564, P0565
Takekawa, C.: OP401
Takemoto, K.: P1643
Takemoto, Y.: P0674
Takemura, S.: P2009
Takenaka, R.: OP401, P1643
Takeshima, F.: OP396*, P1109
Takeshima, K.: P1459
Takeuchi, K.: P2131
Takeuchi, M.: OP346, P0676, P1281,
P1644, P2177
Takeuchi, Y.: OP351, OP431, P2039
Takezawa, M.: P0637, P1357
Takezawa, R.: OP454, P1113
Takikawa, H.: P0534
Takikawa, Y.: P0466
Takisawa, H.: P2113
Takizawa, K.: P0546, P0563, P1268, P1584
Takubo, K.: P1284
Talamini, R.: P0070
Talar-Wojnarowska, R.: P0686, P2146
Talingdan-Te, M.: P1940
Talingdan-Te, M.C.: P2069
Talley, N.: P0049
Talley, N.J.: OP132, P0128
Tam, W.: OP434*
Tamai, H.: P0040, P1262, P1614,
P1996, P2035
Tamayo, D.: P0960
468
Tamayo, J.L.: P0395, P0396
Tambasco, R.: P0334, P0340, P0349
Tamegai, Y.: P1283, P2065
Tamir, A.: P2064
Tamoto, E.: P1382
Tamura, T.: P2131
Tan, J.: P1760
Tan, S.: P1817, P1818
Tan, X.X.: P1242
Tana, P.: OP100, P0075, P0400
Tanabe, H.: OP058
Tanabe, S.: P0120, P0541, P1638, P1645
Tanaka, H.: P1113
Tanaka, J.: OP058, P1847
Tanaka, K.: P0564, P0565, P1076
Tanaka, M.: P0030, P0207, P0408, P0546,
P0563, P0949, P1121, P1150,
P1251, P1268, P1584
Tanaka, N.: P0234, P0911, P1577
Tanaka, R.: P0040
Tanaka, S.: OP344*, P0028, P0030,
P0408, P0562, P2175
Tanaka, T.: OP348*, P0272, P0369*, P1313
Tanaka, Y.: OP009
Tanapanpanit, O.: OP230*
Tanasescu, C.: P0772
Tanczos, B.T.: P2011
Tang, J.: OP118, P0332
Tang, K.L.: OP323
Tang, S.: P0236
Tang, X.: P0373
Tangkijvanich, P.: OP301, P0496
Tangoku, A.: P1900
Tanida, S.: P1121
Taniguchi, T.: OP431
Tanioka, D.: OP401, P0566, P1271
Tank, A.K.: P0711*, P1902
Tannapfel, A.: OP238*
Tano, S.: P0564, P0565
Tanosaki, R.: P2113
Tansini, P.: P1943
Tanswell, I.: P1639, P1640
Tantau, A.: P0730, P1456
Tantau, M.: P0630, P0684, P0730, P1456
Tanuma, T.: P1588
Tanwandee, T.: OP230*
Tao, L.: P1875
Taouli, B.: 40
Taouqi, M.: P0213
Tap, J.: OP018*
P = poster presentation, OP = oral presentation, number only = page number

Tappenden, K.A.: OP141, P0814
Tardio, A.: P1060
Tarique, S.: P1267
Tarlton, J.F.: OP313
Tarnawski, A.: OP070, P0955, P0998
Tarumi, K.: P0007, P0132, P1839
Tasaki, T.: P0981
Tashiro, K.: P0127, P0846, P2175
Tatebe, H.: P2002
Tatebe, S.: P1585
Tatsugami, M.: P0028
Tatsuta, M.: OP431
Tatsuta, Y.: P1109
Tatu, A.: P1336
Tavakkolizadeh, A.: OP266*
Taxonera, C.: OP324, P0366, P0367
Tayar, C.: P1394
Tayfur, O.: P1442
Taylor, C.: P1431
Taylor, C.J.: P0568, P1662
Taylor, W.: P0113, P0698
Taylor-Robinson, S.: P1983
Taylor-Robinson, S.D.: P0281, P0282,
P1389, P1411, P1962
Tchekmedyian, A.J.: P0174
Te, M.T.: P0497, P2023
te Velde, A.A.: P1716
Teare, J.: P2063
Tebaibia, A.: P0635, P0879, P1574
Teder, K.: OP249
Tedjasaputra, T.R.: P0498
Tee, H.: P0645, P0647, P1309
Teixeira, A.C.: P0511, P0512, P1202
Teixeira, A.L.: P0416
Templeton, D.: OP002
ten Hove, W.R.: P0449
ten Kate, F.: P0988
ten Kate, F.J.: OP220*
Ten Kate, F.J.W.: OP449*, P0372
ten Kate, F.J.W.: OP221, OP222, OP223,
OP447, P0145
Tenca, A.: P0179, P0618, P1616
Teo, E.: P1760
Teoh, N.: OP082
Teoh, P.L.: OP440*
Tepetes, K.: P1672
ter Borg, F.: P0026, P0604
ter Linde, J.J.M.: P0186*
Terai, S.: P1191, P1192, P1275, P1923*
Teramoto, H.: P1299
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Teramoto, O.: P1846
Terashima, M.: P1584
Terauchi, H.: P0876, P0877
Tereshchenko, S.: P0018
Terg, R.: P1946
Terhaar sive Droste, J.S.: P1161, P1162,
P1163
Terlinde, J.: OP473*
Ternant, D.: P1805
Terpstra, O.T.: 32
Terrebonne, E.: P0690, P1898
Terreni, N.: P0001, P2048
Terriere, L.: P1505
Terris, B.: P0936, P1458
Terruzzi, V.: P0001, P2048
Tersigni, C.: P1495
Tersigni, R.: P1802
Tesfaye, S.: P1526
Tesori, V.: P1257
Tessari, F.: OP403
Tesse, A.: P0259
Testa, A.: P1781
Testa, R.: OP226*
Testoni, B.: OP297*, P1870
Testoni, P.: OP258*, P2091
Testoni, P.A.: P1863, P2090
Tetlay, I.: P2114
Teubner, A.: P0815
Teusdea, C.: P0131
Thabane, M.: OP094*
Thapa, B.: P1659
Thapa, B.R.: P1656*, P1657
Thapar, A.: P0423
Tharakan, J.: P0957
Thawrani, A.: P1457
Thayumanavan, L.: P0472*, P0515
Theamboonlers, A.: OP301
Theis, B.: P0048
Theis, V.: P0815
Theodore, D.: P1932, P1934
Theodoropoulos, I.: P1775
Theodoropoulou, A.: OP120, P2051
Theodorou, V.: OP274*
Théodorou, V.: P1007*
Thezenas, S.: P2137
Thiéfin, G.: P1178
Thillainayagam, A.V.: P1062, P2052
Thimmappa, R.: P2066
Gyoeri, G.: P0608
Gyökeres, T.: P0183
469

InDeX of aUTHoRs
Thiruppathy, K.: P0382, P1698, P1699
Thiyagarajan, A.: P1983
Tholen, A.: P0875, P0886
Thomas, C.: P0249
Thomas, E.A.: OP096
Thomas, F.: OP188*
Thomas, G.: OP122*
Thomas, H.C.: P1962
Thomas, H.J.W.: OP077*, OP478
Thomas, M.: P0504, P1403
Thomas, P.: P0622, P1471
Thomas, S.: P0042*, P1721
Thomas, T.: P1351
Thomas-Gibson, S.: P1302, P1381
Thomé, T.: P2076
Thomopoulos, K.X.: P0892
Thompson, A.: P1327
Thompson, V.J.: P0139
Thomsen, O.O.: P1815
Thomson, J.M.: P0919
Thomson, M.: OP002, OP182, OP190*,
P0568, P1658
Thorat, V.K.: P1859, P1860
Thorkildsen, C.: OP381*, P1012
Thorlacius, H.: P2115
Thorne, C.: P1666
Thorpe, S.: P0151
Thorpe, S.M.: OP224
Thoua, N.: P0383, P1112
Thoua, N.M.: OP097*, OP413
Thrope, S.: P0908
Thuijls, G.: P1546
Thuluvath, P.J.: OP265
Thursz, M.: P0479, P1909
Tiaka, E.K.: P1038, P1483
Tibbats, C.: P1378
Tiberti, C.: P1539
Tielemans, M.M.: P0142
Tielman, G.: P0737
Tiemann, K.: OP039*
Tijssen, M.: P1142, P1871
Tilanus, H.W.: OP345*, OP349, OP450*,
P0096*, P0097, P0910
Tilinca, M.: P0023
Tillack, C.: OP325*, P0294
Timmer, R.: P1408, P2165
Timmerman, H.: OP146, OP269*
Timofeev, M.E.: P0643
Tirado, P.: P1783
Tiso, A.: P0764
470
Tiszlavicz, L.: OP418*, P0183, P2123*
Titlestad, K.: P0800
Tiwari, I.: P0567
Tiwari, R.: P0050, P0051, P2185
Tiwari, R.P.: P0326, P1059
Tkalèić, M.: P0305
Tlaskalova-Hogenova, H.: P1737
To, K.: OP082, OP267*
Tobal, D.: P0214, P0958
Tobal, F.: P0214, P0958
Tobin, L.: P0933
Tobioka, H.: P1382
Toda, N.: P1313, P1345
Todea, A.: OP317
Todea, D.: P0484
Todeschini, C.: P0469
Toffoli, G.: P0111
Toftedal, P.: P0800
Toftgård, R.: OP218*
Togashi, K.: P0959
Togawa, O.: P1345, P2040, P2178
Toghanian, S.: P1611
Togo, G.: P1313, P2119
Tohyama, Y.: P0707
Toiyama, Y.: OP480, P1149
Tokarczyk, M.: P0055
Tokutomi, T.: P0855
Tolan, D.: P2045*
Toldi, A.: P0001, P2048
Tolia, V.: P0928
Tollefsen, S.: P0068
Tomás, E.: P0934, P1053, P1054
Tomas Moros, E.: P0215
Tomasevic, R.S.: P0499, P1789
Tomaszewska, R.: OP420
Tomba, C.: P0371, P0393
Tomic, S.: P0956
Tomida, H.: P0676
Tominaga, K.: P0663
Tominaga, N.: P1470
Tominaga, S.: OP401
Tomita, E.: P0838, P1975
Tomita, K.: P1088
Tomita, T.: OP058, P1847
Tomlinson, I.P.: OP478
Tomoda, J.: P0826
Tomomatsu, Y.: P1466
Tomori, A.: OP347, OP352, P1582,
P1583, P1642
Tomov, N.: P1980
P = poster presentation, OP = oral presentation, number only = page number

Tondi, P.: P1797
Tondu, F.: P1548
Toner, R.P.: P2067
Tong, D.K.H.: OP350
Toouli, J.: 18, 32
Topal, B.: P0681, P1261
Topless, R.K.G.: P1046
Topping, J.H.: P0074, P0719
Toquero, L.: P1433
Torabi, E.: P0460
Torimaru, H.: P2175
Torimura, T.: P1251
Tornai, I.: P1252, P1253, P1254
Torok, I.: P0023
Torp, R.: P0289, P0290
Torra, S.: P1547
Torralbo, J.: P1159
Torre, S.: P0231
Torreggiani, W.: P1166
Torrejón, A.: P1058
Torrella, E.: P1160
Torrente, F.: P0303
Torres, A.J.: P2024
Torres, M.: OP160*, P0053
Torres Dominguez, Y.: P0619
Torrisani, J.: OP268*
Torroni, F.: P2183
Tortora, A.: P1997*
Tosetti, C.: P1197
Tosh, D.: P0149
Toth, B.: P1522, P1523
Toth, E.: OP219*, OP249, P1432,
P1661, P2115
Toth, J.: P0989, P1754, P1755
Toth, K.: OP484, P0774, P0943, P0944,
P1134*, P1135, P1144
Tóth, K.: P0773*
Touchene, B.: P0635, P0879, P1434, P1574
Tougeron, D.: OP295
Toulas, C.: OP080*
Toumpanakis, C.: OP370*
Toupance, P.: P1178
Townson, G.: P1640
Toy, E.: P1872
Toyoizumi, H.: P1501
Toyokawa, T.: P0826, P2037
Toyonaga, T.: P0562, P0721, P1388*
Toyoshima, A.: P0205
Toyoshima, F.: P1847
Toyoshima, N.: P2046
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Toyoshima, O.: P0205
Toyota, J.: P0490
Tozzi di Angelo, I.: P1436
Trachet, B.: P1921
Tracz, P.: OP249
Trägner, S.: OP457
Trallori, G.: P0735
Tramontano, A.: OP391*
Tran, K.: OP469, P1333
Trande, P.: P0940
Traullé, C.: P0027
Trauner, M.: OP227
Travis, S.: 32
Travis, S.P.: P1828
Travis, S.P.L.: P0312, P0571, P1790
Treeprasertsuk, S.: P2088
Trehanpati, N.: P0513*, P1186*
Treiber, G.: P1769
Treier, R.: OP134
Tremaine, W.: 50
Tremelling, M.: P1039, P1040
Trentino, P.: P1893
Trepo, C.: P1219
Trespi, E.: P0095
Treton, X.: P0273*, P1816
Tréton, X.: P0362
Triantafyllou, K.: OP181, OP441, P0232,
P0255, P1013
Triantafyllou, K.D.: P2068
Tribonias, G.: OP120, P2051
Trifan, A.: P0476, P0491
Trimble, K.: P0640
Tringali, A.: OP013, OP248, P1339,
P1560, P2129
Trinquart, L.: P0659
Tripoli, E.: OP016, P0641, P2027
Tripon, E.S.: P0006, P1559
Tristan, J.: P0583
Tritarelli, A.: P0078
Trivedi, S.: P1186*
Trivedi, S.S.: P0520, P0521
Trojanowska, D.: P0055
Trommeshauser, D.: P1116
Tronc, F.: OP133
Trouilloud, I.: P1458
Trovato, C.: OP068, P0960
Trugnan, G.: OP417*
Truin, W.: OP244*
Trülzsch, K.: OP383
Trus, T.: P2168
471

InDeX of aUTHoRs
Trzcinski, R.: P0235
Tsai, S.: P0510, P0845
Tsai, Y.: P0885
Tsamakides, K.: P2169
Tsaneva, V.: OP196*
Tsaregorodseva, T.: P0991
Tsay, F.: P1473
Tse, A.W.Y.: P0134
Tse, V.: P1499
Tseng, G.: P1467
Tsiamoulos, Z.: P0232, P0255, P1013
Tsiampas, E.: P0977*
Tsianos, E.: OP155, P1757
Tsiberidis, A.: P1038
Tsibouris, P.: P0175, P0896, P0978*,
P1468, P1469, P2116
Tsimbalova, E.: P1791
Tsiobanidis, I.: P1483
Tsiopoulos, F.: P1483
Tsironis, C.: P0175, P0896, P1468,
P1469, P2116
Tskaev, A.Yu.: P0705
Tsoi, K.K.: P0741
Tsoi, K.K.F.: OP173, P0424, P0432
Tsongalis, G.: OP268*
Tsou, L.L.: OP475*
Tsou, Y.: OP118
Tsuchida, A.: P0707
Tsuchiya, K.: OP105*
Tsugeno, H.: P1643
Tsuji, K.: P0534, P1232
Tsuji, T.: P1459
Tsujii, M.: P0573
Tsujikawa, T.: OP348*, P1718, P1806
Tsujimura, T.: P1875
Tsujino, T.: P1345, P2178
Tsujitani, S.: P1585
Tsukada, Y.: P1975
Tsukasa, K.: P2175
Tsukune, Y.: P0662
Tsunada, S.: P1470
Tsurita, G.: P0205, P0265
Tsurumi, H.: P0644
Tsuruoka, N.: P1470
Tsutsui, S.: P0573
Tsutsumi, S.: P1148
Tsuzuki, T.: P0566, P1271
Tsyryuk, O.: P0103
Tsyryuk, O.I.: P0109
Tu, C.: P0454
472
Tuaillon, E.: OP304*
Tucat, G.: P1084
Tucker, E.: P0065
Tudor, G.: OP437
Tudora, A.: P0495, P0525, P1981
Tufare, F.: P0899
Tulassay, Z.: OP026, OP484, P0773*,
P0774, P0943, P0944, P1078,
P1134*, P1135, P1144
Tumpek, J.: P1522
Tumwine, J.K.: P1485
Tuohy, K.M.: P0041*
Turato, C.: P1140
Turchetti, A.: P1539
Turck, D.: OP121, OP153, P1556
Turco, R.: OP391*
Turculeanu, A.: P1223
Turini, D.: P0804, P0805, P0806,
P0807, P0808
Turner, C.: P1748
Turner, D.: P0148
Turner, R.M.: OP073
Turrini, O.: P2140
Turró, J.: P1557
Tursi, A.: P0250, P0251, P0350
Turunen, U.: P1800
Tutuian, R.: P0169, P0170
Tuvemo, T.: P0082
Tuveson, D.: OP084*
Tuvignon, N.A.: OP417*, P2186
Twelves, C.: OP319
Tyagi, P.: P0675, P1521, P2089
Tyrrell-Price, J.: P0052
Tysk, C.: OP272, P1017, P1731
Tytgat, K.M.: OP471*, P2103
Tzafestas, P.: P1719
Tzias, V.D.: P0759
Tzivras, D.: P1775
TZourmakliotis, D.: P0526
U
Ubaldi, E.: P0421
Ubbink, D.T.: P0363
Ubezio, C.: OP048, OP049, P1814*
Ubukata, H.: P0418
Uchida, E.: P0234, P0911, P1577
Uchida, K.: P1183, P1192, P1923*
Uchida, N.: P1362, P2100
Uchida, S.: OP007, P1646, P1690, P1691
Uchiyama, K.: P0064*, P1008, P1752, P2009
P = poster presentation, OP = oral presentation, number only = page number

Uchiyama, Y.: OP042
Udani, B.: P1014*, P1015
Udawat, H.: P2013
Udd, M.: OP247
Udvardy, M.: P0319, P1252, P1253, P1254
Uebel, P.: P0843
Ueda, K.: P0040, P1614, P1996, P2035
Ueda, M.: P0876, P0877
Uedo, N.: OP351, OP431, P2039
Uemura, M.: OP007, OP401, P0566,
P1646, P1690, P1691
Uemura, N.: OP430, P0178, P0542
Ueno, R.: P1850, P1851, P1852, P1853
Ueno, T.: P1251
Uesaka, K.: P0685
Uhmann, A.: OP218*
Ukita, T.: OP114
Ulbrich, G.: OP355*
Ulc, I.: P0827, P0828
Ullah, N.: P1166, P1512
Ullerich, H.: OP209, P1340
Ullman, T.: OP204
Ulukaya, E.: P1230*, P1231
Um, S.H.: OP175, OP180*, OP376*, P0762,
P0948, P1235, P2016, P2049
Umegae, S.: P0358, P0359, P0360
Umemura, K.: P0836
Una, E.: P0425, P1586
Unal, S.: P0816
Underhill, I.D.: P0392
Ung, K.: P0620
Unim, H.: P0789, P0905, P0906,
P0938, P0939
Unita, L.: P1437
Uno, K.: OP444*, P0105, P0915
Uppal, S.: P1666
Urabe, Y.: OP344*
Uragami, N.: P1476
Uraoka, T.: OP428, P2176
Urasinska, E.: OP241
Urayama, S.: P1415
Urban, O.: P0840, P1358*
Urbañczyk, K.: P0295
Urbanek, P.: OP364, P1199
Urbonaviciene, N.: P1481
Urek, M.: P0617, P0634
Urita, S.: P0982
Urman, J.: OP464, P0621
Usai, P.: P0252
Ushirokawa, M.: P1968
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Usnarska-Zubkiewicz, L.: P0442
Usuki, H.: P0465, P0700
Utano, K.: P0959
Utrilla, E.: P1200
Utrilla, P.: P0261
Uy, M.: P1940
Uy, M.C.: P0497, P2023, P2069
Uy, M.M.: P0778
Uyanikoglu, A.: P0870, P1861, P1955
Uzunhasan, I.: OP363
Uzzan, B.: P1141
V
v Eijck, C.: OP250*
v Gulik, T.: OP250*
Vadászi, K.: P0183
Vader, J.: P0308, P1087, P1091, P1825
Vaira, D.: OP060, P0019, P0020, P0021,
P0765, P0766, P1709
Vaishnavi, C.: P0330
Vaizey, C.: P0403, P1106
Väkeväinen, S.: OP289
Vakil, N.: P0020, P0765, P1709
Valantinas, J.: P1180
Valatas, V.: P1738
Valats, J.: OP304*, OP359*
Valcz, G.: P0773*, P0774, P0943, P0944,
P1134*, P1135, P1144
Valdehueza, Z.D.: P1163
Vale, L.: P0115
Valente, G.: P0297
Valente, R.: P1684
Valer, P.: P1053, P1054, P1812
Valeur, J.: OP095*, P0066
Valfrè di Bonzo, L.: OP125*
Valgueblasse, V.: P0009
Vali, Z.: P1792
Valiante, F.: P1878
Valiji-Bharmal, S.: P0598, P2026
Valle, J.: P2117
Valleur, P.: P2157
Valliani, T.: P1471
Valogne, Y.: OP300
Valori, R.: P1297
Valtrova, V.: OP193*
Valvano, M.R.: P1043
Valytova, E.: P0187, P1626
Vamvakas, P.: P1672
Vamvakopoulos, N.: P1038
van Acker, G.J.D.: P2165
473

InDeX of aUTHoRs
Van Assche, G.: OP327*, OP328, P0333,
P0351, P1031*, P1079, 18
Van Assche, G.A.: P0309
van Asseldonk, D.P.: P0352*, P0353
van Ballegooijen, M.: P0427
van Berge Henegouwen, M.I.: OP252*,
OP345*, OP450*, P0569, P0701,
P1647, P2156, P2165, P2166
van Bergen, J.: P0799
van Bijnen, A.: OP384*
van Bodegraven, A.: OP145*
van Bodegraven, A.A.: OP019*, OP159*,
P0352*, P0353
van Boeckel, P.G.A.: P0426, P2187
van Boxel, O.S.: P0186*
van Capel, T.: OP147*
van Coevorden, F.: P0902, P0903, P0904
van Criekinge, W.: OP483*
van Cutsem, E.: 16
van Dam, R.: OP384*
van Dam, R.M.: OP245*, P0712*, P0952,
P1681, P1682
van de Poll, M.C.: P0712*
van de Velde, C.J.H.: OP245*, P1871
van de Vijver, M.: OP240*
van de Water, J.M.W.: P0799
van de Wiel, M.A.: P1146*
Van De Wiele, C.: P1922
van Dekken, H.: OP397*, P0026, P0753
Van den Abbeel, V.: OP273*
Van den Berg, M.M.: P0191
Van den Brink, G.R.: OP315*
van den Brink, G.R.: OP047*, OP104*,
OP218*, P0276
van den Broek, F.: P0579
van den Broek, F.J.: OP471*, P0581
van den Broek, F.J.C.: OP203*, P1419,
P2165
van den Broek, M.A.J.: P0712*
van den Engel, S.: P0460
van den Heuvel, L.: P0801
Van den Neucker, A.: P0802
van den Wijngaard, R.M.: OP408*
van der Gaag, N.: OP250*
van der Heijden, G.G.J.: OP453
Van der Hulst, R.W.M.: P1161, P1162, P1163
van der Lee, A.P.M.: P1610
van der Logt, E.M.J.: P0274, P0275
van der Meer, R.: P0274
van der Pas, M.H.G.M.: OP468*
474
van der Reijden, J.J.: P0449
van der Stok, E.P.: OP349
van der Woude, C.J.: OP159*, OP323, P1029
van der Wouden, E.J.: P0801
van der Zaag, E.S.: OP240*
van der Zanden, E.P.: OP408*
van Deursen, C.: P1024, P1025
van Deursen, C.T.: P1304
van Deventer, S.: OP147*
van Diemen, P.M.: P1143
van Dijk, P.C.M.: P1610
van Dijk, S.: P1067
Van Domselaar, M.: P0354, P0527,
P1082, P1812
van Dongen, G.A.M.S.: OP468*
van Dop, W.A.: OP218*, P0276
van Dullemen, H.J.: P1408
Van Dyck, E.: P1301
van Eeden, S.: OP471*, P0581
van Eijck, C.H.J.: OP065*, P1406, P2097
van Engeland, M.: OP483*, P1873
Van Erpecum, K.: OP473*
van Essen, G.A.: P1965
van Gemert, W.G.: P0775
van Ginhoven, T.M.: P0460
van Gossum, A.: 49
van Grieken, N.C.: OP287*, P0026
van Grieken, N.C.T.: P1146*, P1871, P1873
van Gulik, T.M.: OP090*, OP406
van Hagen, P.: P0910
van Heel, E.: OP065*
van Heel, N.C.M.: P2188
van Heijl, M.: OP345*, OP450*,
P0701, P1647
van Helden, R.R.B.: P1067
van Herwaarden, A.E.: P1209
van Hest, L.: OP078
Van Heukelem, H.A.: P1161, P1162, P1163
van Hinsbergh, V.W.M.: P1143
van Hoek, B.: P0449
van Hout, A.M.G.H.: OP074
van Kalken, C.K.: P0962
van Lanschot, J.J.B.: OP345*, OP349,
OP397*, OP450*, P0701, P0910, P1647
van Leerdam, M.: OP078
van Leerdam, M.E.: P0427
van Leeuwen, M.S.: P1387
van Leeuwen, P.A.M.: P1692
Van Limbergen, J.E.: OP187*, P1664
van Lin, E.N.J.: P1711
P = poster presentation, OP = oral presentation, number only = page number

Van Lommel, L.: P1031*
Van Loo, D.: P1921
van Marion, R.: P0096*, P0097
Van Marle, J.: OP217*
van Marrewijk, C.J.: P0141
Van Moerkercke, W.: OP327*, OP328,
P1032, P1033, P1034
van Mourik, I.D.M.: P0456
van Noesel, C.J.: OP078, P1866
van Noesel, C.J.M.: OP104*
van Noord, D.: P1438*
van Oijen, M.: P1503, P1840
van Oijen, M.G.H.: P0141, P0142, P0428,
P0429, P1209
Van Olmen, G.: OP011
van Pelt, M.J.P.: OP409, P0254
van Randen, A.: OP406
van Rensburg, C.J.: P0843
van Rijn, A.F.: P0961
van Roon, A.H.C.: P0427
van Rossum, L.G.: P0961
van Rossum, L.G.M.: P0142, P0428, P0429
van Sandick, J.W.: P0902, P0903, P0904
Van Santvoort, H.C.: OP474
van Schooten, J.: P1419
van Soest, H.: P1209
Van Someren, N.: P0110, P0436, P1702
van Someren, N.: P0219, P1048, P1049,
P1334, P1666
Van Steen, K.: P0309, P1031*, P1034
Van Steenkiste, C.C.L.: P1920*, P1921,
P1922
van Stijn, M.F.M.: P1692
van 't Veer, C.: P1716
Van Turenhout, S.T.: P1161, P1162, P1163
van Turenhout, S.T.: P0422, P0961, P0962
van Velthuysen, M.F.: P0903, P0904
van Vilsteren, F.G.I.: OP220*, OP221,
OP222, OP223, P0145
Van Vlierberghe, H.: P1920*, P1921, P1922
van Vlymen, J.: OP216*
van Vuuren, A.J.: P0528
van Vuuren, H.J.: P0427
van Wieringen, W.N.: P1871
Van Wijk, M.P.: P0191
Vanásek, T.: P1810
Vance, M.: P0607
Vandamme, P.: OP017*
Vanden Berghe, P.: OP273*, P1838, P1844
Vanden Branden, S.: P1625
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Vandenberghe, S.: P1922
Vandenplas, Y.: P0920, P0921, P0922,
P0923, P0924
Vandepapelière, P.: OP331
Vandeplassche, L.: P0374, P0381, P0387
Vanderpas, J.: OP056
Vanderwinden, J.: P1145*, P1867
Vanhaesebroeck, B.: P0988
Vanickova, Z.: P0950
Vannella, L.: OP338*, P0430
Vannucchi, H.: P1202
vanSomeren, N.: P1308
van't Spijker, A.: P1029
Vardar, R.: P0187, P1597, P1626,
P1627, P1648
Vardas, E.: OP120, P2051
Vardi, H.: OP155
Varga, L.: P1740
Vargas, J.: P1846
Vargas, J.A.: P0395, P0396
Varghese, S.: P0494
Varis, A.: P1627, P1648
Varma, S.: P0788
Varnavas, A.: OP368
Varon, C.: OP057*, P0277
Varro, A.: P0743*, P0744, P0857, P0858
Varyani, F.: P1188
Vasei, M.: P0413
Vasen, H.F.: OP287*, P2152
Vasilev, G.: P1980
Vasileva, G.: P2132
Vasquez, N.: OP020*
Vassallo, M.: P1884
Vassaux, G.: OP127*
Vassiliadis, T.: P1249
Vassiliou, M.C.: OP150*, OP253,
P2167, P2168
Vastola, M.: P0119
Vasyliev, Y.V.: P1598
Vatankhah, A.: OP131
Vathenen, S.A.: P0830
Vatn, M.H.: P0045, P0985
Vavrovsky, A.: P1772
Vazquez, H.: P1519, P1520, P1946
Vázquez de Parga, P.: P1572
Vázquez-Rodríguez, S.: P0287
vd Harst, E.: OP250*
Vecht, J.: P0801
Vecsei, A.: P0745
Vecsei, Z.: P1522, P1523
475

InDeX of aUTHoRs
Veeramootoo, D.: P1649*, P1872, P2164
Veerappan, G.R.: P1569*
Velasquez, M.: P0006, P1559
Velayos, F.: OP204, P1072
Veldt, B.J.: 59
Velin, D.: P2080
Velineni, R.: P1649*, P1872
Velloso, L.A.: P0992
Velosa, J.: OP232*, P1181, P1243,
P1957, P1958
Veloso, R.: P0083, P0500, P1227,
P1472, P1908, P1926
Veltzke-Schlieker, W.: OP441
Venard, V.: P1019
Vendrell, J.: OP304*
Venema, K.: OP472*
Venerito, M.: OP063*, P0024
Venglovecz, V.: OP418*, P1740, P2123*
Venkataraman, J.: P1248
Venkatesh, K.: P0568, P1662
Venturini, S.: P1703
Vera, I.: OP324
Verbaeys, I.: OP276*
Verbeek, A.L.M.: P0428, P0429
Verbeek, W.H.M.: OP337
Verbeke, C.: P1142
Verdecchia, A.: OP293
Verdon, B.: P1622
Verdun, F.: P2080
Vere, C.C.: P0091
Veres, G.: P1135
Vergani, D.: P1179
Vergouwe, F.: OP252*
Verhage, A.: P0820
Verhagen, H.J.: P1438*
Verheem, A.: OP473*
Verheij, T.J.M.: OP409, P0254
Verin, E.: P1126
Verkade, H.J.: OP093
Verkarre, V.: OP378
Verma, G.R.: P0612
Vermeire, S.: OP017*, OP327*, OP328,
P0309, P0351, P0355, P0356,
P1031*, P1032, P1033, P1034,
P1044, P1079, P1548, P1810
Vermeulen, N.: OP017*
Vernic, C.: P0848, P0849
Vernier-Massouille, G.: OP121, OP153
Vero, V.: P0501
Verspaget, H.W.: P0449
476
Verstege, M.I.: P1716
Vertio, H.: OP166
Verveer, C.: P0528
Verwey, M.: P0460
Verwey, M.H.: OP047*
Vetrano, S.: OP311*, P0278
Vetruccio, E.: OP041*
Veysey, M.: P0236, P0431
Viaggi, P.: P1665
Viallon, V.: P0936
Viana, A.L.P.: P1786
Viazis, N.: P0503, P1862, P2118
Vicari, F.: P1317
Vicario, M.: P1114
Vicas, C.: P0468
Vicuña, M.: OP179*
Vida, L.: OP160*
Vidaki, A.: OP120, P2051
Vidali, E.: P0529*
Vidali, M.: P0482, P0502, P1187*
Vidaud, D.: P2148
Vienne, A.: P1052
Vieth, M.: OP132, OP219*, OP425,
P0128, P0162, P1153, P2010
Vietta, E.: P2047
Vigano', C.: P1793
Viguier, J.: P1879
Vila, J.: OP179*, OP464, P1371, P1677
Vila, J.J.: P0621
Vila, V.: P1557
Vilar, P.: P1535
Vilkin, A.: P0229, P0230
Villa, C.: P0215, P0934
Villa, E.: P1999
Villa, J.C.: P1053, P1054
Villacis, P.: P1169
Villadsen, G.: P1563
Villanacci, V.: P0791, P0805, P0808
Villanova, M.G.: P0511, P0512
Villaverde, A.: P0899
Villeneuve, P.: OP199*
Vilmann, P.: OP257*
Vincoli, G.: OP195*
Vincze, A.: P1078, P1977
Vinnitskaya, E.V.: P1919
Vinnytska, A.: P2041
Viñuelas-Chicano, M.: P1444
Viola, F.: OP195*, P1654
Virk, C.: P0695
Viscido, A.: P1090
P = poster presentation, OP = oral presentation, number only = page number

Visokai, V.: P0706
Visschers, R.G.J.: P0775
Visser, L.: OP312*
Visser, M.: P2097
Visser, O.J.: OP001*, OP337
Vitale, G.: P0197, P1774
Vitalis, Z.: P1252, P1253, P1254
Vitek, L.: OP364, P0324, P1199
Vitek, P.: P0206
Vitolo, D.: P0789
Vitone, L.J.: OP281
Vitry, F.: P1178
Vitte, R.: P0737
Vivas, S.: P1706, P1707
Viver, J.: P0077, P1535
Viver, J.M.: OP160*
Vivinus, M.: P1102
Vlachogiannakos, J.: P0503, P1862, P2118
Vlad, A.: P0691
Vlasova, M.: P1230*
Vlavianos, P.: P1062
Vleggaar, F.P.: P0223, P0604, P1387,
P2062, P2103, P2187
Vlug, M.S.: OP471*
Voderholzer, W.: OP205, P0166
Voermans, R.: P2012
Voermans, R.P.: OP252*, P0569, P2156,
P2165, P2166
Vogel, T.: OP020*
Vogelaar, L.: P1029
Vogelsang, H.: P1066, P1771
Voiosu, M.R.: P0772
Vojtiskova, J.: P0138
Volant, A.: P1888*
Volke, F.: OP280
Voll, R.: P0687
Volonté, M.: P1863
von Arnim, U.: P1765
Von Blomberg, B.M.E.: OP001*, P0799
von Burstin, J.: OP089*
von Delius, S.: P0570, P0881
von Renteln, D.: OP150*, OP253, P2167,
P2168
von Stein, O.D.: P0357
von Stein, P.: P0357
von Werder, A.: OP089*
Vonberg, R.: P2079
Voorham, Q.J.M.: P1161, P1873
Vorisek, V.: OP380, P1544
Vorobyova, N.: P0793
Voronina, O.K.: P0109
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Vos, A.C.W.: OP159*
Vos, R.: P0133, P1838, P1844
Vossio, S.: P1910
Voudouri, T.: P0285*
Vowler, S.L.: OP399*
Voxen Hansen, V.: P1065
Vradelis, S.D.: P0571
Vray, M.: P0398
Vreugdenhil, A.: P0802
Vucelic, B.: P0327, P1329, P1825
Vukelic Markovic, M.: P0634
Vulcano, M.: P0278
Vullierme, M.: OP040, OP424, P1402
Vutuc, C.: P1154
Vyuchnova, E.: OP462*
W
Wada, Y.: OP467*, P0028, P0575, P0602,
P0946, P0951, P1311,
P1314, P2046, P2070
Wadehra, V.: P1353, P2003
Wadsworth, C.A.: P1389, P1411
Waeytens, A.: P1745
Wagner, J.: OP325*, P0294
Wagner, M.: OP227, P0990
Wagrowska-Danilewicz, M.: P0224, P1739
Wahed, M.: P1070, P1750
Wai, C.T.: P0216
Wai, R.: P0236
Waid, A.: P0971
Waitz, G.: P1725, P1726
Wajed, S.A.: P1649*, P1872, P2164
Wakabayashi, N.: P1752, P2009
Wakamura, K.: OP467*, P0602, P0946,
P0951, P1311, P1314, P2046
Wald, A.: OP455
Waldner, M.J.: OP067*
Walkden, A.: OP271
Walker, D.G.: P0281, P0282, P1030
Walker, F.: OP111
Walkup, D.: OP204
Wallace, M.: OP360, P0171, P0579, P2012
Wallace, M.B.: OP446*
Wallis, K.: OP140
Wallon, C.: OP269*
Walmsley, R.: P0820
Walsh, A.J.: P0312
Walsh, A.L.: OP389
Walsh, K.: P0474
Walsh, P.: P1166
477

InDeX of aUTHoRs
Walsh, S.: P0346, P1028
Walters, G.: OP393
Walters, J.R.F.: OP140, P0052, P0092,
P0143, P0279, P0787,
P0798, P1062, P1763
Walton, C.: P1748
Waluga, M.: P1971
Wan, A.: P1595
Wanders, A.: P1005
Wang, A.: P0810, P1628
Wang, C.: OP340, P0829, P1587,
P1961, P1966
Wang, D.: P1944
Wang, F.: P1651
Wang, H.: OP088*, P0851*, P1322
Wang, H.M.: OP361
Wang, J.: P0454, P0463*
Wang, J.J.C.: P1395
Wang, K.K.: OP446*, P0176*, P0177
Wang, L.: OP084*, P1455, P1911
Wang, R.: OP055, OP123, P0893,
P1602, P1603
Wang, S.: OP082, OP123, P1264, P1445
Wang, S.S.W.: P0845
Wang, T.: P1445
Wang, X.: OP267*, P0124, P0852,
P0963, P0994
Wang, Y.: P0756
Wang, Z.T.: P0443, P1796
Wapenaar, M.C.: OP474
Ward, C.: P1622
Ward, D.G.: P0102
Ward, M.: P0110
Ward, S.G.: P0283
Wardle, E.A.: P1327, P2059
Waring, R.: P1748
Warnecke, M.: P1877
Warren, B.: OP202
Warren, B.F.: P0312, P0571
Warren, S.: P0110
Warzecha, Z.: OP420, P0834,
P0844, P1543
Wasim Jafri, S.: P0483, P1184
Wasmuth, H.: 28
Wassell, J.: P0399
Wassenberg, L.: P0276
Watabe, H.: P2119
Watabe, K.: P0573
Watanabe, C.: OP064
Watanabe, H.: P0038, P0836
478
Watanabe, K.: P0662, P0663
Watanabe, M.: OP054*, OP105*, P0637,
P1357, P1448, P1614
Watanabe, N.: P0876, P0877, P1225
Watanabe, O.: P0331
Watanabe, S.: P1588
Watanabe, T.: P0264, P0663, P0855, P1897
Watanabe, Y.: P0418, P1313
Watari, J.: OP058, P1847
Waterhouse, C.M.: P1229
Waterloos, M.: P1920*
Waterman, A.: OP024
Watermeyer, G.: P0298, P0782
Waters, H.: OP155
Watkins, R.: P1142
Watkins, S.: P1127
Wato, M.: P2037
Watson, A.: OP068, OP482*, P0167
Watson, A.J.M.: OP103
Watson, D.: 36
Watson, J.: P1822
Watts, G.: P0716
Waye, J.: 62
Wdowiak, K.: P0159
Webb, P.M.: P0914, P1046
Weber, J.: P1126
Wedemeyer, J.: P2071, P2079
Wee, E.W.L.: P1264
Wee, T.: P0053
Wehkamp, J.: P0045, P1807, P1808
Wei, J.: P1651
Wei, W.: P0102
Wei, Y.Y.: P0373, P1103*
Weidinger, M.: OP325*, P0294
Weigt, J.: P1629
Weismüller, T.J.: P2071
Weiss, F.: OP281
Weiss, F.U.: P2136
Weiss, G.: P0964
Weiss, W.: OP365*
Weisshaupt, D.: P0376
Welbourn, R.: P0092
Weldon, M.: P0841
Welling, L.: OP240*
Wells, L.: P1151
Welting, O.: OP408*
Wen, W.: P0894, P1628
Weng, Z.J.: P1592
Wentink, M.Q.: P1163
Wermke, W.: OP205
P = poster presentation, OP = oral presentation, number only = page number

Wernersson, B.: P0926
Wesdorp, E.I.C.: P1161, P1162, P1163
Wesley, E.: P1794
West, G.: OP025*, OP051*, OP309*, P0263
West, J.: OP335*, OP411, OP443*, P1188,
P1529, P1530, P1532, P1533
West, N.J.: OP004, OP321
Westaby, D.: P1062, P1411, P1784
Westerveld, B.D.: P0352*, P0353
Westra, W.: P0163*
Westra, W.M.: P0176*, P0177
Wettstein, A.R.: P0053
Wetzke, M.: OP325*, P0294
Weusten, B.L.: OP220*
Weusten, B.L.A.M.: OP221, OP222, OP223,
OP446*, P0145
Wewer, V.: P0930
Wex, T.: OP063*, OP135, P0025, P0162,
P0180, P1576*, P1877
Weylandt, K.H.: P1157
Wheatley, T.: OP142, P0817
Whelan, K.: P0325, P1003, P1004,
P1080, P1723, P1829
Whitcomb, D.C.: OP281, P2132
White, J.: P1158
Whitehead, R.: P1748
Whitelaw, A.: P0782
Whiteman, D.C.: P0914
Whiting, C.V.: OP313
Whitman, D.C.: P1046
Wichmann, B.: P0943, P0944, P1135, P1144
Wickbom, A.: OP272, P1017
Wickramasinghe, A.R.: P1016, P1224
Wieclawek, A.: P2126
Wiedenmann, B.: OP307*, OP329*, OP441,
P0166, P1157, P1164
Wiener, C.: OP365*
Wierzchniewska-Lawska, A.: P0161*
Wieselmann, E.: P0192
Wig, J.D.: OP255*
Wijmenga, C.: OP474
Wijnhoven, B.P.L.: OP345*, OP349,
OP397*, P0910
Wikström Shemer, E.: P0531
Wild, C.P.: P0913
Wild, J.R.L.: P1433
Wildberger, J.E.: P0952
Wilde, J.C.H.: P0372
Wilder-Smith, C.H.: OP099, OP138,
P1115, 64
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Wilder-Smith, P.: OP138
Wilhelm, D.: P0570, P0881
Wilhelmsson, S.: P0790
Wilkinson, M.L.: P0622
Will, U.: OP257*
Willekens, H.: P0147
Willemse, P.: P1542
Willemse, P.J.: P0797, P1541
Willert, R.: P0640
Willert, R.P.: P2072
Williams, A.M.: OP310*, P0280
Williams, B.: P0080
Williams, E.J.: P0622
Williams, G.T.: OP122*
Williams, H.R.T.: P0281, P0282, P1030
Williams, J.: P1471
Williams, M.P.: P0803
Williams, S.: P1331
Williams, S.J.: OP434*, OP448, P0615,
P0616, P1992
Williams, V.S.L.: P1120
Wilson, D.C.: OP187*, P1036, P1663,
P1664, P1753
Wilson, M.L.: OP187*, P1663
Wilson, P.: P1785
Wind, P.: P0220
Windak, A.: P0138
Windsor, J.A.: P0670, P0819
Winkelhagen, J.: OP406
Winkens, B.: P0221*, P0775, P1304
Winqvist, O.: OP305, P1823
Winslet, M.: P0167
Winstanley, C.: P0226*
Winston, A.: P1983
Winter, H.: P0928
Winter, H.S.: P0929
Winter, J.: OP360
Wirz, A.A.: P0185
Wisedopas, N.: P0496
Wisniewska-Jarosinska, M.: P1475
Wisniewska-Jarosinska, M.A.: P0144
Wissniowski, T.T.: OP003*, OP091*, P0687
Witte, A.: P1848
Wittmann, T.: OP460, P0183, P0348,
P0375, P1740, P1766
Woghiren, O.R.: P0279
Wohl, P.: P1668, P1689
Wolf, C.: OP417*
Wolf, D.C.: P0355, P1817, P1818
Wolf, E.: OP383
479

InDeX of aUTHoRs
Wolf, L.: OP369
Wolfsen, H.: P0171
Wolfsen, H.C.: OP446*
Wolinski, A.: P1429
Wölnerhanssen, B.K.: OP143*
Wolters, F.: OP158, P1024, P1025
Wolters, V.: P0802
Won, C.: OP452
Wondergem, M.J.: OP001*
Wong, D.C.T.: P0702
Wong, J.B.: P0173
Wong, K.H.: OP350
Wong, M.: P1536
Wong, M.C.S.: OP173, P0424, P0432
Wong, M.L.: P0216
Wong, R.K.: P1569*
Wong, R.K.M.: P0216
Wong, S.K.H.: P0702
Wong, T.: P1624, P1845
Wong, V.: OP123
Wong Kee Song, L.: OP446*
Wood, J.: P1297
Woodland, P.J.: P0389
Woodrow, S.: P1014*, P1015
Woodward, T.: P2012
Wooldrage, K.: OP075
Worden, K.: P1291
Woszczynski, M.: P0060
Wozniak-Grygiel, E.: P1971
Wright, A.: P1785
Wright, K.L.: P0283
Wright, N.: 40
Wright, N.A.W.: P2128
Wrobel, K.: P0166
Wroblewski, R.J.: OP254, OP265,
P0720, P2155
Wu, C.: OP082, OP123, OP340, P1587
Wu, C.W.: P0862
Wu, D.: P0845, P1473
Wu, E.: P0332
Wu, E.Q.: OP151, P1094, P1097
Wu, J.: P0963, P1858
Wu, J.C.Y.: OP062, P0134, P0833
Wu, J.J.: P0747
Wu, M.: OP340, P1587
Wu, R.: P1589
Wu, W.W.Z.: P1395
Wu, X.Q.: OP288*, P0112, P1874
Wultanska, D.: P0190
Wunsch, E.: P1246
480
Wylie, P.: OP370*, P1328, P1381
Wyrwicz, L.: P0060, P0861
X
Xaus, J.: P0260*
Xavier, F.E.B.: P1265
Xavier, R.: OP021*
Xiang, J.: P0869
Xiao, Y.: P0880, P0894, P1907
Xiao, Y.L.: P0884, P1609
Xie, D.: P1593
Xie, Q.: P1742
Xie, S.: P1903
Xinopoulos, D.: P0002, P2169
Xiong, L.S.: P0884, P1609
Xirouchakis, E.: P0504, P0572
Xu, F.: P1445
Xu, S.Q.: P1796
Xue, L.: OP288*, P0112, P1874
Y
Yacyshyn, B.: P1790
Yada, T.: P0178
Yadav, T.D.: OP255*
Yaghoobi, A.: P1392
Yaghoobi, M.: OP111
Yagi, K.: P1274
Yagi, N.: P0064*, P1008, P1752, P2009
Yagi, S.: P0912
Yagioka, H.: P0680, P1345, P2178
Yagüe Compadre, J.: P1566
Yahagi, N.: OP402, OP432*, OP433, P0121,
P1315, P1896, P2036, 18
Yahoo, N.: P1954
Yair, M.: P0609
Yajima, H.: P1650
Yakabi, K.: OP144, P1111
Yakar, F.: P0870
Yakoob, J.: P0054
Yakovenko, A.V.: P0505
Yakovenko, E.P.: P0505
Yamada, A.: P0271, P1313, P2119
Yamada, K.: P0480, P0489, P2029
Yamada, M.: P0464, P0480, P0489,
P0676, P2028, P2029
Yamada, S.: P1008, P1671
Yamada, T.: P0234, P0573, P1746
Yamada, Y.: P1373
Yamade, M.: P0836, P1492
Yamafuji, K.: P1459
P = poster presentation, OP = oral presentation, number only = page number

Yamagami, H.: P0663
Yamagata, T.: P0168, P1294
Yamagishi, T.: P1274
Yamaguchi, N.: OP396*, P1650
Yamaguchi, Y.: P0546, P0563, P1268, P1584
Yamai, H.: P1900
Yamaji, Y.: P1313, P2119
Yamaka, T.: P0370
Yamakawa, R.: P2031
Yamamichi, N.: P1686, P2151
Yamamoto, A.: P1795
Yamamoto, E.: OP373
Yamamoto, H.: OP208, P1463, P1588
Yamamoto, K.: OP401, OP428, P0038,
P0566, P0680, P1271, P1272,
P1273, P1274, P1345, P1643,
P2037, P2176, P2178
Yamamoto, N.: P1192, P1923*
Yamamoto, S.: P0573, P0688, P1168
Yamamoto, T.: P0005, P0358, P0359,
P0360, P1693
Yamamoto, Y.: P0465, P1476, P1900
Yamamura, A.: P2043
Yamamura, F.: OP467*, P0602, P0655,
P1311, P2046
Yamamura, H.: P0603
Yamanaka, A.: P0448
Yamanaka, Y.: P1839
Yamano, H.: OP373, P1168
Yamao, K.: OP061, P2144
Yamaoka, Y.: 51
Yamaoto, S.: P0901
Yamasaki, T.: P0574, P1192, P1847, P1923*
Yamashina, M.: P1183
Yamashita, H.: P0909, P1581
Yamashita, K.: P1588
Yamashita, N.: P1839, P2000
Yamashita, S.: OP432*, P0121
Yamashita, Y.: P1446
Yamatsuji, T.: P1638
Yamatuji, T.: OP401
Yamazaki, K.: OP007, OP010, P0490,
P1646, P1690, P1691
Yamazaki, S.: P1284
Yan, X.: OP055, P0893, P1602, P1603
Yanaoka, K.: P0040, P1262, P1614,
P1996, P2035
Yane, K.: P1447
Yang, B.J.: P0537
Yang, C.: P0845, P1202, P1617
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Yang, D.: P0237, P1123
Yang, D.H.: OP477*
Yang, G.: P1298
Yang, H.: OP093, P0747
Yang, K.Y.: P0522
Yang, L.: P0880, P1651, P1907
Yang, Q.: OP456, P1455
Yang, R.: P0475, P1906
Yang, S.: OP367, P0237, P0433,
P1123, P1460
Yang, S.H.: P1263
Yang, S.K.: OP477*
Yang, S.S.K.: P0313
Yang, X.: P0994
Yang, X.S.: P0373
Yano, T.: OP208, P0099, P0947, P1463
Yano, Y.: P1251
Yao, D.: P1903
Yao, J.: P1903
Yao, W.: OP088*
Yao, W.Y.: P1390*
Yasaka, T.: P0534
Yasar, N.: OP124, P0017, P0266,
P0470, P0748, P1787
Yaschenko, A.: P1554
Yashima, Y.: P1345, P2178
Yashui, S.: P0876, P0877
Yassin, K.: P2064
Yasuda, H.: OP480
Yasuda, M.: P0689
Yasuda, Y.: P0959
Yatabe, Y.: OP061
Yates, Z.: P0236
Yavzori, M.: OP330
Yazbek-Hanna, M.: P1534
Ychou, M.: P2137
Ye, B.: P0237, P1123, P1460
Ye, B.D.: OP477*
Ye, G.: P1455, P1911
Ye, W.: P0842, P0963
Yea, C.: OP452
Yeh, D.: P1589
Yeh, H.: P1589
Yela, C.: P0780
Yemelyanenko, V.: P0835
Yenigun, M.: OP363
Yeoh, K.G.: OP440*, P0216, P1594
Yeom, H.: P0049
Yeon, J.E.: P0125, P0535, P1136, P1235
Yeruva, S.: P1740
481

InDeX of aUTHoRs
Yeung, R.: P0114, P0150
Yi, S.: P0049, P0984
Yilmaz, F.: OP363
Yilmaz, M.: P0776
Yilmaz, Y.: P1230*, P1231, P1984
Yim, H.J.: P1235
Yim, J.: P0433
Yin, X.: P0412
Ylstra, B.: P1142, P1146*, P1147, P1871
Ymaguchi, I.: OP169
Yoda, A.: P1109
Yoda, Y.: P0947, P1266
Yogendra, A.: P0219, P1048, P1049
Yokobori, T.: P1149
Yokoe, T.: OP480, P1149
Yokoi, K.: P0234, P0911, P1577
Yokoi, T.: OP061
Yokosawa, S.: OP444*
Yokosuka, O.: P0137, P0795, P1075
Yokoyama, A.: OP072*, P0545,
P0575, P0655
Yokoyama, J.: OP346, P1644
Yokoyama, K.: P1459
Yokoyama, T.: OP454, P1113
Yokoyama, Y.: OP201, P0284,
P0987, P1869*
Yonal, O.: P1861, P1955
Yoneda, M.: OP130*, P1204
Yonemura, J.: P0561, P1581
Yonezawa, J.: P1501
Yoo, K.: P0049, P0984
Yoo, K.S.: P1895
Yoon, B.: P0244
Yoon, H.A.: P0093
Yoon, J.: P0361, P1913
Yoon, K.W.: P0217
Yoon, S.: P0237, P1123
Yoon, S.M.: OP477*, P1214
Yoon, W.J.: P0434*
Yoon, Y.: P1989
Yoon, Y.B.: P0434*
Yoshida, H.: P2119
Yoshida, K.: OP201
Yoshida, M.: OP066, P1388*
Yoshida, N.: P2009
Yoshida, S.: P2035
Yoshida, T.: P1383, P1900
Yoshida, Y.: P1501
Yoshihara, M.: OP344*, P0028
Yoshikawa, K.: OP373
482
Yoshikawa, M.: P0137
Yoshikawa, R.: P0909, P1875
Yoshikawa, T.: P0064*, P0689, P1008,
P1752, P2009
Yoshimoto, H.: P0370
Yoshimura, N.: P0370, P1501
Yoshinaka, H.: OP066, P1388*
Yoshino, J.: P0688, P1466
Yoshino, K.: P2040
Yoshioka, D.: P0140*, P0561, P1581
Yoshioka, M.: P0234
Yoshioka, S.: P1109
Yoshizawa, D.: P1283, P2065
Yoshizawa, K.: P0118
Yotsuya, S.: P1313
You, D.: P1833
You, J.: P0623
Youd, P.: P2027
Youn, J.: P1010
Youn, S.J.: P0390
Youn, Y.: P0623, P1855
Young, G.: 62
Young, I.R.: P1389
Youssef, H.: P1297
Yu, A.: P0332
Yu, A.P.: OP151, P1094, P1097
Yu, J.: OP082, OP123, OP267*,
P0124, P1874
Yu, L.: OP109*, P1590
Yu, L.F.: P0443, P1796
Yu, W.: P0411
Yuan, F.: OP088*
Yuan, Y.: OP088*, P0888, P0889
Yuan, Y.Z.: P1390*
Yuasa, Y.: P1900
Yudin, O.I.: P0643
Yun, K.: P0101
Yun, S.U.: P0245, P2061
Yun, S.Y.: P0245, P1263, P2061
Yusupbekov, A.: P0116
Yuzurihara, M.: P1111
Z
Zaanan, A.: OP295
Zabalza, M.: P1385
Zabana, Y.: P0288, P1082, P1751
Zabel, K.: P1827
Zabeo, E.: P1878
Zachariah, K.: P1361, P2100
Zacharias, R.: OP249
P = poster presentation, OP = oral presentation, number only = page number

Zagainov, V.: P1993
Zagainova, E.: P1993
Zagozda, M.: OP422
Zahmatkeshan, M.: P0194
Zak, A.: P1413
Zakhari, S.: 23
Zakrevskaya, E.: P1270
Zali, M.: P1041
Zalis, M.E.: P1384
Zalonis, A.: P1468, P2116
Zamani, F.: P1969, P1985
Zambeli, E.: P0979
Zamfirescu, A.: P0927
Zamharir, R.: P0713
Zamini, H.: OP302, P1954
Zampetti, A.: P0197
Zanaboni, A.: P0075
Zandi, A.: P1392
Zanette, G.: P1987
Zanini, A.: P0339, P1821
Zanini, B.: P0804, P0805, P0806,
P0807, P0808, P1986
Zanini, N.: P2145
Zanvit, P.: P1737
Zapata, E.: P0473, P1200
Zapletalová, J.: P1436
Zappa, M.: OP165
Zar, S.: P1057, P1513
Zarate, N.: P0980
Zarski, J.: P1336
Zarzuelo, A.: P0260*, P1735, P1736, P1743
Zavada, F.: P0840
Zavala-Solares, M.R.: P0506*
Zavoral, M.: OP481*, P0840
Zavos, C.: P0285*
Zavyalov, D.: OP375*, P1270
Zayachkivska, O.: P0104*, P1554
Zeanandin, G.: P0821, P0822
Zeef, L.A.H.: P0993
Zehetner, J.: OP345*
Zeitoun, J.: OP111
Zeki, S.S.: P0444, P2154
Zelinkova, Z.: P1029
Zeman, K.: P0286
Zeman, M.: P1413
Zendehbad, A.: OP394*
Zeng, Z.: P1906, P1907
Zeng, Z.R.: OP288*, P0112, P1874
Zentilin, P.: P0169, P0170, P0184
Zerbi, A.: OP258*
P = poster presentation, OP = oral presentation, number only = page number
InDeX of aUTHoRs
Zerbib, F.: OP029, P1428, P1611, P1612
Zeromski, J.: P0044
Zevallos, V.F.: P0809
Zevit, N.: P0022, P1528
Zezos, P.: P0181
Zhang, C.: OP395*, OP399*
Zhang, D.: P1742
Zhang, G.: P1591
Zhang, H.: P1039, P1040
Zhang, J.: P0124
Zhang, L.: P0810
Zhang, S.D.: P0536*
Zhang, S.H.: P1592
Zhang, W.: P1455
Zhang, X.: OP092, P1455, P1903
Zhang, Y.: OP084*
Zhang, Y.P.: P1390*
Zhang, Z.: P1591
Zhao, J.: P0073, P1944
Zhao, L.: P0227, P0851*
Zhao, Y.: OP055, P0893, P1602, P1603
Zhao, Z.: P1046
Zheng, H.M.: P1915
Zheng, W.: P0227
Zhernakova, A.: OP474
Zhigalin, A.: OP265, P2155
Zhong, B.H.: P1592
Zhong, J.: P0443, P1796
Zhou, L.: OP312*
Zhu, F.: P1594
Zhu, H.: P1636, P1911
Zhu, L.: OP084*
Zhu, Q.: OP088*, P1799
Zhu, S.: P1593
Zhuang, Z.: P1651
Zhukov, A.G.: P1916
Zielinski, D.: P1153
Zihler, A.: OP388*, P1497*
Zimmer, K.: P1730
Zimmerman, J.: P1864
Zivny, P.: OP380
Zjacic-Rotkvic, V.: OP087*
Zocco, M.: P1797
Zocco, M.A.: P1220
Zoco, M.: P1997*
Zollner, G.: OP227
Zondervan, P.E.: P0528
Zopf, Y.: P0477
Zorn, A.: P2111
Zorzi, F.: OP334, P1379, P1777
483

InDeX of aUTHoRs
Zotti, G.: P0905, P0906
Zou, D.: OP055, P0893, P1602, P1603
Zouari, B.: P1951*
Zouiten, L.: P1618, P1619, P1620
Zoulim, F.: P1219
Zoumbouli-Vafiadi, I.: P0503, P1719
Zsigmond, F.: P0320
Zubek, L.: P0649
Zubiaurre, L.: P1200
Zubkiewicz-Kucharska, A.: P0442
Zucca, E.: P0027
Zucoloto, S.: P0511, P0512, P1202
Zuithoff, N.P.A.: P1610
Zullo, A.: OP060, P0593, P0766
Zulquernain, S.A.: P0749
Zunder, S.S.M.: P1067
Zurita, M.: P1255
Zurstrassen, M.P.: P2076
Zvenigorodskaya, L.A.: P1208
Zwaginga, J.: OP047*
Zwart, C.: OP167*, P1320
Zwirska-Korczala, K.: P1391, P1971
Zwolak, A.: P0106
Zwolinska-Wcislo, M.: P0055,
P0295, P1798
484
P = poster presentation, OP = oral presentation, number only = page number

LIST OF
EXHIBITORS

ausklappb
(extra Do

are seiten
kument)

H
Hitachi Medical Systems Europe
Holding AG 51
I
Imedex – WCGI –
World Congress of GI Cancer I
Immersion 94
Immundiagnostik AG 6
Infai GmbH 31
Institut Rosell – L‘Allemand 40
IntroMedic 65
Inverness Medical 72
k
KARL STORZ GmbH & Co KG 27B
l
Leufen Medical OHG 32
Life Partners Europe 38
Lumenis (Germany) GmbH 92
M
M.I. Tech Co., Ltd. 38
Mauna Kea Technologies 21
Mayoly Spindler 12
Medical Innovations 46
Medical Measurement Systems b.v. 52
Medi-Globe GmbH 45
Meditheque Bookshop 13
medwork medical products and
services GmbH 35
Micro-Tech (Nanjing) Co., Ltd. 25
Movetis NV 73
MTW EndoskopIE IE 57
n
NDS Surgical Imaging 23
New Zealand Society of Gastro-
enterology F
NHS Evidence – gastroenterology
and liver diseases 30
Norgine Limited 54
o
Olympus 59
OMED – World Organisation
of Digestive Endoscopy OMED
Omnimed Limited 88
Otsuka Pharmaceutical Europe Ltd. 7
Ovesco Endoscopy AG 5
P
Pentax Europe GmbH 48
Peter Pflugbeil GmbH 49
Pharmacosmos A/S 28
Procter and Gamble Pharma-
ceuticals UK Ltd 78
Q
Quintron Instrument Co. 10
R
Reckitt Benckiser 74
Rome Foundation E
s
S. Karger AG 17
Sandhill Scientific 29
Satiety Inc. 91
Schering-Plough 20
Shire Pharmaceuticals Group PLC. 55
Sierra Scientific Instruments 34B
Spirus Medical Inc. 70
Sterilox Endoscopy – A division
of PuriCore International Ltd. 26
T
Taewoong Medical 27A
Tillotts Pharma AG 69
U
UEGF – United European Gastro-
enterology Federation UEGF
Up to Date 95
US Endoscopy 89
V
Vifor Pharma 66
W
Wagner Analysen Technick GmbH 18
WGO – World Gastroenterology
Organisation WGO
Wiley-Blackwell 62
Wisepress Ltd 14
(as per September, 2009)

PLANS
OF EXCEL
LONDON

flooR Plan scIenTIfIc coRe PRoGRaMMe & lUncH sessIons
490

flooR Plan scIenTIfIc coRe PRoGRaMMe & lUncH sessIons
491

flooR Plan GI nURses 2009 esGena/sIGnea
492

flooR Plan GI nURses 2009 esGena/sIGnea
493

flooR Plan PGT
494

flooR Plan PUblIc HealTH DaY
495

NOTES: